data_2opv_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2opv _Structure_validation_residue.Date_analyzed 2016-10-08 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 18' ' ' THR . . . . . 0.477 ' OG1' ' HG3' ' A' ' 73' ' ' PRO . 96.5 m . . . . . 0 N--CA 1.452 -0.354 0 N-CA-C 110.146 -0.316 . . . . 0.0 110.146 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 74.7 t -113.09 127.19 70.48 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.618 -178.595 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . 0.616 ' HG2' ' HB2' ' A' ' 80' ' ' CYS . 29.5 tp60 -111.84 112.74 24.63 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 109.43 -0.582 . . . . 0.0 109.43 176.863 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . 0.581 ' HA ' ' O ' ' A' ' 67' ' ' LEU . 12.1 mt-10 -98.53 119.26 36.93 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.369 0.604 . . . . 0.0 112.305 179.257 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 10.1 mm -114.37 150.5 16.35 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 115.185 -0.916 . . . . 0.0 109.44 177.685 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 94.0 mmm -111.53 103.83 12.19 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 172.93 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.624 HG23 HD22 ' A' ' 87' ' ' LEU . 9.3 mm -84.88 125.3 71.14 Favored Pre-proline 0 C--N 1.316 -0.88 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.952 -173.301 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_exo -50.2 139.06 36.13 Favored 'Trans proline' 0 C--N 1.346 0.441 0 C-N-CA 122.904 2.402 . . . . 0.0 112.379 176.566 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -42.41 -57.15 2.72 Favored 'General case' 0 N--CA 1.465 0.287 0 N-CA-C 113.316 0.858 . . . . 0.0 113.316 -173.716 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -90.18 -26.71 23.01 Favored Glycine 0 N--CA 1.453 -0.199 0 C-N-CA 120.679 -0.772 . . . . 0.0 113.069 -174.473 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 45.0 tttp -78.99 -4.56 50.61 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.192 0.52 . . . . 0.0 110.128 179.773 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . 0.501 ' HA ' HG21 ' A' ' 24' ' ' ILE . . . -63.64 -22.93 67.16 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.658 174.844 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -58.39 -25.7 58.19 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 121.073 -0.584 . . . . 0.0 112.134 178.292 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.401 HD12 HG23 ' A' ' 86' ' ' ILE . 63.2 mt -75.97 -45.78 33.08 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.779 0.323 . . . . 0.0 110.855 179.425 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.425 HG12 ' O ' ' A' ' 29' ' ' ALA . 1.4 p -72.02 -32.13 42.77 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.474 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.973 -177.369 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 74.2 mt -78.33 -42.18 26.5 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-O 121.761 0.791 . . . . 0.0 109.772 176.661 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . 0.421 ' HA3' ' HB ' ' A' ' 39' ' ' THR . . . 101.29 51.53 1.13 Allowed Glycine 0 N--CA 1.441 -1.025 0 CA-C-N 115.272 -0.876 . . . . 0.0 112.974 175.529 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.439 ' HD2' ' N ' ' A' ' 35' ' ' LYS . 0.4 OUTLIER 50.68 40.5 24.24 Favored 'General case' 0 C--N 1.329 -0.295 0 O-C-N 124.319 0.658 . . . . 0.0 111.96 173.719 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 133.73 -27.06 3.39 Favored Glycine 0 N--CA 1.449 -0.482 0 C-N-CA 120.653 -0.784 . . . . 0.0 111.94 179.604 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 129.78 22.47 1.15 Allowed Glycine 0 N--CA 1.449 -0.451 0 C-N-CA 120.173 -1.013 . . . . 0.0 113.079 178.524 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . 0.595 ' HG3' HE21 ' A' ' 42' ' ' GLN . 4.5 tp10 -84.53 -54.09 4.98 Favored 'General case' 0 C--N 1.321 -0.648 0 O-C-N 122.296 -0.531 . . . . 0.0 110.119 178.694 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' THR . . . . . 0.674 ' O ' ' HG ' ' A' ' 43' ' ' LEU . 63.0 m -56.21 -44.58 79.63 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.53 -0.759 . . . . 0.0 111.821 -179.405 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 8.9 tt -58.51 -37.79 66.61 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.406 0 CA-C-O 120.596 0.236 . . . . 0.0 111.604 -178.416 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 33.5 mtmm -66.24 -38.65 88.39 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.358 0.599 . . . . 0.0 110.172 178.02 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . 0.595 HE21 ' HG3' ' A' ' 38' ' ' GLU . 68.7 mt-30 -66.07 -45.96 79.44 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.279 178.755 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.674 ' HG ' ' O ' ' A' ' 39' ' ' THR . 89.6 mt -53.47 -46.7 70.05 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.428 -0.805 . . . . 0.0 112.032 -175.609 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 46.9 mt-30 -64.52 -43.36 94.29 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.484 -177.302 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 9.3 mm-40 -81.12 -35.6 31.38 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 112.052 0.39 . . . . 0.0 112.052 -174.261 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 14.8 ptm180 -66.76 -35.28 79.73 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-O 120.735 0.302 . . . . 0.0 111.477 -176.7 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . 0.431 ' HB2' HG21 ' A' ' 49' ' ' VAL . . . -100.65 -12.13 19.43 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.889 0.376 . . . . 0.0 111.577 -177.128 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 71.73 37.93 61.21 Favored Glycine 0 N--CA 1.449 -0.492 0 C-N-CA 120.812 -0.709 . . . . 0.0 111.961 -178.004 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.431 HG21 ' HB2' ' A' ' 47' ' ' ALA . 28.5 m -129.15 178.56 4.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-O 120.761 0.315 . . . . 0.0 110.16 -177.775 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 64.3 tttp -120.75 124.66 45.66 Favored 'General case' 0 C--N 1.319 -0.726 0 C-N-CA 120.662 -0.415 . . . . 0.0 110.214 173.069 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' MET . . . . . 0.567 ' CE ' ' HB3' ' A' ' 79' ' ' ALA . 63.7 mtt -113.94 115.62 27.95 Favored 'General case' 0 C--N 1.319 -0.749 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 176.751 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.524 ' CG2' ' HB2' ' A' ' 68' ' ' ARG . 10.5 tt -99.29 104.77 16.46 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.741 0 CA-C-O 121.772 0.796 . . . . 0.0 110.059 176.91 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.709 HD22 HD12 ' A' ' 67' ' ' LEU . 3.8 mm? -87.53 104.4 16.45 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.053 -0.976 . . . . 0.0 109.26 176.02 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.77 HD11 ' HB2' ' A' ' 66' ' ' PRO . 61.0 mt -72.74 86.56 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-O 121.852 0.834 . . . . 0.0 109.663 178.369 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 52.4 mt-30 . . . . . 0 C--N 1.323 -0.552 0 CA-C-N 114.637 -1.165 . . . . 0.0 109.645 -177.628 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . 0.448 ' HA ' ' O ' ' A' ' 24' ' ' ILE . 1.8 m-20 . . . . . 0 N--CA 1.463 0.191 0 CA-C-O 120.68 0.276 . . . . 0.0 111.363 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . 0.498 ' HA ' ' HD3' ' A' ' 66' ' ' PRO . 39.2 mmtm -110.85 131.39 22.15 Favored Pre-proline 0 C--N 1.327 -0.398 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.659 -175.203 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . 0.77 ' HB2' HD11 ' A' ' 54' ' ' ILE . 10.6 Cg_exo -75.33 111.4 3.3 Favored 'Trans proline' 0 N--CA 1.46 -0.467 0 C-N-CA 123.476 2.784 . . . . 0.0 111.86 176.013 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.709 HD12 HD22 ' A' ' 53' ' ' LEU . 17.8 tp -112.4 120.72 42.64 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.528 177.439 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . 0.524 ' HB2' ' CG2' ' A' ' 52' ' ' ILE . 68.4 mtt180 -111.47 111.72 22.95 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 120.99 0.424 . . . . 0.0 110.651 174.445 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . 0.462 ' HB ' ' HB3' ' A' ' 20' ' ' GLN . 46.9 mt -91.27 112.06 24.76 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 N-CA-C 108.909 -0.774 . . . . 0.0 108.909 173.914 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 13.2 mt -113.85 129.42 69.78 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.739 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.056 -172.562 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 153.42 -140.92 7.91 Favored Glycine 0 N--CA 1.448 -0.518 0 C-N-CA 120.458 -0.877 . . . . 0.0 113.32 173.89 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . 0.519 ' HB3' ' CG ' ' A' ' 75' ' ' LYS . 4.7 t70 -71.99 130.89 86.05 Favored Pre-proline 0 C--N 1.322 -0.614 0 C-N-CA 123.387 0.675 . . . . 0.0 111.126 -176.997 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . 0.477 ' HG3' ' OG1' ' A' ' 18' ' ' THR . 26.8 Cg_exo -57.98 -26.53 75.27 Favored 'Trans proline' 0 C--N 1.35 0.622 0 C-N-CA 123.556 2.838 . . . . 0.0 113.352 -172.027 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 24.1 t80 -79.06 -47.61 15.88 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.156 -0.474 . . . . 0.0 109.873 -176.191 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . 0.519 ' CG ' ' HB3' ' A' ' 72' ' ' ASP . 9.1 ptpt -80.51 -26.61 38.05 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 120.867 -0.333 . . . . 0.0 111.611 178.81 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 24.6 t -60.69 -40.13 83.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-O 120.7 0.286 . . . . 0.0 110.246 173.954 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 2.0 mm100 -73.97 -41.2 62.31 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 120.637 -0.425 . . . . 0.0 110.972 179.472 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 49.6 mt-30 -63.09 -39.07 93.62 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 120.898 0.38 . . . . 0.0 110.251 177.431 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . 0.592 ' HA ' ' HE3' ' A' ' 82' ' ' MET . . . -71.65 -35.34 70.33 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.718 178.5 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' CYS . . . . . 0.616 ' HB2' ' HG2' ' A' ' 20' ' ' GLN . 36.5 t -63.45 -54.09 41.9 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.123 175.245 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 52.5 mt-10 -65.2 -20.66 66.54 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.403 178.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' MET . . . . . 0.592 ' HE3' ' HA ' ' A' ' 79' ' ' ALA . 31.5 ttm -69.48 -55.98 8.71 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.425 -0.807 . . . . 0.0 110.403 176.417 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 32.9 m -79.42 -29.59 13.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.915 -175.453 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' MET . . . . . 0.47 ' O ' ' HG2' ' A' ' 88' ' ' ARG . 56.9 ttp -71.48 -28.94 64.28 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 109.75 -0.463 . . . . 0.0 109.75 178.392 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . 0.474 ' O ' ' HB2' ' A' ' 89' ' ' GLU . 19.0 t70 -62.62 -47.94 81.57 Favored 'General case' 0 CA--C 1.517 -0.29 0 N-CA-C 109.968 -0.382 . . . . 0.0 109.968 175.133 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.401 HG23 HD12 ' A' ' 31' ' ' LEU . 20.3 mt -60.22 -32.45 50.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 121.659 0.742 . . . . 0.0 110.276 177.738 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.624 HD22 HG23 ' A' ' 24' ' ' ILE . 1.0 OUTLIER -81.8 -17.52 47.26 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.389 -0.823 . . . . 0.0 111.57 -176.738 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . 0.47 ' HG2' ' O ' ' A' ' 84' ' ' MET . 23.3 mmm180 -102.86 5.94 38.88 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 121.546 0.689 . . . . 0.0 109.322 174.153 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . 0.474 ' HB2' ' O ' ' A' ' 85' ' ' ASP . 2.1 tm-20 . . . . . 0 C--O 1.25 1.125 0 CA-C-N 114.749 -1.114 . . . . 0.0 108.884 -177.968 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' THR . . . . . 0.518 ' OG1' ' HG3' ' A' ' 73' ' ' PRO . 74.6 m . . . . . 0 N--CA 1.453 -0.29 0 CA-C-O 120.996 0.427 . . . . 0.0 111.129 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.48 HG22 HG22 ' A' ' 70' ' ' ILE . 61.6 t -124.71 120.19 58.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.61 179.251 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 14.2 mm100 -101.17 114.03 27.61 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.983 -0.553 . . . . 0.0 109.539 174.682 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . 0.564 ' HA ' ' O ' ' A' ' 67' ' ' LEU . 37.4 mt-10 -93.69 107.58 19.43 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.283 0.564 . . . . 0.0 110.729 176.065 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 19.0 mm -102.41 148.67 7.56 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.723 0 CA-C-N 115.359 -0.837 . . . . 0.0 109.802 -178.509 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' MET . . . . . 0.478 ' HB3' ' HB3' ' A' ' 64' ' ' ASP . 1.5 mmt -99.87 101.98 13.27 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 108.609 -0.885 . . . . 0.0 108.609 175.428 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.673 ' HB ' ' HB2' ' A' ' 65' ' ' LYS . 44.3 mm -88.66 126.06 61.06 Favored Pre-proline 0 C--N 1.319 -0.733 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.996 -175.38 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . 0.563 ' HB2' ' HB3' ' A' ' 28' ' ' LYS . 95.7 Cg_exo -45.1 132.91 11.41 Favored 'Trans proline' 0 C--N 1.343 0.278 0 C-N-CA 123.423 2.749 . . . . 0.0 112.541 179.564 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -61.82 -38.65 88.96 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 115.511 -0.768 . . . . 0.0 112.954 -168.501 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -89.37 -35.89 7.78 Favored Glycine 0 N--CA 1.449 -0.496 0 C-N-CA 120.404 -0.903 . . . . 0.0 111.837 -178.596 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . 0.563 ' HB3' ' HB2' ' A' ' 25' ' ' PRO . 28.6 ttpt -80.47 -0.62 38.12 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 121.201 0.524 . . . . 0.0 110.77 -178.721 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . 0.515 ' O ' HG12 ' A' ' 32' ' ' VAL . . . -62.83 -20.14 64.78 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.132 177.667 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -57.66 -33.09 66.35 Favored Glycine 0 N--CA 1.448 -0.541 0 C-N-CA 120.792 -0.718 . . . . 0.0 111.885 177.04 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 99.0 mt -77.57 -36.2 52.27 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.643 0.259 . . . . 0.0 111.289 -178.767 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.515 HG12 ' O ' ' A' ' 29' ' ' ALA . 0.5 OUTLIER -70.57 -30.28 41.86 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.326 0 CA-C-O 121.16 0.505 . . . . 0.0 110.768 -178.37 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 71.0 mt -89.39 -38.78 11.7 Favored 'Isoleucine or valine' 0 C--O 1.236 0.388 0 CA-C-N 115.76 -0.654 . . . . 0.0 110.537 178.743 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 105.08 25.0 6.94 Favored Glycine 0 CA--C 1.502 -0.723 0 CA-C-N 115.605 -0.725 . . . . 0.0 112.611 178.57 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 53.6 mtpt 60.87 21.51 11.69 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.316 -0.442 . . . . 0.0 111.327 177.258 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -176.59 -45.7 0.06 OUTLIER Glycine 0 N--CA 1.448 -0.504 0 N-CA-C 111.696 -0.562 . . . . 0.0 111.696 -178.31 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 125.73 7.57 5.59 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.355 -0.926 . . . . 0.0 113.024 176.692 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -85.51 -32.91 21.96 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 120.84 0.352 . . . . 0.0 111.162 178.561 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' THR . . . . . 0.578 ' O ' ' HG ' ' A' ' 43' ' ' LEU . 60.7 m -65.0 -48.18 74.84 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.97 -179.573 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.737 HD11 HD22 ' A' ' 53' ' ' LEU . 1.9 tt -57.18 -38.58 62.05 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-O 120.748 0.309 . . . . 0.0 111.167 178.463 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 4.6 tmmm? -60.97 -40.76 94.62 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 109.57 -0.53 . . . . 0.0 109.57 178.689 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . 0.501 ' O ' ' HG2' ' A' ' 46' ' ' ARG . 49.5 mt-30 -70.32 -37.82 74.79 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.614 -179.851 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.685 HD11 HG11 ' A' ' 83' ' ' VAL . 75.0 mt -58.03 -35.95 72.01 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.678 179.075 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . 0.558 ' HG3' ' O ' ' A' ' 40' ' ' ILE . 68.2 mt-30 -66.57 -47.72 71.89 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.42 178.223 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -64.83 -48.58 73.86 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.694 -0.685 . . . . 0.0 111.195 -177.573 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . 0.501 ' HG2' ' O ' ' A' ' 42' ' ' GLN . 17.5 ptm180 -70.79 -23.66 62.42 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.169 -0.469 . . . . 0.0 112.201 -174.224 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . 0.556 ' HB1' ' HE2' ' A' ' 82' ' ' MET . . . -93.13 -29.14 15.91 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.818 0.342 . . . . 0.0 111.093 178.745 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 87.88 26.41 29.33 Favored Glycine 0 N--CA 1.452 -0.25 0 C-N-CA 121.014 -0.612 . . . . 0.0 112.56 -179.062 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 5.1 m -140.08 179.87 2.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-O 120.876 0.369 . . . . 0.0 110.592 -178.801 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 81.1 tttt -110.8 124.66 52.45 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.238 178.531 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' MET . . . . . 0.563 ' HE3' HG13 ' A' ' 83' ' ' VAL . 17.9 mtm -117.2 116.62 27.63 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 109.821 -0.437 . . . . 0.0 109.821 176.661 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.61 ' CG2' ' HB2' ' A' ' 68' ' ' ARG . 10.8 tt -102.0 113.2 37.7 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.727 0 CA-C-O 121.43 0.633 . . . . 0.0 110.762 178.426 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.853 HD21 HD13 ' A' ' 67' ' ' LEU . 1.3 mm? -88.07 107.52 18.79 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.41 -0.814 . . . . 0.0 109.311 175.906 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.622 HD11 ' HB2' ' A' ' 66' ' ' PRO . 58.4 mt -79.84 84.65 1.25 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.575 0 CA-C-O 122.248 1.023 . . . . 0.0 110.323 179.151 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 2.5 pt20 . . . . . 0 C--N 1.318 -0.802 0 CA-C-N 114.006 -1.452 . . . . 0.0 107.677 167.712 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . 0.478 ' HB3' ' HB3' ' A' ' 23' ' ' MET . 7.3 m-20 . . . . . 0 N--CA 1.457 -0.104 0 CA-C-O 120.931 0.396 . . . . 0.0 110.155 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . 0.673 ' HB2' ' HB ' ' A' ' 24' ' ' ILE . 65.7 mmtt -88.38 134.0 35.4 Favored Pre-proline 0 C--N 1.318 -0.768 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.904 -169.101 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . 0.622 ' HB2' HD11 ' A' ' 54' ' ' ILE . 16.4 Cg_exo -70.86 104.95 1.57 Allowed 'Trans proline' 0 N--CA 1.456 -0.686 0 C-N-CA 122.744 2.296 . . . . 0.0 111.137 172.49 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.853 HD13 HD21 ' A' ' 53' ' ' LEU . 18.9 tp -110.54 118.06 35.22 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.129 178.26 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . 0.61 ' HB2' ' CG2' ' A' ' 52' ' ' ILE . 68.9 mtt180 -108.98 106.36 16.28 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.503 177.345 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . 0.617 HG21 HG22 ' A' ' 76' ' ' VAL . 4.3 mp -87.13 109.49 19.31 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 N-CA-C 107.962 -1.125 . . . . 0.0 107.962 171.163 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.48 HG22 HG22 ' A' ' 19' ' ' VAL . 33.7 mt -110.23 128.37 66.5 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.73 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.979 -171.635 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 150.28 -123.93 1.65 Allowed Glycine 0 N--CA 1.444 -0.798 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.42 173.173 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . 0.587 ' OD2' ' HG2' ' A' ' 75' ' ' LYS . 2.8 t70 -84.26 129.84 56.56 Favored Pre-proline 0 C--N 1.32 -0.705 0 CA-C-N 115.479 -0.361 . . . . 0.0 111.298 -177.333 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . 0.518 ' HG3' ' OG1' ' A' ' 18' ' ' THR . 53.2 Cg_exo -48.22 -27.79 10.07 Favored 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 123.805 3.003 . . . . 0.0 113.56 -178.924 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . 0.536 ' HB3' ' OD2' ' A' ' 72' ' ' ASP . 44.9 t80 -82.75 -60.06 2.3 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.519 -0.31 . . . . 0.0 110.733 -175.987 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . 0.587 ' HG2' ' OD2' ' A' ' 72' ' ' ASP . 12.8 pttt -72.84 -17.46 61.55 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 112.115 0.413 . . . . 0.0 112.115 179.438 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.617 HG22 HG21 ' A' ' 69' ' ' ILE . 12.4 t -69.02 -38.48 78.46 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 N-CA-C 109.106 -0.701 . . . . 0.0 109.106 171.162 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . 0.412 ' O ' ' HG3' ' A' ' 81' ' ' GLU . 22.5 tp60 -74.02 -42.33 60.48 Favored 'General case' 0 N--CA 1.448 -0.528 0 CA-C-N 115.657 -0.701 . . . . 0.0 109.495 177.519 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . 0.488 ' HB2' ' HA ' ' A' ' 75' ' ' LYS . 51.2 mt-30 -56.01 -51.4 67.9 Favored 'General case' 0 C--O 1.223 -0.332 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.398 174.865 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . 0.756 ' HA ' ' HE3' ' A' ' 82' ' ' MET . . . -60.94 -40.13 92.09 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.925 179.201 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 22.6 t -59.54 -54.37 47.33 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.846 -0.615 . . . . 0.0 111.252 177.717 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . 0.412 ' HG3' ' O ' ' A' ' 77' ' ' GLN . 2.3 pp20? -70.77 -25.02 62.71 Favored 'General case' 0 C--O 1.217 -0.642 0 C-N-CA 120.221 -0.592 . . . . 0.0 110.493 -179.334 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' MET . . . . . 0.756 ' HE3' ' HA ' ' A' ' 79' ' ' ALA . 34.8 ttp -67.35 -48.81 66.38 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.578 -0.283 . . . . 0.0 110.878 177.333 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . 0.685 HG11 HD11 ' A' ' 43' ' ' LEU . 33.0 m -74.18 -36.59 44.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 C-N-CA 120.943 -0.303 . . . . 0.0 110.992 -179.766 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 89.2 mtp -71.14 -27.38 63.53 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 110.198 -0.297 . . . . 0.0 110.198 177.607 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . 0.41 ' HB2' ' O ' ' A' ' 81' ' ' GLU . 30.0 t70 -63.4 -40.85 98.34 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.276 175.139 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.498 HG13 ' O ' ' A' ' 82' ' ' MET . 52.2 mt -63.06 -33.09 58.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.734 177.711 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.556 HD23 ' HG2' ' A' ' 28' ' ' LYS . 69.2 mt -86.01 -21.81 27.61 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.789 -174.332 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 39.5 ptt180 -95.93 -2.99 46.01 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.122 0.487 . . . . 0.0 110.682 -178.814 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.249 1.047 0 CA-C-O 118.434 -0.793 . . . . 0.0 109.671 -174.678 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' THR . . . . . 0.592 ' OG1' ' HG3' ' A' ' 73' ' ' PRO . 85.4 m . . . . . 0 N--CA 1.45 -0.437 0 CA-C-O 121.028 0.442 . . . . 0.0 110.461 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.61 ' HA ' ' O ' ' A' ' 69' ' ' ILE . 3.2 p -130.18 129.02 65.09 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.829 -179.837 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 67.6 mt-30 -105.07 119.49 39.15 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.529 177.962 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . 0.742 ' HA ' ' O ' ' A' ' 67' ' ' LEU . 28.8 mt-10 -92.64 108.77 20.23 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.614 -0.721 . . . . 0.0 110.341 175.022 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 22.0 mm -107.28 142.9 18.91 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 CA-C-N 115.55 -0.75 . . . . 0.0 109.422 -179.592 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 90.5 mmm -103.56 92.74 4.59 Favored 'General case' 0 N--CA 1.447 -0.6 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 179.099 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.654 ' HB ' ' HB2' ' A' ' 65' ' ' LYS . 25.5 mm -77.6 128.14 80.62 Favored Pre-proline 0 C--N 1.317 -0.84 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.457 -174.622 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_exo -48.1 133.12 23.71 Favored 'Trans proline' 0 N--CA 1.462 -0.366 0 C-N-CA 122.626 2.217 . . . . 0.0 111.453 175.773 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -44.66 -56.17 4.62 Favored 'General case' 0 C--N 1.328 -0.341 0 O-C-N 124.023 0.827 . . . . 0.0 112.824 -171.536 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -79.31 -12.6 83.72 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.875 -0.679 . . . . 0.0 113.02 -175.425 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . 0.421 ' HD3' ' HB3' ' A' ' 87' ' ' LEU . 19.6 ttmm -88.14 8.91 24.67 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.328 0.585 . . . . 0.0 110.522 -175.864 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . 0.526 ' HB1' ' HZ1' ' A' ' 65' ' ' LYS . . . -66.18 -20.82 66.25 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.061 179.224 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -63.86 -16.06 58.83 Favored Glycine 0 N--CA 1.449 -0.455 0 CA-C-N 115.853 -0.612 . . . . 0.0 112.565 179.575 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.46 HD13 HG22 ' A' ' 86' ' ' ILE . 74.9 mt -94.87 -42.4 8.71 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 111.73 0.27 . . . . 0.0 111.73 -179.394 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.621 HG11 HD22 ' A' ' 87' ' ' LEU . 3.1 m -69.83 -38.21 75.28 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.21 0 CA-C-O 121.037 0.446 . . . . 0.0 111.046 178.629 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.574 ' HA ' ' HB ' ' A' ' 40' ' ' ILE . 57.0 mt -86.45 -32.7 6.77 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-O 121.705 0.764 . . . . 0.0 109.441 179.599 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . 0.492 ' HA3' ' CB ' ' A' ' 39' ' ' THR . . . 92.65 171.52 40.8 Favored Glycine 0 N--CA 1.441 -0.972 0 CA-C-N 114.923 -1.035 . . . . 0.0 112.086 178.438 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 14.5 mptt -76.77 65.77 2.57 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.104 0.478 . . . . 0.0 110.89 -179.611 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 132.92 5.28 3.15 Favored Glycine 0 C--N 1.33 0.224 0 C-N-CA 120.972 -0.632 . . . . 0.0 112.527 175.442 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.495 ' HA2' HG21 ' A' ' 33' ' ' ILE . . . 86.36 -9.2 71.26 Favored Glycine 0 N--CA 1.449 -0.487 0 C-N-CA 120.524 -0.846 . . . . 0.0 112.016 -179.12 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 55.3 mm-40 -64.33 -33.47 75.91 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.689 0.28 . . . . 0.0 111.208 -179.554 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' THR . . . . . 0.753 ' O ' ' HG ' ' A' ' 43' ' ' LEU . 32.3 m -64.62 -57.26 9.57 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.482 -0.326 . . . . 0.0 111.039 -179.839 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.587 ' HA ' HD11 ' A' ' 43' ' ' LEU . 11.0 tt -59.92 -31.74 48.29 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.391 0 CA-C-O 121.318 0.58 . . . . 0.0 110.553 -179.377 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 46.0 tttt -60.39 -50.64 72.78 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.588 -0.733 . . . . 0.0 110.822 173.751 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . 0.642 ' O ' ' HG2' ' A' ' 46' ' ' ARG . 48.2 mt-30 -67.29 -38.77 85.57 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.705 -176.321 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.753 ' HG ' ' O ' ' A' ' 39' ' ' THR . 61.4 mt -55.76 -46.18 77.94 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.397 -176.663 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 43.4 mt-30 -61.26 -34.71 75.61 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.926 -179.862 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -80.74 -45.63 16.75 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.423 -177.583 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . 0.642 ' HG2' ' O ' ' A' ' 42' ' ' GLN . 14.0 ptp180 -74.66 -43.21 56.43 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 112.753 0.649 . . . . 0.0 112.753 -173.879 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . 0.55 ' HB1' HG22 ' A' ' 49' ' ' VAL . . . -83.82 -14.72 50.63 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 112.084 0.402 . . . . 0.0 112.084 -173.508 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 72.24 24.91 75.66 Favored Glycine 0 C--N 1.329 0.17 0 C-N-CA 120.659 -0.782 . . . . 0.0 111.912 -179.134 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.55 HG22 ' HB1' ' A' ' 47' ' ' ALA . 26.8 m -124.08 162.31 25.54 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 N-CA-C 109.937 -0.394 . . . . 0.0 109.937 -179.296 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 61.6 tttp -100.5 122.14 42.72 Favored 'General case' 0 C--N 1.317 -0.833 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 174.624 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' MET . . . . . 0.441 ' HG2' HG12 ' A' ' 69' ' ' ILE . 61.1 mtt -110.12 115.38 29.64 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 174.836 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.655 ' CG2' ' HB2' ' A' ' 68' ' ' ARG . 12.6 tt -109.64 105.13 18.21 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.973 0 CA-C-O 121.88 0.848 . . . . 0.0 109.727 174.886 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -87.84 107.76 18.83 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 114.666 -1.152 . . . . 0.0 109.203 178.278 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.517 ' HB ' ' HB2' ' A' ' 66' ' ' PRO . 46.4 mm -74.54 85.05 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.306 0 CA-C-O 122.006 0.908 . . . . 0.0 110.486 -177.87 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--N 1.315 -0.898 0 CA-C-N 114.361 -1.291 . . . . 0.0 108.111 170.54 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 23.3 m-20 . . . . . 0 N--CA 1.462 0.166 0 CA-C-O 120.772 0.32 . . . . 0.0 110.274 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . 0.654 ' HB2' ' HB ' ' A' ' 24' ' ' ILE . 31.0 mmtp -94.34 118.24 67.04 Favored Pre-proline 0 C--N 1.32 -0.681 0 CA-C-N 116.037 -0.528 . . . . 0.0 110.804 -170.368 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . 0.517 ' HB2' ' HB ' ' A' ' 54' ' ' ILE . 25.4 Cg_exo -65.43 104.69 0.66 Allowed 'Trans proline' 0 N--CA 1.459 -0.53 0 C-N-CA 122.653 2.235 . . . . 0.0 110.942 173.784 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.904 HD21 HG13 ' A' ' 69' ' ' ILE . 4.8 tt -103.88 136.55 43.33 Favored 'General case' 0 C--N 1.315 -0.904 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 179.907 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . 0.655 ' HB2' ' CG2' ' A' ' 52' ' ' ILE . 92.7 mtt180 -131.16 108.38 9.68 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 121.067 0.461 . . . . 0.0 111.003 173.538 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . 0.904 HG13 HD21 ' A' ' 67' ' ' LEU . 13.5 mt -91.77 104.96 16.07 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 N-CA-C 108.828 -0.805 . . . . 0.0 108.828 172.57 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 5.2 mt -105.35 126.06 60.5 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.828 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.476 -174.837 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 160.61 -129.72 2.22 Favored Glycine 0 N--CA 1.446 -0.666 0 C-N-CA 120.591 -0.814 . . . . 0.0 112.705 175.03 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . 0.658 ' OD2' ' HG2' ' A' ' 75' ' ' LYS . 0.9 OUTLIER -88.23 132.94 37.97 Favored Pre-proline 0 C--N 1.322 -0.616 0 C-N-CA 122.833 0.453 . . . . 0.0 111.394 -176.696 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . 0.592 ' HG3' ' OG1' ' A' ' 18' ' ' THR . 45.6 Cg_exo -52.51 -26.41 28.61 Favored 'Trans proline' 0 C--N 1.351 0.679 0 C-N-CA 123.899 3.066 . . . . 0.0 113.301 -174.94 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . 0.469 ' HB3' ' OD2' ' A' ' 72' ' ' ASP . 82.2 t80 -83.49 -56.29 3.82 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.422 -176.664 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . 0.658 ' HG2' ' OD2' ' A' ' 72' ' ' ASP . 12.9 ptpt -71.48 -27.03 62.96 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.54 -179.818 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.626 HG21 HG22 ' A' ' 69' ' ' ILE . 25.2 t -61.18 -40.7 86.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 N-CA-C 110.305 -0.258 . . . . 0.0 110.305 173.799 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -74.97 -43.24 55.16 Favored 'General case' 0 N--CA 1.451 -0.419 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.297 -179.018 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . 0.445 ' O ' ' HB2' ' A' ' 82' ' ' MET . 41.4 mt-30 -62.0 -35.89 79.89 Favored 'General case' 0 C--O 1.224 -0.264 0 CA-C-N 116.52 -0.309 . . . . 0.0 110.674 177.465 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . 0.713 ' HA ' ' HE3' ' A' ' 82' ' ' MET . . . -74.85 -34.15 62.23 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 120.912 0.387 . . . . 0.0 110.478 177.831 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 53.9 t -63.29 -56.7 14.33 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.149 176.438 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -66.23 -23.04 66.36 Favored 'General case' 0 C--O 1.22 -0.499 0 C-N-CA 120.547 -0.461 . . . . 0.0 110.47 179.217 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' MET . . . . . 0.713 ' HE3' ' HA ' ' A' ' 79' ' ' ALA . 30.6 ttm -59.61 -52.66 64.59 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.981 0.419 . . . . 0.0 110.202 174.838 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . 0.633 ' O ' ' HG ' ' A' ' 87' ' ' LEU . 18.7 m -83.86 -35.23 11.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.09 -177.521 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' MET . . . . . 0.449 ' O ' ' HG2' ' A' ' 88' ' ' ARG . 57.1 ttp -65.44 -35.39 80.77 Favored 'General case' 0 CA--C 1.518 -0.265 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.291 -179.894 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . 0.468 ' O ' ' HB2' ' A' ' 89' ' ' GLU . 33.2 t70 -61.3 -39.87 92.09 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.127 177.382 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.46 HG22 HD13 ' A' ' 31' ' ' LEU . 23.5 mt -64.62 -41.18 91.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 121.412 0.625 . . . . 0.0 109.925 176.398 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.633 ' HG ' ' O ' ' A' ' 83' ' ' VAL . 66.1 mt -64.39 -36.11 83.09 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.373 -0.831 . . . . 0.0 111.101 -178.781 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . 0.449 ' HG2' ' O ' ' A' ' 84' ' ' MET . 29.5 mmm180 -95.28 9.91 38.06 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.996 -177.352 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . 0.468 ' HB2' ' O ' ' A' ' 85' ' ' ASP . 35.3 tt0 . . . . . 0 C--O 1.25 1.122 0 CA-C-O 118.836 -0.602 . . . . 0.0 110.34 -177.787 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 85.7 m . . . . . 0 N--CA 1.452 -0.342 0 N-CA-C 109.697 -0.482 . . . . 0.0 109.697 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.657 ' HA ' ' O ' ' A' ' 69' ' ' ILE . 3.2 p -139.86 121.76 16.0 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-O 121.161 0.505 . . . . 0.0 111.932 -175.456 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . 0.405 ' O ' ' HA ' ' A' ' 68' ' ' ARG . 28.8 mt-30 -96.88 157.17 16.03 Favored 'General case' 0 CA--C 1.519 -0.233 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.353 173.363 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . 0.505 ' HG2' ' HG2' ' A' ' 68' ' ' ARG . 35.2 mt-10 -131.18 107.91 9.34 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.177 0.513 . . . . 0.0 111.075 -178.424 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 5.3 mm -101.57 150.37 6.06 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-N 115.54 -0.754 . . . . 0.0 109.405 -179.807 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' MET . . . . . 0.412 ' HE3' ' HB2' ' A' ' 64' ' ' ASP . 79.5 mmm -110.18 92.85 4.21 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 176.77 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.655 ' HB ' ' HB2' ' A' ' 65' ' ' LYS . 32.7 mm -82.3 127.32 71.64 Favored Pre-proline 0 C--N 1.32 -0.676 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.101 -173.895 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 76.7 Cg_exo -50.85 136.5 43.33 Favored 'Trans proline' 0 N--CA 1.463 -0.317 0 C-N-CA 122.491 2.127 . . . . 0.0 111.592 175.398 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -58.1 -29.28 65.35 Favored 'General case' 0 CA--C 1.531 0.226 0 N-CA-C 112.959 0.725 . . . . 0.0 112.959 -172.116 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -89.44 -19.73 47.94 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.484 -0.865 . . . . 0.0 112.138 179.323 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 8.5 tptm -91.95 -1.15 57.42 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.266 0.555 . . . . 0.0 110.363 -177.601 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . 0.463 ' HA ' HG22 ' A' ' 32' ' ' VAL . . . -63.06 -20.93 65.8 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.598 -0.728 . . . . 0.0 111.065 179.471 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -61.0 -16.3 47.14 Favored Glycine 0 C--O 1.228 -0.247 0 CA-C-N 115.876 -0.602 . . . . 0.0 112.652 177.405 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 62.6 mt -93.75 -47.92 6.55 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 122.693 -0.298 . . . . 0.0 111.238 179.539 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.538 HG12 HD22 ' A' ' 87' ' ' LEU . 3.0 m -65.34 -40.07 87.29 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.379 0 CA-C-O 120.889 0.376 . . . . 0.0 111.452 179.523 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.487 HG13 HG23 ' A' ' 32' ' ' VAL . 43.6 mt -85.88 -32.75 7.09 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-O 121.927 0.87 . . . . 0.0 109.162 178.794 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . 0.526 ' HA3' ' HB ' ' A' ' 39' ' ' THR . . . 95.15 178.9 37.3 Favored Glycine 0 N--CA 1.436 -1.318 0 CA-C-N 114.852 -1.067 . . . . 0.0 111.579 -178.105 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 2.9 mppt? -81.13 62.8 5.23 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-O 120.973 0.416 . . . . 0.0 110.373 -178.839 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 133.19 -20.1 4.26 Favored Glycine 0 N--CA 1.448 -0.521 0 C-N-CA 120.823 -0.703 . . . . 0.0 112.416 176.897 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 115.8 -0.16 21.45 Favored Glycine 0 N--CA 1.448 -0.517 0 C-N-CA 120.723 -0.751 . . . . 0.0 111.883 -176.792 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . 0.499 ' O ' ' HB3' ' A' ' 41' ' ' LYS . 49.3 mt-10 -75.44 -31.96 60.5 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 120.724 0.297 . . . . 0.0 111.106 179.474 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' THR . . . . . 0.574 ' O ' ' HG ' ' A' ' 43' ' ' LEU . 23.7 m -69.38 -48.46 61.11 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.774 -178.3 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.632 HD11 HD23 ' A' ' 53' ' ' LEU . 7.0 tt -61.8 -32.79 55.05 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.267 0 CA-C-O 121.107 0.479 . . . . 0.0 110.346 177.356 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . 0.499 ' HB3' ' O ' ' A' ' 38' ' ' GLU . 31.6 ttpt -56.24 -45.22 80.07 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.467 174.398 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . 0.452 ' O ' ' HG2' ' A' ' 46' ' ' ARG . 27.8 mt-30 -73.46 -40.46 64.15 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.404 -0.816 . . . . 0.0 111.116 -177.027 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.574 ' HG ' ' O ' ' A' ' 39' ' ' THR . 81.0 mt -55.71 -47.58 76.63 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.683 -176.577 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 44.6 mt-30 -61.98 -43.13 99.48 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.712 -176.247 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -78.54 -35.21 46.46 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 111.836 0.31 . . . . 0.0 111.836 -175.797 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . 0.452 ' HG2' ' O ' ' A' ' 42' ' ' GLN . 12.9 ptm180 -73.92 -31.39 63.05 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 120.777 -0.369 . . . . 0.0 111.268 -177.89 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -89.19 -28.18 20.16 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.087 0.47 . . . . 0.0 111.348 -179.111 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 82.93 33.21 24.6 Favored Glycine 0 N--CA 1.449 -0.478 0 CA-C-N 115.742 -0.663 . . . . 0.0 112.243 -178.698 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 3.6 m -139.14 179.86 2.76 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.399 0 CA-C-O 120.898 0.38 . . . . 0.0 110.297 178.609 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 54.7 tttp -109.44 123.67 49.75 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 115.945 -0.57 . . . . 0.0 109.919 175.448 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' MET . . . . . 0.762 ' HE1' HG11 ' A' ' 83' ' ' VAL . 65.9 mtp -118.21 114.08 22.49 Favored 'General case' 0 C--N 1.317 -0.808 0 N-CA-C 108.301 -1.0 . . . . 0.0 108.301 174.414 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.49 ' CG2' ' HB2' ' A' ' 68' ' ' ARG . 11.5 tt -104.6 108.54 25.06 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.749 0 CA-C-O 121.622 0.725 . . . . 0.0 110.684 -177.614 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.724 HD22 HD12 ' A' ' 67' ' ' LEU . 2.7 mm? -82.35 102.29 11.15 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.249 -0.887 . . . . 0.0 109.522 174.11 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.613 HD13 ' HB2' ' A' ' 66' ' ' PRO . 56.6 mt -82.48 87.42 1.9 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.55 0 CA-C-O 121.481 0.658 . . . . 0.0 109.35 -179.171 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 70.9 mt-30 . . . . . 0 C--N 1.323 -0.564 0 CA-C-N 115.148 -0.933 . . . . 0.0 111.144 -173.59 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . 0.412 ' HB2' ' HE3' ' A' ' 23' ' ' MET . 10.6 m-20 . . . . . 0 N--CA 1.443 -0.79 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . 0.655 ' HB2' ' HB ' ' A' ' 24' ' ' ILE . 2.7 mmpp? -148.57 113.28 3.74 Favored Pre-proline 0 C--N 1.318 -0.779 0 CA-C-N 115.62 -0.718 . . . . 0.0 109.51 178.779 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . 0.613 ' HB2' HD13 ' A' ' 54' ' ' ILE . 24.7 Cg_exo -63.55 110.26 1.21 Allowed 'Trans proline' 0 N--CA 1.462 -0.353 0 C-N-CA 122.613 2.209 . . . . 0.0 111.807 178.268 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.724 HD12 HD22 ' A' ' 53' ' ' LEU . 24.2 tp -111.16 105.22 13.85 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.069 178.006 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . 0.505 ' HG2' ' HG2' ' A' ' 21' ' ' GLU . 95.2 mtt180 -97.72 113.62 25.42 Favored 'General case' 0 C--N 1.319 -0.717 0 CA-C-O 121.437 0.637 . . . . 0.0 110.581 176.813 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . 0.657 ' O ' ' HA ' ' A' ' 19' ' ' VAL . 19.6 mt -98.83 104.09 15.54 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.786 0 CA-C-N 114.99 -1.004 . . . . 0.0 108.577 177.897 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.526 HG21 ' HB ' ' A' ' 19' ' ' VAL . 2.8 mt -112.58 132.61 60.84 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.788 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.061 -169.348 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 156.44 -119.06 0.88 Allowed Glycine 0 N--CA 1.446 -0.675 0 C-N-CA 120.718 -0.754 . . . . 0.0 112.825 174.832 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -102.69 134.77 19.7 Favored Pre-proline 0 C--N 1.325 -0.46 0 CA-C-O 119.091 -0.48 . . . . 0.0 110.96 -175.667 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_exo -44.31 -42.91 13.59 Favored 'Trans proline' 0 C--O 1.237 0.445 0 C-N-CA 123.231 2.62 . . . . 0.0 113.557 -174.419 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 30.7 t80 -70.95 -47.73 57.34 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.853 -171.911 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . 0.433 ' HA ' ' HB2' ' A' ' 78' ' ' GLN . 14.3 pttt -82.87 -19.24 37.84 Favored 'General case' 0 C--N 1.325 -0.466 0 C-N-CA 120.492 -0.483 . . . . 0.0 111.768 -179.463 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 47.0 t -66.16 -38.55 82.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 170.036 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . 0.409 ' O ' ' HG2' ' A' ' 81' ' ' GLU . 20.9 tp60 -69.92 -49.13 55.06 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.38 -0.827 . . . . 0.0 110.416 175.426 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . 0.433 ' HB2' ' HA ' ' A' ' 75' ' ' LYS . 86.2 mt-30 -60.4 -36.36 77.95 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.567 -0.288 . . . . 0.0 111.693 -179.913 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . 0.693 ' HA ' ' HE1' ' A' ' 82' ' ' MET . . . -69.64 -39.42 77.12 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 120.818 0.342 . . . . 0.0 110.546 177.462 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 52.5 t -65.13 -51.45 61.19 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.051 179.681 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . 0.409 ' HG2' ' O ' ' A' ' 77' ' ' GLN . 10.3 pt-20 -64.99 -24.11 67.41 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.972 0.415 . . . . 0.0 110.37 179.983 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' MET . . . . . 0.693 ' HE1' ' HA ' ' A' ' 79' ' ' ALA . 29.7 ttp -73.14 -52.02 15.76 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.863 179.259 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . 0.762 HG11 ' HE1' ' A' ' 51' ' ' MET . 33.3 m -77.75 -34.0 19.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 120.635 0.255 . . . . 0.0 111.207 -175.647 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 51.7 ttm -63.35 -35.25 79.75 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.106 0.479 . . . . 0.0 109.741 177.194 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -68.54 -36.72 79.22 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.441 179.444 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.551 HG13 ' O ' ' A' ' 82' ' ' MET . 59.9 mt -63.31 -33.25 60.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-O 121.256 0.55 . . . . 0.0 110.543 178.056 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.563 ' HG ' ' O ' ' A' ' 83' ' ' VAL . 58.7 mt -73.87 -19.61 60.67 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.604 -175.945 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . 0.602 ' HG3' ' HG2' ' A' ' 89' ' ' GLU . 37.1 ptt180 -110.8 -19.3 12.88 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.372 0.606 . . . . 0.0 111.142 -175.596 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . 0.602 ' HG2' ' HG3' ' A' ' 88' ' ' ARG . 69.9 mm-40 . . . . . 0 C--O 1.249 1.04 0 CA-C-N 115.235 -0.893 . . . . 0.0 110.425 -175.633 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 99.7 m . . . . . 0 C--O 1.234 0.25 0 CA-C-O 121.008 0.432 . . . . 0.0 111.641 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.564 HG22 HG22 ' A' ' 70' ' ' ILE . 92.9 t -120.8 126.99 75.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.276 178.284 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . 0.559 ' HB2' ' CG1' ' A' ' 76' ' ' VAL . 4.9 tp-100 -106.58 113.93 27.74 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 109.667 -0.494 . . . . 0.0 109.667 175.684 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . 0.6 ' HA ' ' O ' ' A' ' 67' ' ' LEU . 56.1 mt-10 -93.24 121.29 34.47 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.036 0.446 . . . . 0.0 111.457 177.591 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.435 HD11 ' HE1' ' A' ' 84' ' ' MET . 18.7 mm -115.43 146.38 19.94 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 115.529 -0.759 . . . . 0.0 109.355 176.902 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' MET . . . . . 0.475 ' HB3' ' HB2' ' A' ' 64' ' ' ASP . 79.4 mmm -106.77 99.86 9.4 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 175.356 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.705 HD11 HD11 ' A' ' 87' ' ' LEU . 24.5 mm -78.54 129.76 73.36 Favored Pre-proline 0 C--N 1.32 -0.685 0 CA-C-N 115.498 -0.774 . . . . 0.0 111.895 -170.461 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . 0.571 ' HD2' HD13 ' A' ' 87' ' ' LEU . 77.0 Cg_exo -45.2 131.37 11.38 Favored 'Trans proline' 0 C--N 1.349 0.574 0 C-N-CA 123.744 2.963 . . . . 0.0 112.976 175.831 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -71.36 78.5 0.75 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.444 0.64 . . . . 0.0 110.874 179.437 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 157.54 -59.96 0.34 Allowed Glycine 0 N--CA 1.447 -0.593 0 N-CA-C 109.983 -1.247 . . . . 0.0 109.983 -177.456 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.46 -13.97 35.97 Favored 'General case' 0 N--CA 1.451 -0.41 0 CA-C-O 121.0 0.429 . . . . 0.0 110.749 171.929 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . 0.41 ' O ' HG13 ' A' ' 32' ' ' VAL . . . -56.16 -23.49 35.24 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.771 173.379 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -61.8 -24.46 64.54 Favored Glycine 0 N--CA 1.449 -0.494 0 C-N-CA 120.862 -0.685 . . . . 0.0 112.185 176.611 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 93.1 mt -92.4 -32.8 14.81 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.725 0.298 . . . . 0.0 110.859 178.793 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.41 HG13 ' O ' ' A' ' 29' ' ' ALA . 0.3 OUTLIER -68.06 -29.0 43.15 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.296 0 CA-C-O 121.263 0.554 . . . . 0.0 110.395 179.387 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 63.2 mt -92.0 -47.97 13.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 115.568 -0.742 . . . . 0.0 109.424 174.386 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 114.56 -162.12 12.51 Favored Glycine 0 N--CA 1.442 -0.942 0 CA-C-N 115.356 -0.838 . . . . 0.0 112.095 178.418 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.531 ' N ' ' HD3' ' A' ' 35' ' ' LYS . 0.1 OUTLIER -92.29 39.33 1.02 Allowed 'General case' 0 C--N 1.317 -0.818 0 N-CA-C 109.637 -0.505 . . . . 0.0 109.637 -178.298 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 143.52 -21.31 2.21 Favored Glycine 0 N--CA 1.45 -0.431 0 C-N-CA 120.982 -0.628 . . . . 0.0 112.29 -178.245 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 126.17 4.77 6.4 Favored Glycine 0 C--O 1.228 -0.245 0 C-N-CA 120.355 -0.926 . . . . 0.0 112.309 179.939 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -80.59 -28.17 37.2 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 120.659 0.266 . . . . 0.0 111.217 178.897 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' THR . . . . . 0.611 ' O ' ' HG ' ' A' ' 43' ' ' LEU . 57.9 m -70.38 -49.64 47.01 Favored 'General case' 0 C--N 1.324 -0.507 0 C-N-CA 121.101 -0.24 . . . . 0.0 110.444 -179.983 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.703 HD12 HD22 ' A' ' 53' ' ' LEU . 5.2 tt -59.64 -33.72 52.86 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.248 0 CA-C-O 120.81 0.338 . . . . 0.0 110.473 176.31 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . 0.526 ' O ' ' HG2' ' A' ' 45' ' ' GLU . 57.7 tttp -64.86 -46.23 82.74 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.756 175.454 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 41.7 mt-30 -60.88 -35.08 75.69 Favored 'General case' 0 CA--C 1.516 -0.354 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.359 -178.017 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.611 ' HG ' ' O ' ' A' ' 39' ' ' THR . 69.8 mt -62.19 -43.6 98.46 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.421 -0.809 . . . . 0.0 110.402 178.158 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . 0.43 ' HG3' ' O ' ' A' ' 40' ' ' ILE . 67.8 mt-30 -62.61 -47.24 84.63 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.176 177.596 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.526 ' HG2' ' O ' ' A' ' 41' ' ' LYS . 72.0 mm-40 -59.81 -39.41 84.95 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.33 -0.85 . . . . 0.0 111.672 -177.854 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 13.5 ptm180 -90.0 -28.02 19.38 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 112.932 0.716 . . . . 0.0 112.932 -170.865 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . 0.487 ' HB2' HG22 ' A' ' 49' ' ' VAL . . . -94.22 -15.83 24.2 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 112.174 0.435 . . . . 0.0 112.174 -175.642 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 74.23 20.72 79.6 Favored Glycine 0 C--O 1.235 0.217 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.183 -179.855 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.487 HG22 ' HB2' ' A' ' 47' ' ' ALA . 27.3 m -124.51 177.31 4.67 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 N-CA-C 109.902 -0.407 . . . . 0.0 109.902 -179.202 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 87.1 tttt -114.64 123.97 50.66 Favored 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 109.773 -0.455 . . . . 0.0 109.773 173.088 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' MET . . . . . 0.79 ' HE1' ' HB1' ' A' ' 79' ' ' ALA . 55.7 mtt -108.54 115.39 30.02 Favored 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 176.028 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.547 ' CG2' ' HB2' ' A' ' 68' ' ' ARG . 10.2 tt -105.13 105.14 18.08 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.895 0 CA-C-O 121.585 0.707 . . . . 0.0 110.423 177.668 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.982 HD21 HD13 ' A' ' 67' ' ' LEU . 1.4 mm? -80.75 121.8 26.36 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.283 -0.872 . . . . 0.0 108.973 172.608 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.465 ' CG1' ' HB2' ' A' ' 66' ' ' PRO . 48.9 mm -76.67 85.86 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-O 121.845 0.831 . . . . 0.0 109.832 179.514 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 15.3 mt-30 . . . . . 0 C--N 1.323 -0.544 0 CA-C-N 114.743 -1.117 . . . . 0.0 108.64 -179.983 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . 0.475 ' HB2' ' HB3' ' A' ' 23' ' ' MET . 0.6 OUTLIER . . . . . 0 C--O 1.221 -0.431 0 CA-C-O 121.143 0.497 . . . . 0.0 112.334 . . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . 0.649 ' HB2' ' HB ' ' A' ' 24' ' ' ILE . 73.6 mmtt -95.46 132.62 27.25 Favored Pre-proline 0 C--N 1.322 -0.592 0 CA-C-N 115.543 -0.753 . . . . 0.0 112.22 -170.49 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . 0.465 ' HB2' ' CG1' ' A' ' 54' ' ' ILE . 13.7 Cg_exo -71.19 118.53 5.73 Favored 'Trans proline' 0 N--CA 1.457 -0.639 0 C-N-CA 122.867 2.378 . . . . 0.0 111.55 173.422 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.982 HD13 HD21 ' A' ' 53' ' ' LEU . 13.0 tp -123.48 124.7 43.44 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.98 -0.555 . . . . 0.0 109.923 178.091 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . 0.547 ' HB2' ' CG2' ' A' ' 52' ' ' ILE . 87.5 mtt180 -112.58 110.63 20.91 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-O 120.851 0.358 . . . . 0.0 111.292 177.458 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . 0.519 HG21 ' HB3' ' A' ' 79' ' ' ALA . 4.6 mp -88.38 104.7 14.91 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 171.525 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.564 HG22 HG22 ' A' ' 19' ' ' VAL . 11.3 mt -104.65 124.85 59.49 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.703 -174.99 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 173.95 -129.82 1.71 Allowed Glycine 0 N--CA 1.447 -0.592 0 C-N-CA 121.005 -0.617 . . . . 0.0 112.208 179.582 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . 0.49 ' OD1' ' HD2' ' A' ' 73' ' ' PRO . 3.1 t70 -107.58 145.72 31.87 Favored Pre-proline 0 C--N 1.324 -0.523 0 CA-C-O 118.655 -0.688 . . . . 0.0 109.895 -179.793 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . 0.49 ' HD2' ' OD1' ' A' ' 72' ' ' ASP . 94.3 Cg_exo -41.02 -40.42 3.81 Favored 'Trans proline' 0 CA--C 1.535 0.571 0 C-N-CA 122.999 2.466 . . . . 0.0 113.335 -179.398 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 85.9 t80 -70.82 -56.71 5.71 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.295 -176.262 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . 0.444 ' HG2' ' HB3' ' A' ' 72' ' ' ASP . 27.6 pttt -71.22 -27.48 63.51 Favored 'General case' 0 CA--C 1.514 -0.432 0 C-N-CA 120.575 -0.45 . . . . 0.0 111.383 -179.523 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.559 ' CG1' ' HB2' ' A' ' 20' ' ' GLN . 24.2 t -66.71 -36.17 76.59 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-O 121.4 0.619 . . . . 0.0 109.441 177.068 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . 0.465 ' O ' ' HG2' ' A' ' 81' ' ' GLU . 20.1 tp60 -72.7 -47.98 42.68 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.292 176.749 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 25.0 mt-30 -57.8 -37.65 74.13 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-O 121.112 0.482 . . . . 0.0 110.6 177.534 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . 0.79 ' HB1' ' HE1' ' A' ' 51' ' ' MET . . . -71.99 -36.93 69.9 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.638 -0.71 . . . . 0.0 111.188 179.899 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' CYS . . . . . 0.431 ' HA ' HG21 ' A' ' 83' ' ' VAL . 51.7 t -68.37 -48.29 65.17 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.965 179.548 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . 0.465 ' HG2' ' O ' ' A' ' 77' ' ' GLN . 11.2 pt-20 -65.95 -19.48 65.88 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.11 0.481 . . . . 0.0 110.067 178.778 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' MET . . . . . 0.504 ' O ' HG13 ' A' ' 86' ' ' ILE . 51.1 ttp -79.18 -50.05 11.59 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.67 -0.695 . . . . 0.0 110.637 177.05 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . 0.431 HG21 ' HA ' ' A' ' 80' ' ' CYS . 27.2 m -69.08 -35.16 67.27 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.248 0 C-N-CA 121.114 -0.234 . . . . 0.0 111.112 179.918 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' MET . . . . . 0.435 ' HE1' HD11 ' A' ' 22' ' ' ILE . 16.8 mmt -60.93 -37.23 81.59 Favored 'General case' 0 CA--C 1.517 -0.298 0 CA-C-O 121.076 0.465 . . . . 0.0 109.977 174.539 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -65.2 -43.77 90.55 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.482 -0.781 . . . . 0.0 110.95 178.694 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.504 HG13 ' O ' ' A' ' 82' ' ' MET . 51.5 mt -60.54 -37.52 75.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 121.466 0.651 . . . . 0.0 110.882 -179.395 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.705 HD11 HD11 ' A' ' 24' ' ' ILE . 71.5 mt -82.88 -12.83 57.08 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.762 -0.654 . . . . 0.0 111.21 -176.858 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 45.0 ttp180 -103.39 -18.34 14.87 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.467 0.651 . . . . 0.0 111.062 -176.982 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 . . . . . 0 C--O 1.249 1.051 0 CA-C-O 118.191 -0.909 . . . . 0.0 110.095 -178.31 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' THR . . . . . 0.448 ' OG1' ' HG3' ' A' ' 73' ' ' PRO . 92.8 m . . . . . 0 N--CA 1.452 -0.358 0 N-CA-C 110.21 -0.293 . . . . 0.0 110.21 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.533 ' HA ' ' O ' ' A' ' 69' ' ' ILE . 3.8 p -138.22 120.91 19.12 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-O 121.259 0.552 . . . . 0.0 110.808 179.909 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 53.2 mt-30 -102.54 136.11 42.96 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.793 -0.64 . . . . 0.0 109.98 176.646 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . 0.562 ' HA ' ' O ' ' A' ' 67' ' ' LEU . 33.4 mt-10 -112.3 114.75 27.67 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.498 179.232 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 11.5 mm -106.56 156.93 7.01 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-N 115.486 -0.779 . . . . 0.0 110.038 -176.599 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' MET . . . . . 0.458 ' HE3' ' HA ' ' A' ' 23' ' ' MET . 3.6 mmt -108.9 97.26 6.93 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 174.793 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.653 ' HB ' ' HB2' ' A' ' 65' ' ' LYS . 25.6 mm -82.92 125.53 74.96 Favored Pre-proline 0 C--N 1.316 -0.888 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.814 -175.819 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . 0.647 ' HB2' ' HB2' ' A' ' 28' ' ' LYS . 74.0 Cg_exo -50.51 132.8 36.35 Favored 'Trans proline' 0 C--N 1.343 0.289 0 C-N-CA 122.747 2.298 . . . . 0.0 111.416 175.94 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -58.88 -31.84 68.94 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.751 -0.659 . . . . 0.0 112.51 -172.842 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -82.47 -36.7 16.17 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.592 -0.813 . . . . 0.0 111.823 178.426 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . 0.647 ' HB2' ' HB2' ' A' ' 25' ' ' PRO . 36.2 mttp -80.32 3.64 20.39 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.808 0.337 . . . . 0.0 111.393 179.466 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.66 -30.44 70.73 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.096 0.474 . . . . 0.0 110.141 175.742 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -66.17 -18.67 67.34 Favored Glycine 0 N--CA 1.446 -0.656 0 C-N-CA 120.861 -0.685 . . . . 0.0 112.341 177.848 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 82.2 mt -84.36 -46.72 11.44 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.53 0.205 . . . . 0.0 110.789 179.922 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.607 HG23 HG23 ' A' ' 24' ' ' ILE . 2.8 m -66.7 -34.88 72.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-O 120.884 0.373 . . . . 0.0 110.958 177.813 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.726 HD11 ' HG2' ' A' ' 55' ' ' GLN . 84.7 mt -80.21 -44.97 22.51 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-O 121.203 0.525 . . . . 0.0 110.4 178.413 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 98.96 51.05 1.4 Allowed Glycine 0 N--CA 1.448 -0.553 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.841 177.202 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 5.0 mptp? 54.25 30.98 13.3 Favored 'General case' 0 N--CA 1.464 0.254 0 C-N-CA 122.959 0.504 . . . . 0.0 112.118 175.761 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 147.4 -36.86 1.16 Allowed Glycine 0 N--CA 1.446 -0.696 0 C-N-CA 120.294 -0.955 . . . . 0.0 112.575 -178.526 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 147.49 -1.97 0.76 Allowed Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 119.516 -1.326 . . . . 0.0 114.504 177.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 -63.23 -47.48 82.31 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 117.677 0.739 . . . . 0.0 111.301 -179.169 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' THR . . . . . 0.73 ' O ' ' HG ' ' A' ' 43' ' ' LEU . 95.3 m -63.86 -51.55 64.12 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 111.7 0.259 . . . . 0.0 111.7 -177.112 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.548 ' O ' ' HG3' ' A' ' 44' ' ' GLN . 5.3 tt -58.01 -37.49 61.66 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.375 0 CA-C-O 120.989 0.423 . . . . 0.0 110.831 -178.658 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 85.8 tttt -63.38 -44.21 95.41 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.452 177.158 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 70.8 mt-30 -65.0 -40.25 94.66 Favored 'General case' 0 CA--C 1.517 -0.306 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.62 -178.744 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.73 ' HG ' ' O ' ' A' ' 39' ' ' THR . 70.5 mt -56.99 -48.33 78.67 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.588 -0.733 . . . . 0.0 111.558 -177.742 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . 0.548 ' HG3' ' O ' ' A' ' 40' ' ' ILE . 46.5 mt-30 -58.96 -51.78 68.57 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.462 -178.226 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -68.68 -40.71 79.95 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.366 -0.833 . . . . 0.0 111.889 -173.79 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . 0.599 ' HD3' ' SD ' ' A' ' 82' ' ' MET . 13.0 ptm180 -71.94 -27.82 63.05 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 111.74 0.274 . . . . 0.0 111.74 -174.574 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . 0.546 ' HB2' HG23 ' A' ' 49' ' ' VAL . . . -96.98 -22.71 16.67 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.02 0.438 . . . . 0.0 111.302 -178.882 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 79.85 28.55 50.28 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 121.027 -0.606 . . . . 0.0 111.722 -178.213 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.546 HG23 ' HB2' ' A' ' 47' ' ' ALA . 27.1 m -123.06 179.08 2.79 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-O 120.833 0.349 . . . . 0.0 110.114 -176.741 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 61.6 tttp -113.25 123.53 50.4 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 171.56 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' MET . . . . . 0.856 ' HE2' HG13 ' A' ' 83' ' ' VAL . 54.7 mtp -122.64 116.7 24.26 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 109.727 -0.472 . . . . 0.0 109.727 179.567 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.471 ' CG2' ' HB2' ' A' ' 68' ' ' ARG . 6.7 tt -107.13 107.17 22.11 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.792 0 CA-C-O 121.462 0.649 . . . . 0.0 110.878 -179.979 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.673 HD22 HD11 ' A' ' 67' ' ' LEU . 3.5 mm? -82.6 103.58 12.22 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.382 -0.826 . . . . 0.0 109.136 172.314 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.609 HD11 ' HB2' ' A' ' 66' ' ' PRO . 65.5 mt -81.37 89.78 1.85 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-O 121.192 0.52 . . . . 0.0 109.792 178.79 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . 0.726 ' HG2' HD11 ' A' ' 33' ' ' ILE . 0.0 OUTLIER . . . . . 0 C--N 1.322 -0.613 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.654 179.82 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 . . . . . 0 C--O 1.225 -0.195 0 CA-C-O 120.898 0.38 . . . . 0.0 110.807 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . 0.653 ' HB2' ' HB ' ' A' ' 24' ' ' ILE . 69.5 mmtt -96.26 127.15 41.4 Favored Pre-proline 0 C--N 1.317 -0.814 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.409 -170.705 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . 0.609 ' HB2' HD11 ' A' ' 54' ' ' ILE . 20.2 Cg_exo -68.03 109.23 1.89 Allowed 'Trans proline' 0 N--CA 1.461 -0.388 0 C-N-CA 122.952 2.435 . . . . 0.0 111.512 174.314 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.673 HD11 HD22 ' A' ' 53' ' ' LEU . 23.0 tp -109.65 117.41 33.86 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.339 178.38 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . 0.471 ' HB2' ' CG2' ' A' ' 52' ' ' ILE . 92.7 mtt180 -107.09 112.92 26.06 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 120.827 0.346 . . . . 0.0 111.023 175.545 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . 0.533 ' O ' ' HA ' ' A' ' 19' ' ' VAL . 3.9 mp -95.16 110.05 23.39 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 N-CA-C 107.951 -1.129 . . . . 0.0 107.951 172.201 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 28.4 mt -112.32 132.06 62.06 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 116.683 -0.235 . . . . 0.0 111.508 -171.134 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 150.19 -134.92 5.01 Favored Glycine 0 N--CA 1.445 -0.742 0 C-N-CA 120.686 -0.769 . . . . 0.0 113.657 174.021 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . 0.571 ' OD2' ' HB3' ' A' ' 74' ' ' TYR . 0.5 OUTLIER -80.07 139.19 52.96 Favored Pre-proline 0 C--N 1.323 -0.565 0 C-N-CA 123.46 0.704 . . . . 0.0 111.565 -177.283 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . 0.448 ' HG3' ' OG1' ' A' ' 18' ' ' THR . 33.3 Cg_exo -58.55 -18.54 40.22 Favored 'Trans proline' 0 C--N 1.35 0.625 0 C-N-CA 123.583 2.856 . . . . 0.0 113.818 -175.748 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . 0.571 ' HB3' ' OD2' ' A' ' 72' ' ' ASP . 37.8 t80 -86.36 -56.65 3.34 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 120.478 0.18 . . . . 0.0 110.532 -179.406 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . 0.557 ' CE ' ' HB3' ' A' ' 72' ' ' ASP . 26.1 pttt -70.31 -32.58 70.4 Favored 'General case' 0 CA--C 1.519 -0.232 0 N-CA-C 112.075 0.398 . . . . 0.0 112.075 -179.705 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 43.2 t -63.15 -36.24 75.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-O 121.008 0.432 . . . . 0.0 110.192 176.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . 0.411 ' NE2' ' HG3' ' A' ' 81' ' ' GLU . 0.4 OUTLIER -73.07 -44.29 60.77 Favored 'General case' 0 N--CA 1.445 -0.686 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 -178.255 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 48.3 mt-30 -62.46 -45.28 93.78 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.925 0.393 . . . . 0.0 110.531 177.045 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . 0.652 ' HA ' ' HE1' ' A' ' 82' ' ' MET . . . -63.4 -35.62 81.01 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.81 -179.193 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 43.5 t -66.2 -45.67 79.99 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.459 176.117 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . 0.411 ' HG3' ' NE2' ' A' ' 77' ' ' GLN . 38.0 mt-10 -59.48 -42.44 92.08 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.29 0.567 . . . . 0.0 110.051 175.864 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' MET . . . . . 0.652 ' HE1' ' HA ' ' A' ' 79' ' ' ALA . 42.0 ttp -56.72 -49.93 73.7 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 114.772 -1.104 . . . . 0.0 111.574 -179.456 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . 0.856 HG13 ' HE2' ' A' ' 51' ' ' MET . 34.7 m -79.57 -33.41 15.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 C-N-CA 120.871 -0.332 . . . . 0.0 111.131 -176.694 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 57.4 ttp -63.37 -38.57 91.68 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 109.533 -0.543 . . . . 0.0 109.533 175.85 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -61.82 -38.45 88.19 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.328 178.53 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.518 HG13 ' O ' ' A' ' 82' ' ' MET . 45.4 mt -64.13 -31.09 51.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-O 121.376 0.608 . . . . 0.0 110.479 179.657 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.639 HD12 HD11 ' A' ' 24' ' ' ILE . 45.3 mt -88.0 -18.55 28.77 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.542 -179.779 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 33.7 ttt85 -96.69 -4.46 40.8 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.681 0.753 . . . . 0.0 110.629 -176.665 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 20.0 tp10 . . . . . 0 C--N 1.311 -1.083 0 CA-C-O 118.195 -0.907 . . . . 0.0 110.42 -178.728 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' THR . . . . . 0.401 ' OG1' ' HG3' ' A' ' 73' ' ' PRO . 97.8 m . . . . . 0 N--CA 1.45 -0.433 0 CA-C-O 121.054 0.454 . . . . 0.0 110.872 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.498 ' HA ' ' O ' ' A' ' 69' ' ' ILE . 3.2 p -137.64 125.85 32.11 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-N 115.559 -0.746 . . . . 0.0 110.09 177.512 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 28.0 mt-30 -109.6 123.64 49.78 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.174 178.509 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . 0.68 ' HA ' ' O ' ' A' ' 67' ' ' LEU . 45.6 mt-10 -99.7 120.45 39.73 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.714 179.848 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 5.6 mm -106.79 152.1 8.46 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-N 115.54 -0.755 . . . . 0.0 110.307 -176.915 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' MET . . . . . 0.475 ' HA ' ' HE2' ' A' ' 23' ' ' MET . 14.1 mmt -103.5 91.8 4.2 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 170.929 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.734 HD12 HD11 ' A' ' 87' ' ' LEU . 41.6 mm -79.89 134.71 56.33 Favored Pre-proline 0 C--N 1.319 -0.729 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.649 -175.265 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . 0.401 ' HD2' HD13 ' A' ' 87' ' ' LEU . 83.4 Cg_exo -48.26 127.34 15.24 Favored 'Trans proline' 0 C--N 1.347 0.493 0 C-N-CA 123.068 2.512 . . . . 0.0 111.987 172.6 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -60.35 -34.67 74.18 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.273 -177.032 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -72.36 -32.93 61.9 Favored Glycine 0 N--CA 1.448 -0.542 0 CA-C-N 115.819 -0.628 . . . . 0.0 112.951 -177.452 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 43.6 mtpt -104.18 14.3 30.68 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 122.639 -0.33 . . . . 0.0 111.084 -177.844 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -65.56 -28.9 69.49 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.022 179.04 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -65.46 -30.0 76.52 Favored Glycine 0 N--CA 1.445 -0.714 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.137 179.067 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 91.7 mt -71.34 -39.51 71.29 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.771 0.32 . . . . 0.0 111.125 -178.061 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.731 HG23 HG23 ' A' ' 24' ' ' ILE . 0.0 OUTLIER -71.32 -28.87 33.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.876 -178.315 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 62.0 mt -81.24 -34.21 13.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-O 121.583 0.706 . . . . 0.0 109.756 176.039 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . 0.54 ' HA3' ' HB ' ' A' ' 39' ' ' THR . . . 101.89 26.81 7.34 Favored Glycine 0 CA--C 1.5 -0.849 0 CA-C-N 115.099 -0.955 . . . . 0.0 112.398 178.078 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 33.7 mmtp 73.1 -56.81 0.65 Allowed 'General case' 0 C--N 1.325 -0.498 0 C-N-CA 123.705 0.802 . . . . 0.0 111.659 179.43 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -101.26 -39.22 3.1 Favored Glycine 0 N--CA 1.448 -0.524 0 C-N-CA 120.678 -0.772 . . . . 0.0 111.718 -178.745 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 129.0 7.35 4.13 Favored Glycine 0 N--CA 1.448 -0.562 0 C-N-CA 120.996 -0.621 . . . . 0.0 112.533 178.914 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . 0.45 ' O ' ' HG3' ' A' ' 42' ' ' GLN . 1.3 pm0 -78.2 -35.99 47.88 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 110.057 -0.349 . . . . 0.0 110.057 177.238 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' THR . . . . . 0.65 ' O ' ' HG ' ' A' ' 43' ' ' LEU . 40.5 m -62.72 -50.95 69.07 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.173 -179.594 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.655 HD13 ' HB2' ' A' ' 53' ' ' LEU . 4.3 tt -56.41 -36.17 46.23 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.376 0 CA-C-O 120.788 0.327 . . . . 0.0 111.23 -179.282 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.04 -36.78 80.46 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.197 0.522 . . . . 0.0 109.836 179.472 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . 0.672 ' O ' ' HG2' ' A' ' 46' ' ' ARG . 79.1 mt-30 -72.4 -42.69 64.89 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.866 179.891 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.65 ' HG ' ' O ' ' A' ' 39' ' ' THR . 88.8 mt -52.56 -42.71 64.68 Favored 'General case' 0 C--O 1.235 0.313 0 O-C-N 123.835 0.71 . . . . 0.0 111.741 -176.865 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . 0.44 ' HG3' ' O ' ' A' ' 40' ' ' ILE . 62.4 mt-30 -54.08 -47.82 71.32 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.608 -0.724 . . . . 0.0 110.397 178.951 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 9.6 mm-40 -66.87 -39.13 87.43 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.529 -0.76 . . . . 0.0 110.735 -178.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . 0.672 ' HG2' ' O ' ' A' ' 42' ' ' GLN . 8.9 mmm180 -56.99 -45.46 82.94 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.801 -171.436 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . 0.596 ' HB3' HG22 ' A' ' 49' ' ' VAL . . . -95.26 -20.36 19.26 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.138 -175.912 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 82.25 47.57 6.04 Favored Glycine 0 N--CA 1.444 -0.796 0 C-N-CA 120.23 -0.986 . . . . 0.0 111.565 -173.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.596 HG22 ' HB3' ' A' ' 47' ' ' ALA . 2.9 m -145.54 171.19 5.35 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.456 0 CA-C-O 121.138 0.494 . . . . 0.0 110.653 -177.828 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 6.7 tmtm? -100.41 121.58 41.76 Favored 'General case' 0 C--N 1.318 -0.787 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 176.407 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' MET . . . . . 0.956 ' HE2' ' HB2' ' A' ' 79' ' ' ALA . 57.0 mtt -115.12 126.01 54.14 Favored 'General case' 0 CA--C 1.509 -0.629 0 N-CA-C 109.941 -0.392 . . . . 0.0 109.941 179.34 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.608 ' CG2' ' HB2' ' A' ' 68' ' ' ARG . 9.8 tt -118.2 104.05 15.61 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.939 0 CA-C-O 121.614 0.721 . . . . 0.0 110.275 173.223 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.71 HD12 HD11 ' A' ' 67' ' ' LEU . 4.3 mm? -78.73 101.74 7.71 Favored 'General case' 0 N--CA 1.446 -0.639 0 N-CA-C 107.947 -1.131 . . . . 0.0 107.947 170.381 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.58 HD11 ' HB2' ' A' ' 66' ' ' PRO . 15.8 mt -75.98 92.28 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.764 0 CA-C-O 121.5 0.667 . . . . 0.0 109.52 -175.543 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 1.1 pp0? . . . . . 0 C--N 1.32 -0.685 0 CA-C-N 115.345 -0.843 . . . . 0.0 109.885 179.407 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 . . . . . 0 C--O 1.234 0.28 0 CA-C-O 121.148 0.499 . . . . 0.0 110.918 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . 0.485 ' HB2' ' HB ' ' A' ' 24' ' ' ILE . 8.4 mmmm -101.6 119.25 57.82 Favored Pre-proline 0 C--N 1.319 -0.758 0 N-CA-C 113.098 0.777 . . . . 0.0 113.098 -172.574 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . 0.58 ' HB2' HD11 ' A' ' 54' ' ' ILE . 23.5 Cg_exo -67.26 125.86 14.13 Favored 'Trans proline' 0 CA--C 1.533 0.462 0 C-N-CA 123.016 2.477 . . . . 0.0 111.895 171.379 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.71 HD11 HD12 ' A' ' 53' ' ' LEU . 31.6 tp -134.02 127.84 33.1 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.02 177.599 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . 0.654 ' HG2' ' HG2' ' A' ' 21' ' ' GLU . 95.6 mtt180 -116.97 111.49 19.67 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.942 0.401 . . . . 0.0 111.151 178.594 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . 0.498 ' O ' ' HA ' ' A' ' 19' ' ' VAL . 4.7 mp -94.54 104.75 16.13 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 171.108 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 14.6 mt -108.97 126.54 65.97 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.58 -174.193 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 165.26 -135.68 3.83 Favored Glycine 0 N--CA 1.442 -0.938 0 C-N-CA 119.962 -1.113 . . . . 0.0 113.033 176.592 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . 0.456 ' HB3' ' HG2' ' A' ' 75' ' ' LYS . 9.8 t70 -92.88 135.45 26.03 Favored Pre-proline 0 C--N 1.319 -0.729 0 CA-C-O 119.242 -0.408 . . . . 0.0 110.982 -176.564 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . 0.401 ' HG3' ' OG1' ' A' ' 18' ' ' THR . 75.0 Cg_exo -39.67 -42.87 3.0 Favored 'Trans proline' 0 C--O 1.237 0.427 0 C-N-CA 123.602 2.868 . . . . 0.0 113.605 -175.513 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . 0.431 ' O ' ' HG3' ' A' ' 78' ' ' GLN . 35.9 t80 -68.88 -53.51 20.81 Favored 'General case' 0 N--CA 1.453 -0.277 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.924 -175.676 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . 0.584 ' HB2' HG13 ' A' ' 49' ' ' VAL . 0.0 OUTLIER -74.44 -24.36 59.05 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 120.268 -0.573 . . . . 0.0 111.87 -178.46 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.433 HG22 ' O ' ' A' ' 72' ' ' ASP . 75.8 t -63.15 -31.76 53.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-O 121.293 0.568 . . . . 0.0 109.69 174.136 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -76.57 -48.61 18.73 Favored 'General case' 0 N--CA 1.447 -0.582 0 N-CA-C 109.146 -0.686 . . . . 0.0 109.146 178.062 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . 0.431 ' HG3' ' O ' ' A' ' 74' ' ' TYR . 50.4 mt-30 -54.97 -43.46 73.53 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-O 121.551 0.691 . . . . 0.0 110.47 176.779 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . 0.956 ' HB2' ' HE2' ' A' ' 51' ' ' MET . . . -64.68 -40.22 95.02 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.162 -0.926 . . . . 0.0 111.203 -178.63 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 42.3 t -65.65 -46.44 79.2 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.427 -179.659 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -70.6 -19.71 62.82 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 120.822 -0.351 . . . . 0.0 110.661 179.42 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' MET . . . . . 0.658 ' HE3' ' HB2' ' A' ' 46' ' ' ARG . 36.1 ttm -71.99 -54.63 9.33 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.831 0.348 . . . . 0.0 110.636 175.484 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . 0.468 HG12 HD13 ' A' ' 43' ' ' LEU . 34.8 m -74.92 -29.93 23.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.803 -175.537 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 1.6 tmt? -70.09 -31.7 69.4 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.924 -0.58 . . . . 0.0 109.643 177.664 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . 0.472 ' O ' ' HB2' ' A' ' 89' ' ' GLU . 32.9 t70 -60.4 -36.88 79.15 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.392 177.661 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 22.5 mt -68.93 -23.17 27.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-O 121.401 0.619 . . . . 0.0 110.601 179.772 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.734 HD11 HD12 ' A' ' 24' ' ' ILE . 70.1 mt -89.4 -30.3 18.45 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.979 -176.918 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 40.7 ptt180 -86.1 -3.61 58.99 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.614 0.721 . . . . 0.0 109.185 174.805 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . 0.472 ' HB2' ' O ' ' A' ' 85' ' ' ASP . 9.5 tp10 . . . . . 0 C--O 1.252 1.2 0 CA-C-N 114.392 -1.277 . . . . 0.0 109.653 -178.724 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' THR . . . . . 0.595 ' O ' ' HA ' ' A' ' 70' ' ' ILE . 37.5 m . . . . . 0 N--CA 1.45 -0.436 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.504 ' HA ' ' O ' ' A' ' 69' ' ' ILE . 6.4 p -129.31 123.03 57.22 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-O 121.323 0.582 . . . . 0.0 111.339 -179.091 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 26.9 mt-30 -117.06 115.05 24.64 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.673 -0.694 . . . . 0.0 109.333 175.136 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . 0.542 ' HA ' ' O ' ' A' ' 67' ' ' LEU . 42.2 mt-10 -88.73 115.86 26.57 Favored 'General case' 0 CA--C 1.516 -0.35 0 CA-C-O 121.178 0.513 . . . . 0.0 111.372 -178.423 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.486 HD12 ' HG ' ' A' ' 80' ' ' CYS . 11.2 mm -98.72 152.9 4.22 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-N 115.426 -0.807 . . . . 0.0 109.686 179.482 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' MET . . . . . 0.421 ' HA ' ' HE2' ' A' ' 23' ' ' MET . 1.8 mmt -106.39 91.27 3.63 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 174.747 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.678 ' HB ' ' HB2' ' A' ' 65' ' ' LYS . 29.7 mm -75.35 125.88 88.37 Favored Pre-proline 0 C--N 1.317 -0.805 0 CA-C-N 115.806 -0.634 . . . . 0.0 111.215 -173.869 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . 0.569 ' HB2' ' HB2' ' A' ' 28' ' ' LYS . 85.4 Cg_exo -48.09 129.32 18.31 Favored 'Trans proline' 0 C--N 1.346 0.4 0 C-N-CA 123.165 2.577 . . . . 0.0 111.858 177.417 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -58.88 -24.34 62.12 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.838 -0.619 . . . . 0.0 112.579 -173.023 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -95.95 -1.83 61.3 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.622 -0.799 . . . . 0.0 112.804 -179.632 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . 0.569 ' HB2' ' HB2' ' A' ' 25' ' ' PRO . 2.0 mppt? -116.05 19.71 14.84 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.019 0.438 . . . . 0.0 111.441 -179.448 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -76.15 -20.39 57.62 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.102 -178.633 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -69.11 -17.72 72.21 Favored Glycine 0 N--CA 1.449 -0.484 0 C-N-CA 120.994 -0.622 . . . . 0.0 112.697 -178.86 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 86.8 mt -93.96 -38.83 10.98 Favored 'General case' 0 C--N 1.323 -0.573 0 O-C-N 122.515 -0.403 . . . . 0.0 111.571 -177.958 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.417 HG21 HG23 ' A' ' 24' ' ' ILE . 3.5 m -69.98 -34.09 58.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.899 0.38 . . . . 0.0 111.131 179.327 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.595 HD11 ' HG2' ' A' ' 55' ' ' GLN . 64.9 mt -83.99 -44.76 18.23 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-O 121.506 0.67 . . . . 0.0 109.902 177.026 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 118.88 -178.84 16.75 Favored Glycine 0 N--CA 1.441 -1.012 0 CA-C-N 115.291 -0.868 . . . . 0.0 111.359 -178.158 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 39.0 mmtm -77.76 -29.51 51.01 Favored 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 -178.357 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -143.01 17.09 2.36 Favored Glycine 0 N--CA 1.444 -0.79 0 CA-C-N 115.18 -0.918 . . . . 0.0 111.476 176.032 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 95.73 0.79 62.19 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.991 -0.623 . . . . 0.0 112.947 178.899 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -69.08 -34.9 75.87 Favored 'General case' 0 C--N 1.328 -0.367 0 O-C-N 122.598 -0.354 . . . . 0.0 110.841 -178.956 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' THR . . . . . 0.71 ' O ' ' HG ' ' A' ' 43' ' ' LEU . 61.8 m -62.71 -55.47 26.43 Favored 'General case' 0 N--CA 1.452 -0.374 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.913 -177.639 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.44 ' HA ' HD11 ' A' ' 43' ' ' LEU . 7.5 tt -60.02 -34.21 55.73 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.383 0 CA-C-O 120.782 0.325 . . . . 0.0 111.628 -176.665 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 3.9 tmmm? -70.79 -39.4 73.18 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 179.394 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . 0.467 ' O ' ' HG2' ' A' ' 46' ' ' ARG . 20.4 mm-40 -71.75 -37.79 70.5 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.991 -0.549 . . . . 0.0 111.187 -179.225 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.71 ' HG ' ' O ' ' A' ' 39' ' ' THR . 88.8 mt -53.44 -44.88 69.2 Favored 'General case' 0 CA--C 1.519 -0.238 0 CA-C-O 121.204 0.526 . . . . 0.0 110.992 179.428 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 47.1 mt-30 -68.14 -34.27 76.02 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.644 -0.707 . . . . 0.0 111.367 -177.435 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 32.2 mt-10 -80.48 -25.52 38.78 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 111.557 0.206 . . . . 0.0 111.557 -178.458 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . 0.467 ' HG2' ' O ' ' A' ' 42' ' ' GLN . 12.8 ptm180 -89.32 -30.2 18.6 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.688 0.28 . . . . 0.0 111.69 -178.705 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -88.63 -30.75 18.97 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 120.975 0.417 . . . . 0.0 110.905 178.528 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 91.79 -3.26 77.71 Favored Glycine 0 CA--C 1.519 0.339 0 C-N-CA 120.641 -0.79 . . . . 0.0 112.662 -179.219 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.453 ' CG1' ' HG3' ' A' ' 75' ' ' LYS . 16.1 m -103.54 179.22 0.71 Allowed 'Isoleucine or valine' 0 CA--C 1.516 -0.36 0 CA-C-O 121.063 0.459 . . . . 0.0 110.907 179.123 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . 0.667 ' HE3' ' HB ' ' A' ' 52' ' ' ILE . 8.7 tmtm? -109.89 125.05 52.4 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 115.666 -0.697 . . . . 0.0 109.171 177.158 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' MET . . . . . 0.724 ' HE2' HG12 ' A' ' 83' ' ' VAL . 54.7 mtp -119.2 125.36 48.98 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 109.449 -0.574 . . . . 0.0 109.449 179.31 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.667 ' HB ' ' HE3' ' A' ' 50' ' ' LYS . 9.0 tt -115.67 107.69 23.33 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.805 0 CA-C-O 121.523 0.677 . . . . 0.0 110.832 177.823 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.579 HD22 HD13 ' A' ' 67' ' ' LEU . 3.4 mm? -80.95 102.78 10.35 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.206 -0.906 . . . . 0.0 108.574 170.192 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.591 HD13 ' HB2' ' A' ' 66' ' ' PRO . 59.0 mt -78.23 85.68 1.02 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.467 0 CA-C-O 121.868 0.842 . . . . 0.0 110.423 -177.301 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . 0.595 ' HG2' HD11 ' A' ' 33' ' ' ILE . 1.7 pp0? . . . . . 0 C--N 1.317 -0.835 0 CA-C-N 114.573 -1.194 . . . . 0.0 109.579 175.062 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 . . . . . 0 C--O 1.231 0.121 0 N-CA-C 109.879 -0.415 . . . . 0.0 109.879 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . 0.678 ' HB2' ' HB ' ' A' ' 24' ' ' ILE . 27.6 mmtp -91.83 129.19 43.07 Favored Pre-proline 0 C--N 1.324 -0.538 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.44 -169.833 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . 0.591 ' HB2' HD13 ' A' ' 54' ' ' ILE . 23.4 Cg_exo -66.98 111.76 2.3 Favored 'Trans proline' 0 N--CA 1.463 -0.286 0 C-N-CA 123.292 2.661 . . . . 0.0 111.816 176.165 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.579 HD13 HD22 ' A' ' 53' ' ' LEU . 23.0 tp -114.52 114.57 25.95 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.389 178.169 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . 0.625 ' HB2' ' CG2' ' A' ' 52' ' ' ILE . 99.6 mtt180 -104.34 110.52 22.79 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.657 176.682 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . 0.504 ' O ' ' HA ' ' A' ' 19' ' ' VAL . 4.2 mp -93.92 108.33 20.45 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 N-CA-C 107.857 -1.164 . . . . 0.0 107.857 170.608 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.595 ' HA ' ' O ' ' A' ' 18' ' ' THR . 22.8 mt -116.69 133.89 61.92 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.606 -171.199 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 150.68 -108.65 0.39 Allowed Glycine 0 N--CA 1.448 -0.559 0 C-N-CA 120.811 -0.709 . . . . 0.0 113.112 172.579 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . 0.461 ' O ' HG23 ' A' ' 76' ' ' VAL . 14.1 t70 -103.79 132.08 21.38 Favored Pre-proline 0 C--N 1.318 -0.786 0 C-N-CA 123.19 0.596 . . . . 0.0 110.045 -174.916 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . 0.465 ' HG3' ' OG1' ' A' ' 18' ' ' THR . 44.7 Cg_exo -54.82 -25.93 45.46 Favored 'Trans proline' 0 C--N 1.347 0.479 0 C-N-CA 123.541 2.827 . . . . 0.0 113.431 -173.498 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 53.5 t80 -76.19 -53.47 8.22 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.464 -177.228 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . 0.506 ' HA ' ' HB2' ' A' ' 78' ' ' GLN . 5.8 ptpt -83.37 -17.57 41.84 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.866 -0.606 . . . . 0.0 111.992 -177.591 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.461 HG23 ' O ' ' A' ' 72' ' ' ASP . 45.2 t -63.15 -38.02 80.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 N-CA-C 109.552 -0.536 . . . . 0.0 109.552 170.863 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 1.4 mm100 -77.66 -41.13 39.29 Favored 'General case' 0 N--CA 1.451 -0.397 0 C-N-CA 120.807 -0.357 . . . . 0.0 110.608 177.373 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . 0.506 ' HB2' ' HA ' ' A' ' 75' ' ' LYS . 96.4 mt-30 -55.73 -47.12 77.44 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.831 0.348 . . . . 0.0 110.532 175.046 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . 0.888 ' HA ' ' HE3' ' A' ' 82' ' ' MET . . . -66.57 -38.87 88.0 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.122 179.629 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' CYS . . . . . 0.486 ' HG ' HD12 ' A' ' 22' ' ' ILE . 49.9 t -62.33 -52.14 64.82 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.406 177.89 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -63.75 -30.99 72.02 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.338 178.356 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' MET . . . . . 0.888 ' HE3' ' HA ' ' A' ' 79' ' ' ALA . 40.1 ttp -65.08 -52.17 57.13 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.602 -0.726 . . . . 0.0 111.198 178.482 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . 0.724 HG12 ' HE2' ' A' ' 51' ' ' MET . 30.7 m -76.18 -35.54 28.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 N-CA-C 111.74 0.274 . . . . 0.0 111.74 -177.06 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 93.9 mmm -67.85 -28.63 67.71 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.871 0.367 . . . . 0.0 110.012 177.113 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -64.87 -38.43 90.95 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.682 176.674 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.456 HG13 ' O ' ' A' ' 82' ' ' MET . 35.3 mt -64.0 -26.69 41.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.339 179.007 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.544 HD23 ' HB3' ' A' ' 28' ' ' LYS . 22.4 mt -97.64 -10.48 24.99 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.771 -177.859 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 28.0 tpt180 -99.37 -25.38 14.49 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.435 0.636 . . . . 0.0 111.09 -175.721 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 . . . . . 0 C--N 1.305 -1.327 0 CA-C-N 115.359 -0.837 . . . . 0.0 109.867 -178.048 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' THR . . . . . 0.438 HG23 ' HA ' ' A' ' 73' ' ' PRO . 91.3 m . . . . . 0 N--CA 1.454 -0.238 0 CA-C-O 120.705 0.288 . . . . 0.0 110.45 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 7.6 p -140.23 138.35 37.13 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-O 120.928 0.394 . . . . 0.0 110.891 -178.786 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 28.7 mt-30 -119.16 114.61 22.72 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 109.739 -0.467 . . . . 0.0 109.739 174.213 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . 0.699 ' HA ' ' O ' ' A' ' 67' ' ' LEU . 39.4 mt-10 -86.43 113.85 22.72 Favored 'General case' 0 CA--C 1.515 -0.392 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.864 179.079 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.448 ' HB ' ' HB3' ' A' ' 67' ' ' LEU . 14.7 mm -97.68 147.88 6.2 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 CA-C-N 115.257 -0.883 . . . . 0.0 110.227 -177.5 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' MET . . . . . 0.505 ' HB3' ' HB3' ' A' ' 64' ' ' ASP . 3.9 mmt -99.61 91.57 4.95 Favored 'General case' 0 C--N 1.317 -0.822 0 N-CA-C 108.531 -0.915 . . . . 0.0 108.531 173.322 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.649 ' HB ' ' HB2' ' A' ' 65' ' ' LYS . 36.8 mm -82.16 130.39 60.13 Favored Pre-proline 0 C--N 1.319 -0.722 0 CA-C-N 115.772 -0.649 . . . . 0.0 111.046 -174.396 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_exo -50.89 132.07 36.29 Favored 'Trans proline' 0 N--CA 1.46 -0.445 0 C-N-CA 122.885 2.39 . . . . 0.0 111.787 175.222 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -65.46 -18.89 65.67 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.263 -176.958 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -93.55 9.69 73.65 Favored Glycine 0 N--CA 1.445 -0.709 0 C-N-CA 120.97 -0.633 . . . . 0.0 112.325 177.294 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . 0.502 ' HB3' HD23 ' A' ' 87' ' ' LEU . 58.8 mttp -132.38 26.68 4.46 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.861 0.362 . . . . 0.0 111.409 179.947 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -74.77 -23.5 58.54 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.232 0.539 . . . . 0.0 110.239 178.922 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -71.16 -16.36 75.08 Favored Glycine 0 N--CA 1.449 -0.443 0 CA-C-N 115.543 -0.753 . . . . 0.0 112.522 179.565 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 79.5 mt -93.65 -39.92 10.54 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 122.471 -0.429 . . . . 0.0 111.183 -179.299 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.559 HG11 HD22 ' A' ' 87' ' ' LEU . 2.8 m -76.4 -33.03 22.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-O 120.951 0.405 . . . . 0.0 111.533 -179.914 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.642 ' HA ' ' HB ' ' A' ' 40' ' ' ILE . 67.5 mt -93.68 -40.14 11.42 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-O 121.527 0.679 . . . . 0.0 110.18 179.079 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 119.49 160.65 11.37 Favored Glycine 0 N--CA 1.441 -1.025 0 CA-C-N 115.527 -0.76 . . . . 0.0 111.714 -179.634 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -65.47 -23.1 66.83 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.971 0.415 . . . . 0.0 110.504 -179.446 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -134.11 8.33 4.77 Favored Glycine 0 N--CA 1.446 -0.665 0 C-N-CA 120.741 -0.742 . . . . 0.0 111.896 177.244 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.545 ' HA2' HG23 ' A' ' 33' ' ' ILE . . . 87.39 12.14 67.87 Favored Glycine 0 N--CA 1.452 -0.245 0 C-N-CA 120.942 -0.646 . . . . 0.0 112.15 -177.196 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 13.7 mt-10 -84.64 -37.64 20.81 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.101 0.476 . . . . 0.0 110.6 -178.178 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' THR . . . . . 0.68 ' O ' ' HG ' ' A' ' 43' ' ' LEU . 21.2 m -59.84 -47.88 83.96 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.532 -0.758 . . . . 0.0 111.752 -173.41 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.642 ' HB ' ' HA ' ' A' ' 33' ' ' ILE . 9.3 tt -57.68 -34.82 48.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 120.929 0.395 . . . . 0.0 111.334 -178.565 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . 0.484 ' HG3' ' OE2' ' A' ' 45' ' ' GLU . 0.0 OUTLIER -70.77 -36.76 73.21 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.103 0.478 . . . . 0.0 109.972 179.189 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 25.4 mm-40 -71.07 -39.01 72.44 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.572 -178.915 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.68 ' HG ' ' O ' ' A' ' 39' ' ' THR . 54.7 mt -57.07 -47.38 81.12 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.715 179.889 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . 0.405 ' HG3' ' O ' ' A' ' 40' ' ' ILE . 45.2 mt-30 -62.27 -50.65 70.86 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.691 -179.981 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.484 ' OE2' ' HG3' ' A' ' 41' ' ' LYS . 46.1 mt-10 -63.62 -39.56 94.69 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.722 -0.672 . . . . 0.0 112.024 -176.594 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 13.9 ptm180 -77.68 -33.38 53.28 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 111.937 0.347 . . . . 0.0 111.937 -173.847 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -93.75 -12.26 29.56 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 120.985 0.422 . . . . 0.0 111.461 -177.2 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 73.13 35.51 57.29 Favored Glycine 0 N--CA 1.451 -0.323 0 N-CA-C 111.189 -0.764 . . . . 0.0 111.189 -177.482 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 29.5 m -124.45 175.6 6.74 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-O 120.964 0.411 . . . . 0.0 110.741 -173.811 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 78.3 tttt -115.65 123.7 49.04 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 169.414 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' MET . . . . . 0.891 ' HE1' HG13 ' A' ' 83' ' ' VAL . 71.8 mtp -123.6 114.68 20.33 Favored 'General case' 0 C--N 1.317 -0.82 0 N-CA-C 109.082 -0.71 . . . . 0.0 109.082 177.721 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.6 HG23 ' HB2' ' A' ' 68' ' ' ARG . 10.8 tt -109.97 105.51 18.94 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.143 0 CA-C-O 121.662 0.744 . . . . 0.0 109.595 177.362 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -82.53 102.26 11.26 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.169 -0.923 . . . . 0.0 108.625 174.716 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.494 ' HB ' ' HB2' ' A' ' 66' ' ' PRO . 20.3 mt -82.28 85.71 1.75 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.767 0 CA-C-O 121.669 0.747 . . . . 0.0 109.188 -175.939 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 4.1 pp0? . . . . . 0 C--N 1.319 -0.732 0 CA-C-N 115.171 -0.922 . . . . 0.0 110.994 -175.141 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . 0.505 ' HB3' ' HB3' ' A' ' 23' ' ' MET . 8.4 m-20 . . . . . 0 CA--C 1.519 -0.214 0 N-CA-C 109.722 -0.473 . . . . 0.0 109.722 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . 0.649 ' HB2' ' HB ' ' A' ' 24' ' ' ILE . 1.2 mmmm -93.89 122.26 62.49 Favored Pre-proline 0 C--N 1.318 -0.769 0 CA-C-N 115.971 -0.558 . . . . 0.0 111.255 -170.645 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . 0.494 ' HB2' ' HB ' ' A' ' 54' ' ' ILE . 39.3 Cg_exo -63.22 105.95 0.52 Allowed 'Trans proline' 0 N--CA 1.464 -0.21 0 C-N-CA 123.291 2.661 . . . . 0.0 112.225 177.476 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.699 ' O ' ' HA ' ' A' ' 21' ' ' GLU . 3.7 tt -101.42 135.69 42.49 Favored 'General case' 0 C--N 1.319 -0.735 0 N-CA-C 108.481 -0.933 . . . . 0.0 108.481 177.7 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . 0.698 ' N ' HD21 ' A' ' 67' ' ' LEU . 90.9 mtt180 -124.61 107.09 10.66 Favored 'General case' 0 N--CA 1.443 -0.82 0 C-N-CA 119.255 -0.978 . . . . 0.0 112.633 170.123 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . 0.54 ' CD1' HD23 ' A' ' 67' ' ' LEU . 3.8 mp -90.08 106.14 16.92 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.264 0 N-CA-C 107.943 -1.132 . . . . 0.0 107.943 167.72 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 7.4 mt -109.35 127.81 65.81 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.873 0 CA-C-O 120.946 0.403 . . . . 0.0 110.394 -176.141 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 173.64 -132.47 2.31 Favored Glycine 0 N--CA 1.441 -1.026 0 N-CA-C 111.044 -0.822 . . . . 0.0 111.044 179.496 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . 0.809 ' HB3' ' HE2' ' A' ' 75' ' ' LYS . 0.0 OUTLIER -103.55 153.49 38.56 Favored Pre-proline 0 C--N 1.318 -0.799 0 CA-C-O 118.992 -0.528 . . . . 0.0 109.594 176.71 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . 0.438 ' HA ' HG23 ' A' ' 18' ' ' THR . 71.5 Cg_exo -47.1 -39.21 25.76 Favored 'Trans proline' 0 C--N 1.347 0.451 0 C-N-CA 122.273 1.982 . . . . 0.0 112.268 -178.026 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . 0.401 ' HB3' ' OD1' ' A' ' 72' ' ' ASP . 22.6 t80 -67.39 -58.9 3.93 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.089 -0.96 . . . . 0.0 111.504 -177.576 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . 0.809 ' HE2' ' HB3' ' A' ' 72' ' ' ASP . 0.0 OUTLIER -67.54 -33.86 75.92 Favored 'General case' 0 CA--C 1.514 -0.418 0 C-N-CA 120.98 -0.288 . . . . 0.0 111.185 -178.773 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.404 HG12 ' HB ' ' A' ' 69' ' ' ILE . 55.0 t -64.39 -39.72 86.55 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.377 0 N-CA-C 109.647 -0.501 . . . . 0.0 109.647 -178.418 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . 0.642 HE21 ' HG3' ' A' ' 81' ' ' GLU . 17.8 tp60 -76.88 -41.89 42.04 Favored 'General case' 0 N--CA 1.443 -0.807 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.674 -177.739 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 23.8 mt-30 -63.93 -38.56 91.54 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 120.709 -0.396 . . . . 0.0 110.558 177.768 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . 0.515 ' HA ' ' HE1' ' A' ' 82' ' ' MET . . . -69.7 -37.16 76.5 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.534 178.766 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' CYS . . . . . 0.428 ' O ' ' HB2' ' A' ' 84' ' ' MET . 50.6 t -65.52 -46.58 79.05 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.549 176.626 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . 0.642 ' HG3' HE21 ' A' ' 77' ' ' GLN . 73.0 mt-10 -62.93 -21.87 66.36 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 121.047 0.451 . . . . 0.0 110.691 177.852 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' MET . . . . . 0.515 ' HE1' ' HA ' ' A' ' 79' ' ' ALA . 38.5 ttp -77.46 -52.33 9.29 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.25 179.68 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . 0.891 HG13 ' HE1' ' A' ' 51' ' ' MET . 32.9 m -73.52 -35.34 44.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.562 -177.853 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' MET . . . . . 0.428 ' HB2' ' O ' ' A' ' 80' ' ' CYS . 2.7 mmt -66.94 -34.12 77.08 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.682 0.277 . . . . 0.0 111.2 179.293 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . 0.468 ' O ' ' HB2' ' A' ' 89' ' ' GLU . 27.9 t70 -67.67 -31.5 71.53 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 120.836 -0.345 . . . . 0.0 110.154 -179.163 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.422 HG13 ' O ' ' A' ' 82' ' ' MET . 53.0 mt -67.44 -40.4 84.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 121.185 0.517 . . . . 0.0 109.974 176.476 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.559 HD22 HG11 ' A' ' 32' ' ' VAL . 49.1 mt -70.28 -42.02 72.63 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.699 -179.326 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . 0.44 HH11 ' HD3' ' A' ' 88' ' ' ARG . 9.5 mmm180 -85.45 7.52 22.45 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.969 -0.559 . . . . 0.0 111.201 -176.936 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . 0.468 ' HB2' ' O ' ' A' ' 85' ' ' ASP . 40.1 tt0 . . . . . 0 C--O 1.25 1.082 0 CA-C-O 118.222 -0.894 . . . . 0.0 109.663 178.346 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' THR . . . . . 0.56 ' OG1' ' HD3' ' A' ' 73' ' ' PRO . 90.5 m . . . . . 0 CA--C 1.528 0.129 0 CA-C-O 120.439 0.162 . . . . 0.0 111.111 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.482 ' HA ' ' O ' ' A' ' 69' ' ' ILE . 4.7 p -140.74 126.52 20.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-O 121.249 0.547 . . . . 0.0 111.931 -176.833 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 26.5 mt-30 -111.45 128.78 56.1 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.037 173.465 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . 0.505 ' HG2' ' HG2' ' A' ' 68' ' ' ARG . 45.6 mt-10 -96.71 115.37 27.32 Favored 'General case' 0 C--N 1.327 -0.41 0 O-C-N 123.401 0.438 . . . . 0.0 111.263 178.866 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 14.4 mm -100.77 150.29 5.76 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 177.412 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' MET . . . . . 0.473 ' HA ' ' HE2' ' A' ' 23' ' ' MET . 16.5 mmt -103.44 92.01 4.3 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 175.988 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.645 ' HB ' ' HB2' ' A' ' 65' ' ' LYS . 47.1 mm -81.5 128.2 70.56 Favored Pre-proline 0 C--N 1.318 -0.77 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.853 -175.625 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 81.6 Cg_exo -47.77 131.72 20.64 Favored 'Trans proline' 0 C--N 1.345 0.346 0 C-N-CA 123.21 2.607 . . . . 0.0 112.214 176.828 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -59.68 -26.71 65.78 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.855 -0.611 . . . . 0.0 111.342 -178.413 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -75.36 -31.03 57.68 Favored Glycine 0 N--CA 1.449 -0.484 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.371 177.499 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . 0.942 ' HD3' ' HG ' ' A' ' 87' ' ' LEU . 94.6 mttt -98.22 19.18 14.66 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.786 0.327 . . . . 0.0 111.494 -178.192 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . 0.616 ' O ' HG13 ' A' ' 33' ' ' ILE . . . -64.6 -34.07 77.41 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.798 179.288 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -68.64 -25.39 75.05 Favored Glycine 0 N--CA 1.448 -0.531 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.053 179.693 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 88.1 mt -74.03 -42.59 60.05 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.657 0.265 . . . . 0.0 110.634 -178.823 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.492 HG22 HG21 ' A' ' 24' ' ' ILE . 0.0 OUTLIER -72.84 -23.39 20.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.421 179.687 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.616 HG13 ' O ' ' A' ' 29' ' ' ALA . 67.2 mt -76.6 -35.19 25.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-O 121.74 0.781 . . . . 0.0 109.576 172.545 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . 0.677 ' HA3' ' HB ' ' A' ' 39' ' ' THR . . . 98.81 32.34 5.96 Favored Glycine 0 CA--C 1.5 -0.877 0 CA-C-N 114.962 -1.017 . . . . 0.0 112.396 177.911 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 14.5 mmmm 69.7 -64.51 0.34 Allowed 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.398 0.705 . . . . 0.0 111.68 177.633 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -89.58 -30.35 13.79 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 121.072 -0.585 . . . . 0.0 112.161 -177.815 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.512 ' HA2' HG23 ' A' ' 33' ' ' ILE . . . 109.92 -2.61 30.2 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.602 -0.808 . . . . 0.0 112.428 178.878 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -85.75 -27.54 25.16 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-O 120.993 0.425 . . . . 0.0 111.054 178.148 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' THR . . . . . 0.677 ' HB ' ' HA3' ' A' ' 34' ' ' GLY . 17.0 m -67.07 -41.31 86.62 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.393 -177.394 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.468 ' CD1' HD22 ' A' ' 53' ' ' LEU . 8.6 tt -58.36 -33.19 46.96 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.319 0 CA-C-O 120.986 0.422 . . . . 0.0 110.765 178.697 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . 0.4 ' O ' ' HG3' ' A' ' 45' ' ' GLU . 31.3 ttpt -69.89 -43.1 72.46 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.144 0.497 . . . . 0.0 109.952 174.79 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . 0.528 ' O ' ' HG2' ' A' ' 46' ' ' ARG . 49.8 mt-30 -63.5 -38.63 91.89 Favored 'General case' 0 CA--C 1.512 -0.484 0 CA-C-N 115.449 -0.796 . . . . 0.0 110.601 -177.041 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.64 ' HG ' ' O ' ' A' ' 39' ' ' THR . 73.5 mt -55.38 -43.52 75.22 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.724 179.759 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 44.4 mt-30 -64.85 -44.84 88.45 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.328 178.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.4 ' HG3' ' O ' ' A' ' 41' ' ' LYS . 40.8 mt-10 -63.82 -45.99 87.13 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.71 -0.677 . . . . 0.0 111.448 -178.878 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . 0.528 ' HG2' ' O ' ' A' ' 42' ' ' GLN . 11.7 ptp180 -77.46 -28.83 52.52 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 112.69 0.626 . . . . 0.0 112.69 -174.269 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . 0.639 ' HB1' HG22 ' A' ' 49' ' ' VAL . . . -92.14 -18.08 24.03 Favored 'General case' 0 C--N 1.325 -0.478 0 C-N-CA 120.674 -0.41 . . . . 0.0 111.952 -177.441 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 75.33 25.31 68.64 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.701 -0.761 . . . . 0.0 111.652 -178.029 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.639 HG22 ' HB1' ' A' ' 47' ' ' ALA . 33.4 m -127.8 170.46 17.56 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 N-CA-C 109.791 -0.448 . . . . 0.0 109.791 -178.183 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . 0.614 ' HE3' ' HB ' ' A' ' 52' ' ' ILE . 8.9 tmtm? -110.8 124.37 51.9 Favored 'General case' 0 C--N 1.317 -0.84 0 N-CA-C 109.306 -0.628 . . . . 0.0 109.306 175.838 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' MET . . . . . 0.612 ' HE1' ' HB3' ' A' ' 79' ' ' ALA . 62.6 mtt -112.42 129.34 56.36 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 179.347 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.614 ' HB ' ' HE3' ' A' ' 50' ' ' LYS . 8.9 tt -122.3 105.69 16.62 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.933 0 CA-C-O 121.514 0.673 . . . . 0.0 110.133 175.129 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.503 ' O ' ' HG2' ' A' ' 55' ' ' GLN . 4.0 mm? -81.44 103.42 11.17 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 115.3 -0.863 . . . . 0.0 109.035 174.916 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.532 HD13 ' HB2' ' A' ' 66' ' ' PRO . 53.5 mt -75.54 87.04 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 122.013 0.911 . . . . 0.0 109.689 179.185 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . 0.503 ' HG2' ' O ' ' A' ' 53' ' ' LEU . 2.2 pt20 . . . . . 0 C--N 1.317 -0.825 0 CA-C-N 114.359 -1.291 . . . . 0.0 109.293 -178.017 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 . . . . . 0 N--CA 1.465 0.319 0 CA-C-O 120.775 0.321 . . . . 0.0 110.661 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . 0.645 ' HB2' ' HB ' ' A' ' 24' ' ' ILE . 72.1 mmtt -96.72 125.48 46.64 Favored Pre-proline 0 C--N 1.316 -0.865 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.361 -170.449 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . 0.532 ' HB2' HD13 ' A' ' 54' ' ' ILE . 14.0 Cg_exo -70.5 106.31 1.77 Allowed 'Trans proline' 0 N--CA 1.457 -0.647 0 C-N-CA 122.958 2.439 . . . . 0.0 111.317 174.949 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.539 HD21 HG23 ' A' ' 83' ' ' VAL . 23.2 tp -105.4 110.93 23.46 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.841 -0.618 . . . . 0.0 109.693 178.818 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . 0.595 ' HB2' ' CG2' ' A' ' 52' ' ' ILE . 96.1 mtt180 -101.65 109.28 21.04 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-O 120.932 0.396 . . . . 0.0 110.952 177.718 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . 0.482 ' O ' ' HA ' ' A' ' 19' ' ' VAL . 4.4 mp -90.29 104.14 14.96 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 172.237 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 18.3 mt -104.48 121.73 56.59 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.588 -174.647 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 175.95 -125.4 1.05 Allowed Glycine 0 N--CA 1.445 -0.75 0 CA-C-N 116.002 -0.545 . . . . 0.0 112.025 179.872 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -114.84 142.67 28.72 Favored Pre-proline 0 C--N 1.32 -0.698 0 N-CA-C 108.863 -0.791 . . . . 0.0 108.863 179.641 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . 0.56 ' HD3' ' OG1' ' A' ' 18' ' ' THR . 86.0 Cg_exo -43.33 -39.5 9.01 Favored 'Trans proline' 0 C--N 1.351 0.699 0 C-N-CA 123.034 2.489 . . . . 0.0 112.751 -173.636 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 66.6 t80 -63.33 -57.83 9.11 Favored 'General case' 0 N--CA 1.451 -0.425 0 CA-C-N 115.225 -0.898 . . . . 0.0 111.293 -177.949 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 32.9 pttt -75.96 -30.45 58.63 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.482 -0.326 . . . . 0.0 111.571 -178.221 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 51.9 t -57.24 -40.62 74.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-O 120.894 0.378 . . . . 0.0 110.031 176.395 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -73.67 -45.85 50.01 Favored 'General case' 0 N--CA 1.448 -0.544 0 C-N-CA 120.496 -0.481 . . . . 0.0 111.094 179.144 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 11.3 mt-30 -63.41 -37.76 88.52 Favored 'General case' 0 C--N 1.326 -0.419 0 C-N-CA 120.389 -0.524 . . . . 0.0 111.115 -179.355 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . 0.612 ' HB3' ' HE1' ' A' ' 51' ' ' MET . . . -67.57 -37.69 82.99 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.211 176.856 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 37.4 t -63.91 -48.04 78.2 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.586 175.867 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 55.0 mt-10 -61.15 -38.43 86.39 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 110.045 -0.354 . . . . 0.0 110.045 177.19 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' MET . . . . . 0.449 ' O ' HG13 ' A' ' 86' ' ' ILE . 48.1 ttp -61.1 -49.38 77.52 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.658 -0.701 . . . . 0.0 111.315 179.611 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . 0.539 HG23 HD21 ' A' ' 67' ' ' LEU . 27.7 m -77.33 -33.06 19.38 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-O 120.813 0.339 . . . . 0.0 110.897 -176.801 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 54.7 ttp -67.11 -33.69 76.0 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 109.427 -0.583 . . . . 0.0 109.427 176.005 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -67.33 -31.2 71.31 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.417 -0.811 . . . . 0.0 110.641 178.106 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.449 HG13 ' O ' ' A' ' 82' ' ' MET . 59.4 mt -61.32 -30.49 48.06 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.304 0 CA-C-O 121.365 0.603 . . . . 0.0 110.17 176.398 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.942 ' HG ' ' HD3' ' A' ' 28' ' ' LYS . 6.9 mp -88.1 -5.87 58.21 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.733 178.844 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 6.0 tmm_? -114.37 -3.79 13.04 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.443 0.64 . . . . 0.0 110.717 -175.161 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . 0.435 ' O ' ' HG3' ' A' ' 89' ' ' GLU . 9.6 pt-20 . . . . . 0 C--O 1.251 1.143 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.895 -177.317 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 55.4 m . . . . . 0 N--CA 1.448 -0.548 0 CA-C-O 120.784 0.326 . . . . 0.0 110.449 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.63 HG23 HG22 ' A' ' 70' ' ' ILE . 92.8 t -116.72 121.18 67.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 N-CA-C 109.71 -0.478 . . . . 0.0 109.71 176.406 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . 0.512 ' HB2' ' CG1' ' A' ' 76' ' ' VAL . 13.1 tt0 -114.18 113.05 24.14 Favored 'General case' 0 C--N 1.315 -0.903 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 177.927 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . 0.6 ' HA ' ' O ' ' A' ' 67' ' ' LEU . 49.7 mt-10 -99.43 112.9 25.01 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.117 179.194 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 12.6 mm -97.24 155.48 3.58 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-N 115.614 -0.721 . . . . 0.0 109.67 179.111 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' MET . . . . . 0.407 ' HA ' ' HE2' ' A' ' 23' ' ' MET . 1.9 mmt -109.15 91.85 3.81 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 175.845 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.656 ' HB ' ' HB2' ' A' ' 65' ' ' LYS . 37.2 mm -79.27 127.31 79.38 Favored Pre-proline 0 C--N 1.319 -0.752 0 CA-C-N 115.859 -0.609 . . . . 0.0 110.629 -175.209 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . 0.679 ' HB2' ' HB2' ' A' ' 28' ' ' LYS . 87.3 Cg_exo -48.14 131.61 22.15 Favored 'Trans proline' 0 C--N 1.343 0.288 0 C-N-CA 122.84 2.36 . . . . 0.0 111.961 177.126 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -59.59 -30.6 68.78 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.701 -175.434 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -94.47 12.51 68.75 Favored Glycine 0 N--CA 1.45 -0.432 0 C-N-CA 120.785 -0.721 . . . . 0.0 112.332 178.743 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . 0.679 ' HB2' ' HB2' ' A' ' 25' ' ' PRO . 16.4 tptt -126.48 8.36 7.07 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.15 0.5 . . . . 0.0 110.263 -179.677 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -70.0 -22.41 63.12 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.14 -176.898 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -67.59 -17.37 68.81 Favored Glycine 0 N--CA 1.445 -0.761 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.412 178.124 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.426 HD12 ' HG3' ' A' ' 28' ' ' LYS . 54.0 mt -87.59 -38.45 15.94 Favored 'General case' 0 C--N 1.328 -0.345 0 O-C-N 122.613 -0.345 . . . . 0.0 111.436 -179.195 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.709 HG13 HD22 ' A' ' 87' ' ' LEU . 2.8 m -70.81 -32.68 49.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.962 0.41 . . . . 0.0 111.043 179.879 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.547 HD13 ' HG3' ' A' ' 55' ' ' GLN . 60.2 mt -83.2 -36.76 13.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-O 121.669 0.747 . . . . 0.0 109.763 175.262 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 101.62 171.76 27.98 Favored Glycine 0 N--CA 1.445 -0.745 0 CA-C-N 114.977 -1.01 . . . . 0.0 111.608 -179.722 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 10.5 mptt -81.6 48.76 1.22 Allowed 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.098 0.475 . . . . 0.0 110.373 178.977 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 170.45 -44.23 0.2 Allowed Glycine 0 N--CA 1.447 -0.619 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.778 179.238 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.441 ' HA2' HG23 ' A' ' 33' ' ' ILE . . . 123.19 -4.31 9.61 Favored Glycine 0 N--CA 1.449 -0.439 0 C-N-CA 120.785 -0.721 . . . . 0.0 111.536 -177.192 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -75.13 -33.46 61.56 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.019 0.438 . . . . 0.0 109.95 178.651 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' THR . . . . . 0.679 ' O ' ' HG ' ' A' ' 43' ' ' LEU . 69.9 m -58.28 -54.39 47.54 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-N 115.583 -0.735 . . . . 0.0 111.198 -176.289 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.531 ' HA ' HD13 ' A' ' 43' ' ' LEU . 10.3 tt -59.77 -34.61 56.23 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.28 0 CA-C-O 120.837 0.351 . . . . 0.0 111.14 179.915 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . 0.443 ' O ' ' HG2' ' A' ' 45' ' ' GLU . 50.1 tttp -62.33 -48.96 77.52 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.339 175.078 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . 0.45 ' O ' ' HG2' ' A' ' 46' ' ' ARG . 72.4 mm-40 -64.69 -33.56 76.24 Favored 'General case' 0 CA--C 1.509 -0.602 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.013 -175.259 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.679 ' HG ' ' O ' ' A' ' 39' ' ' THR . 67.8 mt -58.25 -48.24 81.03 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.413 179.307 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 43.1 mt-30 -65.79 -38.61 89.48 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.534 179.089 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.443 ' HG2' ' O ' ' A' ' 41' ' ' LYS . 60.0 mm-40 -60.69 -52.66 64.17 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.669 177.817 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . 0.45 ' HG2' ' O ' ' A' ' 42' ' ' GLN . 10.7 ptm180 -77.67 -29.93 51.77 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.592 -0.731 . . . . 0.0 112.634 -170.825 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -87.55 -25.87 23.42 Favored 'General case' 0 C--N 1.323 -0.554 0 C-N-CA 120.702 -0.399 . . . . 0.0 111.927 -176.077 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 78.23 24.84 62.75 Favored Glycine 0 N--CA 1.453 -0.215 0 C-N-CA 120.577 -0.82 . . . . 0.0 112.424 -179.812 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 5.9 m -135.75 179.29 4.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 N-CA-C 109.926 -0.398 . . . . 0.0 109.926 177.343 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 60.8 tttp -107.4 124.67 50.18 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.846 179.905 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' MET . . . . . 0.537 ' HE2' ' HB1' ' A' ' 79' ' ' ALA . 37.3 mtt -118.97 116.43 26.44 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 177.639 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.593 ' CG2' ' HB2' ' A' ' 68' ' ' ARG . 10.7 tt -111.22 113.43 44.23 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.899 0 CA-C-O 121.447 0.641 . . . . 0.0 110.733 178.675 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.692 HD22 HD12 ' A' ' 67' ' ' LEU . 2.9 mm? -88.17 102.51 14.87 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.581 -0.736 . . . . 0.0 109.467 175.7 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.818 HD12 ' HB2' ' A' ' 66' ' ' PRO . 65.2 mt -75.82 95.07 1.09 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-O 121.331 0.586 . . . . 0.0 110.011 -179.63 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . 0.558 HE21 ' HB3' ' A' ' 53' ' ' LEU . 84.6 mm-40 . . . . . 0 C--N 1.324 -0.527 0 CA-C-N 115.516 -0.765 . . . . 0.0 110.604 -176.079 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 12.1 m-20 . . . . . 0 C--O 1.227 -0.085 0 CA-C-O 120.887 0.375 . . . . 0.0 110.388 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . 0.656 ' HB2' ' HB ' ' A' ' 24' ' ' ILE . 74.0 mmtt -95.26 127.0 43.98 Favored Pre-proline 0 C--N 1.319 -0.74 0 CA-C-N 116.103 -0.498 . . . . 0.0 111.567 -170.573 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . 0.818 ' HB2' HD12 ' A' ' 54' ' ' ILE . 10.6 Cg_exo -71.63 109.11 2.56 Favored 'Trans proline' 0 N--CA 1.459 -0.525 0 C-N-CA 123.074 2.516 . . . . 0.0 111.318 175.556 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.692 HD12 HD22 ' A' ' 53' ' ' LEU . 23.9 tp -106.04 100.01 9.58 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.986 -0.552 . . . . 0.0 109.848 178.467 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . 0.593 ' HB2' ' CG2' ' A' ' 52' ' ' ILE . 97.6 mtt180 -85.64 105.11 15.97 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.939 0.4 . . . . 0.0 110.242 176.766 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 31.8 mt -92.4 105.04 16.25 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.718 0 N-CA-C 108.116 -1.068 . . . . 0.0 108.116 171.452 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.63 HG22 HG23 ' A' ' 19' ' ' VAL . 14.5 mt -111.4 129.51 66.62 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.909 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.575 -171.357 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 148.32 -124.67 1.92 Allowed Glycine 0 N--CA 1.441 -0.975 0 C-N-CA 119.847 -1.168 . . . . 0.0 113.833 171.115 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . 0.447 ' OD2' ' HG2' ' A' ' 75' ' ' LYS . 4.7 t70 -85.62 128.95 56.78 Favored Pre-proline 0 C--N 1.321 -0.632 0 CA-C-N 115.206 -0.497 . . . . 0.0 111.685 -171.779 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_exo -45.36 -33.64 9.2 Favored 'Trans proline' 0 C--N 1.349 0.596 0 C-N-CA 124.621 3.547 . . . . 0.0 114.346 -175.742 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 90.5 m-85 -74.91 -60.88 2.09 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.069 0.462 . . . . 0.0 110.214 -178.967 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . 0.629 ' HA ' ' HB2' ' A' ' 78' ' ' GLN . 3.8 pttm -74.09 -17.07 61.0 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.745 -0.661 . . . . 0.0 112.586 -173.881 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.512 ' CG1' ' HB2' ' A' ' 20' ' ' GLN . 37.3 t -65.06 -44.35 95.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 121.429 0.633 . . . . 0.0 109.543 170.406 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -74.54 -43.23 56.74 Favored 'General case' 0 N--CA 1.446 -0.651 0 CA-C-N 115.29 -0.868 . . . . 0.0 109.129 -178.402 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . 0.629 ' HB2' ' HA ' ' A' ' 75' ' ' LYS . 61.9 mt-30 -56.71 -36.2 69.4 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.495 -0.775 . . . . 0.0 110.661 175.269 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . 0.537 ' HB1' ' HE2' ' A' ' 51' ' ' MET . . . -68.38 -45.08 73.7 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.608 -0.724 . . . . 0.0 110.917 177.957 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' CYS . . . . . 0.404 ' HB2' ' OE1' ' A' ' 20' ' ' GLN . 33.4 t -54.84 -56.71 16.5 Favored 'General case' 0 CA--C 1.518 -0.278 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.968 178.516 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -63.42 -27.08 69.05 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 120.77 -0.372 . . . . 0.0 110.877 -178.647 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' MET . . . . . 0.514 ' HE1' ' HA ' ' A' ' 79' ' ' ALA . 47.7 ttp -73.59 -49.67 25.09 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.434 179.839 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . 0.523 HG13 HD11 ' A' ' 43' ' ' LEU . 34.2 m -76.39 -32.75 22.22 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-O 120.853 0.359 . . . . 0.0 110.591 -175.626 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' MET . . . . . 0.448 ' O ' ' HG3' ' A' ' 88' ' ' ARG . 45.2 ttm -68.56 -31.62 70.95 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.075 -0.511 . . . . 0.0 109.859 177.041 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . 0.48 ' HA ' ' HD2' ' A' ' 88' ' ' ARG . 21.4 t70 -62.81 -40.45 97.42 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.892 -0.595 . . . . 0.0 111.113 178.602 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 42.1 mt -61.08 -29.97 46.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.445 179.279 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.709 HD22 HG13 ' A' ' 32' ' ' VAL . 61.2 mt -79.0 -20.89 47.93 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.384 -177.434 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . 0.48 ' HD2' ' HA ' ' A' ' 85' ' ' ASP . 0.0 OUTLIER -117.99 27.56 8.93 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.17 0.51 . . . . 0.0 110.935 -179.84 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 44.9 tt0 . . . . . 0 C--O 1.248 1.007 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.174 179.551 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' THR . . . . . 0.406 ' HB ' HG21 ' A' ' 76' ' ' VAL . 58.8 m . . . . . 0 N--CA 1.446 -0.627 0 N-CA-C 109.63 -0.508 . . . . 0.0 109.63 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.499 ' HA ' ' O ' ' A' ' 69' ' ' ILE . 5.2 p -132.19 126.42 56.01 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-O 121.237 0.541 . . . . 0.0 110.999 179.693 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . 0.402 ' OE1' HG13 ' A' ' 76' ' ' VAL . 55.1 mt-30 -115.5 119.91 37.74 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.561 177.017 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . 0.624 ' HA ' ' O ' ' A' ' 67' ' ' LEU . 49.8 mt-10 -92.03 111.9 23.62 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.244 0.545 . . . . 0.0 110.546 177.429 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 15.8 mm -104.0 155.63 5.73 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-N 115.331 -0.85 . . . . 0.0 109.695 -178.347 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' MET . . . . . 0.514 ' HB3' ' HB3' ' A' ' 64' ' ' ASP . 80.6 mmm -108.43 104.97 14.43 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 176.227 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.631 ' HB ' ' HB2' ' A' ' 65' ' ' LYS . 30.5 mm -91.23 125.0 59.84 Favored Pre-proline 0 C--N 1.321 -0.656 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.115 -174.117 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . 0.549 ' HB2' ' HB3' ' A' ' 28' ' ' LYS . 76.9 Cg_exo -50.3 140.52 33.94 Favored 'Trans proline' 0 CA--C 1.535 0.555 0 C-N-CA 122.845 2.363 . . . . 0.0 113.019 179.715 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -48.88 -61.75 1.88 Allowed 'General case' 0 N--CA 1.468 0.454 0 N-CA-C 113.42 0.896 . . . . 0.0 113.42 -170.605 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -78.67 -25.64 60.26 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.712 -0.756 . . . . 0.0 111.883 -177.334 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . 0.549 ' HB3' ' HB2' ' A' ' 25' ' ' PRO . 13.0 tppt? -67.57 -19.18 65.23 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.99 0.424 . . . . 0.0 110.875 178.891 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . 0.454 ' O ' HG13 ' A' ' 32' ' ' VAL . . . -59.66 -23.5 63.13 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.415 179.802 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -60.58 -27.03 65.47 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.855 -0.688 . . . . 0.0 112.16 176.598 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 92.5 mt -87.61 -33.53 18.82 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.643 0.258 . . . . 0.0 110.705 179.787 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.454 HG13 ' O ' ' A' ' 29' ' ' ALA . 0.9 OUTLIER -73.55 -31.27 32.1 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.387 0 CA-C-O 121.071 0.463 . . . . 0.0 110.916 -178.711 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.502 HG23 ' HA2' ' A' ' 37' ' ' GLY . 75.6 mt -84.87 -44.64 17.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 116.01 -0.541 . . . . 0.0 109.89 176.117 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 132.46 170.16 12.45 Favored Glycine 0 N--CA 1.441 -1.004 0 C-N-CA 120.242 -0.98 . . . . 0.0 112.936 174.606 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.425 ' N ' ' HD3' ' A' ' 35' ' ' LYS . 3.3 mppt? -69.36 -28.52 66.28 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.025 0.44 . . . . 0.0 109.879 -179.114 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -136.69 19.18 3.56 Favored Glycine 0 N--CA 1.447 -0.568 0 C-N-CA 120.825 -0.702 . . . . 0.0 111.355 175.592 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.502 ' HA2' HG23 ' A' ' 33' ' ' ILE . . . 78.57 5.92 88.13 Favored Glycine 0 C--O 1.226 -0.4 0 C-N-CA 120.913 -0.661 . . . . 0.0 112.072 -176.885 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -85.53 -24.18 27.39 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 120.887 0.375 . . . . 0.0 111.537 -178.587 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' THR . . . . . 0.637 ' O ' ' HG ' ' A' ' 43' ' ' LEU . 31.5 m -64.26 -48.97 73.72 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.232 -176.415 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.546 ' HA ' HD13 ' A' ' 43' ' ' LEU . 5.3 tt -55.72 -30.43 27.23 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.342 0 CA-C-O 121.071 0.462 . . . . 0.0 111.513 179.757 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . 0.437 ' O ' ' HG2' ' A' ' 45' ' ' GLU . 7.8 tmtm? -74.47 -39.58 62.42 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.055 -0.52 . . . . 0.0 109.758 -178.904 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 25.4 mt-30 -67.82 -35.62 78.93 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.825 -179.702 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.637 ' HG ' ' O ' ' A' ' 39' ' ' THR . 47.7 mt -58.5 -42.65 88.14 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.454 -179.224 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 65.9 mt-30 -62.69 -39.88 95.37 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.629 179.595 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.437 ' HG2' ' O ' ' A' ' 41' ' ' LYS . 34.6 mm-40 -74.07 -51.2 16.5 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.382 -176.727 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 17.5 ptm180 -66.63 -37.46 84.9 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.966 -0.561 . . . . 0.0 112.25 -171.798 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . 0.403 ' HB2' HG22 ' A' ' 49' ' ' VAL . . . -95.77 -13.39 24.16 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 120.969 0.414 . . . . 0.0 111.391 -176.795 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 69.19 31.17 71.74 Favored Glycine 0 N--CA 1.449 -0.467 0 N-CA-C 111.274 -0.73 . . . . 0.0 111.274 -176.082 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.434 ' CG1' ' HB2' ' A' ' 75' ' ' LYS . 34.4 m -113.04 166.84 6.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-O 120.809 0.337 . . . . 0.0 110.394 -175.735 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -111.65 123.33 50.0 Favored 'General case' 0 C--N 1.318 -0.794 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 171.211 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' MET . . . . . 0.708 ' HE1' HG13 ' A' ' 83' ' ' VAL . 75.8 mtp -123.8 115.32 21.17 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 109.806 -0.442 . . . . 0.0 109.806 178.643 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.488 ' CG2' ' HB2' ' A' ' 68' ' ' ARG . 6.8 tt -104.43 105.84 19.27 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.837 0 CA-C-O 121.437 0.636 . . . . 0.0 109.977 178.432 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.633 HD21 HD11 ' A' ' 67' ' ' LEU . 2.5 mm? -78.28 102.64 7.76 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.681 -0.691 . . . . 0.0 109.594 177.007 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.447 ' HB ' ' HB2' ' A' ' 66' ' ' PRO . 60.8 mt -87.5 85.89 2.51 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-O 121.509 0.671 . . . . 0.0 109.467 -178.239 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 1.3 pt20 . . . . . 0 C--N 1.321 -0.635 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.834 -177.162 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . 0.514 ' HB3' ' HB3' ' A' ' 23' ' ' MET . 1.9 m-20 . . . . . 0 CA--C 1.531 0.222 0 CA-C-O 121.412 0.625 . . . . 0.0 111.981 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . 0.631 ' HB2' ' HB ' ' A' ' 24' ' ' ILE . 71.7 mmtt -99.35 127.59 34.09 Favored Pre-proline 0 C--N 1.322 -0.594 0 CA-C-N 115.156 -0.929 . . . . 0.0 111.49 -174.176 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . 0.447 ' HB2' ' HB ' ' A' ' 54' ' ' ILE . 38.7 Cg_exo -65.03 114.33 2.76 Favored 'Trans proline' 0 CA--C 1.533 0.434 0 C-N-CA 122.896 2.397 . . . . 0.0 111.719 169.619 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.633 HD11 HD21 ' A' ' 53' ' ' LEU . 28.7 tp -122.95 126.58 47.49 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 120.588 0.232 . . . . 0.0 111.114 179.809 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . 0.51 ' HG2' ' HG2' ' A' ' 21' ' ' GLU . 96.4 mtt180 -109.19 115.93 30.95 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 120.674 0.273 . . . . 0.0 111.519 176.086 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . 0.499 ' O ' ' HA ' ' A' ' 19' ' ' VAL . 4.5 mp -97.62 115.8 38.46 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 N-CA-C 108.423 -0.954 . . . . 0.0 108.423 170.866 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 15.0 mt -119.38 140.66 42.6 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.569 -174.473 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 157.36 -160.12 30.28 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.877 -0.678 . . . . 0.0 112.165 176.738 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . 0.546 ' H ' ' HD2' ' A' ' 75' ' ' LYS . 1.0 OUTLIER -61.99 137.19 95.44 Favored Pre-proline 0 N--CA 1.447 -0.617 0 N-CA-C 108.631 -0.877 . . . . 0.0 108.631 174.477 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_exo -42.47 -41.17 7.71 Favored 'Trans proline' 0 CA--C 1.534 0.478 0 C-N-CA 122.825 2.35 . . . . 0.0 114.219 -173.462 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 73.3 m-85 -69.52 -51.61 34.14 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.111 -0.495 . . . . 0.0 112.191 -175.136 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . 0.546 ' HD2' ' H ' ' A' ' 72' ' ' ASP . 16.9 ptpt -62.92 -32.34 73.6 Favored 'General case' 0 C--O 1.222 -0.349 0 CA-C-N 116.687 -0.233 . . . . 0.0 110.689 -179.024 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.486 HG23 ' O ' ' A' ' 72' ' ' ASP . 96.6 t -56.89 -48.05 82.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 120.771 0.319 . . . . 0.0 110.329 177.849 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 1.6 mm100 -71.14 -42.46 69.14 Favored 'General case' 0 N--CA 1.45 -0.456 0 CA-C-N 116.4 -0.363 . . . . 0.0 111.332 178.158 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 47.1 mt-30 -60.17 -42.37 94.82 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.717 0.294 . . . . 0.0 111.069 178.955 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . 0.547 ' HA ' ' HE2' ' A' ' 82' ' ' MET . . . -71.34 -36.43 71.53 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.766 178.917 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 49.8 t -61.17 -54.9 38.62 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.229 176.51 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -61.59 -30.05 70.43 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.885 0.374 . . . . 0.0 110.599 179.247 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' MET . . . . . 0.547 ' HE2' ' HA ' ' A' ' 79' ' ' ALA . 52.5 ttp -64.74 -53.29 49.45 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.886 178.534 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . 0.708 HG13 ' HE1' ' A' ' 51' ' ' MET . 32.9 m -78.65 -33.24 16.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-O 120.656 0.265 . . . . 0.0 110.863 -176.254 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 59.8 ttp -66.51 -35.61 80.67 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.106 178.678 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -60.27 -38.38 83.38 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.62 176.76 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 48.6 mt -66.7 -27.25 39.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-O 121.273 0.559 . . . . 0.0 110.339 178.735 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.615 ' HG ' ' O ' ' A' ' 83' ' ' VAL . 35.4 mt -91.71 -28.12 17.64 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.273 -176.774 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . 0.423 HH11 ' HD2' ' A' ' 88' ' ' ARG . 12.9 mmt180 -85.99 -13.07 48.68 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.316 0.579 . . . . 0.0 111.117 -179.287 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 . . . . . 0 C--N 1.312 -1.064 0 CA-C-N 115.359 -0.837 . . . . 0.0 110.028 -178.009 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' THR . . . . . 0.42 HG21 ' HA ' ' A' ' 73' ' ' PRO . 16.1 m . . . . . 0 N--CA 1.453 -0.312 0 CA-C-O 120.661 0.267 . . . . 0.0 110.712 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 60.5 t -131.71 131.86 62.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.423 179.884 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 28.6 mt-30 -120.84 114.8 22.13 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.086 173.803 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . 0.567 ' HA ' ' O ' ' A' ' 67' ' ' LEU . 48.5 mt-10 -86.61 119.65 27.08 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.958 -0.564 . . . . 0.0 111.052 178.812 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.469 ' HB ' ' HB3' ' A' ' 67' ' ' LEU . 14.9 mm -105.68 163.43 4.56 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 115.341 -0.845 . . . . 0.0 110.091 -178.395 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' MET . . . . . 0.434 ' HB3' ' HB3' ' A' ' 64' ' ' ASP . 2.3 mmt -109.75 94.89 5.26 Favored 'General case' 0 N--CA 1.453 -0.324 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 176.049 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.725 ' HB ' ' HB2' ' A' ' 65' ' ' LYS . 36.5 mm -82.78 126.48 72.99 Favored Pre-proline 0 C--N 1.318 -0.775 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.178 -174.589 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . 0.68 ' HD2' HD11 ' A' ' 87' ' ' LEU . 84.6 Cg_exo -47.39 124.87 9.89 Favored 'Trans proline' 0 C--N 1.346 0.407 0 C-N-CA 123.132 2.555 . . . . 0.0 112.533 178.621 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -63.69 -34.38 77.72 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.645 -0.707 . . . . 0.0 111.872 -174.359 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -90.88 -3.75 70.24 Favored Glycine 0 N--CA 1.448 -0.543 0 C-N-CA 120.609 -0.805 . . . . 0.0 112.93 -178.724 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . 0.462 ' HB3' ' HB2' ' A' ' 25' ' ' PRO . 43.4 tttt -121.44 17.17 11.35 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.222 0.534 . . . . 0.0 110.759 -176.93 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . 0.44 ' O ' HG11 ' A' ' 32' ' ' VAL . . . -70.57 -21.15 62.72 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.901 -0.591 . . . . 0.0 111.275 -178.27 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -65.39 -18.19 65.09 Favored Glycine 0 C--O 1.227 -0.308 0 C-N-CA 121.11 -0.567 . . . . 0.0 112.646 178.458 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.61 ' HB3' HG21 ' A' ' 86' ' ' ILE . 66.1 mt -88.53 -41.57 12.63 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.619 0.247 . . . . 0.0 110.939 178.819 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.714 ' HB ' HD22 ' A' ' 87' ' ' LEU . 4.3 p -69.67 -33.65 57.5 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.435 0 CA-C-O 121.334 0.587 . . . . 0.0 110.824 -178.718 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.574 ' HA ' ' HB ' ' A' ' 40' ' ' ILE . 76.6 mt -90.35 -39.87 12.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-N 115.591 -0.731 . . . . 0.0 110.59 179.061 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 107.63 151.39 16.83 Favored Glycine 0 N--CA 1.443 -0.838 0 CA-C-N 115.756 -0.656 . . . . 0.0 111.777 -179.075 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.505 ' HE3' HD22 ' A' ' 31' ' ' LEU . 0.2 OUTLIER -68.81 -11.34 60.31 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.719 0.295 . . . . 0.0 111.31 -178.088 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -137.36 17.83 3.52 Favored Glycine 0 N--CA 1.449 -0.483 0 C-N-CA 120.715 -0.755 . . . . 0.0 111.693 176.639 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 69.78 1.55 32.07 Favored Glycine 0 CA--C 1.521 0.411 0 C-N-CA 121.248 -0.501 . . . . 0.0 112.785 -177.655 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -69.9 -35.99 75.05 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.834 0.35 . . . . 0.0 111.114 -178.171 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' THR . . . . . 0.753 ' O ' ' HG ' ' A' ' 43' ' ' LEU . 93.8 m -57.72 -61.21 2.68 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.092 -179.304 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.622 ' HA ' HD11 ' A' ' 43' ' ' LEU . 7.6 tt -60.33 -29.83 44.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 116.045 -0.525 . . . . 0.0 112.09 -175.243 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 11.6 tmtt? -74.58 -42.34 58.9 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 109.86 -0.422 . . . . 0.0 109.86 -179.381 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . 0.518 ' O ' ' HG2' ' A' ' 46' ' ' ARG . 47.6 mt-30 -66.09 -31.72 72.76 Favored 'General case' 0 CA--C 1.517 -0.303 0 CA-C-O 120.961 0.41 . . . . 0.0 110.469 -179.305 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.753 ' HG ' ' O ' ' A' ' 39' ' ' THR . 44.4 mt -61.89 -33.25 73.88 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.674 -179.995 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 65.0 mt-30 -71.66 -23.03 61.6 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.433 0.635 . . . . 0.0 110.547 179.661 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 68.5 mm-40 -87.86 -55.1 3.91 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.82 -179.885 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . 0.518 ' HG2' ' O ' ' A' ' 42' ' ' GLN . 14.6 ptp180 -69.84 -30.87 68.47 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 113.02 0.748 . . . . 0.0 113.02 -172.492 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . 0.53 ' HB2' HG22 ' A' ' 49' ' ' VAL . . . -95.48 -18.56 20.57 Favored 'General case' 0 C--N 1.323 -0.553 0 C-N-CA 120.736 -0.386 . . . . 0.0 111.594 -176.487 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 75.74 17.45 80.1 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.83 -0.7 . . . . 0.0 112.212 -179.415 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.53 HG22 ' HB2' ' A' ' 47' ' ' ALA . 21.2 m -116.1 166.41 10.23 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-O 120.809 0.338 . . . . 0.0 110.279 179.846 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 85.6 tttt -108.66 121.29 44.71 Favored 'General case' 0 C--N 1.314 -0.952 0 N-CA-C 108.474 -0.935 . . . . 0.0 108.474 169.31 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' MET . . . . . 0.877 ' HE3' HG11 ' A' ' 83' ' ' VAL . 15.9 mtm -114.08 115.3 27.34 Favored 'General case' 0 C--N 1.316 -0.855 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 177.268 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.567 ' CG2' ' HB2' ' A' ' 68' ' ' ARG . 11.6 tt -100.34 106.94 20.07 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.084 0 CA-C-O 121.418 0.628 . . . . 0.0 110.348 179.561 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.856 HD22 HD11 ' A' ' 67' ' ' LEU . 3.0 mm? -72.78 101.52 3.13 Favored 'General case' 0 N--CA 1.445 -0.675 0 N-CA-C 107.382 -1.34 . . . . 0.0 107.382 171.165 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.668 HD12 ' HB2' ' A' ' 66' ' ' PRO . 62.8 mt -73.54 86.24 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.482 0 CA-C-O 122.078 0.942 . . . . 0.0 111.135 -170.852 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 32.3 mt-30 . . . . . 0 C--N 1.321 -0.654 0 CA-C-N 114.209 -1.359 . . . . 0.0 107.742 170.223 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . 0.434 ' HB3' ' HB3' ' A' ' 23' ' ' MET . 1.1 m-20 . . . . . 0 N--CA 1.456 -0.165 0 CA-C-O 121.05 0.452 . . . . 0.0 110.743 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . 0.725 ' HB2' ' HB ' ' A' ' 24' ' ' ILE . 30.3 mmtp -90.55 132.67 34.56 Favored Pre-proline 0 C--N 1.322 -0.609 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.988 -170.355 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . 0.668 ' HB2' HD12 ' A' ' 54' ' ' ILE . 17.4 Cg_exo -68.16 110.45 2.21 Favored 'Trans proline' 0 N--CA 1.456 -0.708 0 C-N-CA 122.684 2.256 . . . . 0.0 110.965 173.802 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.856 HD11 HD22 ' A' ' 53' ' ' LEU . 30.0 tp -108.6 114.05 27.55 Favored 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 110.138 -0.319 . . . . 0.0 110.138 178.064 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . 0.567 ' HB2' ' CG2' ' A' ' 52' ' ' ILE . 97.3 mtt180 -99.46 106.19 18.21 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 116.487 -0.324 . . . . 0.0 110.479 176.254 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . 0.512 ' HB ' HG11 ' A' ' 76' ' ' VAL . 4.5 mp -86.39 103.93 13.34 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 N-CA-C 107.855 -1.165 . . . . 0.0 107.855 170.196 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 31.1 mt -101.57 116.12 44.59 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.867 0 CA-C-N 115.534 -0.757 . . . . 0.0 110.19 -174.282 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 177.19 -123.99 0.92 Allowed Glycine 0 N--CA 1.442 -0.935 0 C-N-CA 120.42 -0.895 . . . . 0.0 112.258 178.945 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -119.46 141.85 31.55 Favored Pre-proline 0 C--N 1.318 -0.793 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 -177.631 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . 0.42 ' HA ' HG21 ' A' ' 18' ' ' THR . 82.8 Cg_exo -43.66 -38.03 8.87 Favored 'Trans proline' 0 C--N 1.35 0.611 0 C-N-CA 123.064 2.509 . . . . 0.0 113.212 -173.003 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . 0.409 ' O ' ' HG3' ' A' ' 78' ' ' GLN . 47.3 t80 -66.18 -61.99 1.72 Allowed 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.65 -0.705 . . . . 0.0 111.491 -177.416 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . 0.419 ' HB2' HG12 ' A' ' 49' ' ' VAL . 35.3 pttt -67.37 -33.81 75.99 Favored 'General case' 0 N--CA 1.464 0.265 0 C-N-CA 121.103 -0.239 . . . . 0.0 111.573 179.75 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.512 HG11 ' HB ' ' A' ' 69' ' ' ILE . 51.3 t -57.85 -39.54 71.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.805 0.336 . . . . 0.0 110.514 177.672 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . 0.552 ' O ' ' HG2' ' A' ' 81' ' ' GLU . 1.9 mm100 -74.31 -44.78 51.14 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 120.651 -0.42 . . . . 0.0 111.407 178.206 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . 0.409 ' HG3' ' O ' ' A' ' 74' ' ' TYR . 47.0 mt-30 -57.65 -43.99 85.32 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-O 121.361 0.6 . . . . 0.0 110.166 179.398 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . 0.613 ' HA ' ' HE1' ' A' ' 82' ' ' MET . . . -66.6 -40.35 88.81 Favored 'General case' 0 N--CA 1.446 -0.675 0 CA-C-N 115.257 -0.883 . . . . 0.0 110.829 -179.693 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 45.0 t -63.21 -57.2 11.27 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.217 179.596 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . 0.552 ' HG2' ' O ' ' A' ' 77' ' ' GLN . 10.2 pt-20 -63.41 -20.18 65.32 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.981 0.419 . . . . 0.0 110.921 -177.456 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' MET . . . . . 0.613 ' HE1' ' HA ' ' A' ' 79' ' ' ALA . 37.7 ttp -75.56 -52.11 11.37 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.436 177.101 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . 0.877 HG11 ' HE3' ' A' ' 51' ' ' MET . 27.9 m -79.61 -29.77 13.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.083 -174.666 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' MET . . . . . 0.586 ' O ' ' HG3' ' A' ' 88' ' ' ARG . 14.8 tpt -66.62 -31.74 72.63 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.086 -0.506 . . . . 0.0 109.686 177.397 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -62.53 -39.16 92.68 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-O 120.894 0.378 . . . . 0.0 110.667 177.122 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.61 HG21 ' HB3' ' A' ' 31' ' ' LEU . 18.7 mt -62.84 -19.2 22.72 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.401 179.136 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.714 HD22 ' HB ' ' A' ' 32' ' ' VAL . 65.5 mt -102.32 -40.45 6.74 Favored 'General case' 0 N--CA 1.449 -0.488 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.786 -175.582 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . 0.586 ' HG3' ' O ' ' A' ' 84' ' ' MET . 0.0 OUTLIER -78.08 -4.15 45.86 Favored 'General case' 0 N--CA 1.464 0.246 0 C-N-CA 120.471 -0.492 . . . . 0.0 111.87 -178.73 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . 0.437 ' C ' ' HZ2' ' A' ' 28' ' ' LYS . 38.5 tt0 . . . . . 0 C--O 1.249 1.049 0 CA-C-O 118.372 -0.823 . . . . 0.0 109.39 177.287 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' THR . . . . . 0.449 HG22 ' HA ' ' A' ' 73' ' ' PRO . 87.6 m . . . . . 0 C--O 1.231 0.102 0 CA-C-O 120.699 0.285 . . . . 0.0 110.423 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.434 ' HA ' ' O ' ' A' ' 69' ' ' ILE . 90.5 t -138.01 122.06 21.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.882 -177.014 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 26.0 mt-30 -107.27 118.07 35.74 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 109.891 -0.411 . . . . 0.0 109.891 172.688 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . 0.538 ' HA ' ' O ' ' A' ' 67' ' ' LEU . 42.2 mt-10 -90.29 115.76 27.74 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.061 0.458 . . . . 0.0 111.026 176.233 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 12.8 mm -109.33 151.2 11.7 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-N 115.394 -0.821 . . . . 0.0 109.41 177.995 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 86.7 mmm -104.42 98.1 7.93 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 174.591 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.666 ' HB ' ' HB2' ' A' ' 65' ' ' LYS . 36.8 mm -81.49 129.79 64.52 Favored Pre-proline 0 C--N 1.316 -0.863 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.487 -175.491 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . 0.515 ' HB2' ' HB2' ' A' ' 28' ' ' LYS . 86.5 Cg_exo -46.68 128.11 12.64 Favored 'Trans proline' 0 C--N 1.347 0.497 0 C-N-CA 123.019 2.479 . . . . 0.0 112.451 177.891 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -45.43 -55.84 5.66 Favored 'General case' 0 C--O 1.234 0.254 0 N-CA-C 113.093 0.775 . . . . 0.0 113.093 -170.811 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -81.61 -4.87 90.27 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.837 -0.697 . . . . 0.0 113.066 -174.897 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . 0.515 ' HB2' ' HB2' ' A' ' 25' ' ' PRO . 1.8 tptp -95.79 -8.51 34.14 Favored 'General case' 0 C--N 1.323 -0.558 0 O-C-N 122.673 -0.31 . . . . 0.0 110.198 -177.987 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . 0.616 ' HA ' HG21 ' A' ' 32' ' ' VAL . . . -63.89 -24.32 67.69 Favored 'General case' 0 N--CA 1.461 0.11 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.169 -179.982 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -58.76 -27.43 61.65 Favored Glycine 0 C--O 1.227 -0.319 0 C-N-CA 121.052 -0.595 . . . . 0.0 112.456 178.983 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 84.3 mt -82.86 -34.61 26.75 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.672 0.272 . . . . 0.0 111.143 -178.748 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.713 HG23 HD23 ' A' ' 87' ' ' LEU . 0.0 OUTLIER -74.08 -36.19 43.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.865 0.364 . . . . 0.0 110.345 178.399 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.575 HG12 ' O ' ' A' ' 29' ' ' ALA . 14.5 mm -78.35 -43.06 26.95 Favored 'Isoleucine or valine' 0 C--O 1.235 0.302 0 CA-C-O 121.482 0.658 . . . . 0.0 109.7 178.867 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 111.04 173.26 19.81 Favored Glycine 0 N--CA 1.439 -1.122 0 CA-C-N 115.374 -0.83 . . . . 0.0 112.051 178.365 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 31.1 mmmt -75.36 -22.38 57.6 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 120.853 0.359 . . . . 0.0 110.309 -178.913 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -130.93 -5.31 3.94 Favored Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.586 -0.816 . . . . 0.0 112.162 179.489 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 100.56 -1.09 55.61 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.736 -0.745 . . . . 0.0 111.924 -178.207 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -78.0 -21.43 50.86 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.652 0.263 . . . . 0.0 111.158 -178.865 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' THR . . . . . 0.789 ' O ' ' HG ' ' A' ' 43' ' ' LEU . 31.3 m -69.38 -50.86 42.19 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.577 -0.283 . . . . 0.0 110.691 -178.165 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.563 ' HB ' ' HA ' ' A' ' 33' ' ' ILE . 11.6 tt -67.13 -25.18 33.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-O 121.439 0.637 . . . . 0.0 110.448 177.317 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 22.4 tptm -63.24 -53.0 59.89 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.738 175.539 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . 0.4 ' O ' ' HG2' ' A' ' 46' ' ' ARG . 8.9 pt20 -68.78 -37.05 79.04 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.395 -175.023 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.789 ' HG ' ' O ' ' A' ' 39' ' ' THR . 84.4 mt -53.86 -39.65 65.86 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.743 -0.662 . . . . 0.0 111.532 179.632 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . 0.445 ' HG3' ' O ' ' A' ' 40' ' ' ILE . 44.9 mt-30 -69.78 -40.97 75.74 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.219 0.533 . . . . 0.0 110.813 -179.61 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 10.2 mm-40 -72.32 -40.51 67.39 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.668 -0.696 . . . . 0.0 111.705 -175.78 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . 0.4 ' HG2' ' O ' ' A' ' 42' ' ' GLN . 12.0 ptp180 -71.42 -34.24 70.16 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 112.375 0.509 . . . . 0.0 112.375 -174.458 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . 0.587 ' HB1' HG21 ' A' ' 49' ' ' VAL . . . -99.11 -5.92 29.28 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 112.224 0.453 . . . . 0.0 112.224 -173.587 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 66.27 30.39 76.64 Favored Glycine 0 C--N 1.33 0.225 0 C-N-CA 120.818 -0.706 . . . . 0.0 112.046 -178.627 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.587 HG21 ' HB1' ' A' ' 47' ' ' ALA . 26.8 m -125.11 179.58 3.0 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 N-CA-C 109.724 -0.472 . . . . 0.0 109.724 -178.351 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 64.6 tttp -122.48 125.53 45.98 Favored 'General case' 0 C--N 1.314 -0.938 0 CA-C-N 116.027 -0.533 . . . . 0.0 109.817 167.501 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' MET . . . . . 0.97 ' HE3' ' HB3' ' A' ' 79' ' ' ALA . 48.5 mtt -110.75 114.76 28.37 Favored 'General case' 0 C--N 1.315 -0.931 0 N-CA-C 108.418 -0.956 . . . . 0.0 108.418 176.471 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.54 ' CG2' ' HB2' ' A' ' 68' ' ' ARG . 8.9 tt -106.09 105.04 17.96 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.939 0 CA-C-O 121.521 0.677 . . . . 0.0 110.141 177.729 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.509 HD21 ' CD1' ' A' ' 40' ' ' ILE . 4.2 mm? -88.44 101.91 14.37 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.168 -0.924 . . . . 0.0 108.936 174.994 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.504 HD13 ' HB2' ' A' ' 66' ' ' PRO . 51.3 mt -78.98 86.55 1.16 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 178.604 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . 0.471 ' HA ' ' HD2' ' A' ' 65' ' ' LYS . 3.4 pp0? . . . . . 0 C--N 1.322 -0.587 0 CA-C-N 115.626 -0.715 . . . . 0.0 111.592 -174.843 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 25.2 m-20 . . . . . 0 C--O 1.23 0.074 0 CA-C-O 121.048 0.451 . . . . 0.0 110.524 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . 0.666 ' HB2' ' HB ' ' A' ' 24' ' ' ILE . 71.9 mmtt -99.76 121.5 54.22 Favored Pre-proline 0 C--N 1.318 -0.772 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.787 -170.286 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . 0.504 ' HB2' HD13 ' A' ' 54' ' ' ILE . 23.3 Cg_exo -66.26 106.86 1.08 Allowed 'Trans proline' 0 N--CA 1.46 -0.483 0 C-N-CA 122.801 2.334 . . . . 0.0 110.969 173.02 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.538 ' O ' ' HA ' ' A' ' 21' ' ' GLU . 19.3 tp -108.71 112.03 24.11 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.402 -179.866 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . 0.54 ' HB2' ' CG2' ' A' ' 52' ' ' ILE . 98.8 mtt180 -101.58 108.21 19.7 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.365 174.802 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . 0.442 ' HB ' HG11 ' A' ' 76' ' ' VAL . 4.9 mp -87.31 104.41 14.21 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 N-CA-C 108.308 -0.997 . . . . 0.0 108.308 170.995 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 18.6 mt -99.87 120.99 50.03 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 CA-C-N 115.85 -0.613 . . . . 0.0 110.533 -174.502 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 173.57 -135.93 3.44 Favored Glycine 0 CA--C 1.518 0.258 0 C-N-CA 120.807 -0.711 . . . . 0.0 112.985 179.161 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . 0.57 ' OD1' ' HE2' ' A' ' 75' ' ' LYS . 1.5 m-20 -103.28 157.77 33.13 Favored Pre-proline 0 C--N 1.325 -0.481 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 179.684 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . 0.449 ' HA ' HG22 ' A' ' 18' ' ' THR . 82.0 Cg_exo -48.17 -39.28 34.03 Favored 'Trans proline' 0 C--O 1.234 0.29 0 C-N-CA 122.156 1.904 . . . . 0.0 112.367 179.732 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 32.4 m-85 -67.27 -62.99 1.15 Allowed 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.225 -178.617 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . 0.57 ' HE2' ' OD1' ' A' ' 72' ' ' ASP . 41.2 pttt -67.66 -25.83 65.91 Favored 'General case' 0 C--O 1.22 -0.449 0 CA-C-N 116.333 -0.394 . . . . 0.0 112.041 -174.052 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.442 HG11 ' HB ' ' A' ' 69' ' ' ILE . 56.1 t -71.76 -35.1 54.07 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-O 121.165 0.507 . . . . 0.0 110.037 177.97 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -74.04 -51.67 15.1 Favored 'General case' 0 N--CA 1.448 -0.563 0 N-CA-C 108.636 -0.876 . . . . 0.0 108.636 178.32 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 92.0 mt-30 -59.93 -39.34 85.14 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.473 -179.245 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . 0.97 ' HB3' ' HE3' ' A' ' 51' ' ' MET . . . -68.07 -36.59 80.09 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.168 178.851 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 52.2 t -67.26 -47.06 71.85 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.803 -178.937 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -70.24 -19.15 63.16 Favored 'General case' 0 C--N 1.325 -0.496 0 C-N-CA 120.344 -0.542 . . . . 0.0 110.632 178.159 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' MET . . . . . 0.42 ' O ' ' HB3' ' A' ' 85' ' ' ASP . 48.8 ttp -75.43 -47.71 26.09 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.468 175.374 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . 0.568 ' O ' ' HG ' ' A' ' 87' ' ' LEU . 28.3 m -72.29 -33.2 45.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 C-N-CA 120.963 -0.295 . . . . 0.0 110.831 -179.874 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 54.4 mtt -67.61 -27.4 66.87 Favored 'General case' 0 CA--C 1.519 -0.235 0 CA-C-O 120.83 0.348 . . . . 0.0 110.173 174.865 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . 0.517 ' O ' ' HG2' ' A' ' 88' ' ' ARG . 8.0 t70 -65.1 -45.33 85.59 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.597 176.115 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 38.9 mt -63.19 -22.62 31.2 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.644 179.196 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.713 HD23 HG23 ' A' ' 32' ' ' VAL . 64.7 mt -97.24 -12.33 23.1 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.708 -176.322 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . 0.668 ' HG3' ' HG2' ' A' ' 89' ' ' GLU . 29.5 ptt180 -101.16 -24.06 14.34 Favored 'General case' 0 CA--C 1.515 -0.37 0 CA-C-O 121.633 0.73 . . . . 0.0 110.088 -177.137 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . 0.668 ' HG2' ' HG3' ' A' ' 88' ' ' ARG . 37.7 mm-40 . . . . . 0 C--N 1.312 -1.047 0 CA-C-N 114.422 -1.263 . . . . 0.0 110.704 -171.475 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' THR . . . . . 0.505 HG22 ' HA ' ' A' ' 73' ' ' PRO . 95.9 m . . . . . 0 N--CA 1.456 -0.125 0 CA-C-O 120.93 0.395 . . . . 0.0 111.35 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.961 ' HB ' HD11 ' A' ' 70' ' ' ILE . 0.2 OUTLIER -138.24 128.4 34.85 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 115.648 -0.705 . . . . 0.0 110.932 -179.761 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 27.9 mt-30 -118.31 116.04 25.95 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.881 -0.6 . . . . 0.0 109.951 174.148 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . 0.513 ' HG3' ' HG2' ' A' ' 68' ' ' ARG . 4.5 mp0 -86.61 107.75 18.3 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.119 0.485 . . . . 0.0 110.851 178.784 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.428 HD11 ' HE3' ' A' ' 84' ' ' MET . 23.1 mm -88.18 156.03 3.17 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-N 115.67 -0.695 . . . . 0.0 110.046 -178.08 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' MET . . . . . 0.506 ' HE3' ' HA ' ' A' ' 23' ' ' MET . 14.3 mmt -105.83 91.79 3.89 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 109.618 -0.512 . . . . 0.0 109.618 176.653 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.686 ' HB ' ' HB2' ' A' ' 65' ' ' LYS . 26.0 mm -80.85 125.39 80.25 Favored Pre-proline 0 C--N 1.321 -0.668 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.751 -176.488 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . 0.572 ' HB2' ' HB2' ' A' ' 28' ' ' LYS . 64.8 Cg_exo -51.89 130.14 33.22 Favored 'Trans proline' 0 C--O 1.233 0.226 0 C-N-CA 122.813 2.342 . . . . 0.0 111.711 176.412 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -58.34 -38.14 76.57 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 115.754 -0.657 . . . . 0.0 111.45 -177.252 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -90.16 22.47 26.03 Favored Glycine 0 N--CA 1.453 -0.222 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.327 178.268 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . 0.572 ' HB2' ' HB2' ' A' ' 25' ' ' PRO . 21.3 tptt -133.1 0.81 3.47 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 178.136 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.63 -33.96 74.84 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.501 -0.772 . . . . 0.0 111.857 -174.468 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -59.04 -22.08 54.44 Favored Glycine 0 CA--C 1.519 0.33 0 C-N-CA 121.14 -0.552 . . . . 0.0 113.037 -179.397 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.464 ' HB3' HG23 ' A' ' 86' ' ' ILE . 94.2 mt -87.99 -43.19 11.92 Favored 'General case' 0 C--N 1.326 -0.447 0 O-C-N 122.576 -0.367 . . . . 0.0 110.951 -179.887 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.446 HG11 HG22 ' A' ' 24' ' ' ILE . 1.2 p -66.8 -29.97 48.11 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.416 0 CA-C-O 121.199 0.523 . . . . 0.0 110.656 -178.899 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 63.2 mt -81.36 -43.77 20.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-O 121.692 0.758 . . . . 0.0 109.108 173.372 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . 0.538 ' HA3' ' HB ' ' A' ' 39' ' ' THR . . . 116.46 163.43 13.36 Favored Glycine 0 N--CA 1.438 -1.201 0 CA-C-N 115.344 -0.844 . . . . 0.0 112.54 174.805 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.528 ' N ' ' HD3' ' A' ' 35' ' ' LYS . 0.0 OUTLIER -78.64 57.59 2.07 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.305 0.574 . . . . 0.0 110.263 -178.656 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 134.24 14.72 1.21 Allowed Glycine 0 N--CA 1.447 -0.585 0 CA-C-N 115.358 -0.837 . . . . 0.0 111.619 -179.44 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 71.36 6.35 61.47 Favored Glycine 0 C--N 1.333 0.409 0 C-N-CA 121.25 -0.5 . . . . 0.0 112.355 -178.193 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 55.3 mm-40 -84.12 -22.67 31.0 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 120.961 0.41 . . . . 0.0 111.073 -178.511 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' THR . . . . . 0.672 ' O ' ' HG ' ' A' ' 43' ' ' LEU . 57.9 m -70.97 -51.68 24.24 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.3 178.282 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.563 ' HA ' HD13 ' A' ' 43' ' ' LEU . 7.8 tt -58.74 -33.7 49.86 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.385 0 CA-C-O 121.312 0.577 . . . . 0.0 110.568 177.808 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 40.0 ttmt -63.66 -37.96 89.32 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.349 177.332 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . 0.601 ' O ' ' HG2' ' A' ' 46' ' ' ARG . 45.7 mt-30 -79.63 -42.03 25.73 Favored 'General case' 0 C--O 1.222 -0.359 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.498 -178.982 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.672 ' HG ' ' O ' ' A' ' 39' ' ' THR . 70.5 mt -49.0 -45.41 42.37 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-O 120.912 0.387 . . . . 0.0 111.789 -176.073 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 45.9 mt-30 -62.4 -44.71 95.79 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.651 179.161 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -68.66 -42.4 77.95 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.095 -179.264 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . 0.601 ' HG2' ' O ' ' A' ' 42' ' ' GLN . 15.4 mmt180 -52.31 -44.62 65.17 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.805 -175.553 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -102.64 -9.98 19.63 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.618 -175.424 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 71.09 39.86 62.51 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.73 -0.747 . . . . 0.0 111.291 -175.09 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 27.3 m -122.77 178.95 2.8 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-O 120.891 0.377 . . . . 0.0 110.476 -175.534 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . 0.444 ' C ' ' HD3' ' A' ' 50' ' ' LYS . 1.1 tmtp? -116.74 124.41 49.58 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 175.17 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' MET . . . . . 0.54 ' CE ' ' HB3' ' A' ' 79' ' ' ALA . 64.3 mtt -117.37 121.99 42.61 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.482 -0.327 . . . . 0.0 110.43 178.406 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.731 HG21 ' HB2' ' A' ' 68' ' ' ARG . 0.0 OUTLIER -110.44 116.57 52.72 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 CA-C-O 121.648 0.737 . . . . 0.0 109.21 176.146 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.594 HD22 HD13 ' A' ' 67' ' ' LEU . 2.8 mm? -95.7 105.72 17.75 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.388 -0.823 . . . . 0.0 110.339 179.499 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.745 HD11 ' HB2' ' A' ' 66' ' ' PRO . 60.1 mt -75.59 96.26 1.18 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 121.332 0.587 . . . . 0.0 110.223 179.867 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 57.7 mt-30 . . . . . 0 C--N 1.324 -0.509 0 CA-C-N 115.658 -0.701 . . . . 0.0 109.792 -179.83 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . 0.44 ' HB3' ' HB3' ' A' ' 23' ' ' MET . 23.2 m-20 . . . . . 0 N--CA 1.456 -0.155 0 N-CA-C 110.036 -0.357 . . . . 0.0 110.036 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . 0.686 ' HB2' ' HB ' ' A' ' 24' ' ' ILE . 70.6 mmtt -89.43 120.82 69.68 Favored Pre-proline 0 C--N 1.32 -0.686 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.882 -171.097 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . 0.745 ' HB2' HD11 ' A' ' 54' ' ' ILE . 28.5 Cg_exo -66.35 104.68 0.78 Allowed 'Trans proline' 0 N--CA 1.462 -0.377 0 C-N-CA 122.928 2.419 . . . . 0.0 112.124 175.001 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.594 HD13 HD22 ' A' ' 53' ' ' LEU . 14.5 tp -103.21 118.13 36.09 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.906 -0.588 . . . . 0.0 109.946 176.057 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . 0.731 ' HB2' HG21 ' A' ' 52' ' ' ILE . 95.5 mtt180 -98.19 110.85 23.36 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 116.556 -0.293 . . . . 0.0 110.897 177.015 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 4.2 mp -96.47 104.73 16.2 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 171.598 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.961 HD11 ' HB ' ' A' ' 19' ' ' VAL . 3.6 mm -100.85 134.82 39.62 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 N-CA-C 109.914 -0.402 . . . . 0.0 109.914 -178.229 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . 0.415 ' O ' ' HB ' ' A' ' 18' ' ' THR . . . 164.44 -142.14 7.57 Favored Glycine 0 N--CA 1.447 -0.626 0 C-N-CA 121.054 -0.593 . . . . 0.0 111.625 178.568 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . 0.537 ' OD2' ' HB3' ' A' ' 74' ' ' TYR . 8.8 t70 -93.83 140.92 23.15 Favored Pre-proline 0 C--N 1.318 -0.79 0 CA-C-O 118.35 -0.833 . . . . 0.0 109.122 179.686 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . 0.505 ' HA ' HG22 ' A' ' 18' ' ' THR . 84.0 Cg_exo -41.78 -41.1 5.98 Favored 'Trans proline' 0 C--N 1.346 0.433 0 C-N-CA 122.757 2.305 . . . . 0.0 113.066 -177.806 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . 0.537 ' HB3' ' OD2' ' A' ' 72' ' ' ASP . 69.2 t80 -63.48 -58.68 6.25 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.296 -178.74 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . 0.471 ' HG2' ' HB3' ' A' ' 72' ' ' ASP . 38.0 pttt -71.91 -27.87 63.11 Favored 'General case' 0 CA--C 1.518 -0.268 0 C-N-CA 120.446 -0.501 . . . . 0.0 111.557 -178.019 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 55.3 t -63.7 -39.67 86.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 N-CA-C 109.53 -0.545 . . . . 0.0 109.53 176.832 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 22.7 tp60 -75.85 -44.95 38.33 Favored 'General case' 0 N--CA 1.445 -0.698 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.79 -179.717 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . 0.403 ' HA ' ' HG2' ' A' ' 81' ' ' GLU . 55.5 mt-30 -64.82 -35.78 82.22 Favored 'General case' 0 C--N 1.33 -0.271 0 C-N-CA 120.469 -0.493 . . . . 0.0 110.926 -179.921 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . 0.54 ' HB3' ' CE ' ' A' ' 51' ' ' MET . . . -71.38 -34.71 70.68 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 120.93 0.395 . . . . 0.0 110.09 176.222 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 36.7 t -65.22 -47.87 75.35 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.253 178.023 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . 0.403 ' HG2' ' HA ' ' A' ' 78' ' ' GLN . 10.5 pt-20 -69.72 -22.37 63.4 Favored 'General case' 0 C--N 1.322 -0.601 0 C-N-CA 120.684 -0.406 . . . . 0.0 110.14 178.861 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' MET . . . . . 0.463 ' O ' ' HB3' ' A' ' 85' ' ' ASP . 57.4 ttp -73.74 -46.28 46.88 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.664 176.338 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . 0.535 ' O ' ' HG ' ' A' ' 87' ' ' LEU . 33.2 m -72.03 -36.56 57.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 C-N-CA 120.662 -0.415 . . . . 0.0 110.665 178.905 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' MET . . . . . 0.428 ' HE3' HD11 ' A' ' 22' ' ' ILE . 54.1 mtt -65.0 -32.08 73.63 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 109.975 -0.379 . . . . 0.0 109.975 175.146 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . 0.463 ' HB3' ' O ' ' A' ' 82' ' ' MET . 18.8 t70 -58.23 -48.79 79.27 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.648 176.315 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.464 HG23 ' HB3' ' A' ' 31' ' ' LEU . 34.8 mt -60.63 -29.7 45.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 121.271 0.558 . . . . 0.0 110.536 179.562 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.535 ' HG ' ' O ' ' A' ' 83' ' ' VAL . 62.0 mt -92.06 -1.71 57.06 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.661 -0.699 . . . . 0.0 111.927 -174.755 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . 0.416 ' HG2' ' O ' ' A' ' 84' ' ' MET . 19.2 ptp180 -129.83 16.49 5.78 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.059 0.457 . . . . 0.0 111.141 -179.929 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 10.5 tt0 . . . . . 0 C--O 1.249 1.059 0 CA-C-O 118.186 -0.912 . . . . 0.0 109.86 179.218 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' THR . . . . . 0.424 HG23 ' HA ' ' A' ' 73' ' ' PRO . 32.8 m . . . . . 0 N--CA 1.448 -0.536 0 N-CA-C 109.991 -0.374 . . . . 0.0 109.991 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.511 ' HA ' ' O ' ' A' ' 69' ' ' ILE . 7.5 p -141.8 136.27 30.54 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.405 -176.183 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . 0.517 ' O ' ' HA ' ' A' ' 68' ' ' ARG . 35.6 mt-30 -112.84 158.69 19.84 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.194 -0.457 . . . . 0.0 109.802 171.962 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . 0.581 ' HG2' ' HG2' ' A' ' 68' ' ' ARG . 51.9 mt-10 -125.28 113.57 17.79 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.932 0.396 . . . . 0.0 109.968 178.683 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 9.6 mm -104.69 137.8 32.24 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.375 -178.195 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' MET . . . . . 0.411 ' HA ' ' HE2' ' A' ' 23' ' ' MET . 0.1 OUTLIER -86.07 91.52 8.43 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 172.362 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.816 HG23 HD23 ' A' ' 87' ' ' LEU . 33.1 mm -79.86 126.35 80.23 Favored Pre-proline 0 C--N 1.319 -0.76 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.791 -177.546 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . 0.774 ' HB2' ' HB2' ' A' ' 28' ' ' LYS . 72.7 Cg_exo -51.99 135.86 51.8 Favored 'Trans proline' 0 N--CA 1.461 -0.392 0 C-N-CA 122.675 2.25 . . . . 0.0 111.416 175.459 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -57.93 -33.36 68.72 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.661 -0.7 . . . . 0.0 112.626 -172.865 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -82.74 -29.36 35.54 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.495 -0.86 . . . . 0.0 111.688 177.375 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . 0.774 ' HB2' ' HB2' ' A' ' 25' ' ' PRO . 11.7 mptt -79.68 -8.23 59.09 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.981 0.42 . . . . 0.0 110.736 179.802 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . 0.402 ' HB3' ' HG3' ' A' ' 65' ' ' LYS . . . -61.54 -26.63 68.06 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.501 176.832 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -68.93 -17.68 71.82 Favored Glycine 0 N--CA 1.449 -0.499 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.331 177.673 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.4 ' HB3' HG22 ' A' ' 86' ' ' ILE . 84.8 mt -88.86 -37.93 14.96 Favored 'General case' 0 C--N 1.326 -0.427 0 O-C-N 122.677 -0.308 . . . . 0.0 110.902 -179.701 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.551 HG13 HD13 ' A' ' 87' ' ' LEU . 0.5 OUTLIER -71.69 -33.78 49.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 120.792 0.33 . . . . 0.0 110.683 176.392 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.603 ' HA ' ' HB ' ' A' ' 40' ' ' ILE . 83.7 mt -77.64 -40.98 28.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-O 121.601 0.715 . . . . 0.0 109.479 174.191 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . 0.536 ' HA3' ' HB ' ' A' ' 39' ' ' THR . . . 104.3 177.2 25.27 Favored Glycine 0 N--CA 1.442 -0.927 0 CA-C-N 115.514 -0.766 . . . . 0.0 112.467 175.893 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 30.1 mmmt -76.71 62.56 2.01 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.088 0.47 . . . . 0.0 110.419 -178.457 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 118.07 19.68 4.68 Favored Glycine 0 N--CA 1.448 -0.54 0 C-N-CA 120.972 -0.633 . . . . 0.0 112.005 178.492 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.405 ' HA2' HG22 ' A' ' 33' ' ' ILE . . . 82.5 3.78 90.39 Favored Glycine 0 N--CA 1.449 -0.479 0 C-N-CA 120.875 -0.679 . . . . 0.0 112.521 179.081 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . 0.687 ' HG3' HE21 ' A' ' 42' ' ' GLN . 20.8 tp10 -78.21 -37.66 44.95 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 120.79 0.328 . . . . 0.0 110.975 -177.874 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' THR . . . . . 0.591 ' O ' ' HG ' ' A' ' 43' ' ' LEU . 28.8 m -67.43 -40.23 85.48 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.648 -0.251 . . . . 0.0 111.492 -177.176 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.603 ' HB ' ' HA ' ' A' ' 33' ' ' ILE . 14.5 tt -63.8 -28.88 45.89 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.411 0 CA-C-O 121.172 0.511 . . . . 0.0 110.778 179.601 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . 0.622 ' HD3' ' HA ' ' A' ' 38' ' ' GLU . 52.1 mtpt -66.46 -40.59 89.46 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.195 0.522 . . . . 0.0 109.852 174.606 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . 0.687 HE21 ' HG3' ' A' ' 38' ' ' GLU . 76.4 mt-30 -70.76 -42.42 70.47 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.269 -0.878 . . . . 0.0 110.674 -176.693 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.591 ' HG ' ' O ' ' A' ' 39' ' ' THR . 81.8 mt -56.83 -47.06 81.18 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.589 -176.864 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 49.9 mt-30 -61.47 -53.5 55.7 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.431 -176.975 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -68.16 -39.65 82.56 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 112.033 0.383 . . . . 0.0 112.033 -175.591 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . 0.48 ' HD3' ' SD ' ' A' ' 82' ' ' MET . 12.3 ptm180 -70.01 -31.17 68.7 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.936 0.398 . . . . 0.0 111.214 -174.78 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . 0.574 ' HB2' HG21 ' A' ' 49' ' ' VAL . . . -93.27 -15.95 25.28 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.367 -177.111 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 73.49 25.45 72.56 Favored Glycine 0 N--CA 1.45 -0.401 0 CA-C-N 115.947 -0.57 . . . . 0.0 111.953 -178.729 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.574 HG21 ' HB2' ' A' ' 47' ' ' ALA . 35.1 m -123.93 173.88 9.06 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-O 120.843 0.354 . . . . 0.0 110.066 -177.399 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . 0.475 ' HE2' HD13 ' A' ' 70' ' ' ILE . 2.2 tmmm? -109.97 123.33 49.45 Favored 'General case' 0 C--N 1.318 -0.762 0 N-CA-C 108.679 -0.86 . . . . 0.0 108.679 174.753 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' MET . . . . . 0.517 ' CE ' ' HB2' ' A' ' 79' ' ' ALA . 63.5 mtt -114.43 116.42 28.86 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.195 -179.671 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.504 ' CG2' ' HB2' ' A' ' 68' ' ' ARG . 9.9 tt -106.57 105.16 18.23 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.83 0 CA-C-O 121.484 0.659 . . . . 0.0 110.11 176.14 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.593 HD22 HD13 ' A' ' 67' ' ' LEU . 3.5 mm? -82.24 102.58 11.24 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 108.963 -0.754 . . . . 0.0 108.963 173.723 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.663 HD12 ' HB2' ' A' ' 66' ' ' PRO . 53.5 mt -79.25 86.92 1.23 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-O 121.433 0.635 . . . . 0.0 110.166 -176.372 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . 0.485 HE22 ' HB3' ' A' ' 65' ' ' LYS . 25.2 mm-40 . . . . . 0 C--N 1.326 -0.418 0 CA-C-N 115.355 -0.839 . . . . 0.0 109.516 -179.814 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 49.7 m-20 . . . . . 0 N--CA 1.444 -0.734 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . 0.729 ' HB2' ' HB ' ' A' ' 24' ' ' ILE . 66.9 mmtt -141.6 116.73 7.03 Favored Pre-proline 0 C--N 1.314 -0.937 0 CA-C-N 116.708 -0.224 . . . . 0.0 110.632 -176.784 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . 0.663 ' HB2' HD12 ' A' ' 54' ' ' ILE . 25.1 Cg_exo -64.42 124.19 12.94 Favored 'Trans proline' 0 N--CA 1.461 -0.431 0 C-N-CA 122.82 2.347 . . . . 0.0 111.863 176.308 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.593 HD13 HD22 ' A' ' 53' ' ' LEU . 33.7 tp -124.1 106.84 10.67 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.954 -0.567 . . . . 0.0 109.839 177.793 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . 0.581 ' HG2' ' HG2' ' A' ' 21' ' ' GLU . 87.4 mtt180 -96.98 105.59 17.77 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.139 177.711 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . 0.511 ' O ' ' HA ' ' A' ' 19' ' ' VAL . 4.4 mp -87.96 104.49 14.55 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 174.449 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.475 HD13 ' HE2' ' A' ' 50' ' ' LYS . 13.8 mt -104.34 126.93 59.01 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.026 -173.491 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 167.82 -142.52 7.55 Favored Glycine 0 N--CA 1.446 -0.648 0 N-CA-C 111.596 -0.602 . . . . 0.0 111.596 178.65 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . 0.451 ' HB2' ' HG2' ' A' ' 75' ' ' LYS . 15.1 m-20 -91.33 149.12 39.1 Favored Pre-proline 0 C--N 1.325 -0.489 0 CA-C-O 118.963 -0.541 . . . . 0.0 109.692 175.859 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . 0.424 ' HA ' HG23 ' A' ' 18' ' ' THR . 77.5 Cg_exo -49.36 -39.53 43.94 Favored 'Trans proline' 0 C--N 1.343 0.285 0 C-N-CA 122.333 2.022 . . . . 0.0 112.31 -176.948 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 76.0 t80 -64.36 -56.32 15.2 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.262 -176.995 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . 0.451 ' HG2' ' HB2' ' A' ' 72' ' ' ASP . 4.9 ptpt -68.06 -31.97 71.99 Favored 'General case' 0 C--O 1.223 -0.301 0 C-N-CA 120.671 -0.412 . . . . 0.0 111.296 179.41 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 53.1 t -65.18 -40.09 87.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.998 0.427 . . . . 0.0 110.012 178.163 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . 0.467 ' O ' ' HG2' ' A' ' 81' ' ' GLU . 19.4 tp60 -64.81 -51.88 59.81 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.032 176.707 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 25.1 mt-30 -62.97 -35.14 79.17 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 121.0 0.428 . . . . 0.0 110.853 -178.202 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . 0.599 ' HA ' ' HE3' ' A' ' 82' ' ' MET . . . -72.1 -35.31 69.15 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.999 179.812 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 52.7 t -72.29 -45.56 59.52 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.144 -179.457 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . 0.467 ' HG2' ' O ' ' A' ' 77' ' ' GLN . 10.2 pt-20 -66.83 -22.62 65.99 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.101 0.477 . . . . 0.0 110.024 177.834 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' MET . . . . . 0.599 ' HE3' ' HA ' ' A' ' 79' ' ' ALA . 42.8 ttp -71.5 -55.41 7.91 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.54 -0.755 . . . . 0.0 110.423 175.822 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . 0.439 HG13 HD13 ' A' ' 43' ' ' LEU . 31.3 m -66.95 -34.97 73.44 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.169 0 C-N-CA 121.116 -0.234 . . . . 0.0 110.985 -179.455 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 66.6 mmm -62.17 -37.45 85.28 Favored 'General case' 0 CA--C 1.519 -0.229 0 CA-C-O 120.685 0.279 . . . . 0.0 110.505 176.391 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . 0.476 ' O ' ' HB2' ' A' ' 89' ' ' GLU . 36.5 t70 -65.8 -44.52 85.43 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.918 -179.781 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.4 HG22 ' HB3' ' A' ' 31' ' ' LEU . 57.8 mt -60.01 -31.25 47.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 121.148 0.499 . . . . 0.0 110.768 179.822 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.816 HD23 HG23 ' A' ' 24' ' ' ILE . 7.1 mp -81.48 -31.79 32.79 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.815 -0.629 . . . . 0.0 112.268 -177.176 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 15.3 ptm180 -95.88 -5.79 40.74 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.134 0.492 . . . . 0.0 111.132 -176.768 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . 0.476 ' HB2' ' O ' ' A' ' 85' ' ' ASP . 4.7 mm-40 . . . . . 0 C--O 1.251 1.137 0 CA-C-O 118.438 -0.791 . . . . 0.0 110.031 178.473 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 94.3 m . . . . . 0 N--CA 1.45 -0.435 0 CA-C-O 120.669 0.271 . . . . 0.0 110.62 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.647 ' HA ' ' O ' ' A' ' 69' ' ' ILE . 6.2 p -129.72 124.32 58.89 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-O 121.13 0.49 . . . . 0.0 110.801 178.073 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 28.6 mt-30 -110.29 114.6 28.2 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.055 -0.52 . . . . 0.0 109.887 174.663 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . 0.649 ' HA ' ' O ' ' A' ' 67' ' ' LEU . 43.4 mt-10 -90.37 116.04 28.02 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.086 0.469 . . . . 0.0 110.535 176.106 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 22.0 mm -103.69 137.42 32.33 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.767 0 CA-C-N 115.687 -0.688 . . . . 0.0 109.839 -179.561 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' MET . . . . . 0.445 ' HE3' ' HA ' ' A' ' 23' ' ' MET . 3.1 mmt -89.13 94.27 9.87 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 176.593 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.836 HG21 HD12 ' A' ' 87' ' ' LEU . 27.2 mm -77.66 129.19 77.52 Favored Pre-proline 0 C--N 1.318 -0.801 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.027 -175.06 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . 0.52 ' HB2' ' HB2' ' A' ' 28' ' ' LYS . 53.8 Cg_exo -52.93 125.43 18.22 Favored 'Trans proline' 0 N--CA 1.458 -0.596 0 C-N-CA 122.188 1.925 . . . . 0.0 110.685 172.01 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -57.63 -27.87 63.18 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 112.097 0.406 . . . . 0.0 112.097 -174.057 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -80.21 -30.66 40.94 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.511 177.306 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . 0.52 ' HB2' ' HB2' ' A' ' 25' ' ' PRO . 21.2 mmtp -89.42 -4.41 58.02 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.727 0.299 . . . . 0.0 111.234 -177.966 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -57.44 -28.89 63.73 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.707 -178.173 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -62.28 -26.32 67.7 Favored Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 120.925 -0.655 . . . . 0.0 112.856 -179.81 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 69.6 mt -78.73 -39.84 35.18 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.883 0.341 . . . . 0.0 111.398 -178.173 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.554 HG22 HG22 ' A' ' 24' ' ' ILE . 0.0 OUTLIER -65.74 -38.06 81.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 121.19 0.519 . . . . 0.0 110.106 179.177 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 49.9 mt -72.61 -42.67 62.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-O 121.546 0.689 . . . . 0.0 109.499 175.838 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 100.57 39.61 3.16 Favored Glycine 0 CA--C 1.499 -0.938 0 CA-C-N 115.17 -0.923 . . . . 0.0 112.685 176.708 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 3.7 mppt? 53.0 36.9 23.28 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.079 -0.561 . . . . 0.0 111.45 179.265 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 159.04 -48.95 0.41 Allowed Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.54 -0.838 . . . . 0.0 112.145 -179.195 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 145.31 -6.68 1.52 Allowed Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.24 -0.981 . . . . 0.0 113.476 179.866 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 43.9 mm-40 -65.64 -40.76 92.86 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 117.006 0.403 . . . . 0.0 112.012 -179.014 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' THR . . . . . 0.72 ' O ' ' HG ' ' A' ' 43' ' ' LEU . 91.6 m -62.39 -54.64 37.41 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.876 -0.147 . . . . 0.0 111.278 -178.105 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.57 ' HA ' HD13 ' A' ' 43' ' ' LEU . 5.3 tt -58.34 -30.96 41.57 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.365 0 CA-C-O 121.219 0.533 . . . . 0.0 111.157 -179.346 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . 0.461 ' HE2' ' HB3' ' A' ' 41' ' ' LYS . 4.9 tmmm? -70.33 -41.72 72.86 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.932 -0.576 . . . . 0.0 109.819 177.842 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 15.4 mm-40 -69.37 -38.18 77.92 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.956 -179.492 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.72 ' HG ' ' O ' ' A' ' 39' ' ' THR . 73.7 mt -56.42 -43.9 79.83 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.826 -0.624 . . . . 0.0 111.215 -177.755 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 46.7 mt-30 -67.08 -31.25 71.61 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.376 -177.432 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -80.14 -43.01 22.38 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.892 0.377 . . . . 0.0 111.162 -178.833 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 13.5 ptm180 -75.52 -36.51 60.49 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.952 -0.567 . . . . 0.0 112.45 -173.352 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . 0.497 ' HB2' HG21 ' A' ' 49' ' ' VAL . . . -95.89 -17.21 21.27 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.861 0.362 . . . . 0.0 111.33 -178.247 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 79.41 3.17 88.58 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.879 -0.677 . . . . 0.0 112.208 -179.785 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.497 HG21 ' HB2' ' A' ' 47' ' ' ALA . 34.3 m -97.3 166.02 1.98 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-O 120.637 0.256 . . . . 0.0 110.379 -177.769 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 63.9 tttp -105.21 122.84 46.75 Favored 'General case' 0 C--N 1.316 -0.858 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 172.843 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' MET . . . . . 0.678 ' HE3' HG13 ' A' ' 83' ' ' VAL . 77.1 mtp -119.07 115.92 25.31 Favored 'General case' 0 C--N 1.316 -0.854 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 178.263 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.56 ' CG2' ' HB2' ' A' ' 68' ' ' ARG . 8.7 tt -105.4 105.4 18.59 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.937 0 CA-C-O 121.588 0.709 . . . . 0.0 110.734 179.826 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.707 HD22 HD12 ' A' ' 67' ' ' LEU . 3.7 mm? -78.57 103.15 8.32 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 173.042 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.803 HD12 ' HB2' ' A' ' 66' ' ' PRO . 56.7 mt -73.33 89.11 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-O 121.518 0.675 . . . . 0.0 110.462 -178.091 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 58.4 mt-30 . . . . . 0 C--N 1.325 -0.47 0 CA-C-N 115.03 -0.986 . . . . 0.0 110.339 -178.519 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . 0.425 ' HB3' ' HB3' ' A' ' 23' ' ' MET . 7.1 m-20 . . . . . 0 N--CA 1.455 -0.179 0 N-CA-C 109.593 -0.521 . . . . 0.0 109.593 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . 0.693 ' HB2' ' HB ' ' A' ' 24' ' ' ILE . 70.4 mmtt -84.02 129.12 59.98 Favored Pre-proline 0 C--N 1.318 -0.795 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.46 -165.243 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . 0.803 ' HB2' HD12 ' A' ' 54' ' ' ILE . 17.3 Cg_exo -68.83 105.83 1.39 Allowed 'Trans proline' 0 N--CA 1.46 -0.492 0 C-N-CA 123.054 2.502 . . . . 0.0 111.413 174.522 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.707 HD12 HD22 ' A' ' 53' ' ' LEU . 31.6 tp -115.7 104.21 11.45 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.46 -0.336 . . . . 0.0 110.619 179.455 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . 0.56 ' HB2' ' CG2' ' A' ' 52' ' ' ILE . 92.6 mtt180 -91.65 108.23 19.76 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.881 0.372 . . . . 0.0 110.131 176.882 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . 0.647 ' O ' ' HA ' ' A' ' 19' ' ' VAL . 22.1 mt -94.9 104.38 15.74 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 174.681 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 3.7 mt -110.85 127.54 67.86 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.847 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.19 -173.95 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 173.48 -147.17 9.34 Favored Glycine 0 N--CA 1.448 -0.565 0 C-N-CA 120.508 -0.853 . . . . 0.0 112.073 178.104 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . 0.532 ' O ' HG23 ' A' ' 76' ' ' VAL . 41.2 m-20 -84.12 140.1 39.65 Favored Pre-proline 0 C--N 1.323 -0.565 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 177.405 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 76.5 Cg_exo -41.41 -53.4 3.18 Favored 'Trans proline' 0 CA--C 1.534 0.478 0 C-N-CA 123.746 2.964 . . . . 0.0 115.291 -169.443 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 35.8 p90 -76.31 -33.09 59.05 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 112.74 0.644 . . . . 0.0 112.74 -172.227 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . 0.476 ' HG2' ' HB2' ' A' ' 72' ' ' ASP . 6.1 ptpp? -72.49 -30.11 64.23 Favored 'General case' 0 CA--C 1.514 -0.412 0 C-N-CA 119.788 -0.765 . . . . 0.0 110.238 177.038 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.532 HG23 ' O ' ' A' ' 72' ' ' ASP . 92.3 t -63.08 -40.82 90.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 N-CA-C 109.427 -0.583 . . . . 0.0 109.427 177.035 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . 0.619 ' HA ' HE21 ' A' ' 77' ' ' GLN . 0.0 OUTLIER -72.65 -46.56 53.36 Favored 'General case' 0 N--CA 1.447 -0.579 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.903 178.049 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 23.9 mt-30 -61.29 -40.18 93.17 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 120.79 -0.364 . . . . 0.0 111.052 179.637 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . 0.631 ' HA ' ' HE3' ' A' ' 82' ' ' MET . . . -71.67 -32.95 68.43 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.482 177.695 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 5.6 t -61.2 -57.12 13.76 Favored 'General case' 0 CA--C 1.515 -0.393 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.188 177.262 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 17.4 mm-40 -62.29 -29.51 70.48 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.723 -179.162 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' MET . . . . . 0.631 ' HE3' ' HA ' ' A' ' 79' ' ' ALA . 43.6 ttp -63.27 -50.06 71.61 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.398 178.771 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . 0.678 HG13 ' HE3' ' A' ' 51' ' ' MET . 30.5 m -83.77 -36.44 12.31 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-N 116.6 -0.273 . . . . 0.0 111.283 -177.147 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 27.4 ttt -65.3 -36.32 83.71 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.407 -179.849 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . 0.434 ' O ' ' HB2' ' A' ' 89' ' ' GLU . 35.0 t70 -62.54 -42.27 99.42 Favored 'General case' 0 C--O 1.223 -0.34 0 CA-C-N 116.595 -0.275 . . . . 0.0 110.466 178.502 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.494 HG13 ' O ' ' A' ' 82' ' ' MET . 52.8 mt -61.41 -31.29 50.03 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-O 121.446 0.641 . . . . 0.0 110.619 179.112 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.836 HD12 HG21 ' A' ' 24' ' ' ILE . 43.4 mt -88.71 -33.45 17.52 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.128 -176.225 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 17.7 tpt180 -77.33 -14.09 59.8 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.808 0.813 . . . . 0.0 109.504 177.309 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . 0.434 ' HB2' ' O ' ' A' ' 85' ' ' ASP . 6.4 tp10 . . . . . 0 C--O 1.25 1.093 0 CA-C-N 114.5 -1.227 . . . . 0.0 109.42 179.215 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' THR . . . . . 0.563 HG22 ' HA ' ' A' ' 73' ' ' PRO . 84.3 m . . . . . 0 C--O 1.235 0.312 0 CA-C-O 121.149 0.5 . . . . 0.0 111.201 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.649 ' HA ' ' O ' ' A' ' 69' ' ' ILE . 7.1 p -140.76 129.27 24.46 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-N 115.382 -0.826 . . . . 0.0 110.011 177.617 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 80.5 mt-30 -108.43 122.86 47.9 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 121.063 0.459 . . . . 0.0 111.115 176.348 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . 0.628 ' HA ' ' O ' ' A' ' 67' ' ' LEU . 44.1 mt-10 -95.63 117.43 30.44 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.252 -0.885 . . . . 0.0 110.145 177.35 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.734 HG12 HD13 ' A' ' 67' ' ' LEU . 25.5 mm -111.48 147.6 15.31 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.768 0 CA-C-N 116.0 -0.545 . . . . 0.0 109.815 -178.911 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' MET . . . . . 0.555 ' HB3' ' HB3' ' A' ' 64' ' ' ASP . 3.3 mmt -100.8 98.16 8.71 Favored 'General case' 0 N--CA 1.446 -0.656 0 N-CA-C 108.796 -0.816 . . . . 0.0 108.796 176.924 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.744 ' HB ' ' HB2' ' A' ' 65' ' ' LYS . 23.6 mm -80.18 128.68 72.51 Favored Pre-proline 0 C--N 1.32 -0.699 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.032 -173.433 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . 0.586 ' HD2' HD13 ' A' ' 87' ' ' LEU . 52.7 Cg_exo -51.86 125.59 17.54 Favored 'Trans proline' 0 N--CA 1.462 -0.375 0 C-N-CA 122.882 2.388 . . . . 0.0 111.942 176.734 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -47.8 -53.02 16.71 Favored 'General case' 0 C--O 1.237 0.414 0 N-CA-C 112.998 0.74 . . . . 0.0 112.998 -169.571 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -80.54 -26.46 54.26 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.844 -0.693 . . . . 0.0 113.128 -174.891 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 43.2 tttp -89.95 3.1 54.13 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.051 0.453 . . . . 0.0 110.73 -177.185 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . 0.546 ' O ' HG13 ' A' ' 32' ' ' VAL . . . -65.53 -22.81 66.75 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.808 177.98 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -55.45 -38.42 69.89 Favored Glycine 0 N--CA 1.449 -0.447 0 C-N-CA 120.888 -0.672 . . . . 0.0 111.928 176.739 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.553 ' HB3' HG22 ' A' ' 86' ' ' ILE . 31.9 mt -71.34 -37.87 71.67 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 111.595 0.22 . . . . 0.0 111.595 -179.101 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.546 HG13 ' O ' ' A' ' 29' ' ' ALA . 0.3 OUTLIER -67.32 -25.92 34.78 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.352 0 CA-C-O 121.353 0.597 . . . . 0.0 110.358 -179.133 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.442 ' HA ' ' HB ' ' A' ' 40' ' ' ILE . 56.1 mt -84.71 -39.6 14.45 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-N 115.385 -0.825 . . . . 0.0 109.504 174.59 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . 0.415 ' HA3' ' HB ' ' A' ' 39' ' ' THR . . . 125.95 -145.62 15.81 Favored Glycine 0 N--CA 1.445 -0.719 0 CA-C-N 115.72 -0.673 . . . . 0.0 113.11 174.435 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 74.9 mmtt -100.69 -29.18 12.44 Favored 'General case' 0 C--N 1.319 -0.753 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 179.005 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -152.6 31.61 0.84 Allowed Glycine 0 N--CA 1.45 -0.429 0 CA-C-N 115.534 -0.757 . . . . 0.0 111.727 177.409 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 79.87 0.16 84.28 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 121.106 -0.569 . . . . 0.0 112.339 -178.933 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -78.52 -28.45 46.2 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 120.932 0.396 . . . . 0.0 111.106 -179.291 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' THR . . . . . 0.65 ' O ' ' HG ' ' A' ' 43' ' ' LEU . 35.2 m -71.67 -51.71 21.66 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.817 -177.571 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.623 ' HA ' HD12 ' A' ' 43' ' ' LEU . 6.6 tt -58.41 -36.73 60.09 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.285 0 CA-C-O 121.091 0.472 . . . . 0.0 111.186 179.499 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 62.7 tttp -62.07 -40.05 94.51 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.813 -0.631 . . . . 0.0 110.039 178.101 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 41.8 mt-30 -75.96 -38.01 58.0 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.579 -0.737 . . . . 0.0 111.269 -179.269 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.65 ' HG ' ' O ' ' A' ' 39' ' ' THR . 80.8 mt -53.17 -40.49 64.4 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-O 120.897 0.38 . . . . 0.0 111.432 -178.078 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 68.9 mt-30 -59.85 -42.62 94.03 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.289 178.494 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -81.02 -29.34 35.14 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.99 -178.137 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 13.8 mmm180 -52.1 -45.32 64.83 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.736 177.618 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . 0.531 ' HB2' HG22 ' A' ' 49' ' ' VAL . . . -102.42 -11.49 18.56 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.72 -0.673 . . . . 0.0 111.429 -178.198 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 75.3 30.17 59.09 Favored Glycine 0 CA--C 1.52 0.365 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.04 -177.255 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.531 HG22 ' HB2' ' A' ' 47' ' ' ALA . 20.0 m -120.09 177.34 3.08 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-O 120.846 0.355 . . . . 0.0 110.504 -177.638 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 64.5 tttp -105.46 122.28 45.67 Favored 'General case' 0 C--N 1.318 -0.797 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 172.115 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' MET . . . . . 0.654 ' HE3' HG12 ' A' ' 69' ' ' ILE . 36.1 mtp -117.31 115.18 24.76 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 178.833 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.456 ' CG2' ' HB2' ' A' ' 68' ' ' ARG . 10.4 tt -110.76 110.82 33.59 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.798 0 CA-C-O 121.452 0.644 . . . . 0.0 110.901 -178.697 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.594 HD22 HD22 ' A' ' 67' ' ' LEU . 3.7 mm? -93.97 103.84 15.91 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.27 -0.877 . . . . 0.0 109.474 175.279 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.59 HD13 ' HB2' ' A' ' 66' ' ' PRO . 68.3 mt -75.33 87.52 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-O 121.613 0.72 . . . . 0.0 110.216 -178.818 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . 0.586 HE21 ' HB3' ' A' ' 53' ' ' LEU . 72.5 mm-40 . . . . . 0 C--N 1.322 -0.622 0 CA-C-N 115.02 -0.991 . . . . 0.0 109.34 179.705 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . 0.555 ' HB3' ' HB3' ' A' ' 23' ' ' MET . 3.4 m-20 . . . . . 0 C--O 1.226 -0.181 0 N-CA-C 110.116 -0.327 . . . . 0.0 110.116 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . 0.744 ' HB2' ' HB ' ' A' ' 24' ' ' ILE . 34.5 mmtp -82.34 136.19 46.41 Favored Pre-proline 0 C--N 1.321 -0.673 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.393 -168.438 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . 0.59 ' HB2' HD13 ' A' ' 54' ' ' ILE . 10.5 Cg_exo -71.8 110.44 2.9 Favored 'Trans proline' 0 N--CA 1.458 -0.588 0 C-N-CA 123.137 2.558 . . . . 0.0 111.305 175.953 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.851 HD12 HG13 ' A' ' 69' ' ' ILE . 1.6 tm? -114.65 141.1 48.24 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 115.827 -0.624 . . . . 0.0 109.453 179.023 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . 0.531 ' N ' HD21 ' A' ' 67' ' ' LEU . 95.1 mtt180 -134.76 124.04 24.55 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.185 0.517 . . . . 0.0 111.465 168.607 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . 0.851 HG13 HD12 ' A' ' 67' ' ' LEU . 20.9 mt -102.95 104.62 16.86 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-N 115.206 -0.906 . . . . 0.0 109.279 173.445 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 11.8 mt -103.37 125.57 57.87 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.891 0 CA-C-N 116.484 -0.325 . . . . 0.0 110.246 -175.174 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 169.19 -123.21 1.06 Allowed Glycine 0 N--CA 1.447 -0.617 0 C-N-CA 120.505 -0.855 . . . . 0.0 112.934 178.349 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -115.26 139.11 24.07 Favored Pre-proline 0 C--N 1.324 -0.516 0 CA-C-O 118.759 -0.639 . . . . 0.0 109.995 -176.421 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . 0.563 ' HA ' HG22 ' A' ' 18' ' ' THR . 84.3 Cg_exo -40.47 -43.73 4.2 Favored 'Trans proline' 0 C--N 1.347 0.477 0 C-N-CA 123.406 2.737 . . . . 0.0 112.832 -176.264 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 78.8 t80 -60.61 -60.92 3.04 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.147 -0.933 . . . . 0.0 111.334 -178.626 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 25.5 pttt -76.54 -24.05 53.64 Favored 'General case' 0 CA--C 1.517 -0.314 0 N-CA-C 112.131 0.419 . . . . 0.0 112.131 -176.187 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 48.8 t -66.79 -39.89 84.67 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 N-CA-C 109.079 -0.711 . . . . 0.0 109.079 176.865 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . 0.468 ' O ' ' HG2' ' A' ' 81' ' ' GLU . 20.9 tp60 -74.0 -42.64 60.09 Favored 'General case' 0 N--CA 1.445 -0.706 0 CA-C-N 115.523 -0.762 . . . . 0.0 110.502 179.744 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 91.6 mt-30 -60.91 -43.83 98.0 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.848 0.356 . . . . 0.0 110.609 177.732 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . 0.485 ' HA ' ' HE1' ' A' ' 82' ' ' MET . . . -64.95 -38.78 92.09 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.692 178.171 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 44.3 t -62.44 -54.8 34.86 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.733 -0.667 . . . . 0.0 111.471 178.243 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . 0.468 ' HG2' ' O ' ' A' ' 77' ' ' GLN . 12.2 pt-20 -68.53 -19.59 64.51 Favored 'General case' 0 C--N 1.324 -0.511 0 C-N-CA 120.481 -0.488 . . . . 0.0 110.468 -178.468 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' MET . . . . . 0.485 ' HE1' ' HA ' ' A' ' 79' ' ' ALA . 52.3 ttp -72.97 -46.46 52.22 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.85 175.768 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . 0.605 HG12 HD13 ' A' ' 43' ' ' LEU . 29.9 m -80.18 -29.41 12.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 C-N-CA 120.812 -0.355 . . . . 0.0 110.869 -179.352 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 12.8 tmm? -65.47 -34.39 78.16 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 174.143 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . 0.474 ' HB3' ' O ' ' A' ' 82' ' ' MET . 3.8 t70 -59.31 -42.12 90.64 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.229 -0.896 . . . . 0.0 110.626 174.502 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.553 HG22 ' HB3' ' A' ' 31' ' ' LEU . 30.1 mt -63.82 -34.11 66.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-O 121.359 0.599 . . . . 0.0 110.406 178.694 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.586 HD13 ' HD2' ' A' ' 25' ' ' PRO . 59.6 mt -85.52 -6.31 59.2 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.769 -178.952 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 67.7 ttt180 -102.26 -7.67 21.92 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.723 0.773 . . . . 0.0 109.537 176.479 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 10.8 tp10 . . . . . 0 C--O 1.253 1.242 0 CA-C-N 115.191 -0.913 . . . . 0.0 110.022 -174.451 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' THR . . . . . 0.408 HG23 ' HA ' ' A' ' 73' ' ' PRO . 59.5 m . . . . . 0 N--CA 1.451 -0.383 0 CA-C-O 120.736 0.303 . . . . 0.0 110.613 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.451 ' HA ' ' O ' ' A' ' 69' ' ' ILE . 8.5 p -131.75 138.75 52.12 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 CA-C-O 120.91 0.386 . . . . 0.0 110.295 179.192 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 9.2 tt0 -124.24 135.67 53.58 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 109.698 -0.482 . . . . 0.0 109.698 178.607 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . 0.538 ' HG2' ' HG2' ' A' ' 68' ' ' ARG . 51.5 mt-10 -104.28 125.73 50.78 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.309 0.576 . . . . 0.0 112.021 -178.938 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.456 ' HB ' ' HB3' ' A' ' 67' ' ' LEU . 14.2 mm -110.66 146.33 15.93 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 CA-C-N 115.104 -0.953 . . . . 0.0 109.077 174.821 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' MET . . . . . 0.477 ' HE1' ' HA ' ' A' ' 23' ' ' MET . 8.7 mmt -100.41 93.75 5.81 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 108.584 -0.895 . . . . 0.0 108.584 175.103 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.671 ' HB ' ' HB2' ' A' ' 65' ' ' LYS . 37.0 mm -79.35 126.06 81.97 Favored Pre-proline 0 C--N 1.318 -0.774 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.422 -177.331 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . 0.424 ' HB2' ' HB2' ' A' ' 28' ' ' LYS . 71.8 Cg_exo -52.39 134.36 51.46 Favored 'Trans proline' 0 N--CA 1.461 -0.433 0 C-N-CA 122.794 2.329 . . . . 0.0 111.714 175.709 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -58.51 -25.21 62.15 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.998 -177.753 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -89.35 -6.37 71.13 Favored Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.837 -0.697 . . . . 0.0 112.642 178.069 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . 0.532 ' HB3' HD23 ' A' ' 87' ' ' LEU . 51.2 mttp -115.77 10.82 15.48 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.754 0.312 . . . . 0.0 111.366 -179.015 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -68.58 -29.82 68.45 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.205 0.526 . . . . 0.0 110.152 179.307 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -69.9 -17.88 73.85 Favored Glycine 0 N--CA 1.447 -0.584 0 CA-C-N 115.863 -0.608 . . . . 0.0 112.265 176.822 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.415 HD12 ' HG2' ' A' ' 28' ' ' LYS . 84.0 mt -83.13 -43.51 16.14 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.557 0.218 . . . . 0.0 110.706 -179.768 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.626 HG12 HD22 ' A' ' 87' ' ' LEU . 1.6 m -68.86 -33.33 58.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.308 -0.406 . . . . 0.0 111.174 178.697 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.489 ' HA ' ' HB ' ' A' ' 40' ' ' ILE . 88.8 mt -77.83 -40.71 27.48 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-O 121.52 0.676 . . . . 0.0 109.698 175.57 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 103.08 164.51 25.75 Favored Glycine 0 N--CA 1.442 -0.919 0 CA-C-N 115.353 -0.84 . . . . 0.0 111.576 -179.335 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 1.3 mptm? -79.13 54.41 1.63 Allowed 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.189 0.518 . . . . 0.0 110.849 -178.786 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 144.04 21.82 0.17 Allowed Glycine 0 N--CA 1.447 -0.603 0 CA-C-N 115.779 -0.646 . . . . 0.0 111.783 178.759 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 71.79 -0.66 35.12 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 121.028 -0.606 . . . . 0.0 112.358 -178.007 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . 0.518 ' O ' ' HG2' ' A' ' 42' ' ' GLN . 14.2 pt-20 -64.66 -37.81 88.86 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.703 0.287 . . . . 0.0 111.276 -175.573 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' THR . . . . . 0.819 ' O ' ' HG ' ' A' ' 43' ' ' LEU . 56.4 m -69.92 -55.66 9.1 Favored 'General case' 0 N--CA 1.449 -0.482 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.383 -175.086 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.489 ' HB ' ' HA ' ' A' ' 33' ' ' ILE . 12.7 tt -61.91 -25.09 36.26 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-O 121.462 0.649 . . . . 0.0 111.013 -177.48 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 37.6 ttpt -71.8 -47.49 53.01 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.778 178.863 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . 0.518 ' HG2' ' O ' ' A' ' 38' ' ' GLU . 11.3 pt20 -72.32 -41.07 66.97 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.838 -0.619 . . . . 0.0 111.12 -177.259 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.819 ' HG ' ' O ' ' A' ' 39' ' ' THR . 48.6 mt -51.23 -48.44 62.08 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.769 -0.65 . . . . 0.0 111.731 -177.08 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 49.3 mt-30 -58.21 -42.16 85.62 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.27 -178.078 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 -81.33 -35.1 31.36 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.676 -174.308 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . 0.412 ' HG2' ' O ' ' A' ' 42' ' ' GLN . 15.0 ptm180 -78.85 -23.45 44.97 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 111.905 0.335 . . . . 0.0 111.905 -175.894 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . 0.62 ' HB2' ' HE1' ' A' ' 82' ' ' MET . . . -94.59 -24.53 17.18 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 120.908 0.385 . . . . 0.0 111.379 179.906 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 81.77 23.64 57.41 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.863 -0.684 . . . . 0.0 112.082 -178.687 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.46 HG22 ' HB3' ' A' ' 47' ' ' ALA . 17.7 m -130.36 178.98 4.62 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-O 120.833 0.349 . . . . 0.0 110.197 -179.083 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 87.2 tttt -109.83 124.63 51.65 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.012 176.177 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' MET . . . . . 0.92 ' HE3' ' HB3' ' A' ' 79' ' ' ALA . 60.5 mtt -113.38 116.01 28.99 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 109.583 -0.525 . . . . 0.0 109.583 178.632 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.465 ' CG2' ' HB2' ' A' ' 68' ' ' ARG . 11.0 tt -110.64 105.83 19.56 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 CA-C-O 121.632 0.729 . . . . 0.0 110.674 178.047 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.516 HD23 HD11 ' A' ' 67' ' ' LEU . 3.8 mm? -86.12 102.8 14.19 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.336 -0.847 . . . . 0.0 109.358 174.978 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.567 HD13 ' HB2' ' A' ' 66' ' ' PRO . 52.3 mt -80.57 86.51 1.47 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.411 0 CA-C-O 121.913 0.863 . . . . 0.0 110.121 179.588 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . 0.455 ' HG2' HD11 ' A' ' 33' ' ' ILE . 2.7 pp0? . . . . . 0 C--N 1.317 -0.815 0 CA-C-N 114.607 -1.179 . . . . 0.0 109.52 176.246 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 62.7 m-20 . . . . . 0 N--CA 1.464 0.229 0 CA-C-O 120.957 0.408 . . . . 0.0 110.988 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . 0.671 ' HB2' ' HB ' ' A' ' 24' ' ' ILE . 69.8 mmtt -98.81 121.22 56.76 Favored Pre-proline 0 C--N 1.32 -0.677 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.767 -174.273 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . 0.567 ' HB2' HD13 ' A' ' 54' ' ' ILE . 27.1 Cg_exo -64.71 105.29 0.63 Allowed 'Trans proline' 0 N--CA 1.46 -0.473 0 C-N-CA 122.884 2.389 . . . . 0.0 111.746 174.614 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.516 HD11 HD23 ' A' ' 53' ' ' LEU . 25.1 tp -105.2 106.39 16.86 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 109.735 -0.469 . . . . 0.0 109.735 175.85 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . 0.538 ' HG2' ' HG2' ' A' ' 21' ' ' GLU . 96.1 mtt180 -101.68 105.88 16.85 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.437 178.35 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . 0.451 ' O ' ' HA ' ' A' ' 19' ' ' VAL . 4.7 mp -86.22 103.99 13.31 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 N-CA-C 108.195 -1.039 . . . . 0.0 108.195 174.142 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 3.7 mt -103.43 112.86 38.51 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.038 -174.506 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -176.16 -128.38 1.12 Allowed Glycine 0 N--CA 1.439 -1.137 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.324 -179.489 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . 0.502 ' HB3' ' CG ' ' A' ' 75' ' ' LYS . 3.1 t70 -109.61 143.27 27.5 Favored Pre-proline 0 C--N 1.318 -0.769 0 CA-C-O 118.752 -0.642 . . . . 0.0 110.289 -177.006 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . 0.408 ' HA ' HG23 ' A' ' 18' ' ' THR . 86.7 Cg_exo -44.14 -39.94 12.0 Favored 'Trans proline' 0 C--N 1.346 0.443 0 C-N-CA 122.827 2.351 . . . . 0.0 113.262 -175.268 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 93.6 t80 -74.6 -53.71 8.84 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.798 -174.807 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . 0.502 ' CG ' ' HB3' ' A' ' 72' ' ' ASP . 10.4 pttt -75.4 -17.49 60.18 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.531 -0.304 . . . . 0.0 111.79 -179.077 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 24.1 t -70.0 -40.19 78.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 171.855 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . 0.486 ' O ' ' HG2' ' A' ' 81' ' ' GLU . 21.2 tp60 -69.45 -46.3 67.05 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.06 178.904 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 86.4 mt-30 -58.89 -39.53 81.72 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.778 176.553 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . 0.92 ' HB3' ' HE3' ' A' ' 51' ' ' MET . . . -68.84 -36.8 78.61 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.143 178.781 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' CYS . . . . . 0.402 ' O ' ' HG3' ' A' ' 84' ' ' MET . 38.4 t -65.22 -50.8 64.47 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.921 178.974 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . 0.486 ' HG2' ' O ' ' A' ' 77' ' ' GLN . 9.9 pt-20 -69.69 -18.82 63.58 Favored 'General case' 0 C--N 1.324 -0.543 0 C-N-CA 120.513 -0.475 . . . . 0.0 110.2 178.415 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' MET . . . . . 0.626 ' SD ' HD23 ' A' ' 43' ' ' LEU . 36.7 ttm -70.55 -53.43 16.14 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.333 173.86 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . 0.444 ' O ' ' HG ' ' A' ' 87' ' ' LEU . 26.9 m -70.55 -35.74 62.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 C-N-CA 121.048 -0.261 . . . . 0.0 111.399 -178.645 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' MET . . . . . 0.402 ' HG3' ' O ' ' A' ' 80' ' ' CYS . 52.7 mtm -69.64 -26.97 64.67 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.768 0.318 . . . . 0.0 110.177 177.556 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -60.15 -48.38 81.96 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 116.066 -0.515 . . . . 0.0 109.748 175.807 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 48.4 mt -60.49 -34.86 59.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 115.422 -0.808 . . . . 0.0 111.048 179.826 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.626 HD22 HG12 ' A' ' 32' ' ' VAL . 51.3 mt -81.26 -16.12 53.53 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.3 -178.024 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . 0.404 HH11 ' HD3' ' A' ' 88' ' ' ARG . 13.7 ttp180 -97.2 -33.84 11.33 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 121.429 0.633 . . . . 0.0 111.074 -177.759 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 12.3 tp10 . . . . . 0 C--N 1.307 -1.257 0 CA-C-N 114.878 -1.055 . . . . 0.0 110.83 -173.437 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' THR . . . . . 0.549 ' OG1' ' HG3' ' A' ' 73' ' ' PRO . 80.0 m . . . . . 0 N--CA 1.449 -0.481 0 CA-C-O 121.001 0.429 . . . . 0.0 111.079 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.548 ' HA ' ' O ' ' A' ' 69' ' ' ILE . 4.5 p -137.44 134.92 46.85 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.587 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.208 177.672 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . 0.485 ' O ' ' HA ' ' A' ' 68' ' ' ARG . 33.2 mt-30 -121.11 157.84 29.22 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.019 176.142 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . 0.51 ' HG2' ' HG2' ' A' ' 68' ' ' ARG . 40.2 mt-10 -124.16 107.72 11.53 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.024 -176.32 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 5.9 mm -99.01 140.97 17.33 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-N 115.86 -0.609 . . . . 0.0 109.776 -180.0 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 74.1 mmm -102.88 93.9 5.3 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 109.157 -0.683 . . . . 0.0 109.157 177.218 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.701 ' HB ' ' HB2' ' A' ' 65' ' ' LYS . 38.5 mm -81.88 132.59 53.8 Favored Pre-proline 0 C--N 1.321 -0.668 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.235 -174.711 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 75.5 Cg_exo -51.95 134.06 47.79 Favored 'Trans proline' 0 C--N 1.345 0.357 0 C-N-CA 122.959 2.439 . . . . 0.0 111.834 172.558 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -60.02 -33.05 71.48 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.214 179.758 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -68.58 -19.74 73.21 Favored Glycine 0 N--CA 1.449 -0.493 0 C-N-CA 120.892 -0.67 . . . . 0.0 112.578 177.332 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . 0.533 ' HB3' HD22 ' A' ' 87' ' ' LEU . 5.2 mptp? -106.57 12.46 29.42 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.748 0.309 . . . . 0.0 111.004 -179.457 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.64 -31.75 71.86 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.008 0.432 . . . . 0.0 110.602 179.775 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -61.84 -24.24 64.35 Favored Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 120.864 -0.684 . . . . 0.0 112.571 179.564 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 83.7 mt -85.17 -48.52 9.06 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.684 0.242 . . . . 0.0 111.033 -177.99 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.556 HG13 HG13 ' A' ' 24' ' ' ILE . 2.9 m -67.89 -33.65 62.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.814 0.34 . . . . 0.0 111.758 -179.701 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 72.1 mt -80.56 -35.74 15.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 121.915 0.864 . . . . 0.0 109.462 176.321 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . 0.52 ' HA3' ' HB ' ' A' ' 39' ' ' THR . . . 94.99 52.07 1.83 Allowed Glycine 0 N--CA 1.439 -1.145 0 CA-C-N 115.208 -0.905 . . . . 0.0 113.808 172.204 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 30.8 mtmt 50.3 41.94 25.07 Favored 'General case' 0 C--N 1.328 -0.342 0 O-C-N 124.162 0.566 . . . . 0.0 112.204 169.659 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 129.03 -17.36 5.68 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.705 -0.76 . . . . 0.0 111.951 -179.36 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 116.18 7.48 14.54 Favored Glycine 0 N--CA 1.447 -0.611 0 C-N-CA 120.654 -0.784 . . . . 0.0 112.19 178.802 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 36.0 mt-10 -76.08 -47.55 24.12 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.786 0.327 . . . . 0.0 110.827 -178.99 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' THR . . . . . 0.633 ' O ' ' HG ' ' A' ' 43' ' ' LEU . 7.2 m -66.08 -44.05 85.56 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.451 -0.34 . . . . 0.0 111.46 -176.791 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.47 ' CD1' HD22 ' A' ' 53' ' ' LEU . 9.7 tt -60.42 -36.01 66.55 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.495 0 CA-C-O 121.032 0.444 . . . . 0.0 110.703 179.908 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 22.5 ttmm -61.13 -41.19 96.27 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.579 0.704 . . . . 0.0 110.134 175.302 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 48.1 mt-30 -74.51 -44.13 52.7 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.179 -0.919 . . . . 0.0 111.258 -177.387 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.633 ' HG ' ' O ' ' A' ' 39' ' ' THR . 94.9 mt -51.94 -49.96 62.12 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.923 -176.372 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . 0.434 ' HG3' ' O ' ' A' ' 40' ' ' ILE . 40.5 mt-30 -60.07 -57.49 12.6 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.157 -176.629 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -75.24 -22.11 58.12 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.674 -0.694 . . . . 0.0 112.276 -171.681 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 13.8 ptm180 -77.62 -33.41 53.65 Favored 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 120.304 -0.558 . . . . 0.0 110.727 177.865 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . 0.429 ' HB1' ' HE1' ' A' ' 82' ' ' MET . . . -88.33 -28.81 20.78 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.0 -178.3 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 95.57 21.32 24.48 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.856 -0.687 . . . . 0.0 112.709 -179.366 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 10.4 m -130.07 179.95 3.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-O 120.906 0.384 . . . . 0.0 110.684 -178.836 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . 0.666 ' HE3' ' HB ' ' A' ' 52' ' ' ILE . 8.9 tmtm? -111.95 126.09 54.76 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.953 -0.567 . . . . 0.0 109.645 176.7 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' MET . . . . . 0.989 ' HE3' ' HB1' ' A' ' 79' ' ' ALA . 58.6 mtt -113.28 132.33 55.58 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 176.283 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.666 ' HB ' ' HE3' ' A' ' 50' ' ' LYS . 10.9 tt -120.39 113.56 40.73 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.721 0 CA-C-O 121.619 0.723 . . . . 0.0 110.817 175.874 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.721 HD21 HD13 ' A' ' 67' ' ' LEU . 3.6 mm? -88.67 104.19 16.64 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.013 -0.994 . . . . 0.0 109.138 175.45 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.561 ' HB ' ' HB2' ' A' ' 66' ' ' PRO . 52.6 mt -91.13 92.02 3.79 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.19 -176.95 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 11.3 mp0 . . . . . 0 C--N 1.326 -0.423 0 CA-C-O 120.839 0.352 . . . . 0.0 110.772 -178.395 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 40.8 m-20 . . . . . 0 CA--C 1.512 -0.495 0 CA-C-O 121.27 0.557 . . . . 0.0 110.805 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . 0.701 ' HB2' ' HB ' ' A' ' 24' ' ' ILE . 69.8 mmtt -121.06 98.34 47.36 Favored Pre-proline 0 C--N 1.316 -0.863 0 CA-C-N 115.395 -0.821 . . . . 0.0 110.188 179.273 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . 0.561 ' HB2' ' HB ' ' A' ' 54' ' ' ILE . 71.5 Cg_exo -54.2 115.64 2.51 Favored 'Trans proline' 0 C--O 1.234 0.305 0 C-N-CA 123.166 2.577 . . . . 0.0 112.31 174.861 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.721 HD13 HD21 ' A' ' 53' ' ' LEU . 31.3 tp -118.77 113.72 21.57 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.28 179.757 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . 0.51 ' HG2' ' HG2' ' A' ' 21' ' ' GLU . 98.1 mtt180 -104.25 113.0 26.25 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 121.077 0.465 . . . . 0.0 110.707 175.943 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . 0.56 HG22 ' HB3' ' A' ' 79' ' ' ALA . 3.9 mp -95.21 109.45 22.43 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 175.085 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 8.1 mt -112.57 129.11 68.74 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 CA-C-N 116.462 -0.335 . . . . 0.0 111.162 -170.812 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 152.98 -127.14 2.13 Favored Glycine 0 N--CA 1.445 -0.746 0 C-N-CA 120.199 -1.0 . . . . 0.0 113.507 173.73 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . 0.411 ' HA ' ' HD3' ' A' ' 73' ' ' PRO . 19.7 t70 -85.87 133.27 41.75 Favored Pre-proline 0 C--N 1.322 -0.626 0 C-N-CA 123.19 0.596 . . . . 0.0 111.326 -176.626 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . 0.549 ' HG3' ' OG1' ' A' ' 18' ' ' THR . 32.4 Cg_exo -55.52 -28.49 64.83 Favored 'Trans proline' 0 C--N 1.35 0.627 0 C-N-CA 123.8 3.0 . . . . 0.0 113.524 -173.16 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 87.7 t80 -75.58 -54.49 6.92 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.045 0.45 . . . . 0.0 110.128 -177.9 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 7.6 pttm -79.52 -19.01 50.65 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.221 -0.445 . . . . 0.0 112.062 -178.353 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 25.2 t -69.43 -38.04 76.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 N-CA-C 109.815 -0.439 . . . . 0.0 109.815 172.895 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -71.51 -48.57 48.1 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 -179.632 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 27.8 mt-30 -59.06 -37.84 77.99 Favored 'General case' 0 C--O 1.22 -0.459 0 CA-C-N 115.784 -0.643 . . . . 0.0 110.583 176.565 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . 0.989 ' HB1' ' HE3' ' A' ' 51' ' ' MET . . . -64.61 -40.16 95.0 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.049 0.452 . . . . 0.0 110.291 -179.664 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' CYS . . . . . 0.453 ' SG ' HD11 ' A' ' 69' ' ' ILE . 88.6 m -65.72 -49.53 68.15 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.498 -0.774 . . . . 0.0 110.792 179.115 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . 0.451 ' O ' ' HB2' ' A' ' 85' ' ' ASP . 3.0 pp20? -72.08 -19.84 61.75 Favored 'General case' 0 C--N 1.326 -0.433 0 C-N-CA 120.075 -0.65 . . . . 0.0 110.902 -179.96 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' MET . . . . . 0.499 ' HE2' ' HA ' ' A' ' 79' ' ' ALA . 40.8 ttp -75.63 -49.2 19.18 Favored 'General case' 0 C--N 1.33 -0.248 0 O-C-N 123.053 0.221 . . . . 0.0 110.597 176.468 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . 0.556 ' O ' ' HG ' ' A' ' 87' ' ' LEU . 35.7 m -67.18 -36.21 76.23 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.175 0 C-N-CA 120.712 -0.395 . . . . 0.0 110.485 178.487 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 91.2 mtp -72.01 -27.85 63.0 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.208 175.636 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . 0.451 ' HB2' ' O ' ' A' ' 81' ' ' GLU . 32.6 t70 -64.89 -45.5 85.67 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.171 -0.468 . . . . 0.0 109.855 176.022 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.434 HG13 ' O ' ' A' ' 82' ' ' MET . 70.2 mt -56.62 -37.14 50.95 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.183 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.599 176.882 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.615 HD11 HD12 ' A' ' 24' ' ' ILE . 50.3 mt -75.73 -35.87 60.09 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.757 -0.656 . . . . 0.0 111.435 -177.372 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . 0.431 HH11 ' HD2' ' A' ' 88' ' ' ARG . 9.1 ptp85 -79.3 -20.24 48.46 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.25 0.548 . . . . 0.0 110.672 -178.199 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 5.4 tp10 . . . . . 0 C--N 1.312 -1.055 0 CA-C-O 118.327 -0.844 . . . . 0.0 109.979 -173.475 . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 18' ' ' THR . . . . . 0.64 HG23 ' HA ' ' A' ' 73' ' ' PRO . 23.9 m . . . . . 0 N--CA 1.453 -0.283 0 CA-C-O 120.813 0.339 . . . . 0.0 111.347 . . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.628 ' HA ' ' O ' ' A' ' 69' ' ' ILE . 7.2 p -141.34 127.99 20.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.907 176.667 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 85.4 mt-30 -109.43 132.35 54.21 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.589 176.483 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . 0.58 ' HA ' ' O ' ' A' ' 67' ' ' LEU . 6.7 mp0 -103.0 118.77 37.55 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.371 177.15 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 11.7 mm -108.92 144.17 17.81 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-N 116.048 -0.523 . . . . 0.0 109.619 178.696 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 23' ' ' MET . . . . . 0.479 ' HE1' ' HA ' ' A' ' 23' ' ' MET . 9.4 mmt -100.08 91.52 4.81 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 109.699 -0.482 . . . . 0.0 109.699 176.436 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.663 ' HB ' ' HB2' ' A' ' 65' ' ' LYS . 41.3 mm -79.29 126.72 80.88 Favored Pre-proline 0 C--N 1.32 -0.677 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.011 -176.034 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . 0.609 ' HB2' ' HD3' ' A' ' 28' ' ' LYS . 65.9 Cg_exo -52.43 147.49 29.29 Favored 'Trans proline' 0 C--N 1.347 0.486 0 C-N-CA 123.166 2.577 . . . . 0.0 112.94 177.445 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -51.48 -55.96 15.97 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 112.232 0.456 . . . . 0.0 112.232 -173.932 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -75.48 -8.96 84.5 Favored Glycine 0 N--CA 1.454 -0.155 0 C-N-CA 121.103 -0.57 . . . . 0.0 112.618 -176.892 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . 0.609 ' HD3' ' HB2' ' A' ' 25' ' ' PRO . 5.1 mptp? -92.78 -3.94 53.89 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.957 0.408 . . . . 0.0 110.815 -179.896 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -62.17 -32.1 72.68 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.489 177.342 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -67.32 -19.26 70.34 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.861 -0.685 . . . . 0.0 112.44 178.932 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 79.0 mt -87.03 -42.96 12.69 Favored 'General case' 0 C--N 1.327 -0.371 0 O-C-N 122.789 -0.242 . . . . 0.0 110.896 -178.898 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 4.1 m -69.9 -35.88 66.72 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.15 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.152 179.164 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.653 ' HA ' ' HB ' ' A' ' 40' ' ' ILE . 88.2 mt -76.95 -38.21 28.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-O 121.459 0.647 . . . . 0.0 109.892 177.939 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . 0.526 ' CA ' ' HB ' ' A' ' 39' ' ' THR . . . 124.32 157.05 9.63 Favored Glycine 0 N--CA 1.439 -1.137 0 C-N-CA 120.584 -0.817 . . . . 0.0 112.38 174.532 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 32.2 mmtp -58.65 -31.79 68.48 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 120.836 0.351 . . . . 0.0 110.642 -178.888 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -128.42 14.63 6.14 Favored Glycine 0 N--CA 1.449 -0.452 0 C-N-CA 120.952 -0.642 . . . . 0.0 111.879 175.751 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.524 ' HA2' HG22 ' A' ' 33' ' ' ILE . . . 84.48 1.78 89.17 Favored Glycine 0 C--N 1.332 0.315 0 C-N-CA 121.017 -0.611 . . . . 0.0 112.135 -177.347 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -85.39 -29.67 24.24 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 120.706 0.288 . . . . 0.0 111.385 -178.121 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 39' ' ' THR . . . . . 0.758 ' O ' ' HG ' ' A' ' 43' ' ' LEU . 91.3 m -62.51 -42.0 99.21 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.849 -174.796 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.653 ' HB ' ' HA ' ' A' ' 33' ' ' ILE . 15.6 tt -60.62 -30.17 46.29 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.287 0 CA-C-O 121.105 0.478 . . . . 0.0 111.093 -179.308 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . 0.665 ' O ' ' HG2' ' A' ' 45' ' ' GLU . 62.0 tttp -73.19 -44.05 60.43 Favored 'General case' 0 N--CA 1.451 -0.419 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 174.332 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 75.4 mt-30 -58.49 -43.72 89.12 Favored 'General case' 0 CA--C 1.515 -0.401 0 CA-C-N 115.681 -0.69 . . . . 0.0 110.106 -177.167 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.758 ' HG ' ' O ' ' A' ' 39' ' ' THR . 42.1 mt -53.89 -49.66 68.08 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.385 -0.825 . . . . 0.0 110.855 -179.644 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 48.4 mt-30 -64.68 -45.6 85.99 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.411 -0.813 . . . . 0.0 110.985 -179.377 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.665 ' HG2' ' O ' ' A' ' 41' ' ' LYS . 67.7 mm-40 -61.18 -41.91 97.63 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.078 -179.279 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . 0.517 ' HD3' ' SD ' ' A' ' 82' ' ' MET . 10.2 ptm180 -81.65 -36.43 28.84 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.767 -0.652 . . . . 0.0 112.651 -170.063 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . 0.478 ' HB1' HG22 ' A' ' 49' ' ' VAL . . . -90.26 -24.04 21.04 Favored 'General case' 0 C--N 1.324 -0.507 0 C-N-CA 120.498 -0.481 . . . . 0.0 111.187 -178.743 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 87.49 24.0 37.88 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.967 -0.635 . . . . 0.0 112.533 -179.657 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.478 HG22 ' HB1' ' A' ' 47' ' ' ALA . 14.0 m -121.77 179.31 2.42 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-O 120.923 0.392 . . . . 0.0 110.89 -178.002 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 87.3 tttt -117.58 122.41 43.55 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.548 -0.751 . . . . 0.0 109.162 173.708 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 51' ' ' MET . . . . . 0.815 ' HE2' HG12 ' A' ' 83' ' ' VAL . 65.2 mtp -116.9 115.52 25.67 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 -179.008 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.597 ' CG2' ' HB2' ' A' ' 68' ' ' ARG . 6.0 tt -105.61 105.8 19.36 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.782 0 CA-C-O 121.47 0.652 . . . . 0.0 110.984 -178.136 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.811 HD21 HD11 ' A' ' 67' ' ' LEU . 3.4 mm? -83.12 102.17 11.65 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.391 -0.822 . . . . 0.0 109.316 174.008 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.551 ' HB ' ' HB2' ' A' ' 66' ' ' PRO . 64.9 mt -81.65 85.57 1.63 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.432 0 CA-C-O 121.677 0.751 . . . . 0.0 110.333 -177.863 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 1.9 pp0? . . . . . 0 C--N 1.316 -0.849 0 CA-C-N 115.068 -0.969 . . . . 0.0 109.279 171.994 . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 1.2 p30 . . . . . 0 CA--C 1.52 -0.179 0 CA-C-O 121.319 0.581 . . . . 0.0 111.326 . . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . 0.663 ' HB2' ' HB ' ' A' ' 24' ' ' ILE . 31.6 mmtm -129.57 113.44 17.95 Favored Pre-proline 0 C--N 1.315 -0.894 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.696 179.713 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . 0.551 ' HB2' ' HB ' ' A' ' 54' ' ' ILE . 52.6 Cg_exo -58.09 104.56 0.18 Allowed 'Trans proline' 0 N--CA 1.459 -0.512 0 C-N-CA 122.821 2.348 . . . . 0.0 111.632 173.678 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.811 HD11 HD21 ' A' ' 53' ' ' LEU . 18.9 tp -112.85 106.5 14.83 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.235 177.229 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . 0.597 ' HB2' ' CG2' ' A' ' 52' ' ' ILE . 13.1 mtp180 -92.67 117.83 30.39 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 109.476 -0.564 . . . . 0.0 109.476 172.586 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . 0.628 ' O ' ' HA ' ' A' ' 19' ' ' VAL . 28.4 mt -96.94 102.31 13.32 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.089 0 N-CA-C 108.206 -1.035 . . . . 0.0 108.206 171.631 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 5.2 mt -103.4 119.39 51.88 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.042 -172.229 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 176.36 -137.11 3.49 Favored Glycine 0 N--CA 1.444 -0.817 0 C-N-CA 120.96 -0.638 . . . . 0.0 112.393 178.849 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . 0.822 ' HB2' ' HE2' ' A' ' 75' ' ' LYS . 44.9 m-20 -108.12 152.5 41.84 Favored Pre-proline 0 C--N 1.32 -0.713 0 N-CA-C 109.567 -0.531 . . . . 0.0 109.567 179.784 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . 0.64 ' HA ' HG23 ' A' ' 18' ' ' THR . 67.2 Cg_exo -48.89 -48.74 17.0 Favored 'Trans proline' 0 C--N 1.347 0.469 0 C-N-CA 123.359 2.706 . . . . 0.0 113.972 -167.106 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . 0.525 ' O ' ' HG2' ' A' ' 78' ' ' GLN . 45.1 m-85 -64.75 -51.94 59.66 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.703 -174.494 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . 0.822 ' HE2' ' HB2' ' A' ' 72' ' ' ASP . 22.7 pttt -73.7 -23.82 59.85 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 112.175 0.435 . . . . 0.0 112.175 -176.528 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.409 HG22 ' O ' ' A' ' 72' ' ' ASP . 58.0 t -69.68 -40.92 79.89 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 N-CA-C 109.422 -0.584 . . . . 0.0 109.422 175.39 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . 0.581 HE21 ' HG3' ' A' ' 81' ' ' GLU . 18.1 tp60 -71.43 -46.27 60.53 Favored 'General case' 0 N--CA 1.445 -0.715 0 CA-C-N 115.494 -0.776 . . . . 0.0 111.313 -177.698 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . 0.603 ' HG2' ' HA ' ' A' ' 75' ' ' LYS . 3.3 pt20 -64.09 -38.56 91.51 Favored 'General case' 0 CA--C 1.508 -0.643 0 CA-C-O 121.489 0.661 . . . . 0.0 110.225 -179.676 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . 0.793 ' HA ' ' HE3' ' A' ' 82' ' ' MET . . . -63.34 -39.76 95.42 Favored 'General case' 0 C--N 1.313 -1.016 0 CA-C-N 114.556 -1.202 . . . . 0.0 110.384 176.863 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 52.0 t -64.62 -49.47 70.95 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.447 175.893 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . 0.581 ' HG3' HE21 ' A' ' 77' ' ' GLN . 45.4 mt-10 -56.0 -38.98 71.22 Favored 'General case' 0 CA--C 1.518 -0.286 0 CA-C-O 121.205 0.526 . . . . 0.0 110.054 176.244 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 82' ' ' MET . . . . . 0.793 ' HE3' ' HA ' ' A' ' 79' ' ' ALA . 37.5 ttp -63.43 -54.23 39.88 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 114.77 -1.105 . . . . 0.0 111.555 -178.719 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . 0.815 HG12 ' HE2' ' A' ' 51' ' ' MET . 35.4 m -70.74 -37.86 70.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 C-N-CA 120.897 -0.321 . . . . 0.0 111.47 -177.225 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 88.9 mmm -66.38 -33.46 75.76 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.724 0.297 . . . . 0.0 110.34 177.339 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -62.37 -39.07 91.97 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.518 177.171 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.497 HG13 ' O ' ' A' ' 82' ' ' MET . 52.6 mt -66.4 -29.49 46.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.834 179.684 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.492 HD21 ' HB3' ' A' ' 28' ' ' LYS . 61.2 mt -85.1 -23.5 28.46 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.668 -176.231 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 15.7 ptm180 -99.64 -3.14 33.78 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 120.998 0.428 . . . . 0.0 111.192 -175.58 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 12.5 tp10 . . . . . 0 C--O 1.247 0.967 0 CA-C-N 115.661 -0.699 . . . . 0.0 109.892 -174.863 . . . . . . . . 0 0 . 1 . 022 nuclear orig core ' A' A ' 18' ' ' THR . . . . . 0.506 ' OG1' ' HG3' ' A' ' 73' ' ' PRO . 56.5 m . . . . . 0 N--CA 1.453 -0.306 0 CA-C-O 120.875 0.369 . . . . 0.0 110.683 . . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.456 ' HA ' ' O ' ' A' ' 69' ' ' ILE . 4.0 p -135.97 134.26 50.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.811 179.205 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 26.2 mt-30 -110.57 126.92 54.94 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 109.885 -0.413 . . . . 0.0 109.885 174.135 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . 0.571 ' HA ' ' O ' ' A' ' 67' ' ' LEU . 26.0 mt-10 -101.23 122.17 43.18 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.957 -179.072 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 7.0 mm -114.02 155.95 15.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 115.828 -0.624 . . . . 0.0 109.891 -178.047 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 23' ' ' MET . . . . . 0.433 ' HB3' ' HB3' ' A' ' 64' ' ' ASP . 85.2 mmm -112.41 97.54 6.68 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 108.27 -1.011 . . . . 0.0 108.27 173.158 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.556 HG23 HG23 ' A' ' 32' ' ' VAL . 40.2 mm -83.89 126.97 69.13 Favored Pre-proline 0 C--N 1.319 -0.757 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.689 -172.575 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_exo -49.1 130.46 24.11 Favored 'Trans proline' 0 C--N 1.345 0.348 0 C-N-CA 123.071 2.514 . . . . 0.0 112.169 176.938 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -55.02 -29.9 58.37 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.605 -0.725 . . . . 0.0 112.657 -174.112 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -87.45 -31.68 15.63 Favored Glycine 0 N--CA 1.446 -0.658 0 C-N-CA 120.347 -0.93 . . . . 0.0 112.739 -178.712 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 4.2 tptm -93.92 -1.54 54.56 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 122.609 -0.347 . . . . 0.0 110.873 -175.002 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . 0.436 ' HA ' HG22 ' A' ' 32' ' ' VAL . . . -65.57 -21.42 66.59 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.279 -179.143 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -60.18 -37.17 92.5 Favored Glycine 0 N--CA 1.448 -0.561 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.354 179.819 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 92.4 mt -75.29 -27.44 59.34 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.701 0.286 . . . . 0.0 111.371 -174.922 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.657 HG13 ' HB ' ' A' ' 83' ' ' VAL . 1.4 t -69.38 -36.57 72.56 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.365 0 CA-C-O 121.586 0.708 . . . . 0.0 110.222 179.285 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.52 HG12 ' HG ' ' A' ' 53' ' ' LEU . 34.8 mt -86.19 -40.68 14.57 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-N 115.116 -0.947 . . . . 0.0 110.28 -178.302 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 124.88 -170.83 16.87 Favored Glycine 0 N--CA 1.442 -0.933 0 CA-C-N 115.58 -0.736 . . . . 0.0 111.565 179.801 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 33.7 mmtp -82.45 -27.63 31.77 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-O 121.128 0.49 . . . . 0.0 109.711 179.866 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -145.01 12.02 1.87 Allowed Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.861 -0.685 . . . . 0.0 112.367 178.658 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 96.07 16.64 37.56 Favored Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.789 -0.719 . . . . 0.0 111.974 179.542 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -85.13 -37.15 20.56 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 120.635 0.255 . . . . 0.0 110.398 178.84 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 39' ' ' THR . . . . . 0.816 ' O ' ' HG ' ' A' ' 43' ' ' LEU . 26.5 m -60.41 -55.83 28.85 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.928 -179.22 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.505 ' HB ' ' HA ' ' A' ' 33' ' ' ILE . 7.9 tt -55.34 -24.65 15.85 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-O 121.064 0.459 . . . . 0.0 111.781 -178.753 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 25.3 ttmm -79.41 -46.73 16.99 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.589 179.91 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . 0.436 ' O ' ' HG2' ' A' ' 46' ' ' ARG . 11.5 pt20 -69.89 -35.64 74.79 Favored 'General case' 0 CA--C 1.515 -0.387 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.318 -177.259 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.816 ' HG ' ' O ' ' A' ' 39' ' ' THR . 77.0 mt -53.11 -45.75 68.43 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.589 -0.732 . . . . 0.0 111.256 -178.576 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 49.2 mt-30 -67.44 -33.54 75.36 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.747 -0.661 . . . . 0.0 111.037 -178.968 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 31.8 mm-40 -72.94 -32.06 65.01 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.147 -178.064 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . 0.436 ' HG2' ' O ' ' A' ' 42' ' ' GLN . 14.9 ptp180 -92.27 -42.19 9.98 Favored 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 112.143 0.423 . . . . 0.0 112.143 -175.882 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . 0.476 ' O ' ' HD3' ' A' ' 75' ' ' LYS . . . -74.9 -31.67 61.63 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.767 0.318 . . . . 0.0 111.072 -177.724 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 92.11 -3.95 77.26 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.876 -0.678 . . . . 0.0 112.088 -178.432 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.449 ' CG1' ' HG3' ' A' ' 75' ' ' LYS . 15.5 m -102.55 169.02 1.98 Allowed 'Isoleucine or valine' 0 CA--C 1.512 -0.516 0 CA-C-O 121.221 0.534 . . . . 0.0 111.022 -179.623 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 86.0 tttt -101.26 124.48 47.03 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-N 115.347 -0.842 . . . . 0.0 110.045 176.286 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 51' ' ' MET . . . . . 0.852 ' HE3' ' HB2' ' A' ' 79' ' ' ALA . 58.8 mtt -109.55 114.66 28.47 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 175.919 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.571 ' CG2' ' HB2' ' A' ' 68' ' ' ARG . 10.0 tt -109.63 104.94 17.88 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.994 0 CA-C-O 121.724 0.773 . . . . 0.0 109.988 177.791 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.52 ' HG ' HG12 ' A' ' 33' ' ' ILE . 3.8 mm? -77.98 102.82 7.56 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 114.945 -1.025 . . . . 0.0 108.6 173.166 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.767 ' HB ' ' HG2' ' A' ' 66' ' ' PRO . 51.0 mt -76.04 88.52 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-O 121.777 0.798 . . . . 0.0 109.734 -177.233 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 13.6 mm100 . . . . . 0 C--N 1.323 -0.577 0 CA-C-N 114.845 -1.07 . . . . 0.0 111.427 -171.568 . . . . . . . . 0 0 . 1 . 022 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . 0.433 ' HB3' ' HB3' ' A' ' 23' ' ' MET . 19.1 m-20 . . . . . 0 N--CA 1.456 -0.141 0 CA-C-O 121.144 0.497 . . . . 0.0 110.058 . . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . 0.446 ' HB2' ' HB ' ' A' ' 24' ' ' ILE . 12.2 mmmm -90.48 133.62 32.56 Favored Pre-proline 0 C--N 1.323 -0.572 0 CA-C-N 115.385 -0.825 . . . . 0.0 112.738 -168.043 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . 0.767 ' HG2' ' HB ' ' A' ' 54' ' ' ILE . 30.3 Cg_endo -64.62 113.83 2.47 Favored 'Trans proline' 0 CA--C 1.533 0.46 0 C-N-CA 123.465 2.777 . . . . 0.0 111.65 172.539 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.571 ' O ' ' HA ' ' A' ' 21' ' ' GLU . 57.0 tp -123.36 129.35 51.18 Favored 'General case' 0 C--N 1.324 -0.531 0 O-C-N 122.338 -0.226 . . . . 0.0 110.579 179.571 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . 0.571 ' HB2' ' CG2' ' A' ' 52' ' ' ILE . 95.7 mtt180 -120.89 114.9 22.24 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.694 0.283 . . . . 0.0 110.984 176.567 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . 0.456 ' O ' ' HA ' ' A' ' 19' ' ' VAL . 4.5 mp -98.24 106.4 18.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 N-CA-C 108.228 -1.027 . . . . 0.0 108.228 171.82 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.422 HG12 ' CG2' ' A' ' 19' ' ' VAL . 15.4 mt -109.85 132.82 57.05 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-N 116.464 -0.334 . . . . 0.0 111.076 -171.98 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 153.91 -132.54 3.6 Favored Glycine 0 N--CA 1.448 -0.51 0 C-N-CA 120.952 -0.642 . . . . 0.0 112.595 176.28 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . 0.612 ' OD2' ' HG2' ' A' ' 75' ' ' LYS . 1.1 t70 -81.0 134.56 52.62 Favored Pre-proline 0 C--N 1.324 -0.524 0 C-N-CA 122.692 0.397 . . . . 0.0 110.882 -178.674 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . 0.506 ' HG3' ' OG1' ' A' ' 18' ' ' THR . 63.9 Cg_exo -47.96 -34.12 21.92 Favored 'Trans proline' 0 C--N 1.349 0.562 0 C-N-CA 123.878 3.052 . . . . 0.0 113.972 -177.314 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 73.0 m-85 -80.38 -55.81 4.63 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.755 0.312 . . . . 0.0 110.547 -176.123 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . 0.729 ' HB3' ' HZ3' ' A' ' 75' ' ' LYS . 0.3 OUTLIER -71.07 -22.75 62.07 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.256 -177.587 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 20.5 t -64.85 -43.05 96.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 N-CA-C 109.713 -0.477 . . . . 0.0 109.713 171.249 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -68.59 -46.86 68.25 Favored 'General case' 0 N--CA 1.448 -0.527 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 177.845 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 28.0 mm-40 -61.57 -40.44 94.76 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.026 -179.309 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . 0.852 ' HB2' ' HE3' ' A' ' 51' ' ' MET . . . -67.71 -34.37 76.73 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.017 0.437 . . . . 0.0 110.34 177.546 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 49.2 t -63.01 -48.26 79.54 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.577 -0.738 . . . . 0.0 109.693 175.243 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 75.8 mm-40 -57.82 -44.78 86.62 Favored 'General case' 0 C--O 1.22 -0.479 0 N-CA-C 109.766 -0.457 . . . . 0.0 109.766 174.497 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 82' ' ' MET . . . . . 0.515 ' SD ' HD22 ' A' ' 43' ' ' LEU . 32.5 ttm -52.85 -58.52 6.65 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.385 -0.825 . . . . 0.0 111.267 -179.387 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . 0.657 ' HB ' HG13 ' A' ' 32' ' ' VAL . 35.3 m -73.0 -35.49 48.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.887 -175.813 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 83.5 mtp -77.54 -30.06 52.61 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 120.861 -0.335 . . . . 0.0 111.253 -177.707 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -62.34 -43.52 98.64 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-O 120.911 0.386 . . . . 0.0 110.244 178.835 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 57.9 mt -61.15 -29.18 45.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 115.837 -0.619 . . . . 0.0 110.61 178.32 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.43 HD11 HG21 ' A' ' 32' ' ' VAL . 5.9 mp -84.91 -40.63 16.81 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.498 -0.774 . . . . 0.0 112.208 -176.714 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 25.5 ptt180 -84.51 -8.12 59.04 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.867 0.365 . . . . 0.0 111.704 -174.207 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 . . . . . 0 C--O 1.249 1.063 0 CA-C-O 118.359 -0.829 . . . . 0.0 109.956 -178.228 . . . . . . . . 0 0 . 1 . 023 nuclear orig core ' A' A ' 18' ' ' THR . . . . . 0.598 ' OG1' ' HD3' ' A' ' 73' ' ' PRO . 89.0 m . . . . . 0 C--O 1.225 -0.222 0 CA-C-O 120.6 0.238 . . . . 0.0 110.725 . . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.452 ' HA ' ' O ' ' A' ' 69' ' ' ILE . 9.1 p -140.64 140.72 33.36 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-O 120.814 0.34 . . . . 0.0 110.751 -179.783 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 25.7 mt-30 -128.12 138.72 52.64 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 109.642 -0.503 . . . . 0.0 109.642 174.394 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . 0.602 ' HG2' ' HG2' ' A' ' 68' ' ' ARG . 44.8 mt-10 -102.62 116.88 33.48 Favored 'General case' 0 C--N 1.328 -0.368 0 O-C-N 123.315 0.384 . . . . 0.0 110.805 -179.57 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 13.1 mm -100.39 150.31 5.61 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-N 115.918 -0.583 . . . . 0.0 109.639 178.47 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 23' ' ' MET . . . . . 0.408 ' HE1' ' HA ' ' A' ' 23' ' ' MET . 1.7 mmt -103.16 91.61 4.17 Favored 'General case' 0 C--N 1.317 -0.811 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 175.191 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.659 ' HB ' ' HB2' ' A' ' 65' ' ' LYS . 36.1 mm -77.39 124.1 86.88 Favored Pre-proline 0 C--N 1.323 -0.547 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.765 -176.236 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . 0.559 ' HB2' ' HB2' ' A' ' 28' ' ' LYS . 68.4 Cg_exo -51.83 135.41 50.08 Favored 'Trans proline' 0 N--CA 1.461 -0.396 0 C-N-CA 122.898 2.399 . . . . 0.0 111.737 177.717 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -56.25 -35.36 67.32 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 115.649 -0.705 . . . . 0.0 112.371 -175.072 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -80.22 -15.9 77.58 Favored Glycine 0 N--CA 1.452 -0.238 0 C-N-CA 120.519 -0.848 . . . . 0.0 111.875 178.95 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . 0.559 ' HB2' ' HB2' ' A' ' 25' ' ' PRO . 0.3 OUTLIER -94.89 -4.38 47.02 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.755 0.312 . . . . 0.0 110.591 179.441 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.16 -27.95 68.77 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.424 -178.02 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -65.15 -24.27 70.31 Favored Glycine 0 CA--C 1.519 0.309 0 C-N-CA 120.785 -0.721 . . . . 0.0 112.356 178.253 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 95.1 mt -86.14 -42.66 13.68 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 111.352 0.13 . . . . 0.0 111.352 -176.219 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.862 HG12 HD23 ' A' ' 87' ' ' LEU . 2.7 m -65.19 -34.46 70.71 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.19 0 CA-C-O 120.928 0.394 . . . . 0.0 110.857 178.605 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 66.4 mt -79.89 -45.71 22.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-O 121.469 0.652 . . . . 0.0 109.689 176.241 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . 0.409 ' HA3' ' H ' ' A' ' 39' ' ' THR . . . 96.64 60.07 1.0 Allowed Glycine 0 N--CA 1.444 -0.773 0 CA-C-N 115.719 -0.673 . . . . 0.0 113.123 175.514 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.458 ' N ' ' HD3' ' A' ' 35' ' ' LYS . 0.0 OUTLIER 55.32 24.69 6.73 Favored 'General case' 0 N--CA 1.467 0.386 0 C-N-CA 122.949 0.5 . . . . 0.0 112.09 175.093 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 145.36 -52.18 0.59 Allowed Glycine 0 N--CA 1.449 -0.465 0 N-CA-C 111.58 -0.608 . . . . 0.0 111.58 -179.459 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.401 ' O ' ' HB2' ' A' ' 41' ' ' LYS . . . 165.02 24.23 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.429 -0.891 . . . . 0.0 113.694 176.462 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . 0.607 ' O ' ' HG2' ' A' ' 42' ' ' GLN . 40.5 mm-40 -85.03 -43.51 13.88 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 117.344 0.572 . . . . 0.0 110.954 -179.23 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 39' ' ' THR . . . . . 0.712 ' O ' ' HG ' ' A' ' 43' ' ' LEU . 82.2 m -66.51 -53.9 29.83 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.488 -176.865 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.563 HD12 HD21 ' A' ' 53' ' ' LEU . 7.1 tt -56.15 -31.85 32.82 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.419 0 CA-C-O 121.56 0.695 . . . . 0.0 110.472 179.029 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . 0.466 ' HB3' ' O ' ' A' ' 38' ' ' GLU . 83.5 tttt -62.47 -43.26 99.25 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.003 -0.999 . . . . 0.0 110.569 177.687 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . 0.607 ' HG2' ' O ' ' A' ' 38' ' ' GLU . 61.5 mm-40 -72.66 -43.71 62.82 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.962 -177.84 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.712 ' HG ' ' O ' ' A' ' 39' ' ' THR . 37.5 mt -54.87 -49.77 70.32 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.494 -0.775 . . . . 0.0 111.863 -172.913 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 43.8 mt-30 -59.46 -38.44 80.77 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.835 -0.62 . . . . 0.0 111.222 -177.6 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 9.1 mm-40 -76.74 -42.48 40.99 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.382 -176.67 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . 0.438 ' HG2' ' O ' ' A' ' 42' ' ' GLN . 16.2 ptp180 -74.35 -33.73 63.2 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 112.05 0.389 . . . . 0.0 112.05 -174.677 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . 0.535 ' HB3' HG23 ' A' ' 49' ' ' VAL . . . -89.94 -21.1 22.62 Favored 'General case' 0 C--N 1.325 -0.492 0 C-N-CA 120.756 -0.378 . . . . 0.0 111.524 -177.936 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 76.83 28.41 59.03 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.809 -0.71 . . . . 0.0 111.537 -177.733 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.535 HG23 ' HB3' ' A' ' 47' ' ' ALA . 35.9 m -121.49 168.63 13.74 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-O 120.973 0.416 . . . . 0.0 110.654 -176.947 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . 0.625 ' HB3' ' HB ' ' A' ' 70' ' ' ILE . 50.7 tptt -101.04 122.56 43.77 Favored 'General case' 0 C--N 1.318 -0.804 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 171.994 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 51' ' ' MET . . . . . 0.861 ' HE2' HG13 ' A' ' 83' ' ' VAL . 77.3 mtp -118.74 114.9 23.4 Favored 'General case' 0 C--N 1.316 -0.869 0 N-CA-C 109.751 -0.462 . . . . 0.0 109.751 177.422 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.556 ' CG2' ' HB2' ' A' ' 68' ' ' ARG . 10.2 tt -106.22 108.47 25.17 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.841 0 CA-C-O 121.376 0.608 . . . . 0.0 109.901 176.84 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.563 HD21 HD12 ' A' ' 40' ' ' ILE . 2.8 mm? -82.24 102.77 11.37 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.669 -0.696 . . . . 0.0 109.278 177.124 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.52 ' HB ' ' HB2' ' A' ' 66' ' ' PRO . 68.8 mt -82.25 98.14 4.42 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.407 0 CA-C-O 121.514 0.673 . . . . 0.0 109.664 -179.817 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 59.7 mt-30 . . . . . 0 C--N 1.319 -0.745 0 CA-C-N 115.216 -0.902 . . . . 0.0 110.774 -173.09 . . . . . . . . 0 0 . 1 . 023 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 41.1 m-20 . . . . . 0 N--CA 1.446 -0.671 0 N-CA-C 109.737 -0.468 . . . . 0.0 109.737 . . . . . . . . . 0 0 . 1 . 023 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . 0.659 ' HB2' ' HB ' ' A' ' 24' ' ' ILE . 59.5 mmtt -137.27 114.35 9.74 Favored Pre-proline 0 C--N 1.315 -0.904 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.568 -173.971 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . 0.52 ' HB2' ' HB ' ' A' ' 54' ' ' ILE . 48.4 Cg_exo -58.87 116.84 3.54 Favored 'Trans proline' 0 N--CA 1.463 -0.271 0 C-N-CA 123.141 2.56 . . . . 0.0 111.89 175.693 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.539 ' O ' ' HA ' ' A' ' 21' ' ' GLU . 43.2 tp -120.47 114.49 21.86 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.089 179.839 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . 0.602 ' HG2' ' HG2' ' A' ' 21' ' ' GLU . 92.9 mtt180 -102.4 107.19 18.1 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 120.843 0.354 . . . . 0.0 110.551 177.79 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . 0.632 ' HB ' HG13 ' A' ' 76' ' ' VAL . 3.9 mp -90.02 104.73 15.47 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 173.489 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.625 ' HB ' ' HB3' ' A' ' 50' ' ' LYS . 3.0 mt -99.03 123.48 51.69 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.767 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.405 -175.529 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 175.15 -114.36 0.49 Allowed Glycine 0 N--CA 1.443 -0.839 0 C-N-CA 121.072 -0.585 . . . . 0.0 112.568 179.841 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -134.7 147.2 62.12 Favored Pre-proline 0 C--N 1.322 -0.593 0 N-CA-C 108.453 -0.943 . . . . 0.0 108.453 -177.219 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . 0.598 ' HD3' ' OG1' ' A' ' 18' ' ' THR . 87.4 Cg_exo -44.7 -36.01 9.97 Favored 'Trans proline' 0 C--N 1.352 0.724 0 C-N-CA 122.37 2.047 . . . . 0.0 112.339 -176.586 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 94.8 t80 -64.21 -62.77 1.41 Allowed 'General case' 0 N--CA 1.448 -0.547 0 CA-C-N 115.296 -0.865 . . . . 0.0 111.108 179.629 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 34.9 pttt -74.45 -30.17 61.76 Favored 'General case' 0 C--O 1.223 -0.31 0 N-CA-C 112.036 0.384 . . . . 0.0 112.036 -175.914 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.632 HG13 ' HB ' ' A' ' 69' ' ' ILE . 70.0 t -62.88 -38.22 81.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 N-CA-C 109.928 -0.397 . . . . 0.0 109.928 177.539 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . 0.419 ' O ' ' HG2' ' A' ' 81' ' ' GLU . 2.6 mm100 -79.1 -38.12 37.02 Favored 'General case' 0 N--CA 1.451 -0.42 0 C-N-CA 120.733 -0.387 . . . . 0.0 111.366 178.876 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 90.9 mt-30 -62.82 -40.92 98.87 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.971 0.415 . . . . 0.0 110.203 176.447 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . 0.682 ' HA ' ' HE2' ' A' ' 82' ' ' MET . . . -67.96 -37.46 81.59 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.458 177.224 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 43.9 t -65.01 -51.62 60.62 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.302 178.415 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . 0.419 ' HG2' ' O ' ' A' ' 77' ' ' GLN . 14.0 pt-20 -66.01 -27.18 67.92 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.02 0.438 . . . . 0.0 109.986 179.6 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 82' ' ' MET . . . . . 0.682 ' HE2' ' HA ' ' A' ' 79' ' ' ALA . 49.5 ttp -67.01 -50.47 62.07 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.801 177.261 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . 0.861 HG13 ' HE2' ' A' ' 51' ' ' MET . 33.4 m -76.27 -35.15 27.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 C-N-CA 120.909 -0.316 . . . . 0.0 110.73 -177.235 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 22.0 ttt -63.78 -34.7 78.49 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 109.627 -0.508 . . . . 0.0 109.627 177.58 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -59.73 -48.33 82.1 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.254 -0.885 . . . . 0.0 110.618 174.931 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.402 HG13 ' O ' ' A' ' 82' ' ' MET . 57.3 mt -61.73 -38.89 81.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.726 -179.426 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.862 HD23 HG12 ' A' ' 32' ' ' VAL . 52.8 mt -68.11 -43.94 77.28 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.87 -0.604 . . . . 0.0 111.371 -177.341 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 2.8 ptm180 -87.57 4.06 45.16 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.862 0.363 . . . . 0.0 111.043 -175.987 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 . . . . . 0 C--O 1.25 1.097 0 CA-C-O 118.466 -0.778 . . . . 0.0 109.457 179.604 . . . . . . . . 0 0 . 1 . 024 nuclear orig core ' A' A ' 18' ' ' THR . . . . . 0.621 ' OG1' ' HD3' ' A' ' 73' ' ' PRO . 96.7 m . . . . . 0 N--CA 1.453 -0.279 0 N-CA-C 109.647 -0.501 . . . . 0.0 109.647 . . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 92.2 t -138.49 125.8 27.5 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.791 -176.246 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 45.6 mt-30 -113.42 116.07 29.05 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.453 -0.34 . . . . 0.0 110.129 172.992 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . 0.607 ' HA ' ' O ' ' A' ' 67' ' ' LEU . 57.9 mt-10 -86.78 113.91 23.01 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.141 179.428 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 18.6 mm -97.51 151.43 4.29 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-N 115.518 -0.765 . . . . 0.0 108.986 176.527 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 23' ' ' MET . . . . . 0.455 ' HB3' ' HB3' ' A' ' 64' ' ' ASP . 73.7 mmm -104.85 99.2 8.85 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 108.752 -0.832 . . . . 0.0 108.752 176.64 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.653 HD12 HD12 ' A' ' 87' ' ' LEU . 22.9 mm -83.32 123.8 76.63 Favored Pre-proline 0 C--N 1.32 -0.68 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.471 -172.601 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_exo -52.82 130.36 37.07 Favored 'Trans proline' 0 N--CA 1.463 -0.273 0 C-N-CA 122.708 2.272 . . . . 0.0 111.495 176.408 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -57.31 -37.19 72.1 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.681 -0.69 . . . . 0.0 112.435 -173.403 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -80.59 -32.81 32.74 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.536 -0.84 . . . . 0.0 112.316 179.542 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . 0.437 ' HE2' ' O ' ' A' ' 87' ' ' LEU . 49.7 tptt -83.58 -7.27 59.55 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.152 0.501 . . . . 0.0 110.005 -177.544 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . 0.531 ' O ' HG12 ' A' ' 32' ' ' VAL . . . -62.15 -19.29 62.91 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.567 -0.742 . . . . 0.0 111.789 -177.756 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -58.46 -37.01 87.06 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.586 -0.816 . . . . 0.0 111.901 176.757 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 70.0 mt -83.03 -28.92 29.27 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 111.667 0.247 . . . . 0.0 111.667 -178.431 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.531 HG12 ' O ' ' A' ' 29' ' ' ALA . 0.4 OUTLIER -69.37 -28.41 38.21 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.395 0 CA-C-O 121.253 0.549 . . . . 0.0 110.235 178.4 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.531 HG21 ' HA2' ' A' ' 37' ' ' GLY . 69.9 mt -86.18 -48.21 16.0 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.366 0 CA-C-N 115.679 -0.691 . . . . 0.0 109.467 174.871 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 135.77 170.6 12.11 Favored Glycine 0 N--CA 1.439 -1.155 0 C-N-CA 120.277 -0.963 . . . . 0.0 112.99 174.015 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.411 ' H ' ' HE3' ' A' ' 35' ' ' LYS . 0.0 OUTLIER -68.2 -27.2 66.18 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.164 0.506 . . . . 0.0 109.785 179.475 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -141.92 25.75 2.38 Favored Glycine 0 N--CA 1.447 -0.596 0 N-CA-C 111.158 -0.777 . . . . 0.0 111.158 174.472 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.531 ' HA2' HG21 ' A' ' 33' ' ' ILE . . . 77.24 2.83 80.42 Favored Glycine 0 CA--C 1.519 0.302 0 C-N-CA 121.039 -0.601 . . . . 0.0 112.26 -176.559 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -85.75 -28.75 24.38 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 111.759 0.281 . . . . 0.0 111.759 -177.961 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 39' ' ' THR . . . . . 0.716 ' O ' ' HG ' ' A' ' 43' ' ' LEU . 29.5 m -58.76 -47.32 85.09 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.478 -0.328 . . . . 0.0 111.825 -175.935 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.553 ' HA ' HD11 ' A' ' 43' ' ' LEU . 6.3 tt -58.53 -33.02 47.16 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.279 0 CA-C-O 121.075 0.464 . . . . 0.0 111.251 179.4 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 86.8 tttt -71.78 -37.3 70.48 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.168 0.508 . . . . 0.0 109.88 177.868 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . 0.68 ' O ' ' HG2' ' A' ' 46' ' ' ARG . 62.3 mt-30 -67.59 -42.03 83.13 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.485 -0.78 . . . . 0.0 110.429 179.999 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.716 ' HG ' ' O ' ' A' ' 39' ' ' THR . 58.6 mt -54.5 -41.0 69.1 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.604 -0.726 . . . . 0.0 111.247 -179.506 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 48.1 mt-30 -66.1 -39.51 90.03 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.514 -0.767 . . . . 0.0 110.807 179.605 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 11.6 mm-40 -67.92 -39.02 83.61 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.601 177.774 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . 0.857 ' HA ' ' HE ' ' A' ' 46' ' ' ARG . 0.0 OUTLIER -62.99 -44.82 94.96 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.731 -174.717 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -106.11 -0.54 24.65 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 112.603 0.594 . . . . 0.0 112.603 -171.857 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 65.03 40.6 97.18 Favored Glycine 0 C--N 1.33 0.206 0 C-N-CA 120.63 -0.795 . . . . 0.0 111.656 -177.396 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 23.8 m -126.35 179.38 3.43 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-N 115.446 -0.377 . . . . 0.0 110.413 -175.649 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 87.1 tttt -125.94 126.93 45.17 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 109.558 -0.534 . . . . 0.0 109.558 172.715 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 51' ' ' MET . . . . . 0.508 ' HB3' HD13 ' A' ' 67' ' ' LEU . 61.7 mtt -113.79 115.34 27.62 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 109.691 -0.485 . . . . 0.0 109.691 178.581 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.607 ' CG2' ' HB2' ' A' ' 68' ' ' ARG . 10.0 tt -99.59 109.41 24.53 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.752 0 CA-C-O 121.536 0.684 . . . . 0.0 109.646 176.64 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.877 HD21 HD12 ' A' ' 67' ' ' LEU . 0.5 OUTLIER -86.04 102.76 14.11 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.583 -0.735 . . . . 0.0 109.677 179.573 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.705 HD12 ' HB2' ' A' ' 66' ' ' PRO . 67.9 mt -75.13 85.67 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.335 0 CA-C-O 122.019 0.914 . . . . 0.0 108.984 175.837 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . 0.566 HE21 ' HB3' ' A' ' 53' ' ' LEU . 11.5 pt20 . . . . . 0 C--N 1.318 -0.801 0 CA-C-N 114.477 -1.238 . . . . 0.0 109.62 179.917 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . 0.464 ' HA ' ' O ' ' A' ' 24' ' ' ILE . 4.8 m-20 . . . . . 0 N--CA 1.46 0.07 0 N-CA-C 110.046 -0.353 . . . . 0.0 110.046 . . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . 0.641 ' HB2' ' HB ' ' A' ' 24' ' ' ILE . 30.9 mmtp -90.8 132.76 33.86 Favored Pre-proline 0 C--N 1.323 -0.576 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.071 -172.32 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . 0.705 ' HB2' HD12 ' A' ' 54' ' ' ILE . 13.5 Cg_exo -72.14 105.78 1.91 Allowed 'Trans proline' 0 N--CA 1.461 -0.395 0 C-N-CA 122.917 2.412 . . . . 0.0 111.491 173.954 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.877 HD12 HD21 ' A' ' 53' ' ' LEU . 23.8 tp -109.22 115.76 30.62 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.42 -0.355 . . . . 0.0 110.526 179.603 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . 0.607 ' HB2' ' CG2' ' A' ' 52' ' ' ILE . 95.6 mtt180 -99.81 108.22 20.46 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.885 176.484 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . 0.492 HG22 ' HB3' ' A' ' 79' ' ' ALA . 4.6 mp -86.97 104.92 14.54 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.587 0 N-CA-C 108.164 -1.05 . . . . 0.0 108.164 170.915 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 21.0 mt -97.05 126.22 49.87 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.615 -175.182 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 172.95 -117.21 0.64 Allowed Glycine 0 N--CA 1.447 -0.58 0 C-N-CA 120.758 -0.734 . . . . 0.0 113.027 178.367 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . 0.505 ' OD1' ' HD2' ' A' ' 73' ' ' PRO . 8.7 t70 -131.45 146.73 63.23 Favored Pre-proline 0 C--N 1.324 -0.536 0 CA-C-O 118.301 -0.857 . . . . 0.0 108.764 -177.147 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . 0.621 ' HD3' ' OG1' ' A' ' 18' ' ' THR . 88.0 Cg_exo -40.95 -40.59 3.78 Favored 'Trans proline' 0 C--N 1.351 0.7 0 C-N-CA 122.943 2.429 . . . . 0.0 112.894 -177.495 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 90.1 t80 -65.28 -62.59 1.44 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.735 -0.666 . . . . 0.0 111.136 -179.269 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . 0.443 ' HG2' ' HB3' ' A' ' 72' ' ' ASP . 40.8 pttt -70.44 -31.22 68.3 Favored 'General case' 0 C--O 1.219 -0.541 0 C-N-CA 120.911 -0.316 . . . . 0.0 111.843 -175.865 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.413 HG13 ' HB ' ' A' ' 69' ' ' ILE . 79.7 t -66.14 -40.72 87.84 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 C-N-CA 120.833 -0.347 . . . . 0.0 110.166 179.365 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . 0.411 ' O ' ' HG3' ' A' ' 81' ' ' GLU . 0.1 OUTLIER -73.38 -40.84 64.04 Favored 'General case' 0 N--CA 1.45 -0.452 0 N-CA-C 109.531 -0.544 . . . . 0.0 109.531 -179.224 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 66.7 mt-30 -67.64 -32.36 73.01 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 120.735 -0.386 . . . . 0.0 110.672 178.177 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . 0.503 ' HB1' ' CE ' ' A' ' 51' ' ' MET . . . -72.61 -33.88 66.99 Favored 'General case' 0 N--CA 1.446 -0.648 0 CA-C-N 116.136 -0.484 . . . . 0.0 109.876 175.966 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 43.9 t -62.4 -48.58 79.07 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.848 -0.614 . . . . 0.0 109.695 172.669 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . 0.42 ' O ' ' HB2' ' A' ' 85' ' ' ASP . 53.6 mt-10 -56.56 -29.46 62.03 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-O 121.178 0.513 . . . . 0.0 110.794 176.376 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 82' ' ' MET . . . . . 0.483 ' HE3' ' HB2' ' A' ' 46' ' ' ARG . 39.3 ttm -74.41 -51.13 15.85 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.316 -0.857 . . . . 0.0 110.667 -178.086 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . 0.637 ' O ' ' HG ' ' A' ' 87' ' ' LEU . 33.7 m -74.93 -38.22 42.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 120.674 0.273 . . . . 0.0 110.635 -176.082 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 84' ' ' MET . . . . . 0.454 ' O ' ' HG2' ' A' ' 88' ' ' ARG . 26.3 ttt -63.96 -34.44 77.99 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.026 179.735 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . 0.42 ' HB2' ' O ' ' A' ' 81' ' ' GLU . 14.3 t70 -63.53 -46.49 85.75 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.12 179.218 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.417 HG13 ' O ' ' A' ' 82' ' ' MET . 44.6 mt -64.78 -34.39 69.81 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.577 179.429 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.653 HD12 HD12 ' A' ' 24' ' ' ILE . 53.7 mt -76.76 -14.46 59.93 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.928 0.394 . . . . 0.0 110.981 -178.559 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . 0.454 ' HG2' ' O ' ' A' ' 84' ' ' MET . 14.3 mmm180 -109.47 8.55 25.31 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.192 0.52 . . . . 0.0 109.621 175.03 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 10.6 tp10 . . . . . 0 C--O 1.248 0.992 0 CA-C-N 115.197 -0.911 . . . . 0.0 109.267 -179.717 . . . . . . . . 0 0 . 1 . 025 nuclear orig core ' A' A ' 18' ' ' THR . . . . . 0.551 ' OG1' ' HG3' ' A' ' 73' ' ' PRO . 93.3 m . . . . . 0 N--CA 1.451 -0.382 0 CA-C-O 121.214 0.53 . . . . 0.0 111.83 . . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.591 ' HB ' HG23 ' A' ' 70' ' ' ILE . 2.6 p -134.77 121.0 33.21 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-N 115.347 -0.842 . . . . 0.0 109.753 175.724 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 6.0 tt0 -110.16 137.3 48.1 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 110.286 -0.264 . . . . 0.0 110.286 -177.97 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . 0.632 ' HA ' ' O ' ' A' ' 67' ' ' LEU . 45.0 mt-10 -108.34 127.14 53.61 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.998 0.428 . . . . 0.0 111.389 -178.863 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.425 ' HB ' ' HB3' ' A' ' 67' ' ' LEU . 15.9 mm -115.46 153.91 16.95 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-N 115.945 -0.57 . . . . 0.0 109.898 179.651 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 23' ' ' MET . . . . . 0.453 ' HB3' ' HB3' ' A' ' 64' ' ' ASP . 1.6 mmt -104.97 105.09 14.99 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 109.036 -0.727 . . . . 0.0 109.036 173.371 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.682 ' HB ' ' HB2' ' A' ' 65' ' ' LYS . 36.8 mm -88.72 131.42 41.72 Favored Pre-proline 0 C--N 1.322 -0.628 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.029 -175.762 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . 0.662 ' HD2' HD11 ' A' ' 87' ' ' LEU . 91.8 Cg_exo -44.41 137.03 8.33 Favored 'Trans proline' 0 C--N 1.348 0.55 0 C-N-CA 123.57 2.847 . . . . 0.0 113.184 177.457 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -66.52 -27.84 68.08 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.481 -0.782 . . . . 0.0 112.694 -172.489 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -103.48 -26.57 6.82 Favored Glycine 0 N--CA 1.447 -0.598 0 C-N-CA 120.387 -0.911 . . . . 0.0 112.33 -179.147 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . 0.485 ' HB3' ' HB2' ' A' ' 25' ' ' PRO . 15.3 ttpt -94.67 13.26 24.92 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.472 0.654 . . . . 0.0 110.642 -177.488 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . 0.492 ' O ' HG11 ' A' ' 32' ' ' VAL . . . -63.65 -31.07 72.12 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.857 -0.611 . . . . 0.0 110.882 178.181 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -57.06 -26.99 56.74 Favored Glycine 0 CA--C 1.519 0.29 0 CA-C-N 116.173 -0.467 . . . . 0.0 113.211 179.862 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 68.0 mt -78.5 -36.64 44.78 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.913 0.357 . . . . 0.0 110.957 179.542 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.492 HG11 ' O ' ' A' ' 29' ' ' ALA . 0.3 OUTLIER -72.12 -29.92 34.25 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.341 0 CA-C-O 121.19 0.519 . . . . 0.0 110.182 178.343 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 68.1 mt -76.03 -37.39 33.54 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-O 121.925 0.869 . . . . 0.0 109.615 174.109 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . 0.548 ' HA3' ' HB ' ' A' ' 39' ' ' THR . . . 98.14 45.38 2.41 Favored Glycine 0 N--CA 1.441 -0.974 0 CA-C-N 115.228 -0.896 . . . . 0.0 112.928 175.515 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 38.3 mtmt 51.72 47.01 25.63 Favored 'General case' 0 C--N 1.328 -0.326 0 O-C-N 124.143 0.555 . . . . 0.0 111.666 172.81 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 132.16 -28.2 3.52 Favored Glycine 0 N--CA 1.448 -0.562 0 C-N-CA 120.668 -0.777 . . . . 0.0 112.173 179.412 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 125.33 4.57 6.95 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.423 -0.894 . . . . 0.0 112.836 178.089 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 32.7 mt-10 -70.06 -48.75 56.54 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.132 0.491 . . . . 0.0 110.5 -179.993 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 39' ' ' THR . . . . . 0.714 ' O ' ' HG ' ' A' ' 43' ' ' LEU . 17.2 m -64.68 -46.04 84.09 Favored 'General case' 0 N--CA 1.45 -0.437 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.261 -177.433 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.615 ' HA ' HD12 ' A' ' 43' ' ' LEU . 8.1 tt -60.3 -35.65 63.69 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.47 0 CA-C-O 121.036 0.446 . . . . 0.0 110.901 179.977 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 54.8 tttm -61.57 -47.29 86.17 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.262 0.553 . . . . 0.0 109.983 175.515 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 16.4 mm-40 -72.39 -33.86 67.49 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.546 -0.752 . . . . 0.0 111.796 -176.561 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.714 ' HG ' ' O ' ' A' ' 39' ' ' THR . 95.0 mt -54.52 -48.07 72.36 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.046 0.45 . . . . 0.0 110.77 179.817 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 44.0 mt-30 -63.27 -46.21 87.86 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.385 -0.825 . . . . 0.0 110.696 -179.828 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -71.12 -36.69 72.23 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.855 -0.611 . . . . 0.0 112.123 -175.51 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 12.4 ptm180 -75.53 -33.08 60.69 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 111.734 0.272 . . . . 0.0 111.734 -175.317 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . 0.448 ' HB3' HG23 ' A' ' 49' ' ' VAL . . . -96.54 -21.07 17.91 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.993 0.425 . . . . 0.0 111.352 -177.305 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 81.13 31.01 35.93 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.928 -0.653 . . . . 0.0 112.0 -178.161 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.448 HG23 ' HB3' ' A' ' 47' ' ' ALA . 28.6 m -122.92 167.49 16.47 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-O 120.834 0.35 . . . . 0.0 110.643 -176.332 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 60.2 tttp -103.38 123.23 46.44 Favored 'General case' 0 N--CA 1.444 -0.758 0 N-CA-C 108.96 -0.756 . . . . 0.0 108.96 172.242 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 51' ' ' MET . . . . . 0.796 ' HE3' HG12 ' A' ' 83' ' ' VAL . 79.7 mtp -120.32 115.52 23.72 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 120.947 0.403 . . . . 0.0 109.989 179.414 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.551 ' CG2' ' HB2' ' A' ' 68' ' ' ARG . 11.2 tt -107.71 112.33 39.67 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.749 0 CA-C-O 121.478 0.656 . . . . 0.0 110.235 177.896 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.485 ' CD2' HD13 ' A' ' 67' ' ' LEU . 3.1 mm? -94.82 114.29 26.15 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.36 -0.836 . . . . 0.0 109.817 176.863 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.538 ' HB ' ' HD2' ' A' ' 66' ' ' PRO . 31.4 mm -75.36 87.78 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 177.311 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 15.8 mt-30 . . . . . 0 C--N 1.323 -0.565 0 CA-C-N 115.226 -0.897 . . . . 0.0 110.311 -174.803 . . . . . . . . 0 0 . 1 . 025 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . 0.453 ' HB3' ' HB3' ' A' ' 23' ' ' MET . 5.2 m-20 . . . . . 0 C--O 1.232 0.164 0 CA-C-O 121.196 0.522 . . . . 0.0 111.291 . . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . 0.682 ' HB2' ' HB ' ' A' ' 24' ' ' ILE . 70.9 mmtt -101.5 127.1 32.33 Favored Pre-proline 0 C--N 1.324 -0.54 0 CA-C-N 115.804 -0.635 . . . . 0.0 111.056 -175.615 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . 0.538 ' HD2' ' HB ' ' A' ' 54' ' ' ILE . 27.4 Cg_exo -65.41 111.68 1.91 Allowed 'Trans proline' 0 N--CA 1.463 -0.315 0 C-N-CA 123.009 2.472 . . . . 0.0 111.596 172.596 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.632 ' O ' ' HA ' ' A' ' 21' ' ' GLU . 14.3 tp -112.44 122.35 47.45 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 116.155 -0.475 . . . . 0.0 109.97 178.093 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . 0.551 ' HB2' ' CG2' ' A' ' 52' ' ' ILE . 88.0 mtt180 -113.84 112.39 23.3 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 121.19 0.519 . . . . 0.0 111.192 177.727 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 4.5 mp -94.16 105.13 16.54 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 172.449 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.591 HG23 ' HB ' ' A' ' 19' ' ' VAL . 4.0 mt -109.77 132.32 58.31 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 CA-C-N 116.385 -0.371 . . . . 0.0 110.907 -172.394 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 152.52 -123.16 1.41 Allowed Glycine 0 N--CA 1.445 -0.747 0 C-N-CA 120.509 -0.853 . . . . 0.0 113.235 175.618 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . 0.605 ' OD2' ' HG2' ' A' ' 75' ' ' LYS . 0.5 OUTLIER -92.69 133.47 29.31 Favored Pre-proline 0 C--N 1.326 -0.447 0 C-N-CA 122.864 0.466 . . . . 0.0 110.948 -177.215 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . 0.551 ' HG3' ' OG1' ' A' ' 18' ' ' THR . 50.4 Cg_exo -49.43 -33.41 29.64 Favored 'Trans proline' 0 C--N 1.351 0.664 0 C-N-CA 124.267 3.311 . . . . 0.0 113.592 -176.236 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . 0.495 ' O ' ' HG3' ' A' ' 78' ' ' GLN . 19.1 t80 -72.71 -57.08 4.38 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.341 -178.27 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . 0.605 ' HG2' ' OD2' ' A' ' 72' ' ' ASP . 4.6 ptpp? -72.5 -25.83 61.55 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 111.746 0.276 . . . . 0.0 111.746 -178.439 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.403 HG23 ' O ' ' A' ' 72' ' ' ASP . 26.4 t -55.94 -42.26 70.65 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 N-CA-C 109.925 -0.398 . . . . 0.0 109.925 171.424 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . 0.574 ' O ' ' HG2' ' A' ' 81' ' ' GLU . 2.3 mm100 -75.74 -44.28 42.59 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.056 178.789 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . 0.495 ' HG3' ' O ' ' A' ' 74' ' ' TYR . 53.6 mt-30 -52.87 -50.06 64.58 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.065 0.459 . . . . 0.0 110.419 177.697 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . 0.661 ' HA ' ' HE3' ' A' ' 82' ' ' MET . . . -67.43 -37.78 83.54 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.411 -0.813 . . . . 0.0 111.271 -178.315 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 42.7 t -62.55 -57.27 11.74 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.556 -178.9 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . 0.574 ' HG2' ' O ' ' A' ' 77' ' ' GLN . 10.4 pt-20 -67.68 -18.7 65.02 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.912 0.387 . . . . 0.0 110.645 -178.928 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 82' ' ' MET . . . . . 0.661 ' HE3' ' HA ' ' A' ' 79' ' ' ALA . 57.0 ttp -74.09 -50.99 17.11 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.584 174.804 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . 0.796 HG12 ' HE3' ' A' ' 51' ' ' MET . 31.8 m -76.52 -33.87 23.43 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.583 -0.281 . . . . 0.0 111.618 -176.4 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 83.5 mtp -68.37 -25.67 65.19 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 109.911 -0.403 . . . . 0.0 109.911 175.83 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -67.69 -36.25 80.32 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.655 176.364 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 56.7 mt -62.78 -35.49 71.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 121.488 0.661 . . . . 0.0 110.043 179.022 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.662 HD11 ' HD2' ' A' ' 25' ' ' PRO . 42.8 mt -88.09 -8.46 55.47 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.654 -179.381 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 21.5 tpt180 -101.76 -10.54 19.85 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.839 0.828 . . . . 0.0 109.818 -179.638 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 . . . . . 0 C--O 1.248 1.021 0 CA-C-N 114.685 -1.143 . . . . 0.0 109.779 -177.316 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.445 -0.763 0 CA-C-O 120.388 -0.118 . . . . 0.0 112.944 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . 0.421 ' O ' ' HG3' ' A' ' 6' ' ' GLN . 13.1 pt20 -77.41 84.47 3.82 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.604 0.716 . . . . 0.0 109.844 173.548 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . 0.544 ' O ' ' HB2' ' A' ' 72' ' ' ASP . 68.7 m-85 -59.34 -34.94 72.97 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.371 -0.831 . . . . 0.0 110.908 -177.311 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . 0.613 ' HA ' ' HB2' ' A' ' 12' ' ' ASN . 4.7 t60 -85.29 60.86 6.51 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 175.686 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -74.23 -45.14 50.02 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.339 -0.846 . . . . 0.0 110.825 -175.759 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 39.8 t-20 -141.35 -73.08 0.33 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.389 179.66 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -119.17 53.84 1.0 Allowed 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.147 0.499 . . . . 0.0 111.485 -172.158 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . 0.854 HD22 ' HA ' ' A' ' 16' ' ' ASN . 13.8 t-20 -76.86 72.06 3.43 Favored 'General case' 0 N--CA 1.445 -0.697 0 CA-C-N 115.766 -0.652 . . . . 0.0 109.927 176.128 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -91.83 90.97 1.56 Allowed Glycine 0 N--CA 1.447 -0.591 0 C-N-CA 120.991 -0.623 . . . . 0.0 112.333 -178.557 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 129.07 -104.81 0.66 Allowed Glycine 0 N--CA 1.449 -0.471 0 C-N-CA 120.957 -0.64 . . . . 0.0 112.018 178.418 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 14.2 mm100 -95.55 117.54 30.61 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.911 0.386 . . . . 0.0 110.263 -179.82 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . 0.854 ' HA ' HD22 ' A' ' 12' ' ' ASN . 9.1 p30 -58.96 -33.47 70.69 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.54 -0.755 . . . . 0.0 110.754 179.514 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -101.83 81.6 0.43 Allowed Glycine 0 N--CA 1.443 -0.838 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.011 179.743 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' THR . . . . . 0.477 ' OG1' ' HG3' ' A' ' 73' ' ' PRO . 96.5 m -88.99 127.91 35.69 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 110.146 -0.316 . . . . 0.0 110.146 177.209 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 74.7 t -113.09 127.19 70.48 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.618 -178.595 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . 0.616 ' HG2' ' HB2' ' A' ' 80' ' ' CYS . 29.5 tp60 -111.84 112.74 24.63 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 109.43 -0.582 . . . . 0.0 109.43 176.863 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.581 ' HA ' ' O ' ' A' ' 67' ' ' LEU . 12.1 mt-10 -98.53 119.26 36.93 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.369 0.604 . . . . 0.0 112.305 179.257 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 10.1 mm -114.37 150.5 16.35 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 115.185 -0.916 . . . . 0.0 109.44 177.685 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 94.0 mmm -111.53 103.83 12.19 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 172.93 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.624 HG23 HD22 ' A' ' 87' ' ' LEU . 9.3 mm -84.88 125.3 71.14 Favored Pre-proline 0 C--N 1.316 -0.88 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.952 -173.301 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_exo -50.2 139.06 36.13 Favored 'Trans proline' 0 C--N 1.346 0.441 0 C-N-CA 122.904 2.402 . . . . 0.0 112.379 176.566 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -42.41 -57.15 2.72 Favored 'General case' 0 N--CA 1.465 0.287 0 N-CA-C 113.316 0.858 . . . . 0.0 113.316 -173.716 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -90.18 -26.71 23.01 Favored Glycine 0 N--CA 1.453 -0.199 0 C-N-CA 120.679 -0.772 . . . . 0.0 113.069 -174.473 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 45.0 tttp -78.99 -4.56 50.61 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.192 0.52 . . . . 0.0 110.128 179.773 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . 0.501 ' HA ' HG21 ' A' ' 24' ' ' ILE . . . -63.64 -22.93 67.16 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.658 174.844 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -58.39 -25.7 58.19 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 121.073 -0.584 . . . . 0.0 112.134 178.292 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.401 HD12 HG23 ' A' ' 86' ' ' ILE . 63.2 mt -75.97 -45.78 33.08 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.779 0.323 . . . . 0.0 110.855 179.425 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.425 HG12 ' O ' ' A' ' 29' ' ' ALA . 1.4 p -72.02 -32.13 42.77 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.474 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.973 -177.369 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 74.2 mt -78.33 -42.18 26.5 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-O 121.761 0.791 . . . . 0.0 109.772 176.661 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . 0.421 ' HA3' ' HB ' ' A' ' 39' ' ' THR . . . 101.29 51.53 1.13 Allowed Glycine 0 N--CA 1.441 -1.025 0 CA-C-N 115.272 -0.876 . . . . 0.0 112.974 175.529 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.439 ' HD2' ' N ' ' A' ' 35' ' ' LYS . 0.4 OUTLIER 50.68 40.5 24.24 Favored 'General case' 0 C--N 1.329 -0.295 0 O-C-N 124.319 0.658 . . . . 0.0 111.96 173.719 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 133.73 -27.06 3.39 Favored Glycine 0 N--CA 1.449 -0.482 0 C-N-CA 120.653 -0.784 . . . . 0.0 111.94 179.604 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 129.78 22.47 1.15 Allowed Glycine 0 N--CA 1.449 -0.451 0 C-N-CA 120.173 -1.013 . . . . 0.0 113.079 178.524 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.595 ' HG3' HE21 ' A' ' 42' ' ' GLN . 4.5 tp10 -84.53 -54.09 4.98 Favored 'General case' 0 C--N 1.321 -0.648 0 O-C-N 122.296 -0.531 . . . . 0.0 110.119 178.694 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' THR . . . . . 0.674 ' O ' ' HG ' ' A' ' 43' ' ' LEU . 63.0 m -56.21 -44.58 79.63 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.53 -0.759 . . . . 0.0 111.821 -179.405 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 8.9 tt -58.51 -37.79 66.61 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.406 0 CA-C-O 120.596 0.236 . . . . 0.0 111.604 -178.416 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 33.5 mtmm -66.24 -38.65 88.39 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.358 0.599 . . . . 0.0 110.172 178.02 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . 0.595 HE21 ' HG3' ' A' ' 38' ' ' GLU . 68.7 mt-30 -66.07 -45.96 79.44 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.279 178.755 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.674 ' HG ' ' O ' ' A' ' 39' ' ' THR . 89.6 mt -53.47 -46.7 70.05 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.428 -0.805 . . . . 0.0 112.032 -175.609 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 46.9 mt-30 -64.52 -43.36 94.29 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.484 -177.302 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 9.3 mm-40 -81.12 -35.6 31.38 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 112.052 0.39 . . . . 0.0 112.052 -174.261 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 14.8 ptm180 -66.76 -35.28 79.73 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-O 120.735 0.302 . . . . 0.0 111.477 -176.7 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . 0.431 ' HB2' HG21 ' A' ' 49' ' ' VAL . . . -100.65 -12.13 19.43 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.889 0.376 . . . . 0.0 111.577 -177.128 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 71.73 37.93 61.21 Favored Glycine 0 N--CA 1.449 -0.492 0 C-N-CA 120.812 -0.709 . . . . 0.0 111.961 -178.004 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.431 HG21 ' HB2' ' A' ' 47' ' ' ALA . 28.5 m -129.15 178.56 4.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-O 120.761 0.315 . . . . 0.0 110.16 -177.775 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 64.3 tttp -120.75 124.66 45.66 Favored 'General case' 0 C--N 1.319 -0.726 0 C-N-CA 120.662 -0.415 . . . . 0.0 110.214 173.069 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' MET . . . . . 0.567 ' CE ' ' HB3' ' A' ' 79' ' ' ALA . 63.7 mtt -113.94 115.62 27.95 Favored 'General case' 0 C--N 1.319 -0.749 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 176.751 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.524 ' CG2' ' HB2' ' A' ' 68' ' ' ARG . 10.5 tt -99.29 104.77 16.46 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.741 0 CA-C-O 121.772 0.796 . . . . 0.0 110.059 176.91 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.709 HD22 HD12 ' A' ' 67' ' ' LEU . 3.8 mm? -87.53 104.4 16.45 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.053 -0.976 . . . . 0.0 109.26 176.02 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.77 HD11 ' HB2' ' A' ' 66' ' ' PRO . 61.0 mt -72.74 86.56 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-O 121.852 0.834 . . . . 0.0 109.663 178.369 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 52.4 mt-30 -99.73 -23.3 15.05 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 114.637 -1.165 . . . . 0.0 109.645 -177.628 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -114.73 6.14 15.51 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.175 -0.921 . . . . 0.0 110.512 -173.213 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -66.3 -22.72 71.26 Favored Glycine 0 N--CA 1.453 -0.184 0 CA-C-N 115.53 -0.759 . . . . 0.0 112.086 178.539 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' SER . . . . . 0.422 ' HA ' ' CG2' ' A' ' 61' ' ' THR . 31.9 m 65.37 -172.59 0.18 Allowed 'General case' 0 C--O 1.232 0.184 0 C-N-CA 123.215 0.606 . . . . 0.0 111.107 -178.856 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 20.9 mt-30 71.76 -62.29 0.46 Allowed 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 123.118 0.567 . . . . 0.0 110.281 -176.648 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . 0.619 ' ND2' ' HD3' ' A' ' 66' ' ' PRO . 3.1 p-10 -100.65 12.51 37.26 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.325 178.957 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' THR . . . . . 0.422 ' CG2' ' HA ' ' A' ' 58' ' ' SER . 0.3 OUTLIER -60.15 -29.76 68.87 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.035 0.445 . . . . 0.0 111.386 -179.288 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 1.8 m-20 -82.74 -4.3 57.71 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.781 -0.645 . . . . 0.0 111.131 179.725 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 21.1 m -131.83 -153.35 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.248 0 N-CA-C 111.633 0.235 . . . . 0.0 111.633 -174.731 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.448 ' HA ' ' O ' ' A' ' 24' ' ' ILE . 1.8 m-20 -53.55 151.6 5.73 Favored 'General case' 0 C--N 1.331 -0.225 0 C-N-CA 123.545 0.738 . . . . 0.0 111.363 178.201 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . 0.498 ' HA ' ' HD3' ' A' ' 66' ' ' PRO . 39.2 mmtm -110.85 131.39 22.15 Favored Pre-proline 0 C--N 1.327 -0.398 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.659 -175.203 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.77 ' HB2' HD11 ' A' ' 54' ' ' ILE . 10.6 Cg_exo -75.33 111.4 3.3 Favored 'Trans proline' 0 N--CA 1.46 -0.467 0 C-N-CA 123.476 2.784 . . . . 0.0 111.86 176.013 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.709 HD12 HD22 ' A' ' 53' ' ' LEU . 17.8 tp -112.4 120.72 42.64 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.528 177.439 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.524 ' HB2' ' CG2' ' A' ' 52' ' ' ILE . 68.4 mtt180 -111.47 111.72 22.95 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 120.99 0.424 . . . . 0.0 110.651 174.445 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . 0.462 ' HB ' ' HB3' ' A' ' 20' ' ' GLN . 46.9 mt -91.27 112.06 24.76 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 N-CA-C 108.909 -0.774 . . . . 0.0 108.909 173.914 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 13.2 mt -113.85 129.42 69.78 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.739 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.056 -172.562 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . 0.476 ' HA2' ' HD1' ' A' ' 7' ' ' PHE . . . 153.42 -140.92 7.91 Favored Glycine 0 N--CA 1.448 -0.518 0 C-N-CA 120.458 -0.877 . . . . 0.0 113.32 173.89 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . 0.544 ' HB2' ' O ' ' A' ' 7' ' ' PHE . 4.7 t70 -71.99 130.89 86.05 Favored Pre-proline 0 C--N 1.322 -0.614 0 C-N-CA 123.387 0.675 . . . . 0.0 111.126 -176.997 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . 0.627 ' HD2' ' HA ' ' A' ' 12' ' ' ASN . 26.8 Cg_exo -57.98 -26.53 75.27 Favored 'Trans proline' 0 C--N 1.35 0.622 0 C-N-CA 123.556 2.838 . . . . 0.0 113.352 -172.027 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 24.1 t80 -79.06 -47.61 15.88 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.156 -0.474 . . . . 0.0 109.873 -176.191 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.519 ' CG ' ' HB3' ' A' ' 72' ' ' ASP . 9.1 ptpt -80.51 -26.61 38.05 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 120.867 -0.333 . . . . 0.0 111.611 178.81 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 24.6 t -60.69 -40.13 83.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-O 120.7 0.286 . . . . 0.0 110.246 173.954 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 2.0 mm100 -73.97 -41.2 62.31 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 120.637 -0.425 . . . . 0.0 110.972 179.472 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 49.6 mt-30 -63.09 -39.07 93.62 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 120.898 0.38 . . . . 0.0 110.251 177.431 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . 0.592 ' HA ' ' HE3' ' A' ' 82' ' ' MET . . . -71.65 -35.34 70.33 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.718 178.5 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' CYS . . . . . 0.616 ' HB2' ' HG2' ' A' ' 20' ' ' GLN . 36.5 t -63.45 -54.09 41.9 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.123 175.245 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 52.5 mt-10 -65.2 -20.66 66.54 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.403 178.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' MET . . . . . 0.592 ' HE3' ' HA ' ' A' ' 79' ' ' ALA . 31.5 ttm -69.48 -55.98 8.71 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.425 -0.807 . . . . 0.0 110.403 176.417 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 32.9 m -79.42 -29.59 13.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.915 -175.453 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' MET . . . . . 0.47 ' O ' ' HG2' ' A' ' 88' ' ' ARG . 56.9 ttp -71.48 -28.94 64.28 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 109.75 -0.463 . . . . 0.0 109.75 178.392 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . 0.474 ' O ' ' HB2' ' A' ' 89' ' ' GLU . 19.0 t70 -62.62 -47.94 81.57 Favored 'General case' 0 CA--C 1.517 -0.29 0 N-CA-C 109.968 -0.382 . . . . 0.0 109.968 175.133 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.401 HG23 HD12 ' A' ' 31' ' ' LEU . 20.3 mt -60.22 -32.45 50.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 121.659 0.742 . . . . 0.0 110.276 177.738 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.624 HD22 HG23 ' A' ' 24' ' ' ILE . 1.0 OUTLIER -81.8 -17.52 47.26 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.389 -0.823 . . . . 0.0 111.57 -176.738 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . 0.47 ' HG2' ' O ' ' A' ' 84' ' ' MET . 23.3 mmm180 -102.86 5.94 38.88 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 121.546 0.689 . . . . 0.0 109.322 174.153 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . 0.474 ' HB2' ' O ' ' A' ' 85' ' ' ASP . 2.1 tm-20 . . . . . 0 C--O 1.25 1.125 0 CA-C-N 114.749 -1.114 . . . . 0.0 108.884 -177.968 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.445 -0.739 0 N-CA-C 112.076 -0.41 . . . . 0.0 112.076 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 8.5 tp-100 59.67 87.75 0.08 Allowed 'General case' 0 C--O 1.235 0.322 0 CA-C-O 121.314 0.578 . . . . 0.0 110.057 -176.438 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 95.7 m-85 -69.74 104.96 2.58 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.207 -177.887 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . 0.896 ' H ' ' HB2' ' A' ' 72' ' ' ASP . 14.0 t60 74.06 145.67 0.08 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 114.318 -1.31 . . . . 0.0 110.504 -176.876 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -64.61 -26.72 68.52 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.021 -0.991 . . . . 0.0 111.259 -178.18 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 9.2 t30 -162.9 101.32 1.0 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.504 174.885 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . 72.17 123.6 0.04 OUTLIER 'General case' 0 N--CA 1.471 0.616 0 O-C-N 123.867 0.73 . . . . 0.0 112.77 174.599 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 7.4 p30 -117.83 147.38 43.1 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.089 177.631 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -158.05 143.94 9.95 Favored Glycine 0 N--CA 1.452 -0.273 0 N-CA-C 111.588 -0.605 . . . . 0.0 111.588 -178.741 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 79.07 -68.53 3.08 Favored Glycine 0 C--N 1.331 0.283 0 N-CA-C 110.974 -0.851 . . . . 0.0 110.974 -176.425 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 32.5 mm-40 -106.06 125.23 50.74 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 108.952 -0.758 . . . . 0.0 108.952 171.794 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 7.1 m120 -114.23 -71.14 0.76 Allowed 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 109.797 -0.446 . . . . 0.0 109.797 -177.483 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -95.4 80.09 0.84 Allowed Glycine 0 N--CA 1.444 -0.769 0 N-CA-C 111.099 -0.801 . . . . 0.0 111.099 174.838 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' THR . . . . . 0.518 ' OG1' ' HG3' ' A' ' 73' ' ' PRO . 74.6 m -83.24 134.25 34.96 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-O 120.996 0.427 . . . . 0.0 111.129 -176.545 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.48 HG22 HG22 ' A' ' 70' ' ' ILE . 61.6 t -124.71 120.19 58.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.61 179.251 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 14.2 mm100 -101.17 114.03 27.61 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.983 -0.553 . . . . 0.0 109.539 174.682 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.564 ' HA ' ' O ' ' A' ' 67' ' ' LEU . 37.4 mt-10 -93.69 107.58 19.43 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.283 0.564 . . . . 0.0 110.729 176.065 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 19.0 mm -102.41 148.67 7.56 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.723 0 CA-C-N 115.359 -0.837 . . . . 0.0 109.802 -178.509 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' MET . . . . . 0.478 ' HB3' ' HB3' ' A' ' 64' ' ' ASP . 1.5 mmt -99.87 101.98 13.27 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 108.609 -0.885 . . . . 0.0 108.609 175.428 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.673 ' HB ' ' HB2' ' A' ' 65' ' ' LYS . 44.3 mm -88.66 126.06 61.06 Favored Pre-proline 0 C--N 1.319 -0.733 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.996 -175.38 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . 0.563 ' HB2' ' HB3' ' A' ' 28' ' ' LYS . 95.7 Cg_exo -45.1 132.91 11.41 Favored 'Trans proline' 0 C--N 1.343 0.278 0 C-N-CA 123.423 2.749 . . . . 0.0 112.541 179.564 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -61.82 -38.65 88.96 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 115.511 -0.768 . . . . 0.0 112.954 -168.501 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -89.37 -35.89 7.78 Favored Glycine 0 N--CA 1.449 -0.496 0 C-N-CA 120.404 -0.903 . . . . 0.0 111.837 -178.596 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.563 ' HB3' ' HB2' ' A' ' 25' ' ' PRO . 28.6 ttpt -80.47 -0.62 38.12 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 121.201 0.524 . . . . 0.0 110.77 -178.721 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . 0.515 ' O ' HG12 ' A' ' 32' ' ' VAL . . . -62.83 -20.14 64.78 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.132 177.667 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -57.66 -33.09 66.35 Favored Glycine 0 N--CA 1.448 -0.541 0 C-N-CA 120.792 -0.718 . . . . 0.0 111.885 177.04 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 99.0 mt -77.57 -36.2 52.27 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.643 0.259 . . . . 0.0 111.289 -178.767 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.515 HG12 ' O ' ' A' ' 29' ' ' ALA . 0.5 OUTLIER -70.57 -30.28 41.86 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.326 0 CA-C-O 121.16 0.505 . . . . 0.0 110.768 -178.37 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 71.0 mt -89.39 -38.78 11.7 Favored 'Isoleucine or valine' 0 C--O 1.236 0.388 0 CA-C-N 115.76 -0.654 . . . . 0.0 110.537 178.743 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 105.08 25.0 6.94 Favored Glycine 0 CA--C 1.502 -0.723 0 CA-C-N 115.605 -0.725 . . . . 0.0 112.611 178.57 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 53.6 mtpt 60.87 21.51 11.69 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.316 -0.442 . . . . 0.0 111.327 177.258 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -176.59 -45.7 0.06 OUTLIER Glycine 0 N--CA 1.448 -0.504 0 N-CA-C 111.696 -0.562 . . . . 0.0 111.696 -178.31 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 125.73 7.57 5.59 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.355 -0.926 . . . . 0.0 113.024 176.692 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -85.51 -32.91 21.96 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 120.84 0.352 . . . . 0.0 111.162 178.561 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' THR . . . . . 0.578 ' O ' ' HG ' ' A' ' 43' ' ' LEU . 60.7 m -65.0 -48.18 74.84 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.97 -179.573 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.737 HD11 HD22 ' A' ' 53' ' ' LEU . 1.9 tt -57.18 -38.58 62.05 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-O 120.748 0.309 . . . . 0.0 111.167 178.463 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 4.6 tmmm? -60.97 -40.76 94.62 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 109.57 -0.53 . . . . 0.0 109.57 178.689 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . 0.501 ' O ' ' HG2' ' A' ' 46' ' ' ARG . 49.5 mt-30 -70.32 -37.82 74.79 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.614 -179.851 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.685 HD11 HG11 ' A' ' 83' ' ' VAL . 75.0 mt -58.03 -35.95 72.01 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.678 179.075 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . 0.558 ' HG3' ' O ' ' A' ' 40' ' ' ILE . 68.2 mt-30 -66.57 -47.72 71.89 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.42 178.223 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -64.83 -48.58 73.86 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.694 -0.685 . . . . 0.0 111.195 -177.573 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . 0.501 ' HG2' ' O ' ' A' ' 42' ' ' GLN . 17.5 ptm180 -70.79 -23.66 62.42 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.169 -0.469 . . . . 0.0 112.201 -174.224 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . 0.556 ' HB1' ' HE2' ' A' ' 82' ' ' MET . . . -93.13 -29.14 15.91 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.818 0.342 . . . . 0.0 111.093 178.745 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 87.88 26.41 29.33 Favored Glycine 0 N--CA 1.452 -0.25 0 C-N-CA 121.014 -0.612 . . . . 0.0 112.56 -179.062 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 5.1 m -140.08 179.87 2.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-O 120.876 0.369 . . . . 0.0 110.592 -178.801 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 81.1 tttt -110.8 124.66 52.45 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.238 178.531 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' MET . . . . . 0.563 ' HE3' HG13 ' A' ' 83' ' ' VAL . 17.9 mtm -117.2 116.62 27.63 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 109.821 -0.437 . . . . 0.0 109.821 176.661 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.61 ' CG2' ' HB2' ' A' ' 68' ' ' ARG . 10.8 tt -102.0 113.2 37.7 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.727 0 CA-C-O 121.43 0.633 . . . . 0.0 110.762 178.426 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.853 HD21 HD13 ' A' ' 67' ' ' LEU . 1.3 mm? -88.07 107.52 18.79 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.41 -0.814 . . . . 0.0 109.311 175.906 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.622 HD11 ' HB2' ' A' ' 66' ' ' PRO . 58.4 mt -79.84 84.65 1.25 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.575 0 CA-C-O 122.248 1.023 . . . . 0.0 110.323 179.151 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 2.5 pt20 -110.5 -20.42 12.58 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 114.006 -1.452 . . . . 0.0 107.677 167.712 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -62.45 -43.82 97.89 Favored 'General case' 0 N--CA 1.452 -0.361 0 CA-C-N 114.138 -1.392 . . . . 0.0 109.152 173.555 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -75.29 136.84 21.01 Favored Glycine 0 N--CA 1.445 -0.716 0 CA-C-N 115.138 -0.937 . . . . 0.0 111.619 176.575 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 20.1 m -95.64 19.69 10.78 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-O 120.759 0.314 . . . . 0.0 111.644 -174.97 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 15.0 mm100 -78.56 -49.5 13.2 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.085 0.469 . . . . 0.0 110.617 -179.477 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . 0.565 ' HB2' ' HD3' ' A' ' 66' ' ' PRO . 14.4 m120 -127.24 39.83 3.82 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.143 179.902 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 13.6 t -87.14 -23.56 24.8 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.903 -178.165 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 -97.39 4.75 50.57 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.553 0.692 . . . . 0.0 109.642 178.535 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 16.0 m -136.03 -159.01 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-N 115.301 -0.863 . . . . 0.0 110.028 179.155 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.498 ' O ' ' HB3' ' A' ' 60' ' ' ASN . 7.3 m-20 -55.64 136.97 50.14 Favored 'General case' 0 C--N 1.329 -0.325 0 O-C-N 123.408 0.443 . . . . 0.0 110.155 175.863 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . 0.673 ' HB2' ' HB ' ' A' ' 24' ' ' ILE . 65.7 mmtt -88.38 134.0 35.4 Favored Pre-proline 0 C--N 1.318 -0.768 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.904 -169.101 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.622 ' HB2' HD11 ' A' ' 54' ' ' ILE . 16.4 Cg_exo -70.86 104.95 1.57 Allowed 'Trans proline' 0 N--CA 1.456 -0.686 0 C-N-CA 122.744 2.296 . . . . 0.0 111.137 172.49 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.853 HD13 HD21 ' A' ' 53' ' ' LEU . 18.9 tp -110.54 118.06 35.22 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.129 178.26 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.61 ' HB2' ' CG2' ' A' ' 52' ' ' ILE . 68.9 mtt180 -108.98 106.36 16.28 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.503 177.345 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . 0.617 HG21 HG22 ' A' ' 76' ' ' VAL . 4.3 mp -87.13 109.49 19.31 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 N-CA-C 107.962 -1.125 . . . . 0.0 107.962 171.163 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.48 HG22 HG22 ' A' ' 19' ' ' VAL . 33.7 mt -110.23 128.37 66.5 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.73 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.979 -171.635 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 150.28 -123.93 1.65 Allowed Glycine 0 N--CA 1.444 -0.798 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.42 173.173 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . 0.896 ' HB2' ' H ' ' A' ' 8' ' ' HIS . 2.8 t70 -84.26 129.84 56.56 Favored Pre-proline 0 C--N 1.32 -0.705 0 CA-C-N 115.479 -0.361 . . . . 0.0 111.298 -177.333 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . 0.518 ' HG3' ' OG1' ' A' ' 18' ' ' THR . 53.2 Cg_exo -48.22 -27.79 10.07 Favored 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 123.805 3.003 . . . . 0.0 113.56 -178.924 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . 0.536 ' HB3' ' OD2' ' A' ' 72' ' ' ASP . 44.9 t80 -82.75 -60.06 2.3 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.519 -0.31 . . . . 0.0 110.733 -175.987 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.587 ' HG2' ' OD2' ' A' ' 72' ' ' ASP . 12.8 pttt -72.84 -17.46 61.55 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 112.115 0.413 . . . . 0.0 112.115 179.438 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.617 HG22 HG21 ' A' ' 69' ' ' ILE . 12.4 t -69.02 -38.48 78.46 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 N-CA-C 109.106 -0.701 . . . . 0.0 109.106 171.162 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . 0.412 ' O ' ' HG3' ' A' ' 81' ' ' GLU . 22.5 tp60 -74.02 -42.33 60.48 Favored 'General case' 0 N--CA 1.448 -0.528 0 CA-C-N 115.657 -0.701 . . . . 0.0 109.495 177.519 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . 0.488 ' HB2' ' HA ' ' A' ' 75' ' ' LYS . 51.2 mt-30 -56.01 -51.4 67.9 Favored 'General case' 0 C--O 1.223 -0.332 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.398 174.865 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . 0.756 ' HA ' ' HE3' ' A' ' 82' ' ' MET . . . -60.94 -40.13 92.09 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.925 179.201 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 22.6 t -59.54 -54.37 47.33 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.846 -0.615 . . . . 0.0 111.252 177.717 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . 0.412 ' HG3' ' O ' ' A' ' 77' ' ' GLN . 2.3 pp20? -70.77 -25.02 62.71 Favored 'General case' 0 C--O 1.217 -0.642 0 C-N-CA 120.221 -0.592 . . . . 0.0 110.493 -179.334 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' MET . . . . . 0.756 ' HE3' ' HA ' ' A' ' 79' ' ' ALA . 34.8 ttp -67.35 -48.81 66.38 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.578 -0.283 . . . . 0.0 110.878 177.333 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.685 HG11 HD11 ' A' ' 43' ' ' LEU . 33.0 m -74.18 -36.59 44.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 C-N-CA 120.943 -0.303 . . . . 0.0 110.992 -179.766 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 89.2 mtp -71.14 -27.38 63.53 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 110.198 -0.297 . . . . 0.0 110.198 177.607 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . 0.41 ' HB2' ' O ' ' A' ' 81' ' ' GLU . 30.0 t70 -63.4 -40.85 98.34 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.276 175.139 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.498 HG13 ' O ' ' A' ' 82' ' ' MET . 52.2 mt -63.06 -33.09 58.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.734 177.711 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.556 HD23 ' HG2' ' A' ' 28' ' ' LYS . 69.2 mt -86.01 -21.81 27.61 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.789 -174.332 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 39.5 ptt180 -95.93 -2.99 46.01 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.122 0.487 . . . . 0.0 110.682 -178.814 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.249 1.047 0 CA-C-O 118.434 -0.793 . . . . 0.0 109.671 -174.678 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.663 0 N-CA-C 111.913 -0.475 . . . . 0.0 111.913 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 73.6 mt-30 -75.25 65.0 1.53 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.901 0.381 . . . . 0.0 110.829 -179.06 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . 0.633 ' HD1' ' HA2' ' A' ' 71' ' ' GLY . 59.7 m-85 55.12 41.03 32.0 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.361 -0.836 . . . . 0.0 111.569 177.407 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . 0.706 ' HA ' ' OD1' ' A' ' 72' ' ' ASP . 10.6 t-80 -154.66 35.82 0.41 Allowed 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 173.145 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 15.2 t70 66.19 -65.75 0.18 Allowed 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 114.362 -1.29 . . . . 0.0 110.902 -175.179 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 37.8 t30 -148.04 95.13 2.43 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.963 -0.562 . . . . 0.0 109.968 -178.445 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . 69.13 135.95 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 115.343 -0.844 . . . . 0.0 111.972 -176.727 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . 0.485 ' ND2' ' HB3' ' A' ' 16' ' ' ASN . 24.8 p-10 -102.01 163.68 12.12 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.811 177.831 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -117.12 76.67 0.28 Allowed Glycine 0 N--CA 1.448 -0.516 0 N-CA-C 111.43 -0.668 . . . . 0.0 111.43 175.221 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 116.15 -101.37 0.99 Allowed Glycine 0 N--CA 1.448 -0.508 0 C-N-CA 120.788 -0.72 . . . . 0.0 111.862 -178.546 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 30.6 mm-40 -84.2 150.13 25.68 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 120.775 0.322 . . . . 0.0 110.707 178.891 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . 0.485 ' HB3' ' ND2' ' A' ' 12' ' ' ASN . 9.0 p30 -128.56 142.63 51.0 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 109.52 -0.548 . . . . 0.0 109.52 176.344 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 97.25 101.9 2.1 Favored Glycine 0 N--CA 1.448 -0.525 0 C-N-CA 120.551 -0.833 . . . . 0.0 112.992 178.008 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' THR . . . . . 0.592 ' OG1' ' HG3' ' A' ' 73' ' ' PRO . 85.4 m -124.5 129.81 51.31 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.028 0.442 . . . . 0.0 110.461 176.519 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.61 ' HA ' ' O ' ' A' ' 69' ' ' ILE . 3.2 p -130.18 129.02 65.09 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.829 -179.837 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 67.6 mt-30 -105.07 119.49 39.15 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.529 177.962 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.742 ' HA ' ' O ' ' A' ' 67' ' ' LEU . 28.8 mt-10 -92.64 108.77 20.23 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.614 -0.721 . . . . 0.0 110.341 175.022 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 22.0 mm -107.28 142.9 18.91 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 CA-C-N 115.55 -0.75 . . . . 0.0 109.422 -179.592 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 90.5 mmm -103.56 92.74 4.59 Favored 'General case' 0 N--CA 1.447 -0.6 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 179.099 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.654 ' HB ' ' HB2' ' A' ' 65' ' ' LYS . 25.5 mm -77.6 128.14 80.62 Favored Pre-proline 0 C--N 1.317 -0.84 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.457 -174.622 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_exo -48.1 133.12 23.71 Favored 'Trans proline' 0 N--CA 1.462 -0.366 0 C-N-CA 122.626 2.217 . . . . 0.0 111.453 175.773 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -44.66 -56.17 4.62 Favored 'General case' 0 C--N 1.328 -0.341 0 O-C-N 124.023 0.827 . . . . 0.0 112.824 -171.536 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -79.31 -12.6 83.72 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.875 -0.679 . . . . 0.0 113.02 -175.425 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.421 ' HD3' ' HB3' ' A' ' 87' ' ' LEU . 19.6 ttmm -88.14 8.91 24.67 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.328 0.585 . . . . 0.0 110.522 -175.864 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . 0.526 ' HB1' ' HZ1' ' A' ' 65' ' ' LYS . . . -66.18 -20.82 66.25 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.061 179.224 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -63.86 -16.06 58.83 Favored Glycine 0 N--CA 1.449 -0.455 0 CA-C-N 115.853 -0.612 . . . . 0.0 112.565 179.575 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.46 HD13 HG22 ' A' ' 86' ' ' ILE . 74.9 mt -94.87 -42.4 8.71 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 111.73 0.27 . . . . 0.0 111.73 -179.394 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.621 HG11 HD22 ' A' ' 87' ' ' LEU . 3.1 m -69.83 -38.21 75.28 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.21 0 CA-C-O 121.037 0.446 . . . . 0.0 111.046 178.629 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.574 ' HA ' ' HB ' ' A' ' 40' ' ' ILE . 57.0 mt -86.45 -32.7 6.77 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-O 121.705 0.764 . . . . 0.0 109.441 179.599 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . 0.492 ' HA3' ' CB ' ' A' ' 39' ' ' THR . . . 92.65 171.52 40.8 Favored Glycine 0 N--CA 1.441 -0.972 0 CA-C-N 114.923 -1.035 . . . . 0.0 112.086 178.438 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 14.5 mptt -76.77 65.77 2.57 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.104 0.478 . . . . 0.0 110.89 -179.611 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 132.92 5.28 3.15 Favored Glycine 0 C--N 1.33 0.224 0 C-N-CA 120.972 -0.632 . . . . 0.0 112.527 175.442 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.495 ' HA2' HG21 ' A' ' 33' ' ' ILE . . . 86.36 -9.2 71.26 Favored Glycine 0 N--CA 1.449 -0.487 0 C-N-CA 120.524 -0.846 . . . . 0.0 112.016 -179.12 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 55.3 mm-40 -64.33 -33.47 75.91 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.689 0.28 . . . . 0.0 111.208 -179.554 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' THR . . . . . 0.753 ' O ' ' HG ' ' A' ' 43' ' ' LEU . 32.3 m -64.62 -57.26 9.57 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.482 -0.326 . . . . 0.0 111.039 -179.839 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.587 ' HA ' HD11 ' A' ' 43' ' ' LEU . 11.0 tt -59.92 -31.74 48.29 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.391 0 CA-C-O 121.318 0.58 . . . . 0.0 110.553 -179.377 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 46.0 tttt -60.39 -50.64 72.78 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.588 -0.733 . . . . 0.0 110.822 173.751 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . 0.642 ' O ' ' HG2' ' A' ' 46' ' ' ARG . 48.2 mt-30 -67.29 -38.77 85.57 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.705 -176.321 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.753 ' HG ' ' O ' ' A' ' 39' ' ' THR . 61.4 mt -55.76 -46.18 77.94 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.397 -176.663 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 43.4 mt-30 -61.26 -34.71 75.61 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.926 -179.862 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -80.74 -45.63 16.75 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.423 -177.583 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . 0.642 ' HG2' ' O ' ' A' ' 42' ' ' GLN . 14.0 ptp180 -74.66 -43.21 56.43 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 112.753 0.649 . . . . 0.0 112.753 -173.879 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . 0.55 ' HB1' HG22 ' A' ' 49' ' ' VAL . . . -83.82 -14.72 50.63 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 112.084 0.402 . . . . 0.0 112.084 -173.508 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 72.24 24.91 75.66 Favored Glycine 0 C--N 1.329 0.17 0 C-N-CA 120.659 -0.782 . . . . 0.0 111.912 -179.134 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.55 HG22 ' HB1' ' A' ' 47' ' ' ALA . 26.8 m -124.08 162.31 25.54 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 N-CA-C 109.937 -0.394 . . . . 0.0 109.937 -179.296 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 61.6 tttp -100.5 122.14 42.72 Favored 'General case' 0 C--N 1.317 -0.833 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 174.624 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' MET . . . . . 0.441 ' HG2' HG12 ' A' ' 69' ' ' ILE . 61.1 mtt -110.12 115.38 29.64 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 174.836 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.655 ' CG2' ' HB2' ' A' ' 68' ' ' ARG . 12.6 tt -109.64 105.13 18.21 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.973 0 CA-C-O 121.88 0.848 . . . . 0.0 109.727 174.886 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -87.84 107.76 18.83 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 114.666 -1.152 . . . . 0.0 109.203 178.278 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.517 ' HB ' ' HB2' ' A' ' 66' ' ' PRO . 46.4 mm -74.54 85.05 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.306 0 CA-C-O 122.006 0.908 . . . . 0.0 110.486 -177.87 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -124.15 -34.78 2.9 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-N 114.361 -1.291 . . . . 0.0 108.111 170.54 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -75.52 -14.73 60.42 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 114.918 -1.037 . . . . 0.0 109.014 174.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -84.6 11.34 59.34 Favored Glycine 0 N--CA 1.45 -0.42 0 CA-C-N 115.268 -0.878 . . . . 0.0 111.848 176.771 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' SER . . . . . 0.406 ' HB2' ' H ' ' A' ' 59' ' ' GLN . 39.1 p 51.47 -158.59 0.11 Allowed 'General case' 0 N--CA 1.467 0.389 0 C-N-CA 123.782 0.833 . . . . 0.0 111.764 -178.63 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . 0.406 ' H ' ' HB2' ' A' ' 58' ' ' SER . 49.5 mt-30 65.28 -82.69 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.209 0 C-N-CA 123.087 0.555 . . . . 0.0 111.714 179.753 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . 0.641 ' HA ' HG23 ' A' ' 63' ' ' VAL . 1.8 m-20 -90.92 18.49 6.56 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.737 0.304 . . . . 0.0 110.988 -175.216 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' THR . . . . . 0.4 ' O ' ' HE2' ' A' ' 65' ' ' LYS . 11.9 t -67.03 -22.8 65.86 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 173.526 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 52.4 t-20 -85.11 -48.5 9.12 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.107 -0.951 . . . . 0.0 110.337 176.279 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.641 HG23 ' HA ' ' A' ' 60' ' ' ASN . 18.1 m -93.11 -154.95 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.007 -0.542 . . . . 0.0 112.161 -174.058 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.546 ' O ' ' HB3' ' A' ' 60' ' ' ASN . 23.3 m-20 -54.21 140.86 31.29 Favored 'General case' 0 N--CA 1.462 0.166 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.274 176.11 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . 0.654 ' HB2' ' HB ' ' A' ' 24' ' ' ILE . 31.0 mmtp -94.34 118.24 67.04 Favored Pre-proline 0 C--N 1.32 -0.681 0 CA-C-N 116.037 -0.528 . . . . 0.0 110.804 -170.368 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.517 ' HB2' ' HB ' ' A' ' 54' ' ' ILE . 25.4 Cg_exo -65.43 104.69 0.66 Allowed 'Trans proline' 0 N--CA 1.459 -0.53 0 C-N-CA 122.653 2.235 . . . . 0.0 110.942 173.784 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.904 HD21 HG13 ' A' ' 69' ' ' ILE . 4.8 tt -103.88 136.55 43.33 Favored 'General case' 0 C--N 1.315 -0.904 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 179.907 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.655 ' HB2' ' CG2' ' A' ' 52' ' ' ILE . 92.7 mtt180 -131.16 108.38 9.68 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 121.067 0.461 . . . . 0.0 111.003 173.538 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . 0.904 HG13 HD21 ' A' ' 67' ' ' LEU . 13.5 mt -91.77 104.96 16.07 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 N-CA-C 108.828 -0.805 . . . . 0.0 108.828 172.57 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 5.2 mt -105.35 126.06 60.5 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.828 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.476 -174.837 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . 0.633 ' HA2' ' HD1' ' A' ' 7' ' ' PHE . . . 160.61 -129.72 2.22 Favored Glycine 0 N--CA 1.446 -0.666 0 C-N-CA 120.591 -0.814 . . . . 0.0 112.705 175.03 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . 0.706 ' OD1' ' HA ' ' A' ' 8' ' ' HIS . 0.9 OUTLIER -88.23 132.94 37.97 Favored Pre-proline 0 C--N 1.322 -0.616 0 C-N-CA 122.833 0.453 . . . . 0.0 111.394 -176.696 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . 0.592 ' HG3' ' OG1' ' A' ' 18' ' ' THR . 45.6 Cg_exo -52.51 -26.41 28.61 Favored 'Trans proline' 0 C--N 1.351 0.679 0 C-N-CA 123.899 3.066 . . . . 0.0 113.301 -174.94 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . 0.469 ' HB3' ' OD2' ' A' ' 72' ' ' ASP . 82.2 t80 -83.49 -56.29 3.82 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.422 -176.664 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.658 ' HG2' ' OD2' ' A' ' 72' ' ' ASP . 12.9 ptpt -71.48 -27.03 62.96 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.54 -179.818 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.626 HG21 HG22 ' A' ' 69' ' ' ILE . 25.2 t -61.18 -40.7 86.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 N-CA-C 110.305 -0.258 . . . . 0.0 110.305 173.799 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -74.97 -43.24 55.16 Favored 'General case' 0 N--CA 1.451 -0.419 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.297 -179.018 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . 0.445 ' O ' ' HB2' ' A' ' 82' ' ' MET . 41.4 mt-30 -62.0 -35.89 79.89 Favored 'General case' 0 C--O 1.224 -0.264 0 CA-C-N 116.52 -0.309 . . . . 0.0 110.674 177.465 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . 0.713 ' HA ' ' HE3' ' A' ' 82' ' ' MET . . . -74.85 -34.15 62.23 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 120.912 0.387 . . . . 0.0 110.478 177.831 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 53.9 t -63.29 -56.7 14.33 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.149 176.438 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -66.23 -23.04 66.36 Favored 'General case' 0 C--O 1.22 -0.499 0 C-N-CA 120.547 -0.461 . . . . 0.0 110.47 179.217 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' MET . . . . . 0.713 ' HE3' ' HA ' ' A' ' 79' ' ' ALA . 30.6 ttm -59.61 -52.66 64.59 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.981 0.419 . . . . 0.0 110.202 174.838 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.633 ' O ' ' HG ' ' A' ' 87' ' ' LEU . 18.7 m -83.86 -35.23 11.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.09 -177.521 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' MET . . . . . 0.449 ' O ' ' HG2' ' A' ' 88' ' ' ARG . 57.1 ttp -65.44 -35.39 80.77 Favored 'General case' 0 CA--C 1.518 -0.265 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.291 -179.894 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . 0.468 ' O ' ' HB2' ' A' ' 89' ' ' GLU . 33.2 t70 -61.3 -39.87 92.09 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.127 177.382 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.46 HG22 HD13 ' A' ' 31' ' ' LEU . 23.5 mt -64.62 -41.18 91.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 121.412 0.625 . . . . 0.0 109.925 176.398 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.633 ' HG ' ' O ' ' A' ' 83' ' ' VAL . 66.1 mt -64.39 -36.11 83.09 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.373 -0.831 . . . . 0.0 111.101 -178.781 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . 0.449 ' HG2' ' O ' ' A' ' 84' ' ' MET . 29.5 mmm180 -95.28 9.91 38.06 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.996 -177.352 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . 0.468 ' HB2' ' O ' ' A' ' 85' ' ' ASP . 35.3 tt0 . . . . . 0 C--O 1.25 1.122 0 CA-C-O 118.836 -0.602 . . . . 0.0 110.34 -177.787 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.55 0 N-CA-C 112.377 -0.289 . . . . 0.0 112.377 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 33.6 mt-30 -60.52 146.37 45.21 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 108.412 -0.958 . . . . 0.0 108.412 173.79 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 94.6 m-85 -47.14 125.2 7.44 Favored 'General case' 0 CA--C 1.518 -0.261 0 CA-C-O 121.554 0.692 . . . . 0.0 111.884 -169.693 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . 0.513 ' H ' ' HB3' ' A' ' 12' ' ' ASN . 4.7 t-80 -141.84 169.88 16.76 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 114.803 -1.09 . . . . 0.0 108.411 -173.455 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . 0.559 ' HB3' ' O ' ' A' ' 48' ' ' GLY . 0.5 OUTLIER -66.67 -68.82 0.35 Allowed 'General case' 0 C--N 1.318 -0.786 0 CA-C-O 120.578 0.227 . . . . 0.0 111.348 176.132 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 23.3 t-20 -84.96 -72.94 0.45 Allowed 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.794 0.33 . . . . 0.0 111.23 -178.081 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -84.24 87.67 7.19 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.952 0.406 . . . . 0.0 111.52 -176.827 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . 0.513 ' HB3' ' H ' ' A' ' 8' ' ' HIS . 18.7 p30 -113.87 149.95 34.33 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.202 175.229 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -104.35 111.26 3.78 Favored Glycine 0 N--CA 1.447 -0.624 0 C-N-CA 120.997 -0.62 . . . . 0.0 112.576 -176.737 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 157.7 -128.04 2.03 Favored Glycine 0 N--CA 1.446 -0.652 0 N-CA-C 109.888 -1.285 . . . . 0.0 109.888 -177.844 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . 0.449 ' C ' ' H ' ' A' ' 17' ' ' GLY . 32.6 tt0 -129.67 102.86 6.53 Favored 'General case' 0 C--N 1.317 -0.841 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 169.847 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 12.4 m120 59.2 -2.43 0.11 Allowed 'General case' 0 N--CA 1.472 0.649 0 CA-C-N 115.3 -0.864 . . . . 0.0 112.615 -172.908 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . 0.449 ' H ' ' C ' ' A' ' 15' ' ' GLN . . . 81.71 -115.84 4.09 Favored Glycine 0 N--CA 1.447 -0.578 0 N-CA-C 111.438 -0.665 . . . . 0.0 111.438 -176.329 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 85.7 m -120.66 130.67 54.22 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 109.697 -0.482 . . . . 0.0 109.697 175.513 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.657 ' HA ' ' O ' ' A' ' 69' ' ' ILE . 3.2 p -139.86 121.76 16.0 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-O 121.161 0.505 . . . . 0.0 111.932 -175.456 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . 0.405 ' O ' ' HA ' ' A' ' 68' ' ' ARG . 28.8 mt-30 -96.88 157.17 16.03 Favored 'General case' 0 CA--C 1.519 -0.233 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.353 173.363 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.505 ' HG2' ' HG2' ' A' ' 68' ' ' ARG . 35.2 mt-10 -131.18 107.91 9.34 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.177 0.513 . . . . 0.0 111.075 -178.424 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 5.3 mm -101.57 150.37 6.06 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-N 115.54 -0.754 . . . . 0.0 109.405 -179.807 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' MET . . . . . 0.412 ' HE3' ' HB2' ' A' ' 64' ' ' ASP . 79.5 mmm -110.18 92.85 4.21 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 176.77 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.655 ' HB ' ' HB2' ' A' ' 65' ' ' LYS . 32.7 mm -82.3 127.32 71.64 Favored Pre-proline 0 C--N 1.32 -0.676 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.101 -173.895 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 76.7 Cg_exo -50.85 136.5 43.33 Favored 'Trans proline' 0 N--CA 1.463 -0.317 0 C-N-CA 122.491 2.127 . . . . 0.0 111.592 175.398 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -58.1 -29.28 65.35 Favored 'General case' 0 CA--C 1.531 0.226 0 N-CA-C 112.959 0.725 . . . . 0.0 112.959 -172.116 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -89.44 -19.73 47.94 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.484 -0.865 . . . . 0.0 112.138 179.323 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 8.5 tptm -91.95 -1.15 57.42 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.266 0.555 . . . . 0.0 110.363 -177.601 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . 0.463 ' HA ' HG22 ' A' ' 32' ' ' VAL . . . -63.06 -20.93 65.8 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.598 -0.728 . . . . 0.0 111.065 179.471 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -61.0 -16.3 47.14 Favored Glycine 0 C--O 1.228 -0.247 0 CA-C-N 115.876 -0.602 . . . . 0.0 112.652 177.405 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 62.6 mt -93.75 -47.92 6.55 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 122.693 -0.298 . . . . 0.0 111.238 179.539 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.538 HG12 HD22 ' A' ' 87' ' ' LEU . 3.0 m -65.34 -40.07 87.29 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.379 0 CA-C-O 120.889 0.376 . . . . 0.0 111.452 179.523 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.487 HG13 HG23 ' A' ' 32' ' ' VAL . 43.6 mt -85.88 -32.75 7.09 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-O 121.927 0.87 . . . . 0.0 109.162 178.794 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . 0.526 ' HA3' ' HB ' ' A' ' 39' ' ' THR . . . 95.15 178.9 37.3 Favored Glycine 0 N--CA 1.436 -1.318 0 CA-C-N 114.852 -1.067 . . . . 0.0 111.579 -178.105 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 2.9 mppt? -81.13 62.8 5.23 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-O 120.973 0.416 . . . . 0.0 110.373 -178.839 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 133.19 -20.1 4.26 Favored Glycine 0 N--CA 1.448 -0.521 0 C-N-CA 120.823 -0.703 . . . . 0.0 112.416 176.897 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 115.8 -0.16 21.45 Favored Glycine 0 N--CA 1.448 -0.517 0 C-N-CA 120.723 -0.751 . . . . 0.0 111.883 -176.792 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.499 ' O ' ' HB3' ' A' ' 41' ' ' LYS . 49.3 mt-10 -75.44 -31.96 60.5 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 120.724 0.297 . . . . 0.0 111.106 179.474 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' THR . . . . . 0.574 ' O ' ' HG ' ' A' ' 43' ' ' LEU . 23.7 m -69.38 -48.46 61.11 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.774 -178.3 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.632 HD11 HD23 ' A' ' 53' ' ' LEU . 7.0 tt -61.8 -32.79 55.05 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.267 0 CA-C-O 121.107 0.479 . . . . 0.0 110.346 177.356 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . 0.499 ' HB3' ' O ' ' A' ' 38' ' ' GLU . 31.6 ttpt -56.24 -45.22 80.07 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.467 174.398 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . 0.452 ' O ' ' HG2' ' A' ' 46' ' ' ARG . 27.8 mt-30 -73.46 -40.46 64.15 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.404 -0.816 . . . . 0.0 111.116 -177.027 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.574 ' HG ' ' O ' ' A' ' 39' ' ' THR . 81.0 mt -55.71 -47.58 76.63 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.683 -176.577 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 44.6 mt-30 -61.98 -43.13 99.48 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.712 -176.247 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -78.54 -35.21 46.46 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 111.836 0.31 . . . . 0.0 111.836 -175.797 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . 0.452 ' HG2' ' O ' ' A' ' 42' ' ' GLN . 12.9 ptm180 -73.92 -31.39 63.05 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 120.777 -0.369 . . . . 0.0 111.268 -177.89 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -89.19 -28.18 20.16 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.087 0.47 . . . . 0.0 111.348 -179.111 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . 0.559 ' O ' ' HB3' ' A' ' 9' ' ' ASP . . . 82.93 33.21 24.6 Favored Glycine 0 N--CA 1.449 -0.478 0 CA-C-N 115.742 -0.663 . . . . 0.0 112.243 -178.698 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 3.6 m -139.14 179.86 2.76 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.399 0 CA-C-O 120.898 0.38 . . . . 0.0 110.297 178.609 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 54.7 tttp -109.44 123.67 49.75 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 115.945 -0.57 . . . . 0.0 109.919 175.448 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' MET . . . . . 0.762 ' HE1' HG11 ' A' ' 83' ' ' VAL . 65.9 mtp -118.21 114.08 22.49 Favored 'General case' 0 C--N 1.317 -0.808 0 N-CA-C 108.301 -1.0 . . . . 0.0 108.301 174.414 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.49 ' CG2' ' HB2' ' A' ' 68' ' ' ARG . 11.5 tt -104.6 108.54 25.06 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.749 0 CA-C-O 121.622 0.725 . . . . 0.0 110.684 -177.614 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.724 HD22 HD12 ' A' ' 67' ' ' LEU . 2.7 mm? -82.35 102.29 11.15 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.249 -0.887 . . . . 0.0 109.522 174.11 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.613 HD13 ' HB2' ' A' ' 66' ' ' PRO . 56.6 mt -82.48 87.42 1.9 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.55 0 CA-C-O 121.481 0.658 . . . . 0.0 109.35 -179.171 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 70.9 mt-30 -70.91 -37.95 72.95 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.148 -0.933 . . . . 0.0 111.144 -173.59 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . 0.495 ' HA ' HG21 ' A' ' 61' ' ' THR . 19.4 m-20 -130.27 62.28 1.58 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.184 0.516 . . . . 0.0 111.541 178.29 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -91.95 5.15 78.95 Favored Glycine 0 CA--C 1.517 0.2 0 C-N-CA 120.508 -0.853 . . . . 0.0 111.928 172.56 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 16.8 m 64.37 -169.77 0.19 Allowed 'General case' 0 C--O 1.235 0.321 0 C-N-CA 123.426 0.69 . . . . 0.0 111.322 -178.088 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 26.1 mt-30 67.76 -79.23 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 123.376 0.67 . . . . 0.0 111.146 179.768 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 13.6 m120 -101.38 13.01 36.37 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.337 -177.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' THR . . . . . 0.495 HG21 ' HA ' ' A' ' 56' ' ' ASP . 1.2 p -62.52 -33.08 74.19 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 120.861 0.362 . . . . 0.0 111.347 179.296 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 17.9 t-20 -74.63 -10.19 59.3 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.471 -0.786 . . . . 0.0 111.493 -178.701 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -126.51 -60.79 1.45 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-O 121.698 0.761 . . . . 0.0 112.702 -174.387 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.412 ' HB2' ' HE3' ' A' ' 23' ' ' MET . 10.6 m-20 -120.63 -163.68 1.04 Allowed 'General case' 0 C--N 1.307 -1.278 0 CA-C-N 114.67 -1.15 . . . . 0.0 108.901 -171.158 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . 0.655 ' HB2' ' HB ' ' A' ' 24' ' ' ILE . 2.7 mmpp? -148.57 113.28 3.74 Favored Pre-proline 0 C--N 1.318 -0.779 0 CA-C-N 115.62 -0.718 . . . . 0.0 109.51 178.779 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.613 ' HB2' HD13 ' A' ' 54' ' ' ILE . 24.7 Cg_exo -63.55 110.26 1.21 Allowed 'Trans proline' 0 N--CA 1.462 -0.353 0 C-N-CA 122.613 2.209 . . . . 0.0 111.807 178.268 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.724 HD12 HD22 ' A' ' 53' ' ' LEU . 24.2 tp -111.16 105.22 13.85 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.069 178.006 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.505 ' HG2' ' HG2' ' A' ' 21' ' ' GLU . 95.2 mtt180 -97.72 113.62 25.42 Favored 'General case' 0 C--N 1.319 -0.717 0 CA-C-O 121.437 0.637 . . . . 0.0 110.581 176.813 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . 0.657 ' O ' ' HA ' ' A' ' 19' ' ' VAL . 19.6 mt -98.83 104.09 15.54 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.786 0 CA-C-N 114.99 -1.004 . . . . 0.0 108.577 177.897 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.526 HG21 ' HB ' ' A' ' 19' ' ' VAL . 2.8 mt -112.58 132.61 60.84 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.788 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.061 -169.348 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 156.44 -119.06 0.88 Allowed Glycine 0 N--CA 1.446 -0.675 0 C-N-CA 120.718 -0.754 . . . . 0.0 112.825 174.832 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -102.69 134.77 19.7 Favored Pre-proline 0 C--N 1.325 -0.46 0 CA-C-O 119.091 -0.48 . . . . 0.0 110.96 -175.667 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_exo -44.31 -42.91 13.59 Favored 'Trans proline' 0 C--O 1.237 0.445 0 C-N-CA 123.231 2.62 . . . . 0.0 113.557 -174.419 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 30.7 t80 -70.95 -47.73 57.34 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.853 -171.911 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.433 ' HA ' ' HB2' ' A' ' 78' ' ' GLN . 14.3 pttt -82.87 -19.24 37.84 Favored 'General case' 0 C--N 1.325 -0.466 0 C-N-CA 120.492 -0.483 . . . . 0.0 111.768 -179.463 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 47.0 t -66.16 -38.55 82.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 170.036 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . 0.409 ' O ' ' HG2' ' A' ' 81' ' ' GLU . 20.9 tp60 -69.92 -49.13 55.06 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.38 -0.827 . . . . 0.0 110.416 175.426 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . 0.433 ' HB2' ' HA ' ' A' ' 75' ' ' LYS . 86.2 mt-30 -60.4 -36.36 77.95 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.567 -0.288 . . . . 0.0 111.693 -179.913 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . 0.693 ' HA ' ' HE1' ' A' ' 82' ' ' MET . . . -69.64 -39.42 77.12 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 120.818 0.342 . . . . 0.0 110.546 177.462 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 52.5 t -65.13 -51.45 61.19 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.051 179.681 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . 0.409 ' HG2' ' O ' ' A' ' 77' ' ' GLN . 10.3 pt-20 -64.99 -24.11 67.41 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.972 0.415 . . . . 0.0 110.37 179.983 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' MET . . . . . 0.693 ' HE1' ' HA ' ' A' ' 79' ' ' ALA . 29.7 ttp -73.14 -52.02 15.76 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.863 179.259 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.762 HG11 ' HE1' ' A' ' 51' ' ' MET . 33.3 m -77.75 -34.0 19.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 120.635 0.255 . . . . 0.0 111.207 -175.647 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 51.7 ttm -63.35 -35.25 79.75 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.106 0.479 . . . . 0.0 109.741 177.194 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -68.54 -36.72 79.22 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.441 179.444 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.551 HG13 ' O ' ' A' ' 82' ' ' MET . 59.9 mt -63.31 -33.25 60.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-O 121.256 0.55 . . . . 0.0 110.543 178.056 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.563 ' HG ' ' O ' ' A' ' 83' ' ' VAL . 58.7 mt -73.87 -19.61 60.67 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.604 -175.945 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . 0.602 ' HG3' ' HG2' ' A' ' 89' ' ' GLU . 37.1 ptt180 -110.8 -19.3 12.88 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.372 0.606 . . . . 0.0 111.142 -175.596 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . 0.602 ' HG2' ' HG3' ' A' ' 88' ' ' ARG . 69.9 mm-40 . . . . . 0 C--O 1.249 1.04 0 CA-C-N 115.235 -0.893 . . . . 0.0 110.425 -175.633 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.504 -0.6 0 N-CA-C 113.866 0.306 . . . . 0.0 113.866 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 53.7 mt-30 -76.35 -171.28 1.72 Allowed 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 106.987 -1.486 . . . . 0.0 106.987 159.634 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . 0.446 ' HD1' ' N ' ' A' ' 8' ' ' HIS . 0.1 OUTLIER -65.78 -20.45 66.26 Favored 'General case' 0 C--N 1.314 -0.946 0 C-N-CA 119.056 -1.058 . . . . 0.0 111.942 -177.889 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . 0.446 ' N ' ' HD1' ' A' ' 7' ' ' PHE . 11.5 t-160 70.25 77.51 0.2 Allowed 'General case' 0 CA--C 1.53 0.189 0 O-C-N 123.745 0.653 . . . . 0.0 110.649 -178.667 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 30.9 t70 72.63 -57.94 0.61 Allowed 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 115.159 -0.928 . . . . 0.0 112.073 178.207 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . 0.421 ' O ' ' HB2' ' A' ' 7' ' ' PHE . 7.8 p30 -137.4 -163.57 1.45 Allowed 'General case' 0 C--N 1.317 -0.81 0 N-CA-C 109.792 -0.448 . . . . 0.0 109.792 -177.688 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -73.29 76.12 1.34 Allowed 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 109.977 -0.379 . . . . 0.0 109.977 175.225 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 -82.18 75.47 9.1 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.172 0.51 . . . . 0.0 110.914 -171.875 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 101.42 -4.48 54.56 Favored Glycine 0 N--CA 1.449 -0.456 0 CA-C-N 115.784 -0.644 . . . . 0.0 112.736 177.795 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 80.51 -70.51 2.98 Favored Glycine 0 N--CA 1.454 -0.147 0 C-N-CA 120.742 -0.742 . . . . 0.0 111.918 -177.934 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 8.3 tt0 -74.8 124.67 27.25 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 175.554 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . 0.434 ' OD1' ' HA ' ' A' ' 7' ' ' PHE . 16.8 m120 -118.96 -80.52 0.62 Allowed 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 111.972 0.36 . . . . 0.0 111.972 -171.726 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -158.75 -49.7 0.01 OUTLIER Glycine 0 C--N 1.333 0.41 0 C-N-CA 119.819 -1.182 . . . . 0.0 113.666 -178.079 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 99.7 m -62.38 129.37 40.4 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.008 0.432 . . . . 0.0 111.641 -178.182 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.564 HG22 HG22 ' A' ' 70' ' ' ILE . 92.9 t -120.8 126.99 75.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.276 178.284 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . 0.559 ' HB2' ' CG1' ' A' ' 76' ' ' VAL . 4.9 tp-100 -106.58 113.93 27.74 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 109.667 -0.494 . . . . 0.0 109.667 175.684 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.6 ' HA ' ' O ' ' A' ' 67' ' ' LEU . 56.1 mt-10 -93.24 121.29 34.47 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.036 0.446 . . . . 0.0 111.457 177.591 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.435 HD11 ' HE1' ' A' ' 84' ' ' MET . 18.7 mm -115.43 146.38 19.94 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 115.529 -0.759 . . . . 0.0 109.355 176.902 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' MET . . . . . 0.475 ' HB3' ' HB2' ' A' ' 64' ' ' ASP . 79.4 mmm -106.77 99.86 9.4 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 175.356 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.705 HD11 HD11 ' A' ' 87' ' ' LEU . 24.5 mm -78.54 129.76 73.36 Favored Pre-proline 0 C--N 1.32 -0.685 0 CA-C-N 115.498 -0.774 . . . . 0.0 111.895 -170.461 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . 0.571 ' HD2' HD13 ' A' ' 87' ' ' LEU . 77.0 Cg_exo -45.2 131.37 11.38 Favored 'Trans proline' 0 C--N 1.349 0.574 0 C-N-CA 123.744 2.963 . . . . 0.0 112.976 175.831 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -71.36 78.5 0.75 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.444 0.64 . . . . 0.0 110.874 179.437 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 157.54 -59.96 0.34 Allowed Glycine 0 N--CA 1.447 -0.593 0 N-CA-C 109.983 -1.247 . . . . 0.0 109.983 -177.456 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.46 -13.97 35.97 Favored 'General case' 0 N--CA 1.451 -0.41 0 CA-C-O 121.0 0.429 . . . . 0.0 110.749 171.929 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . 0.41 ' O ' HG13 ' A' ' 32' ' ' VAL . . . -56.16 -23.49 35.24 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.771 173.379 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -61.8 -24.46 64.54 Favored Glycine 0 N--CA 1.449 -0.494 0 C-N-CA 120.862 -0.685 . . . . 0.0 112.185 176.611 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 93.1 mt -92.4 -32.8 14.81 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.725 0.298 . . . . 0.0 110.859 178.793 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.41 HG13 ' O ' ' A' ' 29' ' ' ALA . 0.3 OUTLIER -68.06 -29.0 43.15 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.296 0 CA-C-O 121.263 0.554 . . . . 0.0 110.395 179.387 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 63.2 mt -92.0 -47.97 13.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 115.568 -0.742 . . . . 0.0 109.424 174.386 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 114.56 -162.12 12.51 Favored Glycine 0 N--CA 1.442 -0.942 0 CA-C-N 115.356 -0.838 . . . . 0.0 112.095 178.418 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.531 ' N ' ' HD3' ' A' ' 35' ' ' LYS . 0.1 OUTLIER -92.29 39.33 1.02 Allowed 'General case' 0 C--N 1.317 -0.818 0 N-CA-C 109.637 -0.505 . . . . 0.0 109.637 -178.298 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 143.52 -21.31 2.21 Favored Glycine 0 N--CA 1.45 -0.431 0 C-N-CA 120.982 -0.628 . . . . 0.0 112.29 -178.245 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 126.17 4.77 6.4 Favored Glycine 0 C--O 1.228 -0.245 0 C-N-CA 120.355 -0.926 . . . . 0.0 112.309 179.939 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -80.59 -28.17 37.2 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 120.659 0.266 . . . . 0.0 111.217 178.897 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' THR . . . . . 0.611 ' O ' ' HG ' ' A' ' 43' ' ' LEU . 57.9 m -70.38 -49.64 47.01 Favored 'General case' 0 C--N 1.324 -0.507 0 C-N-CA 121.101 -0.24 . . . . 0.0 110.444 -179.983 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.703 HD12 HD22 ' A' ' 53' ' ' LEU . 5.2 tt -59.64 -33.72 52.86 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.248 0 CA-C-O 120.81 0.338 . . . . 0.0 110.473 176.31 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . 0.526 ' O ' ' HG2' ' A' ' 45' ' ' GLU . 57.7 tttp -64.86 -46.23 82.74 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.756 175.454 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 41.7 mt-30 -60.88 -35.08 75.69 Favored 'General case' 0 CA--C 1.516 -0.354 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.359 -178.017 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.611 ' HG ' ' O ' ' A' ' 39' ' ' THR . 69.8 mt -62.19 -43.6 98.46 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.421 -0.809 . . . . 0.0 110.402 178.158 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . 0.43 ' HG3' ' O ' ' A' ' 40' ' ' ILE . 67.8 mt-30 -62.61 -47.24 84.63 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.176 177.596 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.526 ' HG2' ' O ' ' A' ' 41' ' ' LYS . 72.0 mm-40 -59.81 -39.41 84.95 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.33 -0.85 . . . . 0.0 111.672 -177.854 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 13.5 ptm180 -90.0 -28.02 19.38 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 112.932 0.716 . . . . 0.0 112.932 -170.865 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . 0.487 ' HB2' HG22 ' A' ' 49' ' ' VAL . . . -94.22 -15.83 24.2 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 112.174 0.435 . . . . 0.0 112.174 -175.642 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 74.23 20.72 79.6 Favored Glycine 0 C--O 1.235 0.217 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.183 -179.855 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.487 HG22 ' HB2' ' A' ' 47' ' ' ALA . 27.3 m -124.51 177.31 4.67 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 N-CA-C 109.902 -0.407 . . . . 0.0 109.902 -179.202 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 87.1 tttt -114.64 123.97 50.66 Favored 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 109.773 -0.455 . . . . 0.0 109.773 173.088 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' MET . . . . . 0.79 ' HE1' ' HB1' ' A' ' 79' ' ' ALA . 55.7 mtt -108.54 115.39 30.02 Favored 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 176.028 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.547 ' CG2' ' HB2' ' A' ' 68' ' ' ARG . 10.2 tt -105.13 105.14 18.08 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.895 0 CA-C-O 121.585 0.707 . . . . 0.0 110.423 177.668 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.982 HD21 HD13 ' A' ' 67' ' ' LEU . 1.4 mm? -80.75 121.8 26.36 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.283 -0.872 . . . . 0.0 108.973 172.608 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.465 ' CG1' ' HB2' ' A' ' 66' ' ' PRO . 48.9 mm -76.67 85.86 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-O 121.845 0.831 . . . . 0.0 109.832 179.514 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 15.3 mt-30 -102.48 -57.87 1.98 Allowed 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 114.743 -1.117 . . . . 0.0 108.64 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -66.9 -33.09 74.83 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 114.633 -1.167 . . . . 0.0 110.322 177.902 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -70.13 -27.06 73.43 Favored Glycine 0 N--CA 1.451 -0.333 0 CA-C-N 115.577 -0.738 . . . . 0.0 112.382 179.65 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' SER . . . . . 0.605 ' HB3' ' CG2' ' A' ' 61' ' ' THR . 49.2 m 62.1 -127.28 0.72 Allowed 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 122.28 0.232 . . . . 0.0 111.422 178.615 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . 0.404 ' HB2' ' O ' ' A' ' 58' ' ' SER . 23.2 mt-30 78.7 -57.05 0.45 Allowed 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 123.671 0.788 . . . . 0.0 109.519 179.172 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . 0.485 ' HB3' ' O ' ' A' ' 64' ' ' ASP . 13.7 m120 -100.03 52.82 0.91 Allowed 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 107.86 -1.163 . . . . 0.0 107.86 171.37 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' THR . . . . . 0.605 ' CG2' ' HB3' ' A' ' 58' ' ' SER . 2.7 p -55.58 -44.54 77.0 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 114.115 -1.402 . . . . 0.0 112.538 -173.696 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 66.2 t30 -104.69 -18.15 14.39 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 115.859 -0.61 . . . . 0.0 111.729 -173.853 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 33.0 m -108.86 -159.64 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 N-CA-C 112.251 0.463 . . . . 0.0 112.251 -173.898 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.485 ' O ' ' HB3' ' A' ' 60' ' ' ASN . 0.6 OUTLIER -55.06 142.43 30.48 Favored 'General case' 0 C--O 1.221 -0.431 0 CA-C-N 115.293 -0.867 . . . . 0.0 112.334 -179.569 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . 0.649 ' HB2' ' HB ' ' A' ' 24' ' ' ILE . 73.6 mmtt -95.46 132.62 27.25 Favored Pre-proline 0 C--N 1.322 -0.592 0 CA-C-N 115.543 -0.753 . . . . 0.0 112.22 -170.49 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.465 ' HB2' ' CG1' ' A' ' 54' ' ' ILE . 13.7 Cg_exo -71.19 118.53 5.73 Favored 'Trans proline' 0 N--CA 1.457 -0.639 0 C-N-CA 122.867 2.378 . . . . 0.0 111.55 173.422 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.982 HD13 HD21 ' A' ' 53' ' ' LEU . 13.0 tp -123.48 124.7 43.44 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.98 -0.555 . . . . 0.0 109.923 178.091 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.547 ' HB2' ' CG2' ' A' ' 52' ' ' ILE . 87.5 mtt180 -112.58 110.63 20.91 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-O 120.851 0.358 . . . . 0.0 111.292 177.458 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . 0.519 HG21 ' HB3' ' A' ' 79' ' ' ALA . 4.6 mp -88.38 104.7 14.91 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 171.525 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.564 HG22 HG22 ' A' ' 19' ' ' VAL . 11.3 mt -104.65 124.85 59.49 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.703 -174.99 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . 0.417 ' O ' ' HB2' ' A' ' 16' ' ' ASN . . . 173.95 -129.82 1.71 Allowed Glycine 0 N--CA 1.447 -0.592 0 C-N-CA 121.005 -0.617 . . . . 0.0 112.208 179.582 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . 0.49 ' OD1' ' HD2' ' A' ' 73' ' ' PRO . 3.1 t70 -107.58 145.72 31.87 Favored Pre-proline 0 C--N 1.324 -0.523 0 CA-C-O 118.655 -0.688 . . . . 0.0 109.895 -179.793 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . 0.49 ' HD2' ' OD1' ' A' ' 72' ' ' ASP . 94.3 Cg_exo -41.02 -40.42 3.81 Favored 'Trans proline' 0 CA--C 1.535 0.571 0 C-N-CA 122.999 2.466 . . . . 0.0 113.335 -179.398 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 85.9 t80 -70.82 -56.71 5.71 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.295 -176.262 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.444 ' HG2' ' HB3' ' A' ' 72' ' ' ASP . 27.6 pttt -71.22 -27.48 63.51 Favored 'General case' 0 CA--C 1.514 -0.432 0 C-N-CA 120.575 -0.45 . . . . 0.0 111.383 -179.523 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.559 ' CG1' ' HB2' ' A' ' 20' ' ' GLN . 24.2 t -66.71 -36.17 76.59 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-O 121.4 0.619 . . . . 0.0 109.441 177.068 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . 0.465 ' O ' ' HG2' ' A' ' 81' ' ' GLU . 20.1 tp60 -72.7 -47.98 42.68 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.292 176.749 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 25.0 mt-30 -57.8 -37.65 74.13 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-O 121.112 0.482 . . . . 0.0 110.6 177.534 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . 0.79 ' HB1' ' HE1' ' A' ' 51' ' ' MET . . . -71.99 -36.93 69.9 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.638 -0.71 . . . . 0.0 111.188 179.899 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' CYS . . . . . 0.431 ' HA ' HG21 ' A' ' 83' ' ' VAL . 51.7 t -68.37 -48.29 65.17 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.965 179.548 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . 0.465 ' HG2' ' O ' ' A' ' 77' ' ' GLN . 11.2 pt-20 -65.95 -19.48 65.88 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.11 0.481 . . . . 0.0 110.067 178.778 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' MET . . . . . 0.504 ' O ' HG13 ' A' ' 86' ' ' ILE . 51.1 ttp -79.18 -50.05 11.59 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.67 -0.695 . . . . 0.0 110.637 177.05 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.431 HG21 ' HA ' ' A' ' 80' ' ' CYS . 27.2 m -69.08 -35.16 67.27 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.248 0 C-N-CA 121.114 -0.234 . . . . 0.0 111.112 179.918 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' MET . . . . . 0.435 ' HE1' HD11 ' A' ' 22' ' ' ILE . 16.8 mmt -60.93 -37.23 81.59 Favored 'General case' 0 CA--C 1.517 -0.298 0 CA-C-O 121.076 0.465 . . . . 0.0 109.977 174.539 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -65.2 -43.77 90.55 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.482 -0.781 . . . . 0.0 110.95 178.694 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.504 HG13 ' O ' ' A' ' 82' ' ' MET . 51.5 mt -60.54 -37.52 75.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 121.466 0.651 . . . . 0.0 110.882 -179.395 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.705 HD11 HD11 ' A' ' 24' ' ' ILE . 71.5 mt -82.88 -12.83 57.08 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.762 -0.654 . . . . 0.0 111.21 -176.858 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 45.0 ttp180 -103.39 -18.34 14.87 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.467 0.651 . . . . 0.0 111.062 -176.982 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 . . . . . 0 C--O 1.249 1.051 0 CA-C-O 118.191 -0.909 . . . . 0.0 110.095 -178.31 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.488 0 N-CA-C 112.708 -0.157 . . . . 0.0 112.708 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 93.8 mt-30 -90.23 90.48 8.1 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 109.369 -0.604 . . . . 0.0 109.369 177.23 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 86.7 m-85 -64.71 -70.56 0.22 Allowed 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.418 -0.81 . . . . 0.0 111.518 -175.968 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . 0.547 ' HD2' ' HB3' ' A' ' 12' ' ' ASN . 7.9 t-160 52.02 41.14 29.6 Favored 'General case' 0 N--CA 1.464 0.265 0 N-CA-C 108.195 -1.039 . . . . 0.0 108.195 -171.313 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . 0.403 ' CG ' ' HZ1' ' A' ' 75' ' ' LYS . 24.8 t70 -67.29 142.3 56.91 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 114.05 -1.432 . . . . 0.0 112.03 -169.938 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . 0.782 ' H ' ' HA2' ' A' ' 71' ' ' GLY . 18.8 m-80 60.5 -84.91 0.02 OUTLIER 'General case' 0 N--CA 1.461 0.121 0 CA-C-N 115.155 -0.929 . . . . 0.0 110.902 -174.403 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.463 ' HA ' ' HA ' ' A' ' 16' ' ' ASN . . . -134.46 -51.32 0.81 Allowed 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 109.959 -0.386 . . . . 0.0 109.959 178.566 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . 0.547 ' HB3' ' HD2' ' A' ' 8' ' ' HIS . 3.1 t-20 51.61 57.18 6.84 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-O 121.308 0.575 . . . . 0.0 110.857 178.477 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 133.92 -53.81 0.78 Allowed Glycine 0 N--CA 1.446 -0.685 0 CA-C-N 115.684 -0.689 . . . . 0.0 111.996 -179.859 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 174.6 -66.02 0.1 Allowed Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.976 -0.631 . . . . 0.0 111.823 178.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 16.8 mm100 -75.45 144.18 42.25 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 109.677 -0.49 . . . . 0.0 109.677 177.031 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . 0.463 ' HA ' ' HA ' ' A' ' 11' ' ' ALA . 17.9 m120 -77.49 156.44 31.02 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.47 -170.772 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -80.12 -115.86 0.3 Allowed Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 121.043 -0.598 . . . . 0.0 112.372 179.29 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' THR . . . . . 0.448 ' OG1' ' HG3' ' A' ' 73' ' ' PRO . 92.8 m -85.86 127.72 34.65 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 110.21 -0.293 . . . . 0.0 110.21 -179.795 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.533 ' HA ' ' O ' ' A' ' 69' ' ' ILE . 3.8 p -138.22 120.91 19.12 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-O 121.259 0.552 . . . . 0.0 110.808 179.909 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 53.2 mt-30 -102.54 136.11 42.96 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.793 -0.64 . . . . 0.0 109.98 176.646 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.562 ' HA ' ' O ' ' A' ' 67' ' ' LEU . 33.4 mt-10 -112.3 114.75 27.67 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.498 179.232 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 11.5 mm -106.56 156.93 7.01 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-N 115.486 -0.779 . . . . 0.0 110.038 -176.599 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' MET . . . . . 0.458 ' HE3' ' HA ' ' A' ' 23' ' ' MET . 3.6 mmt -108.9 97.26 6.93 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 174.793 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.653 ' HB ' ' HB2' ' A' ' 65' ' ' LYS . 25.6 mm -82.92 125.53 74.96 Favored Pre-proline 0 C--N 1.316 -0.888 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.814 -175.819 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . 0.647 ' HB2' ' HB2' ' A' ' 28' ' ' LYS . 74.0 Cg_exo -50.51 132.8 36.35 Favored 'Trans proline' 0 C--N 1.343 0.289 0 C-N-CA 122.747 2.298 . . . . 0.0 111.416 175.94 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -58.88 -31.84 68.94 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.751 -0.659 . . . . 0.0 112.51 -172.842 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -82.47 -36.7 16.17 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.592 -0.813 . . . . 0.0 111.823 178.426 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.647 ' HB2' ' HB2' ' A' ' 25' ' ' PRO . 36.2 mttp -80.32 3.64 20.39 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.808 0.337 . . . . 0.0 111.393 179.466 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.66 -30.44 70.73 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.096 0.474 . . . . 0.0 110.141 175.742 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -66.17 -18.67 67.34 Favored Glycine 0 N--CA 1.446 -0.656 0 C-N-CA 120.861 -0.685 . . . . 0.0 112.341 177.848 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 82.2 mt -84.36 -46.72 11.44 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.53 0.205 . . . . 0.0 110.789 179.922 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.607 HG23 HG23 ' A' ' 24' ' ' ILE . 2.8 m -66.7 -34.88 72.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-O 120.884 0.373 . . . . 0.0 110.958 177.813 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.726 HD11 ' HG2' ' A' ' 55' ' ' GLN . 84.7 mt -80.21 -44.97 22.51 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-O 121.203 0.525 . . . . 0.0 110.4 178.413 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 98.96 51.05 1.4 Allowed Glycine 0 N--CA 1.448 -0.553 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.841 177.202 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 5.0 mptp? 54.25 30.98 13.3 Favored 'General case' 0 N--CA 1.464 0.254 0 C-N-CA 122.959 0.504 . . . . 0.0 112.118 175.761 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 147.4 -36.86 1.16 Allowed Glycine 0 N--CA 1.446 -0.696 0 C-N-CA 120.294 -0.955 . . . . 0.0 112.575 -178.526 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 147.49 -1.97 0.76 Allowed Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 119.516 -1.326 . . . . 0.0 114.504 177.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 -63.23 -47.48 82.31 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 117.677 0.739 . . . . 0.0 111.301 -179.169 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' THR . . . . . 0.73 ' O ' ' HG ' ' A' ' 43' ' ' LEU . 95.3 m -63.86 -51.55 64.12 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 111.7 0.259 . . . . 0.0 111.7 -177.112 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.548 ' O ' ' HG3' ' A' ' 44' ' ' GLN . 5.3 tt -58.01 -37.49 61.66 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.375 0 CA-C-O 120.989 0.423 . . . . 0.0 110.831 -178.658 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 85.8 tttt -63.38 -44.21 95.41 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.452 177.158 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 70.8 mt-30 -65.0 -40.25 94.66 Favored 'General case' 0 CA--C 1.517 -0.306 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.62 -178.744 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.73 ' HG ' ' O ' ' A' ' 39' ' ' THR . 70.5 mt -56.99 -48.33 78.67 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.588 -0.733 . . . . 0.0 111.558 -177.742 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . 0.548 ' HG3' ' O ' ' A' ' 40' ' ' ILE . 46.5 mt-30 -58.96 -51.78 68.57 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.462 -178.226 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -68.68 -40.71 79.95 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.366 -0.833 . . . . 0.0 111.889 -173.79 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . 0.599 ' HD3' ' SD ' ' A' ' 82' ' ' MET . 13.0 ptm180 -71.94 -27.82 63.05 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 111.74 0.274 . . . . 0.0 111.74 -174.574 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . 0.546 ' HB2' HG23 ' A' ' 49' ' ' VAL . . . -96.98 -22.71 16.67 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.02 0.438 . . . . 0.0 111.302 -178.882 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 79.85 28.55 50.28 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 121.027 -0.606 . . . . 0.0 111.722 -178.213 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.546 HG23 ' HB2' ' A' ' 47' ' ' ALA . 27.1 m -123.06 179.08 2.79 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-O 120.833 0.349 . . . . 0.0 110.114 -176.741 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 61.6 tttp -113.25 123.53 50.4 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 171.56 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' MET . . . . . 0.856 ' HE2' HG13 ' A' ' 83' ' ' VAL . 54.7 mtp -122.64 116.7 24.26 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 109.727 -0.472 . . . . 0.0 109.727 179.567 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.471 ' CG2' ' HB2' ' A' ' 68' ' ' ARG . 6.7 tt -107.13 107.17 22.11 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.792 0 CA-C-O 121.462 0.649 . . . . 0.0 110.878 -179.979 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.673 HD22 HD11 ' A' ' 67' ' ' LEU . 3.5 mm? -82.6 103.58 12.22 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.382 -0.826 . . . . 0.0 109.136 172.314 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.609 HD11 ' HB2' ' A' ' 66' ' ' PRO . 65.5 mt -81.37 89.78 1.85 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-O 121.192 0.52 . . . . 0.0 109.792 178.79 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . 0.726 ' HG2' HD11 ' A' ' 33' ' ' ILE . 0.0 OUTLIER -104.65 -44.63 4.82 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.654 179.82 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -77.42 -21.8 52.49 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.401 178.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . 0.408 ' O ' HG21 ' A' ' 61' ' ' THR . . . -62.83 135.1 43.89 Favored Glycine 0 N--CA 1.445 -0.722 0 C-N-CA 120.656 -0.783 . . . . 0.0 111.422 175.898 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' SER . . . . . 0.483 ' O ' ' HB2' ' A' ' 59' ' ' GLN . 15.6 m -72.74 -167.52 0.37 Allowed 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 120.567 0.222 . . . . 0.0 111.396 -175.764 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . 0.483 ' HB2' ' O ' ' A' ' 58' ' ' SER . 15.9 mm100 74.87 -60.74 0.51 Allowed 'General case' 0 N--CA 1.464 0.234 0 C-N-CA 123.31 0.644 . . . . 0.0 109.841 -173.5 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . 0.662 ' HA ' HG23 ' A' ' 63' ' ' VAL . 2.6 m-20 -110.04 25.91 11.26 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 121.258 0.552 . . . . 0.0 110.802 179.255 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' THR . . . . . 0.422 ' OG1' ' HA ' ' A' ' 58' ' ' SER . 0.0 OUTLIER -63.67 -30.75 71.81 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.826 176.13 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 10.0 p30 -105.11 -1.44 25.55 Favored 'General case' 0 CA--C 1.534 0.351 0 N-CA-C 112.187 0.44 . . . . 0.0 112.187 -178.047 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.662 HG23 ' HA ' ' A' ' 60' ' ' ASN . 18.9 m -127.87 -157.58 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.352 0 CA-C-O 120.646 0.26 . . . . 0.0 111.585 -177.861 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.611 ' O ' ' HB3' ' A' ' 60' ' ' ASN . 5.6 m-20 -56.13 147.81 19.5 Favored 'General case' 0 C--O 1.225 -0.195 0 CA-C-N 115.591 -0.732 . . . . 0.0 110.807 178.17 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . 0.653 ' HB2' ' HB ' ' A' ' 24' ' ' ILE . 69.5 mmtt -96.26 127.15 41.4 Favored Pre-proline 0 C--N 1.317 -0.814 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.409 -170.705 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.609 ' HB2' HD11 ' A' ' 54' ' ' ILE . 20.2 Cg_exo -68.03 109.23 1.89 Allowed 'Trans proline' 0 N--CA 1.461 -0.388 0 C-N-CA 122.952 2.435 . . . . 0.0 111.512 174.314 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.673 HD11 HD22 ' A' ' 53' ' ' LEU . 23.0 tp -109.65 117.41 33.86 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.339 178.38 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.471 ' HB2' ' CG2' ' A' ' 52' ' ' ILE . 92.7 mtt180 -107.09 112.92 26.06 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 120.827 0.346 . . . . 0.0 111.023 175.545 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . 0.533 ' O ' ' HA ' ' A' ' 19' ' ' VAL . 3.9 mp -95.16 110.05 23.39 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 N-CA-C 107.951 -1.129 . . . . 0.0 107.951 172.201 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 28.4 mt -112.32 132.06 62.06 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 116.683 -0.235 . . . . 0.0 111.508 -171.134 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . 0.782 ' HA2' ' H ' ' A' ' 10' ' ' ASN . . . 150.19 -134.92 5.01 Favored Glycine 0 N--CA 1.445 -0.742 0 C-N-CA 120.686 -0.769 . . . . 0.0 113.657 174.021 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . 0.571 ' OD2' ' HB3' ' A' ' 74' ' ' TYR . 0.5 OUTLIER -80.07 139.19 52.96 Favored Pre-proline 0 C--N 1.323 -0.565 0 C-N-CA 123.46 0.704 . . . . 0.0 111.565 -177.283 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . 0.448 ' HG3' ' OG1' ' A' ' 18' ' ' THR . 33.3 Cg_exo -58.55 -18.54 40.22 Favored 'Trans proline' 0 C--N 1.35 0.625 0 C-N-CA 123.583 2.856 . . . . 0.0 113.818 -175.748 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . 0.571 ' HB3' ' OD2' ' A' ' 72' ' ' ASP . 37.8 t80 -86.36 -56.65 3.34 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 120.478 0.18 . . . . 0.0 110.532 -179.406 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.557 ' CE ' ' HB3' ' A' ' 72' ' ' ASP . 26.1 pttt -70.31 -32.58 70.4 Favored 'General case' 0 CA--C 1.519 -0.232 0 N-CA-C 112.075 0.398 . . . . 0.0 112.075 -179.705 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 43.2 t -63.15 -36.24 75.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-O 121.008 0.432 . . . . 0.0 110.192 176.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . 0.411 ' NE2' ' HG3' ' A' ' 81' ' ' GLU . 0.4 OUTLIER -73.07 -44.29 60.77 Favored 'General case' 0 N--CA 1.445 -0.686 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 -178.255 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 48.3 mt-30 -62.46 -45.28 93.78 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.925 0.393 . . . . 0.0 110.531 177.045 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . 0.652 ' HA ' ' HE1' ' A' ' 82' ' ' MET . . . -63.4 -35.62 81.01 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.81 -179.193 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 43.5 t -66.2 -45.67 79.99 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.459 176.117 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . 0.411 ' HG3' ' NE2' ' A' ' 77' ' ' GLN . 38.0 mt-10 -59.48 -42.44 92.08 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.29 0.567 . . . . 0.0 110.051 175.864 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' MET . . . . . 0.652 ' HE1' ' HA ' ' A' ' 79' ' ' ALA . 42.0 ttp -56.72 -49.93 73.7 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 114.772 -1.104 . . . . 0.0 111.574 -179.456 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.856 HG13 ' HE2' ' A' ' 51' ' ' MET . 34.7 m -79.57 -33.41 15.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 C-N-CA 120.871 -0.332 . . . . 0.0 111.131 -176.694 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 57.4 ttp -63.37 -38.57 91.68 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 109.533 -0.543 . . . . 0.0 109.533 175.85 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -61.82 -38.45 88.19 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.328 178.53 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.518 HG13 ' O ' ' A' ' 82' ' ' MET . 45.4 mt -64.13 -31.09 51.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-O 121.376 0.608 . . . . 0.0 110.479 179.657 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.639 HD12 HD11 ' A' ' 24' ' ' ILE . 45.3 mt -88.0 -18.55 28.77 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.542 -179.779 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 33.7 ttt85 -96.69 -4.46 40.8 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.681 0.753 . . . . 0.0 110.629 -176.665 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 20.0 tp10 . . . . . 0 C--N 1.311 -1.083 0 CA-C-O 118.195 -0.907 . . . . 0.0 110.42 -178.728 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.445 -0.756 0 N-CA-C 111.913 -0.475 . . . . 0.0 111.913 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 50.1 mt-30 -51.66 -58.54 6.06 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.202 0.525 . . . . 0.0 110.88 177.79 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . 0.404 ' HD2' ' H ' ' A' ' 9' ' ' ASP . 50.9 p90 -163.78 -176.26 4.52 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.323 -0.853 . . . . 0.0 109.85 -178.555 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 14.2 t60 -162.53 52.62 0.2 Allowed 'General case' 0 C--N 1.317 -0.829 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 174.744 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . 0.404 ' H ' ' HD2' ' A' ' 7' ' ' PHE . 1.7 t70 -45.49 -64.36 0.74 Allowed 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 114.798 -1.092 . . . . 0.0 110.647 179.445 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 9.1 m120 -121.31 -34.86 3.39 Favored 'General case' 0 C--N 1.318 -0.798 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 167.813 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -153.38 -176.74 5.94 Favored 'General case' 0 N--CA 1.451 -0.42 0 CA-C-N 115.084 -0.962 . . . . 0.0 110.607 177.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 56.3 t-20 -168.72 75.64 0.11 Allowed 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 107.921 -1.14 . . . . 0.0 107.921 176.579 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 61.11 -103.62 0.56 Allowed Glycine 0 N--CA 1.448 -0.544 0 N-CA-C 111.342 -0.703 . . . . 0.0 111.342 -174.242 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -140.09 30.28 2.36 Favored Glycine 0 N--CA 1.447 -0.6 0 N-CA-C 110.942 -0.863 . . . . 0.0 110.942 175.657 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 8.3 tt0 -119.89 142.1 48.99 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.061 0.458 . . . . 0.0 110.38 -175.615 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 31.1 p30 -80.16 -174.47 4.53 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.813 -0.631 . . . . 0.0 110.653 179.555 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -150.88 -112.18 0.55 Allowed Glycine 0 N--CA 1.447 -0.596 0 C-N-CA 120.819 -0.705 . . . . 0.0 111.873 -179.081 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' THR . . . . . 0.401 ' OG1' ' HG3' ' A' ' 73' ' ' PRO . 97.8 m -94.89 127.63 41.06 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 121.054 0.454 . . . . 0.0 110.872 -179.46 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.498 ' HA ' ' O ' ' A' ' 69' ' ' ILE . 3.2 p -137.64 125.85 32.11 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-N 115.559 -0.746 . . . . 0.0 110.09 177.512 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 28.0 mt-30 -109.6 123.64 49.78 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.174 178.509 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.68 ' HA ' ' O ' ' A' ' 67' ' ' LEU . 45.6 mt-10 -99.7 120.45 39.73 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.714 179.848 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 5.6 mm -106.79 152.1 8.46 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-N 115.54 -0.755 . . . . 0.0 110.307 -176.915 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' MET . . . . . 0.475 ' HA ' ' HE2' ' A' ' 23' ' ' MET . 14.1 mmt -103.5 91.8 4.2 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 170.929 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.734 HD12 HD11 ' A' ' 87' ' ' LEU . 41.6 mm -79.89 134.71 56.33 Favored Pre-proline 0 C--N 1.319 -0.729 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.649 -175.265 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . 0.401 ' HD2' HD13 ' A' ' 87' ' ' LEU . 83.4 Cg_exo -48.26 127.34 15.24 Favored 'Trans proline' 0 C--N 1.347 0.493 0 C-N-CA 123.068 2.512 . . . . 0.0 111.987 172.6 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -60.35 -34.67 74.18 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.273 -177.032 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -72.36 -32.93 61.9 Favored Glycine 0 N--CA 1.448 -0.542 0 CA-C-N 115.819 -0.628 . . . . 0.0 112.951 -177.452 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 43.6 mtpt -104.18 14.3 30.68 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 122.639 -0.33 . . . . 0.0 111.084 -177.844 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -65.56 -28.9 69.49 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.022 179.04 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -65.46 -30.0 76.52 Favored Glycine 0 N--CA 1.445 -0.714 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.137 179.067 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 91.7 mt -71.34 -39.51 71.29 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.771 0.32 . . . . 0.0 111.125 -178.061 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.731 HG23 HG23 ' A' ' 24' ' ' ILE . 0.0 OUTLIER -71.32 -28.87 33.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.876 -178.315 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 62.0 mt -81.24 -34.21 13.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-O 121.583 0.706 . . . . 0.0 109.756 176.039 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . 0.54 ' HA3' ' HB ' ' A' ' 39' ' ' THR . . . 101.89 26.81 7.34 Favored Glycine 0 CA--C 1.5 -0.849 0 CA-C-N 115.099 -0.955 . . . . 0.0 112.398 178.078 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 33.7 mmtp 73.1 -56.81 0.65 Allowed 'General case' 0 C--N 1.325 -0.498 0 C-N-CA 123.705 0.802 . . . . 0.0 111.659 179.43 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -101.26 -39.22 3.1 Favored Glycine 0 N--CA 1.448 -0.524 0 C-N-CA 120.678 -0.772 . . . . 0.0 111.718 -178.745 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 129.0 7.35 4.13 Favored Glycine 0 N--CA 1.448 -0.562 0 C-N-CA 120.996 -0.621 . . . . 0.0 112.533 178.914 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.45 ' O ' ' HG3' ' A' ' 42' ' ' GLN . 1.3 pm0 -78.2 -35.99 47.88 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 110.057 -0.349 . . . . 0.0 110.057 177.238 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' THR . . . . . 0.65 ' O ' ' HG ' ' A' ' 43' ' ' LEU . 40.5 m -62.72 -50.95 69.07 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.173 -179.594 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.655 HD13 ' HB2' ' A' ' 53' ' ' LEU . 4.3 tt -56.41 -36.17 46.23 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.376 0 CA-C-O 120.788 0.327 . . . . 0.0 111.23 -179.282 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.04 -36.78 80.46 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.197 0.522 . . . . 0.0 109.836 179.472 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . 0.672 ' O ' ' HG2' ' A' ' 46' ' ' ARG . 79.1 mt-30 -72.4 -42.69 64.89 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.866 179.891 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.65 ' HG ' ' O ' ' A' ' 39' ' ' THR . 88.8 mt -52.56 -42.71 64.68 Favored 'General case' 0 C--O 1.235 0.313 0 O-C-N 123.835 0.71 . . . . 0.0 111.741 -176.865 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . 0.44 ' HG3' ' O ' ' A' ' 40' ' ' ILE . 62.4 mt-30 -54.08 -47.82 71.32 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.608 -0.724 . . . . 0.0 110.397 178.951 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 9.6 mm-40 -66.87 -39.13 87.43 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.529 -0.76 . . . . 0.0 110.735 -178.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . 0.672 ' HG2' ' O ' ' A' ' 42' ' ' GLN . 8.9 mmm180 -56.99 -45.46 82.94 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.801 -171.436 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . 0.596 ' HB3' HG22 ' A' ' 49' ' ' VAL . . . -95.26 -20.36 19.26 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.138 -175.912 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 82.25 47.57 6.04 Favored Glycine 0 N--CA 1.444 -0.796 0 C-N-CA 120.23 -0.986 . . . . 0.0 111.565 -173.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.596 HG22 ' HB3' ' A' ' 47' ' ' ALA . 2.9 m -145.54 171.19 5.35 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.456 0 CA-C-O 121.138 0.494 . . . . 0.0 110.653 -177.828 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 6.7 tmtm? -100.41 121.58 41.76 Favored 'General case' 0 C--N 1.318 -0.787 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 176.407 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' MET . . . . . 0.956 ' HE2' ' HB2' ' A' ' 79' ' ' ALA . 57.0 mtt -115.12 126.01 54.14 Favored 'General case' 0 CA--C 1.509 -0.629 0 N-CA-C 109.941 -0.392 . . . . 0.0 109.941 179.34 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.608 ' CG2' ' HB2' ' A' ' 68' ' ' ARG . 9.8 tt -118.2 104.05 15.61 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.939 0 CA-C-O 121.614 0.721 . . . . 0.0 110.275 173.223 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.71 HD12 HD11 ' A' ' 67' ' ' LEU . 4.3 mm? -78.73 101.74 7.71 Favored 'General case' 0 N--CA 1.446 -0.639 0 N-CA-C 107.947 -1.131 . . . . 0.0 107.947 170.381 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.58 HD11 ' HB2' ' A' ' 66' ' ' PRO . 15.8 mt -75.98 92.28 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.764 0 CA-C-O 121.5 0.667 . . . . 0.0 109.52 -175.543 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 1.1 pp0? -126.4 -32.39 2.68 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.345 -0.843 . . . . 0.0 109.885 179.407 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 14.9 p-10 -84.35 -26.63 28.29 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.276 -0.874 . . . . 0.0 109.557 175.795 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -87.33 -7.91 75.57 Favored Glycine 0 N--CA 1.448 -0.507 0 CA-C-N 115.628 -0.715 . . . . 0.0 112.232 177.656 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' SER . . . . . 0.439 ' OG ' HG23 ' A' ' 54' ' ' ILE . 50.4 m -111.84 149.26 32.05 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.418 0.628 . . . . 0.0 112.027 -175.628 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 28.7 mt-30 -112.17 3.12 17.03 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 107.169 -1.419 . . . . 0.0 107.169 163.03 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 7.7 m120 -89.67 15.27 9.86 Favored 'General case' 0 CA--C 1.515 -0.388 0 CA-C-N 113.905 -1.498 . . . . 0.0 108.809 176.422 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' THR . . . . . 0.422 ' HA ' ' CD ' ' A' ' 65' ' ' LYS . 0.2 OUTLIER -67.81 -17.49 64.53 Favored 'General case' 0 C--N 1.314 -0.938 0 CA-C-N 115.328 -0.851 . . . . 0.0 110.904 -177.678 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 16.5 m120 -84.12 -3.67 58.26 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.52 -0.764 . . . . 0.0 110.547 177.501 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 22.4 m -133.65 -154.12 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 115.899 -0.591 . . . . 0.0 109.972 178.938 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -50.84 135.32 24.27 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-O 121.148 0.499 . . . . 0.0 110.918 179.629 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . 0.485 ' HB2' ' HB ' ' A' ' 24' ' ' ILE . 8.4 mmmm -101.6 119.25 57.82 Favored Pre-proline 0 C--N 1.319 -0.758 0 N-CA-C 113.098 0.777 . . . . 0.0 113.098 -172.574 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.58 ' HB2' HD11 ' A' ' 54' ' ' ILE . 23.5 Cg_exo -67.26 125.86 14.13 Favored 'Trans proline' 0 CA--C 1.533 0.462 0 C-N-CA 123.016 2.477 . . . . 0.0 111.895 171.379 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.71 HD11 HD12 ' A' ' 53' ' ' LEU . 31.6 tp -134.02 127.84 33.1 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.02 177.599 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.654 ' HG2' ' HG2' ' A' ' 21' ' ' GLU . 95.6 mtt180 -116.97 111.49 19.67 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.942 0.401 . . . . 0.0 111.151 178.594 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . 0.498 ' O ' ' HA ' ' A' ' 19' ' ' VAL . 4.7 mp -94.54 104.75 16.13 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 171.108 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 14.6 mt -108.97 126.54 65.97 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.58 -174.193 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 165.26 -135.68 3.83 Favored Glycine 0 N--CA 1.442 -0.938 0 C-N-CA 119.962 -1.113 . . . . 0.0 113.033 176.592 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . 0.456 ' HB3' ' HG2' ' A' ' 75' ' ' LYS . 9.8 t70 -92.88 135.45 26.03 Favored Pre-proline 0 C--N 1.319 -0.729 0 CA-C-O 119.242 -0.408 . . . . 0.0 110.982 -176.564 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . 0.401 ' HG3' ' OG1' ' A' ' 18' ' ' THR . 75.0 Cg_exo -39.67 -42.87 3.0 Favored 'Trans proline' 0 C--O 1.237 0.427 0 C-N-CA 123.602 2.868 . . . . 0.0 113.605 -175.513 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . 0.431 ' O ' ' HG3' ' A' ' 78' ' ' GLN . 35.9 t80 -68.88 -53.51 20.81 Favored 'General case' 0 N--CA 1.453 -0.277 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.924 -175.676 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.584 ' HB2' HG13 ' A' ' 49' ' ' VAL . 0.0 OUTLIER -74.44 -24.36 59.05 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 120.268 -0.573 . . . . 0.0 111.87 -178.46 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.433 HG22 ' O ' ' A' ' 72' ' ' ASP . 75.8 t -63.15 -31.76 53.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-O 121.293 0.568 . . . . 0.0 109.69 174.136 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -76.57 -48.61 18.73 Favored 'General case' 0 N--CA 1.447 -0.582 0 N-CA-C 109.146 -0.686 . . . . 0.0 109.146 178.062 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . 0.431 ' HG3' ' O ' ' A' ' 74' ' ' TYR . 50.4 mt-30 -54.97 -43.46 73.53 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-O 121.551 0.691 . . . . 0.0 110.47 176.779 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . 0.956 ' HB2' ' HE2' ' A' ' 51' ' ' MET . . . -64.68 -40.22 95.02 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.162 -0.926 . . . . 0.0 111.203 -178.63 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 42.3 t -65.65 -46.44 79.2 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.427 -179.659 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -70.6 -19.71 62.82 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 120.822 -0.351 . . . . 0.0 110.661 179.42 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' MET . . . . . 0.658 ' HE3' ' HB2' ' A' ' 46' ' ' ARG . 36.1 ttm -71.99 -54.63 9.33 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.831 0.348 . . . . 0.0 110.636 175.484 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.468 HG12 HD13 ' A' ' 43' ' ' LEU . 34.8 m -74.92 -29.93 23.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.803 -175.537 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 1.6 tmt? -70.09 -31.7 69.4 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.924 -0.58 . . . . 0.0 109.643 177.664 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . 0.472 ' O ' ' HB2' ' A' ' 89' ' ' GLU . 32.9 t70 -60.4 -36.88 79.15 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.392 177.661 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 22.5 mt -68.93 -23.17 27.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-O 121.401 0.619 . . . . 0.0 110.601 179.772 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.734 HD11 HD12 ' A' ' 24' ' ' ILE . 70.1 mt -89.4 -30.3 18.45 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.979 -176.918 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 40.7 ptt180 -86.1 -3.61 58.99 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.614 0.721 . . . . 0.0 109.185 174.805 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . 0.472 ' HB2' ' O ' ' A' ' 85' ' ' ASP . 9.5 tp10 . . . . . 0 C--O 1.252 1.2 0 CA-C-N 114.392 -1.277 . . . . 0.0 109.653 -178.724 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.445 -0.73 0 N-CA-C 112.261 -0.336 . . . . 0.0 112.261 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . 0.513 ' O ' ' HG2' ' A' ' 73' ' ' PRO . 5.8 mm-40 -67.04 -56.85 8.34 Favored 'General case' 0 CA--C 1.514 -0.423 0 N-CA-C 108.084 -1.08 . . . . 0.0 108.084 177.606 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . 0.668 ' HB3' ' HD2' ' A' ' 73' ' ' PRO . 0.7 OUTLIER -148.62 154.32 39.55 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.034 -0.985 . . . . 0.0 110.024 172.775 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . 0.7 ' HB3' ' HA ' ' A' ' 12' ' ' ASN . 6.7 t-80 -175.83 16.82 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.465 0 O-C-N 123.437 0.46 . . . . 0.0 110.403 -179.741 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 37.8 t70 64.37 -96.16 0.05 OUTLIER 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 115.695 -0.684 . . . . 0.0 112.457 175.145 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 3.7 t-20 -75.03 -50.68 15.72 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.025 0.441 . . . . 0.0 110.616 -174.44 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -104.4 55.29 0.72 Allowed 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 116.099 -0.501 . . . . 0.0 109.988 176.864 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . 0.7 ' HA ' ' HB3' ' A' ' 8' ' ' HIS . 16.4 p-10 -69.25 -42.66 75.32 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.722 178.934 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 74.27 -78.36 0.97 Allowed Glycine 0 CA--C 1.519 0.298 0 CA-C-N 116.034 -0.53 . . . . 0.0 114.404 169.402 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -57.59 -77.98 0.14 Allowed Glycine 0 C--N 1.332 0.344 0 O-C-N 123.753 0.325 . . . . 0.0 112.914 -173.044 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 7.4 tt0 -88.44 107.38 18.83 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 107.858 -1.164 . . . . 0.0 107.858 173.18 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . 0.427 ' HA ' ' ND2' ' A' ' 12' ' ' ASN . 27.3 t-20 -89.72 -38.2 14.01 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.897 -167.399 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -134.44 84.18 0.28 Allowed Glycine 0 N--CA 1.443 -0.866 0 C-N-CA 120.484 -0.865 . . . . 0.0 112.53 -177.468 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' THR . . . . . 0.595 ' O ' ' HA ' ' A' ' 70' ' ' ILE . 37.5 m -75.6 126.79 31.71 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 175.618 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.504 ' HA ' ' O ' ' A' ' 69' ' ' ILE . 6.4 p -129.31 123.03 57.22 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-O 121.323 0.582 . . . . 0.0 111.339 -179.091 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 26.9 mt-30 -117.06 115.05 24.64 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.673 -0.694 . . . . 0.0 109.333 175.136 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.542 ' HA ' ' O ' ' A' ' 67' ' ' LEU . 42.2 mt-10 -88.73 115.86 26.57 Favored 'General case' 0 CA--C 1.516 -0.35 0 CA-C-O 121.178 0.513 . . . . 0.0 111.372 -178.423 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.486 HD12 ' HG ' ' A' ' 80' ' ' CYS . 11.2 mm -98.72 152.9 4.22 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-N 115.426 -0.807 . . . . 0.0 109.686 179.482 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' MET . . . . . 0.421 ' HA ' ' HE2' ' A' ' 23' ' ' MET . 1.8 mmt -106.39 91.27 3.63 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 174.747 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.678 ' HB ' ' HB2' ' A' ' 65' ' ' LYS . 29.7 mm -75.35 125.88 88.37 Favored Pre-proline 0 C--N 1.317 -0.805 0 CA-C-N 115.806 -0.634 . . . . 0.0 111.215 -173.869 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . 0.569 ' HB2' ' HB2' ' A' ' 28' ' ' LYS . 85.4 Cg_exo -48.09 129.32 18.31 Favored 'Trans proline' 0 C--N 1.346 0.4 0 C-N-CA 123.165 2.577 . . . . 0.0 111.858 177.417 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -58.88 -24.34 62.12 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.838 -0.619 . . . . 0.0 112.579 -173.023 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -95.95 -1.83 61.3 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.622 -0.799 . . . . 0.0 112.804 -179.632 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.569 ' HB2' ' HB2' ' A' ' 25' ' ' PRO . 2.0 mppt? -116.05 19.71 14.84 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.019 0.438 . . . . 0.0 111.441 -179.448 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -76.15 -20.39 57.62 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.102 -178.633 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -69.11 -17.72 72.21 Favored Glycine 0 N--CA 1.449 -0.484 0 C-N-CA 120.994 -0.622 . . . . 0.0 112.697 -178.86 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 86.8 mt -93.96 -38.83 10.98 Favored 'General case' 0 C--N 1.323 -0.573 0 O-C-N 122.515 -0.403 . . . . 0.0 111.571 -177.958 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.417 HG21 HG23 ' A' ' 24' ' ' ILE . 3.5 m -69.98 -34.09 58.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.899 0.38 . . . . 0.0 111.131 179.327 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.595 HD11 ' HG2' ' A' ' 55' ' ' GLN . 64.9 mt -83.99 -44.76 18.23 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-O 121.506 0.67 . . . . 0.0 109.902 177.026 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 118.88 -178.84 16.75 Favored Glycine 0 N--CA 1.441 -1.012 0 CA-C-N 115.291 -0.868 . . . . 0.0 111.359 -178.158 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 39.0 mmtm -77.76 -29.51 51.01 Favored 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 -178.357 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -143.01 17.09 2.36 Favored Glycine 0 N--CA 1.444 -0.79 0 CA-C-N 115.18 -0.918 . . . . 0.0 111.476 176.032 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 95.73 0.79 62.19 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.991 -0.623 . . . . 0.0 112.947 178.899 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -69.08 -34.9 75.87 Favored 'General case' 0 C--N 1.328 -0.367 0 O-C-N 122.598 -0.354 . . . . 0.0 110.841 -178.956 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' THR . . . . . 0.71 ' O ' ' HG ' ' A' ' 43' ' ' LEU . 61.8 m -62.71 -55.47 26.43 Favored 'General case' 0 N--CA 1.452 -0.374 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.913 -177.639 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.44 ' HA ' HD11 ' A' ' 43' ' ' LEU . 7.5 tt -60.02 -34.21 55.73 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.383 0 CA-C-O 120.782 0.325 . . . . 0.0 111.628 -176.665 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 3.9 tmmm? -70.79 -39.4 73.18 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 179.394 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . 0.467 ' O ' ' HG2' ' A' ' 46' ' ' ARG . 20.4 mm-40 -71.75 -37.79 70.5 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.991 -0.549 . . . . 0.0 111.187 -179.225 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.71 ' HG ' ' O ' ' A' ' 39' ' ' THR . 88.8 mt -53.44 -44.88 69.2 Favored 'General case' 0 CA--C 1.519 -0.238 0 CA-C-O 121.204 0.526 . . . . 0.0 110.992 179.428 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 47.1 mt-30 -68.14 -34.27 76.02 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.644 -0.707 . . . . 0.0 111.367 -177.435 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 32.2 mt-10 -80.48 -25.52 38.78 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 111.557 0.206 . . . . 0.0 111.557 -178.458 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . 0.467 ' HG2' ' O ' ' A' ' 42' ' ' GLN . 12.8 ptm180 -89.32 -30.2 18.6 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.688 0.28 . . . . 0.0 111.69 -178.705 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -88.63 -30.75 18.97 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 120.975 0.417 . . . . 0.0 110.905 178.528 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 91.79 -3.26 77.71 Favored Glycine 0 CA--C 1.519 0.339 0 C-N-CA 120.641 -0.79 . . . . 0.0 112.662 -179.219 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.453 ' CG1' ' HG3' ' A' ' 75' ' ' LYS . 16.1 m -103.54 179.22 0.71 Allowed 'Isoleucine or valine' 0 CA--C 1.516 -0.36 0 CA-C-O 121.063 0.459 . . . . 0.0 110.907 179.123 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.667 ' HE3' ' HB ' ' A' ' 52' ' ' ILE . 8.7 tmtm? -109.89 125.05 52.4 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 115.666 -0.697 . . . . 0.0 109.171 177.158 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' MET . . . . . 0.724 ' HE2' HG12 ' A' ' 83' ' ' VAL . 54.7 mtp -119.2 125.36 48.98 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 109.449 -0.574 . . . . 0.0 109.449 179.31 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.667 ' HB ' ' HE3' ' A' ' 50' ' ' LYS . 9.0 tt -115.67 107.69 23.33 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.805 0 CA-C-O 121.523 0.677 . . . . 0.0 110.832 177.823 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.579 HD22 HD13 ' A' ' 67' ' ' LEU . 3.4 mm? -80.95 102.78 10.35 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.206 -0.906 . . . . 0.0 108.574 170.192 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.591 HD13 ' HB2' ' A' ' 66' ' ' PRO . 59.0 mt -78.23 85.68 1.02 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.467 0 CA-C-O 121.868 0.842 . . . . 0.0 110.423 -177.301 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . 0.595 ' HG2' HD11 ' A' ' 33' ' ' ILE . 1.7 pp0? -120.17 -12.93 9.0 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 114.573 -1.194 . . . . 0.0 109.579 175.062 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -82.02 -36.45 27.77 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.131 -0.94 . . . . 0.0 108.955 174.036 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -77.09 113.11 3.68 Favored Glycine 0 N--CA 1.446 -0.658 0 N-CA-C 110.769 -0.932 . . . . 0.0 110.769 173.828 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 28.5 p -86.49 70.81 10.48 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 121.055 0.455 . . . . 0.0 112.03 -173.902 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 1.4 mp0 -121.26 -45.45 2.34 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.946 0.403 . . . . 0.0 110.226 174.408 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . 0.463 ' HB2' ' HD3' ' A' ' 66' ' ' PRO . 9.1 m120 -117.64 28.42 8.45 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 121.242 0.544 . . . . 0.0 109.724 177.838 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 5.2 p -75.43 -25.35 57.44 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.114 -0.494 . . . . 0.0 112.108 -176.212 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 66.8 t30 -89.59 -0.97 57.87 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.357 0.599 . . . . 0.0 110.314 179.758 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.401 ' HB ' ' H ' ' A' ' 64' ' ' ASP . 15.5 m -132.1 -153.11 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.131 -178.858 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.401 ' H ' ' HB ' ' A' ' 63' ' ' VAL . 6.6 m-20 -63.37 143.17 58.04 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 109.879 -0.415 . . . . 0.0 109.879 176.616 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . 0.678 ' HB2' ' HB ' ' A' ' 24' ' ' ILE . 27.6 mmtp -91.83 129.19 43.07 Favored Pre-proline 0 C--N 1.324 -0.538 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.44 -169.833 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.591 ' HB2' HD13 ' A' ' 54' ' ' ILE . 23.4 Cg_exo -66.98 111.76 2.3 Favored 'Trans proline' 0 N--CA 1.463 -0.286 0 C-N-CA 123.292 2.661 . . . . 0.0 111.816 176.165 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.579 HD13 HD22 ' A' ' 53' ' ' LEU . 23.0 tp -114.52 114.57 25.95 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.389 178.169 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.625 ' HB2' ' CG2' ' A' ' 52' ' ' ILE . 99.6 mtt180 -104.34 110.52 22.79 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.657 176.682 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . 0.504 ' O ' ' HA ' ' A' ' 19' ' ' VAL . 4.2 mp -93.92 108.33 20.45 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 N-CA-C 107.857 -1.164 . . . . 0.0 107.857 170.608 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.595 ' HA ' ' O ' ' A' ' 18' ' ' THR . 22.8 mt -116.69 133.89 61.92 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.606 -171.199 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 150.68 -108.65 0.39 Allowed Glycine 0 N--CA 1.448 -0.559 0 C-N-CA 120.811 -0.709 . . . . 0.0 113.112 172.579 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . 0.461 ' O ' HG23 ' A' ' 76' ' ' VAL . 14.1 t70 -103.79 132.08 21.38 Favored Pre-proline 0 C--N 1.318 -0.786 0 C-N-CA 123.19 0.596 . . . . 0.0 110.045 -174.916 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . 0.668 ' HD2' ' HB3' ' A' ' 7' ' ' PHE . 44.7 Cg_exo -54.82 -25.93 45.46 Favored 'Trans proline' 0 C--N 1.347 0.479 0 C-N-CA 123.541 2.827 . . . . 0.0 113.431 -173.498 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 53.5 t80 -76.19 -53.47 8.22 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.464 -177.228 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.506 ' HA ' ' HB2' ' A' ' 78' ' ' GLN . 5.8 ptpt -83.37 -17.57 41.84 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.866 -0.606 . . . . 0.0 111.992 -177.591 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.461 HG23 ' O ' ' A' ' 72' ' ' ASP . 45.2 t -63.15 -38.02 80.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 N-CA-C 109.552 -0.536 . . . . 0.0 109.552 170.863 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 1.4 mm100 -77.66 -41.13 39.29 Favored 'General case' 0 N--CA 1.451 -0.397 0 C-N-CA 120.807 -0.357 . . . . 0.0 110.608 177.373 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . 0.506 ' HB2' ' HA ' ' A' ' 75' ' ' LYS . 96.4 mt-30 -55.73 -47.12 77.44 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.831 0.348 . . . . 0.0 110.532 175.046 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . 0.888 ' HA ' ' HE3' ' A' ' 82' ' ' MET . . . -66.57 -38.87 88.0 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.122 179.629 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' CYS . . . . . 0.486 ' HG ' HD12 ' A' ' 22' ' ' ILE . 49.9 t -62.33 -52.14 64.82 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.406 177.89 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -63.75 -30.99 72.02 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.338 178.356 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' MET . . . . . 0.888 ' HE3' ' HA ' ' A' ' 79' ' ' ALA . 40.1 ttp -65.08 -52.17 57.13 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.602 -0.726 . . . . 0.0 111.198 178.482 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.724 HG12 ' HE2' ' A' ' 51' ' ' MET . 30.7 m -76.18 -35.54 28.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 N-CA-C 111.74 0.274 . . . . 0.0 111.74 -177.06 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 93.9 mmm -67.85 -28.63 67.71 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.871 0.367 . . . . 0.0 110.012 177.113 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -64.87 -38.43 90.95 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.682 176.674 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.456 HG13 ' O ' ' A' ' 82' ' ' MET . 35.3 mt -64.0 -26.69 41.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.339 179.007 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.544 HD23 ' HB3' ' A' ' 28' ' ' LYS . 22.4 mt -97.64 -10.48 24.99 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.771 -177.859 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 28.0 tpt180 -99.37 -25.38 14.49 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.435 0.636 . . . . 0.0 111.09 -175.721 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 . . . . . 0 C--N 1.305 -1.327 0 CA-C-N 115.359 -0.837 . . . . 0.0 109.867 -178.048 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.444 -0.802 0 N-CA-C 111.948 -0.461 . . . . 0.0 111.948 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 81.1 mm-40 -96.57 -9.87 28.47 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 174.285 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . 0.4 ' HA ' ' CB ' ' A' ' 72' ' ' ASP . 5.0 p90 -175.99 176.49 1.77 Allowed 'General case' 0 N--CA 1.455 -0.22 0 CA-C-N 114.407 -1.269 . . . . 0.0 110.23 -179.535 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 12.0 t-80 -130.63 156.71 44.42 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.185 -0.461 . . . . 0.0 109.811 179.025 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . 0.582 ' HB2' ' HB2' ' A' ' 12' ' ' ASN . 4.5 m-20 64.42 33.94 10.77 Favored 'General case' 0 N--CA 1.466 0.357 0 O-C-N 123.577 0.548 . . . . 0.0 111.578 175.805 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 20.2 m120 68.87 -62.18 0.4 Allowed 'General case' 0 N--CA 1.469 0.481 0 O-C-N 123.758 0.661 . . . . 0.0 111.752 179.217 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -148.98 81.04 1.43 Allowed 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 109.759 -0.46 . . . . 0.0 109.759 179.115 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . 0.657 ' ND2' ' HA ' ' A' ' 16' ' ' ASN . 58.1 t30 -115.15 124.19 50.85 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.547 -178.023 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -97.61 135.75 12.37 Favored Glycine 0 N--CA 1.446 -0.634 0 C-N-CA 120.951 -0.642 . . . . 0.0 112.28 -178.523 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 83.54 -122.55 5.83 Favored Glycine 0 N--CA 1.446 -0.685 0 C-N-CA 120.637 -0.792 . . . . 0.0 112.085 -179.281 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . 0.515 ' HG3' HG23 ' A' ' 70' ' ' ILE . 49.8 tt0 -68.92 107.58 3.15 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 120.73 0.3 . . . . 0.0 111.091 -178.783 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . 0.657 ' HA ' ' ND2' ' A' ' 12' ' ' ASN . 0.9 OUTLIER -97.63 -59.37 1.79 Allowed 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.104 176.864 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 176.32 -41.78 0.11 Allowed Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.17 178.144 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' THR . . . . . 0.438 HG23 ' HA ' ' A' ' 73' ' ' PRO . 91.3 m -71.04 131.63 43.92 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 120.705 0.288 . . . . 0.0 110.45 177.396 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 7.6 p -140.23 138.35 37.13 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-O 120.928 0.394 . . . . 0.0 110.891 -178.786 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 28.7 mt-30 -119.16 114.61 22.72 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 109.739 -0.467 . . . . 0.0 109.739 174.213 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.699 ' HA ' ' O ' ' A' ' 67' ' ' LEU . 39.4 mt-10 -86.43 113.85 22.72 Favored 'General case' 0 CA--C 1.515 -0.392 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.864 179.079 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.448 ' HB ' ' HB3' ' A' ' 67' ' ' LEU . 14.7 mm -97.68 147.88 6.2 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 CA-C-N 115.257 -0.883 . . . . 0.0 110.227 -177.5 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' MET . . . . . 0.505 ' HB3' ' HB3' ' A' ' 64' ' ' ASP . 3.9 mmt -99.61 91.57 4.95 Favored 'General case' 0 C--N 1.317 -0.822 0 N-CA-C 108.531 -0.915 . . . . 0.0 108.531 173.322 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.649 ' HB ' ' HB2' ' A' ' 65' ' ' LYS . 36.8 mm -82.16 130.39 60.13 Favored Pre-proline 0 C--N 1.319 -0.722 0 CA-C-N 115.772 -0.649 . . . . 0.0 111.046 -174.396 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_exo -50.89 132.07 36.29 Favored 'Trans proline' 0 N--CA 1.46 -0.445 0 C-N-CA 122.885 2.39 . . . . 0.0 111.787 175.222 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -65.46 -18.89 65.67 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.263 -176.958 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -93.55 9.69 73.65 Favored Glycine 0 N--CA 1.445 -0.709 0 C-N-CA 120.97 -0.633 . . . . 0.0 112.325 177.294 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.502 ' HB3' HD23 ' A' ' 87' ' ' LEU . 58.8 mttp -132.38 26.68 4.46 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.861 0.362 . . . . 0.0 111.409 179.947 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -74.77 -23.5 58.54 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.232 0.539 . . . . 0.0 110.239 178.922 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -71.16 -16.36 75.08 Favored Glycine 0 N--CA 1.449 -0.443 0 CA-C-N 115.543 -0.753 . . . . 0.0 112.522 179.565 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 79.5 mt -93.65 -39.92 10.54 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 122.471 -0.429 . . . . 0.0 111.183 -179.299 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.559 HG11 HD22 ' A' ' 87' ' ' LEU . 2.8 m -76.4 -33.03 22.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-O 120.951 0.405 . . . . 0.0 111.533 -179.914 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.642 ' HA ' ' HB ' ' A' ' 40' ' ' ILE . 67.5 mt -93.68 -40.14 11.42 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-O 121.527 0.679 . . . . 0.0 110.18 179.079 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 119.49 160.65 11.37 Favored Glycine 0 N--CA 1.441 -1.025 0 CA-C-N 115.527 -0.76 . . . . 0.0 111.714 -179.634 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -65.47 -23.1 66.83 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.971 0.415 . . . . 0.0 110.504 -179.446 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -134.11 8.33 4.77 Favored Glycine 0 N--CA 1.446 -0.665 0 C-N-CA 120.741 -0.742 . . . . 0.0 111.896 177.244 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.545 ' HA2' HG23 ' A' ' 33' ' ' ILE . . . 87.39 12.14 67.87 Favored Glycine 0 N--CA 1.452 -0.245 0 C-N-CA 120.942 -0.646 . . . . 0.0 112.15 -177.196 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 13.7 mt-10 -84.64 -37.64 20.81 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.101 0.476 . . . . 0.0 110.6 -178.178 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' THR . . . . . 0.68 ' O ' ' HG ' ' A' ' 43' ' ' LEU . 21.2 m -59.84 -47.88 83.96 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.532 -0.758 . . . . 0.0 111.752 -173.41 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.642 ' HB ' ' HA ' ' A' ' 33' ' ' ILE . 9.3 tt -57.68 -34.82 48.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 120.929 0.395 . . . . 0.0 111.334 -178.565 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . 0.484 ' HG3' ' OE2' ' A' ' 45' ' ' GLU . 0.0 OUTLIER -70.77 -36.76 73.21 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.103 0.478 . . . . 0.0 109.972 179.189 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 25.4 mm-40 -71.07 -39.01 72.44 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.572 -178.915 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.68 ' HG ' ' O ' ' A' ' 39' ' ' THR . 54.7 mt -57.07 -47.38 81.12 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.715 179.889 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . 0.405 ' HG3' ' O ' ' A' ' 40' ' ' ILE . 45.2 mt-30 -62.27 -50.65 70.86 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.691 -179.981 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.484 ' OE2' ' HG3' ' A' ' 41' ' ' LYS . 46.1 mt-10 -63.62 -39.56 94.69 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.722 -0.672 . . . . 0.0 112.024 -176.594 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 13.9 ptm180 -77.68 -33.38 53.28 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 111.937 0.347 . . . . 0.0 111.937 -173.847 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -93.75 -12.26 29.56 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 120.985 0.422 . . . . 0.0 111.461 -177.2 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 73.13 35.51 57.29 Favored Glycine 0 N--CA 1.451 -0.323 0 N-CA-C 111.189 -0.764 . . . . 0.0 111.189 -177.482 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 29.5 m -124.45 175.6 6.74 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-O 120.964 0.411 . . . . 0.0 110.741 -173.811 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 78.3 tttt -115.65 123.7 49.04 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 169.414 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' MET . . . . . 0.891 ' HE1' HG13 ' A' ' 83' ' ' VAL . 71.8 mtp -123.6 114.68 20.33 Favored 'General case' 0 C--N 1.317 -0.82 0 N-CA-C 109.082 -0.71 . . . . 0.0 109.082 177.721 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.6 HG23 ' HB2' ' A' ' 68' ' ' ARG . 10.8 tt -109.97 105.51 18.94 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.143 0 CA-C-O 121.662 0.744 . . . . 0.0 109.595 177.362 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -82.53 102.26 11.26 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.169 -0.923 . . . . 0.0 108.625 174.716 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.494 ' HB ' ' HB2' ' A' ' 66' ' ' PRO . 20.3 mt -82.28 85.71 1.75 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.767 0 CA-C-O 121.669 0.747 . . . . 0.0 109.188 -175.939 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 4.1 pp0? -110.09 -4.63 15.71 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.171 -0.922 . . . . 0.0 110.994 -175.141 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -134.09 -28.5 1.34 Allowed 'General case' 0 C--N 1.32 -0.7 0 CA-C-O 120.946 0.403 . . . . 0.0 110.585 179.311 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -90.44 29.39 6.71 Favored Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 120.588 -0.815 . . . . 0.0 112.967 -177.125 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 42.5 t -152.1 165.32 35.13 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.058 0.456 . . . . 0.0 110.012 -179.207 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 15.1 mm100 -103.28 11.95 36.15 Favored 'General case' 0 N--CA 1.444 -0.754 0 CA-C-N 115.502 -0.772 . . . . 0.0 109.032 -179.443 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . 0.424 ' HA ' HG23 ' A' ' 63' ' ' VAL . 18.0 m120 -100.16 13.1 35.33 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 114.902 -1.045 . . . . 0.0 109.104 170.622 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' THR . . . . . 0.495 ' HA ' ' HE3' ' A' ' 65' ' ' LYS . 9.1 t -64.42 -23.16 67.19 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.392 179.17 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 4.9 p-10 -93.5 -1.69 55.31 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.691 -0.686 . . . . 0.0 111.05 -179.161 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.424 HG23 ' HA ' ' A' ' 60' ' ' ASN . 7.9 m -132.61 -145.53 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 N-CA-C 109.673 -0.491 . . . . 0.0 109.673 -179.661 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.505 ' HB3' ' HB3' ' A' ' 23' ' ' MET . 8.4 m-20 -59.69 137.63 57.98 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 109.722 -0.473 . . . . 0.0 109.722 175.067 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . 0.649 ' HB2' ' HB ' ' A' ' 24' ' ' ILE . 1.2 mmmm -93.89 122.26 62.49 Favored Pre-proline 0 C--N 1.318 -0.769 0 CA-C-N 115.971 -0.558 . . . . 0.0 111.255 -170.645 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.494 ' HB2' ' HB ' ' A' ' 54' ' ' ILE . 39.3 Cg_exo -63.22 105.95 0.52 Allowed 'Trans proline' 0 N--CA 1.464 -0.21 0 C-N-CA 123.291 2.661 . . . . 0.0 112.225 177.476 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.699 ' O ' ' HA ' ' A' ' 21' ' ' GLU . 3.7 tt -101.42 135.69 42.49 Favored 'General case' 0 C--N 1.319 -0.735 0 N-CA-C 108.481 -0.933 . . . . 0.0 108.481 177.7 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.698 ' N ' HD21 ' A' ' 67' ' ' LEU . 90.9 mtt180 -124.61 107.09 10.66 Favored 'General case' 0 N--CA 1.443 -0.82 0 C-N-CA 119.255 -0.978 . . . . 0.0 112.633 170.123 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . 0.54 ' CD1' HD23 ' A' ' 67' ' ' LEU . 3.8 mp -90.08 106.14 16.92 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.264 0 N-CA-C 107.943 -1.132 . . . . 0.0 107.943 167.72 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.515 HG23 ' HG3' ' A' ' 15' ' ' GLN . 7.4 mt -109.35 127.81 65.81 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.873 0 CA-C-O 120.946 0.403 . . . . 0.0 110.394 -176.141 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . 0.615 ' HA2' ' H ' ' A' ' 16' ' ' ASN . . . 173.64 -132.47 2.31 Favored Glycine 0 N--CA 1.441 -1.026 0 N-CA-C 111.044 -0.822 . . . . 0.0 111.044 179.496 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . 0.809 ' HB3' ' HE2' ' A' ' 75' ' ' LYS . 0.0 OUTLIER -103.55 153.49 38.56 Favored Pre-proline 0 C--N 1.318 -0.799 0 CA-C-O 118.992 -0.528 . . . . 0.0 109.594 176.71 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . 0.438 ' HA ' HG23 ' A' ' 18' ' ' THR . 71.5 Cg_exo -47.1 -39.21 25.76 Favored 'Trans proline' 0 C--N 1.347 0.451 0 C-N-CA 122.273 1.982 . . . . 0.0 112.268 -178.026 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . 0.401 ' HB3' ' OD1' ' A' ' 72' ' ' ASP . 22.6 t80 -67.39 -58.9 3.93 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.089 -0.96 . . . . 0.0 111.504 -177.576 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.809 ' HE2' ' HB3' ' A' ' 72' ' ' ASP . 0.0 OUTLIER -67.54 -33.86 75.92 Favored 'General case' 0 CA--C 1.514 -0.418 0 C-N-CA 120.98 -0.288 . . . . 0.0 111.185 -178.773 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.404 HG12 ' HB ' ' A' ' 69' ' ' ILE . 55.0 t -64.39 -39.72 86.55 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.377 0 N-CA-C 109.647 -0.501 . . . . 0.0 109.647 -178.418 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . 0.642 HE21 ' HG3' ' A' ' 81' ' ' GLU . 17.8 tp60 -76.88 -41.89 42.04 Favored 'General case' 0 N--CA 1.443 -0.807 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.674 -177.739 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 23.8 mt-30 -63.93 -38.56 91.54 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 120.709 -0.396 . . . . 0.0 110.558 177.768 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . 0.515 ' HA ' ' HE1' ' A' ' 82' ' ' MET . . . -69.7 -37.16 76.5 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.534 178.766 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' CYS . . . . . 0.428 ' O ' ' HB2' ' A' ' 84' ' ' MET . 50.6 t -65.52 -46.58 79.05 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.549 176.626 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . 0.642 ' HG3' HE21 ' A' ' 77' ' ' GLN . 73.0 mt-10 -62.93 -21.87 66.36 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 121.047 0.451 . . . . 0.0 110.691 177.852 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' MET . . . . . 0.515 ' HE1' ' HA ' ' A' ' 79' ' ' ALA . 38.5 ttp -77.46 -52.33 9.29 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.25 179.68 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.891 HG13 ' HE1' ' A' ' 51' ' ' MET . 32.9 m -73.52 -35.34 44.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.562 -177.853 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' MET . . . . . 0.428 ' HB2' ' O ' ' A' ' 80' ' ' CYS . 2.7 mmt -66.94 -34.12 77.08 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.682 0.277 . . . . 0.0 111.2 179.293 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . 0.468 ' O ' ' HB2' ' A' ' 89' ' ' GLU . 27.9 t70 -67.67 -31.5 71.53 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 120.836 -0.345 . . . . 0.0 110.154 -179.163 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.422 HG13 ' O ' ' A' ' 82' ' ' MET . 53.0 mt -67.44 -40.4 84.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 121.185 0.517 . . . . 0.0 109.974 176.476 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.559 HD22 HG11 ' A' ' 32' ' ' VAL . 49.1 mt -70.28 -42.02 72.63 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.699 -179.326 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . 0.44 HH11 ' HD3' ' A' ' 88' ' ' ARG . 9.5 mmm180 -85.45 7.52 22.45 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.969 -0.559 . . . . 0.0 111.201 -176.936 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . 0.468 ' HB2' ' O ' ' A' ' 85' ' ' ASP . 40.1 tt0 . . . . . 0 C--O 1.25 1.082 0 CA-C-O 118.222 -0.894 . . . . 0.0 109.663 178.346 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.443 -0.871 0 N-CA-C 111.622 -0.591 . . . . 0.0 111.622 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 21.3 mp0 52.51 67.44 0.98 Allowed 'General case' 0 N--CA 1.462 0.173 0 CA-C-O 120.991 0.424 . . . . 0.0 111.222 179.161 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 18.6 p90 -80.45 55.14 2.2 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.656 -177.581 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . 0.936 ' HB3' ' HA ' ' A' ' 12' ' ' ASN . 8.7 t-160 71.25 115.76 0.05 OUTLIER 'General case' 0 N--CA 1.466 0.352 0 CA-C-O 121.977 0.894 . . . . 0.0 110.751 179.131 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -51.02 -46.9 61.73 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 114.171 -1.377 . . . . 0.0 112.972 -174.318 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 58.2 t30 -105.86 121.49 44.17 Favored 'General case' 0 C--N 1.323 -0.574 0 C-N-CA 120.89 -0.324 . . . . 0.0 110.275 178.8 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.483 ' O ' ' HB3' ' A' ' 12' ' ' ASN . . . 60.32 -95.39 0.05 Allowed 'General case' 0 C--O 1.23 0.065 0 O-C-N 124.053 0.846 . . . . 0.0 110.874 -177.606 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . 0.936 ' HA ' ' HB3' ' A' ' 8' ' ' HIS . 9.4 p30 164.86 -34.1 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.215 0 O-C-N 124.158 0.911 . . . . 0.0 109.324 175.365 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -29.29 119.05 0.07 OUTLIER Glycine 0 C--N 1.34 0.804 0 O-C-N 124.559 1.162 . . . . 0.0 115.396 -173.947 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 94.52 -132.15 11.03 Favored Glycine 0 N--CA 1.448 -0.551 0 C-N-CA 121.283 -0.484 . . . . 0.0 112.041 178.878 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 25.6 tt0 -65.6 108.25 1.98 Allowed 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 110.008 -0.367 . . . . 0.0 110.008 177.742 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . 0.679 ' HA ' ' HB2' ' A' ' 8' ' ' HIS . 13.4 m120 -79.69 -79.51 0.14 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.145 179.892 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 175.77 -56.33 0.11 Allowed Glycine 0 C--N 1.331 0.255 0 C-N-CA 119.718 -1.229 . . . . 0.0 113.839 178.416 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' THR . . . . . 0.56 ' OG1' ' HD3' ' A' ' 73' ' ' PRO . 90.5 m -59.85 131.58 51.31 Favored 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 122.689 0.396 . . . . 0.0 111.111 -177.888 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.482 ' HA ' ' O ' ' A' ' 69' ' ' ILE . 4.7 p -140.74 126.52 20.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-O 121.249 0.547 . . . . 0.0 111.931 -176.833 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 26.5 mt-30 -111.45 128.78 56.1 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.037 173.465 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.505 ' HG2' ' HG2' ' A' ' 68' ' ' ARG . 45.6 mt-10 -96.71 115.37 27.32 Favored 'General case' 0 C--N 1.327 -0.41 0 O-C-N 123.401 0.438 . . . . 0.0 111.263 178.866 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 14.4 mm -100.77 150.29 5.76 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 177.412 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' MET . . . . . 0.473 ' HA ' ' HE2' ' A' ' 23' ' ' MET . 16.5 mmt -103.44 92.01 4.3 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 175.988 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.645 ' HB ' ' HB2' ' A' ' 65' ' ' LYS . 47.1 mm -81.5 128.2 70.56 Favored Pre-proline 0 C--N 1.318 -0.77 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.853 -175.625 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 81.6 Cg_exo -47.77 131.72 20.64 Favored 'Trans proline' 0 C--N 1.345 0.346 0 C-N-CA 123.21 2.607 . . . . 0.0 112.214 176.828 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -59.68 -26.71 65.78 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.855 -0.611 . . . . 0.0 111.342 -178.413 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -75.36 -31.03 57.68 Favored Glycine 0 N--CA 1.449 -0.484 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.371 177.499 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.942 ' HD3' ' HG ' ' A' ' 87' ' ' LEU . 94.6 mttt -98.22 19.18 14.66 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.786 0.327 . . . . 0.0 111.494 -178.192 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . 0.616 ' O ' HG13 ' A' ' 33' ' ' ILE . . . -64.6 -34.07 77.41 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.798 179.288 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -68.64 -25.39 75.05 Favored Glycine 0 N--CA 1.448 -0.531 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.053 179.693 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 88.1 mt -74.03 -42.59 60.05 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.657 0.265 . . . . 0.0 110.634 -178.823 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.492 HG22 HG21 ' A' ' 24' ' ' ILE . 0.0 OUTLIER -72.84 -23.39 20.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.421 179.687 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.616 HG13 ' O ' ' A' ' 29' ' ' ALA . 67.2 mt -76.6 -35.19 25.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-O 121.74 0.781 . . . . 0.0 109.576 172.545 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . 0.677 ' HA3' ' HB ' ' A' ' 39' ' ' THR . . . 98.81 32.34 5.96 Favored Glycine 0 CA--C 1.5 -0.877 0 CA-C-N 114.962 -1.017 . . . . 0.0 112.396 177.911 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 14.5 mmmm 69.7 -64.51 0.34 Allowed 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.398 0.705 . . . . 0.0 111.68 177.633 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -89.58 -30.35 13.79 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 121.072 -0.585 . . . . 0.0 112.161 -177.815 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.512 ' HA2' HG23 ' A' ' 33' ' ' ILE . . . 109.92 -2.61 30.2 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.602 -0.808 . . . . 0.0 112.428 178.878 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -85.75 -27.54 25.16 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-O 120.993 0.425 . . . . 0.0 111.054 178.148 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' THR . . . . . 0.677 ' HB ' ' HA3' ' A' ' 34' ' ' GLY . 17.0 m -67.07 -41.31 86.62 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.393 -177.394 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.468 ' CD1' HD22 ' A' ' 53' ' ' LEU . 8.6 tt -58.36 -33.19 46.96 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.319 0 CA-C-O 120.986 0.422 . . . . 0.0 110.765 178.697 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . 0.4 ' O ' ' HG3' ' A' ' 45' ' ' GLU . 31.3 ttpt -69.89 -43.1 72.46 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.144 0.497 . . . . 0.0 109.952 174.79 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . 0.528 ' O ' ' HG2' ' A' ' 46' ' ' ARG . 49.8 mt-30 -63.5 -38.63 91.89 Favored 'General case' 0 CA--C 1.512 -0.484 0 CA-C-N 115.449 -0.796 . . . . 0.0 110.601 -177.041 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.64 ' HG ' ' O ' ' A' ' 39' ' ' THR . 73.5 mt -55.38 -43.52 75.22 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.724 179.759 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 44.4 mt-30 -64.85 -44.84 88.45 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.328 178.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.4 ' HG3' ' O ' ' A' ' 41' ' ' LYS . 40.8 mt-10 -63.82 -45.99 87.13 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.71 -0.677 . . . . 0.0 111.448 -178.878 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . 0.528 ' HG2' ' O ' ' A' ' 42' ' ' GLN . 11.7 ptp180 -77.46 -28.83 52.52 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 112.69 0.626 . . . . 0.0 112.69 -174.269 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . 0.639 ' HB1' HG22 ' A' ' 49' ' ' VAL . . . -92.14 -18.08 24.03 Favored 'General case' 0 C--N 1.325 -0.478 0 C-N-CA 120.674 -0.41 . . . . 0.0 111.952 -177.441 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 75.33 25.31 68.64 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.701 -0.761 . . . . 0.0 111.652 -178.029 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.639 HG22 ' HB1' ' A' ' 47' ' ' ALA . 33.4 m -127.8 170.46 17.56 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 N-CA-C 109.791 -0.448 . . . . 0.0 109.791 -178.183 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.614 ' HE3' ' HB ' ' A' ' 52' ' ' ILE . 8.9 tmtm? -110.8 124.37 51.9 Favored 'General case' 0 C--N 1.317 -0.84 0 N-CA-C 109.306 -0.628 . . . . 0.0 109.306 175.838 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' MET . . . . . 0.612 ' HE1' ' HB3' ' A' ' 79' ' ' ALA . 62.6 mtt -112.42 129.34 56.36 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 179.347 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.614 ' HB ' ' HE3' ' A' ' 50' ' ' LYS . 8.9 tt -122.3 105.69 16.62 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.933 0 CA-C-O 121.514 0.673 . . . . 0.0 110.133 175.129 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.503 ' O ' ' HG2' ' A' ' 55' ' ' GLN . 4.0 mm? -81.44 103.42 11.17 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 115.3 -0.863 . . . . 0.0 109.035 174.916 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.532 HD13 ' HB2' ' A' ' 66' ' ' PRO . 53.5 mt -75.54 87.04 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 122.013 0.911 . . . . 0.0 109.689 179.185 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . 0.503 ' HG2' ' O ' ' A' ' 53' ' ' LEU . 2.2 pt20 -137.25 -36.7 0.65 Allowed 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 114.359 -1.291 . . . . 0.0 109.293 -178.017 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -70.28 -30.95 68.1 Favored 'General case' 0 N--CA 1.455 -0.213 0 CA-C-N 115.329 -0.851 . . . . 0.0 108.923 172.116 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -83.65 128.26 8.47 Favored Glycine 0 N--CA 1.446 -0.671 0 N-CA-C 110.864 -0.894 . . . . 0.0 110.864 173.678 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 5.2 p -80.75 70.21 7.46 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.459 0.647 . . . . 0.0 112.156 -174.42 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 46.1 mt-30 -113.36 -57.42 2.29 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.666 -0.697 . . . . 0.0 109.489 172.1 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . 0.531 ' HB2' ' HD3' ' A' ' 66' ' ' PRO . 4.2 m-20 -114.23 44.05 1.76 Allowed 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.272 178.178 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -64.19 -35.63 81.43 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.42 -178.926 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 13.2 m120 -96.07 -9.59 30.48 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 112.445 0.535 . . . . 0.0 112.445 -177.025 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 28.2 m -126.48 -163.65 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 N-CA-C 112.06 0.393 . . . . 0.0 112.06 -174.335 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.477 ' O ' ' HB3' ' A' ' 60' ' ' ASN . 6.2 m-20 -54.76 149.64 10.89 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.661 178.025 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . 0.645 ' HB2' ' HB ' ' A' ' 24' ' ' ILE . 72.1 mmtt -96.72 125.48 46.64 Favored Pre-proline 0 C--N 1.316 -0.865 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.361 -170.449 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.532 ' HB2' HD13 ' A' ' 54' ' ' ILE . 14.0 Cg_exo -70.5 106.31 1.77 Allowed 'Trans proline' 0 N--CA 1.457 -0.647 0 C-N-CA 122.958 2.439 . . . . 0.0 111.317 174.949 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.539 HD21 HG23 ' A' ' 83' ' ' VAL . 23.2 tp -105.4 110.93 23.46 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.841 -0.618 . . . . 0.0 109.693 178.818 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.595 ' HB2' ' CG2' ' A' ' 52' ' ' ILE . 96.1 mtt180 -101.65 109.28 21.04 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-O 120.932 0.396 . . . . 0.0 110.952 177.718 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . 0.482 ' O ' ' HA ' ' A' ' 19' ' ' VAL . 4.4 mp -90.29 104.14 14.96 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 172.237 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 18.3 mt -104.48 121.73 56.59 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.588 -174.647 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . 0.636 ' HA2' ' HB2' ' A' ' 16' ' ' ASN . . . 175.95 -125.4 1.05 Allowed Glycine 0 N--CA 1.445 -0.75 0 CA-C-N 116.002 -0.545 . . . . 0.0 112.025 179.872 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -114.84 142.67 28.72 Favored Pre-proline 0 C--N 1.32 -0.698 0 N-CA-C 108.863 -0.791 . . . . 0.0 108.863 179.641 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . 0.56 ' HD3' ' OG1' ' A' ' 18' ' ' THR . 86.0 Cg_exo -43.33 -39.5 9.01 Favored 'Trans proline' 0 C--N 1.351 0.699 0 C-N-CA 123.034 2.489 . . . . 0.0 112.751 -173.636 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 66.6 t80 -63.33 -57.83 9.11 Favored 'General case' 0 N--CA 1.451 -0.425 0 CA-C-N 115.225 -0.898 . . . . 0.0 111.293 -177.949 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 32.9 pttt -75.96 -30.45 58.63 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.482 -0.326 . . . . 0.0 111.571 -178.221 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 51.9 t -57.24 -40.62 74.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-O 120.894 0.378 . . . . 0.0 110.031 176.395 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -73.67 -45.85 50.01 Favored 'General case' 0 N--CA 1.448 -0.544 0 C-N-CA 120.496 -0.481 . . . . 0.0 111.094 179.144 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 11.3 mt-30 -63.41 -37.76 88.52 Favored 'General case' 0 C--N 1.326 -0.419 0 C-N-CA 120.389 -0.524 . . . . 0.0 111.115 -179.355 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . 0.612 ' HB3' ' HE1' ' A' ' 51' ' ' MET . . . -67.57 -37.69 82.99 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.211 176.856 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 37.4 t -63.91 -48.04 78.2 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.586 175.867 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 55.0 mt-10 -61.15 -38.43 86.39 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 110.045 -0.354 . . . . 0.0 110.045 177.19 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' MET . . . . . 0.449 ' O ' HG13 ' A' ' 86' ' ' ILE . 48.1 ttp -61.1 -49.38 77.52 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.658 -0.701 . . . . 0.0 111.315 179.611 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.539 HG23 HD21 ' A' ' 67' ' ' LEU . 27.7 m -77.33 -33.06 19.38 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-O 120.813 0.339 . . . . 0.0 110.897 -176.801 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 54.7 ttp -67.11 -33.69 76.0 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 109.427 -0.583 . . . . 0.0 109.427 176.005 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -67.33 -31.2 71.31 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.417 -0.811 . . . . 0.0 110.641 178.106 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.449 HG13 ' O ' ' A' ' 82' ' ' MET . 59.4 mt -61.32 -30.49 48.06 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.304 0 CA-C-O 121.365 0.603 . . . . 0.0 110.17 176.398 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.942 ' HG ' ' HD3' ' A' ' 28' ' ' LYS . 6.9 mp -88.1 -5.87 58.21 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.733 178.844 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 6.0 tmm_? -114.37 -3.79 13.04 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.443 0.64 . . . . 0.0 110.717 -175.161 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . 0.435 ' O ' ' HG3' ' A' ' 89' ' ' GLU . 9.6 pt-20 . . . . . 0 C--O 1.251 1.143 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.895 -177.317 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . 0.649 ' HA3' HD21 ' A' ' 12' ' ' ASN . . . . . . . . 0 N--CA 1.442 -0.919 0 N-CA-C 111.855 -0.498 . . . . 0.0 111.855 . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 23.4 mt-30 61.16 -85.69 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.28 0 C-N-CA 123.389 0.676 . . . . 0.0 110.848 -177.424 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . 0.473 ' HB2' ' OD1' ' A' ' 72' ' ' ASP . 11.3 p90 -138.21 154.24 49.11 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.718 -0.673 . . . . 0.0 109.482 177.231 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . 0.417 ' HB3' ' H ' ' A' ' 9' ' ' ASP . 4.4 t60 -173.12 -92.77 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.77 0.319 . . . . 0.0 110.444 -175.304 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . 0.417 ' H ' ' HB3' ' A' ' 8' ' ' HIS . 17.3 t70 -148.7 113.89 5.52 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 109.971 -0.381 . . . . 0.0 109.971 179.96 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 66.1 t30 52.22 -108.79 0.41 Allowed 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 116.02 -0.536 . . . . 0.0 109.876 -173.475 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -83.16 125.82 31.95 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 109.628 -0.508 . . . . 0.0 109.628 177.593 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . 0.649 HD21 ' HA3' ' A' ' 5' ' ' GLY . 3.3 p-10 -84.01 21.29 1.36 Allowed 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 112.121 0.415 . . . . 0.0 112.121 -172.995 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 101.27 81.63 1.6 Allowed Glycine 0 N--CA 1.448 -0.555 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.205 179.12 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 82.59 -61.68 4.7 Favored Glycine 0 N--CA 1.449 -0.451 0 C-N-CA 120.959 -0.639 . . . . 0.0 111.801 -179.959 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . 0.75 ' HG2' ' H ' ' A' ' 17' ' ' GLY . 27.7 tt0 -59.04 134.3 56.86 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 120.897 0.38 . . . . 0.0 110.093 176.458 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 2.8 p-10 -75.12 -6.47 49.73 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.273 -178.438 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . 0.75 ' H ' ' HG2' ' A' ' 15' ' ' GLN . . . 66.57 -127.64 28.98 Favored Glycine 0 N--CA 1.449 -0.456 0 CA-C-N 115.879 -0.6 . . . . 0.0 112.549 178.149 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 55.4 m -101.3 130.52 47.46 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-O 120.784 0.326 . . . . 0.0 110.449 -178.56 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.63 HG23 HG22 ' A' ' 70' ' ' ILE . 92.8 t -116.72 121.18 67.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 N-CA-C 109.71 -0.478 . . . . 0.0 109.71 176.406 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . 0.512 ' HB2' ' CG1' ' A' ' 76' ' ' VAL . 13.1 tt0 -114.18 113.05 24.14 Favored 'General case' 0 C--N 1.315 -0.903 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 177.927 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.6 ' HA ' ' O ' ' A' ' 67' ' ' LEU . 49.7 mt-10 -99.43 112.9 25.01 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.117 179.194 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 12.6 mm -97.24 155.48 3.58 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-N 115.614 -0.721 . . . . 0.0 109.67 179.111 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' MET . . . . . 0.407 ' HA ' ' HE2' ' A' ' 23' ' ' MET . 1.9 mmt -109.15 91.85 3.81 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 175.845 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.656 ' HB ' ' HB2' ' A' ' 65' ' ' LYS . 37.2 mm -79.27 127.31 79.38 Favored Pre-proline 0 C--N 1.319 -0.752 0 CA-C-N 115.859 -0.609 . . . . 0.0 110.629 -175.209 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . 0.679 ' HB2' ' HB2' ' A' ' 28' ' ' LYS . 87.3 Cg_exo -48.14 131.61 22.15 Favored 'Trans proline' 0 C--N 1.343 0.288 0 C-N-CA 122.84 2.36 . . . . 0.0 111.961 177.126 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -59.59 -30.6 68.78 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.701 -175.434 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -94.47 12.51 68.75 Favored Glycine 0 N--CA 1.45 -0.432 0 C-N-CA 120.785 -0.721 . . . . 0.0 112.332 178.743 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.679 ' HB2' ' HB2' ' A' ' 25' ' ' PRO . 16.4 tptt -126.48 8.36 7.07 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.15 0.5 . . . . 0.0 110.263 -179.677 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -70.0 -22.41 63.12 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.14 -176.898 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -67.59 -17.37 68.81 Favored Glycine 0 N--CA 1.445 -0.761 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.412 178.124 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.426 HD12 ' HG3' ' A' ' 28' ' ' LYS . 54.0 mt -87.59 -38.45 15.94 Favored 'General case' 0 C--N 1.328 -0.345 0 O-C-N 122.613 -0.345 . . . . 0.0 111.436 -179.195 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.709 HG13 HD22 ' A' ' 87' ' ' LEU . 2.8 m -70.81 -32.68 49.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.962 0.41 . . . . 0.0 111.043 179.879 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.547 HD13 ' HG3' ' A' ' 55' ' ' GLN . 60.2 mt -83.2 -36.76 13.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-O 121.669 0.747 . . . . 0.0 109.763 175.262 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 101.62 171.76 27.98 Favored Glycine 0 N--CA 1.445 -0.745 0 CA-C-N 114.977 -1.01 . . . . 0.0 111.608 -179.722 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 10.5 mptt -81.6 48.76 1.22 Allowed 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.098 0.475 . . . . 0.0 110.373 178.977 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 170.45 -44.23 0.2 Allowed Glycine 0 N--CA 1.447 -0.619 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.778 179.238 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.441 ' HA2' HG23 ' A' ' 33' ' ' ILE . . . 123.19 -4.31 9.61 Favored Glycine 0 N--CA 1.449 -0.439 0 C-N-CA 120.785 -0.721 . . . . 0.0 111.536 -177.192 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -75.13 -33.46 61.56 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.019 0.438 . . . . 0.0 109.95 178.651 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' THR . . . . . 0.679 ' O ' ' HG ' ' A' ' 43' ' ' LEU . 69.9 m -58.28 -54.39 47.54 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-N 115.583 -0.735 . . . . 0.0 111.198 -176.289 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.531 ' HA ' HD13 ' A' ' 43' ' ' LEU . 10.3 tt -59.77 -34.61 56.23 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.28 0 CA-C-O 120.837 0.351 . . . . 0.0 111.14 179.915 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . 0.443 ' O ' ' HG2' ' A' ' 45' ' ' GLU . 50.1 tttp -62.33 -48.96 77.52 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.339 175.078 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . 0.45 ' O ' ' HG2' ' A' ' 46' ' ' ARG . 72.4 mm-40 -64.69 -33.56 76.24 Favored 'General case' 0 CA--C 1.509 -0.602 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.013 -175.259 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.679 ' HG ' ' O ' ' A' ' 39' ' ' THR . 67.8 mt -58.25 -48.24 81.03 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.413 179.307 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 43.1 mt-30 -65.79 -38.61 89.48 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.534 179.089 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.443 ' HG2' ' O ' ' A' ' 41' ' ' LYS . 60.0 mm-40 -60.69 -52.66 64.17 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.669 177.817 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . 0.45 ' HG2' ' O ' ' A' ' 42' ' ' GLN . 10.7 ptm180 -77.67 -29.93 51.77 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.592 -0.731 . . . . 0.0 112.634 -170.825 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -87.55 -25.87 23.42 Favored 'General case' 0 C--N 1.323 -0.554 0 C-N-CA 120.702 -0.399 . . . . 0.0 111.927 -176.077 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 78.23 24.84 62.75 Favored Glycine 0 N--CA 1.453 -0.215 0 C-N-CA 120.577 -0.82 . . . . 0.0 112.424 -179.812 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 5.9 m -135.75 179.29 4.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 N-CA-C 109.926 -0.398 . . . . 0.0 109.926 177.343 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 60.8 tttp -107.4 124.67 50.18 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.846 179.905 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' MET . . . . . 0.537 ' HE2' ' HB1' ' A' ' 79' ' ' ALA . 37.3 mtt -118.97 116.43 26.44 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 177.639 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.593 ' CG2' ' HB2' ' A' ' 68' ' ' ARG . 10.7 tt -111.22 113.43 44.23 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.899 0 CA-C-O 121.447 0.641 . . . . 0.0 110.733 178.675 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.692 HD22 HD12 ' A' ' 67' ' ' LEU . 2.9 mm? -88.17 102.51 14.87 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.581 -0.736 . . . . 0.0 109.467 175.7 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.818 HD12 ' HB2' ' A' ' 66' ' ' PRO . 65.2 mt -75.82 95.07 1.09 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-O 121.331 0.586 . . . . 0.0 110.011 -179.63 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . 0.558 HE21 ' HB3' ' A' ' 53' ' ' LEU . 84.6 mm-40 -102.69 -42.47 5.89 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.516 -0.765 . . . . 0.0 110.604 -176.079 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 4.1 p30 -95.35 -2.54 48.94 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.689 -178.396 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . 0.595 ' O ' ' HB ' ' A' ' 61' ' ' THR . . . -70.91 144.02 37.42 Favored Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 120.518 -0.848 . . . . 0.0 111.379 176.999 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' SER . . . . . 0.406 ' O ' ' HB2' ' A' ' 59' ' ' GLN . 9.4 m -71.98 -175.32 1.42 Allowed 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.746 0.308 . . . . 0.0 111.314 -176.61 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . 0.406 ' HB2' ' O ' ' A' ' 58' ' ' SER . 42.7 mt-30 68.46 -72.64 0.1 Allowed 'General case' 0 CA--C 1.518 -0.258 0 CA-C-N 115.54 -0.754 . . . . 0.0 110.381 -174.25 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . 0.869 ' HA ' HG23 ' A' ' 63' ' ' VAL . 6.0 m120 -96.47 15.64 20.89 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 121.161 0.505 . . . . 0.0 111.22 -174.185 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' THR . . . . . 0.595 ' HB ' ' O ' ' A' ' 57' ' ' GLY . 6.8 t -66.24 -29.88 70.21 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 109.912 -0.403 . . . . 0.0 109.912 174.366 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 17.4 m120 -100.83 3.4 41.94 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 112.258 0.466 . . . . 0.0 112.258 179.396 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.869 HG23 ' HA ' ' A' ' 60' ' ' ASN . 22.0 m -136.73 -156.93 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.309 0 O-C-N 122.157 -0.339 . . . . 0.0 111.643 -177.386 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.646 ' O ' ' HB3' ' A' ' 60' ' ' ASN . 12.1 m-20 -54.77 147.1 15.53 Favored 'General case' 0 C--O 1.227 -0.085 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.388 177.648 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . 0.656 ' HB2' ' HB ' ' A' ' 24' ' ' ILE . 74.0 mmtt -95.26 127.0 43.98 Favored Pre-proline 0 C--N 1.319 -0.74 0 CA-C-N 116.103 -0.498 . . . . 0.0 111.567 -170.573 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.818 ' HB2' HD12 ' A' ' 54' ' ' ILE . 10.6 Cg_exo -71.63 109.11 2.56 Favored 'Trans proline' 0 N--CA 1.459 -0.525 0 C-N-CA 123.074 2.516 . . . . 0.0 111.318 175.556 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.692 HD12 HD22 ' A' ' 53' ' ' LEU . 23.9 tp -106.04 100.01 9.58 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.986 -0.552 . . . . 0.0 109.848 178.467 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.593 ' HB2' ' CG2' ' A' ' 52' ' ' ILE . 97.6 mtt180 -85.64 105.11 15.97 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.939 0.4 . . . . 0.0 110.242 176.766 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 31.8 mt -92.4 105.04 16.25 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.718 0 N-CA-C 108.116 -1.068 . . . . 0.0 108.116 171.452 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.63 HG22 HG23 ' A' ' 19' ' ' VAL . 14.5 mt -111.4 129.51 66.62 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.909 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.575 -171.357 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 148.32 -124.67 1.92 Allowed Glycine 0 N--CA 1.441 -0.975 0 C-N-CA 119.847 -1.168 . . . . 0.0 113.833 171.115 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . 0.473 ' OD1' ' HB2' ' A' ' 7' ' ' PHE . 4.7 t70 -85.62 128.95 56.78 Favored Pre-proline 0 C--N 1.321 -0.632 0 CA-C-N 115.206 -0.497 . . . . 0.0 111.685 -171.779 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_exo -45.36 -33.64 9.2 Favored 'Trans proline' 0 C--N 1.349 0.596 0 C-N-CA 124.621 3.547 . . . . 0.0 114.346 -175.742 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 90.5 m-85 -74.91 -60.88 2.09 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.069 0.462 . . . . 0.0 110.214 -178.967 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.629 ' HA ' ' HB2' ' A' ' 78' ' ' GLN . 3.8 pttm -74.09 -17.07 61.0 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.745 -0.661 . . . . 0.0 112.586 -173.881 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.512 ' CG1' ' HB2' ' A' ' 20' ' ' GLN . 37.3 t -65.06 -44.35 95.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 121.429 0.633 . . . . 0.0 109.543 170.406 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -74.54 -43.23 56.74 Favored 'General case' 0 N--CA 1.446 -0.651 0 CA-C-N 115.29 -0.868 . . . . 0.0 109.129 -178.402 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . 0.629 ' HB2' ' HA ' ' A' ' 75' ' ' LYS . 61.9 mt-30 -56.71 -36.2 69.4 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.495 -0.775 . . . . 0.0 110.661 175.269 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . 0.537 ' HB1' ' HE2' ' A' ' 51' ' ' MET . . . -68.38 -45.08 73.7 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.608 -0.724 . . . . 0.0 110.917 177.957 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' CYS . . . . . 0.404 ' HB2' ' OE1' ' A' ' 20' ' ' GLN . 33.4 t -54.84 -56.71 16.5 Favored 'General case' 0 CA--C 1.518 -0.278 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.968 178.516 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -63.42 -27.08 69.05 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 120.77 -0.372 . . . . 0.0 110.877 -178.647 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' MET . . . . . 0.514 ' HE1' ' HA ' ' A' ' 79' ' ' ALA . 47.7 ttp -73.59 -49.67 25.09 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.434 179.839 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.523 HG13 HD11 ' A' ' 43' ' ' LEU . 34.2 m -76.39 -32.75 22.22 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-O 120.853 0.359 . . . . 0.0 110.591 -175.626 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' MET . . . . . 0.448 ' O ' ' HG3' ' A' ' 88' ' ' ARG . 45.2 ttm -68.56 -31.62 70.95 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.075 -0.511 . . . . 0.0 109.859 177.041 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . 0.48 ' HA ' ' HD2' ' A' ' 88' ' ' ARG . 21.4 t70 -62.81 -40.45 97.42 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.892 -0.595 . . . . 0.0 111.113 178.602 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 42.1 mt -61.08 -29.97 46.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.445 179.279 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.709 HD22 HG13 ' A' ' 32' ' ' VAL . 61.2 mt -79.0 -20.89 47.93 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.384 -177.434 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . 0.48 ' HD2' ' HA ' ' A' ' 85' ' ' ASP . 0.0 OUTLIER -117.99 27.56 8.93 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.17 0.51 . . . . 0.0 110.935 -179.84 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 44.9 tt0 . . . . . 0 C--O 1.248 1.007 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.174 179.551 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.444 -0.833 0 N-CA-C 112.336 -0.305 . . . . 0.0 112.336 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . 0.596 ' O ' ' HA2' ' A' ' 71' ' ' GLY . 27.4 mm-40 -103.98 27.82 7.27 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 108.55 -0.908 . . . . 0.0 108.55 171.709 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . 0.583 ' O ' ' HB2' ' A' ' 8' ' ' HIS . 4.9 p90 -155.94 -143.04 0.11 Allowed 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 114.216 -1.357 . . . . 0.0 108.37 -175.976 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . 0.583 ' HB2' ' O ' ' A' ' 7' ' ' PHE . 26.0 m170 79.11 100.24 0.06 Allowed 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 123.207 0.603 . . . . 0.0 110.674 -179.578 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 2.1 t0 179.08 -53.47 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.432 -0.804 . . . . 0.0 109.254 -179.913 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 6.6 p30 -150.21 -5.04 0.34 Allowed 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.402 -0.817 . . . . 0.0 111.637 179.257 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.615 ' HB3' ' HD2' ' A' ' 73' ' ' PRO . . . -151.12 108.09 3.56 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.233 0.54 . . . . 0.0 111.466 178.395 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 4.1 p-10 -135.51 20.46 3.36 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.157 178.831 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -126.39 144.69 15.27 Favored Glycine 0 N--CA 1.448 -0.549 0 CA-C-N 115.663 -0.698 . . . . 0.0 111.791 179.739 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 81.95 -70.3 3.15 Favored Glycine 0 N--CA 1.449 -0.453 0 C-N-CA 120.944 -0.645 . . . . 0.0 111.867 -178.376 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 75.2 mt-30 -113.39 108.4 17.17 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 109.939 -0.393 . . . . 0.0 109.939 176.523 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 31.9 m-80 -85.63 69.67 10.66 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.356 -178.131 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 106.45 104.59 2.96 Favored Glycine 0 N--CA 1.444 -0.796 0 C-N-CA 120.632 -0.794 . . . . 0.0 112.095 -179.919 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' THR . . . . . 0.406 ' HB ' HG21 ' A' ' 76' ' ' VAL . 58.8 m -95.84 138.8 32.97 Favored 'General case' 0 C--N 1.317 -0.834 0 N-CA-C 109.63 -0.508 . . . . 0.0 109.63 177.188 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.499 ' HA ' ' O ' ' A' ' 69' ' ' ILE . 5.2 p -132.19 126.42 56.01 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-O 121.237 0.541 . . . . 0.0 110.999 179.693 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . 0.402 ' OE1' HG13 ' A' ' 76' ' ' VAL . 55.1 mt-30 -115.5 119.91 37.74 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.561 177.017 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.624 ' HA ' ' O ' ' A' ' 67' ' ' LEU . 49.8 mt-10 -92.03 111.9 23.62 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.244 0.545 . . . . 0.0 110.546 177.429 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 15.8 mm -104.0 155.63 5.73 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-N 115.331 -0.85 . . . . 0.0 109.695 -178.347 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' MET . . . . . 0.514 ' HB3' ' HB3' ' A' ' 64' ' ' ASP . 80.6 mmm -108.43 104.97 14.43 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 176.227 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.631 ' HB ' ' HB2' ' A' ' 65' ' ' LYS . 30.5 mm -91.23 125.0 59.84 Favored Pre-proline 0 C--N 1.321 -0.656 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.115 -174.117 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . 0.549 ' HB2' ' HB3' ' A' ' 28' ' ' LYS . 76.9 Cg_exo -50.3 140.52 33.94 Favored 'Trans proline' 0 CA--C 1.535 0.555 0 C-N-CA 122.845 2.363 . . . . 0.0 113.019 179.715 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.418 ' HB1' ' HA ' ' A' ' 63' ' ' VAL . . . -48.88 -61.75 1.88 Allowed 'General case' 0 N--CA 1.468 0.454 0 N-CA-C 113.42 0.896 . . . . 0.0 113.42 -170.605 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -78.67 -25.64 60.26 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.712 -0.756 . . . . 0.0 111.883 -177.334 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.549 ' HB3' ' HB2' ' A' ' 25' ' ' PRO . 13.0 tppt? -67.57 -19.18 65.23 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.99 0.424 . . . . 0.0 110.875 178.891 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . 0.454 ' O ' HG13 ' A' ' 32' ' ' VAL . . . -59.66 -23.5 63.13 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.415 179.802 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -60.58 -27.03 65.47 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.855 -0.688 . . . . 0.0 112.16 176.598 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 92.5 mt -87.61 -33.53 18.82 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.643 0.258 . . . . 0.0 110.705 179.787 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.454 HG13 ' O ' ' A' ' 29' ' ' ALA . 0.9 OUTLIER -73.55 -31.27 32.1 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.387 0 CA-C-O 121.071 0.463 . . . . 0.0 110.916 -178.711 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.502 HG23 ' HA2' ' A' ' 37' ' ' GLY . 75.6 mt -84.87 -44.64 17.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 116.01 -0.541 . . . . 0.0 109.89 176.117 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 132.46 170.16 12.45 Favored Glycine 0 N--CA 1.441 -1.004 0 C-N-CA 120.242 -0.98 . . . . 0.0 112.936 174.606 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.425 ' N ' ' HD3' ' A' ' 35' ' ' LYS . 3.3 mppt? -69.36 -28.52 66.28 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.025 0.44 . . . . 0.0 109.879 -179.114 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -136.69 19.18 3.56 Favored Glycine 0 N--CA 1.447 -0.568 0 C-N-CA 120.825 -0.702 . . . . 0.0 111.355 175.592 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.502 ' HA2' HG23 ' A' ' 33' ' ' ILE . . . 78.57 5.92 88.13 Favored Glycine 0 C--O 1.226 -0.4 0 C-N-CA 120.913 -0.661 . . . . 0.0 112.072 -176.885 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -85.53 -24.18 27.39 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 120.887 0.375 . . . . 0.0 111.537 -178.587 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' THR . . . . . 0.637 ' O ' ' HG ' ' A' ' 43' ' ' LEU . 31.5 m -64.26 -48.97 73.72 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.232 -176.415 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.546 ' HA ' HD13 ' A' ' 43' ' ' LEU . 5.3 tt -55.72 -30.43 27.23 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.342 0 CA-C-O 121.071 0.462 . . . . 0.0 111.513 179.757 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . 0.437 ' O ' ' HG2' ' A' ' 45' ' ' GLU . 7.8 tmtm? -74.47 -39.58 62.42 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.055 -0.52 . . . . 0.0 109.758 -178.904 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 25.4 mt-30 -67.82 -35.62 78.93 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.825 -179.702 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.637 ' HG ' ' O ' ' A' ' 39' ' ' THR . 47.7 mt -58.5 -42.65 88.14 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.454 -179.224 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 65.9 mt-30 -62.69 -39.88 95.37 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.629 179.595 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.437 ' HG2' ' O ' ' A' ' 41' ' ' LYS . 34.6 mm-40 -74.07 -51.2 16.5 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.382 -176.727 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 17.5 ptm180 -66.63 -37.46 84.9 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.966 -0.561 . . . . 0.0 112.25 -171.798 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . 0.403 ' HB2' HG22 ' A' ' 49' ' ' VAL . . . -95.77 -13.39 24.16 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 120.969 0.414 . . . . 0.0 111.391 -176.795 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 69.19 31.17 71.74 Favored Glycine 0 N--CA 1.449 -0.467 0 N-CA-C 111.274 -0.73 . . . . 0.0 111.274 -176.082 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.434 ' CG1' ' HB2' ' A' ' 75' ' ' LYS . 34.4 m -113.04 166.84 6.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-O 120.809 0.337 . . . . 0.0 110.394 -175.735 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -111.65 123.33 50.0 Favored 'General case' 0 C--N 1.318 -0.794 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 171.211 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' MET . . . . . 0.708 ' HE1' HG13 ' A' ' 83' ' ' VAL . 75.8 mtp -123.8 115.32 21.17 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 109.806 -0.442 . . . . 0.0 109.806 178.643 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.488 ' CG2' ' HB2' ' A' ' 68' ' ' ARG . 6.8 tt -104.43 105.84 19.27 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.837 0 CA-C-O 121.437 0.636 . . . . 0.0 109.977 178.432 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.633 HD21 HD11 ' A' ' 67' ' ' LEU . 2.5 mm? -78.28 102.64 7.76 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.681 -0.691 . . . . 0.0 109.594 177.007 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.447 ' HB ' ' HB2' ' A' ' 66' ' ' PRO . 60.8 mt -87.5 85.89 2.51 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-O 121.509 0.671 . . . . 0.0 109.467 -178.239 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 1.3 pt20 -109.81 -17.12 13.73 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.834 -177.162 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 30.1 m-20 -100.19 -33.96 10.22 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.978 0.418 . . . . 0.0 110.119 175.082 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -86.2 39.33 3.05 Favored Glycine 0 C--N 1.33 0.196 0 C-N-CA 120.795 -0.717 . . . . 0.0 112.574 -177.555 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 3.0 p -136.85 146.07 45.15 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-O 120.916 0.389 . . . . 0.0 110.79 -179.11 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -99.34 -16.12 18.56 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 178.558 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . 0.473 ' HB2' ' CG2' ' A' ' 63' ' ' VAL . 27.5 p-10 -95.6 30.02 2.43 Favored 'General case' 0 N--CA 1.447 -0.586 0 CA-C-N 114.588 -1.187 . . . . 0.0 107.987 166.977 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 10.0 t -60.31 -18.86 52.43 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 114.923 -1.035 . . . . 0.0 111.201 -178.35 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 57.4 m-80 -87.71 -1.4 57.94 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.452 -178.648 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.473 ' CG2' ' HB2' ' A' ' 60' ' ' ASN . 23.6 m -133.46 -139.27 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.286 179.009 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.514 ' HB3' ' HB3' ' A' ' 23' ' ' MET . 1.9 m-20 -50.9 136.88 21.89 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.572 -0.74 . . . . 0.0 111.981 179.112 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . 0.631 ' HB2' ' HB ' ' A' ' 24' ' ' ILE . 71.7 mmtt -99.35 127.59 34.09 Favored Pre-proline 0 C--N 1.322 -0.594 0 CA-C-N 115.156 -0.929 . . . . 0.0 111.49 -174.176 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.447 ' HB2' ' HB ' ' A' ' 54' ' ' ILE . 38.7 Cg_exo -65.03 114.33 2.76 Favored 'Trans proline' 0 CA--C 1.533 0.434 0 C-N-CA 122.896 2.397 . . . . 0.0 111.719 169.619 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.633 HD11 HD21 ' A' ' 53' ' ' LEU . 28.7 tp -122.95 126.58 47.49 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 120.588 0.232 . . . . 0.0 111.114 179.809 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.51 ' HG2' ' HG2' ' A' ' 21' ' ' GLU . 96.4 mtt180 -109.19 115.93 30.95 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 120.674 0.273 . . . . 0.0 111.519 176.086 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . 0.499 ' O ' ' HA ' ' A' ' 19' ' ' VAL . 4.5 mp -97.62 115.8 38.46 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 N-CA-C 108.423 -0.954 . . . . 0.0 108.423 170.866 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 15.0 mt -119.38 140.66 42.6 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.569 -174.473 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . 0.596 ' HA2' ' O ' ' A' ' 6' ' ' GLN . . . 157.36 -160.12 30.28 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.877 -0.678 . . . . 0.0 112.165 176.738 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . 0.576 ' HB3' ' HB3' ' A' ' 11' ' ' ALA . 1.0 OUTLIER -61.99 137.19 95.44 Favored Pre-proline 0 N--CA 1.447 -0.617 0 N-CA-C 108.631 -0.877 . . . . 0.0 108.631 174.477 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . 0.615 ' HD2' ' HB3' ' A' ' 11' ' ' ALA . 85.8 Cg_exo -42.47 -41.17 7.71 Favored 'Trans proline' 0 CA--C 1.534 0.478 0 C-N-CA 122.825 2.35 . . . . 0.0 114.219 -173.462 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 73.3 m-85 -69.52 -51.61 34.14 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.111 -0.495 . . . . 0.0 112.191 -175.136 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.546 ' HD2' ' H ' ' A' ' 72' ' ' ASP . 16.9 ptpt -62.92 -32.34 73.6 Favored 'General case' 0 C--O 1.222 -0.349 0 CA-C-N 116.687 -0.233 . . . . 0.0 110.689 -179.024 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.486 HG23 ' O ' ' A' ' 72' ' ' ASP . 96.6 t -56.89 -48.05 82.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 120.771 0.319 . . . . 0.0 110.329 177.849 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 1.6 mm100 -71.14 -42.46 69.14 Favored 'General case' 0 N--CA 1.45 -0.456 0 CA-C-N 116.4 -0.363 . . . . 0.0 111.332 178.158 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 47.1 mt-30 -60.17 -42.37 94.82 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.717 0.294 . . . . 0.0 111.069 178.955 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . 0.547 ' HA ' ' HE2' ' A' ' 82' ' ' MET . . . -71.34 -36.43 71.53 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.766 178.917 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 49.8 t -61.17 -54.9 38.62 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.229 176.51 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -61.59 -30.05 70.43 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.885 0.374 . . . . 0.0 110.599 179.247 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' MET . . . . . 0.547 ' HE2' ' HA ' ' A' ' 79' ' ' ALA . 52.5 ttp -64.74 -53.29 49.45 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.886 178.534 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.708 HG13 ' HE1' ' A' ' 51' ' ' MET . 32.9 m -78.65 -33.24 16.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-O 120.656 0.265 . . . . 0.0 110.863 -176.254 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 59.8 ttp -66.51 -35.61 80.67 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.106 178.678 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -60.27 -38.38 83.38 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.62 176.76 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 48.6 mt -66.7 -27.25 39.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-O 121.273 0.559 . . . . 0.0 110.339 178.735 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.615 ' HG ' ' O ' ' A' ' 83' ' ' VAL . 35.4 mt -91.71 -28.12 17.64 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.273 -176.774 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . 0.423 HH11 ' HD2' ' A' ' 88' ' ' ARG . 12.9 mmt180 -85.99 -13.07 48.68 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.316 0.579 . . . . 0.0 111.117 -179.287 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 . . . . . 0 C--N 1.312 -1.064 0 CA-C-N 115.359 -0.837 . . . . 0.0 110.028 -178.009 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.534 0 N-CA-C 111.738 -0.545 . . . . 0.0 111.738 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . 0.409 ' HB3' ' HG2' ' A' ' 73' ' ' PRO . 23.2 mt-30 -77.81 -22.42 50.07 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.394 0.616 . . . . 0.0 110.1 178.964 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . 0.411 ' HA ' ' HB3' ' A' ' 16' ' ' ASN . 39.2 p90 -126.3 155.4 42.02 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.279 -0.873 . . . . 0.0 109.245 174.815 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . 0.583 ' HB3' ' HB3' ' A' ' 12' ' ' ASN . 2.2 t-160 -83.68 69.5 10.16 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.496 -176.394 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 1.5 p30 36.68 -102.67 0.03 OUTLIER 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 124.3 1.04 . . . . 0.0 113.227 178.29 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -114.5 -24.37 8.85 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 121.039 0.447 . . . . 0.0 110.131 179.033 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -83.38 64.02 7.59 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.011 -178.438 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . 0.583 ' HB3' ' HB3' ' A' ' 8' ' ' HIS . 8.6 p30 -142.82 154.01 43.77 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.211 179.221 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -154.96 96.34 0.16 Allowed Glycine 0 CA--C 1.509 -0.295 0 N-CA-C 111.072 -0.811 . . . . 0.0 111.072 -179.004 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 77.54 -65.32 3.14 Favored Glycine 0 N--CA 1.449 -0.442 0 N-CA-C 110.56 -1.016 . . . . 0.0 110.56 -171.029 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 6.3 pt20 -76.82 116.36 17.41 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 109.698 -0.482 . . . . 0.0 109.698 172.866 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . 0.505 ' O ' ' HB2' ' A' ' 8' ' ' HIS . 3.8 m-20 -101.12 -64.29 1.06 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.43 -179.603 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 174.73 35.97 0.04 OUTLIER Glycine 0 N--CA 1.453 -0.224 0 C-N-CA 120.614 -0.803 . . . . 0.0 112.338 177.498 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' THR . . . . . 0.42 HG21 ' HA ' ' A' ' 73' ' ' PRO . 16.1 m -153.18 130.13 11.01 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 120.661 0.267 . . . . 0.0 110.712 -177.703 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 60.5 t -131.71 131.86 62.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.423 179.884 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 28.6 mt-30 -120.84 114.8 22.13 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.086 173.803 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.567 ' HA ' ' O ' ' A' ' 67' ' ' LEU . 48.5 mt-10 -86.61 119.65 27.08 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.958 -0.564 . . . . 0.0 111.052 178.812 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.469 ' HB ' ' HB3' ' A' ' 67' ' ' LEU . 14.9 mm -105.68 163.43 4.56 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 115.341 -0.845 . . . . 0.0 110.091 -178.395 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' MET . . . . . 0.434 ' HB3' ' HB3' ' A' ' 64' ' ' ASP . 2.3 mmt -109.75 94.89 5.26 Favored 'General case' 0 N--CA 1.453 -0.324 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 176.049 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.725 ' HB ' ' HB2' ' A' ' 65' ' ' LYS . 36.5 mm -82.78 126.48 72.99 Favored Pre-proline 0 C--N 1.318 -0.775 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.178 -174.589 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . 0.68 ' HD2' HD11 ' A' ' 87' ' ' LEU . 84.6 Cg_exo -47.39 124.87 9.89 Favored 'Trans proline' 0 C--N 1.346 0.407 0 C-N-CA 123.132 2.555 . . . . 0.0 112.533 178.621 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -63.69 -34.38 77.72 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.645 -0.707 . . . . 0.0 111.872 -174.359 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -90.88 -3.75 70.24 Favored Glycine 0 N--CA 1.448 -0.543 0 C-N-CA 120.609 -0.805 . . . . 0.0 112.93 -178.724 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.462 ' HB3' ' HB2' ' A' ' 25' ' ' PRO . 43.4 tttt -121.44 17.17 11.35 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.222 0.534 . . . . 0.0 110.759 -176.93 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . 0.44 ' O ' HG11 ' A' ' 32' ' ' VAL . . . -70.57 -21.15 62.72 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.901 -0.591 . . . . 0.0 111.275 -178.27 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -65.39 -18.19 65.09 Favored Glycine 0 C--O 1.227 -0.308 0 C-N-CA 121.11 -0.567 . . . . 0.0 112.646 178.458 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.61 ' HB3' HG21 ' A' ' 86' ' ' ILE . 66.1 mt -88.53 -41.57 12.63 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.619 0.247 . . . . 0.0 110.939 178.819 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.714 ' HB ' HD22 ' A' ' 87' ' ' LEU . 4.3 p -69.67 -33.65 57.5 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.435 0 CA-C-O 121.334 0.587 . . . . 0.0 110.824 -178.718 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.574 ' HA ' ' HB ' ' A' ' 40' ' ' ILE . 76.6 mt -90.35 -39.87 12.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-N 115.591 -0.731 . . . . 0.0 110.59 179.061 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 107.63 151.39 16.83 Favored Glycine 0 N--CA 1.443 -0.838 0 CA-C-N 115.756 -0.656 . . . . 0.0 111.777 -179.075 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.505 ' HE3' HD22 ' A' ' 31' ' ' LEU . 0.2 OUTLIER -68.81 -11.34 60.31 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.719 0.295 . . . . 0.0 111.31 -178.088 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -137.36 17.83 3.52 Favored Glycine 0 N--CA 1.449 -0.483 0 C-N-CA 120.715 -0.755 . . . . 0.0 111.693 176.639 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 69.78 1.55 32.07 Favored Glycine 0 CA--C 1.521 0.411 0 C-N-CA 121.248 -0.501 . . . . 0.0 112.785 -177.655 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -69.9 -35.99 75.05 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.834 0.35 . . . . 0.0 111.114 -178.171 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' THR . . . . . 0.753 ' O ' ' HG ' ' A' ' 43' ' ' LEU . 93.8 m -57.72 -61.21 2.68 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.092 -179.304 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.622 ' HA ' HD11 ' A' ' 43' ' ' LEU . 7.6 tt -60.33 -29.83 44.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 116.045 -0.525 . . . . 0.0 112.09 -175.243 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 11.6 tmtt? -74.58 -42.34 58.9 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 109.86 -0.422 . . . . 0.0 109.86 -179.381 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . 0.518 ' O ' ' HG2' ' A' ' 46' ' ' ARG . 47.6 mt-30 -66.09 -31.72 72.76 Favored 'General case' 0 CA--C 1.517 -0.303 0 CA-C-O 120.961 0.41 . . . . 0.0 110.469 -179.305 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.753 ' HG ' ' O ' ' A' ' 39' ' ' THR . 44.4 mt -61.89 -33.25 73.88 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.674 -179.995 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 65.0 mt-30 -71.66 -23.03 61.6 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.433 0.635 . . . . 0.0 110.547 179.661 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 68.5 mm-40 -87.86 -55.1 3.91 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.82 -179.885 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . 0.518 ' HG2' ' O ' ' A' ' 42' ' ' GLN . 14.6 ptp180 -69.84 -30.87 68.47 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 113.02 0.748 . . . . 0.0 113.02 -172.492 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . 0.53 ' HB2' HG22 ' A' ' 49' ' ' VAL . . . -95.48 -18.56 20.57 Favored 'General case' 0 C--N 1.323 -0.553 0 C-N-CA 120.736 -0.386 . . . . 0.0 111.594 -176.487 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 75.74 17.45 80.1 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.83 -0.7 . . . . 0.0 112.212 -179.415 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.53 HG22 ' HB2' ' A' ' 47' ' ' ALA . 21.2 m -116.1 166.41 10.23 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-O 120.809 0.338 . . . . 0.0 110.279 179.846 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 85.6 tttt -108.66 121.29 44.71 Favored 'General case' 0 C--N 1.314 -0.952 0 N-CA-C 108.474 -0.935 . . . . 0.0 108.474 169.31 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' MET . . . . . 0.877 ' HE3' HG11 ' A' ' 83' ' ' VAL . 15.9 mtm -114.08 115.3 27.34 Favored 'General case' 0 C--N 1.316 -0.855 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 177.268 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.567 ' CG2' ' HB2' ' A' ' 68' ' ' ARG . 11.6 tt -100.34 106.94 20.07 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.084 0 CA-C-O 121.418 0.628 . . . . 0.0 110.348 179.561 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.856 HD22 HD11 ' A' ' 67' ' ' LEU . 3.0 mm? -72.78 101.52 3.13 Favored 'General case' 0 N--CA 1.445 -0.675 0 N-CA-C 107.382 -1.34 . . . . 0.0 107.382 171.165 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.668 HD12 ' HB2' ' A' ' 66' ' ' PRO . 62.8 mt -73.54 86.24 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.482 0 CA-C-O 122.078 0.942 . . . . 0.0 111.135 -170.852 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 32.3 mt-30 -106.35 -28.77 10.17 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 114.209 -1.359 . . . . 0.0 107.742 170.223 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -56.6 -37.45 70.67 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 114.271 -1.331 . . . . 0.0 110.09 173.534 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -94.69 94.67 1.8 Allowed Glycine 0 N--CA 1.443 -0.887 0 N-CA-C 110.723 -0.951 . . . . 0.0 110.723 172.53 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 11.4 m -75.53 55.41 0.82 Allowed 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.226 0.536 . . . . 0.0 111.602 -175.077 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 43.4 mt-30 -97.68 -45.97 6.17 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.399 178.556 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . 0.544 ' HB2' ' HD3' ' A' ' 66' ' ' PRO . 14.7 m120 -120.4 38.01 4.1 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.464 0.649 . . . . 0.0 109.677 179.478 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -77.04 -24.71 52.02 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.578 -0.737 . . . . 0.0 111.333 -179.95 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 8.8 t30 -81.75 -22.15 37.42 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.566 178.869 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.415 ' HB ' ' H ' ' A' ' 64' ' ' ASP . 16.8 m -121.01 -155.42 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.629 -177.829 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.434 ' HB3' ' HB3' ' A' ' 23' ' ' MET . 1.1 m-20 -55.41 140.67 39.16 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.743 175.546 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . 0.725 ' HB2' ' HB ' ' A' ' 24' ' ' ILE . 30.3 mmtp -90.55 132.67 34.56 Favored Pre-proline 0 C--N 1.322 -0.609 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.988 -170.355 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.668 ' HB2' HD12 ' A' ' 54' ' ' ILE . 17.4 Cg_exo -68.16 110.45 2.21 Favored 'Trans proline' 0 N--CA 1.456 -0.708 0 C-N-CA 122.684 2.256 . . . . 0.0 110.965 173.802 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.856 HD11 HD22 ' A' ' 53' ' ' LEU . 30.0 tp -108.6 114.05 27.55 Favored 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 110.138 -0.319 . . . . 0.0 110.138 178.064 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.567 ' HB2' ' CG2' ' A' ' 52' ' ' ILE . 97.3 mtt180 -99.46 106.19 18.21 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 116.487 -0.324 . . . . 0.0 110.479 176.254 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . 0.512 ' HB ' HG11 ' A' ' 76' ' ' VAL . 4.5 mp -86.39 103.93 13.34 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 N-CA-C 107.855 -1.165 . . . . 0.0 107.855 170.196 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 31.1 mt -101.57 116.12 44.59 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.867 0 CA-C-N 115.534 -0.757 . . . . 0.0 110.19 -174.282 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . 0.405 ' HA2' ' H ' ' A' ' 16' ' ' ASN . . . 177.19 -123.99 0.92 Allowed Glycine 0 N--CA 1.442 -0.935 0 C-N-CA 120.42 -0.895 . . . . 0.0 112.258 178.945 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . 0.46 ' HB2' ' ND2' ' A' ' 16' ' ' ASN . 17.0 t70 -119.46 141.85 31.55 Favored Pre-proline 0 C--N 1.318 -0.793 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 -177.631 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . 0.42 ' HA ' HG21 ' A' ' 18' ' ' THR . 82.8 Cg_exo -43.66 -38.03 8.87 Favored 'Trans proline' 0 C--N 1.35 0.611 0 C-N-CA 123.064 2.509 . . . . 0.0 113.212 -173.003 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . 0.409 ' O ' ' HG3' ' A' ' 78' ' ' GLN . 47.3 t80 -66.18 -61.99 1.72 Allowed 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.65 -0.705 . . . . 0.0 111.491 -177.416 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.419 ' HB2' HG12 ' A' ' 49' ' ' VAL . 35.3 pttt -67.37 -33.81 75.99 Favored 'General case' 0 N--CA 1.464 0.265 0 C-N-CA 121.103 -0.239 . . . . 0.0 111.573 179.75 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.512 HG11 ' HB ' ' A' ' 69' ' ' ILE . 51.3 t -57.85 -39.54 71.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.805 0.336 . . . . 0.0 110.514 177.672 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . 0.552 ' O ' ' HG2' ' A' ' 81' ' ' GLU . 1.9 mm100 -74.31 -44.78 51.14 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 120.651 -0.42 . . . . 0.0 111.407 178.206 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . 0.409 ' HG3' ' O ' ' A' ' 74' ' ' TYR . 47.0 mt-30 -57.65 -43.99 85.32 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-O 121.361 0.6 . . . . 0.0 110.166 179.398 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . 0.613 ' HA ' ' HE1' ' A' ' 82' ' ' MET . . . -66.6 -40.35 88.81 Favored 'General case' 0 N--CA 1.446 -0.675 0 CA-C-N 115.257 -0.883 . . . . 0.0 110.829 -179.693 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 45.0 t -63.21 -57.2 11.27 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.217 179.596 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . 0.552 ' HG2' ' O ' ' A' ' 77' ' ' GLN . 10.2 pt-20 -63.41 -20.18 65.32 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.981 0.419 . . . . 0.0 110.921 -177.456 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' MET . . . . . 0.613 ' HE1' ' HA ' ' A' ' 79' ' ' ALA . 37.7 ttp -75.56 -52.11 11.37 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.436 177.101 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.877 HG11 ' HE3' ' A' ' 51' ' ' MET . 27.9 m -79.61 -29.77 13.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.083 -174.666 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' MET . . . . . 0.586 ' O ' ' HG3' ' A' ' 88' ' ' ARG . 14.8 tpt -66.62 -31.74 72.63 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.086 -0.506 . . . . 0.0 109.686 177.397 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -62.53 -39.16 92.68 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-O 120.894 0.378 . . . . 0.0 110.667 177.122 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.61 HG21 ' HB3' ' A' ' 31' ' ' LEU . 18.7 mt -62.84 -19.2 22.72 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.401 179.136 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.714 HD22 ' HB ' ' A' ' 32' ' ' VAL . 65.5 mt -102.32 -40.45 6.74 Favored 'General case' 0 N--CA 1.449 -0.488 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.786 -175.582 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . 0.586 ' HG3' ' O ' ' A' ' 84' ' ' MET . 0.0 OUTLIER -78.08 -4.15 45.86 Favored 'General case' 0 N--CA 1.464 0.246 0 C-N-CA 120.471 -0.492 . . . . 0.0 111.87 -178.73 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . 0.437 ' C ' ' HZ2' ' A' ' 28' ' ' LYS . 38.5 tt0 . . . . . 0 C--O 1.249 1.049 0 CA-C-O 118.372 -0.823 . . . . 0.0 109.39 177.287 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.368 0 CA-C-O 120.286 -0.175 . . . . 0.0 112.71 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . 0.459 ' HA ' ' OH ' ' A' ' 74' ' ' TYR . 27.1 mt-30 65.87 -74.54 0.06 Allowed 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 123.299 0.639 . . . . 0.0 110.586 -174.653 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . 0.69 ' HB2' ' HB3' ' A' ' 12' ' ' ASN . 18.7 p90 -129.85 5.58 5.03 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.447 179.186 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 8.5 t60 67.22 98.74 0.05 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 114.825 -1.079 . . . . 0.0 109.431 -172.448 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -60.21 141.23 56.31 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.197 179.182 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 23.4 t-20 67.37 55.97 0.63 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.759 0.79 . . . . 0.0 109.279 -173.972 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -172.56 -68.39 0.02 OUTLIER 'General case' 0 CA--C 1.528 0.123 0 CA-C-N 114.88 -1.055 . . . . 0.0 110.913 178.873 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . 0.69 ' HB3' ' HB2' ' A' ' 7' ' ' PHE . 7.1 t30 -98.92 93.3 5.95 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.004 0.43 . . . . 0.0 110.776 -177.818 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -138.13 88.14 0.21 Allowed Glycine 0 N--CA 1.45 -0.386 0 N-CA-C 111.218 -0.753 . . . . 0.0 111.218 178.193 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 80.72 -53.81 4.58 Favored Glycine 0 N--CA 1.451 -0.363 0 N-CA-C 110.237 -1.145 . . . . 0.0 110.237 -172.582 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 31.1 mt-30 -82.58 120.82 26.01 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 108.21 -1.033 . . . . 0.0 108.21 171.028 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . 0.881 ' HB3' ' HA2' ' A' ' 71' ' ' GLY . 43.6 m-80 -66.44 120.54 13.53 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.033 0.444 . . . . 0.0 110.035 -178.366 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -100.34 -35.81 4.31 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.715 -0.755 . . . . 0.0 114.072 -168.981 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' THR . . . . . 0.449 HG22 ' HA ' ' A' ' 73' ' ' PRO . 87.6 m -73.92 127.63 33.36 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 117.211 0.506 . . . . 0.0 110.423 -176.785 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.434 ' HA ' ' O ' ' A' ' 69' ' ' ILE . 90.5 t -138.01 122.06 21.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.882 -177.014 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 26.0 mt-30 -107.27 118.07 35.74 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 109.891 -0.411 . . . . 0.0 109.891 172.688 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.538 ' HA ' ' O ' ' A' ' 67' ' ' LEU . 42.2 mt-10 -90.29 115.76 27.74 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.061 0.458 . . . . 0.0 111.026 176.233 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 12.8 mm -109.33 151.2 11.7 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-N 115.394 -0.821 . . . . 0.0 109.41 177.995 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 86.7 mmm -104.42 98.1 7.93 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 174.591 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.666 ' HB ' ' HB2' ' A' ' 65' ' ' LYS . 36.8 mm -81.49 129.79 64.52 Favored Pre-proline 0 C--N 1.316 -0.863 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.487 -175.491 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . 0.515 ' HB2' ' HB2' ' A' ' 28' ' ' LYS . 86.5 Cg_exo -46.68 128.11 12.64 Favored 'Trans proline' 0 C--N 1.347 0.497 0 C-N-CA 123.019 2.479 . . . . 0.0 112.451 177.891 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -45.43 -55.84 5.66 Favored 'General case' 0 C--O 1.234 0.254 0 N-CA-C 113.093 0.775 . . . . 0.0 113.093 -170.811 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -81.61 -4.87 90.27 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.837 -0.697 . . . . 0.0 113.066 -174.897 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.515 ' HB2' ' HB2' ' A' ' 25' ' ' PRO . 1.8 tptp -95.79 -8.51 34.14 Favored 'General case' 0 C--N 1.323 -0.558 0 O-C-N 122.673 -0.31 . . . . 0.0 110.198 -177.987 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . 0.616 ' HA ' HG21 ' A' ' 32' ' ' VAL . . . -63.89 -24.32 67.69 Favored 'General case' 0 N--CA 1.461 0.11 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.169 -179.982 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -58.76 -27.43 61.65 Favored Glycine 0 C--O 1.227 -0.319 0 C-N-CA 121.052 -0.595 . . . . 0.0 112.456 178.983 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 84.3 mt -82.86 -34.61 26.75 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.672 0.272 . . . . 0.0 111.143 -178.748 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.713 HG23 HD23 ' A' ' 87' ' ' LEU . 0.0 OUTLIER -74.08 -36.19 43.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.865 0.364 . . . . 0.0 110.345 178.399 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.575 HG12 ' O ' ' A' ' 29' ' ' ALA . 14.5 mm -78.35 -43.06 26.95 Favored 'Isoleucine or valine' 0 C--O 1.235 0.302 0 CA-C-O 121.482 0.658 . . . . 0.0 109.7 178.867 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 111.04 173.26 19.81 Favored Glycine 0 N--CA 1.439 -1.122 0 CA-C-N 115.374 -0.83 . . . . 0.0 112.051 178.365 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 31.1 mmmt -75.36 -22.38 57.6 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 120.853 0.359 . . . . 0.0 110.309 -178.913 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -130.93 -5.31 3.94 Favored Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.586 -0.816 . . . . 0.0 112.162 179.489 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 100.56 -1.09 55.61 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.736 -0.745 . . . . 0.0 111.924 -178.207 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -78.0 -21.43 50.86 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.652 0.263 . . . . 0.0 111.158 -178.865 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' THR . . . . . 0.789 ' O ' ' HG ' ' A' ' 43' ' ' LEU . 31.3 m -69.38 -50.86 42.19 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.577 -0.283 . . . . 0.0 110.691 -178.165 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.563 ' HB ' ' HA ' ' A' ' 33' ' ' ILE . 11.6 tt -67.13 -25.18 33.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-O 121.439 0.637 . . . . 0.0 110.448 177.317 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 22.4 tptm -63.24 -53.0 59.89 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.738 175.539 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . 0.4 ' O ' ' HG2' ' A' ' 46' ' ' ARG . 8.9 pt20 -68.78 -37.05 79.04 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.395 -175.023 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.789 ' HG ' ' O ' ' A' ' 39' ' ' THR . 84.4 mt -53.86 -39.65 65.86 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.743 -0.662 . . . . 0.0 111.532 179.632 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . 0.445 ' HG3' ' O ' ' A' ' 40' ' ' ILE . 44.9 mt-30 -69.78 -40.97 75.74 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.219 0.533 . . . . 0.0 110.813 -179.61 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 10.2 mm-40 -72.32 -40.51 67.39 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.668 -0.696 . . . . 0.0 111.705 -175.78 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . 0.4 ' HG2' ' O ' ' A' ' 42' ' ' GLN . 12.0 ptp180 -71.42 -34.24 70.16 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 112.375 0.509 . . . . 0.0 112.375 -174.458 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . 0.587 ' HB1' HG21 ' A' ' 49' ' ' VAL . . . -99.11 -5.92 29.28 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 112.224 0.453 . . . . 0.0 112.224 -173.587 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 66.27 30.39 76.64 Favored Glycine 0 C--N 1.33 0.225 0 C-N-CA 120.818 -0.706 . . . . 0.0 112.046 -178.627 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.587 HG21 ' HB1' ' A' ' 47' ' ' ALA . 26.8 m -125.11 179.58 3.0 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 N-CA-C 109.724 -0.472 . . . . 0.0 109.724 -178.351 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 64.6 tttp -122.48 125.53 45.98 Favored 'General case' 0 C--N 1.314 -0.938 0 CA-C-N 116.027 -0.533 . . . . 0.0 109.817 167.501 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' MET . . . . . 0.97 ' HE3' ' HB3' ' A' ' 79' ' ' ALA . 48.5 mtt -110.75 114.76 28.37 Favored 'General case' 0 C--N 1.315 -0.931 0 N-CA-C 108.418 -0.956 . . . . 0.0 108.418 176.471 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.54 ' CG2' ' HB2' ' A' ' 68' ' ' ARG . 8.9 tt -106.09 105.04 17.96 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.939 0 CA-C-O 121.521 0.677 . . . . 0.0 110.141 177.729 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.509 HD21 ' CD1' ' A' ' 40' ' ' ILE . 4.2 mm? -88.44 101.91 14.37 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.168 -0.924 . . . . 0.0 108.936 174.994 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.504 HD13 ' HB2' ' A' ' 66' ' ' PRO . 51.3 mt -78.98 86.55 1.16 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 178.604 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . 0.471 ' HA ' ' HD2' ' A' ' 65' ' ' LYS . 3.4 pp0? -115.46 -22.94 9.06 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.626 -0.715 . . . . 0.0 111.592 -174.843 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -123.25 -14.92 7.37 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.345 -0.389 . . . . 0.0 109.964 179.633 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -80.32 27.24 2.83 Favored Glycine 0 CA--C 1.522 0.474 0 C-N-CA 120.983 -0.627 . . . . 0.0 112.864 -177.831 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' SER . . . . . 0.603 ' HA ' ' OG1' ' A' ' 61' ' ' THR . 18.5 m 59.11 -155.26 0.36 Allowed 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 123.172 0.589 . . . . 0.0 111.667 179.55 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 72.6 mt-30 72.89 -62.2 0.48 Allowed 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 123.658 0.783 . . . . 0.0 110.355 -178.594 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . 0.44 ' HB3' ' O ' ' A' ' 64' ' ' ASP . 8.3 m120 -131.93 46.8 2.6 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.536 0.684 . . . . 0.0 109.52 174.368 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' THR . . . . . 0.603 ' OG1' ' HA ' ' A' ' 58' ' ' SER . 0.0 OUTLIER -68.95 -49.46 57.83 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.519 -0.764 . . . . 0.0 111.967 -176.592 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 29.2 p-10 -87.6 8.03 27.04 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.955 -174.753 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 21.3 m -132.72 -156.94 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 116.794 -0.185 . . . . 0.0 110.859 -178.022 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.44 ' O ' ' HB3' ' A' ' 60' ' ' ASN . 25.2 m-20 -60.97 155.15 20.65 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.048 0.451 . . . . 0.0 110.524 177.663 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . 0.666 ' HB2' ' HB ' ' A' ' 24' ' ' ILE . 71.9 mmtt -99.76 121.5 54.22 Favored Pre-proline 0 C--N 1.318 -0.772 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.787 -170.286 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.504 ' HB2' HD13 ' A' ' 54' ' ' ILE . 23.3 Cg_exo -66.26 106.86 1.08 Allowed 'Trans proline' 0 N--CA 1.46 -0.483 0 C-N-CA 122.801 2.334 . . . . 0.0 110.969 173.02 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.538 ' O ' ' HA ' ' A' ' 21' ' ' GLU . 19.3 tp -108.71 112.03 24.11 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.402 -179.866 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.54 ' HB2' ' CG2' ' A' ' 52' ' ' ILE . 98.8 mtt180 -101.58 108.21 19.7 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.365 174.802 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . 0.442 ' HB ' HG11 ' A' ' 76' ' ' VAL . 4.9 mp -87.31 104.41 14.21 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 N-CA-C 108.308 -0.997 . . . . 0.0 108.308 170.995 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 18.6 mt -99.87 120.99 50.03 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 CA-C-N 115.85 -0.613 . . . . 0.0 110.533 -174.502 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . 0.881 ' HA2' ' HB3' ' A' ' 16' ' ' ASN . . . 173.57 -135.93 3.44 Favored Glycine 0 CA--C 1.518 0.258 0 C-N-CA 120.807 -0.711 . . . . 0.0 112.985 179.161 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . 0.57 ' OD1' ' HE2' ' A' ' 75' ' ' LYS . 1.5 m-20 -103.28 157.77 33.13 Favored Pre-proline 0 C--N 1.325 -0.481 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 179.684 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . 0.449 ' HA ' HG22 ' A' ' 18' ' ' THR . 82.0 Cg_exo -48.17 -39.28 34.03 Favored 'Trans proline' 0 C--O 1.234 0.29 0 C-N-CA 122.156 1.904 . . . . 0.0 112.367 179.732 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . 0.459 ' OH ' ' HA ' ' A' ' 6' ' ' GLN . 32.4 m-85 -67.27 -62.99 1.15 Allowed 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.225 -178.617 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.57 ' HE2' ' OD1' ' A' ' 72' ' ' ASP . 41.2 pttt -67.66 -25.83 65.91 Favored 'General case' 0 C--O 1.22 -0.449 0 CA-C-N 116.333 -0.394 . . . . 0.0 112.041 -174.052 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.442 HG11 ' HB ' ' A' ' 69' ' ' ILE . 56.1 t -71.76 -35.1 54.07 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-O 121.165 0.507 . . . . 0.0 110.037 177.97 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -74.04 -51.67 15.1 Favored 'General case' 0 N--CA 1.448 -0.563 0 N-CA-C 108.636 -0.876 . . . . 0.0 108.636 178.32 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 92.0 mt-30 -59.93 -39.34 85.14 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.473 -179.245 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . 0.97 ' HB3' ' HE3' ' A' ' 51' ' ' MET . . . -68.07 -36.59 80.09 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.168 178.851 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 52.2 t -67.26 -47.06 71.85 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.803 -178.937 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -70.24 -19.15 63.16 Favored 'General case' 0 C--N 1.325 -0.496 0 C-N-CA 120.344 -0.542 . . . . 0.0 110.632 178.159 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' MET . . . . . 0.42 ' O ' ' HB3' ' A' ' 85' ' ' ASP . 48.8 ttp -75.43 -47.71 26.09 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.468 175.374 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.568 ' O ' ' HG ' ' A' ' 87' ' ' LEU . 28.3 m -72.29 -33.2 45.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 C-N-CA 120.963 -0.295 . . . . 0.0 110.831 -179.874 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 54.4 mtt -67.61 -27.4 66.87 Favored 'General case' 0 CA--C 1.519 -0.235 0 CA-C-O 120.83 0.348 . . . . 0.0 110.173 174.865 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . 0.517 ' O ' ' HG2' ' A' ' 88' ' ' ARG . 8.0 t70 -65.1 -45.33 85.59 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.597 176.115 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 38.9 mt -63.19 -22.62 31.2 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.644 179.196 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.713 HD23 HG23 ' A' ' 32' ' ' VAL . 64.7 mt -97.24 -12.33 23.1 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.708 -176.322 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . 0.668 ' HG3' ' HG2' ' A' ' 89' ' ' GLU . 29.5 ptt180 -101.16 -24.06 14.34 Favored 'General case' 0 CA--C 1.515 -0.37 0 CA-C-O 121.633 0.73 . . . . 0.0 110.088 -177.137 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . 0.668 ' HG2' ' HG3' ' A' ' 88' ' ' ARG . 37.7 mm-40 . . . . . 0 C--N 1.312 -1.047 0 CA-C-N 114.422 -1.263 . . . . 0.0 110.704 -171.475 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . 0.681 ' HA3' ' CE1' ' A' ' 7' ' ' PHE . . . . . . . . 0 N--CA 1.45 -0.399 0 CA-C-O 121.359 0.422 . . . . 0.0 113.234 . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . 0.422 ' C ' ' H ' ' A' ' 8' ' ' HIS . 36.0 mt-30 -113.97 40.67 2.41 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 178.365 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . 0.681 ' CE1' ' HA3' ' A' ' 5' ' ' GLY . 64.4 m-85 -69.85 8.3 0.73 Allowed 'General case' 0 CA--C 1.534 0.358 0 CA-C-N 114.94 -1.027 . . . . 0.0 111.889 -172.927 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . 0.422 ' H ' ' C ' ' A' ' 6' ' ' GLN . 68.4 m80 -137.6 87.6 2.27 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.011 0.434 . . . . 0.0 111.475 -173.235 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . 0.474 ' CG ' ' H ' ' A' ' 10' ' ' ASN . 13.3 t70 -124.21 -164.22 1.23 Allowed 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 175.612 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . 0.474 ' H ' ' CG ' ' A' ' 9' ' ' ASP . 36.1 m-80 -56.49 -57.21 13.31 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 109.57 -0.53 . . . . 0.0 109.57 177.898 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.485 ' O ' ' HA ' ' A' ' 16' ' ' ASN . . . -96.28 101.58 13.25 Favored 'General case' 0 N--CA 1.448 -0.527 0 CA-C-N 115.448 -0.797 . . . . 0.0 109.09 172.367 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 9.0 p30 -126.02 -177.97 4.13 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.348 -176.115 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 95.24 -110.64 4.06 Favored Glycine 0 N--CA 1.447 -0.603 0 N-CA-C 111.205 -0.758 . . . . 0.0 111.205 -177.12 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -73.65 -74.6 0.81 Allowed Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.86 -0.686 . . . . 0.0 111.616 177.678 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -82.71 135.62 34.96 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 175.461 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . 0.485 ' HA ' ' O ' ' A' ' 11' ' ' ALA . 0.1 OUTLIER -144.91 42.02 1.31 Allowed 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.349 0.595 . . . . 0.0 110.796 -173.915 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 89.67 -61.55 3.47 Favored Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.704 -0.76 . . . . 0.0 113.596 174.869 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' THR . . . . . 0.505 HG22 ' HA ' ' A' ' 73' ' ' PRO . 95.9 m -65.72 127.71 33.04 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.93 0.395 . . . . 0.0 111.35 -175.907 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.961 ' HB ' HD11 ' A' ' 70' ' ' ILE . 0.2 OUTLIER -138.24 128.4 34.85 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 115.648 -0.705 . . . . 0.0 110.932 -179.761 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 27.9 mt-30 -118.31 116.04 25.95 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.881 -0.6 . . . . 0.0 109.951 174.148 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.513 ' HG3' ' HG2' ' A' ' 68' ' ' ARG . 4.5 mp0 -86.61 107.75 18.3 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.119 0.485 . . . . 0.0 110.851 178.784 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.428 HD11 ' HE3' ' A' ' 84' ' ' MET . 23.1 mm -88.18 156.03 3.17 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-N 115.67 -0.695 . . . . 0.0 110.046 -178.08 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' MET . . . . . 0.506 ' HE3' ' HA ' ' A' ' 23' ' ' MET . 14.3 mmt -105.83 91.79 3.89 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 109.618 -0.512 . . . . 0.0 109.618 176.653 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.686 ' HB ' ' HB2' ' A' ' 65' ' ' LYS . 26.0 mm -80.85 125.39 80.25 Favored Pre-proline 0 C--N 1.321 -0.668 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.751 -176.488 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . 0.572 ' HB2' ' HB2' ' A' ' 28' ' ' LYS . 64.8 Cg_exo -51.89 130.14 33.22 Favored 'Trans proline' 0 C--O 1.233 0.226 0 C-N-CA 122.813 2.342 . . . . 0.0 111.711 176.412 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -58.34 -38.14 76.57 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 115.754 -0.657 . . . . 0.0 111.45 -177.252 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -90.16 22.47 26.03 Favored Glycine 0 N--CA 1.453 -0.222 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.327 178.268 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.572 ' HB2' ' HB2' ' A' ' 25' ' ' PRO . 21.3 tptt -133.1 0.81 3.47 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 178.136 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.63 -33.96 74.84 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.501 -0.772 . . . . 0.0 111.857 -174.468 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -59.04 -22.08 54.44 Favored Glycine 0 CA--C 1.519 0.33 0 C-N-CA 121.14 -0.552 . . . . 0.0 113.037 -179.397 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.464 ' HB3' HG23 ' A' ' 86' ' ' ILE . 94.2 mt -87.99 -43.19 11.92 Favored 'General case' 0 C--N 1.326 -0.447 0 O-C-N 122.576 -0.367 . . . . 0.0 110.951 -179.887 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.446 HG11 HG22 ' A' ' 24' ' ' ILE . 1.2 p -66.8 -29.97 48.11 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.416 0 CA-C-O 121.199 0.523 . . . . 0.0 110.656 -178.899 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 63.2 mt -81.36 -43.77 20.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-O 121.692 0.758 . . . . 0.0 109.108 173.372 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . 0.538 ' HA3' ' HB ' ' A' ' 39' ' ' THR . . . 116.46 163.43 13.36 Favored Glycine 0 N--CA 1.438 -1.201 0 CA-C-N 115.344 -0.844 . . . . 0.0 112.54 174.805 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.528 ' N ' ' HD3' ' A' ' 35' ' ' LYS . 0.0 OUTLIER -78.64 57.59 2.07 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.305 0.574 . . . . 0.0 110.263 -178.656 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 134.24 14.72 1.21 Allowed Glycine 0 N--CA 1.447 -0.585 0 CA-C-N 115.358 -0.837 . . . . 0.0 111.619 -179.44 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 71.36 6.35 61.47 Favored Glycine 0 C--N 1.333 0.409 0 C-N-CA 121.25 -0.5 . . . . 0.0 112.355 -178.193 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 55.3 mm-40 -84.12 -22.67 31.0 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 120.961 0.41 . . . . 0.0 111.073 -178.511 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' THR . . . . . 0.672 ' O ' ' HG ' ' A' ' 43' ' ' LEU . 57.9 m -70.97 -51.68 24.24 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.3 178.282 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.563 ' HA ' HD13 ' A' ' 43' ' ' LEU . 7.8 tt -58.74 -33.7 49.86 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.385 0 CA-C-O 121.312 0.577 . . . . 0.0 110.568 177.808 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 40.0 ttmt -63.66 -37.96 89.32 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.349 177.332 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . 0.601 ' O ' ' HG2' ' A' ' 46' ' ' ARG . 45.7 mt-30 -79.63 -42.03 25.73 Favored 'General case' 0 C--O 1.222 -0.359 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.498 -178.982 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.672 ' HG ' ' O ' ' A' ' 39' ' ' THR . 70.5 mt -49.0 -45.41 42.37 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-O 120.912 0.387 . . . . 0.0 111.789 -176.073 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 45.9 mt-30 -62.4 -44.71 95.79 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.651 179.161 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -68.66 -42.4 77.95 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.095 -179.264 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . 0.601 ' HG2' ' O ' ' A' ' 42' ' ' GLN . 15.4 mmt180 -52.31 -44.62 65.17 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.805 -175.553 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -102.64 -9.98 19.63 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.618 -175.424 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 71.09 39.86 62.51 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.73 -0.747 . . . . 0.0 111.291 -175.09 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 27.3 m -122.77 178.95 2.8 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-O 120.891 0.377 . . . . 0.0 110.476 -175.534 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.444 ' C ' ' HD3' ' A' ' 50' ' ' LYS . 1.1 tmtp? -116.74 124.41 49.58 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 175.17 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' MET . . . . . 0.54 ' CE ' ' HB3' ' A' ' 79' ' ' ALA . 64.3 mtt -117.37 121.99 42.61 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.482 -0.327 . . . . 0.0 110.43 178.406 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.731 HG21 ' HB2' ' A' ' 68' ' ' ARG . 0.0 OUTLIER -110.44 116.57 52.72 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 CA-C-O 121.648 0.737 . . . . 0.0 109.21 176.146 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.594 HD22 HD13 ' A' ' 67' ' ' LEU . 2.8 mm? -95.7 105.72 17.75 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.388 -0.823 . . . . 0.0 110.339 179.499 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.745 HD11 ' HB2' ' A' ' 66' ' ' PRO . 60.1 mt -75.59 96.26 1.18 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 121.332 0.587 . . . . 0.0 110.223 179.867 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 57.7 mt-30 -106.69 -48.9 3.42 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.658 -0.701 . . . . 0.0 109.792 -179.83 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 19.4 m-20 -82.07 -28.33 32.44 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.38 -0.827 . . . . 0.0 110.719 -179.193 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . 0.492 ' O ' ' HB ' ' A' ' 61' ' ' THR . . . -68.22 130.45 26.85 Favored Glycine 0 N--CA 1.447 -0.6 0 C-N-CA 120.66 -0.781 . . . . 0.0 112.09 -176.361 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 47.9 m -80.61 62.52 4.71 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.718 0.771 . . . . 0.0 111.027 179.24 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 23.3 mm-40 -129.85 98.45 4.79 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 107.852 -1.166 . . . . 0.0 107.852 171.801 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 4.3 m-20 59.77 31.06 20.61 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.246 0.546 . . . . 0.0 110.14 -174.001 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' THR . . . . . 0.492 ' HB ' ' O ' ' A' ' 57' ' ' GLY . 14.2 t -72.36 -20.62 61.43 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.991 -0.549 . . . . 0.0 111.675 -173.506 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 81.2 m-20 -104.46 6.5 34.93 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.029 0.442 . . . . 0.0 110.926 -179.583 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 13.8 m -131.69 -144.62 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.018 178.088 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.44 ' HB3' ' HB3' ' A' ' 23' ' ' MET . 23.2 m-20 -61.26 139.36 58.16 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 110.036 -0.357 . . . . 0.0 110.036 176.276 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . 0.686 ' HB2' ' HB ' ' A' ' 24' ' ' ILE . 70.6 mmtt -89.43 120.82 69.68 Favored Pre-proline 0 C--N 1.32 -0.686 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.882 -171.097 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.745 ' HB2' HD11 ' A' ' 54' ' ' ILE . 28.5 Cg_exo -66.35 104.68 0.78 Allowed 'Trans proline' 0 N--CA 1.462 -0.377 0 C-N-CA 122.928 2.419 . . . . 0.0 112.124 175.001 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.594 HD13 HD22 ' A' ' 53' ' ' LEU . 14.5 tp -103.21 118.13 36.09 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.906 -0.588 . . . . 0.0 109.946 176.057 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.731 ' HB2' HG21 ' A' ' 52' ' ' ILE . 95.5 mtt180 -98.19 110.85 23.36 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 116.556 -0.293 . . . . 0.0 110.897 177.015 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 4.2 mp -96.47 104.73 16.2 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 171.598 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.961 HD11 ' HB ' ' A' ' 19' ' ' VAL . 3.6 mm -100.85 134.82 39.62 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 N-CA-C 109.914 -0.402 . . . . 0.0 109.914 -178.229 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . 0.415 ' O ' ' HB ' ' A' ' 18' ' ' THR . . . 164.44 -142.14 7.57 Favored Glycine 0 N--CA 1.447 -0.626 0 C-N-CA 121.054 -0.593 . . . . 0.0 111.625 178.568 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . 0.537 ' OD2' ' HB3' ' A' ' 74' ' ' TYR . 8.8 t70 -93.83 140.92 23.15 Favored Pre-proline 0 C--N 1.318 -0.79 0 CA-C-O 118.35 -0.833 . . . . 0.0 109.122 179.686 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . 0.505 ' HA ' HG22 ' A' ' 18' ' ' THR . 84.0 Cg_exo -41.78 -41.1 5.98 Favored 'Trans proline' 0 C--N 1.346 0.433 0 C-N-CA 122.757 2.305 . . . . 0.0 113.066 -177.806 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . 0.537 ' HB3' ' OD2' ' A' ' 72' ' ' ASP . 69.2 t80 -63.48 -58.68 6.25 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.296 -178.74 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.471 ' HG2' ' HB3' ' A' ' 72' ' ' ASP . 38.0 pttt -71.91 -27.87 63.11 Favored 'General case' 0 CA--C 1.518 -0.268 0 C-N-CA 120.446 -0.501 . . . . 0.0 111.557 -178.019 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 55.3 t -63.7 -39.67 86.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 N-CA-C 109.53 -0.545 . . . . 0.0 109.53 176.832 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 22.7 tp60 -75.85 -44.95 38.33 Favored 'General case' 0 N--CA 1.445 -0.698 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.79 -179.717 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . 0.403 ' HA ' ' HG2' ' A' ' 81' ' ' GLU . 55.5 mt-30 -64.82 -35.78 82.22 Favored 'General case' 0 C--N 1.33 -0.271 0 C-N-CA 120.469 -0.493 . . . . 0.0 110.926 -179.921 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . 0.54 ' HB3' ' CE ' ' A' ' 51' ' ' MET . . . -71.38 -34.71 70.68 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 120.93 0.395 . . . . 0.0 110.09 176.222 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 36.7 t -65.22 -47.87 75.35 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.253 178.023 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . 0.403 ' HG2' ' HA ' ' A' ' 78' ' ' GLN . 10.5 pt-20 -69.72 -22.37 63.4 Favored 'General case' 0 C--N 1.322 -0.601 0 C-N-CA 120.684 -0.406 . . . . 0.0 110.14 178.861 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' MET . . . . . 0.463 ' O ' ' HB3' ' A' ' 85' ' ' ASP . 57.4 ttp -73.74 -46.28 46.88 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.664 176.338 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.535 ' O ' ' HG ' ' A' ' 87' ' ' LEU . 33.2 m -72.03 -36.56 57.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 C-N-CA 120.662 -0.415 . . . . 0.0 110.665 178.905 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' MET . . . . . 0.428 ' HE3' HD11 ' A' ' 22' ' ' ILE . 54.1 mtt -65.0 -32.08 73.63 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 109.975 -0.379 . . . . 0.0 109.975 175.146 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . 0.463 ' HB3' ' O ' ' A' ' 82' ' ' MET . 18.8 t70 -58.23 -48.79 79.27 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.648 176.315 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.464 HG23 ' HB3' ' A' ' 31' ' ' LEU . 34.8 mt -60.63 -29.7 45.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 121.271 0.558 . . . . 0.0 110.536 179.562 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.535 ' HG ' ' O ' ' A' ' 83' ' ' VAL . 62.0 mt -92.06 -1.71 57.06 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.661 -0.699 . . . . 0.0 111.927 -174.755 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . 0.416 ' HG2' ' O ' ' A' ' 84' ' ' MET . 19.2 ptp180 -129.83 16.49 5.78 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.059 0.457 . . . . 0.0 111.141 -179.929 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 10.5 tt0 . . . . . 0 C--O 1.249 1.059 0 CA-C-O 118.186 -0.912 . . . . 0.0 109.86 179.218 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . 0.407 ' C ' ' H ' ' A' ' 7' ' ' PHE . . . . . . . . 0 N--CA 1.448 -0.533 0 N-CA-C 111.998 -0.441 . . . . 0.0 111.998 . . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 14.5 mt-30 -81.64 35.24 0.4 Allowed 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 110.34 -0.244 . . . . 0.0 110.34 -179.921 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . 0.602 ' HD1' ' HB3' ' A' ' 72' ' ' ASP . 50.2 m-85 67.57 152.87 0.08 Allowed 'General case' 0 N--CA 1.465 0.321 0 C-N-CA 123.685 0.794 . . . . 0.0 110.844 -174.984 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . 0.432 ' O ' ' HB3' ' A' ' 9' ' ' ASP . 1.8 t-80 -157.51 -76.08 0.09 Allowed 'General case' 0 C--N 1.319 -0.745 0 N-CA-C 108.863 -0.792 . . . . 0.0 108.863 170.294 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . 0.591 ' HA ' ' OD2' ' A' ' 72' ' ' ASP . 8.5 p-10 174.12 128.02 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.439 0 O-C-N 123.916 0.76 . . . . 0.0 110.971 171.831 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 22.4 t-20 70.26 -68.5 0.2 Allowed 'General case' 0 N--CA 1.471 0.593 0 CA-C-N 115.428 -0.806 . . . . 0.0 111.797 174.928 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -112.93 109.85 19.55 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.184 -178.37 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . 0.656 HD22 ' HD3' ' A' ' 73' ' ' PRO . 20.6 p-10 -135.94 177.96 7.42 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.358 -177.851 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 77.94 -92.52 1.14 Allowed Glycine 0 N--CA 1.449 -0.469 0 C-N-CA 120.849 -0.691 . . . . 0.0 112.439 178.258 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -166.44 -59.75 0.03 OUTLIER Glycine 0 N--CA 1.448 -0.516 0 C-N-CA 121.105 -0.569 . . . . 0.0 112.027 -178.464 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 50.6 mt-30 -96.27 106.77 19.03 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 110.299 -0.26 . . . . 0.0 110.299 179.032 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 89.9 m-20 67.81 -68.77 0.15 Allowed 'General case' 0 N--CA 1.467 0.414 0 O-C-N 123.941 0.776 . . . . 0.0 112.254 177.016 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 156.73 -159.6 29.67 Favored Glycine 0 N--CA 1.446 -0.674 0 N-CA-C 110.599 -1.0 . . . . 0.0 110.599 -176.443 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' THR . . . . . 0.424 HG23 ' HA ' ' A' ' 73' ' ' PRO . 32.8 m -100.57 126.14 47.0 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 117.438 0.619 . . . . 0.0 109.991 176.129 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.511 ' HA ' ' O ' ' A' ' 69' ' ' ILE . 7.5 p -141.8 136.27 30.54 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.405 -176.183 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . 0.517 ' O ' ' HA ' ' A' ' 68' ' ' ARG . 35.6 mt-30 -112.84 158.69 19.84 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.194 -0.457 . . . . 0.0 109.802 171.962 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.581 ' HG2' ' HG2' ' A' ' 68' ' ' ARG . 51.9 mt-10 -125.28 113.57 17.79 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.932 0.396 . . . . 0.0 109.968 178.683 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 9.6 mm -104.69 137.8 32.24 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.375 -178.195 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' MET . . . . . 0.411 ' HA ' ' HE2' ' A' ' 23' ' ' MET . 0.1 OUTLIER -86.07 91.52 8.43 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 172.362 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.816 HG23 HD23 ' A' ' 87' ' ' LEU . 33.1 mm -79.86 126.35 80.23 Favored Pre-proline 0 C--N 1.319 -0.76 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.791 -177.546 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . 0.774 ' HB2' ' HB2' ' A' ' 28' ' ' LYS . 72.7 Cg_exo -51.99 135.86 51.8 Favored 'Trans proline' 0 N--CA 1.461 -0.392 0 C-N-CA 122.675 2.25 . . . . 0.0 111.416 175.459 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -57.93 -33.36 68.72 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.661 -0.7 . . . . 0.0 112.626 -172.865 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -82.74 -29.36 35.54 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.495 -0.86 . . . . 0.0 111.688 177.375 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.774 ' HB2' ' HB2' ' A' ' 25' ' ' PRO . 11.7 mptt -79.68 -8.23 59.09 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.981 0.42 . . . . 0.0 110.736 179.802 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . 0.402 ' HB3' ' HG3' ' A' ' 65' ' ' LYS . . . -61.54 -26.63 68.06 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.501 176.832 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -68.93 -17.68 71.82 Favored Glycine 0 N--CA 1.449 -0.499 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.331 177.673 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.4 ' HB3' HG22 ' A' ' 86' ' ' ILE . 84.8 mt -88.86 -37.93 14.96 Favored 'General case' 0 C--N 1.326 -0.427 0 O-C-N 122.677 -0.308 . . . . 0.0 110.902 -179.701 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.551 HG13 HD13 ' A' ' 87' ' ' LEU . 0.5 OUTLIER -71.69 -33.78 49.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 120.792 0.33 . . . . 0.0 110.683 176.392 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.603 ' HA ' ' HB ' ' A' ' 40' ' ' ILE . 83.7 mt -77.64 -40.98 28.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-O 121.601 0.715 . . . . 0.0 109.479 174.191 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . 0.536 ' HA3' ' HB ' ' A' ' 39' ' ' THR . . . 104.3 177.2 25.27 Favored Glycine 0 N--CA 1.442 -0.927 0 CA-C-N 115.514 -0.766 . . . . 0.0 112.467 175.893 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 30.1 mmmt -76.71 62.56 2.01 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.088 0.47 . . . . 0.0 110.419 -178.457 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 118.07 19.68 4.68 Favored Glycine 0 N--CA 1.448 -0.54 0 C-N-CA 120.972 -0.633 . . . . 0.0 112.005 178.492 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.405 ' HA2' HG22 ' A' ' 33' ' ' ILE . . . 82.5 3.78 90.39 Favored Glycine 0 N--CA 1.449 -0.479 0 C-N-CA 120.875 -0.679 . . . . 0.0 112.521 179.081 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.687 ' HG3' HE21 ' A' ' 42' ' ' GLN . 20.8 tp10 -78.21 -37.66 44.95 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 120.79 0.328 . . . . 0.0 110.975 -177.874 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' THR . . . . . 0.591 ' O ' ' HG ' ' A' ' 43' ' ' LEU . 28.8 m -67.43 -40.23 85.48 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.648 -0.251 . . . . 0.0 111.492 -177.176 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.603 ' HB ' ' HA ' ' A' ' 33' ' ' ILE . 14.5 tt -63.8 -28.88 45.89 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.411 0 CA-C-O 121.172 0.511 . . . . 0.0 110.778 179.601 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . 0.622 ' HD3' ' HA ' ' A' ' 38' ' ' GLU . 52.1 mtpt -66.46 -40.59 89.46 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.195 0.522 . . . . 0.0 109.852 174.606 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . 0.687 HE21 ' HG3' ' A' ' 38' ' ' GLU . 76.4 mt-30 -70.76 -42.42 70.47 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.269 -0.878 . . . . 0.0 110.674 -176.693 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.591 ' HG ' ' O ' ' A' ' 39' ' ' THR . 81.8 mt -56.83 -47.06 81.18 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.589 -176.864 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 49.9 mt-30 -61.47 -53.5 55.7 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.431 -176.975 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -68.16 -39.65 82.56 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 112.033 0.383 . . . . 0.0 112.033 -175.591 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . 0.48 ' HD3' ' SD ' ' A' ' 82' ' ' MET . 12.3 ptm180 -70.01 -31.17 68.7 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.936 0.398 . . . . 0.0 111.214 -174.78 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . 0.574 ' HB2' HG21 ' A' ' 49' ' ' VAL . . . -93.27 -15.95 25.28 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.367 -177.111 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 73.49 25.45 72.56 Favored Glycine 0 N--CA 1.45 -0.401 0 CA-C-N 115.947 -0.57 . . . . 0.0 111.953 -178.729 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.574 HG21 ' HB2' ' A' ' 47' ' ' ALA . 35.1 m -123.93 173.88 9.06 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-O 120.843 0.354 . . . . 0.0 110.066 -177.399 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.475 ' HE2' HD13 ' A' ' 70' ' ' ILE . 2.2 tmmm? -109.97 123.33 49.45 Favored 'General case' 0 C--N 1.318 -0.762 0 N-CA-C 108.679 -0.86 . . . . 0.0 108.679 174.753 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' MET . . . . . 0.517 ' CE ' ' HB2' ' A' ' 79' ' ' ALA . 63.5 mtt -114.43 116.42 28.86 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.195 -179.671 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.504 ' CG2' ' HB2' ' A' ' 68' ' ' ARG . 9.9 tt -106.57 105.16 18.23 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.83 0 CA-C-O 121.484 0.659 . . . . 0.0 110.11 176.14 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.593 HD22 HD13 ' A' ' 67' ' ' LEU . 3.5 mm? -82.24 102.58 11.24 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 108.963 -0.754 . . . . 0.0 108.963 173.723 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.663 HD12 ' HB2' ' A' ' 66' ' ' PRO . 53.5 mt -79.25 86.92 1.23 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-O 121.433 0.635 . . . . 0.0 110.166 -176.372 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . 0.485 HE22 ' HB3' ' A' ' 65' ' ' LYS . 25.2 mm-40 -98.84 -24.91 14.81 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.355 -0.839 . . . . 0.0 109.516 -179.814 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -96.54 -31.69 12.64 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.333 -0.849 . . . . 0.0 110.849 -178.418 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -70.2 138.96 30.12 Favored Glycine 0 N--CA 1.453 -0.218 0 C-N-CA 121.016 -0.611 . . . . 0.0 112.557 -178.484 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 5.1 m -84.74 67.17 9.96 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.43 0.633 . . . . 0.0 110.805 -176.567 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . 0.448 ' HB2' ' HG2' ' A' ' 66' ' ' PRO . 27.5 mm-40 -124.43 67.03 1.07 Allowed 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.771 -0.649 . . . . 0.0 109.872 179.108 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 3.5 m-20 62.88 41.16 8.92 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 116.058 -0.519 . . . . 0.0 109.787 -176.046 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 7.0 t -80.64 -27.66 37.13 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.002 -0.544 . . . . 0.0 111.405 -175.905 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 87.4 m-20 -85.24 20.5 1.95 Allowed 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.338 0.59 . . . . 0.0 111.087 -178.252 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -138.44 -57.48 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-N 115.301 -0.863 . . . . 0.0 110.102 174.197 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 49.7 m-20 -128.92 -166.07 1.59 Allowed 'General case' 0 C--N 1.308 -1.221 0 CA-C-N 114.265 -1.334 . . . . 0.0 108.309 179.122 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . 0.729 ' HB2' ' HB ' ' A' ' 24' ' ' ILE . 66.9 mmtt -141.6 116.73 7.03 Favored Pre-proline 0 C--N 1.314 -0.937 0 CA-C-N 116.708 -0.224 . . . . 0.0 110.632 -176.784 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.663 ' HB2' HD12 ' A' ' 54' ' ' ILE . 25.1 Cg_exo -64.42 124.19 12.94 Favored 'Trans proline' 0 N--CA 1.461 -0.431 0 C-N-CA 122.82 2.347 . . . . 0.0 111.863 176.308 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.593 HD13 HD22 ' A' ' 53' ' ' LEU . 33.7 tp -124.1 106.84 10.67 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.954 -0.567 . . . . 0.0 109.839 177.793 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.581 ' HG2' ' HG2' ' A' ' 21' ' ' GLU . 87.4 mtt180 -96.98 105.59 17.77 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.139 177.711 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . 0.511 ' O ' ' HA ' ' A' ' 19' ' ' VAL . 4.4 mp -87.96 104.49 14.55 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 174.449 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.475 HD13 ' HE2' ' A' ' 50' ' ' LYS . 13.8 mt -104.34 126.93 59.01 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.026 -173.491 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 167.82 -142.52 7.55 Favored Glycine 0 N--CA 1.446 -0.648 0 N-CA-C 111.596 -0.602 . . . . 0.0 111.596 178.65 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . 0.602 ' HB3' ' HD1' ' A' ' 7' ' ' PHE . 15.1 m-20 -91.33 149.12 39.1 Favored Pre-proline 0 C--N 1.325 -0.489 0 CA-C-O 118.963 -0.541 . . . . 0.0 109.692 175.859 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . 0.656 ' HD3' HD22 ' A' ' 12' ' ' ASN . 77.5 Cg_exo -49.36 -39.53 43.94 Favored 'Trans proline' 0 C--N 1.343 0.285 0 C-N-CA 122.333 2.022 . . . . 0.0 112.31 -176.948 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 76.0 t80 -64.36 -56.32 15.2 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.262 -176.995 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.451 ' HG2' ' HB2' ' A' ' 72' ' ' ASP . 4.9 ptpt -68.06 -31.97 71.99 Favored 'General case' 0 C--O 1.223 -0.301 0 C-N-CA 120.671 -0.412 . . . . 0.0 111.296 179.41 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 53.1 t -65.18 -40.09 87.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.998 0.427 . . . . 0.0 110.012 178.163 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . 0.467 ' O ' ' HG2' ' A' ' 81' ' ' GLU . 19.4 tp60 -64.81 -51.88 59.81 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.032 176.707 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 25.1 mt-30 -62.97 -35.14 79.17 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 121.0 0.428 . . . . 0.0 110.853 -178.202 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . 0.599 ' HA ' ' HE3' ' A' ' 82' ' ' MET . . . -72.1 -35.31 69.15 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.999 179.812 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 52.7 t -72.29 -45.56 59.52 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.144 -179.457 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . 0.467 ' HG2' ' O ' ' A' ' 77' ' ' GLN . 10.2 pt-20 -66.83 -22.62 65.99 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.101 0.477 . . . . 0.0 110.024 177.834 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' MET . . . . . 0.599 ' HE3' ' HA ' ' A' ' 79' ' ' ALA . 42.8 ttp -71.5 -55.41 7.91 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.54 -0.755 . . . . 0.0 110.423 175.822 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.439 HG13 HD13 ' A' ' 43' ' ' LEU . 31.3 m -66.95 -34.97 73.44 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.169 0 C-N-CA 121.116 -0.234 . . . . 0.0 110.985 -179.455 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 66.6 mmm -62.17 -37.45 85.28 Favored 'General case' 0 CA--C 1.519 -0.229 0 CA-C-O 120.685 0.279 . . . . 0.0 110.505 176.391 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . 0.476 ' O ' ' HB2' ' A' ' 89' ' ' GLU . 36.5 t70 -65.8 -44.52 85.43 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.918 -179.781 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.4 HG22 ' HB3' ' A' ' 31' ' ' LEU . 57.8 mt -60.01 -31.25 47.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 121.148 0.499 . . . . 0.0 110.768 179.822 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.816 HD23 HG23 ' A' ' 24' ' ' ILE . 7.1 mp -81.48 -31.79 32.79 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.815 -0.629 . . . . 0.0 112.268 -177.176 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 15.3 ptm180 -95.88 -5.79 40.74 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.134 0.492 . . . . 0.0 111.132 -176.768 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . 0.476 ' HB2' ' O ' ' A' ' 85' ' ' ASP . 4.7 mm-40 . . . . . 0 C--O 1.251 1.137 0 CA-C-O 118.438 -0.791 . . . . 0.0 110.031 178.473 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.444 -0.781 0 N-CA-C 111.708 -0.557 . . . . 0.0 111.708 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 9.0 tt0 54.9 59.26 4.17 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.202 0.525 . . . . 0.0 109.916 -177.754 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . 0.651 ' CD1' ' HG2' ' A' ' 73' ' ' PRO . 9.4 m-85 61.05 -97.94 0.07 Allowed 'General case' 0 N--CA 1.463 0.178 0 CA-C-N 115.217 -0.901 . . . . 0.0 109.702 -176.082 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . 0.487 ' H ' ' HB2' ' A' ' 7' ' ' PHE . 0.6 OUTLIER 64.64 176.85 0.19 Allowed 'General case' 0 CA--C 1.534 0.35 0 O-C-N 123.704 0.627 . . . . 0.0 111.867 171.869 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . 0.538 ' HA ' ' NZ ' ' A' ' 75' ' ' LYS . 20.1 m-20 -106.64 85.72 2.21 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.527 -0.306 . . . . 0.0 111.013 179.601 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 38.8 t30 179.39 -77.13 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.063 -0.517 . . . . 0.0 109.865 178.325 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -172.37 99.88 0.15 Allowed 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.367 -0.833 . . . . 0.0 109.595 -178.698 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 6.5 p30 -66.32 114.31 5.28 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.36 0.6 . . . . 0.0 110.802 179.232 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 89.63 -95.33 2.08 Favored Glycine 0 N--CA 1.45 -0.425 0 CA-C-N 115.661 -0.699 . . . . 0.0 112.039 -179.028 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -113.97 -84.05 1.24 Allowed Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 121.017 -0.611 . . . . 0.0 111.668 178.602 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 7.8 tt0 -129.55 108.57 10.34 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 174.663 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . 0.562 ' HB3' HG23 ' A' ' 70' ' ' ILE . 13.6 m120 65.32 -176.29 0.18 Allowed 'General case' 0 CA--C 1.532 0.283 0 O-C-N 123.667 0.605 . . . . 0.0 110.741 -179.882 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -166.73 -71.26 0.03 OUTLIER Glycine 0 N--CA 1.449 -0.445 0 C-N-CA 120.652 -0.785 . . . . 0.0 112.076 179.24 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 94.3 m -72.91 135.1 45.03 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 120.669 0.271 . . . . 0.0 110.62 179.457 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.647 ' HA ' ' O ' ' A' ' 69' ' ' ILE . 6.2 p -129.72 124.32 58.89 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-O 121.13 0.49 . . . . 0.0 110.801 178.073 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 28.6 mt-30 -110.29 114.6 28.2 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.055 -0.52 . . . . 0.0 109.887 174.663 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.649 ' HA ' ' O ' ' A' ' 67' ' ' LEU . 43.4 mt-10 -90.37 116.04 28.02 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.086 0.469 . . . . 0.0 110.535 176.106 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 22.0 mm -103.69 137.42 32.33 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.767 0 CA-C-N 115.687 -0.688 . . . . 0.0 109.839 -179.561 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' MET . . . . . 0.445 ' HE3' ' HA ' ' A' ' 23' ' ' MET . 3.1 mmt -89.13 94.27 9.87 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 176.593 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.836 HG21 HD12 ' A' ' 87' ' ' LEU . 27.2 mm -77.66 129.19 77.52 Favored Pre-proline 0 C--N 1.318 -0.801 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.027 -175.06 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . 0.52 ' HB2' ' HB2' ' A' ' 28' ' ' LYS . 53.8 Cg_exo -52.93 125.43 18.22 Favored 'Trans proline' 0 N--CA 1.458 -0.596 0 C-N-CA 122.188 1.925 . . . . 0.0 110.685 172.01 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -57.63 -27.87 63.18 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 112.097 0.406 . . . . 0.0 112.097 -174.057 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -80.21 -30.66 40.94 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.511 177.306 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.52 ' HB2' ' HB2' ' A' ' 25' ' ' PRO . 21.2 mmtp -89.42 -4.41 58.02 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.727 0.299 . . . . 0.0 111.234 -177.966 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -57.44 -28.89 63.73 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.707 -178.173 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -62.28 -26.32 67.7 Favored Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 120.925 -0.655 . . . . 0.0 112.856 -179.81 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 69.6 mt -78.73 -39.84 35.18 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.883 0.341 . . . . 0.0 111.398 -178.173 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.554 HG22 HG22 ' A' ' 24' ' ' ILE . 0.0 OUTLIER -65.74 -38.06 81.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 121.19 0.519 . . . . 0.0 110.106 179.177 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 49.9 mt -72.61 -42.67 62.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-O 121.546 0.689 . . . . 0.0 109.499 175.838 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 100.57 39.61 3.16 Favored Glycine 0 CA--C 1.499 -0.938 0 CA-C-N 115.17 -0.923 . . . . 0.0 112.685 176.708 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 3.7 mppt? 53.0 36.9 23.28 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.079 -0.561 . . . . 0.0 111.45 179.265 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 159.04 -48.95 0.41 Allowed Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.54 -0.838 . . . . 0.0 112.145 -179.195 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 145.31 -6.68 1.52 Allowed Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.24 -0.981 . . . . 0.0 113.476 179.866 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 43.9 mm-40 -65.64 -40.76 92.86 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 117.006 0.403 . . . . 0.0 112.012 -179.014 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' THR . . . . . 0.72 ' O ' ' HG ' ' A' ' 43' ' ' LEU . 91.6 m -62.39 -54.64 37.41 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.876 -0.147 . . . . 0.0 111.278 -178.105 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.57 ' HA ' HD13 ' A' ' 43' ' ' LEU . 5.3 tt -58.34 -30.96 41.57 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.365 0 CA-C-O 121.219 0.533 . . . . 0.0 111.157 -179.346 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . 0.461 ' HE2' ' HB3' ' A' ' 41' ' ' LYS . 4.9 tmmm? -70.33 -41.72 72.86 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.932 -0.576 . . . . 0.0 109.819 177.842 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 15.4 mm-40 -69.37 -38.18 77.92 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.956 -179.492 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.72 ' HG ' ' O ' ' A' ' 39' ' ' THR . 73.7 mt -56.42 -43.9 79.83 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.826 -0.624 . . . . 0.0 111.215 -177.755 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 46.7 mt-30 -67.08 -31.25 71.61 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.376 -177.432 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -80.14 -43.01 22.38 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.892 0.377 . . . . 0.0 111.162 -178.833 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 13.5 ptm180 -75.52 -36.51 60.49 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.952 -0.567 . . . . 0.0 112.45 -173.352 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . 0.497 ' HB2' HG21 ' A' ' 49' ' ' VAL . . . -95.89 -17.21 21.27 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.861 0.362 . . . . 0.0 111.33 -178.247 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 79.41 3.17 88.58 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.879 -0.677 . . . . 0.0 112.208 -179.785 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.497 HG21 ' HB2' ' A' ' 47' ' ' ALA . 34.3 m -97.3 166.02 1.98 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-O 120.637 0.256 . . . . 0.0 110.379 -177.769 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 63.9 tttp -105.21 122.84 46.75 Favored 'General case' 0 C--N 1.316 -0.858 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 172.843 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' MET . . . . . 0.678 ' HE3' HG13 ' A' ' 83' ' ' VAL . 77.1 mtp -119.07 115.92 25.31 Favored 'General case' 0 C--N 1.316 -0.854 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 178.263 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.56 ' CG2' ' HB2' ' A' ' 68' ' ' ARG . 8.7 tt -105.4 105.4 18.59 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.937 0 CA-C-O 121.588 0.709 . . . . 0.0 110.734 179.826 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.707 HD22 HD12 ' A' ' 67' ' ' LEU . 3.7 mm? -78.57 103.15 8.32 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 173.042 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.803 HD12 ' HB2' ' A' ' 66' ' ' PRO . 56.7 mt -73.33 89.11 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-O 121.518 0.675 . . . . 0.0 110.462 -178.091 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 58.4 mt-30 -100.52 -34.25 9.99 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.03 -0.986 . . . . 0.0 110.339 -178.519 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 35.7 m-20 -96.46 6.25 49.15 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.662 -177.984 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -80.9 -173.07 46.89 Favored Glycine 0 N--CA 1.447 -0.586 0 C-N-CA 120.681 -0.771 . . . . 0.0 111.543 177.396 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 1.7 p -149.92 27.83 0.78 Allowed 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 117.245 0.522 . . . . 0.0 112.079 -178.315 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 5.7 pt20 -93.37 -50.61 5.37 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.976 178.762 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . 0.587 ' HB2' ' HG3' ' A' ' 66' ' ' PRO . 19.6 m120 -142.88 35.21 1.39 Allowed 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 109.592 -0.522 . . . . 0.0 109.592 179.083 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -76.82 -31.89 57.23 Favored 'General case' 0 C--N 1.314 -0.935 0 N-CA-C 112.583 0.586 . . . . 0.0 112.583 -169.669 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 7.4 p30 -82.65 -1.07 50.02 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 120.797 0.332 . . . . 0.0 111.222 -179.487 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 15.6 m -125.28 -146.56 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-N 116.158 -0.474 . . . . 0.0 109.827 179.218 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.425 ' HB3' ' HB3' ' A' ' 23' ' ' MET . 7.1 m-20 -56.62 134.43 54.51 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 109.593 -0.521 . . . . 0.0 109.593 174.777 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . 0.693 ' HB2' ' HB ' ' A' ' 24' ' ' ILE . 70.4 mmtt -84.02 129.12 59.98 Favored Pre-proline 0 C--N 1.318 -0.795 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.46 -165.243 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.803 ' HB2' HD12 ' A' ' 54' ' ' ILE . 17.3 Cg_exo -68.83 105.83 1.39 Allowed 'Trans proline' 0 N--CA 1.46 -0.492 0 C-N-CA 123.054 2.502 . . . . 0.0 111.413 174.522 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.707 HD12 HD22 ' A' ' 53' ' ' LEU . 31.6 tp -115.7 104.21 11.45 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.46 -0.336 . . . . 0.0 110.619 179.455 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.56 ' HB2' ' CG2' ' A' ' 52' ' ' ILE . 92.6 mtt180 -91.65 108.23 19.76 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.881 0.372 . . . . 0.0 110.131 176.882 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . 0.647 ' O ' ' HA ' ' A' ' 19' ' ' VAL . 22.1 mt -94.9 104.38 15.74 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 174.681 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.562 HG23 ' HB3' ' A' ' 16' ' ' ASN . 3.7 mt -110.85 127.54 67.86 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.847 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.19 -173.95 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 173.48 -147.17 9.34 Favored Glycine 0 N--CA 1.448 -0.565 0 C-N-CA 120.508 -0.853 . . . . 0.0 112.073 178.104 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . 0.532 ' O ' HG23 ' A' ' 76' ' ' VAL . 41.2 m-20 -84.12 140.1 39.65 Favored Pre-proline 0 C--N 1.323 -0.565 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 177.405 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . 0.651 ' HG2' ' CD1' ' A' ' 7' ' ' PHE . 76.5 Cg_exo -41.41 -53.4 3.18 Favored 'Trans proline' 0 CA--C 1.534 0.478 0 C-N-CA 123.746 2.964 . . . . 0.0 115.291 -169.443 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 35.8 p90 -76.31 -33.09 59.05 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 112.74 0.644 . . . . 0.0 112.74 -172.227 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.538 ' NZ ' ' HA ' ' A' ' 9' ' ' ASP . 6.1 ptpp? -72.49 -30.11 64.23 Favored 'General case' 0 CA--C 1.514 -0.412 0 C-N-CA 119.788 -0.765 . . . . 0.0 110.238 177.038 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.532 HG23 ' O ' ' A' ' 72' ' ' ASP . 92.3 t -63.08 -40.82 90.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 N-CA-C 109.427 -0.583 . . . . 0.0 109.427 177.035 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . 0.619 ' HA ' HE21 ' A' ' 77' ' ' GLN . 0.0 OUTLIER -72.65 -46.56 53.36 Favored 'General case' 0 N--CA 1.447 -0.579 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.903 178.049 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 23.9 mt-30 -61.29 -40.18 93.17 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 120.79 -0.364 . . . . 0.0 111.052 179.637 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . 0.631 ' HA ' ' HE3' ' A' ' 82' ' ' MET . . . -71.67 -32.95 68.43 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.482 177.695 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 5.6 t -61.2 -57.12 13.76 Favored 'General case' 0 CA--C 1.515 -0.393 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.188 177.262 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 17.4 mm-40 -62.29 -29.51 70.48 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.723 -179.162 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' MET . . . . . 0.631 ' HE3' ' HA ' ' A' ' 79' ' ' ALA . 43.6 ttp -63.27 -50.06 71.61 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.398 178.771 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.678 HG13 ' HE3' ' A' ' 51' ' ' MET . 30.5 m -83.77 -36.44 12.31 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-N 116.6 -0.273 . . . . 0.0 111.283 -177.147 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 27.4 ttt -65.3 -36.32 83.71 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.407 -179.849 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . 0.434 ' O ' ' HB2' ' A' ' 89' ' ' GLU . 35.0 t70 -62.54 -42.27 99.42 Favored 'General case' 0 C--O 1.223 -0.34 0 CA-C-N 116.595 -0.275 . . . . 0.0 110.466 178.502 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.494 HG13 ' O ' ' A' ' 82' ' ' MET . 52.8 mt -61.41 -31.29 50.03 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-O 121.446 0.641 . . . . 0.0 110.619 179.112 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.836 HD12 HG21 ' A' ' 24' ' ' ILE . 43.4 mt -88.71 -33.45 17.52 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.128 -176.225 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 17.7 tpt180 -77.33 -14.09 59.8 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.808 0.813 . . . . 0.0 109.504 177.309 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . 0.434 ' HB2' ' O ' ' A' ' 85' ' ' ASP . 6.4 tp10 . . . . . 0 C--O 1.25 1.093 0 CA-C-N 114.5 -1.227 . . . . 0.0 109.42 179.215 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.444 -0.794 0 N-CA-C 110.492 -1.043 . . . . 0.0 110.492 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 86.6 mm-40 -95.56 5.85 50.45 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 117.17 0.485 . . . . 0.0 110.808 179.963 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . 0.407 ' O ' ' HB2' ' A' ' 8' ' ' HIS . 17.2 m-85 55.63 -119.87 1.46 Allowed 'General case' 0 C--O 1.237 0.445 0 O-C-N 123.716 0.635 . . . . 0.0 110.612 176.623 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . 0.407 ' HB2' ' O ' ' A' ' 7' ' ' PHE . 60.4 m170 76.24 138.94 0.06 Allowed 'General case' 0 C--O 1.235 0.314 0 CA-C-O 121.966 0.888 . . . . 0.0 112.457 171.7 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . 0.543 ' HA ' ' HE2' ' A' ' 75' ' ' LYS . 12.8 p-10 -72.36 -21.43 61.3 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 114.957 -1.02 . . . . 0.0 111.46 -174.57 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 2.6 m120 -86.71 4.4 40.85 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.843 0.354 . . . . 0.0 110.95 175.139 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . 71.48 105.63 0.06 Allowed 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 114.936 -1.029 . . . . 0.0 112.423 174.292 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 3.3 t-20 -63.43 136.21 57.46 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.9 -0.591 . . . . 0.0 109.527 172.526 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -73.66 141.03 28.99 Favored Glycine 0 N--CA 1.45 -0.433 0 C-N-CA 121.07 -0.586 . . . . 0.0 113.011 -175.053 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 85.95 -68.59 3.34 Favored Glycine 0 N--CA 1.449 -0.466 0 C-N-CA 121.132 -0.556 . . . . 0.0 112.417 176.872 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 24.3 mm-40 -126.0 134.81 51.36 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 120.826 0.346 . . . . 0.0 110.245 -179.938 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . 0.607 ' HB2' HG21 ' A' ' 70' ' ' ILE . 13.3 m120 -93.42 -41.98 9.52 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.575 -177.869 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 109.25 -78.44 0.24 Allowed Glycine 0 N--CA 1.446 -0.671 0 C-N-CA 120.536 -0.84 . . . . 0.0 112.608 179.176 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' THR . . . . . 0.563 HG22 ' HA ' ' A' ' 73' ' ' PRO . 84.3 m -73.69 126.65 30.81 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.149 0.5 . . . . 0.0 111.201 -176.889 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.649 ' HA ' ' O ' ' A' ' 69' ' ' ILE . 7.1 p -140.76 129.27 24.46 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-N 115.382 -0.826 . . . . 0.0 110.011 177.617 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 80.5 mt-30 -108.43 122.86 47.9 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 121.063 0.459 . . . . 0.0 111.115 176.348 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.628 ' HA ' ' O ' ' A' ' 67' ' ' LEU . 44.1 mt-10 -95.63 117.43 30.44 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.252 -0.885 . . . . 0.0 110.145 177.35 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.734 HG12 HD13 ' A' ' 67' ' ' LEU . 25.5 mm -111.48 147.6 15.31 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.768 0 CA-C-N 116.0 -0.545 . . . . 0.0 109.815 -178.911 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' MET . . . . . 0.555 ' HB3' ' HB3' ' A' ' 64' ' ' ASP . 3.3 mmt -100.8 98.16 8.71 Favored 'General case' 0 N--CA 1.446 -0.656 0 N-CA-C 108.796 -0.816 . . . . 0.0 108.796 176.924 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.744 ' HB ' ' HB2' ' A' ' 65' ' ' LYS . 23.6 mm -80.18 128.68 72.51 Favored Pre-proline 0 C--N 1.32 -0.699 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.032 -173.433 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . 0.586 ' HD2' HD13 ' A' ' 87' ' ' LEU . 52.7 Cg_exo -51.86 125.59 17.54 Favored 'Trans proline' 0 N--CA 1.462 -0.375 0 C-N-CA 122.882 2.388 . . . . 0.0 111.942 176.734 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -47.8 -53.02 16.71 Favored 'General case' 0 C--O 1.237 0.414 0 N-CA-C 112.998 0.74 . . . . 0.0 112.998 -169.571 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -80.54 -26.46 54.26 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.844 -0.693 . . . . 0.0 113.128 -174.891 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 43.2 tttp -89.95 3.1 54.13 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.051 0.453 . . . . 0.0 110.73 -177.185 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . 0.546 ' O ' HG13 ' A' ' 32' ' ' VAL . . . -65.53 -22.81 66.75 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.808 177.98 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -55.45 -38.42 69.89 Favored Glycine 0 N--CA 1.449 -0.447 0 C-N-CA 120.888 -0.672 . . . . 0.0 111.928 176.739 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.553 ' HB3' HG22 ' A' ' 86' ' ' ILE . 31.9 mt -71.34 -37.87 71.67 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 111.595 0.22 . . . . 0.0 111.595 -179.101 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.546 HG13 ' O ' ' A' ' 29' ' ' ALA . 0.3 OUTLIER -67.32 -25.92 34.78 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.352 0 CA-C-O 121.353 0.597 . . . . 0.0 110.358 -179.133 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.442 ' HA ' ' HB ' ' A' ' 40' ' ' ILE . 56.1 mt -84.71 -39.6 14.45 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-N 115.385 -0.825 . . . . 0.0 109.504 174.59 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . 0.415 ' HA3' ' HB ' ' A' ' 39' ' ' THR . . . 125.95 -145.62 15.81 Favored Glycine 0 N--CA 1.445 -0.719 0 CA-C-N 115.72 -0.673 . . . . 0.0 113.11 174.435 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 74.9 mmtt -100.69 -29.18 12.44 Favored 'General case' 0 C--N 1.319 -0.753 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 179.005 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -152.6 31.61 0.84 Allowed Glycine 0 N--CA 1.45 -0.429 0 CA-C-N 115.534 -0.757 . . . . 0.0 111.727 177.409 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 79.87 0.16 84.28 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 121.106 -0.569 . . . . 0.0 112.339 -178.933 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -78.52 -28.45 46.2 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 120.932 0.396 . . . . 0.0 111.106 -179.291 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' THR . . . . . 0.65 ' O ' ' HG ' ' A' ' 43' ' ' LEU . 35.2 m -71.67 -51.71 21.66 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.817 -177.571 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.623 ' HA ' HD12 ' A' ' 43' ' ' LEU . 6.6 tt -58.41 -36.73 60.09 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.285 0 CA-C-O 121.091 0.472 . . . . 0.0 111.186 179.499 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 62.7 tttp -62.07 -40.05 94.51 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.813 -0.631 . . . . 0.0 110.039 178.101 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 41.8 mt-30 -75.96 -38.01 58.0 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.579 -0.737 . . . . 0.0 111.269 -179.269 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.65 ' HG ' ' O ' ' A' ' 39' ' ' THR . 80.8 mt -53.17 -40.49 64.4 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-O 120.897 0.38 . . . . 0.0 111.432 -178.078 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 68.9 mt-30 -59.85 -42.62 94.03 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.289 178.494 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -81.02 -29.34 35.14 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.99 -178.137 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 13.8 mmm180 -52.1 -45.32 64.83 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.736 177.618 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . 0.531 ' HB2' HG22 ' A' ' 49' ' ' VAL . . . -102.42 -11.49 18.56 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.72 -0.673 . . . . 0.0 111.429 -178.198 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 75.3 30.17 59.09 Favored Glycine 0 CA--C 1.52 0.365 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.04 -177.255 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.531 HG22 ' HB2' ' A' ' 47' ' ' ALA . 20.0 m -120.09 177.34 3.08 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-O 120.846 0.355 . . . . 0.0 110.504 -177.638 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 64.5 tttp -105.46 122.28 45.67 Favored 'General case' 0 C--N 1.318 -0.797 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 172.115 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' MET . . . . . 0.654 ' HE3' HG12 ' A' ' 69' ' ' ILE . 36.1 mtp -117.31 115.18 24.76 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 178.833 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.456 ' CG2' ' HB2' ' A' ' 68' ' ' ARG . 10.4 tt -110.76 110.82 33.59 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.798 0 CA-C-O 121.452 0.644 . . . . 0.0 110.901 -178.697 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.594 HD22 HD22 ' A' ' 67' ' ' LEU . 3.7 mm? -93.97 103.84 15.91 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.27 -0.877 . . . . 0.0 109.474 175.279 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.59 HD13 ' HB2' ' A' ' 66' ' ' PRO . 68.3 mt -75.33 87.52 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-O 121.613 0.72 . . . . 0.0 110.216 -178.818 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . 0.586 HE21 ' HB3' ' A' ' 53' ' ' LEU . 72.5 mm-40 -104.91 -31.32 9.31 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.02 -0.991 . . . . 0.0 109.34 179.705 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -80.87 -16.42 53.69 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.354 177.698 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . 0.704 ' O ' ' HB ' ' A' ' 61' ' ' THR . . . -78.39 130.42 10.05 Favored Glycine 0 N--CA 1.451 -0.337 0 N-CA-C 111.187 -0.765 . . . . 0.0 111.187 175.844 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 39.7 p -81.63 1.86 32.05 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 112.984 0.735 . . . . 0.0 112.984 -171.436 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 22.3 mp0 -65.6 -64.75 0.79 Allowed 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.134 0.492 . . . . 0.0 110.547 -176.696 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . 0.571 ' HB3' ' O ' ' A' ' 64' ' ' ASP . 14.4 m120 -122.0 29.93 6.85 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.277 -179.04 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' THR . . . . . 0.704 ' HB ' ' O ' ' A' ' 57' ' ' GLY . 12.4 t -66.59 -22.08 66.13 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.088 -179.202 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 23.2 t-20 -97.81 -17.28 19.43 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.182 -177.662 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.441 ' HB ' ' H ' ' A' ' 64' ' ' ASP . 16.0 m -121.59 -151.72 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.564 -176.578 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.571 ' O ' ' HB3' ' A' ' 60' ' ' ASN . 3.4 m-20 -51.29 126.1 15.97 Favored 'General case' 0 C--N 1.33 -0.242 0 O-C-N 123.314 0.384 . . . . 0.0 110.116 174.584 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . 0.744 ' HB2' ' HB ' ' A' ' 24' ' ' ILE . 34.5 mmtp -82.34 136.19 46.41 Favored Pre-proline 0 C--N 1.321 -0.673 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.393 -168.438 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.59 ' HB2' HD13 ' A' ' 54' ' ' ILE . 10.5 Cg_exo -71.8 110.44 2.9 Favored 'Trans proline' 0 N--CA 1.458 -0.588 0 C-N-CA 123.137 2.558 . . . . 0.0 111.305 175.953 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.851 HD12 HG13 ' A' ' 69' ' ' ILE . 1.6 tm? -114.65 141.1 48.24 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 115.827 -0.624 . . . . 0.0 109.453 179.023 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.531 ' N ' HD21 ' A' ' 67' ' ' LEU . 95.1 mtt180 -134.76 124.04 24.55 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.185 0.517 . . . . 0.0 111.465 168.607 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . 0.851 HG13 HD12 ' A' ' 67' ' ' LEU . 20.9 mt -102.95 104.62 16.86 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-N 115.206 -0.906 . . . . 0.0 109.279 173.445 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.607 HG21 ' HB2' ' A' ' 16' ' ' ASN . 11.8 mt -103.37 125.57 57.87 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.891 0 CA-C-N 116.484 -0.325 . . . . 0.0 110.246 -175.174 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 169.19 -123.21 1.06 Allowed Glycine 0 N--CA 1.447 -0.617 0 C-N-CA 120.505 -0.855 . . . . 0.0 112.934 178.349 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -115.26 139.11 24.07 Favored Pre-proline 0 C--N 1.324 -0.516 0 CA-C-O 118.759 -0.639 . . . . 0.0 109.995 -176.421 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . 0.563 ' HA ' HG22 ' A' ' 18' ' ' THR . 84.3 Cg_exo -40.47 -43.73 4.2 Favored 'Trans proline' 0 C--N 1.347 0.477 0 C-N-CA 123.406 2.737 . . . . 0.0 112.832 -176.264 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 78.8 t80 -60.61 -60.92 3.04 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.147 -0.933 . . . . 0.0 111.334 -178.626 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.543 ' HE2' ' HA ' ' A' ' 9' ' ' ASP . 25.5 pttt -76.54 -24.05 53.64 Favored 'General case' 0 CA--C 1.517 -0.314 0 N-CA-C 112.131 0.419 . . . . 0.0 112.131 -176.187 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 48.8 t -66.79 -39.89 84.67 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 N-CA-C 109.079 -0.711 . . . . 0.0 109.079 176.865 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . 0.468 ' O ' ' HG2' ' A' ' 81' ' ' GLU . 20.9 tp60 -74.0 -42.64 60.09 Favored 'General case' 0 N--CA 1.445 -0.706 0 CA-C-N 115.523 -0.762 . . . . 0.0 110.502 179.744 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 91.6 mt-30 -60.91 -43.83 98.0 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.848 0.356 . . . . 0.0 110.609 177.732 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . 0.485 ' HA ' ' HE1' ' A' ' 82' ' ' MET . . . -64.95 -38.78 92.09 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.692 178.171 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 44.3 t -62.44 -54.8 34.86 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.733 -0.667 . . . . 0.0 111.471 178.243 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . 0.468 ' HG2' ' O ' ' A' ' 77' ' ' GLN . 12.2 pt-20 -68.53 -19.59 64.51 Favored 'General case' 0 C--N 1.324 -0.511 0 C-N-CA 120.481 -0.488 . . . . 0.0 110.468 -178.468 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' MET . . . . . 0.485 ' HE1' ' HA ' ' A' ' 79' ' ' ALA . 52.3 ttp -72.97 -46.46 52.22 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.85 175.768 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.605 HG12 HD13 ' A' ' 43' ' ' LEU . 29.9 m -80.18 -29.41 12.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 C-N-CA 120.812 -0.355 . . . . 0.0 110.869 -179.352 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 12.8 tmm? -65.47 -34.39 78.16 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 174.143 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . 0.474 ' HB3' ' O ' ' A' ' 82' ' ' MET . 3.8 t70 -59.31 -42.12 90.64 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.229 -0.896 . . . . 0.0 110.626 174.502 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.553 HG22 ' HB3' ' A' ' 31' ' ' LEU . 30.1 mt -63.82 -34.11 66.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-O 121.359 0.599 . . . . 0.0 110.406 178.694 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.586 HD13 ' HD2' ' A' ' 25' ' ' PRO . 59.6 mt -85.52 -6.31 59.2 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.769 -178.952 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 67.7 ttt180 -102.26 -7.67 21.92 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.723 0.773 . . . . 0.0 109.537 176.479 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 10.8 tp10 . . . . . 0 C--O 1.253 1.242 0 CA-C-N 115.191 -0.913 . . . . 0.0 110.022 -174.451 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.445 -0.701 0 N-CA-C 111.751 -0.54 . . . . 0.0 111.751 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . 0.479 ' HA ' ' OE1' ' A' ' 6' ' ' GLN . 11.8 mm-40 61.26 77.49 0.33 Allowed 'General case' 0 C--O 1.237 0.443 0 CA-C-O 121.493 0.663 . . . . 0.0 110.46 -176.305 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 1.6 p90 -71.19 77.35 0.7 Allowed 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 114.877 -1.056 . . . . 0.0 111.873 -177.426 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 9.2 t60 67.54 -165.69 0.21 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.301 -0.863 . . . . 0.0 109.895 176.024 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -58.5 -54.06 51.28 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.896 0.379 . . . . 0.0 110.511 175.744 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 43.8 t30 -143.28 -50.69 0.34 Allowed 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.323 177.304 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -121.86 130.89 53.72 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.912 -0.586 . . . . 0.0 110.958 -177.228 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 3.3 p-10 -111.61 -24.86 9.85 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.888 -0.597 . . . . 0.0 109.949 177.732 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 75.76 -72.39 1.79 Allowed Glycine 0 N--CA 1.45 -0.407 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.764 -178.597 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -143.43 -47.59 0.04 OUTLIER Glycine 0 N--CA 1.446 -0.667 0 N-CA-C 110.682 -0.967 . . . . 0.0 110.682 176.15 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . 0.467 ' HG3' HG22 ' A' ' 70' ' ' ILE . 60.3 tt0 -97.09 108.48 21.23 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.102 0.477 . . . . 0.0 110.54 179.009 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . 0.6 ' HB3' ' O ' ' A' ' 71' ' ' GLY . 26.7 t30 -89.54 -55.83 3.49 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.136 177.357 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 165.06 -36.34 0.27 Allowed Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.782 -0.723 . . . . 0.0 111.734 178.608 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' THR . . . . . 0.408 HG23 ' HA ' ' A' ' 73' ' ' PRO . 59.5 m -66.35 128.31 35.67 Favored 'General case' 0 C--N 1.322 -0.592 0 C-N-CA 122.484 0.314 . . . . 0.0 110.613 176.499 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.451 ' HA ' ' O ' ' A' ' 69' ' ' ILE . 8.5 p -131.75 138.75 52.12 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 CA-C-O 120.91 0.386 . . . . 0.0 110.295 179.192 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 9.2 tt0 -124.24 135.67 53.58 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 109.698 -0.482 . . . . 0.0 109.698 178.607 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.538 ' HG2' ' HG2' ' A' ' 68' ' ' ARG . 51.5 mt-10 -104.28 125.73 50.78 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.309 0.576 . . . . 0.0 112.021 -178.938 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.456 ' HB ' ' HB3' ' A' ' 67' ' ' LEU . 14.2 mm -110.66 146.33 15.93 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 CA-C-N 115.104 -0.953 . . . . 0.0 109.077 174.821 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' MET . . . . . 0.477 ' HE1' ' HA ' ' A' ' 23' ' ' MET . 8.7 mmt -100.41 93.75 5.81 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 108.584 -0.895 . . . . 0.0 108.584 175.103 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.671 ' HB ' ' HB2' ' A' ' 65' ' ' LYS . 37.0 mm -79.35 126.06 81.97 Favored Pre-proline 0 C--N 1.318 -0.774 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.422 -177.331 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . 0.424 ' HB2' ' HB2' ' A' ' 28' ' ' LYS . 71.8 Cg_exo -52.39 134.36 51.46 Favored 'Trans proline' 0 N--CA 1.461 -0.433 0 C-N-CA 122.794 2.329 . . . . 0.0 111.714 175.709 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -58.51 -25.21 62.15 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.998 -177.753 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -89.35 -6.37 71.13 Favored Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.837 -0.697 . . . . 0.0 112.642 178.069 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.532 ' HB3' HD23 ' A' ' 87' ' ' LEU . 51.2 mttp -115.77 10.82 15.48 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.754 0.312 . . . . 0.0 111.366 -179.015 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -68.58 -29.82 68.45 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.205 0.526 . . . . 0.0 110.152 179.307 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -69.9 -17.88 73.85 Favored Glycine 0 N--CA 1.447 -0.584 0 CA-C-N 115.863 -0.608 . . . . 0.0 112.265 176.822 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.415 HD12 ' HG2' ' A' ' 28' ' ' LYS . 84.0 mt -83.13 -43.51 16.14 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.557 0.218 . . . . 0.0 110.706 -179.768 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.626 HG12 HD22 ' A' ' 87' ' ' LEU . 1.6 m -68.86 -33.33 58.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.308 -0.406 . . . . 0.0 111.174 178.697 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.489 ' HA ' ' HB ' ' A' ' 40' ' ' ILE . 88.8 mt -77.83 -40.71 27.48 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-O 121.52 0.676 . . . . 0.0 109.698 175.57 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 103.08 164.51 25.75 Favored Glycine 0 N--CA 1.442 -0.919 0 CA-C-N 115.353 -0.84 . . . . 0.0 111.576 -179.335 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 1.3 mptm? -79.13 54.41 1.63 Allowed 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.189 0.518 . . . . 0.0 110.849 -178.786 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 144.04 21.82 0.17 Allowed Glycine 0 N--CA 1.447 -0.603 0 CA-C-N 115.779 -0.646 . . . . 0.0 111.783 178.759 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 71.79 -0.66 35.12 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 121.028 -0.606 . . . . 0.0 112.358 -178.007 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.518 ' O ' ' HG2' ' A' ' 42' ' ' GLN . 14.2 pt-20 -64.66 -37.81 88.86 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.703 0.287 . . . . 0.0 111.276 -175.573 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' THR . . . . . 0.819 ' O ' ' HG ' ' A' ' 43' ' ' LEU . 56.4 m -69.92 -55.66 9.1 Favored 'General case' 0 N--CA 1.449 -0.482 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.383 -175.086 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.489 ' HB ' ' HA ' ' A' ' 33' ' ' ILE . 12.7 tt -61.91 -25.09 36.26 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-O 121.462 0.649 . . . . 0.0 111.013 -177.48 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 37.6 ttpt -71.8 -47.49 53.01 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.778 178.863 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . 0.518 ' HG2' ' O ' ' A' ' 38' ' ' GLU . 11.3 pt20 -72.32 -41.07 66.97 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.838 -0.619 . . . . 0.0 111.12 -177.259 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.819 ' HG ' ' O ' ' A' ' 39' ' ' THR . 48.6 mt -51.23 -48.44 62.08 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.769 -0.65 . . . . 0.0 111.731 -177.08 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 49.3 mt-30 -58.21 -42.16 85.62 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.27 -178.078 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 -81.33 -35.1 31.36 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.676 -174.308 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . 0.412 ' HG2' ' O ' ' A' ' 42' ' ' GLN . 15.0 ptm180 -78.85 -23.45 44.97 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 111.905 0.335 . . . . 0.0 111.905 -175.894 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . 0.62 ' HB2' ' HE1' ' A' ' 82' ' ' MET . . . -94.59 -24.53 17.18 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 120.908 0.385 . . . . 0.0 111.379 179.906 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 81.77 23.64 57.41 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.863 -0.684 . . . . 0.0 112.082 -178.687 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.46 HG22 ' HB3' ' A' ' 47' ' ' ALA . 17.7 m -130.36 178.98 4.62 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-O 120.833 0.349 . . . . 0.0 110.197 -179.083 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 87.2 tttt -109.83 124.63 51.65 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.012 176.177 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' MET . . . . . 0.92 ' HE3' ' HB3' ' A' ' 79' ' ' ALA . 60.5 mtt -113.38 116.01 28.99 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 109.583 -0.525 . . . . 0.0 109.583 178.632 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.465 ' CG2' ' HB2' ' A' ' 68' ' ' ARG . 11.0 tt -110.64 105.83 19.56 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 CA-C-O 121.632 0.729 . . . . 0.0 110.674 178.047 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.516 HD23 HD11 ' A' ' 67' ' ' LEU . 3.8 mm? -86.12 102.8 14.19 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.336 -0.847 . . . . 0.0 109.358 174.978 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.567 HD13 ' HB2' ' A' ' 66' ' ' PRO . 52.3 mt -80.57 86.51 1.47 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.411 0 CA-C-O 121.913 0.863 . . . . 0.0 110.121 179.588 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . 0.455 ' HG2' HD11 ' A' ' 33' ' ' ILE . 2.7 pp0? -132.66 -12.64 3.0 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 114.607 -1.179 . . . . 0.0 109.52 176.246 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -100.58 -26.42 13.83 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 114.916 -1.038 . . . . 0.0 110.135 -178.734 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -82.99 16.56 27.0 Favored Glycine 0 CA--C 1.518 0.262 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.461 179.847 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 13.8 m 58.22 -139.35 0.81 Allowed 'General case' 0 C--O 1.234 0.272 0 C-N-CA 122.657 0.383 . . . . 0.0 110.483 -177.824 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 96.6 mt-30 70.57 -72.27 0.11 Allowed 'General case' 0 N--CA 1.463 0.197 0 C-N-CA 123.199 0.6 . . . . 0.0 110.924 178.611 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . 0.482 ' HB3' ' O ' ' A' ' 64' ' ' ASP . 4.2 m-20 -102.86 42.01 1.19 Allowed 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 121.575 0.702 . . . . 0.0 109.954 177.077 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -71.54 -27.24 63.05 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.423 -0.808 . . . . 0.0 110.887 -179.922 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 9.2 t30 -93.68 -26.96 16.81 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.818 -0.628 . . . . 0.0 111.781 179.669 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.449 ' HB ' ' H ' ' A' ' 64' ' ' ASP . 30.6 m -111.8 -160.32 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 N-CA-C 112.166 0.432 . . . . 0.0 112.166 -173.967 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.482 ' O ' ' HB3' ' A' ' 60' ' ' ASN . 62.7 m-20 -59.13 154.7 15.38 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 115.451 -0.795 . . . . 0.0 110.988 179.084 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . 0.671 ' HB2' ' HB ' ' A' ' 24' ' ' ILE . 69.8 mmtt -98.81 121.22 56.76 Favored Pre-proline 0 C--N 1.32 -0.677 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.767 -174.273 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.567 ' HB2' HD13 ' A' ' 54' ' ' ILE . 27.1 Cg_exo -64.71 105.29 0.63 Allowed 'Trans proline' 0 N--CA 1.46 -0.473 0 C-N-CA 122.884 2.389 . . . . 0.0 111.746 174.614 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.516 HD11 HD23 ' A' ' 53' ' ' LEU . 25.1 tp -105.2 106.39 16.86 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 109.735 -0.469 . . . . 0.0 109.735 175.85 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.538 ' HG2' ' HG2' ' A' ' 21' ' ' GLU . 96.1 mtt180 -101.68 105.88 16.85 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.437 178.35 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . 0.451 ' O ' ' HA ' ' A' ' 19' ' ' VAL . 4.7 mp -86.22 103.99 13.31 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 N-CA-C 108.195 -1.039 . . . . 0.0 108.195 174.142 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.467 HG22 ' HG3' ' A' ' 15' ' ' GLN . 3.7 mt -103.43 112.86 38.51 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.038 -174.506 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . 0.6 ' O ' ' HB3' ' A' ' 16' ' ' ASN . . . -176.16 -128.38 1.12 Allowed Glycine 0 N--CA 1.439 -1.137 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.324 -179.489 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . 0.502 ' HB3' ' CG ' ' A' ' 75' ' ' LYS . 3.1 t70 -109.61 143.27 27.5 Favored Pre-proline 0 C--N 1.318 -0.769 0 CA-C-O 118.752 -0.642 . . . . 0.0 110.289 -177.006 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . 0.408 ' HA ' HG23 ' A' ' 18' ' ' THR . 86.7 Cg_exo -44.14 -39.94 12.0 Favored 'Trans proline' 0 C--N 1.346 0.443 0 C-N-CA 122.827 2.351 . . . . 0.0 113.262 -175.268 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 93.6 t80 -74.6 -53.71 8.84 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.798 -174.807 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.502 ' CG ' ' HB3' ' A' ' 72' ' ' ASP . 10.4 pttt -75.4 -17.49 60.18 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.531 -0.304 . . . . 0.0 111.79 -179.077 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 24.1 t -70.0 -40.19 78.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 171.855 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . 0.486 ' O ' ' HG2' ' A' ' 81' ' ' GLU . 21.2 tp60 -69.45 -46.3 67.05 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.06 178.904 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 86.4 mt-30 -58.89 -39.53 81.72 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.778 176.553 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . 0.92 ' HB3' ' HE3' ' A' ' 51' ' ' MET . . . -68.84 -36.8 78.61 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.143 178.781 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' CYS . . . . . 0.402 ' O ' ' HG3' ' A' ' 84' ' ' MET . 38.4 t -65.22 -50.8 64.47 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.921 178.974 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . 0.486 ' HG2' ' O ' ' A' ' 77' ' ' GLN . 9.9 pt-20 -69.69 -18.82 63.58 Favored 'General case' 0 C--N 1.324 -0.543 0 C-N-CA 120.513 -0.475 . . . . 0.0 110.2 178.415 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' MET . . . . . 0.626 ' SD ' HD23 ' A' ' 43' ' ' LEU . 36.7 ttm -70.55 -53.43 16.14 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.333 173.86 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.444 ' O ' ' HG ' ' A' ' 87' ' ' LEU . 26.9 m -70.55 -35.74 62.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 C-N-CA 121.048 -0.261 . . . . 0.0 111.399 -178.645 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' MET . . . . . 0.402 ' HG3' ' O ' ' A' ' 80' ' ' CYS . 52.7 mtm -69.64 -26.97 64.67 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.768 0.318 . . . . 0.0 110.177 177.556 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -60.15 -48.38 81.96 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 116.066 -0.515 . . . . 0.0 109.748 175.807 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 48.4 mt -60.49 -34.86 59.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 115.422 -0.808 . . . . 0.0 111.048 179.826 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.626 HD22 HG12 ' A' ' 32' ' ' VAL . 51.3 mt -81.26 -16.12 53.53 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.3 -178.024 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . 0.404 HH11 ' HD3' ' A' ' 88' ' ' ARG . 13.7 ttp180 -97.2 -33.84 11.33 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 121.429 0.633 . . . . 0.0 111.074 -177.759 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 12.3 tp10 . . . . . 0 C--N 1.307 -1.257 0 CA-C-N 114.878 -1.055 . . . . 0.0 110.83 -173.437 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.674 0 N-CA-C 112.398 -0.281 . . . . 0.0 112.398 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 30.1 mm-40 -76.49 -6.9 53.78 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.161 0.505 . . . . 0.0 109.65 176.292 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . 0.767 ' HD1' ' HA3' ' A' ' 17' ' ' GLY . 11.9 m-85 -93.15 -55.32 3.37 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.514 -0.767 . . . . 0.0 109.396 178.15 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 24.1 t-80 70.78 -74.91 0.08 Allowed 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 114.48 -1.236 . . . . 0.0 112.18 172.493 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . 0.781 ' HA ' ' HE2' ' A' ' 75' ' ' LYS . 16.9 p-10 -158.87 -55.29 0.06 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.957 0.408 . . . . 0.0 110.958 -175.674 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . 0.463 ' ND2' ' HB2' ' A' ' 50' ' ' LYS . 54.3 t-20 -131.39 -65.19 0.77 Allowed 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 108.836 -0.801 . . . . 0.0 108.836 -177.636 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -140.18 121.61 15.06 Favored 'General case' 0 N--CA 1.447 -0.61 0 CA-C-N 114.863 -1.062 . . . . 0.0 109.301 176.725 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 9.9 t30 -100.51 93.28 5.54 Favored 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 179.63 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 83.78 -98.69 2.14 Favored Glycine 0 N--CA 1.445 -0.703 0 N-CA-C 111.356 -0.698 . . . . 0.0 111.356 -176.626 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -123.57 2.73 9.47 Favored Glycine 0 N--CA 1.448 -0.562 0 C-N-CA 120.463 -0.875 . . . . 0.0 112.848 -179.931 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 17.8 mm-40 -118.83 139.19 52.02 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.271 0.557 . . . . 0.0 111.955 -174.587 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 20.6 m120 -100.95 129.27 46.77 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 108.035 -1.098 . . . . 0.0 108.035 170.446 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . 0.767 ' HA3' ' HD1' ' A' ' 7' ' ' PHE . . . -79.23 -94.16 0.32 Allowed Glycine 0 N--CA 1.449 -0.438 0 C-N-CA 120.796 -0.716 . . . . 0.0 113.905 -172.239 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' THR . . . . . 0.549 ' OG1' ' HG3' ' A' ' 73' ' ' PRO . 80.0 m -96.82 133.07 41.89 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 121.001 0.429 . . . . 0.0 111.079 -173.982 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.548 ' HA ' ' O ' ' A' ' 69' ' ' ILE . 4.5 p -137.44 134.92 46.85 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.587 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.208 177.672 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . 0.485 ' O ' ' HA ' ' A' ' 68' ' ' ARG . 33.2 mt-30 -121.11 157.84 29.22 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.019 176.142 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.51 ' HG2' ' HG2' ' A' ' 68' ' ' ARG . 40.2 mt-10 -124.16 107.72 11.53 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.024 -176.32 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 5.9 mm -99.01 140.97 17.33 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-N 115.86 -0.609 . . . . 0.0 109.776 -180.0 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 74.1 mmm -102.88 93.9 5.3 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 109.157 -0.683 . . . . 0.0 109.157 177.218 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.701 ' HB ' ' HB2' ' A' ' 65' ' ' LYS . 38.5 mm -81.88 132.59 53.8 Favored Pre-proline 0 C--N 1.321 -0.668 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.235 -174.711 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 75.5 Cg_exo -51.95 134.06 47.79 Favored 'Trans proline' 0 C--N 1.345 0.357 0 C-N-CA 122.959 2.439 . . . . 0.0 111.834 172.558 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -60.02 -33.05 71.48 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.214 179.758 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -68.58 -19.74 73.21 Favored Glycine 0 N--CA 1.449 -0.493 0 C-N-CA 120.892 -0.67 . . . . 0.0 112.578 177.332 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.533 ' HB3' HD22 ' A' ' 87' ' ' LEU . 5.2 mptp? -106.57 12.46 29.42 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.748 0.309 . . . . 0.0 111.004 -179.457 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.64 -31.75 71.86 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.008 0.432 . . . . 0.0 110.602 179.775 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -61.84 -24.24 64.35 Favored Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 120.864 -0.684 . . . . 0.0 112.571 179.564 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 83.7 mt -85.17 -48.52 9.06 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.684 0.242 . . . . 0.0 111.033 -177.99 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.556 HG13 HG13 ' A' ' 24' ' ' ILE . 2.9 m -67.89 -33.65 62.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.814 0.34 . . . . 0.0 111.758 -179.701 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 72.1 mt -80.56 -35.74 15.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 121.915 0.864 . . . . 0.0 109.462 176.321 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . 0.52 ' HA3' ' HB ' ' A' ' 39' ' ' THR . . . 94.99 52.07 1.83 Allowed Glycine 0 N--CA 1.439 -1.145 0 CA-C-N 115.208 -0.905 . . . . 0.0 113.808 172.204 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 30.8 mtmt 50.3 41.94 25.07 Favored 'General case' 0 C--N 1.328 -0.342 0 O-C-N 124.162 0.566 . . . . 0.0 112.204 169.659 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 129.03 -17.36 5.68 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.705 -0.76 . . . . 0.0 111.951 -179.36 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 116.18 7.48 14.54 Favored Glycine 0 N--CA 1.447 -0.611 0 C-N-CA 120.654 -0.784 . . . . 0.0 112.19 178.802 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 36.0 mt-10 -76.08 -47.55 24.12 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.786 0.327 . . . . 0.0 110.827 -178.99 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' THR . . . . . 0.633 ' O ' ' HG ' ' A' ' 43' ' ' LEU . 7.2 m -66.08 -44.05 85.56 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.451 -0.34 . . . . 0.0 111.46 -176.791 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.47 ' CD1' HD22 ' A' ' 53' ' ' LEU . 9.7 tt -60.42 -36.01 66.55 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.495 0 CA-C-O 121.032 0.444 . . . . 0.0 110.703 179.908 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 22.5 ttmm -61.13 -41.19 96.27 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.579 0.704 . . . . 0.0 110.134 175.302 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 48.1 mt-30 -74.51 -44.13 52.7 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.179 -0.919 . . . . 0.0 111.258 -177.387 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.633 ' HG ' ' O ' ' A' ' 39' ' ' THR . 94.9 mt -51.94 -49.96 62.12 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.923 -176.372 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . 0.434 ' HG3' ' O ' ' A' ' 40' ' ' ILE . 40.5 mt-30 -60.07 -57.49 12.6 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.157 -176.629 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -75.24 -22.11 58.12 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.674 -0.694 . . . . 0.0 112.276 -171.681 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 13.8 ptm180 -77.62 -33.41 53.65 Favored 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 120.304 -0.558 . . . . 0.0 110.727 177.865 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . 0.429 ' HB1' ' HE1' ' A' ' 82' ' ' MET . . . -88.33 -28.81 20.78 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.0 -178.3 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 95.57 21.32 24.48 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.856 -0.687 . . . . 0.0 112.709 -179.366 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 10.4 m -130.07 179.95 3.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-O 120.906 0.384 . . . . 0.0 110.684 -178.836 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.666 ' HE3' ' HB ' ' A' ' 52' ' ' ILE . 8.9 tmtm? -111.95 126.09 54.76 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.953 -0.567 . . . . 0.0 109.645 176.7 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' MET . . . . . 0.989 ' HE3' ' HB1' ' A' ' 79' ' ' ALA . 58.6 mtt -113.28 132.33 55.58 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 176.283 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.666 ' HB ' ' HE3' ' A' ' 50' ' ' LYS . 10.9 tt -120.39 113.56 40.73 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.721 0 CA-C-O 121.619 0.723 . . . . 0.0 110.817 175.874 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.721 HD21 HD13 ' A' ' 67' ' ' LEU . 3.6 mm? -88.67 104.19 16.64 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.013 -0.994 . . . . 0.0 109.138 175.45 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.561 ' HB ' ' HB2' ' A' ' 66' ' ' PRO . 52.6 mt -91.13 92.02 3.79 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.19 -176.95 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 11.3 mp0 -94.78 4.17 54.15 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.839 0.352 . . . . 0.0 110.772 -178.395 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -124.09 -50.59 1.8 Allowed 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.831 -178.892 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -82.19 77.85 2.04 Favored Glycine 0 N--CA 1.452 -0.245 0 C-N-CA 120.714 -0.755 . . . . 0.0 113.426 -170.84 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' SER . . . . . 0.925 ' HB3' HG21 ' A' ' 61' ' ' THR . 36.4 t -170.29 -36.44 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.515 0.198 . . . . 0.0 110.878 177.675 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . 0.447 ' HB2' ' O ' ' A' ' 58' ' ' SER . 18.7 mt-30 73.2 -11.58 0.88 Allowed 'General case' 0 N--CA 1.47 0.564 0 CA-C-N 115.934 -0.575 . . . . 0.0 111.463 -178.559 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . 0.45 ' H ' ' C ' ' A' ' 58' ' ' SER . 16.1 m120 -103.92 16.81 25.46 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 170.012 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' THR . . . . . 0.925 HG21 ' HB3' ' A' ' 58' ' ' SER . 0.7 OUTLIER -74.42 -18.88 60.59 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 114.362 -1.29 . . . . 0.0 112.405 -172.117 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 3.8 t-20 -68.93 -17.2 63.92 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.536 0.684 . . . . 0.0 109.188 173.56 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 9.2 t -105.71 -64.14 1.68 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.611 0 CA-C-N 114.915 -1.038 . . . . 0.0 111.307 -179.741 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.537 ' O ' ' HA ' ' A' ' 61' ' ' THR . 40.8 m-20 -114.24 161.95 17.18 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 115.555 -0.748 . . . . 0.0 110.805 -176.401 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . 0.701 ' HB2' ' HB ' ' A' ' 24' ' ' ILE . 69.8 mmtt -121.06 98.34 47.36 Favored Pre-proline 0 C--N 1.316 -0.863 0 CA-C-N 115.395 -0.821 . . . . 0.0 110.188 179.273 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.561 ' HB2' ' HB ' ' A' ' 54' ' ' ILE . 71.5 Cg_exo -54.2 115.64 2.51 Favored 'Trans proline' 0 C--O 1.234 0.305 0 C-N-CA 123.166 2.577 . . . . 0.0 112.31 174.861 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.721 HD13 HD21 ' A' ' 53' ' ' LEU . 31.3 tp -118.77 113.72 21.57 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.28 179.757 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.51 ' HG2' ' HG2' ' A' ' 21' ' ' GLU . 98.1 mtt180 -104.25 113.0 26.25 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 121.077 0.465 . . . . 0.0 110.707 175.943 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . 0.56 HG22 ' HB3' ' A' ' 79' ' ' ALA . 3.9 mp -95.21 109.45 22.43 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 175.085 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 8.1 mt -112.57 129.11 68.74 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 CA-C-N 116.462 -0.335 . . . . 0.0 111.162 -170.812 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 152.98 -127.14 2.13 Favored Glycine 0 N--CA 1.445 -0.746 0 C-N-CA 120.199 -1.0 . . . . 0.0 113.507 173.73 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . 0.436 ' HA ' ' HB3' ' A' ' 7' ' ' PHE . 19.7 t70 -85.87 133.27 41.75 Favored Pre-proline 0 C--N 1.322 -0.626 0 C-N-CA 123.19 0.596 . . . . 0.0 111.326 -176.626 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . 0.549 ' HG3' ' OG1' ' A' ' 18' ' ' THR . 32.4 Cg_exo -55.52 -28.49 64.83 Favored 'Trans proline' 0 C--N 1.35 0.627 0 C-N-CA 123.8 3.0 . . . . 0.0 113.524 -173.16 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 87.7 t80 -75.58 -54.49 6.92 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.045 0.45 . . . . 0.0 110.128 -177.9 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.781 ' HE2' ' HA ' ' A' ' 9' ' ' ASP . 7.6 pttm -79.52 -19.01 50.65 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.221 -0.445 . . . . 0.0 112.062 -178.353 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 25.2 t -69.43 -38.04 76.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 N-CA-C 109.815 -0.439 . . . . 0.0 109.815 172.895 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -71.51 -48.57 48.1 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 -179.632 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 27.8 mt-30 -59.06 -37.84 77.99 Favored 'General case' 0 C--O 1.22 -0.459 0 CA-C-N 115.784 -0.643 . . . . 0.0 110.583 176.565 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . 0.989 ' HB1' ' HE3' ' A' ' 51' ' ' MET . . . -64.61 -40.16 95.0 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.049 0.452 . . . . 0.0 110.291 -179.664 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' CYS . . . . . 0.453 ' SG ' HD11 ' A' ' 69' ' ' ILE . 88.6 m -65.72 -49.53 68.15 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.498 -0.774 . . . . 0.0 110.792 179.115 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . 0.451 ' O ' ' HB2' ' A' ' 85' ' ' ASP . 3.0 pp20? -72.08 -19.84 61.75 Favored 'General case' 0 C--N 1.326 -0.433 0 C-N-CA 120.075 -0.65 . . . . 0.0 110.902 -179.96 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' MET . . . . . 0.499 ' HE2' ' HA ' ' A' ' 79' ' ' ALA . 40.8 ttp -75.63 -49.2 19.18 Favored 'General case' 0 C--N 1.33 -0.248 0 O-C-N 123.053 0.221 . . . . 0.0 110.597 176.468 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.556 ' O ' ' HG ' ' A' ' 87' ' ' LEU . 35.7 m -67.18 -36.21 76.23 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.175 0 C-N-CA 120.712 -0.395 . . . . 0.0 110.485 178.487 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 91.2 mtp -72.01 -27.85 63.0 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.208 175.636 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . 0.451 ' HB2' ' O ' ' A' ' 81' ' ' GLU . 32.6 t70 -64.89 -45.5 85.67 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.171 -0.468 . . . . 0.0 109.855 176.022 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.434 HG13 ' O ' ' A' ' 82' ' ' MET . 70.2 mt -56.62 -37.14 50.95 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.183 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.599 176.882 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.615 HD11 HD12 ' A' ' 24' ' ' ILE . 50.3 mt -75.73 -35.87 60.09 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.757 -0.656 . . . . 0.0 111.435 -177.372 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . 0.431 HH11 ' HD2' ' A' ' 88' ' ' ARG . 9.1 ptp85 -79.3 -20.24 48.46 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.25 0.548 . . . . 0.0 110.672 -178.199 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 5.4 tp10 . . . . . 0 C--N 1.312 -1.055 0 CA-C-O 118.327 -0.844 . . . . 0.0 109.979 -173.475 . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.562 0 N-CA-C 112.255 -0.338 . . . . 0.0 112.255 . . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 80.0 mt-30 -73.74 -12.25 60.65 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-O 120.492 0.187 . . . . 0.0 110.834 178.106 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 24.6 m-85 71.97 -78.27 0.05 OUTLIER 'General case' 0 N--CA 1.465 0.298 0 O-C-N 123.904 0.753 . . . . 0.0 110.731 179.758 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER 60.94 76.5 0.37 Allowed 'General case' 0 N--CA 1.465 0.312 0 CA-C-O 120.905 0.383 . . . . 0.0 110.401 -177.521 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -64.33 -23.88 67.45 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.232 -174.043 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -77.73 55.75 1.4 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.823 0.344 . . . . 0.0 110.76 177.331 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . 59.14 86.48 0.09 Allowed 'General case' 0 C--O 1.234 0.269 0 CA-C-N 115.537 -0.756 . . . . 0.0 111.67 179.582 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . 0.423 HD22 ' ND2' ' A' ' 16' ' ' ASN . 11.0 p30 -72.06 149.75 44.57 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.155 176.138 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -95.01 52.48 1.91 Allowed Glycine 0 N--CA 1.445 -0.702 0 C-N-CA 120.66 -0.781 . . . . 0.0 112.269 -178.688 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -166.15 -109.49 0.22 Allowed Glycine 0 N--CA 1.444 -0.816 0 C-N-CA 120.639 -0.791 . . . . 0.0 112.41 -179.758 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 10.7 pt20 -129.33 148.34 51.24 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 120.743 0.306 . . . . 0.0 110.207 -177.397 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . 0.423 ' ND2' HD22 ' A' ' 12' ' ' ASN . 22.7 m120 -87.83 131.82 34.4 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.184 -0.462 . . . . 0.0 109.823 -179.651 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -102.7 7.66 53.62 Favored Glycine 0 N--CA 1.453 -0.224 0 C-N-CA 120.477 -0.868 . . . . 0.0 114.042 -171.629 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 18' ' ' THR . . . . . 0.64 HG23 ' HA ' ' A' ' 73' ' ' PRO . 23.9 m -124.26 126.73 46.57 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 117.764 0.782 . . . . 0.0 111.347 178.855 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.628 ' HA ' ' O ' ' A' ' 69' ' ' ILE . 7.2 p -141.34 127.99 20.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.907 176.667 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 85.4 mt-30 -109.43 132.35 54.21 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.589 176.483 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.58 ' HA ' ' O ' ' A' ' 67' ' ' LEU . 6.7 mp0 -103.0 118.77 37.55 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.371 177.15 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 11.7 mm -108.92 144.17 17.81 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-N 116.048 -0.523 . . . . 0.0 109.619 178.696 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 23' ' ' MET . . . . . 0.479 ' HE1' ' HA ' ' A' ' 23' ' ' MET . 9.4 mmt -100.08 91.52 4.81 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 109.699 -0.482 . . . . 0.0 109.699 176.436 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.663 ' HB ' ' HB2' ' A' ' 65' ' ' LYS . 41.3 mm -79.29 126.72 80.88 Favored Pre-proline 0 C--N 1.32 -0.677 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.011 -176.034 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . 0.609 ' HB2' ' HD3' ' A' ' 28' ' ' LYS . 65.9 Cg_exo -52.43 147.49 29.29 Favored 'Trans proline' 0 C--N 1.347 0.486 0 C-N-CA 123.166 2.577 . . . . 0.0 112.94 177.445 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -51.48 -55.96 15.97 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 112.232 0.456 . . . . 0.0 112.232 -173.932 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -75.48 -8.96 84.5 Favored Glycine 0 N--CA 1.454 -0.155 0 C-N-CA 121.103 -0.57 . . . . 0.0 112.618 -176.892 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.609 ' HD3' ' HB2' ' A' ' 25' ' ' PRO . 5.1 mptp? -92.78 -3.94 53.89 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.957 0.408 . . . . 0.0 110.815 -179.896 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -62.17 -32.1 72.68 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.489 177.342 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -67.32 -19.26 70.34 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.861 -0.685 . . . . 0.0 112.44 178.932 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 79.0 mt -87.03 -42.96 12.69 Favored 'General case' 0 C--N 1.327 -0.371 0 O-C-N 122.789 -0.242 . . . . 0.0 110.896 -178.898 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 4.1 m -69.9 -35.88 66.72 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.15 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.152 179.164 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.653 ' HA ' ' HB ' ' A' ' 40' ' ' ILE . 88.2 mt -76.95 -38.21 28.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-O 121.459 0.647 . . . . 0.0 109.892 177.939 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . 0.526 ' CA ' ' HB ' ' A' ' 39' ' ' THR . . . 124.32 157.05 9.63 Favored Glycine 0 N--CA 1.439 -1.137 0 C-N-CA 120.584 -0.817 . . . . 0.0 112.38 174.532 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 32.2 mmtp -58.65 -31.79 68.48 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 120.836 0.351 . . . . 0.0 110.642 -178.888 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -128.42 14.63 6.14 Favored Glycine 0 N--CA 1.449 -0.452 0 C-N-CA 120.952 -0.642 . . . . 0.0 111.879 175.751 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.524 ' HA2' HG22 ' A' ' 33' ' ' ILE . . . 84.48 1.78 89.17 Favored Glycine 0 C--N 1.332 0.315 0 C-N-CA 121.017 -0.611 . . . . 0.0 112.135 -177.347 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -85.39 -29.67 24.24 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 120.706 0.288 . . . . 0.0 111.385 -178.121 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 39' ' ' THR . . . . . 0.758 ' O ' ' HG ' ' A' ' 43' ' ' LEU . 91.3 m -62.51 -42.0 99.21 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.849 -174.796 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.653 ' HB ' ' HA ' ' A' ' 33' ' ' ILE . 15.6 tt -60.62 -30.17 46.29 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.287 0 CA-C-O 121.105 0.478 . . . . 0.0 111.093 -179.308 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . 0.665 ' O ' ' HG2' ' A' ' 45' ' ' GLU . 62.0 tttp -73.19 -44.05 60.43 Favored 'General case' 0 N--CA 1.451 -0.419 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 174.332 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 75.4 mt-30 -58.49 -43.72 89.12 Favored 'General case' 0 CA--C 1.515 -0.401 0 CA-C-N 115.681 -0.69 . . . . 0.0 110.106 -177.167 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.758 ' HG ' ' O ' ' A' ' 39' ' ' THR . 42.1 mt -53.89 -49.66 68.08 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.385 -0.825 . . . . 0.0 110.855 -179.644 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 48.4 mt-30 -64.68 -45.6 85.99 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.411 -0.813 . . . . 0.0 110.985 -179.377 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.665 ' HG2' ' O ' ' A' ' 41' ' ' LYS . 67.7 mm-40 -61.18 -41.91 97.63 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.078 -179.279 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . 0.517 ' HD3' ' SD ' ' A' ' 82' ' ' MET . 10.2 ptm180 -81.65 -36.43 28.84 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.767 -0.652 . . . . 0.0 112.651 -170.063 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . 0.478 ' HB1' HG22 ' A' ' 49' ' ' VAL . . . -90.26 -24.04 21.04 Favored 'General case' 0 C--N 1.324 -0.507 0 C-N-CA 120.498 -0.481 . . . . 0.0 111.187 -178.743 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 87.49 24.0 37.88 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.967 -0.635 . . . . 0.0 112.533 -179.657 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.478 HG22 ' HB1' ' A' ' 47' ' ' ALA . 14.0 m -121.77 179.31 2.42 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-O 120.923 0.392 . . . . 0.0 110.89 -178.002 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 87.3 tttt -117.58 122.41 43.55 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.548 -0.751 . . . . 0.0 109.162 173.708 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 51' ' ' MET . . . . . 0.815 ' HE2' HG12 ' A' ' 83' ' ' VAL . 65.2 mtp -116.9 115.52 25.67 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 -179.008 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.597 ' CG2' ' HB2' ' A' ' 68' ' ' ARG . 6.0 tt -105.61 105.8 19.36 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.782 0 CA-C-O 121.47 0.652 . . . . 0.0 110.984 -178.136 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.811 HD21 HD11 ' A' ' 67' ' ' LEU . 3.4 mm? -83.12 102.17 11.65 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.391 -0.822 . . . . 0.0 109.316 174.008 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.551 ' HB ' ' HB2' ' A' ' 66' ' ' PRO . 64.9 mt -81.65 85.57 1.63 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.432 0 CA-C-O 121.677 0.751 . . . . 0.0 110.333 -177.863 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 1.9 pp0? -116.04 -10.46 11.56 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 115.068 -0.969 . . . . 0.0 109.279 171.994 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -83.48 -15.87 47.84 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 114.938 -1.028 . . . . 0.0 109.826 179.456 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -84.79 -0.41 89.15 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.817 -0.706 . . . . 0.0 112.765 -179.786 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 17.8 m 57.32 -154.46 0.35 Allowed 'General case' 0 C--O 1.236 0.356 0 C-N-CA 122.711 0.404 . . . . 0.0 111.379 179.556 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 76.5 mm-40 68.56 -77.79 0.05 OUTLIER 'General case' 0 N--CA 1.466 0.339 0 C-N-CA 123.602 0.761 . . . . 0.0 110.909 178.641 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 2.7 m-20 -84.38 12.11 7.34 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.833 0.349 . . . . 0.0 110.716 -179.781 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 61' ' ' THR . . . . . 0.761 ' HA ' ' HE3' ' A' ' 65' ' ' LYS . 5.7 t -56.63 -31.62 64.51 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.632 0.253 . . . . 0.0 110.91 179.023 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 4.6 m-20 -83.44 -19.11 36.52 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 111.887 0.328 . . . . 0.0 111.887 -179.323 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 5.0 m -113.96 -126.14 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 N-CA-C 111.669 0.248 . . . . 0.0 111.669 -177.696 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -71.89 174.91 6.32 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.319 0.581 . . . . 0.0 111.326 179.007 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . 0.761 ' HE3' ' HA ' ' A' ' 61' ' ' THR . 31.6 mmtm -129.57 113.44 17.95 Favored Pre-proline 0 C--N 1.315 -0.894 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.696 179.713 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.551 ' HB2' ' HB ' ' A' ' 54' ' ' ILE . 52.6 Cg_exo -58.09 104.56 0.18 Allowed 'Trans proline' 0 N--CA 1.459 -0.512 0 C-N-CA 122.821 2.348 . . . . 0.0 111.632 173.678 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.811 HD11 HD21 ' A' ' 53' ' ' LEU . 18.9 tp -112.85 106.5 14.83 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.235 177.229 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.597 ' HB2' ' CG2' ' A' ' 52' ' ' ILE . 13.1 mtp180 -92.67 117.83 30.39 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 109.476 -0.564 . . . . 0.0 109.476 172.586 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . 0.628 ' O ' ' HA ' ' A' ' 19' ' ' VAL . 28.4 mt -96.94 102.31 13.32 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.089 0 N-CA-C 108.206 -1.035 . . . . 0.0 108.206 171.631 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 5.2 mt -103.4 119.39 51.88 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.042 -172.229 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . 0.4 ' O ' ' HB3' ' A' ' 16' ' ' ASN . . . 176.36 -137.11 3.49 Favored Glycine 0 N--CA 1.444 -0.817 0 C-N-CA 120.96 -0.638 . . . . 0.0 112.393 178.849 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . 0.822 ' HB2' ' HE2' ' A' ' 75' ' ' LYS . 44.9 m-20 -108.12 152.5 41.84 Favored Pre-proline 0 C--N 1.32 -0.713 0 N-CA-C 109.567 -0.531 . . . . 0.0 109.567 179.784 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . 0.64 ' HA ' HG23 ' A' ' 18' ' ' THR . 67.2 Cg_exo -48.89 -48.74 17.0 Favored 'Trans proline' 0 C--N 1.347 0.469 0 C-N-CA 123.359 2.706 . . . . 0.0 113.972 -167.106 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . 0.525 ' O ' ' HG2' ' A' ' 78' ' ' GLN . 45.1 m-85 -64.75 -51.94 59.66 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.703 -174.494 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.822 ' HE2' ' HB2' ' A' ' 72' ' ' ASP . 22.7 pttt -73.7 -23.82 59.85 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 112.175 0.435 . . . . 0.0 112.175 -176.528 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.409 HG22 ' O ' ' A' ' 72' ' ' ASP . 58.0 t -69.68 -40.92 79.89 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 N-CA-C 109.422 -0.584 . . . . 0.0 109.422 175.39 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . 0.581 HE21 ' HG3' ' A' ' 81' ' ' GLU . 18.1 tp60 -71.43 -46.27 60.53 Favored 'General case' 0 N--CA 1.445 -0.715 0 CA-C-N 115.494 -0.776 . . . . 0.0 111.313 -177.698 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . 0.603 ' HG2' ' HA ' ' A' ' 75' ' ' LYS . 3.3 pt20 -64.09 -38.56 91.51 Favored 'General case' 0 CA--C 1.508 -0.643 0 CA-C-O 121.489 0.661 . . . . 0.0 110.225 -179.676 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . 0.793 ' HA ' ' HE3' ' A' ' 82' ' ' MET . . . -63.34 -39.76 95.42 Favored 'General case' 0 C--N 1.313 -1.016 0 CA-C-N 114.556 -1.202 . . . . 0.0 110.384 176.863 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 52.0 t -64.62 -49.47 70.95 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.447 175.893 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . 0.581 ' HG3' HE21 ' A' ' 77' ' ' GLN . 45.4 mt-10 -56.0 -38.98 71.22 Favored 'General case' 0 CA--C 1.518 -0.286 0 CA-C-O 121.205 0.526 . . . . 0.0 110.054 176.244 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 82' ' ' MET . . . . . 0.793 ' HE3' ' HA ' ' A' ' 79' ' ' ALA . 37.5 ttp -63.43 -54.23 39.88 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 114.77 -1.105 . . . . 0.0 111.555 -178.719 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.815 HG12 ' HE2' ' A' ' 51' ' ' MET . 35.4 m -70.74 -37.86 70.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 C-N-CA 120.897 -0.321 . . . . 0.0 111.47 -177.225 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 88.9 mmm -66.38 -33.46 75.76 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.724 0.297 . . . . 0.0 110.34 177.339 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -62.37 -39.07 91.97 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.518 177.171 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.497 HG13 ' O ' ' A' ' 82' ' ' MET . 52.6 mt -66.4 -29.49 46.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.834 179.684 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.492 HD21 ' HB3' ' A' ' 28' ' ' LYS . 61.2 mt -85.1 -23.5 28.46 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.668 -176.231 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 15.7 ptm180 -99.64 -3.14 33.78 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 120.998 0.428 . . . . 0.0 111.192 -175.58 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 12.5 tp10 . . . . . 0 C--O 1.247 0.967 0 CA-C-N 115.661 -0.699 . . . . 0.0 109.892 -174.863 . . . . . . . . 0 0 . 1 . 022 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.517 0.165 0 N-CA-C 112.119 -0.392 . . . . 0.0 112.119 . . . . . . . . . 0 0 . 1 . 022 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 27.5 mm-40 61.01 29.72 19.16 Favored 'General case' 0 C--O 1.234 0.258 0 C-N-CA 123.107 0.563 . . . . 0.0 111.241 176.872 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . 0.448 ' O ' ' HD2' ' A' ' 75' ' ' LYS . 96.9 m-85 63.95 -86.12 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 115.042 -0.981 . . . . 0.0 111.305 179.492 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . 0.452 ' HB2' ' OD1' ' A' ' 72' ' ' ASP . 29.3 t-80 -110.61 62.8 0.61 Allowed 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 120.53 -0.468 . . . . 0.0 112.007 -175.272 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 10.4 t70 65.47 -74.29 0.06 Allowed 'General case' 0 CA--C 1.537 0.457 0 N-CA-C 112.75 0.648 . . . . 0.0 112.75 166.661 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 36.4 t30 -123.41 -50.07 1.89 Allowed 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 110.212 -0.292 . . . . 0.0 110.212 -179.807 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -155.85 130.48 9.04 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.921 0.391 . . . . 0.0 111.396 -178.589 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 19.9 t-20 -92.05 -64.3 1.13 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.194 175.825 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 149.36 -89.68 0.14 Allowed Glycine 0 N--CA 1.446 -0.674 0 C-N-CA 120.921 -0.657 . . . . 0.0 111.924 -178.207 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -115.82 -64.04 0.37 Allowed Glycine 0 N--CA 1.448 -0.524 0 C-N-CA 120.683 -0.77 . . . . 0.0 112.521 -178.199 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 52.6 mt-30 -75.45 108.38 8.22 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.917 0.389 . . . . 0.0 110.232 -178.759 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 66.2 t30 -91.55 -70.7 0.67 Allowed 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.136 -172.818 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -81.07 99.72 1.94 Allowed Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 121.015 -0.612 . . . . 0.0 112.878 -175.775 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 18' ' ' THR . . . . . 0.506 ' OG1' ' HG3' ' A' ' 73' ' ' PRO . 56.5 m -116.4 135.96 53.41 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 120.875 0.369 . . . . 0.0 110.683 177.456 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.456 ' HA ' ' O ' ' A' ' 69' ' ' ILE . 4.0 p -135.97 134.26 50.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.811 179.205 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 26.2 mt-30 -110.57 126.92 54.94 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 109.885 -0.413 . . . . 0.0 109.885 174.135 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.571 ' HA ' ' O ' ' A' ' 67' ' ' LEU . 26.0 mt-10 -101.23 122.17 43.18 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.957 -179.072 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 7.0 mm -114.02 155.95 15.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 115.828 -0.624 . . . . 0.0 109.891 -178.047 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 23' ' ' MET . . . . . 0.433 ' HB3' ' HB3' ' A' ' 64' ' ' ASP . 85.2 mmm -112.41 97.54 6.68 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 108.27 -1.011 . . . . 0.0 108.27 173.158 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.556 HG23 HG23 ' A' ' 32' ' ' VAL . 40.2 mm -83.89 126.97 69.13 Favored Pre-proline 0 C--N 1.319 -0.757 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.689 -172.575 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_exo -49.1 130.46 24.11 Favored 'Trans proline' 0 C--N 1.345 0.348 0 C-N-CA 123.071 2.514 . . . . 0.0 112.169 176.938 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -55.02 -29.9 58.37 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.605 -0.725 . . . . 0.0 112.657 -174.112 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -87.45 -31.68 15.63 Favored Glycine 0 N--CA 1.446 -0.658 0 C-N-CA 120.347 -0.93 . . . . 0.0 112.739 -178.712 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 4.2 tptm -93.92 -1.54 54.56 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 122.609 -0.347 . . . . 0.0 110.873 -175.002 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . 0.436 ' HA ' HG22 ' A' ' 32' ' ' VAL . . . -65.57 -21.42 66.59 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.279 -179.143 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -60.18 -37.17 92.5 Favored Glycine 0 N--CA 1.448 -0.561 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.354 179.819 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 92.4 mt -75.29 -27.44 59.34 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.701 0.286 . . . . 0.0 111.371 -174.922 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.657 HG13 ' HB ' ' A' ' 83' ' ' VAL . 1.4 t -69.38 -36.57 72.56 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.365 0 CA-C-O 121.586 0.708 . . . . 0.0 110.222 179.285 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.52 HG12 ' HG ' ' A' ' 53' ' ' LEU . 34.8 mt -86.19 -40.68 14.57 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-N 115.116 -0.947 . . . . 0.0 110.28 -178.302 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 124.88 -170.83 16.87 Favored Glycine 0 N--CA 1.442 -0.933 0 CA-C-N 115.58 -0.736 . . . . 0.0 111.565 179.801 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 33.7 mmtp -82.45 -27.63 31.77 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-O 121.128 0.49 . . . . 0.0 109.711 179.866 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -145.01 12.02 1.87 Allowed Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.861 -0.685 . . . . 0.0 112.367 178.658 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 96.07 16.64 37.56 Favored Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.789 -0.719 . . . . 0.0 111.974 179.542 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -85.13 -37.15 20.56 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 120.635 0.255 . . . . 0.0 110.398 178.84 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 39' ' ' THR . . . . . 0.816 ' O ' ' HG ' ' A' ' 43' ' ' LEU . 26.5 m -60.41 -55.83 28.85 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.928 -179.22 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.505 ' HB ' ' HA ' ' A' ' 33' ' ' ILE . 7.9 tt -55.34 -24.65 15.85 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-O 121.064 0.459 . . . . 0.0 111.781 -178.753 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 25.3 ttmm -79.41 -46.73 16.99 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.589 179.91 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . 0.436 ' O ' ' HG2' ' A' ' 46' ' ' ARG . 11.5 pt20 -69.89 -35.64 74.79 Favored 'General case' 0 CA--C 1.515 -0.387 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.318 -177.259 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.816 ' HG ' ' O ' ' A' ' 39' ' ' THR . 77.0 mt -53.11 -45.75 68.43 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.589 -0.732 . . . . 0.0 111.256 -178.576 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 49.2 mt-30 -67.44 -33.54 75.36 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.747 -0.661 . . . . 0.0 111.037 -178.968 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 31.8 mm-40 -72.94 -32.06 65.01 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.147 -178.064 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . 0.436 ' HG2' ' O ' ' A' ' 42' ' ' GLN . 14.9 ptp180 -92.27 -42.19 9.98 Favored 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 112.143 0.423 . . . . 0.0 112.143 -175.882 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . 0.476 ' O ' ' HD3' ' A' ' 75' ' ' LYS . . . -74.9 -31.67 61.63 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.767 0.318 . . . . 0.0 111.072 -177.724 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 92.11 -3.95 77.26 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.876 -0.678 . . . . 0.0 112.088 -178.432 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.449 ' CG1' ' HG3' ' A' ' 75' ' ' LYS . 15.5 m -102.55 169.02 1.98 Allowed 'Isoleucine or valine' 0 CA--C 1.512 -0.516 0 CA-C-O 121.221 0.534 . . . . 0.0 111.022 -179.623 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 86.0 tttt -101.26 124.48 47.03 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-N 115.347 -0.842 . . . . 0.0 110.045 176.286 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 51' ' ' MET . . . . . 0.852 ' HE3' ' HB2' ' A' ' 79' ' ' ALA . 58.8 mtt -109.55 114.66 28.47 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 175.919 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.571 ' CG2' ' HB2' ' A' ' 68' ' ' ARG . 10.0 tt -109.63 104.94 17.88 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.994 0 CA-C-O 121.724 0.773 . . . . 0.0 109.988 177.791 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.52 ' HG ' HG12 ' A' ' 33' ' ' ILE . 3.8 mm? -77.98 102.82 7.56 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 114.945 -1.025 . . . . 0.0 108.6 173.166 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.767 ' HB ' ' HG2' ' A' ' 66' ' ' PRO . 51.0 mt -76.04 88.52 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-O 121.777 0.798 . . . . 0.0 109.734 -177.233 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 13.6 mm100 -93.22 -10.85 34.23 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 114.845 -1.07 . . . . 0.0 111.427 -171.568 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 1.7 p30 -146.42 11.17 1.13 Allowed 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 111.934 0.346 . . . . 0.0 111.934 179.811 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -101.15 39.88 2.6 Favored Glycine 0 CA--C 1.509 -0.3 0 C-N-CA 120.629 -0.796 . . . . 0.0 112.161 178.88 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 34.4 t -179.02 173.91 1.13 Allowed 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 109.195 -0.669 . . . . 0.0 109.195 -176.253 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 46.3 mt-30 -108.74 4.9 24.22 Favored 'General case' 0 N--CA 1.445 -0.696 0 N-CA-C 107.576 -1.268 . . . . 0.0 107.576 175.009 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . 0.511 ' HA ' HG22 ' A' ' 63' ' ' VAL . 16.4 m120 -84.99 16.08 3.64 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-N 114.403 -1.271 . . . . 0.0 109.121 172.973 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 61' ' ' THR . . . . . 0.567 ' HA ' ' HE3' ' A' ' 65' ' ' LYS . 17.3 p -61.77 -23.15 66.0 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.197 -0.91 . . . . 0.0 111.119 179.176 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 17.0 m120 -106.82 6.37 29.41 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.686 -0.688 . . . . 0.0 111.185 -177.532 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.511 HG22 ' HA ' ' A' ' 60' ' ' ASN . 13.8 m -137.77 -147.85 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 116.002 -0.544 . . . . 0.0 109.729 179.777 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.433 ' HB3' ' HB3' ' A' ' 23' ' ' MET . 19.1 m-20 -58.39 126.69 28.62 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.144 0.497 . . . . 0.0 110.058 178.663 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . 0.567 ' HE3' ' HA ' ' A' ' 61' ' ' THR . 12.2 mmmm -90.48 133.62 32.56 Favored Pre-proline 0 C--N 1.323 -0.572 0 CA-C-N 115.385 -0.825 . . . . 0.0 112.738 -168.043 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.767 ' HG2' ' HB ' ' A' ' 54' ' ' ILE . 30.3 Cg_endo -64.62 113.83 2.47 Favored 'Trans proline' 0 CA--C 1.533 0.46 0 C-N-CA 123.465 2.777 . . . . 0.0 111.65 172.539 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.571 ' O ' ' HA ' ' A' ' 21' ' ' GLU . 57.0 tp -123.36 129.35 51.18 Favored 'General case' 0 C--N 1.324 -0.531 0 O-C-N 122.338 -0.226 . . . . 0.0 110.579 179.571 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.571 ' HB2' ' CG2' ' A' ' 52' ' ' ILE . 95.7 mtt180 -120.89 114.9 22.24 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.694 0.283 . . . . 0.0 110.984 176.567 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . 0.456 ' O ' ' HA ' ' A' ' 19' ' ' VAL . 4.5 mp -98.24 106.4 18.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 N-CA-C 108.228 -1.027 . . . . 0.0 108.228 171.82 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.422 HG12 ' CG2' ' A' ' 19' ' ' VAL . 15.4 mt -109.85 132.82 57.05 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-N 116.464 -0.334 . . . . 0.0 111.076 -171.98 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 153.91 -132.54 3.6 Favored Glycine 0 N--CA 1.448 -0.51 0 C-N-CA 120.952 -0.642 . . . . 0.0 112.595 176.28 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . 0.612 ' OD2' ' HG2' ' A' ' 75' ' ' LYS . 1.1 t70 -81.0 134.56 52.62 Favored Pre-proline 0 C--N 1.324 -0.524 0 C-N-CA 122.692 0.397 . . . . 0.0 110.882 -178.674 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . 0.506 ' HG3' ' OG1' ' A' ' 18' ' ' THR . 63.9 Cg_exo -47.96 -34.12 21.92 Favored 'Trans proline' 0 C--N 1.349 0.562 0 C-N-CA 123.878 3.052 . . . . 0.0 113.972 -177.314 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 73.0 m-85 -80.38 -55.81 4.63 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.755 0.312 . . . . 0.0 110.547 -176.123 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.729 ' HB3' ' HZ3' ' A' ' 75' ' ' LYS . 0.3 OUTLIER -71.07 -22.75 62.07 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.256 -177.587 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 20.5 t -64.85 -43.05 96.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 N-CA-C 109.713 -0.477 . . . . 0.0 109.713 171.249 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -68.59 -46.86 68.25 Favored 'General case' 0 N--CA 1.448 -0.527 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 177.845 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 28.0 mm-40 -61.57 -40.44 94.76 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.026 -179.309 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . 0.852 ' HB2' ' HE3' ' A' ' 51' ' ' MET . . . -67.71 -34.37 76.73 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.017 0.437 . . . . 0.0 110.34 177.546 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 49.2 t -63.01 -48.26 79.54 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.577 -0.738 . . . . 0.0 109.693 175.243 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 75.8 mm-40 -57.82 -44.78 86.62 Favored 'General case' 0 C--O 1.22 -0.479 0 N-CA-C 109.766 -0.457 . . . . 0.0 109.766 174.497 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 82' ' ' MET . . . . . 0.515 ' SD ' HD22 ' A' ' 43' ' ' LEU . 32.5 ttm -52.85 -58.52 6.65 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.385 -0.825 . . . . 0.0 111.267 -179.387 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.657 ' HB ' HG13 ' A' ' 32' ' ' VAL . 35.3 m -73.0 -35.49 48.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.887 -175.813 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 83.5 mtp -77.54 -30.06 52.61 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 120.861 -0.335 . . . . 0.0 111.253 -177.707 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -62.34 -43.52 98.64 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-O 120.911 0.386 . . . . 0.0 110.244 178.835 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 57.9 mt -61.15 -29.18 45.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 115.837 -0.619 . . . . 0.0 110.61 178.32 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.43 HD11 HG21 ' A' ' 32' ' ' VAL . 5.9 mp -84.91 -40.63 16.81 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.498 -0.774 . . . . 0.0 112.208 -176.714 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 25.5 ptt180 -84.51 -8.12 59.04 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.867 0.365 . . . . 0.0 111.704 -174.207 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 . . . . . 0 C--O 1.249 1.063 0 CA-C-O 118.359 -0.829 . . . . 0.0 109.956 -178.228 . . . . . . . . 0 0 . 1 . 023 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.403 0 N-CA-C 111.853 -0.499 . . . . 0.0 111.853 . . . . . . . . . 0 0 . 1 . 023 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 14.0 mt-30 -113.22 26.62 10.29 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.436 0.636 . . . . 0.0 109.931 -178.198 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . 0.77 ' HA ' ' HB2' ' A' ' 72' ' ' ASP . 64.6 t80 83.41 105.43 0.06 Allowed 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 113.958 -1.473 . . . . 0.0 112.38 179.242 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 2.5 t-80 58.73 -85.91 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 113.721 -1.581 . . . . 0.0 112.935 169.916 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . 0.434 ' O ' ' HB2' ' A' ' 10' ' ' ASN . 31.3 m-20 -112.9 37.43 3.11 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.831 -0.168 . . . . 0.0 110.841 -172.544 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . 0.434 ' HB2' ' O ' ' A' ' 9' ' ' ASP . 6.0 m-20 73.94 -53.08 0.69 Allowed 'General case' 0 N--CA 1.467 0.425 0 O-C-N 123.78 0.675 . . . . 0.0 112.097 175.754 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -100.61 84.31 2.73 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 116.621 -0.263 . . . . 0.0 111.229 -177.806 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . 0.68 ' HB3' ' HB3' ' A' ' 7' ' ' PHE . 10.4 p30 -68.64 151.92 46.06 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 109.786 -0.45 . . . . 0.0 109.786 174.846 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -78.72 54.05 4.08 Favored Glycine 0 CA--C 1.518 0.23 0 C-N-CA 120.959 -0.639 . . . . 0.0 113.173 -175.618 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 86.08 -41.31 3.07 Favored Glycine 0 N--CA 1.447 -0.581 0 C-N-CA 121.217 -0.516 . . . . 0.0 112.377 177.874 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 34.2 tt0 -118.98 130.33 55.63 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 120.948 0.404 . . . . 0.0 110.312 -178.389 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . 0.649 ' HB3' ' HA2' ' A' ' 71' ' ' GLY . 31.5 m-80 -71.79 146.01 48.32 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.514 -0.766 . . . . 0.0 109.65 177.005 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -107.28 -36.3 2.52 Favored Glycine 0 CA--C 1.519 0.336 0 C-N-CA 120.638 -0.792 . . . . 0.0 114.231 -171.822 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 18' ' ' THR . . . . . 0.598 ' OG1' ' HD3' ' A' ' 73' ' ' PRO . 89.0 m -70.5 126.73 30.45 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 117.231 0.515 . . . . 0.0 110.725 -177.122 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.452 ' HA ' ' O ' ' A' ' 69' ' ' ILE . 9.1 p -140.64 140.72 33.36 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-O 120.814 0.34 . . . . 0.0 110.751 -179.783 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 25.7 mt-30 -128.12 138.72 52.64 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 109.642 -0.503 . . . . 0.0 109.642 174.394 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.602 ' HG2' ' HG2' ' A' ' 68' ' ' ARG . 44.8 mt-10 -102.62 116.88 33.48 Favored 'General case' 0 C--N 1.328 -0.368 0 O-C-N 123.315 0.384 . . . . 0.0 110.805 -179.57 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 13.1 mm -100.39 150.31 5.61 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-N 115.918 -0.583 . . . . 0.0 109.639 178.47 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 23' ' ' MET . . . . . 0.408 ' HE1' ' HA ' ' A' ' 23' ' ' MET . 1.7 mmt -103.16 91.61 4.17 Favored 'General case' 0 C--N 1.317 -0.811 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 175.191 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.659 ' HB ' ' HB2' ' A' ' 65' ' ' LYS . 36.1 mm -77.39 124.1 86.88 Favored Pre-proline 0 C--N 1.323 -0.547 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.765 -176.236 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . 0.559 ' HB2' ' HB2' ' A' ' 28' ' ' LYS . 68.4 Cg_exo -51.83 135.41 50.08 Favored 'Trans proline' 0 N--CA 1.461 -0.396 0 C-N-CA 122.898 2.399 . . . . 0.0 111.737 177.717 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -56.25 -35.36 67.32 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 115.649 -0.705 . . . . 0.0 112.371 -175.072 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -80.22 -15.9 77.58 Favored Glycine 0 N--CA 1.452 -0.238 0 C-N-CA 120.519 -0.848 . . . . 0.0 111.875 178.95 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.559 ' HB2' ' HB2' ' A' ' 25' ' ' PRO . 0.3 OUTLIER -94.89 -4.38 47.02 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.755 0.312 . . . . 0.0 110.591 179.441 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.16 -27.95 68.77 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.424 -178.02 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -65.15 -24.27 70.31 Favored Glycine 0 CA--C 1.519 0.309 0 C-N-CA 120.785 -0.721 . . . . 0.0 112.356 178.253 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 95.1 mt -86.14 -42.66 13.68 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 111.352 0.13 . . . . 0.0 111.352 -176.219 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.862 HG12 HD23 ' A' ' 87' ' ' LEU . 2.7 m -65.19 -34.46 70.71 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.19 0 CA-C-O 120.928 0.394 . . . . 0.0 110.857 178.605 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 66.4 mt -79.89 -45.71 22.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-O 121.469 0.652 . . . . 0.0 109.689 176.241 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . 0.409 ' HA3' ' H ' ' A' ' 39' ' ' THR . . . 96.64 60.07 1.0 Allowed Glycine 0 N--CA 1.444 -0.773 0 CA-C-N 115.719 -0.673 . . . . 0.0 113.123 175.514 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.458 ' N ' ' HD3' ' A' ' 35' ' ' LYS . 0.0 OUTLIER 55.32 24.69 6.73 Favored 'General case' 0 N--CA 1.467 0.386 0 C-N-CA 122.949 0.5 . . . . 0.0 112.09 175.093 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 145.36 -52.18 0.59 Allowed Glycine 0 N--CA 1.449 -0.465 0 N-CA-C 111.58 -0.608 . . . . 0.0 111.58 -179.459 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.401 ' O ' ' HB2' ' A' ' 41' ' ' LYS . . . 165.02 24.23 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.429 -0.891 . . . . 0.0 113.694 176.462 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.607 ' O ' ' HG2' ' A' ' 42' ' ' GLN . 40.5 mm-40 -85.03 -43.51 13.88 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 117.344 0.572 . . . . 0.0 110.954 -179.23 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 39' ' ' THR . . . . . 0.712 ' O ' ' HG ' ' A' ' 43' ' ' LEU . 82.2 m -66.51 -53.9 29.83 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.488 -176.865 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.563 HD12 HD21 ' A' ' 53' ' ' LEU . 7.1 tt -56.15 -31.85 32.82 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.419 0 CA-C-O 121.56 0.695 . . . . 0.0 110.472 179.029 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . 0.466 ' HB3' ' O ' ' A' ' 38' ' ' GLU . 83.5 tttt -62.47 -43.26 99.25 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.003 -0.999 . . . . 0.0 110.569 177.687 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . 0.607 ' HG2' ' O ' ' A' ' 38' ' ' GLU . 61.5 mm-40 -72.66 -43.71 62.82 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.962 -177.84 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.712 ' HG ' ' O ' ' A' ' 39' ' ' THR . 37.5 mt -54.87 -49.77 70.32 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.494 -0.775 . . . . 0.0 111.863 -172.913 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 43.8 mt-30 -59.46 -38.44 80.77 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.835 -0.62 . . . . 0.0 111.222 -177.6 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 9.1 mm-40 -76.74 -42.48 40.99 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.382 -176.67 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . 0.438 ' HG2' ' O ' ' A' ' 42' ' ' GLN . 16.2 ptp180 -74.35 -33.73 63.2 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 112.05 0.389 . . . . 0.0 112.05 -174.677 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . 0.535 ' HB3' HG23 ' A' ' 49' ' ' VAL . . . -89.94 -21.1 22.62 Favored 'General case' 0 C--N 1.325 -0.492 0 C-N-CA 120.756 -0.378 . . . . 0.0 111.524 -177.936 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 76.83 28.41 59.03 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.809 -0.71 . . . . 0.0 111.537 -177.733 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.535 HG23 ' HB3' ' A' ' 47' ' ' ALA . 35.9 m -121.49 168.63 13.74 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-O 120.973 0.416 . . . . 0.0 110.654 -176.947 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.625 ' HB3' ' HB ' ' A' ' 70' ' ' ILE . 50.7 tptt -101.04 122.56 43.77 Favored 'General case' 0 C--N 1.318 -0.804 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 171.994 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 51' ' ' MET . . . . . 0.861 ' HE2' HG13 ' A' ' 83' ' ' VAL . 77.3 mtp -118.74 114.9 23.4 Favored 'General case' 0 C--N 1.316 -0.869 0 N-CA-C 109.751 -0.462 . . . . 0.0 109.751 177.422 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.556 ' CG2' ' HB2' ' A' ' 68' ' ' ARG . 10.2 tt -106.22 108.47 25.17 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.841 0 CA-C-O 121.376 0.608 . . . . 0.0 109.901 176.84 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.563 HD21 HD12 ' A' ' 40' ' ' ILE . 2.8 mm? -82.24 102.77 11.37 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.669 -0.696 . . . . 0.0 109.278 177.124 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.52 ' HB ' ' HB2' ' A' ' 66' ' ' PRO . 68.8 mt -82.25 98.14 4.42 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.407 0 CA-C-O 121.514 0.673 . . . . 0.0 109.664 -179.817 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 59.7 mt-30 -94.46 -40.91 9.65 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.216 -0.902 . . . . 0.0 110.774 -173.09 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -125.28 0.14 7.72 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.11 -176.101 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -90.19 34.1 4.25 Favored Glycine 0 CA--C 1.519 0.313 0 C-N-CA 120.637 -0.792 . . . . 0.0 112.659 -178.254 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 27.6 t -167.7 156.12 9.28 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 109.368 -0.604 . . . . 0.0 109.368 -178.275 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 17.2 mt-30 -99.23 -3.27 34.64 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.866 0.365 . . . . 0.0 110.508 -179.126 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 16.4 m120 -86.21 11.98 10.83 Favored 'General case' 0 CA--C 1.516 -0.347 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 171.181 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 14.7 t -64.64 -20.47 66.3 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.495 -0.775 . . . . 0.0 110.249 177.358 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 17.2 m120 -71.74 -19.41 62.04 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.822 179.071 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -112.3 -62.32 2.24 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.56 0 CA-C-O 121.277 0.56 . . . . 0.0 111.802 -179.568 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 41.1 m-20 -134.39 -169.47 2.34 Favored 'General case' 0 C--N 1.308 -1.203 0 CA-C-N 114.892 -1.049 . . . . 0.0 109.737 -172.776 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . 0.659 ' HB2' ' HB ' ' A' ' 24' ' ' ILE . 59.5 mmtt -137.27 114.35 9.74 Favored Pre-proline 0 C--N 1.315 -0.904 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.568 -173.971 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.52 ' HB2' ' HB ' ' A' ' 54' ' ' ILE . 48.4 Cg_exo -58.87 116.84 3.54 Favored 'Trans proline' 0 N--CA 1.463 -0.271 0 C-N-CA 123.141 2.56 . . . . 0.0 111.89 175.693 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.539 ' O ' ' HA ' ' A' ' 21' ' ' GLU . 43.2 tp -120.47 114.49 21.86 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.089 179.839 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.602 ' HG2' ' HG2' ' A' ' 21' ' ' GLU . 92.9 mtt180 -102.4 107.19 18.1 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 120.843 0.354 . . . . 0.0 110.551 177.79 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . 0.632 ' HB ' HG13 ' A' ' 76' ' ' VAL . 3.9 mp -90.02 104.73 15.47 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 173.489 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.625 ' HB ' ' HB3' ' A' ' 50' ' ' LYS . 3.0 mt -99.03 123.48 51.69 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.767 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.405 -175.529 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . 0.649 ' HA2' ' HB3' ' A' ' 16' ' ' ASN . . . 175.15 -114.36 0.49 Allowed Glycine 0 N--CA 1.443 -0.839 0 C-N-CA 121.072 -0.585 . . . . 0.0 112.568 179.841 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . 0.77 ' HB2' ' HA ' ' A' ' 7' ' ' PHE . 6.2 t70 -134.7 147.2 62.12 Favored Pre-proline 0 C--N 1.322 -0.593 0 N-CA-C 108.453 -0.943 . . . . 0.0 108.453 -177.219 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . 0.598 ' HD3' ' OG1' ' A' ' 18' ' ' THR . 87.4 Cg_exo -44.7 -36.01 9.97 Favored 'Trans proline' 0 C--N 1.352 0.724 0 C-N-CA 122.37 2.047 . . . . 0.0 112.339 -176.586 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 94.8 t80 -64.21 -62.77 1.41 Allowed 'General case' 0 N--CA 1.448 -0.547 0 CA-C-N 115.296 -0.865 . . . . 0.0 111.108 179.629 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 34.9 pttt -74.45 -30.17 61.76 Favored 'General case' 0 C--O 1.223 -0.31 0 N-CA-C 112.036 0.384 . . . . 0.0 112.036 -175.914 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.632 HG13 ' HB ' ' A' ' 69' ' ' ILE . 70.0 t -62.88 -38.22 81.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 N-CA-C 109.928 -0.397 . . . . 0.0 109.928 177.539 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . 0.419 ' O ' ' HG2' ' A' ' 81' ' ' GLU . 2.6 mm100 -79.1 -38.12 37.02 Favored 'General case' 0 N--CA 1.451 -0.42 0 C-N-CA 120.733 -0.387 . . . . 0.0 111.366 178.876 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 90.9 mt-30 -62.82 -40.92 98.87 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.971 0.415 . . . . 0.0 110.203 176.447 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . 0.682 ' HA ' ' HE2' ' A' ' 82' ' ' MET . . . -67.96 -37.46 81.59 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.458 177.224 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 43.9 t -65.01 -51.62 60.62 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.302 178.415 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . 0.419 ' HG2' ' O ' ' A' ' 77' ' ' GLN . 14.0 pt-20 -66.01 -27.18 67.92 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.02 0.438 . . . . 0.0 109.986 179.6 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 82' ' ' MET . . . . . 0.682 ' HE2' ' HA ' ' A' ' 79' ' ' ALA . 49.5 ttp -67.01 -50.47 62.07 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.801 177.261 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.861 HG13 ' HE2' ' A' ' 51' ' ' MET . 33.4 m -76.27 -35.15 27.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 C-N-CA 120.909 -0.316 . . . . 0.0 110.73 -177.235 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 22.0 ttt -63.78 -34.7 78.49 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 109.627 -0.508 . . . . 0.0 109.627 177.58 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -59.73 -48.33 82.1 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.254 -0.885 . . . . 0.0 110.618 174.931 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.402 HG13 ' O ' ' A' ' 82' ' ' MET . 57.3 mt -61.73 -38.89 81.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.726 -179.426 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.862 HD23 HG12 ' A' ' 32' ' ' VAL . 52.8 mt -68.11 -43.94 77.28 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.87 -0.604 . . . . 0.0 111.371 -177.341 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 2.8 ptm180 -87.57 4.06 45.16 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.862 0.363 . . . . 0.0 111.043 -175.987 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 . . . . . 0 C--O 1.25 1.097 0 CA-C-O 118.466 -0.778 . . . . 0.0 109.457 179.604 . . . . . . . . 0 0 . 1 . 024 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.445 -0.709 0 N-CA-C 111.498 -0.641 . . . . 0.0 111.498 . . . . . . . . . 0 0 . 1 . 024 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . 0.494 ' HB3' ' HB2' ' A' ' 9' ' ' ASP . 10.5 mm-40 -94.91 42.34 1.09 Allowed 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 120.986 0.422 . . . . 0.0 110.332 -176.606 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . 0.559 ' HA ' ' CG ' ' A' ' 72' ' ' ASP . 26.8 p90 -74.28 25.76 0.08 Allowed 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 115.636 -0.711 . . . . 0.0 111.945 -175.935 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . 0.519 ' HA ' ' HB3' ' A' ' 12' ' ' ASN . 19.7 t-80 -171.89 36.09 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 109.349 -0.611 . . . . 0.0 109.349 177.204 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . 0.494 ' HB2' ' HB3' ' A' ' 6' ' ' GLN . 27.4 t70 -73.56 91.65 1.85 Allowed 'General case' 0 C--O 1.236 0.375 0 CA-C-N 115.952 -0.567 . . . . 0.0 109.984 179.233 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 57.0 t30 70.51 -58.71 0.55 Allowed 'General case' 0 N--CA 1.468 0.461 0 O-C-N 124.117 0.886 . . . . 0.0 110.603 -176.283 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -98.15 -157.09 0.57 Allowed 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.477 178.362 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . 0.608 ' HA ' ' O ' ' A' ' 15' ' ' GLN . 2.3 t-20 68.89 -168.44 0.18 Allowed 'General case' 0 C--O 1.236 0.36 0 O-C-N 123.559 0.537 . . . . 0.0 110.678 178.559 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 78.1 -78.56 1.55 Allowed Glycine 0 N--CA 1.449 -0.497 0 N-CA-C 111.27 -0.732 . . . . 0.0 111.27 -175.061 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -77.31 -62.07 2.51 Favored Glycine 0 N--CA 1.447 -0.575 0 N-CA-C 110.984 -0.846 . . . . 0.0 110.984 174.385 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . 0.608 ' O ' ' HA ' ' A' ' 12' ' ' ASN . 52.3 tp60 -94.17 106.77 18.74 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 174.984 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . 0.731 ' HB3' ' HA2' ' A' ' 71' ' ' GLY . 31.3 m-80 -94.23 93.68 7.89 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.761 -0.654 . . . . 0.0 109.754 -177.483 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -90.08 48.01 3.18 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.963 -0.636 . . . . 0.0 113.785 -172.474 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 18' ' ' THR . . . . . 0.621 ' OG1' ' HD3' ' A' ' 73' ' ' PRO . 96.7 m -145.68 126.38 14.3 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 109.647 -0.501 . . . . 0.0 109.647 172.568 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 92.2 t -138.49 125.8 27.5 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.791 -176.246 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 45.6 mt-30 -113.42 116.07 29.05 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.453 -0.34 . . . . 0.0 110.129 172.992 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.607 ' HA ' ' O ' ' A' ' 67' ' ' LEU . 57.9 mt-10 -86.78 113.91 23.01 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.141 179.428 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 18.6 mm -97.51 151.43 4.29 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-N 115.518 -0.765 . . . . 0.0 108.986 176.527 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 23' ' ' MET . . . . . 0.455 ' HB3' ' HB3' ' A' ' 64' ' ' ASP . 73.7 mmm -104.85 99.2 8.85 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 108.752 -0.832 . . . . 0.0 108.752 176.64 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.653 HD12 HD12 ' A' ' 87' ' ' LEU . 22.9 mm -83.32 123.8 76.63 Favored Pre-proline 0 C--N 1.32 -0.68 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.471 -172.601 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_exo -52.82 130.36 37.07 Favored 'Trans proline' 0 N--CA 1.463 -0.273 0 C-N-CA 122.708 2.272 . . . . 0.0 111.495 176.408 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -57.31 -37.19 72.1 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.681 -0.69 . . . . 0.0 112.435 -173.403 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -80.59 -32.81 32.74 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.536 -0.84 . . . . 0.0 112.316 179.542 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.437 ' HE2' ' O ' ' A' ' 87' ' ' LEU . 49.7 tptt -83.58 -7.27 59.55 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.152 0.501 . . . . 0.0 110.005 -177.544 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . 0.531 ' O ' HG12 ' A' ' 32' ' ' VAL . . . -62.15 -19.29 62.91 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.567 -0.742 . . . . 0.0 111.789 -177.756 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -58.46 -37.01 87.06 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.586 -0.816 . . . . 0.0 111.901 176.757 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 70.0 mt -83.03 -28.92 29.27 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 111.667 0.247 . . . . 0.0 111.667 -178.431 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.531 HG12 ' O ' ' A' ' 29' ' ' ALA . 0.4 OUTLIER -69.37 -28.41 38.21 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.395 0 CA-C-O 121.253 0.549 . . . . 0.0 110.235 178.4 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.531 HG21 ' HA2' ' A' ' 37' ' ' GLY . 69.9 mt -86.18 -48.21 16.0 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.366 0 CA-C-N 115.679 -0.691 . . . . 0.0 109.467 174.871 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 135.77 170.6 12.11 Favored Glycine 0 N--CA 1.439 -1.155 0 C-N-CA 120.277 -0.963 . . . . 0.0 112.99 174.015 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.411 ' H ' ' HE3' ' A' ' 35' ' ' LYS . 0.0 OUTLIER -68.2 -27.2 66.18 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.164 0.506 . . . . 0.0 109.785 179.475 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -141.92 25.75 2.38 Favored Glycine 0 N--CA 1.447 -0.596 0 N-CA-C 111.158 -0.777 . . . . 0.0 111.158 174.472 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.531 ' HA2' HG21 ' A' ' 33' ' ' ILE . . . 77.24 2.83 80.42 Favored Glycine 0 CA--C 1.519 0.302 0 C-N-CA 121.039 -0.601 . . . . 0.0 112.26 -176.559 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -85.75 -28.75 24.38 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 111.759 0.281 . . . . 0.0 111.759 -177.961 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 39' ' ' THR . . . . . 0.716 ' O ' ' HG ' ' A' ' 43' ' ' LEU . 29.5 m -58.76 -47.32 85.09 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.478 -0.328 . . . . 0.0 111.825 -175.935 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.553 ' HA ' HD11 ' A' ' 43' ' ' LEU . 6.3 tt -58.53 -33.02 47.16 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.279 0 CA-C-O 121.075 0.464 . . . . 0.0 111.251 179.4 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 86.8 tttt -71.78 -37.3 70.48 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.168 0.508 . . . . 0.0 109.88 177.868 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . 0.68 ' O ' ' HG2' ' A' ' 46' ' ' ARG . 62.3 mt-30 -67.59 -42.03 83.13 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.485 -0.78 . . . . 0.0 110.429 179.999 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.716 ' HG ' ' O ' ' A' ' 39' ' ' THR . 58.6 mt -54.5 -41.0 69.1 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.604 -0.726 . . . . 0.0 111.247 -179.506 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 48.1 mt-30 -66.1 -39.51 90.03 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.514 -0.767 . . . . 0.0 110.807 179.605 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 11.6 mm-40 -67.92 -39.02 83.61 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.601 177.774 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . 0.857 ' HA ' ' HE ' ' A' ' 46' ' ' ARG . 0.0 OUTLIER -62.99 -44.82 94.96 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.731 -174.717 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -106.11 -0.54 24.65 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 112.603 0.594 . . . . 0.0 112.603 -171.857 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 65.03 40.6 97.18 Favored Glycine 0 C--N 1.33 0.206 0 C-N-CA 120.63 -0.795 . . . . 0.0 111.656 -177.396 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 23.8 m -126.35 179.38 3.43 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-N 115.446 -0.377 . . . . 0.0 110.413 -175.649 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 87.1 tttt -125.94 126.93 45.17 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 109.558 -0.534 . . . . 0.0 109.558 172.715 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 51' ' ' MET . . . . . 0.508 ' HB3' HD13 ' A' ' 67' ' ' LEU . 61.7 mtt -113.79 115.34 27.62 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 109.691 -0.485 . . . . 0.0 109.691 178.581 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.607 ' CG2' ' HB2' ' A' ' 68' ' ' ARG . 10.0 tt -99.59 109.41 24.53 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.752 0 CA-C-O 121.536 0.684 . . . . 0.0 109.646 176.64 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.877 HD21 HD12 ' A' ' 67' ' ' LEU . 0.5 OUTLIER -86.04 102.76 14.11 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.583 -0.735 . . . . 0.0 109.677 179.573 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.705 HD12 ' HB2' ' A' ' 66' ' ' PRO . 67.9 mt -75.13 85.67 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.335 0 CA-C-O 122.019 0.914 . . . . 0.0 108.984 175.837 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . 0.566 HE21 ' HB3' ' A' ' 53' ' ' LEU . 11.5 pt20 -115.27 -19.84 10.6 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 114.477 -1.238 . . . . 0.0 109.62 179.917 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -95.16 -27.5 15.52 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.209 -0.905 . . . . 0.0 109.926 176.518 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -64.02 105.27 1.05 Allowed Glycine 0 C--N 1.335 0.528 0 N-CA-C 110.953 -0.859 . . . . 0.0 110.953 175.393 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 58' ' ' SER . . . . . 0.408 ' HA ' ' CG2' ' A' ' 61' ' ' THR . 14.5 m -80.44 64.28 5.19 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 121.436 0.636 . . . . 0.0 112.561 -169.674 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 14.7 mm100 -120.78 -48.38 2.27 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 170.995 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . 0.472 ' HB3' ' O ' ' A' ' 64' ' ' ASP . 15.5 m120 -117.61 29.85 7.62 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.102 -0.953 . . . . 0.0 110.006 179.108 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 61' ' ' THR . . . . . 0.493 ' O ' ' HE2' ' A' ' 65' ' ' LYS . 0.6 OUTLIER -62.7 -36.59 83.45 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.911 -0.586 . . . . 0.0 112.53 -175.423 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 28.9 p-10 -102.1 11.16 38.79 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 111.784 0.29 . . . . 0.0 111.784 -177.073 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 16.3 m -135.39 -156.72 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 116.589 -0.278 . . . . 0.0 110.347 -179.921 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.472 ' O ' ' HB3' ' A' ' 60' ' ' ASN . 4.8 m-20 -57.79 134.79 56.58 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 110.046 -0.353 . . . . 0.0 110.046 177.21 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . 0.641 ' HB2' ' HB ' ' A' ' 24' ' ' ILE . 30.9 mmtp -90.8 132.76 33.86 Favored Pre-proline 0 C--N 1.323 -0.576 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.071 -172.32 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.705 ' HB2' HD12 ' A' ' 54' ' ' ILE . 13.5 Cg_exo -72.14 105.78 1.91 Allowed 'Trans proline' 0 N--CA 1.461 -0.395 0 C-N-CA 122.917 2.412 . . . . 0.0 111.491 173.954 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.877 HD12 HD21 ' A' ' 53' ' ' LEU . 23.8 tp -109.22 115.76 30.62 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.42 -0.355 . . . . 0.0 110.526 179.603 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.607 ' HB2' ' CG2' ' A' ' 52' ' ' ILE . 95.6 mtt180 -99.81 108.22 20.46 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.885 176.484 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . 0.492 HG22 ' HB3' ' A' ' 79' ' ' ALA . 4.6 mp -86.97 104.92 14.54 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.587 0 N-CA-C 108.164 -1.05 . . . . 0.0 108.164 170.915 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 21.0 mt -97.05 126.22 49.87 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.615 -175.182 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . 0.731 ' HA2' ' HB3' ' A' ' 16' ' ' ASN . . . 172.95 -117.21 0.64 Allowed Glycine 0 N--CA 1.447 -0.58 0 C-N-CA 120.758 -0.734 . . . . 0.0 113.027 178.367 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . 0.559 ' CG ' ' HA ' ' A' ' 7' ' ' PHE . 8.7 t70 -131.45 146.73 63.23 Favored Pre-proline 0 C--N 1.324 -0.536 0 CA-C-O 118.301 -0.857 . . . . 0.0 108.764 -177.147 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . 0.621 ' HD3' ' OG1' ' A' ' 18' ' ' THR . 88.0 Cg_exo -40.95 -40.59 3.78 Favored 'Trans proline' 0 C--N 1.351 0.7 0 C-N-CA 122.943 2.429 . . . . 0.0 112.894 -177.495 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 90.1 t80 -65.28 -62.59 1.44 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.735 -0.666 . . . . 0.0 111.136 -179.269 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.443 ' HG2' ' HB3' ' A' ' 72' ' ' ASP . 40.8 pttt -70.44 -31.22 68.3 Favored 'General case' 0 C--O 1.219 -0.541 0 C-N-CA 120.911 -0.316 . . . . 0.0 111.843 -175.865 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.413 HG13 ' HB ' ' A' ' 69' ' ' ILE . 79.7 t -66.14 -40.72 87.84 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 C-N-CA 120.833 -0.347 . . . . 0.0 110.166 179.365 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . 0.411 ' O ' ' HG3' ' A' ' 81' ' ' GLU . 0.1 OUTLIER -73.38 -40.84 64.04 Favored 'General case' 0 N--CA 1.45 -0.452 0 N-CA-C 109.531 -0.544 . . . . 0.0 109.531 -179.224 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 66.7 mt-30 -67.64 -32.36 73.01 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 120.735 -0.386 . . . . 0.0 110.672 178.177 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . 0.503 ' HB1' ' CE ' ' A' ' 51' ' ' MET . . . -72.61 -33.88 66.99 Favored 'General case' 0 N--CA 1.446 -0.648 0 CA-C-N 116.136 -0.484 . . . . 0.0 109.876 175.966 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 43.9 t -62.4 -48.58 79.07 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.848 -0.614 . . . . 0.0 109.695 172.669 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . 0.42 ' O ' ' HB2' ' A' ' 85' ' ' ASP . 53.6 mt-10 -56.56 -29.46 62.03 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-O 121.178 0.513 . . . . 0.0 110.794 176.376 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 82' ' ' MET . . . . . 0.483 ' HE3' ' HB2' ' A' ' 46' ' ' ARG . 39.3 ttm -74.41 -51.13 15.85 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.316 -0.857 . . . . 0.0 110.667 -178.086 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.637 ' O ' ' HG ' ' A' ' 87' ' ' LEU . 33.7 m -74.93 -38.22 42.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 120.674 0.273 . . . . 0.0 110.635 -176.082 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 84' ' ' MET . . . . . 0.454 ' O ' ' HG2' ' A' ' 88' ' ' ARG . 26.3 ttt -63.96 -34.44 77.99 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.026 179.735 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . 0.42 ' HB2' ' O ' ' A' ' 81' ' ' GLU . 14.3 t70 -63.53 -46.49 85.75 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.12 179.218 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.417 HG13 ' O ' ' A' ' 82' ' ' MET . 44.6 mt -64.78 -34.39 69.81 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.577 179.429 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.653 HD12 HD12 ' A' ' 24' ' ' ILE . 53.7 mt -76.76 -14.46 59.93 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.928 0.394 . . . . 0.0 110.981 -178.559 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . 0.454 ' HG2' ' O ' ' A' ' 84' ' ' MET . 14.3 mmm180 -109.47 8.55 25.31 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.192 0.52 . . . . 0.0 109.621 175.03 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 10.6 tp10 . . . . . 0 C--O 1.248 0.992 0 CA-C-N 115.197 -0.911 . . . . 0.0 109.267 -179.717 . . . . . . . . 0 0 . 1 . 025 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.598 0 N-CA-C 112.686 -0.166 . . . . 0.0 112.686 . . . . . . . . . 0 0 . 1 . 025 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 2.5 pt20 -111.44 84.72 1.99 Allowed 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 121.816 0.817 . . . . 0.0 109.497 175.029 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . 0.526 ' O ' ' HB3' ' A' ' 12' ' ' ASN . 42.1 m-85 -79.97 -172.38 3.38 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 114.891 -1.049 . . . . 0.0 110.616 -174.726 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . 0.754 ' HB3' ' HA2' ' A' ' 71' ' ' GLY . 6.8 t60 -160.07 31.26 0.18 Allowed 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.127 0.489 . . . . 0.0 109.874 174.399 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . 0.459 ' HA ' ' O ' ' A' ' 48' ' ' GLY . 5.5 p-10 -70.44 -41.26 73.11 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.12 178.022 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 64.6 t30 -132.21 53.1 2.03 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 174.756 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . 51.51 71.66 0.43 Allowed 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 115.007 -0.997 . . . . 0.0 111.632 -179.135 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . 0.526 ' HB3' ' O ' ' A' ' 7' ' ' PHE . 21.0 t-20 -79.8 99.92 7.72 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.865 0.364 . . . . 0.0 110.142 -176.081 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 78.61 -50.8 3.61 Favored Glycine 0 N--CA 1.453 -0.209 0 CA-C-N 116.112 -0.495 . . . . 0.0 112.149 -177.422 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 143.7 -27.65 2.06 Favored Glycine 0 N--CA 1.446 -0.653 0 N-CA-C 111.605 -0.598 . . . . 0.0 111.605 179.473 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -66.95 138.46 57.28 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.846 0.355 . . . . 0.0 111.14 -177.663 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 42.9 m-80 -99.94 109.11 21.48 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 109.241 -0.652 . . . . 0.0 109.241 170.31 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -80.22 -68.78 1.45 Allowed Glycine 0 N--CA 1.447 -0.592 0 C-N-CA 120.891 -0.671 . . . . 0.0 113.497 -174.31 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 18' ' ' THR . . . . . 0.551 ' OG1' ' HG3' ' A' ' 73' ' ' PRO . 93.3 m -107.62 130.49 54.89 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.214 0.53 . . . . 0.0 111.83 -174.28 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.591 ' HB ' HG23 ' A' ' 70' ' ' ILE . 2.6 p -134.77 121.0 33.21 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-N 115.347 -0.842 . . . . 0.0 109.753 175.724 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 6.0 tt0 -110.16 137.3 48.1 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 110.286 -0.264 . . . . 0.0 110.286 -177.97 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.632 ' HA ' ' O ' ' A' ' 67' ' ' LEU . 45.0 mt-10 -108.34 127.14 53.61 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.998 0.428 . . . . 0.0 111.389 -178.863 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.425 ' HB ' ' HB3' ' A' ' 67' ' ' LEU . 15.9 mm -115.46 153.91 16.95 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-N 115.945 -0.57 . . . . 0.0 109.898 179.651 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 23' ' ' MET . . . . . 0.453 ' HB3' ' HB3' ' A' ' 64' ' ' ASP . 1.6 mmt -104.97 105.09 14.99 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 109.036 -0.727 . . . . 0.0 109.036 173.371 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.682 ' HB ' ' HB2' ' A' ' 65' ' ' LYS . 36.8 mm -88.72 131.42 41.72 Favored Pre-proline 0 C--N 1.322 -0.628 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.029 -175.762 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . 0.662 ' HD2' HD11 ' A' ' 87' ' ' LEU . 91.8 Cg_exo -44.41 137.03 8.33 Favored 'Trans proline' 0 C--N 1.348 0.55 0 C-N-CA 123.57 2.847 . . . . 0.0 113.184 177.457 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -66.52 -27.84 68.08 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.481 -0.782 . . . . 0.0 112.694 -172.489 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -103.48 -26.57 6.82 Favored Glycine 0 N--CA 1.447 -0.598 0 C-N-CA 120.387 -0.911 . . . . 0.0 112.33 -179.147 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.485 ' HB3' ' HB2' ' A' ' 25' ' ' PRO . 15.3 ttpt -94.67 13.26 24.92 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.472 0.654 . . . . 0.0 110.642 -177.488 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . 0.492 ' O ' HG11 ' A' ' 32' ' ' VAL . . . -63.65 -31.07 72.12 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.857 -0.611 . . . . 0.0 110.882 178.181 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -57.06 -26.99 56.74 Favored Glycine 0 CA--C 1.519 0.29 0 CA-C-N 116.173 -0.467 . . . . 0.0 113.211 179.862 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 68.0 mt -78.5 -36.64 44.78 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.913 0.357 . . . . 0.0 110.957 179.542 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.492 HG11 ' O ' ' A' ' 29' ' ' ALA . 0.3 OUTLIER -72.12 -29.92 34.25 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.341 0 CA-C-O 121.19 0.519 . . . . 0.0 110.182 178.343 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 68.1 mt -76.03 -37.39 33.54 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-O 121.925 0.869 . . . . 0.0 109.615 174.109 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . 0.548 ' HA3' ' HB ' ' A' ' 39' ' ' THR . . . 98.14 45.38 2.41 Favored Glycine 0 N--CA 1.441 -0.974 0 CA-C-N 115.228 -0.896 . . . . 0.0 112.928 175.515 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 38.3 mtmt 51.72 47.01 25.63 Favored 'General case' 0 C--N 1.328 -0.326 0 O-C-N 124.143 0.555 . . . . 0.0 111.666 172.81 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 132.16 -28.2 3.52 Favored Glycine 0 N--CA 1.448 -0.562 0 C-N-CA 120.668 -0.777 . . . . 0.0 112.173 179.412 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 125.33 4.57 6.95 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.423 -0.894 . . . . 0.0 112.836 178.089 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 32.7 mt-10 -70.06 -48.75 56.54 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.132 0.491 . . . . 0.0 110.5 -179.993 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 39' ' ' THR . . . . . 0.714 ' O ' ' HG ' ' A' ' 43' ' ' LEU . 17.2 m -64.68 -46.04 84.09 Favored 'General case' 0 N--CA 1.45 -0.437 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.261 -177.433 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.615 ' HA ' HD12 ' A' ' 43' ' ' LEU . 8.1 tt -60.3 -35.65 63.69 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.47 0 CA-C-O 121.036 0.446 . . . . 0.0 110.901 179.977 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 54.8 tttm -61.57 -47.29 86.17 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.262 0.553 . . . . 0.0 109.983 175.515 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 16.4 mm-40 -72.39 -33.86 67.49 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.546 -0.752 . . . . 0.0 111.796 -176.561 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.714 ' HG ' ' O ' ' A' ' 39' ' ' THR . 95.0 mt -54.52 -48.07 72.36 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.046 0.45 . . . . 0.0 110.77 179.817 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 44.0 mt-30 -63.27 -46.21 87.86 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.385 -0.825 . . . . 0.0 110.696 -179.828 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -71.12 -36.69 72.23 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.855 -0.611 . . . . 0.0 112.123 -175.51 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 12.4 ptm180 -75.53 -33.08 60.69 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 111.734 0.272 . . . . 0.0 111.734 -175.317 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . 0.448 ' HB3' HG23 ' A' ' 49' ' ' VAL . . . -96.54 -21.07 17.91 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.993 0.425 . . . . 0.0 111.352 -177.305 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . 0.459 ' O ' ' HA ' ' A' ' 9' ' ' ASP . . . 81.13 31.01 35.93 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.928 -0.653 . . . . 0.0 112.0 -178.161 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.448 HG23 ' HB3' ' A' ' 47' ' ' ALA . 28.6 m -122.92 167.49 16.47 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-O 120.834 0.35 . . . . 0.0 110.643 -176.332 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 60.2 tttp -103.38 123.23 46.44 Favored 'General case' 0 N--CA 1.444 -0.758 0 N-CA-C 108.96 -0.756 . . . . 0.0 108.96 172.242 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 51' ' ' MET . . . . . 0.796 ' HE3' HG12 ' A' ' 83' ' ' VAL . 79.7 mtp -120.32 115.52 23.72 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 120.947 0.403 . . . . 0.0 109.989 179.414 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.551 ' CG2' ' HB2' ' A' ' 68' ' ' ARG . 11.2 tt -107.71 112.33 39.67 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.749 0 CA-C-O 121.478 0.656 . . . . 0.0 110.235 177.896 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.485 ' CD2' HD13 ' A' ' 67' ' ' LEU . 3.1 mm? -94.82 114.29 26.15 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.36 -0.836 . . . . 0.0 109.817 176.863 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.538 ' HB ' ' HD2' ' A' ' 66' ' ' PRO . 31.4 mm -75.36 87.78 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 177.311 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 15.8 mt-30 -99.9 -40.58 7.62 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.226 -0.897 . . . . 0.0 110.311 -174.803 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -111.69 2.05 17.03 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.209 -0.905 . . . . 0.0 110.572 -173.398 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -109.1 166.84 12.74 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.527 -0.844 . . . . 0.0 112.271 179.97 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 50.0 m 62.91 -171.89 0.17 Allowed 'General case' 0 C--O 1.235 0.299 0 CA-C-O 121.396 0.617 . . . . 0.0 111.28 178.993 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . 0.403 ' C ' ' H ' ' A' ' 61' ' ' THR . 12.8 mm100 -119.12 17.45 13.22 Favored 'General case' 0 N--CA 1.443 -0.793 0 CA-C-N 115.594 -0.73 . . . . 0.0 109.738 177.29 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . 0.57 ' HA ' HG21 ' A' ' 63' ' ' VAL . 11.5 m120 -83.82 13.0 5.19 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 108.501 -0.926 . . . . 0.0 108.501 172.285 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 61' ' ' THR . . . . . 0.403 ' H ' ' C ' ' A' ' 59' ' ' GLN . 21.1 p -64.59 -17.66 64.18 Favored 'General case' 0 N--CA 1.444 -0.736 0 CA-C-N 114.721 -1.127 . . . . 0.0 110.869 177.014 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 28.7 p-10 -100.36 -4.4 29.19 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.199 177.137 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.57 HG21 ' HA ' ' A' ' 60' ' ' ASN . 24.1 m -133.72 -155.54 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-O 120.659 0.266 . . . . 0.0 111.157 -177.077 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.453 ' HB3' ' HB3' ' A' ' 23' ' ' MET . 5.2 m-20 -57.04 149.65 18.67 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.638 -0.71 . . . . 0.0 111.291 178.607 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . 0.682 ' HB2' ' HB ' ' A' ' 24' ' ' ILE . 70.9 mmtt -101.5 127.1 32.33 Favored Pre-proline 0 C--N 1.324 -0.54 0 CA-C-N 115.804 -0.635 . . . . 0.0 111.056 -175.615 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.538 ' HD2' ' HB ' ' A' ' 54' ' ' ILE . 27.4 Cg_exo -65.41 111.68 1.91 Allowed 'Trans proline' 0 N--CA 1.463 -0.315 0 C-N-CA 123.009 2.472 . . . . 0.0 111.596 172.596 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.632 ' O ' ' HA ' ' A' ' 21' ' ' GLU . 14.3 tp -112.44 122.35 47.45 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 116.155 -0.475 . . . . 0.0 109.97 178.093 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.551 ' HB2' ' CG2' ' A' ' 52' ' ' ILE . 88.0 mtt180 -113.84 112.39 23.3 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 121.19 0.519 . . . . 0.0 111.192 177.727 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 4.5 mp -94.16 105.13 16.54 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 172.449 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.591 HG23 ' HB ' ' A' ' 19' ' ' VAL . 4.0 mt -109.77 132.32 58.31 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 CA-C-N 116.385 -0.371 . . . . 0.0 110.907 -172.394 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . 0.754 ' HA2' ' HB3' ' A' ' 8' ' ' HIS . . . 152.52 -123.16 1.41 Allowed Glycine 0 N--CA 1.445 -0.747 0 C-N-CA 120.509 -0.853 . . . . 0.0 113.235 175.618 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . 0.605 ' OD2' ' HG2' ' A' ' 75' ' ' LYS . 0.5 OUTLIER -92.69 133.47 29.31 Favored Pre-proline 0 C--N 1.326 -0.447 0 C-N-CA 122.864 0.466 . . . . 0.0 110.948 -177.215 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . 0.551 ' HG3' ' OG1' ' A' ' 18' ' ' THR . 50.4 Cg_exo -49.43 -33.41 29.64 Favored 'Trans proline' 0 C--N 1.351 0.664 0 C-N-CA 124.267 3.311 . . . . 0.0 113.592 -176.236 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . 0.495 ' O ' ' HG3' ' A' ' 78' ' ' GLN . 19.1 t80 -72.71 -57.08 4.38 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.341 -178.27 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.605 ' HG2' ' OD2' ' A' ' 72' ' ' ASP . 4.6 ptpp? -72.5 -25.83 61.55 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 111.746 0.276 . . . . 0.0 111.746 -178.439 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.403 HG23 ' O ' ' A' ' 72' ' ' ASP . 26.4 t -55.94 -42.26 70.65 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 N-CA-C 109.925 -0.398 . . . . 0.0 109.925 171.424 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . 0.574 ' O ' ' HG2' ' A' ' 81' ' ' GLU . 2.3 mm100 -75.74 -44.28 42.59 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.056 178.789 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . 0.495 ' HG3' ' O ' ' A' ' 74' ' ' TYR . 53.6 mt-30 -52.87 -50.06 64.58 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.065 0.459 . . . . 0.0 110.419 177.697 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . 0.661 ' HA ' ' HE3' ' A' ' 82' ' ' MET . . . -67.43 -37.78 83.54 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.411 -0.813 . . . . 0.0 111.271 -178.315 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 42.7 t -62.55 -57.27 11.74 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.556 -178.9 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . 0.574 ' HG2' ' O ' ' A' ' 77' ' ' GLN . 10.4 pt-20 -67.68 -18.7 65.02 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.912 0.387 . . . . 0.0 110.645 -178.928 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 82' ' ' MET . . . . . 0.661 ' HE3' ' HA ' ' A' ' 79' ' ' ALA . 57.0 ttp -74.09 -50.99 17.11 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.584 174.804 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.796 HG12 ' HE3' ' A' ' 51' ' ' MET . 31.8 m -76.52 -33.87 23.43 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.583 -0.281 . . . . 0.0 111.618 -176.4 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 83.5 mtp -68.37 -25.67 65.19 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 109.911 -0.403 . . . . 0.0 109.911 175.83 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -67.69 -36.25 80.32 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.655 176.364 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 56.7 mt -62.78 -35.49 71.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 121.488 0.661 . . . . 0.0 110.043 179.022 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.662 HD11 ' HD2' ' A' ' 25' ' ' PRO . 42.8 mt -88.09 -8.46 55.47 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.654 -179.381 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 21.5 tpt180 -101.76 -10.54 19.85 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.839 0.828 . . . . 0.0 109.818 -179.638 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 . . . . . 0 C--O 1.248 1.021 0 CA-C-N 114.685 -1.143 . . . . 0.0 109.779 -177.316 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.466 ' OG1' ' HG3' ' A' ' 73' ' ' PRO . 96.5 m . . . . . 0 N--CA 1.452 -0.354 0 N-CA-C 110.146 -0.316 . . . . 0.0 110.146 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 74.7 t -113.09 127.19 70.48 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.618 -178.595 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' GLN . . . . . 0.607 ' HG2' ' HB2' ' A' ' 80' ' ' CYS . 29.5 tp60 -111.84 112.74 24.63 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 109.43 -0.582 . . . . 0.0 109.43 176.863 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.588 ' HA ' ' O ' ' A' ' 67' ' ' LEU . 12.1 mt-10 -98.53 119.26 36.93 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.369 0.604 . . . . 0.0 112.305 179.257 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 10.1 mm -114.37 150.5 16.35 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 115.185 -0.916 . . . . 0.0 109.44 177.685 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 94.0 mmm -111.53 103.83 12.19 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 172.93 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.656 HG23 HD21 ' A' ' 87' ' ' LEU . 9.3 mm -84.88 125.3 71.14 Favored Pre-proline 0 C--N 1.316 -0.88 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.952 -173.301 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_exo -50.2 139.06 36.13 Favored 'Trans proline' 0 C--N 1.346 0.441 0 C-N-CA 122.904 2.402 . . . . 0.0 112.379 176.566 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -42.41 -57.15 2.72 Favored 'General case' 0 N--CA 1.465 0.287 0 N-CA-C 113.316 0.858 . . . . 0.0 113.316 -173.716 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -90.18 -26.71 23.01 Favored Glycine 0 N--CA 1.453 -0.199 0 C-N-CA 120.679 -0.772 . . . . 0.0 113.069 -174.473 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.409 ' HE3' ' HA ' ' A' ' 87' ' ' LEU . 45.0 tttp -78.99 -4.56 50.61 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.192 0.52 . . . . 0.0 110.128 179.773 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.482 ' HA ' HG21 ' A' ' 24' ' ' ILE . . . -63.64 -22.93 67.16 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.658 174.844 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -58.39 -25.7 58.19 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 121.073 -0.584 . . . . 0.0 112.134 178.292 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 63.2 mt -75.97 -45.78 33.08 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.779 0.323 . . . . 0.0 110.855 179.425 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.433 HG12 ' O ' ' A' ' 29' ' ' ALA . 1.4 p -72.02 -32.13 42.77 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.474 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.973 -177.369 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 74.2 mt -78.33 -42.18 26.5 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-O 121.761 0.791 . . . . 0.0 109.772 176.661 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' GLY . . . . . 0.503 ' HA3' ' H ' ' A' ' 39' ' ' THR . . . 101.29 51.53 1.13 Allowed Glycine 0 N--CA 1.441 -1.025 0 CA-C-N 115.272 -0.876 . . . . 0.0 112.974 175.529 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.453 ' HD2' ' N ' ' A' ' 35' ' ' LYS . 0.4 OUTLIER 50.68 40.5 24.24 Favored 'General case' 0 C--N 1.329 -0.295 0 O-C-N 124.319 0.658 . . . . 0.0 111.96 173.719 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 133.73 -27.06 3.39 Favored Glycine 0 N--CA 1.449 -0.482 0 C-N-CA 120.653 -0.784 . . . . 0.0 111.94 179.604 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 129.78 22.47 1.15 Allowed Glycine 0 N--CA 1.449 -0.451 0 C-N-CA 120.173 -1.013 . . . . 0.0 113.079 178.524 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.475 ' O ' ' HG3' ' A' ' 42' ' ' GLN . 4.5 tp10 -84.53 -54.09 4.98 Favored 'General case' 0 C--N 1.321 -0.648 0 O-C-N 122.296 -0.531 . . . . 0.0 110.119 178.694 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 39' ' ' THR . . . . . 0.684 ' O ' ' HG ' ' A' ' 43' ' ' LEU . 63.0 m -56.21 -44.58 79.63 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.53 -0.759 . . . . 0.0 111.821 -179.405 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 8.9 tt -58.51 -37.79 66.61 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.406 0 CA-C-O 120.596 0.236 . . . . 0.0 111.604 -178.416 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 33.5 mtmm -66.24 -38.65 88.39 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.358 0.599 . . . . 0.0 110.172 178.02 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' GLN . . . . . 0.475 ' HG3' ' O ' ' A' ' 38' ' ' GLU . 20.5 mt-30 -66.07 -45.96 79.44 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.279 178.755 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.684 ' HG ' ' O ' ' A' ' 39' ' ' THR . 89.6 mt -53.47 -46.7 70.05 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.428 -0.805 . . . . 0.0 112.032 -175.609 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 46.9 mt-30 -64.52 -43.36 94.29 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.484 -177.302 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 9.3 mm-40 -81.12 -35.6 31.38 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 112.052 0.39 . . . . 0.0 112.052 -174.261 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 14.8 ptm180 -66.76 -35.28 79.73 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-O 120.735 0.302 . . . . 0.0 111.477 -176.7 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.452 ' HB3' HG22 ' A' ' 49' ' ' VAL . . . -100.65 -12.13 19.43 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.889 0.376 . . . . 0.0 111.577 -177.128 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 71.73 37.93 61.21 Favored Glycine 0 N--CA 1.449 -0.492 0 C-N-CA 120.812 -0.709 . . . . 0.0 111.961 -178.004 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.452 HG22 ' HB3' ' A' ' 47' ' ' ALA . 28.5 m -129.15 178.56 4.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-O 120.761 0.315 . . . . 0.0 110.16 -177.775 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 64.3 tttp -120.75 124.66 45.66 Favored 'General case' 0 C--N 1.319 -0.726 0 C-N-CA 120.662 -0.415 . . . . 0.0 110.214 173.069 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' MET . . . . . 0.586 ' CE ' ' HB1' ' A' ' 79' ' ' ALA . 63.7 mtt -113.94 115.62 27.95 Favored 'General case' 0 C--N 1.319 -0.749 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 176.751 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.534 ' CG2' ' HB2' ' A' ' 68' ' ' ARG . 10.5 tt -99.29 104.77 16.46 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.741 0 CA-C-O 121.772 0.796 . . . . 0.0 110.059 176.91 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.705 HD22 HD13 ' A' ' 67' ' ' LEU . 3.8 mm? -87.53 104.4 16.45 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.053 -0.976 . . . . 0.0 109.26 176.02 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.8 HD12 ' HB2' ' A' ' 66' ' ' PRO . 61.0 mt -72.74 86.56 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-O 121.852 0.834 . . . . 0.0 109.663 178.369 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 16.0 mt-30 . . . . . 0 C--N 1.323 -0.552 0 CA-C-N 114.637 -1.165 . . . . 0.0 109.645 -177.628 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.461 ' HA ' ' O ' ' A' ' 24' ' ' ILE . 1.8 m-20 . . . . . 0 N--CA 1.463 0.191 0 CA-C-O 120.68 0.276 . . . . 0.0 111.363 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' LYS . . . . . 0.497 ' HA ' ' HD3' ' A' ' 66' ' ' PRO . 39.2 mmtm -110.85 131.39 22.15 Favored Pre-proline 0 C--N 1.327 -0.398 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.659 -175.203 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.8 ' HB2' HD12 ' A' ' 54' ' ' ILE . 10.6 Cg_exo -75.33 111.4 3.3 Favored 'Trans proline' 0 N--CA 1.46 -0.467 0 C-N-CA 123.476 2.784 . . . . 0.0 111.86 176.013 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.705 HD13 HD22 ' A' ' 53' ' ' LEU . 17.8 tp -112.4 120.72 42.64 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.528 177.439 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 68' ' ' ARG . . . . . 0.534 ' HB2' ' CG2' ' A' ' 52' ' ' ILE . 68.4 mtt180 -111.47 111.72 22.95 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 120.99 0.424 . . . . 0.0 110.651 174.445 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.493 ' HB ' ' HB3' ' A' ' 20' ' ' GLN . 46.9 mt -91.27 112.06 24.76 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 N-CA-C 108.909 -0.774 . . . . 0.0 108.909 173.914 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 13.2 mt -113.85 129.42 69.78 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.739 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.056 -172.562 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 153.42 -140.92 7.91 Favored Glycine 0 N--CA 1.448 -0.518 0 C-N-CA 120.458 -0.877 . . . . 0.0 113.32 173.89 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 72' ' ' ASP . . . . . 0.526 ' HB3' ' CG ' ' A' ' 75' ' ' LYS . 4.7 t70 -71.99 130.89 86.05 Favored Pre-proline 0 C--N 1.322 -0.614 0 C-N-CA 123.387 0.675 . . . . 0.0 111.126 -176.997 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 73' ' ' PRO . . . . . 0.466 ' HG3' ' OG1' ' A' ' 18' ' ' THR . 26.8 Cg_exo -57.98 -26.53 75.27 Favored 'Trans proline' 0 C--N 1.35 0.622 0 C-N-CA 123.556 2.838 . . . . 0.0 113.352 -172.027 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 74' ' ' TYR . . . . . 0.401 ' HB3' ' OD1' ' A' ' 72' ' ' ASP . 24.1 t80 -79.06 -47.61 15.88 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.156 -0.474 . . . . 0.0 109.873 -176.191 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.526 ' CG ' ' HB3' ' A' ' 72' ' ' ASP . 9.1 ptpt -80.51 -26.61 38.05 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 120.867 -0.333 . . . . 0.0 111.611 178.81 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.401 ' CG1' ' HB2' ' A' ' 20' ' ' GLN . 24.6 t -60.69 -40.13 83.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-O 120.7 0.286 . . . . 0.0 110.246 173.954 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 6.5 mm-40 -73.97 -41.2 62.31 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 120.637 -0.425 . . . . 0.0 110.972 179.472 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 49.6 mt-30 -63.09 -39.07 93.62 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 120.898 0.38 . . . . 0.0 110.251 177.431 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' ALA . . . . . 0.586 ' HB1' ' CE ' ' A' ' 51' ' ' MET . . . -71.65 -35.34 70.33 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.718 178.5 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 80' ' ' CYS . . . . . 0.607 ' HB2' ' HG2' ' A' ' 20' ' ' GLN . 36.5 t -63.45 -54.09 41.9 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.123 175.245 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 52.5 mt-10 -65.2 -20.66 66.54 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.403 178.998 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 82' ' ' MET . . . . . 0.437 ' HB3' ' O ' ' A' ' 79' ' ' ALA . 31.5 ttm -69.48 -55.98 8.71 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.425 -0.807 . . . . 0.0 110.403 176.417 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 32.9 m -79.42 -29.59 13.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.915 -175.453 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 84' ' ' MET . . . . . 0.476 ' O ' ' HG2' ' A' ' 88' ' ' ARG . 56.9 ttp -71.48 -28.94 64.28 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 109.75 -0.463 . . . . 0.0 109.75 178.392 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 85' ' ' ASP . . . . . 0.483 ' O ' ' HB2' ' A' ' 89' ' ' GLU . 19.0 t70 -62.62 -47.94 81.57 Favored 'General case' 0 CA--C 1.517 -0.29 0 N-CA-C 109.968 -0.382 . . . . 0.0 109.968 175.133 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 20.3 mt -60.22 -32.45 50.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 121.659 0.742 . . . . 0.0 110.276 177.738 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.656 HD21 HG23 ' A' ' 24' ' ' ILE . 1.0 OUTLIER -81.8 -17.52 47.26 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.389 -0.823 . . . . 0.0 111.57 -176.738 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 88' ' ' ARG . . . . . 0.476 ' HG2' ' O ' ' A' ' 84' ' ' MET . 23.3 mmm180 -102.86 5.94 38.88 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 121.546 0.689 . . . . 0.0 109.322 174.153 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 89' ' ' GLU . . . . . 0.483 ' HB2' ' O ' ' A' ' 85' ' ' ASP . 2.1 tm-20 . . . . . 0 C--O 1.25 1.125 0 CA-C-N 114.749 -1.114 . . . . 0.0 108.884 -177.968 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.511 ' OG1' ' HG3' ' A' ' 73' ' ' PRO . 74.6 m . . . . . 0 N--CA 1.453 -0.29 0 CA-C-O 120.996 0.427 . . . . 0.0 111.129 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.493 HG22 HG23 ' A' ' 70' ' ' ILE . 61.6 t -124.71 120.19 58.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.61 179.251 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 14.2 mm100 -101.17 114.03 27.61 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.983 -0.553 . . . . 0.0 109.539 174.682 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.61 ' HG2' ' HG2' ' A' ' 68' ' ' ARG . 37.4 mt-10 -93.69 107.58 19.43 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.283 0.564 . . . . 0.0 110.729 176.065 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 19.0 mm -102.41 148.67 7.56 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.723 0 CA-C-N 115.359 -0.837 . . . . 0.0 109.802 -178.509 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' MET . . . . . 0.51 ' HB3' ' HB3' ' A' ' 64' ' ' ASP . 1.5 mmt -99.87 101.98 13.27 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 108.609 -0.885 . . . . 0.0 108.609 175.428 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.687 ' HB ' ' HB2' ' A' ' 65' ' ' LYS . 44.3 mm -88.66 126.06 61.06 Favored Pre-proline 0 C--N 1.319 -0.733 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.996 -175.38 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 25' ' ' PRO . . . . . 0.604 ' HB2' ' HB3' ' A' ' 28' ' ' LYS . 95.7 Cg_exo -45.1 132.91 11.41 Favored 'Trans proline' 0 C--N 1.343 0.278 0 C-N-CA 123.423 2.749 . . . . 0.0 112.541 179.564 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -61.82 -38.65 88.96 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 115.511 -0.768 . . . . 0.0 112.954 -168.501 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -89.37 -35.89 7.78 Favored Glycine 0 N--CA 1.449 -0.496 0 C-N-CA 120.404 -0.903 . . . . 0.0 111.837 -178.596 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.604 ' HB3' ' HB2' ' A' ' 25' ' ' PRO . 28.6 ttpt -80.47 -0.62 38.12 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 121.201 0.524 . . . . 0.0 110.77 -178.721 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.53 ' O ' HG12 ' A' ' 32' ' ' VAL . . . -62.83 -20.14 64.78 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.132 177.667 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -57.66 -33.09 66.35 Favored Glycine 0 N--CA 1.448 -0.541 0 C-N-CA 120.792 -0.718 . . . . 0.0 111.885 177.04 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 99.0 mt -77.57 -36.2 52.27 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.643 0.259 . . . . 0.0 111.289 -178.767 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.535 HG11 HG21 ' A' ' 24' ' ' ILE . 0.5 OUTLIER -70.57 -30.28 41.86 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.326 0 CA-C-O 121.16 0.505 . . . . 0.0 110.768 -178.37 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 71.0 mt -89.39 -38.78 11.7 Favored 'Isoleucine or valine' 0 C--O 1.236 0.388 0 CA-C-N 115.76 -0.654 . . . . 0.0 110.537 178.743 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 105.08 25.0 6.94 Favored Glycine 0 CA--C 1.502 -0.723 0 CA-C-N 115.605 -0.725 . . . . 0.0 112.611 178.57 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 53.6 mtpt 60.87 21.51 11.69 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.316 -0.442 . . . . 0.0 111.327 177.258 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -176.59 -45.7 0.06 OUTLIER Glycine 0 N--CA 1.448 -0.504 0 N-CA-C 111.696 -0.562 . . . . 0.0 111.696 -178.31 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 125.73 7.57 5.59 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.355 -0.926 . . . . 0.0 113.024 176.692 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -85.51 -32.91 21.96 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 120.84 0.352 . . . . 0.0 111.162 178.561 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 39' ' ' THR . . . . . 0.59 ' O ' ' HG ' ' A' ' 43' ' ' LEU . 60.7 m -65.0 -48.18 74.84 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.97 -179.573 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.734 HD12 HD23 ' A' ' 53' ' ' LEU . 1.9 tt -57.18 -38.58 62.05 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-O 120.748 0.309 . . . . 0.0 111.167 178.463 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 41' ' ' LYS . . . . . 0.406 ' HE2' ' HB3' ' A' ' 41' ' ' LYS . 4.6 tmmm? -60.97 -40.76 94.62 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 109.57 -0.53 . . . . 0.0 109.57 178.689 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 42' ' ' GLN . . . . . 0.499 ' O ' ' HG2' ' A' ' 46' ' ' ARG . 54.4 mt-30 -70.32 -37.82 74.79 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.614 -179.851 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.693 HD13 HG12 ' A' ' 83' ' ' VAL . 75.0 mt -58.03 -35.95 72.01 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.678 179.075 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 44' ' ' GLN . . . . . 0.568 ' HG3' ' O ' ' A' ' 40' ' ' ILE . 19.7 mt-30 -66.57 -47.72 71.89 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.42 178.223 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.403 ' HG3' ' O ' ' A' ' 41' ' ' LYS . 39.0 mt-10 -64.83 -48.58 73.86 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.694 -0.685 . . . . 0.0 111.195 -177.573 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 46' ' ' ARG . . . . . 0.499 ' HG2' ' O ' ' A' ' 42' ' ' GLN . 17.5 ptm180 -70.79 -23.66 62.42 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.169 -0.469 . . . . 0.0 112.201 -174.224 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -93.13 -29.14 15.91 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.818 0.342 . . . . 0.0 111.093 178.745 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 87.88 26.41 29.33 Favored Glycine 0 N--CA 1.452 -0.25 0 C-N-CA 121.014 -0.612 . . . . 0.0 112.56 -179.062 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 5.1 m -140.08 179.87 2.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-O 120.876 0.369 . . . . 0.0 110.592 -178.801 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 81.1 tttt -110.8 124.66 52.45 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.238 178.531 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' MET . . . . . 0.492 ' HG2' HG23 ' A' ' 69' ' ' ILE . 17.9 mtm -117.2 116.62 27.63 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 109.821 -0.437 . . . . 0.0 109.821 176.661 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.618 ' CG2' ' HB2' ' A' ' 68' ' ' ARG . 10.8 tt -102.0 113.2 37.7 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.727 0 CA-C-O 121.43 0.633 . . . . 0.0 110.762 178.426 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.879 HD22 HD13 ' A' ' 67' ' ' LEU . 1.3 mm? -88.07 107.52 18.79 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.41 -0.814 . . . . 0.0 109.311 175.906 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.657 HD12 ' HB2' ' A' ' 66' ' ' PRO . 58.4 mt -79.84 84.65 1.25 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.575 0 CA-C-O 122.248 1.023 . . . . 0.0 110.323 179.151 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 2.5 pt20 . . . . . 0 C--N 1.318 -0.802 0 CA-C-N 114.006 -1.452 . . . . 0.0 107.677 167.712 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.51 ' HB3' ' HB3' ' A' ' 23' ' ' MET . 7.3 m-20 . . . . . 0 N--CA 1.457 -0.104 0 CA-C-O 120.931 0.396 . . . . 0.0 110.155 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' LYS . . . . . 0.687 ' HB2' ' HB ' ' A' ' 24' ' ' ILE . 65.7 mmtt -88.38 134.0 35.4 Favored Pre-proline 0 C--N 1.318 -0.768 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.904 -169.101 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.657 ' HB2' HD12 ' A' ' 54' ' ' ILE . 16.4 Cg_exo -70.86 104.95 1.57 Allowed 'Trans proline' 0 N--CA 1.456 -0.686 0 C-N-CA 122.744 2.296 . . . . 0.0 111.137 172.49 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.879 HD13 HD22 ' A' ' 53' ' ' LEU . 18.9 tp -110.54 118.06 35.22 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.129 178.26 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 68' ' ' ARG . . . . . 0.618 ' HB2' ' CG2' ' A' ' 52' ' ' ILE . 68.9 mtt180 -108.98 106.36 16.28 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.503 177.345 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.631 HG22 HG22 ' A' ' 76' ' ' VAL . 4.3 mp -87.13 109.49 19.31 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 N-CA-C 107.962 -1.125 . . . . 0.0 107.962 171.163 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.493 HG23 HG22 ' A' ' 19' ' ' VAL . 33.7 mt -110.23 128.37 66.5 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.73 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.979 -171.635 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 150.28 -123.93 1.65 Allowed Glycine 0 N--CA 1.444 -0.798 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.42 173.173 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 72' ' ' ASP . . . . . 0.602 ' OD2' ' HG2' ' A' ' 75' ' ' LYS . 2.8 t70 -84.26 129.84 56.56 Favored Pre-proline 0 C--N 1.32 -0.705 0 CA-C-N 115.479 -0.361 . . . . 0.0 111.298 -177.333 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 73' ' ' PRO . . . . . 0.511 ' HG3' ' OG1' ' A' ' 18' ' ' THR . 53.2 Cg_exo -48.22 -27.79 10.07 Favored 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 123.805 3.003 . . . . 0.0 113.56 -178.924 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 74' ' ' TYR . . . . . 0.553 ' HB3' ' OD2' ' A' ' 72' ' ' ASP . 44.9 t80 -82.75 -60.06 2.3 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.519 -0.31 . . . . 0.0 110.733 -175.987 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.602 ' HG2' ' OD2' ' A' ' 72' ' ' ASP . 12.8 pttt -72.84 -17.46 61.55 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 112.115 0.413 . . . . 0.0 112.115 179.438 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.631 HG22 HG22 ' A' ' 69' ' ' ILE . 12.4 t -69.02 -38.48 78.46 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 N-CA-C 109.106 -0.701 . . . . 0.0 109.106 171.162 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 77' ' ' GLN . . . . . 0.417 ' O ' ' HG3' ' A' ' 81' ' ' GLU . 22.5 tp60 -74.02 -42.33 60.48 Favored 'General case' 0 N--CA 1.448 -0.528 0 CA-C-N 115.657 -0.701 . . . . 0.0 109.495 177.519 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 78' ' ' GLN . . . . . 0.481 ' HB2' ' HA ' ' A' ' 75' ' ' LYS . 51.2 mt-30 -56.01 -51.4 67.9 Favored 'General case' 0 C--O 1.223 -0.332 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.398 174.865 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -60.94 -40.13 92.09 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.925 179.201 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 22.6 t -59.54 -54.37 47.33 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.846 -0.615 . . . . 0.0 111.252 177.717 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 81' ' ' GLU . . . . . 0.433 ' O ' ' HB2' ' A' ' 85' ' ' ASP . 2.3 pp20? -70.77 -25.02 62.71 Favored 'General case' 0 C--O 1.217 -0.642 0 C-N-CA 120.221 -0.592 . . . . 0.0 110.493 -179.334 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 82' ' ' MET . . . . . 0.504 ' O ' HG13 ' A' ' 86' ' ' ILE . 34.8 ttp -67.35 -48.81 66.38 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.578 -0.283 . . . . 0.0 110.878 177.333 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.693 HG12 HD13 ' A' ' 43' ' ' LEU . 33.0 m -74.18 -36.59 44.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 C-N-CA 120.943 -0.303 . . . . 0.0 110.992 -179.766 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 89.2 mtp -71.14 -27.38 63.53 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 110.198 -0.297 . . . . 0.0 110.198 177.607 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 85' ' ' ASP . . . . . 0.433 ' HB2' ' O ' ' A' ' 81' ' ' GLU . 30.0 t70 -63.4 -40.85 98.34 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.276 175.139 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.504 HG13 ' O ' ' A' ' 82' ' ' MET . 52.2 mt -63.06 -33.09 58.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.734 177.711 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.561 HD22 ' HG2' ' A' ' 28' ' ' LYS . 69.2 mt -86.01 -21.81 27.61 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.789 -174.332 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 39.5 ptt180 -95.93 -2.99 46.01 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.122 0.487 . . . . 0.0 110.682 -178.814 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.249 1.047 0 CA-C-O 118.434 -0.793 . . . . 0.0 109.671 -174.678 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.59 ' OG1' ' HG3' ' A' ' 73' ' ' PRO . 85.4 m . . . . . 0 N--CA 1.45 -0.437 0 CA-C-O 121.028 0.442 . . . . 0.0 110.461 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.616 ' HA ' ' O ' ' A' ' 69' ' ' ILE . 3.2 p -130.18 129.02 65.09 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.829 -179.837 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 67.6 mt-30 -105.07 119.49 39.15 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.529 177.962 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.747 ' HA ' ' O ' ' A' ' 67' ' ' LEU . 28.8 mt-10 -92.64 108.77 20.23 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.614 -0.721 . . . . 0.0 110.341 175.022 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.448 HG12 HD22 ' A' ' 67' ' ' LEU . 22.0 mm -107.28 142.9 18.91 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 CA-C-N 115.55 -0.75 . . . . 0.0 109.422 -179.592 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 90.5 mmm -103.56 92.74 4.59 Favored 'General case' 0 N--CA 1.447 -0.6 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 179.099 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.672 ' HB ' ' HB2' ' A' ' 65' ' ' LYS . 25.5 mm -77.6 128.14 80.62 Favored Pre-proline 0 C--N 1.317 -0.84 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.457 -174.622 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_exo -48.1 133.12 23.71 Favored 'Trans proline' 0 N--CA 1.462 -0.366 0 C-N-CA 122.626 2.217 . . . . 0.0 111.453 175.773 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -44.66 -56.17 4.62 Favored 'General case' 0 C--N 1.328 -0.341 0 O-C-N 124.023 0.827 . . . . 0.0 112.824 -171.536 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -79.31 -12.6 83.72 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.875 -0.679 . . . . 0.0 113.02 -175.425 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.433 ' HD3' ' HB3' ' A' ' 87' ' ' LEU . 19.6 ttmm -88.14 8.91 24.67 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.328 0.585 . . . . 0.0 110.522 -175.864 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.403 ' HA ' HG22 ' A' ' 32' ' ' VAL . . . -66.18 -20.82 66.25 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.061 179.224 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -63.86 -16.06 58.83 Favored Glycine 0 N--CA 1.449 -0.455 0 CA-C-N 115.853 -0.612 . . . . 0.0 112.565 179.575 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.478 HD13 HG22 ' A' ' 86' ' ' ILE . 74.9 mt -94.87 -42.4 8.71 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 111.73 0.27 . . . . 0.0 111.73 -179.394 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.629 HG13 HD21 ' A' ' 87' ' ' LEU . 3.1 m -69.83 -38.21 75.28 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.21 0 CA-C-O 121.037 0.446 . . . . 0.0 111.046 178.629 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.578 ' HA ' ' HB ' ' A' ' 40' ' ' ILE . 57.0 mt -86.45 -32.7 6.77 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-O 121.705 0.764 . . . . 0.0 109.441 179.599 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 34' ' ' GLY . . . . . 0.506 ' HA3' ' CB ' ' A' ' 39' ' ' THR . . . 92.65 171.52 40.8 Favored Glycine 0 N--CA 1.441 -0.972 0 CA-C-N 114.923 -1.035 . . . . 0.0 112.086 178.438 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 14.5 mptt -76.77 65.77 2.57 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.104 0.478 . . . . 0.0 110.89 -179.611 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 132.92 5.28 3.15 Favored Glycine 0 C--N 1.33 0.224 0 C-N-CA 120.972 -0.632 . . . . 0.0 112.527 175.442 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.502 ' HA2' HG22 ' A' ' 33' ' ' ILE . . . 86.36 -9.2 71.26 Favored Glycine 0 N--CA 1.449 -0.487 0 C-N-CA 120.524 -0.846 . . . . 0.0 112.016 -179.12 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 55.3 mm-40 -64.33 -33.47 75.91 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.689 0.28 . . . . 0.0 111.208 -179.554 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' THR . . . . . 0.762 ' O ' ' HG ' ' A' ' 43' ' ' LEU . 32.3 m -64.62 -57.26 9.57 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.482 -0.326 . . . . 0.0 111.039 -179.839 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.598 ' HA ' HD12 ' A' ' 43' ' ' LEU . 11.0 tt -59.92 -31.74 48.29 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.391 0 CA-C-O 121.318 0.58 . . . . 0.0 110.553 -179.377 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 46.0 tttt -60.39 -50.64 72.78 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.588 -0.733 . . . . 0.0 110.822 173.751 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' GLN . . . . . 0.644 ' O ' ' HG2' ' A' ' 46' ' ' ARG . 48.2 mt-30 -67.29 -38.77 85.57 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.705 -176.321 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.762 ' HG ' ' O ' ' A' ' 39' ' ' THR . 61.4 mt -55.76 -46.18 77.94 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.397 -176.663 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 43.4 mt-30 -61.26 -34.71 75.61 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.926 -179.862 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -80.74 -45.63 16.75 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.423 -177.583 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' ARG . . . . . 0.644 ' HG2' ' O ' ' A' ' 42' ' ' GLN . 14.0 ptp180 -74.66 -43.21 56.43 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 112.753 0.649 . . . . 0.0 112.753 -173.879 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.525 ' HB3' HG22 ' A' ' 49' ' ' VAL . . . -83.82 -14.72 50.63 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 112.084 0.402 . . . . 0.0 112.084 -173.508 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 72.24 24.91 75.66 Favored Glycine 0 C--N 1.329 0.17 0 C-N-CA 120.659 -0.782 . . . . 0.0 111.912 -179.134 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.525 HG22 ' HB3' ' A' ' 47' ' ' ALA . 26.8 m -124.08 162.31 25.54 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 N-CA-C 109.937 -0.394 . . . . 0.0 109.937 -179.296 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 61.6 tttp -100.5 122.14 42.72 Favored 'General case' 0 C--N 1.317 -0.833 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 174.624 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' MET . . . . . 0.478 ' CE ' ' HB1' ' A' ' 79' ' ' ALA . 61.1 mtt -110.12 115.38 29.64 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 174.836 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.67 ' CG2' ' HB2' ' A' ' 68' ' ' ARG . 12.6 tt -109.64 105.13 18.21 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.973 0 CA-C-O 121.88 0.848 . . . . 0.0 109.727 174.886 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -87.84 107.76 18.83 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 114.666 -1.152 . . . . 0.0 109.203 178.278 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.511 ' HB ' ' HB2' ' A' ' 66' ' ' PRO . 46.4 mm -74.54 85.05 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.306 0 CA-C-O 122.006 0.908 . . . . 0.0 110.486 -177.87 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--N 1.315 -0.898 0 CA-C-N 114.361 -1.291 . . . . 0.0 108.111 170.54 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 23.3 m-20 . . . . . 0 N--CA 1.462 0.166 0 CA-C-O 120.772 0.32 . . . . 0.0 110.274 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 65' ' ' LYS . . . . . 0.672 ' HB2' ' HB ' ' A' ' 24' ' ' ILE . 31.0 mmtp -94.34 118.24 67.04 Favored Pre-proline 0 C--N 1.32 -0.681 0 CA-C-N 116.037 -0.528 . . . . 0.0 110.804 -170.368 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.511 ' HB2' ' HB ' ' A' ' 54' ' ' ILE . 25.4 Cg_exo -65.43 104.69 0.66 Allowed 'Trans proline' 0 N--CA 1.459 -0.53 0 C-N-CA 122.653 2.235 . . . . 0.0 110.942 173.784 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.886 HD21 HG13 ' A' ' 69' ' ' ILE . 4.8 tt -103.88 136.55 43.33 Favored 'General case' 0 C--N 1.315 -0.904 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 179.907 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 68' ' ' ARG . . . . . 0.67 ' HB2' ' CG2' ' A' ' 52' ' ' ILE . 92.7 mtt180 -131.16 108.38 9.68 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 121.067 0.461 . . . . 0.0 111.003 173.538 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.886 HG13 HD21 ' A' ' 67' ' ' LEU . 13.5 mt -91.77 104.96 16.07 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 N-CA-C 108.828 -0.805 . . . . 0.0 108.828 172.57 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 5.2 mt -105.35 126.06 60.5 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.828 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.476 -174.837 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 160.61 -129.72 2.22 Favored Glycine 0 N--CA 1.446 -0.666 0 C-N-CA 120.591 -0.814 . . . . 0.0 112.705 175.03 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' ASP . . . . . 0.663 ' OD2' ' HG2' ' A' ' 75' ' ' LYS . 0.9 OUTLIER -88.23 132.94 37.97 Favored Pre-proline 0 C--N 1.322 -0.616 0 C-N-CA 122.833 0.453 . . . . 0.0 111.394 -176.696 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 73' ' ' PRO . . . . . 0.59 ' HG3' ' OG1' ' A' ' 18' ' ' THR . 45.6 Cg_exo -52.51 -26.41 28.61 Favored 'Trans proline' 0 C--N 1.351 0.679 0 C-N-CA 123.899 3.066 . . . . 0.0 113.301 -174.94 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 74' ' ' TYR . . . . . 0.48 ' HB3' ' OD2' ' A' ' 72' ' ' ASP . 82.2 t80 -83.49 -56.29 3.82 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.422 -176.664 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.663 ' HG2' ' OD2' ' A' ' 72' ' ' ASP . 12.9 ptpt -71.48 -27.03 62.96 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.54 -179.818 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.631 HG22 HG22 ' A' ' 69' ' ' ILE . 25.2 t -61.18 -40.7 86.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 N-CA-C 110.305 -0.258 . . . . 0.0 110.305 173.799 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -74.97 -43.24 55.16 Favored 'General case' 0 N--CA 1.451 -0.419 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.297 -179.018 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 78' ' ' GLN . . . . . 0.463 ' O ' ' HB2' ' A' ' 82' ' ' MET . 41.4 mt-30 -62.0 -35.89 79.89 Favored 'General case' 0 C--O 1.224 -0.264 0 CA-C-N 116.52 -0.309 . . . . 0.0 110.674 177.465 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 79' ' ' ALA . . . . . 0.478 ' HB1' ' CE ' ' A' ' 51' ' ' MET . . . -74.85 -34.15 62.23 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 120.912 0.387 . . . . 0.0 110.478 177.831 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 53.9 t -63.29 -56.7 14.33 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.149 176.438 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -66.23 -23.04 66.36 Favored 'General case' 0 C--O 1.22 -0.499 0 C-N-CA 120.547 -0.461 . . . . 0.0 110.47 179.217 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 82' ' ' MET . . . . . 0.463 ' HB2' ' O ' ' A' ' 78' ' ' GLN . 30.6 ttm -59.61 -52.66 64.59 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.981 0.419 . . . . 0.0 110.202 174.838 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.644 ' O ' ' HG ' ' A' ' 87' ' ' LEU . 18.7 m -83.86 -35.23 11.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.09 -177.521 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 84' ' ' MET . . . . . 0.458 ' O ' ' HG2' ' A' ' 88' ' ' ARG . 57.1 ttp -65.44 -35.39 80.77 Favored 'General case' 0 CA--C 1.518 -0.265 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.291 -179.894 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 85' ' ' ASP . . . . . 0.48 ' O ' ' HB2' ' A' ' 89' ' ' GLU . 33.2 t70 -61.3 -39.87 92.09 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.127 177.382 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.478 HG22 HD13 ' A' ' 31' ' ' LEU . 23.5 mt -64.62 -41.18 91.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 121.412 0.625 . . . . 0.0 109.925 176.398 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.644 ' HG ' ' O ' ' A' ' 83' ' ' VAL . 66.1 mt -64.39 -36.11 83.09 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.373 -0.831 . . . . 0.0 111.101 -178.781 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 88' ' ' ARG . . . . . 0.458 ' HG2' ' O ' ' A' ' 84' ' ' MET . 29.5 mmm180 -95.28 9.91 38.06 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.996 -177.352 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 89' ' ' GLU . . . . . 0.48 ' HB2' ' O ' ' A' ' 85' ' ' ASP . 35.3 tt0 . . . . . 0 C--O 1.25 1.122 0 CA-C-O 118.836 -0.602 . . . . 0.0 110.34 -177.787 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 85.7 m . . . . . 0 N--CA 1.452 -0.342 0 N-CA-C 109.697 -0.482 . . . . 0.0 109.697 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.665 ' HA ' ' O ' ' A' ' 69' ' ' ILE . 3.2 p -139.86 121.76 16.0 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-O 121.161 0.505 . . . . 0.0 111.932 -175.456 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 20' ' ' GLN . . . . . 0.411 ' O ' ' HA ' ' A' ' 68' ' ' ARG . 29.6 mt-30 -96.88 157.17 16.03 Favored 'General case' 0 CA--C 1.519 -0.233 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.353 173.363 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.582 ' HG2' ' HG2' ' A' ' 68' ' ' ARG . 35.2 mt-10 -131.18 107.91 9.34 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.177 0.513 . . . . 0.0 111.075 -178.424 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 5.3 mm -101.57 150.37 6.06 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-N 115.54 -0.754 . . . . 0.0 109.405 -179.807 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 79.5 mmm -110.18 92.85 4.21 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 176.77 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.676 ' HB ' ' HB2' ' A' ' 65' ' ' LYS . 32.7 mm -82.3 127.32 71.64 Favored Pre-proline 0 C--N 1.32 -0.676 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.101 -173.895 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 76.7 Cg_exo -50.85 136.5 43.33 Favored 'Trans proline' 0 N--CA 1.463 -0.317 0 C-N-CA 122.491 2.127 . . . . 0.0 111.592 175.398 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -58.1 -29.28 65.35 Favored 'General case' 0 CA--C 1.531 0.226 0 N-CA-C 112.959 0.725 . . . . 0.0 112.959 -172.116 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -89.44 -19.73 47.94 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.484 -0.865 . . . . 0.0 112.138 179.323 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 8.5 tptm -91.95 -1.15 57.42 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.266 0.555 . . . . 0.0 110.363 -177.601 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.487 ' HA ' HG22 ' A' ' 32' ' ' VAL . . . -63.06 -20.93 65.8 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.598 -0.728 . . . . 0.0 111.065 179.471 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -61.0 -16.3 47.14 Favored Glycine 0 C--O 1.228 -0.247 0 CA-C-N 115.876 -0.602 . . . . 0.0 112.652 177.405 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 62.6 mt -93.75 -47.92 6.55 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 122.693 -0.298 . . . . 0.0 111.238 179.539 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.561 HG13 HD21 ' A' ' 87' ' ' LEU . 3.0 m -65.34 -40.07 87.29 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.379 0 CA-C-O 120.889 0.376 . . . . 0.0 111.452 179.523 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.51 HG13 HG23 ' A' ' 32' ' ' VAL . 43.6 mt -85.88 -32.75 7.09 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-O 121.927 0.87 . . . . 0.0 109.162 178.794 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 34' ' ' GLY . . . . . 0.527 ' HA3' ' HB ' ' A' ' 39' ' ' THR . . . 95.15 178.9 37.3 Favored Glycine 0 N--CA 1.436 -1.318 0 CA-C-N 114.852 -1.067 . . . . 0.0 111.579 -178.105 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 2.9 mppt? -81.13 62.8 5.23 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-O 120.973 0.416 . . . . 0.0 110.373 -178.839 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 133.19 -20.1 4.26 Favored Glycine 0 N--CA 1.448 -0.521 0 C-N-CA 120.823 -0.703 . . . . 0.0 112.416 176.897 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 115.8 -0.16 21.45 Favored Glycine 0 N--CA 1.448 -0.517 0 C-N-CA 120.723 -0.751 . . . . 0.0 111.883 -176.792 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.508 ' O ' ' HB3' ' A' ' 41' ' ' LYS . 49.3 mt-10 -75.44 -31.96 60.5 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 120.724 0.297 . . . . 0.0 111.106 179.474 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 39' ' ' THR . . . . . 0.584 ' O ' ' HG ' ' A' ' 43' ' ' LEU . 23.7 m -69.38 -48.46 61.11 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.774 -178.3 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.665 HD12 HD23 ' A' ' 53' ' ' LEU . 7.0 tt -61.8 -32.79 55.05 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.267 0 CA-C-O 121.107 0.479 . . . . 0.0 110.346 177.356 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 41' ' ' LYS . . . . . 0.508 ' HB3' ' O ' ' A' ' 38' ' ' GLU . 31.6 ttpt -56.24 -45.22 80.07 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.467 174.398 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 42' ' ' GLN . . . . . 0.45 ' O ' ' HG2' ' A' ' 46' ' ' ARG . 97.1 mt-30 -73.46 -40.46 64.15 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.404 -0.816 . . . . 0.0 111.116 -177.027 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.584 ' HG ' ' O ' ' A' ' 39' ' ' THR . 81.0 mt -55.71 -47.58 76.63 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.683 -176.577 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 44.6 mt-30 -61.98 -43.13 99.48 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.712 -176.247 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -78.54 -35.21 46.46 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 111.836 0.31 . . . . 0.0 111.836 -175.797 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' ARG . . . . . 0.45 ' HG2' ' O ' ' A' ' 42' ' ' GLN . 12.9 ptm180 -73.92 -31.39 63.05 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 120.777 -0.369 . . . . 0.0 111.268 -177.89 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -89.19 -28.18 20.16 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.087 0.47 . . . . 0.0 111.348 -179.111 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 82.93 33.21 24.6 Favored Glycine 0 N--CA 1.449 -0.478 0 CA-C-N 115.742 -0.663 . . . . 0.0 112.243 -178.698 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 3.6 m -139.14 179.86 2.76 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.399 0 CA-C-O 120.898 0.38 . . . . 0.0 110.297 178.609 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 54.7 tttp -109.44 123.67 49.75 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 115.945 -0.57 . . . . 0.0 109.919 175.448 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' MET . . . . . 0.552 ' HG2' HG23 ' A' ' 69' ' ' ILE . 65.9 mtp -118.21 114.08 22.49 Favored 'General case' 0 C--N 1.317 -0.808 0 N-CA-C 108.301 -1.0 . . . . 0.0 108.301 174.414 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.502 ' CG2' ' HB2' ' A' ' 68' ' ' ARG . 11.5 tt -104.6 108.54 25.06 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.749 0 CA-C-O 121.622 0.725 . . . . 0.0 110.684 -177.614 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.723 HD22 HD13 ' A' ' 67' ' ' LEU . 2.7 mm? -82.35 102.29 11.15 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.249 -0.887 . . . . 0.0 109.522 174.11 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.648 HD12 ' HB2' ' A' ' 66' ' ' PRO . 56.6 mt -82.48 87.42 1.9 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.55 0 CA-C-O 121.481 0.658 . . . . 0.0 109.35 -179.171 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 70.9 mt-30 . . . . . 0 C--N 1.323 -0.564 0 CA-C-N 115.148 -0.933 . . . . 0.0 111.144 -173.59 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 . . . . . 0 N--CA 1.443 -0.79 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 65' ' ' LYS . . . . . 0.676 ' HB2' ' HB ' ' A' ' 24' ' ' ILE . 2.7 mmpp? -148.57 113.28 3.74 Favored Pre-proline 0 C--N 1.318 -0.779 0 CA-C-N 115.62 -0.718 . . . . 0.0 109.51 178.779 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.648 ' HB2' HD12 ' A' ' 54' ' ' ILE . 24.7 Cg_exo -63.55 110.26 1.21 Allowed 'Trans proline' 0 N--CA 1.462 -0.353 0 C-N-CA 122.613 2.209 . . . . 0.0 111.807 178.268 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.723 HD13 HD22 ' A' ' 53' ' ' LEU . 24.2 tp -111.16 105.22 13.85 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.069 178.006 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 68' ' ' ARG . . . . . 0.582 ' HG2' ' HG2' ' A' ' 21' ' ' GLU . 95.2 mtt180 -97.72 113.62 25.42 Favored 'General case' 0 C--N 1.319 -0.717 0 CA-C-O 121.437 0.637 . . . . 0.0 110.581 176.813 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.665 ' O ' ' HA ' ' A' ' 19' ' ' VAL . 19.6 mt -98.83 104.09 15.54 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.786 0 CA-C-N 114.99 -1.004 . . . . 0.0 108.577 177.897 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.545 HG23 ' HB ' ' A' ' 19' ' ' VAL . 2.8 mt -112.58 132.61 60.84 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.788 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.061 -169.348 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 156.44 -119.06 0.88 Allowed Glycine 0 N--CA 1.446 -0.675 0 C-N-CA 120.718 -0.754 . . . . 0.0 112.825 174.832 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 72' ' ' ASP . . . . . 0.401 ' O ' HG23 ' A' ' 76' ' ' VAL . 11.9 t70 -102.69 134.77 19.7 Favored Pre-proline 0 C--N 1.325 -0.46 0 CA-C-O 119.091 -0.48 . . . . 0.0 110.96 -175.667 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_exo -44.31 -42.91 13.59 Favored 'Trans proline' 0 C--O 1.237 0.445 0 C-N-CA 123.231 2.62 . . . . 0.0 113.557 -174.419 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 30.7 t80 -70.95 -47.73 57.34 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.853 -171.911 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.436 ' HA ' ' HB2' ' A' ' 78' ' ' GLN . 14.3 pttt -82.87 -19.24 37.84 Favored 'General case' 0 C--N 1.325 -0.466 0 C-N-CA 120.492 -0.483 . . . . 0.0 111.768 -179.463 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.401 HG23 ' O ' ' A' ' 72' ' ' ASP . 47.0 t -66.16 -38.55 82.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 170.036 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 77' ' ' GLN . . . . . 0.407 ' O ' ' HG2' ' A' ' 81' ' ' GLU . 20.9 tp60 -69.92 -49.13 55.06 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.38 -0.827 . . . . 0.0 110.416 175.426 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 78' ' ' GLN . . . . . 0.436 ' HB2' ' HA ' ' A' ' 75' ' ' LYS . 86.2 mt-30 -60.4 -36.36 77.95 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.567 -0.288 . . . . 0.0 111.693 -179.913 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -69.64 -39.42 77.12 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 120.818 0.342 . . . . 0.0 110.546 177.462 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 52.5 t -65.13 -51.45 61.19 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.051 179.681 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 81' ' ' GLU . . . . . 0.408 ' HG2' ' HA ' ' A' ' 78' ' ' GLN . 10.3 pt-20 -64.99 -24.11 67.41 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.972 0.415 . . . . 0.0 110.37 179.983 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 82' ' ' MET . . . . . 0.557 ' O ' HG13 ' A' ' 86' ' ' ILE . 29.7 ttp -73.14 -52.02 15.76 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.863 179.259 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.57 ' O ' ' HG ' ' A' ' 87' ' ' LEU . 33.3 m -77.75 -34.0 19.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 120.635 0.255 . . . . 0.0 111.207 -175.647 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 51.7 ttm -63.35 -35.25 79.75 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.106 0.479 . . . . 0.0 109.741 177.194 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -68.54 -36.72 79.22 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.441 179.444 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.557 HG13 ' O ' ' A' ' 82' ' ' MET . 59.9 mt -63.31 -33.25 60.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-O 121.256 0.55 . . . . 0.0 110.543 178.056 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.57 ' HG ' ' O ' ' A' ' 83' ' ' VAL . 58.7 mt -73.87 -19.61 60.67 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.604 -175.945 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 88' ' ' ARG . . . . . 0.619 ' HG3' ' HG2' ' A' ' 89' ' ' GLU . 37.1 ptt180 -110.8 -19.3 12.88 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.372 0.606 . . . . 0.0 111.142 -175.596 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 89' ' ' GLU . . . . . 0.619 ' HG2' ' HG3' ' A' ' 88' ' ' ARG . 69.9 mm-40 . . . . . 0 C--O 1.249 1.04 0 CA-C-N 115.235 -0.893 . . . . 0.0 110.425 -175.633 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 99.7 m . . . . . 0 C--O 1.234 0.25 0 CA-C-O 121.008 0.432 . . . . 0.0 111.641 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.586 HG22 HG23 ' A' ' 70' ' ' ILE . 92.9 t -120.8 126.99 75.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.276 178.284 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 20' ' ' GLN . . . . . 0.576 ' HB2' ' CG1' ' A' ' 76' ' ' VAL . 4.9 tp-100 -106.58 113.93 27.74 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 109.667 -0.494 . . . . 0.0 109.667 175.684 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.607 ' HA ' ' O ' ' A' ' 67' ' ' LEU . 56.1 mt-10 -93.24 121.29 34.47 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.036 0.446 . . . . 0.0 111.457 177.591 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 18.7 mm -115.43 146.38 19.94 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 115.529 -0.759 . . . . 0.0 109.355 176.902 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' MET . . . . . 0.494 ' HB3' ' HB2' ' A' ' 64' ' ' ASP . 79.4 mmm -106.77 99.86 9.4 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 175.356 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.709 HD12 HD11 ' A' ' 87' ' ' LEU . 24.5 mm -78.54 129.76 73.36 Favored Pre-proline 0 C--N 1.32 -0.685 0 CA-C-N 115.498 -0.774 . . . . 0.0 111.895 -170.461 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 25' ' ' PRO . . . . . 0.603 ' HD2' HD13 ' A' ' 87' ' ' LEU . 77.0 Cg_exo -45.2 131.37 11.38 Favored 'Trans proline' 0 C--N 1.349 0.574 0 C-N-CA 123.744 2.963 . . . . 0.0 112.976 175.831 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -71.36 78.5 0.75 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.444 0.64 . . . . 0.0 110.874 179.437 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 157.54 -59.96 0.34 Allowed Glycine 0 N--CA 1.447 -0.593 0 N-CA-C 109.983 -1.247 . . . . 0.0 109.983 -177.456 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.46 -13.97 35.97 Favored 'General case' 0 N--CA 1.451 -0.41 0 CA-C-O 121.0 0.429 . . . . 0.0 110.749 171.929 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.425 ' O ' HG12 ' A' ' 32' ' ' VAL . . . -56.16 -23.49 35.24 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.771 173.379 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -61.8 -24.46 64.54 Favored Glycine 0 N--CA 1.449 -0.494 0 C-N-CA 120.862 -0.685 . . . . 0.0 112.185 176.611 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 93.1 mt -92.4 -32.8 14.81 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.725 0.298 . . . . 0.0 110.859 178.793 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.438 HG11 HG21 ' A' ' 24' ' ' ILE . 0.3 OUTLIER -68.06 -29.0 43.15 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.296 0 CA-C-O 121.263 0.554 . . . . 0.0 110.395 179.387 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 63.2 mt -92.0 -47.97 13.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 115.568 -0.742 . . . . 0.0 109.424 174.386 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 114.56 -162.12 12.51 Favored Glycine 0 N--CA 1.442 -0.942 0 CA-C-N 115.356 -0.838 . . . . 0.0 112.095 178.418 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.534 ' N ' ' HD3' ' A' ' 35' ' ' LYS . 0.1 OUTLIER -92.29 39.33 1.02 Allowed 'General case' 0 C--N 1.317 -0.818 0 N-CA-C 109.637 -0.505 . . . . 0.0 109.637 -178.298 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 143.52 -21.31 2.21 Favored Glycine 0 N--CA 1.45 -0.431 0 C-N-CA 120.982 -0.628 . . . . 0.0 112.29 -178.245 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 126.17 4.77 6.4 Favored Glycine 0 C--O 1.228 -0.245 0 C-N-CA 120.355 -0.926 . . . . 0.0 112.309 179.939 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -80.59 -28.17 37.2 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 120.659 0.266 . . . . 0.0 111.217 178.897 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 39' ' ' THR . . . . . 0.623 ' O ' ' HG ' ' A' ' 43' ' ' LEU . 57.9 m -70.38 -49.64 47.01 Favored 'General case' 0 C--N 1.324 -0.507 0 C-N-CA 121.101 -0.24 . . . . 0.0 110.444 -179.983 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.703 HD12 HD23 ' A' ' 53' ' ' LEU . 5.2 tt -59.64 -33.72 52.86 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.248 0 CA-C-O 120.81 0.338 . . . . 0.0 110.473 176.31 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 41' ' ' LYS . . . . . 0.536 ' O ' ' HG2' ' A' ' 45' ' ' GLU . 57.7 tttp -64.86 -46.23 82.74 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.756 175.454 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 41.7 mt-30 -60.88 -35.08 75.69 Favored 'General case' 0 CA--C 1.516 -0.354 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.359 -178.017 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.623 ' HG ' ' O ' ' A' ' 39' ' ' THR . 69.8 mt -62.19 -43.6 98.46 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.421 -0.809 . . . . 0.0 110.402 178.158 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 44' ' ' GLN . . . . . 0.435 ' HG3' ' O ' ' A' ' 40' ' ' ILE . 22.8 mt-30 -62.61 -47.24 84.63 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.176 177.596 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.536 ' HG2' ' O ' ' A' ' 41' ' ' LYS . 72.0 mm-40 -59.81 -39.41 84.95 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.33 -0.85 . . . . 0.0 111.672 -177.854 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 13.5 ptm180 -90.0 -28.02 19.38 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 112.932 0.716 . . . . 0.0 112.932 -170.865 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.45 ' HB3' HG22 ' A' ' 49' ' ' VAL . . . -94.22 -15.83 24.2 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 112.174 0.435 . . . . 0.0 112.174 -175.642 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 74.23 20.72 79.6 Favored Glycine 0 C--O 1.235 0.217 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.183 -179.855 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.45 HG22 ' HB3' ' A' ' 47' ' ' ALA . 27.3 m -124.51 177.31 4.67 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 N-CA-C 109.902 -0.407 . . . . 0.0 109.902 -179.202 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 87.1 tttt -114.64 123.97 50.66 Favored 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 109.773 -0.455 . . . . 0.0 109.773 173.088 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' MET . . . . . 0.592 ' HE2' ' HB1' ' A' ' 79' ' ' ALA . 55.7 mtt -108.54 115.39 30.02 Favored 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 176.028 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.561 ' CG2' ' HB2' ' A' ' 68' ' ' ARG . 10.2 tt -105.13 105.14 18.08 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.895 0 CA-C-O 121.585 0.707 . . . . 0.0 110.423 177.668 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 1.004 HD22 HD13 ' A' ' 67' ' ' LEU . 1.4 mm? -80.75 121.8 26.36 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.283 -0.872 . . . . 0.0 108.973 172.608 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.47 ' CG1' ' HB2' ' A' ' 66' ' ' PRO . 48.9 mm -76.67 85.86 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-O 121.845 0.831 . . . . 0.0 109.832 179.514 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 15.3 mt-30 . . . . . 0 C--N 1.323 -0.544 0 CA-C-N 114.743 -1.117 . . . . 0.0 108.64 -179.983 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.494 ' HB2' ' HB3' ' A' ' 23' ' ' MET . 0.6 OUTLIER . . . . . 0 C--O 1.221 -0.431 0 CA-C-O 121.143 0.497 . . . . 0.0 112.334 . . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 65' ' ' LYS . . . . . 0.665 ' HB2' ' HB ' ' A' ' 24' ' ' ILE . 73.6 mmtt -95.46 132.62 27.25 Favored Pre-proline 0 C--N 1.322 -0.592 0 CA-C-N 115.543 -0.753 . . . . 0.0 112.22 -170.49 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.47 ' HB2' ' CG1' ' A' ' 54' ' ' ILE . 13.7 Cg_exo -71.19 118.53 5.73 Favored 'Trans proline' 0 N--CA 1.457 -0.639 0 C-N-CA 122.867 2.378 . . . . 0.0 111.55 173.422 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 1.004 HD13 HD22 ' A' ' 53' ' ' LEU . 13.0 tp -123.48 124.7 43.44 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.98 -0.555 . . . . 0.0 109.923 178.091 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 68' ' ' ARG . . . . . 0.561 ' HB2' ' CG2' ' A' ' 52' ' ' ILE . 87.5 mtt180 -112.58 110.63 20.91 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-O 120.851 0.358 . . . . 0.0 111.292 177.458 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.461 ' HB ' ' HB3' ' A' ' 20' ' ' GLN . 4.6 mp -88.38 104.7 14.91 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 171.525 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.586 HG23 HG22 ' A' ' 19' ' ' VAL . 11.3 mt -104.65 124.85 59.49 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.703 -174.99 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 173.95 -129.82 1.71 Allowed Glycine 0 N--CA 1.447 -0.592 0 C-N-CA 121.005 -0.617 . . . . 0.0 112.208 179.582 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' ASP . . . . . 0.492 ' OD1' ' HD2' ' A' ' 73' ' ' PRO . 3.1 t70 -107.58 145.72 31.87 Favored Pre-proline 0 C--N 1.324 -0.523 0 CA-C-O 118.655 -0.688 . . . . 0.0 109.895 -179.793 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 73' ' ' PRO . . . . . 0.492 ' HD2' ' OD1' ' A' ' 72' ' ' ASP . 94.3 Cg_exo -41.02 -40.42 3.81 Favored 'Trans proline' 0 CA--C 1.535 0.571 0 C-N-CA 122.999 2.466 . . . . 0.0 113.335 -179.398 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 85.9 t80 -70.82 -56.71 5.71 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.295 -176.262 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.459 ' HG2' ' HB3' ' A' ' 72' ' ' ASP . 27.6 pttt -71.22 -27.48 63.51 Favored 'General case' 0 CA--C 1.514 -0.432 0 C-N-CA 120.575 -0.45 . . . . 0.0 111.383 -179.523 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.576 ' CG1' ' HB2' ' A' ' 20' ' ' GLN . 24.2 t -66.71 -36.17 76.59 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-O 121.4 0.619 . . . . 0.0 109.441 177.068 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 77' ' ' GLN . . . . . 0.463 ' O ' ' HG2' ' A' ' 81' ' ' GLU . 20.1 tp60 -72.7 -47.98 42.68 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.292 176.749 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 25.0 mt-30 -57.8 -37.65 74.13 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-O 121.112 0.482 . . . . 0.0 110.6 177.534 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 79' ' ' ALA . . . . . 0.592 ' HB1' ' HE2' ' A' ' 51' ' ' MET . . . -71.99 -36.93 69.9 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.638 -0.71 . . . . 0.0 111.188 179.899 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 80' ' ' CYS . . . . . 0.44 ' HA ' HG22 ' A' ' 83' ' ' VAL . 51.7 t -68.37 -48.29 65.17 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.965 179.548 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 81' ' ' GLU . . . . . 0.463 ' HG2' ' O ' ' A' ' 77' ' ' GLN . 11.2 pt-20 -65.95 -19.48 65.88 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.11 0.481 . . . . 0.0 110.067 178.778 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 82' ' ' MET . . . . . 0.515 ' O ' HG13 ' A' ' 86' ' ' ILE . 51.1 ttp -79.18 -50.05 11.59 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.67 -0.695 . . . . 0.0 110.637 177.05 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.44 HG22 ' HA ' ' A' ' 80' ' ' CYS . 27.2 m -69.08 -35.16 67.27 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.248 0 C-N-CA 121.114 -0.234 . . . . 0.0 111.112 179.918 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 16.8 mmt -60.93 -37.23 81.59 Favored 'General case' 0 CA--C 1.517 -0.298 0 CA-C-O 121.076 0.465 . . . . 0.0 109.977 174.539 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -65.2 -43.77 90.55 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.482 -0.781 . . . . 0.0 110.95 178.694 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.515 HG13 ' O ' ' A' ' 82' ' ' MET . 51.5 mt -60.54 -37.52 75.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 121.466 0.651 . . . . 0.0 110.882 -179.395 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.709 HD11 HD12 ' A' ' 24' ' ' ILE . 71.5 mt -82.88 -12.83 57.08 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.762 -0.654 . . . . 0.0 111.21 -176.858 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 45.0 ttp180 -103.39 -18.34 14.87 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.467 0.651 . . . . 0.0 111.062 -176.982 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 . . . . . 0 C--O 1.249 1.051 0 CA-C-O 118.191 -0.909 . . . . 0.0 110.095 -178.31 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.439 ' OG1' ' HG3' ' A' ' 73' ' ' PRO . 92.8 m . . . . . 0 N--CA 1.452 -0.358 0 N-CA-C 110.21 -0.293 . . . . 0.0 110.21 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.542 ' HA ' ' O ' ' A' ' 69' ' ' ILE . 3.8 p -138.22 120.91 19.12 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-O 121.259 0.552 . . . . 0.0 110.808 179.909 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 53.2 mt-30 -102.54 136.11 42.96 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.793 -0.64 . . . . 0.0 109.98 176.646 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.568 ' HA ' ' O ' ' A' ' 67' ' ' LEU . 33.4 mt-10 -112.3 114.75 27.67 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.498 179.232 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 11.5 mm -106.56 156.93 7.01 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-N 115.486 -0.779 . . . . 0.0 110.038 -176.599 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 3.6 mmt -108.9 97.26 6.93 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 174.793 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.674 ' HB ' ' HB2' ' A' ' 65' ' ' LYS . 25.6 mm -82.92 125.53 74.96 Favored Pre-proline 0 C--N 1.316 -0.888 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.814 -175.819 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 25' ' ' PRO . . . . . 0.664 ' HB2' ' HB2' ' A' ' 28' ' ' LYS . 74.0 Cg_exo -50.51 132.8 36.35 Favored 'Trans proline' 0 C--N 1.343 0.289 0 C-N-CA 122.747 2.298 . . . . 0.0 111.416 175.94 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -58.88 -31.84 68.94 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.751 -0.659 . . . . 0.0 112.51 -172.842 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -82.47 -36.7 16.17 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.592 -0.813 . . . . 0.0 111.823 178.426 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.664 ' HB2' ' HB2' ' A' ' 25' ' ' PRO . 36.2 mttp -80.32 3.64 20.39 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.808 0.337 . . . . 0.0 111.393 179.466 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.66 -30.44 70.73 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.096 0.474 . . . . 0.0 110.141 175.742 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -66.17 -18.67 67.34 Favored Glycine 0 N--CA 1.446 -0.656 0 C-N-CA 120.861 -0.685 . . . . 0.0 112.341 177.848 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 82.2 mt -84.36 -46.72 11.44 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.53 0.205 . . . . 0.0 110.789 179.922 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.652 HG21 HG21 ' A' ' 24' ' ' ILE . 2.8 m -66.7 -34.88 72.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-O 120.884 0.373 . . . . 0.0 110.958 177.813 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.721 HD11 ' HG2' ' A' ' 55' ' ' GLN . 84.7 mt -80.21 -44.97 22.51 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-O 121.203 0.525 . . . . 0.0 110.4 178.413 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 34' ' ' GLY . . . . . 0.447 ' HA3' ' H ' ' A' ' 39' ' ' THR . . . 98.96 51.05 1.4 Allowed Glycine 0 N--CA 1.448 -0.553 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.841 177.202 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 5.0 mptp? 54.25 30.98 13.3 Favored 'General case' 0 N--CA 1.464 0.254 0 C-N-CA 122.959 0.504 . . . . 0.0 112.118 175.761 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 147.4 -36.86 1.16 Allowed Glycine 0 N--CA 1.446 -0.696 0 C-N-CA 120.294 -0.955 . . . . 0.0 112.575 -178.526 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 147.49 -1.97 0.76 Allowed Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 119.516 -1.326 . . . . 0.0 114.504 177.985 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 -63.23 -47.48 82.31 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 117.677 0.739 . . . . 0.0 111.301 -179.169 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' THR . . . . . 0.738 ' O ' ' HG ' ' A' ' 43' ' ' LEU . 95.3 m -63.86 -51.55 64.12 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 111.7 0.259 . . . . 0.0 111.7 -177.112 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.556 ' O ' ' HG3' ' A' ' 44' ' ' GLN . 5.3 tt -58.01 -37.49 61.66 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.375 0 CA-C-O 120.989 0.423 . . . . 0.0 110.831 -178.658 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 85.8 tttt -63.38 -44.21 95.41 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.452 177.158 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 70.8 mt-30 -65.0 -40.25 94.66 Favored 'General case' 0 CA--C 1.517 -0.306 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.62 -178.744 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.738 ' HG ' ' O ' ' A' ' 39' ' ' THR . 70.5 mt -56.99 -48.33 78.67 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.588 -0.733 . . . . 0.0 111.558 -177.742 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 44' ' ' GLN . . . . . 0.556 ' HG3' ' O ' ' A' ' 40' ' ' ILE . 14.2 mt-30 -58.96 -51.78 68.57 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.462 -178.226 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -68.68 -40.71 79.95 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.366 -0.833 . . . . 0.0 111.889 -173.79 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' ARG . . . . . 0.6 ' HD3' ' SD ' ' A' ' 82' ' ' MET . 13.0 ptm180 -71.94 -27.82 63.05 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 111.74 0.274 . . . . 0.0 111.74 -174.574 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.53 ' HB3' HG22 ' A' ' 49' ' ' VAL . . . -96.98 -22.71 16.67 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.02 0.438 . . . . 0.0 111.302 -178.882 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 79.85 28.55 50.28 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 121.027 -0.606 . . . . 0.0 111.722 -178.213 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.53 HG22 ' HB3' ' A' ' 47' ' ' ALA . 27.1 m -123.06 179.08 2.79 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-O 120.833 0.349 . . . . 0.0 110.114 -176.741 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 61.6 tttp -113.25 123.53 50.4 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 171.56 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' MET . . . . . 0.424 ' HE2' HG13 ' A' ' 69' ' ' ILE . 54.7 mtp -122.64 116.7 24.26 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 109.727 -0.472 . . . . 0.0 109.727 179.567 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.484 ' CG2' ' HB2' ' A' ' 68' ' ' ARG . 6.7 tt -107.13 107.17 22.11 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.792 0 CA-C-O 121.462 0.649 . . . . 0.0 110.878 -179.979 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.677 HD22 HD13 ' A' ' 67' ' ' LEU . 3.5 mm? -82.6 103.58 12.22 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.382 -0.826 . . . . 0.0 109.136 172.314 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.646 HD12 ' HB2' ' A' ' 66' ' ' PRO . 65.5 mt -81.37 89.78 1.85 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-O 121.192 0.52 . . . . 0.0 109.792 178.79 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 55' ' ' GLN . . . . . 0.721 ' HG2' HD11 ' A' ' 33' ' ' ILE . 0.0 OUTLIER . . . . . 0 C--N 1.322 -0.613 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.654 179.82 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 . . . . . 0 C--O 1.225 -0.195 0 CA-C-O 120.898 0.38 . . . . 0.0 110.807 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 65' ' ' LYS . . . . . 0.674 ' HB2' ' HB ' ' A' ' 24' ' ' ILE . 69.5 mmtt -96.26 127.15 41.4 Favored Pre-proline 0 C--N 1.317 -0.814 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.409 -170.705 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.646 ' HB2' HD12 ' A' ' 54' ' ' ILE . 20.2 Cg_exo -68.03 109.23 1.89 Allowed 'Trans proline' 0 N--CA 1.461 -0.388 0 C-N-CA 122.952 2.435 . . . . 0.0 111.512 174.314 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.677 HD13 HD22 ' A' ' 53' ' ' LEU . 23.0 tp -109.65 117.41 33.86 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.339 178.38 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 68' ' ' ARG . . . . . 0.507 ' HG2' ' HG2' ' A' ' 21' ' ' GLU . 92.7 mtt180 -107.09 112.92 26.06 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 120.827 0.346 . . . . 0.0 111.023 175.545 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.542 ' O ' ' HA ' ' A' ' 19' ' ' VAL . 3.9 mp -95.16 110.05 23.39 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 N-CA-C 107.951 -1.129 . . . . 0.0 107.951 172.201 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 28.4 mt -112.32 132.06 62.06 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 116.683 -0.235 . . . . 0.0 111.508 -171.134 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 150.19 -134.92 5.01 Favored Glycine 0 N--CA 1.445 -0.742 0 C-N-CA 120.686 -0.769 . . . . 0.0 113.657 174.021 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' ASP . . . . . 0.581 ' OD2' ' HB3' ' A' ' 74' ' ' TYR . 0.5 OUTLIER -80.07 139.19 52.96 Favored Pre-proline 0 C--N 1.323 -0.565 0 C-N-CA 123.46 0.704 . . . . 0.0 111.565 -177.283 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 73' ' ' PRO . . . . . 0.466 ' HD3' ' HA ' ' A' ' 72' ' ' ASP . 33.3 Cg_exo -58.55 -18.54 40.22 Favored 'Trans proline' 0 C--N 1.35 0.625 0 C-N-CA 123.583 2.856 . . . . 0.0 113.818 -175.748 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 74' ' ' TYR . . . . . 0.581 ' HB3' ' OD2' ' A' ' 72' ' ' ASP . 37.8 t80 -86.36 -56.65 3.34 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 120.478 0.18 . . . . 0.0 110.532 -179.406 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.579 ' CE ' ' HB3' ' A' ' 72' ' ' ASP . 26.1 pttt -70.31 -32.58 70.4 Favored 'General case' 0 CA--C 1.519 -0.232 0 N-CA-C 112.075 0.398 . . . . 0.0 112.075 -179.705 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 43.2 t -63.15 -36.24 75.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-O 121.008 0.432 . . . . 0.0 110.192 176.986 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -73.07 -44.29 60.77 Favored 'General case' 0 N--CA 1.445 -0.686 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 -178.255 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 48.3 mt-30 -62.46 -45.28 93.78 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.925 0.393 . . . . 0.0 110.531 177.045 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -63.4 -35.62 81.01 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.81 -179.193 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 43.5 t -66.2 -45.67 79.99 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.459 176.117 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 -59.48 -42.44 92.08 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.29 0.567 . . . . 0.0 110.051 175.864 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 82' ' ' MET . . . . . 0.6 ' SD ' ' HD3' ' A' ' 46' ' ' ARG . 42.0 ttp -56.72 -49.93 73.7 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 114.772 -1.104 . . . . 0.0 111.574 -179.456 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.408 HG11 ' CE ' ' A' ' 51' ' ' MET . 34.7 m -79.57 -33.41 15.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 C-N-CA 120.871 -0.332 . . . . 0.0 111.131 -176.694 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 57.4 ttp -63.37 -38.57 91.68 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 109.533 -0.543 . . . . 0.0 109.533 175.85 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -61.82 -38.45 88.19 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.328 178.53 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.525 HG13 ' O ' ' A' ' 82' ' ' MET . 45.4 mt -64.13 -31.09 51.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-O 121.376 0.608 . . . . 0.0 110.479 179.657 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.63 HD11 HD12 ' A' ' 24' ' ' ILE . 45.3 mt -88.0 -18.55 28.77 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.542 -179.779 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 33.7 ttt85 -96.69 -4.46 40.8 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.681 0.753 . . . . 0.0 110.629 -176.665 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 20.0 tp10 . . . . . 0 C--N 1.311 -1.083 0 CA-C-O 118.195 -0.907 . . . . 0.0 110.42 -178.728 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 97.8 m . . . . . 0 N--CA 1.45 -0.433 0 CA-C-O 121.054 0.454 . . . . 0.0 110.872 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.506 ' HA ' ' O ' ' A' ' 69' ' ' ILE . 3.2 p -137.64 125.85 32.11 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-N 115.559 -0.746 . . . . 0.0 110.09 177.512 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 92.3 mt-30 -109.6 123.64 49.78 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.174 178.509 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.71 ' HG2' ' HG2' ' A' ' 68' ' ' ARG . 45.6 mt-10 -99.7 120.45 39.73 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.714 179.848 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 5.6 mm -106.79 152.1 8.46 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-N 115.54 -0.755 . . . . 0.0 110.307 -176.915 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 14.1 mmt -103.5 91.8 4.2 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 170.929 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.766 HG21 HG21 ' A' ' 32' ' ' VAL . 41.6 mm -79.89 134.71 56.33 Favored Pre-proline 0 C--N 1.319 -0.729 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.649 -175.265 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 25' ' ' PRO . . . . . 0.429 ' HD2' HD13 ' A' ' 87' ' ' LEU . 83.4 Cg_exo -48.26 127.34 15.24 Favored 'Trans proline' 0 C--N 1.347 0.493 0 C-N-CA 123.068 2.512 . . . . 0.0 111.987 172.6 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -60.35 -34.67 74.18 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.273 -177.032 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -72.36 -32.93 61.9 Favored Glycine 0 N--CA 1.448 -0.542 0 CA-C-N 115.819 -0.628 . . . . 0.0 112.951 -177.452 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 43.6 mtpt -104.18 14.3 30.68 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 122.639 -0.33 . . . . 0.0 111.084 -177.844 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -65.56 -28.9 69.49 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.022 179.04 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -65.46 -30.0 76.52 Favored Glycine 0 N--CA 1.445 -0.714 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.137 179.067 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 91.7 mt -71.34 -39.51 71.29 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.771 0.32 . . . . 0.0 111.125 -178.061 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.766 HG21 HG21 ' A' ' 24' ' ' ILE . 0.0 OUTLIER -71.32 -28.87 33.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.876 -178.315 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 62.0 mt -81.24 -34.21 13.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-O 121.583 0.706 . . . . 0.0 109.756 176.039 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' GLY . . . . . 0.546 ' HA3' ' HB ' ' A' ' 39' ' ' THR . . . 101.89 26.81 7.34 Favored Glycine 0 CA--C 1.5 -0.849 0 CA-C-N 115.099 -0.955 . . . . 0.0 112.398 178.078 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 33.7 mmtp 73.1 -56.81 0.65 Allowed 'General case' 0 C--N 1.325 -0.498 0 C-N-CA 123.705 0.802 . . . . 0.0 111.659 179.43 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -101.26 -39.22 3.1 Favored Glycine 0 N--CA 1.448 -0.524 0 C-N-CA 120.678 -0.772 . . . . 0.0 111.718 -178.745 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 129.0 7.35 4.13 Favored Glycine 0 N--CA 1.448 -0.562 0 C-N-CA 120.996 -0.621 . . . . 0.0 112.533 178.914 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.449 ' O ' ' HG3' ' A' ' 42' ' ' GLN . 1.3 pm0 -78.2 -35.99 47.88 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 110.057 -0.349 . . . . 0.0 110.057 177.238 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 39' ' ' THR . . . . . 0.66 ' O ' ' HG ' ' A' ' 43' ' ' LEU . 40.5 m -62.72 -50.95 69.07 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.173 -179.594 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.681 HD12 ' HB2' ' A' ' 53' ' ' LEU . 4.3 tt -56.41 -36.17 46.23 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.376 0 CA-C-O 120.788 0.327 . . . . 0.0 111.23 -179.282 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.04 -36.78 80.46 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.197 0.522 . . . . 0.0 109.836 179.472 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 42' ' ' GLN . . . . . 0.686 ' O ' ' HG2' ' A' ' 46' ' ' ARG . 79.1 mt-30 -72.4 -42.69 64.89 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.866 179.891 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.66 ' HG ' ' O ' ' A' ' 39' ' ' THR . 88.8 mt -52.56 -42.71 64.68 Favored 'General case' 0 C--O 1.235 0.313 0 O-C-N 123.835 0.71 . . . . 0.0 111.741 -176.865 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 44' ' ' GLN . . . . . 0.445 ' HG3' ' O ' ' A' ' 40' ' ' ILE . 62.4 mt-30 -54.08 -47.82 71.32 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.608 -0.724 . . . . 0.0 110.397 178.951 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 9.6 mm-40 -66.87 -39.13 87.43 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.529 -0.76 . . . . 0.0 110.735 -178.984 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' ARG . . . . . 0.686 ' HG2' ' O ' ' A' ' 42' ' ' GLN . 8.9 mmm180 -56.99 -45.46 82.94 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.801 -171.436 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.566 ' HB3' HG22 ' A' ' 49' ' ' VAL . . . -95.26 -20.36 19.26 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.138 -175.912 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 82.25 47.57 6.04 Favored Glycine 0 N--CA 1.444 -0.796 0 C-N-CA 120.23 -0.986 . . . . 0.0 111.565 -173.996 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.602 HG13 ' HB2' ' A' ' 75' ' ' LYS . 2.9 m -145.54 171.19 5.35 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.456 0 CA-C-O 121.138 0.494 . . . . 0.0 110.653 -177.828 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 6.7 tmtm? -100.41 121.58 41.76 Favored 'General case' 0 C--N 1.318 -0.787 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 176.407 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 57.0 mtt -115.12 126.01 54.14 Favored 'General case' 0 CA--C 1.509 -0.629 0 N-CA-C 109.941 -0.392 . . . . 0.0 109.941 179.34 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.615 ' CG2' ' HB2' ' A' ' 68' ' ' ARG . 9.8 tt -118.2 104.05 15.61 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.939 0 CA-C-O 121.614 0.721 . . . . 0.0 110.275 173.223 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.681 ' HB2' HD12 ' A' ' 40' ' ' ILE . 4.3 mm? -78.73 101.74 7.71 Favored 'General case' 0 N--CA 1.446 -0.639 0 N-CA-C 107.947 -1.131 . . . . 0.0 107.947 170.381 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.608 HD12 ' HB2' ' A' ' 66' ' ' PRO . 15.8 mt -75.98 92.28 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.764 0 CA-C-O 121.5 0.667 . . . . 0.0 109.52 -175.543 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 1.1 pp0? . . . . . 0 C--N 1.32 -0.685 0 CA-C-N 115.345 -0.843 . . . . 0.0 109.885 179.407 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 . . . . . 0 C--O 1.234 0.28 0 CA-C-O 121.148 0.499 . . . . 0.0 110.918 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 65' ' ' LYS . . . . . 0.553 ' HB2' ' HB ' ' A' ' 24' ' ' ILE . 8.4 mmmm -101.6 119.25 57.82 Favored Pre-proline 0 C--N 1.319 -0.758 0 N-CA-C 113.098 0.777 . . . . 0.0 113.098 -172.574 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.608 ' HB2' HD12 ' A' ' 54' ' ' ILE . 23.5 Cg_exo -67.26 125.86 14.13 Favored 'Trans proline' 0 CA--C 1.533 0.462 0 C-N-CA 123.016 2.477 . . . . 0.0 111.895 171.379 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.695 ' O ' ' HA ' ' A' ' 21' ' ' GLU . 31.6 tp -134.02 127.84 33.1 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.02 177.599 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 68' ' ' ARG . . . . . 0.71 ' HG2' ' HG2' ' A' ' 21' ' ' GLU . 95.6 mtt180 -116.97 111.49 19.67 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.942 0.401 . . . . 0.0 111.151 178.594 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.506 ' O ' ' HA ' ' A' ' 19' ' ' VAL . 4.7 mp -94.54 104.75 16.13 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 171.108 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 14.6 mt -108.97 126.54 65.97 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.58 -174.193 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 165.26 -135.68 3.83 Favored Glycine 0 N--CA 1.442 -0.938 0 C-N-CA 119.962 -1.113 . . . . 0.0 113.033 176.592 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 72' ' ' ASP . . . . . 0.477 ' HB3' ' HG2' ' A' ' 75' ' ' LYS . 9.8 t70 -92.88 135.45 26.03 Favored Pre-proline 0 C--N 1.319 -0.729 0 CA-C-O 119.242 -0.408 . . . . 0.0 110.982 -176.564 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 75.0 Cg_exo -39.67 -42.87 3.0 Favored 'Trans proline' 0 C--O 1.237 0.427 0 C-N-CA 123.602 2.868 . . . . 0.0 113.605 -175.513 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 74' ' ' TYR . . . . . 0.433 ' O ' ' HG3' ' A' ' 78' ' ' GLN . 35.9 t80 -68.88 -53.51 20.81 Favored 'General case' 0 N--CA 1.453 -0.277 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.924 -175.676 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.602 ' HB2' HG13 ' A' ' 49' ' ' VAL . 0.0 OUTLIER -74.44 -24.36 59.05 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 120.268 -0.573 . . . . 0.0 111.87 -178.46 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.455 HG23 ' O ' ' A' ' 72' ' ' ASP . 75.8 t -63.15 -31.76 53.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-O 121.293 0.568 . . . . 0.0 109.69 174.136 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -76.57 -48.61 18.73 Favored 'General case' 0 N--CA 1.447 -0.582 0 N-CA-C 109.146 -0.686 . . . . 0.0 109.146 178.062 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 78' ' ' GLN . . . . . 0.433 ' HG3' ' O ' ' A' ' 74' ' ' TYR . 50.4 mt-30 -54.97 -43.46 73.53 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-O 121.551 0.691 . . . . 0.0 110.47 176.779 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 79' ' ' ALA . . . . . 0.456 ' HB3' HG21 ' A' ' 69' ' ' ILE . . . -64.68 -40.22 95.02 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.162 -0.926 . . . . 0.0 111.203 -178.63 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 42.3 t -65.65 -46.44 79.2 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.427 -179.659 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -70.6 -19.71 62.82 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 120.822 -0.351 . . . . 0.0 110.661 179.42 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 82' ' ' MET . . . . . 0.548 ' SD ' HD22 ' A' ' 43' ' ' LEU . 36.1 ttm -71.99 -54.63 9.33 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.831 0.348 . . . . 0.0 110.636 175.484 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.485 HG12 HD13 ' A' ' 43' ' ' LEU . 34.8 m -74.92 -29.93 23.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.803 -175.537 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 1.6 tmt? -70.09 -31.7 69.4 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.924 -0.58 . . . . 0.0 109.643 177.664 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 85' ' ' ASP . . . . . 0.482 ' O ' ' HB2' ' A' ' 89' ' ' GLU . 32.9 t70 -60.4 -36.88 79.15 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.392 177.661 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 22.5 mt -68.93 -23.17 27.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-O 121.401 0.619 . . . . 0.0 110.601 179.772 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.746 HD11 HD12 ' A' ' 24' ' ' ILE . 70.1 mt -89.4 -30.3 18.45 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.979 -176.918 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 40.7 ptt180 -86.1 -3.61 58.99 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.614 0.721 . . . . 0.0 109.185 174.805 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 89' ' ' GLU . . . . . 0.482 ' HB2' ' O ' ' A' ' 85' ' ' ASP . 9.5 tp10 . . . . . 0 C--O 1.252 1.2 0 CA-C-N 114.392 -1.277 . . . . 0.0 109.653 -178.724 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.609 ' O ' ' HA ' ' A' ' 70' ' ' ILE . 37.5 m . . . . . 0 N--CA 1.45 -0.436 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.514 ' HA ' ' O ' ' A' ' 69' ' ' ILE . 6.4 p -129.31 123.03 57.22 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-O 121.323 0.582 . . . . 0.0 111.339 -179.091 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 26.9 mt-30 -117.06 115.05 24.64 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.673 -0.694 . . . . 0.0 109.333 175.136 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.598 ' HG2' ' HG2' ' A' ' 68' ' ' ARG . 42.2 mt-10 -88.73 115.86 26.57 Favored 'General case' 0 CA--C 1.516 -0.35 0 CA-C-O 121.178 0.513 . . . . 0.0 111.372 -178.423 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.427 ' HB ' ' HB3' ' A' ' 67' ' ' LEU . 11.2 mm -98.72 152.9 4.22 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-N 115.426 -0.807 . . . . 0.0 109.686 179.482 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 23' ' ' MET . . . . . 0.417 ' HB3' ' HB3' ' A' ' 64' ' ' ASP . 1.8 mmt -106.39 91.27 3.63 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 174.747 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.69 ' HB ' ' HB2' ' A' ' 65' ' ' LYS . 29.7 mm -75.35 125.88 88.37 Favored Pre-proline 0 C--N 1.317 -0.805 0 CA-C-N 115.806 -0.634 . . . . 0.0 111.215 -173.869 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 25' ' ' PRO . . . . . 0.582 ' HB2' ' HB2' ' A' ' 28' ' ' LYS . 85.4 Cg_exo -48.09 129.32 18.31 Favored 'Trans proline' 0 C--N 1.346 0.4 0 C-N-CA 123.165 2.577 . . . . 0.0 111.858 177.417 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -58.88 -24.34 62.12 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.838 -0.619 . . . . 0.0 112.579 -173.023 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -95.95 -1.83 61.3 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.622 -0.799 . . . . 0.0 112.804 -179.632 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.582 ' HB2' ' HB2' ' A' ' 25' ' ' PRO . 2.0 mppt? -116.05 19.71 14.84 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.019 0.438 . . . . 0.0 111.441 -179.448 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -76.15 -20.39 57.62 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.102 -178.633 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -69.11 -17.72 72.21 Favored Glycine 0 N--CA 1.449 -0.484 0 C-N-CA 120.994 -0.622 . . . . 0.0 112.697 -178.86 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 86.8 mt -93.96 -38.83 10.98 Favored 'General case' 0 C--N 1.323 -0.573 0 O-C-N 122.515 -0.403 . . . . 0.0 111.571 -177.958 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.439 HG21 HG21 ' A' ' 24' ' ' ILE . 3.5 m -69.98 -34.09 58.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.899 0.38 . . . . 0.0 111.131 179.327 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.583 HD11 ' HG2' ' A' ' 55' ' ' GLN . 64.9 mt -83.99 -44.76 18.23 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-O 121.506 0.67 . . . . 0.0 109.902 177.026 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 118.88 -178.84 16.75 Favored Glycine 0 N--CA 1.441 -1.012 0 CA-C-N 115.291 -0.868 . . . . 0.0 111.359 -178.158 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 39.0 mmtm -77.76 -29.51 51.01 Favored 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 -178.357 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -143.01 17.09 2.36 Favored Glycine 0 N--CA 1.444 -0.79 0 CA-C-N 115.18 -0.918 . . . . 0.0 111.476 176.032 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 95.73 0.79 62.19 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.991 -0.623 . . . . 0.0 112.947 178.899 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -69.08 -34.9 75.87 Favored 'General case' 0 C--N 1.328 -0.367 0 O-C-N 122.598 -0.354 . . . . 0.0 110.841 -178.956 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 39' ' ' THR . . . . . 0.721 ' O ' ' HG ' ' A' ' 43' ' ' LEU . 61.8 m -62.71 -55.47 26.43 Favored 'General case' 0 N--CA 1.452 -0.374 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.913 -177.639 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.48 ' HA ' HD12 ' A' ' 43' ' ' LEU . 7.5 tt -60.02 -34.21 55.73 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.383 0 CA-C-O 120.782 0.325 . . . . 0.0 111.628 -176.665 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 3.9 tmmm? -70.79 -39.4 73.18 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 179.394 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' GLN . . . . . 0.462 ' O ' ' HG2' ' A' ' 46' ' ' ARG . 20.4 mm-40 -71.75 -37.79 70.5 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.991 -0.549 . . . . 0.0 111.187 -179.225 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.721 ' HG ' ' O ' ' A' ' 39' ' ' THR . 88.8 mt -53.44 -44.88 69.2 Favored 'General case' 0 CA--C 1.519 -0.238 0 CA-C-O 121.204 0.526 . . . . 0.0 110.992 179.428 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 47.1 mt-30 -68.14 -34.27 76.02 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.644 -0.707 . . . . 0.0 111.367 -177.435 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 32.2 mt-10 -80.48 -25.52 38.78 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 111.557 0.206 . . . . 0.0 111.557 -178.458 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' ARG . . . . . 0.462 ' HG2' ' O ' ' A' ' 42' ' ' GLN . 12.8 ptm180 -89.32 -30.2 18.6 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.688 0.28 . . . . 0.0 111.69 -178.705 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -88.63 -30.75 18.97 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 120.975 0.417 . . . . 0.0 110.905 178.528 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 91.79 -3.26 77.71 Favored Glycine 0 CA--C 1.519 0.339 0 C-N-CA 120.641 -0.79 . . . . 0.0 112.662 -179.219 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.441 ' CG1' ' HG3' ' A' ' 75' ' ' LYS . 16.1 m -103.54 179.22 0.71 Allowed 'Isoleucine or valine' 0 CA--C 1.516 -0.36 0 CA-C-O 121.063 0.459 . . . . 0.0 110.907 179.123 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 50' ' ' LYS . . . . . 0.673 ' HE3' ' HB ' ' A' ' 52' ' ' ILE . 8.7 tmtm? -109.89 125.05 52.4 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 115.666 -0.697 . . . . 0.0 109.171 177.158 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 51' ' ' MET . . . . . 0.484 ' HE3' HG13 ' A' ' 69' ' ' ILE . 54.7 mtp -119.2 125.36 48.98 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 109.449 -0.574 . . . . 0.0 109.449 179.31 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.673 ' HB ' ' HE3' ' A' ' 50' ' ' LYS . 9.0 tt -115.67 107.69 23.33 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.805 0 CA-C-O 121.523 0.677 . . . . 0.0 110.832 177.823 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.602 HD22 HD13 ' A' ' 67' ' ' LEU . 3.4 mm? -80.95 102.78 10.35 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.206 -0.906 . . . . 0.0 108.574 170.192 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.626 HD12 ' HB2' ' A' ' 66' ' ' PRO . 59.0 mt -78.23 85.68 1.02 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.467 0 CA-C-O 121.868 0.842 . . . . 0.0 110.423 -177.301 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 55' ' ' GLN . . . . . 0.583 ' HG2' HD11 ' A' ' 33' ' ' ILE . 1.7 pp0? . . . . . 0 C--N 1.317 -0.835 0 CA-C-N 114.573 -1.194 . . . . 0.0 109.579 175.062 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.417 ' HB3' ' HB3' ' A' ' 23' ' ' MET . 6.6 m-20 . . . . . 0 C--O 1.231 0.121 0 N-CA-C 109.879 -0.415 . . . . 0.0 109.879 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' LYS . . . . . 0.69 ' HB2' ' HB ' ' A' ' 24' ' ' ILE . 27.6 mmtp -91.83 129.19 43.07 Favored Pre-proline 0 C--N 1.324 -0.538 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.44 -169.833 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.626 ' HB2' HD12 ' A' ' 54' ' ' ILE . 23.4 Cg_exo -66.98 111.76 2.3 Favored 'Trans proline' 0 N--CA 1.463 -0.286 0 C-N-CA 123.292 2.661 . . . . 0.0 111.816 176.165 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.602 HD13 HD22 ' A' ' 53' ' ' LEU . 23.0 tp -114.52 114.57 25.95 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.389 178.169 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 68' ' ' ARG . . . . . 0.636 ' HB2' ' CG2' ' A' ' 52' ' ' ILE . 99.6 mtt180 -104.34 110.52 22.79 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.657 176.682 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.514 ' O ' ' HA ' ' A' ' 19' ' ' VAL . 4.2 mp -93.92 108.33 20.45 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 N-CA-C 107.857 -1.164 . . . . 0.0 107.857 170.608 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.609 ' HA ' ' O ' ' A' ' 18' ' ' THR . 22.8 mt -116.69 133.89 61.92 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.606 -171.199 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 150.68 -108.65 0.39 Allowed Glycine 0 N--CA 1.448 -0.559 0 C-N-CA 120.811 -0.709 . . . . 0.0 113.112 172.579 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 72' ' ' ASP . . . . . 0.488 ' O ' HG23 ' A' ' 76' ' ' VAL . 14.1 t70 -103.79 132.08 21.38 Favored Pre-proline 0 C--N 1.318 -0.786 0 C-N-CA 123.19 0.596 . . . . 0.0 110.045 -174.916 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 73' ' ' PRO . . . . . 0.458 ' HG3' ' OG1' ' A' ' 18' ' ' THR . 44.7 Cg_exo -54.82 -25.93 45.46 Favored 'Trans proline' 0 C--N 1.347 0.479 0 C-N-CA 123.541 2.827 . . . . 0.0 113.431 -173.498 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 53.5 t80 -76.19 -53.47 8.22 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.464 -177.228 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.509 ' HA ' ' HB2' ' A' ' 78' ' ' GLN . 5.8 ptpt -83.37 -17.57 41.84 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.866 -0.606 . . . . 0.0 111.992 -177.591 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.488 HG23 ' O ' ' A' ' 72' ' ' ASP . 45.2 t -63.15 -38.02 80.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 N-CA-C 109.552 -0.536 . . . . 0.0 109.552 170.863 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 1.4 mm100 -77.66 -41.13 39.29 Favored 'General case' 0 N--CA 1.451 -0.397 0 C-N-CA 120.807 -0.357 . . . . 0.0 110.608 177.373 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 78' ' ' GLN . . . . . 0.509 ' HB2' ' HA ' ' A' ' 75' ' ' LYS . 96.4 mt-30 -55.73 -47.12 77.44 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.831 0.348 . . . . 0.0 110.532 175.046 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 79' ' ' ALA . . . . . 0.446 ' HA ' ' HE2' ' A' ' 82' ' ' MET . . . -66.57 -38.87 88.0 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.122 179.629 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 49.9 t -62.33 -52.14 64.82 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.406 177.89 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -63.75 -30.99 72.02 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.338 178.356 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 82' ' ' MET . . . . . 0.464 ' O ' HG13 ' A' ' 86' ' ' ILE . 40.1 ttp -65.08 -52.17 57.13 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.602 -0.726 . . . . 0.0 111.198 178.482 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 30.7 m -76.18 -35.54 28.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 N-CA-C 111.74 0.274 . . . . 0.0 111.74 -177.06 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 93.9 mmm -67.85 -28.63 67.71 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.871 0.367 . . . . 0.0 110.012 177.113 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -64.87 -38.43 90.95 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.682 176.674 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.464 HG13 ' O ' ' A' ' 82' ' ' MET . 35.3 mt -64.0 -26.69 41.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.339 179.007 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.58 HD22 ' HB3' ' A' ' 28' ' ' LYS . 22.4 mt -97.64 -10.48 24.99 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.771 -177.859 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 28.0 tpt180 -99.37 -25.38 14.49 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.435 0.636 . . . . 0.0 111.09 -175.721 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 . . . . . 0 C--N 1.305 -1.327 0 CA-C-N 115.359 -0.837 . . . . 0.0 109.867 -178.048 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 91.3 m . . . . . 0 N--CA 1.454 -0.238 0 CA-C-O 120.705 0.288 . . . . 0.0 110.45 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 7.6 p -140.23 138.35 37.13 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-O 120.928 0.394 . . . . 0.0 110.891 -178.786 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 77.9 mt-30 -119.16 114.61 22.72 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 109.739 -0.467 . . . . 0.0 109.739 174.213 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.713 ' HA ' ' O ' ' A' ' 67' ' ' LEU . 39.4 mt-10 -86.43 113.85 22.72 Favored 'General case' 0 CA--C 1.515 -0.392 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.864 179.079 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.483 ' HB ' ' HB3' ' A' ' 67' ' ' LEU . 14.7 mm -97.68 147.88 6.2 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 CA-C-N 115.257 -0.883 . . . . 0.0 110.227 -177.5 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 23' ' ' MET . . . . . 0.527 ' HB3' ' HB3' ' A' ' 64' ' ' ASP . 3.9 mmt -99.61 91.57 4.95 Favored 'General case' 0 C--N 1.317 -0.822 0 N-CA-C 108.531 -0.915 . . . . 0.0 108.531 173.322 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.665 ' HB ' ' HB2' ' A' ' 65' ' ' LYS . 36.8 mm -82.16 130.39 60.13 Favored Pre-proline 0 C--N 1.319 -0.722 0 CA-C-N 115.772 -0.649 . . . . 0.0 111.046 -174.396 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_exo -50.89 132.07 36.29 Favored 'Trans proline' 0 N--CA 1.46 -0.445 0 C-N-CA 122.885 2.39 . . . . 0.0 111.787 175.222 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -65.46 -18.89 65.67 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.263 -176.958 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -93.55 9.69 73.65 Favored Glycine 0 N--CA 1.445 -0.709 0 C-N-CA 120.97 -0.633 . . . . 0.0 112.325 177.294 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.525 ' HB3' HD22 ' A' ' 87' ' ' LEU . 58.8 mttp -132.38 26.68 4.46 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.861 0.362 . . . . 0.0 111.409 179.947 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -74.77 -23.5 58.54 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.232 0.539 . . . . 0.0 110.239 178.922 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -71.16 -16.36 75.08 Favored Glycine 0 N--CA 1.449 -0.443 0 CA-C-N 115.543 -0.753 . . . . 0.0 112.522 179.565 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 79.5 mt -93.65 -39.92 10.54 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 122.471 -0.429 . . . . 0.0 111.183 -179.299 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.58 HG13 HD21 ' A' ' 87' ' ' LEU . 2.8 m -76.4 -33.03 22.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-O 120.951 0.405 . . . . 0.0 111.533 -179.914 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.657 ' HA ' ' HB ' ' A' ' 40' ' ' ILE . 67.5 mt -93.68 -40.14 11.42 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-O 121.527 0.679 . . . . 0.0 110.18 179.079 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 119.49 160.65 11.37 Favored Glycine 0 N--CA 1.441 -1.025 0 CA-C-N 115.527 -0.76 . . . . 0.0 111.714 -179.634 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -65.47 -23.1 66.83 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.971 0.415 . . . . 0.0 110.504 -179.446 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -134.11 8.33 4.77 Favored Glycine 0 N--CA 1.446 -0.665 0 C-N-CA 120.741 -0.742 . . . . 0.0 111.896 177.244 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.591 ' HA2' HG22 ' A' ' 33' ' ' ILE . . . 87.39 12.14 67.87 Favored Glycine 0 N--CA 1.452 -0.245 0 C-N-CA 120.942 -0.646 . . . . 0.0 112.15 -177.196 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 13.7 mt-10 -84.64 -37.64 20.81 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.101 0.476 . . . . 0.0 110.6 -178.178 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' THR . . . . . 0.688 ' O ' ' HG ' ' A' ' 43' ' ' LEU . 21.2 m -59.84 -47.88 83.96 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.532 -0.758 . . . . 0.0 111.752 -173.41 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.657 ' HB ' ' HA ' ' A' ' 33' ' ' ILE . 9.3 tt -57.68 -34.82 48.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 120.929 0.395 . . . . 0.0 111.334 -178.565 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 41' ' ' LYS . . . . . 0.49 ' HG3' ' OE2' ' A' ' 45' ' ' GLU . 0.0 OUTLIER -70.77 -36.76 73.21 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.103 0.478 . . . . 0.0 109.972 179.189 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 15.6 mm100 -71.07 -39.01 72.44 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.572 -178.915 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.688 ' HG ' ' O ' ' A' ' 39' ' ' THR . 54.7 mt -57.07 -47.38 81.12 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.715 179.889 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 44' ' ' GLN . . . . . 0.404 ' HG3' ' O ' ' A' ' 40' ' ' ILE . 45.2 mt-30 -62.27 -50.65 70.86 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.691 -179.981 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.49 ' OE2' ' HG3' ' A' ' 41' ' ' LYS . 46.1 mt-10 -63.62 -39.56 94.69 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.722 -0.672 . . . . 0.0 112.024 -176.594 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 13.9 ptm180 -77.68 -33.38 53.28 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 111.937 0.347 . . . . 0.0 111.937 -173.847 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -93.75 -12.26 29.56 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 120.985 0.422 . . . . 0.0 111.461 -177.2 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 73.13 35.51 57.29 Favored Glycine 0 N--CA 1.451 -0.323 0 N-CA-C 111.189 -0.764 . . . . 0.0 111.189 -177.482 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 29.5 m -124.45 175.6 6.74 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-O 120.964 0.411 . . . . 0.0 110.741 -173.811 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 78.3 tttt -115.65 123.7 49.04 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 169.414 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' MET . . . . . 0.412 ' CE ' HG11 ' A' ' 83' ' ' VAL . 71.8 mtp -123.6 114.68 20.33 Favored 'General case' 0 C--N 1.317 -0.82 0 N-CA-C 109.082 -0.71 . . . . 0.0 109.082 177.721 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.611 ' CG2' ' HB2' ' A' ' 68' ' ' ARG . 10.8 tt -109.97 105.51 18.94 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.143 0 CA-C-O 121.662 0.744 . . . . 0.0 109.595 177.362 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -82.53 102.26 11.26 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.169 -0.923 . . . . 0.0 108.625 174.716 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.502 ' HB ' ' HB2' ' A' ' 66' ' ' PRO . 20.3 mt -82.28 85.71 1.75 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.767 0 CA-C-O 121.669 0.747 . . . . 0.0 109.188 -175.939 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 4.1 pp0? . . . . . 0 C--N 1.319 -0.732 0 CA-C-N 115.171 -0.922 . . . . 0.0 110.994 -175.141 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.527 ' HB3' ' HB3' ' A' ' 23' ' ' MET . 8.4 m-20 . . . . . 0 CA--C 1.519 -0.214 0 N-CA-C 109.722 -0.473 . . . . 0.0 109.722 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' LYS . . . . . 0.665 ' HB2' ' HB ' ' A' ' 24' ' ' ILE . 1.2 mmmm -93.89 122.26 62.49 Favored Pre-proline 0 C--N 1.318 -0.769 0 CA-C-N 115.971 -0.558 . . . . 0.0 111.255 -170.645 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.502 ' HB2' ' HB ' ' A' ' 54' ' ' ILE . 39.3 Cg_exo -63.22 105.95 0.52 Allowed 'Trans proline' 0 N--CA 1.464 -0.21 0 C-N-CA 123.291 2.661 . . . . 0.0 112.225 177.476 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.713 ' O ' ' HA ' ' A' ' 21' ' ' GLU . 3.7 tt -101.42 135.69 42.49 Favored 'General case' 0 C--N 1.319 -0.735 0 N-CA-C 108.481 -0.933 . . . . 0.0 108.481 177.7 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 68' ' ' ARG . . . . . 0.71 ' N ' HD23 ' A' ' 67' ' ' LEU . 90.9 mtt180 -124.61 107.09 10.66 Favored 'General case' 0 N--CA 1.443 -0.82 0 C-N-CA 119.255 -0.978 . . . . 0.0 112.633 170.123 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.554 ' CD1' HD22 ' A' ' 67' ' ' LEU . 3.8 mp -90.08 106.14 16.92 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.264 0 N-CA-C 107.943 -1.132 . . . . 0.0 107.943 167.72 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 7.4 mt -109.35 127.81 65.81 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.873 0 CA-C-O 120.946 0.403 . . . . 0.0 110.394 -176.141 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 173.64 -132.47 2.31 Favored Glycine 0 N--CA 1.441 -1.026 0 N-CA-C 111.044 -0.822 . . . . 0.0 111.044 179.496 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 72' ' ' ASP . . . . . 0.809 ' HB3' ' HE2' ' A' ' 75' ' ' LYS . 0.0 OUTLIER -103.55 153.49 38.56 Favored Pre-proline 0 C--N 1.318 -0.799 0 CA-C-O 118.992 -0.528 . . . . 0.0 109.594 176.71 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_exo -47.1 -39.21 25.76 Favored 'Trans proline' 0 C--N 1.347 0.451 0 C-N-CA 122.273 1.982 . . . . 0.0 112.268 -178.026 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 74' ' ' TYR . . . . . 0.419 ' HB3' ' OD1' ' A' ' 72' ' ' ASP . 22.6 t80 -67.39 -58.9 3.93 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.089 -0.96 . . . . 0.0 111.504 -177.576 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.809 ' HE2' ' HB3' ' A' ' 72' ' ' ASP . 0.0 OUTLIER -67.54 -33.86 75.92 Favored 'General case' 0 CA--C 1.514 -0.418 0 C-N-CA 120.98 -0.288 . . . . 0.0 111.185 -178.773 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.403 HG13 ' HB ' ' A' ' 69' ' ' ILE . 55.0 t -64.39 -39.72 86.55 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.377 0 N-CA-C 109.647 -0.501 . . . . 0.0 109.647 -178.418 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 6.5 tp-100 -76.88 -41.89 42.04 Favored 'General case' 0 N--CA 1.443 -0.807 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.674 -177.739 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 75.3 mt-30 -63.93 -38.56 91.54 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 120.709 -0.396 . . . . 0.0 110.558 177.768 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -69.7 -37.16 76.5 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.534 178.766 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 80' ' ' CYS . . . . . 0.425 ' O ' ' HB2' ' A' ' 84' ' ' MET . 50.6 t -65.52 -46.58 79.05 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.549 176.626 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 73.0 mt-10 -62.93 -21.87 66.36 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 121.047 0.451 . . . . 0.0 110.691 177.852 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 82' ' ' MET . . . . . 0.425 ' O ' HG13 ' A' ' 86' ' ' ILE . 38.5 ttp -77.46 -52.33 9.29 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.25 179.68 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.461 ' O ' ' HG ' ' A' ' 87' ' ' LEU . 32.9 m -73.52 -35.34 44.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.562 -177.853 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 84' ' ' MET . . . . . 0.425 ' HB2' ' O ' ' A' ' 80' ' ' CYS . 2.7 mmt -66.94 -34.12 77.08 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.682 0.277 . . . . 0.0 111.2 179.293 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 85' ' ' ASP . . . . . 0.479 ' O ' ' HB2' ' A' ' 89' ' ' GLU . 27.9 t70 -67.67 -31.5 71.53 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 120.836 -0.345 . . . . 0.0 110.154 -179.163 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.425 HG13 ' O ' ' A' ' 82' ' ' MET . 53.0 mt -67.44 -40.4 84.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 121.185 0.517 . . . . 0.0 109.974 176.476 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.58 HD21 HG13 ' A' ' 32' ' ' VAL . 49.1 mt -70.28 -42.02 72.63 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.699 -179.326 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 88' ' ' ARG . . . . . 0.452 ' HD3' HH11 ' A' ' 88' ' ' ARG . 9.5 mmm180 -85.45 7.52 22.45 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.969 -0.559 . . . . 0.0 111.201 -176.936 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 89' ' ' GLU . . . . . 0.479 ' HB2' ' O ' ' A' ' 85' ' ' ASP . 40.1 tt0 . . . . . 0 C--O 1.25 1.082 0 CA-C-O 118.222 -0.894 . . . . 0.0 109.663 178.346 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.549 ' OG1' ' HD3' ' A' ' 73' ' ' PRO . 90.5 m . . . . . 0 CA--C 1.528 0.129 0 CA-C-O 120.439 0.162 . . . . 0.0 111.111 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.489 ' HA ' ' O ' ' A' ' 69' ' ' ILE . 4.7 p -140.74 126.52 20.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-O 121.249 0.547 . . . . 0.0 111.931 -176.833 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 26.5 mt-30 -111.45 128.78 56.1 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.037 173.465 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.581 ' HG2' ' HG2' ' A' ' 68' ' ' ARG . 45.6 mt-10 -96.71 115.37 27.32 Favored 'General case' 0 C--N 1.327 -0.41 0 O-C-N 123.401 0.438 . . . . 0.0 111.263 178.866 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.414 ' HB ' ' HB3' ' A' ' 67' ' ' LEU . 14.4 mm -100.77 150.29 5.76 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 177.412 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 16.5 mmt -103.44 92.01 4.3 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 175.988 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.66 ' HB ' ' HB2' ' A' ' 65' ' ' LYS . 47.1 mm -81.5 128.2 70.56 Favored Pre-proline 0 C--N 1.318 -0.77 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.853 -175.625 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 81.6 Cg_exo -47.77 131.72 20.64 Favored 'Trans proline' 0 C--N 1.345 0.346 0 C-N-CA 123.21 2.607 . . . . 0.0 112.214 176.828 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -59.68 -26.71 65.78 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.855 -0.611 . . . . 0.0 111.342 -178.413 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -75.36 -31.03 57.68 Favored Glycine 0 N--CA 1.449 -0.484 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.371 177.499 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.963 ' HD3' ' HG ' ' A' ' 87' ' ' LEU . 94.6 mttt -98.22 19.18 14.66 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.786 0.327 . . . . 0.0 111.494 -178.192 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.606 ' O ' HG13 ' A' ' 33' ' ' ILE . . . -64.6 -34.07 77.41 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.798 179.288 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -68.64 -25.39 75.05 Favored Glycine 0 N--CA 1.448 -0.531 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.053 179.693 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 88.1 mt -74.03 -42.59 60.05 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.657 0.265 . . . . 0.0 110.634 -178.823 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.584 HG21 HG21 ' A' ' 24' ' ' ILE . 0.0 OUTLIER -72.84 -23.39 20.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.421 179.687 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.606 HG13 ' O ' ' A' ' 29' ' ' ALA . 67.2 mt -76.6 -35.19 25.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-O 121.74 0.781 . . . . 0.0 109.576 172.545 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 34' ' ' GLY . . . . . 0.708 ' HA3' ' HB ' ' A' ' 39' ' ' THR . . . 98.81 32.34 5.96 Favored Glycine 0 CA--C 1.5 -0.877 0 CA-C-N 114.962 -1.017 . . . . 0.0 112.396 177.911 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 14.5 mmmm 69.7 -64.51 0.34 Allowed 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.398 0.705 . . . . 0.0 111.68 177.633 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -89.58 -30.35 13.79 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 121.072 -0.585 . . . . 0.0 112.161 -177.815 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.584 ' HA2' HG22 ' A' ' 33' ' ' ILE . . . 109.92 -2.61 30.2 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.602 -0.808 . . . . 0.0 112.428 178.878 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -85.75 -27.54 25.16 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-O 120.993 0.425 . . . . 0.0 111.054 178.148 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 39' ' ' THR . . . . . 0.708 ' HB ' ' HA3' ' A' ' 34' ' ' GLY . 17.0 m -67.07 -41.31 86.62 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.393 -177.394 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.477 ' CD1' HD23 ' A' ' 53' ' ' LEU . 8.6 tt -58.36 -33.19 46.96 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.319 0 CA-C-O 120.986 0.422 . . . . 0.0 110.765 178.697 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 41' ' ' LYS . . . . . 0.402 ' O ' ' HG3' ' A' ' 45' ' ' GLU . 31.3 ttpt -69.89 -43.1 72.46 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.144 0.497 . . . . 0.0 109.952 174.79 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 42' ' ' GLN . . . . . 0.52 ' O ' ' HG2' ' A' ' 46' ' ' ARG . 55.0 mt-30 -63.5 -38.63 91.89 Favored 'General case' 0 CA--C 1.512 -0.484 0 CA-C-N 115.449 -0.796 . . . . 0.0 110.601 -177.041 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.654 ' HG ' ' O ' ' A' ' 39' ' ' THR . 73.5 mt -55.38 -43.52 75.22 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.724 179.759 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 44.4 mt-30 -64.85 -44.84 88.45 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.328 178.981 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.402 ' HG3' ' O ' ' A' ' 41' ' ' LYS . 40.8 mt-10 -63.82 -45.99 87.13 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.71 -0.677 . . . . 0.0 111.448 -178.878 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 46' ' ' ARG . . . . . 0.52 ' HG2' ' O ' ' A' ' 42' ' ' GLN . 11.7 ptp180 -77.46 -28.83 52.52 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 112.69 0.626 . . . . 0.0 112.69 -174.269 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.566 ' HB3' HG22 ' A' ' 49' ' ' VAL . . . -92.14 -18.08 24.03 Favored 'General case' 0 C--N 1.325 -0.478 0 C-N-CA 120.674 -0.41 . . . . 0.0 111.952 -177.441 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 75.33 25.31 68.64 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.701 -0.761 . . . . 0.0 111.652 -178.029 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.566 HG22 ' HB3' ' A' ' 47' ' ' ALA . 33.4 m -127.8 170.46 17.56 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 N-CA-C 109.791 -0.448 . . . . 0.0 109.791 -178.183 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 50' ' ' LYS . . . . . 0.62 ' HE3' ' HB ' ' A' ' 52' ' ' ILE . 8.9 tmtm? -110.8 124.37 51.9 Favored 'General case' 0 C--N 1.317 -0.84 0 N-CA-C 109.306 -0.628 . . . . 0.0 109.306 175.838 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 51' ' ' MET . . . . . 0.518 ' CE ' ' HB1' ' A' ' 79' ' ' ALA . 62.6 mtt -112.42 129.34 56.36 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 179.347 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.62 ' HB ' ' HE3' ' A' ' 50' ' ' LYS . 8.9 tt -122.3 105.69 16.62 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.933 0 CA-C-O 121.514 0.673 . . . . 0.0 110.133 175.129 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.519 ' O ' ' HG2' ' A' ' 55' ' ' GLN . 4.0 mm? -81.44 103.42 11.17 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 115.3 -0.863 . . . . 0.0 109.035 174.916 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.577 HD12 ' HB2' ' A' ' 66' ' ' PRO . 53.5 mt -75.54 87.04 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 122.013 0.911 . . . . 0.0 109.689 179.185 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 55' ' ' GLN . . . . . 0.519 ' HG2' ' O ' ' A' ' 53' ' ' LEU . 2.2 pt20 . . . . . 0 C--N 1.317 -0.825 0 CA-C-N 114.359 -1.291 . . . . 0.0 109.293 -178.017 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 . . . . . 0 N--CA 1.465 0.319 0 CA-C-O 120.775 0.321 . . . . 0.0 110.661 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 65' ' ' LYS . . . . . 0.66 ' HB2' ' HB ' ' A' ' 24' ' ' ILE . 72.1 mmtt -96.72 125.48 46.64 Favored Pre-proline 0 C--N 1.316 -0.865 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.361 -170.449 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.577 ' HB2' HD12 ' A' ' 54' ' ' ILE . 14.0 Cg_exo -70.5 106.31 1.77 Allowed 'Trans proline' 0 N--CA 1.457 -0.647 0 C-N-CA 122.958 2.439 . . . . 0.0 111.317 174.949 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.547 HD21 HG21 ' A' ' 83' ' ' VAL . 23.2 tp -105.4 110.93 23.46 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.841 -0.618 . . . . 0.0 109.693 178.818 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 68' ' ' ARG . . . . . 0.606 ' HB2' ' CG2' ' A' ' 52' ' ' ILE . 96.1 mtt180 -101.65 109.28 21.04 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-O 120.932 0.396 . . . . 0.0 110.952 177.718 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.489 ' O ' ' HA ' ' A' ' 19' ' ' VAL . 4.4 mp -90.29 104.14 14.96 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 172.237 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 18.3 mt -104.48 121.73 56.59 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.588 -174.647 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 175.95 -125.4 1.05 Allowed Glycine 0 N--CA 1.445 -0.75 0 CA-C-N 116.002 -0.545 . . . . 0.0 112.025 179.872 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -114.84 142.67 28.72 Favored Pre-proline 0 C--N 1.32 -0.698 0 N-CA-C 108.863 -0.791 . . . . 0.0 108.863 179.641 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' PRO . . . . . 0.549 ' HD3' ' OG1' ' A' ' 18' ' ' THR . 86.0 Cg_exo -43.33 -39.5 9.01 Favored 'Trans proline' 0 C--N 1.351 0.699 0 C-N-CA 123.034 2.489 . . . . 0.0 112.751 -173.636 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 66.6 t80 -63.33 -57.83 9.11 Favored 'General case' 0 N--CA 1.451 -0.425 0 CA-C-N 115.225 -0.898 . . . . 0.0 111.293 -177.949 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 32.9 pttt -75.96 -30.45 58.63 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.482 -0.326 . . . . 0.0 111.571 -178.221 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 51.9 t -57.24 -40.62 74.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-O 120.894 0.378 . . . . 0.0 110.031 176.395 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -73.67 -45.85 50.01 Favored 'General case' 0 N--CA 1.448 -0.544 0 C-N-CA 120.496 -0.481 . . . . 0.0 111.094 179.144 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 49.0 mt-30 -63.41 -37.76 88.52 Favored 'General case' 0 C--N 1.326 -0.419 0 C-N-CA 120.389 -0.524 . . . . 0.0 111.115 -179.355 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 79' ' ' ALA . . . . . 0.518 ' HB1' ' CE ' ' A' ' 51' ' ' MET . . . -67.57 -37.69 82.99 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.211 176.856 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 37.4 t -63.91 -48.04 78.2 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.586 175.867 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 55.0 mt-10 -61.15 -38.43 86.39 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 110.045 -0.354 . . . . 0.0 110.045 177.19 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 82' ' ' MET . . . . . 0.461 ' O ' HG13 ' A' ' 86' ' ' ILE . 48.1 ttp -61.1 -49.38 77.52 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.658 -0.701 . . . . 0.0 111.315 179.611 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.547 HG21 HD21 ' A' ' 67' ' ' LEU . 27.7 m -77.33 -33.06 19.38 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-O 120.813 0.339 . . . . 0.0 110.897 -176.801 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 54.7 ttp -67.11 -33.69 76.0 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 109.427 -0.583 . . . . 0.0 109.427 176.005 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -67.33 -31.2 71.31 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.417 -0.811 . . . . 0.0 110.641 178.106 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.461 HG13 ' O ' ' A' ' 82' ' ' MET . 59.4 mt -61.32 -30.49 48.06 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.304 0 CA-C-O 121.365 0.603 . . . . 0.0 110.17 176.398 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.963 ' HG ' ' HD3' ' A' ' 28' ' ' LYS . 6.9 mp -88.1 -5.87 58.21 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.733 178.844 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 6.0 tmm_? -114.37 -3.79 13.04 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.443 0.64 . . . . 0.0 110.717 -175.161 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 89' ' ' GLU . . . . . 0.443 ' O ' ' HG3' ' A' ' 89' ' ' GLU . 9.6 pt-20 . . . . . 0 C--O 1.251 1.143 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.895 -177.317 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 55.4 m . . . . . 0 N--CA 1.448 -0.548 0 CA-C-O 120.784 0.326 . . . . 0.0 110.449 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.659 HG22 HG23 ' A' ' 70' ' ' ILE . 92.8 t -116.72 121.18 67.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 N-CA-C 109.71 -0.478 . . . . 0.0 109.71 176.406 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 20' ' ' GLN . . . . . 0.53 ' HB2' ' CG1' ' A' ' 76' ' ' VAL . 13.1 tt0 -114.18 113.05 24.14 Favored 'General case' 0 C--N 1.315 -0.903 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 177.927 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.61 ' HA ' ' O ' ' A' ' 67' ' ' LEU . 49.7 mt-10 -99.43 112.9 25.01 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.117 179.194 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 12.6 mm -97.24 155.48 3.58 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-N 115.614 -0.721 . . . . 0.0 109.67 179.111 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 1.9 mmt -109.15 91.85 3.81 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 175.845 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.674 ' HB ' ' HB2' ' A' ' 65' ' ' LYS . 37.2 mm -79.27 127.31 79.38 Favored Pre-proline 0 C--N 1.319 -0.752 0 CA-C-N 115.859 -0.609 . . . . 0.0 110.629 -175.209 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 25' ' ' PRO . . . . . 0.727 ' HB2' ' HB2' ' A' ' 28' ' ' LYS . 87.3 Cg_exo -48.14 131.61 22.15 Favored 'Trans proline' 0 C--N 1.343 0.288 0 C-N-CA 122.84 2.36 . . . . 0.0 111.961 177.126 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -59.59 -30.6 68.78 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.701 -175.434 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -94.47 12.51 68.75 Favored Glycine 0 N--CA 1.45 -0.432 0 C-N-CA 120.785 -0.721 . . . . 0.0 112.332 178.743 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.727 ' HB2' ' HB2' ' A' ' 25' ' ' PRO . 16.4 tptt -126.48 8.36 7.07 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.15 0.5 . . . . 0.0 110.263 -179.677 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -70.0 -22.41 63.12 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.14 -176.898 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -67.59 -17.37 68.81 Favored Glycine 0 N--CA 1.445 -0.761 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.412 178.124 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.415 HD12 ' HG3' ' A' ' 28' ' ' LYS . 54.0 mt -87.59 -38.45 15.94 Favored 'General case' 0 C--N 1.328 -0.345 0 O-C-N 122.613 -0.345 . . . . 0.0 111.436 -179.195 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.741 HG13 HD21 ' A' ' 87' ' ' LEU . 2.8 m -70.81 -32.68 49.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.962 0.41 . . . . 0.0 111.043 179.879 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.561 HD11 ' HG3' ' A' ' 55' ' ' GLN . 60.2 mt -83.2 -36.76 13.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-O 121.669 0.747 . . . . 0.0 109.763 175.262 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 101.62 171.76 27.98 Favored Glycine 0 N--CA 1.445 -0.745 0 CA-C-N 114.977 -1.01 . . . . 0.0 111.608 -179.722 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 10.5 mptt -81.6 48.76 1.22 Allowed 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.098 0.475 . . . . 0.0 110.373 178.977 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 170.45 -44.23 0.2 Allowed Glycine 0 N--CA 1.447 -0.619 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.778 179.238 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.459 ' HA2' HG22 ' A' ' 33' ' ' ILE . . . 123.19 -4.31 9.61 Favored Glycine 0 N--CA 1.449 -0.439 0 C-N-CA 120.785 -0.721 . . . . 0.0 111.536 -177.192 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -75.13 -33.46 61.56 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.019 0.438 . . . . 0.0 109.95 178.651 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' THR . . . . . 0.687 ' O ' ' HG ' ' A' ' 43' ' ' LEU . 69.9 m -58.28 -54.39 47.54 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-N 115.583 -0.735 . . . . 0.0 111.198 -176.289 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.564 ' HA ' HD12 ' A' ' 43' ' ' LEU . 10.3 tt -59.77 -34.61 56.23 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.28 0 CA-C-O 120.837 0.351 . . . . 0.0 111.14 179.915 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 41' ' ' LYS . . . . . 0.465 ' O ' ' HG2' ' A' ' 45' ' ' GLU . 50.1 tttp -62.33 -48.96 77.52 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.339 175.078 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 42' ' ' GLN . . . . . 0.445 ' O ' ' HG2' ' A' ' 46' ' ' ARG . 72.4 mm-40 -64.69 -33.56 76.24 Favored 'General case' 0 CA--C 1.509 -0.602 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.013 -175.259 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.687 ' HG ' ' O ' ' A' ' 39' ' ' THR . 67.8 mt -58.25 -48.24 81.03 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.413 179.307 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 43.1 mt-30 -65.79 -38.61 89.48 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.534 179.089 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.465 ' HG2' ' O ' ' A' ' 41' ' ' LYS . 60.0 mm-40 -60.69 -52.66 64.17 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.669 177.817 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 46' ' ' ARG . . . . . 0.445 ' HG2' ' O ' ' A' ' 42' ' ' GLN . 10.7 ptm180 -77.67 -29.93 51.77 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.592 -0.731 . . . . 0.0 112.634 -170.825 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -87.55 -25.87 23.42 Favored 'General case' 0 C--N 1.323 -0.554 0 C-N-CA 120.702 -0.399 . . . . 0.0 111.927 -176.077 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 78.23 24.84 62.75 Favored Glycine 0 N--CA 1.453 -0.215 0 C-N-CA 120.577 -0.82 . . . . 0.0 112.424 -179.812 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 5.9 m -135.75 179.29 4.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 N-CA-C 109.926 -0.398 . . . . 0.0 109.926 177.343 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 60.8 tttp -107.4 124.67 50.18 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.846 179.905 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 37.3 mtt -118.97 116.43 26.44 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 177.639 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.607 ' CG2' ' HB2' ' A' ' 68' ' ' ARG . 10.7 tt -111.22 113.43 44.23 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.899 0 CA-C-O 121.447 0.641 . . . . 0.0 110.733 178.675 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.722 HD22 HD13 ' A' ' 67' ' ' LEU . 2.9 mm? -88.17 102.51 14.87 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.581 -0.736 . . . . 0.0 109.467 175.7 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.846 HD12 ' HB2' ' A' ' 66' ' ' PRO . 65.2 mt -75.82 95.07 1.09 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-O 121.331 0.586 . . . . 0.0 110.011 -179.63 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 55' ' ' GLN . . . . . 0.561 ' HG3' HD11 ' A' ' 33' ' ' ILE . 14.8 mm100 . . . . . 0 C--N 1.324 -0.527 0 CA-C-N 115.516 -0.765 . . . . 0.0 110.604 -176.079 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 12.1 m-20 . . . . . 0 C--O 1.227 -0.085 0 CA-C-O 120.887 0.375 . . . . 0.0 110.388 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 65' ' ' LYS . . . . . 0.674 ' HB2' ' HB ' ' A' ' 24' ' ' ILE . 74.0 mmtt -95.26 127.0 43.98 Favored Pre-proline 0 C--N 1.319 -0.74 0 CA-C-N 116.103 -0.498 . . . . 0.0 111.567 -170.573 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.846 ' HB2' HD12 ' A' ' 54' ' ' ILE . 10.6 Cg_exo -71.63 109.11 2.56 Favored 'Trans proline' 0 N--CA 1.459 -0.525 0 C-N-CA 123.074 2.516 . . . . 0.0 111.318 175.556 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.722 HD13 HD22 ' A' ' 53' ' ' LEU . 23.9 tp -106.04 100.01 9.58 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.986 -0.552 . . . . 0.0 109.848 178.467 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 68' ' ' ARG . . . . . 0.607 ' HB2' ' CG2' ' A' ' 52' ' ' ILE . 97.6 mtt180 -85.64 105.11 15.97 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.939 0.4 . . . . 0.0 110.242 176.766 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 31.8 mt -92.4 105.04 16.25 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.718 0 N-CA-C 108.116 -1.068 . . . . 0.0 108.116 171.452 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.659 HG23 HG22 ' A' ' 19' ' ' VAL . 14.5 mt -111.4 129.51 66.62 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.909 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.575 -171.357 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 148.32 -124.67 1.92 Allowed Glycine 0 N--CA 1.441 -0.975 0 C-N-CA 119.847 -1.168 . . . . 0.0 113.833 171.115 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 72' ' ' ASP . . . . . 0.464 ' OD2' ' HG2' ' A' ' 75' ' ' LYS . 4.7 t70 -85.62 128.95 56.78 Favored Pre-proline 0 C--N 1.321 -0.632 0 CA-C-N 115.206 -0.497 . . . . 0.0 111.685 -171.779 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_exo -45.36 -33.64 9.2 Favored 'Trans proline' 0 C--N 1.349 0.596 0 C-N-CA 124.621 3.547 . . . . 0.0 114.346 -175.742 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 90.5 m-85 -74.91 -60.88 2.09 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.069 0.462 . . . . 0.0 110.214 -178.967 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.641 ' HA ' ' HB2' ' A' ' 78' ' ' GLN . 3.8 pttm -74.09 -17.07 61.0 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.745 -0.661 . . . . 0.0 112.586 -173.881 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.53 ' CG1' ' HB2' ' A' ' 20' ' ' GLN . 37.3 t -65.06 -44.35 95.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 121.429 0.633 . . . . 0.0 109.543 170.406 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -74.54 -43.23 56.74 Favored 'General case' 0 N--CA 1.446 -0.651 0 CA-C-N 115.29 -0.868 . . . . 0.0 109.129 -178.402 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 78' ' ' GLN . . . . . 0.641 ' HB2' ' HA ' ' A' ' 75' ' ' LYS . 61.9 mt-30 -56.71 -36.2 69.4 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.495 -0.775 . . . . 0.0 110.661 175.269 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -68.38 -45.08 73.7 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.608 -0.724 . . . . 0.0 110.917 177.957 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 80' ' ' CYS . . . . . 0.415 ' HB2' ' OE1' ' A' ' 20' ' ' GLN . 33.4 t -54.84 -56.71 16.5 Favored 'General case' 0 CA--C 1.518 -0.278 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.968 178.516 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -63.42 -27.08 69.05 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 120.77 -0.372 . . . . 0.0 110.877 -178.647 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 47.7 ttp -73.59 -49.67 25.09 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.434 179.839 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.537 HG12 HD13 ' A' ' 43' ' ' LEU . 34.2 m -76.39 -32.75 22.22 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-O 120.853 0.359 . . . . 0.0 110.591 -175.626 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 84' ' ' MET . . . . . 0.46 ' O ' ' HG3' ' A' ' 88' ' ' ARG . 45.2 ttm -68.56 -31.62 70.95 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.075 -0.511 . . . . 0.0 109.859 177.041 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 85' ' ' ASP . . . . . 0.522 ' HA ' ' HD2' ' A' ' 88' ' ' ARG . 21.4 t70 -62.81 -40.45 97.42 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.892 -0.595 . . . . 0.0 111.113 178.602 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 42.1 mt -61.08 -29.97 46.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.445 179.279 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.741 HD21 HG13 ' A' ' 32' ' ' VAL . 61.2 mt -79.0 -20.89 47.93 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.384 -177.434 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 88' ' ' ARG . . . . . 0.522 ' HD2' ' HA ' ' A' ' 85' ' ' ASP . 0.0 OUTLIER -117.99 27.56 8.93 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.17 0.51 . . . . 0.0 110.935 -179.84 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 44.9 tt0 . . . . . 0 C--O 1.248 1.007 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.174 179.551 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.433 ' HB ' HG21 ' A' ' 76' ' ' VAL . 58.8 m . . . . . 0 N--CA 1.446 -0.627 0 N-CA-C 109.63 -0.508 . . . . 0.0 109.63 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.505 ' HA ' ' O ' ' A' ' 69' ' ' ILE . 5.2 p -132.19 126.42 56.01 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-O 121.237 0.541 . . . . 0.0 110.999 179.693 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 20' ' ' GLN . . . . . 0.412 ' OE1' HG12 ' A' ' 76' ' ' VAL . 55.1 mt-30 -115.5 119.91 37.74 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.561 177.017 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.636 ' HA ' ' O ' ' A' ' 67' ' ' LEU . 49.8 mt-10 -92.03 111.9 23.62 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.244 0.545 . . . . 0.0 110.546 177.429 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 15.8 mm -104.0 155.63 5.73 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-N 115.331 -0.85 . . . . 0.0 109.695 -178.347 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' MET . . . . . 0.541 ' HB3' ' HB3' ' A' ' 64' ' ' ASP . 80.6 mmm -108.43 104.97 14.43 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 176.227 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.644 ' HB ' ' HB2' ' A' ' 65' ' ' LYS . 30.5 mm -91.23 125.0 59.84 Favored Pre-proline 0 C--N 1.321 -0.656 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.115 -174.117 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 25' ' ' PRO . . . . . 0.566 ' HB2' ' HB3' ' A' ' 28' ' ' LYS . 76.9 Cg_exo -50.3 140.52 33.94 Favored 'Trans proline' 0 CA--C 1.535 0.555 0 C-N-CA 122.845 2.363 . . . . 0.0 113.019 179.715 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -48.88 -61.75 1.88 Allowed 'General case' 0 N--CA 1.468 0.454 0 N-CA-C 113.42 0.896 . . . . 0.0 113.42 -170.605 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -78.67 -25.64 60.26 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.712 -0.756 . . . . 0.0 111.883 -177.334 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.577 ' HG3' HD22 ' A' ' 87' ' ' LEU . 13.0 tppt? -67.57 -19.18 65.23 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.99 0.424 . . . . 0.0 110.875 178.891 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.477 ' O ' HG12 ' A' ' 32' ' ' VAL . . . -59.66 -23.5 63.13 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.415 179.802 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -60.58 -27.03 65.47 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.855 -0.688 . . . . 0.0 112.16 176.598 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 92.5 mt -87.61 -33.53 18.82 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.643 0.258 . . . . 0.0 110.705 179.787 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.477 HG12 ' O ' ' A' ' 29' ' ' ALA . 0.9 OUTLIER -73.55 -31.27 32.1 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.387 0 CA-C-O 121.071 0.463 . . . . 0.0 110.916 -178.711 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.541 HG22 ' HA2' ' A' ' 37' ' ' GLY . 75.6 mt -84.87 -44.64 17.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 116.01 -0.541 . . . . 0.0 109.89 176.117 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 132.46 170.16 12.45 Favored Glycine 0 N--CA 1.441 -1.004 0 C-N-CA 120.242 -0.98 . . . . 0.0 112.936 174.606 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.409 ' N ' ' HD3' ' A' ' 35' ' ' LYS . 3.3 mppt? -69.36 -28.52 66.28 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.025 0.44 . . . . 0.0 109.879 -179.114 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -136.69 19.18 3.56 Favored Glycine 0 N--CA 1.447 -0.568 0 C-N-CA 120.825 -0.702 . . . . 0.0 111.355 175.592 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.541 ' HA2' HG22 ' A' ' 33' ' ' ILE . . . 78.57 5.92 88.13 Favored Glycine 0 C--O 1.226 -0.4 0 C-N-CA 120.913 -0.661 . . . . 0.0 112.072 -176.885 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -85.53 -24.18 27.39 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 120.887 0.375 . . . . 0.0 111.537 -178.587 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 39' ' ' THR . . . . . 0.649 ' O ' ' HG ' ' A' ' 43' ' ' LEU . 31.5 m -64.26 -48.97 73.72 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.232 -176.415 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.557 ' HA ' HD12 ' A' ' 43' ' ' LEU . 5.3 tt -55.72 -30.43 27.23 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.342 0 CA-C-O 121.071 0.462 . . . . 0.0 111.513 179.757 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 41' ' ' LYS . . . . . 0.444 ' O ' ' HG2' ' A' ' 45' ' ' GLU . 7.8 tmtm? -74.47 -39.58 62.42 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.055 -0.52 . . . . 0.0 109.758 -178.904 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 81.0 mt-30 -67.82 -35.62 78.93 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.825 -179.702 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.649 ' HG ' ' O ' ' A' ' 39' ' ' THR . 47.7 mt -58.5 -42.65 88.14 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.454 -179.224 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 65.9 mt-30 -62.69 -39.88 95.37 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.629 179.595 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.444 ' HG2' ' O ' ' A' ' 41' ' ' LYS . 34.6 mm-40 -74.07 -51.2 16.5 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.382 -176.727 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 17.5 ptm180 -66.63 -37.46 84.9 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.966 -0.561 . . . . 0.0 112.25 -171.798 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.414 ' HB3' HG22 ' A' ' 49' ' ' VAL . . . -95.77 -13.39 24.16 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 120.969 0.414 . . . . 0.0 111.391 -176.795 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 69.19 31.17 71.74 Favored Glycine 0 N--CA 1.449 -0.467 0 N-CA-C 111.274 -0.73 . . . . 0.0 111.274 -176.082 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.501 HG12 ' HD3' ' A' ' 75' ' ' LYS . 34.4 m -113.04 166.84 6.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-O 120.809 0.337 . . . . 0.0 110.394 -175.735 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -111.65 123.33 50.0 Favored 'General case' 0 C--N 1.318 -0.794 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 171.211 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 75.8 mtp -123.8 115.32 21.17 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 109.806 -0.442 . . . . 0.0 109.806 178.643 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.501 ' CG2' ' HB2' ' A' ' 68' ' ' ARG . 6.8 tt -104.43 105.84 19.27 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.837 0 CA-C-O 121.437 0.636 . . . . 0.0 109.977 178.432 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.609 HD22 HD13 ' A' ' 67' ' ' LEU . 2.5 mm? -78.28 102.64 7.76 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.681 -0.691 . . . . 0.0 109.594 177.007 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.453 ' HB ' ' HB2' ' A' ' 66' ' ' PRO . 60.8 mt -87.5 85.89 2.51 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-O 121.509 0.671 . . . . 0.0 109.467 -178.239 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 1.3 pt20 . . . . . 0 C--N 1.321 -0.635 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.834 -177.162 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.541 ' HB3' ' HB3' ' A' ' 23' ' ' MET . 1.9 m-20 . . . . . 0 CA--C 1.531 0.222 0 CA-C-O 121.412 0.625 . . . . 0.0 111.981 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 65' ' ' LYS . . . . . 0.644 ' HB2' ' HB ' ' A' ' 24' ' ' ILE . 71.7 mmtt -99.35 127.59 34.09 Favored Pre-proline 0 C--N 1.322 -0.594 0 CA-C-N 115.156 -0.929 . . . . 0.0 111.49 -174.176 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.453 ' HB2' ' HB ' ' A' ' 54' ' ' ILE . 38.7 Cg_exo -65.03 114.33 2.76 Favored 'Trans proline' 0 CA--C 1.533 0.434 0 C-N-CA 122.896 2.397 . . . . 0.0 111.719 169.619 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.636 ' O ' ' HA ' ' A' ' 21' ' ' GLU . 28.7 tp -122.95 126.58 47.49 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 120.588 0.232 . . . . 0.0 111.114 179.809 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 68' ' ' ARG . . . . . 0.583 ' HG2' ' HG2' ' A' ' 21' ' ' GLU . 96.4 mtt180 -109.19 115.93 30.95 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 120.674 0.273 . . . . 0.0 111.519 176.086 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.505 ' O ' ' HA ' ' A' ' 19' ' ' VAL . 4.5 mp -97.62 115.8 38.46 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 N-CA-C 108.423 -0.954 . . . . 0.0 108.423 170.866 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 15.0 mt -119.38 140.66 42.6 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.569 -174.473 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 157.36 -160.12 30.28 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.877 -0.678 . . . . 0.0 112.165 176.738 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 72' ' ' ASP . . . . . 0.577 ' H ' ' HD2' ' A' ' 75' ' ' LYS . 1.0 OUTLIER -61.99 137.19 95.44 Favored Pre-proline 0 N--CA 1.447 -0.617 0 N-CA-C 108.631 -0.877 . . . . 0.0 108.631 174.477 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_exo -42.47 -41.17 7.71 Favored 'Trans proline' 0 CA--C 1.534 0.478 0 C-N-CA 122.825 2.35 . . . . 0.0 114.219 -173.462 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 73.3 m-85 -69.52 -51.61 34.14 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.111 -0.495 . . . . 0.0 112.191 -175.136 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.577 ' HD2' ' H ' ' A' ' 72' ' ' ASP . 16.9 ptpt -62.92 -32.34 73.6 Favored 'General case' 0 C--O 1.222 -0.349 0 CA-C-N 116.687 -0.233 . . . . 0.0 110.689 -179.024 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.497 HG23 ' O ' ' A' ' 72' ' ' ASP . 96.6 t -56.89 -48.05 82.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 120.771 0.319 . . . . 0.0 110.329 177.849 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 1.6 mm100 -71.14 -42.46 69.14 Favored 'General case' 0 N--CA 1.45 -0.456 0 CA-C-N 116.4 -0.363 . . . . 0.0 111.332 178.158 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 47.1 mt-30 -60.17 -42.37 94.82 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.717 0.294 . . . . 0.0 111.069 178.955 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -71.34 -36.43 71.53 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.766 178.917 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 49.8 t -61.17 -54.9 38.62 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.229 176.51 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -61.59 -30.05 70.43 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.885 0.374 . . . . 0.0 110.599 179.247 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 52.5 ttp -64.74 -53.29 49.45 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.886 178.534 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.617 ' O ' ' HG ' ' A' ' 87' ' ' LEU . 32.9 m -78.65 -33.24 16.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-O 120.656 0.265 . . . . 0.0 110.863 -176.254 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 59.8 ttp -66.51 -35.61 80.67 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.106 178.678 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -60.27 -38.38 83.38 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.62 176.76 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 48.6 mt -66.7 -27.25 39.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-O 121.273 0.559 . . . . 0.0 110.339 178.735 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.617 ' HG ' ' O ' ' A' ' 83' ' ' VAL . 35.4 mt -91.71 -28.12 17.64 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.273 -176.774 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 88' ' ' ARG . . . . . 0.442 HH11 ' HD2' ' A' ' 88' ' ' ARG . 12.9 mmt180 -85.99 -13.07 48.68 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.316 0.579 . . . . 0.0 111.117 -179.287 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 . . . . . 0 C--N 1.312 -1.064 0 CA-C-N 115.359 -0.837 . . . . 0.0 110.028 -178.009 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 16.1 m . . . . . 0 N--CA 1.453 -0.312 0 CA-C-O 120.661 0.267 . . . . 0.0 110.712 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.401 HG22 HG23 ' A' ' 70' ' ' ILE . 60.5 t -131.71 131.86 62.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.423 179.884 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 28.6 mt-30 -120.84 114.8 22.13 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.086 173.803 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.578 ' HA ' ' O ' ' A' ' 67' ' ' LEU . 48.5 mt-10 -86.61 119.65 27.08 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.958 -0.564 . . . . 0.0 111.052 178.812 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.494 ' HB ' ' HB3' ' A' ' 67' ' ' LEU . 14.9 mm -105.68 163.43 4.56 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 115.341 -0.845 . . . . 0.0 110.091 -178.395 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 23' ' ' MET . . . . . 0.456 ' HB3' ' HB3' ' A' ' 64' ' ' ASP . 2.3 mmt -109.75 94.89 5.26 Favored 'General case' 0 N--CA 1.453 -0.324 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 176.049 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.748 ' HB ' ' HB2' ' A' ' 65' ' ' LYS . 36.5 mm -82.78 126.48 72.99 Favored Pre-proline 0 C--N 1.318 -0.775 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.178 -174.589 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 25' ' ' PRO . . . . . 0.718 ' HD2' HD13 ' A' ' 87' ' ' LEU . 84.6 Cg_exo -47.39 124.87 9.89 Favored 'Trans proline' 0 C--N 1.346 0.407 0 C-N-CA 123.132 2.555 . . . . 0.0 112.533 178.621 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -63.69 -34.38 77.72 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.645 -0.707 . . . . 0.0 111.872 -174.359 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -90.88 -3.75 70.24 Favored Glycine 0 N--CA 1.448 -0.543 0 C-N-CA 120.609 -0.805 . . . . 0.0 112.93 -178.724 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.503 ' HB3' ' HB2' ' A' ' 25' ' ' PRO . 43.4 tttt -121.44 17.17 11.35 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.222 0.534 . . . . 0.0 110.759 -176.93 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.447 ' O ' HG12 ' A' ' 32' ' ' VAL . . . -70.57 -21.15 62.72 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.901 -0.591 . . . . 0.0 111.275 -178.27 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -65.39 -18.19 65.09 Favored Glycine 0 C--O 1.227 -0.308 0 C-N-CA 121.11 -0.567 . . . . 0.0 112.646 178.458 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.621 ' HB3' HG22 ' A' ' 86' ' ' ILE . 66.1 mt -88.53 -41.57 12.63 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.619 0.247 . . . . 0.0 110.939 178.819 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.731 ' HB ' HD21 ' A' ' 87' ' ' LEU . 4.3 p -69.67 -33.65 57.5 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.435 0 CA-C-O 121.334 0.587 . . . . 0.0 110.824 -178.718 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.59 ' HA ' ' HB ' ' A' ' 40' ' ' ILE . 76.6 mt -90.35 -39.87 12.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-N 115.591 -0.731 . . . . 0.0 110.59 179.061 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 107.63 151.39 16.83 Favored Glycine 0 N--CA 1.443 -0.838 0 CA-C-N 115.756 -0.656 . . . . 0.0 111.777 -179.075 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.545 ' HE3' HD23 ' A' ' 31' ' ' LEU . 0.2 OUTLIER -68.81 -11.34 60.31 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.719 0.295 . . . . 0.0 111.31 -178.088 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -137.36 17.83 3.52 Favored Glycine 0 N--CA 1.449 -0.483 0 C-N-CA 120.715 -0.755 . . . . 0.0 111.693 176.639 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 69.78 1.55 32.07 Favored Glycine 0 CA--C 1.521 0.411 0 C-N-CA 121.248 -0.501 . . . . 0.0 112.785 -177.655 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -69.9 -35.99 75.05 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.834 0.35 . . . . 0.0 111.114 -178.171 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 39' ' ' THR . . . . . 0.757 ' O ' ' HG ' ' A' ' 43' ' ' LEU . 93.8 m -57.72 -61.21 2.68 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.092 -179.304 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.65 ' HA ' HD12 ' A' ' 43' ' ' LEU . 7.6 tt -60.33 -29.83 44.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 116.045 -0.525 . . . . 0.0 112.09 -175.243 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 11.6 tmtt? -74.58 -42.34 58.9 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 109.86 -0.422 . . . . 0.0 109.86 -179.381 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 42' ' ' GLN . . . . . 0.516 ' O ' ' HG2' ' A' ' 46' ' ' ARG . 47.6 mt-30 -66.09 -31.72 72.76 Favored 'General case' 0 CA--C 1.517 -0.303 0 CA-C-O 120.961 0.41 . . . . 0.0 110.469 -179.305 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.757 ' HG ' ' O ' ' A' ' 39' ' ' THR . 44.4 mt -61.89 -33.25 73.88 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.674 -179.995 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 44' ' ' GLN . . . . . 0.402 ' HA ' ' O ' ' A' ' 49' ' ' VAL . 65.0 mt-30 -71.66 -23.03 61.6 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.433 0.635 . . . . 0.0 110.547 179.661 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 68.5 mm-40 -87.86 -55.1 3.91 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.82 -179.885 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 46' ' ' ARG . . . . . 0.516 ' HG2' ' O ' ' A' ' 42' ' ' GLN . 14.6 ptp180 -69.84 -30.87 68.47 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 113.02 0.748 . . . . 0.0 113.02 -172.492 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.509 ' HB3' HG22 ' A' ' 49' ' ' VAL . . . -95.48 -18.56 20.57 Favored 'General case' 0 C--N 1.323 -0.553 0 C-N-CA 120.736 -0.386 . . . . 0.0 111.594 -176.487 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 75.74 17.45 80.1 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.83 -0.7 . . . . 0.0 112.212 -179.415 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.509 HG22 ' HB3' ' A' ' 47' ' ' ALA . 21.2 m -116.1 166.41 10.23 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-O 120.809 0.338 . . . . 0.0 110.279 179.846 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 85.6 tttt -108.66 121.29 44.71 Favored 'General case' 0 C--N 1.314 -0.952 0 N-CA-C 108.474 -0.935 . . . . 0.0 108.474 169.31 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 51' ' ' MET . . . . . 0.908 ' HE1' HG11 ' A' ' 83' ' ' VAL . 15.9 mtm -114.08 115.3 27.34 Favored 'General case' 0 C--N 1.316 -0.855 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 177.268 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.584 ' CG2' ' HB2' ' A' ' 68' ' ' ARG . 11.6 tt -100.34 106.94 20.07 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.084 0 CA-C-O 121.418 0.628 . . . . 0.0 110.348 179.561 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.867 HD22 HD13 ' A' ' 67' ' ' LEU . 3.0 mm? -72.78 101.52 3.13 Favored 'General case' 0 N--CA 1.445 -0.675 0 N-CA-C 107.382 -1.34 . . . . 0.0 107.382 171.165 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.711 HD12 ' HB2' ' A' ' 66' ' ' PRO . 62.8 mt -73.54 86.24 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.482 0 CA-C-O 122.078 0.942 . . . . 0.0 111.135 -170.852 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 32.3 mt-30 . . . . . 0 C--N 1.321 -0.654 0 CA-C-N 114.209 -1.359 . . . . 0.0 107.742 170.223 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.456 ' HB3' ' HB3' ' A' ' 23' ' ' MET . 1.1 m-20 . . . . . 0 N--CA 1.456 -0.165 0 CA-C-O 121.05 0.452 . . . . 0.0 110.743 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 65' ' ' LYS . . . . . 0.748 ' HB2' ' HB ' ' A' ' 24' ' ' ILE . 30.3 mmtp -90.55 132.67 34.56 Favored Pre-proline 0 C--N 1.322 -0.609 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.988 -170.355 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.711 ' HB2' HD12 ' A' ' 54' ' ' ILE . 17.4 Cg_exo -68.16 110.45 2.21 Favored 'Trans proline' 0 N--CA 1.456 -0.708 0 C-N-CA 122.684 2.256 . . . . 0.0 110.965 173.802 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.867 HD13 HD22 ' A' ' 53' ' ' LEU . 30.0 tp -108.6 114.05 27.55 Favored 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 110.138 -0.319 . . . . 0.0 110.138 178.064 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 68' ' ' ARG . . . . . 0.584 ' HB2' ' CG2' ' A' ' 52' ' ' ILE . 97.3 mtt180 -99.46 106.19 18.21 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 116.487 -0.324 . . . . 0.0 110.479 176.254 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.506 ' HB ' HG13 ' A' ' 76' ' ' VAL . 4.5 mp -86.39 103.93 13.34 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 N-CA-C 107.855 -1.165 . . . . 0.0 107.855 170.196 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.401 HG23 HG22 ' A' ' 19' ' ' VAL . 31.1 mt -101.57 116.12 44.59 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.867 0 CA-C-N 115.534 -0.757 . . . . 0.0 110.19 -174.282 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 177.19 -123.99 0.92 Allowed Glycine 0 N--CA 1.442 -0.935 0 C-N-CA 120.42 -0.895 . . . . 0.0 112.258 178.945 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -119.46 141.85 31.55 Favored Pre-proline 0 C--N 1.318 -0.793 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 -177.631 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 82.8 Cg_exo -43.66 -38.03 8.87 Favored 'Trans proline' 0 C--N 1.35 0.611 0 C-N-CA 123.064 2.509 . . . . 0.0 113.212 -173.003 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 74' ' ' TYR . . . . . 0.417 ' O ' ' HG3' ' A' ' 78' ' ' GLN . 47.3 t80 -66.18 -61.99 1.72 Allowed 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.65 -0.705 . . . . 0.0 111.491 -177.416 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.424 ' HB2' HG13 ' A' ' 49' ' ' VAL . 35.3 pttt -67.37 -33.81 75.99 Favored 'General case' 0 N--CA 1.464 0.265 0 C-N-CA 121.103 -0.239 . . . . 0.0 111.573 179.75 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.506 HG13 ' HB ' ' A' ' 69' ' ' ILE . 51.3 t -57.85 -39.54 71.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.805 0.336 . . . . 0.0 110.514 177.672 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 77' ' ' GLN . . . . . 0.548 ' O ' ' HG2' ' A' ' 81' ' ' GLU . 1.9 mm100 -74.31 -44.78 51.14 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 120.651 -0.42 . . . . 0.0 111.407 178.206 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 78' ' ' GLN . . . . . 0.417 ' HG3' ' O ' ' A' ' 74' ' ' TYR . 47.0 mt-30 -57.65 -43.99 85.32 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-O 121.361 0.6 . . . . 0.0 110.166 179.398 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -66.6 -40.35 88.81 Favored 'General case' 0 N--CA 1.446 -0.675 0 CA-C-N 115.257 -0.883 . . . . 0.0 110.829 -179.693 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 45.0 t -63.21 -57.2 11.27 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.217 179.596 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 81' ' ' GLU . . . . . 0.548 ' HG2' ' O ' ' A' ' 77' ' ' GLN . 10.2 pt-20 -63.41 -20.18 65.32 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.981 0.419 . . . . 0.0 110.921 -177.456 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 37.7 ttp -75.56 -52.11 11.37 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.436 177.101 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.908 HG11 ' HE1' ' A' ' 51' ' ' MET . 27.9 m -79.61 -29.77 13.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.083 -174.666 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 84' ' ' MET . . . . . 0.592 ' O ' ' HG3' ' A' ' 88' ' ' ARG . 14.8 tpt -66.62 -31.74 72.63 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.086 -0.506 . . . . 0.0 109.686 177.397 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -62.53 -39.16 92.68 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-O 120.894 0.378 . . . . 0.0 110.667 177.122 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.621 HG22 ' HB3' ' A' ' 31' ' ' LEU . 18.7 mt -62.84 -19.2 22.72 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.401 179.136 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.731 HD21 ' HB ' ' A' ' 32' ' ' VAL . 65.5 mt -102.32 -40.45 6.74 Favored 'General case' 0 N--CA 1.449 -0.488 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.786 -175.582 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 88' ' ' ARG . . . . . 0.592 ' HG3' ' O ' ' A' ' 84' ' ' MET . 0.0 OUTLIER -78.08 -4.15 45.86 Favored 'General case' 0 N--CA 1.464 0.246 0 C-N-CA 120.471 -0.492 . . . . 0.0 111.87 -178.73 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 . . . . . 0 C--O 1.249 1.049 0 CA-C-O 118.372 -0.823 . . . . 0.0 109.39 177.287 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.432 HG21 ' HA ' ' A' ' 73' ' ' PRO . 87.6 m . . . . . 0 C--O 1.231 0.102 0 CA-C-O 120.699 0.285 . . . . 0.0 110.423 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.44 ' HA ' ' O ' ' A' ' 69' ' ' ILE . 90.5 t -138.01 122.06 21.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.882 -177.014 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 84.6 mt-30 -107.27 118.07 35.74 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 109.891 -0.411 . . . . 0.0 109.891 172.688 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.547 ' HA ' ' O ' ' A' ' 67' ' ' LEU . 42.2 mt-10 -90.29 115.76 27.74 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.061 0.458 . . . . 0.0 111.026 176.233 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 12.8 mm -109.33 151.2 11.7 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-N 115.394 -0.821 . . . . 0.0 109.41 177.995 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 86.7 mmm -104.42 98.1 7.93 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 174.591 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.684 ' HB ' ' HB2' ' A' ' 65' ' ' LYS . 36.8 mm -81.49 129.79 64.52 Favored Pre-proline 0 C--N 1.316 -0.863 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.487 -175.491 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 25' ' ' PRO . . . . . 0.552 ' HB2' ' HB2' ' A' ' 28' ' ' LYS . 86.5 Cg_exo -46.68 128.11 12.64 Favored 'Trans proline' 0 C--N 1.347 0.497 0 C-N-CA 123.019 2.479 . . . . 0.0 112.451 177.891 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -45.43 -55.84 5.66 Favored 'General case' 0 C--O 1.234 0.254 0 N-CA-C 113.093 0.775 . . . . 0.0 113.093 -170.811 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -81.61 -4.87 90.27 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.837 -0.697 . . . . 0.0 113.066 -174.897 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.552 ' HB2' ' HB2' ' A' ' 25' ' ' PRO . 1.8 tptp -95.79 -8.51 34.14 Favored 'General case' 0 C--N 1.323 -0.558 0 O-C-N 122.673 -0.31 . . . . 0.0 110.198 -177.987 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.614 ' HA ' HG23 ' A' ' 32' ' ' VAL . . . -63.89 -24.32 67.69 Favored 'General case' 0 N--CA 1.461 0.11 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.169 -179.982 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -58.76 -27.43 61.65 Favored Glycine 0 C--O 1.227 -0.319 0 C-N-CA 121.052 -0.595 . . . . 0.0 112.456 178.983 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 84.3 mt -82.86 -34.61 26.75 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.672 0.272 . . . . 0.0 111.143 -178.748 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.751 HG22 HD21 ' A' ' 87' ' ' LEU . 0.0 OUTLIER -74.08 -36.19 43.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.865 0.364 . . . . 0.0 110.345 178.399 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.587 HG12 ' O ' ' A' ' 29' ' ' ALA . 14.5 mm -78.35 -43.06 26.95 Favored 'Isoleucine or valine' 0 C--O 1.235 0.302 0 CA-C-O 121.482 0.658 . . . . 0.0 109.7 178.867 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 111.04 173.26 19.81 Favored Glycine 0 N--CA 1.439 -1.122 0 CA-C-N 115.374 -0.83 . . . . 0.0 112.051 178.365 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 31.1 mmmt -75.36 -22.38 57.6 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 120.853 0.359 . . . . 0.0 110.309 -178.913 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -130.93 -5.31 3.94 Favored Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.586 -0.816 . . . . 0.0 112.162 179.489 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 100.56 -1.09 55.61 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.736 -0.745 . . . . 0.0 111.924 -178.207 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -78.0 -21.43 50.86 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.652 0.263 . . . . 0.0 111.158 -178.865 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 39' ' ' THR . . . . . 0.793 ' O ' ' HG ' ' A' ' 43' ' ' LEU . 31.3 m -69.38 -50.86 42.19 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.577 -0.283 . . . . 0.0 110.691 -178.165 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.568 ' HB ' ' HA ' ' A' ' 33' ' ' ILE . 11.6 tt -67.13 -25.18 33.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-O 121.439 0.637 . . . . 0.0 110.448 177.317 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 22.4 tptm -63.24 -53.0 59.89 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.738 175.539 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 42' ' ' GLN . . . . . 0.412 ' HG2' ' O ' ' A' ' 39' ' ' THR . 8.9 pt20 -68.78 -37.05 79.04 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.395 -175.023 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.793 ' HG ' ' O ' ' A' ' 39' ' ' THR . 84.4 mt -53.86 -39.65 65.86 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.743 -0.662 . . . . 0.0 111.532 179.632 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 44' ' ' GLN . . . . . 0.448 ' HG3' ' O ' ' A' ' 40' ' ' ILE . 44.9 mt-30 -69.78 -40.97 75.74 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.219 0.533 . . . . 0.0 110.813 -179.61 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 10.2 mm-40 -72.32 -40.51 67.39 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.668 -0.696 . . . . 0.0 111.705 -175.78 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 46' ' ' ARG . . . . . 0.401 ' HG2' ' O ' ' A' ' 42' ' ' GLN . 12.0 ptp180 -71.42 -34.24 70.16 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 112.375 0.509 . . . . 0.0 112.375 -174.458 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.559 ' HB3' HG22 ' A' ' 49' ' ' VAL . . . -99.11 -5.92 29.28 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 112.224 0.453 . . . . 0.0 112.224 -173.587 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 66.27 30.39 76.64 Favored Glycine 0 C--N 1.33 0.225 0 C-N-CA 120.818 -0.706 . . . . 0.0 112.046 -178.627 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.559 HG22 ' HB3' ' A' ' 47' ' ' ALA . 26.8 m -125.11 179.58 3.0 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 N-CA-C 109.724 -0.472 . . . . 0.0 109.724 -178.351 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 64.6 tttp -122.48 125.53 45.98 Favored 'General case' 0 C--N 1.314 -0.938 0 CA-C-N 116.027 -0.533 . . . . 0.0 109.817 167.501 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 51' ' ' MET . . . . . 0.569 ' CE ' ' HB1' ' A' ' 79' ' ' ALA . 48.5 mtt -110.75 114.76 28.37 Favored 'General case' 0 C--N 1.315 -0.931 0 N-CA-C 108.418 -0.956 . . . . 0.0 108.418 176.471 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.551 ' CG2' ' HB2' ' A' ' 68' ' ' ARG . 8.9 tt -106.09 105.04 17.96 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.939 0 CA-C-O 121.521 0.677 . . . . 0.0 110.141 177.729 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.52 HD23 ' CD1' ' A' ' 40' ' ' ILE . 4.2 mm? -88.44 101.91 14.37 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.168 -0.924 . . . . 0.0 108.936 174.994 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.533 HD12 ' HB2' ' A' ' 66' ' ' PRO . 51.3 mt -78.98 86.55 1.16 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 178.604 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 55' ' ' GLN . . . . . 0.501 ' HA ' ' HD2' ' A' ' 65' ' ' LYS . 3.4 pp0? . . . . . 0 C--N 1.322 -0.587 0 CA-C-N 115.626 -0.715 . . . . 0.0 111.592 -174.843 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 25.2 m-20 . . . . . 0 C--O 1.23 0.074 0 CA-C-O 121.048 0.451 . . . . 0.0 110.524 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 65' ' ' LYS . . . . . 0.684 ' HB2' ' HB ' ' A' ' 24' ' ' ILE . 71.9 mmtt -99.76 121.5 54.22 Favored Pre-proline 0 C--N 1.318 -0.772 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.787 -170.286 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.533 ' HB2' HD12 ' A' ' 54' ' ' ILE . 23.3 Cg_exo -66.26 106.86 1.08 Allowed 'Trans proline' 0 N--CA 1.46 -0.483 0 C-N-CA 122.801 2.334 . . . . 0.0 110.969 173.02 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.547 ' O ' ' HA ' ' A' ' 21' ' ' GLU . 19.3 tp -108.71 112.03 24.11 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.402 -179.866 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 68' ' ' ARG . . . . . 0.551 ' HB2' ' CG2' ' A' ' 52' ' ' ILE . 98.8 mtt180 -101.58 108.21 19.7 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.365 174.802 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.44 ' O ' ' HA ' ' A' ' 19' ' ' VAL . 4.9 mp -87.31 104.41 14.21 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 N-CA-C 108.308 -0.997 . . . . 0.0 108.308 170.995 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 18.6 mt -99.87 120.99 50.03 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 CA-C-N 115.85 -0.613 . . . . 0.0 110.533 -174.502 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 173.57 -135.93 3.44 Favored Glycine 0 CA--C 1.518 0.258 0 C-N-CA 120.807 -0.711 . . . . 0.0 112.985 179.161 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 72' ' ' ASP . . . . . 0.579 ' OD1' ' HE2' ' A' ' 75' ' ' LYS . 1.5 m-20 -103.28 157.77 33.13 Favored Pre-proline 0 C--N 1.325 -0.481 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 179.684 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 73' ' ' PRO . . . . . 0.432 ' HA ' HG21 ' A' ' 18' ' ' THR . 82.0 Cg_exo -48.17 -39.28 34.03 Favored 'Trans proline' 0 C--O 1.234 0.29 0 C-N-CA 122.156 1.904 . . . . 0.0 112.367 179.732 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 32.4 m-85 -67.27 -62.99 1.15 Allowed 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.225 -178.617 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.579 ' HE2' ' OD1' ' A' ' 72' ' ' ASP . 41.2 pttt -67.66 -25.83 65.91 Favored 'General case' 0 C--O 1.22 -0.449 0 CA-C-N 116.333 -0.394 . . . . 0.0 112.041 -174.052 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.436 HG13 ' HB ' ' A' ' 69' ' ' ILE . 56.1 t -71.76 -35.1 54.07 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-O 121.165 0.507 . . . . 0.0 110.037 177.97 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -74.04 -51.67 15.1 Favored 'General case' 0 N--CA 1.448 -0.563 0 N-CA-C 108.636 -0.876 . . . . 0.0 108.636 178.32 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 92.0 mt-30 -59.93 -39.34 85.14 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.473 -179.245 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 79' ' ' ALA . . . . . 0.569 ' HB1' ' CE ' ' A' ' 51' ' ' MET . . . -68.07 -36.59 80.09 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.168 178.851 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 52.2 t -67.26 -47.06 71.85 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.803 -178.937 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -70.24 -19.15 63.16 Favored 'General case' 0 C--N 1.325 -0.496 0 C-N-CA 120.344 -0.542 . . . . 0.0 110.632 178.159 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 82' ' ' MET . . . . . 0.431 ' O ' ' HB3' ' A' ' 85' ' ' ASP . 48.8 ttp -75.43 -47.71 26.09 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.468 175.374 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.575 ' O ' ' HG ' ' A' ' 87' ' ' LEU . 28.3 m -72.29 -33.2 45.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 C-N-CA 120.963 -0.295 . . . . 0.0 110.831 -179.874 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 54.4 mtt -67.61 -27.4 66.87 Favored 'General case' 0 CA--C 1.519 -0.235 0 CA-C-O 120.83 0.348 . . . . 0.0 110.173 174.865 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 85' ' ' ASP . . . . . 0.533 ' O ' ' HG2' ' A' ' 88' ' ' ARG . 8.0 t70 -65.1 -45.33 85.59 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.597 176.115 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 38.9 mt -63.19 -22.62 31.2 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.644 179.196 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.751 HD21 HG22 ' A' ' 32' ' ' VAL . 64.7 mt -97.24 -12.33 23.1 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.708 -176.322 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 88' ' ' ARG . . . . . 0.695 ' HG3' ' HG2' ' A' ' 89' ' ' GLU . 29.5 ptt180 -101.16 -24.06 14.34 Favored 'General case' 0 CA--C 1.515 -0.37 0 CA-C-O 121.633 0.73 . . . . 0.0 110.088 -177.137 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 89' ' ' GLU . . . . . 0.695 ' HG2' ' HG3' ' A' ' 88' ' ' ARG . 37.7 mm-40 . . . . . 0 C--N 1.312 -1.047 0 CA-C-N 114.422 -1.263 . . . . 0.0 110.704 -171.475 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.452 HG21 ' HA ' ' A' ' 73' ' ' PRO . 95.9 m . . . . . 0 N--CA 1.456 -0.125 0 CA-C-O 120.93 0.395 . . . . 0.0 111.35 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.941 ' HB ' HD12 ' A' ' 70' ' ' ILE . 0.2 OUTLIER -138.24 128.4 34.85 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 115.648 -0.705 . . . . 0.0 110.932 -179.761 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 27.9 mt-30 -118.31 116.04 25.95 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.881 -0.6 . . . . 0.0 109.951 174.148 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.56 ' HG3' ' HG2' ' A' ' 68' ' ' ARG . 4.5 mp0 -86.61 107.75 18.3 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.119 0.485 . . . . 0.0 110.851 178.784 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 23.1 mm -88.18 156.03 3.17 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-N 115.67 -0.695 . . . . 0.0 110.046 -178.08 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' MET . . . . . 0.465 ' HB3' ' HB3' ' A' ' 64' ' ' ASP . 14.3 mmt -105.83 91.79 3.89 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 109.618 -0.512 . . . . 0.0 109.618 176.653 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.714 ' HB ' ' HB2' ' A' ' 65' ' ' LYS . 26.0 mm -80.85 125.39 80.25 Favored Pre-proline 0 C--N 1.321 -0.668 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.751 -176.488 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 25' ' ' PRO . . . . . 0.611 ' HB2' ' HB2' ' A' ' 28' ' ' LYS . 64.8 Cg_exo -51.89 130.14 33.22 Favored 'Trans proline' 0 C--O 1.233 0.226 0 C-N-CA 122.813 2.342 . . . . 0.0 111.711 176.412 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -58.34 -38.14 76.57 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 115.754 -0.657 . . . . 0.0 111.45 -177.252 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -90.16 22.47 26.03 Favored Glycine 0 N--CA 1.453 -0.222 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.327 178.268 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.611 ' HB2' ' HB2' ' A' ' 25' ' ' PRO . 21.3 tptt -133.1 0.81 3.47 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 178.136 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.63 -33.96 74.84 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.501 -0.772 . . . . 0.0 111.857 -174.468 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -59.04 -22.08 54.44 Favored Glycine 0 CA--C 1.519 0.33 0 C-N-CA 121.14 -0.552 . . . . 0.0 113.037 -179.397 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.493 ' HB3' HG22 ' A' ' 86' ' ' ILE . 94.2 mt -87.99 -43.19 11.92 Favored 'General case' 0 C--N 1.326 -0.447 0 O-C-N 122.576 -0.367 . . . . 0.0 110.951 -179.887 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.482 HG11 HG21 ' A' ' 24' ' ' ILE . 1.2 p -66.8 -29.97 48.11 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.416 0 CA-C-O 121.199 0.523 . . . . 0.0 110.656 -178.899 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 63.2 mt -81.36 -43.77 20.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-O 121.692 0.758 . . . . 0.0 109.108 173.372 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 34' ' ' GLY . . . . . 0.542 ' HA3' ' HB ' ' A' ' 39' ' ' THR . . . 116.46 163.43 13.36 Favored Glycine 0 N--CA 1.438 -1.201 0 CA-C-N 115.344 -0.844 . . . . 0.0 112.54 174.805 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.519 ' N ' ' HD3' ' A' ' 35' ' ' LYS . 0.0 OUTLIER -78.64 57.59 2.07 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.305 0.574 . . . . 0.0 110.263 -178.656 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 134.24 14.72 1.21 Allowed Glycine 0 N--CA 1.447 -0.585 0 CA-C-N 115.358 -0.837 . . . . 0.0 111.619 -179.44 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 71.36 6.35 61.47 Favored Glycine 0 C--N 1.333 0.409 0 C-N-CA 121.25 -0.5 . . . . 0.0 112.355 -178.193 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 55.3 mm-40 -84.12 -22.67 31.0 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 120.961 0.41 . . . . 0.0 111.073 -178.511 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 39' ' ' THR . . . . . 0.681 ' O ' ' HG ' ' A' ' 43' ' ' LEU . 57.9 m -70.97 -51.68 24.24 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.3 178.282 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.576 ' HA ' HD12 ' A' ' 43' ' ' LEU . 7.8 tt -58.74 -33.7 49.86 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.385 0 CA-C-O 121.312 0.577 . . . . 0.0 110.568 177.808 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 40.0 ttmt -63.66 -37.96 89.32 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.349 177.332 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 42' ' ' GLN . . . . . 0.609 ' O ' ' HG2' ' A' ' 46' ' ' ARG . 45.7 mt-30 -79.63 -42.03 25.73 Favored 'General case' 0 C--O 1.222 -0.359 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.498 -178.982 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.681 ' HG ' ' O ' ' A' ' 39' ' ' THR . 70.5 mt -49.0 -45.41 42.37 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-O 120.912 0.387 . . . . 0.0 111.789 -176.073 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 45.9 mt-30 -62.4 -44.71 95.79 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.651 179.161 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -68.66 -42.4 77.95 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.095 -179.264 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 46' ' ' ARG . . . . . 0.609 ' HG2' ' O ' ' A' ' 42' ' ' GLN . 15.4 mmt180 -52.31 -44.62 65.17 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.805 -175.553 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -102.64 -9.98 19.63 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.618 -175.424 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 71.09 39.86 62.51 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.73 -0.747 . . . . 0.0 111.291 -175.09 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 27.3 m -122.77 178.95 2.8 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-O 120.891 0.377 . . . . 0.0 110.476 -175.534 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 50' ' ' LYS . . . . . 0.452 ' C ' ' HD3' ' A' ' 50' ' ' LYS . 1.1 tmtp? -116.74 124.41 49.58 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 175.17 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 51' ' ' MET . . . . . 0.568 ' CE ' ' HB1' ' A' ' 79' ' ' ALA . 64.3 mtt -117.37 121.99 42.61 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.482 -0.327 . . . . 0.0 110.43 178.406 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.748 HG22 ' HB2' ' A' ' 68' ' ' ARG . 0.0 OUTLIER -110.44 116.57 52.72 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 CA-C-O 121.648 0.737 . . . . 0.0 109.21 176.146 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.635 HD22 HD13 ' A' ' 67' ' ' LEU . 2.8 mm? -95.7 105.72 17.75 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.388 -0.823 . . . . 0.0 110.339 179.499 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.769 HD12 ' HB2' ' A' ' 66' ' ' PRO . 60.1 mt -75.59 96.26 1.18 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 121.332 0.587 . . . . 0.0 110.223 179.867 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 57.7 mt-30 . . . . . 0 C--N 1.324 -0.509 0 CA-C-N 115.658 -0.701 . . . . 0.0 109.792 -179.83 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.465 ' HB3' ' HB3' ' A' ' 23' ' ' MET . 23.2 m-20 . . . . . 0 N--CA 1.456 -0.155 0 N-CA-C 110.036 -0.357 . . . . 0.0 110.036 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 65' ' ' LYS . . . . . 0.714 ' HB2' ' HB ' ' A' ' 24' ' ' ILE . 70.6 mmtt -89.43 120.82 69.68 Favored Pre-proline 0 C--N 1.32 -0.686 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.882 -171.097 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.769 ' HB2' HD12 ' A' ' 54' ' ' ILE . 28.5 Cg_exo -66.35 104.68 0.78 Allowed 'Trans proline' 0 N--CA 1.462 -0.377 0 C-N-CA 122.928 2.419 . . . . 0.0 112.124 175.001 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.635 HD13 HD22 ' A' ' 53' ' ' LEU . 14.5 tp -103.21 118.13 36.09 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.906 -0.588 . . . . 0.0 109.946 176.057 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 68' ' ' ARG . . . . . 0.748 ' HB2' HG22 ' A' ' 52' ' ' ILE . 95.5 mtt180 -98.19 110.85 23.36 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 116.556 -0.293 . . . . 0.0 110.897 177.015 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 4.2 mp -96.47 104.73 16.2 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 171.598 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.941 HD12 ' HB ' ' A' ' 19' ' ' VAL . 3.6 mm -100.85 134.82 39.62 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 N-CA-C 109.914 -0.402 . . . . 0.0 109.914 -178.229 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 71' ' ' GLY . . . . . 0.417 ' O ' ' HB ' ' A' ' 18' ' ' THR . . . 164.44 -142.14 7.57 Favored Glycine 0 N--CA 1.447 -0.626 0 C-N-CA 121.054 -0.593 . . . . 0.0 111.625 178.568 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 72' ' ' ASP . . . . . 0.556 ' OD2' ' HB3' ' A' ' 74' ' ' TYR . 8.8 t70 -93.83 140.92 23.15 Favored Pre-proline 0 C--N 1.318 -0.79 0 CA-C-O 118.35 -0.833 . . . . 0.0 109.122 179.686 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 73' ' ' PRO . . . . . 0.452 ' HA ' HG21 ' A' ' 18' ' ' THR . 84.0 Cg_exo -41.78 -41.1 5.98 Favored 'Trans proline' 0 C--N 1.346 0.433 0 C-N-CA 122.757 2.305 . . . . 0.0 113.066 -177.806 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 74' ' ' TYR . . . . . 0.556 ' HB3' ' OD2' ' A' ' 72' ' ' ASP . 69.2 t80 -63.48 -58.68 6.25 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.296 -178.74 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.495 ' HG2' ' HB3' ' A' ' 72' ' ' ASP . 38.0 pttt -71.91 -27.87 63.11 Favored 'General case' 0 CA--C 1.518 -0.268 0 C-N-CA 120.446 -0.501 . . . . 0.0 111.557 -178.019 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 55.3 t -63.7 -39.67 86.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 N-CA-C 109.53 -0.545 . . . . 0.0 109.53 176.832 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 22.7 tp60 -75.85 -44.95 38.33 Favored 'General case' 0 N--CA 1.445 -0.698 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.79 -179.717 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 78' ' ' GLN . . . . . 0.409 ' HA ' ' HG2' ' A' ' 81' ' ' GLU . 55.5 mt-30 -64.82 -35.78 82.22 Favored 'General case' 0 C--N 1.33 -0.271 0 C-N-CA 120.469 -0.493 . . . . 0.0 110.926 -179.921 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 79' ' ' ALA . . . . . 0.568 ' HB1' ' CE ' ' A' ' 51' ' ' MET . . . -71.38 -34.71 70.68 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 120.93 0.395 . . . . 0.0 110.09 176.222 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 36.7 t -65.22 -47.87 75.35 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.253 178.023 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 81' ' ' GLU . . . . . 0.409 ' HG2' ' HA ' ' A' ' 78' ' ' GLN . 10.5 pt-20 -69.72 -22.37 63.4 Favored 'General case' 0 C--N 1.322 -0.601 0 C-N-CA 120.684 -0.406 . . . . 0.0 110.14 178.861 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 82' ' ' MET . . . . . 0.475 ' O ' ' HB3' ' A' ' 85' ' ' ASP . 57.4 ttp -73.74 -46.28 46.88 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.664 176.338 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.542 ' O ' ' HG ' ' A' ' 87' ' ' LEU . 33.2 m -72.03 -36.56 57.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 C-N-CA 120.662 -0.415 . . . . 0.0 110.665 178.905 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 84' ' ' MET . . . . . 0.404 ' O ' ' HG2' ' A' ' 88' ' ' ARG . 54.1 mtt -65.0 -32.08 73.63 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 109.975 -0.379 . . . . 0.0 109.975 175.146 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 85' ' ' ASP . . . . . 0.475 ' HB3' ' O ' ' A' ' 82' ' ' MET . 18.8 t70 -58.23 -48.79 79.27 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.648 176.315 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.493 HG22 ' HB3' ' A' ' 31' ' ' LEU . 34.8 mt -60.63 -29.7 45.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 121.271 0.558 . . . . 0.0 110.536 179.562 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.542 ' HG ' ' O ' ' A' ' 83' ' ' VAL . 62.0 mt -92.06 -1.71 57.06 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.661 -0.699 . . . . 0.0 111.927 -174.755 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 88' ' ' ARG . . . . . 0.404 ' HG2' ' O ' ' A' ' 84' ' ' MET . 19.2 ptp180 -129.83 16.49 5.78 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.059 0.457 . . . . 0.0 111.141 -179.929 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 10.5 tt0 . . . . . 0 C--O 1.249 1.059 0 CA-C-O 118.186 -0.912 . . . . 0.0 109.86 179.218 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 32.8 m . . . . . 0 N--CA 1.448 -0.536 0 N-CA-C 109.991 -0.374 . . . . 0.0 109.991 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.518 ' HA ' ' O ' ' A' ' 69' ' ' ILE . 7.5 p -141.8 136.27 30.54 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.405 -176.183 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 20' ' ' GLN . . . . . 0.524 ' O ' ' HA ' ' A' ' 68' ' ' ARG . 37.5 mt-30 -112.84 158.69 19.84 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.194 -0.457 . . . . 0.0 109.802 171.962 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.626 ' HG2' ' HG2' ' A' ' 68' ' ' ARG . 51.9 mt-10 -125.28 113.57 17.79 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.932 0.396 . . . . 0.0 109.968 178.683 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 9.6 mm -104.69 137.8 32.24 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.375 -178.195 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -86.07 91.52 8.43 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 172.362 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.838 HG23 HD21 ' A' ' 87' ' ' LEU . 33.1 mm -79.86 126.35 80.23 Favored Pre-proline 0 C--N 1.319 -0.76 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.791 -177.546 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 25' ' ' PRO . . . . . 0.775 ' HB2' ' HB2' ' A' ' 28' ' ' LYS . 72.7 Cg_exo -51.99 135.86 51.8 Favored 'Trans proline' 0 N--CA 1.461 -0.392 0 C-N-CA 122.675 2.25 . . . . 0.0 111.416 175.459 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -57.93 -33.36 68.72 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.661 -0.7 . . . . 0.0 112.626 -172.865 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -82.74 -29.36 35.54 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.495 -0.86 . . . . 0.0 111.688 177.375 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.775 ' HB2' ' HB2' ' A' ' 25' ' ' PRO . 11.7 mptt -79.68 -8.23 59.09 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.981 0.42 . . . . 0.0 110.736 179.802 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.436 ' HB2' ' HG3' ' A' ' 65' ' ' LYS . . . -61.54 -26.63 68.06 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.501 176.832 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -68.93 -17.68 71.82 Favored Glycine 0 N--CA 1.449 -0.499 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.331 177.673 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.432 ' HB3' HG22 ' A' ' 86' ' ' ILE . 84.8 mt -88.86 -37.93 14.96 Favored 'General case' 0 C--N 1.326 -0.427 0 O-C-N 122.677 -0.308 . . . . 0.0 110.902 -179.701 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.557 HG13 HD11 ' A' ' 87' ' ' LEU . 0.5 OUTLIER -71.69 -33.78 49.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 120.792 0.33 . . . . 0.0 110.683 176.392 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.601 ' HA ' ' HB ' ' A' ' 40' ' ' ILE . 83.7 mt -77.64 -40.98 28.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-O 121.601 0.715 . . . . 0.0 109.479 174.191 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 34' ' ' GLY . . . . . 0.552 ' HA3' ' HB ' ' A' ' 39' ' ' THR . . . 104.3 177.2 25.27 Favored Glycine 0 N--CA 1.442 -0.927 0 CA-C-N 115.514 -0.766 . . . . 0.0 112.467 175.893 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 30.1 mmmt -76.71 62.56 2.01 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.088 0.47 . . . . 0.0 110.419 -178.457 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 118.07 19.68 4.68 Favored Glycine 0 N--CA 1.448 -0.54 0 C-N-CA 120.972 -0.633 . . . . 0.0 112.005 178.492 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.401 ' HA2' HG22 ' A' ' 33' ' ' ILE . . . 82.5 3.78 90.39 Favored Glycine 0 N--CA 1.449 -0.479 0 C-N-CA 120.875 -0.679 . . . . 0.0 112.521 179.081 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.638 ' HA ' ' HD3' ' A' ' 41' ' ' LYS . 20.8 tp10 -78.21 -37.66 44.95 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 120.79 0.328 . . . . 0.0 110.975 -177.874 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 39' ' ' THR . . . . . 0.603 ' O ' ' HG ' ' A' ' 43' ' ' LEU . 28.8 m -67.43 -40.23 85.48 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.648 -0.251 . . . . 0.0 111.492 -177.176 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.601 ' HB ' ' HA ' ' A' ' 33' ' ' ILE . 14.5 tt -63.8 -28.88 45.89 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.411 0 CA-C-O 121.172 0.511 . . . . 0.0 110.778 179.601 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 41' ' ' LYS . . . . . 0.638 ' HD3' ' HA ' ' A' ' 38' ' ' GLU . 52.1 mtpt -66.46 -40.59 89.46 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.195 0.522 . . . . 0.0 109.852 174.606 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 27.5 mt-30 -70.76 -42.42 70.47 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.269 -0.878 . . . . 0.0 110.674 -176.693 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.603 ' HG ' ' O ' ' A' ' 39' ' ' THR . 81.8 mt -56.83 -47.06 81.18 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.589 -176.864 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 49.9 mt-30 -61.47 -53.5 55.7 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.431 -176.975 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -68.16 -39.65 82.56 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 112.033 0.383 . . . . 0.0 112.033 -175.591 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 46' ' ' ARG . . . . . 0.472 ' HD3' ' SD ' ' A' ' 82' ' ' MET . 12.3 ptm180 -70.01 -31.17 68.7 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.936 0.398 . . . . 0.0 111.214 -174.78 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.535 ' HB3' HG22 ' A' ' 49' ' ' VAL . . . -93.27 -15.95 25.28 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.367 -177.111 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 73.49 25.45 72.56 Favored Glycine 0 N--CA 1.45 -0.401 0 CA-C-N 115.947 -0.57 . . . . 0.0 111.953 -178.729 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.535 HG22 ' HB3' ' A' ' 47' ' ' ALA . 35.1 m -123.93 173.88 9.06 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-O 120.843 0.354 . . . . 0.0 110.066 -177.399 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 50' ' ' LYS . . . . . 0.502 ' HE2' HD12 ' A' ' 70' ' ' ILE . 2.2 tmmm? -109.97 123.33 49.45 Favored 'General case' 0 C--N 1.318 -0.762 0 N-CA-C 108.679 -0.86 . . . . 0.0 108.679 174.753 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 51' ' ' MET . . . . . 0.532 ' CE ' ' HB1' ' A' ' 79' ' ' ALA . 63.5 mtt -114.43 116.42 28.86 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.195 -179.671 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.512 ' CG2' ' HB2' ' A' ' 68' ' ' ARG . 9.9 tt -106.57 105.16 18.23 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.83 0 CA-C-O 121.484 0.659 . . . . 0.0 110.11 176.14 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.581 HD22 HD13 ' A' ' 67' ' ' LEU . 3.5 mm? -82.24 102.58 11.24 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 108.963 -0.754 . . . . 0.0 108.963 173.723 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.701 HD12 ' HB2' ' A' ' 66' ' ' PRO . 53.5 mt -79.25 86.92 1.23 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-O 121.433 0.635 . . . . 0.0 110.166 -176.372 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 55' ' ' GLN . . . . . 0.432 HE22 ' HB1' ' A' ' 29' ' ' ALA . 10.5 mm100 . . . . . 0 C--N 1.326 -0.418 0 CA-C-N 115.355 -0.839 . . . . 0.0 109.516 -179.814 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 49.7 m-20 . . . . . 0 N--CA 1.444 -0.734 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 65' ' ' LYS . . . . . 0.754 ' HB2' ' HB ' ' A' ' 24' ' ' ILE . 66.9 mmtt -141.6 116.73 7.03 Favored Pre-proline 0 C--N 1.314 -0.937 0 CA-C-N 116.708 -0.224 . . . . 0.0 110.632 -176.784 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.701 ' HB2' HD12 ' A' ' 54' ' ' ILE . 25.1 Cg_exo -64.42 124.19 12.94 Favored 'Trans proline' 0 N--CA 1.461 -0.431 0 C-N-CA 122.82 2.347 . . . . 0.0 111.863 176.308 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.581 HD13 HD22 ' A' ' 53' ' ' LEU . 33.7 tp -124.1 106.84 10.67 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.954 -0.567 . . . . 0.0 109.839 177.793 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 68' ' ' ARG . . . . . 0.626 ' HG2' ' HG2' ' A' ' 21' ' ' GLU . 87.4 mtt180 -96.98 105.59 17.77 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.139 177.711 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.518 ' O ' ' HA ' ' A' ' 19' ' ' VAL . 4.4 mp -87.96 104.49 14.55 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 174.449 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.502 HD12 ' HE2' ' A' ' 50' ' ' LYS . 13.8 mt -104.34 126.93 59.01 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.026 -173.491 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 167.82 -142.52 7.55 Favored Glycine 0 N--CA 1.446 -0.648 0 N-CA-C 111.596 -0.602 . . . . 0.0 111.596 178.65 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 72' ' ' ASP . . . . . 0.477 ' HB2' ' HG2' ' A' ' 75' ' ' LYS . 15.1 m-20 -91.33 149.12 39.1 Favored Pre-proline 0 C--N 1.325 -0.489 0 CA-C-O 118.963 -0.541 . . . . 0.0 109.692 175.859 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 77.5 Cg_exo -49.36 -39.53 43.94 Favored 'Trans proline' 0 C--N 1.343 0.285 0 C-N-CA 122.333 2.022 . . . . 0.0 112.31 -176.948 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 76.0 t80 -64.36 -56.32 15.2 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.262 -176.995 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.477 ' HG2' ' HB2' ' A' ' 72' ' ' ASP . 4.9 ptpt -68.06 -31.97 71.99 Favored 'General case' 0 C--O 1.223 -0.301 0 C-N-CA 120.671 -0.412 . . . . 0.0 111.296 179.41 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.406 HG23 ' O ' ' A' ' 72' ' ' ASP . 53.1 t -65.18 -40.09 87.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.998 0.427 . . . . 0.0 110.012 178.163 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 77' ' ' GLN . . . . . 0.47 ' O ' ' HG2' ' A' ' 81' ' ' GLU . 19.4 tp60 -64.81 -51.88 59.81 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.032 176.707 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 25.1 mt-30 -62.97 -35.14 79.17 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 121.0 0.428 . . . . 0.0 110.853 -178.202 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 79' ' ' ALA . . . . . 0.532 ' HB1' ' CE ' ' A' ' 51' ' ' MET . . . -72.1 -35.31 69.15 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.999 179.812 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 80' ' ' CYS . . . . . 0.4 ' HA ' HG22 ' A' ' 83' ' ' VAL . 52.7 t -72.29 -45.56 59.52 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.144 -179.457 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 81' ' ' GLU . . . . . 0.47 ' HG2' ' O ' ' A' ' 77' ' ' GLN . 10.2 pt-20 -66.83 -22.62 65.99 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.101 0.477 . . . . 0.0 110.024 177.834 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 82' ' ' MET . . . . . 0.472 ' SD ' ' HD3' ' A' ' 46' ' ' ARG . 42.8 ttp -71.5 -55.41 7.91 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.54 -0.755 . . . . 0.0 110.423 175.822 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.451 HG12 HD13 ' A' ' 43' ' ' LEU . 31.3 m -66.95 -34.97 73.44 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.169 0 C-N-CA 121.116 -0.234 . . . . 0.0 110.985 -179.455 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 66.6 mmm -62.17 -37.45 85.28 Favored 'General case' 0 CA--C 1.519 -0.229 0 CA-C-O 120.685 0.279 . . . . 0.0 110.505 176.391 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 85' ' ' ASP . . . . . 0.465 ' O ' ' HB2' ' A' ' 89' ' ' GLU . 36.5 t70 -65.8 -44.52 85.43 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.918 -179.781 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.432 HG22 ' HB3' ' A' ' 31' ' ' LEU . 57.8 mt -60.01 -31.25 47.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 121.148 0.499 . . . . 0.0 110.768 179.822 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.838 HD21 HG23 ' A' ' 24' ' ' ILE . 7.1 mp -81.48 -31.79 32.79 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.815 -0.629 . . . . 0.0 112.268 -177.176 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 15.3 ptm180 -95.88 -5.79 40.74 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.134 0.492 . . . . 0.0 111.132 -176.768 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 89' ' ' GLU . . . . . 0.465 ' HB2' ' O ' ' A' ' 85' ' ' ASP . 4.7 mm-40 . . . . . 0 C--O 1.251 1.137 0 CA-C-O 118.438 -0.791 . . . . 0.0 110.031 178.473 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 94.3 m . . . . . 0 N--CA 1.45 -0.435 0 CA-C-O 120.669 0.271 . . . . 0.0 110.62 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.653 ' HA ' ' O ' ' A' ' 69' ' ' ILE . 6.2 p -129.72 124.32 58.89 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-O 121.13 0.49 . . . . 0.0 110.801 178.073 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 28.6 mt-30 -110.29 114.6 28.2 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.055 -0.52 . . . . 0.0 109.887 174.663 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.659 ' HA ' ' O ' ' A' ' 67' ' ' LEU . 43.4 mt-10 -90.37 116.04 28.02 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.086 0.469 . . . . 0.0 110.535 176.106 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 22.0 mm -103.69 137.42 32.33 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.767 0 CA-C-N 115.687 -0.688 . . . . 0.0 109.839 -179.561 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 23' ' ' MET . . . . . 0.449 ' HB3' ' HB3' ' A' ' 64' ' ' ASP . 3.1 mmt -89.13 94.27 9.87 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 176.593 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.864 HG23 HD13 ' A' ' 87' ' ' LEU . 27.2 mm -77.66 129.19 77.52 Favored Pre-proline 0 C--N 1.318 -0.801 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.027 -175.06 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 25' ' ' PRO . . . . . 0.537 ' HB2' ' HB2' ' A' ' 28' ' ' LYS . 53.8 Cg_exo -52.93 125.43 18.22 Favored 'Trans proline' 0 N--CA 1.458 -0.596 0 C-N-CA 122.188 1.925 . . . . 0.0 110.685 172.01 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -57.63 -27.87 63.18 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 112.097 0.406 . . . . 0.0 112.097 -174.057 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -80.21 -30.66 40.94 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.511 177.306 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.545 ' HB3' HD22 ' A' ' 87' ' ' LEU . 21.2 mmtp -89.42 -4.41 58.02 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.727 0.299 . . . . 0.0 111.234 -177.966 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.411 ' O ' HG23 ' A' ' 32' ' ' VAL . . . -57.44 -28.89 63.73 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.707 -178.173 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -62.28 -26.32 67.7 Favored Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 120.925 -0.655 . . . . 0.0 112.856 -179.81 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 69.6 mt -78.73 -39.84 35.18 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.883 0.341 . . . . 0.0 111.398 -178.173 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.552 HG21 HG21 ' A' ' 24' ' ' ILE . 0.0 OUTLIER -65.74 -38.06 81.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 121.19 0.519 . . . . 0.0 110.106 179.177 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 49.9 mt -72.61 -42.67 62.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-O 121.546 0.689 . . . . 0.0 109.499 175.838 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 100.57 39.61 3.16 Favored Glycine 0 CA--C 1.499 -0.938 0 CA-C-N 115.17 -0.923 . . . . 0.0 112.685 176.708 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 3.7 mppt? 53.0 36.9 23.28 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.079 -0.561 . . . . 0.0 111.45 179.265 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 159.04 -48.95 0.41 Allowed Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.54 -0.838 . . . . 0.0 112.145 -179.195 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 145.31 -6.68 1.52 Allowed Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.24 -0.981 . . . . 0.0 113.476 179.866 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 43.9 mm-40 -65.64 -40.76 92.86 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 117.006 0.403 . . . . 0.0 112.012 -179.014 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 39' ' ' THR . . . . . 0.729 ' O ' ' HG ' ' A' ' 43' ' ' LEU . 91.6 m -62.39 -54.64 37.41 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.876 -0.147 . . . . 0.0 111.278 -178.105 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.593 ' HA ' HD12 ' A' ' 43' ' ' LEU . 5.3 tt -58.34 -30.96 41.57 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.365 0 CA-C-O 121.219 0.533 . . . . 0.0 111.157 -179.346 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 41' ' ' LYS . . . . . 0.459 ' HE2' ' HB3' ' A' ' 41' ' ' LYS . 4.9 tmmm? -70.33 -41.72 72.86 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.932 -0.576 . . . . 0.0 109.819 177.842 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 15.4 mm-40 -69.37 -38.18 77.92 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.956 -179.492 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.729 ' HG ' ' O ' ' A' ' 39' ' ' THR . 73.7 mt -56.42 -43.9 79.83 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.826 -0.624 . . . . 0.0 111.215 -177.755 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 46.7 mt-30 -67.08 -31.25 71.61 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.376 -177.432 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -80.14 -43.01 22.38 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.892 0.377 . . . . 0.0 111.162 -178.833 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 13.5 ptm180 -75.52 -36.51 60.49 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.952 -0.567 . . . . 0.0 112.45 -173.352 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.452 ' HB3' HG22 ' A' ' 49' ' ' VAL . . . -95.89 -17.21 21.27 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.861 0.362 . . . . 0.0 111.33 -178.247 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 79.41 3.17 88.58 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.879 -0.677 . . . . 0.0 112.208 -179.785 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.452 HG22 ' HB3' ' A' ' 47' ' ' ALA . 34.3 m -97.3 166.02 1.98 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-O 120.637 0.256 . . . . 0.0 110.379 -177.769 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 63.9 tttp -105.21 122.84 46.75 Favored 'General case' 0 C--N 1.316 -0.858 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 172.843 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 51' ' ' MET . . . . . 0.592 ' HE3' HG21 ' A' ' 83' ' ' VAL . 77.1 mtp -119.07 115.92 25.31 Favored 'General case' 0 C--N 1.316 -0.854 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 178.263 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.565 ' CG2' ' HB2' ' A' ' 68' ' ' ARG . 8.7 tt -105.4 105.4 18.59 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.937 0 CA-C-O 121.588 0.709 . . . . 0.0 110.734 179.826 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.708 HD22 HD13 ' A' ' 67' ' ' LEU . 3.7 mm? -78.57 103.15 8.32 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 173.042 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.845 HD12 ' HB2' ' A' ' 66' ' ' PRO . 56.7 mt -73.33 89.11 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-O 121.518 0.675 . . . . 0.0 110.462 -178.091 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 19.6 mt-30 . . . . . 0 C--N 1.325 -0.47 0 CA-C-N 115.03 -0.986 . . . . 0.0 110.339 -178.519 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.449 ' HB3' ' HB3' ' A' ' 23' ' ' MET . 7.1 m-20 . . . . . 0 N--CA 1.455 -0.179 0 N-CA-C 109.593 -0.521 . . . . 0.0 109.593 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 65' ' ' LYS . . . . . 0.719 ' HB2' ' HB ' ' A' ' 24' ' ' ILE . 70.4 mmtt -84.02 129.12 59.98 Favored Pre-proline 0 C--N 1.318 -0.795 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.46 -165.243 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.845 ' HB2' HD12 ' A' ' 54' ' ' ILE . 17.3 Cg_exo -68.83 105.83 1.39 Allowed 'Trans proline' 0 N--CA 1.46 -0.492 0 C-N-CA 123.054 2.502 . . . . 0.0 111.413 174.522 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.708 HD13 HD22 ' A' ' 53' ' ' LEU . 31.6 tp -115.7 104.21 11.45 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.46 -0.336 . . . . 0.0 110.619 179.455 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 68' ' ' ARG . . . . . 0.565 ' HB2' ' CG2' ' A' ' 52' ' ' ILE . 92.6 mtt180 -91.65 108.23 19.76 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.881 0.372 . . . . 0.0 110.131 176.882 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.653 ' O ' ' HA ' ' A' ' 19' ' ' VAL . 22.1 mt -94.9 104.38 15.74 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 174.681 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 3.7 mt -110.85 127.54 67.86 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.847 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.19 -173.95 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 173.48 -147.17 9.34 Favored Glycine 0 N--CA 1.448 -0.565 0 C-N-CA 120.508 -0.853 . . . . 0.0 112.073 178.104 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 72' ' ' ASP . . . . . 0.539 ' O ' HG23 ' A' ' 76' ' ' VAL . 41.2 m-20 -84.12 140.1 39.65 Favored Pre-proline 0 C--N 1.323 -0.565 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 177.405 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 76.5 Cg_exo -41.41 -53.4 3.18 Favored 'Trans proline' 0 CA--C 1.534 0.478 0 C-N-CA 123.746 2.964 . . . . 0.0 115.291 -169.443 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 35.8 p90 -76.31 -33.09 59.05 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 112.74 0.644 . . . . 0.0 112.74 -172.227 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.504 ' HG2' ' HB2' ' A' ' 72' ' ' ASP . 6.1 ptpp? -72.49 -30.11 64.23 Favored 'General case' 0 CA--C 1.514 -0.412 0 C-N-CA 119.788 -0.765 . . . . 0.0 110.238 177.038 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.539 HG23 ' O ' ' A' ' 72' ' ' ASP . 92.3 t -63.08 -40.82 90.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 N-CA-C 109.427 -0.583 . . . . 0.0 109.427 177.035 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 3.5 tp60 -72.65 -46.56 53.36 Favored 'General case' 0 N--CA 1.447 -0.579 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.903 178.049 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 76.0 mt-30 -61.29 -40.18 93.17 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 120.79 -0.364 . . . . 0.0 111.052 179.637 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -71.67 -32.95 68.43 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.482 177.695 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 5.6 t -61.2 -57.12 13.76 Favored 'General case' 0 CA--C 1.515 -0.393 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.188 177.262 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 17.4 mm-40 -62.29 -29.51 70.48 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.723 -179.162 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 82' ' ' MET . . . . . 0.493 ' O ' HG13 ' A' ' 86' ' ' ILE . 43.6 ttp -63.27 -50.06 71.61 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.398 178.771 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.629 ' O ' ' HG ' ' A' ' 87' ' ' LEU . 30.5 m -83.77 -36.44 12.31 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-N 116.6 -0.273 . . . . 0.0 111.283 -177.147 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 27.4 ttt -65.3 -36.32 83.71 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.407 -179.849 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 85' ' ' ASP . . . . . 0.447 ' O ' ' HB2' ' A' ' 89' ' ' GLU . 35.0 t70 -62.54 -42.27 99.42 Favored 'General case' 0 C--O 1.223 -0.34 0 CA-C-N 116.595 -0.275 . . . . 0.0 110.466 178.502 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.493 HG13 ' O ' ' A' ' 82' ' ' MET . 52.8 mt -61.41 -31.29 50.03 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-O 121.446 0.641 . . . . 0.0 110.619 179.112 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.864 HD13 HG23 ' A' ' 24' ' ' ILE . 43.4 mt -88.71 -33.45 17.52 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.128 -176.225 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 17.7 tpt180 -77.33 -14.09 59.8 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.808 0.813 . . . . 0.0 109.504 177.309 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 89' ' ' GLU . . . . . 0.447 ' HB2' ' O ' ' A' ' 85' ' ' ASP . 6.4 tp10 . . . . . 0 C--O 1.25 1.093 0 CA-C-N 114.5 -1.227 . . . . 0.0 109.42 179.215 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.545 HG21 ' HA ' ' A' ' 73' ' ' PRO . 84.3 m . . . . . 0 C--O 1.235 0.312 0 CA-C-O 121.149 0.5 . . . . 0.0 111.201 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.655 ' HA ' ' O ' ' A' ' 69' ' ' ILE . 7.1 p -140.76 129.27 24.46 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-N 115.382 -0.826 . . . . 0.0 110.011 177.617 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 80.5 mt-30 -108.43 122.86 47.9 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 121.063 0.459 . . . . 0.0 111.115 176.348 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.645 ' HA ' ' O ' ' A' ' 67' ' ' LEU . 44.1 mt-10 -95.63 117.43 30.44 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.252 -0.885 . . . . 0.0 110.145 177.35 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.771 HG12 HD12 ' A' ' 67' ' ' LEU . 25.5 mm -111.48 147.6 15.31 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.768 0 CA-C-N 116.0 -0.545 . . . . 0.0 109.815 -178.911 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 23' ' ' MET . . . . . 0.589 ' HB3' ' HB3' ' A' ' 64' ' ' ASP . 3.3 mmt -100.8 98.16 8.71 Favored 'General case' 0 N--CA 1.446 -0.656 0 N-CA-C 108.796 -0.816 . . . . 0.0 108.796 176.924 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.772 ' HB ' ' HB2' ' A' ' 65' ' ' LYS . 23.6 mm -80.18 128.68 72.51 Favored Pre-proline 0 C--N 1.32 -0.699 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.032 -173.433 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 25' ' ' PRO . . . . . 0.625 ' HD2' HD13 ' A' ' 87' ' ' LEU . 52.7 Cg_exo -51.86 125.59 17.54 Favored 'Trans proline' 0 N--CA 1.462 -0.375 0 C-N-CA 122.882 2.388 . . . . 0.0 111.942 176.734 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -47.8 -53.02 16.71 Favored 'General case' 0 C--O 1.237 0.414 0 N-CA-C 112.998 0.74 . . . . 0.0 112.998 -169.571 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -80.54 -26.46 54.26 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.844 -0.693 . . . . 0.0 113.128 -174.891 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 43.2 tttp -89.95 3.1 54.13 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.051 0.453 . . . . 0.0 110.73 -177.185 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.555 ' O ' HG12 ' A' ' 32' ' ' VAL . . . -65.53 -22.81 66.75 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.808 177.98 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -55.45 -38.42 69.89 Favored Glycine 0 N--CA 1.449 -0.447 0 C-N-CA 120.888 -0.672 . . . . 0.0 111.928 176.739 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.584 ' HB3' HG22 ' A' ' 86' ' ' ILE . 31.9 mt -71.34 -37.87 71.67 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 111.595 0.22 . . . . 0.0 111.595 -179.101 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.555 HG12 ' O ' ' A' ' 29' ' ' ALA . 0.3 OUTLIER -67.32 -25.92 34.78 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.352 0 CA-C-O 121.353 0.597 . . . . 0.0 110.358 -179.133 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.453 ' HA ' ' HB ' ' A' ' 40' ' ' ILE . 56.1 mt -84.71 -39.6 14.45 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-N 115.385 -0.825 . . . . 0.0 109.504 174.59 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 34' ' ' GLY . . . . . 0.423 ' HA3' ' HB ' ' A' ' 39' ' ' THR . . . 125.95 -145.62 15.81 Favored Glycine 0 N--CA 1.445 -0.719 0 CA-C-N 115.72 -0.673 . . . . 0.0 113.11 174.435 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 74.9 mmtt -100.69 -29.18 12.44 Favored 'General case' 0 C--N 1.319 -0.753 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 179.005 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -152.6 31.61 0.84 Allowed Glycine 0 N--CA 1.45 -0.429 0 CA-C-N 115.534 -0.757 . . . . 0.0 111.727 177.409 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.401 ' HA2' HG22 ' A' ' 33' ' ' ILE . . . 79.87 0.16 84.28 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 121.106 -0.569 . . . . 0.0 112.339 -178.933 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -78.52 -28.45 46.2 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 120.932 0.396 . . . . 0.0 111.106 -179.291 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 39' ' ' THR . . . . . 0.661 ' O ' ' HG ' ' A' ' 43' ' ' LEU . 35.2 m -71.67 -51.71 21.66 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.817 -177.571 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.656 ' HA ' HD12 ' A' ' 43' ' ' LEU . 6.6 tt -58.41 -36.73 60.09 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.285 0 CA-C-O 121.091 0.472 . . . . 0.0 111.186 179.499 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 62.7 tttp -62.07 -40.05 94.51 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.813 -0.631 . . . . 0.0 110.039 178.101 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 41.8 mt-30 -75.96 -38.01 58.0 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.579 -0.737 . . . . 0.0 111.269 -179.269 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.661 ' HG ' ' O ' ' A' ' 39' ' ' THR . 80.8 mt -53.17 -40.49 64.4 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-O 120.897 0.38 . . . . 0.0 111.432 -178.078 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 68.9 mt-30 -59.85 -42.62 94.03 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.289 178.494 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -81.02 -29.34 35.14 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.99 -178.137 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 13.8 mmm180 -52.1 -45.32 64.83 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.736 177.618 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.525 ' HB3' HG22 ' A' ' 49' ' ' VAL . . . -102.42 -11.49 18.56 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.72 -0.673 . . . . 0.0 111.429 -178.198 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 75.3 30.17 59.09 Favored Glycine 0 CA--C 1.52 0.365 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.04 -177.255 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.525 HG22 ' HB3' ' A' ' 47' ' ' ALA . 20.0 m -120.09 177.34 3.08 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-O 120.846 0.355 . . . . 0.0 110.504 -177.638 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 64.5 tttp -105.46 122.28 45.67 Favored 'General case' 0 C--N 1.318 -0.797 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 172.115 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 51' ' ' MET . . . . . 0.658 ' HE2' HG12 ' A' ' 69' ' ' ILE . 36.1 mtp -117.31 115.18 24.76 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 178.833 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.47 ' CG2' ' HB2' ' A' ' 68' ' ' ARG . 10.4 tt -110.76 110.82 33.59 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.798 0 CA-C-O 121.452 0.644 . . . . 0.0 110.901 -178.697 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.613 ' HB3' HE21 ' A' ' 55' ' ' GLN . 3.7 mm? -93.97 103.84 15.91 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.27 -0.877 . . . . 0.0 109.474 175.279 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.618 HD12 ' HB2' ' A' ' 66' ' ' PRO . 68.3 mt -75.33 87.52 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-O 121.613 0.72 . . . . 0.0 110.216 -178.818 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 55' ' ' GLN . . . . . 0.613 HE21 ' HB3' ' A' ' 53' ' ' LEU . 72.5 mm-40 . . . . . 0 C--N 1.322 -0.622 0 CA-C-N 115.02 -0.991 . . . . 0.0 109.34 179.705 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.589 ' HB3' ' HB3' ' A' ' 23' ' ' MET . 3.4 m-20 . . . . . 0 C--O 1.226 -0.181 0 N-CA-C 110.116 -0.327 . . . . 0.0 110.116 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 65' ' ' LYS . . . . . 0.772 ' HB2' ' HB ' ' A' ' 24' ' ' ILE . 34.5 mmtp -82.34 136.19 46.41 Favored Pre-proline 0 C--N 1.321 -0.673 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.393 -168.438 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.618 ' HB2' HD12 ' A' ' 54' ' ' ILE . 10.5 Cg_exo -71.8 110.44 2.9 Favored 'Trans proline' 0 N--CA 1.458 -0.588 0 C-N-CA 123.137 2.558 . . . . 0.0 111.305 175.953 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.862 HD11 HG13 ' A' ' 69' ' ' ILE . 1.6 tm? -114.65 141.1 48.24 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 115.827 -0.624 . . . . 0.0 109.453 179.023 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 68' ' ' ARG . . . . . 0.575 ' HG2' ' HG2' ' A' ' 21' ' ' GLU . 95.1 mtt180 -134.76 124.04 24.55 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.185 0.517 . . . . 0.0 111.465 168.607 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.862 HG13 HD11 ' A' ' 67' ' ' LEU . 20.9 mt -102.95 104.62 16.86 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-N 115.206 -0.906 . . . . 0.0 109.279 173.445 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 11.8 mt -103.37 125.57 57.87 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.891 0 CA-C-N 116.484 -0.325 . . . . 0.0 110.246 -175.174 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 169.19 -123.21 1.06 Allowed Glycine 0 N--CA 1.447 -0.617 0 C-N-CA 120.505 -0.855 . . . . 0.0 112.934 178.349 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 72' ' ' ASP . . . . . 0.401 ' HB3' ' HG2' ' A' ' 75' ' ' LYS . 11.1 t70 -115.26 139.11 24.07 Favored Pre-proline 0 C--N 1.324 -0.516 0 CA-C-O 118.759 -0.639 . . . . 0.0 109.995 -176.421 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 73' ' ' PRO . . . . . 0.545 ' HA ' HG21 ' A' ' 18' ' ' THR . 84.3 Cg_exo -40.47 -43.73 4.2 Favored 'Trans proline' 0 C--N 1.347 0.477 0 C-N-CA 123.406 2.737 . . . . 0.0 112.832 -176.264 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 78.8 t80 -60.61 -60.92 3.04 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.147 -0.933 . . . . 0.0 111.334 -178.626 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.401 ' HG2' ' HB3' ' A' ' 72' ' ' ASP . 25.5 pttt -76.54 -24.05 53.64 Favored 'General case' 0 CA--C 1.517 -0.314 0 N-CA-C 112.131 0.419 . . . . 0.0 112.131 -176.187 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 48.8 t -66.79 -39.89 84.67 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 N-CA-C 109.079 -0.711 . . . . 0.0 109.079 176.865 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 77' ' ' GLN . . . . . 0.47 ' O ' ' HG2' ' A' ' 81' ' ' GLU . 20.9 tp60 -74.0 -42.64 60.09 Favored 'General case' 0 N--CA 1.445 -0.706 0 CA-C-N 115.523 -0.762 . . . . 0.0 110.502 179.744 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 91.6 mt-30 -60.91 -43.83 98.0 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.848 0.356 . . . . 0.0 110.609 177.732 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -64.95 -38.78 92.09 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.692 178.171 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 44.3 t -62.44 -54.8 34.86 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.733 -0.667 . . . . 0.0 111.471 178.243 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 81' ' ' GLU . . . . . 0.47 ' HG2' ' O ' ' A' ' 77' ' ' GLN . 12.2 pt-20 -68.53 -19.59 64.51 Favored 'General case' 0 C--N 1.324 -0.511 0 C-N-CA 120.481 -0.488 . . . . 0.0 110.468 -178.468 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 82' ' ' MET . . . . . 0.484 ' O ' ' HB3' ' A' ' 85' ' ' ASP . 52.3 ttp -72.97 -46.46 52.22 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.85 175.768 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.596 HG12 HD13 ' A' ' 43' ' ' LEU . 29.9 m -80.18 -29.41 12.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 C-N-CA 120.812 -0.355 . . . . 0.0 110.869 -179.352 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 12.8 tmm? -65.47 -34.39 78.16 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 174.143 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 85' ' ' ASP . . . . . 0.484 ' HB3' ' O ' ' A' ' 82' ' ' MET . 3.8 t70 -59.31 -42.12 90.64 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.229 -0.896 . . . . 0.0 110.626 174.502 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.584 HG22 ' HB3' ' A' ' 31' ' ' LEU . 30.1 mt -63.82 -34.11 66.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-O 121.359 0.599 . . . . 0.0 110.406 178.694 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.625 HD13 ' HD2' ' A' ' 25' ' ' PRO . 59.6 mt -85.52 -6.31 59.2 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.769 -178.952 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 67.7 ttt180 -102.26 -7.67 21.92 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.723 0.773 . . . . 0.0 109.537 176.479 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 10.8 tp10 . . . . . 0 C--O 1.253 1.242 0 CA-C-N 115.191 -0.913 . . . . 0.0 110.022 -174.451 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 59.5 m . . . . . 0 N--CA 1.451 -0.383 0 CA-C-O 120.736 0.303 . . . . 0.0 110.613 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.461 ' HA ' ' O ' ' A' ' 69' ' ' ILE . 8.5 p -131.75 138.75 52.12 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 CA-C-O 120.91 0.386 . . . . 0.0 110.295 179.192 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 9.2 tt0 -124.24 135.67 53.58 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 109.698 -0.482 . . . . 0.0 109.698 178.607 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.606 ' HG2' ' HG2' ' A' ' 68' ' ' ARG . 51.5 mt-10 -104.28 125.73 50.78 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.309 0.576 . . . . 0.0 112.021 -178.938 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.473 ' HB ' ' HB3' ' A' ' 67' ' ' LEU . 14.2 mm -110.66 146.33 15.93 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 CA-C-N 115.104 -0.953 . . . . 0.0 109.077 174.821 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 8.7 mmt -100.41 93.75 5.81 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 108.584 -0.895 . . . . 0.0 108.584 175.103 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.692 ' HB ' ' HB2' ' A' ' 65' ' ' LYS . 37.0 mm -79.35 126.06 81.97 Favored Pre-proline 0 C--N 1.318 -0.774 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.422 -177.331 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 25' ' ' PRO . . . . . 0.416 ' HB2' ' HB2' ' A' ' 28' ' ' LYS . 71.8 Cg_exo -52.39 134.36 51.46 Favored 'Trans proline' 0 N--CA 1.461 -0.433 0 C-N-CA 122.794 2.329 . . . . 0.0 111.714 175.709 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -58.51 -25.21 62.15 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.998 -177.753 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -89.35 -6.37 71.13 Favored Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.837 -0.697 . . . . 0.0 112.642 178.069 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.556 ' HB3' HD22 ' A' ' 87' ' ' LEU . 51.2 mttp -115.77 10.82 15.48 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.754 0.312 . . . . 0.0 111.366 -179.015 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -68.58 -29.82 68.45 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.205 0.526 . . . . 0.0 110.152 179.307 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -69.9 -17.88 73.85 Favored Glycine 0 N--CA 1.447 -0.584 0 CA-C-N 115.863 -0.608 . . . . 0.0 112.265 176.822 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 84.0 mt -83.13 -43.51 16.14 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.557 0.218 . . . . 0.0 110.706 -179.768 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.657 HG13 HD21 ' A' ' 87' ' ' LEU . 1.6 m -68.86 -33.33 58.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.308 -0.406 . . . . 0.0 111.174 178.697 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.498 ' HA ' ' HB ' ' A' ' 40' ' ' ILE . 88.8 mt -77.83 -40.71 27.48 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-O 121.52 0.676 . . . . 0.0 109.698 175.57 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 103.08 164.51 25.75 Favored Glycine 0 N--CA 1.442 -0.919 0 CA-C-N 115.353 -0.84 . . . . 0.0 111.576 -179.335 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 1.3 mptm? -79.13 54.41 1.63 Allowed 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.189 0.518 . . . . 0.0 110.849 -178.786 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 144.04 21.82 0.17 Allowed Glycine 0 N--CA 1.447 -0.603 0 CA-C-N 115.779 -0.646 . . . . 0.0 111.783 178.759 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 71.79 -0.66 35.12 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 121.028 -0.606 . . . . 0.0 112.358 -178.007 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.509 ' O ' ' HG2' ' A' ' 42' ' ' GLN . 14.2 pt-20 -64.66 -37.81 88.86 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.703 0.287 . . . . 0.0 111.276 -175.573 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 39' ' ' THR . . . . . 0.833 ' O ' ' HG ' ' A' ' 43' ' ' LEU . 56.4 m -69.92 -55.66 9.1 Favored 'General case' 0 N--CA 1.449 -0.482 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.383 -175.086 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.498 ' HB ' ' HA ' ' A' ' 33' ' ' ILE . 12.7 tt -61.91 -25.09 36.26 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-O 121.462 0.649 . . . . 0.0 111.013 -177.48 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 41' ' ' LYS . . . . . 0.406 ' HB3' ' HE2' ' A' ' 41' ' ' LYS . 37.6 ttpt -71.8 -47.49 53.01 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.778 178.863 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 42' ' ' GLN . . . . . 0.509 ' HG2' ' O ' ' A' ' 38' ' ' GLU . 11.3 pt20 -72.32 -41.07 66.97 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.838 -0.619 . . . . 0.0 111.12 -177.259 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.833 ' HG ' ' O ' ' A' ' 39' ' ' THR . 48.6 mt -51.23 -48.44 62.08 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.769 -0.65 . . . . 0.0 111.731 -177.08 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 49.3 mt-30 -58.21 -42.16 85.62 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.27 -178.078 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 -81.33 -35.1 31.36 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.676 -174.308 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 46' ' ' ARG . . . . . 0.406 ' HG2' ' O ' ' A' ' 42' ' ' GLN . 15.0 ptm180 -78.85 -23.45 44.97 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 111.905 0.335 . . . . 0.0 111.905 -175.894 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -94.59 -24.53 17.18 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 120.908 0.385 . . . . 0.0 111.379 179.906 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 81.77 23.64 57.41 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.863 -0.684 . . . . 0.0 112.082 -178.687 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 17.7 m -130.36 178.98 4.62 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-O 120.833 0.349 . . . . 0.0 110.197 -179.083 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 87.2 tttt -109.83 124.63 51.65 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.012 176.177 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 51' ' ' MET . . . . . 0.472 ' HE2' ' HB1' ' A' ' 79' ' ' ALA . 60.5 mtt -113.38 116.01 28.99 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 109.583 -0.525 . . . . 0.0 109.583 178.632 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.475 ' CG2' ' HB2' ' A' ' 68' ' ' ARG . 11.0 tt -110.64 105.83 19.56 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 CA-C-O 121.632 0.729 . . . . 0.0 110.674 178.047 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.523 HD22 HD13 ' A' ' 67' ' ' LEU . 3.8 mm? -86.12 102.8 14.19 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.336 -0.847 . . . . 0.0 109.358 174.978 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.606 HD12 ' HB2' ' A' ' 66' ' ' PRO . 52.3 mt -80.57 86.51 1.47 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.411 0 CA-C-O 121.913 0.863 . . . . 0.0 110.121 179.588 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 55' ' ' GLN . . . . . 0.46 ' HG2' HD11 ' A' ' 33' ' ' ILE . 2.7 pp0? . . . . . 0 C--N 1.317 -0.815 0 CA-C-N 114.607 -1.179 . . . . 0.0 109.52 176.246 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 62.7 m-20 . . . . . 0 N--CA 1.464 0.229 0 CA-C-O 120.957 0.408 . . . . 0.0 110.988 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 65' ' ' LYS . . . . . 0.692 ' HB2' ' HB ' ' A' ' 24' ' ' ILE . 69.8 mmtt -98.81 121.22 56.76 Favored Pre-proline 0 C--N 1.32 -0.677 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.767 -174.273 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.606 ' HB2' HD12 ' A' ' 54' ' ' ILE . 27.1 Cg_exo -64.71 105.29 0.63 Allowed 'Trans proline' 0 N--CA 1.46 -0.473 0 C-N-CA 122.884 2.389 . . . . 0.0 111.746 174.614 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.523 HD13 HD22 ' A' ' 53' ' ' LEU . 25.1 tp -105.2 106.39 16.86 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 109.735 -0.469 . . . . 0.0 109.735 175.85 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 68' ' ' ARG . . . . . 0.606 ' HG2' ' HG2' ' A' ' 21' ' ' GLU . 96.1 mtt180 -101.68 105.88 16.85 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.437 178.35 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.461 ' O ' ' HA ' ' A' ' 19' ' ' VAL . 4.7 mp -86.22 103.99 13.31 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 N-CA-C 108.195 -1.039 . . . . 0.0 108.195 174.142 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 3.7 mt -103.43 112.86 38.51 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.038 -174.506 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -176.16 -128.38 1.12 Allowed Glycine 0 N--CA 1.439 -1.137 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.324 -179.489 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 72' ' ' ASP . . . . . 0.508 ' HB3' ' CG ' ' A' ' 75' ' ' LYS . 3.1 t70 -109.61 143.27 27.5 Favored Pre-proline 0 C--N 1.318 -0.769 0 CA-C-O 118.752 -0.642 . . . . 0.0 110.289 -177.006 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_exo -44.14 -39.94 12.0 Favored 'Trans proline' 0 C--N 1.346 0.443 0 C-N-CA 122.827 2.351 . . . . 0.0 113.262 -175.268 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 93.6 t80 -74.6 -53.71 8.84 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.798 -174.807 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.508 ' CG ' ' HB3' ' A' ' 72' ' ' ASP . 10.4 pttt -75.4 -17.49 60.18 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.531 -0.304 . . . . 0.0 111.79 -179.077 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 24.1 t -70.0 -40.19 78.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 171.855 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 77' ' ' GLN . . . . . 0.489 ' O ' ' HG2' ' A' ' 81' ' ' GLU . 21.2 tp60 -69.45 -46.3 67.05 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.06 178.904 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 86.4 mt-30 -58.89 -39.53 81.72 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.778 176.553 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 79' ' ' ALA . . . . . 0.472 ' HB1' ' HE2' ' A' ' 51' ' ' MET . . . -68.84 -36.8 78.61 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.143 178.781 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 80' ' ' CYS . . . . . 0.4 ' O ' ' HG3' ' A' ' 84' ' ' MET . 38.4 t -65.22 -50.8 64.47 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.921 178.974 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 81' ' ' GLU . . . . . 0.489 ' HG2' ' O ' ' A' ' 77' ' ' GLN . 9.9 pt-20 -69.69 -18.82 63.58 Favored 'General case' 0 C--N 1.324 -0.543 0 C-N-CA 120.513 -0.475 . . . . 0.0 110.2 178.415 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 82' ' ' MET . . . . . 0.6 ' SD ' HD22 ' A' ' 43' ' ' LEU . 36.7 ttm -70.55 -53.43 16.14 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.333 173.86 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.453 ' O ' ' HG ' ' A' ' 87' ' ' LEU . 26.9 m -70.55 -35.74 62.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 C-N-CA 121.048 -0.261 . . . . 0.0 111.399 -178.645 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 84' ' ' MET . . . . . 0.4 ' HG3' ' O ' ' A' ' 80' ' ' CYS . 52.7 mtm -69.64 -26.97 64.67 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.768 0.318 . . . . 0.0 110.177 177.556 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -60.15 -48.38 81.96 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 116.066 -0.515 . . . . 0.0 109.748 175.807 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 48.4 mt -60.49 -34.86 59.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 115.422 -0.808 . . . . 0.0 111.048 179.826 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.657 HD21 HG13 ' A' ' 32' ' ' VAL . 51.3 mt -81.26 -16.12 53.53 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.3 -178.024 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 88' ' ' ARG . . . . . 0.421 HH11 ' HD3' ' A' ' 88' ' ' ARG . 13.7 ttp180 -97.2 -33.84 11.33 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 121.429 0.633 . . . . 0.0 111.074 -177.759 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 12.3 tp10 . . . . . 0 C--N 1.307 -1.257 0 CA-C-N 114.878 -1.055 . . . . 0.0 110.83 -173.437 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.54 ' OG1' ' HG3' ' A' ' 73' ' ' PRO . 80.0 m . . . . . 0 N--CA 1.449 -0.481 0 CA-C-O 121.001 0.429 . . . . 0.0 111.079 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.559 ' HA ' ' O ' ' A' ' 69' ' ' ILE . 4.5 p -137.44 134.92 46.85 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.587 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.208 177.672 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 20' ' ' GLN . . . . . 0.492 ' O ' ' HA ' ' A' ' 68' ' ' ARG . 34.1 mt-30 -121.11 157.84 29.22 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.019 176.142 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.588 ' HG2' ' HG2' ' A' ' 68' ' ' ARG . 40.2 mt-10 -124.16 107.72 11.53 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.024 -176.32 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 5.9 mm -99.01 140.97 17.33 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-N 115.86 -0.609 . . . . 0.0 109.776 -180.0 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 74.1 mmm -102.88 93.9 5.3 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 109.157 -0.683 . . . . 0.0 109.157 177.218 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.72 ' HB ' ' HB2' ' A' ' 65' ' ' LYS . 38.5 mm -81.88 132.59 53.8 Favored Pre-proline 0 C--N 1.321 -0.668 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.235 -174.711 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 75.5 Cg_exo -51.95 134.06 47.79 Favored 'Trans proline' 0 C--N 1.345 0.357 0 C-N-CA 122.959 2.439 . . . . 0.0 111.834 172.558 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -60.02 -33.05 71.48 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.214 179.758 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -68.58 -19.74 73.21 Favored Glycine 0 N--CA 1.449 -0.493 0 C-N-CA 120.892 -0.67 . . . . 0.0 112.578 177.332 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.596 ' HB3' HD22 ' A' ' 87' ' ' LEU . 5.2 mptp? -106.57 12.46 29.42 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.748 0.309 . . . . 0.0 111.004 -179.457 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.64 -31.75 71.86 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.008 0.432 . . . . 0.0 110.602 179.775 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -61.84 -24.24 64.35 Favored Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 120.864 -0.684 . . . . 0.0 112.571 179.564 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 83.7 mt -85.17 -48.52 9.06 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.684 0.242 . . . . 0.0 111.033 -177.99 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.562 HG11 HG13 ' A' ' 24' ' ' ILE . 2.9 m -67.89 -33.65 62.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.814 0.34 . . . . 0.0 111.758 -179.701 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 72.1 mt -80.56 -35.74 15.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 121.915 0.864 . . . . 0.0 109.462 176.321 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 34' ' ' GLY . . . . . 0.522 ' HA3' ' HB ' ' A' ' 39' ' ' THR . . . 94.99 52.07 1.83 Allowed Glycine 0 N--CA 1.439 -1.145 0 CA-C-N 115.208 -0.905 . . . . 0.0 113.808 172.204 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 30.8 mtmt 50.3 41.94 25.07 Favored 'General case' 0 C--N 1.328 -0.342 0 O-C-N 124.162 0.566 . . . . 0.0 112.204 169.659 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 129.03 -17.36 5.68 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.705 -0.76 . . . . 0.0 111.951 -179.36 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 116.18 7.48 14.54 Favored Glycine 0 N--CA 1.447 -0.611 0 C-N-CA 120.654 -0.784 . . . . 0.0 112.19 178.802 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 36.0 mt-10 -76.08 -47.55 24.12 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.786 0.327 . . . . 0.0 110.827 -178.99 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 39' ' ' THR . . . . . 0.644 ' O ' ' HG ' ' A' ' 43' ' ' LEU . 7.2 m -66.08 -44.05 85.56 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.451 -0.34 . . . . 0.0 111.46 -176.791 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.481 ' CD1' HD23 ' A' ' 53' ' ' LEU . 9.7 tt -60.42 -36.01 66.55 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.495 0 CA-C-O 121.032 0.444 . . . . 0.0 110.703 179.908 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 22.5 ttmm -61.13 -41.19 96.27 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.579 0.704 . . . . 0.0 110.134 175.302 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 53.5 mt-30 -74.51 -44.13 52.7 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.179 -0.919 . . . . 0.0 111.258 -177.387 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.644 ' HG ' ' O ' ' A' ' 39' ' ' THR . 94.9 mt -51.94 -49.96 62.12 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.923 -176.372 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 44' ' ' GLN . . . . . 0.433 ' HG3' ' O ' ' A' ' 40' ' ' ILE . 40.5 mt-30 -60.07 -57.49 12.6 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.157 -176.629 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -75.24 -22.11 58.12 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.674 -0.694 . . . . 0.0 112.276 -171.681 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 13.8 ptm180 -77.62 -33.41 53.65 Favored 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 120.304 -0.558 . . . . 0.0 110.727 177.865 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -88.33 -28.81 20.78 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.0 -178.3 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 95.57 21.32 24.48 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.856 -0.687 . . . . 0.0 112.709 -179.366 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 10.4 m -130.07 179.95 3.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-O 120.906 0.384 . . . . 0.0 110.684 -178.836 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 50' ' ' LYS . . . . . 0.679 ' HE3' ' HB ' ' A' ' 52' ' ' ILE . 8.9 tmtm? -111.95 126.09 54.76 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.953 -0.567 . . . . 0.0 109.645 176.7 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 51' ' ' MET . . . . . 0.474 ' CE ' ' HB1' ' A' ' 79' ' ' ALA . 58.6 mtt -113.28 132.33 55.58 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 176.283 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.679 ' HB ' ' HE3' ' A' ' 50' ' ' LYS . 10.9 tt -120.39 113.56 40.73 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.721 0 CA-C-O 121.619 0.723 . . . . 0.0 110.817 175.874 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.75 HD22 HD13 ' A' ' 67' ' ' LEU . 3.6 mm? -88.67 104.19 16.64 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.013 -0.994 . . . . 0.0 109.138 175.45 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.57 ' HB ' ' HB2' ' A' ' 66' ' ' PRO . 52.6 mt -91.13 92.02 3.79 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.19 -176.95 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 11.3 mp0 . . . . . 0 C--N 1.326 -0.423 0 CA-C-O 120.839 0.352 . . . . 0.0 110.772 -178.395 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 40.8 m-20 . . . . . 0 CA--C 1.512 -0.495 0 CA-C-O 121.27 0.557 . . . . 0.0 110.805 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 65' ' ' LYS . . . . . 0.72 ' HB2' ' HB ' ' A' ' 24' ' ' ILE . 69.8 mmtt -121.06 98.34 47.36 Favored Pre-proline 0 C--N 1.316 -0.863 0 CA-C-N 115.395 -0.821 . . . . 0.0 110.188 179.273 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.57 ' HB2' ' HB ' ' A' ' 54' ' ' ILE . 71.5 Cg_exo -54.2 115.64 2.51 Favored 'Trans proline' 0 C--O 1.234 0.305 0 C-N-CA 123.166 2.577 . . . . 0.0 112.31 174.861 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.75 HD13 HD22 ' A' ' 53' ' ' LEU . 31.3 tp -118.77 113.72 21.57 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.28 179.757 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 68' ' ' ARG . . . . . 0.588 ' HG2' ' HG2' ' A' ' 21' ' ' GLU . 98.1 mtt180 -104.25 113.0 26.25 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 121.077 0.465 . . . . 0.0 110.707 175.943 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.559 ' O ' ' HA ' ' A' ' 19' ' ' VAL . 3.9 mp -95.21 109.45 22.43 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 175.085 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 8.1 mt -112.57 129.11 68.74 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 CA-C-N 116.462 -0.335 . . . . 0.0 111.162 -170.812 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 152.98 -127.14 2.13 Favored Glycine 0 N--CA 1.445 -0.746 0 C-N-CA 120.199 -1.0 . . . . 0.0 113.507 173.73 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 72' ' ' ASP . . . . . 0.438 ' HA ' ' HD3' ' A' ' 73' ' ' PRO . 19.7 t70 -85.87 133.27 41.75 Favored Pre-proline 0 C--N 1.322 -0.626 0 C-N-CA 123.19 0.596 . . . . 0.0 111.326 -176.626 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 73' ' ' PRO . . . . . 0.54 ' HG3' ' OG1' ' A' ' 18' ' ' THR . 32.4 Cg_exo -55.52 -28.49 64.83 Favored 'Trans proline' 0 C--N 1.35 0.627 0 C-N-CA 123.8 3.0 . . . . 0.0 113.524 -173.16 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 87.7 t80 -75.58 -54.49 6.92 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.045 0.45 . . . . 0.0 110.128 -177.9 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.406 ' H ' ' HG2' ' A' ' 75' ' ' LYS . 7.6 pttm -79.52 -19.01 50.65 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.221 -0.445 . . . . 0.0 112.062 -178.353 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.409 HG22 HG22 ' A' ' 69' ' ' ILE . 25.2 t -69.43 -38.04 76.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 N-CA-C 109.815 -0.439 . . . . 0.0 109.815 172.895 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -71.51 -48.57 48.1 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 -179.632 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 27.8 mt-30 -59.06 -37.84 77.99 Favored 'General case' 0 C--O 1.22 -0.459 0 CA-C-N 115.784 -0.643 . . . . 0.0 110.583 176.565 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 79' ' ' ALA . . . . . 0.559 ' HB3' HG21 ' A' ' 69' ' ' ILE . . . -64.61 -40.16 95.0 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.049 0.452 . . . . 0.0 110.291 -179.664 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 80' ' ' CYS . . . . . 0.458 ' SG ' HD13 ' A' ' 69' ' ' ILE . 88.6 m -65.72 -49.53 68.15 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.498 -0.774 . . . . 0.0 110.792 179.115 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 81' ' ' GLU . . . . . 0.466 ' O ' ' HB2' ' A' ' 85' ' ' ASP . 3.0 pp20? -72.08 -19.84 61.75 Favored 'General case' 0 C--N 1.326 -0.433 0 C-N-CA 120.075 -0.65 . . . . 0.0 110.902 -179.96 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 82' ' ' MET . . . . . 0.443 ' O ' HG13 ' A' ' 86' ' ' ILE . 40.8 ttp -75.63 -49.2 19.18 Favored 'General case' 0 C--N 1.33 -0.248 0 O-C-N 123.053 0.221 . . . . 0.0 110.597 176.468 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.565 ' O ' ' HG ' ' A' ' 87' ' ' LEU . 35.7 m -67.18 -36.21 76.23 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.175 0 C-N-CA 120.712 -0.395 . . . . 0.0 110.485 178.487 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 91.2 mtp -72.01 -27.85 63.0 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.208 175.636 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 85' ' ' ASP . . . . . 0.466 ' HB2' ' O ' ' A' ' 81' ' ' GLU . 32.6 t70 -64.89 -45.5 85.67 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.171 -0.468 . . . . 0.0 109.855 176.022 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.443 HG13 ' O ' ' A' ' 82' ' ' MET . 70.2 mt -56.62 -37.14 50.95 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.183 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.599 176.882 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.626 HD11 HD12 ' A' ' 24' ' ' ILE . 50.3 mt -75.73 -35.87 60.09 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.757 -0.656 . . . . 0.0 111.435 -177.372 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 88' ' ' ARG . . . . . 0.441 HH11 ' HD2' ' A' ' 88' ' ' ARG . 9.1 ptp85 -79.3 -20.24 48.46 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.25 0.548 . . . . 0.0 110.672 -178.199 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 5.4 tp10 . . . . . 0 C--N 1.312 -1.055 0 CA-C-O 118.327 -0.844 . . . . 0.0 109.979 -173.475 . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.635 HG21 ' HA ' ' A' ' 73' ' ' PRO . 23.9 m . . . . . 0 N--CA 1.453 -0.283 0 CA-C-O 120.813 0.339 . . . . 0.0 111.347 . . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.635 ' HA ' ' O ' ' A' ' 69' ' ' ILE . 7.2 p -141.34 127.99 20.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.907 176.667 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 85.4 mt-30 -109.43 132.35 54.21 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.589 176.483 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.576 ' HA ' ' O ' ' A' ' 67' ' ' LEU . 6.7 mp0 -103.0 118.77 37.55 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.371 177.15 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 11.7 mm -108.92 144.17 17.81 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-N 116.048 -0.523 . . . . 0.0 109.619 178.696 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 9.4 mmt -100.08 91.52 4.81 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 109.699 -0.482 . . . . 0.0 109.699 176.436 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.683 ' HB ' ' HB2' ' A' ' 65' ' ' LYS . 41.3 mm -79.29 126.72 80.88 Favored Pre-proline 0 C--N 1.32 -0.677 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.011 -176.034 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 25' ' ' PRO . . . . . 0.655 ' HB2' ' HD3' ' A' ' 28' ' ' LYS . 65.9 Cg_exo -52.43 147.49 29.29 Favored 'Trans proline' 0 C--N 1.347 0.486 0 C-N-CA 123.166 2.577 . . . . 0.0 112.94 177.445 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -51.48 -55.96 15.97 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 112.232 0.456 . . . . 0.0 112.232 -173.932 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -75.48 -8.96 84.5 Favored Glycine 0 N--CA 1.454 -0.155 0 C-N-CA 121.103 -0.57 . . . . 0.0 112.618 -176.892 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.655 ' HD3' ' HB2' ' A' ' 25' ' ' PRO . 5.1 mptp? -92.78 -3.94 53.89 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.957 0.408 . . . . 0.0 110.815 -179.896 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -62.17 -32.1 72.68 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.489 177.342 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -67.32 -19.26 70.34 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.861 -0.685 . . . . 0.0 112.44 178.932 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 79.0 mt -87.03 -42.96 12.69 Favored 'General case' 0 C--N 1.327 -0.371 0 O-C-N 122.789 -0.242 . . . . 0.0 110.896 -178.898 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 4.1 m -69.9 -35.88 66.72 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.15 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.152 179.164 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.664 ' HA ' ' HB ' ' A' ' 40' ' ' ILE . 88.2 mt -76.95 -38.21 28.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-O 121.459 0.647 . . . . 0.0 109.892 177.939 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 34' ' ' GLY . . . . . 0.523 ' CA ' ' HB ' ' A' ' 39' ' ' THR . . . 124.32 157.05 9.63 Favored Glycine 0 N--CA 1.439 -1.137 0 C-N-CA 120.584 -0.817 . . . . 0.0 112.38 174.532 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 32.2 mmtp -58.65 -31.79 68.48 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 120.836 0.351 . . . . 0.0 110.642 -178.888 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -128.42 14.63 6.14 Favored Glycine 0 N--CA 1.449 -0.452 0 C-N-CA 120.952 -0.642 . . . . 0.0 111.879 175.751 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.553 ' HA2' HG22 ' A' ' 33' ' ' ILE . . . 84.48 1.78 89.17 Favored Glycine 0 C--N 1.332 0.315 0 C-N-CA 121.017 -0.611 . . . . 0.0 112.135 -177.347 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -85.39 -29.67 24.24 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 120.706 0.288 . . . . 0.0 111.385 -178.121 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 39' ' ' THR . . . . . 0.768 ' O ' ' HG ' ' A' ' 43' ' ' LEU . 91.3 m -62.51 -42.0 99.21 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.849 -174.796 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.664 ' HB ' ' HA ' ' A' ' 33' ' ' ILE . 15.6 tt -60.62 -30.17 46.29 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.287 0 CA-C-O 121.105 0.478 . . . . 0.0 111.093 -179.308 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 41' ' ' LYS . . . . . 0.679 ' O ' ' HG2' ' A' ' 45' ' ' GLU . 62.0 tttp -73.19 -44.05 60.43 Favored 'General case' 0 N--CA 1.451 -0.419 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 174.332 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 75.4 mt-30 -58.49 -43.72 89.12 Favored 'General case' 0 CA--C 1.515 -0.401 0 CA-C-N 115.681 -0.69 . . . . 0.0 110.106 -177.167 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.768 ' HG ' ' O ' ' A' ' 39' ' ' THR . 42.1 mt -53.89 -49.66 68.08 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.385 -0.825 . . . . 0.0 110.855 -179.644 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 48.4 mt-30 -64.68 -45.6 85.99 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.411 -0.813 . . . . 0.0 110.985 -179.377 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.679 ' HG2' ' O ' ' A' ' 41' ' ' LYS . 67.7 mm-40 -61.18 -41.91 97.63 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.078 -179.279 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 46' ' ' ARG . . . . . 0.516 ' HD3' ' SD ' ' A' ' 82' ' ' MET . 10.2 ptm180 -81.65 -36.43 28.84 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.767 -0.652 . . . . 0.0 112.651 -170.063 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -90.26 -24.04 21.04 Favored 'General case' 0 C--N 1.324 -0.507 0 C-N-CA 120.498 -0.481 . . . . 0.0 111.187 -178.743 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 87.49 24.0 37.88 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.967 -0.635 . . . . 0.0 112.533 -179.657 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.478 HG13 ' HB2' ' A' ' 75' ' ' LYS . 14.0 m -121.77 179.31 2.42 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-O 120.923 0.392 . . . . 0.0 110.89 -178.002 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 87.3 tttt -117.58 122.41 43.55 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.548 -0.751 . . . . 0.0 109.162 173.708 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 51' ' ' MET . . . . . 0.573 ' HG2' HG23 ' A' ' 69' ' ' ILE . 65.2 mtp -116.9 115.52 25.67 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 -179.008 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.604 ' CG2' ' HB2' ' A' ' 68' ' ' ARG . 6.0 tt -105.61 105.8 19.36 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.782 0 CA-C-O 121.47 0.652 . . . . 0.0 110.984 -178.136 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.802 HD22 HD13 ' A' ' 67' ' ' LEU . 3.4 mm? -83.12 102.17 11.65 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.391 -0.822 . . . . 0.0 109.316 174.008 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.55 ' HB ' ' HB2' ' A' ' 66' ' ' PRO . 64.9 mt -81.65 85.57 1.63 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.432 0 CA-C-O 121.677 0.751 . . . . 0.0 110.333 -177.863 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 55' ' ' GLN . . . . . 0.404 ' HG2' HD11 ' A' ' 33' ' ' ILE . 1.9 pp0? . . . . . 0 C--N 1.316 -0.849 0 CA-C-N 115.068 -0.969 . . . . 0.0 109.279 171.994 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 1.2 p30 . . . . . 0 CA--C 1.52 -0.179 0 CA-C-O 121.319 0.581 . . . . 0.0 111.326 . . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 65' ' ' LYS . . . . . 0.683 ' HB2' ' HB ' ' A' ' 24' ' ' ILE . 31.6 mmtm -129.57 113.44 17.95 Favored Pre-proline 0 C--N 1.315 -0.894 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.696 179.713 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.55 ' HB2' ' HB ' ' A' ' 54' ' ' ILE . 52.6 Cg_exo -58.09 104.56 0.18 Allowed 'Trans proline' 0 N--CA 1.459 -0.512 0 C-N-CA 122.821 2.348 . . . . 0.0 111.632 173.678 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.802 HD13 HD22 ' A' ' 53' ' ' LEU . 18.9 tp -112.85 106.5 14.83 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.235 177.229 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 68' ' ' ARG . . . . . 0.604 ' HB2' ' CG2' ' A' ' 52' ' ' ILE . 13.1 mtp180 -92.67 117.83 30.39 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 109.476 -0.564 . . . . 0.0 109.476 172.586 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.635 ' O ' ' HA ' ' A' ' 19' ' ' VAL . 28.4 mt -96.94 102.31 13.32 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.089 0 N-CA-C 108.206 -1.035 . . . . 0.0 108.206 171.631 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 5.2 mt -103.4 119.39 51.88 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.042 -172.229 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 176.36 -137.11 3.49 Favored Glycine 0 N--CA 1.444 -0.817 0 C-N-CA 120.96 -0.638 . . . . 0.0 112.393 178.849 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 72' ' ' ASP . . . . . 0.847 ' HB2' ' HE2' ' A' ' 75' ' ' LYS . 44.9 m-20 -108.12 152.5 41.84 Favored Pre-proline 0 C--N 1.32 -0.713 0 N-CA-C 109.567 -0.531 . . . . 0.0 109.567 179.784 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 73' ' ' PRO . . . . . 0.635 ' HA ' HG21 ' A' ' 18' ' ' THR . 67.2 Cg_exo -48.89 -48.74 17.0 Favored 'Trans proline' 0 C--N 1.347 0.469 0 C-N-CA 123.359 2.706 . . . . 0.0 113.972 -167.106 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 74' ' ' TYR . . . . . 0.519 ' O ' ' HG2' ' A' ' 78' ' ' GLN . 45.1 m-85 -64.75 -51.94 59.66 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.703 -174.494 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.847 ' HE2' ' HB2' ' A' ' 72' ' ' ASP . 22.7 pttt -73.7 -23.82 59.85 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 112.175 0.435 . . . . 0.0 112.175 -176.528 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.419 HG23 ' O ' ' A' ' 72' ' ' ASP . 58.0 t -69.68 -40.92 79.89 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 N-CA-C 109.422 -0.584 . . . . 0.0 109.422 175.39 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 6.2 tp-100 -71.43 -46.27 60.53 Favored 'General case' 0 N--CA 1.445 -0.715 0 CA-C-N 115.494 -0.776 . . . . 0.0 111.313 -177.698 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 78' ' ' GLN . . . . . 0.643 ' HG2' ' HA ' ' A' ' 75' ' ' LYS . 3.3 pt20 -64.09 -38.56 91.51 Favored 'General case' 0 CA--C 1.508 -0.643 0 CA-C-O 121.489 0.661 . . . . 0.0 110.225 -179.676 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 79' ' ' ALA . . . . . 0.445 ' HA ' ' HE2' ' A' ' 82' ' ' MET . . . -63.34 -39.76 95.42 Favored 'General case' 0 C--N 1.313 -1.016 0 CA-C-N 114.556 -1.202 . . . . 0.0 110.384 176.863 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 52.0 t -64.62 -49.47 70.95 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.447 175.893 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -56.0 -38.98 71.22 Favored 'General case' 0 CA--C 1.518 -0.286 0 CA-C-O 121.205 0.526 . . . . 0.0 110.054 176.244 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 82' ' ' MET . . . . . 0.516 ' SD ' ' HD3' ' A' ' 46' ' ' ARG . 37.5 ttp -63.43 -54.23 39.88 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 114.77 -1.105 . . . . 0.0 111.555 -178.719 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.477 ' O ' ' HG ' ' A' ' 87' ' ' LEU . 35.4 m -70.74 -37.86 70.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 C-N-CA 120.897 -0.321 . . . . 0.0 111.47 -177.225 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 88.9 mmm -66.38 -33.46 75.76 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.724 0.297 . . . . 0.0 110.34 177.339 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -62.37 -39.07 91.97 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.518 177.171 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.506 HG13 ' O ' ' A' ' 82' ' ' MET . 52.6 mt -66.4 -29.49 46.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.834 179.684 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.561 HD22 ' HB3' ' A' ' 28' ' ' LYS . 61.2 mt -85.1 -23.5 28.46 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.668 -176.231 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 15.7 ptm180 -99.64 -3.14 33.78 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 120.998 0.428 . . . . 0.0 111.192 -175.58 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 12.5 tp10 . . . . . 0 C--O 1.247 0.967 0 CA-C-N 115.661 -0.699 . . . . 0.0 109.892 -174.863 . . . . . . . . 0 0 . 1 . 022 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.502 ' OG1' ' HG3' ' A' ' 73' ' ' PRO . 56.5 m . . . . . 0 N--CA 1.453 -0.306 0 CA-C-O 120.875 0.369 . . . . 0.0 110.683 . . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.461 ' HA ' ' O ' ' A' ' 69' ' ' ILE . 4.0 p -135.97 134.26 50.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.811 179.205 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 26.2 mt-30 -110.57 126.92 54.94 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 109.885 -0.413 . . . . 0.0 109.885 174.135 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.624 ' HG2' ' HG2' ' A' ' 68' ' ' ARG . 26.0 mt-10 -101.23 122.17 43.18 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.957 -179.072 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 7.0 mm -114.02 155.95 15.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 115.828 -0.624 . . . . 0.0 109.891 -178.047 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 23' ' ' MET . . . . . 0.479 ' HB3' ' HB3' ' A' ' 64' ' ' ASP . 85.2 mmm -112.41 97.54 6.68 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 108.27 -1.011 . . . . 0.0 108.27 173.158 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.607 HG21 HG21 ' A' ' 32' ' ' VAL . 40.2 mm -83.89 126.97 69.13 Favored Pre-proline 0 C--N 1.319 -0.757 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.689 -172.575 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_exo -49.1 130.46 24.11 Favored 'Trans proline' 0 C--N 1.345 0.348 0 C-N-CA 123.071 2.514 . . . . 0.0 112.169 176.938 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -55.02 -29.9 58.37 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.605 -0.725 . . . . 0.0 112.657 -174.112 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -87.45 -31.68 15.63 Favored Glycine 0 N--CA 1.446 -0.658 0 C-N-CA 120.347 -0.93 . . . . 0.0 112.739 -178.712 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 4.2 tptm -93.92 -1.54 54.56 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 122.609 -0.347 . . . . 0.0 110.873 -175.002 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -65.57 -21.42 66.59 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.279 -179.143 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -60.18 -37.17 92.5 Favored Glycine 0 N--CA 1.448 -0.561 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.354 179.819 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 92.4 mt -75.29 -27.44 59.34 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.701 0.286 . . . . 0.0 111.371 -174.922 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.703 HG13 ' HB ' ' A' ' 83' ' ' VAL . 1.4 t -69.38 -36.57 72.56 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.365 0 CA-C-O 121.586 0.708 . . . . 0.0 110.222 179.285 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.548 HG12 ' HG ' ' A' ' 53' ' ' LEU . 34.8 mt -86.19 -40.68 14.57 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-N 115.116 -0.947 . . . . 0.0 110.28 -178.302 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 124.88 -170.83 16.87 Favored Glycine 0 N--CA 1.442 -0.933 0 CA-C-N 115.58 -0.736 . . . . 0.0 111.565 179.801 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 33.7 mmtp -82.45 -27.63 31.77 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-O 121.128 0.49 . . . . 0.0 109.711 179.866 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -145.01 12.02 1.87 Allowed Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.861 -0.685 . . . . 0.0 112.367 178.658 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 96.07 16.64 37.56 Favored Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.789 -0.719 . . . . 0.0 111.974 179.542 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -85.13 -37.15 20.56 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 120.635 0.255 . . . . 0.0 110.398 178.84 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 39' ' ' THR . . . . . 0.83 ' O ' ' HG ' ' A' ' 43' ' ' LEU . 26.5 m -60.41 -55.83 28.85 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.928 -179.22 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.523 ' HB ' ' HA ' ' A' ' 33' ' ' ILE . 7.9 tt -55.34 -24.65 15.85 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-O 121.064 0.459 . . . . 0.0 111.781 -178.753 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 25.3 ttmm -79.41 -46.73 16.99 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.589 179.91 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 42' ' ' GLN . . . . . 0.432 ' O ' ' HG2' ' A' ' 46' ' ' ARG . 11.5 pt20 -69.89 -35.64 74.79 Favored 'General case' 0 CA--C 1.515 -0.387 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.318 -177.259 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.83 ' HG ' ' O ' ' A' ' 39' ' ' THR . 77.0 mt -53.11 -45.75 68.43 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.589 -0.732 . . . . 0.0 111.256 -178.576 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 49.2 mt-30 -67.44 -33.54 75.36 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.747 -0.661 . . . . 0.0 111.037 -178.968 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 31.8 mm-40 -72.94 -32.06 65.01 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.147 -178.064 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 46' ' ' ARG . . . . . 0.432 ' HG2' ' O ' ' A' ' 42' ' ' GLN . 14.9 ptp180 -92.27 -42.19 9.98 Favored 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 112.143 0.423 . . . . 0.0 112.143 -175.882 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.474 ' O ' ' HD3' ' A' ' 75' ' ' LYS . . . -74.9 -31.67 61.63 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.767 0.318 . . . . 0.0 111.072 -177.724 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 92.11 -3.95 77.26 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.876 -0.678 . . . . 0.0 112.088 -178.432 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.442 ' CG1' ' HG3' ' A' ' 75' ' ' LYS . 15.5 m -102.55 169.02 1.98 Allowed 'Isoleucine or valine' 0 CA--C 1.512 -0.516 0 CA-C-O 121.221 0.534 . . . . 0.0 111.022 -179.623 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 86.0 tttt -101.26 124.48 47.03 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-N 115.347 -0.842 . . . . 0.0 110.045 176.286 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 51' ' ' MET . . . . . 0.727 ' HE2' ' HB1' ' A' ' 79' ' ' ALA . 58.8 mtt -109.55 114.66 28.47 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 175.919 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.586 ' CG2' ' HB2' ' A' ' 68' ' ' ARG . 10.0 tt -109.63 104.94 17.88 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.994 0 CA-C-O 121.724 0.773 . . . . 0.0 109.988 177.791 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.548 ' HG ' HG12 ' A' ' 33' ' ' ILE . 3.8 mm? -77.98 102.82 7.56 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 114.945 -1.025 . . . . 0.0 108.6 173.166 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.77 ' HB ' ' HG2' ' A' ' 66' ' ' PRO . 51.0 mt -76.04 88.52 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-O 121.777 0.798 . . . . 0.0 109.734 -177.233 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 55' ' ' GLN . . . . . 0.403 ' HG2' ' O ' ' A' ' 53' ' ' LEU . 13.6 mm100 . . . . . 0 C--N 1.323 -0.577 0 CA-C-N 114.845 -1.07 . . . . 0.0 111.427 -171.568 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.479 ' HB3' ' HB3' ' A' ' 23' ' ' MET . 19.1 m-20 . . . . . 0 N--CA 1.456 -0.141 0 CA-C-O 121.144 0.497 . . . . 0.0 110.058 . . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 65' ' ' LYS . . . . . 0.456 ' HB2' ' HB ' ' A' ' 24' ' ' ILE . 12.2 mmmm -90.48 133.62 32.56 Favored Pre-proline 0 C--N 1.323 -0.572 0 CA-C-N 115.385 -0.825 . . . . 0.0 112.738 -168.043 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.77 ' HG2' ' HB ' ' A' ' 54' ' ' ILE . 30.3 Cg_endo -64.62 113.83 2.47 Favored 'Trans proline' 0 CA--C 1.533 0.46 0 C-N-CA 123.465 2.777 . . . . 0.0 111.65 172.539 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.59 ' O ' ' HA ' ' A' ' 21' ' ' GLU . 57.0 tp -123.36 129.35 51.18 Favored 'General case' 0 C--N 1.324 -0.531 0 O-C-N 122.338 -0.226 . . . . 0.0 110.579 179.571 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 68' ' ' ARG . . . . . 0.624 ' HG2' ' HG2' ' A' ' 21' ' ' GLU . 95.7 mtt180 -120.89 114.9 22.24 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.694 0.283 . . . . 0.0 110.984 176.567 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.461 ' O ' ' HA ' ' A' ' 19' ' ' VAL . 4.5 mp -98.24 106.4 18.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 N-CA-C 108.228 -1.027 . . . . 0.0 108.228 171.82 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.437 HG12 ' CG2' ' A' ' 19' ' ' VAL . 15.4 mt -109.85 132.82 57.05 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-N 116.464 -0.334 . . . . 0.0 111.076 -171.98 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 153.91 -132.54 3.6 Favored Glycine 0 N--CA 1.448 -0.51 0 C-N-CA 120.952 -0.642 . . . . 0.0 112.595 176.28 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 72' ' ' ASP . . . . . 0.623 ' OD2' ' HG2' ' A' ' 75' ' ' LYS . 1.1 t70 -81.0 134.56 52.62 Favored Pre-proline 0 C--N 1.324 -0.524 0 C-N-CA 122.692 0.397 . . . . 0.0 110.882 -178.674 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 73' ' ' PRO . . . . . 0.502 ' HG3' ' OG1' ' A' ' 18' ' ' THR . 63.9 Cg_exo -47.96 -34.12 21.92 Favored 'Trans proline' 0 C--N 1.349 0.562 0 C-N-CA 123.878 3.052 . . . . 0.0 113.972 -177.314 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 73.0 m-85 -80.38 -55.81 4.63 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.755 0.312 . . . . 0.0 110.547 -176.123 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.623 ' HG2' ' OD2' ' A' ' 72' ' ' ASP . 0.3 OUTLIER -71.07 -22.75 62.07 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.256 -177.587 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 20.5 t -64.85 -43.05 96.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 N-CA-C 109.713 -0.477 . . . . 0.0 109.713 171.249 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -68.59 -46.86 68.25 Favored 'General case' 0 N--CA 1.448 -0.527 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 177.845 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 28.0 mm-40 -61.57 -40.44 94.76 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.026 -179.309 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 79' ' ' ALA . . . . . 0.727 ' HB1' ' HE2' ' A' ' 51' ' ' MET . . . -67.71 -34.37 76.73 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.017 0.437 . . . . 0.0 110.34 177.546 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 49.2 t -63.01 -48.26 79.54 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.577 -0.738 . . . . 0.0 109.693 175.243 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 75.8 mm-40 -57.82 -44.78 86.62 Favored 'General case' 0 C--O 1.22 -0.479 0 N-CA-C 109.766 -0.457 . . . . 0.0 109.766 174.497 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 82' ' ' MET . . . . . 0.529 ' SD ' HD22 ' A' ' 43' ' ' LEU . 32.5 ttm -52.85 -58.52 6.65 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.385 -0.825 . . . . 0.0 111.267 -179.387 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.703 ' HB ' HG13 ' A' ' 32' ' ' VAL . 35.3 m -73.0 -35.49 48.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.887 -175.813 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 83.5 mtp -77.54 -30.06 52.61 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 120.861 -0.335 . . . . 0.0 111.253 -177.707 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 85' ' ' ASP . . . . . 0.4 ' HA ' ' HG2' ' A' ' 88' ' ' ARG . 33.4 t70 -62.34 -43.52 98.64 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-O 120.911 0.386 . . . . 0.0 110.244 178.835 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 57.9 mt -61.15 -29.18 45.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 115.837 -0.619 . . . . 0.0 110.61 178.32 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.407 HD11 HG22 ' A' ' 32' ' ' VAL . 5.9 mp -84.91 -40.63 16.81 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.498 -0.774 . . . . 0.0 112.208 -176.714 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 88' ' ' ARG . . . . . 0.4 ' HG2' ' HA ' ' A' ' 85' ' ' ASP . 25.5 ptt180 -84.51 -8.12 59.04 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.867 0.365 . . . . 0.0 111.704 -174.207 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 . . . . . 0 C--O 1.249 1.063 0 CA-C-O 118.359 -0.829 . . . . 0.0 109.956 -178.228 . . . . . . . . 0 0 . 1 . 023 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.602 ' OG1' ' HD3' ' A' ' 73' ' ' PRO . 89.0 m . . . . . 0 C--O 1.225 -0.222 0 CA-C-O 120.6 0.238 . . . . 0.0 110.725 . . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.461 ' HA ' ' O ' ' A' ' 69' ' ' ILE . 9.1 p -140.64 140.72 33.36 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-O 120.814 0.34 . . . . 0.0 110.751 -179.783 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 25.7 mt-30 -128.12 138.72 52.64 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 109.642 -0.503 . . . . 0.0 109.642 174.394 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.647 ' HG2' ' HG2' ' A' ' 68' ' ' ARG . 44.8 mt-10 -102.62 116.88 33.48 Favored 'General case' 0 C--N 1.328 -0.368 0 O-C-N 123.315 0.384 . . . . 0.0 110.805 -179.57 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 13.1 mm -100.39 150.31 5.61 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-N 115.918 -0.583 . . . . 0.0 109.639 178.47 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 1.7 mmt -103.16 91.61 4.17 Favored 'General case' 0 C--N 1.317 -0.811 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 175.191 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.672 ' HB ' ' HB2' ' A' ' 65' ' ' LYS . 36.1 mm -77.39 124.1 86.88 Favored Pre-proline 0 C--N 1.323 -0.547 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.765 -176.236 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 25' ' ' PRO . . . . . 0.54 ' HB2' ' HB2' ' A' ' 28' ' ' LYS . 68.4 Cg_exo -51.83 135.41 50.08 Favored 'Trans proline' 0 N--CA 1.461 -0.396 0 C-N-CA 122.898 2.399 . . . . 0.0 111.737 177.717 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -56.25 -35.36 67.32 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 115.649 -0.705 . . . . 0.0 112.371 -175.072 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -80.22 -15.9 77.58 Favored Glycine 0 N--CA 1.452 -0.238 0 C-N-CA 120.519 -0.848 . . . . 0.0 111.875 178.95 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.547 ' HB3' HD22 ' A' ' 87' ' ' LEU . 0.3 OUTLIER -94.89 -4.38 47.02 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.755 0.312 . . . . 0.0 110.591 179.441 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.16 -27.95 68.77 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.424 -178.02 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -65.15 -24.27 70.31 Favored Glycine 0 CA--C 1.519 0.309 0 C-N-CA 120.785 -0.721 . . . . 0.0 112.356 178.253 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 95.1 mt -86.14 -42.66 13.68 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 111.352 0.13 . . . . 0.0 111.352 -176.219 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.844 HG13 HD21 ' A' ' 87' ' ' LEU . 2.7 m -65.19 -34.46 70.71 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.19 0 CA-C-O 120.928 0.394 . . . . 0.0 110.857 178.605 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 66.4 mt -79.89 -45.71 22.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-O 121.469 0.652 . . . . 0.0 109.689 176.241 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 34' ' ' GLY . . . . . 0.495 ' HA3' ' H ' ' A' ' 39' ' ' THR . . . 96.64 60.07 1.0 Allowed Glycine 0 N--CA 1.444 -0.773 0 CA-C-N 115.719 -0.673 . . . . 0.0 113.123 175.514 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.446 ' N ' ' HD3' ' A' ' 35' ' ' LYS . 0.0 OUTLIER 55.32 24.69 6.73 Favored 'General case' 0 N--CA 1.467 0.386 0 C-N-CA 122.949 0.5 . . . . 0.0 112.09 175.093 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 145.36 -52.18 0.59 Allowed Glycine 0 N--CA 1.449 -0.465 0 N-CA-C 111.58 -0.608 . . . . 0.0 111.58 -179.459 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.418 ' O ' ' HB2' ' A' ' 41' ' ' LYS . . . 165.02 24.23 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.429 -0.891 . . . . 0.0 113.694 176.462 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.616 ' O ' ' HG2' ' A' ' 42' ' ' GLN . 40.5 mm-40 -85.03 -43.51 13.88 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 117.344 0.572 . . . . 0.0 110.954 -179.23 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 39' ' ' THR . . . . . 0.717 ' O ' ' HG ' ' A' ' 43' ' ' LEU . 82.2 m -66.51 -53.9 29.83 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.488 -176.865 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.558 HD12 HD23 ' A' ' 53' ' ' LEU . 7.1 tt -56.15 -31.85 32.82 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.419 0 CA-C-O 121.56 0.695 . . . . 0.0 110.472 179.029 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 41' ' ' LYS . . . . . 0.48 ' HB3' ' O ' ' A' ' 38' ' ' GLU . 83.5 tttt -62.47 -43.26 99.25 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.003 -0.999 . . . . 0.0 110.569 177.687 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 42' ' ' GLN . . . . . 0.616 ' HG2' ' O ' ' A' ' 38' ' ' GLU . 61.5 mm-40 -72.66 -43.71 62.82 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.962 -177.84 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.717 ' HG ' ' O ' ' A' ' 39' ' ' THR . 37.5 mt -54.87 -49.77 70.32 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.494 -0.775 . . . . 0.0 111.863 -172.913 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 43.8 mt-30 -59.46 -38.44 80.77 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.835 -0.62 . . . . 0.0 111.222 -177.6 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 9.1 mm-40 -76.74 -42.48 40.99 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.382 -176.67 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 46' ' ' ARG . . . . . 0.432 ' HG2' ' O ' ' A' ' 42' ' ' GLN . 16.2 ptp180 -74.35 -33.73 63.2 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 112.05 0.389 . . . . 0.0 112.05 -174.677 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.536 ' HB3' HG22 ' A' ' 49' ' ' VAL . . . -89.94 -21.1 22.62 Favored 'General case' 0 C--N 1.325 -0.492 0 C-N-CA 120.756 -0.378 . . . . 0.0 111.524 -177.936 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 76.83 28.41 59.03 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.809 -0.71 . . . . 0.0 111.537 -177.733 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.536 HG22 ' HB3' ' A' ' 47' ' ' ALA . 35.9 m -121.49 168.63 13.74 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-O 120.973 0.416 . . . . 0.0 110.654 -176.947 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 50' ' ' LYS . . . . . 0.655 ' HB3' ' HB ' ' A' ' 70' ' ' ILE . 50.7 tptt -101.04 122.56 43.77 Favored 'General case' 0 C--N 1.318 -0.804 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 171.994 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 51' ' ' MET . . . . . 0.545 ' HE3' HG11 ' A' ' 83' ' ' VAL . 77.3 mtp -118.74 114.9 23.4 Favored 'General case' 0 C--N 1.316 -0.869 0 N-CA-C 109.751 -0.462 . . . . 0.0 109.751 177.422 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.565 ' CG2' ' HB2' ' A' ' 68' ' ' ARG . 10.2 tt -106.22 108.47 25.17 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.841 0 CA-C-O 121.376 0.608 . . . . 0.0 109.901 176.84 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.558 HD23 HD12 ' A' ' 40' ' ' ILE . 2.8 mm? -82.24 102.77 11.37 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.669 -0.696 . . . . 0.0 109.278 177.124 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.523 HD12 ' HB2' ' A' ' 66' ' ' PRO . 68.8 mt -82.25 98.14 4.42 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.407 0 CA-C-O 121.514 0.673 . . . . 0.0 109.664 -179.817 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 59.7 mt-30 . . . . . 0 C--N 1.319 -0.745 0 CA-C-N 115.216 -0.902 . . . . 0.0 110.774 -173.09 . . . . . . . . 0 0 . 1 . 023 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 41.1 m-20 . . . . . 0 N--CA 1.446 -0.671 0 N-CA-C 109.737 -0.468 . . . . 0.0 109.737 . . . . . . . . . 0 0 . 1 . 023 nuclear build core ' A' A ' 65' ' ' LYS . . . . . 0.672 ' HB2' ' HB ' ' A' ' 24' ' ' ILE . 59.5 mmtt -137.27 114.35 9.74 Favored Pre-proline 0 C--N 1.315 -0.904 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.568 -173.971 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.523 ' HB2' HD12 ' A' ' 54' ' ' ILE . 48.4 Cg_exo -58.87 116.84 3.54 Favored 'Trans proline' 0 N--CA 1.463 -0.271 0 C-N-CA 123.141 2.56 . . . . 0.0 111.89 175.693 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.547 ' O ' ' HA ' ' A' ' 21' ' ' GLU . 43.2 tp -120.47 114.49 21.86 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.089 179.839 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 68' ' ' ARG . . . . . 0.647 ' HG2' ' HG2' ' A' ' 21' ' ' GLU . 92.9 mtt180 -102.4 107.19 18.1 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 120.843 0.354 . . . . 0.0 110.551 177.79 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.63 ' HB ' HG13 ' A' ' 76' ' ' VAL . 3.9 mp -90.02 104.73 15.47 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 173.489 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.655 ' HB ' ' HB3' ' A' ' 50' ' ' LYS . 3.0 mt -99.03 123.48 51.69 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.767 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.405 -175.529 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 175.15 -114.36 0.49 Allowed Glycine 0 N--CA 1.443 -0.839 0 C-N-CA 121.072 -0.585 . . . . 0.0 112.568 179.841 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -134.7 147.2 62.12 Favored Pre-proline 0 C--N 1.322 -0.593 0 N-CA-C 108.453 -0.943 . . . . 0.0 108.453 -177.219 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 73' ' ' PRO . . . . . 0.602 ' HD3' ' OG1' ' A' ' 18' ' ' THR . 87.4 Cg_exo -44.7 -36.01 9.97 Favored 'Trans proline' 0 C--N 1.352 0.724 0 C-N-CA 122.37 2.047 . . . . 0.0 112.339 -176.586 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 94.8 t80 -64.21 -62.77 1.41 Allowed 'General case' 0 N--CA 1.448 -0.547 0 CA-C-N 115.296 -0.865 . . . . 0.0 111.108 179.629 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 34.9 pttt -74.45 -30.17 61.76 Favored 'General case' 0 C--O 1.223 -0.31 0 N-CA-C 112.036 0.384 . . . . 0.0 112.036 -175.914 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.63 HG13 ' HB ' ' A' ' 69' ' ' ILE . 70.0 t -62.88 -38.22 81.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 N-CA-C 109.928 -0.397 . . . . 0.0 109.928 177.539 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 77' ' ' GLN . . . . . 0.415 ' O ' ' HG2' ' A' ' 81' ' ' GLU . 2.6 mm100 -79.1 -38.12 37.02 Favored 'General case' 0 N--CA 1.451 -0.42 0 C-N-CA 120.733 -0.387 . . . . 0.0 111.366 178.876 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 90.9 mt-30 -62.82 -40.92 98.87 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.971 0.415 . . . . 0.0 110.203 176.447 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -67.96 -37.46 81.59 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.458 177.224 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 43.9 t -65.01 -51.62 60.62 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.302 178.415 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 81' ' ' GLU . . . . . 0.415 ' HG2' ' O ' ' A' ' 77' ' ' GLN . 14.0 pt-20 -66.01 -27.18 67.92 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.02 0.438 . . . . 0.0 109.986 179.6 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 82' ' ' MET . . . . . 0.406 ' O ' HG13 ' A' ' 86' ' ' ILE . 49.5 ttp -67.01 -50.47 62.07 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.801 177.261 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.7 ' O ' ' HG ' ' A' ' 87' ' ' LEU . 33.4 m -76.27 -35.15 27.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 C-N-CA 120.909 -0.316 . . . . 0.0 110.73 -177.235 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 22.0 ttt -63.78 -34.7 78.49 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 109.627 -0.508 . . . . 0.0 109.627 177.58 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 85' ' ' ASP . . . . . 0.404 ' O ' ' HB2' ' A' ' 89' ' ' GLU . 2.7 t70 -59.73 -48.33 82.1 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.254 -0.885 . . . . 0.0 110.618 174.931 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.406 HG13 ' O ' ' A' ' 82' ' ' MET . 57.3 mt -61.73 -38.89 81.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.726 -179.426 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.844 HD21 HG13 ' A' ' 32' ' ' VAL . 52.8 mt -68.11 -43.94 77.28 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.87 -0.604 . . . . 0.0 111.371 -177.341 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 2.8 ptm180 -87.57 4.06 45.16 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.862 0.363 . . . . 0.0 111.043 -175.987 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 89' ' ' GLU . . . . . 0.404 ' HB2' ' O ' ' A' ' 85' ' ' ASP . 7.9 tp10 . . . . . 0 C--O 1.25 1.097 0 CA-C-O 118.466 -0.778 . . . . 0.0 109.457 179.604 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.63 ' OG1' ' HD3' ' A' ' 73' ' ' PRO . 96.7 m . . . . . 0 N--CA 1.453 -0.279 0 N-CA-C 109.647 -0.501 . . . . 0.0 109.647 . . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 92.2 t -138.49 125.8 27.5 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.791 -176.246 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 45.6 mt-30 -113.42 116.07 29.05 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.453 -0.34 . . . . 0.0 110.129 172.992 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.616 ' HA ' ' O ' ' A' ' 67' ' ' LEU . 57.9 mt-10 -86.78 113.91 23.01 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.141 179.428 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 18.6 mm -97.51 151.43 4.29 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-N 115.518 -0.765 . . . . 0.0 108.986 176.527 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 23' ' ' MET . . . . . 0.492 ' HB3' ' HB3' ' A' ' 64' ' ' ASP . 73.7 mmm -104.85 99.2 8.85 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 108.752 -0.832 . . . . 0.0 108.752 176.64 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.665 HD12 HD11 ' A' ' 87' ' ' LEU . 22.9 mm -83.32 123.8 76.63 Favored Pre-proline 0 C--N 1.32 -0.68 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.471 -172.601 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_exo -52.82 130.36 37.07 Favored 'Trans proline' 0 N--CA 1.463 -0.273 0 C-N-CA 122.708 2.272 . . . . 0.0 111.495 176.408 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -57.31 -37.19 72.1 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.681 -0.69 . . . . 0.0 112.435 -173.403 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -80.59 -32.81 32.74 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.536 -0.84 . . . . 0.0 112.316 179.542 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.45 ' HE2' ' O ' ' A' ' 87' ' ' LEU . 49.7 tptt -83.58 -7.27 59.55 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.152 0.501 . . . . 0.0 110.005 -177.544 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.54 ' O ' HG12 ' A' ' 32' ' ' VAL . . . -62.15 -19.29 62.91 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.567 -0.742 . . . . 0.0 111.789 -177.756 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -58.46 -37.01 87.06 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.586 -0.816 . . . . 0.0 111.901 176.757 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 70.0 mt -83.03 -28.92 29.27 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 111.667 0.247 . . . . 0.0 111.667 -178.431 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.54 HG12 ' O ' ' A' ' 29' ' ' ALA . 0.4 OUTLIER -69.37 -28.41 38.21 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.395 0 CA-C-O 121.253 0.549 . . . . 0.0 110.235 178.4 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.558 HG22 ' HA2' ' A' ' 37' ' ' GLY . 69.9 mt -86.18 -48.21 16.0 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.366 0 CA-C-N 115.679 -0.691 . . . . 0.0 109.467 174.871 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 135.77 170.6 12.11 Favored Glycine 0 N--CA 1.439 -1.155 0 C-N-CA 120.277 -0.963 . . . . 0.0 112.99 174.015 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.489 ' H ' ' HE3' ' A' ' 35' ' ' LYS . 0.0 OUTLIER -68.2 -27.2 66.18 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.164 0.506 . . . . 0.0 109.785 179.475 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -141.92 25.75 2.38 Favored Glycine 0 N--CA 1.447 -0.596 0 N-CA-C 111.158 -0.777 . . . . 0.0 111.158 174.472 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.558 ' HA2' HG22 ' A' ' 33' ' ' ILE . . . 77.24 2.83 80.42 Favored Glycine 0 CA--C 1.519 0.302 0 C-N-CA 121.039 -0.601 . . . . 0.0 112.26 -176.559 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -85.75 -28.75 24.38 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 111.759 0.281 . . . . 0.0 111.759 -177.961 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 39' ' ' THR . . . . . 0.723 ' O ' ' HG ' ' A' ' 43' ' ' LEU . 29.5 m -58.76 -47.32 85.09 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.478 -0.328 . . . . 0.0 111.825 -175.935 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.578 ' HA ' HD12 ' A' ' 43' ' ' LEU . 6.3 tt -58.53 -33.02 47.16 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.279 0 CA-C-O 121.075 0.464 . . . . 0.0 111.251 179.4 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 86.8 tttt -71.78 -37.3 70.48 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.168 0.508 . . . . 0.0 109.88 177.868 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 42' ' ' GLN . . . . . 0.691 ' O ' ' HG2' ' A' ' 46' ' ' ARG . 22.2 mt-30 -67.59 -42.03 83.13 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.485 -0.78 . . . . 0.0 110.429 179.999 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.723 ' HG ' ' O ' ' A' ' 39' ' ' THR . 58.6 mt -54.5 -41.0 69.1 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.604 -0.726 . . . . 0.0 111.247 -179.506 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 48.1 mt-30 -66.1 -39.51 90.03 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.514 -0.767 . . . . 0.0 110.807 179.605 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 11.6 mm-40 -67.92 -39.02 83.61 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.601 177.774 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 46' ' ' ARG . . . . . 0.897 ' HA ' ' HE ' ' A' ' 46' ' ' ARG . 0.0 OUTLIER -62.99 -44.82 94.96 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.731 -174.717 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -106.11 -0.54 24.65 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 112.603 0.594 . . . . 0.0 112.603 -171.857 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 65.03 40.6 97.18 Favored Glycine 0 C--N 1.33 0.206 0 C-N-CA 120.63 -0.795 . . . . 0.0 111.656 -177.396 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 23.8 m -126.35 179.38 3.43 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-N 115.446 -0.377 . . . . 0.0 110.413 -175.649 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 87.1 tttt -125.94 126.93 45.17 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 109.558 -0.534 . . . . 0.0 109.558 172.715 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 51' ' ' MET . . . . . 0.556 ' HE2' ' HB1' ' A' ' 79' ' ' ALA . 61.7 mtt -113.79 115.34 27.62 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 109.691 -0.485 . . . . 0.0 109.691 178.581 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.618 ' CG2' ' HB2' ' A' ' 68' ' ' ARG . 10.0 tt -99.59 109.41 24.53 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.752 0 CA-C-O 121.536 0.684 . . . . 0.0 109.646 176.64 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.918 HD22 HD13 ' A' ' 67' ' ' LEU . 0.5 OUTLIER -86.04 102.76 14.11 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.583 -0.735 . . . . 0.0 109.677 179.573 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.739 HD12 ' HB2' ' A' ' 66' ' ' PRO . 67.9 mt -75.13 85.67 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.335 0 CA-C-O 122.019 0.914 . . . . 0.0 108.984 175.837 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 17.6 pt20 . . . . . 0 C--N 1.318 -0.801 0 CA-C-N 114.477 -1.238 . . . . 0.0 109.62 179.917 . . . . . . . . 0 0 . 1 . 024 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.492 ' HB3' ' HB3' ' A' ' 23' ' ' MET . 4.8 m-20 . . . . . 0 N--CA 1.46 0.07 0 N-CA-C 110.046 -0.353 . . . . 0.0 110.046 . . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 65' ' ' LYS . . . . . 0.66 ' HB2' ' HB ' ' A' ' 24' ' ' ILE . 30.9 mmtp -90.8 132.76 33.86 Favored Pre-proline 0 C--N 1.323 -0.576 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.071 -172.32 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.739 ' HB2' HD12 ' A' ' 54' ' ' ILE . 13.5 Cg_exo -72.14 105.78 1.91 Allowed 'Trans proline' 0 N--CA 1.461 -0.395 0 C-N-CA 122.917 2.412 . . . . 0.0 111.491 173.954 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.918 HD13 HD22 ' A' ' 53' ' ' LEU . 23.8 tp -109.22 115.76 30.62 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.42 -0.355 . . . . 0.0 110.526 179.603 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 68' ' ' ARG . . . . . 0.618 ' HB2' ' CG2' ' A' ' 52' ' ' ILE . 95.6 mtt180 -99.81 108.22 20.46 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.885 176.484 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.474 HG21 ' HB3' ' A' ' 79' ' ' ALA . 4.6 mp -86.97 104.92 14.54 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.587 0 N-CA-C 108.164 -1.05 . . . . 0.0 108.164 170.915 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 21.0 mt -97.05 126.22 49.87 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.615 -175.182 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 172.95 -117.21 0.64 Allowed Glycine 0 N--CA 1.447 -0.58 0 C-N-CA 120.758 -0.734 . . . . 0.0 113.027 178.367 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 72' ' ' ASP . . . . . 0.518 ' OD1' ' HD2' ' A' ' 73' ' ' PRO . 8.7 t70 -131.45 146.73 63.23 Favored Pre-proline 0 C--N 1.324 -0.536 0 CA-C-O 118.301 -0.857 . . . . 0.0 108.764 -177.147 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 73' ' ' PRO . . . . . 0.63 ' HD3' ' OG1' ' A' ' 18' ' ' THR . 88.0 Cg_exo -40.95 -40.59 3.78 Favored 'Trans proline' 0 C--N 1.351 0.7 0 C-N-CA 122.943 2.429 . . . . 0.0 112.894 -177.495 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 90.1 t80 -65.28 -62.59 1.44 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.735 -0.666 . . . . 0.0 111.136 -179.269 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.467 ' HG2' ' HB3' ' A' ' 72' ' ' ASP . 40.8 pttt -70.44 -31.22 68.3 Favored 'General case' 0 C--O 1.219 -0.541 0 C-N-CA 120.911 -0.316 . . . . 0.0 111.843 -175.865 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.404 HG13 ' HB ' ' A' ' 69' ' ' ILE . 79.7 t -66.14 -40.72 87.84 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 C-N-CA 120.833 -0.347 . . . . 0.0 110.166 179.365 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 77' ' ' GLN . . . . . 0.413 ' O ' ' HG3' ' A' ' 81' ' ' GLU . 0.0 OUTLIER -73.38 -40.84 64.04 Favored 'General case' 0 N--CA 1.45 -0.452 0 N-CA-C 109.531 -0.544 . . . . 0.0 109.531 -179.224 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 66.7 mt-30 -67.64 -32.36 73.01 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 120.735 -0.386 . . . . 0.0 110.672 178.177 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 79' ' ' ALA . . . . . 0.556 ' HB1' ' HE2' ' A' ' 51' ' ' MET . . . -72.61 -33.88 66.99 Favored 'General case' 0 N--CA 1.446 -0.648 0 CA-C-N 116.136 -0.484 . . . . 0.0 109.876 175.966 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 43.9 t -62.4 -48.58 79.07 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.848 -0.614 . . . . 0.0 109.695 172.669 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 81' ' ' GLU . . . . . 0.451 ' O ' ' HB2' ' A' ' 85' ' ' ASP . 53.6 mt-10 -56.56 -29.46 62.03 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-O 121.178 0.513 . . . . 0.0 110.794 176.376 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 82' ' ' MET . . . . . 0.447 ' HE1' ' HB2' ' A' ' 46' ' ' ARG . 39.3 ttm -74.41 -51.13 15.85 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.316 -0.857 . . . . 0.0 110.667 -178.086 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.648 ' O ' ' HG ' ' A' ' 87' ' ' LEU . 33.7 m -74.93 -38.22 42.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 120.674 0.273 . . . . 0.0 110.635 -176.082 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 84' ' ' MET . . . . . 0.462 ' O ' ' HG2' ' A' ' 88' ' ' ARG . 26.3 ttt -63.96 -34.44 77.99 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.026 179.735 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 85' ' ' ASP . . . . . 0.451 ' HB2' ' O ' ' A' ' 81' ' ' GLU . 14.3 t70 -63.53 -46.49 85.75 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.12 179.218 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.419 HG13 ' O ' ' A' ' 82' ' ' MET . 44.6 mt -64.78 -34.39 69.81 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.577 179.429 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.665 HD11 HD12 ' A' ' 24' ' ' ILE . 53.7 mt -76.76 -14.46 59.93 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.928 0.394 . . . . 0.0 110.981 -178.559 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 88' ' ' ARG . . . . . 0.462 ' HG2' ' O ' ' A' ' 84' ' ' MET . 14.3 mmm180 -109.47 8.55 25.31 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.192 0.52 . . . . 0.0 109.621 175.03 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 10.6 tp10 . . . . . 0 C--O 1.248 0.992 0 CA-C-N 115.197 -0.911 . . . . 0.0 109.267 -179.717 . . . . . . . . 0 0 . 1 . 025 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.534 ' OG1' ' HG3' ' A' ' 73' ' ' PRO . 93.3 m . . . . . 0 N--CA 1.451 -0.382 0 CA-C-O 121.214 0.53 . . . . 0.0 111.83 . . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.606 ' HB ' HG23 ' A' ' 70' ' ' ILE . 2.6 p -134.77 121.0 33.21 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-N 115.347 -0.842 . . . . 0.0 109.753 175.724 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 6.0 tt0 -110.16 137.3 48.1 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 110.286 -0.264 . . . . 0.0 110.286 -177.97 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.646 ' HA ' ' O ' ' A' ' 67' ' ' LEU . 45.0 mt-10 -108.34 127.14 53.61 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.998 0.428 . . . . 0.0 111.389 -178.863 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.449 ' HB ' ' HB3' ' A' ' 67' ' ' LEU . 15.9 mm -115.46 153.91 16.95 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-N 115.945 -0.57 . . . . 0.0 109.898 179.651 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 23' ' ' MET . . . . . 0.47 ' HB3' ' HB3' ' A' ' 64' ' ' ASP . 1.6 mmt -104.97 105.09 14.99 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 109.036 -0.727 . . . . 0.0 109.036 173.371 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.692 ' HB ' ' HB2' ' A' ' 65' ' ' LYS . 36.8 mm -88.72 131.42 41.72 Favored Pre-proline 0 C--N 1.322 -0.628 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.029 -175.762 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 25' ' ' PRO . . . . . 0.685 ' HD2' HD13 ' A' ' 87' ' ' LEU . 91.8 Cg_exo -44.41 137.03 8.33 Favored 'Trans proline' 0 C--N 1.348 0.55 0 C-N-CA 123.57 2.847 . . . . 0.0 113.184 177.457 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -66.52 -27.84 68.08 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.481 -0.782 . . . . 0.0 112.694 -172.489 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -103.48 -26.57 6.82 Favored Glycine 0 N--CA 1.447 -0.598 0 C-N-CA 120.387 -0.911 . . . . 0.0 112.33 -179.147 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.523 ' HB3' ' HB2' ' A' ' 25' ' ' PRO . 15.3 ttpt -94.67 13.26 24.92 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.472 0.654 . . . . 0.0 110.642 -177.488 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.506 ' O ' HG12 ' A' ' 32' ' ' VAL . . . -63.65 -31.07 72.12 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.857 -0.611 . . . . 0.0 110.882 178.181 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -57.06 -26.99 56.74 Favored Glycine 0 CA--C 1.519 0.29 0 CA-C-N 116.173 -0.467 . . . . 0.0 113.211 179.862 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 68.0 mt -78.5 -36.64 44.78 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.913 0.357 . . . . 0.0 110.957 179.542 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.506 HG12 ' O ' ' A' ' 29' ' ' ALA . 0.3 OUTLIER -72.12 -29.92 34.25 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.341 0 CA-C-O 121.19 0.519 . . . . 0.0 110.182 178.343 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 68.1 mt -76.03 -37.39 33.54 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-O 121.925 0.869 . . . . 0.0 109.615 174.109 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 34' ' ' GLY . . . . . 0.549 ' HA3' ' HB ' ' A' ' 39' ' ' THR . . . 98.14 45.38 2.41 Favored Glycine 0 N--CA 1.441 -0.974 0 CA-C-N 115.228 -0.896 . . . . 0.0 112.928 175.515 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 38.3 mtmt 51.72 47.01 25.63 Favored 'General case' 0 C--N 1.328 -0.326 0 O-C-N 124.143 0.555 . . . . 0.0 111.666 172.81 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 132.16 -28.2 3.52 Favored Glycine 0 N--CA 1.448 -0.562 0 C-N-CA 120.668 -0.777 . . . . 0.0 112.173 179.412 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 125.33 4.57 6.95 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.423 -0.894 . . . . 0.0 112.836 178.089 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 32.7 mt-10 -70.06 -48.75 56.54 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.132 0.491 . . . . 0.0 110.5 -179.993 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 39' ' ' THR . . . . . 0.729 ' O ' ' HG ' ' A' ' 43' ' ' LEU . 17.2 m -64.68 -46.04 84.09 Favored 'General case' 0 N--CA 1.45 -0.437 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.261 -177.433 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.628 ' HA ' HD12 ' A' ' 43' ' ' LEU . 8.1 tt -60.3 -35.65 63.69 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.47 0 CA-C-O 121.036 0.446 . . . . 0.0 110.901 179.977 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 54.8 tttm -61.57 -47.29 86.17 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.262 0.553 . . . . 0.0 109.983 175.515 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 16.4 mm-40 -72.39 -33.86 67.49 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.546 -0.752 . . . . 0.0 111.796 -176.561 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.729 ' HG ' ' O ' ' A' ' 39' ' ' THR . 95.0 mt -54.52 -48.07 72.36 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.046 0.45 . . . . 0.0 110.77 179.817 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 44.0 mt-30 -63.27 -46.21 87.86 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.385 -0.825 . . . . 0.0 110.696 -179.828 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -71.12 -36.69 72.23 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.855 -0.611 . . . . 0.0 112.123 -175.51 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 12.4 ptm180 -75.53 -33.08 60.69 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 111.734 0.272 . . . . 0.0 111.734 -175.317 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.439 ' HB3' HG22 ' A' ' 49' ' ' VAL . . . -96.54 -21.07 17.91 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.993 0.425 . . . . 0.0 111.352 -177.305 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 81.13 31.01 35.93 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.928 -0.653 . . . . 0.0 112.0 -178.161 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.439 HG22 ' HB3' ' A' ' 47' ' ' ALA . 28.6 m -122.92 167.49 16.47 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-O 120.834 0.35 . . . . 0.0 110.643 -176.332 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 60.2 tttp -103.38 123.23 46.44 Favored 'General case' 0 N--CA 1.444 -0.758 0 N-CA-C 108.96 -0.756 . . . . 0.0 108.96 172.242 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 51' ' ' MET . . . . . 0.516 ' HE2' HD11 ' A' ' 67' ' ' LEU . 79.7 mtp -120.32 115.52 23.72 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 120.947 0.403 . . . . 0.0 109.989 179.414 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.566 ' CG2' ' HB2' ' A' ' 68' ' ' ARG . 11.2 tt -107.71 112.33 39.67 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.749 0 CA-C-O 121.478 0.656 . . . . 0.0 110.235 177.896 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.494 ' CD2' HD13 ' A' ' 67' ' ' LEU . 3.1 mm? -94.82 114.29 26.15 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.36 -0.836 . . . . 0.0 109.817 176.863 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.534 ' HB ' ' HD2' ' A' ' 66' ' ' PRO . 31.4 mm -75.36 87.78 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 177.311 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 15.8 mt-30 . . . . . 0 C--N 1.323 -0.565 0 CA-C-N 115.226 -0.897 . . . . 0.0 110.311 -174.803 . . . . . . . . 0 0 . 1 . 025 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.47 ' HB3' ' HB3' ' A' ' 23' ' ' MET . 5.2 m-20 . . . . . 0 C--O 1.232 0.164 0 CA-C-O 121.196 0.522 . . . . 0.0 111.291 . . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 65' ' ' LYS . . . . . 0.692 ' HB2' ' HB ' ' A' ' 24' ' ' ILE . 70.9 mmtt -101.5 127.1 32.33 Favored Pre-proline 0 C--N 1.324 -0.54 0 CA-C-N 115.804 -0.635 . . . . 0.0 111.056 -175.615 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.534 ' HD2' ' HB ' ' A' ' 54' ' ' ILE . 27.4 Cg_exo -65.41 111.68 1.91 Allowed 'Trans proline' 0 N--CA 1.463 -0.315 0 C-N-CA 123.009 2.472 . . . . 0.0 111.596 172.596 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.646 ' O ' ' HA ' ' A' ' 21' ' ' GLU . 14.3 tp -112.44 122.35 47.45 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 116.155 -0.475 . . . . 0.0 109.97 178.093 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 68' ' ' ARG . . . . . 0.566 ' HB2' ' CG2' ' A' ' 52' ' ' ILE . 88.0 mtt180 -113.84 112.39 23.3 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 121.19 0.519 . . . . 0.0 111.192 177.727 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.405 ' O ' ' HA ' ' A' ' 19' ' ' VAL . 4.5 mp -94.16 105.13 16.54 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 172.449 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.606 HG23 ' HB ' ' A' ' 19' ' ' VAL . 4.0 mt -109.77 132.32 58.31 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 CA-C-N 116.385 -0.371 . . . . 0.0 110.907 -172.394 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 152.52 -123.16 1.41 Allowed Glycine 0 N--CA 1.445 -0.747 0 C-N-CA 120.509 -0.853 . . . . 0.0 113.235 175.618 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 72' ' ' ASP . . . . . 0.616 ' OD2' ' HG2' ' A' ' 75' ' ' LYS . 0.5 OUTLIER -92.69 133.47 29.31 Favored Pre-proline 0 C--N 1.326 -0.447 0 C-N-CA 122.864 0.466 . . . . 0.0 110.948 -177.215 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 73' ' ' PRO . . . . . 0.534 ' HG3' ' OG1' ' A' ' 18' ' ' THR . 50.4 Cg_exo -49.43 -33.41 29.64 Favored 'Trans proline' 0 C--N 1.351 0.664 0 C-N-CA 124.267 3.311 . . . . 0.0 113.592 -176.236 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 74' ' ' TYR . . . . . 0.496 ' O ' ' HG3' ' A' ' 78' ' ' GLN . 19.1 t80 -72.71 -57.08 4.38 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.341 -178.27 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.616 ' HG2' ' OD2' ' A' ' 72' ' ' ASP . 4.6 ptpp? -72.5 -25.83 61.55 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 111.746 0.276 . . . . 0.0 111.746 -178.439 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.415 HG23 ' O ' ' A' ' 72' ' ' ASP . 26.4 t -55.94 -42.26 70.65 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 N-CA-C 109.925 -0.398 . . . . 0.0 109.925 171.424 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 77' ' ' GLN . . . . . 0.574 ' O ' ' HG2' ' A' ' 81' ' ' GLU . 2.3 mm100 -75.74 -44.28 42.59 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.056 178.789 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 78' ' ' GLN . . . . . 0.496 ' HG3' ' O ' ' A' ' 74' ' ' TYR . 53.6 mt-30 -52.87 -50.06 64.58 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.065 0.459 . . . . 0.0 110.419 177.697 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -67.43 -37.78 83.54 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.411 -0.813 . . . . 0.0 111.271 -178.315 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 42.7 t -62.55 -57.27 11.74 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.556 -178.9 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 81' ' ' GLU . . . . . 0.574 ' HG2' ' O ' ' A' ' 77' ' ' GLN . 10.4 pt-20 -67.68 -18.7 65.02 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.912 0.387 . . . . 0.0 110.645 -178.928 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 57.0 ttp -74.09 -50.99 17.11 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.584 174.804 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 31.8 m -76.52 -33.87 23.43 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.583 -0.281 . . . . 0.0 111.618 -176.4 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 83.5 mtp -68.37 -25.67 65.19 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 109.911 -0.403 . . . . 0.0 109.911 175.83 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -67.69 -36.25 80.32 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.655 176.364 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 56.7 mt -62.78 -35.49 71.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 121.488 0.661 . . . . 0.0 110.043 179.022 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.685 HD13 ' HD2' ' A' ' 25' ' ' PRO . 42.8 mt -88.09 -8.46 55.47 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.654 -179.381 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 21.5 tpt180 -101.76 -10.54 19.85 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.839 0.828 . . . . 0.0 109.818 -179.638 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 . . . . . 0 C--O 1.248 1.021 0 CA-C-N 114.685 -1.143 . . . . 0.0 109.779 -177.316 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.445 -0.763 0 CA-C-O 120.388 -0.118 . . . . 0.0 112.944 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 6' ' ' GLN . . . . . 0.426 ' O ' ' HG3' ' A' ' 6' ' ' GLN . 13.1 pt20 -77.41 84.47 3.82 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.604 0.716 . . . . 0.0 109.844 173.548 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' PHE . . . . . 0.537 ' O ' ' HB2' ' A' ' 72' ' ' ASP . 68.7 m-85 -59.34 -34.94 72.97 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.371 -0.831 . . . . 0.0 110.908 -177.311 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' HIS . . . . . 0.631 ' HA ' ' HB2' ' A' ' 12' ' ' ASN . 4.7 t60 -85.29 60.86 6.51 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 175.686 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -74.23 -45.14 50.02 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.339 -0.846 . . . . 0.0 110.825 -175.759 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 39.8 t-20 -141.35 -73.08 0.33 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.389 179.66 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -119.17 53.84 1.0 Allowed 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.147 0.499 . . . . 0.0 111.485 -172.158 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' ASN . . . . . 0.845 HD21 ' HA ' ' A' ' 16' ' ' ASN . 13.8 t-20 -76.86 72.06 3.43 Favored 'General case' 0 N--CA 1.445 -0.697 0 CA-C-N 115.766 -0.652 . . . . 0.0 109.927 176.128 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -91.83 90.97 1.56 Allowed Glycine 0 N--CA 1.447 -0.591 0 C-N-CA 120.991 -0.623 . . . . 0.0 112.333 -178.557 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 129.07 -104.81 0.66 Allowed Glycine 0 N--CA 1.449 -0.471 0 C-N-CA 120.957 -0.64 . . . . 0.0 112.018 178.418 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 14.2 mm100 -95.55 117.54 30.61 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.911 0.386 . . . . 0.0 110.263 -179.82 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' ASN . . . . . 0.845 ' HA ' HD21 ' A' ' 12' ' ' ASN . 9.1 p30 -58.96 -33.47 70.69 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.54 -0.755 . . . . 0.0 110.754 179.514 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -101.83 81.6 0.43 Allowed Glycine 0 N--CA 1.443 -0.838 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.011 179.743 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.466 ' OG1' ' HG3' ' A' ' 73' ' ' PRO . 96.5 m -88.99 127.91 35.69 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 110.146 -0.316 . . . . 0.0 110.146 177.209 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 74.7 t -113.09 127.19 70.48 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.618 -178.595 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' GLN . . . . . 0.607 ' HG2' ' HB2' ' A' ' 80' ' ' CYS . 29.5 tp60 -111.84 112.74 24.63 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 109.43 -0.582 . . . . 0.0 109.43 176.863 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.588 ' HA ' ' O ' ' A' ' 67' ' ' LEU . 12.1 mt-10 -98.53 119.26 36.93 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.369 0.604 . . . . 0.0 112.305 179.257 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 10.1 mm -114.37 150.5 16.35 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 115.185 -0.916 . . . . 0.0 109.44 177.685 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 94.0 mmm -111.53 103.83 12.19 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 172.93 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.656 HG23 HD21 ' A' ' 87' ' ' LEU . 9.3 mm -84.88 125.3 71.14 Favored Pre-proline 0 C--N 1.316 -0.88 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.952 -173.301 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_exo -50.2 139.06 36.13 Favored 'Trans proline' 0 C--N 1.346 0.441 0 C-N-CA 122.904 2.402 . . . . 0.0 112.379 176.566 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -42.41 -57.15 2.72 Favored 'General case' 0 N--CA 1.465 0.287 0 N-CA-C 113.316 0.858 . . . . 0.0 113.316 -173.716 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -90.18 -26.71 23.01 Favored Glycine 0 N--CA 1.453 -0.199 0 C-N-CA 120.679 -0.772 . . . . 0.0 113.069 -174.473 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.409 ' HE3' ' HA ' ' A' ' 87' ' ' LEU . 45.0 tttp -78.99 -4.56 50.61 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.192 0.52 . . . . 0.0 110.128 179.773 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.482 ' HA ' HG21 ' A' ' 24' ' ' ILE . . . -63.64 -22.93 67.16 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.658 174.844 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -58.39 -25.7 58.19 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 121.073 -0.584 . . . . 0.0 112.134 178.292 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 63.2 mt -75.97 -45.78 33.08 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.779 0.323 . . . . 0.0 110.855 179.425 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.433 HG12 ' O ' ' A' ' 29' ' ' ALA . 1.4 p -72.02 -32.13 42.77 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.474 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.973 -177.369 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 74.2 mt -78.33 -42.18 26.5 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-O 121.761 0.791 . . . . 0.0 109.772 176.661 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.503 ' HA3' ' H ' ' A' ' 39' ' ' THR . . . 101.29 51.53 1.13 Allowed Glycine 0 N--CA 1.441 -1.025 0 CA-C-N 115.272 -0.876 . . . . 0.0 112.974 175.529 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.453 ' HD2' ' N ' ' A' ' 35' ' ' LYS . 0.4 OUTLIER 50.68 40.5 24.24 Favored 'General case' 0 C--N 1.329 -0.295 0 O-C-N 124.319 0.658 . . . . 0.0 111.96 173.719 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 133.73 -27.06 3.39 Favored Glycine 0 N--CA 1.449 -0.482 0 C-N-CA 120.653 -0.784 . . . . 0.0 111.94 179.604 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 129.78 22.47 1.15 Allowed Glycine 0 N--CA 1.449 -0.451 0 C-N-CA 120.173 -1.013 . . . . 0.0 113.079 178.524 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.475 ' O ' ' HG3' ' A' ' 42' ' ' GLN . 4.5 tp10 -84.53 -54.09 4.98 Favored 'General case' 0 C--N 1.321 -0.648 0 O-C-N 122.296 -0.531 . . . . 0.0 110.119 178.694 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.684 ' O ' ' HG ' ' A' ' 43' ' ' LEU . 63.0 m -56.21 -44.58 79.63 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.53 -0.759 . . . . 0.0 111.821 -179.405 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 8.9 tt -58.51 -37.79 66.61 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.406 0 CA-C-O 120.596 0.236 . . . . 0.0 111.604 -178.416 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 33.5 mtmm -66.24 -38.65 88.39 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.358 0.599 . . . . 0.0 110.172 178.02 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.475 ' HG3' ' O ' ' A' ' 38' ' ' GLU . 20.5 mt-30 -66.07 -45.96 79.44 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.279 178.755 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.684 ' HG ' ' O ' ' A' ' 39' ' ' THR . 89.6 mt -53.47 -46.7 70.05 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.428 -0.805 . . . . 0.0 112.032 -175.609 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 46.9 mt-30 -64.52 -43.36 94.29 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.484 -177.302 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 9.3 mm-40 -81.12 -35.6 31.38 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 112.052 0.39 . . . . 0.0 112.052 -174.261 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 14.8 ptm180 -66.76 -35.28 79.73 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-O 120.735 0.302 . . . . 0.0 111.477 -176.7 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.452 ' HB3' HG22 ' A' ' 49' ' ' VAL . . . -100.65 -12.13 19.43 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.889 0.376 . . . . 0.0 111.577 -177.128 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 71.73 37.93 61.21 Favored Glycine 0 N--CA 1.449 -0.492 0 C-N-CA 120.812 -0.709 . . . . 0.0 111.961 -178.004 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.452 HG22 ' HB3' ' A' ' 47' ' ' ALA . 28.5 m -129.15 178.56 4.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-O 120.761 0.315 . . . . 0.0 110.16 -177.775 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 64.3 tttp -120.75 124.66 45.66 Favored 'General case' 0 C--N 1.319 -0.726 0 C-N-CA 120.662 -0.415 . . . . 0.0 110.214 173.069 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' MET . . . . . 0.586 ' CE ' ' HB1' ' A' ' 79' ' ' ALA . 63.7 mtt -113.94 115.62 27.95 Favored 'General case' 0 C--N 1.319 -0.749 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 176.751 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.534 ' CG2' ' HB2' ' A' ' 68' ' ' ARG . 10.5 tt -99.29 104.77 16.46 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.741 0 CA-C-O 121.772 0.796 . . . . 0.0 110.059 176.91 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.705 HD22 HD13 ' A' ' 67' ' ' LEU . 3.8 mm? -87.53 104.4 16.45 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.053 -0.976 . . . . 0.0 109.26 176.02 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.8 HD12 ' HB2' ' A' ' 66' ' ' PRO . 61.0 mt -72.74 86.56 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-O 121.852 0.834 . . . . 0.0 109.663 178.369 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 16.0 mt-30 -99.73 -23.3 15.05 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 114.637 -1.165 . . . . 0.0 109.645 -177.628 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -114.73 6.14 15.51 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.175 -0.921 . . . . 0.0 110.512 -173.213 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -66.3 -22.72 71.26 Favored Glycine 0 N--CA 1.453 -0.184 0 CA-C-N 115.53 -0.759 . . . . 0.0 112.086 178.539 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' SER . . . . . 0.422 ' HA ' ' CG2' ' A' ' 61' ' ' THR . 31.9 m 65.37 -172.59 0.18 Allowed 'General case' 0 C--O 1.232 0.184 0 C-N-CA 123.215 0.606 . . . . 0.0 111.107 -178.856 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 93.9 mt-30 71.76 -62.29 0.46 Allowed 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 123.118 0.567 . . . . 0.0 110.281 -176.648 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.486 ' OD1' ' HD3' ' A' ' 66' ' ' PRO . 9.9 p30 -100.65 12.51 37.26 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.325 178.957 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 61' ' ' THR . . . . . 0.422 ' CG2' ' HA ' ' A' ' 58' ' ' SER . 0.3 OUTLIER -60.15 -29.76 68.87 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.035 0.445 . . . . 0.0 111.386 -179.288 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 1.8 m-20 -82.74 -4.3 57.71 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.781 -0.645 . . . . 0.0 111.131 179.725 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 21.1 m -131.83 -153.35 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.248 0 N-CA-C 111.633 0.235 . . . . 0.0 111.633 -174.731 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.461 ' HA ' ' O ' ' A' ' 24' ' ' ILE . 1.8 m-20 -53.55 151.6 5.73 Favored 'General case' 0 C--N 1.331 -0.225 0 C-N-CA 123.545 0.738 . . . . 0.0 111.363 178.201 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.497 ' HA ' ' HD3' ' A' ' 66' ' ' PRO . 39.2 mmtm -110.85 131.39 22.15 Favored Pre-proline 0 C--N 1.327 -0.398 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.659 -175.203 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.8 ' HB2' HD12 ' A' ' 54' ' ' ILE . 10.6 Cg_exo -75.33 111.4 3.3 Favored 'Trans proline' 0 N--CA 1.46 -0.467 0 C-N-CA 123.476 2.784 . . . . 0.0 111.86 176.013 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.705 HD13 HD22 ' A' ' 53' ' ' LEU . 17.8 tp -112.4 120.72 42.64 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.528 177.439 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.534 ' HB2' ' CG2' ' A' ' 52' ' ' ILE . 68.4 mtt180 -111.47 111.72 22.95 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 120.99 0.424 . . . . 0.0 110.651 174.445 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.493 ' HB ' ' HB3' ' A' ' 20' ' ' GLN . 46.9 mt -91.27 112.06 24.76 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 N-CA-C 108.909 -0.774 . . . . 0.0 108.909 173.914 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 13.2 mt -113.85 129.42 69.78 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.739 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.056 -172.562 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' GLY . . . . . 0.491 ' HA2' ' HD1' ' A' ' 7' ' ' PHE . . . 153.42 -140.92 7.91 Favored Glycine 0 N--CA 1.448 -0.518 0 C-N-CA 120.458 -0.877 . . . . 0.0 113.32 173.89 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 72' ' ' ASP . . . . . 0.537 ' HB2' ' O ' ' A' ' 7' ' ' PHE . 4.7 t70 -71.99 130.89 86.05 Favored Pre-proline 0 C--N 1.322 -0.614 0 C-N-CA 123.387 0.675 . . . . 0.0 111.126 -176.997 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 73' ' ' PRO . . . . . 0.641 ' HD2' ' HA ' ' A' ' 12' ' ' ASN . 26.8 Cg_exo -57.98 -26.53 75.27 Favored 'Trans proline' 0 C--N 1.35 0.622 0 C-N-CA 123.556 2.838 . . . . 0.0 113.352 -172.027 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 74' ' ' TYR . . . . . 0.401 ' HB3' ' OD1' ' A' ' 72' ' ' ASP . 24.1 t80 -79.06 -47.61 15.88 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.156 -0.474 . . . . 0.0 109.873 -176.191 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.526 ' CG ' ' HB3' ' A' ' 72' ' ' ASP . 9.1 ptpt -80.51 -26.61 38.05 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 120.867 -0.333 . . . . 0.0 111.611 178.81 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.401 ' CG1' ' HB2' ' A' ' 20' ' ' GLN . 24.6 t -60.69 -40.13 83.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-O 120.7 0.286 . . . . 0.0 110.246 173.954 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 6.5 mm-40 -73.97 -41.2 62.31 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 120.637 -0.425 . . . . 0.0 110.972 179.472 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 49.6 mt-30 -63.09 -39.07 93.62 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 120.898 0.38 . . . . 0.0 110.251 177.431 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' ALA . . . . . 0.586 ' HB1' ' CE ' ' A' ' 51' ' ' MET . . . -71.65 -35.34 70.33 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.718 178.5 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 80' ' ' CYS . . . . . 0.607 ' HB2' ' HG2' ' A' ' 20' ' ' GLN . 36.5 t -63.45 -54.09 41.9 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.123 175.245 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 52.5 mt-10 -65.2 -20.66 66.54 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.403 178.998 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' MET . . . . . 0.437 ' HB3' ' O ' ' A' ' 79' ' ' ALA . 31.5 ttm -69.48 -55.98 8.71 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.425 -0.807 . . . . 0.0 110.403 176.417 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 32.9 m -79.42 -29.59 13.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.915 -175.453 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' MET . . . . . 0.476 ' O ' ' HG2' ' A' ' 88' ' ' ARG . 56.9 ttp -71.48 -28.94 64.28 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 109.75 -0.463 . . . . 0.0 109.75 178.392 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 85' ' ' ASP . . . . . 0.483 ' O ' ' HB2' ' A' ' 89' ' ' GLU . 19.0 t70 -62.62 -47.94 81.57 Favored 'General case' 0 CA--C 1.517 -0.29 0 N-CA-C 109.968 -0.382 . . . . 0.0 109.968 175.133 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 20.3 mt -60.22 -32.45 50.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 121.659 0.742 . . . . 0.0 110.276 177.738 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.656 HD21 HG23 ' A' ' 24' ' ' ILE . 1.0 OUTLIER -81.8 -17.52 47.26 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.389 -0.823 . . . . 0.0 111.57 -176.738 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 88' ' ' ARG . . . . . 0.476 ' HG2' ' O ' ' A' ' 84' ' ' MET . 23.3 mmm180 -102.86 5.94 38.88 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 121.546 0.689 . . . . 0.0 109.322 174.153 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 89' ' ' GLU . . . . . 0.483 ' HB2' ' O ' ' A' ' 85' ' ' ASP . 2.1 tm-20 . . . . . 0 C--O 1.25 1.125 0 CA-C-N 114.749 -1.114 . . . . 0.0 108.884 -177.968 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.445 -0.739 0 N-CA-C 112.076 -0.41 . . . . 0.0 112.076 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 61.5 tp60 59.67 87.75 0.08 Allowed 'General case' 0 C--O 1.235 0.322 0 CA-C-O 121.314 0.578 . . . . 0.0 110.057 -176.438 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 95.7 m-85 -69.74 104.96 2.58 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.207 -177.887 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' HIS . . . . . 0.953 ' H ' ' HB2' ' A' ' 72' ' ' ASP . 14.0 t60 74.06 145.67 0.08 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 114.318 -1.31 . . . . 0.0 110.504 -176.876 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -64.61 -26.72 68.52 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.021 -0.991 . . . . 0.0 111.259 -178.18 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 9.2 t30 -162.9 101.32 1.0 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.504 174.885 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . 72.17 123.6 0.04 OUTLIER 'General case' 0 N--CA 1.471 0.616 0 O-C-N 123.867 0.73 . . . . 0.0 112.77 174.599 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 2.6 p-10 -117.83 147.38 43.1 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.089 177.631 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -158.05 143.94 9.95 Favored Glycine 0 N--CA 1.452 -0.273 0 N-CA-C 111.588 -0.605 . . . . 0.0 111.588 -178.741 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 79.07 -68.53 3.08 Favored Glycine 0 C--N 1.331 0.283 0 N-CA-C 110.974 -0.851 . . . . 0.0 110.974 -176.425 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' GLN . . . . . 0.402 ' HB3' ' OG1' ' A' ' 18' ' ' THR . 32.5 mm-40 -106.06 125.23 50.74 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 108.952 -0.758 . . . . 0.0 108.952 171.794 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 30.6 m-20 -114.23 -71.14 0.76 Allowed 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 109.797 -0.446 . . . . 0.0 109.797 -177.483 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -95.4 80.09 0.84 Allowed Glycine 0 N--CA 1.444 -0.769 0 N-CA-C 111.099 -0.801 . . . . 0.0 111.099 174.838 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.511 ' OG1' ' HG3' ' A' ' 73' ' ' PRO . 74.6 m -83.24 134.25 34.96 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-O 120.996 0.427 . . . . 0.0 111.129 -176.545 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.493 HG22 HG23 ' A' ' 70' ' ' ILE . 61.6 t -124.71 120.19 58.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.61 179.251 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 14.2 mm100 -101.17 114.03 27.61 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.983 -0.553 . . . . 0.0 109.539 174.682 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.61 ' HG2' ' HG2' ' A' ' 68' ' ' ARG . 37.4 mt-10 -93.69 107.58 19.43 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.283 0.564 . . . . 0.0 110.729 176.065 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 19.0 mm -102.41 148.67 7.56 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.723 0 CA-C-N 115.359 -0.837 . . . . 0.0 109.802 -178.509 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' MET . . . . . 0.51 ' HB3' ' HB3' ' A' ' 64' ' ' ASP . 1.5 mmt -99.87 101.98 13.27 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 108.609 -0.885 . . . . 0.0 108.609 175.428 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.687 ' HB ' ' HB2' ' A' ' 65' ' ' LYS . 44.3 mm -88.66 126.06 61.06 Favored Pre-proline 0 C--N 1.319 -0.733 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.996 -175.38 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.604 ' HB2' ' HB3' ' A' ' 28' ' ' LYS . 95.7 Cg_exo -45.1 132.91 11.41 Favored 'Trans proline' 0 C--N 1.343 0.278 0 C-N-CA 123.423 2.749 . . . . 0.0 112.541 179.564 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -61.82 -38.65 88.96 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 115.511 -0.768 . . . . 0.0 112.954 -168.501 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -89.37 -35.89 7.78 Favored Glycine 0 N--CA 1.449 -0.496 0 C-N-CA 120.404 -0.903 . . . . 0.0 111.837 -178.596 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.604 ' HB3' ' HB2' ' A' ' 25' ' ' PRO . 28.6 ttpt -80.47 -0.62 38.12 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 121.201 0.524 . . . . 0.0 110.77 -178.721 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.53 ' O ' HG12 ' A' ' 32' ' ' VAL . . . -62.83 -20.14 64.78 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.132 177.667 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -57.66 -33.09 66.35 Favored Glycine 0 N--CA 1.448 -0.541 0 C-N-CA 120.792 -0.718 . . . . 0.0 111.885 177.04 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 99.0 mt -77.57 -36.2 52.27 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.643 0.259 . . . . 0.0 111.289 -178.767 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.535 HG11 HG21 ' A' ' 24' ' ' ILE . 0.5 OUTLIER -70.57 -30.28 41.86 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.326 0 CA-C-O 121.16 0.505 . . . . 0.0 110.768 -178.37 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 71.0 mt -89.39 -38.78 11.7 Favored 'Isoleucine or valine' 0 C--O 1.236 0.388 0 CA-C-N 115.76 -0.654 . . . . 0.0 110.537 178.743 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 105.08 25.0 6.94 Favored Glycine 0 CA--C 1.502 -0.723 0 CA-C-N 115.605 -0.725 . . . . 0.0 112.611 178.57 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 53.6 mtpt 60.87 21.51 11.69 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.316 -0.442 . . . . 0.0 111.327 177.258 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -176.59 -45.7 0.06 OUTLIER Glycine 0 N--CA 1.448 -0.504 0 N-CA-C 111.696 -0.562 . . . . 0.0 111.696 -178.31 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 125.73 7.57 5.59 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.355 -0.926 . . . . 0.0 113.024 176.692 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -85.51 -32.91 21.96 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 120.84 0.352 . . . . 0.0 111.162 178.561 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.59 ' O ' ' HG ' ' A' ' 43' ' ' LEU . 60.7 m -65.0 -48.18 74.84 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.97 -179.573 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.734 HD12 HD23 ' A' ' 53' ' ' LEU . 1.9 tt -57.18 -38.58 62.05 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-O 120.748 0.309 . . . . 0.0 111.167 178.463 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.406 ' HE2' ' HB3' ' A' ' 41' ' ' LYS . 4.6 tmmm? -60.97 -40.76 94.62 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 109.57 -0.53 . . . . 0.0 109.57 178.689 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.499 ' O ' ' HG2' ' A' ' 46' ' ' ARG . 54.4 mt-30 -70.32 -37.82 74.79 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.614 -179.851 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.693 HD13 HG12 ' A' ' 83' ' ' VAL . 75.0 mt -58.03 -35.95 72.01 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.678 179.075 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' GLN . . . . . 0.568 ' HG3' ' O ' ' A' ' 40' ' ' ILE . 19.7 mt-30 -66.57 -47.72 71.89 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.42 178.223 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.403 ' HG3' ' O ' ' A' ' 41' ' ' LYS . 39.0 mt-10 -64.83 -48.58 73.86 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.694 -0.685 . . . . 0.0 111.195 -177.573 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 46' ' ' ARG . . . . . 0.499 ' HG2' ' O ' ' A' ' 42' ' ' GLN . 17.5 ptm180 -70.79 -23.66 62.42 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.169 -0.469 . . . . 0.0 112.201 -174.224 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -93.13 -29.14 15.91 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.818 0.342 . . . . 0.0 111.093 178.745 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 87.88 26.41 29.33 Favored Glycine 0 N--CA 1.452 -0.25 0 C-N-CA 121.014 -0.612 . . . . 0.0 112.56 -179.062 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 5.1 m -140.08 179.87 2.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-O 120.876 0.369 . . . . 0.0 110.592 -178.801 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 81.1 tttt -110.8 124.66 52.45 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.238 178.531 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' MET . . . . . 0.492 ' HG2' HG23 ' A' ' 69' ' ' ILE . 17.9 mtm -117.2 116.62 27.63 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 109.821 -0.437 . . . . 0.0 109.821 176.661 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.618 ' CG2' ' HB2' ' A' ' 68' ' ' ARG . 10.8 tt -102.0 113.2 37.7 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.727 0 CA-C-O 121.43 0.633 . . . . 0.0 110.762 178.426 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.879 HD22 HD13 ' A' ' 67' ' ' LEU . 1.3 mm? -88.07 107.52 18.79 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.41 -0.814 . . . . 0.0 109.311 175.906 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.657 HD12 ' HB2' ' A' ' 66' ' ' PRO . 58.4 mt -79.84 84.65 1.25 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.575 0 CA-C-O 122.248 1.023 . . . . 0.0 110.323 179.151 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 2.5 pt20 -110.5 -20.42 12.58 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 114.006 -1.452 . . . . 0.0 107.677 167.712 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -62.45 -43.82 97.89 Favored 'General case' 0 N--CA 1.452 -0.361 0 CA-C-N 114.138 -1.392 . . . . 0.0 109.152 173.555 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -75.29 136.84 21.01 Favored Glycine 0 N--CA 1.445 -0.716 0 CA-C-N 115.138 -0.937 . . . . 0.0 111.619 176.575 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 20.1 m -95.64 19.69 10.78 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-O 120.759 0.314 . . . . 0.0 111.644 -174.97 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 15.0 mm100 -78.56 -49.5 13.2 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.085 0.469 . . . . 0.0 110.617 -179.477 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.577 ' HB2' ' HD3' ' A' ' 66' ' ' PRO . 14.4 m120 -127.24 39.83 3.82 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.143 179.902 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 13.6 t -87.14 -23.56 24.8 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.903 -178.165 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 66.2 t30 -97.39 4.75 50.57 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.553 0.692 . . . . 0.0 109.642 178.535 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.403 ' HB ' ' H ' ' A' ' 64' ' ' ASP . 16.0 m -136.03 -159.01 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-N 115.301 -0.863 . . . . 0.0 110.028 179.155 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.518 ' O ' ' HB3' ' A' ' 60' ' ' ASN . 7.3 m-20 -55.64 136.97 50.14 Favored 'General case' 0 C--N 1.329 -0.325 0 O-C-N 123.408 0.443 . . . . 0.0 110.155 175.863 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.687 ' HB2' ' HB ' ' A' ' 24' ' ' ILE . 65.7 mmtt -88.38 134.0 35.4 Favored Pre-proline 0 C--N 1.318 -0.768 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.904 -169.101 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.657 ' HB2' HD12 ' A' ' 54' ' ' ILE . 16.4 Cg_exo -70.86 104.95 1.57 Allowed 'Trans proline' 0 N--CA 1.456 -0.686 0 C-N-CA 122.744 2.296 . . . . 0.0 111.137 172.49 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.879 HD13 HD22 ' A' ' 53' ' ' LEU . 18.9 tp -110.54 118.06 35.22 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.129 178.26 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.618 ' HB2' ' CG2' ' A' ' 52' ' ' ILE . 68.9 mtt180 -108.98 106.36 16.28 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.503 177.345 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.631 HG22 HG22 ' A' ' 76' ' ' VAL . 4.3 mp -87.13 109.49 19.31 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 N-CA-C 107.962 -1.125 . . . . 0.0 107.962 171.163 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.493 HG23 HG22 ' A' ' 19' ' ' VAL . 33.7 mt -110.23 128.37 66.5 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.73 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.979 -171.635 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 150.28 -123.93 1.65 Allowed Glycine 0 N--CA 1.444 -0.798 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.42 173.173 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' ASP . . . . . 0.953 ' HB2' ' H ' ' A' ' 8' ' ' HIS . 2.8 t70 -84.26 129.84 56.56 Favored Pre-proline 0 C--N 1.32 -0.705 0 CA-C-N 115.479 -0.361 . . . . 0.0 111.298 -177.333 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 73' ' ' PRO . . . . . 0.511 ' HG3' ' OG1' ' A' ' 18' ' ' THR . 53.2 Cg_exo -48.22 -27.79 10.07 Favored 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 123.805 3.003 . . . . 0.0 113.56 -178.924 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 74' ' ' TYR . . . . . 0.553 ' HB3' ' OD2' ' A' ' 72' ' ' ASP . 44.9 t80 -82.75 -60.06 2.3 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.519 -0.31 . . . . 0.0 110.733 -175.987 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.602 ' HG2' ' OD2' ' A' ' 72' ' ' ASP . 12.8 pttt -72.84 -17.46 61.55 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 112.115 0.413 . . . . 0.0 112.115 179.438 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.631 HG22 HG22 ' A' ' 69' ' ' ILE . 12.4 t -69.02 -38.48 78.46 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 N-CA-C 109.106 -0.701 . . . . 0.0 109.106 171.162 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 77' ' ' GLN . . . . . 0.417 ' O ' ' HG3' ' A' ' 81' ' ' GLU . 22.5 tp60 -74.02 -42.33 60.48 Favored 'General case' 0 N--CA 1.448 -0.528 0 CA-C-N 115.657 -0.701 . . . . 0.0 109.495 177.519 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 78' ' ' GLN . . . . . 0.481 ' HB2' ' HA ' ' A' ' 75' ' ' LYS . 51.2 mt-30 -56.01 -51.4 67.9 Favored 'General case' 0 C--O 1.223 -0.332 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.398 174.865 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -60.94 -40.13 92.09 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.925 179.201 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 22.6 t -59.54 -54.37 47.33 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.846 -0.615 . . . . 0.0 111.252 177.717 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' GLU . . . . . 0.433 ' O ' ' HB2' ' A' ' 85' ' ' ASP . 2.3 pp20? -70.77 -25.02 62.71 Favored 'General case' 0 C--O 1.217 -0.642 0 C-N-CA 120.221 -0.592 . . . . 0.0 110.493 -179.334 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 82' ' ' MET . . . . . 0.504 ' O ' HG13 ' A' ' 86' ' ' ILE . 34.8 ttp -67.35 -48.81 66.38 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.578 -0.283 . . . . 0.0 110.878 177.333 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.693 HG12 HD13 ' A' ' 43' ' ' LEU . 33.0 m -74.18 -36.59 44.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 C-N-CA 120.943 -0.303 . . . . 0.0 110.992 -179.766 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 89.2 mtp -71.14 -27.38 63.53 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 110.198 -0.297 . . . . 0.0 110.198 177.607 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' ASP . . . . . 0.433 ' HB2' ' O ' ' A' ' 81' ' ' GLU . 30.0 t70 -63.4 -40.85 98.34 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.276 175.139 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.504 HG13 ' O ' ' A' ' 82' ' ' MET . 52.2 mt -63.06 -33.09 58.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.734 177.711 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.561 HD22 ' HG2' ' A' ' 28' ' ' LYS . 69.2 mt -86.01 -21.81 27.61 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.789 -174.332 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 39.5 ptt180 -95.93 -2.99 46.01 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.122 0.487 . . . . 0.0 110.682 -178.814 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.249 1.047 0 CA-C-O 118.434 -0.793 . . . . 0.0 109.671 -174.678 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.663 0 N-CA-C 111.913 -0.475 . . . . 0.0 111.913 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 73.6 mt-30 -75.25 65.0 1.53 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.901 0.381 . . . . 0.0 110.829 -179.06 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' PHE . . . . . 0.634 ' HD1' ' HA2' ' A' ' 71' ' ' GLY . 59.7 m-85 55.12 41.03 32.0 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.361 -0.836 . . . . 0.0 111.569 177.407 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 8' ' ' HIS . . . . . 0.709 ' HA ' ' OD1' ' A' ' 72' ' ' ASP . 10.6 t-80 -154.66 35.82 0.41 Allowed 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 173.145 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 15.2 t70 66.19 -65.75 0.18 Allowed 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 114.362 -1.29 . . . . 0.0 110.902 -175.179 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 37.8 t30 -148.04 95.13 2.43 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.963 -0.562 . . . . 0.0 109.968 -178.445 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . 69.13 135.95 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 115.343 -0.844 . . . . 0.0 111.972 -176.727 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' ASN . . . . . 0.494 ' ND2' ' HB3' ' A' ' 16' ' ' ASN . 24.8 p-10 -102.01 163.68 12.12 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.811 177.831 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -117.12 76.67 0.28 Allowed Glycine 0 N--CA 1.448 -0.516 0 N-CA-C 111.43 -0.668 . . . . 0.0 111.43 175.221 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 116.15 -101.37 0.99 Allowed Glycine 0 N--CA 1.448 -0.508 0 C-N-CA 120.788 -0.72 . . . . 0.0 111.862 -178.546 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 30.6 mm-40 -84.2 150.13 25.68 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 120.775 0.322 . . . . 0.0 110.707 178.891 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' ASN . . . . . 0.494 ' HB3' ' ND2' ' A' ' 12' ' ' ASN . 9.0 p30 -128.56 142.63 51.0 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 109.52 -0.548 . . . . 0.0 109.52 176.344 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 97.25 101.9 2.1 Favored Glycine 0 N--CA 1.448 -0.525 0 C-N-CA 120.551 -0.833 . . . . 0.0 112.992 178.008 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.59 ' OG1' ' HG3' ' A' ' 73' ' ' PRO . 85.4 m -124.5 129.81 51.31 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.028 0.442 . . . . 0.0 110.461 176.519 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.616 ' HA ' ' O ' ' A' ' 69' ' ' ILE . 3.2 p -130.18 129.02 65.09 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.829 -179.837 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 67.6 mt-30 -105.07 119.49 39.15 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.529 177.962 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.747 ' HA ' ' O ' ' A' ' 67' ' ' LEU . 28.8 mt-10 -92.64 108.77 20.23 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.614 -0.721 . . . . 0.0 110.341 175.022 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.448 HG12 HD22 ' A' ' 67' ' ' LEU . 22.0 mm -107.28 142.9 18.91 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 CA-C-N 115.55 -0.75 . . . . 0.0 109.422 -179.592 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 90.5 mmm -103.56 92.74 4.59 Favored 'General case' 0 N--CA 1.447 -0.6 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 179.099 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.672 ' HB ' ' HB2' ' A' ' 65' ' ' LYS . 25.5 mm -77.6 128.14 80.62 Favored Pre-proline 0 C--N 1.317 -0.84 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.457 -174.622 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_exo -48.1 133.12 23.71 Favored 'Trans proline' 0 N--CA 1.462 -0.366 0 C-N-CA 122.626 2.217 . . . . 0.0 111.453 175.773 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -44.66 -56.17 4.62 Favored 'General case' 0 C--N 1.328 -0.341 0 O-C-N 124.023 0.827 . . . . 0.0 112.824 -171.536 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -79.31 -12.6 83.72 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.875 -0.679 . . . . 0.0 113.02 -175.425 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.433 ' HD3' ' HB3' ' A' ' 87' ' ' LEU . 19.6 ttmm -88.14 8.91 24.67 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.328 0.585 . . . . 0.0 110.522 -175.864 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.403 ' HA ' HG22 ' A' ' 32' ' ' VAL . . . -66.18 -20.82 66.25 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.061 179.224 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -63.86 -16.06 58.83 Favored Glycine 0 N--CA 1.449 -0.455 0 CA-C-N 115.853 -0.612 . . . . 0.0 112.565 179.575 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.478 HD13 HG22 ' A' ' 86' ' ' ILE . 74.9 mt -94.87 -42.4 8.71 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 111.73 0.27 . . . . 0.0 111.73 -179.394 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.629 HG13 HD21 ' A' ' 87' ' ' LEU . 3.1 m -69.83 -38.21 75.28 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.21 0 CA-C-O 121.037 0.446 . . . . 0.0 111.046 178.629 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.578 ' HA ' ' HB ' ' A' ' 40' ' ' ILE . 57.0 mt -86.45 -32.7 6.77 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-O 121.705 0.764 . . . . 0.0 109.441 179.599 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.506 ' HA3' ' CB ' ' A' ' 39' ' ' THR . . . 92.65 171.52 40.8 Favored Glycine 0 N--CA 1.441 -0.972 0 CA-C-N 114.923 -1.035 . . . . 0.0 112.086 178.438 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 14.5 mptt -76.77 65.77 2.57 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.104 0.478 . . . . 0.0 110.89 -179.611 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 132.92 5.28 3.15 Favored Glycine 0 C--N 1.33 0.224 0 C-N-CA 120.972 -0.632 . . . . 0.0 112.527 175.442 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.502 ' HA2' HG22 ' A' ' 33' ' ' ILE . . . 86.36 -9.2 71.26 Favored Glycine 0 N--CA 1.449 -0.487 0 C-N-CA 120.524 -0.846 . . . . 0.0 112.016 -179.12 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 55.3 mm-40 -64.33 -33.47 75.91 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.689 0.28 . . . . 0.0 111.208 -179.554 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.762 ' O ' ' HG ' ' A' ' 43' ' ' LEU . 32.3 m -64.62 -57.26 9.57 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.482 -0.326 . . . . 0.0 111.039 -179.839 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.598 ' HA ' HD12 ' A' ' 43' ' ' LEU . 11.0 tt -59.92 -31.74 48.29 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.391 0 CA-C-O 121.318 0.58 . . . . 0.0 110.553 -179.377 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 46.0 tttt -60.39 -50.64 72.78 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.588 -0.733 . . . . 0.0 110.822 173.751 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.644 ' O ' ' HG2' ' A' ' 46' ' ' ARG . 48.2 mt-30 -67.29 -38.77 85.57 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.705 -176.321 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.762 ' HG ' ' O ' ' A' ' 39' ' ' THR . 61.4 mt -55.76 -46.18 77.94 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.397 -176.663 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 43.4 mt-30 -61.26 -34.71 75.61 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.926 -179.862 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -80.74 -45.63 16.75 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.423 -177.583 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' ARG . . . . . 0.644 ' HG2' ' O ' ' A' ' 42' ' ' GLN . 14.0 ptp180 -74.66 -43.21 56.43 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 112.753 0.649 . . . . 0.0 112.753 -173.879 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.525 ' HB3' HG22 ' A' ' 49' ' ' VAL . . . -83.82 -14.72 50.63 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 112.084 0.402 . . . . 0.0 112.084 -173.508 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 72.24 24.91 75.66 Favored Glycine 0 C--N 1.329 0.17 0 C-N-CA 120.659 -0.782 . . . . 0.0 111.912 -179.134 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.525 HG22 ' HB3' ' A' ' 47' ' ' ALA . 26.8 m -124.08 162.31 25.54 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 N-CA-C 109.937 -0.394 . . . . 0.0 109.937 -179.296 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 61.6 tttp -100.5 122.14 42.72 Favored 'General case' 0 C--N 1.317 -0.833 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 174.624 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' MET . . . . . 0.478 ' CE ' ' HB1' ' A' ' 79' ' ' ALA . 61.1 mtt -110.12 115.38 29.64 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 174.836 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.67 ' CG2' ' HB2' ' A' ' 68' ' ' ARG . 12.6 tt -109.64 105.13 18.21 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.973 0 CA-C-O 121.88 0.848 . . . . 0.0 109.727 174.886 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -87.84 107.76 18.83 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 114.666 -1.152 . . . . 0.0 109.203 178.278 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.511 ' HB ' ' HB2' ' A' ' 66' ' ' PRO . 46.4 mm -74.54 85.05 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.306 0 CA-C-O 122.006 0.908 . . . . 0.0 110.486 -177.87 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -124.15 -34.78 2.9 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-N 114.361 -1.291 . . . . 0.0 108.111 170.54 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -75.52 -14.73 60.42 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 114.918 -1.037 . . . . 0.0 109.014 174.982 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -84.6 11.34 59.34 Favored Glycine 0 N--CA 1.45 -0.42 0 CA-C-N 115.268 -0.878 . . . . 0.0 111.848 176.771 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 39.1 p 51.47 -158.59 0.11 Allowed 'General case' 0 N--CA 1.467 0.389 0 C-N-CA 123.782 0.833 . . . . 0.0 111.764 -178.63 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 49.5 mt-30 65.28 -82.69 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.209 0 C-N-CA 123.087 0.555 . . . . 0.0 111.714 179.753 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.645 ' HA ' HG22 ' A' ' 63' ' ' VAL . 1.8 m-20 -90.92 18.49 6.56 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.737 0.304 . . . . 0.0 110.988 -175.216 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 61' ' ' THR . . . . . 0.415 ' O ' ' HE2' ' A' ' 65' ' ' LYS . 11.9 t -67.03 -22.8 65.86 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 173.526 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 52.4 t-20 -85.11 -48.5 9.12 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.107 -0.951 . . . . 0.0 110.337 176.279 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.645 HG22 ' HA ' ' A' ' 60' ' ' ASN . 18.1 m -93.11 -154.95 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.007 -0.542 . . . . 0.0 112.161 -174.058 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.563 ' O ' ' HB3' ' A' ' 60' ' ' ASN . 23.3 m-20 -54.21 140.86 31.29 Favored 'General case' 0 N--CA 1.462 0.166 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.274 176.11 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.672 ' HB2' ' HB ' ' A' ' 24' ' ' ILE . 31.0 mmtp -94.34 118.24 67.04 Favored Pre-proline 0 C--N 1.32 -0.681 0 CA-C-N 116.037 -0.528 . . . . 0.0 110.804 -170.368 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.511 ' HB2' ' HB ' ' A' ' 54' ' ' ILE . 25.4 Cg_exo -65.43 104.69 0.66 Allowed 'Trans proline' 0 N--CA 1.459 -0.53 0 C-N-CA 122.653 2.235 . . . . 0.0 110.942 173.784 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.886 HD21 HG13 ' A' ' 69' ' ' ILE . 4.8 tt -103.88 136.55 43.33 Favored 'General case' 0 C--N 1.315 -0.904 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 179.907 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.67 ' HB2' ' CG2' ' A' ' 52' ' ' ILE . 92.7 mtt180 -131.16 108.38 9.68 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 121.067 0.461 . . . . 0.0 111.003 173.538 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.886 HG13 HD21 ' A' ' 67' ' ' LEU . 13.5 mt -91.77 104.96 16.07 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 N-CA-C 108.828 -0.805 . . . . 0.0 108.828 172.57 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 5.2 mt -105.35 126.06 60.5 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.828 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.476 -174.837 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' GLY . . . . . 0.634 ' HA2' ' HD1' ' A' ' 7' ' ' PHE . . . 160.61 -129.72 2.22 Favored Glycine 0 N--CA 1.446 -0.666 0 C-N-CA 120.591 -0.814 . . . . 0.0 112.705 175.03 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 72' ' ' ASP . . . . . 0.709 ' OD1' ' HA ' ' A' ' 8' ' ' HIS . 0.9 OUTLIER -88.23 132.94 37.97 Favored Pre-proline 0 C--N 1.322 -0.616 0 C-N-CA 122.833 0.453 . . . . 0.0 111.394 -176.696 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 73' ' ' PRO . . . . . 0.59 ' HG3' ' OG1' ' A' ' 18' ' ' THR . 45.6 Cg_exo -52.51 -26.41 28.61 Favored 'Trans proline' 0 C--N 1.351 0.679 0 C-N-CA 123.899 3.066 . . . . 0.0 113.301 -174.94 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 74' ' ' TYR . . . . . 0.48 ' HB3' ' OD2' ' A' ' 72' ' ' ASP . 82.2 t80 -83.49 -56.29 3.82 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.422 -176.664 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.663 ' HG2' ' OD2' ' A' ' 72' ' ' ASP . 12.9 ptpt -71.48 -27.03 62.96 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.54 -179.818 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.631 HG22 HG22 ' A' ' 69' ' ' ILE . 25.2 t -61.18 -40.7 86.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 N-CA-C 110.305 -0.258 . . . . 0.0 110.305 173.799 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -74.97 -43.24 55.16 Favored 'General case' 0 N--CA 1.451 -0.419 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.297 -179.018 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 78' ' ' GLN . . . . . 0.463 ' O ' ' HB2' ' A' ' 82' ' ' MET . 41.4 mt-30 -62.0 -35.89 79.89 Favored 'General case' 0 C--O 1.224 -0.264 0 CA-C-N 116.52 -0.309 . . . . 0.0 110.674 177.465 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 79' ' ' ALA . . . . . 0.478 ' HB1' ' CE ' ' A' ' 51' ' ' MET . . . -74.85 -34.15 62.23 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 120.912 0.387 . . . . 0.0 110.478 177.831 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 53.9 t -63.29 -56.7 14.33 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.149 176.438 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -66.23 -23.04 66.36 Favored 'General case' 0 C--O 1.22 -0.499 0 C-N-CA 120.547 -0.461 . . . . 0.0 110.47 179.217 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 82' ' ' MET . . . . . 0.463 ' HB2' ' O ' ' A' ' 78' ' ' GLN . 30.6 ttm -59.61 -52.66 64.59 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.981 0.419 . . . . 0.0 110.202 174.838 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.644 ' O ' ' HG ' ' A' ' 87' ' ' LEU . 18.7 m -83.86 -35.23 11.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.09 -177.521 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 84' ' ' MET . . . . . 0.458 ' O ' ' HG2' ' A' ' 88' ' ' ARG . 57.1 ttp -65.44 -35.39 80.77 Favored 'General case' 0 CA--C 1.518 -0.265 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.291 -179.894 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 85' ' ' ASP . . . . . 0.48 ' O ' ' HB2' ' A' ' 89' ' ' GLU . 33.2 t70 -61.3 -39.87 92.09 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.127 177.382 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.478 HG22 HD13 ' A' ' 31' ' ' LEU . 23.5 mt -64.62 -41.18 91.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 121.412 0.625 . . . . 0.0 109.925 176.398 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.644 ' HG ' ' O ' ' A' ' 83' ' ' VAL . 66.1 mt -64.39 -36.11 83.09 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.373 -0.831 . . . . 0.0 111.101 -178.781 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 88' ' ' ARG . . . . . 0.458 ' HG2' ' O ' ' A' ' 84' ' ' MET . 29.5 mmm180 -95.28 9.91 38.06 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.996 -177.352 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 89' ' ' GLU . . . . . 0.48 ' HB2' ' O ' ' A' ' 85' ' ' ASP . 35.3 tt0 . . . . . 0 C--O 1.25 1.122 0 CA-C-O 118.836 -0.602 . . . . 0.0 110.34 -177.787 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.55 0 N-CA-C 112.377 -0.289 . . . . 0.0 112.377 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 33.6 mt-30 -60.52 146.37 45.21 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 108.412 -0.958 . . . . 0.0 108.412 173.79 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 94.6 m-85 -47.14 125.2 7.44 Favored 'General case' 0 CA--C 1.518 -0.261 0 CA-C-O 121.554 0.692 . . . . 0.0 111.884 -169.693 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' HIS . . . . . 0.603 ' H ' ' HB3' ' A' ' 12' ' ' ASN . 4.7 t-80 -141.84 169.88 16.76 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 114.803 -1.09 . . . . 0.0 108.411 -173.455 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' ASP . . . . . 0.573 ' HB3' ' O ' ' A' ' 48' ' ' GLY . 0.5 OUTLIER -66.67 -68.82 0.35 Allowed 'General case' 0 C--N 1.318 -0.786 0 CA-C-O 120.578 0.227 . . . . 0.0 111.348 176.132 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 23.3 t-20 -84.96 -72.94 0.45 Allowed 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.794 0.33 . . . . 0.0 111.23 -178.081 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -84.24 87.67 7.19 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.952 0.406 . . . . 0.0 111.52 -176.827 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' ASN . . . . . 0.603 ' HB3' ' H ' ' A' ' 8' ' ' HIS . 18.7 p30 -113.87 149.95 34.33 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.202 175.229 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -104.35 111.26 3.78 Favored Glycine 0 N--CA 1.447 -0.624 0 C-N-CA 120.997 -0.62 . . . . 0.0 112.576 -176.737 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 157.7 -128.04 2.03 Favored Glycine 0 N--CA 1.446 -0.652 0 N-CA-C 109.888 -1.285 . . . . 0.0 109.888 -177.844 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' GLN . . . . . 0.406 ' C ' ' H ' ' A' ' 17' ' ' GLY . 32.6 tt0 -129.67 102.86 6.53 Favored 'General case' 0 C--N 1.317 -0.841 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 169.847 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 36.1 m-80 59.2 -2.43 0.11 Allowed 'General case' 0 N--CA 1.472 0.649 0 CA-C-N 115.3 -0.864 . . . . 0.0 112.615 -172.908 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' GLY . . . . . 0.406 ' H ' ' C ' ' A' ' 15' ' ' GLN . . . 81.71 -115.84 4.09 Favored Glycine 0 N--CA 1.447 -0.578 0 N-CA-C 111.438 -0.665 . . . . 0.0 111.438 -176.329 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 85.7 m -120.66 130.67 54.22 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 109.697 -0.482 . . . . 0.0 109.697 175.513 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.665 ' HA ' ' O ' ' A' ' 69' ' ' ILE . 3.2 p -139.86 121.76 16.0 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-O 121.161 0.505 . . . . 0.0 111.932 -175.456 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' GLN . . . . . 0.411 ' O ' ' HA ' ' A' ' 68' ' ' ARG . 29.6 mt-30 -96.88 157.17 16.03 Favored 'General case' 0 CA--C 1.519 -0.233 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.353 173.363 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.582 ' HG2' ' HG2' ' A' ' 68' ' ' ARG . 35.2 mt-10 -131.18 107.91 9.34 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.177 0.513 . . . . 0.0 111.075 -178.424 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 5.3 mm -101.57 150.37 6.06 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-N 115.54 -0.754 . . . . 0.0 109.405 -179.807 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 79.5 mmm -110.18 92.85 4.21 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 176.77 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.676 ' HB ' ' HB2' ' A' ' 65' ' ' LYS . 32.7 mm -82.3 127.32 71.64 Favored Pre-proline 0 C--N 1.32 -0.676 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.101 -173.895 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 76.7 Cg_exo -50.85 136.5 43.33 Favored 'Trans proline' 0 N--CA 1.463 -0.317 0 C-N-CA 122.491 2.127 . . . . 0.0 111.592 175.398 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -58.1 -29.28 65.35 Favored 'General case' 0 CA--C 1.531 0.226 0 N-CA-C 112.959 0.725 . . . . 0.0 112.959 -172.116 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -89.44 -19.73 47.94 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.484 -0.865 . . . . 0.0 112.138 179.323 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 8.5 tptm -91.95 -1.15 57.42 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.266 0.555 . . . . 0.0 110.363 -177.601 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.487 ' HA ' HG22 ' A' ' 32' ' ' VAL . . . -63.06 -20.93 65.8 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.598 -0.728 . . . . 0.0 111.065 179.471 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -61.0 -16.3 47.14 Favored Glycine 0 C--O 1.228 -0.247 0 CA-C-N 115.876 -0.602 . . . . 0.0 112.652 177.405 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 62.6 mt -93.75 -47.92 6.55 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 122.693 -0.298 . . . . 0.0 111.238 179.539 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.561 HG13 HD21 ' A' ' 87' ' ' LEU . 3.0 m -65.34 -40.07 87.29 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.379 0 CA-C-O 120.889 0.376 . . . . 0.0 111.452 179.523 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.51 HG13 HG23 ' A' ' 32' ' ' VAL . 43.6 mt -85.88 -32.75 7.09 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-O 121.927 0.87 . . . . 0.0 109.162 178.794 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.527 ' HA3' ' HB ' ' A' ' 39' ' ' THR . . . 95.15 178.9 37.3 Favored Glycine 0 N--CA 1.436 -1.318 0 CA-C-N 114.852 -1.067 . . . . 0.0 111.579 -178.105 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 2.9 mppt? -81.13 62.8 5.23 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-O 120.973 0.416 . . . . 0.0 110.373 -178.839 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 133.19 -20.1 4.26 Favored Glycine 0 N--CA 1.448 -0.521 0 C-N-CA 120.823 -0.703 . . . . 0.0 112.416 176.897 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 115.8 -0.16 21.45 Favored Glycine 0 N--CA 1.448 -0.517 0 C-N-CA 120.723 -0.751 . . . . 0.0 111.883 -176.792 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.508 ' O ' ' HB3' ' A' ' 41' ' ' LYS . 49.3 mt-10 -75.44 -31.96 60.5 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 120.724 0.297 . . . . 0.0 111.106 179.474 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.584 ' O ' ' HG ' ' A' ' 43' ' ' LEU . 23.7 m -69.38 -48.46 61.11 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.774 -178.3 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.665 HD12 HD23 ' A' ' 53' ' ' LEU . 7.0 tt -61.8 -32.79 55.05 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.267 0 CA-C-O 121.107 0.479 . . . . 0.0 110.346 177.356 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.508 ' HB3' ' O ' ' A' ' 38' ' ' GLU . 31.6 ttpt -56.24 -45.22 80.07 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.467 174.398 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.45 ' O ' ' HG2' ' A' ' 46' ' ' ARG . 97.1 mt-30 -73.46 -40.46 64.15 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.404 -0.816 . . . . 0.0 111.116 -177.027 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.584 ' HG ' ' O ' ' A' ' 39' ' ' THR . 81.0 mt -55.71 -47.58 76.63 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.683 -176.577 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 44.6 mt-30 -61.98 -43.13 99.48 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.712 -176.247 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -78.54 -35.21 46.46 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 111.836 0.31 . . . . 0.0 111.836 -175.797 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' ARG . . . . . 0.45 ' HG2' ' O ' ' A' ' 42' ' ' GLN . 12.9 ptm180 -73.92 -31.39 63.05 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 120.777 -0.369 . . . . 0.0 111.268 -177.89 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -89.19 -28.18 20.16 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.087 0.47 . . . . 0.0 111.348 -179.111 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' GLY . . . . . 0.573 ' O ' ' HB3' ' A' ' 9' ' ' ASP . . . 82.93 33.21 24.6 Favored Glycine 0 N--CA 1.449 -0.478 0 CA-C-N 115.742 -0.663 . . . . 0.0 112.243 -178.698 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 3.6 m -139.14 179.86 2.76 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.399 0 CA-C-O 120.898 0.38 . . . . 0.0 110.297 178.609 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 54.7 tttp -109.44 123.67 49.75 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 115.945 -0.57 . . . . 0.0 109.919 175.448 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' MET . . . . . 0.552 ' HG2' HG23 ' A' ' 69' ' ' ILE . 65.9 mtp -118.21 114.08 22.49 Favored 'General case' 0 C--N 1.317 -0.808 0 N-CA-C 108.301 -1.0 . . . . 0.0 108.301 174.414 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.502 ' CG2' ' HB2' ' A' ' 68' ' ' ARG . 11.5 tt -104.6 108.54 25.06 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.749 0 CA-C-O 121.622 0.725 . . . . 0.0 110.684 -177.614 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.723 HD22 HD13 ' A' ' 67' ' ' LEU . 2.7 mm? -82.35 102.29 11.15 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.249 -0.887 . . . . 0.0 109.522 174.11 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.648 HD12 ' HB2' ' A' ' 66' ' ' PRO . 56.6 mt -82.48 87.42 1.9 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.55 0 CA-C-O 121.481 0.658 . . . . 0.0 109.35 -179.171 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 70.9 mt-30 -70.91 -37.95 72.95 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.148 -0.933 . . . . 0.0 111.144 -173.59 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' ASP . . . . . 0.505 ' HA ' HG21 ' A' ' 61' ' ' THR . 19.4 m-20 -130.27 62.28 1.58 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.184 0.516 . . . . 0.0 111.541 178.29 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -91.95 5.15 78.95 Favored Glycine 0 CA--C 1.517 0.2 0 C-N-CA 120.508 -0.853 . . . . 0.0 111.928 172.56 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 16.8 m 64.37 -169.77 0.19 Allowed 'General case' 0 C--O 1.235 0.321 0 C-N-CA 123.426 0.69 . . . . 0.0 111.322 -178.088 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 95.2 mt-30 67.76 -79.23 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 123.376 0.67 . . . . 0.0 111.146 179.768 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 13.6 m120 -101.38 13.01 36.37 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.337 -177.994 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' THR . . . . . 0.505 HG21 ' HA ' ' A' ' 56' ' ' ASP . 1.2 p -62.52 -33.08 74.19 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 120.861 0.362 . . . . 0.0 111.347 179.296 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 17.9 t-20 -74.63 -10.19 59.3 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.471 -0.786 . . . . 0.0 111.493 -178.701 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.53 HG23 ' H ' ' A' ' 64' ' ' ASP . 0.5 OUTLIER -126.51 -60.79 1.45 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-O 121.698 0.761 . . . . 0.0 112.702 -174.387 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.53 ' H ' HG23 ' A' ' 63' ' ' VAL . 10.6 m-20 -120.63 -163.68 1.04 Allowed 'General case' 0 C--N 1.307 -1.278 0 CA-C-N 114.67 -1.15 . . . . 0.0 108.901 -171.158 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.676 ' HB2' ' HB ' ' A' ' 24' ' ' ILE . 2.7 mmpp? -148.57 113.28 3.74 Favored Pre-proline 0 C--N 1.318 -0.779 0 CA-C-N 115.62 -0.718 . . . . 0.0 109.51 178.779 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.648 ' HB2' HD12 ' A' ' 54' ' ' ILE . 24.7 Cg_exo -63.55 110.26 1.21 Allowed 'Trans proline' 0 N--CA 1.462 -0.353 0 C-N-CA 122.613 2.209 . . . . 0.0 111.807 178.268 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.723 HD13 HD22 ' A' ' 53' ' ' LEU . 24.2 tp -111.16 105.22 13.85 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.069 178.006 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.582 ' HG2' ' HG2' ' A' ' 21' ' ' GLU . 95.2 mtt180 -97.72 113.62 25.42 Favored 'General case' 0 C--N 1.319 -0.717 0 CA-C-O 121.437 0.637 . . . . 0.0 110.581 176.813 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.665 ' O ' ' HA ' ' A' ' 19' ' ' VAL . 19.6 mt -98.83 104.09 15.54 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.786 0 CA-C-N 114.99 -1.004 . . . . 0.0 108.577 177.897 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.545 HG23 ' HB ' ' A' ' 19' ' ' VAL . 2.8 mt -112.58 132.61 60.84 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.788 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.061 -169.348 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 156.44 -119.06 0.88 Allowed Glycine 0 N--CA 1.446 -0.675 0 C-N-CA 120.718 -0.754 . . . . 0.0 112.825 174.832 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' ASP . . . . . 0.401 ' O ' HG23 ' A' ' 76' ' ' VAL . 11.9 t70 -102.69 134.77 19.7 Favored Pre-proline 0 C--N 1.325 -0.46 0 CA-C-O 119.091 -0.48 . . . . 0.0 110.96 -175.667 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_exo -44.31 -42.91 13.59 Favored 'Trans proline' 0 C--O 1.237 0.445 0 C-N-CA 123.231 2.62 . . . . 0.0 113.557 -174.419 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 30.7 t80 -70.95 -47.73 57.34 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.853 -171.911 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.436 ' HA ' ' HB2' ' A' ' 78' ' ' GLN . 14.3 pttt -82.87 -19.24 37.84 Favored 'General case' 0 C--N 1.325 -0.466 0 C-N-CA 120.492 -0.483 . . . . 0.0 111.768 -179.463 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.401 HG23 ' O ' ' A' ' 72' ' ' ASP . 47.0 t -66.16 -38.55 82.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 170.036 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 77' ' ' GLN . . . . . 0.407 ' O ' ' HG2' ' A' ' 81' ' ' GLU . 20.9 tp60 -69.92 -49.13 55.06 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.38 -0.827 . . . . 0.0 110.416 175.426 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 78' ' ' GLN . . . . . 0.436 ' HB2' ' HA ' ' A' ' 75' ' ' LYS . 86.2 mt-30 -60.4 -36.36 77.95 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.567 -0.288 . . . . 0.0 111.693 -179.913 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -69.64 -39.42 77.12 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 120.818 0.342 . . . . 0.0 110.546 177.462 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 52.5 t -65.13 -51.45 61.19 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.051 179.681 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' GLU . . . . . 0.408 ' HG2' ' HA ' ' A' ' 78' ' ' GLN . 10.3 pt-20 -64.99 -24.11 67.41 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.972 0.415 . . . . 0.0 110.37 179.983 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 82' ' ' MET . . . . . 0.557 ' O ' HG13 ' A' ' 86' ' ' ILE . 29.7 ttp -73.14 -52.02 15.76 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.863 179.259 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.57 ' O ' ' HG ' ' A' ' 87' ' ' LEU . 33.3 m -77.75 -34.0 19.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 120.635 0.255 . . . . 0.0 111.207 -175.647 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 51.7 ttm -63.35 -35.25 79.75 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.106 0.479 . . . . 0.0 109.741 177.194 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -68.54 -36.72 79.22 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.441 179.444 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.557 HG13 ' O ' ' A' ' 82' ' ' MET . 59.9 mt -63.31 -33.25 60.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-O 121.256 0.55 . . . . 0.0 110.543 178.056 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.57 ' HG ' ' O ' ' A' ' 83' ' ' VAL . 58.7 mt -73.87 -19.61 60.67 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.604 -175.945 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 88' ' ' ARG . . . . . 0.619 ' HG3' ' HG2' ' A' ' 89' ' ' GLU . 37.1 ptt180 -110.8 -19.3 12.88 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.372 0.606 . . . . 0.0 111.142 -175.596 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 89' ' ' GLU . . . . . 0.619 ' HG2' ' HG3' ' A' ' 88' ' ' ARG . 69.9 mm-40 . . . . . 0 C--O 1.249 1.04 0 CA-C-N 115.235 -0.893 . . . . 0.0 110.425 -175.633 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.504 -0.6 0 N-CA-C 113.866 0.306 . . . . 0.0 113.866 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 53.7 mt-30 -76.35 -171.28 1.72 Allowed 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 106.987 -1.486 . . . . 0.0 106.987 159.634 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' PHE . . . . . 0.457 ' HB3' ' HB2' ' A' ' 72' ' ' ASP . 0.1 OUTLIER -65.78 -20.45 66.26 Favored 'General case' 0 C--N 1.314 -0.946 0 C-N-CA 119.056 -1.058 . . . . 0.0 111.942 -177.889 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 8' ' ' HIS . . . . . 0.445 ' N ' ' HD1' ' A' ' 7' ' ' PHE . 11.5 t-160 70.25 77.51 0.2 Allowed 'General case' 0 CA--C 1.53 0.189 0 O-C-N 123.745 0.653 . . . . 0.0 110.649 -178.667 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 30.9 t70 72.63 -57.94 0.61 Allowed 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 115.159 -0.928 . . . . 0.0 112.073 178.207 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' ASN . . . . . 0.422 ' O ' ' HB2' ' A' ' 7' ' ' PHE . 7.8 p30 -137.4 -163.57 1.45 Allowed 'General case' 0 C--N 1.317 -0.81 0 N-CA-C 109.792 -0.448 . . . . 0.0 109.792 -177.688 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -73.29 76.12 1.34 Allowed 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 109.977 -0.379 . . . . 0.0 109.977 175.225 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 -82.18 75.47 9.1 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.172 0.51 . . . . 0.0 110.914 -171.875 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 101.42 -4.48 54.56 Favored Glycine 0 N--CA 1.449 -0.456 0 CA-C-N 115.784 -0.644 . . . . 0.0 112.736 177.795 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 80.51 -70.51 2.98 Favored Glycine 0 N--CA 1.454 -0.147 0 C-N-CA 120.742 -0.742 . . . . 0.0 111.918 -177.934 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 50.2 tt0 -74.8 124.67 27.25 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 175.554 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' ASN . . . . . 0.452 ' OD1' ' HA ' ' A' ' 7' ' ' PHE . 16.8 m120 -118.96 -80.52 0.62 Allowed 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 111.972 0.36 . . . . 0.0 111.972 -171.726 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -158.75 -49.7 0.01 OUTLIER Glycine 0 C--N 1.333 0.41 0 C-N-CA 119.819 -1.182 . . . . 0.0 113.666 -178.079 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 99.7 m -62.38 129.37 40.4 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.008 0.432 . . . . 0.0 111.641 -178.182 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.586 HG22 HG23 ' A' ' 70' ' ' ILE . 92.9 t -120.8 126.99 75.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.276 178.284 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' GLN . . . . . 0.576 ' HB2' ' CG1' ' A' ' 76' ' ' VAL . 4.9 tp-100 -106.58 113.93 27.74 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 109.667 -0.494 . . . . 0.0 109.667 175.684 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.607 ' HA ' ' O ' ' A' ' 67' ' ' LEU . 56.1 mt-10 -93.24 121.29 34.47 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.036 0.446 . . . . 0.0 111.457 177.591 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 18.7 mm -115.43 146.38 19.94 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 115.529 -0.759 . . . . 0.0 109.355 176.902 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' MET . . . . . 0.494 ' HB3' ' HB2' ' A' ' 64' ' ' ASP . 79.4 mmm -106.77 99.86 9.4 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 175.356 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.709 HD12 HD11 ' A' ' 87' ' ' LEU . 24.5 mm -78.54 129.76 73.36 Favored Pre-proline 0 C--N 1.32 -0.685 0 CA-C-N 115.498 -0.774 . . . . 0.0 111.895 -170.461 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.603 ' HD2' HD13 ' A' ' 87' ' ' LEU . 77.0 Cg_exo -45.2 131.37 11.38 Favored 'Trans proline' 0 C--N 1.349 0.574 0 C-N-CA 123.744 2.963 . . . . 0.0 112.976 175.831 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -71.36 78.5 0.75 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.444 0.64 . . . . 0.0 110.874 179.437 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 157.54 -59.96 0.34 Allowed Glycine 0 N--CA 1.447 -0.593 0 N-CA-C 109.983 -1.247 . . . . 0.0 109.983 -177.456 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.46 -13.97 35.97 Favored 'General case' 0 N--CA 1.451 -0.41 0 CA-C-O 121.0 0.429 . . . . 0.0 110.749 171.929 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.425 ' O ' HG12 ' A' ' 32' ' ' VAL . . . -56.16 -23.49 35.24 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.771 173.379 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -61.8 -24.46 64.54 Favored Glycine 0 N--CA 1.449 -0.494 0 C-N-CA 120.862 -0.685 . . . . 0.0 112.185 176.611 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 93.1 mt -92.4 -32.8 14.81 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.725 0.298 . . . . 0.0 110.859 178.793 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.438 HG11 HG21 ' A' ' 24' ' ' ILE . 0.3 OUTLIER -68.06 -29.0 43.15 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.296 0 CA-C-O 121.263 0.554 . . . . 0.0 110.395 179.387 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 63.2 mt -92.0 -47.97 13.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 115.568 -0.742 . . . . 0.0 109.424 174.386 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 114.56 -162.12 12.51 Favored Glycine 0 N--CA 1.442 -0.942 0 CA-C-N 115.356 -0.838 . . . . 0.0 112.095 178.418 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.534 ' N ' ' HD3' ' A' ' 35' ' ' LYS . 0.1 OUTLIER -92.29 39.33 1.02 Allowed 'General case' 0 C--N 1.317 -0.818 0 N-CA-C 109.637 -0.505 . . . . 0.0 109.637 -178.298 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 143.52 -21.31 2.21 Favored Glycine 0 N--CA 1.45 -0.431 0 C-N-CA 120.982 -0.628 . . . . 0.0 112.29 -178.245 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 126.17 4.77 6.4 Favored Glycine 0 C--O 1.228 -0.245 0 C-N-CA 120.355 -0.926 . . . . 0.0 112.309 179.939 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -80.59 -28.17 37.2 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 120.659 0.266 . . . . 0.0 111.217 178.897 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.623 ' O ' ' HG ' ' A' ' 43' ' ' LEU . 57.9 m -70.38 -49.64 47.01 Favored 'General case' 0 C--N 1.324 -0.507 0 C-N-CA 121.101 -0.24 . . . . 0.0 110.444 -179.983 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.703 HD12 HD23 ' A' ' 53' ' ' LEU . 5.2 tt -59.64 -33.72 52.86 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.248 0 CA-C-O 120.81 0.338 . . . . 0.0 110.473 176.31 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.536 ' O ' ' HG2' ' A' ' 45' ' ' GLU . 57.7 tttp -64.86 -46.23 82.74 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.756 175.454 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 41.7 mt-30 -60.88 -35.08 75.69 Favored 'General case' 0 CA--C 1.516 -0.354 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.359 -178.017 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.623 ' HG ' ' O ' ' A' ' 39' ' ' THR . 69.8 mt -62.19 -43.6 98.46 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.421 -0.809 . . . . 0.0 110.402 178.158 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 44' ' ' GLN . . . . . 0.435 ' HG3' ' O ' ' A' ' 40' ' ' ILE . 22.8 mt-30 -62.61 -47.24 84.63 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.176 177.596 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.536 ' HG2' ' O ' ' A' ' 41' ' ' LYS . 72.0 mm-40 -59.81 -39.41 84.95 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.33 -0.85 . . . . 0.0 111.672 -177.854 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 13.5 ptm180 -90.0 -28.02 19.38 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 112.932 0.716 . . . . 0.0 112.932 -170.865 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.45 ' HB3' HG22 ' A' ' 49' ' ' VAL . . . -94.22 -15.83 24.2 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 112.174 0.435 . . . . 0.0 112.174 -175.642 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 74.23 20.72 79.6 Favored Glycine 0 C--O 1.235 0.217 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.183 -179.855 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.45 HG22 ' HB3' ' A' ' 47' ' ' ALA . 27.3 m -124.51 177.31 4.67 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 N-CA-C 109.902 -0.407 . . . . 0.0 109.902 -179.202 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 87.1 tttt -114.64 123.97 50.66 Favored 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 109.773 -0.455 . . . . 0.0 109.773 173.088 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' MET . . . . . 0.592 ' HE2' ' HB1' ' A' ' 79' ' ' ALA . 55.7 mtt -108.54 115.39 30.02 Favored 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 176.028 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.561 ' CG2' ' HB2' ' A' ' 68' ' ' ARG . 10.2 tt -105.13 105.14 18.08 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.895 0 CA-C-O 121.585 0.707 . . . . 0.0 110.423 177.668 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 1.004 HD22 HD13 ' A' ' 67' ' ' LEU . 1.4 mm? -80.75 121.8 26.36 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.283 -0.872 . . . . 0.0 108.973 172.608 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.47 ' CG1' ' HB2' ' A' ' 66' ' ' PRO . 48.9 mm -76.67 85.86 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-O 121.845 0.831 . . . . 0.0 109.832 179.514 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 15.3 mt-30 -102.48 -57.87 1.98 Allowed 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 114.743 -1.117 . . . . 0.0 108.64 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -66.9 -33.09 74.83 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 114.633 -1.167 . . . . 0.0 110.322 177.902 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -70.13 -27.06 73.43 Favored Glycine 0 N--CA 1.451 -0.333 0 CA-C-N 115.577 -0.738 . . . . 0.0 112.382 179.65 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' SER . . . . . 0.605 ' HB3' ' CG2' ' A' ' 61' ' ' THR . 49.2 m 62.1 -127.28 0.72 Allowed 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 122.28 0.232 . . . . 0.0 111.422 178.615 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 59' ' ' GLN . . . . . 0.403 ' HB2' ' O ' ' A' ' 58' ' ' SER . 95.4 mt-30 78.7 -57.05 0.45 Allowed 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 123.671 0.788 . . . . 0.0 109.519 179.172 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.491 ' HB3' ' O ' ' A' ' 64' ' ' ASP . 13.7 m120 -100.03 52.82 0.91 Allowed 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 107.86 -1.163 . . . . 0.0 107.86 171.37 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 61' ' ' THR . . . . . 0.605 ' CG2' ' HB3' ' A' ' 58' ' ' SER . 2.7 p -55.58 -44.54 77.0 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 114.115 -1.402 . . . . 0.0 112.538 -173.696 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 66.2 t30 -104.69 -18.15 14.39 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 115.859 -0.61 . . . . 0.0 111.729 -173.853 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 33.0 m -108.86 -159.64 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 N-CA-C 112.251 0.463 . . . . 0.0 112.251 -173.898 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.494 ' HB2' ' HB3' ' A' ' 23' ' ' MET . 0.6 OUTLIER -55.06 142.43 30.48 Favored 'General case' 0 C--O 1.221 -0.431 0 CA-C-N 115.293 -0.867 . . . . 0.0 112.334 -179.569 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.665 ' HB2' ' HB ' ' A' ' 24' ' ' ILE . 73.6 mmtt -95.46 132.62 27.25 Favored Pre-proline 0 C--N 1.322 -0.592 0 CA-C-N 115.543 -0.753 . . . . 0.0 112.22 -170.49 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.472 ' HD3' ' HB2' ' A' ' 60' ' ' ASN . 13.7 Cg_exo -71.19 118.53 5.73 Favored 'Trans proline' 0 N--CA 1.457 -0.639 0 C-N-CA 122.867 2.378 . . . . 0.0 111.55 173.422 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 1.004 HD13 HD22 ' A' ' 53' ' ' LEU . 13.0 tp -123.48 124.7 43.44 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.98 -0.555 . . . . 0.0 109.923 178.091 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.561 ' HB2' ' CG2' ' A' ' 52' ' ' ILE . 87.5 mtt180 -112.58 110.63 20.91 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-O 120.851 0.358 . . . . 0.0 111.292 177.458 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.461 ' HB ' ' HB3' ' A' ' 20' ' ' GLN . 4.6 mp -88.38 104.7 14.91 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 171.525 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.586 HG23 HG22 ' A' ' 19' ' ' VAL . 11.3 mt -104.65 124.85 59.49 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.703 -174.99 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 71' ' ' GLY . . . . . 0.434 ' O ' ' HB2' ' A' ' 16' ' ' ASN . . . 173.95 -129.82 1.71 Allowed Glycine 0 N--CA 1.447 -0.592 0 C-N-CA 121.005 -0.617 . . . . 0.0 112.208 179.582 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 72' ' ' ASP . . . . . 0.492 ' OD1' ' HD2' ' A' ' 73' ' ' PRO . 3.1 t70 -107.58 145.72 31.87 Favored Pre-proline 0 C--N 1.324 -0.523 0 CA-C-O 118.655 -0.688 . . . . 0.0 109.895 -179.793 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 73' ' ' PRO . . . . . 0.492 ' HD2' ' OD1' ' A' ' 72' ' ' ASP . 94.3 Cg_exo -41.02 -40.42 3.81 Favored 'Trans proline' 0 CA--C 1.535 0.571 0 C-N-CA 122.999 2.466 . . . . 0.0 113.335 -179.398 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 85.9 t80 -70.82 -56.71 5.71 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.295 -176.262 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.459 ' HG2' ' HB3' ' A' ' 72' ' ' ASP . 27.6 pttt -71.22 -27.48 63.51 Favored 'General case' 0 CA--C 1.514 -0.432 0 C-N-CA 120.575 -0.45 . . . . 0.0 111.383 -179.523 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.576 ' CG1' ' HB2' ' A' ' 20' ' ' GLN . 24.2 t -66.71 -36.17 76.59 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-O 121.4 0.619 . . . . 0.0 109.441 177.068 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 77' ' ' GLN . . . . . 0.463 ' O ' ' HG2' ' A' ' 81' ' ' GLU . 20.1 tp60 -72.7 -47.98 42.68 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.292 176.749 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 25.0 mt-30 -57.8 -37.65 74.13 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-O 121.112 0.482 . . . . 0.0 110.6 177.534 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' ALA . . . . . 0.592 ' HB1' ' HE2' ' A' ' 51' ' ' MET . . . -71.99 -36.93 69.9 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.638 -0.71 . . . . 0.0 111.188 179.899 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 80' ' ' CYS . . . . . 0.44 ' HA ' HG22 ' A' ' 83' ' ' VAL . 51.7 t -68.37 -48.29 65.17 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.965 179.548 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 81' ' ' GLU . . . . . 0.463 ' HG2' ' O ' ' A' ' 77' ' ' GLN . 11.2 pt-20 -65.95 -19.48 65.88 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.11 0.481 . . . . 0.0 110.067 178.778 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 82' ' ' MET . . . . . 0.515 ' O ' HG13 ' A' ' 86' ' ' ILE . 51.1 ttp -79.18 -50.05 11.59 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.67 -0.695 . . . . 0.0 110.637 177.05 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.44 HG22 ' HA ' ' A' ' 80' ' ' CYS . 27.2 m -69.08 -35.16 67.27 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.248 0 C-N-CA 121.114 -0.234 . . . . 0.0 111.112 179.918 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 16.8 mmt -60.93 -37.23 81.59 Favored 'General case' 0 CA--C 1.517 -0.298 0 CA-C-O 121.076 0.465 . . . . 0.0 109.977 174.539 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -65.2 -43.77 90.55 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.482 -0.781 . . . . 0.0 110.95 178.694 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.515 HG13 ' O ' ' A' ' 82' ' ' MET . 51.5 mt -60.54 -37.52 75.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 121.466 0.651 . . . . 0.0 110.882 -179.395 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.709 HD11 HD12 ' A' ' 24' ' ' ILE . 71.5 mt -82.88 -12.83 57.08 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.762 -0.654 . . . . 0.0 111.21 -176.858 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 45.0 ttp180 -103.39 -18.34 14.87 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.467 0.651 . . . . 0.0 111.062 -176.982 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 . . . . . 0 C--O 1.249 1.051 0 CA-C-O 118.191 -0.909 . . . . 0.0 110.095 -178.31 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.488 0 N-CA-C 112.708 -0.157 . . . . 0.0 112.708 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 93.8 mt-30 -90.23 90.48 8.1 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 109.369 -0.604 . . . . 0.0 109.369 177.23 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 86.7 m-85 -64.71 -70.56 0.22 Allowed 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.418 -0.81 . . . . 0.0 111.518 -175.968 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 4.2 t60 52.02 41.14 29.6 Favored 'General case' 0 N--CA 1.464 0.265 0 N-CA-C 108.195 -1.039 . . . . 0.0 108.195 -171.313 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -67.29 142.3 56.91 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 114.05 -1.432 . . . . 0.0 112.03 -169.938 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' ASN . . . . . 0.839 ' H ' ' HA2' ' A' ' 71' ' ' GLY . 18.8 m-80 60.5 -84.91 0.02 OUTLIER 'General case' 0 N--CA 1.461 0.121 0 CA-C-N 115.155 -0.929 . . . . 0.0 110.902 -174.403 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.481 ' HA ' ' HA ' ' A' ' 16' ' ' ASN . . . -134.46 -51.32 0.81 Allowed 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 109.959 -0.386 . . . . 0.0 109.959 178.566 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 67.0 t30 51.61 57.18 6.84 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-O 121.308 0.575 . . . . 0.0 110.857 178.477 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 133.92 -53.81 0.78 Allowed Glycine 0 N--CA 1.446 -0.685 0 CA-C-N 115.684 -0.689 . . . . 0.0 111.996 -179.859 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 174.6 -66.02 0.1 Allowed Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.976 -0.631 . . . . 0.0 111.823 178.963 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 88.6 mm-40 -75.45 144.18 42.25 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 109.677 -0.49 . . . . 0.0 109.677 177.031 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' ASN . . . . . 0.481 ' HA ' ' HA ' ' A' ' 11' ' ' ALA . 17.9 m120 -77.49 156.44 31.02 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.47 -170.772 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -80.12 -115.86 0.3 Allowed Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 121.043 -0.598 . . . . 0.0 112.372 179.29 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.439 ' OG1' ' HG3' ' A' ' 73' ' ' PRO . 92.8 m -85.86 127.72 34.65 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 110.21 -0.293 . . . . 0.0 110.21 -179.795 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.542 ' HA ' ' O ' ' A' ' 69' ' ' ILE . 3.8 p -138.22 120.91 19.12 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-O 121.259 0.552 . . . . 0.0 110.808 179.909 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 53.2 mt-30 -102.54 136.11 42.96 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.793 -0.64 . . . . 0.0 109.98 176.646 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.568 ' HA ' ' O ' ' A' ' 67' ' ' LEU . 33.4 mt-10 -112.3 114.75 27.67 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.498 179.232 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 11.5 mm -106.56 156.93 7.01 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-N 115.486 -0.779 . . . . 0.0 110.038 -176.599 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 3.6 mmt -108.9 97.26 6.93 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 174.793 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.674 ' HB ' ' HB2' ' A' ' 65' ' ' LYS . 25.6 mm -82.92 125.53 74.96 Favored Pre-proline 0 C--N 1.316 -0.888 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.814 -175.819 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.664 ' HB2' ' HB2' ' A' ' 28' ' ' LYS . 74.0 Cg_exo -50.51 132.8 36.35 Favored 'Trans proline' 0 C--N 1.343 0.289 0 C-N-CA 122.747 2.298 . . . . 0.0 111.416 175.94 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -58.88 -31.84 68.94 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.751 -0.659 . . . . 0.0 112.51 -172.842 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -82.47 -36.7 16.17 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.592 -0.813 . . . . 0.0 111.823 178.426 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.664 ' HB2' ' HB2' ' A' ' 25' ' ' PRO . 36.2 mttp -80.32 3.64 20.39 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.808 0.337 . . . . 0.0 111.393 179.466 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.66 -30.44 70.73 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.096 0.474 . . . . 0.0 110.141 175.742 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -66.17 -18.67 67.34 Favored Glycine 0 N--CA 1.446 -0.656 0 C-N-CA 120.861 -0.685 . . . . 0.0 112.341 177.848 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 82.2 mt -84.36 -46.72 11.44 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.53 0.205 . . . . 0.0 110.789 179.922 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.652 HG21 HG21 ' A' ' 24' ' ' ILE . 2.8 m -66.7 -34.88 72.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-O 120.884 0.373 . . . . 0.0 110.958 177.813 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.721 HD11 ' HG2' ' A' ' 55' ' ' GLN . 84.7 mt -80.21 -44.97 22.51 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-O 121.203 0.525 . . . . 0.0 110.4 178.413 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.447 ' HA3' ' H ' ' A' ' 39' ' ' THR . . . 98.96 51.05 1.4 Allowed Glycine 0 N--CA 1.448 -0.553 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.841 177.202 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 5.0 mptp? 54.25 30.98 13.3 Favored 'General case' 0 N--CA 1.464 0.254 0 C-N-CA 122.959 0.504 . . . . 0.0 112.118 175.761 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 147.4 -36.86 1.16 Allowed Glycine 0 N--CA 1.446 -0.696 0 C-N-CA 120.294 -0.955 . . . . 0.0 112.575 -178.526 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 147.49 -1.97 0.76 Allowed Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 119.516 -1.326 . . . . 0.0 114.504 177.985 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 -63.23 -47.48 82.31 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 117.677 0.739 . . . . 0.0 111.301 -179.169 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.738 ' O ' ' HG ' ' A' ' 43' ' ' LEU . 95.3 m -63.86 -51.55 64.12 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 111.7 0.259 . . . . 0.0 111.7 -177.112 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.556 ' O ' ' HG3' ' A' ' 44' ' ' GLN . 5.3 tt -58.01 -37.49 61.66 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.375 0 CA-C-O 120.989 0.423 . . . . 0.0 110.831 -178.658 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 85.8 tttt -63.38 -44.21 95.41 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.452 177.158 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 70.8 mt-30 -65.0 -40.25 94.66 Favored 'General case' 0 CA--C 1.517 -0.306 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.62 -178.744 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.738 ' HG ' ' O ' ' A' ' 39' ' ' THR . 70.5 mt -56.99 -48.33 78.67 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.588 -0.733 . . . . 0.0 111.558 -177.742 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 44' ' ' GLN . . . . . 0.556 ' HG3' ' O ' ' A' ' 40' ' ' ILE . 14.2 mt-30 -58.96 -51.78 68.57 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.462 -178.226 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -68.68 -40.71 79.95 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.366 -0.833 . . . . 0.0 111.889 -173.79 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' ARG . . . . . 0.6 ' HD3' ' SD ' ' A' ' 82' ' ' MET . 13.0 ptm180 -71.94 -27.82 63.05 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 111.74 0.274 . . . . 0.0 111.74 -174.574 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.53 ' HB3' HG22 ' A' ' 49' ' ' VAL . . . -96.98 -22.71 16.67 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.02 0.438 . . . . 0.0 111.302 -178.882 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 79.85 28.55 50.28 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 121.027 -0.606 . . . . 0.0 111.722 -178.213 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.53 HG22 ' HB3' ' A' ' 47' ' ' ALA . 27.1 m -123.06 179.08 2.79 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-O 120.833 0.349 . . . . 0.0 110.114 -176.741 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 61.6 tttp -113.25 123.53 50.4 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 171.56 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' MET . . . . . 0.424 ' HE2' HG13 ' A' ' 69' ' ' ILE . 54.7 mtp -122.64 116.7 24.26 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 109.727 -0.472 . . . . 0.0 109.727 179.567 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.484 ' CG2' ' HB2' ' A' ' 68' ' ' ARG . 6.7 tt -107.13 107.17 22.11 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.792 0 CA-C-O 121.462 0.649 . . . . 0.0 110.878 -179.979 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.677 HD22 HD13 ' A' ' 67' ' ' LEU . 3.5 mm? -82.6 103.58 12.22 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.382 -0.826 . . . . 0.0 109.136 172.314 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.646 HD12 ' HB2' ' A' ' 66' ' ' PRO . 65.5 mt -81.37 89.78 1.85 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-O 121.192 0.52 . . . . 0.0 109.792 178.79 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 55' ' ' GLN . . . . . 0.721 ' HG2' HD11 ' A' ' 33' ' ' ILE . 0.0 OUTLIER -104.65 -44.63 4.82 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.654 179.82 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -77.42 -21.8 52.49 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.401 178.987 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' GLY . . . . . 0.418 ' O ' HG23 ' A' ' 61' ' ' THR . . . -62.83 135.1 43.89 Favored Glycine 0 N--CA 1.445 -0.722 0 C-N-CA 120.656 -0.783 . . . . 0.0 111.422 175.898 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 58' ' ' SER . . . . . 0.477 ' O ' ' HB2' ' A' ' 59' ' ' GLN . 15.6 m -72.74 -167.52 0.37 Allowed 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 120.567 0.222 . . . . 0.0 111.396 -175.764 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 59' ' ' GLN . . . . . 0.477 ' HB2' ' O ' ' A' ' 58' ' ' SER . 15.9 mm100 74.87 -60.74 0.51 Allowed 'General case' 0 N--CA 1.464 0.234 0 C-N-CA 123.31 0.644 . . . . 0.0 109.841 -173.5 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.687 ' HA ' HG22 ' A' ' 63' ' ' VAL . 2.6 m-20 -110.04 25.91 11.26 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 121.258 0.552 . . . . 0.0 110.802 179.255 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 61' ' ' THR . . . . . 0.443 ' OG1' ' HA ' ' A' ' 58' ' ' SER . 0.0 OUTLIER -63.67 -30.75 71.81 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.826 176.13 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 10.0 p30 -105.11 -1.44 25.55 Favored 'General case' 0 CA--C 1.534 0.351 0 N-CA-C 112.187 0.44 . . . . 0.0 112.187 -178.047 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.687 HG22 ' HA ' ' A' ' 60' ' ' ASN . 18.9 m -127.87 -157.58 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.352 0 CA-C-O 120.646 0.26 . . . . 0.0 111.585 -177.861 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.618 ' O ' ' HB3' ' A' ' 60' ' ' ASN . 5.6 m-20 -56.13 147.81 19.5 Favored 'General case' 0 C--O 1.225 -0.195 0 CA-C-N 115.591 -0.732 . . . . 0.0 110.807 178.17 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.674 ' HB2' ' HB ' ' A' ' 24' ' ' ILE . 69.5 mmtt -96.26 127.15 41.4 Favored Pre-proline 0 C--N 1.317 -0.814 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.409 -170.705 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.646 ' HB2' HD12 ' A' ' 54' ' ' ILE . 20.2 Cg_exo -68.03 109.23 1.89 Allowed 'Trans proline' 0 N--CA 1.461 -0.388 0 C-N-CA 122.952 2.435 . . . . 0.0 111.512 174.314 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.677 HD13 HD22 ' A' ' 53' ' ' LEU . 23.0 tp -109.65 117.41 33.86 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.339 178.38 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.507 ' HG2' ' HG2' ' A' ' 21' ' ' GLU . 92.7 mtt180 -107.09 112.92 26.06 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 120.827 0.346 . . . . 0.0 111.023 175.545 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.542 ' O ' ' HA ' ' A' ' 19' ' ' VAL . 3.9 mp -95.16 110.05 23.39 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 N-CA-C 107.951 -1.129 . . . . 0.0 107.951 172.201 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 28.4 mt -112.32 132.06 62.06 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 116.683 -0.235 . . . . 0.0 111.508 -171.134 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' GLY . . . . . 0.839 ' HA2' ' H ' ' A' ' 10' ' ' ASN . . . 150.19 -134.92 5.01 Favored Glycine 0 N--CA 1.445 -0.742 0 C-N-CA 120.686 -0.769 . . . . 0.0 113.657 174.021 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 72' ' ' ASP . . . . . 0.581 ' OD2' ' HB3' ' A' ' 74' ' ' TYR . 0.5 OUTLIER -80.07 139.19 52.96 Favored Pre-proline 0 C--N 1.323 -0.565 0 C-N-CA 123.46 0.704 . . . . 0.0 111.565 -177.283 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 73' ' ' PRO . . . . . 0.466 ' HD3' ' HA ' ' A' ' 72' ' ' ASP . 33.3 Cg_exo -58.55 -18.54 40.22 Favored 'Trans proline' 0 C--N 1.35 0.625 0 C-N-CA 123.583 2.856 . . . . 0.0 113.818 -175.748 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 74' ' ' TYR . . . . . 0.581 ' HB3' ' OD2' ' A' ' 72' ' ' ASP . 37.8 t80 -86.36 -56.65 3.34 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 120.478 0.18 . . . . 0.0 110.532 -179.406 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.579 ' CE ' ' HB3' ' A' ' 72' ' ' ASP . 26.1 pttt -70.31 -32.58 70.4 Favored 'General case' 0 CA--C 1.519 -0.232 0 N-CA-C 112.075 0.398 . . . . 0.0 112.075 -179.705 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 43.2 t -63.15 -36.24 75.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-O 121.008 0.432 . . . . 0.0 110.192 176.986 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -73.07 -44.29 60.77 Favored 'General case' 0 N--CA 1.445 -0.686 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 -178.255 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 48.3 mt-30 -62.46 -45.28 93.78 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.925 0.393 . . . . 0.0 110.531 177.045 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -63.4 -35.62 81.01 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.81 -179.193 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 43.5 t -66.2 -45.67 79.99 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.459 176.117 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 -59.48 -42.44 92.08 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.29 0.567 . . . . 0.0 110.051 175.864 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' MET . . . . . 0.6 ' SD ' ' HD3' ' A' ' 46' ' ' ARG . 42.0 ttp -56.72 -49.93 73.7 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 114.772 -1.104 . . . . 0.0 111.574 -179.456 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.408 HG11 ' CE ' ' A' ' 51' ' ' MET . 34.7 m -79.57 -33.41 15.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 C-N-CA 120.871 -0.332 . . . . 0.0 111.131 -176.694 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 57.4 ttp -63.37 -38.57 91.68 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 109.533 -0.543 . . . . 0.0 109.533 175.85 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -61.82 -38.45 88.19 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.328 178.53 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.525 HG13 ' O ' ' A' ' 82' ' ' MET . 45.4 mt -64.13 -31.09 51.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-O 121.376 0.608 . . . . 0.0 110.479 179.657 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.63 HD11 HD12 ' A' ' 24' ' ' ILE . 45.3 mt -88.0 -18.55 28.77 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.542 -179.779 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 33.7 ttt85 -96.69 -4.46 40.8 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.681 0.753 . . . . 0.0 110.629 -176.665 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 20.0 tp10 . . . . . 0 C--N 1.311 -1.083 0 CA-C-O 118.195 -0.907 . . . . 0.0 110.42 -178.728 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.445 -0.756 0 N-CA-C 111.913 -0.475 . . . . 0.0 111.913 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 50.1 mt-30 -51.66 -58.54 6.06 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.202 0.525 . . . . 0.0 110.88 177.79 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' PHE . . . . . 0.405 ' HD2' ' H ' ' A' ' 9' ' ' ASP . 50.9 p90 -163.78 -176.26 4.52 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.323 -0.853 . . . . 0.0 109.85 -178.555 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 45.8 t-80 -162.53 52.62 0.2 Allowed 'General case' 0 C--N 1.317 -0.829 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 174.744 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' ASP . . . . . 0.405 ' H ' ' HD2' ' A' ' 7' ' ' PHE . 1.7 t70 -45.49 -64.36 0.74 Allowed 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 114.798 -1.092 . . . . 0.0 110.647 179.445 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 97.1 m-20 -121.31 -34.86 3.39 Favored 'General case' 0 C--N 1.318 -0.798 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 167.813 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -153.38 -176.74 5.94 Favored 'General case' 0 N--CA 1.451 -0.42 0 CA-C-N 115.084 -0.962 . . . . 0.0 110.607 177.977 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 56.3 t-20 -168.72 75.64 0.11 Allowed 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 107.921 -1.14 . . . . 0.0 107.921 176.579 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 61.11 -103.62 0.56 Allowed Glycine 0 N--CA 1.448 -0.544 0 N-CA-C 111.342 -0.703 . . . . 0.0 111.342 -174.242 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -140.09 30.28 2.36 Favored Glycine 0 N--CA 1.447 -0.6 0 N-CA-C 110.942 -0.863 . . . . 0.0 110.942 175.657 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 50.2 tt0 -119.89 142.1 48.99 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.061 0.458 . . . . 0.0 110.38 -175.615 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 31.1 p30 -80.16 -174.47 4.53 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.813 -0.631 . . . . 0.0 110.653 179.555 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -150.88 -112.18 0.55 Allowed Glycine 0 N--CA 1.447 -0.596 0 C-N-CA 120.819 -0.705 . . . . 0.0 111.873 -179.081 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 97.8 m -94.89 127.63 41.06 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 121.054 0.454 . . . . 0.0 110.872 -179.46 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.506 ' HA ' ' O ' ' A' ' 69' ' ' ILE . 3.2 p -137.64 125.85 32.11 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-N 115.559 -0.746 . . . . 0.0 110.09 177.512 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 92.3 mt-30 -109.6 123.64 49.78 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.174 178.509 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.71 ' HG2' ' HG2' ' A' ' 68' ' ' ARG . 45.6 mt-10 -99.7 120.45 39.73 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.714 179.848 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 5.6 mm -106.79 152.1 8.46 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-N 115.54 -0.755 . . . . 0.0 110.307 -176.915 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 14.1 mmt -103.5 91.8 4.2 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 170.929 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.766 HG21 HG21 ' A' ' 32' ' ' VAL . 41.6 mm -79.89 134.71 56.33 Favored Pre-proline 0 C--N 1.319 -0.729 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.649 -175.265 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.429 ' HD2' HD13 ' A' ' 87' ' ' LEU . 83.4 Cg_exo -48.26 127.34 15.24 Favored 'Trans proline' 0 C--N 1.347 0.493 0 C-N-CA 123.068 2.512 . . . . 0.0 111.987 172.6 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.421 ' HB2' ' O ' ' A' ' 63' ' ' VAL . . . -60.35 -34.67 74.18 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.273 -177.032 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -72.36 -32.93 61.9 Favored Glycine 0 N--CA 1.448 -0.542 0 CA-C-N 115.819 -0.628 . . . . 0.0 112.951 -177.452 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 43.6 mtpt -104.18 14.3 30.68 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 122.639 -0.33 . . . . 0.0 111.084 -177.844 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -65.56 -28.9 69.49 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.022 179.04 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -65.46 -30.0 76.52 Favored Glycine 0 N--CA 1.445 -0.714 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.137 179.067 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 91.7 mt -71.34 -39.51 71.29 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.771 0.32 . . . . 0.0 111.125 -178.061 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.766 HG21 HG21 ' A' ' 24' ' ' ILE . 0.0 OUTLIER -71.32 -28.87 33.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.876 -178.315 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 62.0 mt -81.24 -34.21 13.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-O 121.583 0.706 . . . . 0.0 109.756 176.039 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.546 ' HA3' ' HB ' ' A' ' 39' ' ' THR . . . 101.89 26.81 7.34 Favored Glycine 0 CA--C 1.5 -0.849 0 CA-C-N 115.099 -0.955 . . . . 0.0 112.398 178.078 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 33.7 mmtp 73.1 -56.81 0.65 Allowed 'General case' 0 C--N 1.325 -0.498 0 C-N-CA 123.705 0.802 . . . . 0.0 111.659 179.43 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -101.26 -39.22 3.1 Favored Glycine 0 N--CA 1.448 -0.524 0 C-N-CA 120.678 -0.772 . . . . 0.0 111.718 -178.745 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 129.0 7.35 4.13 Favored Glycine 0 N--CA 1.448 -0.562 0 C-N-CA 120.996 -0.621 . . . . 0.0 112.533 178.914 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.449 ' O ' ' HG3' ' A' ' 42' ' ' GLN . 1.3 pm0 -78.2 -35.99 47.88 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 110.057 -0.349 . . . . 0.0 110.057 177.238 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.66 ' O ' ' HG ' ' A' ' 43' ' ' LEU . 40.5 m -62.72 -50.95 69.07 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.173 -179.594 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.681 HD12 ' HB2' ' A' ' 53' ' ' LEU . 4.3 tt -56.41 -36.17 46.23 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.376 0 CA-C-O 120.788 0.327 . . . . 0.0 111.23 -179.282 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.04 -36.78 80.46 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.197 0.522 . . . . 0.0 109.836 179.472 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.686 ' O ' ' HG2' ' A' ' 46' ' ' ARG . 79.1 mt-30 -72.4 -42.69 64.89 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.866 179.891 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.66 ' HG ' ' O ' ' A' ' 39' ' ' THR . 88.8 mt -52.56 -42.71 64.68 Favored 'General case' 0 C--O 1.235 0.313 0 O-C-N 123.835 0.71 . . . . 0.0 111.741 -176.865 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 44' ' ' GLN . . . . . 0.445 ' HG3' ' O ' ' A' ' 40' ' ' ILE . 62.4 mt-30 -54.08 -47.82 71.32 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.608 -0.724 . . . . 0.0 110.397 178.951 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 9.6 mm-40 -66.87 -39.13 87.43 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.529 -0.76 . . . . 0.0 110.735 -178.984 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' ARG . . . . . 0.686 ' HG2' ' O ' ' A' ' 42' ' ' GLN . 8.9 mmm180 -56.99 -45.46 82.94 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.801 -171.436 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.566 ' HB3' HG22 ' A' ' 49' ' ' VAL . . . -95.26 -20.36 19.26 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.138 -175.912 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 82.25 47.57 6.04 Favored Glycine 0 N--CA 1.444 -0.796 0 C-N-CA 120.23 -0.986 . . . . 0.0 111.565 -173.996 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.602 HG13 ' HB2' ' A' ' 75' ' ' LYS . 2.9 m -145.54 171.19 5.35 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.456 0 CA-C-O 121.138 0.494 . . . . 0.0 110.653 -177.828 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 6.7 tmtm? -100.41 121.58 41.76 Favored 'General case' 0 C--N 1.318 -0.787 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 176.407 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 57.0 mtt -115.12 126.01 54.14 Favored 'General case' 0 CA--C 1.509 -0.629 0 N-CA-C 109.941 -0.392 . . . . 0.0 109.941 179.34 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.615 ' CG2' ' HB2' ' A' ' 68' ' ' ARG . 9.8 tt -118.2 104.05 15.61 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.939 0 CA-C-O 121.614 0.721 . . . . 0.0 110.275 173.223 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.681 ' HB2' HD12 ' A' ' 40' ' ' ILE . 4.3 mm? -78.73 101.74 7.71 Favored 'General case' 0 N--CA 1.446 -0.639 0 N-CA-C 107.947 -1.131 . . . . 0.0 107.947 170.381 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.608 HD12 ' HB2' ' A' ' 66' ' ' PRO . 15.8 mt -75.98 92.28 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.764 0 CA-C-O 121.5 0.667 . . . . 0.0 109.52 -175.543 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 1.1 pp0? -126.4 -32.39 2.68 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.345 -0.843 . . . . 0.0 109.885 179.407 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 14.9 p-10 -84.35 -26.63 28.29 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.276 -0.874 . . . . 0.0 109.557 175.795 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -87.33 -7.91 75.57 Favored Glycine 0 N--CA 1.448 -0.507 0 CA-C-N 115.628 -0.715 . . . . 0.0 112.232 177.656 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' SER . . . . . 0.451 ' OG ' HG22 ' A' ' 54' ' ' ILE . 50.4 m -111.84 149.26 32.05 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.418 0.628 . . . . 0.0 112.027 -175.628 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 77.3 mt-30 -112.17 3.12 17.03 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 107.169 -1.419 . . . . 0.0 107.169 163.03 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 7.7 m120 -89.67 15.27 9.86 Favored 'General case' 0 CA--C 1.515 -0.388 0 CA-C-N 113.905 -1.498 . . . . 0.0 108.809 176.422 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' THR . . . . . 0.436 ' HA ' ' CD ' ' A' ' 65' ' ' LYS . 0.2 OUTLIER -67.81 -17.49 64.53 Favored 'General case' 0 C--N 1.314 -0.938 0 CA-C-N 115.328 -0.851 . . . . 0.0 110.904 -177.678 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 16.5 m120 -84.12 -3.67 58.26 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.52 -0.764 . . . . 0.0 110.547 177.501 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.421 ' O ' ' HB2' ' A' ' 26' ' ' ALA . 22.4 m -133.65 -154.12 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 115.899 -0.591 . . . . 0.0 109.972 178.938 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -50.84 135.32 24.27 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-O 121.148 0.499 . . . . 0.0 110.918 179.629 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.553 ' HB2' ' HB ' ' A' ' 24' ' ' ILE . 8.4 mmmm -101.6 119.25 57.82 Favored Pre-proline 0 C--N 1.319 -0.758 0 N-CA-C 113.098 0.777 . . . . 0.0 113.098 -172.574 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.608 ' HB2' HD12 ' A' ' 54' ' ' ILE . 23.5 Cg_exo -67.26 125.86 14.13 Favored 'Trans proline' 0 CA--C 1.533 0.462 0 C-N-CA 123.016 2.477 . . . . 0.0 111.895 171.379 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.695 ' O ' ' HA ' ' A' ' 21' ' ' GLU . 31.6 tp -134.02 127.84 33.1 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.02 177.599 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.71 ' HG2' ' HG2' ' A' ' 21' ' ' GLU . 95.6 mtt180 -116.97 111.49 19.67 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.942 0.401 . . . . 0.0 111.151 178.594 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.506 ' O ' ' HA ' ' A' ' 19' ' ' VAL . 4.7 mp -94.54 104.75 16.13 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 171.108 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 14.6 mt -108.97 126.54 65.97 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.58 -174.193 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 165.26 -135.68 3.83 Favored Glycine 0 N--CA 1.442 -0.938 0 C-N-CA 119.962 -1.113 . . . . 0.0 113.033 176.592 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' ASP . . . . . 0.477 ' HB3' ' HG2' ' A' ' 75' ' ' LYS . 9.8 t70 -92.88 135.45 26.03 Favored Pre-proline 0 C--N 1.319 -0.729 0 CA-C-O 119.242 -0.408 . . . . 0.0 110.982 -176.564 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 75.0 Cg_exo -39.67 -42.87 3.0 Favored 'Trans proline' 0 C--O 1.237 0.427 0 C-N-CA 123.602 2.868 . . . . 0.0 113.605 -175.513 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' TYR . . . . . 0.433 ' O ' ' HG3' ' A' ' 78' ' ' GLN . 35.9 t80 -68.88 -53.51 20.81 Favored 'General case' 0 N--CA 1.453 -0.277 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.924 -175.676 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.602 ' HB2' HG13 ' A' ' 49' ' ' VAL . 0.0 OUTLIER -74.44 -24.36 59.05 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 120.268 -0.573 . . . . 0.0 111.87 -178.46 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.455 HG23 ' O ' ' A' ' 72' ' ' ASP . 75.8 t -63.15 -31.76 53.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-O 121.293 0.568 . . . . 0.0 109.69 174.136 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -76.57 -48.61 18.73 Favored 'General case' 0 N--CA 1.447 -0.582 0 N-CA-C 109.146 -0.686 . . . . 0.0 109.146 178.062 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 78' ' ' GLN . . . . . 0.433 ' HG3' ' O ' ' A' ' 74' ' ' TYR . 50.4 mt-30 -54.97 -43.46 73.53 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-O 121.551 0.691 . . . . 0.0 110.47 176.779 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 79' ' ' ALA . . . . . 0.456 ' HB3' HG21 ' A' ' 69' ' ' ILE . . . -64.68 -40.22 95.02 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.162 -0.926 . . . . 0.0 111.203 -178.63 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 42.3 t -65.65 -46.44 79.2 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.427 -179.659 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -70.6 -19.71 62.82 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 120.822 -0.351 . . . . 0.0 110.661 179.42 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' MET . . . . . 0.548 ' SD ' HD22 ' A' ' 43' ' ' LEU . 36.1 ttm -71.99 -54.63 9.33 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.831 0.348 . . . . 0.0 110.636 175.484 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.485 HG12 HD13 ' A' ' 43' ' ' LEU . 34.8 m -74.92 -29.93 23.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.803 -175.537 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 1.6 tmt? -70.09 -31.7 69.4 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.924 -0.58 . . . . 0.0 109.643 177.664 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' ASP . . . . . 0.482 ' O ' ' HB2' ' A' ' 89' ' ' GLU . 32.9 t70 -60.4 -36.88 79.15 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.392 177.661 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 22.5 mt -68.93 -23.17 27.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-O 121.401 0.619 . . . . 0.0 110.601 179.772 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.746 HD11 HD12 ' A' ' 24' ' ' ILE . 70.1 mt -89.4 -30.3 18.45 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.979 -176.918 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 40.7 ptt180 -86.1 -3.61 58.99 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.614 0.721 . . . . 0.0 109.185 174.805 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 89' ' ' GLU . . . . . 0.482 ' HB2' ' O ' ' A' ' 85' ' ' ASP . 9.5 tp10 . . . . . 0 C--O 1.252 1.2 0 CA-C-N 114.392 -1.277 . . . . 0.0 109.653 -178.724 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.445 -0.73 0 N-CA-C 112.261 -0.336 . . . . 0.0 112.261 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 6' ' ' GLN . . . . . 0.516 ' O ' ' HG2' ' A' ' 73' ' ' PRO . 5.8 mm-40 -67.04 -56.85 8.34 Favored 'General case' 0 CA--C 1.514 -0.423 0 N-CA-C 108.084 -1.08 . . . . 0.0 108.084 177.606 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 7' ' ' PHE . . . . . 0.668 ' HB3' ' HD2' ' A' ' 73' ' ' PRO . 0.7 OUTLIER -148.62 154.32 39.55 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.034 -0.985 . . . . 0.0 110.024 172.775 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 8' ' ' HIS . . . . . 0.716 ' HB3' ' HA ' ' A' ' 12' ' ' ASN . 6.7 t-80 -175.83 16.82 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.465 0 O-C-N 123.437 0.46 . . . . 0.0 110.403 -179.741 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 37.8 t70 64.37 -96.16 0.05 OUTLIER 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 115.695 -0.684 . . . . 0.0 112.457 175.145 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 54.3 t30 -75.03 -50.68 15.72 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.025 0.441 . . . . 0.0 110.616 -174.44 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -104.4 55.29 0.72 Allowed 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 116.099 -0.501 . . . . 0.0 109.988 176.864 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' ASN . . . . . 0.716 ' HA ' ' HB3' ' A' ' 8' ' ' HIS . 16.4 p-10 -69.25 -42.66 75.32 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.722 178.934 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 74.27 -78.36 0.97 Allowed Glycine 0 CA--C 1.519 0.298 0 CA-C-N 116.034 -0.53 . . . . 0.0 114.404 169.402 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -57.59 -77.98 0.14 Allowed Glycine 0 C--N 1.332 0.344 0 O-C-N 123.753 0.325 . . . . 0.0 112.914 -173.044 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 7.4 tt0 -88.44 107.38 18.83 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 107.858 -1.164 . . . . 0.0 107.858 173.18 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' ASN . . . . . 0.45 ' HA ' ' ND2' ' A' ' 12' ' ' ASN . 27.3 t-20 -89.72 -38.2 14.01 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.897 -167.399 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -134.44 84.18 0.28 Allowed Glycine 0 N--CA 1.443 -0.866 0 C-N-CA 120.484 -0.865 . . . . 0.0 112.53 -177.468 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.609 ' O ' ' HA ' ' A' ' 70' ' ' ILE . 37.5 m -75.6 126.79 31.71 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 175.618 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.514 ' HA ' ' O ' ' A' ' 69' ' ' ILE . 6.4 p -129.31 123.03 57.22 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-O 121.323 0.582 . . . . 0.0 111.339 -179.091 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 26.9 mt-30 -117.06 115.05 24.64 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.673 -0.694 . . . . 0.0 109.333 175.136 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.598 ' HG2' ' HG2' ' A' ' 68' ' ' ARG . 42.2 mt-10 -88.73 115.86 26.57 Favored 'General case' 0 CA--C 1.516 -0.35 0 CA-C-O 121.178 0.513 . . . . 0.0 111.372 -178.423 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.427 ' HB ' ' HB3' ' A' ' 67' ' ' LEU . 11.2 mm -98.72 152.9 4.22 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-N 115.426 -0.807 . . . . 0.0 109.686 179.482 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' MET . . . . . 0.417 ' HB3' ' HB3' ' A' ' 64' ' ' ASP . 1.8 mmt -106.39 91.27 3.63 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 174.747 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.69 ' HB ' ' HB2' ' A' ' 65' ' ' LYS . 29.7 mm -75.35 125.88 88.37 Favored Pre-proline 0 C--N 1.317 -0.805 0 CA-C-N 115.806 -0.634 . . . . 0.0 111.215 -173.869 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.582 ' HB2' ' HB2' ' A' ' 28' ' ' LYS . 85.4 Cg_exo -48.09 129.32 18.31 Favored 'Trans proline' 0 C--N 1.346 0.4 0 C-N-CA 123.165 2.577 . . . . 0.0 111.858 177.417 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -58.88 -24.34 62.12 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.838 -0.619 . . . . 0.0 112.579 -173.023 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -95.95 -1.83 61.3 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.622 -0.799 . . . . 0.0 112.804 -179.632 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.582 ' HB2' ' HB2' ' A' ' 25' ' ' PRO . 2.0 mppt? -116.05 19.71 14.84 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.019 0.438 . . . . 0.0 111.441 -179.448 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -76.15 -20.39 57.62 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.102 -178.633 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -69.11 -17.72 72.21 Favored Glycine 0 N--CA 1.449 -0.484 0 C-N-CA 120.994 -0.622 . . . . 0.0 112.697 -178.86 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 86.8 mt -93.96 -38.83 10.98 Favored 'General case' 0 C--N 1.323 -0.573 0 O-C-N 122.515 -0.403 . . . . 0.0 111.571 -177.958 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.439 HG21 HG21 ' A' ' 24' ' ' ILE . 3.5 m -69.98 -34.09 58.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.899 0.38 . . . . 0.0 111.131 179.327 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.583 HD11 ' HG2' ' A' ' 55' ' ' GLN . 64.9 mt -83.99 -44.76 18.23 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-O 121.506 0.67 . . . . 0.0 109.902 177.026 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 118.88 -178.84 16.75 Favored Glycine 0 N--CA 1.441 -1.012 0 CA-C-N 115.291 -0.868 . . . . 0.0 111.359 -178.158 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 39.0 mmtm -77.76 -29.51 51.01 Favored 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 -178.357 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -143.01 17.09 2.36 Favored Glycine 0 N--CA 1.444 -0.79 0 CA-C-N 115.18 -0.918 . . . . 0.0 111.476 176.032 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 95.73 0.79 62.19 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.991 -0.623 . . . . 0.0 112.947 178.899 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -69.08 -34.9 75.87 Favored 'General case' 0 C--N 1.328 -0.367 0 O-C-N 122.598 -0.354 . . . . 0.0 110.841 -178.956 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.721 ' O ' ' HG ' ' A' ' 43' ' ' LEU . 61.8 m -62.71 -55.47 26.43 Favored 'General case' 0 N--CA 1.452 -0.374 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.913 -177.639 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.48 ' HA ' HD12 ' A' ' 43' ' ' LEU . 7.5 tt -60.02 -34.21 55.73 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.383 0 CA-C-O 120.782 0.325 . . . . 0.0 111.628 -176.665 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 3.9 tmmm? -70.79 -39.4 73.18 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 179.394 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.462 ' O ' ' HG2' ' A' ' 46' ' ' ARG . 20.4 mm-40 -71.75 -37.79 70.5 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.991 -0.549 . . . . 0.0 111.187 -179.225 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.721 ' HG ' ' O ' ' A' ' 39' ' ' THR . 88.8 mt -53.44 -44.88 69.2 Favored 'General case' 0 CA--C 1.519 -0.238 0 CA-C-O 121.204 0.526 . . . . 0.0 110.992 179.428 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 47.1 mt-30 -68.14 -34.27 76.02 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.644 -0.707 . . . . 0.0 111.367 -177.435 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 32.2 mt-10 -80.48 -25.52 38.78 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 111.557 0.206 . . . . 0.0 111.557 -178.458 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' ARG . . . . . 0.462 ' HG2' ' O ' ' A' ' 42' ' ' GLN . 12.8 ptm180 -89.32 -30.2 18.6 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.688 0.28 . . . . 0.0 111.69 -178.705 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -88.63 -30.75 18.97 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 120.975 0.417 . . . . 0.0 110.905 178.528 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 91.79 -3.26 77.71 Favored Glycine 0 CA--C 1.519 0.339 0 C-N-CA 120.641 -0.79 . . . . 0.0 112.662 -179.219 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.441 ' CG1' ' HG3' ' A' ' 75' ' ' LYS . 16.1 m -103.54 179.22 0.71 Allowed 'Isoleucine or valine' 0 CA--C 1.516 -0.36 0 CA-C-O 121.063 0.459 . . . . 0.0 110.907 179.123 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.673 ' HE3' ' HB ' ' A' ' 52' ' ' ILE . 8.7 tmtm? -109.89 125.05 52.4 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 115.666 -0.697 . . . . 0.0 109.171 177.158 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 51' ' ' MET . . . . . 0.484 ' HE3' HG13 ' A' ' 69' ' ' ILE . 54.7 mtp -119.2 125.36 48.98 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 109.449 -0.574 . . . . 0.0 109.449 179.31 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.673 ' HB ' ' HE3' ' A' ' 50' ' ' LYS . 9.0 tt -115.67 107.69 23.33 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.805 0 CA-C-O 121.523 0.677 . . . . 0.0 110.832 177.823 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.602 HD22 HD13 ' A' ' 67' ' ' LEU . 3.4 mm? -80.95 102.78 10.35 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.206 -0.906 . . . . 0.0 108.574 170.192 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.626 HD12 ' HB2' ' A' ' 66' ' ' PRO . 59.0 mt -78.23 85.68 1.02 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.467 0 CA-C-O 121.868 0.842 . . . . 0.0 110.423 -177.301 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 55' ' ' GLN . . . . . 0.583 ' HG2' HD11 ' A' ' 33' ' ' ILE . 1.7 pp0? -120.17 -12.93 9.0 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 114.573 -1.194 . . . . 0.0 109.579 175.062 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -82.02 -36.45 27.77 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.131 -0.94 . . . . 0.0 108.955 174.036 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -77.09 113.11 3.68 Favored Glycine 0 N--CA 1.446 -0.658 0 N-CA-C 110.769 -0.932 . . . . 0.0 110.769 173.828 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 28.5 p -86.49 70.81 10.48 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 121.055 0.455 . . . . 0.0 112.03 -173.902 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 24.4 mp0 -121.26 -45.45 2.34 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.946 0.403 . . . . 0.0 110.226 174.408 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.479 ' HB2' ' HD3' ' A' ' 66' ' ' PRO . 9.1 m120 -117.64 28.42 8.45 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 121.242 0.544 . . . . 0.0 109.724 177.838 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 5.2 p -75.43 -25.35 57.44 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.114 -0.494 . . . . 0.0 112.108 -176.212 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 66.8 t30 -89.59 -0.97 57.87 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.357 0.599 . . . . 0.0 110.314 179.758 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 15.5 m -132.1 -153.11 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.131 -178.858 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.417 ' HB3' ' HB3' ' A' ' 23' ' ' MET . 6.6 m-20 -63.37 143.17 58.04 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 109.879 -0.415 . . . . 0.0 109.879 176.616 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.69 ' HB2' ' HB ' ' A' ' 24' ' ' ILE . 27.6 mmtp -91.83 129.19 43.07 Favored Pre-proline 0 C--N 1.324 -0.538 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.44 -169.833 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.626 ' HB2' HD12 ' A' ' 54' ' ' ILE . 23.4 Cg_exo -66.98 111.76 2.3 Favored 'Trans proline' 0 N--CA 1.463 -0.286 0 C-N-CA 123.292 2.661 . . . . 0.0 111.816 176.165 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.602 HD13 HD22 ' A' ' 53' ' ' LEU . 23.0 tp -114.52 114.57 25.95 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.389 178.169 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.636 ' HB2' ' CG2' ' A' ' 52' ' ' ILE . 99.6 mtt180 -104.34 110.52 22.79 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.657 176.682 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.514 ' O ' ' HA ' ' A' ' 19' ' ' VAL . 4.2 mp -93.92 108.33 20.45 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 N-CA-C 107.857 -1.164 . . . . 0.0 107.857 170.608 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.609 ' HA ' ' O ' ' A' ' 18' ' ' THR . 22.8 mt -116.69 133.89 61.92 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.606 -171.199 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 150.68 -108.65 0.39 Allowed Glycine 0 N--CA 1.448 -0.559 0 C-N-CA 120.811 -0.709 . . . . 0.0 113.112 172.579 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' ASP . . . . . 0.488 ' O ' HG23 ' A' ' 76' ' ' VAL . 14.1 t70 -103.79 132.08 21.38 Favored Pre-proline 0 C--N 1.318 -0.786 0 C-N-CA 123.19 0.596 . . . . 0.0 110.045 -174.916 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 73' ' ' PRO . . . . . 0.668 ' HD2' ' HB3' ' A' ' 7' ' ' PHE . 44.7 Cg_exo -54.82 -25.93 45.46 Favored 'Trans proline' 0 C--N 1.347 0.479 0 C-N-CA 123.541 2.827 . . . . 0.0 113.431 -173.498 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 53.5 t80 -76.19 -53.47 8.22 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.464 -177.228 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.509 ' HA ' ' HB2' ' A' ' 78' ' ' GLN . 5.8 ptpt -83.37 -17.57 41.84 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.866 -0.606 . . . . 0.0 111.992 -177.591 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.488 HG23 ' O ' ' A' ' 72' ' ' ASP . 45.2 t -63.15 -38.02 80.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 N-CA-C 109.552 -0.536 . . . . 0.0 109.552 170.863 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 1.4 mm100 -77.66 -41.13 39.29 Favored 'General case' 0 N--CA 1.451 -0.397 0 C-N-CA 120.807 -0.357 . . . . 0.0 110.608 177.373 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' GLN . . . . . 0.509 ' HB2' ' HA ' ' A' ' 75' ' ' LYS . 96.4 mt-30 -55.73 -47.12 77.44 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.831 0.348 . . . . 0.0 110.532 175.046 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 79' ' ' ALA . . . . . 0.446 ' HA ' ' HE2' ' A' ' 82' ' ' MET . . . -66.57 -38.87 88.0 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.122 179.629 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 49.9 t -62.33 -52.14 64.82 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.406 177.89 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -63.75 -30.99 72.02 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.338 178.356 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' MET . . . . . 0.464 ' O ' HG13 ' A' ' 86' ' ' ILE . 40.1 ttp -65.08 -52.17 57.13 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.602 -0.726 . . . . 0.0 111.198 178.482 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 30.7 m -76.18 -35.54 28.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 N-CA-C 111.74 0.274 . . . . 0.0 111.74 -177.06 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 93.9 mmm -67.85 -28.63 67.71 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.871 0.367 . . . . 0.0 110.012 177.113 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -64.87 -38.43 90.95 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.682 176.674 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.464 HG13 ' O ' ' A' ' 82' ' ' MET . 35.3 mt -64.0 -26.69 41.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.339 179.007 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.58 HD22 ' HB3' ' A' ' 28' ' ' LYS . 22.4 mt -97.64 -10.48 24.99 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.771 -177.859 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 28.0 tpt180 -99.37 -25.38 14.49 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.435 0.636 . . . . 0.0 111.09 -175.721 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 . . . . . 0 C--N 1.305 -1.327 0 CA-C-N 115.359 -0.837 . . . . 0.0 109.867 -178.048 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.444 -0.802 0 N-CA-C 111.948 -0.461 . . . . 0.0 111.948 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 81.1 mm-40 -96.57 -9.87 28.47 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 174.285 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' PHE . . . . . 0.404 ' HA ' ' CB ' ' A' ' 72' ' ' ASP . 5.0 p90 -175.99 176.49 1.77 Allowed 'General case' 0 N--CA 1.455 -0.22 0 CA-C-N 114.407 -1.269 . . . . 0.0 110.23 -179.535 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 12.0 t-80 -130.63 156.71 44.42 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.185 -0.461 . . . . 0.0 109.811 179.025 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' ASP . . . . . 0.618 ' HB2' ' HB2' ' A' ' 12' ' ' ASN . 4.5 m-20 64.42 33.94 10.77 Favored 'General case' 0 N--CA 1.466 0.357 0 O-C-N 123.577 0.548 . . . . 0.0 111.578 175.805 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 20.2 m120 68.87 -62.18 0.4 Allowed 'General case' 0 N--CA 1.469 0.481 0 O-C-N 123.758 0.661 . . . . 0.0 111.752 179.217 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -148.98 81.04 1.43 Allowed 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 109.759 -0.46 . . . . 0.0 109.759 179.115 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' ASN . . . . . 0.618 ' HB2' ' HB2' ' A' ' 9' ' ' ASP . 1.9 t-20 -115.15 124.19 50.85 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.547 -178.023 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -97.61 135.75 12.37 Favored Glycine 0 N--CA 1.446 -0.634 0 C-N-CA 120.951 -0.642 . . . . 0.0 112.28 -178.523 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 83.54 -122.55 5.83 Favored Glycine 0 N--CA 1.446 -0.685 0 C-N-CA 120.637 -0.792 . . . . 0.0 112.085 -179.281 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' GLN . . . . . 0.517 ' HG3' ' CG2' ' A' ' 70' ' ' ILE . 49.8 tt0 -68.92 107.58 3.15 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 120.73 0.3 . . . . 0.0 111.091 -178.783 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 16' ' ' ASN . . . . . 0.661 ' H ' ' HA2' ' A' ' 71' ' ' GLY . 0.9 OUTLIER -97.63 -59.37 1.79 Allowed 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.104 176.864 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 176.32 -41.78 0.11 Allowed Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.17 178.144 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 91.3 m -71.04 131.63 43.92 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 120.705 0.288 . . . . 0.0 110.45 177.396 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 7.6 p -140.23 138.35 37.13 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-O 120.928 0.394 . . . . 0.0 110.891 -178.786 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 77.9 mt-30 -119.16 114.61 22.72 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 109.739 -0.467 . . . . 0.0 109.739 174.213 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.713 ' HA ' ' O ' ' A' ' 67' ' ' LEU . 39.4 mt-10 -86.43 113.85 22.72 Favored 'General case' 0 CA--C 1.515 -0.392 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.864 179.079 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.483 ' HB ' ' HB3' ' A' ' 67' ' ' LEU . 14.7 mm -97.68 147.88 6.2 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 CA-C-N 115.257 -0.883 . . . . 0.0 110.227 -177.5 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 23' ' ' MET . . . . . 0.527 ' HB3' ' HB3' ' A' ' 64' ' ' ASP . 3.9 mmt -99.61 91.57 4.95 Favored 'General case' 0 C--N 1.317 -0.822 0 N-CA-C 108.531 -0.915 . . . . 0.0 108.531 173.322 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.665 ' HB ' ' HB2' ' A' ' 65' ' ' LYS . 36.8 mm -82.16 130.39 60.13 Favored Pre-proline 0 C--N 1.319 -0.722 0 CA-C-N 115.772 -0.649 . . . . 0.0 111.046 -174.396 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_exo -50.89 132.07 36.29 Favored 'Trans proline' 0 N--CA 1.46 -0.445 0 C-N-CA 122.885 2.39 . . . . 0.0 111.787 175.222 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -65.46 -18.89 65.67 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.263 -176.958 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -93.55 9.69 73.65 Favored Glycine 0 N--CA 1.445 -0.709 0 C-N-CA 120.97 -0.633 . . . . 0.0 112.325 177.294 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.525 ' HB3' HD22 ' A' ' 87' ' ' LEU . 58.8 mttp -132.38 26.68 4.46 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.861 0.362 . . . . 0.0 111.409 179.947 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -74.77 -23.5 58.54 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.232 0.539 . . . . 0.0 110.239 178.922 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -71.16 -16.36 75.08 Favored Glycine 0 N--CA 1.449 -0.443 0 CA-C-N 115.543 -0.753 . . . . 0.0 112.522 179.565 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 79.5 mt -93.65 -39.92 10.54 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 122.471 -0.429 . . . . 0.0 111.183 -179.299 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.58 HG13 HD21 ' A' ' 87' ' ' LEU . 2.8 m -76.4 -33.03 22.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-O 120.951 0.405 . . . . 0.0 111.533 -179.914 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.657 ' HA ' ' HB ' ' A' ' 40' ' ' ILE . 67.5 mt -93.68 -40.14 11.42 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-O 121.527 0.679 . . . . 0.0 110.18 179.079 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 119.49 160.65 11.37 Favored Glycine 0 N--CA 1.441 -1.025 0 CA-C-N 115.527 -0.76 . . . . 0.0 111.714 -179.634 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -65.47 -23.1 66.83 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.971 0.415 . . . . 0.0 110.504 -179.446 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -134.11 8.33 4.77 Favored Glycine 0 N--CA 1.446 -0.665 0 C-N-CA 120.741 -0.742 . . . . 0.0 111.896 177.244 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.591 ' HA2' HG22 ' A' ' 33' ' ' ILE . . . 87.39 12.14 67.87 Favored Glycine 0 N--CA 1.452 -0.245 0 C-N-CA 120.942 -0.646 . . . . 0.0 112.15 -177.196 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 13.7 mt-10 -84.64 -37.64 20.81 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.101 0.476 . . . . 0.0 110.6 -178.178 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.688 ' O ' ' HG ' ' A' ' 43' ' ' LEU . 21.2 m -59.84 -47.88 83.96 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.532 -0.758 . . . . 0.0 111.752 -173.41 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.657 ' HB ' ' HA ' ' A' ' 33' ' ' ILE . 9.3 tt -57.68 -34.82 48.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 120.929 0.395 . . . . 0.0 111.334 -178.565 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.49 ' HG3' ' OE2' ' A' ' 45' ' ' GLU . 0.0 OUTLIER -70.77 -36.76 73.21 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.103 0.478 . . . . 0.0 109.972 179.189 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 15.6 mm100 -71.07 -39.01 72.44 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.572 -178.915 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.688 ' HG ' ' O ' ' A' ' 39' ' ' THR . 54.7 mt -57.07 -47.38 81.12 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.715 179.889 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' GLN . . . . . 0.404 ' HG3' ' O ' ' A' ' 40' ' ' ILE . 45.2 mt-30 -62.27 -50.65 70.86 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.691 -179.981 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.49 ' OE2' ' HG3' ' A' ' 41' ' ' LYS . 46.1 mt-10 -63.62 -39.56 94.69 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.722 -0.672 . . . . 0.0 112.024 -176.594 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 13.9 ptm180 -77.68 -33.38 53.28 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 111.937 0.347 . . . . 0.0 111.937 -173.847 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -93.75 -12.26 29.56 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 120.985 0.422 . . . . 0.0 111.461 -177.2 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 73.13 35.51 57.29 Favored Glycine 0 N--CA 1.451 -0.323 0 N-CA-C 111.189 -0.764 . . . . 0.0 111.189 -177.482 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 29.5 m -124.45 175.6 6.74 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-O 120.964 0.411 . . . . 0.0 110.741 -173.811 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 78.3 tttt -115.65 123.7 49.04 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 169.414 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' MET . . . . . 0.412 ' CE ' HG11 ' A' ' 83' ' ' VAL . 71.8 mtp -123.6 114.68 20.33 Favored 'General case' 0 C--N 1.317 -0.82 0 N-CA-C 109.082 -0.71 . . . . 0.0 109.082 177.721 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.611 ' CG2' ' HB2' ' A' ' 68' ' ' ARG . 10.8 tt -109.97 105.51 18.94 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.143 0 CA-C-O 121.662 0.744 . . . . 0.0 109.595 177.362 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -82.53 102.26 11.26 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.169 -0.923 . . . . 0.0 108.625 174.716 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.502 ' HB ' ' HB2' ' A' ' 66' ' ' PRO . 20.3 mt -82.28 85.71 1.75 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.767 0 CA-C-O 121.669 0.747 . . . . 0.0 109.188 -175.939 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 4.1 pp0? -110.09 -4.63 15.71 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.171 -0.922 . . . . 0.0 110.994 -175.141 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -134.09 -28.5 1.34 Allowed 'General case' 0 C--N 1.32 -0.7 0 CA-C-O 120.946 0.403 . . . . 0.0 110.585 179.311 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -90.44 29.39 6.71 Favored Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 120.588 -0.815 . . . . 0.0 112.967 -177.125 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 42.5 t -152.1 165.32 35.13 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.058 0.456 . . . . 0.0 110.012 -179.207 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 86.2 mm-40 -103.28 11.95 36.15 Favored 'General case' 0 N--CA 1.444 -0.754 0 CA-C-N 115.502 -0.772 . . . . 0.0 109.032 -179.443 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.434 ' HA ' HG22 ' A' ' 63' ' ' VAL . 18.0 m120 -100.16 13.1 35.33 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 114.902 -1.045 . . . . 0.0 109.104 170.622 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 61' ' ' THR . . . . . 0.488 ' HA ' ' HE3' ' A' ' 65' ' ' LYS . 9.1 t -64.42 -23.16 67.19 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.392 179.17 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 4.9 p-10 -93.5 -1.69 55.31 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.691 -0.686 . . . . 0.0 111.05 -179.161 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.463 ' HB ' ' H ' ' A' ' 64' ' ' ASP . 7.9 m -132.61 -145.53 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 N-CA-C 109.673 -0.491 . . . . 0.0 109.673 -179.661 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.527 ' HB3' ' HB3' ' A' ' 23' ' ' MET . 8.4 m-20 -59.69 137.63 57.98 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 109.722 -0.473 . . . . 0.0 109.722 175.067 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.665 ' HB2' ' HB ' ' A' ' 24' ' ' ILE . 1.2 mmmm -93.89 122.26 62.49 Favored Pre-proline 0 C--N 1.318 -0.769 0 CA-C-N 115.971 -0.558 . . . . 0.0 111.255 -170.645 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.502 ' HB2' ' HB ' ' A' ' 54' ' ' ILE . 39.3 Cg_exo -63.22 105.95 0.52 Allowed 'Trans proline' 0 N--CA 1.464 -0.21 0 C-N-CA 123.291 2.661 . . . . 0.0 112.225 177.476 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.713 ' O ' ' HA ' ' A' ' 21' ' ' GLU . 3.7 tt -101.42 135.69 42.49 Favored 'General case' 0 C--N 1.319 -0.735 0 N-CA-C 108.481 -0.933 . . . . 0.0 108.481 177.7 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.71 ' N ' HD23 ' A' ' 67' ' ' LEU . 90.9 mtt180 -124.61 107.09 10.66 Favored 'General case' 0 N--CA 1.443 -0.82 0 C-N-CA 119.255 -0.978 . . . . 0.0 112.633 170.123 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.554 ' CD1' HD22 ' A' ' 67' ' ' LEU . 3.8 mp -90.08 106.14 16.92 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.264 0 N-CA-C 107.943 -1.132 . . . . 0.0 107.943 167.72 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.517 ' CG2' ' HG3' ' A' ' 15' ' ' GLN . 7.4 mt -109.35 127.81 65.81 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.873 0 CA-C-O 120.946 0.403 . . . . 0.0 110.394 -176.141 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 71' ' ' GLY . . . . . 0.661 ' HA2' ' H ' ' A' ' 16' ' ' ASN . . . 173.64 -132.47 2.31 Favored Glycine 0 N--CA 1.441 -1.026 0 N-CA-C 111.044 -0.822 . . . . 0.0 111.044 179.496 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 72' ' ' ASP . . . . . 0.809 ' HB3' ' HE2' ' A' ' 75' ' ' LYS . 0.0 OUTLIER -103.55 153.49 38.56 Favored Pre-proline 0 C--N 1.318 -0.799 0 CA-C-O 118.992 -0.528 . . . . 0.0 109.594 176.71 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_exo -47.1 -39.21 25.76 Favored 'Trans proline' 0 C--N 1.347 0.451 0 C-N-CA 122.273 1.982 . . . . 0.0 112.268 -178.026 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' TYR . . . . . 0.419 ' HB3' ' OD1' ' A' ' 72' ' ' ASP . 22.6 t80 -67.39 -58.9 3.93 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.089 -0.96 . . . . 0.0 111.504 -177.576 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.809 ' HE2' ' HB3' ' A' ' 72' ' ' ASP . 0.0 OUTLIER -67.54 -33.86 75.92 Favored 'General case' 0 CA--C 1.514 -0.418 0 C-N-CA 120.98 -0.288 . . . . 0.0 111.185 -178.773 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.403 HG13 ' HB ' ' A' ' 69' ' ' ILE . 55.0 t -64.39 -39.72 86.55 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.377 0 N-CA-C 109.647 -0.501 . . . . 0.0 109.647 -178.418 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 6.5 tp-100 -76.88 -41.89 42.04 Favored 'General case' 0 N--CA 1.443 -0.807 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.674 -177.739 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 75.3 mt-30 -63.93 -38.56 91.54 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 120.709 -0.396 . . . . 0.0 110.558 177.768 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -69.7 -37.16 76.5 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.534 178.766 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' CYS . . . . . 0.425 ' O ' ' HB2' ' A' ' 84' ' ' MET . 50.6 t -65.52 -46.58 79.05 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.549 176.626 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 73.0 mt-10 -62.93 -21.87 66.36 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 121.047 0.451 . . . . 0.0 110.691 177.852 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' MET . . . . . 0.425 ' O ' HG13 ' A' ' 86' ' ' ILE . 38.5 ttp -77.46 -52.33 9.29 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.25 179.68 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.461 ' O ' ' HG ' ' A' ' 87' ' ' LEU . 32.9 m -73.52 -35.34 44.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.562 -177.853 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 84' ' ' MET . . . . . 0.425 ' HB2' ' O ' ' A' ' 80' ' ' CYS . 2.7 mmt -66.94 -34.12 77.08 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.682 0.277 . . . . 0.0 111.2 179.293 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 85' ' ' ASP . . . . . 0.479 ' O ' ' HB2' ' A' ' 89' ' ' GLU . 27.9 t70 -67.67 -31.5 71.53 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 120.836 -0.345 . . . . 0.0 110.154 -179.163 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.425 HG13 ' O ' ' A' ' 82' ' ' MET . 53.0 mt -67.44 -40.4 84.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 121.185 0.517 . . . . 0.0 109.974 176.476 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.58 HD21 HG13 ' A' ' 32' ' ' VAL . 49.1 mt -70.28 -42.02 72.63 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.699 -179.326 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 88' ' ' ARG . . . . . 0.452 ' HD3' HH11 ' A' ' 88' ' ' ARG . 9.5 mmm180 -85.45 7.52 22.45 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.969 -0.559 . . . . 0.0 111.201 -176.936 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 89' ' ' GLU . . . . . 0.479 ' HB2' ' O ' ' A' ' 85' ' ' ASP . 40.1 tt0 . . . . . 0 C--O 1.25 1.082 0 CA-C-O 118.222 -0.894 . . . . 0.0 109.663 178.346 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.443 -0.871 0 N-CA-C 111.622 -0.591 . . . . 0.0 111.622 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 21.3 mp0 52.51 67.44 0.98 Allowed 'General case' 0 N--CA 1.462 0.173 0 CA-C-O 120.991 0.424 . . . . 0.0 111.222 179.161 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 18.6 p90 -80.45 55.14 2.2 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.656 -177.581 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' HIS . . . . . 0.974 ' HB3' ' HA ' ' A' ' 12' ' ' ASN . 8.7 t-160 71.25 115.76 0.05 OUTLIER 'General case' 0 N--CA 1.466 0.352 0 CA-C-O 121.977 0.894 . . . . 0.0 110.751 179.131 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -51.02 -46.9 61.73 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 114.171 -1.377 . . . . 0.0 112.972 -174.318 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 58.2 t30 -105.86 121.49 44.17 Favored 'General case' 0 C--N 1.323 -0.574 0 C-N-CA 120.89 -0.324 . . . . 0.0 110.275 178.8 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.479 ' O ' ' HB3' ' A' ' 12' ' ' ASN . . . 60.32 -95.39 0.05 Allowed 'General case' 0 C--O 1.23 0.065 0 O-C-N 124.053 0.846 . . . . 0.0 110.874 -177.606 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 12' ' ' ASN . . . . . 0.974 ' HA ' ' HB3' ' A' ' 8' ' ' HIS . 9.4 p30 164.86 -34.1 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.215 0 O-C-N 124.158 0.911 . . . . 0.0 109.324 175.365 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -29.29 119.05 0.07 OUTLIER Glycine 0 C--N 1.34 0.804 0 O-C-N 124.559 1.162 . . . . 0.0 115.396 -173.947 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 94.52 -132.15 11.03 Favored Glycine 0 N--CA 1.448 -0.551 0 C-N-CA 121.283 -0.484 . . . . 0.0 112.041 178.878 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 25.6 tt0 -65.6 108.25 1.98 Allowed 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 110.008 -0.367 . . . . 0.0 110.008 177.742 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' ASN . . . . . 0.694 ' HA ' ' HB2' ' A' ' 8' ' ' HIS . 13.4 m120 -79.69 -79.51 0.14 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.145 179.892 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 175.77 -56.33 0.11 Allowed Glycine 0 C--N 1.331 0.255 0 C-N-CA 119.718 -1.229 . . . . 0.0 113.839 178.416 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.549 ' OG1' ' HD3' ' A' ' 73' ' ' PRO . 90.5 m -59.85 131.58 51.31 Favored 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 122.689 0.396 . . . . 0.0 111.111 -177.888 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.489 ' HA ' ' O ' ' A' ' 69' ' ' ILE . 4.7 p -140.74 126.52 20.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-O 121.249 0.547 . . . . 0.0 111.931 -176.833 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 26.5 mt-30 -111.45 128.78 56.1 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.037 173.465 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.581 ' HG2' ' HG2' ' A' ' 68' ' ' ARG . 45.6 mt-10 -96.71 115.37 27.32 Favored 'General case' 0 C--N 1.327 -0.41 0 O-C-N 123.401 0.438 . . . . 0.0 111.263 178.866 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.414 ' HB ' ' HB3' ' A' ' 67' ' ' LEU . 14.4 mm -100.77 150.29 5.76 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 177.412 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 16.5 mmt -103.44 92.01 4.3 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 175.988 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.66 ' HB ' ' HB2' ' A' ' 65' ' ' LYS . 47.1 mm -81.5 128.2 70.56 Favored Pre-proline 0 C--N 1.318 -0.77 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.853 -175.625 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 81.6 Cg_exo -47.77 131.72 20.64 Favored 'Trans proline' 0 C--N 1.345 0.346 0 C-N-CA 123.21 2.607 . . . . 0.0 112.214 176.828 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -59.68 -26.71 65.78 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.855 -0.611 . . . . 0.0 111.342 -178.413 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -75.36 -31.03 57.68 Favored Glycine 0 N--CA 1.449 -0.484 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.371 177.499 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.963 ' HD3' ' HG ' ' A' ' 87' ' ' LEU . 94.6 mttt -98.22 19.18 14.66 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.786 0.327 . . . . 0.0 111.494 -178.192 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.606 ' O ' HG13 ' A' ' 33' ' ' ILE . . . -64.6 -34.07 77.41 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.798 179.288 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -68.64 -25.39 75.05 Favored Glycine 0 N--CA 1.448 -0.531 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.053 179.693 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 88.1 mt -74.03 -42.59 60.05 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.657 0.265 . . . . 0.0 110.634 -178.823 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.584 HG21 HG21 ' A' ' 24' ' ' ILE . 0.0 OUTLIER -72.84 -23.39 20.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.421 179.687 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.606 HG13 ' O ' ' A' ' 29' ' ' ALA . 67.2 mt -76.6 -35.19 25.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-O 121.74 0.781 . . . . 0.0 109.576 172.545 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.708 ' HA3' ' HB ' ' A' ' 39' ' ' THR . . . 98.81 32.34 5.96 Favored Glycine 0 CA--C 1.5 -0.877 0 CA-C-N 114.962 -1.017 . . . . 0.0 112.396 177.911 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 14.5 mmmm 69.7 -64.51 0.34 Allowed 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.398 0.705 . . . . 0.0 111.68 177.633 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -89.58 -30.35 13.79 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 121.072 -0.585 . . . . 0.0 112.161 -177.815 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.584 ' HA2' HG22 ' A' ' 33' ' ' ILE . . . 109.92 -2.61 30.2 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.602 -0.808 . . . . 0.0 112.428 178.878 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -85.75 -27.54 25.16 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-O 120.993 0.425 . . . . 0.0 111.054 178.148 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.708 ' HB ' ' HA3' ' A' ' 34' ' ' GLY . 17.0 m -67.07 -41.31 86.62 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.393 -177.394 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.477 ' CD1' HD23 ' A' ' 53' ' ' LEU . 8.6 tt -58.36 -33.19 46.96 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.319 0 CA-C-O 120.986 0.422 . . . . 0.0 110.765 178.697 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.402 ' O ' ' HG3' ' A' ' 45' ' ' GLU . 31.3 ttpt -69.89 -43.1 72.46 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.144 0.497 . . . . 0.0 109.952 174.79 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.52 ' O ' ' HG2' ' A' ' 46' ' ' ARG . 55.0 mt-30 -63.5 -38.63 91.89 Favored 'General case' 0 CA--C 1.512 -0.484 0 CA-C-N 115.449 -0.796 . . . . 0.0 110.601 -177.041 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.654 ' HG ' ' O ' ' A' ' 39' ' ' THR . 73.5 mt -55.38 -43.52 75.22 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.724 179.759 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 44.4 mt-30 -64.85 -44.84 88.45 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.328 178.981 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.402 ' HG3' ' O ' ' A' ' 41' ' ' LYS . 40.8 mt-10 -63.82 -45.99 87.13 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.71 -0.677 . . . . 0.0 111.448 -178.878 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 46' ' ' ARG . . . . . 0.52 ' HG2' ' O ' ' A' ' 42' ' ' GLN . 11.7 ptp180 -77.46 -28.83 52.52 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 112.69 0.626 . . . . 0.0 112.69 -174.269 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.566 ' HB3' HG22 ' A' ' 49' ' ' VAL . . . -92.14 -18.08 24.03 Favored 'General case' 0 C--N 1.325 -0.478 0 C-N-CA 120.674 -0.41 . . . . 0.0 111.952 -177.441 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 75.33 25.31 68.64 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.701 -0.761 . . . . 0.0 111.652 -178.029 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.566 HG22 ' HB3' ' A' ' 47' ' ' ALA . 33.4 m -127.8 170.46 17.56 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 N-CA-C 109.791 -0.448 . . . . 0.0 109.791 -178.183 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.62 ' HE3' ' HB ' ' A' ' 52' ' ' ILE . 8.9 tmtm? -110.8 124.37 51.9 Favored 'General case' 0 C--N 1.317 -0.84 0 N-CA-C 109.306 -0.628 . . . . 0.0 109.306 175.838 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 51' ' ' MET . . . . . 0.518 ' CE ' ' HB1' ' A' ' 79' ' ' ALA . 62.6 mtt -112.42 129.34 56.36 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 179.347 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.62 ' HB ' ' HE3' ' A' ' 50' ' ' LYS . 8.9 tt -122.3 105.69 16.62 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.933 0 CA-C-O 121.514 0.673 . . . . 0.0 110.133 175.129 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.519 ' O ' ' HG2' ' A' ' 55' ' ' GLN . 4.0 mm? -81.44 103.42 11.17 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 115.3 -0.863 . . . . 0.0 109.035 174.916 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.577 HD12 ' HB2' ' A' ' 66' ' ' PRO . 53.5 mt -75.54 87.04 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 122.013 0.911 . . . . 0.0 109.689 179.185 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 55' ' ' GLN . . . . . 0.519 ' HG2' ' O ' ' A' ' 53' ' ' LEU . 2.2 pt20 -137.25 -36.7 0.65 Allowed 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 114.359 -1.291 . . . . 0.0 109.293 -178.017 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -70.28 -30.95 68.1 Favored 'General case' 0 N--CA 1.455 -0.213 0 CA-C-N 115.329 -0.851 . . . . 0.0 108.923 172.116 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -83.65 128.26 8.47 Favored Glycine 0 N--CA 1.446 -0.671 0 N-CA-C 110.864 -0.894 . . . . 0.0 110.864 173.678 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' SER . . . . . 0.476 ' HA ' HG23 ' A' ' 61' ' ' THR . 5.2 p -80.75 70.21 7.46 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.459 0.647 . . . . 0.0 112.156 -174.42 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 46.1 mt-30 -113.36 -57.42 2.29 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.666 -0.697 . . . . 0.0 109.489 172.1 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.561 ' HB2' ' HD3' ' A' ' 66' ' ' PRO . 4.2 m-20 -114.23 44.05 1.76 Allowed 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.272 178.178 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 61' ' ' THR . . . . . 0.476 HG23 ' HA ' ' A' ' 58' ' ' SER . 0.6 OUTLIER -64.19 -35.63 81.43 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.42 -178.926 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 91.6 m-20 -96.07 -9.59 30.48 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 112.445 0.535 . . . . 0.0 112.445 -177.025 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 28.2 m -126.48 -163.65 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 N-CA-C 112.06 0.393 . . . . 0.0 112.06 -174.335 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.487 ' O ' ' HB3' ' A' ' 60' ' ' ASN . 6.2 m-20 -54.76 149.64 10.89 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.661 178.025 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.66 ' HB2' ' HB ' ' A' ' 24' ' ' ILE . 72.1 mmtt -96.72 125.48 46.64 Favored Pre-proline 0 C--N 1.316 -0.865 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.361 -170.449 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.577 ' HB2' HD12 ' A' ' 54' ' ' ILE . 14.0 Cg_exo -70.5 106.31 1.77 Allowed 'Trans proline' 0 N--CA 1.457 -0.647 0 C-N-CA 122.958 2.439 . . . . 0.0 111.317 174.949 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.547 HD21 HG21 ' A' ' 83' ' ' VAL . 23.2 tp -105.4 110.93 23.46 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.841 -0.618 . . . . 0.0 109.693 178.818 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.606 ' HB2' ' CG2' ' A' ' 52' ' ' ILE . 96.1 mtt180 -101.65 109.28 21.04 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-O 120.932 0.396 . . . . 0.0 110.952 177.718 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.489 ' O ' ' HA ' ' A' ' 19' ' ' VAL . 4.4 mp -90.29 104.14 14.96 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 172.237 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 18.3 mt -104.48 121.73 56.59 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.588 -174.647 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' GLY . . . . . 0.611 ' HA2' ' HB2' ' A' ' 16' ' ' ASN . . . 175.95 -125.4 1.05 Allowed Glycine 0 N--CA 1.445 -0.75 0 CA-C-N 116.002 -0.545 . . . . 0.0 112.025 179.872 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -114.84 142.67 28.72 Favored Pre-proline 0 C--N 1.32 -0.698 0 N-CA-C 108.863 -0.791 . . . . 0.0 108.863 179.641 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' PRO . . . . . 0.549 ' HD3' ' OG1' ' A' ' 18' ' ' THR . 86.0 Cg_exo -43.33 -39.5 9.01 Favored 'Trans proline' 0 C--N 1.351 0.699 0 C-N-CA 123.034 2.489 . . . . 0.0 112.751 -173.636 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 66.6 t80 -63.33 -57.83 9.11 Favored 'General case' 0 N--CA 1.451 -0.425 0 CA-C-N 115.225 -0.898 . . . . 0.0 111.293 -177.949 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 32.9 pttt -75.96 -30.45 58.63 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.482 -0.326 . . . . 0.0 111.571 -178.221 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 51.9 t -57.24 -40.62 74.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-O 120.894 0.378 . . . . 0.0 110.031 176.395 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -73.67 -45.85 50.01 Favored 'General case' 0 N--CA 1.448 -0.544 0 C-N-CA 120.496 -0.481 . . . . 0.0 111.094 179.144 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 49.0 mt-30 -63.41 -37.76 88.52 Favored 'General case' 0 C--N 1.326 -0.419 0 C-N-CA 120.389 -0.524 . . . . 0.0 111.115 -179.355 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' ALA . . . . . 0.518 ' HB1' ' CE ' ' A' ' 51' ' ' MET . . . -67.57 -37.69 82.99 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.211 176.856 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 37.4 t -63.91 -48.04 78.2 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.586 175.867 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 55.0 mt-10 -61.15 -38.43 86.39 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 110.045 -0.354 . . . . 0.0 110.045 177.19 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' MET . . . . . 0.461 ' O ' HG13 ' A' ' 86' ' ' ILE . 48.1 ttp -61.1 -49.38 77.52 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.658 -0.701 . . . . 0.0 111.315 179.611 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.547 HG21 HD21 ' A' ' 67' ' ' LEU . 27.7 m -77.33 -33.06 19.38 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-O 120.813 0.339 . . . . 0.0 110.897 -176.801 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 54.7 ttp -67.11 -33.69 76.0 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 109.427 -0.583 . . . . 0.0 109.427 176.005 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -67.33 -31.2 71.31 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.417 -0.811 . . . . 0.0 110.641 178.106 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.461 HG13 ' O ' ' A' ' 82' ' ' MET . 59.4 mt -61.32 -30.49 48.06 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.304 0 CA-C-O 121.365 0.603 . . . . 0.0 110.17 176.398 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.963 ' HG ' ' HD3' ' A' ' 28' ' ' LYS . 6.9 mp -88.1 -5.87 58.21 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.733 178.844 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 6.0 tmm_? -114.37 -3.79 13.04 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.443 0.64 . . . . 0.0 110.717 -175.161 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 89' ' ' GLU . . . . . 0.443 ' O ' ' HG3' ' A' ' 89' ' ' GLU . 9.6 pt-20 . . . . . 0 C--O 1.251 1.143 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.895 -177.317 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.442 -0.919 0 N-CA-C 111.855 -0.498 . . . . 0.0 111.855 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 95.6 mt-30 61.16 -85.69 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.28 0 C-N-CA 123.389 0.676 . . . . 0.0 110.848 -177.424 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' PHE . . . . . 0.492 ' HB2' ' OD1' ' A' ' 72' ' ' ASP . 11.3 p90 -138.21 154.24 49.11 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.718 -0.673 . . . . 0.0 109.482 177.231 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 8' ' ' HIS . . . . . 0.425 ' HB3' ' H ' ' A' ' 9' ' ' ASP . 4.4 t60 -173.12 -92.77 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.77 0.319 . . . . 0.0 110.444 -175.304 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 9' ' ' ASP . . . . . 0.425 ' H ' ' HB3' ' A' ' 8' ' ' HIS . 17.3 t70 -148.7 113.89 5.52 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 109.971 -0.381 . . . . 0.0 109.971 179.96 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 66.1 t30 52.22 -108.79 0.41 Allowed 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 116.02 -0.536 . . . . 0.0 109.876 -173.475 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -83.16 125.82 31.95 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 109.628 -0.508 . . . . 0.0 109.628 177.593 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 9.1 p30 -84.01 21.29 1.36 Allowed 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 112.121 0.415 . . . . 0.0 112.121 -172.995 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 101.27 81.63 1.6 Allowed Glycine 0 N--CA 1.448 -0.555 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.205 179.12 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 82.59 -61.68 4.7 Favored Glycine 0 N--CA 1.449 -0.451 0 C-N-CA 120.959 -0.639 . . . . 0.0 111.801 -179.959 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' GLN . . . . . 0.826 ' HG2' ' H ' ' A' ' 17' ' ' GLY . 35.4 tt0 -59.04 134.3 56.86 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 120.897 0.38 . . . . 0.0 110.093 176.458 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 9.3 p30 -75.12 -6.47 49.73 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.273 -178.438 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' GLY . . . . . 0.826 ' H ' ' HG2' ' A' ' 15' ' ' GLN . . . 66.57 -127.64 28.98 Favored Glycine 0 N--CA 1.449 -0.456 0 CA-C-N 115.879 -0.6 . . . . 0.0 112.549 178.149 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 55.4 m -101.3 130.52 47.46 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-O 120.784 0.326 . . . . 0.0 110.449 -178.56 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.659 HG22 HG23 ' A' ' 70' ' ' ILE . 92.8 t -116.72 121.18 67.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 N-CA-C 109.71 -0.478 . . . . 0.0 109.71 176.406 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 20' ' ' GLN . . . . . 0.53 ' HB2' ' CG1' ' A' ' 76' ' ' VAL . 13.1 tt0 -114.18 113.05 24.14 Favored 'General case' 0 C--N 1.315 -0.903 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 177.927 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.61 ' HA ' ' O ' ' A' ' 67' ' ' LEU . 49.7 mt-10 -99.43 112.9 25.01 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.117 179.194 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 12.6 mm -97.24 155.48 3.58 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-N 115.614 -0.721 . . . . 0.0 109.67 179.111 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 1.9 mmt -109.15 91.85 3.81 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 175.845 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.674 ' HB ' ' HB2' ' A' ' 65' ' ' LYS . 37.2 mm -79.27 127.31 79.38 Favored Pre-proline 0 C--N 1.319 -0.752 0 CA-C-N 115.859 -0.609 . . . . 0.0 110.629 -175.209 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.727 ' HB2' ' HB2' ' A' ' 28' ' ' LYS . 87.3 Cg_exo -48.14 131.61 22.15 Favored 'Trans proline' 0 C--N 1.343 0.288 0 C-N-CA 122.84 2.36 . . . . 0.0 111.961 177.126 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -59.59 -30.6 68.78 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.701 -175.434 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -94.47 12.51 68.75 Favored Glycine 0 N--CA 1.45 -0.432 0 C-N-CA 120.785 -0.721 . . . . 0.0 112.332 178.743 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.727 ' HB2' ' HB2' ' A' ' 25' ' ' PRO . 16.4 tptt -126.48 8.36 7.07 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.15 0.5 . . . . 0.0 110.263 -179.677 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -70.0 -22.41 63.12 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.14 -176.898 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -67.59 -17.37 68.81 Favored Glycine 0 N--CA 1.445 -0.761 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.412 178.124 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.415 HD12 ' HG3' ' A' ' 28' ' ' LYS . 54.0 mt -87.59 -38.45 15.94 Favored 'General case' 0 C--N 1.328 -0.345 0 O-C-N 122.613 -0.345 . . . . 0.0 111.436 -179.195 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.741 HG13 HD21 ' A' ' 87' ' ' LEU . 2.8 m -70.81 -32.68 49.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.962 0.41 . . . . 0.0 111.043 179.879 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.561 HD11 ' HG3' ' A' ' 55' ' ' GLN . 60.2 mt -83.2 -36.76 13.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-O 121.669 0.747 . . . . 0.0 109.763 175.262 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 101.62 171.76 27.98 Favored Glycine 0 N--CA 1.445 -0.745 0 CA-C-N 114.977 -1.01 . . . . 0.0 111.608 -179.722 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 10.5 mptt -81.6 48.76 1.22 Allowed 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.098 0.475 . . . . 0.0 110.373 178.977 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 170.45 -44.23 0.2 Allowed Glycine 0 N--CA 1.447 -0.619 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.778 179.238 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.459 ' HA2' HG22 ' A' ' 33' ' ' ILE . . . 123.19 -4.31 9.61 Favored Glycine 0 N--CA 1.449 -0.439 0 C-N-CA 120.785 -0.721 . . . . 0.0 111.536 -177.192 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -75.13 -33.46 61.56 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.019 0.438 . . . . 0.0 109.95 178.651 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.687 ' O ' ' HG ' ' A' ' 43' ' ' LEU . 69.9 m -58.28 -54.39 47.54 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-N 115.583 -0.735 . . . . 0.0 111.198 -176.289 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.564 ' HA ' HD12 ' A' ' 43' ' ' LEU . 10.3 tt -59.77 -34.61 56.23 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.28 0 CA-C-O 120.837 0.351 . . . . 0.0 111.14 179.915 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.465 ' O ' ' HG2' ' A' ' 45' ' ' GLU . 50.1 tttp -62.33 -48.96 77.52 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.339 175.078 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.445 ' O ' ' HG2' ' A' ' 46' ' ' ARG . 72.4 mm-40 -64.69 -33.56 76.24 Favored 'General case' 0 CA--C 1.509 -0.602 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.013 -175.259 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.687 ' HG ' ' O ' ' A' ' 39' ' ' THR . 67.8 mt -58.25 -48.24 81.03 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.413 179.307 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 43.1 mt-30 -65.79 -38.61 89.48 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.534 179.089 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.465 ' HG2' ' O ' ' A' ' 41' ' ' LYS . 60.0 mm-40 -60.69 -52.66 64.17 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.669 177.817 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 46' ' ' ARG . . . . . 0.445 ' HG2' ' O ' ' A' ' 42' ' ' GLN . 10.7 ptm180 -77.67 -29.93 51.77 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.592 -0.731 . . . . 0.0 112.634 -170.825 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -87.55 -25.87 23.42 Favored 'General case' 0 C--N 1.323 -0.554 0 C-N-CA 120.702 -0.399 . . . . 0.0 111.927 -176.077 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 78.23 24.84 62.75 Favored Glycine 0 N--CA 1.453 -0.215 0 C-N-CA 120.577 -0.82 . . . . 0.0 112.424 -179.812 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 5.9 m -135.75 179.29 4.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 N-CA-C 109.926 -0.398 . . . . 0.0 109.926 177.343 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 60.8 tttp -107.4 124.67 50.18 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.846 179.905 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 37.3 mtt -118.97 116.43 26.44 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 177.639 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.607 ' CG2' ' HB2' ' A' ' 68' ' ' ARG . 10.7 tt -111.22 113.43 44.23 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.899 0 CA-C-O 121.447 0.641 . . . . 0.0 110.733 178.675 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.722 HD22 HD13 ' A' ' 67' ' ' LEU . 2.9 mm? -88.17 102.51 14.87 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.581 -0.736 . . . . 0.0 109.467 175.7 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.846 HD12 ' HB2' ' A' ' 66' ' ' PRO . 65.2 mt -75.82 95.07 1.09 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-O 121.331 0.586 . . . . 0.0 110.011 -179.63 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 55' ' ' GLN . . . . . 0.561 ' HG3' HD11 ' A' ' 33' ' ' ILE . 14.8 mm100 -102.69 -42.47 5.89 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.516 -0.765 . . . . 0.0 110.604 -176.079 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 4.1 p30 -95.35 -2.54 48.94 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.689 -178.396 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' GLY . . . . . 0.614 ' O ' ' HB ' ' A' ' 61' ' ' THR . . . -70.91 144.02 37.42 Favored Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 120.518 -0.848 . . . . 0.0 111.379 176.999 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 58' ' ' SER . . . . . 0.402 ' O ' ' HB2' ' A' ' 59' ' ' GLN . 9.4 m -71.98 -175.32 1.42 Allowed 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.746 0.308 . . . . 0.0 111.314 -176.61 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 59' ' ' GLN . . . . . 0.402 ' HB2' ' O ' ' A' ' 58' ' ' SER . 42.7 mt-30 68.46 -72.64 0.1 Allowed 'General case' 0 CA--C 1.518 -0.258 0 CA-C-N 115.54 -0.754 . . . . 0.0 110.381 -174.25 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.888 ' HA ' HG22 ' A' ' 63' ' ' VAL . 6.0 m120 -96.47 15.64 20.89 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 121.161 0.505 . . . . 0.0 111.22 -174.185 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 61' ' ' THR . . . . . 0.614 ' HB ' ' O ' ' A' ' 57' ' ' GLY . 6.8 t -66.24 -29.88 70.21 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 109.912 -0.403 . . . . 0.0 109.912 174.366 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 17.4 m120 -100.83 3.4 41.94 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 112.258 0.466 . . . . 0.0 112.258 179.396 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.888 HG22 ' HA ' ' A' ' 60' ' ' ASN . 22.0 m -136.73 -156.93 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.309 0 O-C-N 122.157 -0.339 . . . . 0.0 111.643 -177.386 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.662 ' O ' ' HB3' ' A' ' 60' ' ' ASN . 12.1 m-20 -54.77 147.1 15.53 Favored 'General case' 0 C--O 1.227 -0.085 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.388 177.648 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.674 ' HB2' ' HB ' ' A' ' 24' ' ' ILE . 74.0 mmtt -95.26 127.0 43.98 Favored Pre-proline 0 C--N 1.319 -0.74 0 CA-C-N 116.103 -0.498 . . . . 0.0 111.567 -170.573 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.846 ' HB2' HD12 ' A' ' 54' ' ' ILE . 10.6 Cg_exo -71.63 109.11 2.56 Favored 'Trans proline' 0 N--CA 1.459 -0.525 0 C-N-CA 123.074 2.516 . . . . 0.0 111.318 175.556 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.722 HD13 HD22 ' A' ' 53' ' ' LEU . 23.9 tp -106.04 100.01 9.58 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.986 -0.552 . . . . 0.0 109.848 178.467 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.607 ' HB2' ' CG2' ' A' ' 52' ' ' ILE . 97.6 mtt180 -85.64 105.11 15.97 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.939 0.4 . . . . 0.0 110.242 176.766 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 31.8 mt -92.4 105.04 16.25 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.718 0 N-CA-C 108.116 -1.068 . . . . 0.0 108.116 171.452 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.659 HG23 HG22 ' A' ' 19' ' ' VAL . 14.5 mt -111.4 129.51 66.62 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.909 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.575 -171.357 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 148.32 -124.67 1.92 Allowed Glycine 0 N--CA 1.441 -0.975 0 C-N-CA 119.847 -1.168 . . . . 0.0 113.833 171.115 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 72' ' ' ASP . . . . . 0.492 ' OD1' ' HB2' ' A' ' 7' ' ' PHE . 4.7 t70 -85.62 128.95 56.78 Favored Pre-proline 0 C--N 1.321 -0.632 0 CA-C-N 115.206 -0.497 . . . . 0.0 111.685 -171.779 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 73' ' ' PRO . . . . . 0.405 ' HD2' ' HB3' ' A' ' 7' ' ' PHE . 88.6 Cg_exo -45.36 -33.64 9.2 Favored 'Trans proline' 0 C--N 1.349 0.596 0 C-N-CA 124.621 3.547 . . . . 0.0 114.346 -175.742 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 90.5 m-85 -74.91 -60.88 2.09 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.069 0.462 . . . . 0.0 110.214 -178.967 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.641 ' HA ' ' HB2' ' A' ' 78' ' ' GLN . 3.8 pttm -74.09 -17.07 61.0 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.745 -0.661 . . . . 0.0 112.586 -173.881 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.53 ' CG1' ' HB2' ' A' ' 20' ' ' GLN . 37.3 t -65.06 -44.35 95.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 121.429 0.633 . . . . 0.0 109.543 170.406 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -74.54 -43.23 56.74 Favored 'General case' 0 N--CA 1.446 -0.651 0 CA-C-N 115.29 -0.868 . . . . 0.0 109.129 -178.402 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 78' ' ' GLN . . . . . 0.641 ' HB2' ' HA ' ' A' ' 75' ' ' LYS . 61.9 mt-30 -56.71 -36.2 69.4 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.495 -0.775 . . . . 0.0 110.661 175.269 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -68.38 -45.08 73.7 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.608 -0.724 . . . . 0.0 110.917 177.957 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 80' ' ' CYS . . . . . 0.415 ' HB2' ' OE1' ' A' ' 20' ' ' GLN . 33.4 t -54.84 -56.71 16.5 Favored 'General case' 0 CA--C 1.518 -0.278 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.968 178.516 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -63.42 -27.08 69.05 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 120.77 -0.372 . . . . 0.0 110.877 -178.647 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 47.7 ttp -73.59 -49.67 25.09 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.434 179.839 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.537 HG12 HD13 ' A' ' 43' ' ' LEU . 34.2 m -76.39 -32.75 22.22 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-O 120.853 0.359 . . . . 0.0 110.591 -175.626 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 84' ' ' MET . . . . . 0.46 ' O ' ' HG3' ' A' ' 88' ' ' ARG . 45.2 ttm -68.56 -31.62 70.95 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.075 -0.511 . . . . 0.0 109.859 177.041 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 85' ' ' ASP . . . . . 0.522 ' HA ' ' HD2' ' A' ' 88' ' ' ARG . 21.4 t70 -62.81 -40.45 97.42 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.892 -0.595 . . . . 0.0 111.113 178.602 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 42.1 mt -61.08 -29.97 46.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.445 179.279 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.741 HD21 HG13 ' A' ' 32' ' ' VAL . 61.2 mt -79.0 -20.89 47.93 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.384 -177.434 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 88' ' ' ARG . . . . . 0.522 ' HD2' ' HA ' ' A' ' 85' ' ' ASP . 0.0 OUTLIER -117.99 27.56 8.93 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.17 0.51 . . . . 0.0 110.935 -179.84 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 44.9 tt0 . . . . . 0 C--O 1.248 1.007 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.174 179.551 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.444 -0.833 0 N-CA-C 112.336 -0.305 . . . . 0.0 112.336 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 6' ' ' GLN . . . . . 0.6 ' O ' ' HA2' ' A' ' 71' ' ' GLY . 27.4 mm-40 -103.98 27.82 7.27 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 108.55 -0.908 . . . . 0.0 108.55 171.709 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 7' ' ' PHE . . . . . 0.587 ' O ' ' HB2' ' A' ' 8' ' ' HIS . 4.9 p90 -155.94 -143.04 0.11 Allowed 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 114.216 -1.357 . . . . 0.0 108.37 -175.976 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 8' ' ' HIS . . . . . 0.587 ' HB2' ' O ' ' A' ' 7' ' ' PHE . 1.6 m-70 79.11 100.24 0.06 Allowed 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 123.207 0.603 . . . . 0.0 110.674 -179.578 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 2.1 t0 179.08 -53.47 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.432 -0.804 . . . . 0.0 109.254 -179.913 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 6.6 p30 -150.21 -5.04 0.34 Allowed 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.402 -0.817 . . . . 0.0 111.637 179.257 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.612 ' HB3' ' HB3' ' A' ' 72' ' ' ASP . . . -151.12 108.09 3.56 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.233 0.54 . . . . 0.0 111.466 178.395 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 4.1 p-10 -135.51 20.46 3.36 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.157 178.831 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -126.39 144.69 15.27 Favored Glycine 0 N--CA 1.448 -0.549 0 CA-C-N 115.663 -0.698 . . . . 0.0 111.791 179.739 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 81.95 -70.3 3.15 Favored Glycine 0 N--CA 1.449 -0.453 0 C-N-CA 120.944 -0.645 . . . . 0.0 111.867 -178.376 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 75.2 mt-30 -113.39 108.4 17.17 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 109.939 -0.393 . . . . 0.0 109.939 176.523 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 31.9 m-80 -85.63 69.67 10.66 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.356 -178.131 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 106.45 104.59 2.96 Favored Glycine 0 N--CA 1.444 -0.796 0 C-N-CA 120.632 -0.794 . . . . 0.0 112.095 -179.919 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.433 ' HB ' HG21 ' A' ' 76' ' ' VAL . 58.8 m -95.84 138.8 32.97 Favored 'General case' 0 C--N 1.317 -0.834 0 N-CA-C 109.63 -0.508 . . . . 0.0 109.63 177.188 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.505 ' HA ' ' O ' ' A' ' 69' ' ' ILE . 5.2 p -132.19 126.42 56.01 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-O 121.237 0.541 . . . . 0.0 110.999 179.693 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 20' ' ' GLN . . . . . 0.412 ' OE1' HG12 ' A' ' 76' ' ' VAL . 55.1 mt-30 -115.5 119.91 37.74 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.561 177.017 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.636 ' HA ' ' O ' ' A' ' 67' ' ' LEU . 49.8 mt-10 -92.03 111.9 23.62 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.244 0.545 . . . . 0.0 110.546 177.429 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 15.8 mm -104.0 155.63 5.73 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-N 115.331 -0.85 . . . . 0.0 109.695 -178.347 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' MET . . . . . 0.541 ' HB3' ' HB3' ' A' ' 64' ' ' ASP . 80.6 mmm -108.43 104.97 14.43 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 176.227 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.644 ' HB ' ' HB2' ' A' ' 65' ' ' LYS . 30.5 mm -91.23 125.0 59.84 Favored Pre-proline 0 C--N 1.321 -0.656 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.115 -174.117 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.566 ' HB2' ' HB3' ' A' ' 28' ' ' LYS . 76.9 Cg_exo -50.3 140.52 33.94 Favored 'Trans proline' 0 CA--C 1.535 0.555 0 C-N-CA 122.845 2.363 . . . . 0.0 113.019 179.715 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.444 ' HB2' ' HA ' ' A' ' 63' ' ' VAL . . . -48.88 -61.75 1.88 Allowed 'General case' 0 N--CA 1.468 0.454 0 N-CA-C 113.42 0.896 . . . . 0.0 113.42 -170.605 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -78.67 -25.64 60.26 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.712 -0.756 . . . . 0.0 111.883 -177.334 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.577 ' HG3' HD22 ' A' ' 87' ' ' LEU . 13.0 tppt? -67.57 -19.18 65.23 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.99 0.424 . . . . 0.0 110.875 178.891 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.477 ' O ' HG12 ' A' ' 32' ' ' VAL . . . -59.66 -23.5 63.13 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.415 179.802 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -60.58 -27.03 65.47 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.855 -0.688 . . . . 0.0 112.16 176.598 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 92.5 mt -87.61 -33.53 18.82 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.643 0.258 . . . . 0.0 110.705 179.787 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.477 HG12 ' O ' ' A' ' 29' ' ' ALA . 0.9 OUTLIER -73.55 -31.27 32.1 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.387 0 CA-C-O 121.071 0.463 . . . . 0.0 110.916 -178.711 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.541 HG22 ' HA2' ' A' ' 37' ' ' GLY . 75.6 mt -84.87 -44.64 17.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 116.01 -0.541 . . . . 0.0 109.89 176.117 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 132.46 170.16 12.45 Favored Glycine 0 N--CA 1.441 -1.004 0 C-N-CA 120.242 -0.98 . . . . 0.0 112.936 174.606 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.409 ' N ' ' HD3' ' A' ' 35' ' ' LYS . 3.3 mppt? -69.36 -28.52 66.28 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.025 0.44 . . . . 0.0 109.879 -179.114 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -136.69 19.18 3.56 Favored Glycine 0 N--CA 1.447 -0.568 0 C-N-CA 120.825 -0.702 . . . . 0.0 111.355 175.592 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.541 ' HA2' HG22 ' A' ' 33' ' ' ILE . . . 78.57 5.92 88.13 Favored Glycine 0 C--O 1.226 -0.4 0 C-N-CA 120.913 -0.661 . . . . 0.0 112.072 -176.885 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -85.53 -24.18 27.39 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 120.887 0.375 . . . . 0.0 111.537 -178.587 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.649 ' O ' ' HG ' ' A' ' 43' ' ' LEU . 31.5 m -64.26 -48.97 73.72 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.232 -176.415 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.557 ' HA ' HD12 ' A' ' 43' ' ' LEU . 5.3 tt -55.72 -30.43 27.23 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.342 0 CA-C-O 121.071 0.462 . . . . 0.0 111.513 179.757 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.444 ' O ' ' HG2' ' A' ' 45' ' ' GLU . 7.8 tmtm? -74.47 -39.58 62.42 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.055 -0.52 . . . . 0.0 109.758 -178.904 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 81.0 mt-30 -67.82 -35.62 78.93 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.825 -179.702 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.649 ' HG ' ' O ' ' A' ' 39' ' ' THR . 47.7 mt -58.5 -42.65 88.14 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.454 -179.224 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 65.9 mt-30 -62.69 -39.88 95.37 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.629 179.595 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.444 ' HG2' ' O ' ' A' ' 41' ' ' LYS . 34.6 mm-40 -74.07 -51.2 16.5 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.382 -176.727 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 17.5 ptm180 -66.63 -37.46 84.9 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.966 -0.561 . . . . 0.0 112.25 -171.798 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.414 ' HB3' HG22 ' A' ' 49' ' ' VAL . . . -95.77 -13.39 24.16 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 120.969 0.414 . . . . 0.0 111.391 -176.795 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 69.19 31.17 71.74 Favored Glycine 0 N--CA 1.449 -0.467 0 N-CA-C 111.274 -0.73 . . . . 0.0 111.274 -176.082 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.501 HG12 ' HD3' ' A' ' 75' ' ' LYS . 34.4 m -113.04 166.84 6.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-O 120.809 0.337 . . . . 0.0 110.394 -175.735 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -111.65 123.33 50.0 Favored 'General case' 0 C--N 1.318 -0.794 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 171.211 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 75.8 mtp -123.8 115.32 21.17 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 109.806 -0.442 . . . . 0.0 109.806 178.643 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.501 ' CG2' ' HB2' ' A' ' 68' ' ' ARG . 6.8 tt -104.43 105.84 19.27 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.837 0 CA-C-O 121.437 0.636 . . . . 0.0 109.977 178.432 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.609 HD22 HD13 ' A' ' 67' ' ' LEU . 2.5 mm? -78.28 102.64 7.76 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.681 -0.691 . . . . 0.0 109.594 177.007 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.453 ' HB ' ' HB2' ' A' ' 66' ' ' PRO . 60.8 mt -87.5 85.89 2.51 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-O 121.509 0.671 . . . . 0.0 109.467 -178.239 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 1.3 pt20 -109.81 -17.12 13.73 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.834 -177.162 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 30.1 m-20 -100.19 -33.96 10.22 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.978 0.418 . . . . 0.0 110.119 175.082 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -86.2 39.33 3.05 Favored Glycine 0 C--N 1.33 0.196 0 C-N-CA 120.795 -0.717 . . . . 0.0 112.574 -177.555 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 3.0 p -136.85 146.07 45.15 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-O 120.916 0.389 . . . . 0.0 110.79 -179.11 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -99.34 -16.12 18.56 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 178.558 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.483 ' HB2' ' CG2' ' A' ' 63' ' ' VAL . 27.5 p-10 -95.6 30.02 2.43 Favored 'General case' 0 N--CA 1.447 -0.586 0 CA-C-N 114.588 -1.187 . . . . 0.0 107.987 166.977 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 10.0 t -60.31 -18.86 52.43 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 114.923 -1.035 . . . . 0.0 111.201 -178.35 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 57.4 m-80 -87.71 -1.4 57.94 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.452 -178.648 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.483 ' CG2' ' HB2' ' A' ' 60' ' ' ASN . 23.6 m -133.46 -139.27 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.286 179.009 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.541 ' HB3' ' HB3' ' A' ' 23' ' ' MET . 1.9 m-20 -50.9 136.88 21.89 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.572 -0.74 . . . . 0.0 111.981 179.112 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.644 ' HB2' ' HB ' ' A' ' 24' ' ' ILE . 71.7 mmtt -99.35 127.59 34.09 Favored Pre-proline 0 C--N 1.322 -0.594 0 CA-C-N 115.156 -0.929 . . . . 0.0 111.49 -174.176 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.453 ' HB2' ' HB ' ' A' ' 54' ' ' ILE . 38.7 Cg_exo -65.03 114.33 2.76 Favored 'Trans proline' 0 CA--C 1.533 0.434 0 C-N-CA 122.896 2.397 . . . . 0.0 111.719 169.619 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.636 ' O ' ' HA ' ' A' ' 21' ' ' GLU . 28.7 tp -122.95 126.58 47.49 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 120.588 0.232 . . . . 0.0 111.114 179.809 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.583 ' HG2' ' HG2' ' A' ' 21' ' ' GLU . 96.4 mtt180 -109.19 115.93 30.95 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 120.674 0.273 . . . . 0.0 111.519 176.086 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.505 ' O ' ' HA ' ' A' ' 19' ' ' VAL . 4.5 mp -97.62 115.8 38.46 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 N-CA-C 108.423 -0.954 . . . . 0.0 108.423 170.866 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 15.0 mt -119.38 140.66 42.6 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.569 -174.473 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' GLY . . . . . 0.6 ' HA2' ' O ' ' A' ' 6' ' ' GLN . . . 157.36 -160.12 30.28 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.877 -0.678 . . . . 0.0 112.165 176.738 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 72' ' ' ASP . . . . . 0.612 ' HB3' ' HB3' ' A' ' 11' ' ' ALA . 1.0 OUTLIER -61.99 137.19 95.44 Favored Pre-proline 0 N--CA 1.447 -0.617 0 N-CA-C 108.631 -0.877 . . . . 0.0 108.631 174.477 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 73' ' ' PRO . . . . . 0.609 ' HD2' ' HB3' ' A' ' 11' ' ' ALA . 85.8 Cg_exo -42.47 -41.17 7.71 Favored 'Trans proline' 0 CA--C 1.534 0.478 0 C-N-CA 122.825 2.35 . . . . 0.0 114.219 -173.462 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 73.3 m-85 -69.52 -51.61 34.14 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.111 -0.495 . . . . 0.0 112.191 -175.136 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.577 ' HD2' ' H ' ' A' ' 72' ' ' ASP . 16.9 ptpt -62.92 -32.34 73.6 Favored 'General case' 0 C--O 1.222 -0.349 0 CA-C-N 116.687 -0.233 . . . . 0.0 110.689 -179.024 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.497 HG23 ' O ' ' A' ' 72' ' ' ASP . 96.6 t -56.89 -48.05 82.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 120.771 0.319 . . . . 0.0 110.329 177.849 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 1.6 mm100 -71.14 -42.46 69.14 Favored 'General case' 0 N--CA 1.45 -0.456 0 CA-C-N 116.4 -0.363 . . . . 0.0 111.332 178.158 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 47.1 mt-30 -60.17 -42.37 94.82 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.717 0.294 . . . . 0.0 111.069 178.955 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -71.34 -36.43 71.53 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.766 178.917 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 49.8 t -61.17 -54.9 38.62 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.229 176.51 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -61.59 -30.05 70.43 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.885 0.374 . . . . 0.0 110.599 179.247 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 52.5 ttp -64.74 -53.29 49.45 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.886 178.534 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.617 ' O ' ' HG ' ' A' ' 87' ' ' LEU . 32.9 m -78.65 -33.24 16.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-O 120.656 0.265 . . . . 0.0 110.863 -176.254 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 59.8 ttp -66.51 -35.61 80.67 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.106 178.678 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -60.27 -38.38 83.38 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.62 176.76 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 48.6 mt -66.7 -27.25 39.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-O 121.273 0.559 . . . . 0.0 110.339 178.735 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.617 ' HG ' ' O ' ' A' ' 83' ' ' VAL . 35.4 mt -91.71 -28.12 17.64 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.273 -176.774 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 88' ' ' ARG . . . . . 0.442 HH11 ' HD2' ' A' ' 88' ' ' ARG . 12.9 mmt180 -85.99 -13.07 48.68 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.316 0.579 . . . . 0.0 111.117 -179.287 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 . . . . . 0 C--N 1.312 -1.064 0 CA-C-N 115.359 -0.837 . . . . 0.0 110.028 -178.009 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.534 0 N-CA-C 111.738 -0.545 . . . . 0.0 111.738 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 6' ' ' GLN . . . . . 0.438 ' HB3' ' HG2' ' A' ' 73' ' ' PRO . 89.0 mt-30 -77.81 -22.42 50.07 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.394 0.616 . . . . 0.0 110.1 178.964 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 7' ' ' PHE . . . . . 0.456 ' HA ' ' HB3' ' A' ' 16' ' ' ASN . 39.2 p90 -126.3 155.4 42.02 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.279 -0.873 . . . . 0.0 109.245 174.815 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 8' ' ' HIS . . . . . 0.614 ' HB3' ' HB3' ' A' ' 12' ' ' ASN . 2.2 t-160 -83.68 69.5 10.16 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.496 -176.394 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 1.5 p30 36.68 -102.67 0.03 OUTLIER 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 124.3 1.04 . . . . 0.0 113.227 178.29 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 5.0 m-20 -114.5 -24.37 8.85 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 121.039 0.447 . . . . 0.0 110.131 179.033 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -83.38 64.02 7.59 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.011 -178.438 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' ASN . . . . . 0.614 ' HB3' ' HB3' ' A' ' 8' ' ' HIS . 8.6 p30 -142.82 154.01 43.77 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.211 179.221 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -154.96 96.34 0.16 Allowed Glycine 0 CA--C 1.509 -0.295 0 N-CA-C 111.072 -0.811 . . . . 0.0 111.072 -179.004 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 77.54 -65.32 3.14 Favored Glycine 0 N--CA 1.449 -0.442 0 N-CA-C 110.56 -1.016 . . . . 0.0 110.56 -171.029 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 6.3 pt20 -76.82 116.36 17.41 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 109.698 -0.482 . . . . 0.0 109.698 172.866 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' ASN . . . . . 0.518 ' O ' ' HB2' ' A' ' 8' ' ' HIS . 3.8 m-20 -101.12 -64.29 1.06 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.43 -179.603 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 174.73 35.97 0.04 OUTLIER Glycine 0 N--CA 1.453 -0.224 0 C-N-CA 120.614 -0.803 . . . . 0.0 112.338 177.498 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 16.1 m -153.18 130.13 11.01 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 120.661 0.267 . . . . 0.0 110.712 -177.703 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.401 HG22 HG23 ' A' ' 70' ' ' ILE . 60.5 t -131.71 131.86 62.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.423 179.884 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 28.6 mt-30 -120.84 114.8 22.13 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.086 173.803 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.578 ' HA ' ' O ' ' A' ' 67' ' ' LEU . 48.5 mt-10 -86.61 119.65 27.08 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.958 -0.564 . . . . 0.0 111.052 178.812 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.494 ' HB ' ' HB3' ' A' ' 67' ' ' LEU . 14.9 mm -105.68 163.43 4.56 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 115.341 -0.845 . . . . 0.0 110.091 -178.395 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 23' ' ' MET . . . . . 0.456 ' HB3' ' HB3' ' A' ' 64' ' ' ASP . 2.3 mmt -109.75 94.89 5.26 Favored 'General case' 0 N--CA 1.453 -0.324 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 176.049 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.748 ' HB ' ' HB2' ' A' ' 65' ' ' LYS . 36.5 mm -82.78 126.48 72.99 Favored Pre-proline 0 C--N 1.318 -0.775 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.178 -174.589 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.718 ' HD2' HD13 ' A' ' 87' ' ' LEU . 84.6 Cg_exo -47.39 124.87 9.89 Favored 'Trans proline' 0 C--N 1.346 0.407 0 C-N-CA 123.132 2.555 . . . . 0.0 112.533 178.621 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -63.69 -34.38 77.72 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.645 -0.707 . . . . 0.0 111.872 -174.359 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -90.88 -3.75 70.24 Favored Glycine 0 N--CA 1.448 -0.543 0 C-N-CA 120.609 -0.805 . . . . 0.0 112.93 -178.724 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.503 ' HB3' ' HB2' ' A' ' 25' ' ' PRO . 43.4 tttt -121.44 17.17 11.35 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.222 0.534 . . . . 0.0 110.759 -176.93 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.447 ' O ' HG12 ' A' ' 32' ' ' VAL . . . -70.57 -21.15 62.72 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.901 -0.591 . . . . 0.0 111.275 -178.27 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -65.39 -18.19 65.09 Favored Glycine 0 C--O 1.227 -0.308 0 C-N-CA 121.11 -0.567 . . . . 0.0 112.646 178.458 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.621 ' HB3' HG22 ' A' ' 86' ' ' ILE . 66.1 mt -88.53 -41.57 12.63 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.619 0.247 . . . . 0.0 110.939 178.819 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.731 ' HB ' HD21 ' A' ' 87' ' ' LEU . 4.3 p -69.67 -33.65 57.5 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.435 0 CA-C-O 121.334 0.587 . . . . 0.0 110.824 -178.718 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.59 ' HA ' ' HB ' ' A' ' 40' ' ' ILE . 76.6 mt -90.35 -39.87 12.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-N 115.591 -0.731 . . . . 0.0 110.59 179.061 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 107.63 151.39 16.83 Favored Glycine 0 N--CA 1.443 -0.838 0 CA-C-N 115.756 -0.656 . . . . 0.0 111.777 -179.075 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.545 ' HE3' HD23 ' A' ' 31' ' ' LEU . 0.2 OUTLIER -68.81 -11.34 60.31 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.719 0.295 . . . . 0.0 111.31 -178.088 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -137.36 17.83 3.52 Favored Glycine 0 N--CA 1.449 -0.483 0 C-N-CA 120.715 -0.755 . . . . 0.0 111.693 176.639 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 69.78 1.55 32.07 Favored Glycine 0 CA--C 1.521 0.411 0 C-N-CA 121.248 -0.501 . . . . 0.0 112.785 -177.655 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -69.9 -35.99 75.05 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.834 0.35 . . . . 0.0 111.114 -178.171 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.757 ' O ' ' HG ' ' A' ' 43' ' ' LEU . 93.8 m -57.72 -61.21 2.68 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.092 -179.304 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.65 ' HA ' HD12 ' A' ' 43' ' ' LEU . 7.6 tt -60.33 -29.83 44.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 116.045 -0.525 . . . . 0.0 112.09 -175.243 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 11.6 tmtt? -74.58 -42.34 58.9 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 109.86 -0.422 . . . . 0.0 109.86 -179.381 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.516 ' O ' ' HG2' ' A' ' 46' ' ' ARG . 47.6 mt-30 -66.09 -31.72 72.76 Favored 'General case' 0 CA--C 1.517 -0.303 0 CA-C-O 120.961 0.41 . . . . 0.0 110.469 -179.305 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.757 ' HG ' ' O ' ' A' ' 39' ' ' THR . 44.4 mt -61.89 -33.25 73.88 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.674 -179.995 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 44' ' ' GLN . . . . . 0.402 ' HA ' ' O ' ' A' ' 49' ' ' VAL . 65.0 mt-30 -71.66 -23.03 61.6 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.433 0.635 . . . . 0.0 110.547 179.661 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 68.5 mm-40 -87.86 -55.1 3.91 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.82 -179.885 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' ARG . . . . . 0.516 ' HG2' ' O ' ' A' ' 42' ' ' GLN . 14.6 ptp180 -69.84 -30.87 68.47 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 113.02 0.748 . . . . 0.0 113.02 -172.492 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.509 ' HB3' HG22 ' A' ' 49' ' ' VAL . . . -95.48 -18.56 20.57 Favored 'General case' 0 C--N 1.323 -0.553 0 C-N-CA 120.736 -0.386 . . . . 0.0 111.594 -176.487 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 75.74 17.45 80.1 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.83 -0.7 . . . . 0.0 112.212 -179.415 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.509 HG22 ' HB3' ' A' ' 47' ' ' ALA . 21.2 m -116.1 166.41 10.23 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-O 120.809 0.338 . . . . 0.0 110.279 179.846 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 85.6 tttt -108.66 121.29 44.71 Favored 'General case' 0 C--N 1.314 -0.952 0 N-CA-C 108.474 -0.935 . . . . 0.0 108.474 169.31 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' MET . . . . . 0.908 ' HE1' HG11 ' A' ' 83' ' ' VAL . 15.9 mtm -114.08 115.3 27.34 Favored 'General case' 0 C--N 1.316 -0.855 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 177.268 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.584 ' CG2' ' HB2' ' A' ' 68' ' ' ARG . 11.6 tt -100.34 106.94 20.07 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.084 0 CA-C-O 121.418 0.628 . . . . 0.0 110.348 179.561 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.867 HD22 HD13 ' A' ' 67' ' ' LEU . 3.0 mm? -72.78 101.52 3.13 Favored 'General case' 0 N--CA 1.445 -0.675 0 N-CA-C 107.382 -1.34 . . . . 0.0 107.382 171.165 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.711 HD12 ' HB2' ' A' ' 66' ' ' PRO . 62.8 mt -73.54 86.24 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.482 0 CA-C-O 122.078 0.942 . . . . 0.0 111.135 -170.852 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 32.3 mt-30 -106.35 -28.77 10.17 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 114.209 -1.359 . . . . 0.0 107.742 170.223 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -56.6 -37.45 70.67 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 114.271 -1.331 . . . . 0.0 110.09 173.534 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -94.69 94.67 1.8 Allowed Glycine 0 N--CA 1.443 -0.887 0 N-CA-C 110.723 -0.951 . . . . 0.0 110.723 172.53 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 11.4 m -75.53 55.41 0.82 Allowed 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.226 0.536 . . . . 0.0 111.602 -175.077 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 43.4 mt-30 -97.68 -45.97 6.17 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.399 178.556 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.555 ' HB2' ' HD3' ' A' ' 66' ' ' PRO . 14.7 m120 -120.4 38.01 4.1 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.464 0.649 . . . . 0.0 109.677 179.478 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -77.04 -24.71 52.02 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.578 -0.737 . . . . 0.0 111.333 -179.95 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 25.6 t-20 -81.75 -22.15 37.42 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.566 178.869 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 16.8 m -121.01 -155.42 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.629 -177.829 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.456 ' HB3' ' HB3' ' A' ' 23' ' ' MET . 1.1 m-20 -55.41 140.67 39.16 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.743 175.546 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.748 ' HB2' ' HB ' ' A' ' 24' ' ' ILE . 30.3 mmtp -90.55 132.67 34.56 Favored Pre-proline 0 C--N 1.322 -0.609 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.988 -170.355 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.711 ' HB2' HD12 ' A' ' 54' ' ' ILE . 17.4 Cg_exo -68.16 110.45 2.21 Favored 'Trans proline' 0 N--CA 1.456 -0.708 0 C-N-CA 122.684 2.256 . . . . 0.0 110.965 173.802 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.867 HD13 HD22 ' A' ' 53' ' ' LEU . 30.0 tp -108.6 114.05 27.55 Favored 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 110.138 -0.319 . . . . 0.0 110.138 178.064 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.584 ' HB2' ' CG2' ' A' ' 52' ' ' ILE . 97.3 mtt180 -99.46 106.19 18.21 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 116.487 -0.324 . . . . 0.0 110.479 176.254 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.506 ' HB ' HG13 ' A' ' 76' ' ' VAL . 4.5 mp -86.39 103.93 13.34 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 N-CA-C 107.855 -1.165 . . . . 0.0 107.855 170.196 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.401 HG23 HG22 ' A' ' 19' ' ' VAL . 31.1 mt -101.57 116.12 44.59 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.867 0 CA-C-N 115.534 -0.757 . . . . 0.0 110.19 -174.282 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 71' ' ' GLY . . . . . 0.4 ' O ' ' HB2' ' A' ' 16' ' ' ASN . . . 177.19 -123.99 0.92 Allowed Glycine 0 N--CA 1.442 -0.935 0 C-N-CA 120.42 -0.895 . . . . 0.0 112.258 178.945 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 72' ' ' ASP . . . . . 0.47 ' HB2' ' ND2' ' A' ' 16' ' ' ASN . 17.0 t70 -119.46 141.85 31.55 Favored Pre-proline 0 C--N 1.318 -0.793 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 -177.631 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 73' ' ' PRO . . . . . 0.438 ' HG2' ' HB3' ' A' ' 6' ' ' GLN . 82.8 Cg_exo -43.66 -38.03 8.87 Favored 'Trans proline' 0 C--N 1.35 0.611 0 C-N-CA 123.064 2.509 . . . . 0.0 113.212 -173.003 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 74' ' ' TYR . . . . . 0.417 ' O ' ' HG3' ' A' ' 78' ' ' GLN . 47.3 t80 -66.18 -61.99 1.72 Allowed 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.65 -0.705 . . . . 0.0 111.491 -177.416 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.424 ' HB2' HG13 ' A' ' 49' ' ' VAL . 35.3 pttt -67.37 -33.81 75.99 Favored 'General case' 0 N--CA 1.464 0.265 0 C-N-CA 121.103 -0.239 . . . . 0.0 111.573 179.75 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.506 HG13 ' HB ' ' A' ' 69' ' ' ILE . 51.3 t -57.85 -39.54 71.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.805 0.336 . . . . 0.0 110.514 177.672 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 77' ' ' GLN . . . . . 0.548 ' O ' ' HG2' ' A' ' 81' ' ' GLU . 1.9 mm100 -74.31 -44.78 51.14 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 120.651 -0.42 . . . . 0.0 111.407 178.206 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 78' ' ' GLN . . . . . 0.417 ' HG3' ' O ' ' A' ' 74' ' ' TYR . 47.0 mt-30 -57.65 -43.99 85.32 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-O 121.361 0.6 . . . . 0.0 110.166 179.398 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -66.6 -40.35 88.81 Favored 'General case' 0 N--CA 1.446 -0.675 0 CA-C-N 115.257 -0.883 . . . . 0.0 110.829 -179.693 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 45.0 t -63.21 -57.2 11.27 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.217 179.596 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 81' ' ' GLU . . . . . 0.548 ' HG2' ' O ' ' A' ' 77' ' ' GLN . 10.2 pt-20 -63.41 -20.18 65.32 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.981 0.419 . . . . 0.0 110.921 -177.456 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 37.7 ttp -75.56 -52.11 11.37 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.436 177.101 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.908 HG11 ' HE1' ' A' ' 51' ' ' MET . 27.9 m -79.61 -29.77 13.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.083 -174.666 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 84' ' ' MET . . . . . 0.592 ' O ' ' HG3' ' A' ' 88' ' ' ARG . 14.8 tpt -66.62 -31.74 72.63 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.086 -0.506 . . . . 0.0 109.686 177.397 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -62.53 -39.16 92.68 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-O 120.894 0.378 . . . . 0.0 110.667 177.122 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.621 HG22 ' HB3' ' A' ' 31' ' ' LEU . 18.7 mt -62.84 -19.2 22.72 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.401 179.136 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.731 HD21 ' HB ' ' A' ' 32' ' ' VAL . 65.5 mt -102.32 -40.45 6.74 Favored 'General case' 0 N--CA 1.449 -0.488 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.786 -175.582 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 88' ' ' ARG . . . . . 0.592 ' HG3' ' O ' ' A' ' 84' ' ' MET . 0.0 OUTLIER -78.08 -4.15 45.86 Favored 'General case' 0 N--CA 1.464 0.246 0 C-N-CA 120.471 -0.492 . . . . 0.0 111.87 -178.73 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 . . . . . 0 C--O 1.249 1.049 0 CA-C-O 118.372 -0.823 . . . . 0.0 109.39 177.287 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.368 0 CA-C-O 120.286 -0.175 . . . . 0.0 112.71 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 6' ' ' GLN . . . . . 0.468 ' HA ' ' OH ' ' A' ' 74' ' ' TYR . 98.3 mt-30 65.87 -74.54 0.06 Allowed 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 123.299 0.639 . . . . 0.0 110.586 -174.653 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 7' ' ' PHE . . . . . 0.687 ' HB2' ' HB3' ' A' ' 12' ' ' ASN . 18.7 p90 -129.85 5.58 5.03 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.447 179.186 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 8.5 t60 67.22 98.74 0.05 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 114.825 -1.079 . . . . 0.0 109.431 -172.448 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -60.21 141.23 56.31 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.197 179.182 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 23.4 t-20 67.37 55.97 0.63 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.759 0.79 . . . . 0.0 109.279 -173.972 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -172.56 -68.39 0.02 OUTLIER 'General case' 0 CA--C 1.528 0.123 0 CA-C-N 114.88 -1.055 . . . . 0.0 110.913 178.873 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' ASN . . . . . 0.687 ' HB3' ' HB2' ' A' ' 7' ' ' PHE . 7.1 t30 -98.92 93.3 5.95 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.004 0.43 . . . . 0.0 110.776 -177.818 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -138.13 88.14 0.21 Allowed Glycine 0 N--CA 1.45 -0.386 0 N-CA-C 111.218 -0.753 . . . . 0.0 111.218 178.193 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 80.72 -53.81 4.58 Favored Glycine 0 N--CA 1.451 -0.363 0 N-CA-C 110.237 -1.145 . . . . 0.0 110.237 -172.582 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 31.1 mt-30 -82.58 120.82 26.01 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 108.21 -1.033 . . . . 0.0 108.21 171.028 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' ASN . . . . . 0.86 ' HB3' ' HA2' ' A' ' 71' ' ' GLY . 43.6 m-80 -66.44 120.54 13.53 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.033 0.444 . . . . 0.0 110.035 -178.366 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -100.34 -35.81 4.31 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.715 -0.755 . . . . 0.0 114.072 -168.981 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.432 HG21 ' HA ' ' A' ' 73' ' ' PRO . 87.6 m -73.92 127.63 33.36 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 117.211 0.506 . . . . 0.0 110.423 -176.785 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.44 ' HA ' ' O ' ' A' ' 69' ' ' ILE . 90.5 t -138.01 122.06 21.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.882 -177.014 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 84.6 mt-30 -107.27 118.07 35.74 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 109.891 -0.411 . . . . 0.0 109.891 172.688 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.547 ' HA ' ' O ' ' A' ' 67' ' ' LEU . 42.2 mt-10 -90.29 115.76 27.74 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.061 0.458 . . . . 0.0 111.026 176.233 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 12.8 mm -109.33 151.2 11.7 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-N 115.394 -0.821 . . . . 0.0 109.41 177.995 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 86.7 mmm -104.42 98.1 7.93 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 174.591 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.684 ' HB ' ' HB2' ' A' ' 65' ' ' LYS . 36.8 mm -81.49 129.79 64.52 Favored Pre-proline 0 C--N 1.316 -0.863 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.487 -175.491 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.552 ' HB2' ' HB2' ' A' ' 28' ' ' LYS . 86.5 Cg_exo -46.68 128.11 12.64 Favored 'Trans proline' 0 C--N 1.347 0.497 0 C-N-CA 123.019 2.479 . . . . 0.0 112.451 177.891 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -45.43 -55.84 5.66 Favored 'General case' 0 C--O 1.234 0.254 0 N-CA-C 113.093 0.775 . . . . 0.0 113.093 -170.811 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -81.61 -4.87 90.27 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.837 -0.697 . . . . 0.0 113.066 -174.897 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.552 ' HB2' ' HB2' ' A' ' 25' ' ' PRO . 1.8 tptp -95.79 -8.51 34.14 Favored 'General case' 0 C--N 1.323 -0.558 0 O-C-N 122.673 -0.31 . . . . 0.0 110.198 -177.987 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.614 ' HA ' HG23 ' A' ' 32' ' ' VAL . . . -63.89 -24.32 67.69 Favored 'General case' 0 N--CA 1.461 0.11 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.169 -179.982 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -58.76 -27.43 61.65 Favored Glycine 0 C--O 1.227 -0.319 0 C-N-CA 121.052 -0.595 . . . . 0.0 112.456 178.983 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 84.3 mt -82.86 -34.61 26.75 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.672 0.272 . . . . 0.0 111.143 -178.748 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.751 HG22 HD21 ' A' ' 87' ' ' LEU . 0.0 OUTLIER -74.08 -36.19 43.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.865 0.364 . . . . 0.0 110.345 178.399 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.587 HG12 ' O ' ' A' ' 29' ' ' ALA . 14.5 mm -78.35 -43.06 26.95 Favored 'Isoleucine or valine' 0 C--O 1.235 0.302 0 CA-C-O 121.482 0.658 . . . . 0.0 109.7 178.867 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 111.04 173.26 19.81 Favored Glycine 0 N--CA 1.439 -1.122 0 CA-C-N 115.374 -0.83 . . . . 0.0 112.051 178.365 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 31.1 mmmt -75.36 -22.38 57.6 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 120.853 0.359 . . . . 0.0 110.309 -178.913 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -130.93 -5.31 3.94 Favored Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.586 -0.816 . . . . 0.0 112.162 179.489 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 100.56 -1.09 55.61 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.736 -0.745 . . . . 0.0 111.924 -178.207 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -78.0 -21.43 50.86 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.652 0.263 . . . . 0.0 111.158 -178.865 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.793 ' O ' ' HG ' ' A' ' 43' ' ' LEU . 31.3 m -69.38 -50.86 42.19 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.577 -0.283 . . . . 0.0 110.691 -178.165 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.568 ' HB ' ' HA ' ' A' ' 33' ' ' ILE . 11.6 tt -67.13 -25.18 33.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-O 121.439 0.637 . . . . 0.0 110.448 177.317 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 22.4 tptm -63.24 -53.0 59.89 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.738 175.539 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.412 ' HG2' ' O ' ' A' ' 39' ' ' THR . 8.9 pt20 -68.78 -37.05 79.04 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.395 -175.023 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.793 ' HG ' ' O ' ' A' ' 39' ' ' THR . 84.4 mt -53.86 -39.65 65.86 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.743 -0.662 . . . . 0.0 111.532 179.632 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 44' ' ' GLN . . . . . 0.448 ' HG3' ' O ' ' A' ' 40' ' ' ILE . 44.9 mt-30 -69.78 -40.97 75.74 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.219 0.533 . . . . 0.0 110.813 -179.61 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 10.2 mm-40 -72.32 -40.51 67.39 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.668 -0.696 . . . . 0.0 111.705 -175.78 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' ARG . . . . . 0.401 ' HG2' ' O ' ' A' ' 42' ' ' GLN . 12.0 ptp180 -71.42 -34.24 70.16 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 112.375 0.509 . . . . 0.0 112.375 -174.458 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.559 ' HB3' HG22 ' A' ' 49' ' ' VAL . . . -99.11 -5.92 29.28 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 112.224 0.453 . . . . 0.0 112.224 -173.587 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 66.27 30.39 76.64 Favored Glycine 0 C--N 1.33 0.225 0 C-N-CA 120.818 -0.706 . . . . 0.0 112.046 -178.627 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.559 HG22 ' HB3' ' A' ' 47' ' ' ALA . 26.8 m -125.11 179.58 3.0 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 N-CA-C 109.724 -0.472 . . . . 0.0 109.724 -178.351 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 64.6 tttp -122.48 125.53 45.98 Favored 'General case' 0 C--N 1.314 -0.938 0 CA-C-N 116.027 -0.533 . . . . 0.0 109.817 167.501 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' MET . . . . . 0.569 ' CE ' ' HB1' ' A' ' 79' ' ' ALA . 48.5 mtt -110.75 114.76 28.37 Favored 'General case' 0 C--N 1.315 -0.931 0 N-CA-C 108.418 -0.956 . . . . 0.0 108.418 176.471 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.551 ' CG2' ' HB2' ' A' ' 68' ' ' ARG . 8.9 tt -106.09 105.04 17.96 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.939 0 CA-C-O 121.521 0.677 . . . . 0.0 110.141 177.729 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.52 HD23 ' CD1' ' A' ' 40' ' ' ILE . 4.2 mm? -88.44 101.91 14.37 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.168 -0.924 . . . . 0.0 108.936 174.994 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.533 HD12 ' HB2' ' A' ' 66' ' ' PRO . 51.3 mt -78.98 86.55 1.16 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 178.604 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 55' ' ' GLN . . . . . 0.501 ' HA ' ' HD2' ' A' ' 65' ' ' LYS . 3.4 pp0? -115.46 -22.94 9.06 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.626 -0.715 . . . . 0.0 111.592 -174.843 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -123.25 -14.92 7.37 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.345 -0.389 . . . . 0.0 109.964 179.633 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -80.32 27.24 2.83 Favored Glycine 0 CA--C 1.522 0.474 0 C-N-CA 120.983 -0.627 . . . . 0.0 112.864 -177.831 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' SER . . . . . 0.619 ' HA ' ' OG1' ' A' ' 61' ' ' THR . 18.5 m 59.11 -155.26 0.36 Allowed 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 123.172 0.589 . . . . 0.0 111.667 179.55 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 72.6 mt-30 72.89 -62.2 0.48 Allowed 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 123.658 0.783 . . . . 0.0 110.355 -178.594 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.457 ' HB3' ' O ' ' A' ' 64' ' ' ASP . 8.3 m120 -131.93 46.8 2.6 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.536 0.684 . . . . 0.0 109.52 174.368 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 61' ' ' THR . . . . . 0.619 ' OG1' ' HA ' ' A' ' 58' ' ' SER . 0.0 OUTLIER -68.95 -49.46 57.83 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.519 -0.764 . . . . 0.0 111.967 -176.592 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 29.2 p-10 -87.6 8.03 27.04 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.955 -174.753 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.415 ' HB ' ' H ' ' A' ' 64' ' ' ASP . 21.3 m -132.72 -156.94 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 116.794 -0.185 . . . . 0.0 110.859 -178.022 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.457 ' O ' ' HB3' ' A' ' 60' ' ' ASN . 25.2 m-20 -60.97 155.15 20.65 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.048 0.451 . . . . 0.0 110.524 177.663 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.684 ' HB2' ' HB ' ' A' ' 24' ' ' ILE . 71.9 mmtt -99.76 121.5 54.22 Favored Pre-proline 0 C--N 1.318 -0.772 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.787 -170.286 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.533 ' HB2' HD12 ' A' ' 54' ' ' ILE . 23.3 Cg_exo -66.26 106.86 1.08 Allowed 'Trans proline' 0 N--CA 1.46 -0.483 0 C-N-CA 122.801 2.334 . . . . 0.0 110.969 173.02 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.547 ' O ' ' HA ' ' A' ' 21' ' ' GLU . 19.3 tp -108.71 112.03 24.11 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.402 -179.866 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.551 ' HB2' ' CG2' ' A' ' 52' ' ' ILE . 98.8 mtt180 -101.58 108.21 19.7 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.365 174.802 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.44 ' O ' ' HA ' ' A' ' 19' ' ' VAL . 4.9 mp -87.31 104.41 14.21 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 N-CA-C 108.308 -0.997 . . . . 0.0 108.308 170.995 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 18.6 mt -99.87 120.99 50.03 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 CA-C-N 115.85 -0.613 . . . . 0.0 110.533 -174.502 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' GLY . . . . . 0.86 ' HA2' ' HB3' ' A' ' 16' ' ' ASN . . . 173.57 -135.93 3.44 Favored Glycine 0 CA--C 1.518 0.258 0 C-N-CA 120.807 -0.711 . . . . 0.0 112.985 179.161 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 72' ' ' ASP . . . . . 0.579 ' OD1' ' HE2' ' A' ' 75' ' ' LYS . 1.5 m-20 -103.28 157.77 33.13 Favored Pre-proline 0 C--N 1.325 -0.481 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 179.684 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 73' ' ' PRO . . . . . 0.432 ' HA ' HG21 ' A' ' 18' ' ' THR . 82.0 Cg_exo -48.17 -39.28 34.03 Favored 'Trans proline' 0 C--O 1.234 0.29 0 C-N-CA 122.156 1.904 . . . . 0.0 112.367 179.732 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 74' ' ' TYR . . . . . 0.468 ' OH ' ' HA ' ' A' ' 6' ' ' GLN . 32.4 m-85 -67.27 -62.99 1.15 Allowed 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.225 -178.617 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.579 ' HE2' ' OD1' ' A' ' 72' ' ' ASP . 41.2 pttt -67.66 -25.83 65.91 Favored 'General case' 0 C--O 1.22 -0.449 0 CA-C-N 116.333 -0.394 . . . . 0.0 112.041 -174.052 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.436 HG13 ' HB ' ' A' ' 69' ' ' ILE . 56.1 t -71.76 -35.1 54.07 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-O 121.165 0.507 . . . . 0.0 110.037 177.97 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -74.04 -51.67 15.1 Favored 'General case' 0 N--CA 1.448 -0.563 0 N-CA-C 108.636 -0.876 . . . . 0.0 108.636 178.32 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 92.0 mt-30 -59.93 -39.34 85.14 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.473 -179.245 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 79' ' ' ALA . . . . . 0.569 ' HB1' ' CE ' ' A' ' 51' ' ' MET . . . -68.07 -36.59 80.09 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.168 178.851 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 52.2 t -67.26 -47.06 71.85 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.803 -178.937 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -70.24 -19.15 63.16 Favored 'General case' 0 C--N 1.325 -0.496 0 C-N-CA 120.344 -0.542 . . . . 0.0 110.632 178.159 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 82' ' ' MET . . . . . 0.431 ' O ' ' HB3' ' A' ' 85' ' ' ASP . 48.8 ttp -75.43 -47.71 26.09 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.468 175.374 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.575 ' O ' ' HG ' ' A' ' 87' ' ' LEU . 28.3 m -72.29 -33.2 45.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 C-N-CA 120.963 -0.295 . . . . 0.0 110.831 -179.874 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 54.4 mtt -67.61 -27.4 66.87 Favored 'General case' 0 CA--C 1.519 -0.235 0 CA-C-O 120.83 0.348 . . . . 0.0 110.173 174.865 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 85' ' ' ASP . . . . . 0.533 ' O ' ' HG2' ' A' ' 88' ' ' ARG . 8.0 t70 -65.1 -45.33 85.59 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.597 176.115 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 38.9 mt -63.19 -22.62 31.2 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.644 179.196 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.751 HD21 HG22 ' A' ' 32' ' ' VAL . 64.7 mt -97.24 -12.33 23.1 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.708 -176.322 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 88' ' ' ARG . . . . . 0.695 ' HG3' ' HG2' ' A' ' 89' ' ' GLU . 29.5 ptt180 -101.16 -24.06 14.34 Favored 'General case' 0 CA--C 1.515 -0.37 0 CA-C-O 121.633 0.73 . . . . 0.0 110.088 -177.137 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 89' ' ' GLU . . . . . 0.695 ' HG2' ' HG3' ' A' ' 88' ' ' ARG . 37.7 mm-40 . . . . . 0 C--N 1.312 -1.047 0 CA-C-N 114.422 -1.263 . . . . 0.0 110.704 -171.475 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' GLY . . . . . 0.693 ' HA3' ' CE1' ' A' ' 7' ' ' PHE . . . . . . . . 0 N--CA 1.45 -0.399 0 CA-C-O 121.359 0.422 . . . . 0.0 113.234 . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 36.0 mt-30 -113.97 40.67 2.41 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 178.365 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' PHE . . . . . 0.693 ' CE1' ' HA3' ' A' ' 5' ' ' GLY . 64.4 m-85 -69.85 8.3 0.73 Allowed 'General case' 0 CA--C 1.534 0.358 0 CA-C-N 114.94 -1.027 . . . . 0.0 111.889 -172.927 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 68.4 m80 -137.6 87.6 2.27 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.011 0.434 . . . . 0.0 111.475 -173.235 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' ASP . . . . . 0.441 ' CG ' ' H ' ' A' ' 10' ' ' ASN . 13.3 t70 -124.21 -164.22 1.23 Allowed 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 175.612 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 10' ' ' ASN . . . . . 0.441 ' H ' ' CG ' ' A' ' 9' ' ' ASP . 36.1 m-80 -56.49 -57.21 13.31 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 109.57 -0.53 . . . . 0.0 109.57 177.898 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.5 ' O ' ' HA ' ' A' ' 16' ' ' ASN . . . -96.28 101.58 13.25 Favored 'General case' 0 N--CA 1.448 -0.527 0 CA-C-N 115.448 -0.797 . . . . 0.0 109.09 172.367 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 12' ' ' ASN . . . . . 0.421 ' HB3' ' H ' ' A' ' 9' ' ' ASP . 9.0 p30 -126.02 -177.97 4.13 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.348 -176.115 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 95.24 -110.64 4.06 Favored Glycine 0 N--CA 1.447 -0.603 0 N-CA-C 111.205 -0.758 . . . . 0.0 111.205 -177.12 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -73.65 -74.6 0.81 Allowed Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.86 -0.686 . . . . 0.0 111.616 177.678 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 5.4 pm0 -82.71 135.62 34.96 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 175.461 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' ASN . . . . . 0.5 ' HA ' ' O ' ' A' ' 11' ' ' ALA . 0.1 OUTLIER -144.91 42.02 1.31 Allowed 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.349 0.595 . . . . 0.0 110.796 -173.915 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 89.67 -61.55 3.47 Favored Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.704 -0.76 . . . . 0.0 113.596 174.869 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.452 HG21 ' HA ' ' A' ' 73' ' ' PRO . 95.9 m -65.72 127.71 33.04 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.93 0.395 . . . . 0.0 111.35 -175.907 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.941 ' HB ' HD12 ' A' ' 70' ' ' ILE . 0.2 OUTLIER -138.24 128.4 34.85 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 115.648 -0.705 . . . . 0.0 110.932 -179.761 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 27.9 mt-30 -118.31 116.04 25.95 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.881 -0.6 . . . . 0.0 109.951 174.148 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.56 ' HG3' ' HG2' ' A' ' 68' ' ' ARG . 4.5 mp0 -86.61 107.75 18.3 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.119 0.485 . . . . 0.0 110.851 178.784 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 23.1 mm -88.18 156.03 3.17 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-N 115.67 -0.695 . . . . 0.0 110.046 -178.08 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' MET . . . . . 0.465 ' HB3' ' HB3' ' A' ' 64' ' ' ASP . 14.3 mmt -105.83 91.79 3.89 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 109.618 -0.512 . . . . 0.0 109.618 176.653 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.714 ' HB ' ' HB2' ' A' ' 65' ' ' LYS . 26.0 mm -80.85 125.39 80.25 Favored Pre-proline 0 C--N 1.321 -0.668 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.751 -176.488 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.611 ' HB2' ' HB2' ' A' ' 28' ' ' LYS . 64.8 Cg_exo -51.89 130.14 33.22 Favored 'Trans proline' 0 C--O 1.233 0.226 0 C-N-CA 122.813 2.342 . . . . 0.0 111.711 176.412 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -58.34 -38.14 76.57 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 115.754 -0.657 . . . . 0.0 111.45 -177.252 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -90.16 22.47 26.03 Favored Glycine 0 N--CA 1.453 -0.222 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.327 178.268 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.611 ' HB2' ' HB2' ' A' ' 25' ' ' PRO . 21.3 tptt -133.1 0.81 3.47 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 178.136 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.63 -33.96 74.84 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.501 -0.772 . . . . 0.0 111.857 -174.468 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -59.04 -22.08 54.44 Favored Glycine 0 CA--C 1.519 0.33 0 C-N-CA 121.14 -0.552 . . . . 0.0 113.037 -179.397 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.493 ' HB3' HG22 ' A' ' 86' ' ' ILE . 94.2 mt -87.99 -43.19 11.92 Favored 'General case' 0 C--N 1.326 -0.447 0 O-C-N 122.576 -0.367 . . . . 0.0 110.951 -179.887 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.482 HG11 HG21 ' A' ' 24' ' ' ILE . 1.2 p -66.8 -29.97 48.11 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.416 0 CA-C-O 121.199 0.523 . . . . 0.0 110.656 -178.899 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 63.2 mt -81.36 -43.77 20.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-O 121.692 0.758 . . . . 0.0 109.108 173.372 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.542 ' HA3' ' HB ' ' A' ' 39' ' ' THR . . . 116.46 163.43 13.36 Favored Glycine 0 N--CA 1.438 -1.201 0 CA-C-N 115.344 -0.844 . . . . 0.0 112.54 174.805 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.519 ' N ' ' HD3' ' A' ' 35' ' ' LYS . 0.0 OUTLIER -78.64 57.59 2.07 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.305 0.574 . . . . 0.0 110.263 -178.656 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 134.24 14.72 1.21 Allowed Glycine 0 N--CA 1.447 -0.585 0 CA-C-N 115.358 -0.837 . . . . 0.0 111.619 -179.44 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 71.36 6.35 61.47 Favored Glycine 0 C--N 1.333 0.409 0 C-N-CA 121.25 -0.5 . . . . 0.0 112.355 -178.193 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 55.3 mm-40 -84.12 -22.67 31.0 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 120.961 0.41 . . . . 0.0 111.073 -178.511 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.681 ' O ' ' HG ' ' A' ' 43' ' ' LEU . 57.9 m -70.97 -51.68 24.24 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.3 178.282 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.576 ' HA ' HD12 ' A' ' 43' ' ' LEU . 7.8 tt -58.74 -33.7 49.86 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.385 0 CA-C-O 121.312 0.577 . . . . 0.0 110.568 177.808 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 40.0 ttmt -63.66 -37.96 89.32 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.349 177.332 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.609 ' O ' ' HG2' ' A' ' 46' ' ' ARG . 45.7 mt-30 -79.63 -42.03 25.73 Favored 'General case' 0 C--O 1.222 -0.359 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.498 -178.982 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.681 ' HG ' ' O ' ' A' ' 39' ' ' THR . 70.5 mt -49.0 -45.41 42.37 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-O 120.912 0.387 . . . . 0.0 111.789 -176.073 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 45.9 mt-30 -62.4 -44.71 95.79 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.651 179.161 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -68.66 -42.4 77.95 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.095 -179.264 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' ARG . . . . . 0.609 ' HG2' ' O ' ' A' ' 42' ' ' GLN . 15.4 mmt180 -52.31 -44.62 65.17 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.805 -175.553 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -102.64 -9.98 19.63 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.618 -175.424 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 71.09 39.86 62.51 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.73 -0.747 . . . . 0.0 111.291 -175.09 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 27.3 m -122.77 178.95 2.8 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-O 120.891 0.377 . . . . 0.0 110.476 -175.534 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.452 ' C ' ' HD3' ' A' ' 50' ' ' LYS . 1.1 tmtp? -116.74 124.41 49.58 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 175.17 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 51' ' ' MET . . . . . 0.568 ' CE ' ' HB1' ' A' ' 79' ' ' ALA . 64.3 mtt -117.37 121.99 42.61 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.482 -0.327 . . . . 0.0 110.43 178.406 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.748 HG22 ' HB2' ' A' ' 68' ' ' ARG . 0.0 OUTLIER -110.44 116.57 52.72 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 CA-C-O 121.648 0.737 . . . . 0.0 109.21 176.146 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.635 HD22 HD13 ' A' ' 67' ' ' LEU . 2.8 mm? -95.7 105.72 17.75 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.388 -0.823 . . . . 0.0 110.339 179.499 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.769 HD12 ' HB2' ' A' ' 66' ' ' PRO . 60.1 mt -75.59 96.26 1.18 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 121.332 0.587 . . . . 0.0 110.223 179.867 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 57.7 mt-30 -106.69 -48.9 3.42 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.658 -0.701 . . . . 0.0 109.792 -179.83 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 19.4 m-20 -82.07 -28.33 32.44 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.38 -0.827 . . . . 0.0 110.719 -179.193 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' GLY . . . . . 0.496 ' O ' ' HB ' ' A' ' 61' ' ' THR . . . -68.22 130.45 26.85 Favored Glycine 0 N--CA 1.447 -0.6 0 C-N-CA 120.66 -0.781 . . . . 0.0 112.09 -176.361 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 47.9 m -80.61 62.52 4.71 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.718 0.771 . . . . 0.0 111.027 179.24 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 23.3 mm-40 -129.85 98.45 4.79 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 107.852 -1.166 . . . . 0.0 107.852 171.801 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 4.3 m-20 59.77 31.06 20.61 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.246 0.546 . . . . 0.0 110.14 -174.001 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' THR . . . . . 0.496 ' HB ' ' O ' ' A' ' 57' ' ' GLY . 14.2 t -72.36 -20.62 61.43 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.991 -0.549 . . . . 0.0 111.675 -173.506 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 81.2 m-20 -104.46 6.5 34.93 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.029 0.442 . . . . 0.0 110.926 -179.583 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.408 ' HB ' ' H ' ' A' ' 64' ' ' ASP . 13.8 m -131.69 -144.62 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.018 178.088 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.465 ' HB3' ' HB3' ' A' ' 23' ' ' MET . 23.2 m-20 -61.26 139.36 58.16 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 110.036 -0.357 . . . . 0.0 110.036 176.276 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.714 ' HB2' ' HB ' ' A' ' 24' ' ' ILE . 70.6 mmtt -89.43 120.82 69.68 Favored Pre-proline 0 C--N 1.32 -0.686 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.882 -171.097 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.769 ' HB2' HD12 ' A' ' 54' ' ' ILE . 28.5 Cg_exo -66.35 104.68 0.78 Allowed 'Trans proline' 0 N--CA 1.462 -0.377 0 C-N-CA 122.928 2.419 . . . . 0.0 112.124 175.001 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.635 HD13 HD22 ' A' ' 53' ' ' LEU . 14.5 tp -103.21 118.13 36.09 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.906 -0.588 . . . . 0.0 109.946 176.057 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.748 ' HB2' HG22 ' A' ' 52' ' ' ILE . 95.5 mtt180 -98.19 110.85 23.36 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 116.556 -0.293 . . . . 0.0 110.897 177.015 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 4.2 mp -96.47 104.73 16.2 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 171.598 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.941 HD12 ' HB ' ' A' ' 19' ' ' VAL . 3.6 mm -100.85 134.82 39.62 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 N-CA-C 109.914 -0.402 . . . . 0.0 109.914 -178.229 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 71' ' ' GLY . . . . . 0.417 ' O ' ' HB ' ' A' ' 18' ' ' THR . . . 164.44 -142.14 7.57 Favored Glycine 0 N--CA 1.447 -0.626 0 C-N-CA 121.054 -0.593 . . . . 0.0 111.625 178.568 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 72' ' ' ASP . . . . . 0.556 ' OD2' ' HB3' ' A' ' 74' ' ' TYR . 8.8 t70 -93.83 140.92 23.15 Favored Pre-proline 0 C--N 1.318 -0.79 0 CA-C-O 118.35 -0.833 . . . . 0.0 109.122 179.686 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 73' ' ' PRO . . . . . 0.452 ' HA ' HG21 ' A' ' 18' ' ' THR . 84.0 Cg_exo -41.78 -41.1 5.98 Favored 'Trans proline' 0 C--N 1.346 0.433 0 C-N-CA 122.757 2.305 . . . . 0.0 113.066 -177.806 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 74' ' ' TYR . . . . . 0.556 ' HB3' ' OD2' ' A' ' 72' ' ' ASP . 69.2 t80 -63.48 -58.68 6.25 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.296 -178.74 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.495 ' HG2' ' HB3' ' A' ' 72' ' ' ASP . 38.0 pttt -71.91 -27.87 63.11 Favored 'General case' 0 CA--C 1.518 -0.268 0 C-N-CA 120.446 -0.501 . . . . 0.0 111.557 -178.019 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 55.3 t -63.7 -39.67 86.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 N-CA-C 109.53 -0.545 . . . . 0.0 109.53 176.832 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 22.7 tp60 -75.85 -44.95 38.33 Favored 'General case' 0 N--CA 1.445 -0.698 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.79 -179.717 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 78' ' ' GLN . . . . . 0.409 ' HA ' ' HG2' ' A' ' 81' ' ' GLU . 55.5 mt-30 -64.82 -35.78 82.22 Favored 'General case' 0 C--N 1.33 -0.271 0 C-N-CA 120.469 -0.493 . . . . 0.0 110.926 -179.921 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 79' ' ' ALA . . . . . 0.568 ' HB1' ' CE ' ' A' ' 51' ' ' MET . . . -71.38 -34.71 70.68 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 120.93 0.395 . . . . 0.0 110.09 176.222 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 36.7 t -65.22 -47.87 75.35 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.253 178.023 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 81' ' ' GLU . . . . . 0.409 ' HG2' ' HA ' ' A' ' 78' ' ' GLN . 10.5 pt-20 -69.72 -22.37 63.4 Favored 'General case' 0 C--N 1.322 -0.601 0 C-N-CA 120.684 -0.406 . . . . 0.0 110.14 178.861 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 82' ' ' MET . . . . . 0.475 ' O ' ' HB3' ' A' ' 85' ' ' ASP . 57.4 ttp -73.74 -46.28 46.88 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.664 176.338 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.542 ' O ' ' HG ' ' A' ' 87' ' ' LEU . 33.2 m -72.03 -36.56 57.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 C-N-CA 120.662 -0.415 . . . . 0.0 110.665 178.905 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 84' ' ' MET . . . . . 0.404 ' O ' ' HG2' ' A' ' 88' ' ' ARG . 54.1 mtt -65.0 -32.08 73.63 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 109.975 -0.379 . . . . 0.0 109.975 175.146 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 85' ' ' ASP . . . . . 0.475 ' HB3' ' O ' ' A' ' 82' ' ' MET . 18.8 t70 -58.23 -48.79 79.27 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.648 176.315 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.493 HG22 ' HB3' ' A' ' 31' ' ' LEU . 34.8 mt -60.63 -29.7 45.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 121.271 0.558 . . . . 0.0 110.536 179.562 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.542 ' HG ' ' O ' ' A' ' 83' ' ' VAL . 62.0 mt -92.06 -1.71 57.06 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.661 -0.699 . . . . 0.0 111.927 -174.755 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 88' ' ' ARG . . . . . 0.404 ' HG2' ' O ' ' A' ' 84' ' ' MET . 19.2 ptp180 -129.83 16.49 5.78 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.059 0.457 . . . . 0.0 111.141 -179.929 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 10.5 tt0 . . . . . 0 C--O 1.249 1.059 0 CA-C-O 118.186 -0.912 . . . . 0.0 109.86 179.218 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.533 0 N-CA-C 111.998 -0.441 . . . . 0.0 111.998 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 51.9 mt-30 -81.64 35.24 0.4 Allowed 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 110.34 -0.244 . . . . 0.0 110.34 -179.921 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' PHE . . . . . 0.623 ' HD1' ' HB3' ' A' ' 72' ' ' ASP . 50.2 m-85 67.57 152.87 0.08 Allowed 'General case' 0 N--CA 1.465 0.321 0 C-N-CA 123.685 0.794 . . . . 0.0 110.844 -174.984 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 8' ' ' HIS . . . . . 0.429 ' O ' ' HB3' ' A' ' 9' ' ' ASP . 1.8 t-80 -157.51 -76.08 0.09 Allowed 'General case' 0 C--N 1.319 -0.745 0 N-CA-C 108.863 -0.792 . . . . 0.0 108.863 170.294 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 9' ' ' ASP . . . . . 0.593 ' HA ' ' OD2' ' A' ' 72' ' ' ASP . 8.5 p-10 174.12 128.02 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.439 0 O-C-N 123.916 0.76 . . . . 0.0 110.971 171.831 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 22.4 t-20 70.26 -68.5 0.2 Allowed 'General case' 0 N--CA 1.471 0.593 0 CA-C-N 115.428 -0.806 . . . . 0.0 111.797 174.928 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -112.93 109.85 19.55 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.184 -178.37 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' ASN . . . . . 0.483 HD21 ' H ' ' A' ' 12' ' ' ASN . 0.1 OUTLIER -135.94 177.96 7.42 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.358 -177.851 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 77.94 -92.52 1.14 Allowed Glycine 0 N--CA 1.449 -0.469 0 C-N-CA 120.849 -0.691 . . . . 0.0 112.439 178.258 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -166.44 -59.75 0.03 OUTLIER Glycine 0 N--CA 1.448 -0.516 0 C-N-CA 121.105 -0.569 . . . . 0.0 112.027 -178.464 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 50.6 mt-30 -96.27 106.77 19.03 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 110.299 -0.26 . . . . 0.0 110.299 179.032 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 89.9 m-20 67.81 -68.77 0.15 Allowed 'General case' 0 N--CA 1.467 0.414 0 O-C-N 123.941 0.776 . . . . 0.0 112.254 177.016 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 156.73 -159.6 29.67 Favored Glycine 0 N--CA 1.446 -0.674 0 N-CA-C 110.599 -1.0 . . . . 0.0 110.599 -176.443 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 32.8 m -100.57 126.14 47.0 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 117.438 0.619 . . . . 0.0 109.991 176.129 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.518 ' HA ' ' O ' ' A' ' 69' ' ' ILE . 7.5 p -141.8 136.27 30.54 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.405 -176.183 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 20' ' ' GLN . . . . . 0.524 ' O ' ' HA ' ' A' ' 68' ' ' ARG . 37.5 mt-30 -112.84 158.69 19.84 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.194 -0.457 . . . . 0.0 109.802 171.962 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.626 ' HG2' ' HG2' ' A' ' 68' ' ' ARG . 51.9 mt-10 -125.28 113.57 17.79 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.932 0.396 . . . . 0.0 109.968 178.683 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 9.6 mm -104.69 137.8 32.24 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.375 -178.195 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -86.07 91.52 8.43 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 172.362 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.838 HG23 HD21 ' A' ' 87' ' ' LEU . 33.1 mm -79.86 126.35 80.23 Favored Pre-proline 0 C--N 1.319 -0.76 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.791 -177.546 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.775 ' HB2' ' HB2' ' A' ' 28' ' ' LYS . 72.7 Cg_exo -51.99 135.86 51.8 Favored 'Trans proline' 0 N--CA 1.461 -0.392 0 C-N-CA 122.675 2.25 . . . . 0.0 111.416 175.459 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -57.93 -33.36 68.72 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.661 -0.7 . . . . 0.0 112.626 -172.865 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -82.74 -29.36 35.54 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.495 -0.86 . . . . 0.0 111.688 177.375 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.775 ' HB2' ' HB2' ' A' ' 25' ' ' PRO . 11.7 mptt -79.68 -8.23 59.09 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.981 0.42 . . . . 0.0 110.736 179.802 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.436 ' HB2' ' HG3' ' A' ' 65' ' ' LYS . . . -61.54 -26.63 68.06 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.501 176.832 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -68.93 -17.68 71.82 Favored Glycine 0 N--CA 1.449 -0.499 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.331 177.673 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.432 ' HB3' HG22 ' A' ' 86' ' ' ILE . 84.8 mt -88.86 -37.93 14.96 Favored 'General case' 0 C--N 1.326 -0.427 0 O-C-N 122.677 -0.308 . . . . 0.0 110.902 -179.701 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.557 HG13 HD11 ' A' ' 87' ' ' LEU . 0.5 OUTLIER -71.69 -33.78 49.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 120.792 0.33 . . . . 0.0 110.683 176.392 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.601 ' HA ' ' HB ' ' A' ' 40' ' ' ILE . 83.7 mt -77.64 -40.98 28.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-O 121.601 0.715 . . . . 0.0 109.479 174.191 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.552 ' HA3' ' HB ' ' A' ' 39' ' ' THR . . . 104.3 177.2 25.27 Favored Glycine 0 N--CA 1.442 -0.927 0 CA-C-N 115.514 -0.766 . . . . 0.0 112.467 175.893 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 30.1 mmmt -76.71 62.56 2.01 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.088 0.47 . . . . 0.0 110.419 -178.457 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 118.07 19.68 4.68 Favored Glycine 0 N--CA 1.448 -0.54 0 C-N-CA 120.972 -0.633 . . . . 0.0 112.005 178.492 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.401 ' HA2' HG22 ' A' ' 33' ' ' ILE . . . 82.5 3.78 90.39 Favored Glycine 0 N--CA 1.449 -0.479 0 C-N-CA 120.875 -0.679 . . . . 0.0 112.521 179.081 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.638 ' HA ' ' HD3' ' A' ' 41' ' ' LYS . 20.8 tp10 -78.21 -37.66 44.95 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 120.79 0.328 . . . . 0.0 110.975 -177.874 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.603 ' O ' ' HG ' ' A' ' 43' ' ' LEU . 28.8 m -67.43 -40.23 85.48 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.648 -0.251 . . . . 0.0 111.492 -177.176 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.601 ' HB ' ' HA ' ' A' ' 33' ' ' ILE . 14.5 tt -63.8 -28.88 45.89 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.411 0 CA-C-O 121.172 0.511 . . . . 0.0 110.778 179.601 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.638 ' HD3' ' HA ' ' A' ' 38' ' ' GLU . 52.1 mtpt -66.46 -40.59 89.46 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.195 0.522 . . . . 0.0 109.852 174.606 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 27.5 mt-30 -70.76 -42.42 70.47 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.269 -0.878 . . . . 0.0 110.674 -176.693 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.603 ' HG ' ' O ' ' A' ' 39' ' ' THR . 81.8 mt -56.83 -47.06 81.18 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.589 -176.864 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 49.9 mt-30 -61.47 -53.5 55.7 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.431 -176.975 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -68.16 -39.65 82.56 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 112.033 0.383 . . . . 0.0 112.033 -175.591 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' ARG . . . . . 0.472 ' HD3' ' SD ' ' A' ' 82' ' ' MET . 12.3 ptm180 -70.01 -31.17 68.7 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.936 0.398 . . . . 0.0 111.214 -174.78 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.535 ' HB3' HG22 ' A' ' 49' ' ' VAL . . . -93.27 -15.95 25.28 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.367 -177.111 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 73.49 25.45 72.56 Favored Glycine 0 N--CA 1.45 -0.401 0 CA-C-N 115.947 -0.57 . . . . 0.0 111.953 -178.729 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.535 HG22 ' HB3' ' A' ' 47' ' ' ALA . 35.1 m -123.93 173.88 9.06 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-O 120.843 0.354 . . . . 0.0 110.066 -177.399 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.502 ' HE2' HD12 ' A' ' 70' ' ' ILE . 2.2 tmmm? -109.97 123.33 49.45 Favored 'General case' 0 C--N 1.318 -0.762 0 N-CA-C 108.679 -0.86 . . . . 0.0 108.679 174.753 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 51' ' ' MET . . . . . 0.532 ' CE ' ' HB1' ' A' ' 79' ' ' ALA . 63.5 mtt -114.43 116.42 28.86 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.195 -179.671 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.512 ' CG2' ' HB2' ' A' ' 68' ' ' ARG . 9.9 tt -106.57 105.16 18.23 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.83 0 CA-C-O 121.484 0.659 . . . . 0.0 110.11 176.14 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.581 HD22 HD13 ' A' ' 67' ' ' LEU . 3.5 mm? -82.24 102.58 11.24 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 108.963 -0.754 . . . . 0.0 108.963 173.723 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.701 HD12 ' HB2' ' A' ' 66' ' ' PRO . 53.5 mt -79.25 86.92 1.23 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-O 121.433 0.635 . . . . 0.0 110.166 -176.372 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 55' ' ' GLN . . . . . 0.432 HE22 ' HB1' ' A' ' 29' ' ' ALA . 10.5 mm100 -98.84 -24.91 14.81 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.355 -0.839 . . . . 0.0 109.516 -179.814 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -96.54 -31.69 12.64 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.333 -0.849 . . . . 0.0 110.849 -178.418 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -70.2 138.96 30.12 Favored Glycine 0 N--CA 1.453 -0.218 0 C-N-CA 121.016 -0.611 . . . . 0.0 112.557 -178.484 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 5.1 m -84.74 67.17 9.96 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.43 0.633 . . . . 0.0 110.805 -176.567 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' GLN . . . . . 0.494 ' HB2' ' HG2' ' A' ' 66' ' ' PRO . 27.5 mm-40 -124.43 67.03 1.07 Allowed 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.771 -0.649 . . . . 0.0 109.872 179.108 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 3.5 m-20 62.88 41.16 8.92 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 116.058 -0.519 . . . . 0.0 109.787 -176.046 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 7.0 t -80.64 -27.66 37.13 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.002 -0.544 . . . . 0.0 111.405 -175.905 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 87.4 m-20 -85.24 20.5 1.95 Allowed 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.338 0.59 . . . . 0.0 111.087 -178.252 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.567 HG23 ' H ' ' A' ' 64' ' ' ASP . 0.2 OUTLIER -138.44 -57.48 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-N 115.301 -0.863 . . . . 0.0 110.102 174.197 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.567 ' H ' HG23 ' A' ' 63' ' ' VAL . 49.7 m-20 -128.92 -166.07 1.59 Allowed 'General case' 0 C--N 1.308 -1.221 0 CA-C-N 114.265 -1.334 . . . . 0.0 108.309 179.122 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.754 ' HB2' ' HB ' ' A' ' 24' ' ' ILE . 66.9 mmtt -141.6 116.73 7.03 Favored Pre-proline 0 C--N 1.314 -0.937 0 CA-C-N 116.708 -0.224 . . . . 0.0 110.632 -176.784 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.701 ' HB2' HD12 ' A' ' 54' ' ' ILE . 25.1 Cg_exo -64.42 124.19 12.94 Favored 'Trans proline' 0 N--CA 1.461 -0.431 0 C-N-CA 122.82 2.347 . . . . 0.0 111.863 176.308 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.581 HD13 HD22 ' A' ' 53' ' ' LEU . 33.7 tp -124.1 106.84 10.67 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.954 -0.567 . . . . 0.0 109.839 177.793 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.626 ' HG2' ' HG2' ' A' ' 21' ' ' GLU . 87.4 mtt180 -96.98 105.59 17.77 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.139 177.711 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.518 ' O ' ' HA ' ' A' ' 19' ' ' VAL . 4.4 mp -87.96 104.49 14.55 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 174.449 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.502 HD12 ' HE2' ' A' ' 50' ' ' LYS . 13.8 mt -104.34 126.93 59.01 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.026 -173.491 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 167.82 -142.52 7.55 Favored Glycine 0 N--CA 1.446 -0.648 0 N-CA-C 111.596 -0.602 . . . . 0.0 111.596 178.65 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 72' ' ' ASP . . . . . 0.623 ' HB3' ' HD1' ' A' ' 7' ' ' PHE . 15.1 m-20 -91.33 149.12 39.1 Favored Pre-proline 0 C--N 1.325 -0.489 0 CA-C-O 118.963 -0.541 . . . . 0.0 109.692 175.859 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 73' ' ' PRO . . . . . 0.464 ' HD2' ' CD1' ' A' ' 7' ' ' PHE . 77.5 Cg_exo -49.36 -39.53 43.94 Favored 'Trans proline' 0 C--N 1.343 0.285 0 C-N-CA 122.333 2.022 . . . . 0.0 112.31 -176.948 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 76.0 t80 -64.36 -56.32 15.2 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.262 -176.995 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.477 ' HG2' ' HB2' ' A' ' 72' ' ' ASP . 4.9 ptpt -68.06 -31.97 71.99 Favored 'General case' 0 C--O 1.223 -0.301 0 C-N-CA 120.671 -0.412 . . . . 0.0 111.296 179.41 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.406 HG23 ' O ' ' A' ' 72' ' ' ASP . 53.1 t -65.18 -40.09 87.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.998 0.427 . . . . 0.0 110.012 178.163 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 77' ' ' GLN . . . . . 0.47 ' O ' ' HG2' ' A' ' 81' ' ' GLU . 19.4 tp60 -64.81 -51.88 59.81 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.032 176.707 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 25.1 mt-30 -62.97 -35.14 79.17 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 121.0 0.428 . . . . 0.0 110.853 -178.202 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 79' ' ' ALA . . . . . 0.532 ' HB1' ' CE ' ' A' ' 51' ' ' MET . . . -72.1 -35.31 69.15 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.999 179.812 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 80' ' ' CYS . . . . . 0.4 ' HA ' HG22 ' A' ' 83' ' ' VAL . 52.7 t -72.29 -45.56 59.52 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.144 -179.457 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 81' ' ' GLU . . . . . 0.47 ' HG2' ' O ' ' A' ' 77' ' ' GLN . 10.2 pt-20 -66.83 -22.62 65.99 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.101 0.477 . . . . 0.0 110.024 177.834 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 82' ' ' MET . . . . . 0.472 ' SD ' ' HD3' ' A' ' 46' ' ' ARG . 42.8 ttp -71.5 -55.41 7.91 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.54 -0.755 . . . . 0.0 110.423 175.822 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.451 HG12 HD13 ' A' ' 43' ' ' LEU . 31.3 m -66.95 -34.97 73.44 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.169 0 C-N-CA 121.116 -0.234 . . . . 0.0 110.985 -179.455 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 66.6 mmm -62.17 -37.45 85.28 Favored 'General case' 0 CA--C 1.519 -0.229 0 CA-C-O 120.685 0.279 . . . . 0.0 110.505 176.391 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 85' ' ' ASP . . . . . 0.465 ' O ' ' HB2' ' A' ' 89' ' ' GLU . 36.5 t70 -65.8 -44.52 85.43 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.918 -179.781 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.432 HG22 ' HB3' ' A' ' 31' ' ' LEU . 57.8 mt -60.01 -31.25 47.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 121.148 0.499 . . . . 0.0 110.768 179.822 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.838 HD21 HG23 ' A' ' 24' ' ' ILE . 7.1 mp -81.48 -31.79 32.79 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.815 -0.629 . . . . 0.0 112.268 -177.176 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 15.3 ptm180 -95.88 -5.79 40.74 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.134 0.492 . . . . 0.0 111.132 -176.768 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 89' ' ' GLU . . . . . 0.465 ' HB2' ' O ' ' A' ' 85' ' ' ASP . 4.7 mm-40 . . . . . 0 C--O 1.251 1.137 0 CA-C-O 118.438 -0.791 . . . . 0.0 110.031 178.473 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.444 -0.781 0 N-CA-C 111.708 -0.557 . . . . 0.0 111.708 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 49.6 tt0 54.9 59.26 4.17 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.202 0.525 . . . . 0.0 109.916 -177.754 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' PHE . . . . . 0.662 ' CD1' ' HG2' ' A' ' 73' ' ' PRO . 9.4 m-85 61.05 -97.94 0.07 Allowed 'General case' 0 N--CA 1.463 0.178 0 CA-C-N 115.217 -0.901 . . . . 0.0 109.702 -176.082 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 8' ' ' HIS . . . . . 0.465 ' H ' ' HB2' ' A' ' 7' ' ' PHE . 0.6 OUTLIER 64.64 176.85 0.19 Allowed 'General case' 0 CA--C 1.534 0.35 0 O-C-N 123.704 0.627 . . . . 0.0 111.867 171.869 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 9' ' ' ASP . . . . . 0.55 ' HA ' ' NZ ' ' A' ' 75' ' ' LYS . 20.1 m-20 -106.64 85.72 2.21 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.527 -0.306 . . . . 0.0 111.013 179.601 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 38.8 t30 179.39 -77.13 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.063 -0.517 . . . . 0.0 109.865 178.325 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -172.37 99.88 0.15 Allowed 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.367 -0.833 . . . . 0.0 109.595 -178.698 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 6.5 p30 -66.32 114.31 5.28 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.36 0.6 . . . . 0.0 110.802 179.232 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 89.63 -95.33 2.08 Favored Glycine 0 N--CA 1.45 -0.425 0 CA-C-N 115.661 -0.699 . . . . 0.0 112.039 -179.028 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -113.97 -84.05 1.24 Allowed Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 121.017 -0.611 . . . . 0.0 111.668 178.602 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 55.8 tt0 -129.55 108.57 10.34 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 174.663 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' ASN . . . . . 0.588 ' HB3' HG22 ' A' ' 70' ' ' ILE . 74.8 m-20 65.32 -176.29 0.18 Allowed 'General case' 0 CA--C 1.532 0.283 0 O-C-N 123.667 0.605 . . . . 0.0 110.741 -179.882 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -166.73 -71.26 0.03 OUTLIER Glycine 0 N--CA 1.449 -0.445 0 C-N-CA 120.652 -0.785 . . . . 0.0 112.076 179.24 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 94.3 m -72.91 135.1 45.03 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 120.669 0.271 . . . . 0.0 110.62 179.457 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.653 ' HA ' ' O ' ' A' ' 69' ' ' ILE . 6.2 p -129.72 124.32 58.89 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-O 121.13 0.49 . . . . 0.0 110.801 178.073 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 28.6 mt-30 -110.29 114.6 28.2 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.055 -0.52 . . . . 0.0 109.887 174.663 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.659 ' HA ' ' O ' ' A' ' 67' ' ' LEU . 43.4 mt-10 -90.37 116.04 28.02 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.086 0.469 . . . . 0.0 110.535 176.106 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 22.0 mm -103.69 137.42 32.33 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.767 0 CA-C-N 115.687 -0.688 . . . . 0.0 109.839 -179.561 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' MET . . . . . 0.449 ' HB3' ' HB3' ' A' ' 64' ' ' ASP . 3.1 mmt -89.13 94.27 9.87 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 176.593 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.864 HG23 HD13 ' A' ' 87' ' ' LEU . 27.2 mm -77.66 129.19 77.52 Favored Pre-proline 0 C--N 1.318 -0.801 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.027 -175.06 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.537 ' HB2' ' HB2' ' A' ' 28' ' ' LYS . 53.8 Cg_exo -52.93 125.43 18.22 Favored 'Trans proline' 0 N--CA 1.458 -0.596 0 C-N-CA 122.188 1.925 . . . . 0.0 110.685 172.01 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -57.63 -27.87 63.18 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 112.097 0.406 . . . . 0.0 112.097 -174.057 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -80.21 -30.66 40.94 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.511 177.306 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.545 ' HB3' HD22 ' A' ' 87' ' ' LEU . 21.2 mmtp -89.42 -4.41 58.02 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.727 0.299 . . . . 0.0 111.234 -177.966 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.411 ' O ' HG23 ' A' ' 32' ' ' VAL . . . -57.44 -28.89 63.73 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.707 -178.173 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -62.28 -26.32 67.7 Favored Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 120.925 -0.655 . . . . 0.0 112.856 -179.81 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 69.6 mt -78.73 -39.84 35.18 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.883 0.341 . . . . 0.0 111.398 -178.173 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.552 HG21 HG21 ' A' ' 24' ' ' ILE . 0.0 OUTLIER -65.74 -38.06 81.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 121.19 0.519 . . . . 0.0 110.106 179.177 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 49.9 mt -72.61 -42.67 62.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-O 121.546 0.689 . . . . 0.0 109.499 175.838 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 100.57 39.61 3.16 Favored Glycine 0 CA--C 1.499 -0.938 0 CA-C-N 115.17 -0.923 . . . . 0.0 112.685 176.708 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 3.7 mppt? 53.0 36.9 23.28 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.079 -0.561 . . . . 0.0 111.45 179.265 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 159.04 -48.95 0.41 Allowed Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.54 -0.838 . . . . 0.0 112.145 -179.195 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 145.31 -6.68 1.52 Allowed Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.24 -0.981 . . . . 0.0 113.476 179.866 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 43.9 mm-40 -65.64 -40.76 92.86 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 117.006 0.403 . . . . 0.0 112.012 -179.014 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.729 ' O ' ' HG ' ' A' ' 43' ' ' LEU . 91.6 m -62.39 -54.64 37.41 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.876 -0.147 . . . . 0.0 111.278 -178.105 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.593 ' HA ' HD12 ' A' ' 43' ' ' LEU . 5.3 tt -58.34 -30.96 41.57 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.365 0 CA-C-O 121.219 0.533 . . . . 0.0 111.157 -179.346 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.459 ' HE2' ' HB3' ' A' ' 41' ' ' LYS . 4.9 tmmm? -70.33 -41.72 72.86 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.932 -0.576 . . . . 0.0 109.819 177.842 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 15.4 mm-40 -69.37 -38.18 77.92 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.956 -179.492 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.729 ' HG ' ' O ' ' A' ' 39' ' ' THR . 73.7 mt -56.42 -43.9 79.83 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.826 -0.624 . . . . 0.0 111.215 -177.755 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 46.7 mt-30 -67.08 -31.25 71.61 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.376 -177.432 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -80.14 -43.01 22.38 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.892 0.377 . . . . 0.0 111.162 -178.833 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 13.5 ptm180 -75.52 -36.51 60.49 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.952 -0.567 . . . . 0.0 112.45 -173.352 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.452 ' HB3' HG22 ' A' ' 49' ' ' VAL . . . -95.89 -17.21 21.27 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.861 0.362 . . . . 0.0 111.33 -178.247 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 79.41 3.17 88.58 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.879 -0.677 . . . . 0.0 112.208 -179.785 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.452 HG22 ' HB3' ' A' ' 47' ' ' ALA . 34.3 m -97.3 166.02 1.98 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-O 120.637 0.256 . . . . 0.0 110.379 -177.769 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 63.9 tttp -105.21 122.84 46.75 Favored 'General case' 0 C--N 1.316 -0.858 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 172.843 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' MET . . . . . 0.592 ' HE3' HG21 ' A' ' 83' ' ' VAL . 77.1 mtp -119.07 115.92 25.31 Favored 'General case' 0 C--N 1.316 -0.854 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 178.263 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.565 ' CG2' ' HB2' ' A' ' 68' ' ' ARG . 8.7 tt -105.4 105.4 18.59 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.937 0 CA-C-O 121.588 0.709 . . . . 0.0 110.734 179.826 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.708 HD22 HD13 ' A' ' 67' ' ' LEU . 3.7 mm? -78.57 103.15 8.32 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 173.042 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.845 HD12 ' HB2' ' A' ' 66' ' ' PRO . 56.7 mt -73.33 89.11 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-O 121.518 0.675 . . . . 0.0 110.462 -178.091 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 19.6 mt-30 -100.52 -34.25 9.99 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.03 -0.986 . . . . 0.0 110.339 -178.519 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 35.7 m-20 -96.46 6.25 49.15 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.662 -177.984 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -80.9 -173.07 46.89 Favored Glycine 0 N--CA 1.447 -0.586 0 C-N-CA 120.681 -0.771 . . . . 0.0 111.543 177.396 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 1.7 p -149.92 27.83 0.78 Allowed 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 117.245 0.522 . . . . 0.0 112.079 -178.315 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 5.7 pt20 -93.37 -50.61 5.37 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.976 178.762 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.605 ' HB2' ' HG3' ' A' ' 66' ' ' PRO . 19.6 m120 -142.88 35.21 1.39 Allowed 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 109.592 -0.522 . . . . 0.0 109.592 179.083 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -76.82 -31.89 57.23 Favored 'General case' 0 C--N 1.314 -0.935 0 N-CA-C 112.583 0.586 . . . . 0.0 112.583 -169.669 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 7.4 p30 -82.65 -1.07 50.02 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 120.797 0.332 . . . . 0.0 111.222 -179.487 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 15.6 m -125.28 -146.56 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-N 116.158 -0.474 . . . . 0.0 109.827 179.218 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.449 ' HB3' ' HB3' ' A' ' 23' ' ' MET . 7.1 m-20 -56.62 134.43 54.51 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 109.593 -0.521 . . . . 0.0 109.593 174.777 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.719 ' HB2' ' HB ' ' A' ' 24' ' ' ILE . 70.4 mmtt -84.02 129.12 59.98 Favored Pre-proline 0 C--N 1.318 -0.795 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.46 -165.243 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.845 ' HB2' HD12 ' A' ' 54' ' ' ILE . 17.3 Cg_exo -68.83 105.83 1.39 Allowed 'Trans proline' 0 N--CA 1.46 -0.492 0 C-N-CA 123.054 2.502 . . . . 0.0 111.413 174.522 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.708 HD13 HD22 ' A' ' 53' ' ' LEU . 31.6 tp -115.7 104.21 11.45 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.46 -0.336 . . . . 0.0 110.619 179.455 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.565 ' HB2' ' CG2' ' A' ' 52' ' ' ILE . 92.6 mtt180 -91.65 108.23 19.76 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.881 0.372 . . . . 0.0 110.131 176.882 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.653 ' O ' ' HA ' ' A' ' 19' ' ' VAL . 22.1 mt -94.9 104.38 15.74 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 174.681 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.588 HG22 ' HB3' ' A' ' 16' ' ' ASN . 3.7 mt -110.85 127.54 67.86 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.847 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.19 -173.95 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 173.48 -147.17 9.34 Favored Glycine 0 N--CA 1.448 -0.565 0 C-N-CA 120.508 -0.853 . . . . 0.0 112.073 178.104 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 72' ' ' ASP . . . . . 0.539 ' O ' HG23 ' A' ' 76' ' ' VAL . 41.2 m-20 -84.12 140.1 39.65 Favored Pre-proline 0 C--N 1.323 -0.565 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 177.405 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 73' ' ' PRO . . . . . 0.662 ' HG2' ' CD1' ' A' ' 7' ' ' PHE . 76.5 Cg_exo -41.41 -53.4 3.18 Favored 'Trans proline' 0 CA--C 1.534 0.478 0 C-N-CA 123.746 2.964 . . . . 0.0 115.291 -169.443 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 35.8 p90 -76.31 -33.09 59.05 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 112.74 0.644 . . . . 0.0 112.74 -172.227 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.55 ' NZ ' ' HA ' ' A' ' 9' ' ' ASP . 6.1 ptpp? -72.49 -30.11 64.23 Favored 'General case' 0 CA--C 1.514 -0.412 0 C-N-CA 119.788 -0.765 . . . . 0.0 110.238 177.038 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.539 HG23 ' O ' ' A' ' 72' ' ' ASP . 92.3 t -63.08 -40.82 90.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 N-CA-C 109.427 -0.583 . . . . 0.0 109.427 177.035 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 3.5 tp60 -72.65 -46.56 53.36 Favored 'General case' 0 N--CA 1.447 -0.579 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.903 178.049 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 76.0 mt-30 -61.29 -40.18 93.17 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 120.79 -0.364 . . . . 0.0 111.052 179.637 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -71.67 -32.95 68.43 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.482 177.695 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 5.6 t -61.2 -57.12 13.76 Favored 'General case' 0 CA--C 1.515 -0.393 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.188 177.262 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 17.4 mm-40 -62.29 -29.51 70.48 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.723 -179.162 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 82' ' ' MET . . . . . 0.493 ' O ' HG13 ' A' ' 86' ' ' ILE . 43.6 ttp -63.27 -50.06 71.61 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.398 178.771 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.629 ' O ' ' HG ' ' A' ' 87' ' ' LEU . 30.5 m -83.77 -36.44 12.31 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-N 116.6 -0.273 . . . . 0.0 111.283 -177.147 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 27.4 ttt -65.3 -36.32 83.71 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.407 -179.849 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 85' ' ' ASP . . . . . 0.447 ' O ' ' HB2' ' A' ' 89' ' ' GLU . 35.0 t70 -62.54 -42.27 99.42 Favored 'General case' 0 C--O 1.223 -0.34 0 CA-C-N 116.595 -0.275 . . . . 0.0 110.466 178.502 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.493 HG13 ' O ' ' A' ' 82' ' ' MET . 52.8 mt -61.41 -31.29 50.03 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-O 121.446 0.641 . . . . 0.0 110.619 179.112 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.864 HD13 HG23 ' A' ' 24' ' ' ILE . 43.4 mt -88.71 -33.45 17.52 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.128 -176.225 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 17.7 tpt180 -77.33 -14.09 59.8 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.808 0.813 . . . . 0.0 109.504 177.309 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 89' ' ' GLU . . . . . 0.447 ' HB2' ' O ' ' A' ' 85' ' ' ASP . 6.4 tp10 . . . . . 0 C--O 1.25 1.093 0 CA-C-N 114.5 -1.227 . . . . 0.0 109.42 179.215 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.444 -0.794 0 N-CA-C 110.492 -1.043 . . . . 0.0 110.492 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 86.6 mm-40 -95.56 5.85 50.45 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 117.17 0.485 . . . . 0.0 110.808 179.963 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' PHE . . . . . 0.405 ' O ' ' HB2' ' A' ' 8' ' ' HIS . 17.2 m-85 55.63 -119.87 1.46 Allowed 'General case' 0 C--O 1.237 0.445 0 O-C-N 123.716 0.635 . . . . 0.0 110.612 176.623 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 8' ' ' HIS . . . . . 0.405 ' HB2' ' O ' ' A' ' 7' ' ' PHE . 60.4 m170 76.24 138.94 0.06 Allowed 'General case' 0 C--O 1.235 0.314 0 CA-C-O 121.966 0.888 . . . . 0.0 112.457 171.7 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 9' ' ' ASP . . . . . 0.537 ' HA ' ' HE2' ' A' ' 75' ' ' LYS . 12.8 p-10 -72.36 -21.43 61.3 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 114.957 -1.02 . . . . 0.0 111.46 -174.57 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 51.0 m-20 -86.71 4.4 40.85 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.843 0.354 . . . . 0.0 110.95 175.139 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . 71.48 105.63 0.06 Allowed 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 114.936 -1.029 . . . . 0.0 112.423 174.292 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 3.3 t-20 -63.43 136.21 57.46 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.9 -0.591 . . . . 0.0 109.527 172.526 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -73.66 141.03 28.99 Favored Glycine 0 N--CA 1.45 -0.433 0 C-N-CA 121.07 -0.586 . . . . 0.0 113.011 -175.053 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 85.95 -68.59 3.34 Favored Glycine 0 N--CA 1.449 -0.466 0 C-N-CA 121.132 -0.556 . . . . 0.0 112.417 176.872 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 24.3 mm-40 -126.0 134.81 51.36 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 120.826 0.346 . . . . 0.0 110.245 -179.938 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' ASN . . . . . 0.612 ' HB2' HG22 ' A' ' 70' ' ' ILE . 13.3 m120 -93.42 -41.98 9.52 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.575 -177.869 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 109.25 -78.44 0.24 Allowed Glycine 0 N--CA 1.446 -0.671 0 C-N-CA 120.536 -0.84 . . . . 0.0 112.608 179.176 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.545 HG21 ' HA ' ' A' ' 73' ' ' PRO . 84.3 m -73.69 126.65 30.81 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.149 0.5 . . . . 0.0 111.201 -176.889 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.655 ' HA ' ' O ' ' A' ' 69' ' ' ILE . 7.1 p -140.76 129.27 24.46 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-N 115.382 -0.826 . . . . 0.0 110.011 177.617 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 80.5 mt-30 -108.43 122.86 47.9 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 121.063 0.459 . . . . 0.0 111.115 176.348 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.645 ' HA ' ' O ' ' A' ' 67' ' ' LEU . 44.1 mt-10 -95.63 117.43 30.44 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.252 -0.885 . . . . 0.0 110.145 177.35 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.771 HG12 HD12 ' A' ' 67' ' ' LEU . 25.5 mm -111.48 147.6 15.31 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.768 0 CA-C-N 116.0 -0.545 . . . . 0.0 109.815 -178.911 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 23' ' ' MET . . . . . 0.589 ' HB3' ' HB3' ' A' ' 64' ' ' ASP . 3.3 mmt -100.8 98.16 8.71 Favored 'General case' 0 N--CA 1.446 -0.656 0 N-CA-C 108.796 -0.816 . . . . 0.0 108.796 176.924 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.772 ' HB ' ' HB2' ' A' ' 65' ' ' LYS . 23.6 mm -80.18 128.68 72.51 Favored Pre-proline 0 C--N 1.32 -0.699 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.032 -173.433 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.625 ' HD2' HD13 ' A' ' 87' ' ' LEU . 52.7 Cg_exo -51.86 125.59 17.54 Favored 'Trans proline' 0 N--CA 1.462 -0.375 0 C-N-CA 122.882 2.388 . . . . 0.0 111.942 176.734 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -47.8 -53.02 16.71 Favored 'General case' 0 C--O 1.237 0.414 0 N-CA-C 112.998 0.74 . . . . 0.0 112.998 -169.571 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -80.54 -26.46 54.26 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.844 -0.693 . . . . 0.0 113.128 -174.891 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 43.2 tttp -89.95 3.1 54.13 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.051 0.453 . . . . 0.0 110.73 -177.185 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.555 ' O ' HG12 ' A' ' 32' ' ' VAL . . . -65.53 -22.81 66.75 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.808 177.98 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -55.45 -38.42 69.89 Favored Glycine 0 N--CA 1.449 -0.447 0 C-N-CA 120.888 -0.672 . . . . 0.0 111.928 176.739 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.584 ' HB3' HG22 ' A' ' 86' ' ' ILE . 31.9 mt -71.34 -37.87 71.67 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 111.595 0.22 . . . . 0.0 111.595 -179.101 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.555 HG12 ' O ' ' A' ' 29' ' ' ALA . 0.3 OUTLIER -67.32 -25.92 34.78 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.352 0 CA-C-O 121.353 0.597 . . . . 0.0 110.358 -179.133 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.453 ' HA ' ' HB ' ' A' ' 40' ' ' ILE . 56.1 mt -84.71 -39.6 14.45 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-N 115.385 -0.825 . . . . 0.0 109.504 174.59 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.423 ' HA3' ' HB ' ' A' ' 39' ' ' THR . . . 125.95 -145.62 15.81 Favored Glycine 0 N--CA 1.445 -0.719 0 CA-C-N 115.72 -0.673 . . . . 0.0 113.11 174.435 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 74.9 mmtt -100.69 -29.18 12.44 Favored 'General case' 0 C--N 1.319 -0.753 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 179.005 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -152.6 31.61 0.84 Allowed Glycine 0 N--CA 1.45 -0.429 0 CA-C-N 115.534 -0.757 . . . . 0.0 111.727 177.409 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.401 ' HA2' HG22 ' A' ' 33' ' ' ILE . . . 79.87 0.16 84.28 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 121.106 -0.569 . . . . 0.0 112.339 -178.933 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -78.52 -28.45 46.2 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 120.932 0.396 . . . . 0.0 111.106 -179.291 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.661 ' O ' ' HG ' ' A' ' 43' ' ' LEU . 35.2 m -71.67 -51.71 21.66 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.817 -177.571 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.656 ' HA ' HD12 ' A' ' 43' ' ' LEU . 6.6 tt -58.41 -36.73 60.09 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.285 0 CA-C-O 121.091 0.472 . . . . 0.0 111.186 179.499 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 62.7 tttp -62.07 -40.05 94.51 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.813 -0.631 . . . . 0.0 110.039 178.101 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 41.8 mt-30 -75.96 -38.01 58.0 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.579 -0.737 . . . . 0.0 111.269 -179.269 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.661 ' HG ' ' O ' ' A' ' 39' ' ' THR . 80.8 mt -53.17 -40.49 64.4 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-O 120.897 0.38 . . . . 0.0 111.432 -178.078 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 68.9 mt-30 -59.85 -42.62 94.03 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.289 178.494 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -81.02 -29.34 35.14 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.99 -178.137 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 13.8 mmm180 -52.1 -45.32 64.83 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.736 177.618 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.525 ' HB3' HG22 ' A' ' 49' ' ' VAL . . . -102.42 -11.49 18.56 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.72 -0.673 . . . . 0.0 111.429 -178.198 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 75.3 30.17 59.09 Favored Glycine 0 CA--C 1.52 0.365 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.04 -177.255 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.525 HG22 ' HB3' ' A' ' 47' ' ' ALA . 20.0 m -120.09 177.34 3.08 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-O 120.846 0.355 . . . . 0.0 110.504 -177.638 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 64.5 tttp -105.46 122.28 45.67 Favored 'General case' 0 C--N 1.318 -0.797 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 172.115 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' MET . . . . . 0.658 ' HE2' HG12 ' A' ' 69' ' ' ILE . 36.1 mtp -117.31 115.18 24.76 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 178.833 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.47 ' CG2' ' HB2' ' A' ' 68' ' ' ARG . 10.4 tt -110.76 110.82 33.59 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.798 0 CA-C-O 121.452 0.644 . . . . 0.0 110.901 -178.697 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.613 ' HB3' HE21 ' A' ' 55' ' ' GLN . 3.7 mm? -93.97 103.84 15.91 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.27 -0.877 . . . . 0.0 109.474 175.279 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.618 HD12 ' HB2' ' A' ' 66' ' ' PRO . 68.3 mt -75.33 87.52 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-O 121.613 0.72 . . . . 0.0 110.216 -178.818 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 55' ' ' GLN . . . . . 0.613 HE21 ' HB3' ' A' ' 53' ' ' LEU . 72.5 mm-40 -104.91 -31.32 9.31 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.02 -0.991 . . . . 0.0 109.34 179.705 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -80.87 -16.42 53.69 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.354 177.698 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' GLY . . . . . 0.712 ' O ' ' HB ' ' A' ' 61' ' ' THR . . . -78.39 130.42 10.05 Favored Glycine 0 N--CA 1.451 -0.337 0 N-CA-C 111.187 -0.765 . . . . 0.0 111.187 175.844 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 39.7 p -81.63 1.86 32.05 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 112.984 0.735 . . . . 0.0 112.984 -171.436 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 22.3 mp0 -65.6 -64.75 0.79 Allowed 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.134 0.492 . . . . 0.0 110.547 -176.696 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.591 ' HB3' ' O ' ' A' ' 64' ' ' ASP . 89.8 m-20 -122.0 29.93 6.85 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.277 -179.04 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 61' ' ' THR . . . . . 0.712 ' HB ' ' O ' ' A' ' 57' ' ' GLY . 12.4 t -66.59 -22.08 66.13 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.088 -179.202 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 23.2 t-20 -97.81 -17.28 19.43 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.182 -177.662 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.418 ' HB ' ' H ' ' A' ' 64' ' ' ASP . 16.0 m -121.59 -151.72 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.564 -176.578 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.591 ' O ' ' HB3' ' A' ' 60' ' ' ASN . 3.4 m-20 -51.29 126.1 15.97 Favored 'General case' 0 C--N 1.33 -0.242 0 O-C-N 123.314 0.384 . . . . 0.0 110.116 174.584 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.772 ' HB2' ' HB ' ' A' ' 24' ' ' ILE . 34.5 mmtp -82.34 136.19 46.41 Favored Pre-proline 0 C--N 1.321 -0.673 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.393 -168.438 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.618 ' HB2' HD12 ' A' ' 54' ' ' ILE . 10.5 Cg_exo -71.8 110.44 2.9 Favored 'Trans proline' 0 N--CA 1.458 -0.588 0 C-N-CA 123.137 2.558 . . . . 0.0 111.305 175.953 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.862 HD11 HG13 ' A' ' 69' ' ' ILE . 1.6 tm? -114.65 141.1 48.24 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 115.827 -0.624 . . . . 0.0 109.453 179.023 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.575 ' HG2' ' HG2' ' A' ' 21' ' ' GLU . 95.1 mtt180 -134.76 124.04 24.55 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.185 0.517 . . . . 0.0 111.465 168.607 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.862 HG13 HD11 ' A' ' 67' ' ' LEU . 20.9 mt -102.95 104.62 16.86 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-N 115.206 -0.906 . . . . 0.0 109.279 173.445 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.612 HG22 ' HB2' ' A' ' 16' ' ' ASN . 11.8 mt -103.37 125.57 57.87 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.891 0 CA-C-N 116.484 -0.325 . . . . 0.0 110.246 -175.174 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 169.19 -123.21 1.06 Allowed Glycine 0 N--CA 1.447 -0.617 0 C-N-CA 120.505 -0.855 . . . . 0.0 112.934 178.349 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 72' ' ' ASP . . . . . 0.401 ' HB3' ' HG2' ' A' ' 75' ' ' LYS . 11.1 t70 -115.26 139.11 24.07 Favored Pre-proline 0 C--N 1.324 -0.516 0 CA-C-O 118.759 -0.639 . . . . 0.0 109.995 -176.421 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 73' ' ' PRO . . . . . 0.545 ' HA ' HG21 ' A' ' 18' ' ' THR . 84.3 Cg_exo -40.47 -43.73 4.2 Favored 'Trans proline' 0 C--N 1.347 0.477 0 C-N-CA 123.406 2.737 . . . . 0.0 112.832 -176.264 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 78.8 t80 -60.61 -60.92 3.04 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.147 -0.933 . . . . 0.0 111.334 -178.626 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.537 ' HE2' ' HA ' ' A' ' 9' ' ' ASP . 25.5 pttt -76.54 -24.05 53.64 Favored 'General case' 0 CA--C 1.517 -0.314 0 N-CA-C 112.131 0.419 . . . . 0.0 112.131 -176.187 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 48.8 t -66.79 -39.89 84.67 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 N-CA-C 109.079 -0.711 . . . . 0.0 109.079 176.865 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 77' ' ' GLN . . . . . 0.47 ' O ' ' HG2' ' A' ' 81' ' ' GLU . 20.9 tp60 -74.0 -42.64 60.09 Favored 'General case' 0 N--CA 1.445 -0.706 0 CA-C-N 115.523 -0.762 . . . . 0.0 110.502 179.744 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 91.6 mt-30 -60.91 -43.83 98.0 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.848 0.356 . . . . 0.0 110.609 177.732 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -64.95 -38.78 92.09 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.692 178.171 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 44.3 t -62.44 -54.8 34.86 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.733 -0.667 . . . . 0.0 111.471 178.243 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 81' ' ' GLU . . . . . 0.47 ' HG2' ' O ' ' A' ' 77' ' ' GLN . 12.2 pt-20 -68.53 -19.59 64.51 Favored 'General case' 0 C--N 1.324 -0.511 0 C-N-CA 120.481 -0.488 . . . . 0.0 110.468 -178.468 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 82' ' ' MET . . . . . 0.484 ' O ' ' HB3' ' A' ' 85' ' ' ASP . 52.3 ttp -72.97 -46.46 52.22 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.85 175.768 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.596 HG12 HD13 ' A' ' 43' ' ' LEU . 29.9 m -80.18 -29.41 12.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 C-N-CA 120.812 -0.355 . . . . 0.0 110.869 -179.352 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 12.8 tmm? -65.47 -34.39 78.16 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 174.143 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 85' ' ' ASP . . . . . 0.484 ' HB3' ' O ' ' A' ' 82' ' ' MET . 3.8 t70 -59.31 -42.12 90.64 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.229 -0.896 . . . . 0.0 110.626 174.502 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.584 HG22 ' HB3' ' A' ' 31' ' ' LEU . 30.1 mt -63.82 -34.11 66.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-O 121.359 0.599 . . . . 0.0 110.406 178.694 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.625 HD13 ' HD2' ' A' ' 25' ' ' PRO . 59.6 mt -85.52 -6.31 59.2 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.769 -178.952 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 67.7 ttt180 -102.26 -7.67 21.92 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.723 0.773 . . . . 0.0 109.537 176.479 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 10.8 tp10 . . . . . 0 C--O 1.253 1.242 0 CA-C-N 115.191 -0.913 . . . . 0.0 110.022 -174.451 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.445 -0.701 0 N-CA-C 111.751 -0.54 . . . . 0.0 111.751 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 6' ' ' GLN . . . . . 0.498 ' HA ' ' OE1' ' A' ' 6' ' ' GLN . 11.8 mm-40 61.26 77.49 0.33 Allowed 'General case' 0 C--O 1.237 0.443 0 CA-C-O 121.493 0.663 . . . . 0.0 110.46 -176.305 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 1.6 p90 -71.19 77.35 0.7 Allowed 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 114.877 -1.056 . . . . 0.0 111.873 -177.426 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 9.2 t60 67.54 -165.69 0.21 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.301 -0.863 . . . . 0.0 109.895 176.024 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -58.5 -54.06 51.28 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.896 0.379 . . . . 0.0 110.511 175.744 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 43.8 t30 -143.28 -50.69 0.34 Allowed 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.323 177.304 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -121.86 130.89 53.72 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.912 -0.586 . . . . 0.0 110.958 -177.228 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 3.3 p-10 -111.61 -24.86 9.85 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.888 -0.597 . . . . 0.0 109.949 177.732 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 75.76 -72.39 1.79 Allowed Glycine 0 N--CA 1.45 -0.407 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.764 -178.597 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -143.43 -47.59 0.04 OUTLIER Glycine 0 N--CA 1.446 -0.667 0 N-CA-C 110.682 -0.967 . . . . 0.0 110.682 176.15 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' GLN . . . . . 0.498 ' HG3' HG22 ' A' ' 70' ' ' ILE . 60.3 tt0 -97.09 108.48 21.23 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.102 0.477 . . . . 0.0 110.54 179.009 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 16' ' ' ASN . . . . . 0.611 ' HB3' ' O ' ' A' ' 71' ' ' GLY . 26.7 t30 -89.54 -55.83 3.49 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.136 177.357 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 165.06 -36.34 0.27 Allowed Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.782 -0.723 . . . . 0.0 111.734 178.608 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 59.5 m -66.35 128.31 35.67 Favored 'General case' 0 C--N 1.322 -0.592 0 C-N-CA 122.484 0.314 . . . . 0.0 110.613 176.499 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.461 ' HA ' ' O ' ' A' ' 69' ' ' ILE . 8.5 p -131.75 138.75 52.12 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 CA-C-O 120.91 0.386 . . . . 0.0 110.295 179.192 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 9.2 tt0 -124.24 135.67 53.58 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 109.698 -0.482 . . . . 0.0 109.698 178.607 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.606 ' HG2' ' HG2' ' A' ' 68' ' ' ARG . 51.5 mt-10 -104.28 125.73 50.78 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.309 0.576 . . . . 0.0 112.021 -178.938 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.473 ' HB ' ' HB3' ' A' ' 67' ' ' LEU . 14.2 mm -110.66 146.33 15.93 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 CA-C-N 115.104 -0.953 . . . . 0.0 109.077 174.821 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 8.7 mmt -100.41 93.75 5.81 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 108.584 -0.895 . . . . 0.0 108.584 175.103 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.692 ' HB ' ' HB2' ' A' ' 65' ' ' LYS . 37.0 mm -79.35 126.06 81.97 Favored Pre-proline 0 C--N 1.318 -0.774 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.422 -177.331 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.416 ' HB2' ' HB2' ' A' ' 28' ' ' LYS . 71.8 Cg_exo -52.39 134.36 51.46 Favored 'Trans proline' 0 N--CA 1.461 -0.433 0 C-N-CA 122.794 2.329 . . . . 0.0 111.714 175.709 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -58.51 -25.21 62.15 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.998 -177.753 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -89.35 -6.37 71.13 Favored Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.837 -0.697 . . . . 0.0 112.642 178.069 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.556 ' HB3' HD22 ' A' ' 87' ' ' LEU . 51.2 mttp -115.77 10.82 15.48 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.754 0.312 . . . . 0.0 111.366 -179.015 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -68.58 -29.82 68.45 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.205 0.526 . . . . 0.0 110.152 179.307 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -69.9 -17.88 73.85 Favored Glycine 0 N--CA 1.447 -0.584 0 CA-C-N 115.863 -0.608 . . . . 0.0 112.265 176.822 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 84.0 mt -83.13 -43.51 16.14 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.557 0.218 . . . . 0.0 110.706 -179.768 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.657 HG13 HD21 ' A' ' 87' ' ' LEU . 1.6 m -68.86 -33.33 58.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.308 -0.406 . . . . 0.0 111.174 178.697 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.498 ' HA ' ' HB ' ' A' ' 40' ' ' ILE . 88.8 mt -77.83 -40.71 27.48 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-O 121.52 0.676 . . . . 0.0 109.698 175.57 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 103.08 164.51 25.75 Favored Glycine 0 N--CA 1.442 -0.919 0 CA-C-N 115.353 -0.84 . . . . 0.0 111.576 -179.335 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 1.3 mptm? -79.13 54.41 1.63 Allowed 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.189 0.518 . . . . 0.0 110.849 -178.786 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 144.04 21.82 0.17 Allowed Glycine 0 N--CA 1.447 -0.603 0 CA-C-N 115.779 -0.646 . . . . 0.0 111.783 178.759 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 71.79 -0.66 35.12 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 121.028 -0.606 . . . . 0.0 112.358 -178.007 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.509 ' O ' ' HG2' ' A' ' 42' ' ' GLN . 14.2 pt-20 -64.66 -37.81 88.86 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.703 0.287 . . . . 0.0 111.276 -175.573 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.833 ' O ' ' HG ' ' A' ' 43' ' ' LEU . 56.4 m -69.92 -55.66 9.1 Favored 'General case' 0 N--CA 1.449 -0.482 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.383 -175.086 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.498 ' HB ' ' HA ' ' A' ' 33' ' ' ILE . 12.7 tt -61.91 -25.09 36.26 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-O 121.462 0.649 . . . . 0.0 111.013 -177.48 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.406 ' HB3' ' HE2' ' A' ' 41' ' ' LYS . 37.6 ttpt -71.8 -47.49 53.01 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.778 178.863 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.509 ' HG2' ' O ' ' A' ' 38' ' ' GLU . 11.3 pt20 -72.32 -41.07 66.97 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.838 -0.619 . . . . 0.0 111.12 -177.259 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.833 ' HG ' ' O ' ' A' ' 39' ' ' THR . 48.6 mt -51.23 -48.44 62.08 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.769 -0.65 . . . . 0.0 111.731 -177.08 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 49.3 mt-30 -58.21 -42.16 85.62 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.27 -178.078 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 -81.33 -35.1 31.36 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.676 -174.308 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' ARG . . . . . 0.406 ' HG2' ' O ' ' A' ' 42' ' ' GLN . 15.0 ptm180 -78.85 -23.45 44.97 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 111.905 0.335 . . . . 0.0 111.905 -175.894 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -94.59 -24.53 17.18 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 120.908 0.385 . . . . 0.0 111.379 179.906 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 81.77 23.64 57.41 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.863 -0.684 . . . . 0.0 112.082 -178.687 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 17.7 m -130.36 178.98 4.62 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-O 120.833 0.349 . . . . 0.0 110.197 -179.083 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 87.2 tttt -109.83 124.63 51.65 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.012 176.177 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' MET . . . . . 0.472 ' HE2' ' HB1' ' A' ' 79' ' ' ALA . 60.5 mtt -113.38 116.01 28.99 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 109.583 -0.525 . . . . 0.0 109.583 178.632 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.475 ' CG2' ' HB2' ' A' ' 68' ' ' ARG . 11.0 tt -110.64 105.83 19.56 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 CA-C-O 121.632 0.729 . . . . 0.0 110.674 178.047 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.523 HD22 HD13 ' A' ' 67' ' ' LEU . 3.8 mm? -86.12 102.8 14.19 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.336 -0.847 . . . . 0.0 109.358 174.978 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.606 HD12 ' HB2' ' A' ' 66' ' ' PRO . 52.3 mt -80.57 86.51 1.47 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.411 0 CA-C-O 121.913 0.863 . . . . 0.0 110.121 179.588 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 55' ' ' GLN . . . . . 0.46 ' HG2' HD11 ' A' ' 33' ' ' ILE . 2.7 pp0? -132.66 -12.64 3.0 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 114.607 -1.179 . . . . 0.0 109.52 176.246 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -100.58 -26.42 13.83 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 114.916 -1.038 . . . . 0.0 110.135 -178.734 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -82.99 16.56 27.0 Favored Glycine 0 CA--C 1.518 0.262 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.461 179.847 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 13.8 m 58.22 -139.35 0.81 Allowed 'General case' 0 C--O 1.234 0.272 0 C-N-CA 122.657 0.383 . . . . 0.0 110.483 -177.824 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 96.6 mt-30 70.57 -72.27 0.11 Allowed 'General case' 0 N--CA 1.463 0.197 0 C-N-CA 123.199 0.6 . . . . 0.0 110.924 178.611 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.498 ' HB3' ' O ' ' A' ' 64' ' ' ASP . 4.2 m-20 -102.86 42.01 1.19 Allowed 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 121.575 0.702 . . . . 0.0 109.954 177.077 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -71.54 -27.24 63.05 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.423 -0.808 . . . . 0.0 110.887 -179.922 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 9.2 t30 -93.68 -26.96 16.81 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.818 -0.628 . . . . 0.0 111.781 179.669 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 30.6 m -111.8 -160.32 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 N-CA-C 112.166 0.432 . . . . 0.0 112.166 -173.967 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.498 ' O ' ' HB3' ' A' ' 60' ' ' ASN . 62.7 m-20 -59.13 154.7 15.38 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 115.451 -0.795 . . . . 0.0 110.988 179.084 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.692 ' HB2' ' HB ' ' A' ' 24' ' ' ILE . 69.8 mmtt -98.81 121.22 56.76 Favored Pre-proline 0 C--N 1.32 -0.677 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.767 -174.273 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.606 ' HB2' HD12 ' A' ' 54' ' ' ILE . 27.1 Cg_exo -64.71 105.29 0.63 Allowed 'Trans proline' 0 N--CA 1.46 -0.473 0 C-N-CA 122.884 2.389 . . . . 0.0 111.746 174.614 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.523 HD13 HD22 ' A' ' 53' ' ' LEU . 25.1 tp -105.2 106.39 16.86 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 109.735 -0.469 . . . . 0.0 109.735 175.85 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.606 ' HG2' ' HG2' ' A' ' 21' ' ' GLU . 96.1 mtt180 -101.68 105.88 16.85 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.437 178.35 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.461 ' O ' ' HA ' ' A' ' 19' ' ' VAL . 4.7 mp -86.22 103.99 13.31 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 N-CA-C 108.195 -1.039 . . . . 0.0 108.195 174.142 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.498 HG22 ' HG3' ' A' ' 15' ' ' GLN . 3.7 mt -103.43 112.86 38.51 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.038 -174.506 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 71' ' ' GLY . . . . . 0.611 ' O ' ' HB3' ' A' ' 16' ' ' ASN . . . -176.16 -128.38 1.12 Allowed Glycine 0 N--CA 1.439 -1.137 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.324 -179.489 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 72' ' ' ASP . . . . . 0.508 ' HB3' ' CG ' ' A' ' 75' ' ' LYS . 3.1 t70 -109.61 143.27 27.5 Favored Pre-proline 0 C--N 1.318 -0.769 0 CA-C-O 118.752 -0.642 . . . . 0.0 110.289 -177.006 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_exo -44.14 -39.94 12.0 Favored 'Trans proline' 0 C--N 1.346 0.443 0 C-N-CA 122.827 2.351 . . . . 0.0 113.262 -175.268 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 93.6 t80 -74.6 -53.71 8.84 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.798 -174.807 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.508 ' CG ' ' HB3' ' A' ' 72' ' ' ASP . 10.4 pttt -75.4 -17.49 60.18 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.531 -0.304 . . . . 0.0 111.79 -179.077 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 24.1 t -70.0 -40.19 78.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 171.855 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 77' ' ' GLN . . . . . 0.489 ' O ' ' HG2' ' A' ' 81' ' ' GLU . 21.2 tp60 -69.45 -46.3 67.05 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.06 178.904 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 86.4 mt-30 -58.89 -39.53 81.72 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.778 176.553 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 79' ' ' ALA . . . . . 0.472 ' HB1' ' HE2' ' A' ' 51' ' ' MET . . . -68.84 -36.8 78.61 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.143 178.781 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 80' ' ' CYS . . . . . 0.4 ' O ' ' HG3' ' A' ' 84' ' ' MET . 38.4 t -65.22 -50.8 64.47 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.921 178.974 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 81' ' ' GLU . . . . . 0.489 ' HG2' ' O ' ' A' ' 77' ' ' GLN . 9.9 pt-20 -69.69 -18.82 63.58 Favored 'General case' 0 C--N 1.324 -0.543 0 C-N-CA 120.513 -0.475 . . . . 0.0 110.2 178.415 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 82' ' ' MET . . . . . 0.6 ' SD ' HD22 ' A' ' 43' ' ' LEU . 36.7 ttm -70.55 -53.43 16.14 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.333 173.86 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.453 ' O ' ' HG ' ' A' ' 87' ' ' LEU . 26.9 m -70.55 -35.74 62.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 C-N-CA 121.048 -0.261 . . . . 0.0 111.399 -178.645 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 84' ' ' MET . . . . . 0.4 ' HG3' ' O ' ' A' ' 80' ' ' CYS . 52.7 mtm -69.64 -26.97 64.67 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.768 0.318 . . . . 0.0 110.177 177.556 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -60.15 -48.38 81.96 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 116.066 -0.515 . . . . 0.0 109.748 175.807 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 48.4 mt -60.49 -34.86 59.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 115.422 -0.808 . . . . 0.0 111.048 179.826 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.657 HD21 HG13 ' A' ' 32' ' ' VAL . 51.3 mt -81.26 -16.12 53.53 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.3 -178.024 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 88' ' ' ARG . . . . . 0.421 HH11 ' HD3' ' A' ' 88' ' ' ARG . 13.7 ttp180 -97.2 -33.84 11.33 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 121.429 0.633 . . . . 0.0 111.074 -177.759 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 12.3 tp10 . . . . . 0 C--N 1.307 -1.257 0 CA-C-N 114.878 -1.055 . . . . 0.0 110.83 -173.437 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.674 0 N-CA-C 112.398 -0.281 . . . . 0.0 112.398 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 30.1 mm-40 -76.49 -6.9 53.78 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.161 0.505 . . . . 0.0 109.65 176.292 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' PHE . . . . . 0.779 ' HD1' ' HA3' ' A' ' 17' ' ' GLY . 11.9 m-85 -93.15 -55.32 3.37 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.514 -0.767 . . . . 0.0 109.396 178.15 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 24.1 t-80 70.78 -74.91 0.08 Allowed 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 114.48 -1.236 . . . . 0.0 112.18 172.493 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' ASP . . . . . 0.816 ' HA ' ' HE2' ' A' ' 75' ' ' LYS . 16.9 p-10 -158.87 -55.29 0.06 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.957 0.408 . . . . 0.0 110.958 -175.674 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 10' ' ' ASN . . . . . 0.471 ' ND2' ' HB2' ' A' ' 50' ' ' LYS . 54.3 t-20 -131.39 -65.19 0.77 Allowed 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 108.836 -0.801 . . . . 0.0 108.836 -177.636 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -140.18 121.61 15.06 Favored 'General case' 0 N--CA 1.447 -0.61 0 CA-C-N 114.863 -1.062 . . . . 0.0 109.301 176.725 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 9.9 t30 -100.51 93.28 5.54 Favored 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 179.63 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 83.78 -98.69 2.14 Favored Glycine 0 N--CA 1.445 -0.703 0 N-CA-C 111.356 -0.698 . . . . 0.0 111.356 -176.626 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -123.57 2.73 9.47 Favored Glycine 0 N--CA 1.448 -0.562 0 C-N-CA 120.463 -0.875 . . . . 0.0 112.848 -179.931 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 17.8 mm-40 -118.83 139.19 52.02 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.271 0.557 . . . . 0.0 111.955 -174.587 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 20.6 m120 -100.95 129.27 46.77 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 108.035 -1.098 . . . . 0.0 108.035 170.446 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' GLY . . . . . 0.779 ' HA3' ' HD1' ' A' ' 7' ' ' PHE . . . -79.23 -94.16 0.32 Allowed Glycine 0 N--CA 1.449 -0.438 0 C-N-CA 120.796 -0.716 . . . . 0.0 113.905 -172.239 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.54 ' OG1' ' HG3' ' A' ' 73' ' ' PRO . 80.0 m -96.82 133.07 41.89 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 121.001 0.429 . . . . 0.0 111.079 -173.982 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.559 ' HA ' ' O ' ' A' ' 69' ' ' ILE . 4.5 p -137.44 134.92 46.85 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.587 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.208 177.672 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 20' ' ' GLN . . . . . 0.492 ' O ' ' HA ' ' A' ' 68' ' ' ARG . 34.1 mt-30 -121.11 157.84 29.22 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.019 176.142 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.588 ' HG2' ' HG2' ' A' ' 68' ' ' ARG . 40.2 mt-10 -124.16 107.72 11.53 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.024 -176.32 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 5.9 mm -99.01 140.97 17.33 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-N 115.86 -0.609 . . . . 0.0 109.776 -180.0 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 74.1 mmm -102.88 93.9 5.3 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 109.157 -0.683 . . . . 0.0 109.157 177.218 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.72 ' HB ' ' HB2' ' A' ' 65' ' ' LYS . 38.5 mm -81.88 132.59 53.8 Favored Pre-proline 0 C--N 1.321 -0.668 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.235 -174.711 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 75.5 Cg_exo -51.95 134.06 47.79 Favored 'Trans proline' 0 C--N 1.345 0.357 0 C-N-CA 122.959 2.439 . . . . 0.0 111.834 172.558 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -60.02 -33.05 71.48 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.214 179.758 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -68.58 -19.74 73.21 Favored Glycine 0 N--CA 1.449 -0.493 0 C-N-CA 120.892 -0.67 . . . . 0.0 112.578 177.332 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.596 ' HB3' HD22 ' A' ' 87' ' ' LEU . 5.2 mptp? -106.57 12.46 29.42 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.748 0.309 . . . . 0.0 111.004 -179.457 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.64 -31.75 71.86 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.008 0.432 . . . . 0.0 110.602 179.775 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -61.84 -24.24 64.35 Favored Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 120.864 -0.684 . . . . 0.0 112.571 179.564 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 83.7 mt -85.17 -48.52 9.06 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.684 0.242 . . . . 0.0 111.033 -177.99 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.562 HG11 HG13 ' A' ' 24' ' ' ILE . 2.9 m -67.89 -33.65 62.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.814 0.34 . . . . 0.0 111.758 -179.701 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 72.1 mt -80.56 -35.74 15.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 121.915 0.864 . . . . 0.0 109.462 176.321 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.522 ' HA3' ' HB ' ' A' ' 39' ' ' THR . . . 94.99 52.07 1.83 Allowed Glycine 0 N--CA 1.439 -1.145 0 CA-C-N 115.208 -0.905 . . . . 0.0 113.808 172.204 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 30.8 mtmt 50.3 41.94 25.07 Favored 'General case' 0 C--N 1.328 -0.342 0 O-C-N 124.162 0.566 . . . . 0.0 112.204 169.659 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 129.03 -17.36 5.68 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.705 -0.76 . . . . 0.0 111.951 -179.36 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 116.18 7.48 14.54 Favored Glycine 0 N--CA 1.447 -0.611 0 C-N-CA 120.654 -0.784 . . . . 0.0 112.19 178.802 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 36.0 mt-10 -76.08 -47.55 24.12 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.786 0.327 . . . . 0.0 110.827 -178.99 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.644 ' O ' ' HG ' ' A' ' 43' ' ' LEU . 7.2 m -66.08 -44.05 85.56 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.451 -0.34 . . . . 0.0 111.46 -176.791 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.481 ' CD1' HD23 ' A' ' 53' ' ' LEU . 9.7 tt -60.42 -36.01 66.55 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.495 0 CA-C-O 121.032 0.444 . . . . 0.0 110.703 179.908 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 22.5 ttmm -61.13 -41.19 96.27 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.579 0.704 . . . . 0.0 110.134 175.302 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 53.5 mt-30 -74.51 -44.13 52.7 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.179 -0.919 . . . . 0.0 111.258 -177.387 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.644 ' HG ' ' O ' ' A' ' 39' ' ' THR . 94.9 mt -51.94 -49.96 62.12 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.923 -176.372 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 44' ' ' GLN . . . . . 0.433 ' HG3' ' O ' ' A' ' 40' ' ' ILE . 40.5 mt-30 -60.07 -57.49 12.6 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.157 -176.629 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -75.24 -22.11 58.12 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.674 -0.694 . . . . 0.0 112.276 -171.681 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 13.8 ptm180 -77.62 -33.41 53.65 Favored 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 120.304 -0.558 . . . . 0.0 110.727 177.865 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -88.33 -28.81 20.78 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.0 -178.3 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 95.57 21.32 24.48 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.856 -0.687 . . . . 0.0 112.709 -179.366 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 10.4 m -130.07 179.95 3.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-O 120.906 0.384 . . . . 0.0 110.684 -178.836 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.679 ' HE3' ' HB ' ' A' ' 52' ' ' ILE . 8.9 tmtm? -111.95 126.09 54.76 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.953 -0.567 . . . . 0.0 109.645 176.7 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 51' ' ' MET . . . . . 0.474 ' CE ' ' HB1' ' A' ' 79' ' ' ALA . 58.6 mtt -113.28 132.33 55.58 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 176.283 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.679 ' HB ' ' HE3' ' A' ' 50' ' ' LYS . 10.9 tt -120.39 113.56 40.73 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.721 0 CA-C-O 121.619 0.723 . . . . 0.0 110.817 175.874 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.75 HD22 HD13 ' A' ' 67' ' ' LEU . 3.6 mm? -88.67 104.19 16.64 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.013 -0.994 . . . . 0.0 109.138 175.45 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.57 ' HB ' ' HB2' ' A' ' 66' ' ' PRO . 52.6 mt -91.13 92.02 3.79 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.19 -176.95 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 11.3 mp0 -94.78 4.17 54.15 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.839 0.352 . . . . 0.0 110.772 -178.395 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -124.09 -50.59 1.8 Allowed 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.831 -178.892 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -82.19 77.85 2.04 Favored Glycine 0 N--CA 1.452 -0.245 0 C-N-CA 120.714 -0.755 . . . . 0.0 113.426 -170.84 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 58' ' ' SER . . . . . 0.953 ' HB3' HG23 ' A' ' 61' ' ' THR . 36.4 t -170.29 -36.44 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.515 0.198 . . . . 0.0 110.878 177.675 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 59' ' ' GLN . . . . . 0.45 ' HB2' ' O ' ' A' ' 58' ' ' SER . 89.7 mt-30 73.2 -11.58 0.88 Allowed 'General case' 0 N--CA 1.47 0.564 0 CA-C-N 115.934 -0.575 . . . . 0.0 111.463 -178.559 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.419 ' H ' ' C ' ' A' ' 58' ' ' SER . 16.1 m120 -103.92 16.81 25.46 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 170.012 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 61' ' ' THR . . . . . 0.953 HG23 ' HB3' ' A' ' 58' ' ' SER . 0.7 OUTLIER -74.42 -18.88 60.59 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 114.362 -1.29 . . . . 0.0 112.405 -172.117 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 61.0 t30 -68.93 -17.2 63.92 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.536 0.684 . . . . 0.0 109.188 173.56 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 9.2 t -105.71 -64.14 1.68 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.611 0 CA-C-N 114.915 -1.038 . . . . 0.0 111.307 -179.741 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.561 ' O ' ' HA ' ' A' ' 61' ' ' THR . 40.8 m-20 -114.24 161.95 17.18 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 115.555 -0.748 . . . . 0.0 110.805 -176.401 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.72 ' HB2' ' HB ' ' A' ' 24' ' ' ILE . 69.8 mmtt -121.06 98.34 47.36 Favored Pre-proline 0 C--N 1.316 -0.863 0 CA-C-N 115.395 -0.821 . . . . 0.0 110.188 179.273 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.57 ' HB2' ' HB ' ' A' ' 54' ' ' ILE . 71.5 Cg_exo -54.2 115.64 2.51 Favored 'Trans proline' 0 C--O 1.234 0.305 0 C-N-CA 123.166 2.577 . . . . 0.0 112.31 174.861 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.75 HD13 HD22 ' A' ' 53' ' ' LEU . 31.3 tp -118.77 113.72 21.57 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.28 179.757 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.588 ' HG2' ' HG2' ' A' ' 21' ' ' GLU . 98.1 mtt180 -104.25 113.0 26.25 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 121.077 0.465 . . . . 0.0 110.707 175.943 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.559 ' O ' ' HA ' ' A' ' 19' ' ' VAL . 3.9 mp -95.21 109.45 22.43 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 175.085 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 8.1 mt -112.57 129.11 68.74 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 CA-C-N 116.462 -0.335 . . . . 0.0 111.162 -170.812 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 152.98 -127.14 2.13 Favored Glycine 0 N--CA 1.445 -0.746 0 C-N-CA 120.199 -1.0 . . . . 0.0 113.507 173.73 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 72' ' ' ASP . . . . . 0.455 ' HA ' ' HB3' ' A' ' 7' ' ' PHE . 19.7 t70 -85.87 133.27 41.75 Favored Pre-proline 0 C--N 1.322 -0.626 0 C-N-CA 123.19 0.596 . . . . 0.0 111.326 -176.626 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 73' ' ' PRO . . . . . 0.54 ' HG3' ' OG1' ' A' ' 18' ' ' THR . 32.4 Cg_exo -55.52 -28.49 64.83 Favored 'Trans proline' 0 C--N 1.35 0.627 0 C-N-CA 123.8 3.0 . . . . 0.0 113.524 -173.16 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 87.7 t80 -75.58 -54.49 6.92 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.045 0.45 . . . . 0.0 110.128 -177.9 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.816 ' HE2' ' HA ' ' A' ' 9' ' ' ASP . 7.6 pttm -79.52 -19.01 50.65 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.221 -0.445 . . . . 0.0 112.062 -178.353 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.409 HG22 HG22 ' A' ' 69' ' ' ILE . 25.2 t -69.43 -38.04 76.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 N-CA-C 109.815 -0.439 . . . . 0.0 109.815 172.895 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -71.51 -48.57 48.1 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 -179.632 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 27.8 mt-30 -59.06 -37.84 77.99 Favored 'General case' 0 C--O 1.22 -0.459 0 CA-C-N 115.784 -0.643 . . . . 0.0 110.583 176.565 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 79' ' ' ALA . . . . . 0.559 ' HB3' HG21 ' A' ' 69' ' ' ILE . . . -64.61 -40.16 95.0 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.049 0.452 . . . . 0.0 110.291 -179.664 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 80' ' ' CYS . . . . . 0.458 ' SG ' HD13 ' A' ' 69' ' ' ILE . 88.6 m -65.72 -49.53 68.15 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.498 -0.774 . . . . 0.0 110.792 179.115 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 81' ' ' GLU . . . . . 0.466 ' O ' ' HB2' ' A' ' 85' ' ' ASP . 3.0 pp20? -72.08 -19.84 61.75 Favored 'General case' 0 C--N 1.326 -0.433 0 C-N-CA 120.075 -0.65 . . . . 0.0 110.902 -179.96 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 82' ' ' MET . . . . . 0.443 ' O ' HG13 ' A' ' 86' ' ' ILE . 40.8 ttp -75.63 -49.2 19.18 Favored 'General case' 0 C--N 1.33 -0.248 0 O-C-N 123.053 0.221 . . . . 0.0 110.597 176.468 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.565 ' O ' ' HG ' ' A' ' 87' ' ' LEU . 35.7 m -67.18 -36.21 76.23 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.175 0 C-N-CA 120.712 -0.395 . . . . 0.0 110.485 178.487 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 91.2 mtp -72.01 -27.85 63.0 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.208 175.636 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 85' ' ' ASP . . . . . 0.466 ' HB2' ' O ' ' A' ' 81' ' ' GLU . 32.6 t70 -64.89 -45.5 85.67 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.171 -0.468 . . . . 0.0 109.855 176.022 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.443 HG13 ' O ' ' A' ' 82' ' ' MET . 70.2 mt -56.62 -37.14 50.95 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.183 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.599 176.882 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.626 HD11 HD12 ' A' ' 24' ' ' ILE . 50.3 mt -75.73 -35.87 60.09 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.757 -0.656 . . . . 0.0 111.435 -177.372 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 88' ' ' ARG . . . . . 0.441 HH11 ' HD2' ' A' ' 88' ' ' ARG . 9.1 ptp85 -79.3 -20.24 48.46 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.25 0.548 . . . . 0.0 110.672 -178.199 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 5.4 tp10 . . . . . 0 C--N 1.312 -1.055 0 CA-C-O 118.327 -0.844 . . . . 0.0 109.979 -173.475 . . . . . . . . 0 0 . 1 . 021 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.562 0 N-CA-C 112.255 -0.338 . . . . 0.0 112.255 . . . . . . . . . 0 0 . 1 . 021 nuclear build full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 80.0 mt-30 -73.74 -12.25 60.65 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-O 120.492 0.187 . . . . 0.0 110.834 178.106 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 24.6 m-85 71.97 -78.27 0.05 OUTLIER 'General case' 0 N--CA 1.465 0.298 0 O-C-N 123.904 0.753 . . . . 0.0 110.731 179.758 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER 60.94 76.5 0.37 Allowed 'General case' 0 N--CA 1.465 0.312 0 CA-C-O 120.905 0.383 . . . . 0.0 110.401 -177.521 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -64.33 -23.88 67.45 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.232 -174.043 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 4.1 m-20 -77.73 55.75 1.4 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.823 0.344 . . . . 0.0 110.76 177.331 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . 59.14 86.48 0.09 Allowed 'General case' 0 C--O 1.234 0.269 0 CA-C-N 115.537 -0.756 . . . . 0.0 111.67 179.582 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 11.0 p30 -72.06 149.75 44.57 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.155 176.138 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -95.01 52.48 1.91 Allowed Glycine 0 N--CA 1.445 -0.702 0 C-N-CA 120.66 -0.781 . . . . 0.0 112.269 -178.688 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -166.15 -109.49 0.22 Allowed Glycine 0 N--CA 1.444 -0.816 0 C-N-CA 120.639 -0.791 . . . . 0.0 112.41 -179.758 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 10.7 pt20 -129.33 148.34 51.24 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 120.743 0.306 . . . . 0.0 110.207 -177.397 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 16' ' ' ASN . . . . . 0.411 ' HB3' ' O ' ' A' ' 71' ' ' GLY . 56.3 m-80 -87.83 131.82 34.4 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.184 -0.462 . . . . 0.0 109.823 -179.651 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -102.7 7.66 53.62 Favored Glycine 0 N--CA 1.453 -0.224 0 C-N-CA 120.477 -0.868 . . . . 0.0 114.042 -171.629 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.635 HG21 ' HA ' ' A' ' 73' ' ' PRO . 23.9 m -124.26 126.73 46.57 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 117.764 0.782 . . . . 0.0 111.347 178.855 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.635 ' HA ' ' O ' ' A' ' 69' ' ' ILE . 7.2 p -141.34 127.99 20.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.907 176.667 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 85.4 mt-30 -109.43 132.35 54.21 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.589 176.483 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.576 ' HA ' ' O ' ' A' ' 67' ' ' LEU . 6.7 mp0 -103.0 118.77 37.55 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.371 177.15 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 11.7 mm -108.92 144.17 17.81 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-N 116.048 -0.523 . . . . 0.0 109.619 178.696 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 9.4 mmt -100.08 91.52 4.81 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 109.699 -0.482 . . . . 0.0 109.699 176.436 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.683 ' HB ' ' HB2' ' A' ' 65' ' ' LYS . 41.3 mm -79.29 126.72 80.88 Favored Pre-proline 0 C--N 1.32 -0.677 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.011 -176.034 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.655 ' HB2' ' HD3' ' A' ' 28' ' ' LYS . 65.9 Cg_exo -52.43 147.49 29.29 Favored 'Trans proline' 0 C--N 1.347 0.486 0 C-N-CA 123.166 2.577 . . . . 0.0 112.94 177.445 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -51.48 -55.96 15.97 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 112.232 0.456 . . . . 0.0 112.232 -173.932 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -75.48 -8.96 84.5 Favored Glycine 0 N--CA 1.454 -0.155 0 C-N-CA 121.103 -0.57 . . . . 0.0 112.618 -176.892 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.655 ' HD3' ' HB2' ' A' ' 25' ' ' PRO . 5.1 mptp? -92.78 -3.94 53.89 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.957 0.408 . . . . 0.0 110.815 -179.896 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -62.17 -32.1 72.68 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.489 177.342 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -67.32 -19.26 70.34 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.861 -0.685 . . . . 0.0 112.44 178.932 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 79.0 mt -87.03 -42.96 12.69 Favored 'General case' 0 C--N 1.327 -0.371 0 O-C-N 122.789 -0.242 . . . . 0.0 110.896 -178.898 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 4.1 m -69.9 -35.88 66.72 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.15 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.152 179.164 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.664 ' HA ' ' HB ' ' A' ' 40' ' ' ILE . 88.2 mt -76.95 -38.21 28.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-O 121.459 0.647 . . . . 0.0 109.892 177.939 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.523 ' CA ' ' HB ' ' A' ' 39' ' ' THR . . . 124.32 157.05 9.63 Favored Glycine 0 N--CA 1.439 -1.137 0 C-N-CA 120.584 -0.817 . . . . 0.0 112.38 174.532 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 32.2 mmtp -58.65 -31.79 68.48 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 120.836 0.351 . . . . 0.0 110.642 -178.888 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -128.42 14.63 6.14 Favored Glycine 0 N--CA 1.449 -0.452 0 C-N-CA 120.952 -0.642 . . . . 0.0 111.879 175.751 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.553 ' HA2' HG22 ' A' ' 33' ' ' ILE . . . 84.48 1.78 89.17 Favored Glycine 0 C--N 1.332 0.315 0 C-N-CA 121.017 -0.611 . . . . 0.0 112.135 -177.347 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -85.39 -29.67 24.24 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 120.706 0.288 . . . . 0.0 111.385 -178.121 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.768 ' O ' ' HG ' ' A' ' 43' ' ' LEU . 91.3 m -62.51 -42.0 99.21 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.849 -174.796 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.664 ' HB ' ' HA ' ' A' ' 33' ' ' ILE . 15.6 tt -60.62 -30.17 46.29 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.287 0 CA-C-O 121.105 0.478 . . . . 0.0 111.093 -179.308 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.679 ' O ' ' HG2' ' A' ' 45' ' ' GLU . 62.0 tttp -73.19 -44.05 60.43 Favored 'General case' 0 N--CA 1.451 -0.419 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 174.332 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 75.4 mt-30 -58.49 -43.72 89.12 Favored 'General case' 0 CA--C 1.515 -0.401 0 CA-C-N 115.681 -0.69 . . . . 0.0 110.106 -177.167 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.768 ' HG ' ' O ' ' A' ' 39' ' ' THR . 42.1 mt -53.89 -49.66 68.08 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.385 -0.825 . . . . 0.0 110.855 -179.644 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 48.4 mt-30 -64.68 -45.6 85.99 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.411 -0.813 . . . . 0.0 110.985 -179.377 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.679 ' HG2' ' O ' ' A' ' 41' ' ' LYS . 67.7 mm-40 -61.18 -41.91 97.63 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.078 -179.279 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 46' ' ' ARG . . . . . 0.516 ' HD3' ' SD ' ' A' ' 82' ' ' MET . 10.2 ptm180 -81.65 -36.43 28.84 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.767 -0.652 . . . . 0.0 112.651 -170.063 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -90.26 -24.04 21.04 Favored 'General case' 0 C--N 1.324 -0.507 0 C-N-CA 120.498 -0.481 . . . . 0.0 111.187 -178.743 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 87.49 24.0 37.88 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.967 -0.635 . . . . 0.0 112.533 -179.657 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.478 HG13 ' HB2' ' A' ' 75' ' ' LYS . 14.0 m -121.77 179.31 2.42 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-O 120.923 0.392 . . . . 0.0 110.89 -178.002 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 87.3 tttt -117.58 122.41 43.55 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.548 -0.751 . . . . 0.0 109.162 173.708 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 51' ' ' MET . . . . . 0.573 ' HG2' HG23 ' A' ' 69' ' ' ILE . 65.2 mtp -116.9 115.52 25.67 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 -179.008 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.604 ' CG2' ' HB2' ' A' ' 68' ' ' ARG . 6.0 tt -105.61 105.8 19.36 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.782 0 CA-C-O 121.47 0.652 . . . . 0.0 110.984 -178.136 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.802 HD22 HD13 ' A' ' 67' ' ' LEU . 3.4 mm? -83.12 102.17 11.65 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.391 -0.822 . . . . 0.0 109.316 174.008 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.55 ' HB ' ' HB2' ' A' ' 66' ' ' PRO . 64.9 mt -81.65 85.57 1.63 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.432 0 CA-C-O 121.677 0.751 . . . . 0.0 110.333 -177.863 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 55' ' ' GLN . . . . . 0.404 ' HG2' HD11 ' A' ' 33' ' ' ILE . 1.9 pp0? -116.04 -10.46 11.56 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 115.068 -0.969 . . . . 0.0 109.279 171.994 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -83.48 -15.87 47.84 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 114.938 -1.028 . . . . 0.0 109.826 179.456 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -84.79 -0.41 89.15 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.817 -0.706 . . . . 0.0 112.765 -179.786 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 17.8 m 57.32 -154.46 0.35 Allowed 'General case' 0 C--O 1.236 0.356 0 C-N-CA 122.711 0.404 . . . . 0.0 111.379 179.556 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 76.5 mm-40 68.56 -77.79 0.05 OUTLIER 'General case' 0 N--CA 1.466 0.339 0 C-N-CA 123.602 0.761 . . . . 0.0 110.909 178.641 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 2.7 m-20 -84.38 12.11 7.34 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.833 0.349 . . . . 0.0 110.716 -179.781 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 61' ' ' THR . . . . . 0.771 ' HA ' ' HE3' ' A' ' 65' ' ' LYS . 5.7 t -56.63 -31.62 64.51 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.632 0.253 . . . . 0.0 110.91 179.023 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 62' ' ' ASN . . . . . 0.404 ' OD1' HG23 ' A' ' 61' ' ' THR . 4.6 m-20 -83.44 -19.11 36.52 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 111.887 0.328 . . . . 0.0 111.887 -179.323 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 5.0 m -113.96 -126.14 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 N-CA-C 111.669 0.248 . . . . 0.0 111.669 -177.696 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -71.89 174.91 6.32 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.319 0.581 . . . . 0.0 111.326 179.007 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.771 ' HE3' ' HA ' ' A' ' 61' ' ' THR . 31.6 mmtm -129.57 113.44 17.95 Favored Pre-proline 0 C--N 1.315 -0.894 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.696 179.713 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.55 ' HB2' ' HB ' ' A' ' 54' ' ' ILE . 52.6 Cg_exo -58.09 104.56 0.18 Allowed 'Trans proline' 0 N--CA 1.459 -0.512 0 C-N-CA 122.821 2.348 . . . . 0.0 111.632 173.678 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.802 HD13 HD22 ' A' ' 53' ' ' LEU . 18.9 tp -112.85 106.5 14.83 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.235 177.229 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.604 ' HB2' ' CG2' ' A' ' 52' ' ' ILE . 13.1 mtp180 -92.67 117.83 30.39 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 109.476 -0.564 . . . . 0.0 109.476 172.586 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.635 ' O ' ' HA ' ' A' ' 19' ' ' VAL . 28.4 mt -96.94 102.31 13.32 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.089 0 N-CA-C 108.206 -1.035 . . . . 0.0 108.206 171.631 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 5.2 mt -103.4 119.39 51.88 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.042 -172.229 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 71' ' ' GLY . . . . . 0.411 ' O ' ' HB3' ' A' ' 16' ' ' ASN . . . 176.36 -137.11 3.49 Favored Glycine 0 N--CA 1.444 -0.817 0 C-N-CA 120.96 -0.638 . . . . 0.0 112.393 178.849 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 72' ' ' ASP . . . . . 0.847 ' HB2' ' HE2' ' A' ' 75' ' ' LYS . 44.9 m-20 -108.12 152.5 41.84 Favored Pre-proline 0 C--N 1.32 -0.713 0 N-CA-C 109.567 -0.531 . . . . 0.0 109.567 179.784 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 73' ' ' PRO . . . . . 0.635 ' HA ' HG21 ' A' ' 18' ' ' THR . 67.2 Cg_exo -48.89 -48.74 17.0 Favored 'Trans proline' 0 C--N 1.347 0.469 0 C-N-CA 123.359 2.706 . . . . 0.0 113.972 -167.106 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 74' ' ' TYR . . . . . 0.519 ' O ' ' HG2' ' A' ' 78' ' ' GLN . 45.1 m-85 -64.75 -51.94 59.66 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.703 -174.494 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.847 ' HE2' ' HB2' ' A' ' 72' ' ' ASP . 22.7 pttt -73.7 -23.82 59.85 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 112.175 0.435 . . . . 0.0 112.175 -176.528 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.419 HG23 ' O ' ' A' ' 72' ' ' ASP . 58.0 t -69.68 -40.92 79.89 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 N-CA-C 109.422 -0.584 . . . . 0.0 109.422 175.39 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 6.2 tp-100 -71.43 -46.27 60.53 Favored 'General case' 0 N--CA 1.445 -0.715 0 CA-C-N 115.494 -0.776 . . . . 0.0 111.313 -177.698 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 78' ' ' GLN . . . . . 0.643 ' HG2' ' HA ' ' A' ' 75' ' ' LYS . 3.3 pt20 -64.09 -38.56 91.51 Favored 'General case' 0 CA--C 1.508 -0.643 0 CA-C-O 121.489 0.661 . . . . 0.0 110.225 -179.676 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 79' ' ' ALA . . . . . 0.445 ' HA ' ' HE2' ' A' ' 82' ' ' MET . . . -63.34 -39.76 95.42 Favored 'General case' 0 C--N 1.313 -1.016 0 CA-C-N 114.556 -1.202 . . . . 0.0 110.384 176.863 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 52.0 t -64.62 -49.47 70.95 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.447 175.893 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -56.0 -38.98 71.22 Favored 'General case' 0 CA--C 1.518 -0.286 0 CA-C-O 121.205 0.526 . . . . 0.0 110.054 176.244 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 82' ' ' MET . . . . . 0.516 ' SD ' ' HD3' ' A' ' 46' ' ' ARG . 37.5 ttp -63.43 -54.23 39.88 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 114.77 -1.105 . . . . 0.0 111.555 -178.719 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.477 ' O ' ' HG ' ' A' ' 87' ' ' LEU . 35.4 m -70.74 -37.86 70.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 C-N-CA 120.897 -0.321 . . . . 0.0 111.47 -177.225 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 88.9 mmm -66.38 -33.46 75.76 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.724 0.297 . . . . 0.0 110.34 177.339 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -62.37 -39.07 91.97 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.518 177.171 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.506 HG13 ' O ' ' A' ' 82' ' ' MET . 52.6 mt -66.4 -29.49 46.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.834 179.684 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.561 HD22 ' HB3' ' A' ' 28' ' ' LYS . 61.2 mt -85.1 -23.5 28.46 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.668 -176.231 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 15.7 ptm180 -99.64 -3.14 33.78 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 120.998 0.428 . . . . 0.0 111.192 -175.58 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 12.5 tp10 . . . . . 0 C--O 1.247 0.967 0 CA-C-N 115.661 -0.699 . . . . 0.0 109.892 -174.863 . . . . . . . . 0 0 . 1 . 022 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.517 0.165 0 N-CA-C 112.119 -0.392 . . . . 0.0 112.119 . . . . . . . . . 0 0 . 1 . 022 nuclear build full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 27.5 mm-40 61.01 29.72 19.16 Favored 'General case' 0 C--O 1.234 0.258 0 C-N-CA 123.107 0.563 . . . . 0.0 111.241 176.872 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 7' ' ' PHE . . . . . 0.448 ' O ' ' HD2' ' A' ' 75' ' ' LYS . 96.9 m-85 63.95 -86.12 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 115.042 -0.981 . . . . 0.0 111.305 179.492 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 8' ' ' HIS . . . . . 0.44 ' HB2' ' OD1' ' A' ' 72' ' ' ASP . 29.3 t-80 -110.61 62.8 0.61 Allowed 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 120.53 -0.468 . . . . 0.0 112.007 -175.272 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 10.4 t70 65.47 -74.29 0.06 Allowed 'General case' 0 CA--C 1.537 0.457 0 N-CA-C 112.75 0.648 . . . . 0.0 112.75 166.661 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 36.4 t30 -123.41 -50.07 1.89 Allowed 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 110.212 -0.292 . . . . 0.0 110.212 -179.807 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -155.85 130.48 9.04 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.921 0.391 . . . . 0.0 111.396 -178.589 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 19.9 t-20 -92.05 -64.3 1.13 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.194 175.825 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 149.36 -89.68 0.14 Allowed Glycine 0 N--CA 1.446 -0.674 0 C-N-CA 120.921 -0.657 . . . . 0.0 111.924 -178.207 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -115.82 -64.04 0.37 Allowed Glycine 0 N--CA 1.448 -0.524 0 C-N-CA 120.683 -0.77 . . . . 0.0 112.521 -178.199 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 52.6 mt-30 -75.45 108.38 8.22 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.917 0.389 . . . . 0.0 110.232 -178.759 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 66.2 t30 -91.55 -70.7 0.67 Allowed 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.136 -172.818 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -81.07 99.72 1.94 Allowed Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 121.015 -0.612 . . . . 0.0 112.878 -175.775 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.502 ' OG1' ' HG3' ' A' ' 73' ' ' PRO . 56.5 m -116.4 135.96 53.41 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 120.875 0.369 . . . . 0.0 110.683 177.456 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.461 ' HA ' ' O ' ' A' ' 69' ' ' ILE . 4.0 p -135.97 134.26 50.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.811 179.205 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 26.2 mt-30 -110.57 126.92 54.94 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 109.885 -0.413 . . . . 0.0 109.885 174.135 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.624 ' HG2' ' HG2' ' A' ' 68' ' ' ARG . 26.0 mt-10 -101.23 122.17 43.18 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.957 -179.072 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 7.0 mm -114.02 155.95 15.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 115.828 -0.624 . . . . 0.0 109.891 -178.047 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 23' ' ' MET . . . . . 0.479 ' HB3' ' HB3' ' A' ' 64' ' ' ASP . 85.2 mmm -112.41 97.54 6.68 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 108.27 -1.011 . . . . 0.0 108.27 173.158 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.607 HG21 HG21 ' A' ' 32' ' ' VAL . 40.2 mm -83.89 126.97 69.13 Favored Pre-proline 0 C--N 1.319 -0.757 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.689 -172.575 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_exo -49.1 130.46 24.11 Favored 'Trans proline' 0 C--N 1.345 0.348 0 C-N-CA 123.071 2.514 . . . . 0.0 112.169 176.938 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -55.02 -29.9 58.37 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.605 -0.725 . . . . 0.0 112.657 -174.112 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -87.45 -31.68 15.63 Favored Glycine 0 N--CA 1.446 -0.658 0 C-N-CA 120.347 -0.93 . . . . 0.0 112.739 -178.712 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 4.2 tptm -93.92 -1.54 54.56 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 122.609 -0.347 . . . . 0.0 110.873 -175.002 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -65.57 -21.42 66.59 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.279 -179.143 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -60.18 -37.17 92.5 Favored Glycine 0 N--CA 1.448 -0.561 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.354 179.819 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 92.4 mt -75.29 -27.44 59.34 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.701 0.286 . . . . 0.0 111.371 -174.922 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.703 HG13 ' HB ' ' A' ' 83' ' ' VAL . 1.4 t -69.38 -36.57 72.56 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.365 0 CA-C-O 121.586 0.708 . . . . 0.0 110.222 179.285 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.548 HG12 ' HG ' ' A' ' 53' ' ' LEU . 34.8 mt -86.19 -40.68 14.57 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-N 115.116 -0.947 . . . . 0.0 110.28 -178.302 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 124.88 -170.83 16.87 Favored Glycine 0 N--CA 1.442 -0.933 0 CA-C-N 115.58 -0.736 . . . . 0.0 111.565 179.801 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 33.7 mmtp -82.45 -27.63 31.77 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-O 121.128 0.49 . . . . 0.0 109.711 179.866 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -145.01 12.02 1.87 Allowed Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.861 -0.685 . . . . 0.0 112.367 178.658 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 96.07 16.64 37.56 Favored Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.789 -0.719 . . . . 0.0 111.974 179.542 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -85.13 -37.15 20.56 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 120.635 0.255 . . . . 0.0 110.398 178.84 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.83 ' O ' ' HG ' ' A' ' 43' ' ' LEU . 26.5 m -60.41 -55.83 28.85 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.928 -179.22 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.523 ' HB ' ' HA ' ' A' ' 33' ' ' ILE . 7.9 tt -55.34 -24.65 15.85 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-O 121.064 0.459 . . . . 0.0 111.781 -178.753 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 25.3 ttmm -79.41 -46.73 16.99 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.589 179.91 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.432 ' O ' ' HG2' ' A' ' 46' ' ' ARG . 11.5 pt20 -69.89 -35.64 74.79 Favored 'General case' 0 CA--C 1.515 -0.387 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.318 -177.259 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.83 ' HG ' ' O ' ' A' ' 39' ' ' THR . 77.0 mt -53.11 -45.75 68.43 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.589 -0.732 . . . . 0.0 111.256 -178.576 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 49.2 mt-30 -67.44 -33.54 75.36 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.747 -0.661 . . . . 0.0 111.037 -178.968 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 31.8 mm-40 -72.94 -32.06 65.01 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.147 -178.064 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 46' ' ' ARG . . . . . 0.432 ' HG2' ' O ' ' A' ' 42' ' ' GLN . 14.9 ptp180 -92.27 -42.19 9.98 Favored 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 112.143 0.423 . . . . 0.0 112.143 -175.882 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.474 ' O ' ' HD3' ' A' ' 75' ' ' LYS . . . -74.9 -31.67 61.63 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.767 0.318 . . . . 0.0 111.072 -177.724 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 92.11 -3.95 77.26 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.876 -0.678 . . . . 0.0 112.088 -178.432 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.442 ' CG1' ' HG3' ' A' ' 75' ' ' LYS . 15.5 m -102.55 169.02 1.98 Allowed 'Isoleucine or valine' 0 CA--C 1.512 -0.516 0 CA-C-O 121.221 0.534 . . . . 0.0 111.022 -179.623 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 86.0 tttt -101.26 124.48 47.03 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-N 115.347 -0.842 . . . . 0.0 110.045 176.286 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 51' ' ' MET . . . . . 0.727 ' HE2' ' HB1' ' A' ' 79' ' ' ALA . 58.8 mtt -109.55 114.66 28.47 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 175.919 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.586 ' CG2' ' HB2' ' A' ' 68' ' ' ARG . 10.0 tt -109.63 104.94 17.88 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.994 0 CA-C-O 121.724 0.773 . . . . 0.0 109.988 177.791 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.548 ' HG ' HG12 ' A' ' 33' ' ' ILE . 3.8 mm? -77.98 102.82 7.56 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 114.945 -1.025 . . . . 0.0 108.6 173.166 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.77 ' HB ' ' HG2' ' A' ' 66' ' ' PRO . 51.0 mt -76.04 88.52 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-O 121.777 0.798 . . . . 0.0 109.734 -177.233 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 55' ' ' GLN . . . . . 0.403 ' HG2' ' O ' ' A' ' 53' ' ' LEU . 13.6 mm100 -93.22 -10.85 34.23 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 114.845 -1.07 . . . . 0.0 111.427 -171.568 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 1.7 p30 -146.42 11.17 1.13 Allowed 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 111.934 0.346 . . . . 0.0 111.934 179.811 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -101.15 39.88 2.6 Favored Glycine 0 CA--C 1.509 -0.3 0 C-N-CA 120.629 -0.796 . . . . 0.0 112.161 178.88 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 34.4 t -179.02 173.91 1.13 Allowed 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 109.195 -0.669 . . . . 0.0 109.195 -176.253 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 46.3 mt-30 -108.74 4.9 24.22 Favored 'General case' 0 N--CA 1.445 -0.696 0 N-CA-C 107.576 -1.268 . . . . 0.0 107.576 175.009 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.52 ' HA ' HG22 ' A' ' 63' ' ' VAL . 88.0 m-20 -84.99 16.08 3.64 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-N 114.403 -1.271 . . . . 0.0 109.121 172.973 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 61' ' ' THR . . . . . 0.573 ' HA ' ' HE3' ' A' ' 65' ' ' LYS . 17.3 p -61.77 -23.15 66.0 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.197 -0.91 . . . . 0.0 111.119 179.176 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 17.0 m120 -106.82 6.37 29.41 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.686 -0.688 . . . . 0.0 111.185 -177.532 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.52 HG22 ' HA ' ' A' ' 60' ' ' ASN . 13.8 m -137.77 -147.85 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 116.002 -0.544 . . . . 0.0 109.729 179.777 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.479 ' HB3' ' HB3' ' A' ' 23' ' ' MET . 19.1 m-20 -58.39 126.69 28.62 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.144 0.497 . . . . 0.0 110.058 178.663 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.573 ' HE3' ' HA ' ' A' ' 61' ' ' THR . 12.2 mmmm -90.48 133.62 32.56 Favored Pre-proline 0 C--N 1.323 -0.572 0 CA-C-N 115.385 -0.825 . . . . 0.0 112.738 -168.043 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.77 ' HG2' ' HB ' ' A' ' 54' ' ' ILE . 30.3 Cg_endo -64.62 113.83 2.47 Favored 'Trans proline' 0 CA--C 1.533 0.46 0 C-N-CA 123.465 2.777 . . . . 0.0 111.65 172.539 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.59 ' O ' ' HA ' ' A' ' 21' ' ' GLU . 57.0 tp -123.36 129.35 51.18 Favored 'General case' 0 C--N 1.324 -0.531 0 O-C-N 122.338 -0.226 . . . . 0.0 110.579 179.571 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.624 ' HG2' ' HG2' ' A' ' 21' ' ' GLU . 95.7 mtt180 -120.89 114.9 22.24 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.694 0.283 . . . . 0.0 110.984 176.567 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.461 ' O ' ' HA ' ' A' ' 19' ' ' VAL . 4.5 mp -98.24 106.4 18.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 N-CA-C 108.228 -1.027 . . . . 0.0 108.228 171.82 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.437 HG12 ' CG2' ' A' ' 19' ' ' VAL . 15.4 mt -109.85 132.82 57.05 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-N 116.464 -0.334 . . . . 0.0 111.076 -171.98 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 153.91 -132.54 3.6 Favored Glycine 0 N--CA 1.448 -0.51 0 C-N-CA 120.952 -0.642 . . . . 0.0 112.595 176.28 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 72' ' ' ASP . . . . . 0.623 ' OD2' ' HG2' ' A' ' 75' ' ' LYS . 1.1 t70 -81.0 134.56 52.62 Favored Pre-proline 0 C--N 1.324 -0.524 0 C-N-CA 122.692 0.397 . . . . 0.0 110.882 -178.674 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 73' ' ' PRO . . . . . 0.502 ' HG3' ' OG1' ' A' ' 18' ' ' THR . 63.9 Cg_exo -47.96 -34.12 21.92 Favored 'Trans proline' 0 C--N 1.349 0.562 0 C-N-CA 123.878 3.052 . . . . 0.0 113.972 -177.314 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 73.0 m-85 -80.38 -55.81 4.63 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.755 0.312 . . . . 0.0 110.547 -176.123 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.623 ' HG2' ' OD2' ' A' ' 72' ' ' ASP . 0.3 OUTLIER -71.07 -22.75 62.07 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.256 -177.587 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 20.5 t -64.85 -43.05 96.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 N-CA-C 109.713 -0.477 . . . . 0.0 109.713 171.249 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -68.59 -46.86 68.25 Favored 'General case' 0 N--CA 1.448 -0.527 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 177.845 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 28.0 mm-40 -61.57 -40.44 94.76 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.026 -179.309 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 79' ' ' ALA . . . . . 0.727 ' HB1' ' HE2' ' A' ' 51' ' ' MET . . . -67.71 -34.37 76.73 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.017 0.437 . . . . 0.0 110.34 177.546 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 49.2 t -63.01 -48.26 79.54 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.577 -0.738 . . . . 0.0 109.693 175.243 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 75.8 mm-40 -57.82 -44.78 86.62 Favored 'General case' 0 C--O 1.22 -0.479 0 N-CA-C 109.766 -0.457 . . . . 0.0 109.766 174.497 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 82' ' ' MET . . . . . 0.529 ' SD ' HD22 ' A' ' 43' ' ' LEU . 32.5 ttm -52.85 -58.52 6.65 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.385 -0.825 . . . . 0.0 111.267 -179.387 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.703 ' HB ' HG13 ' A' ' 32' ' ' VAL . 35.3 m -73.0 -35.49 48.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.887 -175.813 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 83.5 mtp -77.54 -30.06 52.61 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 120.861 -0.335 . . . . 0.0 111.253 -177.707 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 85' ' ' ASP . . . . . 0.4 ' HA ' ' HG2' ' A' ' 88' ' ' ARG . 33.4 t70 -62.34 -43.52 98.64 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-O 120.911 0.386 . . . . 0.0 110.244 178.835 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 57.9 mt -61.15 -29.18 45.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 115.837 -0.619 . . . . 0.0 110.61 178.32 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.407 HD11 HG22 ' A' ' 32' ' ' VAL . 5.9 mp -84.91 -40.63 16.81 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.498 -0.774 . . . . 0.0 112.208 -176.714 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 88' ' ' ARG . . . . . 0.4 ' HG2' ' HA ' ' A' ' 85' ' ' ASP . 25.5 ptt180 -84.51 -8.12 59.04 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.867 0.365 . . . . 0.0 111.704 -174.207 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 . . . . . 0 C--O 1.249 1.063 0 CA-C-O 118.359 -0.829 . . . . 0.0 109.956 -178.228 . . . . . . . . 0 0 . 1 . 023 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.403 0 N-CA-C 111.853 -0.499 . . . . 0.0 111.853 . . . . . . . . . 0 0 . 1 . 023 nuclear build full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 78.2 mt-30 -113.22 26.62 10.29 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.436 0.636 . . . . 0.0 109.931 -178.198 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 7' ' ' PHE . . . . . 0.796 ' HA ' ' HB2' ' A' ' 72' ' ' ASP . 64.6 t80 83.41 105.43 0.06 Allowed 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 113.958 -1.473 . . . . 0.0 112.38 179.242 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 2.5 t-80 58.73 -85.91 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 113.721 -1.581 . . . . 0.0 112.935 169.916 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 9' ' ' ASP . . . . . 0.428 ' O ' ' HB2' ' A' ' 10' ' ' ASN . 31.3 m-20 -112.9 37.43 3.11 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.831 -0.168 . . . . 0.0 110.841 -172.544 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 10' ' ' ASN . . . . . 0.428 ' HB2' ' O ' ' A' ' 9' ' ' ASP . 6.0 m-20 73.94 -53.08 0.69 Allowed 'General case' 0 N--CA 1.467 0.425 0 O-C-N 123.78 0.675 . . . . 0.0 112.097 175.754 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -100.61 84.31 2.73 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 116.621 -0.263 . . . . 0.0 111.229 -177.806 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 12' ' ' ASN . . . . . 0.685 ' HB3' ' HB3' ' A' ' 7' ' ' PHE . 10.4 p30 -68.64 151.92 46.06 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 109.786 -0.45 . . . . 0.0 109.786 174.846 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -78.72 54.05 4.08 Favored Glycine 0 CA--C 1.518 0.23 0 C-N-CA 120.959 -0.639 . . . . 0.0 113.173 -175.618 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 86.08 -41.31 3.07 Favored Glycine 0 N--CA 1.447 -0.581 0 C-N-CA 121.217 -0.516 . . . . 0.0 112.377 177.874 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 34.2 tt0 -118.98 130.33 55.63 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 120.948 0.404 . . . . 0.0 110.312 -178.389 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 16' ' ' ASN . . . . . 0.644 ' HB3' ' HA2' ' A' ' 71' ' ' GLY . 31.5 m-80 -71.79 146.01 48.32 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.514 -0.766 . . . . 0.0 109.65 177.005 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -107.28 -36.3 2.52 Favored Glycine 0 CA--C 1.519 0.336 0 C-N-CA 120.638 -0.792 . . . . 0.0 114.231 -171.822 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.602 ' OG1' ' HD3' ' A' ' 73' ' ' PRO . 89.0 m -70.5 126.73 30.45 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 117.231 0.515 . . . . 0.0 110.725 -177.122 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.461 ' HA ' ' O ' ' A' ' 69' ' ' ILE . 9.1 p -140.64 140.72 33.36 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-O 120.814 0.34 . . . . 0.0 110.751 -179.783 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 25.7 mt-30 -128.12 138.72 52.64 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 109.642 -0.503 . . . . 0.0 109.642 174.394 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.647 ' HG2' ' HG2' ' A' ' 68' ' ' ARG . 44.8 mt-10 -102.62 116.88 33.48 Favored 'General case' 0 C--N 1.328 -0.368 0 O-C-N 123.315 0.384 . . . . 0.0 110.805 -179.57 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 13.1 mm -100.39 150.31 5.61 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-N 115.918 -0.583 . . . . 0.0 109.639 178.47 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 1.7 mmt -103.16 91.61 4.17 Favored 'General case' 0 C--N 1.317 -0.811 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 175.191 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.672 ' HB ' ' HB2' ' A' ' 65' ' ' LYS . 36.1 mm -77.39 124.1 86.88 Favored Pre-proline 0 C--N 1.323 -0.547 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.765 -176.236 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.54 ' HB2' ' HB2' ' A' ' 28' ' ' LYS . 68.4 Cg_exo -51.83 135.41 50.08 Favored 'Trans proline' 0 N--CA 1.461 -0.396 0 C-N-CA 122.898 2.399 . . . . 0.0 111.737 177.717 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -56.25 -35.36 67.32 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 115.649 -0.705 . . . . 0.0 112.371 -175.072 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -80.22 -15.9 77.58 Favored Glycine 0 N--CA 1.452 -0.238 0 C-N-CA 120.519 -0.848 . . . . 0.0 111.875 178.95 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.547 ' HB3' HD22 ' A' ' 87' ' ' LEU . 0.3 OUTLIER -94.89 -4.38 47.02 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.755 0.312 . . . . 0.0 110.591 179.441 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.16 -27.95 68.77 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.424 -178.02 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -65.15 -24.27 70.31 Favored Glycine 0 CA--C 1.519 0.309 0 C-N-CA 120.785 -0.721 . . . . 0.0 112.356 178.253 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 95.1 mt -86.14 -42.66 13.68 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 111.352 0.13 . . . . 0.0 111.352 -176.219 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.844 HG13 HD21 ' A' ' 87' ' ' LEU . 2.7 m -65.19 -34.46 70.71 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.19 0 CA-C-O 120.928 0.394 . . . . 0.0 110.857 178.605 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 66.4 mt -79.89 -45.71 22.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-O 121.469 0.652 . . . . 0.0 109.689 176.241 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.495 ' HA3' ' H ' ' A' ' 39' ' ' THR . . . 96.64 60.07 1.0 Allowed Glycine 0 N--CA 1.444 -0.773 0 CA-C-N 115.719 -0.673 . . . . 0.0 113.123 175.514 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.446 ' N ' ' HD3' ' A' ' 35' ' ' LYS . 0.0 OUTLIER 55.32 24.69 6.73 Favored 'General case' 0 N--CA 1.467 0.386 0 C-N-CA 122.949 0.5 . . . . 0.0 112.09 175.093 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 145.36 -52.18 0.59 Allowed Glycine 0 N--CA 1.449 -0.465 0 N-CA-C 111.58 -0.608 . . . . 0.0 111.58 -179.459 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.418 ' O ' ' HB2' ' A' ' 41' ' ' LYS . . . 165.02 24.23 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.429 -0.891 . . . . 0.0 113.694 176.462 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.616 ' O ' ' HG2' ' A' ' 42' ' ' GLN . 40.5 mm-40 -85.03 -43.51 13.88 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 117.344 0.572 . . . . 0.0 110.954 -179.23 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.717 ' O ' ' HG ' ' A' ' 43' ' ' LEU . 82.2 m -66.51 -53.9 29.83 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.488 -176.865 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.558 HD12 HD23 ' A' ' 53' ' ' LEU . 7.1 tt -56.15 -31.85 32.82 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.419 0 CA-C-O 121.56 0.695 . . . . 0.0 110.472 179.029 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.48 ' HB3' ' O ' ' A' ' 38' ' ' GLU . 83.5 tttt -62.47 -43.26 99.25 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.003 -0.999 . . . . 0.0 110.569 177.687 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.616 ' HG2' ' O ' ' A' ' 38' ' ' GLU . 61.5 mm-40 -72.66 -43.71 62.82 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.962 -177.84 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.717 ' HG ' ' O ' ' A' ' 39' ' ' THR . 37.5 mt -54.87 -49.77 70.32 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.494 -0.775 . . . . 0.0 111.863 -172.913 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 43.8 mt-30 -59.46 -38.44 80.77 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.835 -0.62 . . . . 0.0 111.222 -177.6 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 9.1 mm-40 -76.74 -42.48 40.99 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.382 -176.67 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 46' ' ' ARG . . . . . 0.432 ' HG2' ' O ' ' A' ' 42' ' ' GLN . 16.2 ptp180 -74.35 -33.73 63.2 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 112.05 0.389 . . . . 0.0 112.05 -174.677 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.536 ' HB3' HG22 ' A' ' 49' ' ' VAL . . . -89.94 -21.1 22.62 Favored 'General case' 0 C--N 1.325 -0.492 0 C-N-CA 120.756 -0.378 . . . . 0.0 111.524 -177.936 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 76.83 28.41 59.03 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.809 -0.71 . . . . 0.0 111.537 -177.733 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.536 HG22 ' HB3' ' A' ' 47' ' ' ALA . 35.9 m -121.49 168.63 13.74 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-O 120.973 0.416 . . . . 0.0 110.654 -176.947 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.655 ' HB3' ' HB ' ' A' ' 70' ' ' ILE . 50.7 tptt -101.04 122.56 43.77 Favored 'General case' 0 C--N 1.318 -0.804 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 171.994 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 51' ' ' MET . . . . . 0.545 ' HE3' HG11 ' A' ' 83' ' ' VAL . 77.3 mtp -118.74 114.9 23.4 Favored 'General case' 0 C--N 1.316 -0.869 0 N-CA-C 109.751 -0.462 . . . . 0.0 109.751 177.422 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.565 ' CG2' ' HB2' ' A' ' 68' ' ' ARG . 10.2 tt -106.22 108.47 25.17 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.841 0 CA-C-O 121.376 0.608 . . . . 0.0 109.901 176.84 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.558 HD23 HD12 ' A' ' 40' ' ' ILE . 2.8 mm? -82.24 102.77 11.37 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.669 -0.696 . . . . 0.0 109.278 177.124 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.523 HD12 ' HB2' ' A' ' 66' ' ' PRO . 68.8 mt -82.25 98.14 4.42 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.407 0 CA-C-O 121.514 0.673 . . . . 0.0 109.664 -179.817 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 59.7 mt-30 -94.46 -40.91 9.65 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.216 -0.902 . . . . 0.0 110.774 -173.09 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -125.28 0.14 7.72 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.11 -176.101 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -90.19 34.1 4.25 Favored Glycine 0 CA--C 1.519 0.313 0 C-N-CA 120.637 -0.792 . . . . 0.0 112.659 -178.254 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 27.6 t -167.7 156.12 9.28 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 109.368 -0.604 . . . . 0.0 109.368 -178.275 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 66.4 mt-30 -99.23 -3.27 34.64 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.866 0.365 . . . . 0.0 110.508 -179.126 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 16.4 m120 -86.21 11.98 10.83 Favored 'General case' 0 CA--C 1.516 -0.347 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 171.181 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 14.7 t -64.64 -20.47 66.3 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.495 -0.775 . . . . 0.0 110.249 177.358 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 17.2 m120 -71.74 -19.41 62.04 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.822 179.071 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.545 HG23 ' H ' ' A' ' 64' ' ' ASP . 0.2 OUTLIER -112.3 -62.32 2.24 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.56 0 CA-C-O 121.277 0.56 . . . . 0.0 111.802 -179.568 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.545 ' H ' HG23 ' A' ' 63' ' ' VAL . 41.1 m-20 -134.39 -169.47 2.34 Favored 'General case' 0 C--N 1.308 -1.203 0 CA-C-N 114.892 -1.049 . . . . 0.0 109.737 -172.776 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.672 ' HB2' ' HB ' ' A' ' 24' ' ' ILE . 59.5 mmtt -137.27 114.35 9.74 Favored Pre-proline 0 C--N 1.315 -0.904 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.568 -173.971 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.523 ' HB2' HD12 ' A' ' 54' ' ' ILE . 48.4 Cg_exo -58.87 116.84 3.54 Favored 'Trans proline' 0 N--CA 1.463 -0.271 0 C-N-CA 123.141 2.56 . . . . 0.0 111.89 175.693 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.547 ' O ' ' HA ' ' A' ' 21' ' ' GLU . 43.2 tp -120.47 114.49 21.86 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.089 179.839 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.647 ' HG2' ' HG2' ' A' ' 21' ' ' GLU . 92.9 mtt180 -102.4 107.19 18.1 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 120.843 0.354 . . . . 0.0 110.551 177.79 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.63 ' HB ' HG13 ' A' ' 76' ' ' VAL . 3.9 mp -90.02 104.73 15.47 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 173.489 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.655 ' HB ' ' HB3' ' A' ' 50' ' ' LYS . 3.0 mt -99.03 123.48 51.69 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.767 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.405 -175.529 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 71' ' ' GLY . . . . . 0.644 ' HA2' ' HB3' ' A' ' 16' ' ' ASN . . . 175.15 -114.36 0.49 Allowed Glycine 0 N--CA 1.443 -0.839 0 C-N-CA 121.072 -0.585 . . . . 0.0 112.568 179.841 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 72' ' ' ASP . . . . . 0.796 ' HB2' ' HA ' ' A' ' 7' ' ' PHE . 6.2 t70 -134.7 147.2 62.12 Favored Pre-proline 0 C--N 1.322 -0.593 0 N-CA-C 108.453 -0.943 . . . . 0.0 108.453 -177.219 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 73' ' ' PRO . . . . . 0.602 ' HD3' ' OG1' ' A' ' 18' ' ' THR . 87.4 Cg_exo -44.7 -36.01 9.97 Favored 'Trans proline' 0 C--N 1.352 0.724 0 C-N-CA 122.37 2.047 . . . . 0.0 112.339 -176.586 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 94.8 t80 -64.21 -62.77 1.41 Allowed 'General case' 0 N--CA 1.448 -0.547 0 CA-C-N 115.296 -0.865 . . . . 0.0 111.108 179.629 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 34.9 pttt -74.45 -30.17 61.76 Favored 'General case' 0 C--O 1.223 -0.31 0 N-CA-C 112.036 0.384 . . . . 0.0 112.036 -175.914 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.63 HG13 ' HB ' ' A' ' 69' ' ' ILE . 70.0 t -62.88 -38.22 81.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 N-CA-C 109.928 -0.397 . . . . 0.0 109.928 177.539 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 77' ' ' GLN . . . . . 0.415 ' O ' ' HG2' ' A' ' 81' ' ' GLU . 2.6 mm100 -79.1 -38.12 37.02 Favored 'General case' 0 N--CA 1.451 -0.42 0 C-N-CA 120.733 -0.387 . . . . 0.0 111.366 178.876 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 90.9 mt-30 -62.82 -40.92 98.87 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.971 0.415 . . . . 0.0 110.203 176.447 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -67.96 -37.46 81.59 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.458 177.224 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 43.9 t -65.01 -51.62 60.62 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.302 178.415 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 81' ' ' GLU . . . . . 0.415 ' HG2' ' O ' ' A' ' 77' ' ' GLN . 14.0 pt-20 -66.01 -27.18 67.92 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.02 0.438 . . . . 0.0 109.986 179.6 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 82' ' ' MET . . . . . 0.406 ' O ' HG13 ' A' ' 86' ' ' ILE . 49.5 ttp -67.01 -50.47 62.07 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.801 177.261 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.7 ' O ' ' HG ' ' A' ' 87' ' ' LEU . 33.4 m -76.27 -35.15 27.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 C-N-CA 120.909 -0.316 . . . . 0.0 110.73 -177.235 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 22.0 ttt -63.78 -34.7 78.49 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 109.627 -0.508 . . . . 0.0 109.627 177.58 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 85' ' ' ASP . . . . . 0.404 ' O ' ' HB2' ' A' ' 89' ' ' GLU . 2.7 t70 -59.73 -48.33 82.1 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.254 -0.885 . . . . 0.0 110.618 174.931 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.406 HG13 ' O ' ' A' ' 82' ' ' MET . 57.3 mt -61.73 -38.89 81.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.726 -179.426 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.844 HD21 HG13 ' A' ' 32' ' ' VAL . 52.8 mt -68.11 -43.94 77.28 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.87 -0.604 . . . . 0.0 111.371 -177.341 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 2.8 ptm180 -87.57 4.06 45.16 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.862 0.363 . . . . 0.0 111.043 -175.987 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 89' ' ' GLU . . . . . 0.404 ' HB2' ' O ' ' A' ' 85' ' ' ASP . 7.9 tp10 . . . . . 0 C--O 1.25 1.097 0 CA-C-O 118.466 -0.778 . . . . 0.0 109.457 179.604 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.445 -0.709 0 N-CA-C 111.498 -0.641 . . . . 0.0 111.498 . . . . . . . . . 0 0 . 1 . 024 nuclear build full ' A' A ' 6' ' ' GLN . . . . . 0.519 ' HB3' ' HB2' ' A' ' 9' ' ' ASP . 10.5 mm-40 -94.91 42.34 1.09 Allowed 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 120.986 0.422 . . . . 0.0 110.332 -176.606 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 7' ' ' PHE . . . . . 0.553 ' HA ' ' CG ' ' A' ' 72' ' ' ASP . 26.8 p90 -74.28 25.76 0.08 Allowed 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 115.636 -0.711 . . . . 0.0 111.945 -175.935 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 8' ' ' HIS . . . . . 0.532 ' HA ' ' HB3' ' A' ' 12' ' ' ASN . 19.7 t-80 -171.89 36.09 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 109.349 -0.611 . . . . 0.0 109.349 177.204 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 9' ' ' ASP . . . . . 0.519 ' HB2' ' HB3' ' A' ' 6' ' ' GLN . 27.4 t70 -73.56 91.65 1.85 Allowed 'General case' 0 C--O 1.236 0.375 0 CA-C-N 115.952 -0.567 . . . . 0.0 109.984 179.233 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 57.0 t30 70.51 -58.71 0.55 Allowed 'General case' 0 N--CA 1.468 0.461 0 O-C-N 124.117 0.886 . . . . 0.0 110.603 -176.283 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -98.15 -157.09 0.57 Allowed 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.477 178.362 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 12' ' ' ASN . . . . . 0.605 ' HA ' ' O ' ' A' ' 15' ' ' GLN . 2.3 t-20 68.89 -168.44 0.18 Allowed 'General case' 0 C--O 1.236 0.36 0 O-C-N 123.559 0.537 . . . . 0.0 110.678 178.559 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 78.1 -78.56 1.55 Allowed Glycine 0 N--CA 1.449 -0.497 0 N-CA-C 111.27 -0.732 . . . . 0.0 111.27 -175.061 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -77.31 -62.07 2.51 Favored Glycine 0 N--CA 1.447 -0.575 0 N-CA-C 110.984 -0.846 . . . . 0.0 110.984 174.385 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 15' ' ' GLN . . . . . 0.605 ' O ' ' HA ' ' A' ' 12' ' ' ASN . 52.3 tp60 -94.17 106.77 18.74 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 174.984 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 16' ' ' ASN . . . . . 0.717 ' HB3' ' HA2' ' A' ' 71' ' ' GLY . 31.3 m-80 -94.23 93.68 7.89 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.761 -0.654 . . . . 0.0 109.754 -177.483 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -90.08 48.01 3.18 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.963 -0.636 . . . . 0.0 113.785 -172.474 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.63 ' OG1' ' HD3' ' A' ' 73' ' ' PRO . 96.7 m -145.68 126.38 14.3 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 109.647 -0.501 . . . . 0.0 109.647 172.568 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 92.2 t -138.49 125.8 27.5 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.791 -176.246 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 45.6 mt-30 -113.42 116.07 29.05 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.453 -0.34 . . . . 0.0 110.129 172.992 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.616 ' HA ' ' O ' ' A' ' 67' ' ' LEU . 57.9 mt-10 -86.78 113.91 23.01 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.141 179.428 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 18.6 mm -97.51 151.43 4.29 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-N 115.518 -0.765 . . . . 0.0 108.986 176.527 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 23' ' ' MET . . . . . 0.492 ' HB3' ' HB3' ' A' ' 64' ' ' ASP . 73.7 mmm -104.85 99.2 8.85 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 108.752 -0.832 . . . . 0.0 108.752 176.64 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.665 HD12 HD11 ' A' ' 87' ' ' LEU . 22.9 mm -83.32 123.8 76.63 Favored Pre-proline 0 C--N 1.32 -0.68 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.471 -172.601 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_exo -52.82 130.36 37.07 Favored 'Trans proline' 0 N--CA 1.463 -0.273 0 C-N-CA 122.708 2.272 . . . . 0.0 111.495 176.408 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -57.31 -37.19 72.1 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.681 -0.69 . . . . 0.0 112.435 -173.403 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -80.59 -32.81 32.74 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.536 -0.84 . . . . 0.0 112.316 179.542 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.45 ' HE2' ' O ' ' A' ' 87' ' ' LEU . 49.7 tptt -83.58 -7.27 59.55 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.152 0.501 . . . . 0.0 110.005 -177.544 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.54 ' O ' HG12 ' A' ' 32' ' ' VAL . . . -62.15 -19.29 62.91 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.567 -0.742 . . . . 0.0 111.789 -177.756 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -58.46 -37.01 87.06 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.586 -0.816 . . . . 0.0 111.901 176.757 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 70.0 mt -83.03 -28.92 29.27 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 111.667 0.247 . . . . 0.0 111.667 -178.431 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.54 HG12 ' O ' ' A' ' 29' ' ' ALA . 0.4 OUTLIER -69.37 -28.41 38.21 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.395 0 CA-C-O 121.253 0.549 . . . . 0.0 110.235 178.4 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.558 HG22 ' HA2' ' A' ' 37' ' ' GLY . 69.9 mt -86.18 -48.21 16.0 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.366 0 CA-C-N 115.679 -0.691 . . . . 0.0 109.467 174.871 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 135.77 170.6 12.11 Favored Glycine 0 N--CA 1.439 -1.155 0 C-N-CA 120.277 -0.963 . . . . 0.0 112.99 174.015 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.489 ' H ' ' HE3' ' A' ' 35' ' ' LYS . 0.0 OUTLIER -68.2 -27.2 66.18 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.164 0.506 . . . . 0.0 109.785 179.475 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -141.92 25.75 2.38 Favored Glycine 0 N--CA 1.447 -0.596 0 N-CA-C 111.158 -0.777 . . . . 0.0 111.158 174.472 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.558 ' HA2' HG22 ' A' ' 33' ' ' ILE . . . 77.24 2.83 80.42 Favored Glycine 0 CA--C 1.519 0.302 0 C-N-CA 121.039 -0.601 . . . . 0.0 112.26 -176.559 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -85.75 -28.75 24.38 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 111.759 0.281 . . . . 0.0 111.759 -177.961 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.723 ' O ' ' HG ' ' A' ' 43' ' ' LEU . 29.5 m -58.76 -47.32 85.09 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.478 -0.328 . . . . 0.0 111.825 -175.935 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.578 ' HA ' HD12 ' A' ' 43' ' ' LEU . 6.3 tt -58.53 -33.02 47.16 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.279 0 CA-C-O 121.075 0.464 . . . . 0.0 111.251 179.4 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 86.8 tttt -71.78 -37.3 70.48 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.168 0.508 . . . . 0.0 109.88 177.868 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.691 ' O ' ' HG2' ' A' ' 46' ' ' ARG . 22.2 mt-30 -67.59 -42.03 83.13 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.485 -0.78 . . . . 0.0 110.429 179.999 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.723 ' HG ' ' O ' ' A' ' 39' ' ' THR . 58.6 mt -54.5 -41.0 69.1 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.604 -0.726 . . . . 0.0 111.247 -179.506 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 48.1 mt-30 -66.1 -39.51 90.03 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.514 -0.767 . . . . 0.0 110.807 179.605 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 11.6 mm-40 -67.92 -39.02 83.61 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.601 177.774 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 46' ' ' ARG . . . . . 0.897 ' HA ' ' HE ' ' A' ' 46' ' ' ARG . 0.0 OUTLIER -62.99 -44.82 94.96 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.731 -174.717 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -106.11 -0.54 24.65 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 112.603 0.594 . . . . 0.0 112.603 -171.857 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 65.03 40.6 97.18 Favored Glycine 0 C--N 1.33 0.206 0 C-N-CA 120.63 -0.795 . . . . 0.0 111.656 -177.396 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 23.8 m -126.35 179.38 3.43 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-N 115.446 -0.377 . . . . 0.0 110.413 -175.649 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 87.1 tttt -125.94 126.93 45.17 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 109.558 -0.534 . . . . 0.0 109.558 172.715 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 51' ' ' MET . . . . . 0.556 ' HE2' ' HB1' ' A' ' 79' ' ' ALA . 61.7 mtt -113.79 115.34 27.62 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 109.691 -0.485 . . . . 0.0 109.691 178.581 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.618 ' CG2' ' HB2' ' A' ' 68' ' ' ARG . 10.0 tt -99.59 109.41 24.53 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.752 0 CA-C-O 121.536 0.684 . . . . 0.0 109.646 176.64 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.918 HD22 HD13 ' A' ' 67' ' ' LEU . 0.5 OUTLIER -86.04 102.76 14.11 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.583 -0.735 . . . . 0.0 109.677 179.573 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.739 HD12 ' HB2' ' A' ' 66' ' ' PRO . 67.9 mt -75.13 85.67 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.335 0 CA-C-O 122.019 0.914 . . . . 0.0 108.984 175.837 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 17.6 pt20 -115.27 -19.84 10.6 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 114.477 -1.238 . . . . 0.0 109.62 179.917 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -95.16 -27.5 15.52 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.209 -0.905 . . . . 0.0 109.926 176.518 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -64.02 105.27 1.05 Allowed Glycine 0 C--N 1.335 0.528 0 N-CA-C 110.953 -0.859 . . . . 0.0 110.953 175.393 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 58' ' ' SER . . . . . 0.41 ' HA ' HG23 ' A' ' 61' ' ' THR . 14.5 m -80.44 64.28 5.19 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 121.436 0.636 . . . . 0.0 112.561 -169.674 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 79.6 mm-40 -120.78 -48.38 2.27 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 170.995 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.49 ' HB3' ' O ' ' A' ' 64' ' ' ASP . 15.5 m120 -117.61 29.85 7.62 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.102 -0.953 . . . . 0.0 110.006 179.108 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 61' ' ' THR . . . . . 0.505 ' O ' ' HE2' ' A' ' 65' ' ' LYS . 0.6 OUTLIER -62.7 -36.59 83.45 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.911 -0.586 . . . . 0.0 112.53 -175.423 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 28.9 p-10 -102.1 11.16 38.79 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 111.784 0.29 . . . . 0.0 111.784 -177.073 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 16.3 m -135.39 -156.72 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 116.589 -0.278 . . . . 0.0 110.347 -179.921 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.492 ' HB3' ' HB3' ' A' ' 23' ' ' MET . 4.8 m-20 -57.79 134.79 56.58 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 110.046 -0.353 . . . . 0.0 110.046 177.21 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.66 ' HB2' ' HB ' ' A' ' 24' ' ' ILE . 30.9 mmtp -90.8 132.76 33.86 Favored Pre-proline 0 C--N 1.323 -0.576 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.071 -172.32 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.739 ' HB2' HD12 ' A' ' 54' ' ' ILE . 13.5 Cg_exo -72.14 105.78 1.91 Allowed 'Trans proline' 0 N--CA 1.461 -0.395 0 C-N-CA 122.917 2.412 . . . . 0.0 111.491 173.954 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.918 HD13 HD22 ' A' ' 53' ' ' LEU . 23.8 tp -109.22 115.76 30.62 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.42 -0.355 . . . . 0.0 110.526 179.603 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.618 ' HB2' ' CG2' ' A' ' 52' ' ' ILE . 95.6 mtt180 -99.81 108.22 20.46 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.885 176.484 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.474 HG21 ' HB3' ' A' ' 79' ' ' ALA . 4.6 mp -86.97 104.92 14.54 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.587 0 N-CA-C 108.164 -1.05 . . . . 0.0 108.164 170.915 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 21.0 mt -97.05 126.22 49.87 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.615 -175.182 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 71' ' ' GLY . . . . . 0.717 ' HA2' ' HB3' ' A' ' 16' ' ' ASN . . . 172.95 -117.21 0.64 Allowed Glycine 0 N--CA 1.447 -0.58 0 C-N-CA 120.758 -0.734 . . . . 0.0 113.027 178.367 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 72' ' ' ASP . . . . . 0.553 ' CG ' ' HA ' ' A' ' 7' ' ' PHE . 8.7 t70 -131.45 146.73 63.23 Favored Pre-proline 0 C--N 1.324 -0.536 0 CA-C-O 118.301 -0.857 . . . . 0.0 108.764 -177.147 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 73' ' ' PRO . . . . . 0.63 ' HD3' ' OG1' ' A' ' 18' ' ' THR . 88.0 Cg_exo -40.95 -40.59 3.78 Favored 'Trans proline' 0 C--N 1.351 0.7 0 C-N-CA 122.943 2.429 . . . . 0.0 112.894 -177.495 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 90.1 t80 -65.28 -62.59 1.44 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.735 -0.666 . . . . 0.0 111.136 -179.269 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.467 ' HG2' ' HB3' ' A' ' 72' ' ' ASP . 40.8 pttt -70.44 -31.22 68.3 Favored 'General case' 0 C--O 1.219 -0.541 0 C-N-CA 120.911 -0.316 . . . . 0.0 111.843 -175.865 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.404 HG13 ' HB ' ' A' ' 69' ' ' ILE . 79.7 t -66.14 -40.72 87.84 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 C-N-CA 120.833 -0.347 . . . . 0.0 110.166 179.365 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 77' ' ' GLN . . . . . 0.413 ' O ' ' HG3' ' A' ' 81' ' ' GLU . 0.0 OUTLIER -73.38 -40.84 64.04 Favored 'General case' 0 N--CA 1.45 -0.452 0 N-CA-C 109.531 -0.544 . . . . 0.0 109.531 -179.224 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 66.7 mt-30 -67.64 -32.36 73.01 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 120.735 -0.386 . . . . 0.0 110.672 178.177 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 79' ' ' ALA . . . . . 0.556 ' HB1' ' HE2' ' A' ' 51' ' ' MET . . . -72.61 -33.88 66.99 Favored 'General case' 0 N--CA 1.446 -0.648 0 CA-C-N 116.136 -0.484 . . . . 0.0 109.876 175.966 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 43.9 t -62.4 -48.58 79.07 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.848 -0.614 . . . . 0.0 109.695 172.669 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 81' ' ' GLU . . . . . 0.451 ' O ' ' HB2' ' A' ' 85' ' ' ASP . 53.6 mt-10 -56.56 -29.46 62.03 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-O 121.178 0.513 . . . . 0.0 110.794 176.376 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 82' ' ' MET . . . . . 0.447 ' HE1' ' HB2' ' A' ' 46' ' ' ARG . 39.3 ttm -74.41 -51.13 15.85 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.316 -0.857 . . . . 0.0 110.667 -178.086 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.648 ' O ' ' HG ' ' A' ' 87' ' ' LEU . 33.7 m -74.93 -38.22 42.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 120.674 0.273 . . . . 0.0 110.635 -176.082 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 84' ' ' MET . . . . . 0.462 ' O ' ' HG2' ' A' ' 88' ' ' ARG . 26.3 ttt -63.96 -34.44 77.99 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.026 179.735 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 85' ' ' ASP . . . . . 0.451 ' HB2' ' O ' ' A' ' 81' ' ' GLU . 14.3 t70 -63.53 -46.49 85.75 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.12 179.218 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.419 HG13 ' O ' ' A' ' 82' ' ' MET . 44.6 mt -64.78 -34.39 69.81 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.577 179.429 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.665 HD11 HD12 ' A' ' 24' ' ' ILE . 53.7 mt -76.76 -14.46 59.93 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.928 0.394 . . . . 0.0 110.981 -178.559 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 88' ' ' ARG . . . . . 0.462 ' HG2' ' O ' ' A' ' 84' ' ' MET . 14.3 mmm180 -109.47 8.55 25.31 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.192 0.52 . . . . 0.0 109.621 175.03 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 10.6 tp10 . . . . . 0 C--O 1.248 0.992 0 CA-C-N 115.197 -0.911 . . . . 0.0 109.267 -179.717 . . . . . . . . 0 0 . 1 . 025 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.598 0 N-CA-C 112.686 -0.166 . . . . 0.0 112.686 . . . . . . . . . 0 0 . 1 . 025 nuclear build full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 9.9 pt20 -111.44 84.72 1.99 Allowed 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 121.816 0.817 . . . . 0.0 109.497 175.029 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 7' ' ' PHE . . . . . 0.543 ' O ' ' HB3' ' A' ' 12' ' ' ASN . 42.1 m-85 -79.97 -172.38 3.38 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 114.891 -1.049 . . . . 0.0 110.616 -174.726 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 8' ' ' HIS . . . . . 0.784 ' HB3' ' HA2' ' A' ' 71' ' ' GLY . 6.8 t60 -160.07 31.26 0.18 Allowed 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.127 0.489 . . . . 0.0 109.874 174.399 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 9' ' ' ASP . . . . . 0.475 ' HA ' ' O ' ' A' ' 48' ' ' GLY . 5.5 p-10 -70.44 -41.26 73.11 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.12 178.022 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 64.6 t30 -132.21 53.1 2.03 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 174.756 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . 51.51 71.66 0.43 Allowed 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 115.007 -0.997 . . . . 0.0 111.632 -179.135 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 12' ' ' ASN . . . . . 0.543 ' HB3' ' O ' ' A' ' 7' ' ' PHE . 21.0 t-20 -79.8 99.92 7.72 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.865 0.364 . . . . 0.0 110.142 -176.081 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 78.61 -50.8 3.61 Favored Glycine 0 N--CA 1.453 -0.209 0 CA-C-N 116.112 -0.495 . . . . 0.0 112.149 -177.422 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 143.7 -27.65 2.06 Favored Glycine 0 N--CA 1.446 -0.653 0 N-CA-C 111.605 -0.598 . . . . 0.0 111.605 179.473 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -66.95 138.46 57.28 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.846 0.355 . . . . 0.0 111.14 -177.663 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 42.9 m-80 -99.94 109.11 21.48 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 109.241 -0.652 . . . . 0.0 109.241 170.31 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -80.22 -68.78 1.45 Allowed Glycine 0 N--CA 1.447 -0.592 0 C-N-CA 120.891 -0.671 . . . . 0.0 113.497 -174.31 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.534 ' OG1' ' HG3' ' A' ' 73' ' ' PRO . 93.3 m -107.62 130.49 54.89 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.214 0.53 . . . . 0.0 111.83 -174.28 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.606 ' HB ' HG23 ' A' ' 70' ' ' ILE . 2.6 p -134.77 121.0 33.21 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-N 115.347 -0.842 . . . . 0.0 109.753 175.724 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 6.0 tt0 -110.16 137.3 48.1 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 110.286 -0.264 . . . . 0.0 110.286 -177.97 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.646 ' HA ' ' O ' ' A' ' 67' ' ' LEU . 45.0 mt-10 -108.34 127.14 53.61 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.998 0.428 . . . . 0.0 111.389 -178.863 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.449 ' HB ' ' HB3' ' A' ' 67' ' ' LEU . 15.9 mm -115.46 153.91 16.95 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-N 115.945 -0.57 . . . . 0.0 109.898 179.651 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 23' ' ' MET . . . . . 0.47 ' HB3' ' HB3' ' A' ' 64' ' ' ASP . 1.6 mmt -104.97 105.09 14.99 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 109.036 -0.727 . . . . 0.0 109.036 173.371 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.692 ' HB ' ' HB2' ' A' ' 65' ' ' LYS . 36.8 mm -88.72 131.42 41.72 Favored Pre-proline 0 C--N 1.322 -0.628 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.029 -175.762 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.685 ' HD2' HD13 ' A' ' 87' ' ' LEU . 91.8 Cg_exo -44.41 137.03 8.33 Favored 'Trans proline' 0 C--N 1.348 0.55 0 C-N-CA 123.57 2.847 . . . . 0.0 113.184 177.457 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -66.52 -27.84 68.08 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.481 -0.782 . . . . 0.0 112.694 -172.489 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -103.48 -26.57 6.82 Favored Glycine 0 N--CA 1.447 -0.598 0 C-N-CA 120.387 -0.911 . . . . 0.0 112.33 -179.147 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.523 ' HB3' ' HB2' ' A' ' 25' ' ' PRO . 15.3 ttpt -94.67 13.26 24.92 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.472 0.654 . . . . 0.0 110.642 -177.488 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.506 ' O ' HG12 ' A' ' 32' ' ' VAL . . . -63.65 -31.07 72.12 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.857 -0.611 . . . . 0.0 110.882 178.181 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -57.06 -26.99 56.74 Favored Glycine 0 CA--C 1.519 0.29 0 CA-C-N 116.173 -0.467 . . . . 0.0 113.211 179.862 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 68.0 mt -78.5 -36.64 44.78 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.913 0.357 . . . . 0.0 110.957 179.542 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.506 HG12 ' O ' ' A' ' 29' ' ' ALA . 0.3 OUTLIER -72.12 -29.92 34.25 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.341 0 CA-C-O 121.19 0.519 . . . . 0.0 110.182 178.343 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 68.1 mt -76.03 -37.39 33.54 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-O 121.925 0.869 . . . . 0.0 109.615 174.109 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.549 ' HA3' ' HB ' ' A' ' 39' ' ' THR . . . 98.14 45.38 2.41 Favored Glycine 0 N--CA 1.441 -0.974 0 CA-C-N 115.228 -0.896 . . . . 0.0 112.928 175.515 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 38.3 mtmt 51.72 47.01 25.63 Favored 'General case' 0 C--N 1.328 -0.326 0 O-C-N 124.143 0.555 . . . . 0.0 111.666 172.81 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 132.16 -28.2 3.52 Favored Glycine 0 N--CA 1.448 -0.562 0 C-N-CA 120.668 -0.777 . . . . 0.0 112.173 179.412 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 125.33 4.57 6.95 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.423 -0.894 . . . . 0.0 112.836 178.089 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 32.7 mt-10 -70.06 -48.75 56.54 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.132 0.491 . . . . 0.0 110.5 -179.993 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.729 ' O ' ' HG ' ' A' ' 43' ' ' LEU . 17.2 m -64.68 -46.04 84.09 Favored 'General case' 0 N--CA 1.45 -0.437 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.261 -177.433 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.628 ' HA ' HD12 ' A' ' 43' ' ' LEU . 8.1 tt -60.3 -35.65 63.69 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.47 0 CA-C-O 121.036 0.446 . . . . 0.0 110.901 179.977 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 54.8 tttm -61.57 -47.29 86.17 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.262 0.553 . . . . 0.0 109.983 175.515 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 16.4 mm-40 -72.39 -33.86 67.49 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.546 -0.752 . . . . 0.0 111.796 -176.561 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.729 ' HG ' ' O ' ' A' ' 39' ' ' THR . 95.0 mt -54.52 -48.07 72.36 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.046 0.45 . . . . 0.0 110.77 179.817 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 44.0 mt-30 -63.27 -46.21 87.86 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.385 -0.825 . . . . 0.0 110.696 -179.828 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -71.12 -36.69 72.23 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.855 -0.611 . . . . 0.0 112.123 -175.51 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 12.4 ptm180 -75.53 -33.08 60.69 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 111.734 0.272 . . . . 0.0 111.734 -175.317 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.439 ' HB3' HG22 ' A' ' 49' ' ' VAL . . . -96.54 -21.07 17.91 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.993 0.425 . . . . 0.0 111.352 -177.305 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 48' ' ' GLY . . . . . 0.475 ' O ' ' HA ' ' A' ' 9' ' ' ASP . . . 81.13 31.01 35.93 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.928 -0.653 . . . . 0.0 112.0 -178.161 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.439 HG22 ' HB3' ' A' ' 47' ' ' ALA . 28.6 m -122.92 167.49 16.47 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-O 120.834 0.35 . . . . 0.0 110.643 -176.332 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 60.2 tttp -103.38 123.23 46.44 Favored 'General case' 0 N--CA 1.444 -0.758 0 N-CA-C 108.96 -0.756 . . . . 0.0 108.96 172.242 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 51' ' ' MET . . . . . 0.516 ' HE2' HD11 ' A' ' 67' ' ' LEU . 79.7 mtp -120.32 115.52 23.72 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 120.947 0.403 . . . . 0.0 109.989 179.414 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.566 ' CG2' ' HB2' ' A' ' 68' ' ' ARG . 11.2 tt -107.71 112.33 39.67 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.749 0 CA-C-O 121.478 0.656 . . . . 0.0 110.235 177.896 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.494 ' CD2' HD13 ' A' ' 67' ' ' LEU . 3.1 mm? -94.82 114.29 26.15 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.36 -0.836 . . . . 0.0 109.817 176.863 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.534 ' HB ' ' HD2' ' A' ' 66' ' ' PRO . 31.4 mm -75.36 87.78 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 177.311 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 15.8 mt-30 -99.9 -40.58 7.62 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.226 -0.897 . . . . 0.0 110.311 -174.803 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -111.69 2.05 17.03 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.209 -0.905 . . . . 0.0 110.572 -173.398 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -109.1 166.84 12.74 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.527 -0.844 . . . . 0.0 112.271 179.97 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 50.0 m 62.91 -171.89 0.17 Allowed 'General case' 0 C--O 1.235 0.299 0 CA-C-O 121.396 0.617 . . . . 0.0 111.28 178.993 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 80.9 mm-40 -119.12 17.45 13.22 Favored 'General case' 0 N--CA 1.443 -0.793 0 CA-C-N 115.594 -0.73 . . . . 0.0 109.738 177.29 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.577 ' HA ' HG22 ' A' ' 63' ' ' VAL . 11.5 m120 -83.82 13.0 5.19 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 108.501 -0.926 . . . . 0.0 108.501 172.285 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 21.1 p -64.59 -17.66 64.18 Favored 'General case' 0 N--CA 1.444 -0.736 0 CA-C-N 114.721 -1.127 . . . . 0.0 110.869 177.014 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 28.7 p-10 -100.36 -4.4 29.19 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.199 177.137 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.577 HG22 ' HA ' ' A' ' 60' ' ' ASN . 24.1 m -133.72 -155.54 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-O 120.659 0.266 . . . . 0.0 111.157 -177.077 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.47 ' HB3' ' HB3' ' A' ' 23' ' ' MET . 5.2 m-20 -57.04 149.65 18.67 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.638 -0.71 . . . . 0.0 111.291 178.607 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.692 ' HB2' ' HB ' ' A' ' 24' ' ' ILE . 70.9 mmtt -101.5 127.1 32.33 Favored Pre-proline 0 C--N 1.324 -0.54 0 CA-C-N 115.804 -0.635 . . . . 0.0 111.056 -175.615 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.534 ' HD2' ' HB ' ' A' ' 54' ' ' ILE . 27.4 Cg_exo -65.41 111.68 1.91 Allowed 'Trans proline' 0 N--CA 1.463 -0.315 0 C-N-CA 123.009 2.472 . . . . 0.0 111.596 172.596 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.646 ' O ' ' HA ' ' A' ' 21' ' ' GLU . 14.3 tp -112.44 122.35 47.45 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 116.155 -0.475 . . . . 0.0 109.97 178.093 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.566 ' HB2' ' CG2' ' A' ' 52' ' ' ILE . 88.0 mtt180 -113.84 112.39 23.3 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 121.19 0.519 . . . . 0.0 111.192 177.727 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.405 ' O ' ' HA ' ' A' ' 19' ' ' VAL . 4.5 mp -94.16 105.13 16.54 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 172.449 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.606 HG23 ' HB ' ' A' ' 19' ' ' VAL . 4.0 mt -109.77 132.32 58.31 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 CA-C-N 116.385 -0.371 . . . . 0.0 110.907 -172.394 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 71' ' ' GLY . . . . . 0.784 ' HA2' ' HB3' ' A' ' 8' ' ' HIS . . . 152.52 -123.16 1.41 Allowed Glycine 0 N--CA 1.445 -0.747 0 C-N-CA 120.509 -0.853 . . . . 0.0 113.235 175.618 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 72' ' ' ASP . . . . . 0.616 ' OD2' ' HG2' ' A' ' 75' ' ' LYS . 0.5 OUTLIER -92.69 133.47 29.31 Favored Pre-proline 0 C--N 1.326 -0.447 0 C-N-CA 122.864 0.466 . . . . 0.0 110.948 -177.215 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 73' ' ' PRO . . . . . 0.534 ' HG3' ' OG1' ' A' ' 18' ' ' THR . 50.4 Cg_exo -49.43 -33.41 29.64 Favored 'Trans proline' 0 C--N 1.351 0.664 0 C-N-CA 124.267 3.311 . . . . 0.0 113.592 -176.236 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 74' ' ' TYR . . . . . 0.496 ' O ' ' HG3' ' A' ' 78' ' ' GLN . 19.1 t80 -72.71 -57.08 4.38 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.341 -178.27 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.616 ' HG2' ' OD2' ' A' ' 72' ' ' ASP . 4.6 ptpp? -72.5 -25.83 61.55 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 111.746 0.276 . . . . 0.0 111.746 -178.439 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.415 HG23 ' O ' ' A' ' 72' ' ' ASP . 26.4 t -55.94 -42.26 70.65 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 N-CA-C 109.925 -0.398 . . . . 0.0 109.925 171.424 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 77' ' ' GLN . . . . . 0.574 ' O ' ' HG2' ' A' ' 81' ' ' GLU . 2.3 mm100 -75.74 -44.28 42.59 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.056 178.789 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 78' ' ' GLN . . . . . 0.496 ' HG3' ' O ' ' A' ' 74' ' ' TYR . 53.6 mt-30 -52.87 -50.06 64.58 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.065 0.459 . . . . 0.0 110.419 177.697 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -67.43 -37.78 83.54 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.411 -0.813 . . . . 0.0 111.271 -178.315 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 42.7 t -62.55 -57.27 11.74 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.556 -178.9 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 81' ' ' GLU . . . . . 0.574 ' HG2' ' O ' ' A' ' 77' ' ' GLN . 10.4 pt-20 -67.68 -18.7 65.02 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.912 0.387 . . . . 0.0 110.645 -178.928 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 57.0 ttp -74.09 -50.99 17.11 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.584 174.804 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 31.8 m -76.52 -33.87 23.43 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.583 -0.281 . . . . 0.0 111.618 -176.4 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 83.5 mtp -68.37 -25.67 65.19 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 109.911 -0.403 . . . . 0.0 109.911 175.83 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -67.69 -36.25 80.32 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.655 176.364 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 56.7 mt -62.78 -35.49 71.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 121.488 0.661 . . . . 0.0 110.043 179.022 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.685 HD13 ' HD2' ' A' ' 25' ' ' PRO . 42.8 mt -88.09 -8.46 55.47 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.654 -179.381 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 21.5 tpt180 -101.76 -10.54 19.85 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.839 0.828 . . . . 0.0 109.818 -179.638 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 . . . . . 0 C--O 1.248 1.021 0 CA-C-N 114.685 -1.143 . . . . 0.0 109.779 -177.316 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.466 ' OG1' ' HG3' ' A' ' 73' ' ' PRO . 96.5 m . . . . . 0 N--CA 1.452 -0.354 0 N-CA-C 110.146 -0.316 . . . . 0.0 110.146 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 74.7 t -113.09 127.19 70.48 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.618 -178.595 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . 0.607 ' HG2' ' HB2' ' A' ' 80' ' ' CYS . 29.5 tp60 -111.84 112.74 24.63 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 109.43 -0.582 . . . . 0.0 109.43 176.863 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.588 ' HA ' ' O ' ' A' ' 67' ' ' LEU . 12.1 mt-10 -98.53 119.26 36.93 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.369 0.604 . . . . 0.0 112.305 179.257 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 10.1 mm -114.37 150.5 16.35 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 115.185 -0.916 . . . . 0.0 109.44 177.685 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 94.0 mmm -111.53 103.83 12.19 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 172.93 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.656 HG23 HD21 ' A' ' 87' ' ' LEU . 9.3 mm -84.88 125.3 71.14 Favored Pre-proline 0 C--N 1.316 -0.88 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.952 -173.301 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_exo -50.2 139.06 36.13 Favored 'Trans proline' 0 C--N 1.346 0.441 0 C-N-CA 122.904 2.402 . . . . 0.0 112.379 176.566 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -42.41 -57.15 2.72 Favored 'General case' 0 N--CA 1.465 0.287 0 N-CA-C 113.316 0.858 . . . . 0.0 113.316 -173.716 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -90.18 -26.71 23.01 Favored Glycine 0 N--CA 1.453 -0.199 0 C-N-CA 120.679 -0.772 . . . . 0.0 113.069 -174.473 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.409 ' HE3' ' HA ' ' A' ' 87' ' ' LEU . 45.0 tttp -78.99 -4.56 50.61 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.192 0.52 . . . . 0.0 110.128 179.773 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.482 ' HA ' HG21 ' A' ' 24' ' ' ILE . . . -63.64 -22.93 67.16 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.658 174.844 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -58.39 -25.7 58.19 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 121.073 -0.584 . . . . 0.0 112.134 178.292 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 63.2 mt -75.97 -45.78 33.08 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.779 0.323 . . . . 0.0 110.855 179.425 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.433 HG12 ' O ' ' A' ' 29' ' ' ALA . 1.4 p -72.02 -32.13 42.77 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.474 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.973 -177.369 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 74.2 mt -78.33 -42.18 26.5 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-O 121.761 0.791 . . . . 0.0 109.772 176.661 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . 0.503 ' HA3' ' H ' ' A' ' 39' ' ' THR . . . 101.29 51.53 1.13 Allowed Glycine 0 N--CA 1.441 -1.025 0 CA-C-N 115.272 -0.876 . . . . 0.0 112.974 175.529 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.453 ' HD2' ' N ' ' A' ' 35' ' ' LYS . 0.4 OUTLIER 50.68 40.5 24.24 Favored 'General case' 0 C--N 1.329 -0.295 0 O-C-N 124.319 0.658 . . . . 0.0 111.96 173.719 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 133.73 -27.06 3.39 Favored Glycine 0 N--CA 1.449 -0.482 0 C-N-CA 120.653 -0.784 . . . . 0.0 111.94 179.604 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 129.78 22.47 1.15 Allowed Glycine 0 N--CA 1.449 -0.451 0 C-N-CA 120.173 -1.013 . . . . 0.0 113.079 178.524 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.661 ' HG3' HE21 ' A' ' 42' ' ' GLN . 4.5 tp10 -84.53 -54.09 4.98 Favored 'General case' 0 C--N 1.321 -0.648 0 O-C-N 122.296 -0.531 . . . . 0.0 110.119 178.694 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . 0.684 ' O ' ' HG ' ' A' ' 43' ' ' LEU . 63.0 m -56.21 -44.58 79.63 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.53 -0.759 . . . . 0.0 111.821 -179.405 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 8.9 tt -58.51 -37.79 66.61 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.406 0 CA-C-O 120.596 0.236 . . . . 0.0 111.604 -178.416 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 33.5 mtmm -66.24 -38.65 88.39 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.358 0.599 . . . . 0.0 110.172 178.02 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.661 HE21 ' HG3' ' A' ' 38' ' ' GLU . 68.7 mt-30 -66.07 -45.96 79.44 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.279 178.755 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.684 ' HG ' ' O ' ' A' ' 39' ' ' THR . 89.6 mt -53.47 -46.7 70.05 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.428 -0.805 . . . . 0.0 112.032 -175.609 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 46.9 mt-30 -64.52 -43.36 94.29 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.484 -177.302 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 9.3 mm-40 -81.12 -35.6 31.38 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 112.052 0.39 . . . . 0.0 112.052 -174.261 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 14.8 ptm180 -66.76 -35.28 79.73 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-O 120.735 0.302 . . . . 0.0 111.477 -176.7 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.452 ' HB3' HG22 ' A' ' 49' ' ' VAL . . . -100.65 -12.13 19.43 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.889 0.376 . . . . 0.0 111.577 -177.128 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 71.73 37.93 61.21 Favored Glycine 0 N--CA 1.449 -0.492 0 C-N-CA 120.812 -0.709 . . . . 0.0 111.961 -178.004 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.452 HG22 ' HB3' ' A' ' 47' ' ' ALA . 28.5 m -129.15 178.56 4.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-O 120.761 0.315 . . . . 0.0 110.16 -177.775 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 64.3 tttp -120.75 124.66 45.66 Favored 'General case' 0 C--N 1.319 -0.726 0 C-N-CA 120.662 -0.415 . . . . 0.0 110.214 173.069 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . 0.586 ' CE ' ' HB1' ' A' ' 79' ' ' ALA . 63.7 mtt -113.94 115.62 27.95 Favored 'General case' 0 C--N 1.319 -0.749 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 176.751 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.534 ' CG2' ' HB2' ' A' ' 68' ' ' ARG . 10.5 tt -99.29 104.77 16.46 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.741 0 CA-C-O 121.772 0.796 . . . . 0.0 110.059 176.91 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.705 HD22 HD13 ' A' ' 67' ' ' LEU . 3.8 mm? -87.53 104.4 16.45 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.053 -0.976 . . . . 0.0 109.26 176.02 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.8 HD12 ' HB2' ' A' ' 66' ' ' PRO . 61.0 mt -72.74 86.56 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-O 121.852 0.834 . . . . 0.0 109.663 178.369 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 52.4 mt-30 . . . . . 0 C--N 1.323 -0.552 0 CA-C-N 114.637 -1.165 . . . . 0.0 109.645 -177.628 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.461 ' HA ' ' O ' ' A' ' 24' ' ' ILE . 1.8 m-20 . . . . . 0 N--CA 1.463 0.191 0 CA-C-O 120.68 0.276 . . . . 0.0 111.363 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . 0.497 ' HA ' ' HD3' ' A' ' 66' ' ' PRO . 39.2 mmtm -110.85 131.39 22.15 Favored Pre-proline 0 C--N 1.327 -0.398 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.659 -175.203 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.8 ' HB2' HD12 ' A' ' 54' ' ' ILE . 10.6 Cg_exo -75.33 111.4 3.3 Favored 'Trans proline' 0 N--CA 1.46 -0.467 0 C-N-CA 123.476 2.784 . . . . 0.0 111.86 176.013 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.705 HD13 HD22 ' A' ' 53' ' ' LEU . 17.8 tp -112.4 120.72 42.64 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.528 177.439 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . 0.534 ' HB2' ' CG2' ' A' ' 52' ' ' ILE . 68.4 mtt180 -111.47 111.72 22.95 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 120.99 0.424 . . . . 0.0 110.651 174.445 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.493 ' HB ' ' HB3' ' A' ' 20' ' ' GLN . 46.9 mt -91.27 112.06 24.76 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 N-CA-C 108.909 -0.774 . . . . 0.0 108.909 173.914 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 13.2 mt -113.85 129.42 69.78 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.739 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.056 -172.562 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 153.42 -140.92 7.91 Favored Glycine 0 N--CA 1.448 -0.518 0 C-N-CA 120.458 -0.877 . . . . 0.0 113.32 173.89 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . 0.526 ' HB3' ' CG ' ' A' ' 75' ' ' LYS . 4.7 t70 -71.99 130.89 86.05 Favored Pre-proline 0 C--N 1.322 -0.614 0 C-N-CA 123.387 0.675 . . . . 0.0 111.126 -176.997 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . 0.466 ' HG3' ' OG1' ' A' ' 18' ' ' THR . 26.8 Cg_exo -57.98 -26.53 75.27 Favored 'Trans proline' 0 C--N 1.35 0.622 0 C-N-CA 123.556 2.838 . . . . 0.0 113.352 -172.027 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . 0.401 ' HB3' ' OD1' ' A' ' 72' ' ' ASP . 24.1 t80 -79.06 -47.61 15.88 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.156 -0.474 . . . . 0.0 109.873 -176.191 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.526 ' CG ' ' HB3' ' A' ' 72' ' ' ASP . 9.1 ptpt -80.51 -26.61 38.05 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 120.867 -0.333 . . . . 0.0 111.611 178.81 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.401 ' CG1' ' HB2' ' A' ' 20' ' ' GLN . 24.6 t -60.69 -40.13 83.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-O 120.7 0.286 . . . . 0.0 110.246 173.954 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 2.0 mm100 -73.97 -41.2 62.31 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 120.637 -0.425 . . . . 0.0 110.972 179.472 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 49.6 mt-30 -63.09 -39.07 93.62 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 120.898 0.38 . . . . 0.0 110.251 177.431 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . 0.586 ' HB1' ' CE ' ' A' ' 51' ' ' MET . . . -71.65 -35.34 70.33 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.718 178.5 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' CYS . . . . . 0.607 ' HB2' ' HG2' ' A' ' 20' ' ' GLN . 36.5 t -63.45 -54.09 41.9 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.123 175.245 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 52.5 mt-10 -65.2 -20.66 66.54 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.403 178.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' MET . . . . . 0.437 ' HB3' ' O ' ' A' ' 79' ' ' ALA . 31.5 ttm -69.48 -55.98 8.71 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.425 -0.807 . . . . 0.0 110.403 176.417 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 32.9 m -79.42 -29.59 13.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.915 -175.453 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' MET . . . . . 0.476 ' O ' ' HG2' ' A' ' 88' ' ' ARG . 56.9 ttp -71.48 -28.94 64.28 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 109.75 -0.463 . . . . 0.0 109.75 178.392 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . 0.483 ' O ' ' HB2' ' A' ' 89' ' ' GLU . 19.0 t70 -62.62 -47.94 81.57 Favored 'General case' 0 CA--C 1.517 -0.29 0 N-CA-C 109.968 -0.382 . . . . 0.0 109.968 175.133 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 20.3 mt -60.22 -32.45 50.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 121.659 0.742 . . . . 0.0 110.276 177.738 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.656 HD21 HG23 ' A' ' 24' ' ' ILE . 1.0 OUTLIER -81.8 -17.52 47.26 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.389 -0.823 . . . . 0.0 111.57 -176.738 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . 0.476 ' HG2' ' O ' ' A' ' 84' ' ' MET . 23.3 mmm180 -102.86 5.94 38.88 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 121.546 0.689 . . . . 0.0 109.322 174.153 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . 0.483 ' HB2' ' O ' ' A' ' 85' ' ' ASP . 2.1 tm-20 . . . . . 0 C--O 1.25 1.125 0 CA-C-N 114.749 -1.114 . . . . 0.0 108.884 -177.968 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.511 ' OG1' ' HG3' ' A' ' 73' ' ' PRO . 74.6 m . . . . . 0 N--CA 1.453 -0.29 0 CA-C-O 120.996 0.427 . . . . 0.0 111.129 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.493 HG22 HG23 ' A' ' 70' ' ' ILE . 61.6 t -124.71 120.19 58.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.61 179.251 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 14.2 mm100 -101.17 114.03 27.61 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.983 -0.553 . . . . 0.0 109.539 174.682 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.61 ' HG2' ' HG2' ' A' ' 68' ' ' ARG . 37.4 mt-10 -93.69 107.58 19.43 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.283 0.564 . . . . 0.0 110.729 176.065 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 19.0 mm -102.41 148.67 7.56 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.723 0 CA-C-N 115.359 -0.837 . . . . 0.0 109.802 -178.509 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' MET . . . . . 0.51 ' HB3' ' HB3' ' A' ' 64' ' ' ASP . 1.5 mmt -99.87 101.98 13.27 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 108.609 -0.885 . . . . 0.0 108.609 175.428 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.687 ' HB ' ' HB2' ' A' ' 65' ' ' LYS . 44.3 mm -88.66 126.06 61.06 Favored Pre-proline 0 C--N 1.319 -0.733 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.996 -175.38 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . 0.604 ' HB2' ' HB3' ' A' ' 28' ' ' LYS . 95.7 Cg_exo -45.1 132.91 11.41 Favored 'Trans proline' 0 C--N 1.343 0.278 0 C-N-CA 123.423 2.749 . . . . 0.0 112.541 179.564 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -61.82 -38.65 88.96 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 115.511 -0.768 . . . . 0.0 112.954 -168.501 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -89.37 -35.89 7.78 Favored Glycine 0 N--CA 1.449 -0.496 0 C-N-CA 120.404 -0.903 . . . . 0.0 111.837 -178.596 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.604 ' HB3' ' HB2' ' A' ' 25' ' ' PRO . 28.6 ttpt -80.47 -0.62 38.12 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 121.201 0.524 . . . . 0.0 110.77 -178.721 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.53 ' O ' HG12 ' A' ' 32' ' ' VAL . . . -62.83 -20.14 64.78 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.132 177.667 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -57.66 -33.09 66.35 Favored Glycine 0 N--CA 1.448 -0.541 0 C-N-CA 120.792 -0.718 . . . . 0.0 111.885 177.04 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 99.0 mt -77.57 -36.2 52.27 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.643 0.259 . . . . 0.0 111.289 -178.767 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.535 HG11 HG21 ' A' ' 24' ' ' ILE . 0.5 OUTLIER -70.57 -30.28 41.86 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.326 0 CA-C-O 121.16 0.505 . . . . 0.0 110.768 -178.37 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 71.0 mt -89.39 -38.78 11.7 Favored 'Isoleucine or valine' 0 C--O 1.236 0.388 0 CA-C-N 115.76 -0.654 . . . . 0.0 110.537 178.743 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 105.08 25.0 6.94 Favored Glycine 0 CA--C 1.502 -0.723 0 CA-C-N 115.605 -0.725 . . . . 0.0 112.611 178.57 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 53.6 mtpt 60.87 21.51 11.69 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.316 -0.442 . . . . 0.0 111.327 177.258 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -176.59 -45.7 0.06 OUTLIER Glycine 0 N--CA 1.448 -0.504 0 N-CA-C 111.696 -0.562 . . . . 0.0 111.696 -178.31 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 125.73 7.57 5.59 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.355 -0.926 . . . . 0.0 113.024 176.692 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -85.51 -32.91 21.96 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 120.84 0.352 . . . . 0.0 111.162 178.561 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . 0.59 ' O ' ' HG ' ' A' ' 43' ' ' LEU . 60.7 m -65.0 -48.18 74.84 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.97 -179.573 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.734 HD12 HD23 ' A' ' 53' ' ' LEU . 1.9 tt -57.18 -38.58 62.05 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-O 120.748 0.309 . . . . 0.0 111.167 178.463 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . 0.406 ' HE2' ' HB3' ' A' ' 41' ' ' LYS . 4.6 tmmm? -60.97 -40.76 94.62 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 109.57 -0.53 . . . . 0.0 109.57 178.689 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.499 ' O ' ' HG2' ' A' ' 46' ' ' ARG . 49.5 mt-30 -70.32 -37.82 74.79 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.614 -179.851 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.693 HD13 HG12 ' A' ' 83' ' ' VAL . 75.0 mt -58.03 -35.95 72.01 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.678 179.075 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . 0.568 ' HG3' ' O ' ' A' ' 40' ' ' ILE . 68.2 mt-30 -66.57 -47.72 71.89 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.42 178.223 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.403 ' HG3' ' O ' ' A' ' 41' ' ' LYS . 39.0 mt-10 -64.83 -48.58 73.86 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.694 -0.685 . . . . 0.0 111.195 -177.573 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . 0.499 ' HG2' ' O ' ' A' ' 42' ' ' GLN . 17.5 ptm180 -70.79 -23.66 62.42 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.169 -0.469 . . . . 0.0 112.201 -174.224 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -93.13 -29.14 15.91 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.818 0.342 . . . . 0.0 111.093 178.745 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 87.88 26.41 29.33 Favored Glycine 0 N--CA 1.452 -0.25 0 C-N-CA 121.014 -0.612 . . . . 0.0 112.56 -179.062 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 5.1 m -140.08 179.87 2.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-O 120.876 0.369 . . . . 0.0 110.592 -178.801 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 81.1 tttt -110.8 124.66 52.45 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.238 178.531 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . 0.492 ' HG2' HG23 ' A' ' 69' ' ' ILE . 17.9 mtm -117.2 116.62 27.63 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 109.821 -0.437 . . . . 0.0 109.821 176.661 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.618 ' CG2' ' HB2' ' A' ' 68' ' ' ARG . 10.8 tt -102.0 113.2 37.7 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.727 0 CA-C-O 121.43 0.633 . . . . 0.0 110.762 178.426 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.879 HD22 HD13 ' A' ' 67' ' ' LEU . 1.3 mm? -88.07 107.52 18.79 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.41 -0.814 . . . . 0.0 109.311 175.906 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.657 HD12 ' HB2' ' A' ' 66' ' ' PRO . 58.4 mt -79.84 84.65 1.25 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.575 0 CA-C-O 122.248 1.023 . . . . 0.0 110.323 179.151 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 2.5 pt20 . . . . . 0 C--N 1.318 -0.802 0 CA-C-N 114.006 -1.452 . . . . 0.0 107.677 167.712 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.51 ' HB3' ' HB3' ' A' ' 23' ' ' MET . 7.3 m-20 . . . . . 0 N--CA 1.457 -0.104 0 CA-C-O 120.931 0.396 . . . . 0.0 110.155 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . 0.687 ' HB2' ' HB ' ' A' ' 24' ' ' ILE . 65.7 mmtt -88.38 134.0 35.4 Favored Pre-proline 0 C--N 1.318 -0.768 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.904 -169.101 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.657 ' HB2' HD12 ' A' ' 54' ' ' ILE . 16.4 Cg_exo -70.86 104.95 1.57 Allowed 'Trans proline' 0 N--CA 1.456 -0.686 0 C-N-CA 122.744 2.296 . . . . 0.0 111.137 172.49 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.879 HD13 HD22 ' A' ' 53' ' ' LEU . 18.9 tp -110.54 118.06 35.22 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.129 178.26 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . 0.618 ' HB2' ' CG2' ' A' ' 52' ' ' ILE . 68.9 mtt180 -108.98 106.36 16.28 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.503 177.345 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.631 HG22 HG22 ' A' ' 76' ' ' VAL . 4.3 mp -87.13 109.49 19.31 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 N-CA-C 107.962 -1.125 . . . . 0.0 107.962 171.163 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.493 HG23 HG22 ' A' ' 19' ' ' VAL . 33.7 mt -110.23 128.37 66.5 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.73 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.979 -171.635 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 150.28 -123.93 1.65 Allowed Glycine 0 N--CA 1.444 -0.798 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.42 173.173 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . 0.602 ' OD2' ' HG2' ' A' ' 75' ' ' LYS . 2.8 t70 -84.26 129.84 56.56 Favored Pre-proline 0 C--N 1.32 -0.705 0 CA-C-N 115.479 -0.361 . . . . 0.0 111.298 -177.333 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . 0.511 ' HG3' ' OG1' ' A' ' 18' ' ' THR . 53.2 Cg_exo -48.22 -27.79 10.07 Favored 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 123.805 3.003 . . . . 0.0 113.56 -178.924 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . 0.553 ' HB3' ' OD2' ' A' ' 72' ' ' ASP . 44.9 t80 -82.75 -60.06 2.3 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.519 -0.31 . . . . 0.0 110.733 -175.987 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.602 ' HG2' ' OD2' ' A' ' 72' ' ' ASP . 12.8 pttt -72.84 -17.46 61.55 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 112.115 0.413 . . . . 0.0 112.115 179.438 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.631 HG22 HG22 ' A' ' 69' ' ' ILE . 12.4 t -69.02 -38.48 78.46 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 N-CA-C 109.106 -0.701 . . . . 0.0 109.106 171.162 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . 0.417 ' O ' ' HG3' ' A' ' 81' ' ' GLU . 22.5 tp60 -74.02 -42.33 60.48 Favored 'General case' 0 N--CA 1.448 -0.528 0 CA-C-N 115.657 -0.701 . . . . 0.0 109.495 177.519 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . 0.481 ' HB2' ' HA ' ' A' ' 75' ' ' LYS . 51.2 mt-30 -56.01 -51.4 67.9 Favored 'General case' 0 C--O 1.223 -0.332 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.398 174.865 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -60.94 -40.13 92.09 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.925 179.201 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 22.6 t -59.54 -54.37 47.33 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.846 -0.615 . . . . 0.0 111.252 177.717 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . 0.433 ' O ' ' HB2' ' A' ' 85' ' ' ASP . 2.3 pp20? -70.77 -25.02 62.71 Favored 'General case' 0 C--O 1.217 -0.642 0 C-N-CA 120.221 -0.592 . . . . 0.0 110.493 -179.334 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' MET . . . . . 0.504 ' O ' HG13 ' A' ' 86' ' ' ILE . 34.8 ttp -67.35 -48.81 66.38 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.578 -0.283 . . . . 0.0 110.878 177.333 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.693 HG12 HD13 ' A' ' 43' ' ' LEU . 33.0 m -74.18 -36.59 44.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 C-N-CA 120.943 -0.303 . . . . 0.0 110.992 -179.766 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 89.2 mtp -71.14 -27.38 63.53 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 110.198 -0.297 . . . . 0.0 110.198 177.607 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . 0.433 ' HB2' ' O ' ' A' ' 81' ' ' GLU . 30.0 t70 -63.4 -40.85 98.34 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.276 175.139 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.504 HG13 ' O ' ' A' ' 82' ' ' MET . 52.2 mt -63.06 -33.09 58.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.734 177.711 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.561 HD22 ' HG2' ' A' ' 28' ' ' LYS . 69.2 mt -86.01 -21.81 27.61 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.789 -174.332 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 39.5 ptt180 -95.93 -2.99 46.01 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.122 0.487 . . . . 0.0 110.682 -178.814 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.249 1.047 0 CA-C-O 118.434 -0.793 . . . . 0.0 109.671 -174.678 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.59 ' OG1' ' HG3' ' A' ' 73' ' ' PRO . 85.4 m . . . . . 0 N--CA 1.45 -0.437 0 CA-C-O 121.028 0.442 . . . . 0.0 110.461 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.616 ' HA ' ' O ' ' A' ' 69' ' ' ILE . 3.2 p -130.18 129.02 65.09 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.829 -179.837 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 67.6 mt-30 -105.07 119.49 39.15 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.529 177.962 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.747 ' HA ' ' O ' ' A' ' 67' ' ' LEU . 28.8 mt-10 -92.64 108.77 20.23 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.614 -0.721 . . . . 0.0 110.341 175.022 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.448 HG12 HD22 ' A' ' 67' ' ' LEU . 22.0 mm -107.28 142.9 18.91 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 CA-C-N 115.55 -0.75 . . . . 0.0 109.422 -179.592 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 90.5 mmm -103.56 92.74 4.59 Favored 'General case' 0 N--CA 1.447 -0.6 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 179.099 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.672 ' HB ' ' HB2' ' A' ' 65' ' ' LYS . 25.5 mm -77.6 128.14 80.62 Favored Pre-proline 0 C--N 1.317 -0.84 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.457 -174.622 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_exo -48.1 133.12 23.71 Favored 'Trans proline' 0 N--CA 1.462 -0.366 0 C-N-CA 122.626 2.217 . . . . 0.0 111.453 175.773 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -44.66 -56.17 4.62 Favored 'General case' 0 C--N 1.328 -0.341 0 O-C-N 124.023 0.827 . . . . 0.0 112.824 -171.536 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -79.31 -12.6 83.72 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.875 -0.679 . . . . 0.0 113.02 -175.425 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.433 ' HD3' ' HB3' ' A' ' 87' ' ' LEU . 19.6 ttmm -88.14 8.91 24.67 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.328 0.585 . . . . 0.0 110.522 -175.864 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.403 ' HA ' HG22 ' A' ' 32' ' ' VAL . . . -66.18 -20.82 66.25 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.061 179.224 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -63.86 -16.06 58.83 Favored Glycine 0 N--CA 1.449 -0.455 0 CA-C-N 115.853 -0.612 . . . . 0.0 112.565 179.575 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.478 HD13 HG22 ' A' ' 86' ' ' ILE . 74.9 mt -94.87 -42.4 8.71 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 111.73 0.27 . . . . 0.0 111.73 -179.394 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.629 HG13 HD21 ' A' ' 87' ' ' LEU . 3.1 m -69.83 -38.21 75.28 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.21 0 CA-C-O 121.037 0.446 . . . . 0.0 111.046 178.629 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.578 ' HA ' ' HB ' ' A' ' 40' ' ' ILE . 57.0 mt -86.45 -32.7 6.77 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-O 121.705 0.764 . . . . 0.0 109.441 179.599 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . 0.506 ' HA3' ' CB ' ' A' ' 39' ' ' THR . . . 92.65 171.52 40.8 Favored Glycine 0 N--CA 1.441 -0.972 0 CA-C-N 114.923 -1.035 . . . . 0.0 112.086 178.438 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 14.5 mptt -76.77 65.77 2.57 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.104 0.478 . . . . 0.0 110.89 -179.611 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 132.92 5.28 3.15 Favored Glycine 0 C--N 1.33 0.224 0 C-N-CA 120.972 -0.632 . . . . 0.0 112.527 175.442 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.502 ' HA2' HG22 ' A' ' 33' ' ' ILE . . . 86.36 -9.2 71.26 Favored Glycine 0 N--CA 1.449 -0.487 0 C-N-CA 120.524 -0.846 . . . . 0.0 112.016 -179.12 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 55.3 mm-40 -64.33 -33.47 75.91 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.689 0.28 . . . . 0.0 111.208 -179.554 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . 0.762 ' O ' ' HG ' ' A' ' 43' ' ' LEU . 32.3 m -64.62 -57.26 9.57 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.482 -0.326 . . . . 0.0 111.039 -179.839 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.598 ' HA ' HD12 ' A' ' 43' ' ' LEU . 11.0 tt -59.92 -31.74 48.29 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.391 0 CA-C-O 121.318 0.58 . . . . 0.0 110.553 -179.377 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 46.0 tttt -60.39 -50.64 72.78 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.588 -0.733 . . . . 0.0 110.822 173.751 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.644 ' O ' ' HG2' ' A' ' 46' ' ' ARG . 48.2 mt-30 -67.29 -38.77 85.57 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.705 -176.321 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.762 ' HG ' ' O ' ' A' ' 39' ' ' THR . 61.4 mt -55.76 -46.18 77.94 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.397 -176.663 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 43.4 mt-30 -61.26 -34.71 75.61 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.926 -179.862 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -80.74 -45.63 16.75 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.423 -177.583 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . 0.644 ' HG2' ' O ' ' A' ' 42' ' ' GLN . 14.0 ptp180 -74.66 -43.21 56.43 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 112.753 0.649 . . . . 0.0 112.753 -173.879 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.525 ' HB3' HG22 ' A' ' 49' ' ' VAL . . . -83.82 -14.72 50.63 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 112.084 0.402 . . . . 0.0 112.084 -173.508 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 72.24 24.91 75.66 Favored Glycine 0 C--N 1.329 0.17 0 C-N-CA 120.659 -0.782 . . . . 0.0 111.912 -179.134 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.525 HG22 ' HB3' ' A' ' 47' ' ' ALA . 26.8 m -124.08 162.31 25.54 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 N-CA-C 109.937 -0.394 . . . . 0.0 109.937 -179.296 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 61.6 tttp -100.5 122.14 42.72 Favored 'General case' 0 C--N 1.317 -0.833 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 174.624 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . 0.478 ' CE ' ' HB1' ' A' ' 79' ' ' ALA . 61.1 mtt -110.12 115.38 29.64 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 174.836 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.67 ' CG2' ' HB2' ' A' ' 68' ' ' ARG . 12.6 tt -109.64 105.13 18.21 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.973 0 CA-C-O 121.88 0.848 . . . . 0.0 109.727 174.886 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -87.84 107.76 18.83 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 114.666 -1.152 . . . . 0.0 109.203 178.278 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.511 ' HB ' ' HB2' ' A' ' 66' ' ' PRO . 46.4 mm -74.54 85.05 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.306 0 CA-C-O 122.006 0.908 . . . . 0.0 110.486 -177.87 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--N 1.315 -0.898 0 CA-C-N 114.361 -1.291 . . . . 0.0 108.111 170.54 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 23.3 m-20 . . . . . 0 N--CA 1.462 0.166 0 CA-C-O 120.772 0.32 . . . . 0.0 110.274 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . 0.672 ' HB2' ' HB ' ' A' ' 24' ' ' ILE . 31.0 mmtp -94.34 118.24 67.04 Favored Pre-proline 0 C--N 1.32 -0.681 0 CA-C-N 116.037 -0.528 . . . . 0.0 110.804 -170.368 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.511 ' HB2' ' HB ' ' A' ' 54' ' ' ILE . 25.4 Cg_exo -65.43 104.69 0.66 Allowed 'Trans proline' 0 N--CA 1.459 -0.53 0 C-N-CA 122.653 2.235 . . . . 0.0 110.942 173.784 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.886 HD21 HG13 ' A' ' 69' ' ' ILE . 4.8 tt -103.88 136.55 43.33 Favored 'General case' 0 C--N 1.315 -0.904 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 179.907 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . 0.67 ' HB2' ' CG2' ' A' ' 52' ' ' ILE . 92.7 mtt180 -131.16 108.38 9.68 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 121.067 0.461 . . . . 0.0 111.003 173.538 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.886 HG13 HD21 ' A' ' 67' ' ' LEU . 13.5 mt -91.77 104.96 16.07 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 N-CA-C 108.828 -0.805 . . . . 0.0 108.828 172.57 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 5.2 mt -105.35 126.06 60.5 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.828 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.476 -174.837 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 160.61 -129.72 2.22 Favored Glycine 0 N--CA 1.446 -0.666 0 C-N-CA 120.591 -0.814 . . . . 0.0 112.705 175.03 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . 0.663 ' OD2' ' HG2' ' A' ' 75' ' ' LYS . 0.9 OUTLIER -88.23 132.94 37.97 Favored Pre-proline 0 C--N 1.322 -0.616 0 C-N-CA 122.833 0.453 . . . . 0.0 111.394 -176.696 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . 0.59 ' HG3' ' OG1' ' A' ' 18' ' ' THR . 45.6 Cg_exo -52.51 -26.41 28.61 Favored 'Trans proline' 0 C--N 1.351 0.679 0 C-N-CA 123.899 3.066 . . . . 0.0 113.301 -174.94 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . 0.48 ' HB3' ' OD2' ' A' ' 72' ' ' ASP . 82.2 t80 -83.49 -56.29 3.82 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.422 -176.664 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.663 ' HG2' ' OD2' ' A' ' 72' ' ' ASP . 12.9 ptpt -71.48 -27.03 62.96 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.54 -179.818 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.631 HG22 HG22 ' A' ' 69' ' ' ILE . 25.2 t -61.18 -40.7 86.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 N-CA-C 110.305 -0.258 . . . . 0.0 110.305 173.799 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -74.97 -43.24 55.16 Favored 'General case' 0 N--CA 1.451 -0.419 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.297 -179.018 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . 0.463 ' O ' ' HB2' ' A' ' 82' ' ' MET . 41.4 mt-30 -62.0 -35.89 79.89 Favored 'General case' 0 C--O 1.224 -0.264 0 CA-C-N 116.52 -0.309 . . . . 0.0 110.674 177.465 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . 0.478 ' HB1' ' CE ' ' A' ' 51' ' ' MET . . . -74.85 -34.15 62.23 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 120.912 0.387 . . . . 0.0 110.478 177.831 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 53.9 t -63.29 -56.7 14.33 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.149 176.438 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -66.23 -23.04 66.36 Favored 'General case' 0 C--O 1.22 -0.499 0 C-N-CA 120.547 -0.461 . . . . 0.0 110.47 179.217 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' MET . . . . . 0.463 ' HB2' ' O ' ' A' ' 78' ' ' GLN . 30.6 ttm -59.61 -52.66 64.59 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.981 0.419 . . . . 0.0 110.202 174.838 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.644 ' O ' ' HG ' ' A' ' 87' ' ' LEU . 18.7 m -83.86 -35.23 11.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.09 -177.521 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' MET . . . . . 0.458 ' O ' ' HG2' ' A' ' 88' ' ' ARG . 57.1 ttp -65.44 -35.39 80.77 Favored 'General case' 0 CA--C 1.518 -0.265 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.291 -179.894 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . 0.48 ' O ' ' HB2' ' A' ' 89' ' ' GLU . 33.2 t70 -61.3 -39.87 92.09 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.127 177.382 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.478 HG22 HD13 ' A' ' 31' ' ' LEU . 23.5 mt -64.62 -41.18 91.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 121.412 0.625 . . . . 0.0 109.925 176.398 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.644 ' HG ' ' O ' ' A' ' 83' ' ' VAL . 66.1 mt -64.39 -36.11 83.09 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.373 -0.831 . . . . 0.0 111.101 -178.781 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . 0.458 ' HG2' ' O ' ' A' ' 84' ' ' MET . 29.5 mmm180 -95.28 9.91 38.06 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.996 -177.352 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . 0.48 ' HB2' ' O ' ' A' ' 85' ' ' ASP . 35.3 tt0 . . . . . 0 C--O 1.25 1.122 0 CA-C-O 118.836 -0.602 . . . . 0.0 110.34 -177.787 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 85.7 m . . . . . 0 N--CA 1.452 -0.342 0 N-CA-C 109.697 -0.482 . . . . 0.0 109.697 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.665 ' HA ' ' O ' ' A' ' 69' ' ' ILE . 3.2 p -139.86 121.76 16.0 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-O 121.161 0.505 . . . . 0.0 111.932 -175.456 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . 0.411 ' O ' ' HA ' ' A' ' 68' ' ' ARG . 28.8 mt-30 -96.88 157.17 16.03 Favored 'General case' 0 CA--C 1.519 -0.233 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.353 173.363 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.582 ' HG2' ' HG2' ' A' ' 68' ' ' ARG . 35.2 mt-10 -131.18 107.91 9.34 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.177 0.513 . . . . 0.0 111.075 -178.424 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 5.3 mm -101.57 150.37 6.06 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-N 115.54 -0.754 . . . . 0.0 109.405 -179.807 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 79.5 mmm -110.18 92.85 4.21 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 176.77 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.676 ' HB ' ' HB2' ' A' ' 65' ' ' LYS . 32.7 mm -82.3 127.32 71.64 Favored Pre-proline 0 C--N 1.32 -0.676 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.101 -173.895 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 76.7 Cg_exo -50.85 136.5 43.33 Favored 'Trans proline' 0 N--CA 1.463 -0.317 0 C-N-CA 122.491 2.127 . . . . 0.0 111.592 175.398 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -58.1 -29.28 65.35 Favored 'General case' 0 CA--C 1.531 0.226 0 N-CA-C 112.959 0.725 . . . . 0.0 112.959 -172.116 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -89.44 -19.73 47.94 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.484 -0.865 . . . . 0.0 112.138 179.323 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 8.5 tptm -91.95 -1.15 57.42 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.266 0.555 . . . . 0.0 110.363 -177.601 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.487 ' HA ' HG22 ' A' ' 32' ' ' VAL . . . -63.06 -20.93 65.8 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.598 -0.728 . . . . 0.0 111.065 179.471 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -61.0 -16.3 47.14 Favored Glycine 0 C--O 1.228 -0.247 0 CA-C-N 115.876 -0.602 . . . . 0.0 112.652 177.405 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 62.6 mt -93.75 -47.92 6.55 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 122.693 -0.298 . . . . 0.0 111.238 179.539 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.561 HG13 HD21 ' A' ' 87' ' ' LEU . 3.0 m -65.34 -40.07 87.29 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.379 0 CA-C-O 120.889 0.376 . . . . 0.0 111.452 179.523 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.51 HG13 HG23 ' A' ' 32' ' ' VAL . 43.6 mt -85.88 -32.75 7.09 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-O 121.927 0.87 . . . . 0.0 109.162 178.794 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . 0.527 ' HA3' ' HB ' ' A' ' 39' ' ' THR . . . 95.15 178.9 37.3 Favored Glycine 0 N--CA 1.436 -1.318 0 CA-C-N 114.852 -1.067 . . . . 0.0 111.579 -178.105 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 2.9 mppt? -81.13 62.8 5.23 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-O 120.973 0.416 . . . . 0.0 110.373 -178.839 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 133.19 -20.1 4.26 Favored Glycine 0 N--CA 1.448 -0.521 0 C-N-CA 120.823 -0.703 . . . . 0.0 112.416 176.897 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 115.8 -0.16 21.45 Favored Glycine 0 N--CA 1.448 -0.517 0 C-N-CA 120.723 -0.751 . . . . 0.0 111.883 -176.792 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.508 ' O ' ' HB3' ' A' ' 41' ' ' LYS . 49.3 mt-10 -75.44 -31.96 60.5 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 120.724 0.297 . . . . 0.0 111.106 179.474 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . 0.584 ' O ' ' HG ' ' A' ' 43' ' ' LEU . 23.7 m -69.38 -48.46 61.11 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.774 -178.3 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.665 HD12 HD23 ' A' ' 53' ' ' LEU . 7.0 tt -61.8 -32.79 55.05 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.267 0 CA-C-O 121.107 0.479 . . . . 0.0 110.346 177.356 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . 0.508 ' HB3' ' O ' ' A' ' 38' ' ' GLU . 31.6 ttpt -56.24 -45.22 80.07 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.467 174.398 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.45 ' O ' ' HG2' ' A' ' 46' ' ' ARG . 27.8 mt-30 -73.46 -40.46 64.15 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.404 -0.816 . . . . 0.0 111.116 -177.027 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.584 ' HG ' ' O ' ' A' ' 39' ' ' THR . 81.0 mt -55.71 -47.58 76.63 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.683 -176.577 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 44.6 mt-30 -61.98 -43.13 99.48 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.712 -176.247 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -78.54 -35.21 46.46 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 111.836 0.31 . . . . 0.0 111.836 -175.797 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . 0.45 ' HG2' ' O ' ' A' ' 42' ' ' GLN . 12.9 ptm180 -73.92 -31.39 63.05 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 120.777 -0.369 . . . . 0.0 111.268 -177.89 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -89.19 -28.18 20.16 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.087 0.47 . . . . 0.0 111.348 -179.111 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 82.93 33.21 24.6 Favored Glycine 0 N--CA 1.449 -0.478 0 CA-C-N 115.742 -0.663 . . . . 0.0 112.243 -178.698 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 3.6 m -139.14 179.86 2.76 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.399 0 CA-C-O 120.898 0.38 . . . . 0.0 110.297 178.609 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 54.7 tttp -109.44 123.67 49.75 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 115.945 -0.57 . . . . 0.0 109.919 175.448 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . 0.552 ' HG2' HG23 ' A' ' 69' ' ' ILE . 65.9 mtp -118.21 114.08 22.49 Favored 'General case' 0 C--N 1.317 -0.808 0 N-CA-C 108.301 -1.0 . . . . 0.0 108.301 174.414 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.502 ' CG2' ' HB2' ' A' ' 68' ' ' ARG . 11.5 tt -104.6 108.54 25.06 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.749 0 CA-C-O 121.622 0.725 . . . . 0.0 110.684 -177.614 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.723 HD22 HD13 ' A' ' 67' ' ' LEU . 2.7 mm? -82.35 102.29 11.15 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.249 -0.887 . . . . 0.0 109.522 174.11 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.648 HD12 ' HB2' ' A' ' 66' ' ' PRO . 56.6 mt -82.48 87.42 1.9 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.55 0 CA-C-O 121.481 0.658 . . . . 0.0 109.35 -179.171 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 70.9 mt-30 . . . . . 0 C--N 1.323 -0.564 0 CA-C-N 115.148 -0.933 . . . . 0.0 111.144 -173.59 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 . . . . . 0 N--CA 1.443 -0.79 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . 0.676 ' HB2' ' HB ' ' A' ' 24' ' ' ILE . 2.7 mmpp? -148.57 113.28 3.74 Favored Pre-proline 0 C--N 1.318 -0.779 0 CA-C-N 115.62 -0.718 . . . . 0.0 109.51 178.779 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.648 ' HB2' HD12 ' A' ' 54' ' ' ILE . 24.7 Cg_exo -63.55 110.26 1.21 Allowed 'Trans proline' 0 N--CA 1.462 -0.353 0 C-N-CA 122.613 2.209 . . . . 0.0 111.807 178.268 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.723 HD13 HD22 ' A' ' 53' ' ' LEU . 24.2 tp -111.16 105.22 13.85 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.069 178.006 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . 0.582 ' HG2' ' HG2' ' A' ' 21' ' ' GLU . 95.2 mtt180 -97.72 113.62 25.42 Favored 'General case' 0 C--N 1.319 -0.717 0 CA-C-O 121.437 0.637 . . . . 0.0 110.581 176.813 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.665 ' O ' ' HA ' ' A' ' 19' ' ' VAL . 19.6 mt -98.83 104.09 15.54 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.786 0 CA-C-N 114.99 -1.004 . . . . 0.0 108.577 177.897 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.545 HG23 ' HB ' ' A' ' 19' ' ' VAL . 2.8 mt -112.58 132.61 60.84 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.788 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.061 -169.348 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 156.44 -119.06 0.88 Allowed Glycine 0 N--CA 1.446 -0.675 0 C-N-CA 120.718 -0.754 . . . . 0.0 112.825 174.832 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . 0.401 ' O ' HG23 ' A' ' 76' ' ' VAL . 11.9 t70 -102.69 134.77 19.7 Favored Pre-proline 0 C--N 1.325 -0.46 0 CA-C-O 119.091 -0.48 . . . . 0.0 110.96 -175.667 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_exo -44.31 -42.91 13.59 Favored 'Trans proline' 0 C--O 1.237 0.445 0 C-N-CA 123.231 2.62 . . . . 0.0 113.557 -174.419 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 30.7 t80 -70.95 -47.73 57.34 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.853 -171.911 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.436 ' HA ' ' HB2' ' A' ' 78' ' ' GLN . 14.3 pttt -82.87 -19.24 37.84 Favored 'General case' 0 C--N 1.325 -0.466 0 C-N-CA 120.492 -0.483 . . . . 0.0 111.768 -179.463 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.401 HG23 ' O ' ' A' ' 72' ' ' ASP . 47.0 t -66.16 -38.55 82.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 170.036 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . 0.407 ' O ' ' HG2' ' A' ' 81' ' ' GLU . 20.9 tp60 -69.92 -49.13 55.06 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.38 -0.827 . . . . 0.0 110.416 175.426 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . 0.436 ' HB2' ' HA ' ' A' ' 75' ' ' LYS . 86.2 mt-30 -60.4 -36.36 77.95 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.567 -0.288 . . . . 0.0 111.693 -179.913 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -69.64 -39.42 77.12 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 120.818 0.342 . . . . 0.0 110.546 177.462 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 52.5 t -65.13 -51.45 61.19 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.051 179.681 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . 0.408 ' HG2' ' HA ' ' A' ' 78' ' ' GLN . 10.3 pt-20 -64.99 -24.11 67.41 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.972 0.415 . . . . 0.0 110.37 179.983 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' MET . . . . . 0.557 ' O ' HG13 ' A' ' 86' ' ' ILE . 29.7 ttp -73.14 -52.02 15.76 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.863 179.259 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.57 ' O ' ' HG ' ' A' ' 87' ' ' LEU . 33.3 m -77.75 -34.0 19.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 120.635 0.255 . . . . 0.0 111.207 -175.647 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 51.7 ttm -63.35 -35.25 79.75 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.106 0.479 . . . . 0.0 109.741 177.194 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -68.54 -36.72 79.22 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.441 179.444 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.557 HG13 ' O ' ' A' ' 82' ' ' MET . 59.9 mt -63.31 -33.25 60.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-O 121.256 0.55 . . . . 0.0 110.543 178.056 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.57 ' HG ' ' O ' ' A' ' 83' ' ' VAL . 58.7 mt -73.87 -19.61 60.67 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.604 -175.945 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . 0.619 ' HG3' ' HG2' ' A' ' 89' ' ' GLU . 37.1 ptt180 -110.8 -19.3 12.88 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.372 0.606 . . . . 0.0 111.142 -175.596 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . 0.619 ' HG2' ' HG3' ' A' ' 88' ' ' ARG . 69.9 mm-40 . . . . . 0 C--O 1.249 1.04 0 CA-C-N 115.235 -0.893 . . . . 0.0 110.425 -175.633 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 99.7 m . . . . . 0 C--O 1.234 0.25 0 CA-C-O 121.008 0.432 . . . . 0.0 111.641 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.586 HG22 HG23 ' A' ' 70' ' ' ILE . 92.9 t -120.8 126.99 75.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.276 178.284 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . 0.576 ' HB2' ' CG1' ' A' ' 76' ' ' VAL . 4.9 tp-100 -106.58 113.93 27.74 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 109.667 -0.494 . . . . 0.0 109.667 175.684 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.607 ' HA ' ' O ' ' A' ' 67' ' ' LEU . 56.1 mt-10 -93.24 121.29 34.47 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.036 0.446 . . . . 0.0 111.457 177.591 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 18.7 mm -115.43 146.38 19.94 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 115.529 -0.759 . . . . 0.0 109.355 176.902 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' MET . . . . . 0.494 ' HB3' ' HB2' ' A' ' 64' ' ' ASP . 79.4 mmm -106.77 99.86 9.4 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 175.356 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.709 HD12 HD11 ' A' ' 87' ' ' LEU . 24.5 mm -78.54 129.76 73.36 Favored Pre-proline 0 C--N 1.32 -0.685 0 CA-C-N 115.498 -0.774 . . . . 0.0 111.895 -170.461 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . 0.603 ' HD2' HD13 ' A' ' 87' ' ' LEU . 77.0 Cg_exo -45.2 131.37 11.38 Favored 'Trans proline' 0 C--N 1.349 0.574 0 C-N-CA 123.744 2.963 . . . . 0.0 112.976 175.831 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -71.36 78.5 0.75 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.444 0.64 . . . . 0.0 110.874 179.437 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 157.54 -59.96 0.34 Allowed Glycine 0 N--CA 1.447 -0.593 0 N-CA-C 109.983 -1.247 . . . . 0.0 109.983 -177.456 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.46 -13.97 35.97 Favored 'General case' 0 N--CA 1.451 -0.41 0 CA-C-O 121.0 0.429 . . . . 0.0 110.749 171.929 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.425 ' O ' HG12 ' A' ' 32' ' ' VAL . . . -56.16 -23.49 35.24 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.771 173.379 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -61.8 -24.46 64.54 Favored Glycine 0 N--CA 1.449 -0.494 0 C-N-CA 120.862 -0.685 . . . . 0.0 112.185 176.611 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 93.1 mt -92.4 -32.8 14.81 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.725 0.298 . . . . 0.0 110.859 178.793 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.438 HG11 HG21 ' A' ' 24' ' ' ILE . 0.3 OUTLIER -68.06 -29.0 43.15 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.296 0 CA-C-O 121.263 0.554 . . . . 0.0 110.395 179.387 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 63.2 mt -92.0 -47.97 13.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 115.568 -0.742 . . . . 0.0 109.424 174.386 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 114.56 -162.12 12.51 Favored Glycine 0 N--CA 1.442 -0.942 0 CA-C-N 115.356 -0.838 . . . . 0.0 112.095 178.418 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.534 ' N ' ' HD3' ' A' ' 35' ' ' LYS . 0.1 OUTLIER -92.29 39.33 1.02 Allowed 'General case' 0 C--N 1.317 -0.818 0 N-CA-C 109.637 -0.505 . . . . 0.0 109.637 -178.298 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 143.52 -21.31 2.21 Favored Glycine 0 N--CA 1.45 -0.431 0 C-N-CA 120.982 -0.628 . . . . 0.0 112.29 -178.245 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 126.17 4.77 6.4 Favored Glycine 0 C--O 1.228 -0.245 0 C-N-CA 120.355 -0.926 . . . . 0.0 112.309 179.939 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -80.59 -28.17 37.2 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 120.659 0.266 . . . . 0.0 111.217 178.897 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . 0.623 ' O ' ' HG ' ' A' ' 43' ' ' LEU . 57.9 m -70.38 -49.64 47.01 Favored 'General case' 0 C--N 1.324 -0.507 0 C-N-CA 121.101 -0.24 . . . . 0.0 110.444 -179.983 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.703 HD12 HD23 ' A' ' 53' ' ' LEU . 5.2 tt -59.64 -33.72 52.86 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.248 0 CA-C-O 120.81 0.338 . . . . 0.0 110.473 176.31 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . 0.536 ' O ' ' HG2' ' A' ' 45' ' ' GLU . 57.7 tttp -64.86 -46.23 82.74 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.756 175.454 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 41.7 mt-30 -60.88 -35.08 75.69 Favored 'General case' 0 CA--C 1.516 -0.354 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.359 -178.017 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.623 ' HG ' ' O ' ' A' ' 39' ' ' THR . 69.8 mt -62.19 -43.6 98.46 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.421 -0.809 . . . . 0.0 110.402 178.158 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . 0.452 HE21 HG12 ' A' ' 40' ' ' ILE . 67.8 mt-30 -62.61 -47.24 84.63 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.176 177.596 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.536 ' HG2' ' O ' ' A' ' 41' ' ' LYS . 72.0 mm-40 -59.81 -39.41 84.95 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.33 -0.85 . . . . 0.0 111.672 -177.854 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 13.5 ptm180 -90.0 -28.02 19.38 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 112.932 0.716 . . . . 0.0 112.932 -170.865 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.45 ' HB3' HG22 ' A' ' 49' ' ' VAL . . . -94.22 -15.83 24.2 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 112.174 0.435 . . . . 0.0 112.174 -175.642 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 74.23 20.72 79.6 Favored Glycine 0 C--O 1.235 0.217 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.183 -179.855 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.45 HG22 ' HB3' ' A' ' 47' ' ' ALA . 27.3 m -124.51 177.31 4.67 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 N-CA-C 109.902 -0.407 . . . . 0.0 109.902 -179.202 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 87.1 tttt -114.64 123.97 50.66 Favored 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 109.773 -0.455 . . . . 0.0 109.773 173.088 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . 0.592 ' HE2' ' HB1' ' A' ' 79' ' ' ALA . 55.7 mtt -108.54 115.39 30.02 Favored 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 176.028 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.561 ' CG2' ' HB2' ' A' ' 68' ' ' ARG . 10.2 tt -105.13 105.14 18.08 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.895 0 CA-C-O 121.585 0.707 . . . . 0.0 110.423 177.668 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 1.004 HD22 HD13 ' A' ' 67' ' ' LEU . 1.4 mm? -80.75 121.8 26.36 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.283 -0.872 . . . . 0.0 108.973 172.608 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.47 ' CG1' ' HB2' ' A' ' 66' ' ' PRO . 48.9 mm -76.67 85.86 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-O 121.845 0.831 . . . . 0.0 109.832 179.514 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 15.3 mt-30 . . . . . 0 C--N 1.323 -0.544 0 CA-C-N 114.743 -1.117 . . . . 0.0 108.64 -179.983 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.494 ' HB2' ' HB3' ' A' ' 23' ' ' MET . 0.6 OUTLIER . . . . . 0 C--O 1.221 -0.431 0 CA-C-O 121.143 0.497 . . . . 0.0 112.334 . . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . 0.665 ' HB2' ' HB ' ' A' ' 24' ' ' ILE . 73.6 mmtt -95.46 132.62 27.25 Favored Pre-proline 0 C--N 1.322 -0.592 0 CA-C-N 115.543 -0.753 . . . . 0.0 112.22 -170.49 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.47 ' HB2' ' CG1' ' A' ' 54' ' ' ILE . 13.7 Cg_exo -71.19 118.53 5.73 Favored 'Trans proline' 0 N--CA 1.457 -0.639 0 C-N-CA 122.867 2.378 . . . . 0.0 111.55 173.422 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 1.004 HD13 HD22 ' A' ' 53' ' ' LEU . 13.0 tp -123.48 124.7 43.44 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.98 -0.555 . . . . 0.0 109.923 178.091 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . 0.561 ' HB2' ' CG2' ' A' ' 52' ' ' ILE . 87.5 mtt180 -112.58 110.63 20.91 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-O 120.851 0.358 . . . . 0.0 111.292 177.458 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.461 ' HB ' ' HB3' ' A' ' 20' ' ' GLN . 4.6 mp -88.38 104.7 14.91 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 171.525 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.586 HG23 HG22 ' A' ' 19' ' ' VAL . 11.3 mt -104.65 124.85 59.49 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.703 -174.99 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 173.95 -129.82 1.71 Allowed Glycine 0 N--CA 1.447 -0.592 0 C-N-CA 121.005 -0.617 . . . . 0.0 112.208 179.582 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . 0.492 ' OD1' ' HD2' ' A' ' 73' ' ' PRO . 3.1 t70 -107.58 145.72 31.87 Favored Pre-proline 0 C--N 1.324 -0.523 0 CA-C-O 118.655 -0.688 . . . . 0.0 109.895 -179.793 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . 0.492 ' HD2' ' OD1' ' A' ' 72' ' ' ASP . 94.3 Cg_exo -41.02 -40.42 3.81 Favored 'Trans proline' 0 CA--C 1.535 0.571 0 C-N-CA 122.999 2.466 . . . . 0.0 113.335 -179.398 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 85.9 t80 -70.82 -56.71 5.71 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.295 -176.262 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.459 ' HG2' ' HB3' ' A' ' 72' ' ' ASP . 27.6 pttt -71.22 -27.48 63.51 Favored 'General case' 0 CA--C 1.514 -0.432 0 C-N-CA 120.575 -0.45 . . . . 0.0 111.383 -179.523 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.576 ' CG1' ' HB2' ' A' ' 20' ' ' GLN . 24.2 t -66.71 -36.17 76.59 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-O 121.4 0.619 . . . . 0.0 109.441 177.068 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . 0.463 ' O ' ' HG2' ' A' ' 81' ' ' GLU . 20.1 tp60 -72.7 -47.98 42.68 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.292 176.749 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 25.0 mt-30 -57.8 -37.65 74.13 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-O 121.112 0.482 . . . . 0.0 110.6 177.534 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . 0.592 ' HB1' ' HE2' ' A' ' 51' ' ' MET . . . -71.99 -36.93 69.9 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.638 -0.71 . . . . 0.0 111.188 179.899 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' CYS . . . . . 0.44 ' HA ' HG22 ' A' ' 83' ' ' VAL . 51.7 t -68.37 -48.29 65.17 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.965 179.548 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . 0.463 ' HG2' ' O ' ' A' ' 77' ' ' GLN . 11.2 pt-20 -65.95 -19.48 65.88 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.11 0.481 . . . . 0.0 110.067 178.778 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' MET . . . . . 0.515 ' O ' HG13 ' A' ' 86' ' ' ILE . 51.1 ttp -79.18 -50.05 11.59 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.67 -0.695 . . . . 0.0 110.637 177.05 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.44 HG22 ' HA ' ' A' ' 80' ' ' CYS . 27.2 m -69.08 -35.16 67.27 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.248 0 C-N-CA 121.114 -0.234 . . . . 0.0 111.112 179.918 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 16.8 mmt -60.93 -37.23 81.59 Favored 'General case' 0 CA--C 1.517 -0.298 0 CA-C-O 121.076 0.465 . . . . 0.0 109.977 174.539 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -65.2 -43.77 90.55 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.482 -0.781 . . . . 0.0 110.95 178.694 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.515 HG13 ' O ' ' A' ' 82' ' ' MET . 51.5 mt -60.54 -37.52 75.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 121.466 0.651 . . . . 0.0 110.882 -179.395 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.709 HD11 HD12 ' A' ' 24' ' ' ILE . 71.5 mt -82.88 -12.83 57.08 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.762 -0.654 . . . . 0.0 111.21 -176.858 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 45.0 ttp180 -103.39 -18.34 14.87 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.467 0.651 . . . . 0.0 111.062 -176.982 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 . . . . . 0 C--O 1.249 1.051 0 CA-C-O 118.191 -0.909 . . . . 0.0 110.095 -178.31 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.439 ' OG1' ' HG3' ' A' ' 73' ' ' PRO . 92.8 m . . . . . 0 N--CA 1.452 -0.358 0 N-CA-C 110.21 -0.293 . . . . 0.0 110.21 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.542 ' HA ' ' O ' ' A' ' 69' ' ' ILE . 3.8 p -138.22 120.91 19.12 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-O 121.259 0.552 . . . . 0.0 110.808 179.909 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 53.2 mt-30 -102.54 136.11 42.96 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.793 -0.64 . . . . 0.0 109.98 176.646 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.568 ' HA ' ' O ' ' A' ' 67' ' ' LEU . 33.4 mt-10 -112.3 114.75 27.67 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.498 179.232 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 11.5 mm -106.56 156.93 7.01 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-N 115.486 -0.779 . . . . 0.0 110.038 -176.599 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 3.6 mmt -108.9 97.26 6.93 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 174.793 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.674 ' HB ' ' HB2' ' A' ' 65' ' ' LYS . 25.6 mm -82.92 125.53 74.96 Favored Pre-proline 0 C--N 1.316 -0.888 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.814 -175.819 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . 0.664 ' HB2' ' HB2' ' A' ' 28' ' ' LYS . 74.0 Cg_exo -50.51 132.8 36.35 Favored 'Trans proline' 0 C--N 1.343 0.289 0 C-N-CA 122.747 2.298 . . . . 0.0 111.416 175.94 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -58.88 -31.84 68.94 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.751 -0.659 . . . . 0.0 112.51 -172.842 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -82.47 -36.7 16.17 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.592 -0.813 . . . . 0.0 111.823 178.426 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.664 ' HB2' ' HB2' ' A' ' 25' ' ' PRO . 36.2 mttp -80.32 3.64 20.39 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.808 0.337 . . . . 0.0 111.393 179.466 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.66 -30.44 70.73 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.096 0.474 . . . . 0.0 110.141 175.742 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -66.17 -18.67 67.34 Favored Glycine 0 N--CA 1.446 -0.656 0 C-N-CA 120.861 -0.685 . . . . 0.0 112.341 177.848 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 82.2 mt -84.36 -46.72 11.44 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.53 0.205 . . . . 0.0 110.789 179.922 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.652 HG21 HG21 ' A' ' 24' ' ' ILE . 2.8 m -66.7 -34.88 72.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-O 120.884 0.373 . . . . 0.0 110.958 177.813 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.721 HD11 ' HG2' ' A' ' 55' ' ' GLN . 84.7 mt -80.21 -44.97 22.51 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-O 121.203 0.525 . . . . 0.0 110.4 178.413 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . 0.447 ' HA3' ' H ' ' A' ' 39' ' ' THR . . . 98.96 51.05 1.4 Allowed Glycine 0 N--CA 1.448 -0.553 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.841 177.202 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 5.0 mptp? 54.25 30.98 13.3 Favored 'General case' 0 N--CA 1.464 0.254 0 C-N-CA 122.959 0.504 . . . . 0.0 112.118 175.761 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 147.4 -36.86 1.16 Allowed Glycine 0 N--CA 1.446 -0.696 0 C-N-CA 120.294 -0.955 . . . . 0.0 112.575 -178.526 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 147.49 -1.97 0.76 Allowed Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 119.516 -1.326 . . . . 0.0 114.504 177.985 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 -63.23 -47.48 82.31 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 117.677 0.739 . . . . 0.0 111.301 -179.169 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . 0.738 ' O ' ' HG ' ' A' ' 43' ' ' LEU . 95.3 m -63.86 -51.55 64.12 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 111.7 0.259 . . . . 0.0 111.7 -177.112 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.556 ' O ' ' HG3' ' A' ' 44' ' ' GLN . 5.3 tt -58.01 -37.49 61.66 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.375 0 CA-C-O 120.989 0.423 . . . . 0.0 110.831 -178.658 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 85.8 tttt -63.38 -44.21 95.41 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.452 177.158 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 70.8 mt-30 -65.0 -40.25 94.66 Favored 'General case' 0 CA--C 1.517 -0.306 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.62 -178.744 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.738 ' HG ' ' O ' ' A' ' 39' ' ' THR . 70.5 mt -56.99 -48.33 78.67 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.588 -0.733 . . . . 0.0 111.558 -177.742 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . 0.556 ' HG3' ' O ' ' A' ' 40' ' ' ILE . 46.5 mt-30 -58.96 -51.78 68.57 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.462 -178.226 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -68.68 -40.71 79.95 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.366 -0.833 . . . . 0.0 111.889 -173.79 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . 0.6 ' HD3' ' SD ' ' A' ' 82' ' ' MET . 13.0 ptm180 -71.94 -27.82 63.05 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 111.74 0.274 . . . . 0.0 111.74 -174.574 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.53 ' HB3' HG22 ' A' ' 49' ' ' VAL . . . -96.98 -22.71 16.67 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.02 0.438 . . . . 0.0 111.302 -178.882 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 79.85 28.55 50.28 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 121.027 -0.606 . . . . 0.0 111.722 -178.213 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.53 HG22 ' HB3' ' A' ' 47' ' ' ALA . 27.1 m -123.06 179.08 2.79 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-O 120.833 0.349 . . . . 0.0 110.114 -176.741 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 61.6 tttp -113.25 123.53 50.4 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 171.56 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . 0.424 ' HE2' HG13 ' A' ' 69' ' ' ILE . 54.7 mtp -122.64 116.7 24.26 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 109.727 -0.472 . . . . 0.0 109.727 179.567 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.484 ' CG2' ' HB2' ' A' ' 68' ' ' ARG . 6.7 tt -107.13 107.17 22.11 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.792 0 CA-C-O 121.462 0.649 . . . . 0.0 110.878 -179.979 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.677 HD22 HD13 ' A' ' 67' ' ' LEU . 3.5 mm? -82.6 103.58 12.22 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.382 -0.826 . . . . 0.0 109.136 172.314 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.646 HD12 ' HB2' ' A' ' 66' ' ' PRO . 65.5 mt -81.37 89.78 1.85 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-O 121.192 0.52 . . . . 0.0 109.792 178.79 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . 0.721 ' HG2' HD11 ' A' ' 33' ' ' ILE . 0.0 OUTLIER . . . . . 0 C--N 1.322 -0.613 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.654 179.82 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 . . . . . 0 C--O 1.225 -0.195 0 CA-C-O 120.898 0.38 . . . . 0.0 110.807 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . 0.674 ' HB2' ' HB ' ' A' ' 24' ' ' ILE . 69.5 mmtt -96.26 127.15 41.4 Favored Pre-proline 0 C--N 1.317 -0.814 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.409 -170.705 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.646 ' HB2' HD12 ' A' ' 54' ' ' ILE . 20.2 Cg_exo -68.03 109.23 1.89 Allowed 'Trans proline' 0 N--CA 1.461 -0.388 0 C-N-CA 122.952 2.435 . . . . 0.0 111.512 174.314 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.677 HD13 HD22 ' A' ' 53' ' ' LEU . 23.0 tp -109.65 117.41 33.86 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.339 178.38 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . 0.507 ' HG2' ' HG2' ' A' ' 21' ' ' GLU . 92.7 mtt180 -107.09 112.92 26.06 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 120.827 0.346 . . . . 0.0 111.023 175.545 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.542 ' O ' ' HA ' ' A' ' 19' ' ' VAL . 3.9 mp -95.16 110.05 23.39 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 N-CA-C 107.951 -1.129 . . . . 0.0 107.951 172.201 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 28.4 mt -112.32 132.06 62.06 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 116.683 -0.235 . . . . 0.0 111.508 -171.134 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 150.19 -134.92 5.01 Favored Glycine 0 N--CA 1.445 -0.742 0 C-N-CA 120.686 -0.769 . . . . 0.0 113.657 174.021 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . 0.581 ' OD2' ' HB3' ' A' ' 74' ' ' TYR . 0.5 OUTLIER -80.07 139.19 52.96 Favored Pre-proline 0 C--N 1.323 -0.565 0 C-N-CA 123.46 0.704 . . . . 0.0 111.565 -177.283 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . 0.466 ' HD3' ' HA ' ' A' ' 72' ' ' ASP . 33.3 Cg_exo -58.55 -18.54 40.22 Favored 'Trans proline' 0 C--N 1.35 0.625 0 C-N-CA 123.583 2.856 . . . . 0.0 113.818 -175.748 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . 0.581 ' HB3' ' OD2' ' A' ' 72' ' ' ASP . 37.8 t80 -86.36 -56.65 3.34 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 120.478 0.18 . . . . 0.0 110.532 -179.406 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.579 ' CE ' ' HB3' ' A' ' 72' ' ' ASP . 26.1 pttt -70.31 -32.58 70.4 Favored 'General case' 0 CA--C 1.519 -0.232 0 N-CA-C 112.075 0.398 . . . . 0.0 112.075 -179.705 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 43.2 t -63.15 -36.24 75.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-O 121.008 0.432 . . . . 0.0 110.192 176.986 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . 0.419 ' NE2' ' HG3' ' A' ' 81' ' ' GLU . 0.4 OUTLIER -73.07 -44.29 60.77 Favored 'General case' 0 N--CA 1.445 -0.686 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 -178.255 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 48.3 mt-30 -62.46 -45.28 93.78 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.925 0.393 . . . . 0.0 110.531 177.045 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -63.4 -35.62 81.01 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.81 -179.193 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 43.5 t -66.2 -45.67 79.99 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.459 176.117 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . 0.419 ' HG3' ' NE2' ' A' ' 77' ' ' GLN . 38.0 mt-10 -59.48 -42.44 92.08 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.29 0.567 . . . . 0.0 110.051 175.864 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' MET . . . . . 0.6 ' SD ' ' HD3' ' A' ' 46' ' ' ARG . 42.0 ttp -56.72 -49.93 73.7 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 114.772 -1.104 . . . . 0.0 111.574 -179.456 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.408 HG11 ' CE ' ' A' ' 51' ' ' MET . 34.7 m -79.57 -33.41 15.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 C-N-CA 120.871 -0.332 . . . . 0.0 111.131 -176.694 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 57.4 ttp -63.37 -38.57 91.68 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 109.533 -0.543 . . . . 0.0 109.533 175.85 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -61.82 -38.45 88.19 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.328 178.53 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.525 HG13 ' O ' ' A' ' 82' ' ' MET . 45.4 mt -64.13 -31.09 51.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-O 121.376 0.608 . . . . 0.0 110.479 179.657 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.63 HD11 HD12 ' A' ' 24' ' ' ILE . 45.3 mt -88.0 -18.55 28.77 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.542 -179.779 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 33.7 ttt85 -96.69 -4.46 40.8 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.681 0.753 . . . . 0.0 110.629 -176.665 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 20.0 tp10 . . . . . 0 C--N 1.311 -1.083 0 CA-C-O 118.195 -0.907 . . . . 0.0 110.42 -178.728 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 97.8 m . . . . . 0 N--CA 1.45 -0.433 0 CA-C-O 121.054 0.454 . . . . 0.0 110.872 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.506 ' HA ' ' O ' ' A' ' 69' ' ' ILE . 3.2 p -137.64 125.85 32.11 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-N 115.559 -0.746 . . . . 0.0 110.09 177.512 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 28.0 mt-30 -109.6 123.64 49.78 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.174 178.509 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.71 ' HG2' ' HG2' ' A' ' 68' ' ' ARG . 45.6 mt-10 -99.7 120.45 39.73 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.714 179.848 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 5.6 mm -106.79 152.1 8.46 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-N 115.54 -0.755 . . . . 0.0 110.307 -176.915 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 14.1 mmt -103.5 91.8 4.2 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 170.929 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.766 HG21 HG21 ' A' ' 32' ' ' VAL . 41.6 mm -79.89 134.71 56.33 Favored Pre-proline 0 C--N 1.319 -0.729 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.649 -175.265 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . 0.429 ' HD2' HD13 ' A' ' 87' ' ' LEU . 83.4 Cg_exo -48.26 127.34 15.24 Favored 'Trans proline' 0 C--N 1.347 0.493 0 C-N-CA 123.068 2.512 . . . . 0.0 111.987 172.6 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -60.35 -34.67 74.18 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.273 -177.032 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -72.36 -32.93 61.9 Favored Glycine 0 N--CA 1.448 -0.542 0 CA-C-N 115.819 -0.628 . . . . 0.0 112.951 -177.452 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 43.6 mtpt -104.18 14.3 30.68 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 122.639 -0.33 . . . . 0.0 111.084 -177.844 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -65.56 -28.9 69.49 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.022 179.04 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -65.46 -30.0 76.52 Favored Glycine 0 N--CA 1.445 -0.714 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.137 179.067 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 91.7 mt -71.34 -39.51 71.29 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.771 0.32 . . . . 0.0 111.125 -178.061 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.766 HG21 HG21 ' A' ' 24' ' ' ILE . 0.0 OUTLIER -71.32 -28.87 33.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.876 -178.315 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 62.0 mt -81.24 -34.21 13.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-O 121.583 0.706 . . . . 0.0 109.756 176.039 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . 0.546 ' HA3' ' HB ' ' A' ' 39' ' ' THR . . . 101.89 26.81 7.34 Favored Glycine 0 CA--C 1.5 -0.849 0 CA-C-N 115.099 -0.955 . . . . 0.0 112.398 178.078 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 33.7 mmtp 73.1 -56.81 0.65 Allowed 'General case' 0 C--N 1.325 -0.498 0 C-N-CA 123.705 0.802 . . . . 0.0 111.659 179.43 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -101.26 -39.22 3.1 Favored Glycine 0 N--CA 1.448 -0.524 0 C-N-CA 120.678 -0.772 . . . . 0.0 111.718 -178.745 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 129.0 7.35 4.13 Favored Glycine 0 N--CA 1.448 -0.562 0 C-N-CA 120.996 -0.621 . . . . 0.0 112.533 178.914 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.449 ' O ' ' HG3' ' A' ' 42' ' ' GLN . 1.3 pm0 -78.2 -35.99 47.88 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 110.057 -0.349 . . . . 0.0 110.057 177.238 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . 0.66 ' O ' ' HG ' ' A' ' 43' ' ' LEU . 40.5 m -62.72 -50.95 69.07 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.173 -179.594 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.681 HD12 ' HB2' ' A' ' 53' ' ' LEU . 4.3 tt -56.41 -36.17 46.23 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.376 0 CA-C-O 120.788 0.327 . . . . 0.0 111.23 -179.282 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.04 -36.78 80.46 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.197 0.522 . . . . 0.0 109.836 179.472 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.686 ' O ' ' HG2' ' A' ' 46' ' ' ARG . 79.1 mt-30 -72.4 -42.69 64.89 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.866 179.891 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.66 ' HG ' ' O ' ' A' ' 39' ' ' THR . 88.8 mt -52.56 -42.71 64.68 Favored 'General case' 0 C--O 1.235 0.313 0 O-C-N 123.835 0.71 . . . . 0.0 111.741 -176.865 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . 0.445 ' HG3' ' O ' ' A' ' 40' ' ' ILE . 62.4 mt-30 -54.08 -47.82 71.32 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.608 -0.724 . . . . 0.0 110.397 178.951 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 9.6 mm-40 -66.87 -39.13 87.43 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.529 -0.76 . . . . 0.0 110.735 -178.984 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . 0.686 ' HG2' ' O ' ' A' ' 42' ' ' GLN . 8.9 mmm180 -56.99 -45.46 82.94 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.801 -171.436 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.566 ' HB3' HG22 ' A' ' 49' ' ' VAL . . . -95.26 -20.36 19.26 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.138 -175.912 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 82.25 47.57 6.04 Favored Glycine 0 N--CA 1.444 -0.796 0 C-N-CA 120.23 -0.986 . . . . 0.0 111.565 -173.996 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.602 HG13 ' HB2' ' A' ' 75' ' ' LYS . 2.9 m -145.54 171.19 5.35 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.456 0 CA-C-O 121.138 0.494 . . . . 0.0 110.653 -177.828 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 6.7 tmtm? -100.41 121.58 41.76 Favored 'General case' 0 C--N 1.318 -0.787 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 176.407 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 57.0 mtt -115.12 126.01 54.14 Favored 'General case' 0 CA--C 1.509 -0.629 0 N-CA-C 109.941 -0.392 . . . . 0.0 109.941 179.34 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.615 ' CG2' ' HB2' ' A' ' 68' ' ' ARG . 9.8 tt -118.2 104.05 15.61 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.939 0 CA-C-O 121.614 0.721 . . . . 0.0 110.275 173.223 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.681 ' HB2' HD12 ' A' ' 40' ' ' ILE . 4.3 mm? -78.73 101.74 7.71 Favored 'General case' 0 N--CA 1.446 -0.639 0 N-CA-C 107.947 -1.131 . . . . 0.0 107.947 170.381 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.608 HD12 ' HB2' ' A' ' 66' ' ' PRO . 15.8 mt -75.98 92.28 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.764 0 CA-C-O 121.5 0.667 . . . . 0.0 109.52 -175.543 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 1.1 pp0? . . . . . 0 C--N 1.32 -0.685 0 CA-C-N 115.345 -0.843 . . . . 0.0 109.885 179.407 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 . . . . . 0 C--O 1.234 0.28 0 CA-C-O 121.148 0.499 . . . . 0.0 110.918 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . 0.553 ' HB2' ' HB ' ' A' ' 24' ' ' ILE . 8.4 mmmm -101.6 119.25 57.82 Favored Pre-proline 0 C--N 1.319 -0.758 0 N-CA-C 113.098 0.777 . . . . 0.0 113.098 -172.574 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.608 ' HB2' HD12 ' A' ' 54' ' ' ILE . 23.5 Cg_exo -67.26 125.86 14.13 Favored 'Trans proline' 0 CA--C 1.533 0.462 0 C-N-CA 123.016 2.477 . . . . 0.0 111.895 171.379 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.695 ' O ' ' HA ' ' A' ' 21' ' ' GLU . 31.6 tp -134.02 127.84 33.1 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.02 177.599 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . 0.71 ' HG2' ' HG2' ' A' ' 21' ' ' GLU . 95.6 mtt180 -116.97 111.49 19.67 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.942 0.401 . . . . 0.0 111.151 178.594 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.506 ' O ' ' HA ' ' A' ' 19' ' ' VAL . 4.7 mp -94.54 104.75 16.13 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 171.108 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 14.6 mt -108.97 126.54 65.97 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.58 -174.193 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 165.26 -135.68 3.83 Favored Glycine 0 N--CA 1.442 -0.938 0 C-N-CA 119.962 -1.113 . . . . 0.0 113.033 176.592 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . 0.477 ' HB3' ' HG2' ' A' ' 75' ' ' LYS . 9.8 t70 -92.88 135.45 26.03 Favored Pre-proline 0 C--N 1.319 -0.729 0 CA-C-O 119.242 -0.408 . . . . 0.0 110.982 -176.564 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 75.0 Cg_exo -39.67 -42.87 3.0 Favored 'Trans proline' 0 C--O 1.237 0.427 0 C-N-CA 123.602 2.868 . . . . 0.0 113.605 -175.513 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . 0.433 ' O ' ' HG3' ' A' ' 78' ' ' GLN . 35.9 t80 -68.88 -53.51 20.81 Favored 'General case' 0 N--CA 1.453 -0.277 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.924 -175.676 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.602 ' HB2' HG13 ' A' ' 49' ' ' VAL . 0.0 OUTLIER -74.44 -24.36 59.05 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 120.268 -0.573 . . . . 0.0 111.87 -178.46 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.455 HG23 ' O ' ' A' ' 72' ' ' ASP . 75.8 t -63.15 -31.76 53.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-O 121.293 0.568 . . . . 0.0 109.69 174.136 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -76.57 -48.61 18.73 Favored 'General case' 0 N--CA 1.447 -0.582 0 N-CA-C 109.146 -0.686 . . . . 0.0 109.146 178.062 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . 0.433 ' HG3' ' O ' ' A' ' 74' ' ' TYR . 50.4 mt-30 -54.97 -43.46 73.53 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-O 121.551 0.691 . . . . 0.0 110.47 176.779 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . 0.456 ' HB3' HG21 ' A' ' 69' ' ' ILE . . . -64.68 -40.22 95.02 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.162 -0.926 . . . . 0.0 111.203 -178.63 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 42.3 t -65.65 -46.44 79.2 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.427 -179.659 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -70.6 -19.71 62.82 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 120.822 -0.351 . . . . 0.0 110.661 179.42 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' MET . . . . . 0.548 ' SD ' HD22 ' A' ' 43' ' ' LEU . 36.1 ttm -71.99 -54.63 9.33 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.831 0.348 . . . . 0.0 110.636 175.484 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.485 HG12 HD13 ' A' ' 43' ' ' LEU . 34.8 m -74.92 -29.93 23.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.803 -175.537 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 1.6 tmt? -70.09 -31.7 69.4 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.924 -0.58 . . . . 0.0 109.643 177.664 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . 0.482 ' O ' ' HB2' ' A' ' 89' ' ' GLU . 32.9 t70 -60.4 -36.88 79.15 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.392 177.661 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 22.5 mt -68.93 -23.17 27.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-O 121.401 0.619 . . . . 0.0 110.601 179.772 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.746 HD11 HD12 ' A' ' 24' ' ' ILE . 70.1 mt -89.4 -30.3 18.45 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.979 -176.918 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 40.7 ptt180 -86.1 -3.61 58.99 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.614 0.721 . . . . 0.0 109.185 174.805 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . 0.482 ' HB2' ' O ' ' A' ' 85' ' ' ASP . 9.5 tp10 . . . . . 0 C--O 1.252 1.2 0 CA-C-N 114.392 -1.277 . . . . 0.0 109.653 -178.724 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.609 ' O ' ' HA ' ' A' ' 70' ' ' ILE . 37.5 m . . . . . 0 N--CA 1.45 -0.436 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.514 ' HA ' ' O ' ' A' ' 69' ' ' ILE . 6.4 p -129.31 123.03 57.22 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-O 121.323 0.582 . . . . 0.0 111.339 -179.091 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 26.9 mt-30 -117.06 115.05 24.64 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.673 -0.694 . . . . 0.0 109.333 175.136 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.598 ' HG2' ' HG2' ' A' ' 68' ' ' ARG . 42.2 mt-10 -88.73 115.86 26.57 Favored 'General case' 0 CA--C 1.516 -0.35 0 CA-C-O 121.178 0.513 . . . . 0.0 111.372 -178.423 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.427 ' HB ' ' HB3' ' A' ' 67' ' ' LEU . 11.2 mm -98.72 152.9 4.22 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-N 115.426 -0.807 . . . . 0.0 109.686 179.482 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' MET . . . . . 0.417 ' HB3' ' HB3' ' A' ' 64' ' ' ASP . 1.8 mmt -106.39 91.27 3.63 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 174.747 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.69 ' HB ' ' HB2' ' A' ' 65' ' ' LYS . 29.7 mm -75.35 125.88 88.37 Favored Pre-proline 0 C--N 1.317 -0.805 0 CA-C-N 115.806 -0.634 . . . . 0.0 111.215 -173.869 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . 0.582 ' HB2' ' HB2' ' A' ' 28' ' ' LYS . 85.4 Cg_exo -48.09 129.32 18.31 Favored 'Trans proline' 0 C--N 1.346 0.4 0 C-N-CA 123.165 2.577 . . . . 0.0 111.858 177.417 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -58.88 -24.34 62.12 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.838 -0.619 . . . . 0.0 112.579 -173.023 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -95.95 -1.83 61.3 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.622 -0.799 . . . . 0.0 112.804 -179.632 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.582 ' HB2' ' HB2' ' A' ' 25' ' ' PRO . 2.0 mppt? -116.05 19.71 14.84 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.019 0.438 . . . . 0.0 111.441 -179.448 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -76.15 -20.39 57.62 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.102 -178.633 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -69.11 -17.72 72.21 Favored Glycine 0 N--CA 1.449 -0.484 0 C-N-CA 120.994 -0.622 . . . . 0.0 112.697 -178.86 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 86.8 mt -93.96 -38.83 10.98 Favored 'General case' 0 C--N 1.323 -0.573 0 O-C-N 122.515 -0.403 . . . . 0.0 111.571 -177.958 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.439 HG21 HG21 ' A' ' 24' ' ' ILE . 3.5 m -69.98 -34.09 58.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.899 0.38 . . . . 0.0 111.131 179.327 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.583 HD11 ' HG2' ' A' ' 55' ' ' GLN . 64.9 mt -83.99 -44.76 18.23 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-O 121.506 0.67 . . . . 0.0 109.902 177.026 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 118.88 -178.84 16.75 Favored Glycine 0 N--CA 1.441 -1.012 0 CA-C-N 115.291 -0.868 . . . . 0.0 111.359 -178.158 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 39.0 mmtm -77.76 -29.51 51.01 Favored 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 -178.357 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -143.01 17.09 2.36 Favored Glycine 0 N--CA 1.444 -0.79 0 CA-C-N 115.18 -0.918 . . . . 0.0 111.476 176.032 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 95.73 0.79 62.19 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.991 -0.623 . . . . 0.0 112.947 178.899 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -69.08 -34.9 75.87 Favored 'General case' 0 C--N 1.328 -0.367 0 O-C-N 122.598 -0.354 . . . . 0.0 110.841 -178.956 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . 0.721 ' O ' ' HG ' ' A' ' 43' ' ' LEU . 61.8 m -62.71 -55.47 26.43 Favored 'General case' 0 N--CA 1.452 -0.374 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.913 -177.639 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.48 ' HA ' HD12 ' A' ' 43' ' ' LEU . 7.5 tt -60.02 -34.21 55.73 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.383 0 CA-C-O 120.782 0.325 . . . . 0.0 111.628 -176.665 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 3.9 tmmm? -70.79 -39.4 73.18 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 179.394 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.462 ' O ' ' HG2' ' A' ' 46' ' ' ARG . 20.4 mm-40 -71.75 -37.79 70.5 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.991 -0.549 . . . . 0.0 111.187 -179.225 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.721 ' HG ' ' O ' ' A' ' 39' ' ' THR . 88.8 mt -53.44 -44.88 69.2 Favored 'General case' 0 CA--C 1.519 -0.238 0 CA-C-O 121.204 0.526 . . . . 0.0 110.992 179.428 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 47.1 mt-30 -68.14 -34.27 76.02 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.644 -0.707 . . . . 0.0 111.367 -177.435 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 32.2 mt-10 -80.48 -25.52 38.78 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 111.557 0.206 . . . . 0.0 111.557 -178.458 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . 0.462 ' HG2' ' O ' ' A' ' 42' ' ' GLN . 12.8 ptm180 -89.32 -30.2 18.6 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.688 0.28 . . . . 0.0 111.69 -178.705 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -88.63 -30.75 18.97 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 120.975 0.417 . . . . 0.0 110.905 178.528 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 91.79 -3.26 77.71 Favored Glycine 0 CA--C 1.519 0.339 0 C-N-CA 120.641 -0.79 . . . . 0.0 112.662 -179.219 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.441 ' CG1' ' HG3' ' A' ' 75' ' ' LYS . 16.1 m -103.54 179.22 0.71 Allowed 'Isoleucine or valine' 0 CA--C 1.516 -0.36 0 CA-C-O 121.063 0.459 . . . . 0.0 110.907 179.123 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . 0.673 ' HE3' ' HB ' ' A' ' 52' ' ' ILE . 8.7 tmtm? -109.89 125.05 52.4 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 115.666 -0.697 . . . . 0.0 109.171 177.158 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . 0.484 ' HE3' HG13 ' A' ' 69' ' ' ILE . 54.7 mtp -119.2 125.36 48.98 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 109.449 -0.574 . . . . 0.0 109.449 179.31 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.673 ' HB ' ' HE3' ' A' ' 50' ' ' LYS . 9.0 tt -115.67 107.69 23.33 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.805 0 CA-C-O 121.523 0.677 . . . . 0.0 110.832 177.823 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.602 HD22 HD13 ' A' ' 67' ' ' LEU . 3.4 mm? -80.95 102.78 10.35 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.206 -0.906 . . . . 0.0 108.574 170.192 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.626 HD12 ' HB2' ' A' ' 66' ' ' PRO . 59.0 mt -78.23 85.68 1.02 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.467 0 CA-C-O 121.868 0.842 . . . . 0.0 110.423 -177.301 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . 0.583 ' HG2' HD11 ' A' ' 33' ' ' ILE . 1.7 pp0? . . . . . 0 C--N 1.317 -0.835 0 CA-C-N 114.573 -1.194 . . . . 0.0 109.579 175.062 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.417 ' HB3' ' HB3' ' A' ' 23' ' ' MET . 6.6 m-20 . . . . . 0 C--O 1.231 0.121 0 N-CA-C 109.879 -0.415 . . . . 0.0 109.879 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . 0.69 ' HB2' ' HB ' ' A' ' 24' ' ' ILE . 27.6 mmtp -91.83 129.19 43.07 Favored Pre-proline 0 C--N 1.324 -0.538 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.44 -169.833 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.626 ' HB2' HD12 ' A' ' 54' ' ' ILE . 23.4 Cg_exo -66.98 111.76 2.3 Favored 'Trans proline' 0 N--CA 1.463 -0.286 0 C-N-CA 123.292 2.661 . . . . 0.0 111.816 176.165 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.602 HD13 HD22 ' A' ' 53' ' ' LEU . 23.0 tp -114.52 114.57 25.95 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.389 178.169 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . 0.636 ' HB2' ' CG2' ' A' ' 52' ' ' ILE . 99.6 mtt180 -104.34 110.52 22.79 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.657 176.682 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.514 ' O ' ' HA ' ' A' ' 19' ' ' VAL . 4.2 mp -93.92 108.33 20.45 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 N-CA-C 107.857 -1.164 . . . . 0.0 107.857 170.608 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.609 ' HA ' ' O ' ' A' ' 18' ' ' THR . 22.8 mt -116.69 133.89 61.92 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.606 -171.199 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 150.68 -108.65 0.39 Allowed Glycine 0 N--CA 1.448 -0.559 0 C-N-CA 120.811 -0.709 . . . . 0.0 113.112 172.579 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . 0.488 ' O ' HG23 ' A' ' 76' ' ' VAL . 14.1 t70 -103.79 132.08 21.38 Favored Pre-proline 0 C--N 1.318 -0.786 0 C-N-CA 123.19 0.596 . . . . 0.0 110.045 -174.916 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . 0.458 ' HG3' ' OG1' ' A' ' 18' ' ' THR . 44.7 Cg_exo -54.82 -25.93 45.46 Favored 'Trans proline' 0 C--N 1.347 0.479 0 C-N-CA 123.541 2.827 . . . . 0.0 113.431 -173.498 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 53.5 t80 -76.19 -53.47 8.22 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.464 -177.228 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.509 ' HA ' ' HB2' ' A' ' 78' ' ' GLN . 5.8 ptpt -83.37 -17.57 41.84 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.866 -0.606 . . . . 0.0 111.992 -177.591 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.488 HG23 ' O ' ' A' ' 72' ' ' ASP . 45.2 t -63.15 -38.02 80.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 N-CA-C 109.552 -0.536 . . . . 0.0 109.552 170.863 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 1.4 mm100 -77.66 -41.13 39.29 Favored 'General case' 0 N--CA 1.451 -0.397 0 C-N-CA 120.807 -0.357 . . . . 0.0 110.608 177.373 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . 0.509 ' HB2' ' HA ' ' A' ' 75' ' ' LYS . 96.4 mt-30 -55.73 -47.12 77.44 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.831 0.348 . . . . 0.0 110.532 175.046 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . 0.446 ' HA ' ' HE2' ' A' ' 82' ' ' MET . . . -66.57 -38.87 88.0 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.122 179.629 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 49.9 t -62.33 -52.14 64.82 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.406 177.89 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -63.75 -30.99 72.02 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.338 178.356 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' MET . . . . . 0.464 ' O ' HG13 ' A' ' 86' ' ' ILE . 40.1 ttp -65.08 -52.17 57.13 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.602 -0.726 . . . . 0.0 111.198 178.482 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 30.7 m -76.18 -35.54 28.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 N-CA-C 111.74 0.274 . . . . 0.0 111.74 -177.06 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 93.9 mmm -67.85 -28.63 67.71 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.871 0.367 . . . . 0.0 110.012 177.113 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -64.87 -38.43 90.95 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.682 176.674 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.464 HG13 ' O ' ' A' ' 82' ' ' MET . 35.3 mt -64.0 -26.69 41.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.339 179.007 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.58 HD22 ' HB3' ' A' ' 28' ' ' LYS . 22.4 mt -97.64 -10.48 24.99 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.771 -177.859 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 28.0 tpt180 -99.37 -25.38 14.49 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.435 0.636 . . . . 0.0 111.09 -175.721 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 . . . . . 0 C--N 1.305 -1.327 0 CA-C-N 115.359 -0.837 . . . . 0.0 109.867 -178.048 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 91.3 m . . . . . 0 N--CA 1.454 -0.238 0 CA-C-O 120.705 0.288 . . . . 0.0 110.45 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 7.6 p -140.23 138.35 37.13 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-O 120.928 0.394 . . . . 0.0 110.891 -178.786 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 28.7 mt-30 -119.16 114.61 22.72 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 109.739 -0.467 . . . . 0.0 109.739 174.213 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.713 ' HA ' ' O ' ' A' ' 67' ' ' LEU . 39.4 mt-10 -86.43 113.85 22.72 Favored 'General case' 0 CA--C 1.515 -0.392 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.864 179.079 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.483 ' HB ' ' HB3' ' A' ' 67' ' ' LEU . 14.7 mm -97.68 147.88 6.2 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 CA-C-N 115.257 -0.883 . . . . 0.0 110.227 -177.5 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' MET . . . . . 0.527 ' HB3' ' HB3' ' A' ' 64' ' ' ASP . 3.9 mmt -99.61 91.57 4.95 Favored 'General case' 0 C--N 1.317 -0.822 0 N-CA-C 108.531 -0.915 . . . . 0.0 108.531 173.322 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.665 ' HB ' ' HB2' ' A' ' 65' ' ' LYS . 36.8 mm -82.16 130.39 60.13 Favored Pre-proline 0 C--N 1.319 -0.722 0 CA-C-N 115.772 -0.649 . . . . 0.0 111.046 -174.396 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_exo -50.89 132.07 36.29 Favored 'Trans proline' 0 N--CA 1.46 -0.445 0 C-N-CA 122.885 2.39 . . . . 0.0 111.787 175.222 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -65.46 -18.89 65.67 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.263 -176.958 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -93.55 9.69 73.65 Favored Glycine 0 N--CA 1.445 -0.709 0 C-N-CA 120.97 -0.633 . . . . 0.0 112.325 177.294 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.525 ' HB3' HD22 ' A' ' 87' ' ' LEU . 58.8 mttp -132.38 26.68 4.46 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.861 0.362 . . . . 0.0 111.409 179.947 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -74.77 -23.5 58.54 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.232 0.539 . . . . 0.0 110.239 178.922 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -71.16 -16.36 75.08 Favored Glycine 0 N--CA 1.449 -0.443 0 CA-C-N 115.543 -0.753 . . . . 0.0 112.522 179.565 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 79.5 mt -93.65 -39.92 10.54 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 122.471 -0.429 . . . . 0.0 111.183 -179.299 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.58 HG13 HD21 ' A' ' 87' ' ' LEU . 2.8 m -76.4 -33.03 22.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-O 120.951 0.405 . . . . 0.0 111.533 -179.914 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.657 ' HA ' ' HB ' ' A' ' 40' ' ' ILE . 67.5 mt -93.68 -40.14 11.42 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-O 121.527 0.679 . . . . 0.0 110.18 179.079 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 119.49 160.65 11.37 Favored Glycine 0 N--CA 1.441 -1.025 0 CA-C-N 115.527 -0.76 . . . . 0.0 111.714 -179.634 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -65.47 -23.1 66.83 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.971 0.415 . . . . 0.0 110.504 -179.446 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -134.11 8.33 4.77 Favored Glycine 0 N--CA 1.446 -0.665 0 C-N-CA 120.741 -0.742 . . . . 0.0 111.896 177.244 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.591 ' HA2' HG22 ' A' ' 33' ' ' ILE . . . 87.39 12.14 67.87 Favored Glycine 0 N--CA 1.452 -0.245 0 C-N-CA 120.942 -0.646 . . . . 0.0 112.15 -177.196 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 13.7 mt-10 -84.64 -37.64 20.81 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.101 0.476 . . . . 0.0 110.6 -178.178 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . 0.688 ' O ' ' HG ' ' A' ' 43' ' ' LEU . 21.2 m -59.84 -47.88 83.96 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.532 -0.758 . . . . 0.0 111.752 -173.41 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.657 ' HB ' ' HA ' ' A' ' 33' ' ' ILE . 9.3 tt -57.68 -34.82 48.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 120.929 0.395 . . . . 0.0 111.334 -178.565 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . 0.49 ' HG3' ' OE2' ' A' ' 45' ' ' GLU . 0.0 OUTLIER -70.77 -36.76 73.21 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.103 0.478 . . . . 0.0 109.972 179.189 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 25.4 mm-40 -71.07 -39.01 72.44 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.572 -178.915 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.688 ' HG ' ' O ' ' A' ' 39' ' ' THR . 54.7 mt -57.07 -47.38 81.12 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.715 179.889 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . 0.404 ' HG3' ' O ' ' A' ' 40' ' ' ILE . 45.2 mt-30 -62.27 -50.65 70.86 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.691 -179.981 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.49 ' OE2' ' HG3' ' A' ' 41' ' ' LYS . 46.1 mt-10 -63.62 -39.56 94.69 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.722 -0.672 . . . . 0.0 112.024 -176.594 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 13.9 ptm180 -77.68 -33.38 53.28 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 111.937 0.347 . . . . 0.0 111.937 -173.847 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -93.75 -12.26 29.56 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 120.985 0.422 . . . . 0.0 111.461 -177.2 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 73.13 35.51 57.29 Favored Glycine 0 N--CA 1.451 -0.323 0 N-CA-C 111.189 -0.764 . . . . 0.0 111.189 -177.482 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 29.5 m -124.45 175.6 6.74 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-O 120.964 0.411 . . . . 0.0 110.741 -173.811 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 78.3 tttt -115.65 123.7 49.04 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 169.414 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . 0.412 ' CE ' HG11 ' A' ' 83' ' ' VAL . 71.8 mtp -123.6 114.68 20.33 Favored 'General case' 0 C--N 1.317 -0.82 0 N-CA-C 109.082 -0.71 . . . . 0.0 109.082 177.721 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.611 ' CG2' ' HB2' ' A' ' 68' ' ' ARG . 10.8 tt -109.97 105.51 18.94 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.143 0 CA-C-O 121.662 0.744 . . . . 0.0 109.595 177.362 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -82.53 102.26 11.26 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.169 -0.923 . . . . 0.0 108.625 174.716 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.502 ' HB ' ' HB2' ' A' ' 66' ' ' PRO . 20.3 mt -82.28 85.71 1.75 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.767 0 CA-C-O 121.669 0.747 . . . . 0.0 109.188 -175.939 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 4.1 pp0? . . . . . 0 C--N 1.319 -0.732 0 CA-C-N 115.171 -0.922 . . . . 0.0 110.994 -175.141 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.527 ' HB3' ' HB3' ' A' ' 23' ' ' MET . 8.4 m-20 . . . . . 0 CA--C 1.519 -0.214 0 N-CA-C 109.722 -0.473 . . . . 0.0 109.722 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . 0.665 ' HB2' ' HB ' ' A' ' 24' ' ' ILE . 1.2 mmmm -93.89 122.26 62.49 Favored Pre-proline 0 C--N 1.318 -0.769 0 CA-C-N 115.971 -0.558 . . . . 0.0 111.255 -170.645 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.502 ' HB2' ' HB ' ' A' ' 54' ' ' ILE . 39.3 Cg_exo -63.22 105.95 0.52 Allowed 'Trans proline' 0 N--CA 1.464 -0.21 0 C-N-CA 123.291 2.661 . . . . 0.0 112.225 177.476 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.713 ' O ' ' HA ' ' A' ' 21' ' ' GLU . 3.7 tt -101.42 135.69 42.49 Favored 'General case' 0 C--N 1.319 -0.735 0 N-CA-C 108.481 -0.933 . . . . 0.0 108.481 177.7 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . 0.71 ' N ' HD23 ' A' ' 67' ' ' LEU . 90.9 mtt180 -124.61 107.09 10.66 Favored 'General case' 0 N--CA 1.443 -0.82 0 C-N-CA 119.255 -0.978 . . . . 0.0 112.633 170.123 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.554 ' CD1' HD22 ' A' ' 67' ' ' LEU . 3.8 mp -90.08 106.14 16.92 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.264 0 N-CA-C 107.943 -1.132 . . . . 0.0 107.943 167.72 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 7.4 mt -109.35 127.81 65.81 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.873 0 CA-C-O 120.946 0.403 . . . . 0.0 110.394 -176.141 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 173.64 -132.47 2.31 Favored Glycine 0 N--CA 1.441 -1.026 0 N-CA-C 111.044 -0.822 . . . . 0.0 111.044 179.496 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . 0.809 ' HB3' ' HE2' ' A' ' 75' ' ' LYS . 0.0 OUTLIER -103.55 153.49 38.56 Favored Pre-proline 0 C--N 1.318 -0.799 0 CA-C-O 118.992 -0.528 . . . . 0.0 109.594 176.71 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_exo -47.1 -39.21 25.76 Favored 'Trans proline' 0 C--N 1.347 0.451 0 C-N-CA 122.273 1.982 . . . . 0.0 112.268 -178.026 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . 0.419 ' HB3' ' OD1' ' A' ' 72' ' ' ASP . 22.6 t80 -67.39 -58.9 3.93 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.089 -0.96 . . . . 0.0 111.504 -177.576 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.809 ' HE2' ' HB3' ' A' ' 72' ' ' ASP . 0.0 OUTLIER -67.54 -33.86 75.92 Favored 'General case' 0 CA--C 1.514 -0.418 0 C-N-CA 120.98 -0.288 . . . . 0.0 111.185 -178.773 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.403 HG13 ' HB ' ' A' ' 69' ' ' ILE . 55.0 t -64.39 -39.72 86.55 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.377 0 N-CA-C 109.647 -0.501 . . . . 0.0 109.647 -178.418 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . 0.698 HE21 ' HG3' ' A' ' 81' ' ' GLU . 17.8 tp60 -76.88 -41.89 42.04 Favored 'General case' 0 N--CA 1.443 -0.807 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.674 -177.739 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 23.8 mt-30 -63.93 -38.56 91.54 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 120.709 -0.396 . . . . 0.0 110.558 177.768 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -69.7 -37.16 76.5 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.534 178.766 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' CYS . . . . . 0.425 ' O ' ' HB2' ' A' ' 84' ' ' MET . 50.6 t -65.52 -46.58 79.05 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.549 176.626 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . 0.698 ' HG3' HE21 ' A' ' 77' ' ' GLN . 73.0 mt-10 -62.93 -21.87 66.36 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 121.047 0.451 . . . . 0.0 110.691 177.852 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' MET . . . . . 0.425 ' O ' HG13 ' A' ' 86' ' ' ILE . 38.5 ttp -77.46 -52.33 9.29 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.25 179.68 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.461 ' O ' ' HG ' ' A' ' 87' ' ' LEU . 32.9 m -73.52 -35.34 44.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.562 -177.853 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' MET . . . . . 0.425 ' HB2' ' O ' ' A' ' 80' ' ' CYS . 2.7 mmt -66.94 -34.12 77.08 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.682 0.277 . . . . 0.0 111.2 179.293 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . 0.479 ' O ' ' HB2' ' A' ' 89' ' ' GLU . 27.9 t70 -67.67 -31.5 71.53 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 120.836 -0.345 . . . . 0.0 110.154 -179.163 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.425 HG13 ' O ' ' A' ' 82' ' ' MET . 53.0 mt -67.44 -40.4 84.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 121.185 0.517 . . . . 0.0 109.974 176.476 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.58 HD21 HG13 ' A' ' 32' ' ' VAL . 49.1 mt -70.28 -42.02 72.63 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.699 -179.326 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . 0.452 ' HD3' HH11 ' A' ' 88' ' ' ARG . 9.5 mmm180 -85.45 7.52 22.45 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.969 -0.559 . . . . 0.0 111.201 -176.936 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . 0.479 ' HB2' ' O ' ' A' ' 85' ' ' ASP . 40.1 tt0 . . . . . 0 C--O 1.25 1.082 0 CA-C-O 118.222 -0.894 . . . . 0.0 109.663 178.346 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.549 ' OG1' ' HD3' ' A' ' 73' ' ' PRO . 90.5 m . . . . . 0 CA--C 1.528 0.129 0 CA-C-O 120.439 0.162 . . . . 0.0 111.111 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.489 ' HA ' ' O ' ' A' ' 69' ' ' ILE . 4.7 p -140.74 126.52 20.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-O 121.249 0.547 . . . . 0.0 111.931 -176.833 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 26.5 mt-30 -111.45 128.78 56.1 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.037 173.465 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.581 ' HG2' ' HG2' ' A' ' 68' ' ' ARG . 45.6 mt-10 -96.71 115.37 27.32 Favored 'General case' 0 C--N 1.327 -0.41 0 O-C-N 123.401 0.438 . . . . 0.0 111.263 178.866 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.414 ' HB ' ' HB3' ' A' ' 67' ' ' LEU . 14.4 mm -100.77 150.29 5.76 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 177.412 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 16.5 mmt -103.44 92.01 4.3 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 175.988 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.66 ' HB ' ' HB2' ' A' ' 65' ' ' LYS . 47.1 mm -81.5 128.2 70.56 Favored Pre-proline 0 C--N 1.318 -0.77 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.853 -175.625 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 81.6 Cg_exo -47.77 131.72 20.64 Favored 'Trans proline' 0 C--N 1.345 0.346 0 C-N-CA 123.21 2.607 . . . . 0.0 112.214 176.828 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -59.68 -26.71 65.78 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.855 -0.611 . . . . 0.0 111.342 -178.413 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -75.36 -31.03 57.68 Favored Glycine 0 N--CA 1.449 -0.484 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.371 177.499 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.963 ' HD3' ' HG ' ' A' ' 87' ' ' LEU . 94.6 mttt -98.22 19.18 14.66 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.786 0.327 . . . . 0.0 111.494 -178.192 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.606 ' O ' HG13 ' A' ' 33' ' ' ILE . . . -64.6 -34.07 77.41 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.798 179.288 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -68.64 -25.39 75.05 Favored Glycine 0 N--CA 1.448 -0.531 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.053 179.693 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 88.1 mt -74.03 -42.59 60.05 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.657 0.265 . . . . 0.0 110.634 -178.823 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.584 HG21 HG21 ' A' ' 24' ' ' ILE . 0.0 OUTLIER -72.84 -23.39 20.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.421 179.687 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.606 HG13 ' O ' ' A' ' 29' ' ' ALA . 67.2 mt -76.6 -35.19 25.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-O 121.74 0.781 . . . . 0.0 109.576 172.545 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . 0.708 ' HA3' ' HB ' ' A' ' 39' ' ' THR . . . 98.81 32.34 5.96 Favored Glycine 0 CA--C 1.5 -0.877 0 CA-C-N 114.962 -1.017 . . . . 0.0 112.396 177.911 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 14.5 mmmm 69.7 -64.51 0.34 Allowed 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.398 0.705 . . . . 0.0 111.68 177.633 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -89.58 -30.35 13.79 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 121.072 -0.585 . . . . 0.0 112.161 -177.815 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.584 ' HA2' HG22 ' A' ' 33' ' ' ILE . . . 109.92 -2.61 30.2 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.602 -0.808 . . . . 0.0 112.428 178.878 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -85.75 -27.54 25.16 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-O 120.993 0.425 . . . . 0.0 111.054 178.148 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . 0.708 ' HB ' ' HA3' ' A' ' 34' ' ' GLY . 17.0 m -67.07 -41.31 86.62 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.393 -177.394 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.477 ' CD1' HD23 ' A' ' 53' ' ' LEU . 8.6 tt -58.36 -33.19 46.96 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.319 0 CA-C-O 120.986 0.422 . . . . 0.0 110.765 178.697 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . 0.402 ' O ' ' HG3' ' A' ' 45' ' ' GLU . 31.3 ttpt -69.89 -43.1 72.46 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.144 0.497 . . . . 0.0 109.952 174.79 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.525 HE21 ' HA ' ' A' ' 39' ' ' THR . 49.8 mt-30 -63.5 -38.63 91.89 Favored 'General case' 0 CA--C 1.512 -0.484 0 CA-C-N 115.449 -0.796 . . . . 0.0 110.601 -177.041 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.654 ' HG ' ' O ' ' A' ' 39' ' ' THR . 73.5 mt -55.38 -43.52 75.22 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.724 179.759 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 44.4 mt-30 -64.85 -44.84 88.45 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.328 178.981 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.402 ' HG3' ' O ' ' A' ' 41' ' ' LYS . 40.8 mt-10 -63.82 -45.99 87.13 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.71 -0.677 . . . . 0.0 111.448 -178.878 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . 0.52 ' HG2' ' O ' ' A' ' 42' ' ' GLN . 11.7 ptp180 -77.46 -28.83 52.52 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 112.69 0.626 . . . . 0.0 112.69 -174.269 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.566 ' HB3' HG22 ' A' ' 49' ' ' VAL . . . -92.14 -18.08 24.03 Favored 'General case' 0 C--N 1.325 -0.478 0 C-N-CA 120.674 -0.41 . . . . 0.0 111.952 -177.441 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 75.33 25.31 68.64 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.701 -0.761 . . . . 0.0 111.652 -178.029 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.566 HG22 ' HB3' ' A' ' 47' ' ' ALA . 33.4 m -127.8 170.46 17.56 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 N-CA-C 109.791 -0.448 . . . . 0.0 109.791 -178.183 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . 0.62 ' HE3' ' HB ' ' A' ' 52' ' ' ILE . 8.9 tmtm? -110.8 124.37 51.9 Favored 'General case' 0 C--N 1.317 -0.84 0 N-CA-C 109.306 -0.628 . . . . 0.0 109.306 175.838 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . 0.518 ' CE ' ' HB1' ' A' ' 79' ' ' ALA . 62.6 mtt -112.42 129.34 56.36 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 179.347 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.62 ' HB ' ' HE3' ' A' ' 50' ' ' LYS . 8.9 tt -122.3 105.69 16.62 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.933 0 CA-C-O 121.514 0.673 . . . . 0.0 110.133 175.129 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.519 ' O ' ' HG2' ' A' ' 55' ' ' GLN . 4.0 mm? -81.44 103.42 11.17 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 115.3 -0.863 . . . . 0.0 109.035 174.916 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.577 HD12 ' HB2' ' A' ' 66' ' ' PRO . 53.5 mt -75.54 87.04 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 122.013 0.911 . . . . 0.0 109.689 179.185 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . 0.519 ' HG2' ' O ' ' A' ' 53' ' ' LEU . 2.2 pt20 . . . . . 0 C--N 1.317 -0.825 0 CA-C-N 114.359 -1.291 . . . . 0.0 109.293 -178.017 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 . . . . . 0 N--CA 1.465 0.319 0 CA-C-O 120.775 0.321 . . . . 0.0 110.661 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . 0.66 ' HB2' ' HB ' ' A' ' 24' ' ' ILE . 72.1 mmtt -96.72 125.48 46.64 Favored Pre-proline 0 C--N 1.316 -0.865 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.361 -170.449 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.577 ' HB2' HD12 ' A' ' 54' ' ' ILE . 14.0 Cg_exo -70.5 106.31 1.77 Allowed 'Trans proline' 0 N--CA 1.457 -0.647 0 C-N-CA 122.958 2.439 . . . . 0.0 111.317 174.949 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.547 HD21 HG21 ' A' ' 83' ' ' VAL . 23.2 tp -105.4 110.93 23.46 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.841 -0.618 . . . . 0.0 109.693 178.818 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . 0.606 ' HB2' ' CG2' ' A' ' 52' ' ' ILE . 96.1 mtt180 -101.65 109.28 21.04 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-O 120.932 0.396 . . . . 0.0 110.952 177.718 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.489 ' O ' ' HA ' ' A' ' 19' ' ' VAL . 4.4 mp -90.29 104.14 14.96 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 172.237 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 18.3 mt -104.48 121.73 56.59 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.588 -174.647 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 175.95 -125.4 1.05 Allowed Glycine 0 N--CA 1.445 -0.75 0 CA-C-N 116.002 -0.545 . . . . 0.0 112.025 179.872 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -114.84 142.67 28.72 Favored Pre-proline 0 C--N 1.32 -0.698 0 N-CA-C 108.863 -0.791 . . . . 0.0 108.863 179.641 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . 0.549 ' HD3' ' OG1' ' A' ' 18' ' ' THR . 86.0 Cg_exo -43.33 -39.5 9.01 Favored 'Trans proline' 0 C--N 1.351 0.699 0 C-N-CA 123.034 2.489 . . . . 0.0 112.751 -173.636 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 66.6 t80 -63.33 -57.83 9.11 Favored 'General case' 0 N--CA 1.451 -0.425 0 CA-C-N 115.225 -0.898 . . . . 0.0 111.293 -177.949 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 32.9 pttt -75.96 -30.45 58.63 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.482 -0.326 . . . . 0.0 111.571 -178.221 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 51.9 t -57.24 -40.62 74.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-O 120.894 0.378 . . . . 0.0 110.031 176.395 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -73.67 -45.85 50.01 Favored 'General case' 0 N--CA 1.448 -0.544 0 C-N-CA 120.496 -0.481 . . . . 0.0 111.094 179.144 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 11.3 mt-30 -63.41 -37.76 88.52 Favored 'General case' 0 C--N 1.326 -0.419 0 C-N-CA 120.389 -0.524 . . . . 0.0 111.115 -179.355 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . 0.518 ' HB1' ' CE ' ' A' ' 51' ' ' MET . . . -67.57 -37.69 82.99 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.211 176.856 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 37.4 t -63.91 -48.04 78.2 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.586 175.867 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 55.0 mt-10 -61.15 -38.43 86.39 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 110.045 -0.354 . . . . 0.0 110.045 177.19 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' MET . . . . . 0.461 ' O ' HG13 ' A' ' 86' ' ' ILE . 48.1 ttp -61.1 -49.38 77.52 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.658 -0.701 . . . . 0.0 111.315 179.611 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.547 HG21 HD21 ' A' ' 67' ' ' LEU . 27.7 m -77.33 -33.06 19.38 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-O 120.813 0.339 . . . . 0.0 110.897 -176.801 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 54.7 ttp -67.11 -33.69 76.0 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 109.427 -0.583 . . . . 0.0 109.427 176.005 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -67.33 -31.2 71.31 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.417 -0.811 . . . . 0.0 110.641 178.106 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.461 HG13 ' O ' ' A' ' 82' ' ' MET . 59.4 mt -61.32 -30.49 48.06 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.304 0 CA-C-O 121.365 0.603 . . . . 0.0 110.17 176.398 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.963 ' HG ' ' HD3' ' A' ' 28' ' ' LYS . 6.9 mp -88.1 -5.87 58.21 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.733 178.844 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 6.0 tmm_? -114.37 -3.79 13.04 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.443 0.64 . . . . 0.0 110.717 -175.161 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . 0.443 ' O ' ' HG3' ' A' ' 89' ' ' GLU . 9.6 pt-20 . . . . . 0 C--O 1.251 1.143 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.895 -177.317 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 55.4 m . . . . . 0 N--CA 1.448 -0.548 0 CA-C-O 120.784 0.326 . . . . 0.0 110.449 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.659 HG22 HG23 ' A' ' 70' ' ' ILE . 92.8 t -116.72 121.18 67.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 N-CA-C 109.71 -0.478 . . . . 0.0 109.71 176.406 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . 0.53 ' HB2' ' CG1' ' A' ' 76' ' ' VAL . 13.1 tt0 -114.18 113.05 24.14 Favored 'General case' 0 C--N 1.315 -0.903 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 177.927 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.61 ' HA ' ' O ' ' A' ' 67' ' ' LEU . 49.7 mt-10 -99.43 112.9 25.01 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.117 179.194 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 12.6 mm -97.24 155.48 3.58 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-N 115.614 -0.721 . . . . 0.0 109.67 179.111 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 1.9 mmt -109.15 91.85 3.81 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 175.845 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.674 ' HB ' ' HB2' ' A' ' 65' ' ' LYS . 37.2 mm -79.27 127.31 79.38 Favored Pre-proline 0 C--N 1.319 -0.752 0 CA-C-N 115.859 -0.609 . . . . 0.0 110.629 -175.209 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . 0.727 ' HB2' ' HB2' ' A' ' 28' ' ' LYS . 87.3 Cg_exo -48.14 131.61 22.15 Favored 'Trans proline' 0 C--N 1.343 0.288 0 C-N-CA 122.84 2.36 . . . . 0.0 111.961 177.126 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -59.59 -30.6 68.78 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.701 -175.434 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -94.47 12.51 68.75 Favored Glycine 0 N--CA 1.45 -0.432 0 C-N-CA 120.785 -0.721 . . . . 0.0 112.332 178.743 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.727 ' HB2' ' HB2' ' A' ' 25' ' ' PRO . 16.4 tptt -126.48 8.36 7.07 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.15 0.5 . . . . 0.0 110.263 -179.677 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -70.0 -22.41 63.12 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.14 -176.898 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -67.59 -17.37 68.81 Favored Glycine 0 N--CA 1.445 -0.761 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.412 178.124 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.415 HD12 ' HG3' ' A' ' 28' ' ' LYS . 54.0 mt -87.59 -38.45 15.94 Favored 'General case' 0 C--N 1.328 -0.345 0 O-C-N 122.613 -0.345 . . . . 0.0 111.436 -179.195 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.741 HG13 HD21 ' A' ' 87' ' ' LEU . 2.8 m -70.81 -32.68 49.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.962 0.41 . . . . 0.0 111.043 179.879 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.561 HD11 ' HG3' ' A' ' 55' ' ' GLN . 60.2 mt -83.2 -36.76 13.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-O 121.669 0.747 . . . . 0.0 109.763 175.262 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 101.62 171.76 27.98 Favored Glycine 0 N--CA 1.445 -0.745 0 CA-C-N 114.977 -1.01 . . . . 0.0 111.608 -179.722 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 10.5 mptt -81.6 48.76 1.22 Allowed 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.098 0.475 . . . . 0.0 110.373 178.977 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 170.45 -44.23 0.2 Allowed Glycine 0 N--CA 1.447 -0.619 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.778 179.238 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.459 ' HA2' HG22 ' A' ' 33' ' ' ILE . . . 123.19 -4.31 9.61 Favored Glycine 0 N--CA 1.449 -0.439 0 C-N-CA 120.785 -0.721 . . . . 0.0 111.536 -177.192 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -75.13 -33.46 61.56 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.019 0.438 . . . . 0.0 109.95 178.651 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . 0.687 ' O ' ' HG ' ' A' ' 43' ' ' LEU . 69.9 m -58.28 -54.39 47.54 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-N 115.583 -0.735 . . . . 0.0 111.198 -176.289 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.564 ' HA ' HD12 ' A' ' 43' ' ' LEU . 10.3 tt -59.77 -34.61 56.23 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.28 0 CA-C-O 120.837 0.351 . . . . 0.0 111.14 179.915 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . 0.465 ' O ' ' HG2' ' A' ' 45' ' ' GLU . 50.1 tttp -62.33 -48.96 77.52 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.339 175.078 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.445 ' O ' ' HG2' ' A' ' 46' ' ' ARG . 72.4 mm-40 -64.69 -33.56 76.24 Favored 'General case' 0 CA--C 1.509 -0.602 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.013 -175.259 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.687 ' HG ' ' O ' ' A' ' 39' ' ' THR . 67.8 mt -58.25 -48.24 81.03 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.413 179.307 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 43.1 mt-30 -65.79 -38.61 89.48 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.534 179.089 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.465 ' HG2' ' O ' ' A' ' 41' ' ' LYS . 60.0 mm-40 -60.69 -52.66 64.17 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.669 177.817 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . 0.445 ' HG2' ' O ' ' A' ' 42' ' ' GLN . 10.7 ptm180 -77.67 -29.93 51.77 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.592 -0.731 . . . . 0.0 112.634 -170.825 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -87.55 -25.87 23.42 Favored 'General case' 0 C--N 1.323 -0.554 0 C-N-CA 120.702 -0.399 . . . . 0.0 111.927 -176.077 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 78.23 24.84 62.75 Favored Glycine 0 N--CA 1.453 -0.215 0 C-N-CA 120.577 -0.82 . . . . 0.0 112.424 -179.812 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 5.9 m -135.75 179.29 4.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 N-CA-C 109.926 -0.398 . . . . 0.0 109.926 177.343 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 60.8 tttp -107.4 124.67 50.18 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.846 179.905 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 37.3 mtt -118.97 116.43 26.44 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 177.639 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.607 ' CG2' ' HB2' ' A' ' 68' ' ' ARG . 10.7 tt -111.22 113.43 44.23 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.899 0 CA-C-O 121.447 0.641 . . . . 0.0 110.733 178.675 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.722 HD22 HD13 ' A' ' 67' ' ' LEU . 2.9 mm? -88.17 102.51 14.87 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.581 -0.736 . . . . 0.0 109.467 175.7 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.846 HD12 ' HB2' ' A' ' 66' ' ' PRO . 65.2 mt -75.82 95.07 1.09 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-O 121.331 0.586 . . . . 0.0 110.011 -179.63 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . 0.599 HE21 ' HB3' ' A' ' 53' ' ' LEU . 84.6 mm-40 . . . . . 0 C--N 1.324 -0.527 0 CA-C-N 115.516 -0.765 . . . . 0.0 110.604 -176.079 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 12.1 m-20 . . . . . 0 C--O 1.227 -0.085 0 CA-C-O 120.887 0.375 . . . . 0.0 110.388 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . 0.674 ' HB2' ' HB ' ' A' ' 24' ' ' ILE . 74.0 mmtt -95.26 127.0 43.98 Favored Pre-proline 0 C--N 1.319 -0.74 0 CA-C-N 116.103 -0.498 . . . . 0.0 111.567 -170.573 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.846 ' HB2' HD12 ' A' ' 54' ' ' ILE . 10.6 Cg_exo -71.63 109.11 2.56 Favored 'Trans proline' 0 N--CA 1.459 -0.525 0 C-N-CA 123.074 2.516 . . . . 0.0 111.318 175.556 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.722 HD13 HD22 ' A' ' 53' ' ' LEU . 23.9 tp -106.04 100.01 9.58 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.986 -0.552 . . . . 0.0 109.848 178.467 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . 0.607 ' HB2' ' CG2' ' A' ' 52' ' ' ILE . 97.6 mtt180 -85.64 105.11 15.97 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.939 0.4 . . . . 0.0 110.242 176.766 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 31.8 mt -92.4 105.04 16.25 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.718 0 N-CA-C 108.116 -1.068 . . . . 0.0 108.116 171.452 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.659 HG23 HG22 ' A' ' 19' ' ' VAL . 14.5 mt -111.4 129.51 66.62 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.909 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.575 -171.357 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 148.32 -124.67 1.92 Allowed Glycine 0 N--CA 1.441 -0.975 0 C-N-CA 119.847 -1.168 . . . . 0.0 113.833 171.115 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . 0.464 ' OD2' ' HG2' ' A' ' 75' ' ' LYS . 4.7 t70 -85.62 128.95 56.78 Favored Pre-proline 0 C--N 1.321 -0.632 0 CA-C-N 115.206 -0.497 . . . . 0.0 111.685 -171.779 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_exo -45.36 -33.64 9.2 Favored 'Trans proline' 0 C--N 1.349 0.596 0 C-N-CA 124.621 3.547 . . . . 0.0 114.346 -175.742 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 90.5 m-85 -74.91 -60.88 2.09 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.069 0.462 . . . . 0.0 110.214 -178.967 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.641 ' HA ' ' HB2' ' A' ' 78' ' ' GLN . 3.8 pttm -74.09 -17.07 61.0 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.745 -0.661 . . . . 0.0 112.586 -173.881 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.53 ' CG1' ' HB2' ' A' ' 20' ' ' GLN . 37.3 t -65.06 -44.35 95.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 121.429 0.633 . . . . 0.0 109.543 170.406 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -74.54 -43.23 56.74 Favored 'General case' 0 N--CA 1.446 -0.651 0 CA-C-N 115.29 -0.868 . . . . 0.0 109.129 -178.402 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . 0.641 ' HB2' ' HA ' ' A' ' 75' ' ' LYS . 61.9 mt-30 -56.71 -36.2 69.4 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.495 -0.775 . . . . 0.0 110.661 175.269 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -68.38 -45.08 73.7 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.608 -0.724 . . . . 0.0 110.917 177.957 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' CYS . . . . . 0.415 ' HB2' ' OE1' ' A' ' 20' ' ' GLN . 33.4 t -54.84 -56.71 16.5 Favored 'General case' 0 CA--C 1.518 -0.278 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.968 178.516 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -63.42 -27.08 69.05 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 120.77 -0.372 . . . . 0.0 110.877 -178.647 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 47.7 ttp -73.59 -49.67 25.09 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.434 179.839 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.537 HG12 HD13 ' A' ' 43' ' ' LEU . 34.2 m -76.39 -32.75 22.22 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-O 120.853 0.359 . . . . 0.0 110.591 -175.626 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' MET . . . . . 0.46 ' O ' ' HG3' ' A' ' 88' ' ' ARG . 45.2 ttm -68.56 -31.62 70.95 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.075 -0.511 . . . . 0.0 109.859 177.041 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . 0.522 ' HA ' ' HD2' ' A' ' 88' ' ' ARG . 21.4 t70 -62.81 -40.45 97.42 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.892 -0.595 . . . . 0.0 111.113 178.602 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 42.1 mt -61.08 -29.97 46.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.445 179.279 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.741 HD21 HG13 ' A' ' 32' ' ' VAL . 61.2 mt -79.0 -20.89 47.93 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.384 -177.434 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . 0.522 ' HD2' ' HA ' ' A' ' 85' ' ' ASP . 0.0 OUTLIER -117.99 27.56 8.93 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.17 0.51 . . . . 0.0 110.935 -179.84 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 44.9 tt0 . . . . . 0 C--O 1.248 1.007 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.174 179.551 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.433 ' HB ' HG21 ' A' ' 76' ' ' VAL . 58.8 m . . . . . 0 N--CA 1.446 -0.627 0 N-CA-C 109.63 -0.508 . . . . 0.0 109.63 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.505 ' HA ' ' O ' ' A' ' 69' ' ' ILE . 5.2 p -132.19 126.42 56.01 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-O 121.237 0.541 . . . . 0.0 110.999 179.693 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . 0.412 ' OE1' HG12 ' A' ' 76' ' ' VAL . 55.1 mt-30 -115.5 119.91 37.74 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.561 177.017 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.636 ' HA ' ' O ' ' A' ' 67' ' ' LEU . 49.8 mt-10 -92.03 111.9 23.62 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.244 0.545 . . . . 0.0 110.546 177.429 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 15.8 mm -104.0 155.63 5.73 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-N 115.331 -0.85 . . . . 0.0 109.695 -178.347 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' MET . . . . . 0.541 ' HB3' ' HB3' ' A' ' 64' ' ' ASP . 80.6 mmm -108.43 104.97 14.43 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 176.227 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.644 ' HB ' ' HB2' ' A' ' 65' ' ' LYS . 30.5 mm -91.23 125.0 59.84 Favored Pre-proline 0 C--N 1.321 -0.656 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.115 -174.117 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . 0.566 ' HB2' ' HB3' ' A' ' 28' ' ' LYS . 76.9 Cg_exo -50.3 140.52 33.94 Favored 'Trans proline' 0 CA--C 1.535 0.555 0 C-N-CA 122.845 2.363 . . . . 0.0 113.019 179.715 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -48.88 -61.75 1.88 Allowed 'General case' 0 N--CA 1.468 0.454 0 N-CA-C 113.42 0.896 . . . . 0.0 113.42 -170.605 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -78.67 -25.64 60.26 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.712 -0.756 . . . . 0.0 111.883 -177.334 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.577 ' HG3' HD22 ' A' ' 87' ' ' LEU . 13.0 tppt? -67.57 -19.18 65.23 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.99 0.424 . . . . 0.0 110.875 178.891 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.477 ' O ' HG12 ' A' ' 32' ' ' VAL . . . -59.66 -23.5 63.13 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.415 179.802 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -60.58 -27.03 65.47 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.855 -0.688 . . . . 0.0 112.16 176.598 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 92.5 mt -87.61 -33.53 18.82 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.643 0.258 . . . . 0.0 110.705 179.787 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.477 HG12 ' O ' ' A' ' 29' ' ' ALA . 0.9 OUTLIER -73.55 -31.27 32.1 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.387 0 CA-C-O 121.071 0.463 . . . . 0.0 110.916 -178.711 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.541 HG22 ' HA2' ' A' ' 37' ' ' GLY . 75.6 mt -84.87 -44.64 17.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 116.01 -0.541 . . . . 0.0 109.89 176.117 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 132.46 170.16 12.45 Favored Glycine 0 N--CA 1.441 -1.004 0 C-N-CA 120.242 -0.98 . . . . 0.0 112.936 174.606 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.409 ' N ' ' HD3' ' A' ' 35' ' ' LYS . 3.3 mppt? -69.36 -28.52 66.28 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.025 0.44 . . . . 0.0 109.879 -179.114 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -136.69 19.18 3.56 Favored Glycine 0 N--CA 1.447 -0.568 0 C-N-CA 120.825 -0.702 . . . . 0.0 111.355 175.592 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.541 ' HA2' HG22 ' A' ' 33' ' ' ILE . . . 78.57 5.92 88.13 Favored Glycine 0 C--O 1.226 -0.4 0 C-N-CA 120.913 -0.661 . . . . 0.0 112.072 -176.885 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -85.53 -24.18 27.39 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 120.887 0.375 . . . . 0.0 111.537 -178.587 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . 0.649 ' O ' ' HG ' ' A' ' 43' ' ' LEU . 31.5 m -64.26 -48.97 73.72 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.232 -176.415 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.557 ' HA ' HD12 ' A' ' 43' ' ' LEU . 5.3 tt -55.72 -30.43 27.23 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.342 0 CA-C-O 121.071 0.462 . . . . 0.0 111.513 179.757 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . 0.444 ' O ' ' HG2' ' A' ' 45' ' ' GLU . 7.8 tmtm? -74.47 -39.58 62.42 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.055 -0.52 . . . . 0.0 109.758 -178.904 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 25.4 mt-30 -67.82 -35.62 78.93 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.825 -179.702 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.649 ' HG ' ' O ' ' A' ' 39' ' ' THR . 47.7 mt -58.5 -42.65 88.14 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.454 -179.224 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 65.9 mt-30 -62.69 -39.88 95.37 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.629 179.595 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.444 ' HG2' ' O ' ' A' ' 41' ' ' LYS . 34.6 mm-40 -74.07 -51.2 16.5 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.382 -176.727 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 17.5 ptm180 -66.63 -37.46 84.9 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.966 -0.561 . . . . 0.0 112.25 -171.798 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.414 ' HB3' HG22 ' A' ' 49' ' ' VAL . . . -95.77 -13.39 24.16 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 120.969 0.414 . . . . 0.0 111.391 -176.795 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 69.19 31.17 71.74 Favored Glycine 0 N--CA 1.449 -0.467 0 N-CA-C 111.274 -0.73 . . . . 0.0 111.274 -176.082 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.501 HG12 ' HD3' ' A' ' 75' ' ' LYS . 34.4 m -113.04 166.84 6.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-O 120.809 0.337 . . . . 0.0 110.394 -175.735 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -111.65 123.33 50.0 Favored 'General case' 0 C--N 1.318 -0.794 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 171.211 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 75.8 mtp -123.8 115.32 21.17 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 109.806 -0.442 . . . . 0.0 109.806 178.643 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.501 ' CG2' ' HB2' ' A' ' 68' ' ' ARG . 6.8 tt -104.43 105.84 19.27 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.837 0 CA-C-O 121.437 0.636 . . . . 0.0 109.977 178.432 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.609 HD22 HD13 ' A' ' 67' ' ' LEU . 2.5 mm? -78.28 102.64 7.76 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.681 -0.691 . . . . 0.0 109.594 177.007 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.453 ' HB ' ' HB2' ' A' ' 66' ' ' PRO . 60.8 mt -87.5 85.89 2.51 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-O 121.509 0.671 . . . . 0.0 109.467 -178.239 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 1.3 pt20 . . . . . 0 C--N 1.321 -0.635 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.834 -177.162 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.541 ' HB3' ' HB3' ' A' ' 23' ' ' MET . 1.9 m-20 . . . . . 0 CA--C 1.531 0.222 0 CA-C-O 121.412 0.625 . . . . 0.0 111.981 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . 0.644 ' HB2' ' HB ' ' A' ' 24' ' ' ILE . 71.7 mmtt -99.35 127.59 34.09 Favored Pre-proline 0 C--N 1.322 -0.594 0 CA-C-N 115.156 -0.929 . . . . 0.0 111.49 -174.176 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.453 ' HB2' ' HB ' ' A' ' 54' ' ' ILE . 38.7 Cg_exo -65.03 114.33 2.76 Favored 'Trans proline' 0 CA--C 1.533 0.434 0 C-N-CA 122.896 2.397 . . . . 0.0 111.719 169.619 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.636 ' O ' ' HA ' ' A' ' 21' ' ' GLU . 28.7 tp -122.95 126.58 47.49 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 120.588 0.232 . . . . 0.0 111.114 179.809 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . 0.583 ' HG2' ' HG2' ' A' ' 21' ' ' GLU . 96.4 mtt180 -109.19 115.93 30.95 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 120.674 0.273 . . . . 0.0 111.519 176.086 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.505 ' O ' ' HA ' ' A' ' 19' ' ' VAL . 4.5 mp -97.62 115.8 38.46 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 N-CA-C 108.423 -0.954 . . . . 0.0 108.423 170.866 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 15.0 mt -119.38 140.66 42.6 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.569 -174.473 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 157.36 -160.12 30.28 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.877 -0.678 . . . . 0.0 112.165 176.738 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . 0.577 ' H ' ' HD2' ' A' ' 75' ' ' LYS . 1.0 OUTLIER -61.99 137.19 95.44 Favored Pre-proline 0 N--CA 1.447 -0.617 0 N-CA-C 108.631 -0.877 . . . . 0.0 108.631 174.477 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_exo -42.47 -41.17 7.71 Favored 'Trans proline' 0 CA--C 1.534 0.478 0 C-N-CA 122.825 2.35 . . . . 0.0 114.219 -173.462 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 73.3 m-85 -69.52 -51.61 34.14 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.111 -0.495 . . . . 0.0 112.191 -175.136 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.577 ' HD2' ' H ' ' A' ' 72' ' ' ASP . 16.9 ptpt -62.92 -32.34 73.6 Favored 'General case' 0 C--O 1.222 -0.349 0 CA-C-N 116.687 -0.233 . . . . 0.0 110.689 -179.024 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.497 HG23 ' O ' ' A' ' 72' ' ' ASP . 96.6 t -56.89 -48.05 82.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 120.771 0.319 . . . . 0.0 110.329 177.849 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 1.6 mm100 -71.14 -42.46 69.14 Favored 'General case' 0 N--CA 1.45 -0.456 0 CA-C-N 116.4 -0.363 . . . . 0.0 111.332 178.158 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 47.1 mt-30 -60.17 -42.37 94.82 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.717 0.294 . . . . 0.0 111.069 178.955 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -71.34 -36.43 71.53 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.766 178.917 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 49.8 t -61.17 -54.9 38.62 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.229 176.51 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -61.59 -30.05 70.43 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.885 0.374 . . . . 0.0 110.599 179.247 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 52.5 ttp -64.74 -53.29 49.45 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.886 178.534 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.617 ' O ' ' HG ' ' A' ' 87' ' ' LEU . 32.9 m -78.65 -33.24 16.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-O 120.656 0.265 . . . . 0.0 110.863 -176.254 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 59.8 ttp -66.51 -35.61 80.67 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.106 178.678 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -60.27 -38.38 83.38 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.62 176.76 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 48.6 mt -66.7 -27.25 39.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-O 121.273 0.559 . . . . 0.0 110.339 178.735 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.617 ' HG ' ' O ' ' A' ' 83' ' ' VAL . 35.4 mt -91.71 -28.12 17.64 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.273 -176.774 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . 0.442 HH11 ' HD2' ' A' ' 88' ' ' ARG . 12.9 mmt180 -85.99 -13.07 48.68 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.316 0.579 . . . . 0.0 111.117 -179.287 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 . . . . . 0 C--N 1.312 -1.064 0 CA-C-N 115.359 -0.837 . . . . 0.0 110.028 -178.009 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 16.1 m . . . . . 0 N--CA 1.453 -0.312 0 CA-C-O 120.661 0.267 . . . . 0.0 110.712 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.401 HG22 HG23 ' A' ' 70' ' ' ILE . 60.5 t -131.71 131.86 62.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.423 179.884 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 28.6 mt-30 -120.84 114.8 22.13 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.086 173.803 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.578 ' HA ' ' O ' ' A' ' 67' ' ' LEU . 48.5 mt-10 -86.61 119.65 27.08 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.958 -0.564 . . . . 0.0 111.052 178.812 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.494 ' HB ' ' HB3' ' A' ' 67' ' ' LEU . 14.9 mm -105.68 163.43 4.56 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 115.341 -0.845 . . . . 0.0 110.091 -178.395 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' MET . . . . . 0.456 ' HB3' ' HB3' ' A' ' 64' ' ' ASP . 2.3 mmt -109.75 94.89 5.26 Favored 'General case' 0 N--CA 1.453 -0.324 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 176.049 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.748 ' HB ' ' HB2' ' A' ' 65' ' ' LYS . 36.5 mm -82.78 126.48 72.99 Favored Pre-proline 0 C--N 1.318 -0.775 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.178 -174.589 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . 0.718 ' HD2' HD13 ' A' ' 87' ' ' LEU . 84.6 Cg_exo -47.39 124.87 9.89 Favored 'Trans proline' 0 C--N 1.346 0.407 0 C-N-CA 123.132 2.555 . . . . 0.0 112.533 178.621 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -63.69 -34.38 77.72 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.645 -0.707 . . . . 0.0 111.872 -174.359 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -90.88 -3.75 70.24 Favored Glycine 0 N--CA 1.448 -0.543 0 C-N-CA 120.609 -0.805 . . . . 0.0 112.93 -178.724 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.503 ' HB3' ' HB2' ' A' ' 25' ' ' PRO . 43.4 tttt -121.44 17.17 11.35 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.222 0.534 . . . . 0.0 110.759 -176.93 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.447 ' O ' HG12 ' A' ' 32' ' ' VAL . . . -70.57 -21.15 62.72 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.901 -0.591 . . . . 0.0 111.275 -178.27 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -65.39 -18.19 65.09 Favored Glycine 0 C--O 1.227 -0.308 0 C-N-CA 121.11 -0.567 . . . . 0.0 112.646 178.458 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.621 ' HB3' HG22 ' A' ' 86' ' ' ILE . 66.1 mt -88.53 -41.57 12.63 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.619 0.247 . . . . 0.0 110.939 178.819 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.731 ' HB ' HD21 ' A' ' 87' ' ' LEU . 4.3 p -69.67 -33.65 57.5 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.435 0 CA-C-O 121.334 0.587 . . . . 0.0 110.824 -178.718 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.59 ' HA ' ' HB ' ' A' ' 40' ' ' ILE . 76.6 mt -90.35 -39.87 12.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-N 115.591 -0.731 . . . . 0.0 110.59 179.061 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 107.63 151.39 16.83 Favored Glycine 0 N--CA 1.443 -0.838 0 CA-C-N 115.756 -0.656 . . . . 0.0 111.777 -179.075 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.545 ' HE3' HD23 ' A' ' 31' ' ' LEU . 0.2 OUTLIER -68.81 -11.34 60.31 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.719 0.295 . . . . 0.0 111.31 -178.088 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -137.36 17.83 3.52 Favored Glycine 0 N--CA 1.449 -0.483 0 C-N-CA 120.715 -0.755 . . . . 0.0 111.693 176.639 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 69.78 1.55 32.07 Favored Glycine 0 CA--C 1.521 0.411 0 C-N-CA 121.248 -0.501 . . . . 0.0 112.785 -177.655 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -69.9 -35.99 75.05 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.834 0.35 . . . . 0.0 111.114 -178.171 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . 0.757 ' O ' ' HG ' ' A' ' 43' ' ' LEU . 93.8 m -57.72 -61.21 2.68 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.092 -179.304 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.65 ' HA ' HD12 ' A' ' 43' ' ' LEU . 7.6 tt -60.33 -29.83 44.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 116.045 -0.525 . . . . 0.0 112.09 -175.243 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 11.6 tmtt? -74.58 -42.34 58.9 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 109.86 -0.422 . . . . 0.0 109.86 -179.381 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.516 ' O ' ' HG2' ' A' ' 46' ' ' ARG . 47.6 mt-30 -66.09 -31.72 72.76 Favored 'General case' 0 CA--C 1.517 -0.303 0 CA-C-O 120.961 0.41 . . . . 0.0 110.469 -179.305 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.757 ' HG ' ' O ' ' A' ' 39' ' ' THR . 44.4 mt -61.89 -33.25 73.88 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.674 -179.995 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . 0.402 ' HA ' ' O ' ' A' ' 49' ' ' VAL . 65.0 mt-30 -71.66 -23.03 61.6 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.433 0.635 . . . . 0.0 110.547 179.661 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 68.5 mm-40 -87.86 -55.1 3.91 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.82 -179.885 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . 0.516 ' HG2' ' O ' ' A' ' 42' ' ' GLN . 14.6 ptp180 -69.84 -30.87 68.47 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 113.02 0.748 . . . . 0.0 113.02 -172.492 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.509 ' HB3' HG22 ' A' ' 49' ' ' VAL . . . -95.48 -18.56 20.57 Favored 'General case' 0 C--N 1.323 -0.553 0 C-N-CA 120.736 -0.386 . . . . 0.0 111.594 -176.487 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 75.74 17.45 80.1 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.83 -0.7 . . . . 0.0 112.212 -179.415 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.509 HG22 ' HB3' ' A' ' 47' ' ' ALA . 21.2 m -116.1 166.41 10.23 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-O 120.809 0.338 . . . . 0.0 110.279 179.846 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 85.6 tttt -108.66 121.29 44.71 Favored 'General case' 0 C--N 1.314 -0.952 0 N-CA-C 108.474 -0.935 . . . . 0.0 108.474 169.31 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . 0.908 ' HE1' HG11 ' A' ' 83' ' ' VAL . 15.9 mtm -114.08 115.3 27.34 Favored 'General case' 0 C--N 1.316 -0.855 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 177.268 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.584 ' CG2' ' HB2' ' A' ' 68' ' ' ARG . 11.6 tt -100.34 106.94 20.07 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.084 0 CA-C-O 121.418 0.628 . . . . 0.0 110.348 179.561 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.867 HD22 HD13 ' A' ' 67' ' ' LEU . 3.0 mm? -72.78 101.52 3.13 Favored 'General case' 0 N--CA 1.445 -0.675 0 N-CA-C 107.382 -1.34 . . . . 0.0 107.382 171.165 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.711 HD12 ' HB2' ' A' ' 66' ' ' PRO . 62.8 mt -73.54 86.24 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.482 0 CA-C-O 122.078 0.942 . . . . 0.0 111.135 -170.852 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 32.3 mt-30 . . . . . 0 C--N 1.321 -0.654 0 CA-C-N 114.209 -1.359 . . . . 0.0 107.742 170.223 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.456 ' HB3' ' HB3' ' A' ' 23' ' ' MET . 1.1 m-20 . . . . . 0 N--CA 1.456 -0.165 0 CA-C-O 121.05 0.452 . . . . 0.0 110.743 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . 0.748 ' HB2' ' HB ' ' A' ' 24' ' ' ILE . 30.3 mmtp -90.55 132.67 34.56 Favored Pre-proline 0 C--N 1.322 -0.609 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.988 -170.355 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.711 ' HB2' HD12 ' A' ' 54' ' ' ILE . 17.4 Cg_exo -68.16 110.45 2.21 Favored 'Trans proline' 0 N--CA 1.456 -0.708 0 C-N-CA 122.684 2.256 . . . . 0.0 110.965 173.802 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.867 HD13 HD22 ' A' ' 53' ' ' LEU . 30.0 tp -108.6 114.05 27.55 Favored 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 110.138 -0.319 . . . . 0.0 110.138 178.064 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . 0.584 ' HB2' ' CG2' ' A' ' 52' ' ' ILE . 97.3 mtt180 -99.46 106.19 18.21 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 116.487 -0.324 . . . . 0.0 110.479 176.254 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.506 ' HB ' HG13 ' A' ' 76' ' ' VAL . 4.5 mp -86.39 103.93 13.34 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 N-CA-C 107.855 -1.165 . . . . 0.0 107.855 170.196 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.401 HG23 HG22 ' A' ' 19' ' ' VAL . 31.1 mt -101.57 116.12 44.59 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.867 0 CA-C-N 115.534 -0.757 . . . . 0.0 110.19 -174.282 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 177.19 -123.99 0.92 Allowed Glycine 0 N--CA 1.442 -0.935 0 C-N-CA 120.42 -0.895 . . . . 0.0 112.258 178.945 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -119.46 141.85 31.55 Favored Pre-proline 0 C--N 1.318 -0.793 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 -177.631 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 82.8 Cg_exo -43.66 -38.03 8.87 Favored 'Trans proline' 0 C--N 1.35 0.611 0 C-N-CA 123.064 2.509 . . . . 0.0 113.212 -173.003 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . 0.417 ' O ' ' HG3' ' A' ' 78' ' ' GLN . 47.3 t80 -66.18 -61.99 1.72 Allowed 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.65 -0.705 . . . . 0.0 111.491 -177.416 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.424 ' HB2' HG13 ' A' ' 49' ' ' VAL . 35.3 pttt -67.37 -33.81 75.99 Favored 'General case' 0 N--CA 1.464 0.265 0 C-N-CA 121.103 -0.239 . . . . 0.0 111.573 179.75 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.506 HG13 ' HB ' ' A' ' 69' ' ' ILE . 51.3 t -57.85 -39.54 71.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.805 0.336 . . . . 0.0 110.514 177.672 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . 0.548 ' O ' ' HG2' ' A' ' 81' ' ' GLU . 1.9 mm100 -74.31 -44.78 51.14 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 120.651 -0.42 . . . . 0.0 111.407 178.206 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . 0.417 ' HG3' ' O ' ' A' ' 74' ' ' TYR . 47.0 mt-30 -57.65 -43.99 85.32 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-O 121.361 0.6 . . . . 0.0 110.166 179.398 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -66.6 -40.35 88.81 Favored 'General case' 0 N--CA 1.446 -0.675 0 CA-C-N 115.257 -0.883 . . . . 0.0 110.829 -179.693 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 45.0 t -63.21 -57.2 11.27 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.217 179.596 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . 0.548 ' HG2' ' O ' ' A' ' 77' ' ' GLN . 10.2 pt-20 -63.41 -20.18 65.32 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.981 0.419 . . . . 0.0 110.921 -177.456 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 37.7 ttp -75.56 -52.11 11.37 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.436 177.101 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.908 HG11 ' HE1' ' A' ' 51' ' ' MET . 27.9 m -79.61 -29.77 13.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.083 -174.666 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' MET . . . . . 0.592 ' O ' ' HG3' ' A' ' 88' ' ' ARG . 14.8 tpt -66.62 -31.74 72.63 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.086 -0.506 . . . . 0.0 109.686 177.397 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -62.53 -39.16 92.68 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-O 120.894 0.378 . . . . 0.0 110.667 177.122 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.621 HG22 ' HB3' ' A' ' 31' ' ' LEU . 18.7 mt -62.84 -19.2 22.72 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.401 179.136 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.731 HD21 ' HB ' ' A' ' 32' ' ' VAL . 65.5 mt -102.32 -40.45 6.74 Favored 'General case' 0 N--CA 1.449 -0.488 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.786 -175.582 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . 0.592 ' HG3' ' O ' ' A' ' 84' ' ' MET . 0.0 OUTLIER -78.08 -4.15 45.86 Favored 'General case' 0 N--CA 1.464 0.246 0 C-N-CA 120.471 -0.492 . . . . 0.0 111.87 -178.73 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 . . . . . 0 C--O 1.249 1.049 0 CA-C-O 118.372 -0.823 . . . . 0.0 109.39 177.287 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.432 HG21 ' HA ' ' A' ' 73' ' ' PRO . 87.6 m . . . . . 0 C--O 1.231 0.102 0 CA-C-O 120.699 0.285 . . . . 0.0 110.423 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.44 ' HA ' ' O ' ' A' ' 69' ' ' ILE . 90.5 t -138.01 122.06 21.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.882 -177.014 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 26.0 mt-30 -107.27 118.07 35.74 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 109.891 -0.411 . . . . 0.0 109.891 172.688 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.547 ' HA ' ' O ' ' A' ' 67' ' ' LEU . 42.2 mt-10 -90.29 115.76 27.74 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.061 0.458 . . . . 0.0 111.026 176.233 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 12.8 mm -109.33 151.2 11.7 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-N 115.394 -0.821 . . . . 0.0 109.41 177.995 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 86.7 mmm -104.42 98.1 7.93 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 174.591 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.684 ' HB ' ' HB2' ' A' ' 65' ' ' LYS . 36.8 mm -81.49 129.79 64.52 Favored Pre-proline 0 C--N 1.316 -0.863 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.487 -175.491 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . 0.552 ' HB2' ' HB2' ' A' ' 28' ' ' LYS . 86.5 Cg_exo -46.68 128.11 12.64 Favored 'Trans proline' 0 C--N 1.347 0.497 0 C-N-CA 123.019 2.479 . . . . 0.0 112.451 177.891 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -45.43 -55.84 5.66 Favored 'General case' 0 C--O 1.234 0.254 0 N-CA-C 113.093 0.775 . . . . 0.0 113.093 -170.811 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -81.61 -4.87 90.27 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.837 -0.697 . . . . 0.0 113.066 -174.897 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.552 ' HB2' ' HB2' ' A' ' 25' ' ' PRO . 1.8 tptp -95.79 -8.51 34.14 Favored 'General case' 0 C--N 1.323 -0.558 0 O-C-N 122.673 -0.31 . . . . 0.0 110.198 -177.987 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.614 ' HA ' HG23 ' A' ' 32' ' ' VAL . . . -63.89 -24.32 67.69 Favored 'General case' 0 N--CA 1.461 0.11 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.169 -179.982 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -58.76 -27.43 61.65 Favored Glycine 0 C--O 1.227 -0.319 0 C-N-CA 121.052 -0.595 . . . . 0.0 112.456 178.983 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 84.3 mt -82.86 -34.61 26.75 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.672 0.272 . . . . 0.0 111.143 -178.748 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.751 HG22 HD21 ' A' ' 87' ' ' LEU . 0.0 OUTLIER -74.08 -36.19 43.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.865 0.364 . . . . 0.0 110.345 178.399 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.587 HG12 ' O ' ' A' ' 29' ' ' ALA . 14.5 mm -78.35 -43.06 26.95 Favored 'Isoleucine or valine' 0 C--O 1.235 0.302 0 CA-C-O 121.482 0.658 . . . . 0.0 109.7 178.867 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 111.04 173.26 19.81 Favored Glycine 0 N--CA 1.439 -1.122 0 CA-C-N 115.374 -0.83 . . . . 0.0 112.051 178.365 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 31.1 mmmt -75.36 -22.38 57.6 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 120.853 0.359 . . . . 0.0 110.309 -178.913 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -130.93 -5.31 3.94 Favored Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.586 -0.816 . . . . 0.0 112.162 179.489 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 100.56 -1.09 55.61 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.736 -0.745 . . . . 0.0 111.924 -178.207 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -78.0 -21.43 50.86 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.652 0.263 . . . . 0.0 111.158 -178.865 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . 0.793 ' O ' ' HG ' ' A' ' 43' ' ' LEU . 31.3 m -69.38 -50.86 42.19 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.577 -0.283 . . . . 0.0 110.691 -178.165 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.568 ' HB ' ' HA ' ' A' ' 33' ' ' ILE . 11.6 tt -67.13 -25.18 33.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-O 121.439 0.637 . . . . 0.0 110.448 177.317 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 22.4 tptm -63.24 -53.0 59.89 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.738 175.539 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.412 ' HG2' ' O ' ' A' ' 39' ' ' THR . 8.9 pt20 -68.78 -37.05 79.04 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.395 -175.023 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.793 ' HG ' ' O ' ' A' ' 39' ' ' THR . 84.4 mt -53.86 -39.65 65.86 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.743 -0.662 . . . . 0.0 111.532 179.632 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . 0.448 ' HG3' ' O ' ' A' ' 40' ' ' ILE . 44.9 mt-30 -69.78 -40.97 75.74 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.219 0.533 . . . . 0.0 110.813 -179.61 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 10.2 mm-40 -72.32 -40.51 67.39 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.668 -0.696 . . . . 0.0 111.705 -175.78 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . 0.401 ' HG2' ' O ' ' A' ' 42' ' ' GLN . 12.0 ptp180 -71.42 -34.24 70.16 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 112.375 0.509 . . . . 0.0 112.375 -174.458 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.559 ' HB3' HG22 ' A' ' 49' ' ' VAL . . . -99.11 -5.92 29.28 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 112.224 0.453 . . . . 0.0 112.224 -173.587 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 66.27 30.39 76.64 Favored Glycine 0 C--N 1.33 0.225 0 C-N-CA 120.818 -0.706 . . . . 0.0 112.046 -178.627 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.559 HG22 ' HB3' ' A' ' 47' ' ' ALA . 26.8 m -125.11 179.58 3.0 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 N-CA-C 109.724 -0.472 . . . . 0.0 109.724 -178.351 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 64.6 tttp -122.48 125.53 45.98 Favored 'General case' 0 C--N 1.314 -0.938 0 CA-C-N 116.027 -0.533 . . . . 0.0 109.817 167.501 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . 0.569 ' CE ' ' HB1' ' A' ' 79' ' ' ALA . 48.5 mtt -110.75 114.76 28.37 Favored 'General case' 0 C--N 1.315 -0.931 0 N-CA-C 108.418 -0.956 . . . . 0.0 108.418 176.471 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.551 ' CG2' ' HB2' ' A' ' 68' ' ' ARG . 8.9 tt -106.09 105.04 17.96 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.939 0 CA-C-O 121.521 0.677 . . . . 0.0 110.141 177.729 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.52 HD23 ' CD1' ' A' ' 40' ' ' ILE . 4.2 mm? -88.44 101.91 14.37 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.168 -0.924 . . . . 0.0 108.936 174.994 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.533 HD12 ' HB2' ' A' ' 66' ' ' PRO . 51.3 mt -78.98 86.55 1.16 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 178.604 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . 0.501 ' HA ' ' HD2' ' A' ' 65' ' ' LYS . 3.4 pp0? . . . . . 0 C--N 1.322 -0.587 0 CA-C-N 115.626 -0.715 . . . . 0.0 111.592 -174.843 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 25.2 m-20 . . . . . 0 C--O 1.23 0.074 0 CA-C-O 121.048 0.451 . . . . 0.0 110.524 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . 0.684 ' HB2' ' HB ' ' A' ' 24' ' ' ILE . 71.9 mmtt -99.76 121.5 54.22 Favored Pre-proline 0 C--N 1.318 -0.772 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.787 -170.286 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.533 ' HB2' HD12 ' A' ' 54' ' ' ILE . 23.3 Cg_exo -66.26 106.86 1.08 Allowed 'Trans proline' 0 N--CA 1.46 -0.483 0 C-N-CA 122.801 2.334 . . . . 0.0 110.969 173.02 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.547 ' O ' ' HA ' ' A' ' 21' ' ' GLU . 19.3 tp -108.71 112.03 24.11 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.402 -179.866 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . 0.551 ' HB2' ' CG2' ' A' ' 52' ' ' ILE . 98.8 mtt180 -101.58 108.21 19.7 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.365 174.802 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.44 ' O ' ' HA ' ' A' ' 19' ' ' VAL . 4.9 mp -87.31 104.41 14.21 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 N-CA-C 108.308 -0.997 . . . . 0.0 108.308 170.995 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 18.6 mt -99.87 120.99 50.03 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 CA-C-N 115.85 -0.613 . . . . 0.0 110.533 -174.502 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 173.57 -135.93 3.44 Favored Glycine 0 CA--C 1.518 0.258 0 C-N-CA 120.807 -0.711 . . . . 0.0 112.985 179.161 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . 0.579 ' OD1' ' HE2' ' A' ' 75' ' ' LYS . 1.5 m-20 -103.28 157.77 33.13 Favored Pre-proline 0 C--N 1.325 -0.481 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 179.684 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . 0.432 ' HA ' HG21 ' A' ' 18' ' ' THR . 82.0 Cg_exo -48.17 -39.28 34.03 Favored 'Trans proline' 0 C--O 1.234 0.29 0 C-N-CA 122.156 1.904 . . . . 0.0 112.367 179.732 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 32.4 m-85 -67.27 -62.99 1.15 Allowed 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.225 -178.617 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.579 ' HE2' ' OD1' ' A' ' 72' ' ' ASP . 41.2 pttt -67.66 -25.83 65.91 Favored 'General case' 0 C--O 1.22 -0.449 0 CA-C-N 116.333 -0.394 . . . . 0.0 112.041 -174.052 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.436 HG13 ' HB ' ' A' ' 69' ' ' ILE . 56.1 t -71.76 -35.1 54.07 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-O 121.165 0.507 . . . . 0.0 110.037 177.97 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -74.04 -51.67 15.1 Favored 'General case' 0 N--CA 1.448 -0.563 0 N-CA-C 108.636 -0.876 . . . . 0.0 108.636 178.32 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 92.0 mt-30 -59.93 -39.34 85.14 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.473 -179.245 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . 0.569 ' HB1' ' CE ' ' A' ' 51' ' ' MET . . . -68.07 -36.59 80.09 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.168 178.851 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 52.2 t -67.26 -47.06 71.85 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.803 -178.937 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -70.24 -19.15 63.16 Favored 'General case' 0 C--N 1.325 -0.496 0 C-N-CA 120.344 -0.542 . . . . 0.0 110.632 178.159 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' MET . . . . . 0.431 ' O ' ' HB3' ' A' ' 85' ' ' ASP . 48.8 ttp -75.43 -47.71 26.09 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.468 175.374 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.575 ' O ' ' HG ' ' A' ' 87' ' ' LEU . 28.3 m -72.29 -33.2 45.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 C-N-CA 120.963 -0.295 . . . . 0.0 110.831 -179.874 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 54.4 mtt -67.61 -27.4 66.87 Favored 'General case' 0 CA--C 1.519 -0.235 0 CA-C-O 120.83 0.348 . . . . 0.0 110.173 174.865 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . 0.533 ' O ' ' HG2' ' A' ' 88' ' ' ARG . 8.0 t70 -65.1 -45.33 85.59 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.597 176.115 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 38.9 mt -63.19 -22.62 31.2 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.644 179.196 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.751 HD21 HG22 ' A' ' 32' ' ' VAL . 64.7 mt -97.24 -12.33 23.1 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.708 -176.322 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . 0.695 ' HG3' ' HG2' ' A' ' 89' ' ' GLU . 29.5 ptt180 -101.16 -24.06 14.34 Favored 'General case' 0 CA--C 1.515 -0.37 0 CA-C-O 121.633 0.73 . . . . 0.0 110.088 -177.137 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . 0.695 ' HG2' ' HG3' ' A' ' 88' ' ' ARG . 37.7 mm-40 . . . . . 0 C--N 1.312 -1.047 0 CA-C-N 114.422 -1.263 . . . . 0.0 110.704 -171.475 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.452 HG21 ' HA ' ' A' ' 73' ' ' PRO . 95.9 m . . . . . 0 N--CA 1.456 -0.125 0 CA-C-O 120.93 0.395 . . . . 0.0 111.35 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.941 ' HB ' HD12 ' A' ' 70' ' ' ILE . 0.2 OUTLIER -138.24 128.4 34.85 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 115.648 -0.705 . . . . 0.0 110.932 -179.761 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 27.9 mt-30 -118.31 116.04 25.95 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.881 -0.6 . . . . 0.0 109.951 174.148 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.56 ' HG3' ' HG2' ' A' ' 68' ' ' ARG . 4.5 mp0 -86.61 107.75 18.3 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.119 0.485 . . . . 0.0 110.851 178.784 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 23.1 mm -88.18 156.03 3.17 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-N 115.67 -0.695 . . . . 0.0 110.046 -178.08 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' MET . . . . . 0.465 ' HB3' ' HB3' ' A' ' 64' ' ' ASP . 14.3 mmt -105.83 91.79 3.89 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 109.618 -0.512 . . . . 0.0 109.618 176.653 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.714 ' HB ' ' HB2' ' A' ' 65' ' ' LYS . 26.0 mm -80.85 125.39 80.25 Favored Pre-proline 0 C--N 1.321 -0.668 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.751 -176.488 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . 0.611 ' HB2' ' HB2' ' A' ' 28' ' ' LYS . 64.8 Cg_exo -51.89 130.14 33.22 Favored 'Trans proline' 0 C--O 1.233 0.226 0 C-N-CA 122.813 2.342 . . . . 0.0 111.711 176.412 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -58.34 -38.14 76.57 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 115.754 -0.657 . . . . 0.0 111.45 -177.252 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -90.16 22.47 26.03 Favored Glycine 0 N--CA 1.453 -0.222 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.327 178.268 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.611 ' HB2' ' HB2' ' A' ' 25' ' ' PRO . 21.3 tptt -133.1 0.81 3.47 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 178.136 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.63 -33.96 74.84 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.501 -0.772 . . . . 0.0 111.857 -174.468 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -59.04 -22.08 54.44 Favored Glycine 0 CA--C 1.519 0.33 0 C-N-CA 121.14 -0.552 . . . . 0.0 113.037 -179.397 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.493 ' HB3' HG22 ' A' ' 86' ' ' ILE . 94.2 mt -87.99 -43.19 11.92 Favored 'General case' 0 C--N 1.326 -0.447 0 O-C-N 122.576 -0.367 . . . . 0.0 110.951 -179.887 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.482 HG11 HG21 ' A' ' 24' ' ' ILE . 1.2 p -66.8 -29.97 48.11 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.416 0 CA-C-O 121.199 0.523 . . . . 0.0 110.656 -178.899 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 63.2 mt -81.36 -43.77 20.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-O 121.692 0.758 . . . . 0.0 109.108 173.372 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . 0.542 ' HA3' ' HB ' ' A' ' 39' ' ' THR . . . 116.46 163.43 13.36 Favored Glycine 0 N--CA 1.438 -1.201 0 CA-C-N 115.344 -0.844 . . . . 0.0 112.54 174.805 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.519 ' N ' ' HD3' ' A' ' 35' ' ' LYS . 0.0 OUTLIER -78.64 57.59 2.07 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.305 0.574 . . . . 0.0 110.263 -178.656 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 134.24 14.72 1.21 Allowed Glycine 0 N--CA 1.447 -0.585 0 CA-C-N 115.358 -0.837 . . . . 0.0 111.619 -179.44 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 71.36 6.35 61.47 Favored Glycine 0 C--N 1.333 0.409 0 C-N-CA 121.25 -0.5 . . . . 0.0 112.355 -178.193 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 55.3 mm-40 -84.12 -22.67 31.0 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 120.961 0.41 . . . . 0.0 111.073 -178.511 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . 0.681 ' O ' ' HG ' ' A' ' 43' ' ' LEU . 57.9 m -70.97 -51.68 24.24 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.3 178.282 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.576 ' HA ' HD12 ' A' ' 43' ' ' LEU . 7.8 tt -58.74 -33.7 49.86 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.385 0 CA-C-O 121.312 0.577 . . . . 0.0 110.568 177.808 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 40.0 ttmt -63.66 -37.96 89.32 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.349 177.332 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.609 ' O ' ' HG2' ' A' ' 46' ' ' ARG . 45.7 mt-30 -79.63 -42.03 25.73 Favored 'General case' 0 C--O 1.222 -0.359 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.498 -178.982 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.681 ' HG ' ' O ' ' A' ' 39' ' ' THR . 70.5 mt -49.0 -45.41 42.37 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-O 120.912 0.387 . . . . 0.0 111.789 -176.073 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 45.9 mt-30 -62.4 -44.71 95.79 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.651 179.161 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -68.66 -42.4 77.95 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.095 -179.264 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . 0.609 ' HG2' ' O ' ' A' ' 42' ' ' GLN . 15.4 mmt180 -52.31 -44.62 65.17 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.805 -175.553 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -102.64 -9.98 19.63 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.618 -175.424 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 71.09 39.86 62.51 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.73 -0.747 . . . . 0.0 111.291 -175.09 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 27.3 m -122.77 178.95 2.8 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-O 120.891 0.377 . . . . 0.0 110.476 -175.534 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . 0.452 ' C ' ' HD3' ' A' ' 50' ' ' LYS . 1.1 tmtp? -116.74 124.41 49.58 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 175.17 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . 0.568 ' CE ' ' HB1' ' A' ' 79' ' ' ALA . 64.3 mtt -117.37 121.99 42.61 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.482 -0.327 . . . . 0.0 110.43 178.406 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.748 HG22 ' HB2' ' A' ' 68' ' ' ARG . 0.0 OUTLIER -110.44 116.57 52.72 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 CA-C-O 121.648 0.737 . . . . 0.0 109.21 176.146 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.635 HD22 HD13 ' A' ' 67' ' ' LEU . 2.8 mm? -95.7 105.72 17.75 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.388 -0.823 . . . . 0.0 110.339 179.499 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.769 HD12 ' HB2' ' A' ' 66' ' ' PRO . 60.1 mt -75.59 96.26 1.18 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 121.332 0.587 . . . . 0.0 110.223 179.867 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 57.7 mt-30 . . . . . 0 C--N 1.324 -0.509 0 CA-C-N 115.658 -0.701 . . . . 0.0 109.792 -179.83 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.465 ' HB3' ' HB3' ' A' ' 23' ' ' MET . 23.2 m-20 . . . . . 0 N--CA 1.456 -0.155 0 N-CA-C 110.036 -0.357 . . . . 0.0 110.036 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . 0.714 ' HB2' ' HB ' ' A' ' 24' ' ' ILE . 70.6 mmtt -89.43 120.82 69.68 Favored Pre-proline 0 C--N 1.32 -0.686 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.882 -171.097 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.769 ' HB2' HD12 ' A' ' 54' ' ' ILE . 28.5 Cg_exo -66.35 104.68 0.78 Allowed 'Trans proline' 0 N--CA 1.462 -0.377 0 C-N-CA 122.928 2.419 . . . . 0.0 112.124 175.001 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.635 HD13 HD22 ' A' ' 53' ' ' LEU . 14.5 tp -103.21 118.13 36.09 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.906 -0.588 . . . . 0.0 109.946 176.057 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . 0.748 ' HB2' HG22 ' A' ' 52' ' ' ILE . 95.5 mtt180 -98.19 110.85 23.36 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 116.556 -0.293 . . . . 0.0 110.897 177.015 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 4.2 mp -96.47 104.73 16.2 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 171.598 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.941 HD12 ' HB ' ' A' ' 19' ' ' VAL . 3.6 mm -100.85 134.82 39.62 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 N-CA-C 109.914 -0.402 . . . . 0.0 109.914 -178.229 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . 0.417 ' O ' ' HB ' ' A' ' 18' ' ' THR . . . 164.44 -142.14 7.57 Favored Glycine 0 N--CA 1.447 -0.626 0 C-N-CA 121.054 -0.593 . . . . 0.0 111.625 178.568 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . 0.556 ' OD2' ' HB3' ' A' ' 74' ' ' TYR . 8.8 t70 -93.83 140.92 23.15 Favored Pre-proline 0 C--N 1.318 -0.79 0 CA-C-O 118.35 -0.833 . . . . 0.0 109.122 179.686 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . 0.452 ' HA ' HG21 ' A' ' 18' ' ' THR . 84.0 Cg_exo -41.78 -41.1 5.98 Favored 'Trans proline' 0 C--N 1.346 0.433 0 C-N-CA 122.757 2.305 . . . . 0.0 113.066 -177.806 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . 0.556 ' HB3' ' OD2' ' A' ' 72' ' ' ASP . 69.2 t80 -63.48 -58.68 6.25 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.296 -178.74 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.495 ' HG2' ' HB3' ' A' ' 72' ' ' ASP . 38.0 pttt -71.91 -27.87 63.11 Favored 'General case' 0 CA--C 1.518 -0.268 0 C-N-CA 120.446 -0.501 . . . . 0.0 111.557 -178.019 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 55.3 t -63.7 -39.67 86.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 N-CA-C 109.53 -0.545 . . . . 0.0 109.53 176.832 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 22.7 tp60 -75.85 -44.95 38.33 Favored 'General case' 0 N--CA 1.445 -0.698 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.79 -179.717 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . 0.409 ' HA ' ' HG2' ' A' ' 81' ' ' GLU . 55.5 mt-30 -64.82 -35.78 82.22 Favored 'General case' 0 C--N 1.33 -0.271 0 C-N-CA 120.469 -0.493 . . . . 0.0 110.926 -179.921 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . 0.568 ' HB1' ' CE ' ' A' ' 51' ' ' MET . . . -71.38 -34.71 70.68 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 120.93 0.395 . . . . 0.0 110.09 176.222 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 36.7 t -65.22 -47.87 75.35 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.253 178.023 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . 0.409 ' HG2' ' HA ' ' A' ' 78' ' ' GLN . 10.5 pt-20 -69.72 -22.37 63.4 Favored 'General case' 0 C--N 1.322 -0.601 0 C-N-CA 120.684 -0.406 . . . . 0.0 110.14 178.861 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' MET . . . . . 0.475 ' O ' ' HB3' ' A' ' 85' ' ' ASP . 57.4 ttp -73.74 -46.28 46.88 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.664 176.338 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.542 ' O ' ' HG ' ' A' ' 87' ' ' LEU . 33.2 m -72.03 -36.56 57.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 C-N-CA 120.662 -0.415 . . . . 0.0 110.665 178.905 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' MET . . . . . 0.404 ' O ' ' HG2' ' A' ' 88' ' ' ARG . 54.1 mtt -65.0 -32.08 73.63 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 109.975 -0.379 . . . . 0.0 109.975 175.146 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . 0.475 ' HB3' ' O ' ' A' ' 82' ' ' MET . 18.8 t70 -58.23 -48.79 79.27 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.648 176.315 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.493 HG22 ' HB3' ' A' ' 31' ' ' LEU . 34.8 mt -60.63 -29.7 45.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 121.271 0.558 . . . . 0.0 110.536 179.562 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.542 ' HG ' ' O ' ' A' ' 83' ' ' VAL . 62.0 mt -92.06 -1.71 57.06 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.661 -0.699 . . . . 0.0 111.927 -174.755 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . 0.404 ' HG2' ' O ' ' A' ' 84' ' ' MET . 19.2 ptp180 -129.83 16.49 5.78 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.059 0.457 . . . . 0.0 111.141 -179.929 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 10.5 tt0 . . . . . 0 C--O 1.249 1.059 0 CA-C-O 118.186 -0.912 . . . . 0.0 109.86 179.218 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 32.8 m . . . . . 0 N--CA 1.448 -0.536 0 N-CA-C 109.991 -0.374 . . . . 0.0 109.991 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.518 ' HA ' ' O ' ' A' ' 69' ' ' ILE . 7.5 p -141.8 136.27 30.54 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.405 -176.183 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . 0.524 ' O ' ' HA ' ' A' ' 68' ' ' ARG . 35.6 mt-30 -112.84 158.69 19.84 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.194 -0.457 . . . . 0.0 109.802 171.962 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.626 ' HG2' ' HG2' ' A' ' 68' ' ' ARG . 51.9 mt-10 -125.28 113.57 17.79 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.932 0.396 . . . . 0.0 109.968 178.683 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 9.6 mm -104.69 137.8 32.24 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.375 -178.195 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -86.07 91.52 8.43 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 172.362 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.838 HG23 HD21 ' A' ' 87' ' ' LEU . 33.1 mm -79.86 126.35 80.23 Favored Pre-proline 0 C--N 1.319 -0.76 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.791 -177.546 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . 0.775 ' HB2' ' HB2' ' A' ' 28' ' ' LYS . 72.7 Cg_exo -51.99 135.86 51.8 Favored 'Trans proline' 0 N--CA 1.461 -0.392 0 C-N-CA 122.675 2.25 . . . . 0.0 111.416 175.459 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -57.93 -33.36 68.72 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.661 -0.7 . . . . 0.0 112.626 -172.865 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -82.74 -29.36 35.54 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.495 -0.86 . . . . 0.0 111.688 177.375 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.775 ' HB2' ' HB2' ' A' ' 25' ' ' PRO . 11.7 mptt -79.68 -8.23 59.09 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.981 0.42 . . . . 0.0 110.736 179.802 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.436 ' HB2' ' HG3' ' A' ' 65' ' ' LYS . . . -61.54 -26.63 68.06 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.501 176.832 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -68.93 -17.68 71.82 Favored Glycine 0 N--CA 1.449 -0.499 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.331 177.673 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.432 ' HB3' HG22 ' A' ' 86' ' ' ILE . 84.8 mt -88.86 -37.93 14.96 Favored 'General case' 0 C--N 1.326 -0.427 0 O-C-N 122.677 -0.308 . . . . 0.0 110.902 -179.701 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.557 HG13 HD11 ' A' ' 87' ' ' LEU . 0.5 OUTLIER -71.69 -33.78 49.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 120.792 0.33 . . . . 0.0 110.683 176.392 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.601 ' HA ' ' HB ' ' A' ' 40' ' ' ILE . 83.7 mt -77.64 -40.98 28.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-O 121.601 0.715 . . . . 0.0 109.479 174.191 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . 0.552 ' HA3' ' HB ' ' A' ' 39' ' ' THR . . . 104.3 177.2 25.27 Favored Glycine 0 N--CA 1.442 -0.927 0 CA-C-N 115.514 -0.766 . . . . 0.0 112.467 175.893 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 30.1 mmmt -76.71 62.56 2.01 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.088 0.47 . . . . 0.0 110.419 -178.457 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 118.07 19.68 4.68 Favored Glycine 0 N--CA 1.448 -0.54 0 C-N-CA 120.972 -0.633 . . . . 0.0 112.005 178.492 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.401 ' HA2' HG22 ' A' ' 33' ' ' ILE . . . 82.5 3.78 90.39 Favored Glycine 0 N--CA 1.449 -0.479 0 C-N-CA 120.875 -0.679 . . . . 0.0 112.521 179.081 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.734 ' HG3' HE21 ' A' ' 42' ' ' GLN . 20.8 tp10 -78.21 -37.66 44.95 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 120.79 0.328 . . . . 0.0 110.975 -177.874 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . 0.603 ' O ' ' HG ' ' A' ' 43' ' ' LEU . 28.8 m -67.43 -40.23 85.48 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.648 -0.251 . . . . 0.0 111.492 -177.176 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.601 ' HB ' ' HA ' ' A' ' 33' ' ' ILE . 14.5 tt -63.8 -28.88 45.89 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.411 0 CA-C-O 121.172 0.511 . . . . 0.0 110.778 179.601 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . 0.638 ' HD3' ' HA ' ' A' ' 38' ' ' GLU . 52.1 mtpt -66.46 -40.59 89.46 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.195 0.522 . . . . 0.0 109.852 174.606 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.734 HE21 ' HG3' ' A' ' 38' ' ' GLU . 76.4 mt-30 -70.76 -42.42 70.47 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.269 -0.878 . . . . 0.0 110.674 -176.693 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.603 ' HG ' ' O ' ' A' ' 39' ' ' THR . 81.8 mt -56.83 -47.06 81.18 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.589 -176.864 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 49.9 mt-30 -61.47 -53.5 55.7 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.431 -176.975 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -68.16 -39.65 82.56 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 112.033 0.383 . . . . 0.0 112.033 -175.591 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . 0.472 ' HD3' ' SD ' ' A' ' 82' ' ' MET . 12.3 ptm180 -70.01 -31.17 68.7 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.936 0.398 . . . . 0.0 111.214 -174.78 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.535 ' HB3' HG22 ' A' ' 49' ' ' VAL . . . -93.27 -15.95 25.28 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.367 -177.111 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 73.49 25.45 72.56 Favored Glycine 0 N--CA 1.45 -0.401 0 CA-C-N 115.947 -0.57 . . . . 0.0 111.953 -178.729 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.535 HG22 ' HB3' ' A' ' 47' ' ' ALA . 35.1 m -123.93 173.88 9.06 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-O 120.843 0.354 . . . . 0.0 110.066 -177.399 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . 0.502 ' HE2' HD12 ' A' ' 70' ' ' ILE . 2.2 tmmm? -109.97 123.33 49.45 Favored 'General case' 0 C--N 1.318 -0.762 0 N-CA-C 108.679 -0.86 . . . . 0.0 108.679 174.753 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . 0.532 ' CE ' ' HB1' ' A' ' 79' ' ' ALA . 63.5 mtt -114.43 116.42 28.86 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.195 -179.671 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.512 ' CG2' ' HB2' ' A' ' 68' ' ' ARG . 9.9 tt -106.57 105.16 18.23 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.83 0 CA-C-O 121.484 0.659 . . . . 0.0 110.11 176.14 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.581 HD22 HD13 ' A' ' 67' ' ' LEU . 3.5 mm? -82.24 102.58 11.24 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 108.963 -0.754 . . . . 0.0 108.963 173.723 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.701 HD12 ' HB2' ' A' ' 66' ' ' PRO . 53.5 mt -79.25 86.92 1.23 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-O 121.433 0.635 . . . . 0.0 110.166 -176.372 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . 0.522 HE22 ' HB3' ' A' ' 65' ' ' LYS . 25.2 mm-40 . . . . . 0 C--N 1.326 -0.418 0 CA-C-N 115.355 -0.839 . . . . 0.0 109.516 -179.814 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 49.7 m-20 . . . . . 0 N--CA 1.444 -0.734 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . 0.754 ' HB2' ' HB ' ' A' ' 24' ' ' ILE . 66.9 mmtt -141.6 116.73 7.03 Favored Pre-proline 0 C--N 1.314 -0.937 0 CA-C-N 116.708 -0.224 . . . . 0.0 110.632 -176.784 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.701 ' HB2' HD12 ' A' ' 54' ' ' ILE . 25.1 Cg_exo -64.42 124.19 12.94 Favored 'Trans proline' 0 N--CA 1.461 -0.431 0 C-N-CA 122.82 2.347 . . . . 0.0 111.863 176.308 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.581 HD13 HD22 ' A' ' 53' ' ' LEU . 33.7 tp -124.1 106.84 10.67 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.954 -0.567 . . . . 0.0 109.839 177.793 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . 0.626 ' HG2' ' HG2' ' A' ' 21' ' ' GLU . 87.4 mtt180 -96.98 105.59 17.77 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.139 177.711 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.518 ' O ' ' HA ' ' A' ' 19' ' ' VAL . 4.4 mp -87.96 104.49 14.55 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 174.449 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.502 HD12 ' HE2' ' A' ' 50' ' ' LYS . 13.8 mt -104.34 126.93 59.01 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.026 -173.491 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 167.82 -142.52 7.55 Favored Glycine 0 N--CA 1.446 -0.648 0 N-CA-C 111.596 -0.602 . . . . 0.0 111.596 178.65 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . 0.477 ' HB2' ' HG2' ' A' ' 75' ' ' LYS . 15.1 m-20 -91.33 149.12 39.1 Favored Pre-proline 0 C--N 1.325 -0.489 0 CA-C-O 118.963 -0.541 . . . . 0.0 109.692 175.859 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 77.5 Cg_exo -49.36 -39.53 43.94 Favored 'Trans proline' 0 C--N 1.343 0.285 0 C-N-CA 122.333 2.022 . . . . 0.0 112.31 -176.948 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 76.0 t80 -64.36 -56.32 15.2 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.262 -176.995 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.477 ' HG2' ' HB2' ' A' ' 72' ' ' ASP . 4.9 ptpt -68.06 -31.97 71.99 Favored 'General case' 0 C--O 1.223 -0.301 0 C-N-CA 120.671 -0.412 . . . . 0.0 111.296 179.41 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.406 HG23 ' O ' ' A' ' 72' ' ' ASP . 53.1 t -65.18 -40.09 87.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.998 0.427 . . . . 0.0 110.012 178.163 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . 0.47 ' O ' ' HG2' ' A' ' 81' ' ' GLU . 19.4 tp60 -64.81 -51.88 59.81 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.032 176.707 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 25.1 mt-30 -62.97 -35.14 79.17 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 121.0 0.428 . . . . 0.0 110.853 -178.202 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . 0.532 ' HB1' ' CE ' ' A' ' 51' ' ' MET . . . -72.1 -35.31 69.15 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.999 179.812 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' CYS . . . . . 0.4 ' HA ' HG22 ' A' ' 83' ' ' VAL . 52.7 t -72.29 -45.56 59.52 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.144 -179.457 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . 0.47 ' HG2' ' O ' ' A' ' 77' ' ' GLN . 10.2 pt-20 -66.83 -22.62 65.99 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.101 0.477 . . . . 0.0 110.024 177.834 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' MET . . . . . 0.472 ' SD ' ' HD3' ' A' ' 46' ' ' ARG . 42.8 ttp -71.5 -55.41 7.91 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.54 -0.755 . . . . 0.0 110.423 175.822 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.451 HG12 HD13 ' A' ' 43' ' ' LEU . 31.3 m -66.95 -34.97 73.44 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.169 0 C-N-CA 121.116 -0.234 . . . . 0.0 110.985 -179.455 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 66.6 mmm -62.17 -37.45 85.28 Favored 'General case' 0 CA--C 1.519 -0.229 0 CA-C-O 120.685 0.279 . . . . 0.0 110.505 176.391 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . 0.465 ' O ' ' HB2' ' A' ' 89' ' ' GLU . 36.5 t70 -65.8 -44.52 85.43 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.918 -179.781 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.432 HG22 ' HB3' ' A' ' 31' ' ' LEU . 57.8 mt -60.01 -31.25 47.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 121.148 0.499 . . . . 0.0 110.768 179.822 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.838 HD21 HG23 ' A' ' 24' ' ' ILE . 7.1 mp -81.48 -31.79 32.79 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.815 -0.629 . . . . 0.0 112.268 -177.176 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 15.3 ptm180 -95.88 -5.79 40.74 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.134 0.492 . . . . 0.0 111.132 -176.768 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . 0.465 ' HB2' ' O ' ' A' ' 85' ' ' ASP . 4.7 mm-40 . . . . . 0 C--O 1.251 1.137 0 CA-C-O 118.438 -0.791 . . . . 0.0 110.031 178.473 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 94.3 m . . . . . 0 N--CA 1.45 -0.435 0 CA-C-O 120.669 0.271 . . . . 0.0 110.62 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.653 ' HA ' ' O ' ' A' ' 69' ' ' ILE . 6.2 p -129.72 124.32 58.89 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-O 121.13 0.49 . . . . 0.0 110.801 178.073 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 28.6 mt-30 -110.29 114.6 28.2 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.055 -0.52 . . . . 0.0 109.887 174.663 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.659 ' HA ' ' O ' ' A' ' 67' ' ' LEU . 43.4 mt-10 -90.37 116.04 28.02 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.086 0.469 . . . . 0.0 110.535 176.106 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 22.0 mm -103.69 137.42 32.33 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.767 0 CA-C-N 115.687 -0.688 . . . . 0.0 109.839 -179.561 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' MET . . . . . 0.449 ' HB3' ' HB3' ' A' ' 64' ' ' ASP . 3.1 mmt -89.13 94.27 9.87 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 176.593 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.864 HG23 HD13 ' A' ' 87' ' ' LEU . 27.2 mm -77.66 129.19 77.52 Favored Pre-proline 0 C--N 1.318 -0.801 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.027 -175.06 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . 0.537 ' HB2' ' HB2' ' A' ' 28' ' ' LYS . 53.8 Cg_exo -52.93 125.43 18.22 Favored 'Trans proline' 0 N--CA 1.458 -0.596 0 C-N-CA 122.188 1.925 . . . . 0.0 110.685 172.01 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -57.63 -27.87 63.18 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 112.097 0.406 . . . . 0.0 112.097 -174.057 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -80.21 -30.66 40.94 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.511 177.306 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.545 ' HB3' HD22 ' A' ' 87' ' ' LEU . 21.2 mmtp -89.42 -4.41 58.02 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.727 0.299 . . . . 0.0 111.234 -177.966 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.411 ' O ' HG23 ' A' ' 32' ' ' VAL . . . -57.44 -28.89 63.73 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.707 -178.173 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -62.28 -26.32 67.7 Favored Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 120.925 -0.655 . . . . 0.0 112.856 -179.81 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 69.6 mt -78.73 -39.84 35.18 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.883 0.341 . . . . 0.0 111.398 -178.173 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.552 HG21 HG21 ' A' ' 24' ' ' ILE . 0.0 OUTLIER -65.74 -38.06 81.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 121.19 0.519 . . . . 0.0 110.106 179.177 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 49.9 mt -72.61 -42.67 62.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-O 121.546 0.689 . . . . 0.0 109.499 175.838 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 100.57 39.61 3.16 Favored Glycine 0 CA--C 1.499 -0.938 0 CA-C-N 115.17 -0.923 . . . . 0.0 112.685 176.708 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 3.7 mppt? 53.0 36.9 23.28 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.079 -0.561 . . . . 0.0 111.45 179.265 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 159.04 -48.95 0.41 Allowed Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.54 -0.838 . . . . 0.0 112.145 -179.195 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 145.31 -6.68 1.52 Allowed Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.24 -0.981 . . . . 0.0 113.476 179.866 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 43.9 mm-40 -65.64 -40.76 92.86 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 117.006 0.403 . . . . 0.0 112.012 -179.014 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . 0.729 ' O ' ' HG ' ' A' ' 43' ' ' LEU . 91.6 m -62.39 -54.64 37.41 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.876 -0.147 . . . . 0.0 111.278 -178.105 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.593 ' HA ' HD12 ' A' ' 43' ' ' LEU . 5.3 tt -58.34 -30.96 41.57 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.365 0 CA-C-O 121.219 0.533 . . . . 0.0 111.157 -179.346 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . 0.459 ' HE2' ' HB3' ' A' ' 41' ' ' LYS . 4.9 tmmm? -70.33 -41.72 72.86 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.932 -0.576 . . . . 0.0 109.819 177.842 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 15.4 mm-40 -69.37 -38.18 77.92 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.956 -179.492 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.729 ' HG ' ' O ' ' A' ' 39' ' ' THR . 73.7 mt -56.42 -43.9 79.83 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.826 -0.624 . . . . 0.0 111.215 -177.755 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 46.7 mt-30 -67.08 -31.25 71.61 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.376 -177.432 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -80.14 -43.01 22.38 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.892 0.377 . . . . 0.0 111.162 -178.833 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 13.5 ptm180 -75.52 -36.51 60.49 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.952 -0.567 . . . . 0.0 112.45 -173.352 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.452 ' HB3' HG22 ' A' ' 49' ' ' VAL . . . -95.89 -17.21 21.27 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.861 0.362 . . . . 0.0 111.33 -178.247 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 79.41 3.17 88.58 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.879 -0.677 . . . . 0.0 112.208 -179.785 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.452 HG22 ' HB3' ' A' ' 47' ' ' ALA . 34.3 m -97.3 166.02 1.98 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-O 120.637 0.256 . . . . 0.0 110.379 -177.769 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 63.9 tttp -105.21 122.84 46.75 Favored 'General case' 0 C--N 1.316 -0.858 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 172.843 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . 0.592 ' HE3' HG21 ' A' ' 83' ' ' VAL . 77.1 mtp -119.07 115.92 25.31 Favored 'General case' 0 C--N 1.316 -0.854 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 178.263 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.565 ' CG2' ' HB2' ' A' ' 68' ' ' ARG . 8.7 tt -105.4 105.4 18.59 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.937 0 CA-C-O 121.588 0.709 . . . . 0.0 110.734 179.826 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.708 HD22 HD13 ' A' ' 67' ' ' LEU . 3.7 mm? -78.57 103.15 8.32 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 173.042 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.845 HD12 ' HB2' ' A' ' 66' ' ' PRO . 56.7 mt -73.33 89.11 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-O 121.518 0.675 . . . . 0.0 110.462 -178.091 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 58.4 mt-30 . . . . . 0 C--N 1.325 -0.47 0 CA-C-N 115.03 -0.986 . . . . 0.0 110.339 -178.519 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.449 ' HB3' ' HB3' ' A' ' 23' ' ' MET . 7.1 m-20 . . . . . 0 N--CA 1.455 -0.179 0 N-CA-C 109.593 -0.521 . . . . 0.0 109.593 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . 0.719 ' HB2' ' HB ' ' A' ' 24' ' ' ILE . 70.4 mmtt -84.02 129.12 59.98 Favored Pre-proline 0 C--N 1.318 -0.795 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.46 -165.243 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.845 ' HB2' HD12 ' A' ' 54' ' ' ILE . 17.3 Cg_exo -68.83 105.83 1.39 Allowed 'Trans proline' 0 N--CA 1.46 -0.492 0 C-N-CA 123.054 2.502 . . . . 0.0 111.413 174.522 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.708 HD13 HD22 ' A' ' 53' ' ' LEU . 31.6 tp -115.7 104.21 11.45 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.46 -0.336 . . . . 0.0 110.619 179.455 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . 0.565 ' HB2' ' CG2' ' A' ' 52' ' ' ILE . 92.6 mtt180 -91.65 108.23 19.76 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.881 0.372 . . . . 0.0 110.131 176.882 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.653 ' O ' ' HA ' ' A' ' 19' ' ' VAL . 22.1 mt -94.9 104.38 15.74 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 174.681 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 3.7 mt -110.85 127.54 67.86 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.847 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.19 -173.95 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 173.48 -147.17 9.34 Favored Glycine 0 N--CA 1.448 -0.565 0 C-N-CA 120.508 -0.853 . . . . 0.0 112.073 178.104 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . 0.539 ' O ' HG23 ' A' ' 76' ' ' VAL . 41.2 m-20 -84.12 140.1 39.65 Favored Pre-proline 0 C--N 1.323 -0.565 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 177.405 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 76.5 Cg_exo -41.41 -53.4 3.18 Favored 'Trans proline' 0 CA--C 1.534 0.478 0 C-N-CA 123.746 2.964 . . . . 0.0 115.291 -169.443 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 35.8 p90 -76.31 -33.09 59.05 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 112.74 0.644 . . . . 0.0 112.74 -172.227 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.504 ' HG2' ' HB2' ' A' ' 72' ' ' ASP . 6.1 ptpp? -72.49 -30.11 64.23 Favored 'General case' 0 CA--C 1.514 -0.412 0 C-N-CA 119.788 -0.765 . . . . 0.0 110.238 177.038 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.539 HG23 ' O ' ' A' ' 72' ' ' ASP . 92.3 t -63.08 -40.82 90.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 N-CA-C 109.427 -0.583 . . . . 0.0 109.427 177.035 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . 0.715 ' HA ' HE21 ' A' ' 77' ' ' GLN . 0.0 OUTLIER -72.65 -46.56 53.36 Favored 'General case' 0 N--CA 1.447 -0.579 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.903 178.049 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 23.9 mt-30 -61.29 -40.18 93.17 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 120.79 -0.364 . . . . 0.0 111.052 179.637 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -71.67 -32.95 68.43 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.482 177.695 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 5.6 t -61.2 -57.12 13.76 Favored 'General case' 0 CA--C 1.515 -0.393 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.188 177.262 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 17.4 mm-40 -62.29 -29.51 70.48 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.723 -179.162 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' MET . . . . . 0.493 ' O ' HG13 ' A' ' 86' ' ' ILE . 43.6 ttp -63.27 -50.06 71.61 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.398 178.771 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.629 ' O ' ' HG ' ' A' ' 87' ' ' LEU . 30.5 m -83.77 -36.44 12.31 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-N 116.6 -0.273 . . . . 0.0 111.283 -177.147 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 27.4 ttt -65.3 -36.32 83.71 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.407 -179.849 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . 0.447 ' O ' ' HB2' ' A' ' 89' ' ' GLU . 35.0 t70 -62.54 -42.27 99.42 Favored 'General case' 0 C--O 1.223 -0.34 0 CA-C-N 116.595 -0.275 . . . . 0.0 110.466 178.502 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.493 HG13 ' O ' ' A' ' 82' ' ' MET . 52.8 mt -61.41 -31.29 50.03 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-O 121.446 0.641 . . . . 0.0 110.619 179.112 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.864 HD13 HG23 ' A' ' 24' ' ' ILE . 43.4 mt -88.71 -33.45 17.52 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.128 -176.225 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 17.7 tpt180 -77.33 -14.09 59.8 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.808 0.813 . . . . 0.0 109.504 177.309 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . 0.447 ' HB2' ' O ' ' A' ' 85' ' ' ASP . 6.4 tp10 . . . . . 0 C--O 1.25 1.093 0 CA-C-N 114.5 -1.227 . . . . 0.0 109.42 179.215 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.545 HG21 ' HA ' ' A' ' 73' ' ' PRO . 84.3 m . . . . . 0 C--O 1.235 0.312 0 CA-C-O 121.149 0.5 . . . . 0.0 111.201 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.655 ' HA ' ' O ' ' A' ' 69' ' ' ILE . 7.1 p -140.76 129.27 24.46 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-N 115.382 -0.826 . . . . 0.0 110.011 177.617 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 80.5 mt-30 -108.43 122.86 47.9 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 121.063 0.459 . . . . 0.0 111.115 176.348 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.645 ' HA ' ' O ' ' A' ' 67' ' ' LEU . 44.1 mt-10 -95.63 117.43 30.44 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.252 -0.885 . . . . 0.0 110.145 177.35 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.771 HG12 HD12 ' A' ' 67' ' ' LEU . 25.5 mm -111.48 147.6 15.31 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.768 0 CA-C-N 116.0 -0.545 . . . . 0.0 109.815 -178.911 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' MET . . . . . 0.589 ' HB3' ' HB3' ' A' ' 64' ' ' ASP . 3.3 mmt -100.8 98.16 8.71 Favored 'General case' 0 N--CA 1.446 -0.656 0 N-CA-C 108.796 -0.816 . . . . 0.0 108.796 176.924 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.772 ' HB ' ' HB2' ' A' ' 65' ' ' LYS . 23.6 mm -80.18 128.68 72.51 Favored Pre-proline 0 C--N 1.32 -0.699 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.032 -173.433 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . 0.625 ' HD2' HD13 ' A' ' 87' ' ' LEU . 52.7 Cg_exo -51.86 125.59 17.54 Favored 'Trans proline' 0 N--CA 1.462 -0.375 0 C-N-CA 122.882 2.388 . . . . 0.0 111.942 176.734 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -47.8 -53.02 16.71 Favored 'General case' 0 C--O 1.237 0.414 0 N-CA-C 112.998 0.74 . . . . 0.0 112.998 -169.571 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -80.54 -26.46 54.26 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.844 -0.693 . . . . 0.0 113.128 -174.891 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 43.2 tttp -89.95 3.1 54.13 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.051 0.453 . . . . 0.0 110.73 -177.185 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.555 ' O ' HG12 ' A' ' 32' ' ' VAL . . . -65.53 -22.81 66.75 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.808 177.98 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -55.45 -38.42 69.89 Favored Glycine 0 N--CA 1.449 -0.447 0 C-N-CA 120.888 -0.672 . . . . 0.0 111.928 176.739 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.584 ' HB3' HG22 ' A' ' 86' ' ' ILE . 31.9 mt -71.34 -37.87 71.67 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 111.595 0.22 . . . . 0.0 111.595 -179.101 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.555 HG12 ' O ' ' A' ' 29' ' ' ALA . 0.3 OUTLIER -67.32 -25.92 34.78 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.352 0 CA-C-O 121.353 0.597 . . . . 0.0 110.358 -179.133 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.453 ' HA ' ' HB ' ' A' ' 40' ' ' ILE . 56.1 mt -84.71 -39.6 14.45 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-N 115.385 -0.825 . . . . 0.0 109.504 174.59 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . 0.423 ' HA3' ' HB ' ' A' ' 39' ' ' THR . . . 125.95 -145.62 15.81 Favored Glycine 0 N--CA 1.445 -0.719 0 CA-C-N 115.72 -0.673 . . . . 0.0 113.11 174.435 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 74.9 mmtt -100.69 -29.18 12.44 Favored 'General case' 0 C--N 1.319 -0.753 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 179.005 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -152.6 31.61 0.84 Allowed Glycine 0 N--CA 1.45 -0.429 0 CA-C-N 115.534 -0.757 . . . . 0.0 111.727 177.409 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.401 ' HA2' HG22 ' A' ' 33' ' ' ILE . . . 79.87 0.16 84.28 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 121.106 -0.569 . . . . 0.0 112.339 -178.933 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -78.52 -28.45 46.2 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 120.932 0.396 . . . . 0.0 111.106 -179.291 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . 0.661 ' O ' ' HG ' ' A' ' 43' ' ' LEU . 35.2 m -71.67 -51.71 21.66 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.817 -177.571 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.656 ' HA ' HD12 ' A' ' 43' ' ' LEU . 6.6 tt -58.41 -36.73 60.09 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.285 0 CA-C-O 121.091 0.472 . . . . 0.0 111.186 179.499 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 62.7 tttp -62.07 -40.05 94.51 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.813 -0.631 . . . . 0.0 110.039 178.101 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 41.8 mt-30 -75.96 -38.01 58.0 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.579 -0.737 . . . . 0.0 111.269 -179.269 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.661 ' HG ' ' O ' ' A' ' 39' ' ' THR . 80.8 mt -53.17 -40.49 64.4 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-O 120.897 0.38 . . . . 0.0 111.432 -178.078 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 68.9 mt-30 -59.85 -42.62 94.03 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.289 178.494 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -81.02 -29.34 35.14 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.99 -178.137 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 13.8 mmm180 -52.1 -45.32 64.83 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.736 177.618 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.525 ' HB3' HG22 ' A' ' 49' ' ' VAL . . . -102.42 -11.49 18.56 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.72 -0.673 . . . . 0.0 111.429 -178.198 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 75.3 30.17 59.09 Favored Glycine 0 CA--C 1.52 0.365 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.04 -177.255 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.525 HG22 ' HB3' ' A' ' 47' ' ' ALA . 20.0 m -120.09 177.34 3.08 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-O 120.846 0.355 . . . . 0.0 110.504 -177.638 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 64.5 tttp -105.46 122.28 45.67 Favored 'General case' 0 C--N 1.318 -0.797 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 172.115 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . 0.658 ' HE2' HG12 ' A' ' 69' ' ' ILE . 36.1 mtp -117.31 115.18 24.76 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 178.833 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.47 ' CG2' ' HB2' ' A' ' 68' ' ' ARG . 10.4 tt -110.76 110.82 33.59 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.798 0 CA-C-O 121.452 0.644 . . . . 0.0 110.901 -178.697 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.613 ' HB3' HE21 ' A' ' 55' ' ' GLN . 3.7 mm? -93.97 103.84 15.91 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.27 -0.877 . . . . 0.0 109.474 175.279 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.618 HD12 ' HB2' ' A' ' 66' ' ' PRO . 68.3 mt -75.33 87.52 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-O 121.613 0.72 . . . . 0.0 110.216 -178.818 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . 0.613 HE21 ' HB3' ' A' ' 53' ' ' LEU . 72.5 mm-40 . . . . . 0 C--N 1.322 -0.622 0 CA-C-N 115.02 -0.991 . . . . 0.0 109.34 179.705 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.589 ' HB3' ' HB3' ' A' ' 23' ' ' MET . 3.4 m-20 . . . . . 0 C--O 1.226 -0.181 0 N-CA-C 110.116 -0.327 . . . . 0.0 110.116 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . 0.772 ' HB2' ' HB ' ' A' ' 24' ' ' ILE . 34.5 mmtp -82.34 136.19 46.41 Favored Pre-proline 0 C--N 1.321 -0.673 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.393 -168.438 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.618 ' HB2' HD12 ' A' ' 54' ' ' ILE . 10.5 Cg_exo -71.8 110.44 2.9 Favored 'Trans proline' 0 N--CA 1.458 -0.588 0 C-N-CA 123.137 2.558 . . . . 0.0 111.305 175.953 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.862 HD11 HG13 ' A' ' 69' ' ' ILE . 1.6 tm? -114.65 141.1 48.24 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 115.827 -0.624 . . . . 0.0 109.453 179.023 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . 0.575 ' HG2' ' HG2' ' A' ' 21' ' ' GLU . 95.1 mtt180 -134.76 124.04 24.55 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.185 0.517 . . . . 0.0 111.465 168.607 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.862 HG13 HD11 ' A' ' 67' ' ' LEU . 20.9 mt -102.95 104.62 16.86 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-N 115.206 -0.906 . . . . 0.0 109.279 173.445 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 11.8 mt -103.37 125.57 57.87 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.891 0 CA-C-N 116.484 -0.325 . . . . 0.0 110.246 -175.174 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 169.19 -123.21 1.06 Allowed Glycine 0 N--CA 1.447 -0.617 0 C-N-CA 120.505 -0.855 . . . . 0.0 112.934 178.349 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . 0.401 ' HB3' ' HG2' ' A' ' 75' ' ' LYS . 11.1 t70 -115.26 139.11 24.07 Favored Pre-proline 0 C--N 1.324 -0.516 0 CA-C-O 118.759 -0.639 . . . . 0.0 109.995 -176.421 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . 0.545 ' HA ' HG21 ' A' ' 18' ' ' THR . 84.3 Cg_exo -40.47 -43.73 4.2 Favored 'Trans proline' 0 C--N 1.347 0.477 0 C-N-CA 123.406 2.737 . . . . 0.0 112.832 -176.264 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 78.8 t80 -60.61 -60.92 3.04 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.147 -0.933 . . . . 0.0 111.334 -178.626 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.401 ' HG2' ' HB3' ' A' ' 72' ' ' ASP . 25.5 pttt -76.54 -24.05 53.64 Favored 'General case' 0 CA--C 1.517 -0.314 0 N-CA-C 112.131 0.419 . . . . 0.0 112.131 -176.187 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 48.8 t -66.79 -39.89 84.67 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 N-CA-C 109.079 -0.711 . . . . 0.0 109.079 176.865 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . 0.47 ' O ' ' HG2' ' A' ' 81' ' ' GLU . 20.9 tp60 -74.0 -42.64 60.09 Favored 'General case' 0 N--CA 1.445 -0.706 0 CA-C-N 115.523 -0.762 . . . . 0.0 110.502 179.744 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 91.6 mt-30 -60.91 -43.83 98.0 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.848 0.356 . . . . 0.0 110.609 177.732 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -64.95 -38.78 92.09 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.692 178.171 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 44.3 t -62.44 -54.8 34.86 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.733 -0.667 . . . . 0.0 111.471 178.243 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . 0.47 ' HG2' ' O ' ' A' ' 77' ' ' GLN . 12.2 pt-20 -68.53 -19.59 64.51 Favored 'General case' 0 C--N 1.324 -0.511 0 C-N-CA 120.481 -0.488 . . . . 0.0 110.468 -178.468 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' MET . . . . . 0.484 ' O ' ' HB3' ' A' ' 85' ' ' ASP . 52.3 ttp -72.97 -46.46 52.22 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.85 175.768 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.596 HG12 HD13 ' A' ' 43' ' ' LEU . 29.9 m -80.18 -29.41 12.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 C-N-CA 120.812 -0.355 . . . . 0.0 110.869 -179.352 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 12.8 tmm? -65.47 -34.39 78.16 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 174.143 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . 0.484 ' HB3' ' O ' ' A' ' 82' ' ' MET . 3.8 t70 -59.31 -42.12 90.64 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.229 -0.896 . . . . 0.0 110.626 174.502 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.584 HG22 ' HB3' ' A' ' 31' ' ' LEU . 30.1 mt -63.82 -34.11 66.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-O 121.359 0.599 . . . . 0.0 110.406 178.694 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.625 HD13 ' HD2' ' A' ' 25' ' ' PRO . 59.6 mt -85.52 -6.31 59.2 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.769 -178.952 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 67.7 ttt180 -102.26 -7.67 21.92 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.723 0.773 . . . . 0.0 109.537 176.479 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 10.8 tp10 . . . . . 0 C--O 1.253 1.242 0 CA-C-N 115.191 -0.913 . . . . 0.0 110.022 -174.451 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 59.5 m . . . . . 0 N--CA 1.451 -0.383 0 CA-C-O 120.736 0.303 . . . . 0.0 110.613 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.461 ' HA ' ' O ' ' A' ' 69' ' ' ILE . 8.5 p -131.75 138.75 52.12 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 CA-C-O 120.91 0.386 . . . . 0.0 110.295 179.192 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 9.2 tt0 -124.24 135.67 53.58 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 109.698 -0.482 . . . . 0.0 109.698 178.607 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.606 ' HG2' ' HG2' ' A' ' 68' ' ' ARG . 51.5 mt-10 -104.28 125.73 50.78 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.309 0.576 . . . . 0.0 112.021 -178.938 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.473 ' HB ' ' HB3' ' A' ' 67' ' ' LEU . 14.2 mm -110.66 146.33 15.93 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 CA-C-N 115.104 -0.953 . . . . 0.0 109.077 174.821 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 8.7 mmt -100.41 93.75 5.81 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 108.584 -0.895 . . . . 0.0 108.584 175.103 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.692 ' HB ' ' HB2' ' A' ' 65' ' ' LYS . 37.0 mm -79.35 126.06 81.97 Favored Pre-proline 0 C--N 1.318 -0.774 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.422 -177.331 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . 0.416 ' HB2' ' HB2' ' A' ' 28' ' ' LYS . 71.8 Cg_exo -52.39 134.36 51.46 Favored 'Trans proline' 0 N--CA 1.461 -0.433 0 C-N-CA 122.794 2.329 . . . . 0.0 111.714 175.709 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -58.51 -25.21 62.15 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.998 -177.753 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -89.35 -6.37 71.13 Favored Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.837 -0.697 . . . . 0.0 112.642 178.069 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.556 ' HB3' HD22 ' A' ' 87' ' ' LEU . 51.2 mttp -115.77 10.82 15.48 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.754 0.312 . . . . 0.0 111.366 -179.015 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -68.58 -29.82 68.45 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.205 0.526 . . . . 0.0 110.152 179.307 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -69.9 -17.88 73.85 Favored Glycine 0 N--CA 1.447 -0.584 0 CA-C-N 115.863 -0.608 . . . . 0.0 112.265 176.822 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 84.0 mt -83.13 -43.51 16.14 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.557 0.218 . . . . 0.0 110.706 -179.768 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.657 HG13 HD21 ' A' ' 87' ' ' LEU . 1.6 m -68.86 -33.33 58.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.308 -0.406 . . . . 0.0 111.174 178.697 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.498 ' HA ' ' HB ' ' A' ' 40' ' ' ILE . 88.8 mt -77.83 -40.71 27.48 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-O 121.52 0.676 . . . . 0.0 109.698 175.57 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 103.08 164.51 25.75 Favored Glycine 0 N--CA 1.442 -0.919 0 CA-C-N 115.353 -0.84 . . . . 0.0 111.576 -179.335 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 1.3 mptm? -79.13 54.41 1.63 Allowed 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.189 0.518 . . . . 0.0 110.849 -178.786 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 144.04 21.82 0.17 Allowed Glycine 0 N--CA 1.447 -0.603 0 CA-C-N 115.779 -0.646 . . . . 0.0 111.783 178.759 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 71.79 -0.66 35.12 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 121.028 -0.606 . . . . 0.0 112.358 -178.007 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.509 ' O ' ' HG2' ' A' ' 42' ' ' GLN . 14.2 pt-20 -64.66 -37.81 88.86 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.703 0.287 . . . . 0.0 111.276 -175.573 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . 0.833 ' O ' ' HG ' ' A' ' 43' ' ' LEU . 56.4 m -69.92 -55.66 9.1 Favored 'General case' 0 N--CA 1.449 -0.482 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.383 -175.086 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.498 ' HB ' ' HA ' ' A' ' 33' ' ' ILE . 12.7 tt -61.91 -25.09 36.26 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-O 121.462 0.649 . . . . 0.0 111.013 -177.48 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . 0.406 ' HB3' ' HE2' ' A' ' 41' ' ' LYS . 37.6 ttpt -71.8 -47.49 53.01 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.778 178.863 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.509 ' HG2' ' O ' ' A' ' 38' ' ' GLU . 11.3 pt20 -72.32 -41.07 66.97 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.838 -0.619 . . . . 0.0 111.12 -177.259 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.833 ' HG ' ' O ' ' A' ' 39' ' ' THR . 48.6 mt -51.23 -48.44 62.08 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.769 -0.65 . . . . 0.0 111.731 -177.08 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 49.3 mt-30 -58.21 -42.16 85.62 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.27 -178.078 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 -81.33 -35.1 31.36 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.676 -174.308 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . 0.406 ' HG2' ' O ' ' A' ' 42' ' ' GLN . 15.0 ptm180 -78.85 -23.45 44.97 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 111.905 0.335 . . . . 0.0 111.905 -175.894 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -94.59 -24.53 17.18 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 120.908 0.385 . . . . 0.0 111.379 179.906 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 81.77 23.64 57.41 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.863 -0.684 . . . . 0.0 112.082 -178.687 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 17.7 m -130.36 178.98 4.62 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-O 120.833 0.349 . . . . 0.0 110.197 -179.083 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 87.2 tttt -109.83 124.63 51.65 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.012 176.177 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . 0.472 ' HE2' ' HB1' ' A' ' 79' ' ' ALA . 60.5 mtt -113.38 116.01 28.99 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 109.583 -0.525 . . . . 0.0 109.583 178.632 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.475 ' CG2' ' HB2' ' A' ' 68' ' ' ARG . 11.0 tt -110.64 105.83 19.56 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 CA-C-O 121.632 0.729 . . . . 0.0 110.674 178.047 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.523 HD22 HD13 ' A' ' 67' ' ' LEU . 3.8 mm? -86.12 102.8 14.19 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.336 -0.847 . . . . 0.0 109.358 174.978 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.606 HD12 ' HB2' ' A' ' 66' ' ' PRO . 52.3 mt -80.57 86.51 1.47 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.411 0 CA-C-O 121.913 0.863 . . . . 0.0 110.121 179.588 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . 0.46 ' HG2' HD11 ' A' ' 33' ' ' ILE . 2.7 pp0? . . . . . 0 C--N 1.317 -0.815 0 CA-C-N 114.607 -1.179 . . . . 0.0 109.52 176.246 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 62.7 m-20 . . . . . 0 N--CA 1.464 0.229 0 CA-C-O 120.957 0.408 . . . . 0.0 110.988 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . 0.692 ' HB2' ' HB ' ' A' ' 24' ' ' ILE . 69.8 mmtt -98.81 121.22 56.76 Favored Pre-proline 0 C--N 1.32 -0.677 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.767 -174.273 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.606 ' HB2' HD12 ' A' ' 54' ' ' ILE . 27.1 Cg_exo -64.71 105.29 0.63 Allowed 'Trans proline' 0 N--CA 1.46 -0.473 0 C-N-CA 122.884 2.389 . . . . 0.0 111.746 174.614 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.523 HD13 HD22 ' A' ' 53' ' ' LEU . 25.1 tp -105.2 106.39 16.86 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 109.735 -0.469 . . . . 0.0 109.735 175.85 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . 0.606 ' HG2' ' HG2' ' A' ' 21' ' ' GLU . 96.1 mtt180 -101.68 105.88 16.85 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.437 178.35 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.461 ' O ' ' HA ' ' A' ' 19' ' ' VAL . 4.7 mp -86.22 103.99 13.31 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 N-CA-C 108.195 -1.039 . . . . 0.0 108.195 174.142 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 3.7 mt -103.43 112.86 38.51 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.038 -174.506 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -176.16 -128.38 1.12 Allowed Glycine 0 N--CA 1.439 -1.137 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.324 -179.489 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . 0.508 ' HB3' ' CG ' ' A' ' 75' ' ' LYS . 3.1 t70 -109.61 143.27 27.5 Favored Pre-proline 0 C--N 1.318 -0.769 0 CA-C-O 118.752 -0.642 . . . . 0.0 110.289 -177.006 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_exo -44.14 -39.94 12.0 Favored 'Trans proline' 0 C--N 1.346 0.443 0 C-N-CA 122.827 2.351 . . . . 0.0 113.262 -175.268 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 93.6 t80 -74.6 -53.71 8.84 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.798 -174.807 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.508 ' CG ' ' HB3' ' A' ' 72' ' ' ASP . 10.4 pttt -75.4 -17.49 60.18 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.531 -0.304 . . . . 0.0 111.79 -179.077 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 24.1 t -70.0 -40.19 78.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 171.855 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . 0.489 ' O ' ' HG2' ' A' ' 81' ' ' GLU . 21.2 tp60 -69.45 -46.3 67.05 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.06 178.904 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 86.4 mt-30 -58.89 -39.53 81.72 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.778 176.553 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . 0.472 ' HB1' ' HE2' ' A' ' 51' ' ' MET . . . -68.84 -36.8 78.61 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.143 178.781 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' CYS . . . . . 0.4 ' O ' ' HG3' ' A' ' 84' ' ' MET . 38.4 t -65.22 -50.8 64.47 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.921 178.974 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . 0.489 ' HG2' ' O ' ' A' ' 77' ' ' GLN . 9.9 pt-20 -69.69 -18.82 63.58 Favored 'General case' 0 C--N 1.324 -0.543 0 C-N-CA 120.513 -0.475 . . . . 0.0 110.2 178.415 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' MET . . . . . 0.6 ' SD ' HD22 ' A' ' 43' ' ' LEU . 36.7 ttm -70.55 -53.43 16.14 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.333 173.86 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.453 ' O ' ' HG ' ' A' ' 87' ' ' LEU . 26.9 m -70.55 -35.74 62.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 C-N-CA 121.048 -0.261 . . . . 0.0 111.399 -178.645 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' MET . . . . . 0.4 ' HG3' ' O ' ' A' ' 80' ' ' CYS . 52.7 mtm -69.64 -26.97 64.67 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.768 0.318 . . . . 0.0 110.177 177.556 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -60.15 -48.38 81.96 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 116.066 -0.515 . . . . 0.0 109.748 175.807 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 48.4 mt -60.49 -34.86 59.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 115.422 -0.808 . . . . 0.0 111.048 179.826 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.657 HD21 HG13 ' A' ' 32' ' ' VAL . 51.3 mt -81.26 -16.12 53.53 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.3 -178.024 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . 0.421 HH11 ' HD3' ' A' ' 88' ' ' ARG . 13.7 ttp180 -97.2 -33.84 11.33 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 121.429 0.633 . . . . 0.0 111.074 -177.759 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 12.3 tp10 . . . . . 0 C--N 1.307 -1.257 0 CA-C-N 114.878 -1.055 . . . . 0.0 110.83 -173.437 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.54 ' OG1' ' HG3' ' A' ' 73' ' ' PRO . 80.0 m . . . . . 0 N--CA 1.449 -0.481 0 CA-C-O 121.001 0.429 . . . . 0.0 111.079 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.559 ' HA ' ' O ' ' A' ' 69' ' ' ILE . 4.5 p -137.44 134.92 46.85 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.587 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.208 177.672 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . 0.492 ' O ' ' HA ' ' A' ' 68' ' ' ARG . 33.2 mt-30 -121.11 157.84 29.22 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.019 176.142 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.588 ' HG2' ' HG2' ' A' ' 68' ' ' ARG . 40.2 mt-10 -124.16 107.72 11.53 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.024 -176.32 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 5.9 mm -99.01 140.97 17.33 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-N 115.86 -0.609 . . . . 0.0 109.776 -180.0 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 74.1 mmm -102.88 93.9 5.3 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 109.157 -0.683 . . . . 0.0 109.157 177.218 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.72 ' HB ' ' HB2' ' A' ' 65' ' ' LYS . 38.5 mm -81.88 132.59 53.8 Favored Pre-proline 0 C--N 1.321 -0.668 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.235 -174.711 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 75.5 Cg_exo -51.95 134.06 47.79 Favored 'Trans proline' 0 C--N 1.345 0.357 0 C-N-CA 122.959 2.439 . . . . 0.0 111.834 172.558 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -60.02 -33.05 71.48 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.214 179.758 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -68.58 -19.74 73.21 Favored Glycine 0 N--CA 1.449 -0.493 0 C-N-CA 120.892 -0.67 . . . . 0.0 112.578 177.332 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.596 ' HB3' HD22 ' A' ' 87' ' ' LEU . 5.2 mptp? -106.57 12.46 29.42 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.748 0.309 . . . . 0.0 111.004 -179.457 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.64 -31.75 71.86 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.008 0.432 . . . . 0.0 110.602 179.775 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -61.84 -24.24 64.35 Favored Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 120.864 -0.684 . . . . 0.0 112.571 179.564 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 83.7 mt -85.17 -48.52 9.06 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.684 0.242 . . . . 0.0 111.033 -177.99 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.562 HG11 HG13 ' A' ' 24' ' ' ILE . 2.9 m -67.89 -33.65 62.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.814 0.34 . . . . 0.0 111.758 -179.701 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 72.1 mt -80.56 -35.74 15.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 121.915 0.864 . . . . 0.0 109.462 176.321 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . 0.522 ' HA3' ' HB ' ' A' ' 39' ' ' THR . . . 94.99 52.07 1.83 Allowed Glycine 0 N--CA 1.439 -1.145 0 CA-C-N 115.208 -0.905 . . . . 0.0 113.808 172.204 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 30.8 mtmt 50.3 41.94 25.07 Favored 'General case' 0 C--N 1.328 -0.342 0 O-C-N 124.162 0.566 . . . . 0.0 112.204 169.659 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 129.03 -17.36 5.68 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.705 -0.76 . . . . 0.0 111.951 -179.36 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 116.18 7.48 14.54 Favored Glycine 0 N--CA 1.447 -0.611 0 C-N-CA 120.654 -0.784 . . . . 0.0 112.19 178.802 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 36.0 mt-10 -76.08 -47.55 24.12 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.786 0.327 . . . . 0.0 110.827 -178.99 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . 0.644 ' O ' ' HG ' ' A' ' 43' ' ' LEU . 7.2 m -66.08 -44.05 85.56 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.451 -0.34 . . . . 0.0 111.46 -176.791 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.481 ' CD1' HD23 ' A' ' 53' ' ' LEU . 9.7 tt -60.42 -36.01 66.55 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.495 0 CA-C-O 121.032 0.444 . . . . 0.0 110.703 179.908 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 22.5 ttmm -61.13 -41.19 96.27 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.579 0.704 . . . . 0.0 110.134 175.302 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 48.1 mt-30 -74.51 -44.13 52.7 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.179 -0.919 . . . . 0.0 111.258 -177.387 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.644 ' HG ' ' O ' ' A' ' 39' ' ' THR . 94.9 mt -51.94 -49.96 62.12 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.923 -176.372 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . 0.433 ' HG3' ' O ' ' A' ' 40' ' ' ILE . 40.5 mt-30 -60.07 -57.49 12.6 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.157 -176.629 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -75.24 -22.11 58.12 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.674 -0.694 . . . . 0.0 112.276 -171.681 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 13.8 ptm180 -77.62 -33.41 53.65 Favored 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 120.304 -0.558 . . . . 0.0 110.727 177.865 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -88.33 -28.81 20.78 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.0 -178.3 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 95.57 21.32 24.48 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.856 -0.687 . . . . 0.0 112.709 -179.366 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 10.4 m -130.07 179.95 3.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-O 120.906 0.384 . . . . 0.0 110.684 -178.836 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . 0.679 ' HE3' ' HB ' ' A' ' 52' ' ' ILE . 8.9 tmtm? -111.95 126.09 54.76 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.953 -0.567 . . . . 0.0 109.645 176.7 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . 0.474 ' CE ' ' HB1' ' A' ' 79' ' ' ALA . 58.6 mtt -113.28 132.33 55.58 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 176.283 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.679 ' HB ' ' HE3' ' A' ' 50' ' ' LYS . 10.9 tt -120.39 113.56 40.73 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.721 0 CA-C-O 121.619 0.723 . . . . 0.0 110.817 175.874 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.75 HD22 HD13 ' A' ' 67' ' ' LEU . 3.6 mm? -88.67 104.19 16.64 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.013 -0.994 . . . . 0.0 109.138 175.45 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.57 ' HB ' ' HB2' ' A' ' 66' ' ' PRO . 52.6 mt -91.13 92.02 3.79 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.19 -176.95 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 11.3 mp0 . . . . . 0 C--N 1.326 -0.423 0 CA-C-O 120.839 0.352 . . . . 0.0 110.772 -178.395 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 40.8 m-20 . . . . . 0 CA--C 1.512 -0.495 0 CA-C-O 121.27 0.557 . . . . 0.0 110.805 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . 0.72 ' HB2' ' HB ' ' A' ' 24' ' ' ILE . 69.8 mmtt -121.06 98.34 47.36 Favored Pre-proline 0 C--N 1.316 -0.863 0 CA-C-N 115.395 -0.821 . . . . 0.0 110.188 179.273 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.57 ' HB2' ' HB ' ' A' ' 54' ' ' ILE . 71.5 Cg_exo -54.2 115.64 2.51 Favored 'Trans proline' 0 C--O 1.234 0.305 0 C-N-CA 123.166 2.577 . . . . 0.0 112.31 174.861 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.75 HD13 HD22 ' A' ' 53' ' ' LEU . 31.3 tp -118.77 113.72 21.57 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.28 179.757 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . 0.588 ' HG2' ' HG2' ' A' ' 21' ' ' GLU . 98.1 mtt180 -104.25 113.0 26.25 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 121.077 0.465 . . . . 0.0 110.707 175.943 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.559 ' O ' ' HA ' ' A' ' 19' ' ' VAL . 3.9 mp -95.21 109.45 22.43 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 175.085 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 8.1 mt -112.57 129.11 68.74 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 CA-C-N 116.462 -0.335 . . . . 0.0 111.162 -170.812 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 152.98 -127.14 2.13 Favored Glycine 0 N--CA 1.445 -0.746 0 C-N-CA 120.199 -1.0 . . . . 0.0 113.507 173.73 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . 0.438 ' HA ' ' HD3' ' A' ' 73' ' ' PRO . 19.7 t70 -85.87 133.27 41.75 Favored Pre-proline 0 C--N 1.322 -0.626 0 C-N-CA 123.19 0.596 . . . . 0.0 111.326 -176.626 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . 0.54 ' HG3' ' OG1' ' A' ' 18' ' ' THR . 32.4 Cg_exo -55.52 -28.49 64.83 Favored 'Trans proline' 0 C--N 1.35 0.627 0 C-N-CA 123.8 3.0 . . . . 0.0 113.524 -173.16 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 87.7 t80 -75.58 -54.49 6.92 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.045 0.45 . . . . 0.0 110.128 -177.9 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.406 ' H ' ' HG2' ' A' ' 75' ' ' LYS . 7.6 pttm -79.52 -19.01 50.65 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.221 -0.445 . . . . 0.0 112.062 -178.353 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.409 HG22 HG22 ' A' ' 69' ' ' ILE . 25.2 t -69.43 -38.04 76.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 N-CA-C 109.815 -0.439 . . . . 0.0 109.815 172.895 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -71.51 -48.57 48.1 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 -179.632 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 27.8 mt-30 -59.06 -37.84 77.99 Favored 'General case' 0 C--O 1.22 -0.459 0 CA-C-N 115.784 -0.643 . . . . 0.0 110.583 176.565 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . 0.559 ' HB3' HG21 ' A' ' 69' ' ' ILE . . . -64.61 -40.16 95.0 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.049 0.452 . . . . 0.0 110.291 -179.664 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' CYS . . . . . 0.458 ' SG ' HD13 ' A' ' 69' ' ' ILE . 88.6 m -65.72 -49.53 68.15 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.498 -0.774 . . . . 0.0 110.792 179.115 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . 0.466 ' O ' ' HB2' ' A' ' 85' ' ' ASP . 3.0 pp20? -72.08 -19.84 61.75 Favored 'General case' 0 C--N 1.326 -0.433 0 C-N-CA 120.075 -0.65 . . . . 0.0 110.902 -179.96 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' MET . . . . . 0.443 ' O ' HG13 ' A' ' 86' ' ' ILE . 40.8 ttp -75.63 -49.2 19.18 Favored 'General case' 0 C--N 1.33 -0.248 0 O-C-N 123.053 0.221 . . . . 0.0 110.597 176.468 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.565 ' O ' ' HG ' ' A' ' 87' ' ' LEU . 35.7 m -67.18 -36.21 76.23 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.175 0 C-N-CA 120.712 -0.395 . . . . 0.0 110.485 178.487 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 91.2 mtp -72.01 -27.85 63.0 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.208 175.636 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . 0.466 ' HB2' ' O ' ' A' ' 81' ' ' GLU . 32.6 t70 -64.89 -45.5 85.67 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.171 -0.468 . . . . 0.0 109.855 176.022 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.443 HG13 ' O ' ' A' ' 82' ' ' MET . 70.2 mt -56.62 -37.14 50.95 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.183 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.599 176.882 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.626 HD11 HD12 ' A' ' 24' ' ' ILE . 50.3 mt -75.73 -35.87 60.09 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.757 -0.656 . . . . 0.0 111.435 -177.372 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . 0.441 HH11 ' HD2' ' A' ' 88' ' ' ARG . 9.1 ptp85 -79.3 -20.24 48.46 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.25 0.548 . . . . 0.0 110.672 -178.199 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 5.4 tp10 . . . . . 0 C--N 1.312 -1.055 0 CA-C-O 118.327 -0.844 . . . . 0.0 109.979 -173.475 . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.635 HG21 ' HA ' ' A' ' 73' ' ' PRO . 23.9 m . . . . . 0 N--CA 1.453 -0.283 0 CA-C-O 120.813 0.339 . . . . 0.0 111.347 . . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.635 ' HA ' ' O ' ' A' ' 69' ' ' ILE . 7.2 p -141.34 127.99 20.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.907 176.667 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 85.4 mt-30 -109.43 132.35 54.21 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.589 176.483 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.576 ' HA ' ' O ' ' A' ' 67' ' ' LEU . 6.7 mp0 -103.0 118.77 37.55 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.371 177.15 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 11.7 mm -108.92 144.17 17.81 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-N 116.048 -0.523 . . . . 0.0 109.619 178.696 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 9.4 mmt -100.08 91.52 4.81 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 109.699 -0.482 . . . . 0.0 109.699 176.436 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.683 ' HB ' ' HB2' ' A' ' 65' ' ' LYS . 41.3 mm -79.29 126.72 80.88 Favored Pre-proline 0 C--N 1.32 -0.677 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.011 -176.034 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . 0.655 ' HB2' ' HD3' ' A' ' 28' ' ' LYS . 65.9 Cg_exo -52.43 147.49 29.29 Favored 'Trans proline' 0 C--N 1.347 0.486 0 C-N-CA 123.166 2.577 . . . . 0.0 112.94 177.445 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -51.48 -55.96 15.97 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 112.232 0.456 . . . . 0.0 112.232 -173.932 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -75.48 -8.96 84.5 Favored Glycine 0 N--CA 1.454 -0.155 0 C-N-CA 121.103 -0.57 . . . . 0.0 112.618 -176.892 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.655 ' HD3' ' HB2' ' A' ' 25' ' ' PRO . 5.1 mptp? -92.78 -3.94 53.89 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.957 0.408 . . . . 0.0 110.815 -179.896 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -62.17 -32.1 72.68 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.489 177.342 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -67.32 -19.26 70.34 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.861 -0.685 . . . . 0.0 112.44 178.932 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 79.0 mt -87.03 -42.96 12.69 Favored 'General case' 0 C--N 1.327 -0.371 0 O-C-N 122.789 -0.242 . . . . 0.0 110.896 -178.898 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 4.1 m -69.9 -35.88 66.72 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.15 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.152 179.164 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.664 ' HA ' ' HB ' ' A' ' 40' ' ' ILE . 88.2 mt -76.95 -38.21 28.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-O 121.459 0.647 . . . . 0.0 109.892 177.939 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . 0.523 ' CA ' ' HB ' ' A' ' 39' ' ' THR . . . 124.32 157.05 9.63 Favored Glycine 0 N--CA 1.439 -1.137 0 C-N-CA 120.584 -0.817 . . . . 0.0 112.38 174.532 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 32.2 mmtp -58.65 -31.79 68.48 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 120.836 0.351 . . . . 0.0 110.642 -178.888 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -128.42 14.63 6.14 Favored Glycine 0 N--CA 1.449 -0.452 0 C-N-CA 120.952 -0.642 . . . . 0.0 111.879 175.751 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.553 ' HA2' HG22 ' A' ' 33' ' ' ILE . . . 84.48 1.78 89.17 Favored Glycine 0 C--N 1.332 0.315 0 C-N-CA 121.017 -0.611 . . . . 0.0 112.135 -177.347 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -85.39 -29.67 24.24 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 120.706 0.288 . . . . 0.0 111.385 -178.121 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . 0.768 ' O ' ' HG ' ' A' ' 43' ' ' LEU . 91.3 m -62.51 -42.0 99.21 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.849 -174.796 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.664 ' HB ' ' HA ' ' A' ' 33' ' ' ILE . 15.6 tt -60.62 -30.17 46.29 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.287 0 CA-C-O 121.105 0.478 . . . . 0.0 111.093 -179.308 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . 0.679 ' O ' ' HG2' ' A' ' 45' ' ' GLU . 62.0 tttp -73.19 -44.05 60.43 Favored 'General case' 0 N--CA 1.451 -0.419 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 174.332 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 75.4 mt-30 -58.49 -43.72 89.12 Favored 'General case' 0 CA--C 1.515 -0.401 0 CA-C-N 115.681 -0.69 . . . . 0.0 110.106 -177.167 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.768 ' HG ' ' O ' ' A' ' 39' ' ' THR . 42.1 mt -53.89 -49.66 68.08 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.385 -0.825 . . . . 0.0 110.855 -179.644 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 48.4 mt-30 -64.68 -45.6 85.99 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.411 -0.813 . . . . 0.0 110.985 -179.377 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.679 ' HG2' ' O ' ' A' ' 41' ' ' LYS . 67.7 mm-40 -61.18 -41.91 97.63 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.078 -179.279 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . 0.516 ' HD3' ' SD ' ' A' ' 82' ' ' MET . 10.2 ptm180 -81.65 -36.43 28.84 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.767 -0.652 . . . . 0.0 112.651 -170.063 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -90.26 -24.04 21.04 Favored 'General case' 0 C--N 1.324 -0.507 0 C-N-CA 120.498 -0.481 . . . . 0.0 111.187 -178.743 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 87.49 24.0 37.88 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.967 -0.635 . . . . 0.0 112.533 -179.657 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.478 HG13 ' HB2' ' A' ' 75' ' ' LYS . 14.0 m -121.77 179.31 2.42 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-O 120.923 0.392 . . . . 0.0 110.89 -178.002 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 87.3 tttt -117.58 122.41 43.55 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.548 -0.751 . . . . 0.0 109.162 173.708 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . 0.573 ' HG2' HG23 ' A' ' 69' ' ' ILE . 65.2 mtp -116.9 115.52 25.67 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 -179.008 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.604 ' CG2' ' HB2' ' A' ' 68' ' ' ARG . 6.0 tt -105.61 105.8 19.36 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.782 0 CA-C-O 121.47 0.652 . . . . 0.0 110.984 -178.136 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.802 HD22 HD13 ' A' ' 67' ' ' LEU . 3.4 mm? -83.12 102.17 11.65 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.391 -0.822 . . . . 0.0 109.316 174.008 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.55 ' HB ' ' HB2' ' A' ' 66' ' ' PRO . 64.9 mt -81.65 85.57 1.63 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.432 0 CA-C-O 121.677 0.751 . . . . 0.0 110.333 -177.863 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . 0.404 ' HG2' HD11 ' A' ' 33' ' ' ILE . 1.9 pp0? . . . . . 0 C--N 1.316 -0.849 0 CA-C-N 115.068 -0.969 . . . . 0.0 109.279 171.994 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 1.2 p30 . . . . . 0 CA--C 1.52 -0.179 0 CA-C-O 121.319 0.581 . . . . 0.0 111.326 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . 0.683 ' HB2' ' HB ' ' A' ' 24' ' ' ILE . 31.6 mmtm -129.57 113.44 17.95 Favored Pre-proline 0 C--N 1.315 -0.894 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.696 179.713 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.55 ' HB2' ' HB ' ' A' ' 54' ' ' ILE . 52.6 Cg_exo -58.09 104.56 0.18 Allowed 'Trans proline' 0 N--CA 1.459 -0.512 0 C-N-CA 122.821 2.348 . . . . 0.0 111.632 173.678 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.802 HD13 HD22 ' A' ' 53' ' ' LEU . 18.9 tp -112.85 106.5 14.83 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.235 177.229 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . 0.604 ' HB2' ' CG2' ' A' ' 52' ' ' ILE . 13.1 mtp180 -92.67 117.83 30.39 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 109.476 -0.564 . . . . 0.0 109.476 172.586 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.635 ' O ' ' HA ' ' A' ' 19' ' ' VAL . 28.4 mt -96.94 102.31 13.32 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.089 0 N-CA-C 108.206 -1.035 . . . . 0.0 108.206 171.631 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 5.2 mt -103.4 119.39 51.88 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.042 -172.229 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 176.36 -137.11 3.49 Favored Glycine 0 N--CA 1.444 -0.817 0 C-N-CA 120.96 -0.638 . . . . 0.0 112.393 178.849 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . 0.847 ' HB2' ' HE2' ' A' ' 75' ' ' LYS . 44.9 m-20 -108.12 152.5 41.84 Favored Pre-proline 0 C--N 1.32 -0.713 0 N-CA-C 109.567 -0.531 . . . . 0.0 109.567 179.784 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . 0.635 ' HA ' HG21 ' A' ' 18' ' ' THR . 67.2 Cg_exo -48.89 -48.74 17.0 Favored 'Trans proline' 0 C--N 1.347 0.469 0 C-N-CA 123.359 2.706 . . . . 0.0 113.972 -167.106 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . 0.519 ' O ' ' HG2' ' A' ' 78' ' ' GLN . 45.1 m-85 -64.75 -51.94 59.66 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.703 -174.494 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.847 ' HE2' ' HB2' ' A' ' 72' ' ' ASP . 22.7 pttt -73.7 -23.82 59.85 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 112.175 0.435 . . . . 0.0 112.175 -176.528 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.419 HG23 ' O ' ' A' ' 72' ' ' ASP . 58.0 t -69.68 -40.92 79.89 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 N-CA-C 109.422 -0.584 . . . . 0.0 109.422 175.39 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . 0.636 HE21 ' HG3' ' A' ' 81' ' ' GLU . 18.1 tp60 -71.43 -46.27 60.53 Favored 'General case' 0 N--CA 1.445 -0.715 0 CA-C-N 115.494 -0.776 . . . . 0.0 111.313 -177.698 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . 0.643 ' HG2' ' HA ' ' A' ' 75' ' ' LYS . 3.3 pt20 -64.09 -38.56 91.51 Favored 'General case' 0 CA--C 1.508 -0.643 0 CA-C-O 121.489 0.661 . . . . 0.0 110.225 -179.676 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . 0.445 ' HA ' ' HE2' ' A' ' 82' ' ' MET . . . -63.34 -39.76 95.42 Favored 'General case' 0 C--N 1.313 -1.016 0 CA-C-N 114.556 -1.202 . . . . 0.0 110.384 176.863 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 52.0 t -64.62 -49.47 70.95 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.447 175.893 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . 0.636 ' HG3' HE21 ' A' ' 77' ' ' GLN . 45.4 mt-10 -56.0 -38.98 71.22 Favored 'General case' 0 CA--C 1.518 -0.286 0 CA-C-O 121.205 0.526 . . . . 0.0 110.054 176.244 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 82' ' ' MET . . . . . 0.516 ' SD ' ' HD3' ' A' ' 46' ' ' ARG . 37.5 ttp -63.43 -54.23 39.88 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 114.77 -1.105 . . . . 0.0 111.555 -178.719 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.477 ' O ' ' HG ' ' A' ' 87' ' ' LEU . 35.4 m -70.74 -37.86 70.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 C-N-CA 120.897 -0.321 . . . . 0.0 111.47 -177.225 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 88.9 mmm -66.38 -33.46 75.76 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.724 0.297 . . . . 0.0 110.34 177.339 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -62.37 -39.07 91.97 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.518 177.171 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.506 HG13 ' O ' ' A' ' 82' ' ' MET . 52.6 mt -66.4 -29.49 46.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.834 179.684 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.561 HD22 ' HB3' ' A' ' 28' ' ' LYS . 61.2 mt -85.1 -23.5 28.46 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.668 -176.231 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 15.7 ptm180 -99.64 -3.14 33.78 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 120.998 0.428 . . . . 0.0 111.192 -175.58 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 12.5 tp10 . . . . . 0 C--O 1.247 0.967 0 CA-C-N 115.661 -0.699 . . . . 0.0 109.892 -174.863 . . . . . . . . 0 0 . 1 . 022 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.502 ' OG1' ' HG3' ' A' ' 73' ' ' PRO . 56.5 m . . . . . 0 N--CA 1.453 -0.306 0 CA-C-O 120.875 0.369 . . . . 0.0 110.683 . . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.461 ' HA ' ' O ' ' A' ' 69' ' ' ILE . 4.0 p -135.97 134.26 50.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.811 179.205 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 26.2 mt-30 -110.57 126.92 54.94 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 109.885 -0.413 . . . . 0.0 109.885 174.135 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.624 ' HG2' ' HG2' ' A' ' 68' ' ' ARG . 26.0 mt-10 -101.23 122.17 43.18 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.957 -179.072 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 7.0 mm -114.02 155.95 15.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 115.828 -0.624 . . . . 0.0 109.891 -178.047 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 23' ' ' MET . . . . . 0.479 ' HB3' ' HB3' ' A' ' 64' ' ' ASP . 85.2 mmm -112.41 97.54 6.68 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 108.27 -1.011 . . . . 0.0 108.27 173.158 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.607 HG21 HG21 ' A' ' 32' ' ' VAL . 40.2 mm -83.89 126.97 69.13 Favored Pre-proline 0 C--N 1.319 -0.757 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.689 -172.575 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_exo -49.1 130.46 24.11 Favored 'Trans proline' 0 C--N 1.345 0.348 0 C-N-CA 123.071 2.514 . . . . 0.0 112.169 176.938 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -55.02 -29.9 58.37 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.605 -0.725 . . . . 0.0 112.657 -174.112 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -87.45 -31.68 15.63 Favored Glycine 0 N--CA 1.446 -0.658 0 C-N-CA 120.347 -0.93 . . . . 0.0 112.739 -178.712 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 4.2 tptm -93.92 -1.54 54.56 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 122.609 -0.347 . . . . 0.0 110.873 -175.002 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -65.57 -21.42 66.59 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.279 -179.143 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -60.18 -37.17 92.5 Favored Glycine 0 N--CA 1.448 -0.561 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.354 179.819 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 92.4 mt -75.29 -27.44 59.34 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.701 0.286 . . . . 0.0 111.371 -174.922 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.703 HG13 ' HB ' ' A' ' 83' ' ' VAL . 1.4 t -69.38 -36.57 72.56 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.365 0 CA-C-O 121.586 0.708 . . . . 0.0 110.222 179.285 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.548 HG12 ' HG ' ' A' ' 53' ' ' LEU . 34.8 mt -86.19 -40.68 14.57 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-N 115.116 -0.947 . . . . 0.0 110.28 -178.302 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 124.88 -170.83 16.87 Favored Glycine 0 N--CA 1.442 -0.933 0 CA-C-N 115.58 -0.736 . . . . 0.0 111.565 179.801 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 33.7 mmtp -82.45 -27.63 31.77 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-O 121.128 0.49 . . . . 0.0 109.711 179.866 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -145.01 12.02 1.87 Allowed Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.861 -0.685 . . . . 0.0 112.367 178.658 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 96.07 16.64 37.56 Favored Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.789 -0.719 . . . . 0.0 111.974 179.542 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -85.13 -37.15 20.56 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 120.635 0.255 . . . . 0.0 110.398 178.84 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . 0.83 ' O ' ' HG ' ' A' ' 43' ' ' LEU . 26.5 m -60.41 -55.83 28.85 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.928 -179.22 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.523 ' HB ' ' HA ' ' A' ' 33' ' ' ILE . 7.9 tt -55.34 -24.65 15.85 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-O 121.064 0.459 . . . . 0.0 111.781 -178.753 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 25.3 ttmm -79.41 -46.73 16.99 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.589 179.91 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.432 ' O ' ' HG2' ' A' ' 46' ' ' ARG . 11.5 pt20 -69.89 -35.64 74.79 Favored 'General case' 0 CA--C 1.515 -0.387 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.318 -177.259 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.83 ' HG ' ' O ' ' A' ' 39' ' ' THR . 77.0 mt -53.11 -45.75 68.43 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.589 -0.732 . . . . 0.0 111.256 -178.576 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 49.2 mt-30 -67.44 -33.54 75.36 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.747 -0.661 . . . . 0.0 111.037 -178.968 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 31.8 mm-40 -72.94 -32.06 65.01 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.147 -178.064 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . 0.432 ' HG2' ' O ' ' A' ' 42' ' ' GLN . 14.9 ptp180 -92.27 -42.19 9.98 Favored 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 112.143 0.423 . . . . 0.0 112.143 -175.882 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.474 ' O ' ' HD3' ' A' ' 75' ' ' LYS . . . -74.9 -31.67 61.63 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.767 0.318 . . . . 0.0 111.072 -177.724 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 92.11 -3.95 77.26 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.876 -0.678 . . . . 0.0 112.088 -178.432 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.442 ' CG1' ' HG3' ' A' ' 75' ' ' LYS . 15.5 m -102.55 169.02 1.98 Allowed 'Isoleucine or valine' 0 CA--C 1.512 -0.516 0 CA-C-O 121.221 0.534 . . . . 0.0 111.022 -179.623 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 86.0 tttt -101.26 124.48 47.03 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-N 115.347 -0.842 . . . . 0.0 110.045 176.286 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . 0.727 ' HE2' ' HB1' ' A' ' 79' ' ' ALA . 58.8 mtt -109.55 114.66 28.47 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 175.919 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.586 ' CG2' ' HB2' ' A' ' 68' ' ' ARG . 10.0 tt -109.63 104.94 17.88 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.994 0 CA-C-O 121.724 0.773 . . . . 0.0 109.988 177.791 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.548 ' HG ' HG12 ' A' ' 33' ' ' ILE . 3.8 mm? -77.98 102.82 7.56 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 114.945 -1.025 . . . . 0.0 108.6 173.166 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.77 ' HB ' ' HG2' ' A' ' 66' ' ' PRO . 51.0 mt -76.04 88.52 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-O 121.777 0.798 . . . . 0.0 109.734 -177.233 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . 0.403 ' HG2' ' O ' ' A' ' 53' ' ' LEU . 13.6 mm100 . . . . . 0 C--N 1.323 -0.577 0 CA-C-N 114.845 -1.07 . . . . 0.0 111.427 -171.568 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.479 ' HB3' ' HB3' ' A' ' 23' ' ' MET . 19.1 m-20 . . . . . 0 N--CA 1.456 -0.141 0 CA-C-O 121.144 0.497 . . . . 0.0 110.058 . . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . 0.456 ' HB2' ' HB ' ' A' ' 24' ' ' ILE . 12.2 mmmm -90.48 133.62 32.56 Favored Pre-proline 0 C--N 1.323 -0.572 0 CA-C-N 115.385 -0.825 . . . . 0.0 112.738 -168.043 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.77 ' HG2' ' HB ' ' A' ' 54' ' ' ILE . 30.3 Cg_endo -64.62 113.83 2.47 Favored 'Trans proline' 0 CA--C 1.533 0.46 0 C-N-CA 123.465 2.777 . . . . 0.0 111.65 172.539 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.59 ' O ' ' HA ' ' A' ' 21' ' ' GLU . 57.0 tp -123.36 129.35 51.18 Favored 'General case' 0 C--N 1.324 -0.531 0 O-C-N 122.338 -0.226 . . . . 0.0 110.579 179.571 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . 0.624 ' HG2' ' HG2' ' A' ' 21' ' ' GLU . 95.7 mtt180 -120.89 114.9 22.24 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.694 0.283 . . . . 0.0 110.984 176.567 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.461 ' O ' ' HA ' ' A' ' 19' ' ' VAL . 4.5 mp -98.24 106.4 18.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 N-CA-C 108.228 -1.027 . . . . 0.0 108.228 171.82 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.437 HG12 ' CG2' ' A' ' 19' ' ' VAL . 15.4 mt -109.85 132.82 57.05 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-N 116.464 -0.334 . . . . 0.0 111.076 -171.98 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 153.91 -132.54 3.6 Favored Glycine 0 N--CA 1.448 -0.51 0 C-N-CA 120.952 -0.642 . . . . 0.0 112.595 176.28 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . 0.623 ' OD2' ' HG2' ' A' ' 75' ' ' LYS . 1.1 t70 -81.0 134.56 52.62 Favored Pre-proline 0 C--N 1.324 -0.524 0 C-N-CA 122.692 0.397 . . . . 0.0 110.882 -178.674 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . 0.502 ' HG3' ' OG1' ' A' ' 18' ' ' THR . 63.9 Cg_exo -47.96 -34.12 21.92 Favored 'Trans proline' 0 C--N 1.349 0.562 0 C-N-CA 123.878 3.052 . . . . 0.0 113.972 -177.314 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 73.0 m-85 -80.38 -55.81 4.63 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.755 0.312 . . . . 0.0 110.547 -176.123 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.623 ' HG2' ' OD2' ' A' ' 72' ' ' ASP . 0.3 OUTLIER -71.07 -22.75 62.07 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.256 -177.587 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 20.5 t -64.85 -43.05 96.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 N-CA-C 109.713 -0.477 . . . . 0.0 109.713 171.249 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -68.59 -46.86 68.25 Favored 'General case' 0 N--CA 1.448 -0.527 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 177.845 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 28.0 mm-40 -61.57 -40.44 94.76 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.026 -179.309 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . 0.727 ' HB1' ' HE2' ' A' ' 51' ' ' MET . . . -67.71 -34.37 76.73 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.017 0.437 . . . . 0.0 110.34 177.546 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 49.2 t -63.01 -48.26 79.54 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.577 -0.738 . . . . 0.0 109.693 175.243 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 75.8 mm-40 -57.82 -44.78 86.62 Favored 'General case' 0 C--O 1.22 -0.479 0 N-CA-C 109.766 -0.457 . . . . 0.0 109.766 174.497 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 82' ' ' MET . . . . . 0.529 ' SD ' HD22 ' A' ' 43' ' ' LEU . 32.5 ttm -52.85 -58.52 6.65 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.385 -0.825 . . . . 0.0 111.267 -179.387 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.703 ' HB ' HG13 ' A' ' 32' ' ' VAL . 35.3 m -73.0 -35.49 48.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.887 -175.813 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 83.5 mtp -77.54 -30.06 52.61 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 120.861 -0.335 . . . . 0.0 111.253 -177.707 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . 0.4 ' HA ' ' HG2' ' A' ' 88' ' ' ARG . 33.4 t70 -62.34 -43.52 98.64 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-O 120.911 0.386 . . . . 0.0 110.244 178.835 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 57.9 mt -61.15 -29.18 45.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 115.837 -0.619 . . . . 0.0 110.61 178.32 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.407 HD11 HG22 ' A' ' 32' ' ' VAL . 5.9 mp -84.91 -40.63 16.81 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.498 -0.774 . . . . 0.0 112.208 -176.714 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . 0.4 ' HG2' ' HA ' ' A' ' 85' ' ' ASP . 25.5 ptt180 -84.51 -8.12 59.04 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.867 0.365 . . . . 0.0 111.704 -174.207 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 . . . . . 0 C--O 1.249 1.063 0 CA-C-O 118.359 -0.829 . . . . 0.0 109.956 -178.228 . . . . . . . . 0 0 . 1 . 023 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.602 ' OG1' ' HD3' ' A' ' 73' ' ' PRO . 89.0 m . . . . . 0 C--O 1.225 -0.222 0 CA-C-O 120.6 0.238 . . . . 0.0 110.725 . . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.461 ' HA ' ' O ' ' A' ' 69' ' ' ILE . 9.1 p -140.64 140.72 33.36 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-O 120.814 0.34 . . . . 0.0 110.751 -179.783 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 25.7 mt-30 -128.12 138.72 52.64 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 109.642 -0.503 . . . . 0.0 109.642 174.394 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.647 ' HG2' ' HG2' ' A' ' 68' ' ' ARG . 44.8 mt-10 -102.62 116.88 33.48 Favored 'General case' 0 C--N 1.328 -0.368 0 O-C-N 123.315 0.384 . . . . 0.0 110.805 -179.57 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 13.1 mm -100.39 150.31 5.61 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-N 115.918 -0.583 . . . . 0.0 109.639 178.47 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 1.7 mmt -103.16 91.61 4.17 Favored 'General case' 0 C--N 1.317 -0.811 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 175.191 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.672 ' HB ' ' HB2' ' A' ' 65' ' ' LYS . 36.1 mm -77.39 124.1 86.88 Favored Pre-proline 0 C--N 1.323 -0.547 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.765 -176.236 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . 0.54 ' HB2' ' HB2' ' A' ' 28' ' ' LYS . 68.4 Cg_exo -51.83 135.41 50.08 Favored 'Trans proline' 0 N--CA 1.461 -0.396 0 C-N-CA 122.898 2.399 . . . . 0.0 111.737 177.717 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -56.25 -35.36 67.32 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 115.649 -0.705 . . . . 0.0 112.371 -175.072 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -80.22 -15.9 77.58 Favored Glycine 0 N--CA 1.452 -0.238 0 C-N-CA 120.519 -0.848 . . . . 0.0 111.875 178.95 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.547 ' HB3' HD22 ' A' ' 87' ' ' LEU . 0.3 OUTLIER -94.89 -4.38 47.02 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.755 0.312 . . . . 0.0 110.591 179.441 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.16 -27.95 68.77 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.424 -178.02 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -65.15 -24.27 70.31 Favored Glycine 0 CA--C 1.519 0.309 0 C-N-CA 120.785 -0.721 . . . . 0.0 112.356 178.253 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 95.1 mt -86.14 -42.66 13.68 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 111.352 0.13 . . . . 0.0 111.352 -176.219 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.844 HG13 HD21 ' A' ' 87' ' ' LEU . 2.7 m -65.19 -34.46 70.71 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.19 0 CA-C-O 120.928 0.394 . . . . 0.0 110.857 178.605 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 66.4 mt -79.89 -45.71 22.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-O 121.469 0.652 . . . . 0.0 109.689 176.241 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . 0.495 ' HA3' ' H ' ' A' ' 39' ' ' THR . . . 96.64 60.07 1.0 Allowed Glycine 0 N--CA 1.444 -0.773 0 CA-C-N 115.719 -0.673 . . . . 0.0 113.123 175.514 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.446 ' N ' ' HD3' ' A' ' 35' ' ' LYS . 0.0 OUTLIER 55.32 24.69 6.73 Favored 'General case' 0 N--CA 1.467 0.386 0 C-N-CA 122.949 0.5 . . . . 0.0 112.09 175.093 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 145.36 -52.18 0.59 Allowed Glycine 0 N--CA 1.449 -0.465 0 N-CA-C 111.58 -0.608 . . . . 0.0 111.58 -179.459 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.418 ' O ' ' HB2' ' A' ' 41' ' ' LYS . . . 165.02 24.23 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.429 -0.891 . . . . 0.0 113.694 176.462 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.616 ' O ' ' HG2' ' A' ' 42' ' ' GLN . 40.5 mm-40 -85.03 -43.51 13.88 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 117.344 0.572 . . . . 0.0 110.954 -179.23 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . 0.717 ' O ' ' HG ' ' A' ' 43' ' ' LEU . 82.2 m -66.51 -53.9 29.83 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.488 -176.865 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.558 HD12 HD23 ' A' ' 53' ' ' LEU . 7.1 tt -56.15 -31.85 32.82 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.419 0 CA-C-O 121.56 0.695 . . . . 0.0 110.472 179.029 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . 0.48 ' HB3' ' O ' ' A' ' 38' ' ' GLU . 83.5 tttt -62.47 -43.26 99.25 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.003 -0.999 . . . . 0.0 110.569 177.687 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.616 ' HG2' ' O ' ' A' ' 38' ' ' GLU . 61.5 mm-40 -72.66 -43.71 62.82 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.962 -177.84 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.717 ' HG ' ' O ' ' A' ' 39' ' ' THR . 37.5 mt -54.87 -49.77 70.32 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.494 -0.775 . . . . 0.0 111.863 -172.913 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 43.8 mt-30 -59.46 -38.44 80.77 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.835 -0.62 . . . . 0.0 111.222 -177.6 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 9.1 mm-40 -76.74 -42.48 40.99 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.382 -176.67 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . 0.432 ' HG2' ' O ' ' A' ' 42' ' ' GLN . 16.2 ptp180 -74.35 -33.73 63.2 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 112.05 0.389 . . . . 0.0 112.05 -174.677 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.536 ' HB3' HG22 ' A' ' 49' ' ' VAL . . . -89.94 -21.1 22.62 Favored 'General case' 0 C--N 1.325 -0.492 0 C-N-CA 120.756 -0.378 . . . . 0.0 111.524 -177.936 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 76.83 28.41 59.03 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.809 -0.71 . . . . 0.0 111.537 -177.733 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.536 HG22 ' HB3' ' A' ' 47' ' ' ALA . 35.9 m -121.49 168.63 13.74 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-O 120.973 0.416 . . . . 0.0 110.654 -176.947 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . 0.655 ' HB3' ' HB ' ' A' ' 70' ' ' ILE . 50.7 tptt -101.04 122.56 43.77 Favored 'General case' 0 C--N 1.318 -0.804 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 171.994 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . 0.545 ' HE3' HG11 ' A' ' 83' ' ' VAL . 77.3 mtp -118.74 114.9 23.4 Favored 'General case' 0 C--N 1.316 -0.869 0 N-CA-C 109.751 -0.462 . . . . 0.0 109.751 177.422 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.565 ' CG2' ' HB2' ' A' ' 68' ' ' ARG . 10.2 tt -106.22 108.47 25.17 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.841 0 CA-C-O 121.376 0.608 . . . . 0.0 109.901 176.84 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.558 HD23 HD12 ' A' ' 40' ' ' ILE . 2.8 mm? -82.24 102.77 11.37 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.669 -0.696 . . . . 0.0 109.278 177.124 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.523 HD12 ' HB2' ' A' ' 66' ' ' PRO . 68.8 mt -82.25 98.14 4.42 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.407 0 CA-C-O 121.514 0.673 . . . . 0.0 109.664 -179.817 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 59.7 mt-30 . . . . . 0 C--N 1.319 -0.745 0 CA-C-N 115.216 -0.902 . . . . 0.0 110.774 -173.09 . . . . . . . . 0 0 . 1 . 023 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 41.1 m-20 . . . . . 0 N--CA 1.446 -0.671 0 N-CA-C 109.737 -0.468 . . . . 0.0 109.737 . . . . . . . . . 0 0 . 1 . 023 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . 0.672 ' HB2' ' HB ' ' A' ' 24' ' ' ILE . 59.5 mmtt -137.27 114.35 9.74 Favored Pre-proline 0 C--N 1.315 -0.904 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.568 -173.971 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.523 ' HB2' HD12 ' A' ' 54' ' ' ILE . 48.4 Cg_exo -58.87 116.84 3.54 Favored 'Trans proline' 0 N--CA 1.463 -0.271 0 C-N-CA 123.141 2.56 . . . . 0.0 111.89 175.693 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.547 ' O ' ' HA ' ' A' ' 21' ' ' GLU . 43.2 tp -120.47 114.49 21.86 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.089 179.839 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . 0.647 ' HG2' ' HG2' ' A' ' 21' ' ' GLU . 92.9 mtt180 -102.4 107.19 18.1 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 120.843 0.354 . . . . 0.0 110.551 177.79 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.63 ' HB ' HG13 ' A' ' 76' ' ' VAL . 3.9 mp -90.02 104.73 15.47 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 173.489 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.655 ' HB ' ' HB3' ' A' ' 50' ' ' LYS . 3.0 mt -99.03 123.48 51.69 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.767 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.405 -175.529 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 175.15 -114.36 0.49 Allowed Glycine 0 N--CA 1.443 -0.839 0 C-N-CA 121.072 -0.585 . . . . 0.0 112.568 179.841 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -134.7 147.2 62.12 Favored Pre-proline 0 C--N 1.322 -0.593 0 N-CA-C 108.453 -0.943 . . . . 0.0 108.453 -177.219 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . 0.602 ' HD3' ' OG1' ' A' ' 18' ' ' THR . 87.4 Cg_exo -44.7 -36.01 9.97 Favored 'Trans proline' 0 C--N 1.352 0.724 0 C-N-CA 122.37 2.047 . . . . 0.0 112.339 -176.586 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 94.8 t80 -64.21 -62.77 1.41 Allowed 'General case' 0 N--CA 1.448 -0.547 0 CA-C-N 115.296 -0.865 . . . . 0.0 111.108 179.629 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 34.9 pttt -74.45 -30.17 61.76 Favored 'General case' 0 C--O 1.223 -0.31 0 N-CA-C 112.036 0.384 . . . . 0.0 112.036 -175.914 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.63 HG13 ' HB ' ' A' ' 69' ' ' ILE . 70.0 t -62.88 -38.22 81.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 N-CA-C 109.928 -0.397 . . . . 0.0 109.928 177.539 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . 0.415 ' O ' ' HG2' ' A' ' 81' ' ' GLU . 2.6 mm100 -79.1 -38.12 37.02 Favored 'General case' 0 N--CA 1.451 -0.42 0 C-N-CA 120.733 -0.387 . . . . 0.0 111.366 178.876 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 90.9 mt-30 -62.82 -40.92 98.87 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.971 0.415 . . . . 0.0 110.203 176.447 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -67.96 -37.46 81.59 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.458 177.224 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 43.9 t -65.01 -51.62 60.62 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.302 178.415 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . 0.415 ' HG2' ' O ' ' A' ' 77' ' ' GLN . 14.0 pt-20 -66.01 -27.18 67.92 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.02 0.438 . . . . 0.0 109.986 179.6 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 82' ' ' MET . . . . . 0.406 ' O ' HG13 ' A' ' 86' ' ' ILE . 49.5 ttp -67.01 -50.47 62.07 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.801 177.261 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.7 ' O ' ' HG ' ' A' ' 87' ' ' LEU . 33.4 m -76.27 -35.15 27.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 C-N-CA 120.909 -0.316 . . . . 0.0 110.73 -177.235 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 22.0 ttt -63.78 -34.7 78.49 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 109.627 -0.508 . . . . 0.0 109.627 177.58 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . 0.404 ' O ' ' HB2' ' A' ' 89' ' ' GLU . 2.7 t70 -59.73 -48.33 82.1 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.254 -0.885 . . . . 0.0 110.618 174.931 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.406 HG13 ' O ' ' A' ' 82' ' ' MET . 57.3 mt -61.73 -38.89 81.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.726 -179.426 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.844 HD21 HG13 ' A' ' 32' ' ' VAL . 52.8 mt -68.11 -43.94 77.28 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.87 -0.604 . . . . 0.0 111.371 -177.341 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 2.8 ptm180 -87.57 4.06 45.16 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.862 0.363 . . . . 0.0 111.043 -175.987 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . 0.404 ' HB2' ' O ' ' A' ' 85' ' ' ASP . 7.9 tp10 . . . . . 0 C--O 1.25 1.097 0 CA-C-O 118.466 -0.778 . . . . 0.0 109.457 179.604 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.63 ' OG1' ' HD3' ' A' ' 73' ' ' PRO . 96.7 m . . . . . 0 N--CA 1.453 -0.279 0 N-CA-C 109.647 -0.501 . . . . 0.0 109.647 . . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 92.2 t -138.49 125.8 27.5 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.791 -176.246 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 45.6 mt-30 -113.42 116.07 29.05 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.453 -0.34 . . . . 0.0 110.129 172.992 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.616 ' HA ' ' O ' ' A' ' 67' ' ' LEU . 57.9 mt-10 -86.78 113.91 23.01 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.141 179.428 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 18.6 mm -97.51 151.43 4.29 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-N 115.518 -0.765 . . . . 0.0 108.986 176.527 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 23' ' ' MET . . . . . 0.492 ' HB3' ' HB3' ' A' ' 64' ' ' ASP . 73.7 mmm -104.85 99.2 8.85 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 108.752 -0.832 . . . . 0.0 108.752 176.64 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.665 HD12 HD11 ' A' ' 87' ' ' LEU . 22.9 mm -83.32 123.8 76.63 Favored Pre-proline 0 C--N 1.32 -0.68 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.471 -172.601 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_exo -52.82 130.36 37.07 Favored 'Trans proline' 0 N--CA 1.463 -0.273 0 C-N-CA 122.708 2.272 . . . . 0.0 111.495 176.408 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -57.31 -37.19 72.1 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.681 -0.69 . . . . 0.0 112.435 -173.403 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -80.59 -32.81 32.74 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.536 -0.84 . . . . 0.0 112.316 179.542 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.45 ' HE2' ' O ' ' A' ' 87' ' ' LEU . 49.7 tptt -83.58 -7.27 59.55 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.152 0.501 . . . . 0.0 110.005 -177.544 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.54 ' O ' HG12 ' A' ' 32' ' ' VAL . . . -62.15 -19.29 62.91 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.567 -0.742 . . . . 0.0 111.789 -177.756 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -58.46 -37.01 87.06 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.586 -0.816 . . . . 0.0 111.901 176.757 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 70.0 mt -83.03 -28.92 29.27 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 111.667 0.247 . . . . 0.0 111.667 -178.431 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.54 HG12 ' O ' ' A' ' 29' ' ' ALA . 0.4 OUTLIER -69.37 -28.41 38.21 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.395 0 CA-C-O 121.253 0.549 . . . . 0.0 110.235 178.4 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.558 HG22 ' HA2' ' A' ' 37' ' ' GLY . 69.9 mt -86.18 -48.21 16.0 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.366 0 CA-C-N 115.679 -0.691 . . . . 0.0 109.467 174.871 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 135.77 170.6 12.11 Favored Glycine 0 N--CA 1.439 -1.155 0 C-N-CA 120.277 -0.963 . . . . 0.0 112.99 174.015 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.489 ' H ' ' HE3' ' A' ' 35' ' ' LYS . 0.0 OUTLIER -68.2 -27.2 66.18 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.164 0.506 . . . . 0.0 109.785 179.475 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -141.92 25.75 2.38 Favored Glycine 0 N--CA 1.447 -0.596 0 N-CA-C 111.158 -0.777 . . . . 0.0 111.158 174.472 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.558 ' HA2' HG22 ' A' ' 33' ' ' ILE . . . 77.24 2.83 80.42 Favored Glycine 0 CA--C 1.519 0.302 0 C-N-CA 121.039 -0.601 . . . . 0.0 112.26 -176.559 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.442 ' HB2' HE21 ' A' ' 42' ' ' GLN . 0.0 OUTLIER -85.75 -28.75 24.38 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 111.759 0.281 . . . . 0.0 111.759 -177.961 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . 0.723 ' O ' ' HG ' ' A' ' 43' ' ' LEU . 29.5 m -58.76 -47.32 85.09 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.478 -0.328 . . . . 0.0 111.825 -175.935 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.578 ' HA ' HD12 ' A' ' 43' ' ' LEU . 6.3 tt -58.53 -33.02 47.16 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.279 0 CA-C-O 121.075 0.464 . . . . 0.0 111.251 179.4 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 86.8 tttt -71.78 -37.3 70.48 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.168 0.508 . . . . 0.0 109.88 177.868 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.691 ' O ' ' HG2' ' A' ' 46' ' ' ARG . 62.3 mt-30 -67.59 -42.03 83.13 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.485 -0.78 . . . . 0.0 110.429 179.999 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.723 ' HG ' ' O ' ' A' ' 39' ' ' THR . 58.6 mt -54.5 -41.0 69.1 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.604 -0.726 . . . . 0.0 111.247 -179.506 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 48.1 mt-30 -66.1 -39.51 90.03 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.514 -0.767 . . . . 0.0 110.807 179.605 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 11.6 mm-40 -67.92 -39.02 83.61 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.601 177.774 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . 0.897 ' HA ' ' HE ' ' A' ' 46' ' ' ARG . 0.0 OUTLIER -62.99 -44.82 94.96 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.731 -174.717 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -106.11 -0.54 24.65 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 112.603 0.594 . . . . 0.0 112.603 -171.857 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 65.03 40.6 97.18 Favored Glycine 0 C--N 1.33 0.206 0 C-N-CA 120.63 -0.795 . . . . 0.0 111.656 -177.396 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 23.8 m -126.35 179.38 3.43 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-N 115.446 -0.377 . . . . 0.0 110.413 -175.649 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 87.1 tttt -125.94 126.93 45.17 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 109.558 -0.534 . . . . 0.0 109.558 172.715 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . 0.556 ' HE2' ' HB1' ' A' ' 79' ' ' ALA . 61.7 mtt -113.79 115.34 27.62 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 109.691 -0.485 . . . . 0.0 109.691 178.581 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.618 ' CG2' ' HB2' ' A' ' 68' ' ' ARG . 10.0 tt -99.59 109.41 24.53 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.752 0 CA-C-O 121.536 0.684 . . . . 0.0 109.646 176.64 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.918 HD22 HD13 ' A' ' 67' ' ' LEU . 0.5 OUTLIER -86.04 102.76 14.11 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.583 -0.735 . . . . 0.0 109.677 179.573 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.739 HD12 ' HB2' ' A' ' 66' ' ' PRO . 67.9 mt -75.13 85.67 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.335 0 CA-C-O 122.019 0.914 . . . . 0.0 108.984 175.837 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . 0.624 HE21 ' HB3' ' A' ' 53' ' ' LEU . 11.5 pt20 . . . . . 0 C--N 1.318 -0.801 0 CA-C-N 114.477 -1.238 . . . . 0.0 109.62 179.917 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.492 ' HB3' ' HB3' ' A' ' 23' ' ' MET . 4.8 m-20 . . . . . 0 N--CA 1.46 0.07 0 N-CA-C 110.046 -0.353 . . . . 0.0 110.046 . . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . 0.66 ' HB2' ' HB ' ' A' ' 24' ' ' ILE . 30.9 mmtp -90.8 132.76 33.86 Favored Pre-proline 0 C--N 1.323 -0.576 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.071 -172.32 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.739 ' HB2' HD12 ' A' ' 54' ' ' ILE . 13.5 Cg_exo -72.14 105.78 1.91 Allowed 'Trans proline' 0 N--CA 1.461 -0.395 0 C-N-CA 122.917 2.412 . . . . 0.0 111.491 173.954 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.918 HD13 HD22 ' A' ' 53' ' ' LEU . 23.8 tp -109.22 115.76 30.62 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.42 -0.355 . . . . 0.0 110.526 179.603 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . 0.618 ' HB2' ' CG2' ' A' ' 52' ' ' ILE . 95.6 mtt180 -99.81 108.22 20.46 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.885 176.484 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.474 HG21 ' HB3' ' A' ' 79' ' ' ALA . 4.6 mp -86.97 104.92 14.54 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.587 0 N-CA-C 108.164 -1.05 . . . . 0.0 108.164 170.915 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 21.0 mt -97.05 126.22 49.87 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.615 -175.182 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 172.95 -117.21 0.64 Allowed Glycine 0 N--CA 1.447 -0.58 0 C-N-CA 120.758 -0.734 . . . . 0.0 113.027 178.367 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . 0.518 ' OD1' ' HD2' ' A' ' 73' ' ' PRO . 8.7 t70 -131.45 146.73 63.23 Favored Pre-proline 0 C--N 1.324 -0.536 0 CA-C-O 118.301 -0.857 . . . . 0.0 108.764 -177.147 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . 0.63 ' HD3' ' OG1' ' A' ' 18' ' ' THR . 88.0 Cg_exo -40.95 -40.59 3.78 Favored 'Trans proline' 0 C--N 1.351 0.7 0 C-N-CA 122.943 2.429 . . . . 0.0 112.894 -177.495 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 90.1 t80 -65.28 -62.59 1.44 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.735 -0.666 . . . . 0.0 111.136 -179.269 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.467 ' HG2' ' HB3' ' A' ' 72' ' ' ASP . 40.8 pttt -70.44 -31.22 68.3 Favored 'General case' 0 C--O 1.219 -0.541 0 C-N-CA 120.911 -0.316 . . . . 0.0 111.843 -175.865 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.404 HG13 ' HB ' ' A' ' 69' ' ' ILE . 79.7 t -66.14 -40.72 87.84 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 C-N-CA 120.833 -0.347 . . . . 0.0 110.166 179.365 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . 0.413 ' O ' ' HG3' ' A' ' 81' ' ' GLU . 0.1 OUTLIER -73.38 -40.84 64.04 Favored 'General case' 0 N--CA 1.45 -0.452 0 N-CA-C 109.531 -0.544 . . . . 0.0 109.531 -179.224 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 66.7 mt-30 -67.64 -32.36 73.01 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 120.735 -0.386 . . . . 0.0 110.672 178.177 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . 0.556 ' HB1' ' HE2' ' A' ' 51' ' ' MET . . . -72.61 -33.88 66.99 Favored 'General case' 0 N--CA 1.446 -0.648 0 CA-C-N 116.136 -0.484 . . . . 0.0 109.876 175.966 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 43.9 t -62.4 -48.58 79.07 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.848 -0.614 . . . . 0.0 109.695 172.669 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . 0.451 ' O ' ' HB2' ' A' ' 85' ' ' ASP . 53.6 mt-10 -56.56 -29.46 62.03 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-O 121.178 0.513 . . . . 0.0 110.794 176.376 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 82' ' ' MET . . . . . 0.447 ' HE1' ' HB2' ' A' ' 46' ' ' ARG . 39.3 ttm -74.41 -51.13 15.85 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.316 -0.857 . . . . 0.0 110.667 -178.086 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.648 ' O ' ' HG ' ' A' ' 87' ' ' LEU . 33.7 m -74.93 -38.22 42.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 120.674 0.273 . . . . 0.0 110.635 -176.082 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 84' ' ' MET . . . . . 0.462 ' O ' ' HG2' ' A' ' 88' ' ' ARG . 26.3 ttt -63.96 -34.44 77.99 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.026 179.735 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . 0.451 ' HB2' ' O ' ' A' ' 81' ' ' GLU . 14.3 t70 -63.53 -46.49 85.75 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.12 179.218 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.419 HG13 ' O ' ' A' ' 82' ' ' MET . 44.6 mt -64.78 -34.39 69.81 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.577 179.429 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.665 HD11 HD12 ' A' ' 24' ' ' ILE . 53.7 mt -76.76 -14.46 59.93 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.928 0.394 . . . . 0.0 110.981 -178.559 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . 0.462 ' HG2' ' O ' ' A' ' 84' ' ' MET . 14.3 mmm180 -109.47 8.55 25.31 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.192 0.52 . . . . 0.0 109.621 175.03 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 10.6 tp10 . . . . . 0 C--O 1.248 0.992 0 CA-C-N 115.197 -0.911 . . . . 0.0 109.267 -179.717 . . . . . . . . 0 0 . 1 . 025 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.534 ' OG1' ' HG3' ' A' ' 73' ' ' PRO . 93.3 m . . . . . 0 N--CA 1.451 -0.382 0 CA-C-O 121.214 0.53 . . . . 0.0 111.83 . . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.606 ' HB ' HG23 ' A' ' 70' ' ' ILE . 2.6 p -134.77 121.0 33.21 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-N 115.347 -0.842 . . . . 0.0 109.753 175.724 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 6.0 tt0 -110.16 137.3 48.1 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 110.286 -0.264 . . . . 0.0 110.286 -177.97 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.646 ' HA ' ' O ' ' A' ' 67' ' ' LEU . 45.0 mt-10 -108.34 127.14 53.61 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.998 0.428 . . . . 0.0 111.389 -178.863 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.449 ' HB ' ' HB3' ' A' ' 67' ' ' LEU . 15.9 mm -115.46 153.91 16.95 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-N 115.945 -0.57 . . . . 0.0 109.898 179.651 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 23' ' ' MET . . . . . 0.47 ' HB3' ' HB3' ' A' ' 64' ' ' ASP . 1.6 mmt -104.97 105.09 14.99 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 109.036 -0.727 . . . . 0.0 109.036 173.371 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.692 ' HB ' ' HB2' ' A' ' 65' ' ' LYS . 36.8 mm -88.72 131.42 41.72 Favored Pre-proline 0 C--N 1.322 -0.628 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.029 -175.762 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . 0.685 ' HD2' HD13 ' A' ' 87' ' ' LEU . 91.8 Cg_exo -44.41 137.03 8.33 Favored 'Trans proline' 0 C--N 1.348 0.55 0 C-N-CA 123.57 2.847 . . . . 0.0 113.184 177.457 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -66.52 -27.84 68.08 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.481 -0.782 . . . . 0.0 112.694 -172.489 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -103.48 -26.57 6.82 Favored Glycine 0 N--CA 1.447 -0.598 0 C-N-CA 120.387 -0.911 . . . . 0.0 112.33 -179.147 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.523 ' HB3' ' HB2' ' A' ' 25' ' ' PRO . 15.3 ttpt -94.67 13.26 24.92 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.472 0.654 . . . . 0.0 110.642 -177.488 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.506 ' O ' HG12 ' A' ' 32' ' ' VAL . . . -63.65 -31.07 72.12 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.857 -0.611 . . . . 0.0 110.882 178.181 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -57.06 -26.99 56.74 Favored Glycine 0 CA--C 1.519 0.29 0 CA-C-N 116.173 -0.467 . . . . 0.0 113.211 179.862 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 68.0 mt -78.5 -36.64 44.78 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.913 0.357 . . . . 0.0 110.957 179.542 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.506 HG12 ' O ' ' A' ' 29' ' ' ALA . 0.3 OUTLIER -72.12 -29.92 34.25 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.341 0 CA-C-O 121.19 0.519 . . . . 0.0 110.182 178.343 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 68.1 mt -76.03 -37.39 33.54 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-O 121.925 0.869 . . . . 0.0 109.615 174.109 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . 0.549 ' HA3' ' HB ' ' A' ' 39' ' ' THR . . . 98.14 45.38 2.41 Favored Glycine 0 N--CA 1.441 -0.974 0 CA-C-N 115.228 -0.896 . . . . 0.0 112.928 175.515 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 38.3 mtmt 51.72 47.01 25.63 Favored 'General case' 0 C--N 1.328 -0.326 0 O-C-N 124.143 0.555 . . . . 0.0 111.666 172.81 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 132.16 -28.2 3.52 Favored Glycine 0 N--CA 1.448 -0.562 0 C-N-CA 120.668 -0.777 . . . . 0.0 112.173 179.412 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 125.33 4.57 6.95 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.423 -0.894 . . . . 0.0 112.836 178.089 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 32.7 mt-10 -70.06 -48.75 56.54 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.132 0.491 . . . . 0.0 110.5 -179.993 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . 0.729 ' O ' ' HG ' ' A' ' 43' ' ' LEU . 17.2 m -64.68 -46.04 84.09 Favored 'General case' 0 N--CA 1.45 -0.437 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.261 -177.433 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.628 ' HA ' HD12 ' A' ' 43' ' ' LEU . 8.1 tt -60.3 -35.65 63.69 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.47 0 CA-C-O 121.036 0.446 . . . . 0.0 110.901 179.977 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 54.8 tttm -61.57 -47.29 86.17 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.262 0.553 . . . . 0.0 109.983 175.515 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 16.4 mm-40 -72.39 -33.86 67.49 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.546 -0.752 . . . . 0.0 111.796 -176.561 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.729 ' HG ' ' O ' ' A' ' 39' ' ' THR . 95.0 mt -54.52 -48.07 72.36 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.046 0.45 . . . . 0.0 110.77 179.817 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 44.0 mt-30 -63.27 -46.21 87.86 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.385 -0.825 . . . . 0.0 110.696 -179.828 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -71.12 -36.69 72.23 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.855 -0.611 . . . . 0.0 112.123 -175.51 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 12.4 ptm180 -75.53 -33.08 60.69 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 111.734 0.272 . . . . 0.0 111.734 -175.317 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.439 ' HB3' HG22 ' A' ' 49' ' ' VAL . . . -96.54 -21.07 17.91 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.993 0.425 . . . . 0.0 111.352 -177.305 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 81.13 31.01 35.93 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.928 -0.653 . . . . 0.0 112.0 -178.161 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.439 HG22 ' HB3' ' A' ' 47' ' ' ALA . 28.6 m -122.92 167.49 16.47 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-O 120.834 0.35 . . . . 0.0 110.643 -176.332 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 60.2 tttp -103.38 123.23 46.44 Favored 'General case' 0 N--CA 1.444 -0.758 0 N-CA-C 108.96 -0.756 . . . . 0.0 108.96 172.242 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . 0.516 ' HE2' HD11 ' A' ' 67' ' ' LEU . 79.7 mtp -120.32 115.52 23.72 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 120.947 0.403 . . . . 0.0 109.989 179.414 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.566 ' CG2' ' HB2' ' A' ' 68' ' ' ARG . 11.2 tt -107.71 112.33 39.67 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.749 0 CA-C-O 121.478 0.656 . . . . 0.0 110.235 177.896 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.494 ' CD2' HD13 ' A' ' 67' ' ' LEU . 3.1 mm? -94.82 114.29 26.15 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.36 -0.836 . . . . 0.0 109.817 176.863 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.534 ' HB ' ' HD2' ' A' ' 66' ' ' PRO . 31.4 mm -75.36 87.78 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 177.311 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 15.8 mt-30 . . . . . 0 C--N 1.323 -0.565 0 CA-C-N 115.226 -0.897 . . . . 0.0 110.311 -174.803 . . . . . . . . 0 0 . 1 . 025 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.47 ' HB3' ' HB3' ' A' ' 23' ' ' MET . 5.2 m-20 . . . . . 0 C--O 1.232 0.164 0 CA-C-O 121.196 0.522 . . . . 0.0 111.291 . . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . 0.692 ' HB2' ' HB ' ' A' ' 24' ' ' ILE . 70.9 mmtt -101.5 127.1 32.33 Favored Pre-proline 0 C--N 1.324 -0.54 0 CA-C-N 115.804 -0.635 . . . . 0.0 111.056 -175.615 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.534 ' HD2' ' HB ' ' A' ' 54' ' ' ILE . 27.4 Cg_exo -65.41 111.68 1.91 Allowed 'Trans proline' 0 N--CA 1.463 -0.315 0 C-N-CA 123.009 2.472 . . . . 0.0 111.596 172.596 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.646 ' O ' ' HA ' ' A' ' 21' ' ' GLU . 14.3 tp -112.44 122.35 47.45 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 116.155 -0.475 . . . . 0.0 109.97 178.093 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . 0.566 ' HB2' ' CG2' ' A' ' 52' ' ' ILE . 88.0 mtt180 -113.84 112.39 23.3 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 121.19 0.519 . . . . 0.0 111.192 177.727 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.405 ' O ' ' HA ' ' A' ' 19' ' ' VAL . 4.5 mp -94.16 105.13 16.54 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 172.449 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.606 HG23 ' HB ' ' A' ' 19' ' ' VAL . 4.0 mt -109.77 132.32 58.31 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 CA-C-N 116.385 -0.371 . . . . 0.0 110.907 -172.394 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 152.52 -123.16 1.41 Allowed Glycine 0 N--CA 1.445 -0.747 0 C-N-CA 120.509 -0.853 . . . . 0.0 113.235 175.618 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . 0.616 ' OD2' ' HG2' ' A' ' 75' ' ' LYS . 0.5 OUTLIER -92.69 133.47 29.31 Favored Pre-proline 0 C--N 1.326 -0.447 0 C-N-CA 122.864 0.466 . . . . 0.0 110.948 -177.215 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . 0.534 ' HG3' ' OG1' ' A' ' 18' ' ' THR . 50.4 Cg_exo -49.43 -33.41 29.64 Favored 'Trans proline' 0 C--N 1.351 0.664 0 C-N-CA 124.267 3.311 . . . . 0.0 113.592 -176.236 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . 0.496 ' O ' ' HG3' ' A' ' 78' ' ' GLN . 19.1 t80 -72.71 -57.08 4.38 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.341 -178.27 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.616 ' HG2' ' OD2' ' A' ' 72' ' ' ASP . 4.6 ptpp? -72.5 -25.83 61.55 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 111.746 0.276 . . . . 0.0 111.746 -178.439 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.415 HG23 ' O ' ' A' ' 72' ' ' ASP . 26.4 t -55.94 -42.26 70.65 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 N-CA-C 109.925 -0.398 . . . . 0.0 109.925 171.424 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . 0.574 ' O ' ' HG2' ' A' ' 81' ' ' GLU . 2.3 mm100 -75.74 -44.28 42.59 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.056 178.789 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . 0.496 ' HG3' ' O ' ' A' ' 74' ' ' TYR . 53.6 mt-30 -52.87 -50.06 64.58 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.065 0.459 . . . . 0.0 110.419 177.697 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -67.43 -37.78 83.54 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.411 -0.813 . . . . 0.0 111.271 -178.315 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 42.7 t -62.55 -57.27 11.74 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.556 -178.9 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . 0.574 ' HG2' ' O ' ' A' ' 77' ' ' GLN . 10.4 pt-20 -67.68 -18.7 65.02 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.912 0.387 . . . . 0.0 110.645 -178.928 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 57.0 ttp -74.09 -50.99 17.11 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.584 174.804 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 31.8 m -76.52 -33.87 23.43 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.583 -0.281 . . . . 0.0 111.618 -176.4 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 83.5 mtp -68.37 -25.67 65.19 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 109.911 -0.403 . . . . 0.0 109.911 175.83 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -67.69 -36.25 80.32 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.655 176.364 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 56.7 mt -62.78 -35.49 71.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 121.488 0.661 . . . . 0.0 110.043 179.022 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.685 HD13 ' HD2' ' A' ' 25' ' ' PRO . 42.8 mt -88.09 -8.46 55.47 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.654 -179.381 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 21.5 tpt180 -101.76 -10.54 19.85 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.839 0.828 . . . . 0.0 109.818 -179.638 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 . . . . . 0 C--O 1.248 1.021 0 CA-C-N 114.685 -1.143 . . . . 0.0 109.779 -177.316 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.445 -0.763 0 CA-C-O 120.388 -0.118 . . . . 0.0 112.944 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . 0.426 ' O ' ' HG3' ' A' ' 6' ' ' GLN . 13.1 pt20 -77.41 84.47 3.82 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.604 0.716 . . . . 0.0 109.844 173.548 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . 0.537 ' O ' ' HB2' ' A' ' 72' ' ' ASP . 68.7 m-85 -59.34 -34.94 72.97 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.371 -0.831 . . . . 0.0 110.908 -177.311 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . 0.631 ' HA ' ' HB2' ' A' ' 12' ' ' ASN . 4.7 t60 -85.29 60.86 6.51 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 175.686 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -74.23 -45.14 50.02 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.339 -0.846 . . . . 0.0 110.825 -175.759 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 39.8 t-20 -141.35 -73.08 0.33 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.389 179.66 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -119.17 53.84 1.0 Allowed 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.147 0.499 . . . . 0.0 111.485 -172.158 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . 0.845 HD21 ' HA ' ' A' ' 16' ' ' ASN . 13.8 t-20 -76.86 72.06 3.43 Favored 'General case' 0 N--CA 1.445 -0.697 0 CA-C-N 115.766 -0.652 . . . . 0.0 109.927 176.128 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -91.83 90.97 1.56 Allowed Glycine 0 N--CA 1.447 -0.591 0 C-N-CA 120.991 -0.623 . . . . 0.0 112.333 -178.557 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 129.07 -104.81 0.66 Allowed Glycine 0 N--CA 1.449 -0.471 0 C-N-CA 120.957 -0.64 . . . . 0.0 112.018 178.418 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 14.2 mm100 -95.55 117.54 30.61 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.911 0.386 . . . . 0.0 110.263 -179.82 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . 0.845 ' HA ' HD21 ' A' ' 12' ' ' ASN . 9.1 p30 -58.96 -33.47 70.69 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.54 -0.755 . . . . 0.0 110.754 179.514 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -101.83 81.6 0.43 Allowed Glycine 0 N--CA 1.443 -0.838 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.011 179.743 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.466 ' OG1' ' HG3' ' A' ' 73' ' ' PRO . 96.5 m -88.99 127.91 35.69 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 110.146 -0.316 . . . . 0.0 110.146 177.209 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 74.7 t -113.09 127.19 70.48 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.618 -178.595 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . 0.607 ' HG2' ' HB2' ' A' ' 80' ' ' CYS . 29.5 tp60 -111.84 112.74 24.63 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 109.43 -0.582 . . . . 0.0 109.43 176.863 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.588 ' HA ' ' O ' ' A' ' 67' ' ' LEU . 12.1 mt-10 -98.53 119.26 36.93 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.369 0.604 . . . . 0.0 112.305 179.257 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 10.1 mm -114.37 150.5 16.35 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 115.185 -0.916 . . . . 0.0 109.44 177.685 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 94.0 mmm -111.53 103.83 12.19 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 172.93 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.656 HG23 HD21 ' A' ' 87' ' ' LEU . 9.3 mm -84.88 125.3 71.14 Favored Pre-proline 0 C--N 1.316 -0.88 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.952 -173.301 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_exo -50.2 139.06 36.13 Favored 'Trans proline' 0 C--N 1.346 0.441 0 C-N-CA 122.904 2.402 . . . . 0.0 112.379 176.566 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -42.41 -57.15 2.72 Favored 'General case' 0 N--CA 1.465 0.287 0 N-CA-C 113.316 0.858 . . . . 0.0 113.316 -173.716 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -90.18 -26.71 23.01 Favored Glycine 0 N--CA 1.453 -0.199 0 C-N-CA 120.679 -0.772 . . . . 0.0 113.069 -174.473 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.409 ' HE3' ' HA ' ' A' ' 87' ' ' LEU . 45.0 tttp -78.99 -4.56 50.61 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.192 0.52 . . . . 0.0 110.128 179.773 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.482 ' HA ' HG21 ' A' ' 24' ' ' ILE . . . -63.64 -22.93 67.16 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.658 174.844 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -58.39 -25.7 58.19 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 121.073 -0.584 . . . . 0.0 112.134 178.292 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 63.2 mt -75.97 -45.78 33.08 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.779 0.323 . . . . 0.0 110.855 179.425 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.433 HG12 ' O ' ' A' ' 29' ' ' ALA . 1.4 p -72.02 -32.13 42.77 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.474 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.973 -177.369 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 74.2 mt -78.33 -42.18 26.5 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-O 121.761 0.791 . . . . 0.0 109.772 176.661 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.503 ' HA3' ' H ' ' A' ' 39' ' ' THR . . . 101.29 51.53 1.13 Allowed Glycine 0 N--CA 1.441 -1.025 0 CA-C-N 115.272 -0.876 . . . . 0.0 112.974 175.529 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.453 ' HD2' ' N ' ' A' ' 35' ' ' LYS . 0.4 OUTLIER 50.68 40.5 24.24 Favored 'General case' 0 C--N 1.329 -0.295 0 O-C-N 124.319 0.658 . . . . 0.0 111.96 173.719 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 133.73 -27.06 3.39 Favored Glycine 0 N--CA 1.449 -0.482 0 C-N-CA 120.653 -0.784 . . . . 0.0 111.94 179.604 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 129.78 22.47 1.15 Allowed Glycine 0 N--CA 1.449 -0.451 0 C-N-CA 120.173 -1.013 . . . . 0.0 113.079 178.524 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.661 ' HG3' HE21 ' A' ' 42' ' ' GLN . 4.5 tp10 -84.53 -54.09 4.98 Favored 'General case' 0 C--N 1.321 -0.648 0 O-C-N 122.296 -0.531 . . . . 0.0 110.119 178.694 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.684 ' O ' ' HG ' ' A' ' 43' ' ' LEU . 63.0 m -56.21 -44.58 79.63 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.53 -0.759 . . . . 0.0 111.821 -179.405 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 8.9 tt -58.51 -37.79 66.61 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.406 0 CA-C-O 120.596 0.236 . . . . 0.0 111.604 -178.416 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 33.5 mtmm -66.24 -38.65 88.39 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.358 0.599 . . . . 0.0 110.172 178.02 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.661 HE21 ' HG3' ' A' ' 38' ' ' GLU . 68.7 mt-30 -66.07 -45.96 79.44 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.279 178.755 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.684 ' HG ' ' O ' ' A' ' 39' ' ' THR . 89.6 mt -53.47 -46.7 70.05 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.428 -0.805 . . . . 0.0 112.032 -175.609 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 46.9 mt-30 -64.52 -43.36 94.29 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.484 -177.302 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 9.3 mm-40 -81.12 -35.6 31.38 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 112.052 0.39 . . . . 0.0 112.052 -174.261 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 14.8 ptm180 -66.76 -35.28 79.73 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-O 120.735 0.302 . . . . 0.0 111.477 -176.7 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.452 ' HB3' HG22 ' A' ' 49' ' ' VAL . . . -100.65 -12.13 19.43 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.889 0.376 . . . . 0.0 111.577 -177.128 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 71.73 37.93 61.21 Favored Glycine 0 N--CA 1.449 -0.492 0 C-N-CA 120.812 -0.709 . . . . 0.0 111.961 -178.004 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.452 HG22 ' HB3' ' A' ' 47' ' ' ALA . 28.5 m -129.15 178.56 4.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-O 120.761 0.315 . . . . 0.0 110.16 -177.775 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 64.3 tttp -120.75 124.66 45.66 Favored 'General case' 0 C--N 1.319 -0.726 0 C-N-CA 120.662 -0.415 . . . . 0.0 110.214 173.069 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . 0.586 ' CE ' ' HB1' ' A' ' 79' ' ' ALA . 63.7 mtt -113.94 115.62 27.95 Favored 'General case' 0 C--N 1.319 -0.749 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 176.751 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.534 ' CG2' ' HB2' ' A' ' 68' ' ' ARG . 10.5 tt -99.29 104.77 16.46 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.741 0 CA-C-O 121.772 0.796 . . . . 0.0 110.059 176.91 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.705 HD22 HD13 ' A' ' 67' ' ' LEU . 3.8 mm? -87.53 104.4 16.45 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.053 -0.976 . . . . 0.0 109.26 176.02 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.8 HD12 ' HB2' ' A' ' 66' ' ' PRO . 61.0 mt -72.74 86.56 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-O 121.852 0.834 . . . . 0.0 109.663 178.369 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 52.4 mt-30 -99.73 -23.3 15.05 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 114.637 -1.165 . . . . 0.0 109.645 -177.628 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -114.73 6.14 15.51 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.175 -0.921 . . . . 0.0 110.512 -173.213 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -66.3 -22.72 71.26 Favored Glycine 0 N--CA 1.453 -0.184 0 CA-C-N 115.53 -0.759 . . . . 0.0 112.086 178.539 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . 0.422 ' HA ' ' CG2' ' A' ' 61' ' ' THR . 31.9 m 65.37 -172.59 0.18 Allowed 'General case' 0 C--O 1.232 0.184 0 C-N-CA 123.215 0.606 . . . . 0.0 111.107 -178.856 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 20.9 mt-30 71.76 -62.29 0.46 Allowed 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 123.118 0.567 . . . . 0.0 110.281 -176.648 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.636 ' ND2' ' HD3' ' A' ' 66' ' ' PRO . 3.1 p-10 -100.65 12.51 37.26 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.325 178.957 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . 0.422 ' CG2' ' HA ' ' A' ' 58' ' ' SER . 0.3 OUTLIER -60.15 -29.76 68.87 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.035 0.445 . . . . 0.0 111.386 -179.288 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 1.8 m-20 -82.74 -4.3 57.71 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.781 -0.645 . . . . 0.0 111.131 179.725 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 21.1 m -131.83 -153.35 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.248 0 N-CA-C 111.633 0.235 . . . . 0.0 111.633 -174.731 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.461 ' HA ' ' O ' ' A' ' 24' ' ' ILE . 1.8 m-20 -53.55 151.6 5.73 Favored 'General case' 0 C--N 1.331 -0.225 0 C-N-CA 123.545 0.738 . . . . 0.0 111.363 178.201 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.497 ' HA ' ' HD3' ' A' ' 66' ' ' PRO . 39.2 mmtm -110.85 131.39 22.15 Favored Pre-proline 0 C--N 1.327 -0.398 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.659 -175.203 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.8 ' HB2' HD12 ' A' ' 54' ' ' ILE . 10.6 Cg_exo -75.33 111.4 3.3 Favored 'Trans proline' 0 N--CA 1.46 -0.467 0 C-N-CA 123.476 2.784 . . . . 0.0 111.86 176.013 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.705 HD13 HD22 ' A' ' 53' ' ' LEU . 17.8 tp -112.4 120.72 42.64 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.528 177.439 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.534 ' HB2' ' CG2' ' A' ' 52' ' ' ILE . 68.4 mtt180 -111.47 111.72 22.95 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 120.99 0.424 . . . . 0.0 110.651 174.445 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.493 ' HB ' ' HB3' ' A' ' 20' ' ' GLN . 46.9 mt -91.27 112.06 24.76 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 N-CA-C 108.909 -0.774 . . . . 0.0 108.909 173.914 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 13.2 mt -113.85 129.42 69.78 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.739 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.056 -172.562 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . 0.491 ' HA2' ' HD1' ' A' ' 7' ' ' PHE . . . 153.42 -140.92 7.91 Favored Glycine 0 N--CA 1.448 -0.518 0 C-N-CA 120.458 -0.877 . . . . 0.0 113.32 173.89 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . 0.537 ' HB2' ' O ' ' A' ' 7' ' ' PHE . 4.7 t70 -71.99 130.89 86.05 Favored Pre-proline 0 C--N 1.322 -0.614 0 C-N-CA 123.387 0.675 . . . . 0.0 111.126 -176.997 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . 0.641 ' HD2' ' HA ' ' A' ' 12' ' ' ASN . 26.8 Cg_exo -57.98 -26.53 75.27 Favored 'Trans proline' 0 C--N 1.35 0.622 0 C-N-CA 123.556 2.838 . . . . 0.0 113.352 -172.027 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . 0.401 ' HB3' ' OD1' ' A' ' 72' ' ' ASP . 24.1 t80 -79.06 -47.61 15.88 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.156 -0.474 . . . . 0.0 109.873 -176.191 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.526 ' CG ' ' HB3' ' A' ' 72' ' ' ASP . 9.1 ptpt -80.51 -26.61 38.05 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 120.867 -0.333 . . . . 0.0 111.611 178.81 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.401 ' CG1' ' HB2' ' A' ' 20' ' ' GLN . 24.6 t -60.69 -40.13 83.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-O 120.7 0.286 . . . . 0.0 110.246 173.954 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 2.0 mm100 -73.97 -41.2 62.31 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 120.637 -0.425 . . . . 0.0 110.972 179.472 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 49.6 mt-30 -63.09 -39.07 93.62 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 120.898 0.38 . . . . 0.0 110.251 177.431 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . 0.586 ' HB1' ' CE ' ' A' ' 51' ' ' MET . . . -71.65 -35.34 70.33 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.718 178.5 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' CYS . . . . . 0.607 ' HB2' ' HG2' ' A' ' 20' ' ' GLN . 36.5 t -63.45 -54.09 41.9 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.123 175.245 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 52.5 mt-10 -65.2 -20.66 66.54 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.403 178.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' MET . . . . . 0.437 ' HB3' ' O ' ' A' ' 79' ' ' ALA . 31.5 ttm -69.48 -55.98 8.71 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.425 -0.807 . . . . 0.0 110.403 176.417 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 32.9 m -79.42 -29.59 13.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.915 -175.453 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' MET . . . . . 0.476 ' O ' ' HG2' ' A' ' 88' ' ' ARG . 56.9 ttp -71.48 -28.94 64.28 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 109.75 -0.463 . . . . 0.0 109.75 178.392 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . 0.483 ' O ' ' HB2' ' A' ' 89' ' ' GLU . 19.0 t70 -62.62 -47.94 81.57 Favored 'General case' 0 CA--C 1.517 -0.29 0 N-CA-C 109.968 -0.382 . . . . 0.0 109.968 175.133 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 20.3 mt -60.22 -32.45 50.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 121.659 0.742 . . . . 0.0 110.276 177.738 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.656 HD21 HG23 ' A' ' 24' ' ' ILE . 1.0 OUTLIER -81.8 -17.52 47.26 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.389 -0.823 . . . . 0.0 111.57 -176.738 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . 0.476 ' HG2' ' O ' ' A' ' 84' ' ' MET . 23.3 mmm180 -102.86 5.94 38.88 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 121.546 0.689 . . . . 0.0 109.322 174.153 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . 0.483 ' HB2' ' O ' ' A' ' 85' ' ' ASP . 2.1 tm-20 . . . . . 0 C--O 1.25 1.125 0 CA-C-N 114.749 -1.114 . . . . 0.0 108.884 -177.968 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.445 -0.739 0 N-CA-C 112.076 -0.41 . . . . 0.0 112.076 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 8.5 tp-100 59.67 87.75 0.08 Allowed 'General case' 0 C--O 1.235 0.322 0 CA-C-O 121.314 0.578 . . . . 0.0 110.057 -176.438 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 95.7 m-85 -69.74 104.96 2.58 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.207 -177.887 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . 0.953 ' H ' ' HB2' ' A' ' 72' ' ' ASP . 14.0 t60 74.06 145.67 0.08 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 114.318 -1.31 . . . . 0.0 110.504 -176.876 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -64.61 -26.72 68.52 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.021 -0.991 . . . . 0.0 111.259 -178.18 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 9.2 t30 -162.9 101.32 1.0 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.504 174.885 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . 72.17 123.6 0.04 OUTLIER 'General case' 0 N--CA 1.471 0.616 0 O-C-N 123.867 0.73 . . . . 0.0 112.77 174.599 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 7.4 p30 -117.83 147.38 43.1 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.089 177.631 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -158.05 143.94 9.95 Favored Glycine 0 N--CA 1.452 -0.273 0 N-CA-C 111.588 -0.605 . . . . 0.0 111.588 -178.741 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 79.07 -68.53 3.08 Favored Glycine 0 C--N 1.331 0.283 0 N-CA-C 110.974 -0.851 . . . . 0.0 110.974 -176.425 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . 0.402 ' HB3' ' OG1' ' A' ' 18' ' ' THR . 32.5 mm-40 -106.06 125.23 50.74 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 108.952 -0.758 . . . . 0.0 108.952 171.794 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 7.1 m120 -114.23 -71.14 0.76 Allowed 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 109.797 -0.446 . . . . 0.0 109.797 -177.483 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -95.4 80.09 0.84 Allowed Glycine 0 N--CA 1.444 -0.769 0 N-CA-C 111.099 -0.801 . . . . 0.0 111.099 174.838 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.511 ' OG1' ' HG3' ' A' ' 73' ' ' PRO . 74.6 m -83.24 134.25 34.96 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-O 120.996 0.427 . . . . 0.0 111.129 -176.545 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.493 HG22 HG23 ' A' ' 70' ' ' ILE . 61.6 t -124.71 120.19 58.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.61 179.251 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 14.2 mm100 -101.17 114.03 27.61 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.983 -0.553 . . . . 0.0 109.539 174.682 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.61 ' HG2' ' HG2' ' A' ' 68' ' ' ARG . 37.4 mt-10 -93.69 107.58 19.43 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.283 0.564 . . . . 0.0 110.729 176.065 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 19.0 mm -102.41 148.67 7.56 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.723 0 CA-C-N 115.359 -0.837 . . . . 0.0 109.802 -178.509 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' MET . . . . . 0.51 ' HB3' ' HB3' ' A' ' 64' ' ' ASP . 1.5 mmt -99.87 101.98 13.27 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 108.609 -0.885 . . . . 0.0 108.609 175.428 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.687 ' HB ' ' HB2' ' A' ' 65' ' ' LYS . 44.3 mm -88.66 126.06 61.06 Favored Pre-proline 0 C--N 1.319 -0.733 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.996 -175.38 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.604 ' HB2' ' HB3' ' A' ' 28' ' ' LYS . 95.7 Cg_exo -45.1 132.91 11.41 Favored 'Trans proline' 0 C--N 1.343 0.278 0 C-N-CA 123.423 2.749 . . . . 0.0 112.541 179.564 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -61.82 -38.65 88.96 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 115.511 -0.768 . . . . 0.0 112.954 -168.501 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -89.37 -35.89 7.78 Favored Glycine 0 N--CA 1.449 -0.496 0 C-N-CA 120.404 -0.903 . . . . 0.0 111.837 -178.596 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.604 ' HB3' ' HB2' ' A' ' 25' ' ' PRO . 28.6 ttpt -80.47 -0.62 38.12 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 121.201 0.524 . . . . 0.0 110.77 -178.721 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.53 ' O ' HG12 ' A' ' 32' ' ' VAL . . . -62.83 -20.14 64.78 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.132 177.667 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -57.66 -33.09 66.35 Favored Glycine 0 N--CA 1.448 -0.541 0 C-N-CA 120.792 -0.718 . . . . 0.0 111.885 177.04 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 99.0 mt -77.57 -36.2 52.27 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.643 0.259 . . . . 0.0 111.289 -178.767 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.535 HG11 HG21 ' A' ' 24' ' ' ILE . 0.5 OUTLIER -70.57 -30.28 41.86 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.326 0 CA-C-O 121.16 0.505 . . . . 0.0 110.768 -178.37 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 71.0 mt -89.39 -38.78 11.7 Favored 'Isoleucine or valine' 0 C--O 1.236 0.388 0 CA-C-N 115.76 -0.654 . . . . 0.0 110.537 178.743 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 105.08 25.0 6.94 Favored Glycine 0 CA--C 1.502 -0.723 0 CA-C-N 115.605 -0.725 . . . . 0.0 112.611 178.57 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 53.6 mtpt 60.87 21.51 11.69 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.316 -0.442 . . . . 0.0 111.327 177.258 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -176.59 -45.7 0.06 OUTLIER Glycine 0 N--CA 1.448 -0.504 0 N-CA-C 111.696 -0.562 . . . . 0.0 111.696 -178.31 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 125.73 7.57 5.59 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.355 -0.926 . . . . 0.0 113.024 176.692 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -85.51 -32.91 21.96 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 120.84 0.352 . . . . 0.0 111.162 178.561 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.59 ' O ' ' HG ' ' A' ' 43' ' ' LEU . 60.7 m -65.0 -48.18 74.84 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.97 -179.573 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.734 HD12 HD23 ' A' ' 53' ' ' LEU . 1.9 tt -57.18 -38.58 62.05 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-O 120.748 0.309 . . . . 0.0 111.167 178.463 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.406 ' HE2' ' HB3' ' A' ' 41' ' ' LYS . 4.6 tmmm? -60.97 -40.76 94.62 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 109.57 -0.53 . . . . 0.0 109.57 178.689 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.499 ' O ' ' HG2' ' A' ' 46' ' ' ARG . 49.5 mt-30 -70.32 -37.82 74.79 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.614 -179.851 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.693 HD13 HG12 ' A' ' 83' ' ' VAL . 75.0 mt -58.03 -35.95 72.01 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.678 179.075 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . 0.568 ' HG3' ' O ' ' A' ' 40' ' ' ILE . 68.2 mt-30 -66.57 -47.72 71.89 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.42 178.223 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.403 ' HG3' ' O ' ' A' ' 41' ' ' LYS . 39.0 mt-10 -64.83 -48.58 73.86 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.694 -0.685 . . . . 0.0 111.195 -177.573 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 0.499 ' HG2' ' O ' ' A' ' 42' ' ' GLN . 17.5 ptm180 -70.79 -23.66 62.42 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.169 -0.469 . . . . 0.0 112.201 -174.224 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -93.13 -29.14 15.91 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.818 0.342 . . . . 0.0 111.093 178.745 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 87.88 26.41 29.33 Favored Glycine 0 N--CA 1.452 -0.25 0 C-N-CA 121.014 -0.612 . . . . 0.0 112.56 -179.062 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 5.1 m -140.08 179.87 2.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-O 120.876 0.369 . . . . 0.0 110.592 -178.801 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 81.1 tttt -110.8 124.66 52.45 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.238 178.531 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . 0.492 ' HG2' HG23 ' A' ' 69' ' ' ILE . 17.9 mtm -117.2 116.62 27.63 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 109.821 -0.437 . . . . 0.0 109.821 176.661 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.618 ' CG2' ' HB2' ' A' ' 68' ' ' ARG . 10.8 tt -102.0 113.2 37.7 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.727 0 CA-C-O 121.43 0.633 . . . . 0.0 110.762 178.426 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.879 HD22 HD13 ' A' ' 67' ' ' LEU . 1.3 mm? -88.07 107.52 18.79 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.41 -0.814 . . . . 0.0 109.311 175.906 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.657 HD12 ' HB2' ' A' ' 66' ' ' PRO . 58.4 mt -79.84 84.65 1.25 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.575 0 CA-C-O 122.248 1.023 . . . . 0.0 110.323 179.151 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 2.5 pt20 -110.5 -20.42 12.58 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 114.006 -1.452 . . . . 0.0 107.677 167.712 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -62.45 -43.82 97.89 Favored 'General case' 0 N--CA 1.452 -0.361 0 CA-C-N 114.138 -1.392 . . . . 0.0 109.152 173.555 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -75.29 136.84 21.01 Favored Glycine 0 N--CA 1.445 -0.716 0 CA-C-N 115.138 -0.937 . . . . 0.0 111.619 176.575 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 20.1 m -95.64 19.69 10.78 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-O 120.759 0.314 . . . . 0.0 111.644 -174.97 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 15.0 mm100 -78.56 -49.5 13.2 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.085 0.469 . . . . 0.0 110.617 -179.477 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.577 ' HB2' ' HD3' ' A' ' 66' ' ' PRO . 14.4 m120 -127.24 39.83 3.82 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.143 179.902 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 13.6 t -87.14 -23.56 24.8 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.903 -178.165 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 -97.39 4.75 50.57 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.553 0.692 . . . . 0.0 109.642 178.535 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.403 ' HB ' ' H ' ' A' ' 64' ' ' ASP . 16.0 m -136.03 -159.01 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-N 115.301 -0.863 . . . . 0.0 110.028 179.155 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.518 ' O ' ' HB3' ' A' ' 60' ' ' ASN . 7.3 m-20 -55.64 136.97 50.14 Favored 'General case' 0 C--N 1.329 -0.325 0 O-C-N 123.408 0.443 . . . . 0.0 110.155 175.863 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.687 ' HB2' ' HB ' ' A' ' 24' ' ' ILE . 65.7 mmtt -88.38 134.0 35.4 Favored Pre-proline 0 C--N 1.318 -0.768 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.904 -169.101 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.657 ' HB2' HD12 ' A' ' 54' ' ' ILE . 16.4 Cg_exo -70.86 104.95 1.57 Allowed 'Trans proline' 0 N--CA 1.456 -0.686 0 C-N-CA 122.744 2.296 . . . . 0.0 111.137 172.49 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.879 HD13 HD22 ' A' ' 53' ' ' LEU . 18.9 tp -110.54 118.06 35.22 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.129 178.26 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.618 ' HB2' ' CG2' ' A' ' 52' ' ' ILE . 68.9 mtt180 -108.98 106.36 16.28 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.503 177.345 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.631 HG22 HG22 ' A' ' 76' ' ' VAL . 4.3 mp -87.13 109.49 19.31 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 N-CA-C 107.962 -1.125 . . . . 0.0 107.962 171.163 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.493 HG23 HG22 ' A' ' 19' ' ' VAL . 33.7 mt -110.23 128.37 66.5 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.73 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.979 -171.635 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 150.28 -123.93 1.65 Allowed Glycine 0 N--CA 1.444 -0.798 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.42 173.173 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . 0.953 ' HB2' ' H ' ' A' ' 8' ' ' HIS . 2.8 t70 -84.26 129.84 56.56 Favored Pre-proline 0 C--N 1.32 -0.705 0 CA-C-N 115.479 -0.361 . . . . 0.0 111.298 -177.333 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . 0.511 ' HG3' ' OG1' ' A' ' 18' ' ' THR . 53.2 Cg_exo -48.22 -27.79 10.07 Favored 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 123.805 3.003 . . . . 0.0 113.56 -178.924 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . 0.553 ' HB3' ' OD2' ' A' ' 72' ' ' ASP . 44.9 t80 -82.75 -60.06 2.3 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.519 -0.31 . . . . 0.0 110.733 -175.987 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.602 ' HG2' ' OD2' ' A' ' 72' ' ' ASP . 12.8 pttt -72.84 -17.46 61.55 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 112.115 0.413 . . . . 0.0 112.115 179.438 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.631 HG22 HG22 ' A' ' 69' ' ' ILE . 12.4 t -69.02 -38.48 78.46 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 N-CA-C 109.106 -0.701 . . . . 0.0 109.106 171.162 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . 0.417 ' O ' ' HG3' ' A' ' 81' ' ' GLU . 22.5 tp60 -74.02 -42.33 60.48 Favored 'General case' 0 N--CA 1.448 -0.528 0 CA-C-N 115.657 -0.701 . . . . 0.0 109.495 177.519 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . 0.481 ' HB2' ' HA ' ' A' ' 75' ' ' LYS . 51.2 mt-30 -56.01 -51.4 67.9 Favored 'General case' 0 C--O 1.223 -0.332 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.398 174.865 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -60.94 -40.13 92.09 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.925 179.201 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 22.6 t -59.54 -54.37 47.33 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.846 -0.615 . . . . 0.0 111.252 177.717 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . 0.433 ' O ' ' HB2' ' A' ' 85' ' ' ASP . 2.3 pp20? -70.77 -25.02 62.71 Favored 'General case' 0 C--O 1.217 -0.642 0 C-N-CA 120.221 -0.592 . . . . 0.0 110.493 -179.334 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' MET . . . . . 0.504 ' O ' HG13 ' A' ' 86' ' ' ILE . 34.8 ttp -67.35 -48.81 66.38 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.578 -0.283 . . . . 0.0 110.878 177.333 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.693 HG12 HD13 ' A' ' 43' ' ' LEU . 33.0 m -74.18 -36.59 44.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 C-N-CA 120.943 -0.303 . . . . 0.0 110.992 -179.766 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 89.2 mtp -71.14 -27.38 63.53 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 110.198 -0.297 . . . . 0.0 110.198 177.607 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . 0.433 ' HB2' ' O ' ' A' ' 81' ' ' GLU . 30.0 t70 -63.4 -40.85 98.34 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.276 175.139 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.504 HG13 ' O ' ' A' ' 82' ' ' MET . 52.2 mt -63.06 -33.09 58.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.734 177.711 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.561 HD22 ' HG2' ' A' ' 28' ' ' LYS . 69.2 mt -86.01 -21.81 27.61 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.789 -174.332 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 39.5 ptt180 -95.93 -2.99 46.01 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.122 0.487 . . . . 0.0 110.682 -178.814 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.249 1.047 0 CA-C-O 118.434 -0.793 . . . . 0.0 109.671 -174.678 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.663 0 N-CA-C 111.913 -0.475 . . . . 0.0 111.913 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 73.6 mt-30 -75.25 65.0 1.53 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.901 0.381 . . . . 0.0 110.829 -179.06 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . 0.634 ' HD1' ' HA2' ' A' ' 71' ' ' GLY . 59.7 m-85 55.12 41.03 32.0 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.361 -0.836 . . . . 0.0 111.569 177.407 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . 0.709 ' HA ' ' OD1' ' A' ' 72' ' ' ASP . 10.6 t-80 -154.66 35.82 0.41 Allowed 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 173.145 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 15.2 t70 66.19 -65.75 0.18 Allowed 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 114.362 -1.29 . . . . 0.0 110.902 -175.179 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 37.8 t30 -148.04 95.13 2.43 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.963 -0.562 . . . . 0.0 109.968 -178.445 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . 69.13 135.95 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 115.343 -0.844 . . . . 0.0 111.972 -176.727 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . 0.494 ' ND2' ' HB3' ' A' ' 16' ' ' ASN . 24.8 p-10 -102.01 163.68 12.12 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.811 177.831 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -117.12 76.67 0.28 Allowed Glycine 0 N--CA 1.448 -0.516 0 N-CA-C 111.43 -0.668 . . . . 0.0 111.43 175.221 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 116.15 -101.37 0.99 Allowed Glycine 0 N--CA 1.448 -0.508 0 C-N-CA 120.788 -0.72 . . . . 0.0 111.862 -178.546 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 30.6 mm-40 -84.2 150.13 25.68 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 120.775 0.322 . . . . 0.0 110.707 178.891 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . 0.494 ' HB3' ' ND2' ' A' ' 12' ' ' ASN . 9.0 p30 -128.56 142.63 51.0 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 109.52 -0.548 . . . . 0.0 109.52 176.344 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 97.25 101.9 2.1 Favored Glycine 0 N--CA 1.448 -0.525 0 C-N-CA 120.551 -0.833 . . . . 0.0 112.992 178.008 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.59 ' OG1' ' HG3' ' A' ' 73' ' ' PRO . 85.4 m -124.5 129.81 51.31 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.028 0.442 . . . . 0.0 110.461 176.519 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.616 ' HA ' ' O ' ' A' ' 69' ' ' ILE . 3.2 p -130.18 129.02 65.09 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.829 -179.837 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 67.6 mt-30 -105.07 119.49 39.15 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.529 177.962 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.747 ' HA ' ' O ' ' A' ' 67' ' ' LEU . 28.8 mt-10 -92.64 108.77 20.23 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.614 -0.721 . . . . 0.0 110.341 175.022 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.448 HG12 HD22 ' A' ' 67' ' ' LEU . 22.0 mm -107.28 142.9 18.91 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 CA-C-N 115.55 -0.75 . . . . 0.0 109.422 -179.592 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 90.5 mmm -103.56 92.74 4.59 Favored 'General case' 0 N--CA 1.447 -0.6 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 179.099 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.672 ' HB ' ' HB2' ' A' ' 65' ' ' LYS . 25.5 mm -77.6 128.14 80.62 Favored Pre-proline 0 C--N 1.317 -0.84 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.457 -174.622 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_exo -48.1 133.12 23.71 Favored 'Trans proline' 0 N--CA 1.462 -0.366 0 C-N-CA 122.626 2.217 . . . . 0.0 111.453 175.773 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -44.66 -56.17 4.62 Favored 'General case' 0 C--N 1.328 -0.341 0 O-C-N 124.023 0.827 . . . . 0.0 112.824 -171.536 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -79.31 -12.6 83.72 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.875 -0.679 . . . . 0.0 113.02 -175.425 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.433 ' HD3' ' HB3' ' A' ' 87' ' ' LEU . 19.6 ttmm -88.14 8.91 24.67 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.328 0.585 . . . . 0.0 110.522 -175.864 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.403 ' HA ' HG22 ' A' ' 32' ' ' VAL . . . -66.18 -20.82 66.25 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.061 179.224 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -63.86 -16.06 58.83 Favored Glycine 0 N--CA 1.449 -0.455 0 CA-C-N 115.853 -0.612 . . . . 0.0 112.565 179.575 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.478 HD13 HG22 ' A' ' 86' ' ' ILE . 74.9 mt -94.87 -42.4 8.71 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 111.73 0.27 . . . . 0.0 111.73 -179.394 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.629 HG13 HD21 ' A' ' 87' ' ' LEU . 3.1 m -69.83 -38.21 75.28 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.21 0 CA-C-O 121.037 0.446 . . . . 0.0 111.046 178.629 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.578 ' HA ' ' HB ' ' A' ' 40' ' ' ILE . 57.0 mt -86.45 -32.7 6.77 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-O 121.705 0.764 . . . . 0.0 109.441 179.599 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.506 ' HA3' ' CB ' ' A' ' 39' ' ' THR . . . 92.65 171.52 40.8 Favored Glycine 0 N--CA 1.441 -0.972 0 CA-C-N 114.923 -1.035 . . . . 0.0 112.086 178.438 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 14.5 mptt -76.77 65.77 2.57 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.104 0.478 . . . . 0.0 110.89 -179.611 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 132.92 5.28 3.15 Favored Glycine 0 C--N 1.33 0.224 0 C-N-CA 120.972 -0.632 . . . . 0.0 112.527 175.442 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.502 ' HA2' HG22 ' A' ' 33' ' ' ILE . . . 86.36 -9.2 71.26 Favored Glycine 0 N--CA 1.449 -0.487 0 C-N-CA 120.524 -0.846 . . . . 0.0 112.016 -179.12 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 55.3 mm-40 -64.33 -33.47 75.91 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.689 0.28 . . . . 0.0 111.208 -179.554 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.762 ' O ' ' HG ' ' A' ' 43' ' ' LEU . 32.3 m -64.62 -57.26 9.57 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.482 -0.326 . . . . 0.0 111.039 -179.839 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.598 ' HA ' HD12 ' A' ' 43' ' ' LEU . 11.0 tt -59.92 -31.74 48.29 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.391 0 CA-C-O 121.318 0.58 . . . . 0.0 110.553 -179.377 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 46.0 tttt -60.39 -50.64 72.78 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.588 -0.733 . . . . 0.0 110.822 173.751 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.644 ' O ' ' HG2' ' A' ' 46' ' ' ARG . 48.2 mt-30 -67.29 -38.77 85.57 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.705 -176.321 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.762 ' HG ' ' O ' ' A' ' 39' ' ' THR . 61.4 mt -55.76 -46.18 77.94 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.397 -176.663 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 43.4 mt-30 -61.26 -34.71 75.61 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.926 -179.862 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -80.74 -45.63 16.75 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.423 -177.583 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 0.644 ' HG2' ' O ' ' A' ' 42' ' ' GLN . 14.0 ptp180 -74.66 -43.21 56.43 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 112.753 0.649 . . . . 0.0 112.753 -173.879 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.525 ' HB3' HG22 ' A' ' 49' ' ' VAL . . . -83.82 -14.72 50.63 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 112.084 0.402 . . . . 0.0 112.084 -173.508 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 72.24 24.91 75.66 Favored Glycine 0 C--N 1.329 0.17 0 C-N-CA 120.659 -0.782 . . . . 0.0 111.912 -179.134 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.525 HG22 ' HB3' ' A' ' 47' ' ' ALA . 26.8 m -124.08 162.31 25.54 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 N-CA-C 109.937 -0.394 . . . . 0.0 109.937 -179.296 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 61.6 tttp -100.5 122.14 42.72 Favored 'General case' 0 C--N 1.317 -0.833 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 174.624 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . 0.478 ' CE ' ' HB1' ' A' ' 79' ' ' ALA . 61.1 mtt -110.12 115.38 29.64 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 174.836 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.67 ' CG2' ' HB2' ' A' ' 68' ' ' ARG . 12.6 tt -109.64 105.13 18.21 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.973 0 CA-C-O 121.88 0.848 . . . . 0.0 109.727 174.886 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -87.84 107.76 18.83 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 114.666 -1.152 . . . . 0.0 109.203 178.278 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.511 ' HB ' ' HB2' ' A' ' 66' ' ' PRO . 46.4 mm -74.54 85.05 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.306 0 CA-C-O 122.006 0.908 . . . . 0.0 110.486 -177.87 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -124.15 -34.78 2.9 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-N 114.361 -1.291 . . . . 0.0 108.111 170.54 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -75.52 -14.73 60.42 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 114.918 -1.037 . . . . 0.0 109.014 174.982 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -84.6 11.34 59.34 Favored Glycine 0 N--CA 1.45 -0.42 0 CA-C-N 115.268 -0.878 . . . . 0.0 111.848 176.771 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 39.1 p 51.47 -158.59 0.11 Allowed 'General case' 0 N--CA 1.467 0.389 0 C-N-CA 123.782 0.833 . . . . 0.0 111.764 -178.63 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 49.5 mt-30 65.28 -82.69 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.209 0 C-N-CA 123.087 0.555 . . . . 0.0 111.714 179.753 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.645 ' HA ' HG22 ' A' ' 63' ' ' VAL . 1.8 m-20 -90.92 18.49 6.56 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.737 0.304 . . . . 0.0 110.988 -175.216 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . 0.415 ' O ' ' HE2' ' A' ' 65' ' ' LYS . 11.9 t -67.03 -22.8 65.86 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 173.526 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 52.4 t-20 -85.11 -48.5 9.12 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.107 -0.951 . . . . 0.0 110.337 176.279 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.645 HG22 ' HA ' ' A' ' 60' ' ' ASN . 18.1 m -93.11 -154.95 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.007 -0.542 . . . . 0.0 112.161 -174.058 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.563 ' O ' ' HB3' ' A' ' 60' ' ' ASN . 23.3 m-20 -54.21 140.86 31.29 Favored 'General case' 0 N--CA 1.462 0.166 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.274 176.11 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.672 ' HB2' ' HB ' ' A' ' 24' ' ' ILE . 31.0 mmtp -94.34 118.24 67.04 Favored Pre-proline 0 C--N 1.32 -0.681 0 CA-C-N 116.037 -0.528 . . . . 0.0 110.804 -170.368 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.511 ' HB2' ' HB ' ' A' ' 54' ' ' ILE . 25.4 Cg_exo -65.43 104.69 0.66 Allowed 'Trans proline' 0 N--CA 1.459 -0.53 0 C-N-CA 122.653 2.235 . . . . 0.0 110.942 173.784 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.886 HD21 HG13 ' A' ' 69' ' ' ILE . 4.8 tt -103.88 136.55 43.33 Favored 'General case' 0 C--N 1.315 -0.904 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 179.907 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.67 ' HB2' ' CG2' ' A' ' 52' ' ' ILE . 92.7 mtt180 -131.16 108.38 9.68 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 121.067 0.461 . . . . 0.0 111.003 173.538 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.886 HG13 HD21 ' A' ' 67' ' ' LEU . 13.5 mt -91.77 104.96 16.07 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 N-CA-C 108.828 -0.805 . . . . 0.0 108.828 172.57 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 5.2 mt -105.35 126.06 60.5 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.828 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.476 -174.837 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . 0.634 ' HA2' ' HD1' ' A' ' 7' ' ' PHE . . . 160.61 -129.72 2.22 Favored Glycine 0 N--CA 1.446 -0.666 0 C-N-CA 120.591 -0.814 . . . . 0.0 112.705 175.03 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . 0.709 ' OD1' ' HA ' ' A' ' 8' ' ' HIS . 0.9 OUTLIER -88.23 132.94 37.97 Favored Pre-proline 0 C--N 1.322 -0.616 0 C-N-CA 122.833 0.453 . . . . 0.0 111.394 -176.696 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . 0.59 ' HG3' ' OG1' ' A' ' 18' ' ' THR . 45.6 Cg_exo -52.51 -26.41 28.61 Favored 'Trans proline' 0 C--N 1.351 0.679 0 C-N-CA 123.899 3.066 . . . . 0.0 113.301 -174.94 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . 0.48 ' HB3' ' OD2' ' A' ' 72' ' ' ASP . 82.2 t80 -83.49 -56.29 3.82 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.422 -176.664 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.663 ' HG2' ' OD2' ' A' ' 72' ' ' ASP . 12.9 ptpt -71.48 -27.03 62.96 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.54 -179.818 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.631 HG22 HG22 ' A' ' 69' ' ' ILE . 25.2 t -61.18 -40.7 86.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 N-CA-C 110.305 -0.258 . . . . 0.0 110.305 173.799 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -74.97 -43.24 55.16 Favored 'General case' 0 N--CA 1.451 -0.419 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.297 -179.018 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . 0.463 ' O ' ' HB2' ' A' ' 82' ' ' MET . 41.4 mt-30 -62.0 -35.89 79.89 Favored 'General case' 0 C--O 1.224 -0.264 0 CA-C-N 116.52 -0.309 . . . . 0.0 110.674 177.465 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . 0.478 ' HB1' ' CE ' ' A' ' 51' ' ' MET . . . -74.85 -34.15 62.23 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 120.912 0.387 . . . . 0.0 110.478 177.831 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 53.9 t -63.29 -56.7 14.33 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.149 176.438 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -66.23 -23.04 66.36 Favored 'General case' 0 C--O 1.22 -0.499 0 C-N-CA 120.547 -0.461 . . . . 0.0 110.47 179.217 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' MET . . . . . 0.463 ' HB2' ' O ' ' A' ' 78' ' ' GLN . 30.6 ttm -59.61 -52.66 64.59 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.981 0.419 . . . . 0.0 110.202 174.838 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.644 ' O ' ' HG ' ' A' ' 87' ' ' LEU . 18.7 m -83.86 -35.23 11.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.09 -177.521 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' MET . . . . . 0.458 ' O ' ' HG2' ' A' ' 88' ' ' ARG . 57.1 ttp -65.44 -35.39 80.77 Favored 'General case' 0 CA--C 1.518 -0.265 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.291 -179.894 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . 0.48 ' O ' ' HB2' ' A' ' 89' ' ' GLU . 33.2 t70 -61.3 -39.87 92.09 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.127 177.382 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.478 HG22 HD13 ' A' ' 31' ' ' LEU . 23.5 mt -64.62 -41.18 91.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 121.412 0.625 . . . . 0.0 109.925 176.398 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.644 ' HG ' ' O ' ' A' ' 83' ' ' VAL . 66.1 mt -64.39 -36.11 83.09 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.373 -0.831 . . . . 0.0 111.101 -178.781 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . 0.458 ' HG2' ' O ' ' A' ' 84' ' ' MET . 29.5 mmm180 -95.28 9.91 38.06 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.996 -177.352 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . 0.48 ' HB2' ' O ' ' A' ' 85' ' ' ASP . 35.3 tt0 . . . . . 0 C--O 1.25 1.122 0 CA-C-O 118.836 -0.602 . . . . 0.0 110.34 -177.787 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.55 0 N-CA-C 112.377 -0.289 . . . . 0.0 112.377 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 33.6 mt-30 -60.52 146.37 45.21 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 108.412 -0.958 . . . . 0.0 108.412 173.79 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 94.6 m-85 -47.14 125.2 7.44 Favored 'General case' 0 CA--C 1.518 -0.261 0 CA-C-O 121.554 0.692 . . . . 0.0 111.884 -169.693 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . 0.603 ' H ' ' HB3' ' A' ' 12' ' ' ASN . 4.7 t-80 -141.84 169.88 16.76 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 114.803 -1.09 . . . . 0.0 108.411 -173.455 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . 0.573 ' HB3' ' O ' ' A' ' 48' ' ' GLY . 0.5 OUTLIER -66.67 -68.82 0.35 Allowed 'General case' 0 C--N 1.318 -0.786 0 CA-C-O 120.578 0.227 . . . . 0.0 111.348 176.132 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 23.3 t-20 -84.96 -72.94 0.45 Allowed 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.794 0.33 . . . . 0.0 111.23 -178.081 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -84.24 87.67 7.19 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.952 0.406 . . . . 0.0 111.52 -176.827 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . 0.603 ' HB3' ' H ' ' A' ' 8' ' ' HIS . 18.7 p30 -113.87 149.95 34.33 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.202 175.229 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -104.35 111.26 3.78 Favored Glycine 0 N--CA 1.447 -0.624 0 C-N-CA 120.997 -0.62 . . . . 0.0 112.576 -176.737 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 157.7 -128.04 2.03 Favored Glycine 0 N--CA 1.446 -0.652 0 N-CA-C 109.888 -1.285 . . . . 0.0 109.888 -177.844 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . 0.406 ' C ' ' H ' ' A' ' 17' ' ' GLY . 32.6 tt0 -129.67 102.86 6.53 Favored 'General case' 0 C--N 1.317 -0.841 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 169.847 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 12.4 m120 59.2 -2.43 0.11 Allowed 'General case' 0 N--CA 1.472 0.649 0 CA-C-N 115.3 -0.864 . . . . 0.0 112.615 -172.908 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 0.406 ' H ' ' C ' ' A' ' 15' ' ' GLN . . . 81.71 -115.84 4.09 Favored Glycine 0 N--CA 1.447 -0.578 0 N-CA-C 111.438 -0.665 . . . . 0.0 111.438 -176.329 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 85.7 m -120.66 130.67 54.22 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 109.697 -0.482 . . . . 0.0 109.697 175.513 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.665 ' HA ' ' O ' ' A' ' 69' ' ' ILE . 3.2 p -139.86 121.76 16.0 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-O 121.161 0.505 . . . . 0.0 111.932 -175.456 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . 0.411 ' O ' ' HA ' ' A' ' 68' ' ' ARG . 28.8 mt-30 -96.88 157.17 16.03 Favored 'General case' 0 CA--C 1.519 -0.233 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.353 173.363 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.582 ' HG2' ' HG2' ' A' ' 68' ' ' ARG . 35.2 mt-10 -131.18 107.91 9.34 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.177 0.513 . . . . 0.0 111.075 -178.424 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 5.3 mm -101.57 150.37 6.06 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-N 115.54 -0.754 . . . . 0.0 109.405 -179.807 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 79.5 mmm -110.18 92.85 4.21 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 176.77 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.676 ' HB ' ' HB2' ' A' ' 65' ' ' LYS . 32.7 mm -82.3 127.32 71.64 Favored Pre-proline 0 C--N 1.32 -0.676 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.101 -173.895 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 76.7 Cg_exo -50.85 136.5 43.33 Favored 'Trans proline' 0 N--CA 1.463 -0.317 0 C-N-CA 122.491 2.127 . . . . 0.0 111.592 175.398 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -58.1 -29.28 65.35 Favored 'General case' 0 CA--C 1.531 0.226 0 N-CA-C 112.959 0.725 . . . . 0.0 112.959 -172.116 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -89.44 -19.73 47.94 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.484 -0.865 . . . . 0.0 112.138 179.323 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 8.5 tptm -91.95 -1.15 57.42 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.266 0.555 . . . . 0.0 110.363 -177.601 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.487 ' HA ' HG22 ' A' ' 32' ' ' VAL . . . -63.06 -20.93 65.8 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.598 -0.728 . . . . 0.0 111.065 179.471 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -61.0 -16.3 47.14 Favored Glycine 0 C--O 1.228 -0.247 0 CA-C-N 115.876 -0.602 . . . . 0.0 112.652 177.405 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 62.6 mt -93.75 -47.92 6.55 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 122.693 -0.298 . . . . 0.0 111.238 179.539 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.561 HG13 HD21 ' A' ' 87' ' ' LEU . 3.0 m -65.34 -40.07 87.29 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.379 0 CA-C-O 120.889 0.376 . . . . 0.0 111.452 179.523 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.51 HG13 HG23 ' A' ' 32' ' ' VAL . 43.6 mt -85.88 -32.75 7.09 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-O 121.927 0.87 . . . . 0.0 109.162 178.794 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.527 ' HA3' ' HB ' ' A' ' 39' ' ' THR . . . 95.15 178.9 37.3 Favored Glycine 0 N--CA 1.436 -1.318 0 CA-C-N 114.852 -1.067 . . . . 0.0 111.579 -178.105 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 2.9 mppt? -81.13 62.8 5.23 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-O 120.973 0.416 . . . . 0.0 110.373 -178.839 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 133.19 -20.1 4.26 Favored Glycine 0 N--CA 1.448 -0.521 0 C-N-CA 120.823 -0.703 . . . . 0.0 112.416 176.897 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 115.8 -0.16 21.45 Favored Glycine 0 N--CA 1.448 -0.517 0 C-N-CA 120.723 -0.751 . . . . 0.0 111.883 -176.792 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.508 ' O ' ' HB3' ' A' ' 41' ' ' LYS . 49.3 mt-10 -75.44 -31.96 60.5 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 120.724 0.297 . . . . 0.0 111.106 179.474 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.584 ' O ' ' HG ' ' A' ' 43' ' ' LEU . 23.7 m -69.38 -48.46 61.11 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.774 -178.3 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.665 HD12 HD23 ' A' ' 53' ' ' LEU . 7.0 tt -61.8 -32.79 55.05 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.267 0 CA-C-O 121.107 0.479 . . . . 0.0 110.346 177.356 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.508 ' HB3' ' O ' ' A' ' 38' ' ' GLU . 31.6 ttpt -56.24 -45.22 80.07 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.467 174.398 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.45 ' O ' ' HG2' ' A' ' 46' ' ' ARG . 27.8 mt-30 -73.46 -40.46 64.15 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.404 -0.816 . . . . 0.0 111.116 -177.027 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.584 ' HG ' ' O ' ' A' ' 39' ' ' THR . 81.0 mt -55.71 -47.58 76.63 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.683 -176.577 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 44.6 mt-30 -61.98 -43.13 99.48 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.712 -176.247 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -78.54 -35.21 46.46 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 111.836 0.31 . . . . 0.0 111.836 -175.797 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 0.45 ' HG2' ' O ' ' A' ' 42' ' ' GLN . 12.9 ptm180 -73.92 -31.39 63.05 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 120.777 -0.369 . . . . 0.0 111.268 -177.89 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -89.19 -28.18 20.16 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.087 0.47 . . . . 0.0 111.348 -179.111 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . 0.573 ' O ' ' HB3' ' A' ' 9' ' ' ASP . . . 82.93 33.21 24.6 Favored Glycine 0 N--CA 1.449 -0.478 0 CA-C-N 115.742 -0.663 . . . . 0.0 112.243 -178.698 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 3.6 m -139.14 179.86 2.76 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.399 0 CA-C-O 120.898 0.38 . . . . 0.0 110.297 178.609 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 54.7 tttp -109.44 123.67 49.75 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 115.945 -0.57 . . . . 0.0 109.919 175.448 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . 0.552 ' HG2' HG23 ' A' ' 69' ' ' ILE . 65.9 mtp -118.21 114.08 22.49 Favored 'General case' 0 C--N 1.317 -0.808 0 N-CA-C 108.301 -1.0 . . . . 0.0 108.301 174.414 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.502 ' CG2' ' HB2' ' A' ' 68' ' ' ARG . 11.5 tt -104.6 108.54 25.06 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.749 0 CA-C-O 121.622 0.725 . . . . 0.0 110.684 -177.614 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.723 HD22 HD13 ' A' ' 67' ' ' LEU . 2.7 mm? -82.35 102.29 11.15 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.249 -0.887 . . . . 0.0 109.522 174.11 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.648 HD12 ' HB2' ' A' ' 66' ' ' PRO . 56.6 mt -82.48 87.42 1.9 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.55 0 CA-C-O 121.481 0.658 . . . . 0.0 109.35 -179.171 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 70.9 mt-30 -70.91 -37.95 72.95 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.148 -0.933 . . . . 0.0 111.144 -173.59 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . 0.505 ' HA ' HG21 ' A' ' 61' ' ' THR . 19.4 m-20 -130.27 62.28 1.58 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.184 0.516 . . . . 0.0 111.541 178.29 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -91.95 5.15 78.95 Favored Glycine 0 CA--C 1.517 0.2 0 C-N-CA 120.508 -0.853 . . . . 0.0 111.928 172.56 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 16.8 m 64.37 -169.77 0.19 Allowed 'General case' 0 C--O 1.235 0.321 0 C-N-CA 123.426 0.69 . . . . 0.0 111.322 -178.088 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 26.1 mt-30 67.76 -79.23 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 123.376 0.67 . . . . 0.0 111.146 179.768 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 13.6 m120 -101.38 13.01 36.37 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.337 -177.994 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . 0.505 HG21 ' HA ' ' A' ' 56' ' ' ASP . 1.2 p -62.52 -33.08 74.19 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 120.861 0.362 . . . . 0.0 111.347 179.296 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 17.9 t-20 -74.63 -10.19 59.3 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.471 -0.786 . . . . 0.0 111.493 -178.701 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.53 HG23 ' H ' ' A' ' 64' ' ' ASP . 0.5 OUTLIER -126.51 -60.79 1.45 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-O 121.698 0.761 . . . . 0.0 112.702 -174.387 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.53 ' H ' HG23 ' A' ' 63' ' ' VAL . 10.6 m-20 -120.63 -163.68 1.04 Allowed 'General case' 0 C--N 1.307 -1.278 0 CA-C-N 114.67 -1.15 . . . . 0.0 108.901 -171.158 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.676 ' HB2' ' HB ' ' A' ' 24' ' ' ILE . 2.7 mmpp? -148.57 113.28 3.74 Favored Pre-proline 0 C--N 1.318 -0.779 0 CA-C-N 115.62 -0.718 . . . . 0.0 109.51 178.779 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.648 ' HB2' HD12 ' A' ' 54' ' ' ILE . 24.7 Cg_exo -63.55 110.26 1.21 Allowed 'Trans proline' 0 N--CA 1.462 -0.353 0 C-N-CA 122.613 2.209 . . . . 0.0 111.807 178.268 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.723 HD13 HD22 ' A' ' 53' ' ' LEU . 24.2 tp -111.16 105.22 13.85 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.069 178.006 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.582 ' HG2' ' HG2' ' A' ' 21' ' ' GLU . 95.2 mtt180 -97.72 113.62 25.42 Favored 'General case' 0 C--N 1.319 -0.717 0 CA-C-O 121.437 0.637 . . . . 0.0 110.581 176.813 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.665 ' O ' ' HA ' ' A' ' 19' ' ' VAL . 19.6 mt -98.83 104.09 15.54 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.786 0 CA-C-N 114.99 -1.004 . . . . 0.0 108.577 177.897 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.545 HG23 ' HB ' ' A' ' 19' ' ' VAL . 2.8 mt -112.58 132.61 60.84 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.788 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.061 -169.348 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 156.44 -119.06 0.88 Allowed Glycine 0 N--CA 1.446 -0.675 0 C-N-CA 120.718 -0.754 . . . . 0.0 112.825 174.832 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . 0.401 ' O ' HG23 ' A' ' 76' ' ' VAL . 11.9 t70 -102.69 134.77 19.7 Favored Pre-proline 0 C--N 1.325 -0.46 0 CA-C-O 119.091 -0.48 . . . . 0.0 110.96 -175.667 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_exo -44.31 -42.91 13.59 Favored 'Trans proline' 0 C--O 1.237 0.445 0 C-N-CA 123.231 2.62 . . . . 0.0 113.557 -174.419 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 30.7 t80 -70.95 -47.73 57.34 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.853 -171.911 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.436 ' HA ' ' HB2' ' A' ' 78' ' ' GLN . 14.3 pttt -82.87 -19.24 37.84 Favored 'General case' 0 C--N 1.325 -0.466 0 C-N-CA 120.492 -0.483 . . . . 0.0 111.768 -179.463 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.401 HG23 ' O ' ' A' ' 72' ' ' ASP . 47.0 t -66.16 -38.55 82.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 170.036 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . 0.407 ' O ' ' HG2' ' A' ' 81' ' ' GLU . 20.9 tp60 -69.92 -49.13 55.06 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.38 -0.827 . . . . 0.0 110.416 175.426 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . 0.436 ' HB2' ' HA ' ' A' ' 75' ' ' LYS . 86.2 mt-30 -60.4 -36.36 77.95 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.567 -0.288 . . . . 0.0 111.693 -179.913 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -69.64 -39.42 77.12 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 120.818 0.342 . . . . 0.0 110.546 177.462 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 52.5 t -65.13 -51.45 61.19 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.051 179.681 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . 0.408 ' HG2' ' HA ' ' A' ' 78' ' ' GLN . 10.3 pt-20 -64.99 -24.11 67.41 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.972 0.415 . . . . 0.0 110.37 179.983 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' MET . . . . . 0.557 ' O ' HG13 ' A' ' 86' ' ' ILE . 29.7 ttp -73.14 -52.02 15.76 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.863 179.259 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.57 ' O ' ' HG ' ' A' ' 87' ' ' LEU . 33.3 m -77.75 -34.0 19.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 120.635 0.255 . . . . 0.0 111.207 -175.647 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 51.7 ttm -63.35 -35.25 79.75 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.106 0.479 . . . . 0.0 109.741 177.194 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -68.54 -36.72 79.22 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.441 179.444 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.557 HG13 ' O ' ' A' ' 82' ' ' MET . 59.9 mt -63.31 -33.25 60.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-O 121.256 0.55 . . . . 0.0 110.543 178.056 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.57 ' HG ' ' O ' ' A' ' 83' ' ' VAL . 58.7 mt -73.87 -19.61 60.67 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.604 -175.945 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . 0.619 ' HG3' ' HG2' ' A' ' 89' ' ' GLU . 37.1 ptt180 -110.8 -19.3 12.88 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.372 0.606 . . . . 0.0 111.142 -175.596 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . 0.619 ' HG2' ' HG3' ' A' ' 88' ' ' ARG . 69.9 mm-40 . . . . . 0 C--O 1.249 1.04 0 CA-C-N 115.235 -0.893 . . . . 0.0 110.425 -175.633 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.504 -0.6 0 N-CA-C 113.866 0.306 . . . . 0.0 113.866 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 53.7 mt-30 -76.35 -171.28 1.72 Allowed 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 106.987 -1.486 . . . . 0.0 106.987 159.634 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . 0.457 ' HB3' ' HB2' ' A' ' 72' ' ' ASP . 0.1 OUTLIER -65.78 -20.45 66.26 Favored 'General case' 0 C--N 1.314 -0.946 0 C-N-CA 119.056 -1.058 . . . . 0.0 111.942 -177.889 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . 0.445 ' N ' ' HD1' ' A' ' 7' ' ' PHE . 11.5 t-160 70.25 77.51 0.2 Allowed 'General case' 0 CA--C 1.53 0.189 0 O-C-N 123.745 0.653 . . . . 0.0 110.649 -178.667 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 30.9 t70 72.63 -57.94 0.61 Allowed 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 115.159 -0.928 . . . . 0.0 112.073 178.207 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . 0.422 ' O ' ' HB2' ' A' ' 7' ' ' PHE . 7.8 p30 -137.4 -163.57 1.45 Allowed 'General case' 0 C--N 1.317 -0.81 0 N-CA-C 109.792 -0.448 . . . . 0.0 109.792 -177.688 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -73.29 76.12 1.34 Allowed 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 109.977 -0.379 . . . . 0.0 109.977 175.225 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 -82.18 75.47 9.1 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.172 0.51 . . . . 0.0 110.914 -171.875 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 101.42 -4.48 54.56 Favored Glycine 0 N--CA 1.449 -0.456 0 CA-C-N 115.784 -0.644 . . . . 0.0 112.736 177.795 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 80.51 -70.51 2.98 Favored Glycine 0 N--CA 1.454 -0.147 0 C-N-CA 120.742 -0.742 . . . . 0.0 111.918 -177.934 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 8.3 tt0 -74.8 124.67 27.25 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 175.554 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . 0.452 ' OD1' ' HA ' ' A' ' 7' ' ' PHE . 16.8 m120 -118.96 -80.52 0.62 Allowed 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 111.972 0.36 . . . . 0.0 111.972 -171.726 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -158.75 -49.7 0.01 OUTLIER Glycine 0 C--N 1.333 0.41 0 C-N-CA 119.819 -1.182 . . . . 0.0 113.666 -178.079 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 99.7 m -62.38 129.37 40.4 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.008 0.432 . . . . 0.0 111.641 -178.182 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.586 HG22 HG23 ' A' ' 70' ' ' ILE . 92.9 t -120.8 126.99 75.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.276 178.284 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . 0.576 ' HB2' ' CG1' ' A' ' 76' ' ' VAL . 4.9 tp-100 -106.58 113.93 27.74 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 109.667 -0.494 . . . . 0.0 109.667 175.684 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.607 ' HA ' ' O ' ' A' ' 67' ' ' LEU . 56.1 mt-10 -93.24 121.29 34.47 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.036 0.446 . . . . 0.0 111.457 177.591 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 18.7 mm -115.43 146.38 19.94 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 115.529 -0.759 . . . . 0.0 109.355 176.902 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' MET . . . . . 0.494 ' HB3' ' HB2' ' A' ' 64' ' ' ASP . 79.4 mmm -106.77 99.86 9.4 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 175.356 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.709 HD12 HD11 ' A' ' 87' ' ' LEU . 24.5 mm -78.54 129.76 73.36 Favored Pre-proline 0 C--N 1.32 -0.685 0 CA-C-N 115.498 -0.774 . . . . 0.0 111.895 -170.461 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.603 ' HD2' HD13 ' A' ' 87' ' ' LEU . 77.0 Cg_exo -45.2 131.37 11.38 Favored 'Trans proline' 0 C--N 1.349 0.574 0 C-N-CA 123.744 2.963 . . . . 0.0 112.976 175.831 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -71.36 78.5 0.75 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.444 0.64 . . . . 0.0 110.874 179.437 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 157.54 -59.96 0.34 Allowed Glycine 0 N--CA 1.447 -0.593 0 N-CA-C 109.983 -1.247 . . . . 0.0 109.983 -177.456 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.46 -13.97 35.97 Favored 'General case' 0 N--CA 1.451 -0.41 0 CA-C-O 121.0 0.429 . . . . 0.0 110.749 171.929 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.425 ' O ' HG12 ' A' ' 32' ' ' VAL . . . -56.16 -23.49 35.24 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.771 173.379 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -61.8 -24.46 64.54 Favored Glycine 0 N--CA 1.449 -0.494 0 C-N-CA 120.862 -0.685 . . . . 0.0 112.185 176.611 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 93.1 mt -92.4 -32.8 14.81 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.725 0.298 . . . . 0.0 110.859 178.793 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.438 HG11 HG21 ' A' ' 24' ' ' ILE . 0.3 OUTLIER -68.06 -29.0 43.15 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.296 0 CA-C-O 121.263 0.554 . . . . 0.0 110.395 179.387 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 63.2 mt -92.0 -47.97 13.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 115.568 -0.742 . . . . 0.0 109.424 174.386 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 114.56 -162.12 12.51 Favored Glycine 0 N--CA 1.442 -0.942 0 CA-C-N 115.356 -0.838 . . . . 0.0 112.095 178.418 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.534 ' N ' ' HD3' ' A' ' 35' ' ' LYS . 0.1 OUTLIER -92.29 39.33 1.02 Allowed 'General case' 0 C--N 1.317 -0.818 0 N-CA-C 109.637 -0.505 . . . . 0.0 109.637 -178.298 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 143.52 -21.31 2.21 Favored Glycine 0 N--CA 1.45 -0.431 0 C-N-CA 120.982 -0.628 . . . . 0.0 112.29 -178.245 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 126.17 4.77 6.4 Favored Glycine 0 C--O 1.228 -0.245 0 C-N-CA 120.355 -0.926 . . . . 0.0 112.309 179.939 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -80.59 -28.17 37.2 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 120.659 0.266 . . . . 0.0 111.217 178.897 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.623 ' O ' ' HG ' ' A' ' 43' ' ' LEU . 57.9 m -70.38 -49.64 47.01 Favored 'General case' 0 C--N 1.324 -0.507 0 C-N-CA 121.101 -0.24 . . . . 0.0 110.444 -179.983 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.703 HD12 HD23 ' A' ' 53' ' ' LEU . 5.2 tt -59.64 -33.72 52.86 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.248 0 CA-C-O 120.81 0.338 . . . . 0.0 110.473 176.31 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.536 ' O ' ' HG2' ' A' ' 45' ' ' GLU . 57.7 tttp -64.86 -46.23 82.74 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.756 175.454 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 41.7 mt-30 -60.88 -35.08 75.69 Favored 'General case' 0 CA--C 1.516 -0.354 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.359 -178.017 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.623 ' HG ' ' O ' ' A' ' 39' ' ' THR . 69.8 mt -62.19 -43.6 98.46 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.421 -0.809 . . . . 0.0 110.402 178.158 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . 0.452 HE21 HG12 ' A' ' 40' ' ' ILE . 67.8 mt-30 -62.61 -47.24 84.63 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.176 177.596 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.536 ' HG2' ' O ' ' A' ' 41' ' ' LYS . 72.0 mm-40 -59.81 -39.41 84.95 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.33 -0.85 . . . . 0.0 111.672 -177.854 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 13.5 ptm180 -90.0 -28.02 19.38 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 112.932 0.716 . . . . 0.0 112.932 -170.865 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.45 ' HB3' HG22 ' A' ' 49' ' ' VAL . . . -94.22 -15.83 24.2 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 112.174 0.435 . . . . 0.0 112.174 -175.642 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 74.23 20.72 79.6 Favored Glycine 0 C--O 1.235 0.217 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.183 -179.855 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.45 HG22 ' HB3' ' A' ' 47' ' ' ALA . 27.3 m -124.51 177.31 4.67 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 N-CA-C 109.902 -0.407 . . . . 0.0 109.902 -179.202 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 87.1 tttt -114.64 123.97 50.66 Favored 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 109.773 -0.455 . . . . 0.0 109.773 173.088 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . 0.592 ' HE2' ' HB1' ' A' ' 79' ' ' ALA . 55.7 mtt -108.54 115.39 30.02 Favored 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 176.028 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.561 ' CG2' ' HB2' ' A' ' 68' ' ' ARG . 10.2 tt -105.13 105.14 18.08 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.895 0 CA-C-O 121.585 0.707 . . . . 0.0 110.423 177.668 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 1.004 HD22 HD13 ' A' ' 67' ' ' LEU . 1.4 mm? -80.75 121.8 26.36 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.283 -0.872 . . . . 0.0 108.973 172.608 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.47 ' CG1' ' HB2' ' A' ' 66' ' ' PRO . 48.9 mm -76.67 85.86 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-O 121.845 0.831 . . . . 0.0 109.832 179.514 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 15.3 mt-30 -102.48 -57.87 1.98 Allowed 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 114.743 -1.117 . . . . 0.0 108.64 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -66.9 -33.09 74.83 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 114.633 -1.167 . . . . 0.0 110.322 177.902 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -70.13 -27.06 73.43 Favored Glycine 0 N--CA 1.451 -0.333 0 CA-C-N 115.577 -0.738 . . . . 0.0 112.382 179.65 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . 0.605 ' HB3' ' CG2' ' A' ' 61' ' ' THR . 49.2 m 62.1 -127.28 0.72 Allowed 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 122.28 0.232 . . . . 0.0 111.422 178.615 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . 0.403 ' HB2' ' O ' ' A' ' 58' ' ' SER . 23.2 mt-30 78.7 -57.05 0.45 Allowed 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 123.671 0.788 . . . . 0.0 109.519 179.172 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.491 ' HB3' ' O ' ' A' ' 64' ' ' ASP . 13.7 m120 -100.03 52.82 0.91 Allowed 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 107.86 -1.163 . . . . 0.0 107.86 171.37 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . 0.605 ' CG2' ' HB3' ' A' ' 58' ' ' SER . 2.7 p -55.58 -44.54 77.0 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 114.115 -1.402 . . . . 0.0 112.538 -173.696 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 66.2 t30 -104.69 -18.15 14.39 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 115.859 -0.61 . . . . 0.0 111.729 -173.853 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 33.0 m -108.86 -159.64 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 N-CA-C 112.251 0.463 . . . . 0.0 112.251 -173.898 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.494 ' HB2' ' HB3' ' A' ' 23' ' ' MET . 0.6 OUTLIER -55.06 142.43 30.48 Favored 'General case' 0 C--O 1.221 -0.431 0 CA-C-N 115.293 -0.867 . . . . 0.0 112.334 -179.569 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.665 ' HB2' ' HB ' ' A' ' 24' ' ' ILE . 73.6 mmtt -95.46 132.62 27.25 Favored Pre-proline 0 C--N 1.322 -0.592 0 CA-C-N 115.543 -0.753 . . . . 0.0 112.22 -170.49 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.472 ' HD3' ' HB2' ' A' ' 60' ' ' ASN . 13.7 Cg_exo -71.19 118.53 5.73 Favored 'Trans proline' 0 N--CA 1.457 -0.639 0 C-N-CA 122.867 2.378 . . . . 0.0 111.55 173.422 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 1.004 HD13 HD22 ' A' ' 53' ' ' LEU . 13.0 tp -123.48 124.7 43.44 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.98 -0.555 . . . . 0.0 109.923 178.091 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.561 ' HB2' ' CG2' ' A' ' 52' ' ' ILE . 87.5 mtt180 -112.58 110.63 20.91 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-O 120.851 0.358 . . . . 0.0 111.292 177.458 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.461 ' HB ' ' HB3' ' A' ' 20' ' ' GLN . 4.6 mp -88.38 104.7 14.91 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 171.525 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.586 HG23 HG22 ' A' ' 19' ' ' VAL . 11.3 mt -104.65 124.85 59.49 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.703 -174.99 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . 0.434 ' O ' ' HB2' ' A' ' 16' ' ' ASN . . . 173.95 -129.82 1.71 Allowed Glycine 0 N--CA 1.447 -0.592 0 C-N-CA 121.005 -0.617 . . . . 0.0 112.208 179.582 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . 0.492 ' OD1' ' HD2' ' A' ' 73' ' ' PRO . 3.1 t70 -107.58 145.72 31.87 Favored Pre-proline 0 C--N 1.324 -0.523 0 CA-C-O 118.655 -0.688 . . . . 0.0 109.895 -179.793 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . 0.492 ' HD2' ' OD1' ' A' ' 72' ' ' ASP . 94.3 Cg_exo -41.02 -40.42 3.81 Favored 'Trans proline' 0 CA--C 1.535 0.571 0 C-N-CA 122.999 2.466 . . . . 0.0 113.335 -179.398 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 85.9 t80 -70.82 -56.71 5.71 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.295 -176.262 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.459 ' HG2' ' HB3' ' A' ' 72' ' ' ASP . 27.6 pttt -71.22 -27.48 63.51 Favored 'General case' 0 CA--C 1.514 -0.432 0 C-N-CA 120.575 -0.45 . . . . 0.0 111.383 -179.523 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.576 ' CG1' ' HB2' ' A' ' 20' ' ' GLN . 24.2 t -66.71 -36.17 76.59 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-O 121.4 0.619 . . . . 0.0 109.441 177.068 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . 0.463 ' O ' ' HG2' ' A' ' 81' ' ' GLU . 20.1 tp60 -72.7 -47.98 42.68 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.292 176.749 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 25.0 mt-30 -57.8 -37.65 74.13 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-O 121.112 0.482 . . . . 0.0 110.6 177.534 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . 0.592 ' HB1' ' HE2' ' A' ' 51' ' ' MET . . . -71.99 -36.93 69.9 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.638 -0.71 . . . . 0.0 111.188 179.899 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' CYS . . . . . 0.44 ' HA ' HG22 ' A' ' 83' ' ' VAL . 51.7 t -68.37 -48.29 65.17 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.965 179.548 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . 0.463 ' HG2' ' O ' ' A' ' 77' ' ' GLN . 11.2 pt-20 -65.95 -19.48 65.88 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.11 0.481 . . . . 0.0 110.067 178.778 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' MET . . . . . 0.515 ' O ' HG13 ' A' ' 86' ' ' ILE . 51.1 ttp -79.18 -50.05 11.59 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.67 -0.695 . . . . 0.0 110.637 177.05 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.44 HG22 ' HA ' ' A' ' 80' ' ' CYS . 27.2 m -69.08 -35.16 67.27 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.248 0 C-N-CA 121.114 -0.234 . . . . 0.0 111.112 179.918 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 16.8 mmt -60.93 -37.23 81.59 Favored 'General case' 0 CA--C 1.517 -0.298 0 CA-C-O 121.076 0.465 . . . . 0.0 109.977 174.539 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -65.2 -43.77 90.55 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.482 -0.781 . . . . 0.0 110.95 178.694 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.515 HG13 ' O ' ' A' ' 82' ' ' MET . 51.5 mt -60.54 -37.52 75.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 121.466 0.651 . . . . 0.0 110.882 -179.395 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.709 HD11 HD12 ' A' ' 24' ' ' ILE . 71.5 mt -82.88 -12.83 57.08 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.762 -0.654 . . . . 0.0 111.21 -176.858 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 45.0 ttp180 -103.39 -18.34 14.87 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.467 0.651 . . . . 0.0 111.062 -176.982 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 . . . . . 0 C--O 1.249 1.051 0 CA-C-O 118.191 -0.909 . . . . 0.0 110.095 -178.31 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.488 0 N-CA-C 112.708 -0.157 . . . . 0.0 112.708 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 93.8 mt-30 -90.23 90.48 8.1 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 109.369 -0.604 . . . . 0.0 109.369 177.23 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 86.7 m-85 -64.71 -70.56 0.22 Allowed 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.418 -0.81 . . . . 0.0 111.518 -175.968 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . 0.543 ' HD2' ' HB3' ' A' ' 12' ' ' ASN . 7.9 t-160 52.02 41.14 29.6 Favored 'General case' 0 N--CA 1.464 0.265 0 N-CA-C 108.195 -1.039 . . . . 0.0 108.195 -171.313 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -67.29 142.3 56.91 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 114.05 -1.432 . . . . 0.0 112.03 -169.938 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . 0.839 ' H ' ' HA2' ' A' ' 71' ' ' GLY . 18.8 m-80 60.5 -84.91 0.02 OUTLIER 'General case' 0 N--CA 1.461 0.121 0 CA-C-N 115.155 -0.929 . . . . 0.0 110.902 -174.403 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.481 ' HA ' ' HA ' ' A' ' 16' ' ' ASN . . . -134.46 -51.32 0.81 Allowed 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 109.959 -0.386 . . . . 0.0 109.959 178.566 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . 0.543 ' HB3' ' HD2' ' A' ' 8' ' ' HIS . 3.1 t-20 51.61 57.18 6.84 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-O 121.308 0.575 . . . . 0.0 110.857 178.477 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 133.92 -53.81 0.78 Allowed Glycine 0 N--CA 1.446 -0.685 0 CA-C-N 115.684 -0.689 . . . . 0.0 111.996 -179.859 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 174.6 -66.02 0.1 Allowed Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.976 -0.631 . . . . 0.0 111.823 178.963 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 16.8 mm100 -75.45 144.18 42.25 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 109.677 -0.49 . . . . 0.0 109.677 177.031 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . 0.481 ' HA ' ' HA ' ' A' ' 11' ' ' ALA . 17.9 m120 -77.49 156.44 31.02 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.47 -170.772 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -80.12 -115.86 0.3 Allowed Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 121.043 -0.598 . . . . 0.0 112.372 179.29 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.439 ' OG1' ' HG3' ' A' ' 73' ' ' PRO . 92.8 m -85.86 127.72 34.65 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 110.21 -0.293 . . . . 0.0 110.21 -179.795 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.542 ' HA ' ' O ' ' A' ' 69' ' ' ILE . 3.8 p -138.22 120.91 19.12 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-O 121.259 0.552 . . . . 0.0 110.808 179.909 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 53.2 mt-30 -102.54 136.11 42.96 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.793 -0.64 . . . . 0.0 109.98 176.646 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.568 ' HA ' ' O ' ' A' ' 67' ' ' LEU . 33.4 mt-10 -112.3 114.75 27.67 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.498 179.232 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 11.5 mm -106.56 156.93 7.01 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-N 115.486 -0.779 . . . . 0.0 110.038 -176.599 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 3.6 mmt -108.9 97.26 6.93 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 174.793 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.674 ' HB ' ' HB2' ' A' ' 65' ' ' LYS . 25.6 mm -82.92 125.53 74.96 Favored Pre-proline 0 C--N 1.316 -0.888 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.814 -175.819 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.664 ' HB2' ' HB2' ' A' ' 28' ' ' LYS . 74.0 Cg_exo -50.51 132.8 36.35 Favored 'Trans proline' 0 C--N 1.343 0.289 0 C-N-CA 122.747 2.298 . . . . 0.0 111.416 175.94 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -58.88 -31.84 68.94 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.751 -0.659 . . . . 0.0 112.51 -172.842 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -82.47 -36.7 16.17 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.592 -0.813 . . . . 0.0 111.823 178.426 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.664 ' HB2' ' HB2' ' A' ' 25' ' ' PRO . 36.2 mttp -80.32 3.64 20.39 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.808 0.337 . . . . 0.0 111.393 179.466 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.66 -30.44 70.73 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.096 0.474 . . . . 0.0 110.141 175.742 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -66.17 -18.67 67.34 Favored Glycine 0 N--CA 1.446 -0.656 0 C-N-CA 120.861 -0.685 . . . . 0.0 112.341 177.848 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 82.2 mt -84.36 -46.72 11.44 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.53 0.205 . . . . 0.0 110.789 179.922 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.652 HG21 HG21 ' A' ' 24' ' ' ILE . 2.8 m -66.7 -34.88 72.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-O 120.884 0.373 . . . . 0.0 110.958 177.813 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.721 HD11 ' HG2' ' A' ' 55' ' ' GLN . 84.7 mt -80.21 -44.97 22.51 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-O 121.203 0.525 . . . . 0.0 110.4 178.413 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.447 ' HA3' ' H ' ' A' ' 39' ' ' THR . . . 98.96 51.05 1.4 Allowed Glycine 0 N--CA 1.448 -0.553 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.841 177.202 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 5.0 mptp? 54.25 30.98 13.3 Favored 'General case' 0 N--CA 1.464 0.254 0 C-N-CA 122.959 0.504 . . . . 0.0 112.118 175.761 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 147.4 -36.86 1.16 Allowed Glycine 0 N--CA 1.446 -0.696 0 C-N-CA 120.294 -0.955 . . . . 0.0 112.575 -178.526 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 147.49 -1.97 0.76 Allowed Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 119.516 -1.326 . . . . 0.0 114.504 177.985 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 -63.23 -47.48 82.31 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 117.677 0.739 . . . . 0.0 111.301 -179.169 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.738 ' O ' ' HG ' ' A' ' 43' ' ' LEU . 95.3 m -63.86 -51.55 64.12 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 111.7 0.259 . . . . 0.0 111.7 -177.112 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.556 ' O ' ' HG3' ' A' ' 44' ' ' GLN . 5.3 tt -58.01 -37.49 61.66 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.375 0 CA-C-O 120.989 0.423 . . . . 0.0 110.831 -178.658 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 85.8 tttt -63.38 -44.21 95.41 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.452 177.158 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 70.8 mt-30 -65.0 -40.25 94.66 Favored 'General case' 0 CA--C 1.517 -0.306 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.62 -178.744 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.738 ' HG ' ' O ' ' A' ' 39' ' ' THR . 70.5 mt -56.99 -48.33 78.67 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.588 -0.733 . . . . 0.0 111.558 -177.742 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . 0.556 ' HG3' ' O ' ' A' ' 40' ' ' ILE . 46.5 mt-30 -58.96 -51.78 68.57 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.462 -178.226 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -68.68 -40.71 79.95 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.366 -0.833 . . . . 0.0 111.889 -173.79 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 0.6 ' HD3' ' SD ' ' A' ' 82' ' ' MET . 13.0 ptm180 -71.94 -27.82 63.05 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 111.74 0.274 . . . . 0.0 111.74 -174.574 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.53 ' HB3' HG22 ' A' ' 49' ' ' VAL . . . -96.98 -22.71 16.67 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.02 0.438 . . . . 0.0 111.302 -178.882 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 79.85 28.55 50.28 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 121.027 -0.606 . . . . 0.0 111.722 -178.213 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.53 HG22 ' HB3' ' A' ' 47' ' ' ALA . 27.1 m -123.06 179.08 2.79 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-O 120.833 0.349 . . . . 0.0 110.114 -176.741 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 61.6 tttp -113.25 123.53 50.4 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 171.56 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . 0.424 ' HE2' HG13 ' A' ' 69' ' ' ILE . 54.7 mtp -122.64 116.7 24.26 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 109.727 -0.472 . . . . 0.0 109.727 179.567 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.484 ' CG2' ' HB2' ' A' ' 68' ' ' ARG . 6.7 tt -107.13 107.17 22.11 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.792 0 CA-C-O 121.462 0.649 . . . . 0.0 110.878 -179.979 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.677 HD22 HD13 ' A' ' 67' ' ' LEU . 3.5 mm? -82.6 103.58 12.22 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.382 -0.826 . . . . 0.0 109.136 172.314 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.646 HD12 ' HB2' ' A' ' 66' ' ' PRO . 65.5 mt -81.37 89.78 1.85 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-O 121.192 0.52 . . . . 0.0 109.792 178.79 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . 0.721 ' HG2' HD11 ' A' ' 33' ' ' ILE . 0.0 OUTLIER -104.65 -44.63 4.82 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.654 179.82 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -77.42 -21.8 52.49 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.401 178.987 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . 0.418 ' O ' HG23 ' A' ' 61' ' ' THR . . . -62.83 135.1 43.89 Favored Glycine 0 N--CA 1.445 -0.722 0 C-N-CA 120.656 -0.783 . . . . 0.0 111.422 175.898 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . 0.477 ' O ' ' HB2' ' A' ' 59' ' ' GLN . 15.6 m -72.74 -167.52 0.37 Allowed 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 120.567 0.222 . . . . 0.0 111.396 -175.764 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . 0.477 ' HB2' ' O ' ' A' ' 58' ' ' SER . 15.9 mm100 74.87 -60.74 0.51 Allowed 'General case' 0 N--CA 1.464 0.234 0 C-N-CA 123.31 0.644 . . . . 0.0 109.841 -173.5 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.687 ' HA ' HG22 ' A' ' 63' ' ' VAL . 2.6 m-20 -110.04 25.91 11.26 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 121.258 0.552 . . . . 0.0 110.802 179.255 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . 0.443 ' OG1' ' HA ' ' A' ' 58' ' ' SER . 0.0 OUTLIER -63.67 -30.75 71.81 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.826 176.13 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 10.0 p30 -105.11 -1.44 25.55 Favored 'General case' 0 CA--C 1.534 0.351 0 N-CA-C 112.187 0.44 . . . . 0.0 112.187 -178.047 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.687 HG22 ' HA ' ' A' ' 60' ' ' ASN . 18.9 m -127.87 -157.58 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.352 0 CA-C-O 120.646 0.26 . . . . 0.0 111.585 -177.861 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.618 ' O ' ' HB3' ' A' ' 60' ' ' ASN . 5.6 m-20 -56.13 147.81 19.5 Favored 'General case' 0 C--O 1.225 -0.195 0 CA-C-N 115.591 -0.732 . . . . 0.0 110.807 178.17 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.674 ' HB2' ' HB ' ' A' ' 24' ' ' ILE . 69.5 mmtt -96.26 127.15 41.4 Favored Pre-proline 0 C--N 1.317 -0.814 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.409 -170.705 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.646 ' HB2' HD12 ' A' ' 54' ' ' ILE . 20.2 Cg_exo -68.03 109.23 1.89 Allowed 'Trans proline' 0 N--CA 1.461 -0.388 0 C-N-CA 122.952 2.435 . . . . 0.0 111.512 174.314 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.677 HD13 HD22 ' A' ' 53' ' ' LEU . 23.0 tp -109.65 117.41 33.86 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.339 178.38 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.507 ' HG2' ' HG2' ' A' ' 21' ' ' GLU . 92.7 mtt180 -107.09 112.92 26.06 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 120.827 0.346 . . . . 0.0 111.023 175.545 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.542 ' O ' ' HA ' ' A' ' 19' ' ' VAL . 3.9 mp -95.16 110.05 23.39 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 N-CA-C 107.951 -1.129 . . . . 0.0 107.951 172.201 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 28.4 mt -112.32 132.06 62.06 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 116.683 -0.235 . . . . 0.0 111.508 -171.134 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . 0.839 ' HA2' ' H ' ' A' ' 10' ' ' ASN . . . 150.19 -134.92 5.01 Favored Glycine 0 N--CA 1.445 -0.742 0 C-N-CA 120.686 -0.769 . . . . 0.0 113.657 174.021 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . 0.581 ' OD2' ' HB3' ' A' ' 74' ' ' TYR . 0.5 OUTLIER -80.07 139.19 52.96 Favored Pre-proline 0 C--N 1.323 -0.565 0 C-N-CA 123.46 0.704 . . . . 0.0 111.565 -177.283 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . 0.466 ' HD3' ' HA ' ' A' ' 72' ' ' ASP . 33.3 Cg_exo -58.55 -18.54 40.22 Favored 'Trans proline' 0 C--N 1.35 0.625 0 C-N-CA 123.583 2.856 . . . . 0.0 113.818 -175.748 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . 0.581 ' HB3' ' OD2' ' A' ' 72' ' ' ASP . 37.8 t80 -86.36 -56.65 3.34 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 120.478 0.18 . . . . 0.0 110.532 -179.406 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.579 ' CE ' ' HB3' ' A' ' 72' ' ' ASP . 26.1 pttt -70.31 -32.58 70.4 Favored 'General case' 0 CA--C 1.519 -0.232 0 N-CA-C 112.075 0.398 . . . . 0.0 112.075 -179.705 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 43.2 t -63.15 -36.24 75.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-O 121.008 0.432 . . . . 0.0 110.192 176.986 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . 0.419 ' NE2' ' HG3' ' A' ' 81' ' ' GLU . 0.4 OUTLIER -73.07 -44.29 60.77 Favored 'General case' 0 N--CA 1.445 -0.686 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 -178.255 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 48.3 mt-30 -62.46 -45.28 93.78 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.925 0.393 . . . . 0.0 110.531 177.045 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -63.4 -35.62 81.01 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.81 -179.193 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 43.5 t -66.2 -45.67 79.99 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.459 176.117 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . 0.419 ' HG3' ' NE2' ' A' ' 77' ' ' GLN . 38.0 mt-10 -59.48 -42.44 92.08 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.29 0.567 . . . . 0.0 110.051 175.864 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' MET . . . . . 0.6 ' SD ' ' HD3' ' A' ' 46' ' ' ARG . 42.0 ttp -56.72 -49.93 73.7 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 114.772 -1.104 . . . . 0.0 111.574 -179.456 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.408 HG11 ' CE ' ' A' ' 51' ' ' MET . 34.7 m -79.57 -33.41 15.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 C-N-CA 120.871 -0.332 . . . . 0.0 111.131 -176.694 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 57.4 ttp -63.37 -38.57 91.68 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 109.533 -0.543 . . . . 0.0 109.533 175.85 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -61.82 -38.45 88.19 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.328 178.53 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.525 HG13 ' O ' ' A' ' 82' ' ' MET . 45.4 mt -64.13 -31.09 51.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-O 121.376 0.608 . . . . 0.0 110.479 179.657 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.63 HD11 HD12 ' A' ' 24' ' ' ILE . 45.3 mt -88.0 -18.55 28.77 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.542 -179.779 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 33.7 ttt85 -96.69 -4.46 40.8 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.681 0.753 . . . . 0.0 110.629 -176.665 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 20.0 tp10 . . . . . 0 C--N 1.311 -1.083 0 CA-C-O 118.195 -0.907 . . . . 0.0 110.42 -178.728 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.445 -0.756 0 N-CA-C 111.913 -0.475 . . . . 0.0 111.913 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 50.1 mt-30 -51.66 -58.54 6.06 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.202 0.525 . . . . 0.0 110.88 177.79 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . 0.405 ' HD2' ' H ' ' A' ' 9' ' ' ASP . 50.9 p90 -163.78 -176.26 4.52 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.323 -0.853 . . . . 0.0 109.85 -178.555 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 14.2 t60 -162.53 52.62 0.2 Allowed 'General case' 0 C--N 1.317 -0.829 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 174.744 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . 0.405 ' H ' ' HD2' ' A' ' 7' ' ' PHE . 1.7 t70 -45.49 -64.36 0.74 Allowed 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 114.798 -1.092 . . . . 0.0 110.647 179.445 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . 0.404 HD22 ' HA ' ' A' ' 10' ' ' ASN . 9.1 m120 -121.31 -34.86 3.39 Favored 'General case' 0 C--N 1.318 -0.798 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 167.813 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -153.38 -176.74 5.94 Favored 'General case' 0 N--CA 1.451 -0.42 0 CA-C-N 115.084 -0.962 . . . . 0.0 110.607 177.977 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 56.3 t-20 -168.72 75.64 0.11 Allowed 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 107.921 -1.14 . . . . 0.0 107.921 176.579 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 61.11 -103.62 0.56 Allowed Glycine 0 N--CA 1.448 -0.544 0 N-CA-C 111.342 -0.703 . . . . 0.0 111.342 -174.242 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -140.09 30.28 2.36 Favored Glycine 0 N--CA 1.447 -0.6 0 N-CA-C 110.942 -0.863 . . . . 0.0 110.942 175.657 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 8.3 tt0 -119.89 142.1 48.99 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.061 0.458 . . . . 0.0 110.38 -175.615 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 31.1 p30 -80.16 -174.47 4.53 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.813 -0.631 . . . . 0.0 110.653 179.555 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -150.88 -112.18 0.55 Allowed Glycine 0 N--CA 1.447 -0.596 0 C-N-CA 120.819 -0.705 . . . . 0.0 111.873 -179.081 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 97.8 m -94.89 127.63 41.06 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 121.054 0.454 . . . . 0.0 110.872 -179.46 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.506 ' HA ' ' O ' ' A' ' 69' ' ' ILE . 3.2 p -137.64 125.85 32.11 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-N 115.559 -0.746 . . . . 0.0 110.09 177.512 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 28.0 mt-30 -109.6 123.64 49.78 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.174 178.509 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.71 ' HG2' ' HG2' ' A' ' 68' ' ' ARG . 45.6 mt-10 -99.7 120.45 39.73 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.714 179.848 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 5.6 mm -106.79 152.1 8.46 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-N 115.54 -0.755 . . . . 0.0 110.307 -176.915 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 14.1 mmt -103.5 91.8 4.2 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 170.929 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.766 HG21 HG21 ' A' ' 32' ' ' VAL . 41.6 mm -79.89 134.71 56.33 Favored Pre-proline 0 C--N 1.319 -0.729 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.649 -175.265 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.429 ' HD2' HD13 ' A' ' 87' ' ' LEU . 83.4 Cg_exo -48.26 127.34 15.24 Favored 'Trans proline' 0 C--N 1.347 0.493 0 C-N-CA 123.068 2.512 . . . . 0.0 111.987 172.6 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.421 ' HB2' ' O ' ' A' ' 63' ' ' VAL . . . -60.35 -34.67 74.18 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.273 -177.032 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -72.36 -32.93 61.9 Favored Glycine 0 N--CA 1.448 -0.542 0 CA-C-N 115.819 -0.628 . . . . 0.0 112.951 -177.452 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 43.6 mtpt -104.18 14.3 30.68 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 122.639 -0.33 . . . . 0.0 111.084 -177.844 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -65.56 -28.9 69.49 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.022 179.04 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -65.46 -30.0 76.52 Favored Glycine 0 N--CA 1.445 -0.714 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.137 179.067 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 91.7 mt -71.34 -39.51 71.29 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.771 0.32 . . . . 0.0 111.125 -178.061 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.766 HG21 HG21 ' A' ' 24' ' ' ILE . 0.0 OUTLIER -71.32 -28.87 33.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.876 -178.315 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 62.0 mt -81.24 -34.21 13.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-O 121.583 0.706 . . . . 0.0 109.756 176.039 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.546 ' HA3' ' HB ' ' A' ' 39' ' ' THR . . . 101.89 26.81 7.34 Favored Glycine 0 CA--C 1.5 -0.849 0 CA-C-N 115.099 -0.955 . . . . 0.0 112.398 178.078 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 33.7 mmtp 73.1 -56.81 0.65 Allowed 'General case' 0 C--N 1.325 -0.498 0 C-N-CA 123.705 0.802 . . . . 0.0 111.659 179.43 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -101.26 -39.22 3.1 Favored Glycine 0 N--CA 1.448 -0.524 0 C-N-CA 120.678 -0.772 . . . . 0.0 111.718 -178.745 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 129.0 7.35 4.13 Favored Glycine 0 N--CA 1.448 -0.562 0 C-N-CA 120.996 -0.621 . . . . 0.0 112.533 178.914 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.449 ' O ' ' HG3' ' A' ' 42' ' ' GLN . 1.3 pm0 -78.2 -35.99 47.88 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 110.057 -0.349 . . . . 0.0 110.057 177.238 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.66 ' O ' ' HG ' ' A' ' 43' ' ' LEU . 40.5 m -62.72 -50.95 69.07 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.173 -179.594 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.681 HD12 ' HB2' ' A' ' 53' ' ' LEU . 4.3 tt -56.41 -36.17 46.23 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.376 0 CA-C-O 120.788 0.327 . . . . 0.0 111.23 -179.282 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.04 -36.78 80.46 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.197 0.522 . . . . 0.0 109.836 179.472 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.686 ' O ' ' HG2' ' A' ' 46' ' ' ARG . 79.1 mt-30 -72.4 -42.69 64.89 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.866 179.891 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.66 ' HG ' ' O ' ' A' ' 39' ' ' THR . 88.8 mt -52.56 -42.71 64.68 Favored 'General case' 0 C--O 1.235 0.313 0 O-C-N 123.835 0.71 . . . . 0.0 111.741 -176.865 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . 0.445 ' HG3' ' O ' ' A' ' 40' ' ' ILE . 62.4 mt-30 -54.08 -47.82 71.32 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.608 -0.724 . . . . 0.0 110.397 178.951 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 9.6 mm-40 -66.87 -39.13 87.43 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.529 -0.76 . . . . 0.0 110.735 -178.984 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 0.686 ' HG2' ' O ' ' A' ' 42' ' ' GLN . 8.9 mmm180 -56.99 -45.46 82.94 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.801 -171.436 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.566 ' HB3' HG22 ' A' ' 49' ' ' VAL . . . -95.26 -20.36 19.26 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.138 -175.912 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 82.25 47.57 6.04 Favored Glycine 0 N--CA 1.444 -0.796 0 C-N-CA 120.23 -0.986 . . . . 0.0 111.565 -173.996 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.602 HG13 ' HB2' ' A' ' 75' ' ' LYS . 2.9 m -145.54 171.19 5.35 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.456 0 CA-C-O 121.138 0.494 . . . . 0.0 110.653 -177.828 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 6.7 tmtm? -100.41 121.58 41.76 Favored 'General case' 0 C--N 1.318 -0.787 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 176.407 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 57.0 mtt -115.12 126.01 54.14 Favored 'General case' 0 CA--C 1.509 -0.629 0 N-CA-C 109.941 -0.392 . . . . 0.0 109.941 179.34 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.615 ' CG2' ' HB2' ' A' ' 68' ' ' ARG . 9.8 tt -118.2 104.05 15.61 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.939 0 CA-C-O 121.614 0.721 . . . . 0.0 110.275 173.223 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.681 ' HB2' HD12 ' A' ' 40' ' ' ILE . 4.3 mm? -78.73 101.74 7.71 Favored 'General case' 0 N--CA 1.446 -0.639 0 N-CA-C 107.947 -1.131 . . . . 0.0 107.947 170.381 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.608 HD12 ' HB2' ' A' ' 66' ' ' PRO . 15.8 mt -75.98 92.28 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.764 0 CA-C-O 121.5 0.667 . . . . 0.0 109.52 -175.543 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 1.1 pp0? -126.4 -32.39 2.68 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.345 -0.843 . . . . 0.0 109.885 179.407 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 14.9 p-10 -84.35 -26.63 28.29 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.276 -0.874 . . . . 0.0 109.557 175.795 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -87.33 -7.91 75.57 Favored Glycine 0 N--CA 1.448 -0.507 0 CA-C-N 115.628 -0.715 . . . . 0.0 112.232 177.656 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . 0.451 ' OG ' HG22 ' A' ' 54' ' ' ILE . 50.4 m -111.84 149.26 32.05 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.418 0.628 . . . . 0.0 112.027 -175.628 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 28.7 mt-30 -112.17 3.12 17.03 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 107.169 -1.419 . . . . 0.0 107.169 163.03 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 7.7 m120 -89.67 15.27 9.86 Favored 'General case' 0 CA--C 1.515 -0.388 0 CA-C-N 113.905 -1.498 . . . . 0.0 108.809 176.422 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . 0.436 ' HA ' ' CD ' ' A' ' 65' ' ' LYS . 0.2 OUTLIER -67.81 -17.49 64.53 Favored 'General case' 0 C--N 1.314 -0.938 0 CA-C-N 115.328 -0.851 . . . . 0.0 110.904 -177.678 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 16.5 m120 -84.12 -3.67 58.26 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.52 -0.764 . . . . 0.0 110.547 177.501 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.421 ' O ' ' HB2' ' A' ' 26' ' ' ALA . 22.4 m -133.65 -154.12 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 115.899 -0.591 . . . . 0.0 109.972 178.938 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -50.84 135.32 24.27 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-O 121.148 0.499 . . . . 0.0 110.918 179.629 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.553 ' HB2' ' HB ' ' A' ' 24' ' ' ILE . 8.4 mmmm -101.6 119.25 57.82 Favored Pre-proline 0 C--N 1.319 -0.758 0 N-CA-C 113.098 0.777 . . . . 0.0 113.098 -172.574 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.608 ' HB2' HD12 ' A' ' 54' ' ' ILE . 23.5 Cg_exo -67.26 125.86 14.13 Favored 'Trans proline' 0 CA--C 1.533 0.462 0 C-N-CA 123.016 2.477 . . . . 0.0 111.895 171.379 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.695 ' O ' ' HA ' ' A' ' 21' ' ' GLU . 31.6 tp -134.02 127.84 33.1 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.02 177.599 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.71 ' HG2' ' HG2' ' A' ' 21' ' ' GLU . 95.6 mtt180 -116.97 111.49 19.67 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.942 0.401 . . . . 0.0 111.151 178.594 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.506 ' O ' ' HA ' ' A' ' 19' ' ' VAL . 4.7 mp -94.54 104.75 16.13 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 171.108 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 14.6 mt -108.97 126.54 65.97 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.58 -174.193 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 165.26 -135.68 3.83 Favored Glycine 0 N--CA 1.442 -0.938 0 C-N-CA 119.962 -1.113 . . . . 0.0 113.033 176.592 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . 0.477 ' HB3' ' HG2' ' A' ' 75' ' ' LYS . 9.8 t70 -92.88 135.45 26.03 Favored Pre-proline 0 C--N 1.319 -0.729 0 CA-C-O 119.242 -0.408 . . . . 0.0 110.982 -176.564 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 75.0 Cg_exo -39.67 -42.87 3.0 Favored 'Trans proline' 0 C--O 1.237 0.427 0 C-N-CA 123.602 2.868 . . . . 0.0 113.605 -175.513 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . 0.433 ' O ' ' HG3' ' A' ' 78' ' ' GLN . 35.9 t80 -68.88 -53.51 20.81 Favored 'General case' 0 N--CA 1.453 -0.277 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.924 -175.676 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.602 ' HB2' HG13 ' A' ' 49' ' ' VAL . 0.0 OUTLIER -74.44 -24.36 59.05 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 120.268 -0.573 . . . . 0.0 111.87 -178.46 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.455 HG23 ' O ' ' A' ' 72' ' ' ASP . 75.8 t -63.15 -31.76 53.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-O 121.293 0.568 . . . . 0.0 109.69 174.136 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -76.57 -48.61 18.73 Favored 'General case' 0 N--CA 1.447 -0.582 0 N-CA-C 109.146 -0.686 . . . . 0.0 109.146 178.062 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . 0.433 ' HG3' ' O ' ' A' ' 74' ' ' TYR . 50.4 mt-30 -54.97 -43.46 73.53 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-O 121.551 0.691 . . . . 0.0 110.47 176.779 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . 0.456 ' HB3' HG21 ' A' ' 69' ' ' ILE . . . -64.68 -40.22 95.02 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.162 -0.926 . . . . 0.0 111.203 -178.63 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 42.3 t -65.65 -46.44 79.2 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.427 -179.659 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -70.6 -19.71 62.82 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 120.822 -0.351 . . . . 0.0 110.661 179.42 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' MET . . . . . 0.548 ' SD ' HD22 ' A' ' 43' ' ' LEU . 36.1 ttm -71.99 -54.63 9.33 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.831 0.348 . . . . 0.0 110.636 175.484 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.485 HG12 HD13 ' A' ' 43' ' ' LEU . 34.8 m -74.92 -29.93 23.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.803 -175.537 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 1.6 tmt? -70.09 -31.7 69.4 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.924 -0.58 . . . . 0.0 109.643 177.664 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . 0.482 ' O ' ' HB2' ' A' ' 89' ' ' GLU . 32.9 t70 -60.4 -36.88 79.15 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.392 177.661 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 22.5 mt -68.93 -23.17 27.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-O 121.401 0.619 . . . . 0.0 110.601 179.772 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.746 HD11 HD12 ' A' ' 24' ' ' ILE . 70.1 mt -89.4 -30.3 18.45 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.979 -176.918 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 40.7 ptt180 -86.1 -3.61 58.99 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.614 0.721 . . . . 0.0 109.185 174.805 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . 0.482 ' HB2' ' O ' ' A' ' 85' ' ' ASP . 9.5 tp10 . . . . . 0 C--O 1.252 1.2 0 CA-C-N 114.392 -1.277 . . . . 0.0 109.653 -178.724 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.445 -0.73 0 N-CA-C 112.261 -0.336 . . . . 0.0 112.261 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . 0.516 ' O ' ' HG2' ' A' ' 73' ' ' PRO . 5.8 mm-40 -67.04 -56.85 8.34 Favored 'General case' 0 CA--C 1.514 -0.423 0 N-CA-C 108.084 -1.08 . . . . 0.0 108.084 177.606 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . 0.668 ' HB3' ' HD2' ' A' ' 73' ' ' PRO . 0.7 OUTLIER -148.62 154.32 39.55 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.034 -0.985 . . . . 0.0 110.024 172.775 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . 0.716 ' HB3' ' HA ' ' A' ' 12' ' ' ASN . 6.7 t-80 -175.83 16.82 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.465 0 O-C-N 123.437 0.46 . . . . 0.0 110.403 -179.741 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 37.8 t70 64.37 -96.16 0.05 OUTLIER 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 115.695 -0.684 . . . . 0.0 112.457 175.145 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 3.7 t-20 -75.03 -50.68 15.72 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.025 0.441 . . . . 0.0 110.616 -174.44 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -104.4 55.29 0.72 Allowed 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 116.099 -0.501 . . . . 0.0 109.988 176.864 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . 0.716 ' HA ' ' HB3' ' A' ' 8' ' ' HIS . 16.4 p-10 -69.25 -42.66 75.32 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.722 178.934 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 74.27 -78.36 0.97 Allowed Glycine 0 CA--C 1.519 0.298 0 CA-C-N 116.034 -0.53 . . . . 0.0 114.404 169.402 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -57.59 -77.98 0.14 Allowed Glycine 0 C--N 1.332 0.344 0 O-C-N 123.753 0.325 . . . . 0.0 112.914 -173.044 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 7.4 tt0 -88.44 107.38 18.83 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 107.858 -1.164 . . . . 0.0 107.858 173.18 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . 0.45 ' HA ' ' ND2' ' A' ' 12' ' ' ASN . 27.3 t-20 -89.72 -38.2 14.01 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.897 -167.399 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -134.44 84.18 0.28 Allowed Glycine 0 N--CA 1.443 -0.866 0 C-N-CA 120.484 -0.865 . . . . 0.0 112.53 -177.468 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.609 ' O ' ' HA ' ' A' ' 70' ' ' ILE . 37.5 m -75.6 126.79 31.71 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 175.618 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.514 ' HA ' ' O ' ' A' ' 69' ' ' ILE . 6.4 p -129.31 123.03 57.22 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-O 121.323 0.582 . . . . 0.0 111.339 -179.091 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 26.9 mt-30 -117.06 115.05 24.64 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.673 -0.694 . . . . 0.0 109.333 175.136 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.598 ' HG2' ' HG2' ' A' ' 68' ' ' ARG . 42.2 mt-10 -88.73 115.86 26.57 Favored 'General case' 0 CA--C 1.516 -0.35 0 CA-C-O 121.178 0.513 . . . . 0.0 111.372 -178.423 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.427 ' HB ' ' HB3' ' A' ' 67' ' ' LEU . 11.2 mm -98.72 152.9 4.22 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-N 115.426 -0.807 . . . . 0.0 109.686 179.482 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' MET . . . . . 0.417 ' HB3' ' HB3' ' A' ' 64' ' ' ASP . 1.8 mmt -106.39 91.27 3.63 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 174.747 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.69 ' HB ' ' HB2' ' A' ' 65' ' ' LYS . 29.7 mm -75.35 125.88 88.37 Favored Pre-proline 0 C--N 1.317 -0.805 0 CA-C-N 115.806 -0.634 . . . . 0.0 111.215 -173.869 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.582 ' HB2' ' HB2' ' A' ' 28' ' ' LYS . 85.4 Cg_exo -48.09 129.32 18.31 Favored 'Trans proline' 0 C--N 1.346 0.4 0 C-N-CA 123.165 2.577 . . . . 0.0 111.858 177.417 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -58.88 -24.34 62.12 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.838 -0.619 . . . . 0.0 112.579 -173.023 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -95.95 -1.83 61.3 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.622 -0.799 . . . . 0.0 112.804 -179.632 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.582 ' HB2' ' HB2' ' A' ' 25' ' ' PRO . 2.0 mppt? -116.05 19.71 14.84 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.019 0.438 . . . . 0.0 111.441 -179.448 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -76.15 -20.39 57.62 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.102 -178.633 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -69.11 -17.72 72.21 Favored Glycine 0 N--CA 1.449 -0.484 0 C-N-CA 120.994 -0.622 . . . . 0.0 112.697 -178.86 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 86.8 mt -93.96 -38.83 10.98 Favored 'General case' 0 C--N 1.323 -0.573 0 O-C-N 122.515 -0.403 . . . . 0.0 111.571 -177.958 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.439 HG21 HG21 ' A' ' 24' ' ' ILE . 3.5 m -69.98 -34.09 58.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.899 0.38 . . . . 0.0 111.131 179.327 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.583 HD11 ' HG2' ' A' ' 55' ' ' GLN . 64.9 mt -83.99 -44.76 18.23 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-O 121.506 0.67 . . . . 0.0 109.902 177.026 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 118.88 -178.84 16.75 Favored Glycine 0 N--CA 1.441 -1.012 0 CA-C-N 115.291 -0.868 . . . . 0.0 111.359 -178.158 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 39.0 mmtm -77.76 -29.51 51.01 Favored 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 -178.357 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -143.01 17.09 2.36 Favored Glycine 0 N--CA 1.444 -0.79 0 CA-C-N 115.18 -0.918 . . . . 0.0 111.476 176.032 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 95.73 0.79 62.19 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.991 -0.623 . . . . 0.0 112.947 178.899 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -69.08 -34.9 75.87 Favored 'General case' 0 C--N 1.328 -0.367 0 O-C-N 122.598 -0.354 . . . . 0.0 110.841 -178.956 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.721 ' O ' ' HG ' ' A' ' 43' ' ' LEU . 61.8 m -62.71 -55.47 26.43 Favored 'General case' 0 N--CA 1.452 -0.374 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.913 -177.639 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.48 ' HA ' HD12 ' A' ' 43' ' ' LEU . 7.5 tt -60.02 -34.21 55.73 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.383 0 CA-C-O 120.782 0.325 . . . . 0.0 111.628 -176.665 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 3.9 tmmm? -70.79 -39.4 73.18 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 179.394 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.462 ' O ' ' HG2' ' A' ' 46' ' ' ARG . 20.4 mm-40 -71.75 -37.79 70.5 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.991 -0.549 . . . . 0.0 111.187 -179.225 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.721 ' HG ' ' O ' ' A' ' 39' ' ' THR . 88.8 mt -53.44 -44.88 69.2 Favored 'General case' 0 CA--C 1.519 -0.238 0 CA-C-O 121.204 0.526 . . . . 0.0 110.992 179.428 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 47.1 mt-30 -68.14 -34.27 76.02 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.644 -0.707 . . . . 0.0 111.367 -177.435 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 32.2 mt-10 -80.48 -25.52 38.78 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 111.557 0.206 . . . . 0.0 111.557 -178.458 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 0.462 ' HG2' ' O ' ' A' ' 42' ' ' GLN . 12.8 ptm180 -89.32 -30.2 18.6 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.688 0.28 . . . . 0.0 111.69 -178.705 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -88.63 -30.75 18.97 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 120.975 0.417 . . . . 0.0 110.905 178.528 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 91.79 -3.26 77.71 Favored Glycine 0 CA--C 1.519 0.339 0 C-N-CA 120.641 -0.79 . . . . 0.0 112.662 -179.219 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.441 ' CG1' ' HG3' ' A' ' 75' ' ' LYS . 16.1 m -103.54 179.22 0.71 Allowed 'Isoleucine or valine' 0 CA--C 1.516 -0.36 0 CA-C-O 121.063 0.459 . . . . 0.0 110.907 179.123 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.673 ' HE3' ' HB ' ' A' ' 52' ' ' ILE . 8.7 tmtm? -109.89 125.05 52.4 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 115.666 -0.697 . . . . 0.0 109.171 177.158 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . 0.484 ' HE3' HG13 ' A' ' 69' ' ' ILE . 54.7 mtp -119.2 125.36 48.98 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 109.449 -0.574 . . . . 0.0 109.449 179.31 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.673 ' HB ' ' HE3' ' A' ' 50' ' ' LYS . 9.0 tt -115.67 107.69 23.33 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.805 0 CA-C-O 121.523 0.677 . . . . 0.0 110.832 177.823 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.602 HD22 HD13 ' A' ' 67' ' ' LEU . 3.4 mm? -80.95 102.78 10.35 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.206 -0.906 . . . . 0.0 108.574 170.192 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.626 HD12 ' HB2' ' A' ' 66' ' ' PRO . 59.0 mt -78.23 85.68 1.02 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.467 0 CA-C-O 121.868 0.842 . . . . 0.0 110.423 -177.301 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . 0.583 ' HG2' HD11 ' A' ' 33' ' ' ILE . 1.7 pp0? -120.17 -12.93 9.0 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 114.573 -1.194 . . . . 0.0 109.579 175.062 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -82.02 -36.45 27.77 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.131 -0.94 . . . . 0.0 108.955 174.036 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -77.09 113.11 3.68 Favored Glycine 0 N--CA 1.446 -0.658 0 N-CA-C 110.769 -0.932 . . . . 0.0 110.769 173.828 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 28.5 p -86.49 70.81 10.48 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 121.055 0.455 . . . . 0.0 112.03 -173.902 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . 0.447 HE21 ' HB2' ' A' ' 59' ' ' GLN . 1.4 mp0 -121.26 -45.45 2.34 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.946 0.403 . . . . 0.0 110.226 174.408 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.479 ' HB2' ' HD3' ' A' ' 66' ' ' PRO . 9.1 m120 -117.64 28.42 8.45 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 121.242 0.544 . . . . 0.0 109.724 177.838 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 5.2 p -75.43 -25.35 57.44 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.114 -0.494 . . . . 0.0 112.108 -176.212 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 66.8 t30 -89.59 -0.97 57.87 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.357 0.599 . . . . 0.0 110.314 179.758 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 15.5 m -132.1 -153.11 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.131 -178.858 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.417 ' HB3' ' HB3' ' A' ' 23' ' ' MET . 6.6 m-20 -63.37 143.17 58.04 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 109.879 -0.415 . . . . 0.0 109.879 176.616 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.69 ' HB2' ' HB ' ' A' ' 24' ' ' ILE . 27.6 mmtp -91.83 129.19 43.07 Favored Pre-proline 0 C--N 1.324 -0.538 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.44 -169.833 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.626 ' HB2' HD12 ' A' ' 54' ' ' ILE . 23.4 Cg_exo -66.98 111.76 2.3 Favored 'Trans proline' 0 N--CA 1.463 -0.286 0 C-N-CA 123.292 2.661 . . . . 0.0 111.816 176.165 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.602 HD13 HD22 ' A' ' 53' ' ' LEU . 23.0 tp -114.52 114.57 25.95 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.389 178.169 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.636 ' HB2' ' CG2' ' A' ' 52' ' ' ILE . 99.6 mtt180 -104.34 110.52 22.79 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.657 176.682 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.514 ' O ' ' HA ' ' A' ' 19' ' ' VAL . 4.2 mp -93.92 108.33 20.45 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 N-CA-C 107.857 -1.164 . . . . 0.0 107.857 170.608 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.609 ' HA ' ' O ' ' A' ' 18' ' ' THR . 22.8 mt -116.69 133.89 61.92 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.606 -171.199 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 150.68 -108.65 0.39 Allowed Glycine 0 N--CA 1.448 -0.559 0 C-N-CA 120.811 -0.709 . . . . 0.0 113.112 172.579 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . 0.488 ' O ' HG23 ' A' ' 76' ' ' VAL . 14.1 t70 -103.79 132.08 21.38 Favored Pre-proline 0 C--N 1.318 -0.786 0 C-N-CA 123.19 0.596 . . . . 0.0 110.045 -174.916 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . 0.668 ' HD2' ' HB3' ' A' ' 7' ' ' PHE . 44.7 Cg_exo -54.82 -25.93 45.46 Favored 'Trans proline' 0 C--N 1.347 0.479 0 C-N-CA 123.541 2.827 . . . . 0.0 113.431 -173.498 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 53.5 t80 -76.19 -53.47 8.22 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.464 -177.228 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.509 ' HA ' ' HB2' ' A' ' 78' ' ' GLN . 5.8 ptpt -83.37 -17.57 41.84 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.866 -0.606 . . . . 0.0 111.992 -177.591 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.488 HG23 ' O ' ' A' ' 72' ' ' ASP . 45.2 t -63.15 -38.02 80.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 N-CA-C 109.552 -0.536 . . . . 0.0 109.552 170.863 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 1.4 mm100 -77.66 -41.13 39.29 Favored 'General case' 0 N--CA 1.451 -0.397 0 C-N-CA 120.807 -0.357 . . . . 0.0 110.608 177.373 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . 0.509 ' HB2' ' HA ' ' A' ' 75' ' ' LYS . 96.4 mt-30 -55.73 -47.12 77.44 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.831 0.348 . . . . 0.0 110.532 175.046 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . 0.446 ' HA ' ' HE2' ' A' ' 82' ' ' MET . . . -66.57 -38.87 88.0 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.122 179.629 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 49.9 t -62.33 -52.14 64.82 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.406 177.89 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -63.75 -30.99 72.02 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.338 178.356 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' MET . . . . . 0.464 ' O ' HG13 ' A' ' 86' ' ' ILE . 40.1 ttp -65.08 -52.17 57.13 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.602 -0.726 . . . . 0.0 111.198 178.482 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 30.7 m -76.18 -35.54 28.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 N-CA-C 111.74 0.274 . . . . 0.0 111.74 -177.06 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 93.9 mmm -67.85 -28.63 67.71 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.871 0.367 . . . . 0.0 110.012 177.113 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -64.87 -38.43 90.95 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.682 176.674 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.464 HG13 ' O ' ' A' ' 82' ' ' MET . 35.3 mt -64.0 -26.69 41.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.339 179.007 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.58 HD22 ' HB3' ' A' ' 28' ' ' LYS . 22.4 mt -97.64 -10.48 24.99 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.771 -177.859 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 28.0 tpt180 -99.37 -25.38 14.49 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.435 0.636 . . . . 0.0 111.09 -175.721 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 . . . . . 0 C--N 1.305 -1.327 0 CA-C-N 115.359 -0.837 . . . . 0.0 109.867 -178.048 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.444 -0.802 0 N-CA-C 111.948 -0.461 . . . . 0.0 111.948 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 81.1 mm-40 -96.57 -9.87 28.47 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 174.285 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . 0.404 ' HA ' ' CB ' ' A' ' 72' ' ' ASP . 5.0 p90 -175.99 176.49 1.77 Allowed 'General case' 0 N--CA 1.455 -0.22 0 CA-C-N 114.407 -1.269 . . . . 0.0 110.23 -179.535 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 12.0 t-80 -130.63 156.71 44.42 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.185 -0.461 . . . . 0.0 109.811 179.025 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . 0.618 ' HB2' ' HB2' ' A' ' 12' ' ' ASN . 4.5 m-20 64.42 33.94 10.77 Favored 'General case' 0 N--CA 1.466 0.357 0 O-C-N 123.577 0.548 . . . . 0.0 111.578 175.805 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 20.2 m120 68.87 -62.18 0.4 Allowed 'General case' 0 N--CA 1.469 0.481 0 O-C-N 123.758 0.661 . . . . 0.0 111.752 179.217 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -148.98 81.04 1.43 Allowed 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 109.759 -0.46 . . . . 0.0 109.759 179.115 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . 0.673 ' ND2' ' HA ' ' A' ' 16' ' ' ASN . 58.1 t30 -115.15 124.19 50.85 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.547 -178.023 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -97.61 135.75 12.37 Favored Glycine 0 N--CA 1.446 -0.634 0 C-N-CA 120.951 -0.642 . . . . 0.0 112.28 -178.523 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 83.54 -122.55 5.83 Favored Glycine 0 N--CA 1.446 -0.685 0 C-N-CA 120.637 -0.792 . . . . 0.0 112.085 -179.281 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . 0.517 ' HG3' ' CG2' ' A' ' 70' ' ' ILE . 49.8 tt0 -68.92 107.58 3.15 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 120.73 0.3 . . . . 0.0 111.091 -178.783 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . 0.673 ' HA ' ' ND2' ' A' ' 12' ' ' ASN . 0.9 OUTLIER -97.63 -59.37 1.79 Allowed 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.104 176.864 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 176.32 -41.78 0.11 Allowed Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.17 178.144 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 91.3 m -71.04 131.63 43.92 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 120.705 0.288 . . . . 0.0 110.45 177.396 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 7.6 p -140.23 138.35 37.13 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-O 120.928 0.394 . . . . 0.0 110.891 -178.786 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 28.7 mt-30 -119.16 114.61 22.72 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 109.739 -0.467 . . . . 0.0 109.739 174.213 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.713 ' HA ' ' O ' ' A' ' 67' ' ' LEU . 39.4 mt-10 -86.43 113.85 22.72 Favored 'General case' 0 CA--C 1.515 -0.392 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.864 179.079 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.483 ' HB ' ' HB3' ' A' ' 67' ' ' LEU . 14.7 mm -97.68 147.88 6.2 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 CA-C-N 115.257 -0.883 . . . . 0.0 110.227 -177.5 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' MET . . . . . 0.527 ' HB3' ' HB3' ' A' ' 64' ' ' ASP . 3.9 mmt -99.61 91.57 4.95 Favored 'General case' 0 C--N 1.317 -0.822 0 N-CA-C 108.531 -0.915 . . . . 0.0 108.531 173.322 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.665 ' HB ' ' HB2' ' A' ' 65' ' ' LYS . 36.8 mm -82.16 130.39 60.13 Favored Pre-proline 0 C--N 1.319 -0.722 0 CA-C-N 115.772 -0.649 . . . . 0.0 111.046 -174.396 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_exo -50.89 132.07 36.29 Favored 'Trans proline' 0 N--CA 1.46 -0.445 0 C-N-CA 122.885 2.39 . . . . 0.0 111.787 175.222 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -65.46 -18.89 65.67 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.263 -176.958 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -93.55 9.69 73.65 Favored Glycine 0 N--CA 1.445 -0.709 0 C-N-CA 120.97 -0.633 . . . . 0.0 112.325 177.294 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.525 ' HB3' HD22 ' A' ' 87' ' ' LEU . 58.8 mttp -132.38 26.68 4.46 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.861 0.362 . . . . 0.0 111.409 179.947 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -74.77 -23.5 58.54 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.232 0.539 . . . . 0.0 110.239 178.922 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -71.16 -16.36 75.08 Favored Glycine 0 N--CA 1.449 -0.443 0 CA-C-N 115.543 -0.753 . . . . 0.0 112.522 179.565 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 79.5 mt -93.65 -39.92 10.54 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 122.471 -0.429 . . . . 0.0 111.183 -179.299 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.58 HG13 HD21 ' A' ' 87' ' ' LEU . 2.8 m -76.4 -33.03 22.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-O 120.951 0.405 . . . . 0.0 111.533 -179.914 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.657 ' HA ' ' HB ' ' A' ' 40' ' ' ILE . 67.5 mt -93.68 -40.14 11.42 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-O 121.527 0.679 . . . . 0.0 110.18 179.079 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 119.49 160.65 11.37 Favored Glycine 0 N--CA 1.441 -1.025 0 CA-C-N 115.527 -0.76 . . . . 0.0 111.714 -179.634 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -65.47 -23.1 66.83 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.971 0.415 . . . . 0.0 110.504 -179.446 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -134.11 8.33 4.77 Favored Glycine 0 N--CA 1.446 -0.665 0 C-N-CA 120.741 -0.742 . . . . 0.0 111.896 177.244 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.591 ' HA2' HG22 ' A' ' 33' ' ' ILE . . . 87.39 12.14 67.87 Favored Glycine 0 N--CA 1.452 -0.245 0 C-N-CA 120.942 -0.646 . . . . 0.0 112.15 -177.196 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 13.7 mt-10 -84.64 -37.64 20.81 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.101 0.476 . . . . 0.0 110.6 -178.178 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.688 ' O ' ' HG ' ' A' ' 43' ' ' LEU . 21.2 m -59.84 -47.88 83.96 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.532 -0.758 . . . . 0.0 111.752 -173.41 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.657 ' HB ' ' HA ' ' A' ' 33' ' ' ILE . 9.3 tt -57.68 -34.82 48.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 120.929 0.395 . . . . 0.0 111.334 -178.565 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.49 ' HG3' ' OE2' ' A' ' 45' ' ' GLU . 0.0 OUTLIER -70.77 -36.76 73.21 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.103 0.478 . . . . 0.0 109.972 179.189 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 25.4 mm-40 -71.07 -39.01 72.44 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.572 -178.915 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.688 ' HG ' ' O ' ' A' ' 39' ' ' THR . 54.7 mt -57.07 -47.38 81.12 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.715 179.889 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . 0.404 ' HG3' ' O ' ' A' ' 40' ' ' ILE . 45.2 mt-30 -62.27 -50.65 70.86 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.691 -179.981 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.49 ' OE2' ' HG3' ' A' ' 41' ' ' LYS . 46.1 mt-10 -63.62 -39.56 94.69 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.722 -0.672 . . . . 0.0 112.024 -176.594 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 13.9 ptm180 -77.68 -33.38 53.28 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 111.937 0.347 . . . . 0.0 111.937 -173.847 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -93.75 -12.26 29.56 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 120.985 0.422 . . . . 0.0 111.461 -177.2 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 73.13 35.51 57.29 Favored Glycine 0 N--CA 1.451 -0.323 0 N-CA-C 111.189 -0.764 . . . . 0.0 111.189 -177.482 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 29.5 m -124.45 175.6 6.74 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-O 120.964 0.411 . . . . 0.0 110.741 -173.811 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 78.3 tttt -115.65 123.7 49.04 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 169.414 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . 0.412 ' CE ' HG11 ' A' ' 83' ' ' VAL . 71.8 mtp -123.6 114.68 20.33 Favored 'General case' 0 C--N 1.317 -0.82 0 N-CA-C 109.082 -0.71 . . . . 0.0 109.082 177.721 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.611 ' CG2' ' HB2' ' A' ' 68' ' ' ARG . 10.8 tt -109.97 105.51 18.94 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.143 0 CA-C-O 121.662 0.744 . . . . 0.0 109.595 177.362 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -82.53 102.26 11.26 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.169 -0.923 . . . . 0.0 108.625 174.716 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.502 ' HB ' ' HB2' ' A' ' 66' ' ' PRO . 20.3 mt -82.28 85.71 1.75 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.767 0 CA-C-O 121.669 0.747 . . . . 0.0 109.188 -175.939 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 4.1 pp0? -110.09 -4.63 15.71 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.171 -0.922 . . . . 0.0 110.994 -175.141 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -134.09 -28.5 1.34 Allowed 'General case' 0 C--N 1.32 -0.7 0 CA-C-O 120.946 0.403 . . . . 0.0 110.585 179.311 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -90.44 29.39 6.71 Favored Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 120.588 -0.815 . . . . 0.0 112.967 -177.125 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 42.5 t -152.1 165.32 35.13 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.058 0.456 . . . . 0.0 110.012 -179.207 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 15.1 mm100 -103.28 11.95 36.15 Favored 'General case' 0 N--CA 1.444 -0.754 0 CA-C-N 115.502 -0.772 . . . . 0.0 109.032 -179.443 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.434 ' HA ' HG22 ' A' ' 63' ' ' VAL . 18.0 m120 -100.16 13.1 35.33 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 114.902 -1.045 . . . . 0.0 109.104 170.622 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . 0.488 ' HA ' ' HE3' ' A' ' 65' ' ' LYS . 9.1 t -64.42 -23.16 67.19 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.392 179.17 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 4.9 p-10 -93.5 -1.69 55.31 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.691 -0.686 . . . . 0.0 111.05 -179.161 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.463 ' HB ' ' H ' ' A' ' 64' ' ' ASP . 7.9 m -132.61 -145.53 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 N-CA-C 109.673 -0.491 . . . . 0.0 109.673 -179.661 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.527 ' HB3' ' HB3' ' A' ' 23' ' ' MET . 8.4 m-20 -59.69 137.63 57.98 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 109.722 -0.473 . . . . 0.0 109.722 175.067 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.665 ' HB2' ' HB ' ' A' ' 24' ' ' ILE . 1.2 mmmm -93.89 122.26 62.49 Favored Pre-proline 0 C--N 1.318 -0.769 0 CA-C-N 115.971 -0.558 . . . . 0.0 111.255 -170.645 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.502 ' HB2' ' HB ' ' A' ' 54' ' ' ILE . 39.3 Cg_exo -63.22 105.95 0.52 Allowed 'Trans proline' 0 N--CA 1.464 -0.21 0 C-N-CA 123.291 2.661 . . . . 0.0 112.225 177.476 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.713 ' O ' ' HA ' ' A' ' 21' ' ' GLU . 3.7 tt -101.42 135.69 42.49 Favored 'General case' 0 C--N 1.319 -0.735 0 N-CA-C 108.481 -0.933 . . . . 0.0 108.481 177.7 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.71 ' N ' HD23 ' A' ' 67' ' ' LEU . 90.9 mtt180 -124.61 107.09 10.66 Favored 'General case' 0 N--CA 1.443 -0.82 0 C-N-CA 119.255 -0.978 . . . . 0.0 112.633 170.123 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.554 ' CD1' HD22 ' A' ' 67' ' ' LEU . 3.8 mp -90.08 106.14 16.92 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.264 0 N-CA-C 107.943 -1.132 . . . . 0.0 107.943 167.72 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.517 ' CG2' ' HG3' ' A' ' 15' ' ' GLN . 7.4 mt -109.35 127.81 65.81 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.873 0 CA-C-O 120.946 0.403 . . . . 0.0 110.394 -176.141 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . 0.661 ' HA2' ' H ' ' A' ' 16' ' ' ASN . . . 173.64 -132.47 2.31 Favored Glycine 0 N--CA 1.441 -1.026 0 N-CA-C 111.044 -0.822 . . . . 0.0 111.044 179.496 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . 0.809 ' HB3' ' HE2' ' A' ' 75' ' ' LYS . 0.0 OUTLIER -103.55 153.49 38.56 Favored Pre-proline 0 C--N 1.318 -0.799 0 CA-C-O 118.992 -0.528 . . . . 0.0 109.594 176.71 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_exo -47.1 -39.21 25.76 Favored 'Trans proline' 0 C--N 1.347 0.451 0 C-N-CA 122.273 1.982 . . . . 0.0 112.268 -178.026 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . 0.419 ' HB3' ' OD1' ' A' ' 72' ' ' ASP . 22.6 t80 -67.39 -58.9 3.93 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.089 -0.96 . . . . 0.0 111.504 -177.576 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.809 ' HE2' ' HB3' ' A' ' 72' ' ' ASP . 0.0 OUTLIER -67.54 -33.86 75.92 Favored 'General case' 0 CA--C 1.514 -0.418 0 C-N-CA 120.98 -0.288 . . . . 0.0 111.185 -178.773 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.403 HG13 ' HB ' ' A' ' 69' ' ' ILE . 55.0 t -64.39 -39.72 86.55 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.377 0 N-CA-C 109.647 -0.501 . . . . 0.0 109.647 -178.418 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . 0.698 HE21 ' HG3' ' A' ' 81' ' ' GLU . 17.8 tp60 -76.88 -41.89 42.04 Favored 'General case' 0 N--CA 1.443 -0.807 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.674 -177.739 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 23.8 mt-30 -63.93 -38.56 91.54 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 120.709 -0.396 . . . . 0.0 110.558 177.768 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -69.7 -37.16 76.5 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.534 178.766 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' CYS . . . . . 0.425 ' O ' ' HB2' ' A' ' 84' ' ' MET . 50.6 t -65.52 -46.58 79.05 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.549 176.626 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . 0.698 ' HG3' HE21 ' A' ' 77' ' ' GLN . 73.0 mt-10 -62.93 -21.87 66.36 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 121.047 0.451 . . . . 0.0 110.691 177.852 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' MET . . . . . 0.425 ' O ' HG13 ' A' ' 86' ' ' ILE . 38.5 ttp -77.46 -52.33 9.29 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.25 179.68 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.461 ' O ' ' HG ' ' A' ' 87' ' ' LEU . 32.9 m -73.52 -35.34 44.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.562 -177.853 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' MET . . . . . 0.425 ' HB2' ' O ' ' A' ' 80' ' ' CYS . 2.7 mmt -66.94 -34.12 77.08 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.682 0.277 . . . . 0.0 111.2 179.293 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . 0.479 ' O ' ' HB2' ' A' ' 89' ' ' GLU . 27.9 t70 -67.67 -31.5 71.53 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 120.836 -0.345 . . . . 0.0 110.154 -179.163 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.425 HG13 ' O ' ' A' ' 82' ' ' MET . 53.0 mt -67.44 -40.4 84.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 121.185 0.517 . . . . 0.0 109.974 176.476 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.58 HD21 HG13 ' A' ' 32' ' ' VAL . 49.1 mt -70.28 -42.02 72.63 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.699 -179.326 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . 0.452 ' HD3' HH11 ' A' ' 88' ' ' ARG . 9.5 mmm180 -85.45 7.52 22.45 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.969 -0.559 . . . . 0.0 111.201 -176.936 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . 0.479 ' HB2' ' O ' ' A' ' 85' ' ' ASP . 40.1 tt0 . . . . . 0 C--O 1.25 1.082 0 CA-C-O 118.222 -0.894 . . . . 0.0 109.663 178.346 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.443 -0.871 0 N-CA-C 111.622 -0.591 . . . . 0.0 111.622 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 21.3 mp0 52.51 67.44 0.98 Allowed 'General case' 0 N--CA 1.462 0.173 0 CA-C-O 120.991 0.424 . . . . 0.0 111.222 179.161 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 18.6 p90 -80.45 55.14 2.2 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.656 -177.581 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . 0.974 ' HB3' ' HA ' ' A' ' 12' ' ' ASN . 8.7 t-160 71.25 115.76 0.05 OUTLIER 'General case' 0 N--CA 1.466 0.352 0 CA-C-O 121.977 0.894 . . . . 0.0 110.751 179.131 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -51.02 -46.9 61.73 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 114.171 -1.377 . . . . 0.0 112.972 -174.318 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 58.2 t30 -105.86 121.49 44.17 Favored 'General case' 0 C--N 1.323 -0.574 0 C-N-CA 120.89 -0.324 . . . . 0.0 110.275 178.8 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.479 ' O ' ' HB3' ' A' ' 12' ' ' ASN . . . 60.32 -95.39 0.05 Allowed 'General case' 0 C--O 1.23 0.065 0 O-C-N 124.053 0.846 . . . . 0.0 110.874 -177.606 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . 0.974 ' HA ' ' HB3' ' A' ' 8' ' ' HIS . 9.4 p30 164.86 -34.1 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.215 0 O-C-N 124.158 0.911 . . . . 0.0 109.324 175.365 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -29.29 119.05 0.07 OUTLIER Glycine 0 C--N 1.34 0.804 0 O-C-N 124.559 1.162 . . . . 0.0 115.396 -173.947 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 94.52 -132.15 11.03 Favored Glycine 0 N--CA 1.448 -0.551 0 C-N-CA 121.283 -0.484 . . . . 0.0 112.041 178.878 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 25.6 tt0 -65.6 108.25 1.98 Allowed 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 110.008 -0.367 . . . . 0.0 110.008 177.742 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . 0.694 ' HA ' ' HB2' ' A' ' 8' ' ' HIS . 13.4 m120 -79.69 -79.51 0.14 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.145 179.892 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 175.77 -56.33 0.11 Allowed Glycine 0 C--N 1.331 0.255 0 C-N-CA 119.718 -1.229 . . . . 0.0 113.839 178.416 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.549 ' OG1' ' HD3' ' A' ' 73' ' ' PRO . 90.5 m -59.85 131.58 51.31 Favored 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 122.689 0.396 . . . . 0.0 111.111 -177.888 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.489 ' HA ' ' O ' ' A' ' 69' ' ' ILE . 4.7 p -140.74 126.52 20.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-O 121.249 0.547 . . . . 0.0 111.931 -176.833 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 26.5 mt-30 -111.45 128.78 56.1 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.037 173.465 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.581 ' HG2' ' HG2' ' A' ' 68' ' ' ARG . 45.6 mt-10 -96.71 115.37 27.32 Favored 'General case' 0 C--N 1.327 -0.41 0 O-C-N 123.401 0.438 . . . . 0.0 111.263 178.866 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.414 ' HB ' ' HB3' ' A' ' 67' ' ' LEU . 14.4 mm -100.77 150.29 5.76 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 177.412 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 16.5 mmt -103.44 92.01 4.3 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 175.988 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.66 ' HB ' ' HB2' ' A' ' 65' ' ' LYS . 47.1 mm -81.5 128.2 70.56 Favored Pre-proline 0 C--N 1.318 -0.77 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.853 -175.625 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 81.6 Cg_exo -47.77 131.72 20.64 Favored 'Trans proline' 0 C--N 1.345 0.346 0 C-N-CA 123.21 2.607 . . . . 0.0 112.214 176.828 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -59.68 -26.71 65.78 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.855 -0.611 . . . . 0.0 111.342 -178.413 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -75.36 -31.03 57.68 Favored Glycine 0 N--CA 1.449 -0.484 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.371 177.499 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.963 ' HD3' ' HG ' ' A' ' 87' ' ' LEU . 94.6 mttt -98.22 19.18 14.66 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.786 0.327 . . . . 0.0 111.494 -178.192 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.606 ' O ' HG13 ' A' ' 33' ' ' ILE . . . -64.6 -34.07 77.41 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.798 179.288 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -68.64 -25.39 75.05 Favored Glycine 0 N--CA 1.448 -0.531 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.053 179.693 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 88.1 mt -74.03 -42.59 60.05 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.657 0.265 . . . . 0.0 110.634 -178.823 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.584 HG21 HG21 ' A' ' 24' ' ' ILE . 0.0 OUTLIER -72.84 -23.39 20.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.421 179.687 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.606 HG13 ' O ' ' A' ' 29' ' ' ALA . 67.2 mt -76.6 -35.19 25.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-O 121.74 0.781 . . . . 0.0 109.576 172.545 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.708 ' HA3' ' HB ' ' A' ' 39' ' ' THR . . . 98.81 32.34 5.96 Favored Glycine 0 CA--C 1.5 -0.877 0 CA-C-N 114.962 -1.017 . . . . 0.0 112.396 177.911 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 14.5 mmmm 69.7 -64.51 0.34 Allowed 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.398 0.705 . . . . 0.0 111.68 177.633 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -89.58 -30.35 13.79 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 121.072 -0.585 . . . . 0.0 112.161 -177.815 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.584 ' HA2' HG22 ' A' ' 33' ' ' ILE . . . 109.92 -2.61 30.2 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.602 -0.808 . . . . 0.0 112.428 178.878 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -85.75 -27.54 25.16 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-O 120.993 0.425 . . . . 0.0 111.054 178.148 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.708 ' HB ' ' HA3' ' A' ' 34' ' ' GLY . 17.0 m -67.07 -41.31 86.62 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.393 -177.394 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.477 ' CD1' HD23 ' A' ' 53' ' ' LEU . 8.6 tt -58.36 -33.19 46.96 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.319 0 CA-C-O 120.986 0.422 . . . . 0.0 110.765 178.697 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.402 ' O ' ' HG3' ' A' ' 45' ' ' GLU . 31.3 ttpt -69.89 -43.1 72.46 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.144 0.497 . . . . 0.0 109.952 174.79 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.525 HE21 ' HA ' ' A' ' 39' ' ' THR . 49.8 mt-30 -63.5 -38.63 91.89 Favored 'General case' 0 CA--C 1.512 -0.484 0 CA-C-N 115.449 -0.796 . . . . 0.0 110.601 -177.041 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.654 ' HG ' ' O ' ' A' ' 39' ' ' THR . 73.5 mt -55.38 -43.52 75.22 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.724 179.759 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 44.4 mt-30 -64.85 -44.84 88.45 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.328 178.981 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.402 ' HG3' ' O ' ' A' ' 41' ' ' LYS . 40.8 mt-10 -63.82 -45.99 87.13 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.71 -0.677 . . . . 0.0 111.448 -178.878 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 0.52 ' HG2' ' O ' ' A' ' 42' ' ' GLN . 11.7 ptp180 -77.46 -28.83 52.52 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 112.69 0.626 . . . . 0.0 112.69 -174.269 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.566 ' HB3' HG22 ' A' ' 49' ' ' VAL . . . -92.14 -18.08 24.03 Favored 'General case' 0 C--N 1.325 -0.478 0 C-N-CA 120.674 -0.41 . . . . 0.0 111.952 -177.441 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 75.33 25.31 68.64 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.701 -0.761 . . . . 0.0 111.652 -178.029 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.566 HG22 ' HB3' ' A' ' 47' ' ' ALA . 33.4 m -127.8 170.46 17.56 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 N-CA-C 109.791 -0.448 . . . . 0.0 109.791 -178.183 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.62 ' HE3' ' HB ' ' A' ' 52' ' ' ILE . 8.9 tmtm? -110.8 124.37 51.9 Favored 'General case' 0 C--N 1.317 -0.84 0 N-CA-C 109.306 -0.628 . . . . 0.0 109.306 175.838 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . 0.518 ' CE ' ' HB1' ' A' ' 79' ' ' ALA . 62.6 mtt -112.42 129.34 56.36 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 179.347 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.62 ' HB ' ' HE3' ' A' ' 50' ' ' LYS . 8.9 tt -122.3 105.69 16.62 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.933 0 CA-C-O 121.514 0.673 . . . . 0.0 110.133 175.129 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.519 ' O ' ' HG2' ' A' ' 55' ' ' GLN . 4.0 mm? -81.44 103.42 11.17 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 115.3 -0.863 . . . . 0.0 109.035 174.916 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.577 HD12 ' HB2' ' A' ' 66' ' ' PRO . 53.5 mt -75.54 87.04 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 122.013 0.911 . . . . 0.0 109.689 179.185 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . 0.519 ' HG2' ' O ' ' A' ' 53' ' ' LEU . 2.2 pt20 -137.25 -36.7 0.65 Allowed 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 114.359 -1.291 . . . . 0.0 109.293 -178.017 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -70.28 -30.95 68.1 Favored 'General case' 0 N--CA 1.455 -0.213 0 CA-C-N 115.329 -0.851 . . . . 0.0 108.923 172.116 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -83.65 128.26 8.47 Favored Glycine 0 N--CA 1.446 -0.671 0 N-CA-C 110.864 -0.894 . . . . 0.0 110.864 173.678 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . 0.476 ' HA ' HG23 ' A' ' 61' ' ' THR . 5.2 p -80.75 70.21 7.46 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.459 0.647 . . . . 0.0 112.156 -174.42 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 46.1 mt-30 -113.36 -57.42 2.29 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.666 -0.697 . . . . 0.0 109.489 172.1 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.561 ' HB2' ' HD3' ' A' ' 66' ' ' PRO . 4.2 m-20 -114.23 44.05 1.76 Allowed 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.272 178.178 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . 0.476 HG23 ' HA ' ' A' ' 58' ' ' SER . 0.6 OUTLIER -64.19 -35.63 81.43 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.42 -178.926 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 13.2 m120 -96.07 -9.59 30.48 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 112.445 0.535 . . . . 0.0 112.445 -177.025 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 28.2 m -126.48 -163.65 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 N-CA-C 112.06 0.393 . . . . 0.0 112.06 -174.335 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.487 ' O ' ' HB3' ' A' ' 60' ' ' ASN . 6.2 m-20 -54.76 149.64 10.89 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.661 178.025 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.66 ' HB2' ' HB ' ' A' ' 24' ' ' ILE . 72.1 mmtt -96.72 125.48 46.64 Favored Pre-proline 0 C--N 1.316 -0.865 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.361 -170.449 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.577 ' HB2' HD12 ' A' ' 54' ' ' ILE . 14.0 Cg_exo -70.5 106.31 1.77 Allowed 'Trans proline' 0 N--CA 1.457 -0.647 0 C-N-CA 122.958 2.439 . . . . 0.0 111.317 174.949 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.547 HD21 HG21 ' A' ' 83' ' ' VAL . 23.2 tp -105.4 110.93 23.46 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.841 -0.618 . . . . 0.0 109.693 178.818 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.606 ' HB2' ' CG2' ' A' ' 52' ' ' ILE . 96.1 mtt180 -101.65 109.28 21.04 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-O 120.932 0.396 . . . . 0.0 110.952 177.718 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.489 ' O ' ' HA ' ' A' ' 19' ' ' VAL . 4.4 mp -90.29 104.14 14.96 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 172.237 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 18.3 mt -104.48 121.73 56.59 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.588 -174.647 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . 0.611 ' HA2' ' HB2' ' A' ' 16' ' ' ASN . . . 175.95 -125.4 1.05 Allowed Glycine 0 N--CA 1.445 -0.75 0 CA-C-N 116.002 -0.545 . . . . 0.0 112.025 179.872 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -114.84 142.67 28.72 Favored Pre-proline 0 C--N 1.32 -0.698 0 N-CA-C 108.863 -0.791 . . . . 0.0 108.863 179.641 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . 0.549 ' HD3' ' OG1' ' A' ' 18' ' ' THR . 86.0 Cg_exo -43.33 -39.5 9.01 Favored 'Trans proline' 0 C--N 1.351 0.699 0 C-N-CA 123.034 2.489 . . . . 0.0 112.751 -173.636 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 66.6 t80 -63.33 -57.83 9.11 Favored 'General case' 0 N--CA 1.451 -0.425 0 CA-C-N 115.225 -0.898 . . . . 0.0 111.293 -177.949 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 32.9 pttt -75.96 -30.45 58.63 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.482 -0.326 . . . . 0.0 111.571 -178.221 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 51.9 t -57.24 -40.62 74.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-O 120.894 0.378 . . . . 0.0 110.031 176.395 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -73.67 -45.85 50.01 Favored 'General case' 0 N--CA 1.448 -0.544 0 C-N-CA 120.496 -0.481 . . . . 0.0 111.094 179.144 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 11.3 mt-30 -63.41 -37.76 88.52 Favored 'General case' 0 C--N 1.326 -0.419 0 C-N-CA 120.389 -0.524 . . . . 0.0 111.115 -179.355 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . 0.518 ' HB1' ' CE ' ' A' ' 51' ' ' MET . . . -67.57 -37.69 82.99 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.211 176.856 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 37.4 t -63.91 -48.04 78.2 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.586 175.867 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 55.0 mt-10 -61.15 -38.43 86.39 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 110.045 -0.354 . . . . 0.0 110.045 177.19 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' MET . . . . . 0.461 ' O ' HG13 ' A' ' 86' ' ' ILE . 48.1 ttp -61.1 -49.38 77.52 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.658 -0.701 . . . . 0.0 111.315 179.611 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.547 HG21 HD21 ' A' ' 67' ' ' LEU . 27.7 m -77.33 -33.06 19.38 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-O 120.813 0.339 . . . . 0.0 110.897 -176.801 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 54.7 ttp -67.11 -33.69 76.0 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 109.427 -0.583 . . . . 0.0 109.427 176.005 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -67.33 -31.2 71.31 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.417 -0.811 . . . . 0.0 110.641 178.106 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.461 HG13 ' O ' ' A' ' 82' ' ' MET . 59.4 mt -61.32 -30.49 48.06 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.304 0 CA-C-O 121.365 0.603 . . . . 0.0 110.17 176.398 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.963 ' HG ' ' HD3' ' A' ' 28' ' ' LYS . 6.9 mp -88.1 -5.87 58.21 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.733 178.844 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 6.0 tmm_? -114.37 -3.79 13.04 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.443 0.64 . . . . 0.0 110.717 -175.161 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . 0.443 ' O ' ' HG3' ' A' ' 89' ' ' GLU . 9.6 pt-20 . . . . . 0 C--O 1.251 1.143 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.895 -177.317 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . 0.683 ' HA3' HD22 ' A' ' 12' ' ' ASN . . . . . . . . 0 N--CA 1.442 -0.919 0 N-CA-C 111.855 -0.498 . . . . 0.0 111.855 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 23.4 mt-30 61.16 -85.69 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.28 0 C-N-CA 123.389 0.676 . . . . 0.0 110.848 -177.424 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . 0.492 ' HB2' ' OD1' ' A' ' 72' ' ' ASP . 11.3 p90 -138.21 154.24 49.11 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.718 -0.673 . . . . 0.0 109.482 177.231 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . 0.425 ' HB3' ' H ' ' A' ' 9' ' ' ASP . 4.4 t60 -173.12 -92.77 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.77 0.319 . . . . 0.0 110.444 -175.304 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . 0.425 ' H ' ' HB3' ' A' ' 8' ' ' HIS . 17.3 t70 -148.7 113.89 5.52 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 109.971 -0.381 . . . . 0.0 109.971 179.96 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 66.1 t30 52.22 -108.79 0.41 Allowed 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 116.02 -0.536 . . . . 0.0 109.876 -173.475 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -83.16 125.82 31.95 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 109.628 -0.508 . . . . 0.0 109.628 177.593 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . 0.683 HD22 ' HA3' ' A' ' 5' ' ' GLY . 3.3 p-10 -84.01 21.29 1.36 Allowed 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 112.121 0.415 . . . . 0.0 112.121 -172.995 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 101.27 81.63 1.6 Allowed Glycine 0 N--CA 1.448 -0.555 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.205 179.12 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 82.59 -61.68 4.7 Favored Glycine 0 N--CA 1.449 -0.451 0 C-N-CA 120.959 -0.639 . . . . 0.0 111.801 -179.959 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . 0.826 ' HG2' ' H ' ' A' ' 17' ' ' GLY . 27.7 tt0 -59.04 134.3 56.86 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 120.897 0.38 . . . . 0.0 110.093 176.458 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 2.8 p-10 -75.12 -6.47 49.73 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.273 -178.438 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 0.826 ' H ' ' HG2' ' A' ' 15' ' ' GLN . . . 66.57 -127.64 28.98 Favored Glycine 0 N--CA 1.449 -0.456 0 CA-C-N 115.879 -0.6 . . . . 0.0 112.549 178.149 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 55.4 m -101.3 130.52 47.46 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-O 120.784 0.326 . . . . 0.0 110.449 -178.56 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.659 HG22 HG23 ' A' ' 70' ' ' ILE . 92.8 t -116.72 121.18 67.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 N-CA-C 109.71 -0.478 . . . . 0.0 109.71 176.406 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . 0.53 ' HB2' ' CG1' ' A' ' 76' ' ' VAL . 13.1 tt0 -114.18 113.05 24.14 Favored 'General case' 0 C--N 1.315 -0.903 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 177.927 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.61 ' HA ' ' O ' ' A' ' 67' ' ' LEU . 49.7 mt-10 -99.43 112.9 25.01 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.117 179.194 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 12.6 mm -97.24 155.48 3.58 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-N 115.614 -0.721 . . . . 0.0 109.67 179.111 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 1.9 mmt -109.15 91.85 3.81 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 175.845 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.674 ' HB ' ' HB2' ' A' ' 65' ' ' LYS . 37.2 mm -79.27 127.31 79.38 Favored Pre-proline 0 C--N 1.319 -0.752 0 CA-C-N 115.859 -0.609 . . . . 0.0 110.629 -175.209 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.727 ' HB2' ' HB2' ' A' ' 28' ' ' LYS . 87.3 Cg_exo -48.14 131.61 22.15 Favored 'Trans proline' 0 C--N 1.343 0.288 0 C-N-CA 122.84 2.36 . . . . 0.0 111.961 177.126 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -59.59 -30.6 68.78 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.701 -175.434 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -94.47 12.51 68.75 Favored Glycine 0 N--CA 1.45 -0.432 0 C-N-CA 120.785 -0.721 . . . . 0.0 112.332 178.743 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.727 ' HB2' ' HB2' ' A' ' 25' ' ' PRO . 16.4 tptt -126.48 8.36 7.07 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.15 0.5 . . . . 0.0 110.263 -179.677 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -70.0 -22.41 63.12 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.14 -176.898 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -67.59 -17.37 68.81 Favored Glycine 0 N--CA 1.445 -0.761 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.412 178.124 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.415 HD12 ' HG3' ' A' ' 28' ' ' LYS . 54.0 mt -87.59 -38.45 15.94 Favored 'General case' 0 C--N 1.328 -0.345 0 O-C-N 122.613 -0.345 . . . . 0.0 111.436 -179.195 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.741 HG13 HD21 ' A' ' 87' ' ' LEU . 2.8 m -70.81 -32.68 49.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.962 0.41 . . . . 0.0 111.043 179.879 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.561 HD11 ' HG3' ' A' ' 55' ' ' GLN . 60.2 mt -83.2 -36.76 13.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-O 121.669 0.747 . . . . 0.0 109.763 175.262 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 101.62 171.76 27.98 Favored Glycine 0 N--CA 1.445 -0.745 0 CA-C-N 114.977 -1.01 . . . . 0.0 111.608 -179.722 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 10.5 mptt -81.6 48.76 1.22 Allowed 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.098 0.475 . . . . 0.0 110.373 178.977 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 170.45 -44.23 0.2 Allowed Glycine 0 N--CA 1.447 -0.619 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.778 179.238 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.459 ' HA2' HG22 ' A' ' 33' ' ' ILE . . . 123.19 -4.31 9.61 Favored Glycine 0 N--CA 1.449 -0.439 0 C-N-CA 120.785 -0.721 . . . . 0.0 111.536 -177.192 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -75.13 -33.46 61.56 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.019 0.438 . . . . 0.0 109.95 178.651 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.687 ' O ' ' HG ' ' A' ' 43' ' ' LEU . 69.9 m -58.28 -54.39 47.54 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-N 115.583 -0.735 . . . . 0.0 111.198 -176.289 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.564 ' HA ' HD12 ' A' ' 43' ' ' LEU . 10.3 tt -59.77 -34.61 56.23 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.28 0 CA-C-O 120.837 0.351 . . . . 0.0 111.14 179.915 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.465 ' O ' ' HG2' ' A' ' 45' ' ' GLU . 50.1 tttp -62.33 -48.96 77.52 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.339 175.078 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.445 ' O ' ' HG2' ' A' ' 46' ' ' ARG . 72.4 mm-40 -64.69 -33.56 76.24 Favored 'General case' 0 CA--C 1.509 -0.602 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.013 -175.259 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.687 ' HG ' ' O ' ' A' ' 39' ' ' THR . 67.8 mt -58.25 -48.24 81.03 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.413 179.307 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 43.1 mt-30 -65.79 -38.61 89.48 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.534 179.089 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.465 ' HG2' ' O ' ' A' ' 41' ' ' LYS . 60.0 mm-40 -60.69 -52.66 64.17 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.669 177.817 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 0.445 ' HG2' ' O ' ' A' ' 42' ' ' GLN . 10.7 ptm180 -77.67 -29.93 51.77 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.592 -0.731 . . . . 0.0 112.634 -170.825 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -87.55 -25.87 23.42 Favored 'General case' 0 C--N 1.323 -0.554 0 C-N-CA 120.702 -0.399 . . . . 0.0 111.927 -176.077 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 78.23 24.84 62.75 Favored Glycine 0 N--CA 1.453 -0.215 0 C-N-CA 120.577 -0.82 . . . . 0.0 112.424 -179.812 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 5.9 m -135.75 179.29 4.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 N-CA-C 109.926 -0.398 . . . . 0.0 109.926 177.343 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 60.8 tttp -107.4 124.67 50.18 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.846 179.905 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 37.3 mtt -118.97 116.43 26.44 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 177.639 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.607 ' CG2' ' HB2' ' A' ' 68' ' ' ARG . 10.7 tt -111.22 113.43 44.23 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.899 0 CA-C-O 121.447 0.641 . . . . 0.0 110.733 178.675 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.722 HD22 HD13 ' A' ' 67' ' ' LEU . 2.9 mm? -88.17 102.51 14.87 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.581 -0.736 . . . . 0.0 109.467 175.7 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.846 HD12 ' HB2' ' A' ' 66' ' ' PRO . 65.2 mt -75.82 95.07 1.09 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-O 121.331 0.586 . . . . 0.0 110.011 -179.63 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . 0.599 HE21 ' HB3' ' A' ' 53' ' ' LEU . 84.6 mm-40 -102.69 -42.47 5.89 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.516 -0.765 . . . . 0.0 110.604 -176.079 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 4.1 p30 -95.35 -2.54 48.94 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.689 -178.396 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . 0.614 ' O ' ' HB ' ' A' ' 61' ' ' THR . . . -70.91 144.02 37.42 Favored Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 120.518 -0.848 . . . . 0.0 111.379 176.999 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . 0.402 ' O ' ' HB2' ' A' ' 59' ' ' GLN . 9.4 m -71.98 -175.32 1.42 Allowed 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.746 0.308 . . . . 0.0 111.314 -176.61 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . 0.402 ' HB2' ' O ' ' A' ' 58' ' ' SER . 42.7 mt-30 68.46 -72.64 0.1 Allowed 'General case' 0 CA--C 1.518 -0.258 0 CA-C-N 115.54 -0.754 . . . . 0.0 110.381 -174.25 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.888 ' HA ' HG22 ' A' ' 63' ' ' VAL . 6.0 m120 -96.47 15.64 20.89 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 121.161 0.505 . . . . 0.0 111.22 -174.185 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . 0.614 ' HB ' ' O ' ' A' ' 57' ' ' GLY . 6.8 t -66.24 -29.88 70.21 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 109.912 -0.403 . . . . 0.0 109.912 174.366 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 17.4 m120 -100.83 3.4 41.94 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 112.258 0.466 . . . . 0.0 112.258 179.396 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.888 HG22 ' HA ' ' A' ' 60' ' ' ASN . 22.0 m -136.73 -156.93 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.309 0 O-C-N 122.157 -0.339 . . . . 0.0 111.643 -177.386 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.662 ' O ' ' HB3' ' A' ' 60' ' ' ASN . 12.1 m-20 -54.77 147.1 15.53 Favored 'General case' 0 C--O 1.227 -0.085 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.388 177.648 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.674 ' HB2' ' HB ' ' A' ' 24' ' ' ILE . 74.0 mmtt -95.26 127.0 43.98 Favored Pre-proline 0 C--N 1.319 -0.74 0 CA-C-N 116.103 -0.498 . . . . 0.0 111.567 -170.573 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.846 ' HB2' HD12 ' A' ' 54' ' ' ILE . 10.6 Cg_exo -71.63 109.11 2.56 Favored 'Trans proline' 0 N--CA 1.459 -0.525 0 C-N-CA 123.074 2.516 . . . . 0.0 111.318 175.556 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.722 HD13 HD22 ' A' ' 53' ' ' LEU . 23.9 tp -106.04 100.01 9.58 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.986 -0.552 . . . . 0.0 109.848 178.467 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.607 ' HB2' ' CG2' ' A' ' 52' ' ' ILE . 97.6 mtt180 -85.64 105.11 15.97 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.939 0.4 . . . . 0.0 110.242 176.766 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 31.8 mt -92.4 105.04 16.25 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.718 0 N-CA-C 108.116 -1.068 . . . . 0.0 108.116 171.452 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.659 HG23 HG22 ' A' ' 19' ' ' VAL . 14.5 mt -111.4 129.51 66.62 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.909 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.575 -171.357 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 148.32 -124.67 1.92 Allowed Glycine 0 N--CA 1.441 -0.975 0 C-N-CA 119.847 -1.168 . . . . 0.0 113.833 171.115 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . 0.492 ' OD1' ' HB2' ' A' ' 7' ' ' PHE . 4.7 t70 -85.62 128.95 56.78 Favored Pre-proline 0 C--N 1.321 -0.632 0 CA-C-N 115.206 -0.497 . . . . 0.0 111.685 -171.779 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . 0.405 ' HD2' ' HB3' ' A' ' 7' ' ' PHE . 88.6 Cg_exo -45.36 -33.64 9.2 Favored 'Trans proline' 0 C--N 1.349 0.596 0 C-N-CA 124.621 3.547 . . . . 0.0 114.346 -175.742 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 90.5 m-85 -74.91 -60.88 2.09 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.069 0.462 . . . . 0.0 110.214 -178.967 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.641 ' HA ' ' HB2' ' A' ' 78' ' ' GLN . 3.8 pttm -74.09 -17.07 61.0 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.745 -0.661 . . . . 0.0 112.586 -173.881 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.53 ' CG1' ' HB2' ' A' ' 20' ' ' GLN . 37.3 t -65.06 -44.35 95.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 121.429 0.633 . . . . 0.0 109.543 170.406 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -74.54 -43.23 56.74 Favored 'General case' 0 N--CA 1.446 -0.651 0 CA-C-N 115.29 -0.868 . . . . 0.0 109.129 -178.402 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . 0.641 ' HB2' ' HA ' ' A' ' 75' ' ' LYS . 61.9 mt-30 -56.71 -36.2 69.4 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.495 -0.775 . . . . 0.0 110.661 175.269 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -68.38 -45.08 73.7 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.608 -0.724 . . . . 0.0 110.917 177.957 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' CYS . . . . . 0.415 ' HB2' ' OE1' ' A' ' 20' ' ' GLN . 33.4 t -54.84 -56.71 16.5 Favored 'General case' 0 CA--C 1.518 -0.278 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.968 178.516 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -63.42 -27.08 69.05 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 120.77 -0.372 . . . . 0.0 110.877 -178.647 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 47.7 ttp -73.59 -49.67 25.09 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.434 179.839 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.537 HG12 HD13 ' A' ' 43' ' ' LEU . 34.2 m -76.39 -32.75 22.22 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-O 120.853 0.359 . . . . 0.0 110.591 -175.626 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' MET . . . . . 0.46 ' O ' ' HG3' ' A' ' 88' ' ' ARG . 45.2 ttm -68.56 -31.62 70.95 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.075 -0.511 . . . . 0.0 109.859 177.041 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . 0.522 ' HA ' ' HD2' ' A' ' 88' ' ' ARG . 21.4 t70 -62.81 -40.45 97.42 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.892 -0.595 . . . . 0.0 111.113 178.602 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 42.1 mt -61.08 -29.97 46.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.445 179.279 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.741 HD21 HG13 ' A' ' 32' ' ' VAL . 61.2 mt -79.0 -20.89 47.93 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.384 -177.434 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . 0.522 ' HD2' ' HA ' ' A' ' 85' ' ' ASP . 0.0 OUTLIER -117.99 27.56 8.93 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.17 0.51 . . . . 0.0 110.935 -179.84 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 44.9 tt0 . . . . . 0 C--O 1.248 1.007 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.174 179.551 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.444 -0.833 0 N-CA-C 112.336 -0.305 . . . . 0.0 112.336 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . 0.6 ' O ' ' HA2' ' A' ' 71' ' ' GLY . 27.4 mm-40 -103.98 27.82 7.27 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 108.55 -0.908 . . . . 0.0 108.55 171.709 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . 0.587 ' O ' ' HB2' ' A' ' 8' ' ' HIS . 4.9 p90 -155.94 -143.04 0.11 Allowed 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 114.216 -1.357 . . . . 0.0 108.37 -175.976 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . 0.587 ' HB2' ' O ' ' A' ' 7' ' ' PHE . 26.0 m170 79.11 100.24 0.06 Allowed 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 123.207 0.603 . . . . 0.0 110.674 -179.578 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 2.1 t0 179.08 -53.47 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.432 -0.804 . . . . 0.0 109.254 -179.913 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 6.6 p30 -150.21 -5.04 0.34 Allowed 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.402 -0.817 . . . . 0.0 111.637 179.257 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.612 ' HB3' ' HB3' ' A' ' 72' ' ' ASP . . . -151.12 108.09 3.56 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.233 0.54 . . . . 0.0 111.466 178.395 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 4.1 p-10 -135.51 20.46 3.36 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.157 178.831 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -126.39 144.69 15.27 Favored Glycine 0 N--CA 1.448 -0.549 0 CA-C-N 115.663 -0.698 . . . . 0.0 111.791 179.739 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 81.95 -70.3 3.15 Favored Glycine 0 N--CA 1.449 -0.453 0 C-N-CA 120.944 -0.645 . . . . 0.0 111.867 -178.376 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 75.2 mt-30 -113.39 108.4 17.17 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 109.939 -0.393 . . . . 0.0 109.939 176.523 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 31.9 m-80 -85.63 69.67 10.66 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.356 -178.131 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 106.45 104.59 2.96 Favored Glycine 0 N--CA 1.444 -0.796 0 C-N-CA 120.632 -0.794 . . . . 0.0 112.095 -179.919 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.433 ' HB ' HG21 ' A' ' 76' ' ' VAL . 58.8 m -95.84 138.8 32.97 Favored 'General case' 0 C--N 1.317 -0.834 0 N-CA-C 109.63 -0.508 . . . . 0.0 109.63 177.188 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.505 ' HA ' ' O ' ' A' ' 69' ' ' ILE . 5.2 p -132.19 126.42 56.01 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-O 121.237 0.541 . . . . 0.0 110.999 179.693 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . 0.412 ' OE1' HG12 ' A' ' 76' ' ' VAL . 55.1 mt-30 -115.5 119.91 37.74 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.561 177.017 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.636 ' HA ' ' O ' ' A' ' 67' ' ' LEU . 49.8 mt-10 -92.03 111.9 23.62 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.244 0.545 . . . . 0.0 110.546 177.429 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 15.8 mm -104.0 155.63 5.73 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-N 115.331 -0.85 . . . . 0.0 109.695 -178.347 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' MET . . . . . 0.541 ' HB3' ' HB3' ' A' ' 64' ' ' ASP . 80.6 mmm -108.43 104.97 14.43 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 176.227 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.644 ' HB ' ' HB2' ' A' ' 65' ' ' LYS . 30.5 mm -91.23 125.0 59.84 Favored Pre-proline 0 C--N 1.321 -0.656 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.115 -174.117 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.566 ' HB2' ' HB3' ' A' ' 28' ' ' LYS . 76.9 Cg_exo -50.3 140.52 33.94 Favored 'Trans proline' 0 CA--C 1.535 0.555 0 C-N-CA 122.845 2.363 . . . . 0.0 113.019 179.715 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.444 ' HB2' ' HA ' ' A' ' 63' ' ' VAL . . . -48.88 -61.75 1.88 Allowed 'General case' 0 N--CA 1.468 0.454 0 N-CA-C 113.42 0.896 . . . . 0.0 113.42 -170.605 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -78.67 -25.64 60.26 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.712 -0.756 . . . . 0.0 111.883 -177.334 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.577 ' HG3' HD22 ' A' ' 87' ' ' LEU . 13.0 tppt? -67.57 -19.18 65.23 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.99 0.424 . . . . 0.0 110.875 178.891 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.477 ' O ' HG12 ' A' ' 32' ' ' VAL . . . -59.66 -23.5 63.13 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.415 179.802 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -60.58 -27.03 65.47 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.855 -0.688 . . . . 0.0 112.16 176.598 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 92.5 mt -87.61 -33.53 18.82 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.643 0.258 . . . . 0.0 110.705 179.787 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.477 HG12 ' O ' ' A' ' 29' ' ' ALA . 0.9 OUTLIER -73.55 -31.27 32.1 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.387 0 CA-C-O 121.071 0.463 . . . . 0.0 110.916 -178.711 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.541 HG22 ' HA2' ' A' ' 37' ' ' GLY . 75.6 mt -84.87 -44.64 17.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 116.01 -0.541 . . . . 0.0 109.89 176.117 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 132.46 170.16 12.45 Favored Glycine 0 N--CA 1.441 -1.004 0 C-N-CA 120.242 -0.98 . . . . 0.0 112.936 174.606 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.409 ' N ' ' HD3' ' A' ' 35' ' ' LYS . 3.3 mppt? -69.36 -28.52 66.28 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.025 0.44 . . . . 0.0 109.879 -179.114 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -136.69 19.18 3.56 Favored Glycine 0 N--CA 1.447 -0.568 0 C-N-CA 120.825 -0.702 . . . . 0.0 111.355 175.592 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.541 ' HA2' HG22 ' A' ' 33' ' ' ILE . . . 78.57 5.92 88.13 Favored Glycine 0 C--O 1.226 -0.4 0 C-N-CA 120.913 -0.661 . . . . 0.0 112.072 -176.885 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -85.53 -24.18 27.39 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 120.887 0.375 . . . . 0.0 111.537 -178.587 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.649 ' O ' ' HG ' ' A' ' 43' ' ' LEU . 31.5 m -64.26 -48.97 73.72 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.232 -176.415 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.557 ' HA ' HD12 ' A' ' 43' ' ' LEU . 5.3 tt -55.72 -30.43 27.23 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.342 0 CA-C-O 121.071 0.462 . . . . 0.0 111.513 179.757 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.444 ' O ' ' HG2' ' A' ' 45' ' ' GLU . 7.8 tmtm? -74.47 -39.58 62.42 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.055 -0.52 . . . . 0.0 109.758 -178.904 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 25.4 mt-30 -67.82 -35.62 78.93 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.825 -179.702 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.649 ' HG ' ' O ' ' A' ' 39' ' ' THR . 47.7 mt -58.5 -42.65 88.14 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.454 -179.224 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 65.9 mt-30 -62.69 -39.88 95.37 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.629 179.595 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.444 ' HG2' ' O ' ' A' ' 41' ' ' LYS . 34.6 mm-40 -74.07 -51.2 16.5 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.382 -176.727 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 17.5 ptm180 -66.63 -37.46 84.9 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.966 -0.561 . . . . 0.0 112.25 -171.798 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.414 ' HB3' HG22 ' A' ' 49' ' ' VAL . . . -95.77 -13.39 24.16 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 120.969 0.414 . . . . 0.0 111.391 -176.795 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 69.19 31.17 71.74 Favored Glycine 0 N--CA 1.449 -0.467 0 N-CA-C 111.274 -0.73 . . . . 0.0 111.274 -176.082 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.501 HG12 ' HD3' ' A' ' 75' ' ' LYS . 34.4 m -113.04 166.84 6.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-O 120.809 0.337 . . . . 0.0 110.394 -175.735 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -111.65 123.33 50.0 Favored 'General case' 0 C--N 1.318 -0.794 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 171.211 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 75.8 mtp -123.8 115.32 21.17 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 109.806 -0.442 . . . . 0.0 109.806 178.643 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.501 ' CG2' ' HB2' ' A' ' 68' ' ' ARG . 6.8 tt -104.43 105.84 19.27 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.837 0 CA-C-O 121.437 0.636 . . . . 0.0 109.977 178.432 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.609 HD22 HD13 ' A' ' 67' ' ' LEU . 2.5 mm? -78.28 102.64 7.76 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.681 -0.691 . . . . 0.0 109.594 177.007 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.453 ' HB ' ' HB2' ' A' ' 66' ' ' PRO . 60.8 mt -87.5 85.89 2.51 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-O 121.509 0.671 . . . . 0.0 109.467 -178.239 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 1.3 pt20 -109.81 -17.12 13.73 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.834 -177.162 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 30.1 m-20 -100.19 -33.96 10.22 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.978 0.418 . . . . 0.0 110.119 175.082 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -86.2 39.33 3.05 Favored Glycine 0 C--N 1.33 0.196 0 C-N-CA 120.795 -0.717 . . . . 0.0 112.574 -177.555 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 3.0 p -136.85 146.07 45.15 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-O 120.916 0.389 . . . . 0.0 110.79 -179.11 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -99.34 -16.12 18.56 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 178.558 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.483 ' HB2' ' CG2' ' A' ' 63' ' ' VAL . 27.5 p-10 -95.6 30.02 2.43 Favored 'General case' 0 N--CA 1.447 -0.586 0 CA-C-N 114.588 -1.187 . . . . 0.0 107.987 166.977 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 10.0 t -60.31 -18.86 52.43 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 114.923 -1.035 . . . . 0.0 111.201 -178.35 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 57.4 m-80 -87.71 -1.4 57.94 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.452 -178.648 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.483 ' CG2' ' HB2' ' A' ' 60' ' ' ASN . 23.6 m -133.46 -139.27 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.286 179.009 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.541 ' HB3' ' HB3' ' A' ' 23' ' ' MET . 1.9 m-20 -50.9 136.88 21.89 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.572 -0.74 . . . . 0.0 111.981 179.112 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.644 ' HB2' ' HB ' ' A' ' 24' ' ' ILE . 71.7 mmtt -99.35 127.59 34.09 Favored Pre-proline 0 C--N 1.322 -0.594 0 CA-C-N 115.156 -0.929 . . . . 0.0 111.49 -174.176 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.453 ' HB2' ' HB ' ' A' ' 54' ' ' ILE . 38.7 Cg_exo -65.03 114.33 2.76 Favored 'Trans proline' 0 CA--C 1.533 0.434 0 C-N-CA 122.896 2.397 . . . . 0.0 111.719 169.619 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.636 ' O ' ' HA ' ' A' ' 21' ' ' GLU . 28.7 tp -122.95 126.58 47.49 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 120.588 0.232 . . . . 0.0 111.114 179.809 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.583 ' HG2' ' HG2' ' A' ' 21' ' ' GLU . 96.4 mtt180 -109.19 115.93 30.95 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 120.674 0.273 . . . . 0.0 111.519 176.086 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.505 ' O ' ' HA ' ' A' ' 19' ' ' VAL . 4.5 mp -97.62 115.8 38.46 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 N-CA-C 108.423 -0.954 . . . . 0.0 108.423 170.866 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 15.0 mt -119.38 140.66 42.6 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.569 -174.473 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . 0.6 ' HA2' ' O ' ' A' ' 6' ' ' GLN . . . 157.36 -160.12 30.28 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.877 -0.678 . . . . 0.0 112.165 176.738 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . 0.612 ' HB3' ' HB3' ' A' ' 11' ' ' ALA . 1.0 OUTLIER -61.99 137.19 95.44 Favored Pre-proline 0 N--CA 1.447 -0.617 0 N-CA-C 108.631 -0.877 . . . . 0.0 108.631 174.477 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . 0.609 ' HD2' ' HB3' ' A' ' 11' ' ' ALA . 85.8 Cg_exo -42.47 -41.17 7.71 Favored 'Trans proline' 0 CA--C 1.534 0.478 0 C-N-CA 122.825 2.35 . . . . 0.0 114.219 -173.462 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 73.3 m-85 -69.52 -51.61 34.14 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.111 -0.495 . . . . 0.0 112.191 -175.136 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.577 ' HD2' ' H ' ' A' ' 72' ' ' ASP . 16.9 ptpt -62.92 -32.34 73.6 Favored 'General case' 0 C--O 1.222 -0.349 0 CA-C-N 116.687 -0.233 . . . . 0.0 110.689 -179.024 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.497 HG23 ' O ' ' A' ' 72' ' ' ASP . 96.6 t -56.89 -48.05 82.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 120.771 0.319 . . . . 0.0 110.329 177.849 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 1.6 mm100 -71.14 -42.46 69.14 Favored 'General case' 0 N--CA 1.45 -0.456 0 CA-C-N 116.4 -0.363 . . . . 0.0 111.332 178.158 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 47.1 mt-30 -60.17 -42.37 94.82 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.717 0.294 . . . . 0.0 111.069 178.955 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -71.34 -36.43 71.53 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.766 178.917 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 49.8 t -61.17 -54.9 38.62 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.229 176.51 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -61.59 -30.05 70.43 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.885 0.374 . . . . 0.0 110.599 179.247 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 52.5 ttp -64.74 -53.29 49.45 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.886 178.534 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.617 ' O ' ' HG ' ' A' ' 87' ' ' LEU . 32.9 m -78.65 -33.24 16.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-O 120.656 0.265 . . . . 0.0 110.863 -176.254 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 59.8 ttp -66.51 -35.61 80.67 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.106 178.678 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -60.27 -38.38 83.38 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.62 176.76 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 48.6 mt -66.7 -27.25 39.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-O 121.273 0.559 . . . . 0.0 110.339 178.735 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.617 ' HG ' ' O ' ' A' ' 83' ' ' VAL . 35.4 mt -91.71 -28.12 17.64 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.273 -176.774 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . 0.442 HH11 ' HD2' ' A' ' 88' ' ' ARG . 12.9 mmt180 -85.99 -13.07 48.68 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.316 0.579 . . . . 0.0 111.117 -179.287 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 . . . . . 0 C--N 1.312 -1.064 0 CA-C-N 115.359 -0.837 . . . . 0.0 110.028 -178.009 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.534 0 N-CA-C 111.738 -0.545 . . . . 0.0 111.738 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . 0.438 ' HB3' ' HG2' ' A' ' 73' ' ' PRO . 23.2 mt-30 -77.81 -22.42 50.07 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.394 0.616 . . . . 0.0 110.1 178.964 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . 0.456 ' HA ' ' HB3' ' A' ' 16' ' ' ASN . 39.2 p90 -126.3 155.4 42.02 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.279 -0.873 . . . . 0.0 109.245 174.815 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . 0.614 ' HB3' ' HB3' ' A' ' 12' ' ' ASN . 2.2 t-160 -83.68 69.5 10.16 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.496 -176.394 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . 0.4 ' C ' HD22 ' A' ' 10' ' ' ASN . 1.5 p30 36.68 -102.67 0.03 OUTLIER 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 124.3 1.04 . . . . 0.0 113.227 178.29 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . 0.4 HD22 ' C ' ' A' ' 9' ' ' ASP . 0.9 OUTLIER -114.5 -24.37 8.85 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 121.039 0.447 . . . . 0.0 110.131 179.033 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -83.38 64.02 7.59 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.011 -178.438 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . 0.614 ' HB3' ' HB3' ' A' ' 8' ' ' HIS . 8.6 p30 -142.82 154.01 43.77 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.211 179.221 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -154.96 96.34 0.16 Allowed Glycine 0 CA--C 1.509 -0.295 0 N-CA-C 111.072 -0.811 . . . . 0.0 111.072 -179.004 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 77.54 -65.32 3.14 Favored Glycine 0 N--CA 1.449 -0.442 0 N-CA-C 110.56 -1.016 . . . . 0.0 110.56 -171.029 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 6.3 pt20 -76.82 116.36 17.41 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 109.698 -0.482 . . . . 0.0 109.698 172.866 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . 0.518 ' O ' ' HB2' ' A' ' 8' ' ' HIS . 3.8 m-20 -101.12 -64.29 1.06 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.43 -179.603 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 174.73 35.97 0.04 OUTLIER Glycine 0 N--CA 1.453 -0.224 0 C-N-CA 120.614 -0.803 . . . . 0.0 112.338 177.498 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 16.1 m -153.18 130.13 11.01 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 120.661 0.267 . . . . 0.0 110.712 -177.703 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.401 HG22 HG23 ' A' ' 70' ' ' ILE . 60.5 t -131.71 131.86 62.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.423 179.884 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 28.6 mt-30 -120.84 114.8 22.13 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.086 173.803 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.578 ' HA ' ' O ' ' A' ' 67' ' ' LEU . 48.5 mt-10 -86.61 119.65 27.08 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.958 -0.564 . . . . 0.0 111.052 178.812 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.494 ' HB ' ' HB3' ' A' ' 67' ' ' LEU . 14.9 mm -105.68 163.43 4.56 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 115.341 -0.845 . . . . 0.0 110.091 -178.395 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' MET . . . . . 0.456 ' HB3' ' HB3' ' A' ' 64' ' ' ASP . 2.3 mmt -109.75 94.89 5.26 Favored 'General case' 0 N--CA 1.453 -0.324 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 176.049 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.748 ' HB ' ' HB2' ' A' ' 65' ' ' LYS . 36.5 mm -82.78 126.48 72.99 Favored Pre-proline 0 C--N 1.318 -0.775 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.178 -174.589 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.718 ' HD2' HD13 ' A' ' 87' ' ' LEU . 84.6 Cg_exo -47.39 124.87 9.89 Favored 'Trans proline' 0 C--N 1.346 0.407 0 C-N-CA 123.132 2.555 . . . . 0.0 112.533 178.621 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -63.69 -34.38 77.72 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.645 -0.707 . . . . 0.0 111.872 -174.359 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -90.88 -3.75 70.24 Favored Glycine 0 N--CA 1.448 -0.543 0 C-N-CA 120.609 -0.805 . . . . 0.0 112.93 -178.724 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.503 ' HB3' ' HB2' ' A' ' 25' ' ' PRO . 43.4 tttt -121.44 17.17 11.35 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.222 0.534 . . . . 0.0 110.759 -176.93 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.447 ' O ' HG12 ' A' ' 32' ' ' VAL . . . -70.57 -21.15 62.72 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.901 -0.591 . . . . 0.0 111.275 -178.27 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -65.39 -18.19 65.09 Favored Glycine 0 C--O 1.227 -0.308 0 C-N-CA 121.11 -0.567 . . . . 0.0 112.646 178.458 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.621 ' HB3' HG22 ' A' ' 86' ' ' ILE . 66.1 mt -88.53 -41.57 12.63 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.619 0.247 . . . . 0.0 110.939 178.819 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.731 ' HB ' HD21 ' A' ' 87' ' ' LEU . 4.3 p -69.67 -33.65 57.5 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.435 0 CA-C-O 121.334 0.587 . . . . 0.0 110.824 -178.718 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.59 ' HA ' ' HB ' ' A' ' 40' ' ' ILE . 76.6 mt -90.35 -39.87 12.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-N 115.591 -0.731 . . . . 0.0 110.59 179.061 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 107.63 151.39 16.83 Favored Glycine 0 N--CA 1.443 -0.838 0 CA-C-N 115.756 -0.656 . . . . 0.0 111.777 -179.075 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.545 ' HE3' HD23 ' A' ' 31' ' ' LEU . 0.2 OUTLIER -68.81 -11.34 60.31 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.719 0.295 . . . . 0.0 111.31 -178.088 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -137.36 17.83 3.52 Favored Glycine 0 N--CA 1.449 -0.483 0 C-N-CA 120.715 -0.755 . . . . 0.0 111.693 176.639 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 69.78 1.55 32.07 Favored Glycine 0 CA--C 1.521 0.411 0 C-N-CA 121.248 -0.501 . . . . 0.0 112.785 -177.655 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -69.9 -35.99 75.05 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.834 0.35 . . . . 0.0 111.114 -178.171 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.757 ' O ' ' HG ' ' A' ' 43' ' ' LEU . 93.8 m -57.72 -61.21 2.68 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.092 -179.304 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.65 ' HA ' HD12 ' A' ' 43' ' ' LEU . 7.6 tt -60.33 -29.83 44.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 116.045 -0.525 . . . . 0.0 112.09 -175.243 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 11.6 tmtt? -74.58 -42.34 58.9 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 109.86 -0.422 . . . . 0.0 109.86 -179.381 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.516 ' O ' ' HG2' ' A' ' 46' ' ' ARG . 47.6 mt-30 -66.09 -31.72 72.76 Favored 'General case' 0 CA--C 1.517 -0.303 0 CA-C-O 120.961 0.41 . . . . 0.0 110.469 -179.305 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.757 ' HG ' ' O ' ' A' ' 39' ' ' THR . 44.4 mt -61.89 -33.25 73.88 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.674 -179.995 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . 0.402 ' HA ' ' O ' ' A' ' 49' ' ' VAL . 65.0 mt-30 -71.66 -23.03 61.6 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.433 0.635 . . . . 0.0 110.547 179.661 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 68.5 mm-40 -87.86 -55.1 3.91 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.82 -179.885 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 0.516 ' HG2' ' O ' ' A' ' 42' ' ' GLN . 14.6 ptp180 -69.84 -30.87 68.47 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 113.02 0.748 . . . . 0.0 113.02 -172.492 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.509 ' HB3' HG22 ' A' ' 49' ' ' VAL . . . -95.48 -18.56 20.57 Favored 'General case' 0 C--N 1.323 -0.553 0 C-N-CA 120.736 -0.386 . . . . 0.0 111.594 -176.487 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 75.74 17.45 80.1 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.83 -0.7 . . . . 0.0 112.212 -179.415 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.509 HG22 ' HB3' ' A' ' 47' ' ' ALA . 21.2 m -116.1 166.41 10.23 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-O 120.809 0.338 . . . . 0.0 110.279 179.846 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 85.6 tttt -108.66 121.29 44.71 Favored 'General case' 0 C--N 1.314 -0.952 0 N-CA-C 108.474 -0.935 . . . . 0.0 108.474 169.31 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . 0.908 ' HE1' HG11 ' A' ' 83' ' ' VAL . 15.9 mtm -114.08 115.3 27.34 Favored 'General case' 0 C--N 1.316 -0.855 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 177.268 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.584 ' CG2' ' HB2' ' A' ' 68' ' ' ARG . 11.6 tt -100.34 106.94 20.07 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.084 0 CA-C-O 121.418 0.628 . . . . 0.0 110.348 179.561 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.867 HD22 HD13 ' A' ' 67' ' ' LEU . 3.0 mm? -72.78 101.52 3.13 Favored 'General case' 0 N--CA 1.445 -0.675 0 N-CA-C 107.382 -1.34 . . . . 0.0 107.382 171.165 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.711 HD12 ' HB2' ' A' ' 66' ' ' PRO . 62.8 mt -73.54 86.24 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.482 0 CA-C-O 122.078 0.942 . . . . 0.0 111.135 -170.852 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 32.3 mt-30 -106.35 -28.77 10.17 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 114.209 -1.359 . . . . 0.0 107.742 170.223 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -56.6 -37.45 70.67 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 114.271 -1.331 . . . . 0.0 110.09 173.534 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -94.69 94.67 1.8 Allowed Glycine 0 N--CA 1.443 -0.887 0 N-CA-C 110.723 -0.951 . . . . 0.0 110.723 172.53 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 11.4 m -75.53 55.41 0.82 Allowed 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.226 0.536 . . . . 0.0 111.602 -175.077 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 43.4 mt-30 -97.68 -45.97 6.17 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.399 178.556 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.555 ' HB2' ' HD3' ' A' ' 66' ' ' PRO . 14.7 m120 -120.4 38.01 4.1 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.464 0.649 . . . . 0.0 109.677 179.478 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -77.04 -24.71 52.02 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.578 -0.737 . . . . 0.0 111.333 -179.95 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 8.8 t30 -81.75 -22.15 37.42 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.566 178.869 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 16.8 m -121.01 -155.42 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.629 -177.829 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.456 ' HB3' ' HB3' ' A' ' 23' ' ' MET . 1.1 m-20 -55.41 140.67 39.16 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.743 175.546 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.748 ' HB2' ' HB ' ' A' ' 24' ' ' ILE . 30.3 mmtp -90.55 132.67 34.56 Favored Pre-proline 0 C--N 1.322 -0.609 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.988 -170.355 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.711 ' HB2' HD12 ' A' ' 54' ' ' ILE . 17.4 Cg_exo -68.16 110.45 2.21 Favored 'Trans proline' 0 N--CA 1.456 -0.708 0 C-N-CA 122.684 2.256 . . . . 0.0 110.965 173.802 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.867 HD13 HD22 ' A' ' 53' ' ' LEU . 30.0 tp -108.6 114.05 27.55 Favored 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 110.138 -0.319 . . . . 0.0 110.138 178.064 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.584 ' HB2' ' CG2' ' A' ' 52' ' ' ILE . 97.3 mtt180 -99.46 106.19 18.21 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 116.487 -0.324 . . . . 0.0 110.479 176.254 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.506 ' HB ' HG13 ' A' ' 76' ' ' VAL . 4.5 mp -86.39 103.93 13.34 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 N-CA-C 107.855 -1.165 . . . . 0.0 107.855 170.196 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.401 HG23 HG22 ' A' ' 19' ' ' VAL . 31.1 mt -101.57 116.12 44.59 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.867 0 CA-C-N 115.534 -0.757 . . . . 0.0 110.19 -174.282 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . 0.4 ' O ' ' HB2' ' A' ' 16' ' ' ASN . . . 177.19 -123.99 0.92 Allowed Glycine 0 N--CA 1.442 -0.935 0 C-N-CA 120.42 -0.895 . . . . 0.0 112.258 178.945 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . 0.47 ' HB2' ' ND2' ' A' ' 16' ' ' ASN . 17.0 t70 -119.46 141.85 31.55 Favored Pre-proline 0 C--N 1.318 -0.793 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 -177.631 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . 0.438 ' HG2' ' HB3' ' A' ' 6' ' ' GLN . 82.8 Cg_exo -43.66 -38.03 8.87 Favored 'Trans proline' 0 C--N 1.35 0.611 0 C-N-CA 123.064 2.509 . . . . 0.0 113.212 -173.003 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . 0.417 ' O ' ' HG3' ' A' ' 78' ' ' GLN . 47.3 t80 -66.18 -61.99 1.72 Allowed 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.65 -0.705 . . . . 0.0 111.491 -177.416 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.424 ' HB2' HG13 ' A' ' 49' ' ' VAL . 35.3 pttt -67.37 -33.81 75.99 Favored 'General case' 0 N--CA 1.464 0.265 0 C-N-CA 121.103 -0.239 . . . . 0.0 111.573 179.75 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.506 HG13 ' HB ' ' A' ' 69' ' ' ILE . 51.3 t -57.85 -39.54 71.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.805 0.336 . . . . 0.0 110.514 177.672 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . 0.548 ' O ' ' HG2' ' A' ' 81' ' ' GLU . 1.9 mm100 -74.31 -44.78 51.14 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 120.651 -0.42 . . . . 0.0 111.407 178.206 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . 0.417 ' HG3' ' O ' ' A' ' 74' ' ' TYR . 47.0 mt-30 -57.65 -43.99 85.32 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-O 121.361 0.6 . . . . 0.0 110.166 179.398 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -66.6 -40.35 88.81 Favored 'General case' 0 N--CA 1.446 -0.675 0 CA-C-N 115.257 -0.883 . . . . 0.0 110.829 -179.693 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 45.0 t -63.21 -57.2 11.27 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.217 179.596 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . 0.548 ' HG2' ' O ' ' A' ' 77' ' ' GLN . 10.2 pt-20 -63.41 -20.18 65.32 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.981 0.419 . . . . 0.0 110.921 -177.456 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 37.7 ttp -75.56 -52.11 11.37 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.436 177.101 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.908 HG11 ' HE1' ' A' ' 51' ' ' MET . 27.9 m -79.61 -29.77 13.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.083 -174.666 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' MET . . . . . 0.592 ' O ' ' HG3' ' A' ' 88' ' ' ARG . 14.8 tpt -66.62 -31.74 72.63 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.086 -0.506 . . . . 0.0 109.686 177.397 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -62.53 -39.16 92.68 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-O 120.894 0.378 . . . . 0.0 110.667 177.122 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.621 HG22 ' HB3' ' A' ' 31' ' ' LEU . 18.7 mt -62.84 -19.2 22.72 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.401 179.136 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.731 HD21 ' HB ' ' A' ' 32' ' ' VAL . 65.5 mt -102.32 -40.45 6.74 Favored 'General case' 0 N--CA 1.449 -0.488 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.786 -175.582 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . 0.592 ' HG3' ' O ' ' A' ' 84' ' ' MET . 0.0 OUTLIER -78.08 -4.15 45.86 Favored 'General case' 0 N--CA 1.464 0.246 0 C-N-CA 120.471 -0.492 . . . . 0.0 111.87 -178.73 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 . . . . . 0 C--O 1.249 1.049 0 CA-C-O 118.372 -0.823 . . . . 0.0 109.39 177.287 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.368 0 CA-C-O 120.286 -0.175 . . . . 0.0 112.71 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . 0.468 ' HA ' ' OH ' ' A' ' 74' ' ' TYR . 27.1 mt-30 65.87 -74.54 0.06 Allowed 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 123.299 0.639 . . . . 0.0 110.586 -174.653 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . 0.687 ' HB2' ' HB3' ' A' ' 12' ' ' ASN . 18.7 p90 -129.85 5.58 5.03 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.447 179.186 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 8.5 t60 67.22 98.74 0.05 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 114.825 -1.079 . . . . 0.0 109.431 -172.448 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -60.21 141.23 56.31 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.197 179.182 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 23.4 t-20 67.37 55.97 0.63 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.759 0.79 . . . . 0.0 109.279 -173.972 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -172.56 -68.39 0.02 OUTLIER 'General case' 0 CA--C 1.528 0.123 0 CA-C-N 114.88 -1.055 . . . . 0.0 110.913 178.873 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . 0.687 ' HB3' ' HB2' ' A' ' 7' ' ' PHE . 7.1 t30 -98.92 93.3 5.95 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.004 0.43 . . . . 0.0 110.776 -177.818 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -138.13 88.14 0.21 Allowed Glycine 0 N--CA 1.45 -0.386 0 N-CA-C 111.218 -0.753 . . . . 0.0 111.218 178.193 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 80.72 -53.81 4.58 Favored Glycine 0 N--CA 1.451 -0.363 0 N-CA-C 110.237 -1.145 . . . . 0.0 110.237 -172.582 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 31.1 mt-30 -82.58 120.82 26.01 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 108.21 -1.033 . . . . 0.0 108.21 171.028 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . 0.86 ' HB3' ' HA2' ' A' ' 71' ' ' GLY . 43.6 m-80 -66.44 120.54 13.53 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.033 0.444 . . . . 0.0 110.035 -178.366 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -100.34 -35.81 4.31 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.715 -0.755 . . . . 0.0 114.072 -168.981 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.432 HG21 ' HA ' ' A' ' 73' ' ' PRO . 87.6 m -73.92 127.63 33.36 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 117.211 0.506 . . . . 0.0 110.423 -176.785 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.44 ' HA ' ' O ' ' A' ' 69' ' ' ILE . 90.5 t -138.01 122.06 21.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.882 -177.014 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 26.0 mt-30 -107.27 118.07 35.74 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 109.891 -0.411 . . . . 0.0 109.891 172.688 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.547 ' HA ' ' O ' ' A' ' 67' ' ' LEU . 42.2 mt-10 -90.29 115.76 27.74 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.061 0.458 . . . . 0.0 111.026 176.233 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 12.8 mm -109.33 151.2 11.7 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-N 115.394 -0.821 . . . . 0.0 109.41 177.995 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 86.7 mmm -104.42 98.1 7.93 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 174.591 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.684 ' HB ' ' HB2' ' A' ' 65' ' ' LYS . 36.8 mm -81.49 129.79 64.52 Favored Pre-proline 0 C--N 1.316 -0.863 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.487 -175.491 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.552 ' HB2' ' HB2' ' A' ' 28' ' ' LYS . 86.5 Cg_exo -46.68 128.11 12.64 Favored 'Trans proline' 0 C--N 1.347 0.497 0 C-N-CA 123.019 2.479 . . . . 0.0 112.451 177.891 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -45.43 -55.84 5.66 Favored 'General case' 0 C--O 1.234 0.254 0 N-CA-C 113.093 0.775 . . . . 0.0 113.093 -170.811 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -81.61 -4.87 90.27 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.837 -0.697 . . . . 0.0 113.066 -174.897 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.552 ' HB2' ' HB2' ' A' ' 25' ' ' PRO . 1.8 tptp -95.79 -8.51 34.14 Favored 'General case' 0 C--N 1.323 -0.558 0 O-C-N 122.673 -0.31 . . . . 0.0 110.198 -177.987 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.614 ' HA ' HG23 ' A' ' 32' ' ' VAL . . . -63.89 -24.32 67.69 Favored 'General case' 0 N--CA 1.461 0.11 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.169 -179.982 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -58.76 -27.43 61.65 Favored Glycine 0 C--O 1.227 -0.319 0 C-N-CA 121.052 -0.595 . . . . 0.0 112.456 178.983 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 84.3 mt -82.86 -34.61 26.75 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.672 0.272 . . . . 0.0 111.143 -178.748 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.751 HG22 HD21 ' A' ' 87' ' ' LEU . 0.0 OUTLIER -74.08 -36.19 43.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.865 0.364 . . . . 0.0 110.345 178.399 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.587 HG12 ' O ' ' A' ' 29' ' ' ALA . 14.5 mm -78.35 -43.06 26.95 Favored 'Isoleucine or valine' 0 C--O 1.235 0.302 0 CA-C-O 121.482 0.658 . . . . 0.0 109.7 178.867 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 111.04 173.26 19.81 Favored Glycine 0 N--CA 1.439 -1.122 0 CA-C-N 115.374 -0.83 . . . . 0.0 112.051 178.365 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 31.1 mmmt -75.36 -22.38 57.6 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 120.853 0.359 . . . . 0.0 110.309 -178.913 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -130.93 -5.31 3.94 Favored Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.586 -0.816 . . . . 0.0 112.162 179.489 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 100.56 -1.09 55.61 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.736 -0.745 . . . . 0.0 111.924 -178.207 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -78.0 -21.43 50.86 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.652 0.263 . . . . 0.0 111.158 -178.865 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.793 ' O ' ' HG ' ' A' ' 43' ' ' LEU . 31.3 m -69.38 -50.86 42.19 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.577 -0.283 . . . . 0.0 110.691 -178.165 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.568 ' HB ' ' HA ' ' A' ' 33' ' ' ILE . 11.6 tt -67.13 -25.18 33.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-O 121.439 0.637 . . . . 0.0 110.448 177.317 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 22.4 tptm -63.24 -53.0 59.89 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.738 175.539 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.412 ' HG2' ' O ' ' A' ' 39' ' ' THR . 8.9 pt20 -68.78 -37.05 79.04 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.395 -175.023 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.793 ' HG ' ' O ' ' A' ' 39' ' ' THR . 84.4 mt -53.86 -39.65 65.86 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.743 -0.662 . . . . 0.0 111.532 179.632 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . 0.448 ' HG3' ' O ' ' A' ' 40' ' ' ILE . 44.9 mt-30 -69.78 -40.97 75.74 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.219 0.533 . . . . 0.0 110.813 -179.61 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 10.2 mm-40 -72.32 -40.51 67.39 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.668 -0.696 . . . . 0.0 111.705 -175.78 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 0.401 ' HG2' ' O ' ' A' ' 42' ' ' GLN . 12.0 ptp180 -71.42 -34.24 70.16 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 112.375 0.509 . . . . 0.0 112.375 -174.458 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.559 ' HB3' HG22 ' A' ' 49' ' ' VAL . . . -99.11 -5.92 29.28 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 112.224 0.453 . . . . 0.0 112.224 -173.587 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 66.27 30.39 76.64 Favored Glycine 0 C--N 1.33 0.225 0 C-N-CA 120.818 -0.706 . . . . 0.0 112.046 -178.627 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.559 HG22 ' HB3' ' A' ' 47' ' ' ALA . 26.8 m -125.11 179.58 3.0 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 N-CA-C 109.724 -0.472 . . . . 0.0 109.724 -178.351 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 64.6 tttp -122.48 125.53 45.98 Favored 'General case' 0 C--N 1.314 -0.938 0 CA-C-N 116.027 -0.533 . . . . 0.0 109.817 167.501 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . 0.569 ' CE ' ' HB1' ' A' ' 79' ' ' ALA . 48.5 mtt -110.75 114.76 28.37 Favored 'General case' 0 C--N 1.315 -0.931 0 N-CA-C 108.418 -0.956 . . . . 0.0 108.418 176.471 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.551 ' CG2' ' HB2' ' A' ' 68' ' ' ARG . 8.9 tt -106.09 105.04 17.96 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.939 0 CA-C-O 121.521 0.677 . . . . 0.0 110.141 177.729 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.52 HD23 ' CD1' ' A' ' 40' ' ' ILE . 4.2 mm? -88.44 101.91 14.37 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.168 -0.924 . . . . 0.0 108.936 174.994 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.533 HD12 ' HB2' ' A' ' 66' ' ' PRO . 51.3 mt -78.98 86.55 1.16 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 178.604 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . 0.501 ' HA ' ' HD2' ' A' ' 65' ' ' LYS . 3.4 pp0? -115.46 -22.94 9.06 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.626 -0.715 . . . . 0.0 111.592 -174.843 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -123.25 -14.92 7.37 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.345 -0.389 . . . . 0.0 109.964 179.633 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -80.32 27.24 2.83 Favored Glycine 0 CA--C 1.522 0.474 0 C-N-CA 120.983 -0.627 . . . . 0.0 112.864 -177.831 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . 0.619 ' HA ' ' OG1' ' A' ' 61' ' ' THR . 18.5 m 59.11 -155.26 0.36 Allowed 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 123.172 0.589 . . . . 0.0 111.667 179.55 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 72.6 mt-30 72.89 -62.2 0.48 Allowed 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 123.658 0.783 . . . . 0.0 110.355 -178.594 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.457 ' HB3' ' O ' ' A' ' 64' ' ' ASP . 8.3 m120 -131.93 46.8 2.6 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.536 0.684 . . . . 0.0 109.52 174.368 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . 0.619 ' OG1' ' HA ' ' A' ' 58' ' ' SER . 0.0 OUTLIER -68.95 -49.46 57.83 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.519 -0.764 . . . . 0.0 111.967 -176.592 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 29.2 p-10 -87.6 8.03 27.04 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.955 -174.753 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.415 ' HB ' ' H ' ' A' ' 64' ' ' ASP . 21.3 m -132.72 -156.94 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 116.794 -0.185 . . . . 0.0 110.859 -178.022 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.457 ' O ' ' HB3' ' A' ' 60' ' ' ASN . 25.2 m-20 -60.97 155.15 20.65 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.048 0.451 . . . . 0.0 110.524 177.663 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.684 ' HB2' ' HB ' ' A' ' 24' ' ' ILE . 71.9 mmtt -99.76 121.5 54.22 Favored Pre-proline 0 C--N 1.318 -0.772 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.787 -170.286 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.533 ' HB2' HD12 ' A' ' 54' ' ' ILE . 23.3 Cg_exo -66.26 106.86 1.08 Allowed 'Trans proline' 0 N--CA 1.46 -0.483 0 C-N-CA 122.801 2.334 . . . . 0.0 110.969 173.02 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.547 ' O ' ' HA ' ' A' ' 21' ' ' GLU . 19.3 tp -108.71 112.03 24.11 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.402 -179.866 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.551 ' HB2' ' CG2' ' A' ' 52' ' ' ILE . 98.8 mtt180 -101.58 108.21 19.7 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.365 174.802 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.44 ' O ' ' HA ' ' A' ' 19' ' ' VAL . 4.9 mp -87.31 104.41 14.21 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 N-CA-C 108.308 -0.997 . . . . 0.0 108.308 170.995 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 18.6 mt -99.87 120.99 50.03 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 CA-C-N 115.85 -0.613 . . . . 0.0 110.533 -174.502 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . 0.86 ' HA2' ' HB3' ' A' ' 16' ' ' ASN . . . 173.57 -135.93 3.44 Favored Glycine 0 CA--C 1.518 0.258 0 C-N-CA 120.807 -0.711 . . . . 0.0 112.985 179.161 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . 0.579 ' OD1' ' HE2' ' A' ' 75' ' ' LYS . 1.5 m-20 -103.28 157.77 33.13 Favored Pre-proline 0 C--N 1.325 -0.481 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 179.684 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . 0.432 ' HA ' HG21 ' A' ' 18' ' ' THR . 82.0 Cg_exo -48.17 -39.28 34.03 Favored 'Trans proline' 0 C--O 1.234 0.29 0 C-N-CA 122.156 1.904 . . . . 0.0 112.367 179.732 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . 0.468 ' OH ' ' HA ' ' A' ' 6' ' ' GLN . 32.4 m-85 -67.27 -62.99 1.15 Allowed 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.225 -178.617 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.579 ' HE2' ' OD1' ' A' ' 72' ' ' ASP . 41.2 pttt -67.66 -25.83 65.91 Favored 'General case' 0 C--O 1.22 -0.449 0 CA-C-N 116.333 -0.394 . . . . 0.0 112.041 -174.052 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.436 HG13 ' HB ' ' A' ' 69' ' ' ILE . 56.1 t -71.76 -35.1 54.07 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-O 121.165 0.507 . . . . 0.0 110.037 177.97 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -74.04 -51.67 15.1 Favored 'General case' 0 N--CA 1.448 -0.563 0 N-CA-C 108.636 -0.876 . . . . 0.0 108.636 178.32 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 92.0 mt-30 -59.93 -39.34 85.14 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.473 -179.245 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . 0.569 ' HB1' ' CE ' ' A' ' 51' ' ' MET . . . -68.07 -36.59 80.09 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.168 178.851 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 52.2 t -67.26 -47.06 71.85 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.803 -178.937 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -70.24 -19.15 63.16 Favored 'General case' 0 C--N 1.325 -0.496 0 C-N-CA 120.344 -0.542 . . . . 0.0 110.632 178.159 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' MET . . . . . 0.431 ' O ' ' HB3' ' A' ' 85' ' ' ASP . 48.8 ttp -75.43 -47.71 26.09 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.468 175.374 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.575 ' O ' ' HG ' ' A' ' 87' ' ' LEU . 28.3 m -72.29 -33.2 45.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 C-N-CA 120.963 -0.295 . . . . 0.0 110.831 -179.874 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 54.4 mtt -67.61 -27.4 66.87 Favored 'General case' 0 CA--C 1.519 -0.235 0 CA-C-O 120.83 0.348 . . . . 0.0 110.173 174.865 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . 0.533 ' O ' ' HG2' ' A' ' 88' ' ' ARG . 8.0 t70 -65.1 -45.33 85.59 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.597 176.115 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 38.9 mt -63.19 -22.62 31.2 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.644 179.196 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.751 HD21 HG22 ' A' ' 32' ' ' VAL . 64.7 mt -97.24 -12.33 23.1 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.708 -176.322 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . 0.695 ' HG3' ' HG2' ' A' ' 89' ' ' GLU . 29.5 ptt180 -101.16 -24.06 14.34 Favored 'General case' 0 CA--C 1.515 -0.37 0 CA-C-O 121.633 0.73 . . . . 0.0 110.088 -177.137 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . 0.695 ' HG2' ' HG3' ' A' ' 88' ' ' ARG . 37.7 mm-40 . . . . . 0 C--N 1.312 -1.047 0 CA-C-N 114.422 -1.263 . . . . 0.0 110.704 -171.475 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . 0.693 ' HA3' ' CE1' ' A' ' 7' ' ' PHE . . . . . . . . 0 N--CA 1.45 -0.399 0 CA-C-O 121.359 0.422 . . . . 0.0 113.234 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 36.0 mt-30 -113.97 40.67 2.41 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 178.365 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . 0.693 ' CE1' ' HA3' ' A' ' 5' ' ' GLY . 64.4 m-85 -69.85 8.3 0.73 Allowed 'General case' 0 CA--C 1.534 0.358 0 CA-C-N 114.94 -1.027 . . . . 0.0 111.889 -172.927 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 68.4 m80 -137.6 87.6 2.27 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.011 0.434 . . . . 0.0 111.475 -173.235 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . 0.441 ' CG ' ' H ' ' A' ' 10' ' ' ASN . 13.3 t70 -124.21 -164.22 1.23 Allowed 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 175.612 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . 0.441 ' H ' ' CG ' ' A' ' 9' ' ' ASP . 36.1 m-80 -56.49 -57.21 13.31 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 109.57 -0.53 . . . . 0.0 109.57 177.898 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.5 ' O ' ' HA ' ' A' ' 16' ' ' ASN . . . -96.28 101.58 13.25 Favored 'General case' 0 N--CA 1.448 -0.527 0 CA-C-N 115.448 -0.797 . . . . 0.0 109.09 172.367 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . 0.421 ' HB3' ' H ' ' A' ' 9' ' ' ASP . 9.0 p30 -126.02 -177.97 4.13 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.348 -176.115 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 95.24 -110.64 4.06 Favored Glycine 0 N--CA 1.447 -0.603 0 N-CA-C 111.205 -0.758 . . . . 0.0 111.205 -177.12 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -73.65 -74.6 0.81 Allowed Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.86 -0.686 . . . . 0.0 111.616 177.678 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . 0.418 HE21 ' HB3' ' A' ' 15' ' ' GLN . 0.0 OUTLIER -82.71 135.62 34.96 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 175.461 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . 0.5 ' HA ' ' O ' ' A' ' 11' ' ' ALA . 0.1 OUTLIER -144.91 42.02 1.31 Allowed 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.349 0.595 . . . . 0.0 110.796 -173.915 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 89.67 -61.55 3.47 Favored Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.704 -0.76 . . . . 0.0 113.596 174.869 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.452 HG21 ' HA ' ' A' ' 73' ' ' PRO . 95.9 m -65.72 127.71 33.04 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.93 0.395 . . . . 0.0 111.35 -175.907 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.941 ' HB ' HD12 ' A' ' 70' ' ' ILE . 0.2 OUTLIER -138.24 128.4 34.85 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 115.648 -0.705 . . . . 0.0 110.932 -179.761 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 27.9 mt-30 -118.31 116.04 25.95 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.881 -0.6 . . . . 0.0 109.951 174.148 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.56 ' HG3' ' HG2' ' A' ' 68' ' ' ARG . 4.5 mp0 -86.61 107.75 18.3 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.119 0.485 . . . . 0.0 110.851 178.784 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 23.1 mm -88.18 156.03 3.17 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-N 115.67 -0.695 . . . . 0.0 110.046 -178.08 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' MET . . . . . 0.465 ' HB3' ' HB3' ' A' ' 64' ' ' ASP . 14.3 mmt -105.83 91.79 3.89 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 109.618 -0.512 . . . . 0.0 109.618 176.653 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.714 ' HB ' ' HB2' ' A' ' 65' ' ' LYS . 26.0 mm -80.85 125.39 80.25 Favored Pre-proline 0 C--N 1.321 -0.668 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.751 -176.488 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.611 ' HB2' ' HB2' ' A' ' 28' ' ' LYS . 64.8 Cg_exo -51.89 130.14 33.22 Favored 'Trans proline' 0 C--O 1.233 0.226 0 C-N-CA 122.813 2.342 . . . . 0.0 111.711 176.412 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -58.34 -38.14 76.57 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 115.754 -0.657 . . . . 0.0 111.45 -177.252 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -90.16 22.47 26.03 Favored Glycine 0 N--CA 1.453 -0.222 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.327 178.268 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.611 ' HB2' ' HB2' ' A' ' 25' ' ' PRO . 21.3 tptt -133.1 0.81 3.47 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 178.136 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.63 -33.96 74.84 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.501 -0.772 . . . . 0.0 111.857 -174.468 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -59.04 -22.08 54.44 Favored Glycine 0 CA--C 1.519 0.33 0 C-N-CA 121.14 -0.552 . . . . 0.0 113.037 -179.397 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.493 ' HB3' HG22 ' A' ' 86' ' ' ILE . 94.2 mt -87.99 -43.19 11.92 Favored 'General case' 0 C--N 1.326 -0.447 0 O-C-N 122.576 -0.367 . . . . 0.0 110.951 -179.887 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.482 HG11 HG21 ' A' ' 24' ' ' ILE . 1.2 p -66.8 -29.97 48.11 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.416 0 CA-C-O 121.199 0.523 . . . . 0.0 110.656 -178.899 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 63.2 mt -81.36 -43.77 20.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-O 121.692 0.758 . . . . 0.0 109.108 173.372 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.542 ' HA3' ' HB ' ' A' ' 39' ' ' THR . . . 116.46 163.43 13.36 Favored Glycine 0 N--CA 1.438 -1.201 0 CA-C-N 115.344 -0.844 . . . . 0.0 112.54 174.805 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.519 ' N ' ' HD3' ' A' ' 35' ' ' LYS . 0.0 OUTLIER -78.64 57.59 2.07 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.305 0.574 . . . . 0.0 110.263 -178.656 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 134.24 14.72 1.21 Allowed Glycine 0 N--CA 1.447 -0.585 0 CA-C-N 115.358 -0.837 . . . . 0.0 111.619 -179.44 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 71.36 6.35 61.47 Favored Glycine 0 C--N 1.333 0.409 0 C-N-CA 121.25 -0.5 . . . . 0.0 112.355 -178.193 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 55.3 mm-40 -84.12 -22.67 31.0 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 120.961 0.41 . . . . 0.0 111.073 -178.511 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.681 ' O ' ' HG ' ' A' ' 43' ' ' LEU . 57.9 m -70.97 -51.68 24.24 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.3 178.282 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.576 ' HA ' HD12 ' A' ' 43' ' ' LEU . 7.8 tt -58.74 -33.7 49.86 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.385 0 CA-C-O 121.312 0.577 . . . . 0.0 110.568 177.808 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 40.0 ttmt -63.66 -37.96 89.32 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.349 177.332 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.609 ' O ' ' HG2' ' A' ' 46' ' ' ARG . 45.7 mt-30 -79.63 -42.03 25.73 Favored 'General case' 0 C--O 1.222 -0.359 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.498 -178.982 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.681 ' HG ' ' O ' ' A' ' 39' ' ' THR . 70.5 mt -49.0 -45.41 42.37 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-O 120.912 0.387 . . . . 0.0 111.789 -176.073 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 45.9 mt-30 -62.4 -44.71 95.79 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.651 179.161 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -68.66 -42.4 77.95 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.095 -179.264 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 0.609 ' HG2' ' O ' ' A' ' 42' ' ' GLN . 15.4 mmt180 -52.31 -44.62 65.17 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.805 -175.553 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -102.64 -9.98 19.63 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.618 -175.424 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 71.09 39.86 62.51 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.73 -0.747 . . . . 0.0 111.291 -175.09 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 27.3 m -122.77 178.95 2.8 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-O 120.891 0.377 . . . . 0.0 110.476 -175.534 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.452 ' C ' ' HD3' ' A' ' 50' ' ' LYS . 1.1 tmtp? -116.74 124.41 49.58 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 175.17 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . 0.568 ' CE ' ' HB1' ' A' ' 79' ' ' ALA . 64.3 mtt -117.37 121.99 42.61 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.482 -0.327 . . . . 0.0 110.43 178.406 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.748 HG22 ' HB2' ' A' ' 68' ' ' ARG . 0.0 OUTLIER -110.44 116.57 52.72 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 CA-C-O 121.648 0.737 . . . . 0.0 109.21 176.146 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.635 HD22 HD13 ' A' ' 67' ' ' LEU . 2.8 mm? -95.7 105.72 17.75 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.388 -0.823 . . . . 0.0 110.339 179.499 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.769 HD12 ' HB2' ' A' ' 66' ' ' PRO . 60.1 mt -75.59 96.26 1.18 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 121.332 0.587 . . . . 0.0 110.223 179.867 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 57.7 mt-30 -106.69 -48.9 3.42 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.658 -0.701 . . . . 0.0 109.792 -179.83 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 19.4 m-20 -82.07 -28.33 32.44 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.38 -0.827 . . . . 0.0 110.719 -179.193 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . 0.496 ' O ' ' HB ' ' A' ' 61' ' ' THR . . . -68.22 130.45 26.85 Favored Glycine 0 N--CA 1.447 -0.6 0 C-N-CA 120.66 -0.781 . . . . 0.0 112.09 -176.361 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 47.9 m -80.61 62.52 4.71 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.718 0.771 . . . . 0.0 111.027 179.24 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 23.3 mm-40 -129.85 98.45 4.79 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 107.852 -1.166 . . . . 0.0 107.852 171.801 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 4.3 m-20 59.77 31.06 20.61 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.246 0.546 . . . . 0.0 110.14 -174.001 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . 0.496 ' HB ' ' O ' ' A' ' 57' ' ' GLY . 14.2 t -72.36 -20.62 61.43 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.991 -0.549 . . . . 0.0 111.675 -173.506 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 81.2 m-20 -104.46 6.5 34.93 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.029 0.442 . . . . 0.0 110.926 -179.583 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.408 ' HB ' ' H ' ' A' ' 64' ' ' ASP . 13.8 m -131.69 -144.62 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.018 178.088 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.465 ' HB3' ' HB3' ' A' ' 23' ' ' MET . 23.2 m-20 -61.26 139.36 58.16 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 110.036 -0.357 . . . . 0.0 110.036 176.276 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.714 ' HB2' ' HB ' ' A' ' 24' ' ' ILE . 70.6 mmtt -89.43 120.82 69.68 Favored Pre-proline 0 C--N 1.32 -0.686 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.882 -171.097 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.769 ' HB2' HD12 ' A' ' 54' ' ' ILE . 28.5 Cg_exo -66.35 104.68 0.78 Allowed 'Trans proline' 0 N--CA 1.462 -0.377 0 C-N-CA 122.928 2.419 . . . . 0.0 112.124 175.001 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.635 HD13 HD22 ' A' ' 53' ' ' LEU . 14.5 tp -103.21 118.13 36.09 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.906 -0.588 . . . . 0.0 109.946 176.057 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.748 ' HB2' HG22 ' A' ' 52' ' ' ILE . 95.5 mtt180 -98.19 110.85 23.36 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 116.556 -0.293 . . . . 0.0 110.897 177.015 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 4.2 mp -96.47 104.73 16.2 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 171.598 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.941 HD12 ' HB ' ' A' ' 19' ' ' VAL . 3.6 mm -100.85 134.82 39.62 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 N-CA-C 109.914 -0.402 . . . . 0.0 109.914 -178.229 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . 0.417 ' O ' ' HB ' ' A' ' 18' ' ' THR . . . 164.44 -142.14 7.57 Favored Glycine 0 N--CA 1.447 -0.626 0 C-N-CA 121.054 -0.593 . . . . 0.0 111.625 178.568 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . 0.556 ' OD2' ' HB3' ' A' ' 74' ' ' TYR . 8.8 t70 -93.83 140.92 23.15 Favored Pre-proline 0 C--N 1.318 -0.79 0 CA-C-O 118.35 -0.833 . . . . 0.0 109.122 179.686 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . 0.452 ' HA ' HG21 ' A' ' 18' ' ' THR . 84.0 Cg_exo -41.78 -41.1 5.98 Favored 'Trans proline' 0 C--N 1.346 0.433 0 C-N-CA 122.757 2.305 . . . . 0.0 113.066 -177.806 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . 0.556 ' HB3' ' OD2' ' A' ' 72' ' ' ASP . 69.2 t80 -63.48 -58.68 6.25 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.296 -178.74 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.495 ' HG2' ' HB3' ' A' ' 72' ' ' ASP . 38.0 pttt -71.91 -27.87 63.11 Favored 'General case' 0 CA--C 1.518 -0.268 0 C-N-CA 120.446 -0.501 . . . . 0.0 111.557 -178.019 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 55.3 t -63.7 -39.67 86.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 N-CA-C 109.53 -0.545 . . . . 0.0 109.53 176.832 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 22.7 tp60 -75.85 -44.95 38.33 Favored 'General case' 0 N--CA 1.445 -0.698 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.79 -179.717 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . 0.409 ' HA ' ' HG2' ' A' ' 81' ' ' GLU . 55.5 mt-30 -64.82 -35.78 82.22 Favored 'General case' 0 C--N 1.33 -0.271 0 C-N-CA 120.469 -0.493 . . . . 0.0 110.926 -179.921 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . 0.568 ' HB1' ' CE ' ' A' ' 51' ' ' MET . . . -71.38 -34.71 70.68 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 120.93 0.395 . . . . 0.0 110.09 176.222 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 36.7 t -65.22 -47.87 75.35 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.253 178.023 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . 0.409 ' HG2' ' HA ' ' A' ' 78' ' ' GLN . 10.5 pt-20 -69.72 -22.37 63.4 Favored 'General case' 0 C--N 1.322 -0.601 0 C-N-CA 120.684 -0.406 . . . . 0.0 110.14 178.861 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' MET . . . . . 0.475 ' O ' ' HB3' ' A' ' 85' ' ' ASP . 57.4 ttp -73.74 -46.28 46.88 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.664 176.338 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.542 ' O ' ' HG ' ' A' ' 87' ' ' LEU . 33.2 m -72.03 -36.56 57.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 C-N-CA 120.662 -0.415 . . . . 0.0 110.665 178.905 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' MET . . . . . 0.404 ' O ' ' HG2' ' A' ' 88' ' ' ARG . 54.1 mtt -65.0 -32.08 73.63 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 109.975 -0.379 . . . . 0.0 109.975 175.146 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . 0.475 ' HB3' ' O ' ' A' ' 82' ' ' MET . 18.8 t70 -58.23 -48.79 79.27 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.648 176.315 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.493 HG22 ' HB3' ' A' ' 31' ' ' LEU . 34.8 mt -60.63 -29.7 45.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 121.271 0.558 . . . . 0.0 110.536 179.562 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.542 ' HG ' ' O ' ' A' ' 83' ' ' VAL . 62.0 mt -92.06 -1.71 57.06 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.661 -0.699 . . . . 0.0 111.927 -174.755 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . 0.404 ' HG2' ' O ' ' A' ' 84' ' ' MET . 19.2 ptp180 -129.83 16.49 5.78 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.059 0.457 . . . . 0.0 111.141 -179.929 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 10.5 tt0 . . . . . 0 C--O 1.249 1.059 0 CA-C-O 118.186 -0.912 . . . . 0.0 109.86 179.218 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.533 0 N-CA-C 111.998 -0.441 . . . . 0.0 111.998 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 14.5 mt-30 -81.64 35.24 0.4 Allowed 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 110.34 -0.244 . . . . 0.0 110.34 -179.921 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . 0.623 ' HD1' ' HB3' ' A' ' 72' ' ' ASP . 50.2 m-85 67.57 152.87 0.08 Allowed 'General case' 0 N--CA 1.465 0.321 0 C-N-CA 123.685 0.794 . . . . 0.0 110.844 -174.984 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . 0.429 ' O ' ' HB3' ' A' ' 9' ' ' ASP . 1.8 t-80 -157.51 -76.08 0.09 Allowed 'General case' 0 C--N 1.319 -0.745 0 N-CA-C 108.863 -0.792 . . . . 0.0 108.863 170.294 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . 0.593 ' HA ' ' OD2' ' A' ' 72' ' ' ASP . 8.5 p-10 174.12 128.02 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.439 0 O-C-N 123.916 0.76 . . . . 0.0 110.971 171.831 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 22.4 t-20 70.26 -68.5 0.2 Allowed 'General case' 0 N--CA 1.471 0.593 0 CA-C-N 115.428 -0.806 . . . . 0.0 111.797 174.928 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -112.93 109.85 19.55 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.184 -178.37 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . 0.708 HD21 ' HD3' ' A' ' 73' ' ' PRO . 20.6 p-10 -135.94 177.96 7.42 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.358 -177.851 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 77.94 -92.52 1.14 Allowed Glycine 0 N--CA 1.449 -0.469 0 C-N-CA 120.849 -0.691 . . . . 0.0 112.439 178.258 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -166.44 -59.75 0.03 OUTLIER Glycine 0 N--CA 1.448 -0.516 0 C-N-CA 121.105 -0.569 . . . . 0.0 112.027 -178.464 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 50.6 mt-30 -96.27 106.77 19.03 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 110.299 -0.26 . . . . 0.0 110.299 179.032 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 89.9 m-20 67.81 -68.77 0.15 Allowed 'General case' 0 N--CA 1.467 0.414 0 O-C-N 123.941 0.776 . . . . 0.0 112.254 177.016 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 156.73 -159.6 29.67 Favored Glycine 0 N--CA 1.446 -0.674 0 N-CA-C 110.599 -1.0 . . . . 0.0 110.599 -176.443 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 32.8 m -100.57 126.14 47.0 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 117.438 0.619 . . . . 0.0 109.991 176.129 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.518 ' HA ' ' O ' ' A' ' 69' ' ' ILE . 7.5 p -141.8 136.27 30.54 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.405 -176.183 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . 0.524 ' O ' ' HA ' ' A' ' 68' ' ' ARG . 35.6 mt-30 -112.84 158.69 19.84 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.194 -0.457 . . . . 0.0 109.802 171.962 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.626 ' HG2' ' HG2' ' A' ' 68' ' ' ARG . 51.9 mt-10 -125.28 113.57 17.79 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.932 0.396 . . . . 0.0 109.968 178.683 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 9.6 mm -104.69 137.8 32.24 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.375 -178.195 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -86.07 91.52 8.43 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 172.362 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.838 HG23 HD21 ' A' ' 87' ' ' LEU . 33.1 mm -79.86 126.35 80.23 Favored Pre-proline 0 C--N 1.319 -0.76 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.791 -177.546 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.775 ' HB2' ' HB2' ' A' ' 28' ' ' LYS . 72.7 Cg_exo -51.99 135.86 51.8 Favored 'Trans proline' 0 N--CA 1.461 -0.392 0 C-N-CA 122.675 2.25 . . . . 0.0 111.416 175.459 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -57.93 -33.36 68.72 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.661 -0.7 . . . . 0.0 112.626 -172.865 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -82.74 -29.36 35.54 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.495 -0.86 . . . . 0.0 111.688 177.375 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.775 ' HB2' ' HB2' ' A' ' 25' ' ' PRO . 11.7 mptt -79.68 -8.23 59.09 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.981 0.42 . . . . 0.0 110.736 179.802 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.436 ' HB2' ' HG3' ' A' ' 65' ' ' LYS . . . -61.54 -26.63 68.06 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.501 176.832 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -68.93 -17.68 71.82 Favored Glycine 0 N--CA 1.449 -0.499 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.331 177.673 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.432 ' HB3' HG22 ' A' ' 86' ' ' ILE . 84.8 mt -88.86 -37.93 14.96 Favored 'General case' 0 C--N 1.326 -0.427 0 O-C-N 122.677 -0.308 . . . . 0.0 110.902 -179.701 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.557 HG13 HD11 ' A' ' 87' ' ' LEU . 0.5 OUTLIER -71.69 -33.78 49.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 120.792 0.33 . . . . 0.0 110.683 176.392 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.601 ' HA ' ' HB ' ' A' ' 40' ' ' ILE . 83.7 mt -77.64 -40.98 28.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-O 121.601 0.715 . . . . 0.0 109.479 174.191 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.552 ' HA3' ' HB ' ' A' ' 39' ' ' THR . . . 104.3 177.2 25.27 Favored Glycine 0 N--CA 1.442 -0.927 0 CA-C-N 115.514 -0.766 . . . . 0.0 112.467 175.893 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 30.1 mmmt -76.71 62.56 2.01 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.088 0.47 . . . . 0.0 110.419 -178.457 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 118.07 19.68 4.68 Favored Glycine 0 N--CA 1.448 -0.54 0 C-N-CA 120.972 -0.633 . . . . 0.0 112.005 178.492 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.401 ' HA2' HG22 ' A' ' 33' ' ' ILE . . . 82.5 3.78 90.39 Favored Glycine 0 N--CA 1.449 -0.479 0 C-N-CA 120.875 -0.679 . . . . 0.0 112.521 179.081 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.734 ' HG3' HE21 ' A' ' 42' ' ' GLN . 20.8 tp10 -78.21 -37.66 44.95 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 120.79 0.328 . . . . 0.0 110.975 -177.874 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.603 ' O ' ' HG ' ' A' ' 43' ' ' LEU . 28.8 m -67.43 -40.23 85.48 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.648 -0.251 . . . . 0.0 111.492 -177.176 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.601 ' HB ' ' HA ' ' A' ' 33' ' ' ILE . 14.5 tt -63.8 -28.88 45.89 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.411 0 CA-C-O 121.172 0.511 . . . . 0.0 110.778 179.601 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.638 ' HD3' ' HA ' ' A' ' 38' ' ' GLU . 52.1 mtpt -66.46 -40.59 89.46 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.195 0.522 . . . . 0.0 109.852 174.606 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.734 HE21 ' HG3' ' A' ' 38' ' ' GLU . 76.4 mt-30 -70.76 -42.42 70.47 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.269 -0.878 . . . . 0.0 110.674 -176.693 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.603 ' HG ' ' O ' ' A' ' 39' ' ' THR . 81.8 mt -56.83 -47.06 81.18 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.589 -176.864 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 49.9 mt-30 -61.47 -53.5 55.7 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.431 -176.975 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -68.16 -39.65 82.56 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 112.033 0.383 . . . . 0.0 112.033 -175.591 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 0.472 ' HD3' ' SD ' ' A' ' 82' ' ' MET . 12.3 ptm180 -70.01 -31.17 68.7 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.936 0.398 . . . . 0.0 111.214 -174.78 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.535 ' HB3' HG22 ' A' ' 49' ' ' VAL . . . -93.27 -15.95 25.28 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.367 -177.111 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 73.49 25.45 72.56 Favored Glycine 0 N--CA 1.45 -0.401 0 CA-C-N 115.947 -0.57 . . . . 0.0 111.953 -178.729 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.535 HG22 ' HB3' ' A' ' 47' ' ' ALA . 35.1 m -123.93 173.88 9.06 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-O 120.843 0.354 . . . . 0.0 110.066 -177.399 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.502 ' HE2' HD12 ' A' ' 70' ' ' ILE . 2.2 tmmm? -109.97 123.33 49.45 Favored 'General case' 0 C--N 1.318 -0.762 0 N-CA-C 108.679 -0.86 . . . . 0.0 108.679 174.753 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . 0.532 ' CE ' ' HB1' ' A' ' 79' ' ' ALA . 63.5 mtt -114.43 116.42 28.86 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.195 -179.671 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.512 ' CG2' ' HB2' ' A' ' 68' ' ' ARG . 9.9 tt -106.57 105.16 18.23 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.83 0 CA-C-O 121.484 0.659 . . . . 0.0 110.11 176.14 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.581 HD22 HD13 ' A' ' 67' ' ' LEU . 3.5 mm? -82.24 102.58 11.24 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 108.963 -0.754 . . . . 0.0 108.963 173.723 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.701 HD12 ' HB2' ' A' ' 66' ' ' PRO . 53.5 mt -79.25 86.92 1.23 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-O 121.433 0.635 . . . . 0.0 110.166 -176.372 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . 0.522 HE22 ' HB3' ' A' ' 65' ' ' LYS . 25.2 mm-40 -98.84 -24.91 14.81 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.355 -0.839 . . . . 0.0 109.516 -179.814 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -96.54 -31.69 12.64 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.333 -0.849 . . . . 0.0 110.849 -178.418 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -70.2 138.96 30.12 Favored Glycine 0 N--CA 1.453 -0.218 0 C-N-CA 121.016 -0.611 . . . . 0.0 112.557 -178.484 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 5.1 m -84.74 67.17 9.96 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.43 0.633 . . . . 0.0 110.805 -176.567 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . 0.494 ' HB2' ' HG2' ' A' ' 66' ' ' PRO . 27.5 mm-40 -124.43 67.03 1.07 Allowed 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.771 -0.649 . . . . 0.0 109.872 179.108 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 3.5 m-20 62.88 41.16 8.92 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 116.058 -0.519 . . . . 0.0 109.787 -176.046 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 7.0 t -80.64 -27.66 37.13 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.002 -0.544 . . . . 0.0 111.405 -175.905 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 87.4 m-20 -85.24 20.5 1.95 Allowed 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.338 0.59 . . . . 0.0 111.087 -178.252 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.567 HG23 ' H ' ' A' ' 64' ' ' ASP . 0.2 OUTLIER -138.44 -57.48 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-N 115.301 -0.863 . . . . 0.0 110.102 174.197 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.567 ' H ' HG23 ' A' ' 63' ' ' VAL . 49.7 m-20 -128.92 -166.07 1.59 Allowed 'General case' 0 C--N 1.308 -1.221 0 CA-C-N 114.265 -1.334 . . . . 0.0 108.309 179.122 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.754 ' HB2' ' HB ' ' A' ' 24' ' ' ILE . 66.9 mmtt -141.6 116.73 7.03 Favored Pre-proline 0 C--N 1.314 -0.937 0 CA-C-N 116.708 -0.224 . . . . 0.0 110.632 -176.784 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.701 ' HB2' HD12 ' A' ' 54' ' ' ILE . 25.1 Cg_exo -64.42 124.19 12.94 Favored 'Trans proline' 0 N--CA 1.461 -0.431 0 C-N-CA 122.82 2.347 . . . . 0.0 111.863 176.308 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.581 HD13 HD22 ' A' ' 53' ' ' LEU . 33.7 tp -124.1 106.84 10.67 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.954 -0.567 . . . . 0.0 109.839 177.793 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.626 ' HG2' ' HG2' ' A' ' 21' ' ' GLU . 87.4 mtt180 -96.98 105.59 17.77 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.139 177.711 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.518 ' O ' ' HA ' ' A' ' 19' ' ' VAL . 4.4 mp -87.96 104.49 14.55 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 174.449 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.502 HD12 ' HE2' ' A' ' 50' ' ' LYS . 13.8 mt -104.34 126.93 59.01 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.026 -173.491 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 167.82 -142.52 7.55 Favored Glycine 0 N--CA 1.446 -0.648 0 N-CA-C 111.596 -0.602 . . . . 0.0 111.596 178.65 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . 0.623 ' HB3' ' HD1' ' A' ' 7' ' ' PHE . 15.1 m-20 -91.33 149.12 39.1 Favored Pre-proline 0 C--N 1.325 -0.489 0 CA-C-O 118.963 -0.541 . . . . 0.0 109.692 175.859 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . 0.708 ' HD3' HD21 ' A' ' 12' ' ' ASN . 77.5 Cg_exo -49.36 -39.53 43.94 Favored 'Trans proline' 0 C--N 1.343 0.285 0 C-N-CA 122.333 2.022 . . . . 0.0 112.31 -176.948 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 76.0 t80 -64.36 -56.32 15.2 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.262 -176.995 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.477 ' HG2' ' HB2' ' A' ' 72' ' ' ASP . 4.9 ptpt -68.06 -31.97 71.99 Favored 'General case' 0 C--O 1.223 -0.301 0 C-N-CA 120.671 -0.412 . . . . 0.0 111.296 179.41 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.406 HG23 ' O ' ' A' ' 72' ' ' ASP . 53.1 t -65.18 -40.09 87.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.998 0.427 . . . . 0.0 110.012 178.163 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . 0.47 ' O ' ' HG2' ' A' ' 81' ' ' GLU . 19.4 tp60 -64.81 -51.88 59.81 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.032 176.707 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 25.1 mt-30 -62.97 -35.14 79.17 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 121.0 0.428 . . . . 0.0 110.853 -178.202 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . 0.532 ' HB1' ' CE ' ' A' ' 51' ' ' MET . . . -72.1 -35.31 69.15 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.999 179.812 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' CYS . . . . . 0.4 ' HA ' HG22 ' A' ' 83' ' ' VAL . 52.7 t -72.29 -45.56 59.52 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.144 -179.457 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . 0.47 ' HG2' ' O ' ' A' ' 77' ' ' GLN . 10.2 pt-20 -66.83 -22.62 65.99 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.101 0.477 . . . . 0.0 110.024 177.834 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' MET . . . . . 0.472 ' SD ' ' HD3' ' A' ' 46' ' ' ARG . 42.8 ttp -71.5 -55.41 7.91 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.54 -0.755 . . . . 0.0 110.423 175.822 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.451 HG12 HD13 ' A' ' 43' ' ' LEU . 31.3 m -66.95 -34.97 73.44 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.169 0 C-N-CA 121.116 -0.234 . . . . 0.0 110.985 -179.455 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 66.6 mmm -62.17 -37.45 85.28 Favored 'General case' 0 CA--C 1.519 -0.229 0 CA-C-O 120.685 0.279 . . . . 0.0 110.505 176.391 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . 0.465 ' O ' ' HB2' ' A' ' 89' ' ' GLU . 36.5 t70 -65.8 -44.52 85.43 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.918 -179.781 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.432 HG22 ' HB3' ' A' ' 31' ' ' LEU . 57.8 mt -60.01 -31.25 47.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 121.148 0.499 . . . . 0.0 110.768 179.822 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.838 HD21 HG23 ' A' ' 24' ' ' ILE . 7.1 mp -81.48 -31.79 32.79 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.815 -0.629 . . . . 0.0 112.268 -177.176 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 15.3 ptm180 -95.88 -5.79 40.74 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.134 0.492 . . . . 0.0 111.132 -176.768 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . 0.465 ' HB2' ' O ' ' A' ' 85' ' ' ASP . 4.7 mm-40 . . . . . 0 C--O 1.251 1.137 0 CA-C-O 118.438 -0.791 . . . . 0.0 110.031 178.473 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.444 -0.781 0 N-CA-C 111.708 -0.557 . . . . 0.0 111.708 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 9.0 tt0 54.9 59.26 4.17 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.202 0.525 . . . . 0.0 109.916 -177.754 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . 0.662 ' CD1' ' HG2' ' A' ' 73' ' ' PRO . 9.4 m-85 61.05 -97.94 0.07 Allowed 'General case' 0 N--CA 1.463 0.178 0 CA-C-N 115.217 -0.901 . . . . 0.0 109.702 -176.082 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . 0.465 ' H ' ' HB2' ' A' ' 7' ' ' PHE . 0.6 OUTLIER 64.64 176.85 0.19 Allowed 'General case' 0 CA--C 1.534 0.35 0 O-C-N 123.704 0.627 . . . . 0.0 111.867 171.869 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . 0.55 ' HA ' ' NZ ' ' A' ' 75' ' ' LYS . 20.1 m-20 -106.64 85.72 2.21 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.527 -0.306 . . . . 0.0 111.013 179.601 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 38.8 t30 179.39 -77.13 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.063 -0.517 . . . . 0.0 109.865 178.325 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -172.37 99.88 0.15 Allowed 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.367 -0.833 . . . . 0.0 109.595 -178.698 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 6.5 p30 -66.32 114.31 5.28 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.36 0.6 . . . . 0.0 110.802 179.232 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 89.63 -95.33 2.08 Favored Glycine 0 N--CA 1.45 -0.425 0 CA-C-N 115.661 -0.699 . . . . 0.0 112.039 -179.028 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -113.97 -84.05 1.24 Allowed Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 121.017 -0.611 . . . . 0.0 111.668 178.602 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 7.8 tt0 -129.55 108.57 10.34 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 174.663 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . 0.588 ' HB3' HG22 ' A' ' 70' ' ' ILE . 13.6 m120 65.32 -176.29 0.18 Allowed 'General case' 0 CA--C 1.532 0.283 0 O-C-N 123.667 0.605 . . . . 0.0 110.741 -179.882 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -166.73 -71.26 0.03 OUTLIER Glycine 0 N--CA 1.449 -0.445 0 C-N-CA 120.652 -0.785 . . . . 0.0 112.076 179.24 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 94.3 m -72.91 135.1 45.03 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 120.669 0.271 . . . . 0.0 110.62 179.457 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.653 ' HA ' ' O ' ' A' ' 69' ' ' ILE . 6.2 p -129.72 124.32 58.89 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-O 121.13 0.49 . . . . 0.0 110.801 178.073 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 28.6 mt-30 -110.29 114.6 28.2 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.055 -0.52 . . . . 0.0 109.887 174.663 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.659 ' HA ' ' O ' ' A' ' 67' ' ' LEU . 43.4 mt-10 -90.37 116.04 28.02 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.086 0.469 . . . . 0.0 110.535 176.106 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 22.0 mm -103.69 137.42 32.33 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.767 0 CA-C-N 115.687 -0.688 . . . . 0.0 109.839 -179.561 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' MET . . . . . 0.449 ' HB3' ' HB3' ' A' ' 64' ' ' ASP . 3.1 mmt -89.13 94.27 9.87 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 176.593 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.864 HG23 HD13 ' A' ' 87' ' ' LEU . 27.2 mm -77.66 129.19 77.52 Favored Pre-proline 0 C--N 1.318 -0.801 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.027 -175.06 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.537 ' HB2' ' HB2' ' A' ' 28' ' ' LYS . 53.8 Cg_exo -52.93 125.43 18.22 Favored 'Trans proline' 0 N--CA 1.458 -0.596 0 C-N-CA 122.188 1.925 . . . . 0.0 110.685 172.01 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -57.63 -27.87 63.18 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 112.097 0.406 . . . . 0.0 112.097 -174.057 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -80.21 -30.66 40.94 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.511 177.306 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.545 ' HB3' HD22 ' A' ' 87' ' ' LEU . 21.2 mmtp -89.42 -4.41 58.02 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.727 0.299 . . . . 0.0 111.234 -177.966 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.411 ' O ' HG23 ' A' ' 32' ' ' VAL . . . -57.44 -28.89 63.73 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.707 -178.173 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -62.28 -26.32 67.7 Favored Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 120.925 -0.655 . . . . 0.0 112.856 -179.81 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 69.6 mt -78.73 -39.84 35.18 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.883 0.341 . . . . 0.0 111.398 -178.173 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.552 HG21 HG21 ' A' ' 24' ' ' ILE . 0.0 OUTLIER -65.74 -38.06 81.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 121.19 0.519 . . . . 0.0 110.106 179.177 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 49.9 mt -72.61 -42.67 62.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-O 121.546 0.689 . . . . 0.0 109.499 175.838 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 100.57 39.61 3.16 Favored Glycine 0 CA--C 1.499 -0.938 0 CA-C-N 115.17 -0.923 . . . . 0.0 112.685 176.708 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 3.7 mppt? 53.0 36.9 23.28 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.079 -0.561 . . . . 0.0 111.45 179.265 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 159.04 -48.95 0.41 Allowed Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.54 -0.838 . . . . 0.0 112.145 -179.195 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 145.31 -6.68 1.52 Allowed Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.24 -0.981 . . . . 0.0 113.476 179.866 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 43.9 mm-40 -65.64 -40.76 92.86 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 117.006 0.403 . . . . 0.0 112.012 -179.014 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.729 ' O ' ' HG ' ' A' ' 43' ' ' LEU . 91.6 m -62.39 -54.64 37.41 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.876 -0.147 . . . . 0.0 111.278 -178.105 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.593 ' HA ' HD12 ' A' ' 43' ' ' LEU . 5.3 tt -58.34 -30.96 41.57 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.365 0 CA-C-O 121.219 0.533 . . . . 0.0 111.157 -179.346 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.459 ' HE2' ' HB3' ' A' ' 41' ' ' LYS . 4.9 tmmm? -70.33 -41.72 72.86 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.932 -0.576 . . . . 0.0 109.819 177.842 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 15.4 mm-40 -69.37 -38.18 77.92 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.956 -179.492 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.729 ' HG ' ' O ' ' A' ' 39' ' ' THR . 73.7 mt -56.42 -43.9 79.83 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.826 -0.624 . . . . 0.0 111.215 -177.755 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 46.7 mt-30 -67.08 -31.25 71.61 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.376 -177.432 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -80.14 -43.01 22.38 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.892 0.377 . . . . 0.0 111.162 -178.833 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 13.5 ptm180 -75.52 -36.51 60.49 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.952 -0.567 . . . . 0.0 112.45 -173.352 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.452 ' HB3' HG22 ' A' ' 49' ' ' VAL . . . -95.89 -17.21 21.27 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.861 0.362 . . . . 0.0 111.33 -178.247 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 79.41 3.17 88.58 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.879 -0.677 . . . . 0.0 112.208 -179.785 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.452 HG22 ' HB3' ' A' ' 47' ' ' ALA . 34.3 m -97.3 166.02 1.98 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-O 120.637 0.256 . . . . 0.0 110.379 -177.769 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 63.9 tttp -105.21 122.84 46.75 Favored 'General case' 0 C--N 1.316 -0.858 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 172.843 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . 0.592 ' HE3' HG21 ' A' ' 83' ' ' VAL . 77.1 mtp -119.07 115.92 25.31 Favored 'General case' 0 C--N 1.316 -0.854 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 178.263 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.565 ' CG2' ' HB2' ' A' ' 68' ' ' ARG . 8.7 tt -105.4 105.4 18.59 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.937 0 CA-C-O 121.588 0.709 . . . . 0.0 110.734 179.826 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.708 HD22 HD13 ' A' ' 67' ' ' LEU . 3.7 mm? -78.57 103.15 8.32 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 173.042 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.845 HD12 ' HB2' ' A' ' 66' ' ' PRO . 56.7 mt -73.33 89.11 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-O 121.518 0.675 . . . . 0.0 110.462 -178.091 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 58.4 mt-30 -100.52 -34.25 9.99 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.03 -0.986 . . . . 0.0 110.339 -178.519 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 35.7 m-20 -96.46 6.25 49.15 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.662 -177.984 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -80.9 -173.07 46.89 Favored Glycine 0 N--CA 1.447 -0.586 0 C-N-CA 120.681 -0.771 . . . . 0.0 111.543 177.396 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 1.7 p -149.92 27.83 0.78 Allowed 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 117.245 0.522 . . . . 0.0 112.079 -178.315 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 5.7 pt20 -93.37 -50.61 5.37 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.976 178.762 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.605 ' HB2' ' HG3' ' A' ' 66' ' ' PRO . 19.6 m120 -142.88 35.21 1.39 Allowed 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 109.592 -0.522 . . . . 0.0 109.592 179.083 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -76.82 -31.89 57.23 Favored 'General case' 0 C--N 1.314 -0.935 0 N-CA-C 112.583 0.586 . . . . 0.0 112.583 -169.669 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 7.4 p30 -82.65 -1.07 50.02 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 120.797 0.332 . . . . 0.0 111.222 -179.487 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 15.6 m -125.28 -146.56 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-N 116.158 -0.474 . . . . 0.0 109.827 179.218 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.449 ' HB3' ' HB3' ' A' ' 23' ' ' MET . 7.1 m-20 -56.62 134.43 54.51 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 109.593 -0.521 . . . . 0.0 109.593 174.777 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.719 ' HB2' ' HB ' ' A' ' 24' ' ' ILE . 70.4 mmtt -84.02 129.12 59.98 Favored Pre-proline 0 C--N 1.318 -0.795 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.46 -165.243 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.845 ' HB2' HD12 ' A' ' 54' ' ' ILE . 17.3 Cg_exo -68.83 105.83 1.39 Allowed 'Trans proline' 0 N--CA 1.46 -0.492 0 C-N-CA 123.054 2.502 . . . . 0.0 111.413 174.522 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.708 HD13 HD22 ' A' ' 53' ' ' LEU . 31.6 tp -115.7 104.21 11.45 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.46 -0.336 . . . . 0.0 110.619 179.455 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.565 ' HB2' ' CG2' ' A' ' 52' ' ' ILE . 92.6 mtt180 -91.65 108.23 19.76 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.881 0.372 . . . . 0.0 110.131 176.882 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.653 ' O ' ' HA ' ' A' ' 19' ' ' VAL . 22.1 mt -94.9 104.38 15.74 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 174.681 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.588 HG22 ' HB3' ' A' ' 16' ' ' ASN . 3.7 mt -110.85 127.54 67.86 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.847 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.19 -173.95 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 173.48 -147.17 9.34 Favored Glycine 0 N--CA 1.448 -0.565 0 C-N-CA 120.508 -0.853 . . . . 0.0 112.073 178.104 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . 0.539 ' O ' HG23 ' A' ' 76' ' ' VAL . 41.2 m-20 -84.12 140.1 39.65 Favored Pre-proline 0 C--N 1.323 -0.565 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 177.405 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . 0.662 ' HG2' ' CD1' ' A' ' 7' ' ' PHE . 76.5 Cg_exo -41.41 -53.4 3.18 Favored 'Trans proline' 0 CA--C 1.534 0.478 0 C-N-CA 123.746 2.964 . . . . 0.0 115.291 -169.443 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 35.8 p90 -76.31 -33.09 59.05 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 112.74 0.644 . . . . 0.0 112.74 -172.227 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.55 ' NZ ' ' HA ' ' A' ' 9' ' ' ASP . 6.1 ptpp? -72.49 -30.11 64.23 Favored 'General case' 0 CA--C 1.514 -0.412 0 C-N-CA 119.788 -0.765 . . . . 0.0 110.238 177.038 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.539 HG23 ' O ' ' A' ' 72' ' ' ASP . 92.3 t -63.08 -40.82 90.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 N-CA-C 109.427 -0.583 . . . . 0.0 109.427 177.035 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . 0.715 ' HA ' HE21 ' A' ' 77' ' ' GLN . 0.0 OUTLIER -72.65 -46.56 53.36 Favored 'General case' 0 N--CA 1.447 -0.579 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.903 178.049 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 23.9 mt-30 -61.29 -40.18 93.17 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 120.79 -0.364 . . . . 0.0 111.052 179.637 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -71.67 -32.95 68.43 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.482 177.695 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 5.6 t -61.2 -57.12 13.76 Favored 'General case' 0 CA--C 1.515 -0.393 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.188 177.262 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 17.4 mm-40 -62.29 -29.51 70.48 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.723 -179.162 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' MET . . . . . 0.493 ' O ' HG13 ' A' ' 86' ' ' ILE . 43.6 ttp -63.27 -50.06 71.61 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.398 178.771 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.629 ' O ' ' HG ' ' A' ' 87' ' ' LEU . 30.5 m -83.77 -36.44 12.31 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-N 116.6 -0.273 . . . . 0.0 111.283 -177.147 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 27.4 ttt -65.3 -36.32 83.71 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.407 -179.849 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . 0.447 ' O ' ' HB2' ' A' ' 89' ' ' GLU . 35.0 t70 -62.54 -42.27 99.42 Favored 'General case' 0 C--O 1.223 -0.34 0 CA-C-N 116.595 -0.275 . . . . 0.0 110.466 178.502 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.493 HG13 ' O ' ' A' ' 82' ' ' MET . 52.8 mt -61.41 -31.29 50.03 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-O 121.446 0.641 . . . . 0.0 110.619 179.112 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.864 HD13 HG23 ' A' ' 24' ' ' ILE . 43.4 mt -88.71 -33.45 17.52 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.128 -176.225 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 17.7 tpt180 -77.33 -14.09 59.8 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.808 0.813 . . . . 0.0 109.504 177.309 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . 0.447 ' HB2' ' O ' ' A' ' 85' ' ' ASP . 6.4 tp10 . . . . . 0 C--O 1.25 1.093 0 CA-C-N 114.5 -1.227 . . . . 0.0 109.42 179.215 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.444 -0.794 0 N-CA-C 110.492 -1.043 . . . . 0.0 110.492 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 86.6 mm-40 -95.56 5.85 50.45 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 117.17 0.485 . . . . 0.0 110.808 179.963 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . 0.405 ' O ' ' HB2' ' A' ' 8' ' ' HIS . 17.2 m-85 55.63 -119.87 1.46 Allowed 'General case' 0 C--O 1.237 0.445 0 O-C-N 123.716 0.635 . . . . 0.0 110.612 176.623 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . 0.405 ' HB2' ' O ' ' A' ' 7' ' ' PHE . 60.4 m170 76.24 138.94 0.06 Allowed 'General case' 0 C--O 1.235 0.314 0 CA-C-O 121.966 0.888 . . . . 0.0 112.457 171.7 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . 0.537 ' HA ' ' HE2' ' A' ' 75' ' ' LYS . 12.8 p-10 -72.36 -21.43 61.3 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 114.957 -1.02 . . . . 0.0 111.46 -174.57 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 2.6 m120 -86.71 4.4 40.85 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.843 0.354 . . . . 0.0 110.95 175.139 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . 71.48 105.63 0.06 Allowed 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 114.936 -1.029 . . . . 0.0 112.423 174.292 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 3.3 t-20 -63.43 136.21 57.46 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.9 -0.591 . . . . 0.0 109.527 172.526 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -73.66 141.03 28.99 Favored Glycine 0 N--CA 1.45 -0.433 0 C-N-CA 121.07 -0.586 . . . . 0.0 113.011 -175.053 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 85.95 -68.59 3.34 Favored Glycine 0 N--CA 1.449 -0.466 0 C-N-CA 121.132 -0.556 . . . . 0.0 112.417 176.872 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 24.3 mm-40 -126.0 134.81 51.36 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 120.826 0.346 . . . . 0.0 110.245 -179.938 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . 0.612 ' HB2' HG22 ' A' ' 70' ' ' ILE . 13.3 m120 -93.42 -41.98 9.52 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.575 -177.869 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 109.25 -78.44 0.24 Allowed Glycine 0 N--CA 1.446 -0.671 0 C-N-CA 120.536 -0.84 . . . . 0.0 112.608 179.176 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.545 HG21 ' HA ' ' A' ' 73' ' ' PRO . 84.3 m -73.69 126.65 30.81 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.149 0.5 . . . . 0.0 111.201 -176.889 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.655 ' HA ' ' O ' ' A' ' 69' ' ' ILE . 7.1 p -140.76 129.27 24.46 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-N 115.382 -0.826 . . . . 0.0 110.011 177.617 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 80.5 mt-30 -108.43 122.86 47.9 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 121.063 0.459 . . . . 0.0 111.115 176.348 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.645 ' HA ' ' O ' ' A' ' 67' ' ' LEU . 44.1 mt-10 -95.63 117.43 30.44 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.252 -0.885 . . . . 0.0 110.145 177.35 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.771 HG12 HD12 ' A' ' 67' ' ' LEU . 25.5 mm -111.48 147.6 15.31 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.768 0 CA-C-N 116.0 -0.545 . . . . 0.0 109.815 -178.911 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' MET . . . . . 0.589 ' HB3' ' HB3' ' A' ' 64' ' ' ASP . 3.3 mmt -100.8 98.16 8.71 Favored 'General case' 0 N--CA 1.446 -0.656 0 N-CA-C 108.796 -0.816 . . . . 0.0 108.796 176.924 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.772 ' HB ' ' HB2' ' A' ' 65' ' ' LYS . 23.6 mm -80.18 128.68 72.51 Favored Pre-proline 0 C--N 1.32 -0.699 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.032 -173.433 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.625 ' HD2' HD13 ' A' ' 87' ' ' LEU . 52.7 Cg_exo -51.86 125.59 17.54 Favored 'Trans proline' 0 N--CA 1.462 -0.375 0 C-N-CA 122.882 2.388 . . . . 0.0 111.942 176.734 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -47.8 -53.02 16.71 Favored 'General case' 0 C--O 1.237 0.414 0 N-CA-C 112.998 0.74 . . . . 0.0 112.998 -169.571 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -80.54 -26.46 54.26 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.844 -0.693 . . . . 0.0 113.128 -174.891 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 43.2 tttp -89.95 3.1 54.13 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.051 0.453 . . . . 0.0 110.73 -177.185 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.555 ' O ' HG12 ' A' ' 32' ' ' VAL . . . -65.53 -22.81 66.75 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.808 177.98 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -55.45 -38.42 69.89 Favored Glycine 0 N--CA 1.449 -0.447 0 C-N-CA 120.888 -0.672 . . . . 0.0 111.928 176.739 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.584 ' HB3' HG22 ' A' ' 86' ' ' ILE . 31.9 mt -71.34 -37.87 71.67 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 111.595 0.22 . . . . 0.0 111.595 -179.101 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.555 HG12 ' O ' ' A' ' 29' ' ' ALA . 0.3 OUTLIER -67.32 -25.92 34.78 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.352 0 CA-C-O 121.353 0.597 . . . . 0.0 110.358 -179.133 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.453 ' HA ' ' HB ' ' A' ' 40' ' ' ILE . 56.1 mt -84.71 -39.6 14.45 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-N 115.385 -0.825 . . . . 0.0 109.504 174.59 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.423 ' HA3' ' HB ' ' A' ' 39' ' ' THR . . . 125.95 -145.62 15.81 Favored Glycine 0 N--CA 1.445 -0.719 0 CA-C-N 115.72 -0.673 . . . . 0.0 113.11 174.435 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 74.9 mmtt -100.69 -29.18 12.44 Favored 'General case' 0 C--N 1.319 -0.753 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 179.005 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -152.6 31.61 0.84 Allowed Glycine 0 N--CA 1.45 -0.429 0 CA-C-N 115.534 -0.757 . . . . 0.0 111.727 177.409 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.401 ' HA2' HG22 ' A' ' 33' ' ' ILE . . . 79.87 0.16 84.28 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 121.106 -0.569 . . . . 0.0 112.339 -178.933 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -78.52 -28.45 46.2 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 120.932 0.396 . . . . 0.0 111.106 -179.291 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.661 ' O ' ' HG ' ' A' ' 43' ' ' LEU . 35.2 m -71.67 -51.71 21.66 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.817 -177.571 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.656 ' HA ' HD12 ' A' ' 43' ' ' LEU . 6.6 tt -58.41 -36.73 60.09 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.285 0 CA-C-O 121.091 0.472 . . . . 0.0 111.186 179.499 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 62.7 tttp -62.07 -40.05 94.51 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.813 -0.631 . . . . 0.0 110.039 178.101 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 41.8 mt-30 -75.96 -38.01 58.0 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.579 -0.737 . . . . 0.0 111.269 -179.269 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.661 ' HG ' ' O ' ' A' ' 39' ' ' THR . 80.8 mt -53.17 -40.49 64.4 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-O 120.897 0.38 . . . . 0.0 111.432 -178.078 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 68.9 mt-30 -59.85 -42.62 94.03 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.289 178.494 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -81.02 -29.34 35.14 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.99 -178.137 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 13.8 mmm180 -52.1 -45.32 64.83 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.736 177.618 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.525 ' HB3' HG22 ' A' ' 49' ' ' VAL . . . -102.42 -11.49 18.56 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.72 -0.673 . . . . 0.0 111.429 -178.198 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 75.3 30.17 59.09 Favored Glycine 0 CA--C 1.52 0.365 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.04 -177.255 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.525 HG22 ' HB3' ' A' ' 47' ' ' ALA . 20.0 m -120.09 177.34 3.08 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-O 120.846 0.355 . . . . 0.0 110.504 -177.638 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 64.5 tttp -105.46 122.28 45.67 Favored 'General case' 0 C--N 1.318 -0.797 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 172.115 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . 0.658 ' HE2' HG12 ' A' ' 69' ' ' ILE . 36.1 mtp -117.31 115.18 24.76 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 178.833 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.47 ' CG2' ' HB2' ' A' ' 68' ' ' ARG . 10.4 tt -110.76 110.82 33.59 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.798 0 CA-C-O 121.452 0.644 . . . . 0.0 110.901 -178.697 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.613 ' HB3' HE21 ' A' ' 55' ' ' GLN . 3.7 mm? -93.97 103.84 15.91 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.27 -0.877 . . . . 0.0 109.474 175.279 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.618 HD12 ' HB2' ' A' ' 66' ' ' PRO . 68.3 mt -75.33 87.52 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-O 121.613 0.72 . . . . 0.0 110.216 -178.818 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . 0.613 HE21 ' HB3' ' A' ' 53' ' ' LEU . 72.5 mm-40 -104.91 -31.32 9.31 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.02 -0.991 . . . . 0.0 109.34 179.705 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -80.87 -16.42 53.69 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.354 177.698 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . 0.712 ' O ' ' HB ' ' A' ' 61' ' ' THR . . . -78.39 130.42 10.05 Favored Glycine 0 N--CA 1.451 -0.337 0 N-CA-C 111.187 -0.765 . . . . 0.0 111.187 175.844 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 39.7 p -81.63 1.86 32.05 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 112.984 0.735 . . . . 0.0 112.984 -171.436 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 22.3 mp0 -65.6 -64.75 0.79 Allowed 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.134 0.492 . . . . 0.0 110.547 -176.696 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.591 ' HB3' ' O ' ' A' ' 64' ' ' ASP . 14.4 m120 -122.0 29.93 6.85 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.277 -179.04 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . 0.712 ' HB ' ' O ' ' A' ' 57' ' ' GLY . 12.4 t -66.59 -22.08 66.13 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.088 -179.202 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 23.2 t-20 -97.81 -17.28 19.43 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.182 -177.662 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.418 ' HB ' ' H ' ' A' ' 64' ' ' ASP . 16.0 m -121.59 -151.72 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.564 -176.578 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.591 ' O ' ' HB3' ' A' ' 60' ' ' ASN . 3.4 m-20 -51.29 126.1 15.97 Favored 'General case' 0 C--N 1.33 -0.242 0 O-C-N 123.314 0.384 . . . . 0.0 110.116 174.584 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.772 ' HB2' ' HB ' ' A' ' 24' ' ' ILE . 34.5 mmtp -82.34 136.19 46.41 Favored Pre-proline 0 C--N 1.321 -0.673 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.393 -168.438 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.618 ' HB2' HD12 ' A' ' 54' ' ' ILE . 10.5 Cg_exo -71.8 110.44 2.9 Favored 'Trans proline' 0 N--CA 1.458 -0.588 0 C-N-CA 123.137 2.558 . . . . 0.0 111.305 175.953 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.862 HD11 HG13 ' A' ' 69' ' ' ILE . 1.6 tm? -114.65 141.1 48.24 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 115.827 -0.624 . . . . 0.0 109.453 179.023 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.575 ' HG2' ' HG2' ' A' ' 21' ' ' GLU . 95.1 mtt180 -134.76 124.04 24.55 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.185 0.517 . . . . 0.0 111.465 168.607 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.862 HG13 HD11 ' A' ' 67' ' ' LEU . 20.9 mt -102.95 104.62 16.86 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-N 115.206 -0.906 . . . . 0.0 109.279 173.445 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.612 HG22 ' HB2' ' A' ' 16' ' ' ASN . 11.8 mt -103.37 125.57 57.87 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.891 0 CA-C-N 116.484 -0.325 . . . . 0.0 110.246 -175.174 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 169.19 -123.21 1.06 Allowed Glycine 0 N--CA 1.447 -0.617 0 C-N-CA 120.505 -0.855 . . . . 0.0 112.934 178.349 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . 0.401 ' HB3' ' HG2' ' A' ' 75' ' ' LYS . 11.1 t70 -115.26 139.11 24.07 Favored Pre-proline 0 C--N 1.324 -0.516 0 CA-C-O 118.759 -0.639 . . . . 0.0 109.995 -176.421 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . 0.545 ' HA ' HG21 ' A' ' 18' ' ' THR . 84.3 Cg_exo -40.47 -43.73 4.2 Favored 'Trans proline' 0 C--N 1.347 0.477 0 C-N-CA 123.406 2.737 . . . . 0.0 112.832 -176.264 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 78.8 t80 -60.61 -60.92 3.04 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.147 -0.933 . . . . 0.0 111.334 -178.626 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.537 ' HE2' ' HA ' ' A' ' 9' ' ' ASP . 25.5 pttt -76.54 -24.05 53.64 Favored 'General case' 0 CA--C 1.517 -0.314 0 N-CA-C 112.131 0.419 . . . . 0.0 112.131 -176.187 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 48.8 t -66.79 -39.89 84.67 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 N-CA-C 109.079 -0.711 . . . . 0.0 109.079 176.865 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . 0.47 ' O ' ' HG2' ' A' ' 81' ' ' GLU . 20.9 tp60 -74.0 -42.64 60.09 Favored 'General case' 0 N--CA 1.445 -0.706 0 CA-C-N 115.523 -0.762 . . . . 0.0 110.502 179.744 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 91.6 mt-30 -60.91 -43.83 98.0 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.848 0.356 . . . . 0.0 110.609 177.732 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -64.95 -38.78 92.09 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.692 178.171 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 44.3 t -62.44 -54.8 34.86 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.733 -0.667 . . . . 0.0 111.471 178.243 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . 0.47 ' HG2' ' O ' ' A' ' 77' ' ' GLN . 12.2 pt-20 -68.53 -19.59 64.51 Favored 'General case' 0 C--N 1.324 -0.511 0 C-N-CA 120.481 -0.488 . . . . 0.0 110.468 -178.468 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' MET . . . . . 0.484 ' O ' ' HB3' ' A' ' 85' ' ' ASP . 52.3 ttp -72.97 -46.46 52.22 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.85 175.768 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.596 HG12 HD13 ' A' ' 43' ' ' LEU . 29.9 m -80.18 -29.41 12.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 C-N-CA 120.812 -0.355 . . . . 0.0 110.869 -179.352 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 12.8 tmm? -65.47 -34.39 78.16 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 174.143 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . 0.484 ' HB3' ' O ' ' A' ' 82' ' ' MET . 3.8 t70 -59.31 -42.12 90.64 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.229 -0.896 . . . . 0.0 110.626 174.502 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.584 HG22 ' HB3' ' A' ' 31' ' ' LEU . 30.1 mt -63.82 -34.11 66.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-O 121.359 0.599 . . . . 0.0 110.406 178.694 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.625 HD13 ' HD2' ' A' ' 25' ' ' PRO . 59.6 mt -85.52 -6.31 59.2 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.769 -178.952 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 67.7 ttt180 -102.26 -7.67 21.92 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.723 0.773 . . . . 0.0 109.537 176.479 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 10.8 tp10 . . . . . 0 C--O 1.253 1.242 0 CA-C-N 115.191 -0.913 . . . . 0.0 110.022 -174.451 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.445 -0.701 0 N-CA-C 111.751 -0.54 . . . . 0.0 111.751 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . 0.498 ' HA ' ' OE1' ' A' ' 6' ' ' GLN . 11.8 mm-40 61.26 77.49 0.33 Allowed 'General case' 0 C--O 1.237 0.443 0 CA-C-O 121.493 0.663 . . . . 0.0 110.46 -176.305 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 1.6 p90 -71.19 77.35 0.7 Allowed 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 114.877 -1.056 . . . . 0.0 111.873 -177.426 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 9.2 t60 67.54 -165.69 0.21 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.301 -0.863 . . . . 0.0 109.895 176.024 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -58.5 -54.06 51.28 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.896 0.379 . . . . 0.0 110.511 175.744 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 43.8 t30 -143.28 -50.69 0.34 Allowed 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.323 177.304 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -121.86 130.89 53.72 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.912 -0.586 . . . . 0.0 110.958 -177.228 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 3.3 p-10 -111.61 -24.86 9.85 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.888 -0.597 . . . . 0.0 109.949 177.732 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 75.76 -72.39 1.79 Allowed Glycine 0 N--CA 1.45 -0.407 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.764 -178.597 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -143.43 -47.59 0.04 OUTLIER Glycine 0 N--CA 1.446 -0.667 0 N-CA-C 110.682 -0.967 . . . . 0.0 110.682 176.15 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . 0.498 ' HG3' HG22 ' A' ' 70' ' ' ILE . 60.3 tt0 -97.09 108.48 21.23 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.102 0.477 . . . . 0.0 110.54 179.009 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . 0.611 ' HB3' ' O ' ' A' ' 71' ' ' GLY . 26.7 t30 -89.54 -55.83 3.49 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.136 177.357 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 165.06 -36.34 0.27 Allowed Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.782 -0.723 . . . . 0.0 111.734 178.608 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 59.5 m -66.35 128.31 35.67 Favored 'General case' 0 C--N 1.322 -0.592 0 C-N-CA 122.484 0.314 . . . . 0.0 110.613 176.499 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.461 ' HA ' ' O ' ' A' ' 69' ' ' ILE . 8.5 p -131.75 138.75 52.12 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 CA-C-O 120.91 0.386 . . . . 0.0 110.295 179.192 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 9.2 tt0 -124.24 135.67 53.58 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 109.698 -0.482 . . . . 0.0 109.698 178.607 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.606 ' HG2' ' HG2' ' A' ' 68' ' ' ARG . 51.5 mt-10 -104.28 125.73 50.78 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.309 0.576 . . . . 0.0 112.021 -178.938 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.473 ' HB ' ' HB3' ' A' ' 67' ' ' LEU . 14.2 mm -110.66 146.33 15.93 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 CA-C-N 115.104 -0.953 . . . . 0.0 109.077 174.821 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 8.7 mmt -100.41 93.75 5.81 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 108.584 -0.895 . . . . 0.0 108.584 175.103 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.692 ' HB ' ' HB2' ' A' ' 65' ' ' LYS . 37.0 mm -79.35 126.06 81.97 Favored Pre-proline 0 C--N 1.318 -0.774 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.422 -177.331 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.416 ' HB2' ' HB2' ' A' ' 28' ' ' LYS . 71.8 Cg_exo -52.39 134.36 51.46 Favored 'Trans proline' 0 N--CA 1.461 -0.433 0 C-N-CA 122.794 2.329 . . . . 0.0 111.714 175.709 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -58.51 -25.21 62.15 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.998 -177.753 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -89.35 -6.37 71.13 Favored Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.837 -0.697 . . . . 0.0 112.642 178.069 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.556 ' HB3' HD22 ' A' ' 87' ' ' LEU . 51.2 mttp -115.77 10.82 15.48 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.754 0.312 . . . . 0.0 111.366 -179.015 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -68.58 -29.82 68.45 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.205 0.526 . . . . 0.0 110.152 179.307 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -69.9 -17.88 73.85 Favored Glycine 0 N--CA 1.447 -0.584 0 CA-C-N 115.863 -0.608 . . . . 0.0 112.265 176.822 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 84.0 mt -83.13 -43.51 16.14 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.557 0.218 . . . . 0.0 110.706 -179.768 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.657 HG13 HD21 ' A' ' 87' ' ' LEU . 1.6 m -68.86 -33.33 58.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.308 -0.406 . . . . 0.0 111.174 178.697 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.498 ' HA ' ' HB ' ' A' ' 40' ' ' ILE . 88.8 mt -77.83 -40.71 27.48 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-O 121.52 0.676 . . . . 0.0 109.698 175.57 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 103.08 164.51 25.75 Favored Glycine 0 N--CA 1.442 -0.919 0 CA-C-N 115.353 -0.84 . . . . 0.0 111.576 -179.335 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 1.3 mptm? -79.13 54.41 1.63 Allowed 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.189 0.518 . . . . 0.0 110.849 -178.786 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 144.04 21.82 0.17 Allowed Glycine 0 N--CA 1.447 -0.603 0 CA-C-N 115.779 -0.646 . . . . 0.0 111.783 178.759 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 71.79 -0.66 35.12 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 121.028 -0.606 . . . . 0.0 112.358 -178.007 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.509 ' O ' ' HG2' ' A' ' 42' ' ' GLN . 14.2 pt-20 -64.66 -37.81 88.86 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.703 0.287 . . . . 0.0 111.276 -175.573 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.833 ' O ' ' HG ' ' A' ' 43' ' ' LEU . 56.4 m -69.92 -55.66 9.1 Favored 'General case' 0 N--CA 1.449 -0.482 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.383 -175.086 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.498 ' HB ' ' HA ' ' A' ' 33' ' ' ILE . 12.7 tt -61.91 -25.09 36.26 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-O 121.462 0.649 . . . . 0.0 111.013 -177.48 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.406 ' HB3' ' HE2' ' A' ' 41' ' ' LYS . 37.6 ttpt -71.8 -47.49 53.01 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.778 178.863 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.509 ' HG2' ' O ' ' A' ' 38' ' ' GLU . 11.3 pt20 -72.32 -41.07 66.97 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.838 -0.619 . . . . 0.0 111.12 -177.259 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.833 ' HG ' ' O ' ' A' ' 39' ' ' THR . 48.6 mt -51.23 -48.44 62.08 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.769 -0.65 . . . . 0.0 111.731 -177.08 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 49.3 mt-30 -58.21 -42.16 85.62 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.27 -178.078 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 -81.33 -35.1 31.36 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.676 -174.308 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 0.406 ' HG2' ' O ' ' A' ' 42' ' ' GLN . 15.0 ptm180 -78.85 -23.45 44.97 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 111.905 0.335 . . . . 0.0 111.905 -175.894 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -94.59 -24.53 17.18 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 120.908 0.385 . . . . 0.0 111.379 179.906 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 81.77 23.64 57.41 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.863 -0.684 . . . . 0.0 112.082 -178.687 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 17.7 m -130.36 178.98 4.62 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-O 120.833 0.349 . . . . 0.0 110.197 -179.083 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 87.2 tttt -109.83 124.63 51.65 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.012 176.177 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . 0.472 ' HE2' ' HB1' ' A' ' 79' ' ' ALA . 60.5 mtt -113.38 116.01 28.99 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 109.583 -0.525 . . . . 0.0 109.583 178.632 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.475 ' CG2' ' HB2' ' A' ' 68' ' ' ARG . 11.0 tt -110.64 105.83 19.56 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 CA-C-O 121.632 0.729 . . . . 0.0 110.674 178.047 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.523 HD22 HD13 ' A' ' 67' ' ' LEU . 3.8 mm? -86.12 102.8 14.19 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.336 -0.847 . . . . 0.0 109.358 174.978 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.606 HD12 ' HB2' ' A' ' 66' ' ' PRO . 52.3 mt -80.57 86.51 1.47 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.411 0 CA-C-O 121.913 0.863 . . . . 0.0 110.121 179.588 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . 0.46 ' HG2' HD11 ' A' ' 33' ' ' ILE . 2.7 pp0? -132.66 -12.64 3.0 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 114.607 -1.179 . . . . 0.0 109.52 176.246 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -100.58 -26.42 13.83 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 114.916 -1.038 . . . . 0.0 110.135 -178.734 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -82.99 16.56 27.0 Favored Glycine 0 CA--C 1.518 0.262 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.461 179.847 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 13.8 m 58.22 -139.35 0.81 Allowed 'General case' 0 C--O 1.234 0.272 0 C-N-CA 122.657 0.383 . . . . 0.0 110.483 -177.824 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 96.6 mt-30 70.57 -72.27 0.11 Allowed 'General case' 0 N--CA 1.463 0.197 0 C-N-CA 123.199 0.6 . . . . 0.0 110.924 178.611 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.498 ' HB3' ' O ' ' A' ' 64' ' ' ASP . 4.2 m-20 -102.86 42.01 1.19 Allowed 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 121.575 0.702 . . . . 0.0 109.954 177.077 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -71.54 -27.24 63.05 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.423 -0.808 . . . . 0.0 110.887 -179.922 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 9.2 t30 -93.68 -26.96 16.81 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.818 -0.628 . . . . 0.0 111.781 179.669 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 30.6 m -111.8 -160.32 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 N-CA-C 112.166 0.432 . . . . 0.0 112.166 -173.967 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.498 ' O ' ' HB3' ' A' ' 60' ' ' ASN . 62.7 m-20 -59.13 154.7 15.38 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 115.451 -0.795 . . . . 0.0 110.988 179.084 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.692 ' HB2' ' HB ' ' A' ' 24' ' ' ILE . 69.8 mmtt -98.81 121.22 56.76 Favored Pre-proline 0 C--N 1.32 -0.677 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.767 -174.273 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.606 ' HB2' HD12 ' A' ' 54' ' ' ILE . 27.1 Cg_exo -64.71 105.29 0.63 Allowed 'Trans proline' 0 N--CA 1.46 -0.473 0 C-N-CA 122.884 2.389 . . . . 0.0 111.746 174.614 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.523 HD13 HD22 ' A' ' 53' ' ' LEU . 25.1 tp -105.2 106.39 16.86 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 109.735 -0.469 . . . . 0.0 109.735 175.85 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.606 ' HG2' ' HG2' ' A' ' 21' ' ' GLU . 96.1 mtt180 -101.68 105.88 16.85 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.437 178.35 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.461 ' O ' ' HA ' ' A' ' 19' ' ' VAL . 4.7 mp -86.22 103.99 13.31 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 N-CA-C 108.195 -1.039 . . . . 0.0 108.195 174.142 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.498 HG22 ' HG3' ' A' ' 15' ' ' GLN . 3.7 mt -103.43 112.86 38.51 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.038 -174.506 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . 0.611 ' O ' ' HB3' ' A' ' 16' ' ' ASN . . . -176.16 -128.38 1.12 Allowed Glycine 0 N--CA 1.439 -1.137 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.324 -179.489 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . 0.508 ' HB3' ' CG ' ' A' ' 75' ' ' LYS . 3.1 t70 -109.61 143.27 27.5 Favored Pre-proline 0 C--N 1.318 -0.769 0 CA-C-O 118.752 -0.642 . . . . 0.0 110.289 -177.006 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_exo -44.14 -39.94 12.0 Favored 'Trans proline' 0 C--N 1.346 0.443 0 C-N-CA 122.827 2.351 . . . . 0.0 113.262 -175.268 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 93.6 t80 -74.6 -53.71 8.84 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.798 -174.807 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.508 ' CG ' ' HB3' ' A' ' 72' ' ' ASP . 10.4 pttt -75.4 -17.49 60.18 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.531 -0.304 . . . . 0.0 111.79 -179.077 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 24.1 t -70.0 -40.19 78.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 171.855 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . 0.489 ' O ' ' HG2' ' A' ' 81' ' ' GLU . 21.2 tp60 -69.45 -46.3 67.05 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.06 178.904 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 86.4 mt-30 -58.89 -39.53 81.72 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.778 176.553 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . 0.472 ' HB1' ' HE2' ' A' ' 51' ' ' MET . . . -68.84 -36.8 78.61 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.143 178.781 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' CYS . . . . . 0.4 ' O ' ' HG3' ' A' ' 84' ' ' MET . 38.4 t -65.22 -50.8 64.47 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.921 178.974 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . 0.489 ' HG2' ' O ' ' A' ' 77' ' ' GLN . 9.9 pt-20 -69.69 -18.82 63.58 Favored 'General case' 0 C--N 1.324 -0.543 0 C-N-CA 120.513 -0.475 . . . . 0.0 110.2 178.415 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' MET . . . . . 0.6 ' SD ' HD22 ' A' ' 43' ' ' LEU . 36.7 ttm -70.55 -53.43 16.14 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.333 173.86 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.453 ' O ' ' HG ' ' A' ' 87' ' ' LEU . 26.9 m -70.55 -35.74 62.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 C-N-CA 121.048 -0.261 . . . . 0.0 111.399 -178.645 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' MET . . . . . 0.4 ' HG3' ' O ' ' A' ' 80' ' ' CYS . 52.7 mtm -69.64 -26.97 64.67 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.768 0.318 . . . . 0.0 110.177 177.556 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -60.15 -48.38 81.96 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 116.066 -0.515 . . . . 0.0 109.748 175.807 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 48.4 mt -60.49 -34.86 59.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 115.422 -0.808 . . . . 0.0 111.048 179.826 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.657 HD21 HG13 ' A' ' 32' ' ' VAL . 51.3 mt -81.26 -16.12 53.53 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.3 -178.024 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . 0.421 HH11 ' HD3' ' A' ' 88' ' ' ARG . 13.7 ttp180 -97.2 -33.84 11.33 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 121.429 0.633 . . . . 0.0 111.074 -177.759 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 12.3 tp10 . . . . . 0 C--N 1.307 -1.257 0 CA-C-N 114.878 -1.055 . . . . 0.0 110.83 -173.437 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.674 0 N-CA-C 112.398 -0.281 . . . . 0.0 112.398 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 30.1 mm-40 -76.49 -6.9 53.78 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.161 0.505 . . . . 0.0 109.65 176.292 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . 0.779 ' HD1' ' HA3' ' A' ' 17' ' ' GLY . 11.9 m-85 -93.15 -55.32 3.37 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.514 -0.767 . . . . 0.0 109.396 178.15 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 24.1 t-80 70.78 -74.91 0.08 Allowed 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 114.48 -1.236 . . . . 0.0 112.18 172.493 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . 0.816 ' HA ' ' HE2' ' A' ' 75' ' ' LYS . 16.9 p-10 -158.87 -55.29 0.06 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.957 0.408 . . . . 0.0 110.958 -175.674 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . 0.471 ' ND2' ' HB2' ' A' ' 50' ' ' LYS . 54.3 t-20 -131.39 -65.19 0.77 Allowed 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 108.836 -0.801 . . . . 0.0 108.836 -177.636 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -140.18 121.61 15.06 Favored 'General case' 0 N--CA 1.447 -0.61 0 CA-C-N 114.863 -1.062 . . . . 0.0 109.301 176.725 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 9.9 t30 -100.51 93.28 5.54 Favored 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 179.63 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 83.78 -98.69 2.14 Favored Glycine 0 N--CA 1.445 -0.703 0 N-CA-C 111.356 -0.698 . . . . 0.0 111.356 -176.626 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -123.57 2.73 9.47 Favored Glycine 0 N--CA 1.448 -0.562 0 C-N-CA 120.463 -0.875 . . . . 0.0 112.848 -179.931 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 17.8 mm-40 -118.83 139.19 52.02 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.271 0.557 . . . . 0.0 111.955 -174.587 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 20.6 m120 -100.95 129.27 46.77 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 108.035 -1.098 . . . . 0.0 108.035 170.446 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 0.779 ' HA3' ' HD1' ' A' ' 7' ' ' PHE . . . -79.23 -94.16 0.32 Allowed Glycine 0 N--CA 1.449 -0.438 0 C-N-CA 120.796 -0.716 . . . . 0.0 113.905 -172.239 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.54 ' OG1' ' HG3' ' A' ' 73' ' ' PRO . 80.0 m -96.82 133.07 41.89 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 121.001 0.429 . . . . 0.0 111.079 -173.982 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.559 ' HA ' ' O ' ' A' ' 69' ' ' ILE . 4.5 p -137.44 134.92 46.85 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.587 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.208 177.672 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . 0.492 ' O ' ' HA ' ' A' ' 68' ' ' ARG . 33.2 mt-30 -121.11 157.84 29.22 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.019 176.142 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.588 ' HG2' ' HG2' ' A' ' 68' ' ' ARG . 40.2 mt-10 -124.16 107.72 11.53 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.024 -176.32 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 5.9 mm -99.01 140.97 17.33 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-N 115.86 -0.609 . . . . 0.0 109.776 -180.0 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 74.1 mmm -102.88 93.9 5.3 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 109.157 -0.683 . . . . 0.0 109.157 177.218 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.72 ' HB ' ' HB2' ' A' ' 65' ' ' LYS . 38.5 mm -81.88 132.59 53.8 Favored Pre-proline 0 C--N 1.321 -0.668 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.235 -174.711 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 75.5 Cg_exo -51.95 134.06 47.79 Favored 'Trans proline' 0 C--N 1.345 0.357 0 C-N-CA 122.959 2.439 . . . . 0.0 111.834 172.558 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -60.02 -33.05 71.48 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.214 179.758 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -68.58 -19.74 73.21 Favored Glycine 0 N--CA 1.449 -0.493 0 C-N-CA 120.892 -0.67 . . . . 0.0 112.578 177.332 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.596 ' HB3' HD22 ' A' ' 87' ' ' LEU . 5.2 mptp? -106.57 12.46 29.42 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.748 0.309 . . . . 0.0 111.004 -179.457 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.64 -31.75 71.86 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.008 0.432 . . . . 0.0 110.602 179.775 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -61.84 -24.24 64.35 Favored Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 120.864 -0.684 . . . . 0.0 112.571 179.564 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 83.7 mt -85.17 -48.52 9.06 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.684 0.242 . . . . 0.0 111.033 -177.99 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.562 HG11 HG13 ' A' ' 24' ' ' ILE . 2.9 m -67.89 -33.65 62.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.814 0.34 . . . . 0.0 111.758 -179.701 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 72.1 mt -80.56 -35.74 15.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 121.915 0.864 . . . . 0.0 109.462 176.321 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.522 ' HA3' ' HB ' ' A' ' 39' ' ' THR . . . 94.99 52.07 1.83 Allowed Glycine 0 N--CA 1.439 -1.145 0 CA-C-N 115.208 -0.905 . . . . 0.0 113.808 172.204 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 30.8 mtmt 50.3 41.94 25.07 Favored 'General case' 0 C--N 1.328 -0.342 0 O-C-N 124.162 0.566 . . . . 0.0 112.204 169.659 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 129.03 -17.36 5.68 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.705 -0.76 . . . . 0.0 111.951 -179.36 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 116.18 7.48 14.54 Favored Glycine 0 N--CA 1.447 -0.611 0 C-N-CA 120.654 -0.784 . . . . 0.0 112.19 178.802 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 36.0 mt-10 -76.08 -47.55 24.12 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.786 0.327 . . . . 0.0 110.827 -178.99 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.644 ' O ' ' HG ' ' A' ' 43' ' ' LEU . 7.2 m -66.08 -44.05 85.56 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.451 -0.34 . . . . 0.0 111.46 -176.791 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.481 ' CD1' HD23 ' A' ' 53' ' ' LEU . 9.7 tt -60.42 -36.01 66.55 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.495 0 CA-C-O 121.032 0.444 . . . . 0.0 110.703 179.908 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 22.5 ttmm -61.13 -41.19 96.27 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.579 0.704 . . . . 0.0 110.134 175.302 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 48.1 mt-30 -74.51 -44.13 52.7 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.179 -0.919 . . . . 0.0 111.258 -177.387 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.644 ' HG ' ' O ' ' A' ' 39' ' ' THR . 94.9 mt -51.94 -49.96 62.12 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.923 -176.372 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . 0.433 ' HG3' ' O ' ' A' ' 40' ' ' ILE . 40.5 mt-30 -60.07 -57.49 12.6 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.157 -176.629 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -75.24 -22.11 58.12 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.674 -0.694 . . . . 0.0 112.276 -171.681 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 13.8 ptm180 -77.62 -33.41 53.65 Favored 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 120.304 -0.558 . . . . 0.0 110.727 177.865 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -88.33 -28.81 20.78 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.0 -178.3 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 95.57 21.32 24.48 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.856 -0.687 . . . . 0.0 112.709 -179.366 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 10.4 m -130.07 179.95 3.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-O 120.906 0.384 . . . . 0.0 110.684 -178.836 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.679 ' HE3' ' HB ' ' A' ' 52' ' ' ILE . 8.9 tmtm? -111.95 126.09 54.76 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.953 -0.567 . . . . 0.0 109.645 176.7 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . 0.474 ' CE ' ' HB1' ' A' ' 79' ' ' ALA . 58.6 mtt -113.28 132.33 55.58 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 176.283 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.679 ' HB ' ' HE3' ' A' ' 50' ' ' LYS . 10.9 tt -120.39 113.56 40.73 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.721 0 CA-C-O 121.619 0.723 . . . . 0.0 110.817 175.874 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.75 HD22 HD13 ' A' ' 67' ' ' LEU . 3.6 mm? -88.67 104.19 16.64 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.013 -0.994 . . . . 0.0 109.138 175.45 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.57 ' HB ' ' HB2' ' A' ' 66' ' ' PRO . 52.6 mt -91.13 92.02 3.79 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.19 -176.95 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 11.3 mp0 -94.78 4.17 54.15 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.839 0.352 . . . . 0.0 110.772 -178.395 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -124.09 -50.59 1.8 Allowed 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.831 -178.892 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -82.19 77.85 2.04 Favored Glycine 0 N--CA 1.452 -0.245 0 C-N-CA 120.714 -0.755 . . . . 0.0 113.426 -170.84 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . 0.953 ' HB3' HG23 ' A' ' 61' ' ' THR . 36.4 t -170.29 -36.44 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.515 0.198 . . . . 0.0 110.878 177.675 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . 0.45 ' HB2' ' O ' ' A' ' 58' ' ' SER . 18.7 mt-30 73.2 -11.58 0.88 Allowed 'General case' 0 N--CA 1.47 0.564 0 CA-C-N 115.934 -0.575 . . . . 0.0 111.463 -178.559 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.419 ' H ' ' C ' ' A' ' 58' ' ' SER . 16.1 m120 -103.92 16.81 25.46 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 170.012 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . 0.953 HG23 ' HB3' ' A' ' 58' ' ' SER . 0.7 OUTLIER -74.42 -18.88 60.59 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 114.362 -1.29 . . . . 0.0 112.405 -172.117 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 3.8 t-20 -68.93 -17.2 63.92 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.536 0.684 . . . . 0.0 109.188 173.56 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 9.2 t -105.71 -64.14 1.68 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.611 0 CA-C-N 114.915 -1.038 . . . . 0.0 111.307 -179.741 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.561 ' O ' ' HA ' ' A' ' 61' ' ' THR . 40.8 m-20 -114.24 161.95 17.18 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 115.555 -0.748 . . . . 0.0 110.805 -176.401 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.72 ' HB2' ' HB ' ' A' ' 24' ' ' ILE . 69.8 mmtt -121.06 98.34 47.36 Favored Pre-proline 0 C--N 1.316 -0.863 0 CA-C-N 115.395 -0.821 . . . . 0.0 110.188 179.273 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.57 ' HB2' ' HB ' ' A' ' 54' ' ' ILE . 71.5 Cg_exo -54.2 115.64 2.51 Favored 'Trans proline' 0 C--O 1.234 0.305 0 C-N-CA 123.166 2.577 . . . . 0.0 112.31 174.861 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.75 HD13 HD22 ' A' ' 53' ' ' LEU . 31.3 tp -118.77 113.72 21.57 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.28 179.757 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.588 ' HG2' ' HG2' ' A' ' 21' ' ' GLU . 98.1 mtt180 -104.25 113.0 26.25 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 121.077 0.465 . . . . 0.0 110.707 175.943 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.559 ' O ' ' HA ' ' A' ' 19' ' ' VAL . 3.9 mp -95.21 109.45 22.43 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 175.085 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 8.1 mt -112.57 129.11 68.74 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 CA-C-N 116.462 -0.335 . . . . 0.0 111.162 -170.812 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 152.98 -127.14 2.13 Favored Glycine 0 N--CA 1.445 -0.746 0 C-N-CA 120.199 -1.0 . . . . 0.0 113.507 173.73 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . 0.455 ' HA ' ' HB3' ' A' ' 7' ' ' PHE . 19.7 t70 -85.87 133.27 41.75 Favored Pre-proline 0 C--N 1.322 -0.626 0 C-N-CA 123.19 0.596 . . . . 0.0 111.326 -176.626 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . 0.54 ' HG3' ' OG1' ' A' ' 18' ' ' THR . 32.4 Cg_exo -55.52 -28.49 64.83 Favored 'Trans proline' 0 C--N 1.35 0.627 0 C-N-CA 123.8 3.0 . . . . 0.0 113.524 -173.16 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 87.7 t80 -75.58 -54.49 6.92 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.045 0.45 . . . . 0.0 110.128 -177.9 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.816 ' HE2' ' HA ' ' A' ' 9' ' ' ASP . 7.6 pttm -79.52 -19.01 50.65 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.221 -0.445 . . . . 0.0 112.062 -178.353 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.409 HG22 HG22 ' A' ' 69' ' ' ILE . 25.2 t -69.43 -38.04 76.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 N-CA-C 109.815 -0.439 . . . . 0.0 109.815 172.895 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -71.51 -48.57 48.1 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 -179.632 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 27.8 mt-30 -59.06 -37.84 77.99 Favored 'General case' 0 C--O 1.22 -0.459 0 CA-C-N 115.784 -0.643 . . . . 0.0 110.583 176.565 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . 0.559 ' HB3' HG21 ' A' ' 69' ' ' ILE . . . -64.61 -40.16 95.0 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.049 0.452 . . . . 0.0 110.291 -179.664 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' CYS . . . . . 0.458 ' SG ' HD13 ' A' ' 69' ' ' ILE . 88.6 m -65.72 -49.53 68.15 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.498 -0.774 . . . . 0.0 110.792 179.115 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . 0.466 ' O ' ' HB2' ' A' ' 85' ' ' ASP . 3.0 pp20? -72.08 -19.84 61.75 Favored 'General case' 0 C--N 1.326 -0.433 0 C-N-CA 120.075 -0.65 . . . . 0.0 110.902 -179.96 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' MET . . . . . 0.443 ' O ' HG13 ' A' ' 86' ' ' ILE . 40.8 ttp -75.63 -49.2 19.18 Favored 'General case' 0 C--N 1.33 -0.248 0 O-C-N 123.053 0.221 . . . . 0.0 110.597 176.468 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.565 ' O ' ' HG ' ' A' ' 87' ' ' LEU . 35.7 m -67.18 -36.21 76.23 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.175 0 C-N-CA 120.712 -0.395 . . . . 0.0 110.485 178.487 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 91.2 mtp -72.01 -27.85 63.0 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.208 175.636 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . 0.466 ' HB2' ' O ' ' A' ' 81' ' ' GLU . 32.6 t70 -64.89 -45.5 85.67 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.171 -0.468 . . . . 0.0 109.855 176.022 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.443 HG13 ' O ' ' A' ' 82' ' ' MET . 70.2 mt -56.62 -37.14 50.95 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.183 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.599 176.882 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.626 HD11 HD12 ' A' ' 24' ' ' ILE . 50.3 mt -75.73 -35.87 60.09 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.757 -0.656 . . . . 0.0 111.435 -177.372 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . 0.441 HH11 ' HD2' ' A' ' 88' ' ' ARG . 9.1 ptp85 -79.3 -20.24 48.46 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.25 0.548 . . . . 0.0 110.672 -178.199 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 5.4 tp10 . . . . . 0 C--N 1.312 -1.055 0 CA-C-O 118.327 -0.844 . . . . 0.0 109.979 -173.475 . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.562 0 N-CA-C 112.255 -0.338 . . . . 0.0 112.255 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 80.0 mt-30 -73.74 -12.25 60.65 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-O 120.492 0.187 . . . . 0.0 110.834 178.106 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 24.6 m-85 71.97 -78.27 0.05 OUTLIER 'General case' 0 N--CA 1.465 0.298 0 O-C-N 123.904 0.753 . . . . 0.0 110.731 179.758 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER 60.94 76.5 0.37 Allowed 'General case' 0 N--CA 1.465 0.312 0 CA-C-O 120.905 0.383 . . . . 0.0 110.401 -177.521 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -64.33 -23.88 67.45 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.232 -174.043 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -77.73 55.75 1.4 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.823 0.344 . . . . 0.0 110.76 177.331 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . 59.14 86.48 0.09 Allowed 'General case' 0 C--O 1.234 0.269 0 CA-C-N 115.537 -0.756 . . . . 0.0 111.67 179.582 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . 0.466 HD21 ' ND2' ' A' ' 16' ' ' ASN . 11.0 p30 -72.06 149.75 44.57 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.155 176.138 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -95.01 52.48 1.91 Allowed Glycine 0 N--CA 1.445 -0.702 0 C-N-CA 120.66 -0.781 . . . . 0.0 112.269 -178.688 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -166.15 -109.49 0.22 Allowed Glycine 0 N--CA 1.444 -0.816 0 C-N-CA 120.639 -0.791 . . . . 0.0 112.41 -179.758 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 10.7 pt20 -129.33 148.34 51.24 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 120.743 0.306 . . . . 0.0 110.207 -177.397 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . 0.466 ' ND2' HD21 ' A' ' 12' ' ' ASN . 22.7 m120 -87.83 131.82 34.4 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.184 -0.462 . . . . 0.0 109.823 -179.651 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -102.7 7.66 53.62 Favored Glycine 0 N--CA 1.453 -0.224 0 C-N-CA 120.477 -0.868 . . . . 0.0 114.042 -171.629 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.635 HG21 ' HA ' ' A' ' 73' ' ' PRO . 23.9 m -124.26 126.73 46.57 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 117.764 0.782 . . . . 0.0 111.347 178.855 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.635 ' HA ' ' O ' ' A' ' 69' ' ' ILE . 7.2 p -141.34 127.99 20.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.907 176.667 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 85.4 mt-30 -109.43 132.35 54.21 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.589 176.483 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.576 ' HA ' ' O ' ' A' ' 67' ' ' LEU . 6.7 mp0 -103.0 118.77 37.55 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.371 177.15 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 11.7 mm -108.92 144.17 17.81 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-N 116.048 -0.523 . . . . 0.0 109.619 178.696 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 9.4 mmt -100.08 91.52 4.81 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 109.699 -0.482 . . . . 0.0 109.699 176.436 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.683 ' HB ' ' HB2' ' A' ' 65' ' ' LYS . 41.3 mm -79.29 126.72 80.88 Favored Pre-proline 0 C--N 1.32 -0.677 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.011 -176.034 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.655 ' HB2' ' HD3' ' A' ' 28' ' ' LYS . 65.9 Cg_exo -52.43 147.49 29.29 Favored 'Trans proline' 0 C--N 1.347 0.486 0 C-N-CA 123.166 2.577 . . . . 0.0 112.94 177.445 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -51.48 -55.96 15.97 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 112.232 0.456 . . . . 0.0 112.232 -173.932 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -75.48 -8.96 84.5 Favored Glycine 0 N--CA 1.454 -0.155 0 C-N-CA 121.103 -0.57 . . . . 0.0 112.618 -176.892 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.655 ' HD3' ' HB2' ' A' ' 25' ' ' PRO . 5.1 mptp? -92.78 -3.94 53.89 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.957 0.408 . . . . 0.0 110.815 -179.896 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -62.17 -32.1 72.68 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.489 177.342 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -67.32 -19.26 70.34 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.861 -0.685 . . . . 0.0 112.44 178.932 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 79.0 mt -87.03 -42.96 12.69 Favored 'General case' 0 C--N 1.327 -0.371 0 O-C-N 122.789 -0.242 . . . . 0.0 110.896 -178.898 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 4.1 m -69.9 -35.88 66.72 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.15 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.152 179.164 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.664 ' HA ' ' HB ' ' A' ' 40' ' ' ILE . 88.2 mt -76.95 -38.21 28.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-O 121.459 0.647 . . . . 0.0 109.892 177.939 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.523 ' CA ' ' HB ' ' A' ' 39' ' ' THR . . . 124.32 157.05 9.63 Favored Glycine 0 N--CA 1.439 -1.137 0 C-N-CA 120.584 -0.817 . . . . 0.0 112.38 174.532 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 32.2 mmtp -58.65 -31.79 68.48 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 120.836 0.351 . . . . 0.0 110.642 -178.888 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -128.42 14.63 6.14 Favored Glycine 0 N--CA 1.449 -0.452 0 C-N-CA 120.952 -0.642 . . . . 0.0 111.879 175.751 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.553 ' HA2' HG22 ' A' ' 33' ' ' ILE . . . 84.48 1.78 89.17 Favored Glycine 0 C--N 1.332 0.315 0 C-N-CA 121.017 -0.611 . . . . 0.0 112.135 -177.347 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -85.39 -29.67 24.24 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 120.706 0.288 . . . . 0.0 111.385 -178.121 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.768 ' O ' ' HG ' ' A' ' 43' ' ' LEU . 91.3 m -62.51 -42.0 99.21 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.849 -174.796 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.664 ' HB ' ' HA ' ' A' ' 33' ' ' ILE . 15.6 tt -60.62 -30.17 46.29 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.287 0 CA-C-O 121.105 0.478 . . . . 0.0 111.093 -179.308 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.679 ' O ' ' HG2' ' A' ' 45' ' ' GLU . 62.0 tttp -73.19 -44.05 60.43 Favored 'General case' 0 N--CA 1.451 -0.419 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 174.332 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 75.4 mt-30 -58.49 -43.72 89.12 Favored 'General case' 0 CA--C 1.515 -0.401 0 CA-C-N 115.681 -0.69 . . . . 0.0 110.106 -177.167 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.768 ' HG ' ' O ' ' A' ' 39' ' ' THR . 42.1 mt -53.89 -49.66 68.08 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.385 -0.825 . . . . 0.0 110.855 -179.644 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 48.4 mt-30 -64.68 -45.6 85.99 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.411 -0.813 . . . . 0.0 110.985 -179.377 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.679 ' HG2' ' O ' ' A' ' 41' ' ' LYS . 67.7 mm-40 -61.18 -41.91 97.63 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.078 -179.279 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 0.516 ' HD3' ' SD ' ' A' ' 82' ' ' MET . 10.2 ptm180 -81.65 -36.43 28.84 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.767 -0.652 . . . . 0.0 112.651 -170.063 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -90.26 -24.04 21.04 Favored 'General case' 0 C--N 1.324 -0.507 0 C-N-CA 120.498 -0.481 . . . . 0.0 111.187 -178.743 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 87.49 24.0 37.88 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.967 -0.635 . . . . 0.0 112.533 -179.657 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.478 HG13 ' HB2' ' A' ' 75' ' ' LYS . 14.0 m -121.77 179.31 2.42 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-O 120.923 0.392 . . . . 0.0 110.89 -178.002 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 87.3 tttt -117.58 122.41 43.55 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.548 -0.751 . . . . 0.0 109.162 173.708 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . 0.573 ' HG2' HG23 ' A' ' 69' ' ' ILE . 65.2 mtp -116.9 115.52 25.67 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 -179.008 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.604 ' CG2' ' HB2' ' A' ' 68' ' ' ARG . 6.0 tt -105.61 105.8 19.36 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.782 0 CA-C-O 121.47 0.652 . . . . 0.0 110.984 -178.136 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.802 HD22 HD13 ' A' ' 67' ' ' LEU . 3.4 mm? -83.12 102.17 11.65 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.391 -0.822 . . . . 0.0 109.316 174.008 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.55 ' HB ' ' HB2' ' A' ' 66' ' ' PRO . 64.9 mt -81.65 85.57 1.63 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.432 0 CA-C-O 121.677 0.751 . . . . 0.0 110.333 -177.863 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . 0.404 ' HG2' HD11 ' A' ' 33' ' ' ILE . 1.9 pp0? -116.04 -10.46 11.56 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 115.068 -0.969 . . . . 0.0 109.279 171.994 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -83.48 -15.87 47.84 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 114.938 -1.028 . . . . 0.0 109.826 179.456 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -84.79 -0.41 89.15 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.817 -0.706 . . . . 0.0 112.765 -179.786 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 17.8 m 57.32 -154.46 0.35 Allowed 'General case' 0 C--O 1.236 0.356 0 C-N-CA 122.711 0.404 . . . . 0.0 111.379 179.556 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 76.5 mm-40 68.56 -77.79 0.05 OUTLIER 'General case' 0 N--CA 1.466 0.339 0 C-N-CA 123.602 0.761 . . . . 0.0 110.909 178.641 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 2.7 m-20 -84.38 12.11 7.34 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.833 0.349 . . . . 0.0 110.716 -179.781 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . 0.771 ' HA ' ' HE3' ' A' ' 65' ' ' LYS . 5.7 t -56.63 -31.62 64.51 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.632 0.253 . . . . 0.0 110.91 179.023 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.404 ' OD1' HG23 ' A' ' 61' ' ' THR . 4.6 m-20 -83.44 -19.11 36.52 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 111.887 0.328 . . . . 0.0 111.887 -179.323 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 5.0 m -113.96 -126.14 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 N-CA-C 111.669 0.248 . . . . 0.0 111.669 -177.696 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -71.89 174.91 6.32 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.319 0.581 . . . . 0.0 111.326 179.007 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.771 ' HE3' ' HA ' ' A' ' 61' ' ' THR . 31.6 mmtm -129.57 113.44 17.95 Favored Pre-proline 0 C--N 1.315 -0.894 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.696 179.713 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.55 ' HB2' ' HB ' ' A' ' 54' ' ' ILE . 52.6 Cg_exo -58.09 104.56 0.18 Allowed 'Trans proline' 0 N--CA 1.459 -0.512 0 C-N-CA 122.821 2.348 . . . . 0.0 111.632 173.678 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.802 HD13 HD22 ' A' ' 53' ' ' LEU . 18.9 tp -112.85 106.5 14.83 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.235 177.229 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.604 ' HB2' ' CG2' ' A' ' 52' ' ' ILE . 13.1 mtp180 -92.67 117.83 30.39 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 109.476 -0.564 . . . . 0.0 109.476 172.586 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.635 ' O ' ' HA ' ' A' ' 19' ' ' VAL . 28.4 mt -96.94 102.31 13.32 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.089 0 N-CA-C 108.206 -1.035 . . . . 0.0 108.206 171.631 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 5.2 mt -103.4 119.39 51.88 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.042 -172.229 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . 0.411 ' O ' ' HB3' ' A' ' 16' ' ' ASN . . . 176.36 -137.11 3.49 Favored Glycine 0 N--CA 1.444 -0.817 0 C-N-CA 120.96 -0.638 . . . . 0.0 112.393 178.849 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . 0.847 ' HB2' ' HE2' ' A' ' 75' ' ' LYS . 44.9 m-20 -108.12 152.5 41.84 Favored Pre-proline 0 C--N 1.32 -0.713 0 N-CA-C 109.567 -0.531 . . . . 0.0 109.567 179.784 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . 0.635 ' HA ' HG21 ' A' ' 18' ' ' THR . 67.2 Cg_exo -48.89 -48.74 17.0 Favored 'Trans proline' 0 C--N 1.347 0.469 0 C-N-CA 123.359 2.706 . . . . 0.0 113.972 -167.106 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . 0.519 ' O ' ' HG2' ' A' ' 78' ' ' GLN . 45.1 m-85 -64.75 -51.94 59.66 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.703 -174.494 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.847 ' HE2' ' HB2' ' A' ' 72' ' ' ASP . 22.7 pttt -73.7 -23.82 59.85 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 112.175 0.435 . . . . 0.0 112.175 -176.528 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.419 HG23 ' O ' ' A' ' 72' ' ' ASP . 58.0 t -69.68 -40.92 79.89 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 N-CA-C 109.422 -0.584 . . . . 0.0 109.422 175.39 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . 0.636 HE21 ' HG3' ' A' ' 81' ' ' GLU . 18.1 tp60 -71.43 -46.27 60.53 Favored 'General case' 0 N--CA 1.445 -0.715 0 CA-C-N 115.494 -0.776 . . . . 0.0 111.313 -177.698 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . 0.643 ' HG2' ' HA ' ' A' ' 75' ' ' LYS . 3.3 pt20 -64.09 -38.56 91.51 Favored 'General case' 0 CA--C 1.508 -0.643 0 CA-C-O 121.489 0.661 . . . . 0.0 110.225 -179.676 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . 0.445 ' HA ' ' HE2' ' A' ' 82' ' ' MET . . . -63.34 -39.76 95.42 Favored 'General case' 0 C--N 1.313 -1.016 0 CA-C-N 114.556 -1.202 . . . . 0.0 110.384 176.863 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 52.0 t -64.62 -49.47 70.95 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.447 175.893 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . 0.636 ' HG3' HE21 ' A' ' 77' ' ' GLN . 45.4 mt-10 -56.0 -38.98 71.22 Favored 'General case' 0 CA--C 1.518 -0.286 0 CA-C-O 121.205 0.526 . . . . 0.0 110.054 176.244 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 82' ' ' MET . . . . . 0.516 ' SD ' ' HD3' ' A' ' 46' ' ' ARG . 37.5 ttp -63.43 -54.23 39.88 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 114.77 -1.105 . . . . 0.0 111.555 -178.719 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.477 ' O ' ' HG ' ' A' ' 87' ' ' LEU . 35.4 m -70.74 -37.86 70.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 C-N-CA 120.897 -0.321 . . . . 0.0 111.47 -177.225 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 88.9 mmm -66.38 -33.46 75.76 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.724 0.297 . . . . 0.0 110.34 177.339 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -62.37 -39.07 91.97 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.518 177.171 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.506 HG13 ' O ' ' A' ' 82' ' ' MET . 52.6 mt -66.4 -29.49 46.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.834 179.684 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.561 HD22 ' HB3' ' A' ' 28' ' ' LYS . 61.2 mt -85.1 -23.5 28.46 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.668 -176.231 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 15.7 ptm180 -99.64 -3.14 33.78 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 120.998 0.428 . . . . 0.0 111.192 -175.58 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 12.5 tp10 . . . . . 0 C--O 1.247 0.967 0 CA-C-N 115.661 -0.699 . . . . 0.0 109.892 -174.863 . . . . . . . . 0 0 . 1 . 022 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.517 0.165 0 N-CA-C 112.119 -0.392 . . . . 0.0 112.119 . . . . . . . . . 0 0 . 1 . 022 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 27.5 mm-40 61.01 29.72 19.16 Favored 'General case' 0 C--O 1.234 0.258 0 C-N-CA 123.107 0.563 . . . . 0.0 111.241 176.872 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . 0.448 ' O ' ' HD2' ' A' ' 75' ' ' LYS . 96.9 m-85 63.95 -86.12 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 115.042 -0.981 . . . . 0.0 111.305 179.492 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . 0.44 ' HB2' ' OD1' ' A' ' 72' ' ' ASP . 29.3 t-80 -110.61 62.8 0.61 Allowed 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 120.53 -0.468 . . . . 0.0 112.007 -175.272 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 10.4 t70 65.47 -74.29 0.06 Allowed 'General case' 0 CA--C 1.537 0.457 0 N-CA-C 112.75 0.648 . . . . 0.0 112.75 166.661 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 36.4 t30 -123.41 -50.07 1.89 Allowed 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 110.212 -0.292 . . . . 0.0 110.212 -179.807 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -155.85 130.48 9.04 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.921 0.391 . . . . 0.0 111.396 -178.589 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 19.9 t-20 -92.05 -64.3 1.13 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.194 175.825 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 149.36 -89.68 0.14 Allowed Glycine 0 N--CA 1.446 -0.674 0 C-N-CA 120.921 -0.657 . . . . 0.0 111.924 -178.207 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -115.82 -64.04 0.37 Allowed Glycine 0 N--CA 1.448 -0.524 0 C-N-CA 120.683 -0.77 . . . . 0.0 112.521 -178.199 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 52.6 mt-30 -75.45 108.38 8.22 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.917 0.389 . . . . 0.0 110.232 -178.759 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 66.2 t30 -91.55 -70.7 0.67 Allowed 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.136 -172.818 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -81.07 99.72 1.94 Allowed Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 121.015 -0.612 . . . . 0.0 112.878 -175.775 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.502 ' OG1' ' HG3' ' A' ' 73' ' ' PRO . 56.5 m -116.4 135.96 53.41 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 120.875 0.369 . . . . 0.0 110.683 177.456 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.461 ' HA ' ' O ' ' A' ' 69' ' ' ILE . 4.0 p -135.97 134.26 50.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.811 179.205 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 26.2 mt-30 -110.57 126.92 54.94 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 109.885 -0.413 . . . . 0.0 109.885 174.135 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.624 ' HG2' ' HG2' ' A' ' 68' ' ' ARG . 26.0 mt-10 -101.23 122.17 43.18 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.957 -179.072 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 7.0 mm -114.02 155.95 15.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 115.828 -0.624 . . . . 0.0 109.891 -178.047 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 23' ' ' MET . . . . . 0.479 ' HB3' ' HB3' ' A' ' 64' ' ' ASP . 85.2 mmm -112.41 97.54 6.68 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 108.27 -1.011 . . . . 0.0 108.27 173.158 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.607 HG21 HG21 ' A' ' 32' ' ' VAL . 40.2 mm -83.89 126.97 69.13 Favored Pre-proline 0 C--N 1.319 -0.757 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.689 -172.575 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_exo -49.1 130.46 24.11 Favored 'Trans proline' 0 C--N 1.345 0.348 0 C-N-CA 123.071 2.514 . . . . 0.0 112.169 176.938 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -55.02 -29.9 58.37 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.605 -0.725 . . . . 0.0 112.657 -174.112 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -87.45 -31.68 15.63 Favored Glycine 0 N--CA 1.446 -0.658 0 C-N-CA 120.347 -0.93 . . . . 0.0 112.739 -178.712 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 4.2 tptm -93.92 -1.54 54.56 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 122.609 -0.347 . . . . 0.0 110.873 -175.002 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -65.57 -21.42 66.59 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.279 -179.143 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -60.18 -37.17 92.5 Favored Glycine 0 N--CA 1.448 -0.561 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.354 179.819 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 92.4 mt -75.29 -27.44 59.34 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.701 0.286 . . . . 0.0 111.371 -174.922 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.703 HG13 ' HB ' ' A' ' 83' ' ' VAL . 1.4 t -69.38 -36.57 72.56 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.365 0 CA-C-O 121.586 0.708 . . . . 0.0 110.222 179.285 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.548 HG12 ' HG ' ' A' ' 53' ' ' LEU . 34.8 mt -86.19 -40.68 14.57 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-N 115.116 -0.947 . . . . 0.0 110.28 -178.302 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 124.88 -170.83 16.87 Favored Glycine 0 N--CA 1.442 -0.933 0 CA-C-N 115.58 -0.736 . . . . 0.0 111.565 179.801 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 33.7 mmtp -82.45 -27.63 31.77 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-O 121.128 0.49 . . . . 0.0 109.711 179.866 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -145.01 12.02 1.87 Allowed Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.861 -0.685 . . . . 0.0 112.367 178.658 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 96.07 16.64 37.56 Favored Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.789 -0.719 . . . . 0.0 111.974 179.542 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -85.13 -37.15 20.56 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 120.635 0.255 . . . . 0.0 110.398 178.84 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.83 ' O ' ' HG ' ' A' ' 43' ' ' LEU . 26.5 m -60.41 -55.83 28.85 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.928 -179.22 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.523 ' HB ' ' HA ' ' A' ' 33' ' ' ILE . 7.9 tt -55.34 -24.65 15.85 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-O 121.064 0.459 . . . . 0.0 111.781 -178.753 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 25.3 ttmm -79.41 -46.73 16.99 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.589 179.91 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.432 ' O ' ' HG2' ' A' ' 46' ' ' ARG . 11.5 pt20 -69.89 -35.64 74.79 Favored 'General case' 0 CA--C 1.515 -0.387 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.318 -177.259 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.83 ' HG ' ' O ' ' A' ' 39' ' ' THR . 77.0 mt -53.11 -45.75 68.43 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.589 -0.732 . . . . 0.0 111.256 -178.576 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 49.2 mt-30 -67.44 -33.54 75.36 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.747 -0.661 . . . . 0.0 111.037 -178.968 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 31.8 mm-40 -72.94 -32.06 65.01 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.147 -178.064 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 0.432 ' HG2' ' O ' ' A' ' 42' ' ' GLN . 14.9 ptp180 -92.27 -42.19 9.98 Favored 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 112.143 0.423 . . . . 0.0 112.143 -175.882 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.474 ' O ' ' HD3' ' A' ' 75' ' ' LYS . . . -74.9 -31.67 61.63 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.767 0.318 . . . . 0.0 111.072 -177.724 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 92.11 -3.95 77.26 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.876 -0.678 . . . . 0.0 112.088 -178.432 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.442 ' CG1' ' HG3' ' A' ' 75' ' ' LYS . 15.5 m -102.55 169.02 1.98 Allowed 'Isoleucine or valine' 0 CA--C 1.512 -0.516 0 CA-C-O 121.221 0.534 . . . . 0.0 111.022 -179.623 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 86.0 tttt -101.26 124.48 47.03 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-N 115.347 -0.842 . . . . 0.0 110.045 176.286 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . 0.727 ' HE2' ' HB1' ' A' ' 79' ' ' ALA . 58.8 mtt -109.55 114.66 28.47 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 175.919 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.586 ' CG2' ' HB2' ' A' ' 68' ' ' ARG . 10.0 tt -109.63 104.94 17.88 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.994 0 CA-C-O 121.724 0.773 . . . . 0.0 109.988 177.791 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.548 ' HG ' HG12 ' A' ' 33' ' ' ILE . 3.8 mm? -77.98 102.82 7.56 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 114.945 -1.025 . . . . 0.0 108.6 173.166 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.77 ' HB ' ' HG2' ' A' ' 66' ' ' PRO . 51.0 mt -76.04 88.52 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-O 121.777 0.798 . . . . 0.0 109.734 -177.233 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . 0.403 ' HG2' ' O ' ' A' ' 53' ' ' LEU . 13.6 mm100 -93.22 -10.85 34.23 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 114.845 -1.07 . . . . 0.0 111.427 -171.568 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 1.7 p30 -146.42 11.17 1.13 Allowed 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 111.934 0.346 . . . . 0.0 111.934 179.811 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -101.15 39.88 2.6 Favored Glycine 0 CA--C 1.509 -0.3 0 C-N-CA 120.629 -0.796 . . . . 0.0 112.161 178.88 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 34.4 t -179.02 173.91 1.13 Allowed 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 109.195 -0.669 . . . . 0.0 109.195 -176.253 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 46.3 mt-30 -108.74 4.9 24.22 Favored 'General case' 0 N--CA 1.445 -0.696 0 N-CA-C 107.576 -1.268 . . . . 0.0 107.576 175.009 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.52 ' HA ' HG22 ' A' ' 63' ' ' VAL . 16.4 m120 -84.99 16.08 3.64 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-N 114.403 -1.271 . . . . 0.0 109.121 172.973 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . 0.573 ' HA ' ' HE3' ' A' ' 65' ' ' LYS . 17.3 p -61.77 -23.15 66.0 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.197 -0.91 . . . . 0.0 111.119 179.176 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 17.0 m120 -106.82 6.37 29.41 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.686 -0.688 . . . . 0.0 111.185 -177.532 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.52 HG22 ' HA ' ' A' ' 60' ' ' ASN . 13.8 m -137.77 -147.85 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 116.002 -0.544 . . . . 0.0 109.729 179.777 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.479 ' HB3' ' HB3' ' A' ' 23' ' ' MET . 19.1 m-20 -58.39 126.69 28.62 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.144 0.497 . . . . 0.0 110.058 178.663 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.573 ' HE3' ' HA ' ' A' ' 61' ' ' THR . 12.2 mmmm -90.48 133.62 32.56 Favored Pre-proline 0 C--N 1.323 -0.572 0 CA-C-N 115.385 -0.825 . . . . 0.0 112.738 -168.043 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.77 ' HG2' ' HB ' ' A' ' 54' ' ' ILE . 30.3 Cg_endo -64.62 113.83 2.47 Favored 'Trans proline' 0 CA--C 1.533 0.46 0 C-N-CA 123.465 2.777 . . . . 0.0 111.65 172.539 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.59 ' O ' ' HA ' ' A' ' 21' ' ' GLU . 57.0 tp -123.36 129.35 51.18 Favored 'General case' 0 C--N 1.324 -0.531 0 O-C-N 122.338 -0.226 . . . . 0.0 110.579 179.571 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.624 ' HG2' ' HG2' ' A' ' 21' ' ' GLU . 95.7 mtt180 -120.89 114.9 22.24 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.694 0.283 . . . . 0.0 110.984 176.567 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.461 ' O ' ' HA ' ' A' ' 19' ' ' VAL . 4.5 mp -98.24 106.4 18.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 N-CA-C 108.228 -1.027 . . . . 0.0 108.228 171.82 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.437 HG12 ' CG2' ' A' ' 19' ' ' VAL . 15.4 mt -109.85 132.82 57.05 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-N 116.464 -0.334 . . . . 0.0 111.076 -171.98 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 153.91 -132.54 3.6 Favored Glycine 0 N--CA 1.448 -0.51 0 C-N-CA 120.952 -0.642 . . . . 0.0 112.595 176.28 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . 0.623 ' OD2' ' HG2' ' A' ' 75' ' ' LYS . 1.1 t70 -81.0 134.56 52.62 Favored Pre-proline 0 C--N 1.324 -0.524 0 C-N-CA 122.692 0.397 . . . . 0.0 110.882 -178.674 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . 0.502 ' HG3' ' OG1' ' A' ' 18' ' ' THR . 63.9 Cg_exo -47.96 -34.12 21.92 Favored 'Trans proline' 0 C--N 1.349 0.562 0 C-N-CA 123.878 3.052 . . . . 0.0 113.972 -177.314 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 73.0 m-85 -80.38 -55.81 4.63 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.755 0.312 . . . . 0.0 110.547 -176.123 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.623 ' HG2' ' OD2' ' A' ' 72' ' ' ASP . 0.3 OUTLIER -71.07 -22.75 62.07 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.256 -177.587 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 20.5 t -64.85 -43.05 96.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 N-CA-C 109.713 -0.477 . . . . 0.0 109.713 171.249 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -68.59 -46.86 68.25 Favored 'General case' 0 N--CA 1.448 -0.527 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 177.845 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 28.0 mm-40 -61.57 -40.44 94.76 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.026 -179.309 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . 0.727 ' HB1' ' HE2' ' A' ' 51' ' ' MET . . . -67.71 -34.37 76.73 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.017 0.437 . . . . 0.0 110.34 177.546 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 49.2 t -63.01 -48.26 79.54 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.577 -0.738 . . . . 0.0 109.693 175.243 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 75.8 mm-40 -57.82 -44.78 86.62 Favored 'General case' 0 C--O 1.22 -0.479 0 N-CA-C 109.766 -0.457 . . . . 0.0 109.766 174.497 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 82' ' ' MET . . . . . 0.529 ' SD ' HD22 ' A' ' 43' ' ' LEU . 32.5 ttm -52.85 -58.52 6.65 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.385 -0.825 . . . . 0.0 111.267 -179.387 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.703 ' HB ' HG13 ' A' ' 32' ' ' VAL . 35.3 m -73.0 -35.49 48.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.887 -175.813 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 83.5 mtp -77.54 -30.06 52.61 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 120.861 -0.335 . . . . 0.0 111.253 -177.707 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . 0.4 ' HA ' ' HG2' ' A' ' 88' ' ' ARG . 33.4 t70 -62.34 -43.52 98.64 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-O 120.911 0.386 . . . . 0.0 110.244 178.835 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 57.9 mt -61.15 -29.18 45.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 115.837 -0.619 . . . . 0.0 110.61 178.32 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.407 HD11 HG22 ' A' ' 32' ' ' VAL . 5.9 mp -84.91 -40.63 16.81 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.498 -0.774 . . . . 0.0 112.208 -176.714 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . 0.4 ' HG2' ' HA ' ' A' ' 85' ' ' ASP . 25.5 ptt180 -84.51 -8.12 59.04 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.867 0.365 . . . . 0.0 111.704 -174.207 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 . . . . . 0 C--O 1.249 1.063 0 CA-C-O 118.359 -0.829 . . . . 0.0 109.956 -178.228 . . . . . . . . 0 0 . 1 . 023 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.403 0 N-CA-C 111.853 -0.499 . . . . 0.0 111.853 . . . . . . . . . 0 0 . 1 . 023 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 14.0 mt-30 -113.22 26.62 10.29 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.436 0.636 . . . . 0.0 109.931 -178.198 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . 0.796 ' HA ' ' HB2' ' A' ' 72' ' ' ASP . 64.6 t80 83.41 105.43 0.06 Allowed 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 113.958 -1.473 . . . . 0.0 112.38 179.242 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 2.5 t-80 58.73 -85.91 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 113.721 -1.581 . . . . 0.0 112.935 169.916 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . 0.428 ' O ' ' HB2' ' A' ' 10' ' ' ASN . 31.3 m-20 -112.9 37.43 3.11 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.831 -0.168 . . . . 0.0 110.841 -172.544 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . 0.428 ' HB2' ' O ' ' A' ' 9' ' ' ASP . 6.0 m-20 73.94 -53.08 0.69 Allowed 'General case' 0 N--CA 1.467 0.425 0 O-C-N 123.78 0.675 . . . . 0.0 112.097 175.754 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -100.61 84.31 2.73 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 116.621 -0.263 . . . . 0.0 111.229 -177.806 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . 0.685 ' HB3' ' HB3' ' A' ' 7' ' ' PHE . 10.4 p30 -68.64 151.92 46.06 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 109.786 -0.45 . . . . 0.0 109.786 174.846 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -78.72 54.05 4.08 Favored Glycine 0 CA--C 1.518 0.23 0 C-N-CA 120.959 -0.639 . . . . 0.0 113.173 -175.618 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 86.08 -41.31 3.07 Favored Glycine 0 N--CA 1.447 -0.581 0 C-N-CA 121.217 -0.516 . . . . 0.0 112.377 177.874 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 34.2 tt0 -118.98 130.33 55.63 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 120.948 0.404 . . . . 0.0 110.312 -178.389 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . 0.644 ' HB3' ' HA2' ' A' ' 71' ' ' GLY . 31.5 m-80 -71.79 146.01 48.32 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.514 -0.766 . . . . 0.0 109.65 177.005 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -107.28 -36.3 2.52 Favored Glycine 0 CA--C 1.519 0.336 0 C-N-CA 120.638 -0.792 . . . . 0.0 114.231 -171.822 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.602 ' OG1' ' HD3' ' A' ' 73' ' ' PRO . 89.0 m -70.5 126.73 30.45 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 117.231 0.515 . . . . 0.0 110.725 -177.122 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.461 ' HA ' ' O ' ' A' ' 69' ' ' ILE . 9.1 p -140.64 140.72 33.36 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-O 120.814 0.34 . . . . 0.0 110.751 -179.783 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 25.7 mt-30 -128.12 138.72 52.64 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 109.642 -0.503 . . . . 0.0 109.642 174.394 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.647 ' HG2' ' HG2' ' A' ' 68' ' ' ARG . 44.8 mt-10 -102.62 116.88 33.48 Favored 'General case' 0 C--N 1.328 -0.368 0 O-C-N 123.315 0.384 . . . . 0.0 110.805 -179.57 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 13.1 mm -100.39 150.31 5.61 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-N 115.918 -0.583 . . . . 0.0 109.639 178.47 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 1.7 mmt -103.16 91.61 4.17 Favored 'General case' 0 C--N 1.317 -0.811 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 175.191 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.672 ' HB ' ' HB2' ' A' ' 65' ' ' LYS . 36.1 mm -77.39 124.1 86.88 Favored Pre-proline 0 C--N 1.323 -0.547 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.765 -176.236 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.54 ' HB2' ' HB2' ' A' ' 28' ' ' LYS . 68.4 Cg_exo -51.83 135.41 50.08 Favored 'Trans proline' 0 N--CA 1.461 -0.396 0 C-N-CA 122.898 2.399 . . . . 0.0 111.737 177.717 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -56.25 -35.36 67.32 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 115.649 -0.705 . . . . 0.0 112.371 -175.072 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -80.22 -15.9 77.58 Favored Glycine 0 N--CA 1.452 -0.238 0 C-N-CA 120.519 -0.848 . . . . 0.0 111.875 178.95 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.547 ' HB3' HD22 ' A' ' 87' ' ' LEU . 0.3 OUTLIER -94.89 -4.38 47.02 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.755 0.312 . . . . 0.0 110.591 179.441 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.16 -27.95 68.77 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.424 -178.02 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -65.15 -24.27 70.31 Favored Glycine 0 CA--C 1.519 0.309 0 C-N-CA 120.785 -0.721 . . . . 0.0 112.356 178.253 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 95.1 mt -86.14 -42.66 13.68 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 111.352 0.13 . . . . 0.0 111.352 -176.219 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.844 HG13 HD21 ' A' ' 87' ' ' LEU . 2.7 m -65.19 -34.46 70.71 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.19 0 CA-C-O 120.928 0.394 . . . . 0.0 110.857 178.605 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 66.4 mt -79.89 -45.71 22.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-O 121.469 0.652 . . . . 0.0 109.689 176.241 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.495 ' HA3' ' H ' ' A' ' 39' ' ' THR . . . 96.64 60.07 1.0 Allowed Glycine 0 N--CA 1.444 -0.773 0 CA-C-N 115.719 -0.673 . . . . 0.0 113.123 175.514 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.446 ' N ' ' HD3' ' A' ' 35' ' ' LYS . 0.0 OUTLIER 55.32 24.69 6.73 Favored 'General case' 0 N--CA 1.467 0.386 0 C-N-CA 122.949 0.5 . . . . 0.0 112.09 175.093 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 145.36 -52.18 0.59 Allowed Glycine 0 N--CA 1.449 -0.465 0 N-CA-C 111.58 -0.608 . . . . 0.0 111.58 -179.459 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.418 ' O ' ' HB2' ' A' ' 41' ' ' LYS . . . 165.02 24.23 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.429 -0.891 . . . . 0.0 113.694 176.462 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.616 ' O ' ' HG2' ' A' ' 42' ' ' GLN . 40.5 mm-40 -85.03 -43.51 13.88 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 117.344 0.572 . . . . 0.0 110.954 -179.23 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.717 ' O ' ' HG ' ' A' ' 43' ' ' LEU . 82.2 m -66.51 -53.9 29.83 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.488 -176.865 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.558 HD12 HD23 ' A' ' 53' ' ' LEU . 7.1 tt -56.15 -31.85 32.82 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.419 0 CA-C-O 121.56 0.695 . . . . 0.0 110.472 179.029 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.48 ' HB3' ' O ' ' A' ' 38' ' ' GLU . 83.5 tttt -62.47 -43.26 99.25 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.003 -0.999 . . . . 0.0 110.569 177.687 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.616 ' HG2' ' O ' ' A' ' 38' ' ' GLU . 61.5 mm-40 -72.66 -43.71 62.82 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.962 -177.84 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.717 ' HG ' ' O ' ' A' ' 39' ' ' THR . 37.5 mt -54.87 -49.77 70.32 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.494 -0.775 . . . . 0.0 111.863 -172.913 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 43.8 mt-30 -59.46 -38.44 80.77 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.835 -0.62 . . . . 0.0 111.222 -177.6 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 9.1 mm-40 -76.74 -42.48 40.99 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.382 -176.67 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 0.432 ' HG2' ' O ' ' A' ' 42' ' ' GLN . 16.2 ptp180 -74.35 -33.73 63.2 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 112.05 0.389 . . . . 0.0 112.05 -174.677 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.536 ' HB3' HG22 ' A' ' 49' ' ' VAL . . . -89.94 -21.1 22.62 Favored 'General case' 0 C--N 1.325 -0.492 0 C-N-CA 120.756 -0.378 . . . . 0.0 111.524 -177.936 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 76.83 28.41 59.03 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.809 -0.71 . . . . 0.0 111.537 -177.733 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.536 HG22 ' HB3' ' A' ' 47' ' ' ALA . 35.9 m -121.49 168.63 13.74 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-O 120.973 0.416 . . . . 0.0 110.654 -176.947 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.655 ' HB3' ' HB ' ' A' ' 70' ' ' ILE . 50.7 tptt -101.04 122.56 43.77 Favored 'General case' 0 C--N 1.318 -0.804 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 171.994 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . 0.545 ' HE3' HG11 ' A' ' 83' ' ' VAL . 77.3 mtp -118.74 114.9 23.4 Favored 'General case' 0 C--N 1.316 -0.869 0 N-CA-C 109.751 -0.462 . . . . 0.0 109.751 177.422 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.565 ' CG2' ' HB2' ' A' ' 68' ' ' ARG . 10.2 tt -106.22 108.47 25.17 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.841 0 CA-C-O 121.376 0.608 . . . . 0.0 109.901 176.84 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.558 HD23 HD12 ' A' ' 40' ' ' ILE . 2.8 mm? -82.24 102.77 11.37 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.669 -0.696 . . . . 0.0 109.278 177.124 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.523 HD12 ' HB2' ' A' ' 66' ' ' PRO . 68.8 mt -82.25 98.14 4.42 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.407 0 CA-C-O 121.514 0.673 . . . . 0.0 109.664 -179.817 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 59.7 mt-30 -94.46 -40.91 9.65 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.216 -0.902 . . . . 0.0 110.774 -173.09 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -125.28 0.14 7.72 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.11 -176.101 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -90.19 34.1 4.25 Favored Glycine 0 CA--C 1.519 0.313 0 C-N-CA 120.637 -0.792 . . . . 0.0 112.659 -178.254 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 27.6 t -167.7 156.12 9.28 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 109.368 -0.604 . . . . 0.0 109.368 -178.275 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . 0.423 HE21 ' HB3' ' A' ' 59' ' ' GLN . 17.2 mt-30 -99.23 -3.27 34.64 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.866 0.365 . . . . 0.0 110.508 -179.126 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 16.4 m120 -86.21 11.98 10.83 Favored 'General case' 0 CA--C 1.516 -0.347 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 171.181 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 14.7 t -64.64 -20.47 66.3 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.495 -0.775 . . . . 0.0 110.249 177.358 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 17.2 m120 -71.74 -19.41 62.04 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.822 179.071 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.545 HG23 ' H ' ' A' ' 64' ' ' ASP . 0.2 OUTLIER -112.3 -62.32 2.24 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.56 0 CA-C-O 121.277 0.56 . . . . 0.0 111.802 -179.568 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.545 ' H ' HG23 ' A' ' 63' ' ' VAL . 41.1 m-20 -134.39 -169.47 2.34 Favored 'General case' 0 C--N 1.308 -1.203 0 CA-C-N 114.892 -1.049 . . . . 0.0 109.737 -172.776 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.672 ' HB2' ' HB ' ' A' ' 24' ' ' ILE . 59.5 mmtt -137.27 114.35 9.74 Favored Pre-proline 0 C--N 1.315 -0.904 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.568 -173.971 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.523 ' HB2' HD12 ' A' ' 54' ' ' ILE . 48.4 Cg_exo -58.87 116.84 3.54 Favored 'Trans proline' 0 N--CA 1.463 -0.271 0 C-N-CA 123.141 2.56 . . . . 0.0 111.89 175.693 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.547 ' O ' ' HA ' ' A' ' 21' ' ' GLU . 43.2 tp -120.47 114.49 21.86 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.089 179.839 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.647 ' HG2' ' HG2' ' A' ' 21' ' ' GLU . 92.9 mtt180 -102.4 107.19 18.1 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 120.843 0.354 . . . . 0.0 110.551 177.79 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.63 ' HB ' HG13 ' A' ' 76' ' ' VAL . 3.9 mp -90.02 104.73 15.47 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 173.489 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.655 ' HB ' ' HB3' ' A' ' 50' ' ' LYS . 3.0 mt -99.03 123.48 51.69 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.767 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.405 -175.529 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . 0.644 ' HA2' ' HB3' ' A' ' 16' ' ' ASN . . . 175.15 -114.36 0.49 Allowed Glycine 0 N--CA 1.443 -0.839 0 C-N-CA 121.072 -0.585 . . . . 0.0 112.568 179.841 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . 0.796 ' HB2' ' HA ' ' A' ' 7' ' ' PHE . 6.2 t70 -134.7 147.2 62.12 Favored Pre-proline 0 C--N 1.322 -0.593 0 N-CA-C 108.453 -0.943 . . . . 0.0 108.453 -177.219 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . 0.602 ' HD3' ' OG1' ' A' ' 18' ' ' THR . 87.4 Cg_exo -44.7 -36.01 9.97 Favored 'Trans proline' 0 C--N 1.352 0.724 0 C-N-CA 122.37 2.047 . . . . 0.0 112.339 -176.586 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 94.8 t80 -64.21 -62.77 1.41 Allowed 'General case' 0 N--CA 1.448 -0.547 0 CA-C-N 115.296 -0.865 . . . . 0.0 111.108 179.629 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 34.9 pttt -74.45 -30.17 61.76 Favored 'General case' 0 C--O 1.223 -0.31 0 N-CA-C 112.036 0.384 . . . . 0.0 112.036 -175.914 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.63 HG13 ' HB ' ' A' ' 69' ' ' ILE . 70.0 t -62.88 -38.22 81.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 N-CA-C 109.928 -0.397 . . . . 0.0 109.928 177.539 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . 0.415 ' O ' ' HG2' ' A' ' 81' ' ' GLU . 2.6 mm100 -79.1 -38.12 37.02 Favored 'General case' 0 N--CA 1.451 -0.42 0 C-N-CA 120.733 -0.387 . . . . 0.0 111.366 178.876 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 90.9 mt-30 -62.82 -40.92 98.87 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.971 0.415 . . . . 0.0 110.203 176.447 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -67.96 -37.46 81.59 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.458 177.224 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 43.9 t -65.01 -51.62 60.62 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.302 178.415 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . 0.415 ' HG2' ' O ' ' A' ' 77' ' ' GLN . 14.0 pt-20 -66.01 -27.18 67.92 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.02 0.438 . . . . 0.0 109.986 179.6 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 82' ' ' MET . . . . . 0.406 ' O ' HG13 ' A' ' 86' ' ' ILE . 49.5 ttp -67.01 -50.47 62.07 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.801 177.261 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.7 ' O ' ' HG ' ' A' ' 87' ' ' LEU . 33.4 m -76.27 -35.15 27.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 C-N-CA 120.909 -0.316 . . . . 0.0 110.73 -177.235 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 22.0 ttt -63.78 -34.7 78.49 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 109.627 -0.508 . . . . 0.0 109.627 177.58 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . 0.404 ' O ' ' HB2' ' A' ' 89' ' ' GLU . 2.7 t70 -59.73 -48.33 82.1 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.254 -0.885 . . . . 0.0 110.618 174.931 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.406 HG13 ' O ' ' A' ' 82' ' ' MET . 57.3 mt -61.73 -38.89 81.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.726 -179.426 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.844 HD21 HG13 ' A' ' 32' ' ' VAL . 52.8 mt -68.11 -43.94 77.28 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.87 -0.604 . . . . 0.0 111.371 -177.341 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 2.8 ptm180 -87.57 4.06 45.16 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.862 0.363 . . . . 0.0 111.043 -175.987 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . 0.404 ' HB2' ' O ' ' A' ' 85' ' ' ASP . 7.9 tp10 . . . . . 0 C--O 1.25 1.097 0 CA-C-O 118.466 -0.778 . . . . 0.0 109.457 179.604 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.445 -0.709 0 N-CA-C 111.498 -0.641 . . . . 0.0 111.498 . . . . . . . . . 0 0 . 1 . 024 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . 0.519 ' HB3' ' HB2' ' A' ' 9' ' ' ASP . 10.5 mm-40 -94.91 42.34 1.09 Allowed 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 120.986 0.422 . . . . 0.0 110.332 -176.606 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . 0.553 ' HA ' ' CG ' ' A' ' 72' ' ' ASP . 26.8 p90 -74.28 25.76 0.08 Allowed 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 115.636 -0.711 . . . . 0.0 111.945 -175.935 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . 0.532 ' HA ' ' HB3' ' A' ' 12' ' ' ASN . 19.7 t-80 -171.89 36.09 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 109.349 -0.611 . . . . 0.0 109.349 177.204 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . 0.519 ' HB2' ' HB3' ' A' ' 6' ' ' GLN . 27.4 t70 -73.56 91.65 1.85 Allowed 'General case' 0 C--O 1.236 0.375 0 CA-C-N 115.952 -0.567 . . . . 0.0 109.984 179.233 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 57.0 t30 70.51 -58.71 0.55 Allowed 'General case' 0 N--CA 1.468 0.461 0 O-C-N 124.117 0.886 . . . . 0.0 110.603 -176.283 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -98.15 -157.09 0.57 Allowed 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.477 178.362 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . 0.605 ' HA ' ' O ' ' A' ' 15' ' ' GLN . 2.3 t-20 68.89 -168.44 0.18 Allowed 'General case' 0 C--O 1.236 0.36 0 O-C-N 123.559 0.537 . . . . 0.0 110.678 178.559 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 78.1 -78.56 1.55 Allowed Glycine 0 N--CA 1.449 -0.497 0 N-CA-C 111.27 -0.732 . . . . 0.0 111.27 -175.061 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -77.31 -62.07 2.51 Favored Glycine 0 N--CA 1.447 -0.575 0 N-CA-C 110.984 -0.846 . . . . 0.0 110.984 174.385 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . 0.605 ' O ' ' HA ' ' A' ' 12' ' ' ASN . 52.3 tp60 -94.17 106.77 18.74 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 174.984 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . 0.717 ' HB3' ' HA2' ' A' ' 71' ' ' GLY . 31.3 m-80 -94.23 93.68 7.89 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.761 -0.654 . . . . 0.0 109.754 -177.483 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -90.08 48.01 3.18 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.963 -0.636 . . . . 0.0 113.785 -172.474 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.63 ' OG1' ' HD3' ' A' ' 73' ' ' PRO . 96.7 m -145.68 126.38 14.3 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 109.647 -0.501 . . . . 0.0 109.647 172.568 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 92.2 t -138.49 125.8 27.5 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.791 -176.246 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 45.6 mt-30 -113.42 116.07 29.05 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.453 -0.34 . . . . 0.0 110.129 172.992 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.616 ' HA ' ' O ' ' A' ' 67' ' ' LEU . 57.9 mt-10 -86.78 113.91 23.01 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.141 179.428 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 18.6 mm -97.51 151.43 4.29 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-N 115.518 -0.765 . . . . 0.0 108.986 176.527 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 23' ' ' MET . . . . . 0.492 ' HB3' ' HB3' ' A' ' 64' ' ' ASP . 73.7 mmm -104.85 99.2 8.85 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 108.752 -0.832 . . . . 0.0 108.752 176.64 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.665 HD12 HD11 ' A' ' 87' ' ' LEU . 22.9 mm -83.32 123.8 76.63 Favored Pre-proline 0 C--N 1.32 -0.68 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.471 -172.601 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_exo -52.82 130.36 37.07 Favored 'Trans proline' 0 N--CA 1.463 -0.273 0 C-N-CA 122.708 2.272 . . . . 0.0 111.495 176.408 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -57.31 -37.19 72.1 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.681 -0.69 . . . . 0.0 112.435 -173.403 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -80.59 -32.81 32.74 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.536 -0.84 . . . . 0.0 112.316 179.542 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.45 ' HE2' ' O ' ' A' ' 87' ' ' LEU . 49.7 tptt -83.58 -7.27 59.55 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.152 0.501 . . . . 0.0 110.005 -177.544 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.54 ' O ' HG12 ' A' ' 32' ' ' VAL . . . -62.15 -19.29 62.91 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.567 -0.742 . . . . 0.0 111.789 -177.756 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -58.46 -37.01 87.06 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.586 -0.816 . . . . 0.0 111.901 176.757 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 70.0 mt -83.03 -28.92 29.27 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 111.667 0.247 . . . . 0.0 111.667 -178.431 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.54 HG12 ' O ' ' A' ' 29' ' ' ALA . 0.4 OUTLIER -69.37 -28.41 38.21 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.395 0 CA-C-O 121.253 0.549 . . . . 0.0 110.235 178.4 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.558 HG22 ' HA2' ' A' ' 37' ' ' GLY . 69.9 mt -86.18 -48.21 16.0 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.366 0 CA-C-N 115.679 -0.691 . . . . 0.0 109.467 174.871 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 135.77 170.6 12.11 Favored Glycine 0 N--CA 1.439 -1.155 0 C-N-CA 120.277 -0.963 . . . . 0.0 112.99 174.015 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.489 ' H ' ' HE3' ' A' ' 35' ' ' LYS . 0.0 OUTLIER -68.2 -27.2 66.18 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.164 0.506 . . . . 0.0 109.785 179.475 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -141.92 25.75 2.38 Favored Glycine 0 N--CA 1.447 -0.596 0 N-CA-C 111.158 -0.777 . . . . 0.0 111.158 174.472 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.558 ' HA2' HG22 ' A' ' 33' ' ' ILE . . . 77.24 2.83 80.42 Favored Glycine 0 CA--C 1.519 0.302 0 C-N-CA 121.039 -0.601 . . . . 0.0 112.26 -176.559 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.442 ' HB2' HE21 ' A' ' 42' ' ' GLN . 0.0 OUTLIER -85.75 -28.75 24.38 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 111.759 0.281 . . . . 0.0 111.759 -177.961 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.723 ' O ' ' HG ' ' A' ' 43' ' ' LEU . 29.5 m -58.76 -47.32 85.09 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.478 -0.328 . . . . 0.0 111.825 -175.935 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.578 ' HA ' HD12 ' A' ' 43' ' ' LEU . 6.3 tt -58.53 -33.02 47.16 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.279 0 CA-C-O 121.075 0.464 . . . . 0.0 111.251 179.4 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 86.8 tttt -71.78 -37.3 70.48 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.168 0.508 . . . . 0.0 109.88 177.868 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.691 ' O ' ' HG2' ' A' ' 46' ' ' ARG . 62.3 mt-30 -67.59 -42.03 83.13 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.485 -0.78 . . . . 0.0 110.429 179.999 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.723 ' HG ' ' O ' ' A' ' 39' ' ' THR . 58.6 mt -54.5 -41.0 69.1 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.604 -0.726 . . . . 0.0 111.247 -179.506 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 48.1 mt-30 -66.1 -39.51 90.03 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.514 -0.767 . . . . 0.0 110.807 179.605 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 11.6 mm-40 -67.92 -39.02 83.61 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.601 177.774 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 0.897 ' HA ' ' HE ' ' A' ' 46' ' ' ARG . 0.0 OUTLIER -62.99 -44.82 94.96 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.731 -174.717 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -106.11 -0.54 24.65 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 112.603 0.594 . . . . 0.0 112.603 -171.857 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 65.03 40.6 97.18 Favored Glycine 0 C--N 1.33 0.206 0 C-N-CA 120.63 -0.795 . . . . 0.0 111.656 -177.396 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 23.8 m -126.35 179.38 3.43 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-N 115.446 -0.377 . . . . 0.0 110.413 -175.649 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 87.1 tttt -125.94 126.93 45.17 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 109.558 -0.534 . . . . 0.0 109.558 172.715 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . 0.556 ' HE2' ' HB1' ' A' ' 79' ' ' ALA . 61.7 mtt -113.79 115.34 27.62 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 109.691 -0.485 . . . . 0.0 109.691 178.581 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.618 ' CG2' ' HB2' ' A' ' 68' ' ' ARG . 10.0 tt -99.59 109.41 24.53 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.752 0 CA-C-O 121.536 0.684 . . . . 0.0 109.646 176.64 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.918 HD22 HD13 ' A' ' 67' ' ' LEU . 0.5 OUTLIER -86.04 102.76 14.11 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.583 -0.735 . . . . 0.0 109.677 179.573 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.739 HD12 ' HB2' ' A' ' 66' ' ' PRO . 67.9 mt -75.13 85.67 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.335 0 CA-C-O 122.019 0.914 . . . . 0.0 108.984 175.837 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . 0.624 HE21 ' HB3' ' A' ' 53' ' ' LEU . 11.5 pt20 -115.27 -19.84 10.6 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 114.477 -1.238 . . . . 0.0 109.62 179.917 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -95.16 -27.5 15.52 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.209 -0.905 . . . . 0.0 109.926 176.518 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -64.02 105.27 1.05 Allowed Glycine 0 C--N 1.335 0.528 0 N-CA-C 110.953 -0.859 . . . . 0.0 110.953 175.393 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . 0.41 ' HA ' HG23 ' A' ' 61' ' ' THR . 14.5 m -80.44 64.28 5.19 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 121.436 0.636 . . . . 0.0 112.561 -169.674 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 14.7 mm100 -120.78 -48.38 2.27 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 170.995 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.49 ' HB3' ' O ' ' A' ' 64' ' ' ASP . 15.5 m120 -117.61 29.85 7.62 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.102 -0.953 . . . . 0.0 110.006 179.108 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . 0.505 ' O ' ' HE2' ' A' ' 65' ' ' LYS . 0.6 OUTLIER -62.7 -36.59 83.45 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.911 -0.586 . . . . 0.0 112.53 -175.423 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 28.9 p-10 -102.1 11.16 38.79 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 111.784 0.29 . . . . 0.0 111.784 -177.073 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 16.3 m -135.39 -156.72 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 116.589 -0.278 . . . . 0.0 110.347 -179.921 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.492 ' HB3' ' HB3' ' A' ' 23' ' ' MET . 4.8 m-20 -57.79 134.79 56.58 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 110.046 -0.353 . . . . 0.0 110.046 177.21 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.66 ' HB2' ' HB ' ' A' ' 24' ' ' ILE . 30.9 mmtp -90.8 132.76 33.86 Favored Pre-proline 0 C--N 1.323 -0.576 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.071 -172.32 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.739 ' HB2' HD12 ' A' ' 54' ' ' ILE . 13.5 Cg_exo -72.14 105.78 1.91 Allowed 'Trans proline' 0 N--CA 1.461 -0.395 0 C-N-CA 122.917 2.412 . . . . 0.0 111.491 173.954 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.918 HD13 HD22 ' A' ' 53' ' ' LEU . 23.8 tp -109.22 115.76 30.62 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.42 -0.355 . . . . 0.0 110.526 179.603 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.618 ' HB2' ' CG2' ' A' ' 52' ' ' ILE . 95.6 mtt180 -99.81 108.22 20.46 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.885 176.484 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.474 HG21 ' HB3' ' A' ' 79' ' ' ALA . 4.6 mp -86.97 104.92 14.54 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.587 0 N-CA-C 108.164 -1.05 . . . . 0.0 108.164 170.915 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 21.0 mt -97.05 126.22 49.87 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.615 -175.182 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . 0.717 ' HA2' ' HB3' ' A' ' 16' ' ' ASN . . . 172.95 -117.21 0.64 Allowed Glycine 0 N--CA 1.447 -0.58 0 C-N-CA 120.758 -0.734 . . . . 0.0 113.027 178.367 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . 0.553 ' CG ' ' HA ' ' A' ' 7' ' ' PHE . 8.7 t70 -131.45 146.73 63.23 Favored Pre-proline 0 C--N 1.324 -0.536 0 CA-C-O 118.301 -0.857 . . . . 0.0 108.764 -177.147 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . 0.63 ' HD3' ' OG1' ' A' ' 18' ' ' THR . 88.0 Cg_exo -40.95 -40.59 3.78 Favored 'Trans proline' 0 C--N 1.351 0.7 0 C-N-CA 122.943 2.429 . . . . 0.0 112.894 -177.495 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 90.1 t80 -65.28 -62.59 1.44 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.735 -0.666 . . . . 0.0 111.136 -179.269 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.467 ' HG2' ' HB3' ' A' ' 72' ' ' ASP . 40.8 pttt -70.44 -31.22 68.3 Favored 'General case' 0 C--O 1.219 -0.541 0 C-N-CA 120.911 -0.316 . . . . 0.0 111.843 -175.865 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.404 HG13 ' HB ' ' A' ' 69' ' ' ILE . 79.7 t -66.14 -40.72 87.84 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 C-N-CA 120.833 -0.347 . . . . 0.0 110.166 179.365 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . 0.413 ' O ' ' HG3' ' A' ' 81' ' ' GLU . 0.1 OUTLIER -73.38 -40.84 64.04 Favored 'General case' 0 N--CA 1.45 -0.452 0 N-CA-C 109.531 -0.544 . . . . 0.0 109.531 -179.224 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 66.7 mt-30 -67.64 -32.36 73.01 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 120.735 -0.386 . . . . 0.0 110.672 178.177 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . 0.556 ' HB1' ' HE2' ' A' ' 51' ' ' MET . . . -72.61 -33.88 66.99 Favored 'General case' 0 N--CA 1.446 -0.648 0 CA-C-N 116.136 -0.484 . . . . 0.0 109.876 175.966 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 43.9 t -62.4 -48.58 79.07 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.848 -0.614 . . . . 0.0 109.695 172.669 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . 0.451 ' O ' ' HB2' ' A' ' 85' ' ' ASP . 53.6 mt-10 -56.56 -29.46 62.03 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-O 121.178 0.513 . . . . 0.0 110.794 176.376 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 82' ' ' MET . . . . . 0.447 ' HE1' ' HB2' ' A' ' 46' ' ' ARG . 39.3 ttm -74.41 -51.13 15.85 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.316 -0.857 . . . . 0.0 110.667 -178.086 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.648 ' O ' ' HG ' ' A' ' 87' ' ' LEU . 33.7 m -74.93 -38.22 42.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 120.674 0.273 . . . . 0.0 110.635 -176.082 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 84' ' ' MET . . . . . 0.462 ' O ' ' HG2' ' A' ' 88' ' ' ARG . 26.3 ttt -63.96 -34.44 77.99 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.026 179.735 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . 0.451 ' HB2' ' O ' ' A' ' 81' ' ' GLU . 14.3 t70 -63.53 -46.49 85.75 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.12 179.218 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.419 HG13 ' O ' ' A' ' 82' ' ' MET . 44.6 mt -64.78 -34.39 69.81 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.577 179.429 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.665 HD11 HD12 ' A' ' 24' ' ' ILE . 53.7 mt -76.76 -14.46 59.93 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.928 0.394 . . . . 0.0 110.981 -178.559 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . 0.462 ' HG2' ' O ' ' A' ' 84' ' ' MET . 14.3 mmm180 -109.47 8.55 25.31 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.192 0.52 . . . . 0.0 109.621 175.03 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 10.6 tp10 . . . . . 0 C--O 1.248 0.992 0 CA-C-N 115.197 -0.911 . . . . 0.0 109.267 -179.717 . . . . . . . . 0 0 . 1 . 025 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.598 0 N-CA-C 112.686 -0.166 . . . . 0.0 112.686 . . . . . . . . . 0 0 . 1 . 025 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 2.5 pt20 -111.44 84.72 1.99 Allowed 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 121.816 0.817 . . . . 0.0 109.497 175.029 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . 0.543 ' O ' ' HB3' ' A' ' 12' ' ' ASN . 42.1 m-85 -79.97 -172.38 3.38 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 114.891 -1.049 . . . . 0.0 110.616 -174.726 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . 0.784 ' HB3' ' HA2' ' A' ' 71' ' ' GLY . 6.8 t60 -160.07 31.26 0.18 Allowed 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.127 0.489 . . . . 0.0 109.874 174.399 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . 0.475 ' HA ' ' O ' ' A' ' 48' ' ' GLY . 5.5 p-10 -70.44 -41.26 73.11 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.12 178.022 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 64.6 t30 -132.21 53.1 2.03 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 174.756 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . 51.51 71.66 0.43 Allowed 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 115.007 -0.997 . . . . 0.0 111.632 -179.135 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . 0.543 ' HB3' ' O ' ' A' ' 7' ' ' PHE . 21.0 t-20 -79.8 99.92 7.72 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.865 0.364 . . . . 0.0 110.142 -176.081 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 78.61 -50.8 3.61 Favored Glycine 0 N--CA 1.453 -0.209 0 CA-C-N 116.112 -0.495 . . . . 0.0 112.149 -177.422 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 143.7 -27.65 2.06 Favored Glycine 0 N--CA 1.446 -0.653 0 N-CA-C 111.605 -0.598 . . . . 0.0 111.605 179.473 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -66.95 138.46 57.28 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.846 0.355 . . . . 0.0 111.14 -177.663 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 42.9 m-80 -99.94 109.11 21.48 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 109.241 -0.652 . . . . 0.0 109.241 170.31 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -80.22 -68.78 1.45 Allowed Glycine 0 N--CA 1.447 -0.592 0 C-N-CA 120.891 -0.671 . . . . 0.0 113.497 -174.31 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.534 ' OG1' ' HG3' ' A' ' 73' ' ' PRO . 93.3 m -107.62 130.49 54.89 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.214 0.53 . . . . 0.0 111.83 -174.28 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.606 ' HB ' HG23 ' A' ' 70' ' ' ILE . 2.6 p -134.77 121.0 33.21 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-N 115.347 -0.842 . . . . 0.0 109.753 175.724 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 6.0 tt0 -110.16 137.3 48.1 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 110.286 -0.264 . . . . 0.0 110.286 -177.97 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.646 ' HA ' ' O ' ' A' ' 67' ' ' LEU . 45.0 mt-10 -108.34 127.14 53.61 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.998 0.428 . . . . 0.0 111.389 -178.863 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.449 ' HB ' ' HB3' ' A' ' 67' ' ' LEU . 15.9 mm -115.46 153.91 16.95 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-N 115.945 -0.57 . . . . 0.0 109.898 179.651 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 23' ' ' MET . . . . . 0.47 ' HB3' ' HB3' ' A' ' 64' ' ' ASP . 1.6 mmt -104.97 105.09 14.99 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 109.036 -0.727 . . . . 0.0 109.036 173.371 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.692 ' HB ' ' HB2' ' A' ' 65' ' ' LYS . 36.8 mm -88.72 131.42 41.72 Favored Pre-proline 0 C--N 1.322 -0.628 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.029 -175.762 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.685 ' HD2' HD13 ' A' ' 87' ' ' LEU . 91.8 Cg_exo -44.41 137.03 8.33 Favored 'Trans proline' 0 C--N 1.348 0.55 0 C-N-CA 123.57 2.847 . . . . 0.0 113.184 177.457 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -66.52 -27.84 68.08 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.481 -0.782 . . . . 0.0 112.694 -172.489 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -103.48 -26.57 6.82 Favored Glycine 0 N--CA 1.447 -0.598 0 C-N-CA 120.387 -0.911 . . . . 0.0 112.33 -179.147 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.523 ' HB3' ' HB2' ' A' ' 25' ' ' PRO . 15.3 ttpt -94.67 13.26 24.92 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.472 0.654 . . . . 0.0 110.642 -177.488 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.506 ' O ' HG12 ' A' ' 32' ' ' VAL . . . -63.65 -31.07 72.12 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.857 -0.611 . . . . 0.0 110.882 178.181 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -57.06 -26.99 56.74 Favored Glycine 0 CA--C 1.519 0.29 0 CA-C-N 116.173 -0.467 . . . . 0.0 113.211 179.862 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 68.0 mt -78.5 -36.64 44.78 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.913 0.357 . . . . 0.0 110.957 179.542 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.506 HG12 ' O ' ' A' ' 29' ' ' ALA . 0.3 OUTLIER -72.12 -29.92 34.25 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.341 0 CA-C-O 121.19 0.519 . . . . 0.0 110.182 178.343 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 68.1 mt -76.03 -37.39 33.54 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-O 121.925 0.869 . . . . 0.0 109.615 174.109 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.549 ' HA3' ' HB ' ' A' ' 39' ' ' THR . . . 98.14 45.38 2.41 Favored Glycine 0 N--CA 1.441 -0.974 0 CA-C-N 115.228 -0.896 . . . . 0.0 112.928 175.515 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 38.3 mtmt 51.72 47.01 25.63 Favored 'General case' 0 C--N 1.328 -0.326 0 O-C-N 124.143 0.555 . . . . 0.0 111.666 172.81 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 132.16 -28.2 3.52 Favored Glycine 0 N--CA 1.448 -0.562 0 C-N-CA 120.668 -0.777 . . . . 0.0 112.173 179.412 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 125.33 4.57 6.95 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.423 -0.894 . . . . 0.0 112.836 178.089 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 32.7 mt-10 -70.06 -48.75 56.54 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.132 0.491 . . . . 0.0 110.5 -179.993 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.729 ' O ' ' HG ' ' A' ' 43' ' ' LEU . 17.2 m -64.68 -46.04 84.09 Favored 'General case' 0 N--CA 1.45 -0.437 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.261 -177.433 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.628 ' HA ' HD12 ' A' ' 43' ' ' LEU . 8.1 tt -60.3 -35.65 63.69 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.47 0 CA-C-O 121.036 0.446 . . . . 0.0 110.901 179.977 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 54.8 tttm -61.57 -47.29 86.17 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.262 0.553 . . . . 0.0 109.983 175.515 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 16.4 mm-40 -72.39 -33.86 67.49 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.546 -0.752 . . . . 0.0 111.796 -176.561 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.729 ' HG ' ' O ' ' A' ' 39' ' ' THR . 95.0 mt -54.52 -48.07 72.36 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.046 0.45 . . . . 0.0 110.77 179.817 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 44.0 mt-30 -63.27 -46.21 87.86 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.385 -0.825 . . . . 0.0 110.696 -179.828 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -71.12 -36.69 72.23 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.855 -0.611 . . . . 0.0 112.123 -175.51 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 12.4 ptm180 -75.53 -33.08 60.69 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 111.734 0.272 . . . . 0.0 111.734 -175.317 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.439 ' HB3' HG22 ' A' ' 49' ' ' VAL . . . -96.54 -21.07 17.91 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.993 0.425 . . . . 0.0 111.352 -177.305 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . 0.475 ' O ' ' HA ' ' A' ' 9' ' ' ASP . . . 81.13 31.01 35.93 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.928 -0.653 . . . . 0.0 112.0 -178.161 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.439 HG22 ' HB3' ' A' ' 47' ' ' ALA . 28.6 m -122.92 167.49 16.47 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-O 120.834 0.35 . . . . 0.0 110.643 -176.332 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 60.2 tttp -103.38 123.23 46.44 Favored 'General case' 0 N--CA 1.444 -0.758 0 N-CA-C 108.96 -0.756 . . . . 0.0 108.96 172.242 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . 0.516 ' HE2' HD11 ' A' ' 67' ' ' LEU . 79.7 mtp -120.32 115.52 23.72 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 120.947 0.403 . . . . 0.0 109.989 179.414 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.566 ' CG2' ' HB2' ' A' ' 68' ' ' ARG . 11.2 tt -107.71 112.33 39.67 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.749 0 CA-C-O 121.478 0.656 . . . . 0.0 110.235 177.896 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.494 ' CD2' HD13 ' A' ' 67' ' ' LEU . 3.1 mm? -94.82 114.29 26.15 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.36 -0.836 . . . . 0.0 109.817 176.863 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.534 ' HB ' ' HD2' ' A' ' 66' ' ' PRO . 31.4 mm -75.36 87.78 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 177.311 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 15.8 mt-30 -99.9 -40.58 7.62 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.226 -0.897 . . . . 0.0 110.311 -174.803 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -111.69 2.05 17.03 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.209 -0.905 . . . . 0.0 110.572 -173.398 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -109.1 166.84 12.74 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.527 -0.844 . . . . 0.0 112.271 179.97 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 50.0 m 62.91 -171.89 0.17 Allowed 'General case' 0 C--O 1.235 0.299 0 CA-C-O 121.396 0.617 . . . . 0.0 111.28 178.993 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 12.8 mm100 -119.12 17.45 13.22 Favored 'General case' 0 N--CA 1.443 -0.793 0 CA-C-N 115.594 -0.73 . . . . 0.0 109.738 177.29 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.577 ' HA ' HG22 ' A' ' 63' ' ' VAL . 11.5 m120 -83.82 13.0 5.19 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 108.501 -0.926 . . . . 0.0 108.501 172.285 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 21.1 p -64.59 -17.66 64.18 Favored 'General case' 0 N--CA 1.444 -0.736 0 CA-C-N 114.721 -1.127 . . . . 0.0 110.869 177.014 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 28.7 p-10 -100.36 -4.4 29.19 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.199 177.137 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.577 HG22 ' HA ' ' A' ' 60' ' ' ASN . 24.1 m -133.72 -155.54 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-O 120.659 0.266 . . . . 0.0 111.157 -177.077 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.47 ' HB3' ' HB3' ' A' ' 23' ' ' MET . 5.2 m-20 -57.04 149.65 18.67 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.638 -0.71 . . . . 0.0 111.291 178.607 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.692 ' HB2' ' HB ' ' A' ' 24' ' ' ILE . 70.9 mmtt -101.5 127.1 32.33 Favored Pre-proline 0 C--N 1.324 -0.54 0 CA-C-N 115.804 -0.635 . . . . 0.0 111.056 -175.615 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.534 ' HD2' ' HB ' ' A' ' 54' ' ' ILE . 27.4 Cg_exo -65.41 111.68 1.91 Allowed 'Trans proline' 0 N--CA 1.463 -0.315 0 C-N-CA 123.009 2.472 . . . . 0.0 111.596 172.596 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.646 ' O ' ' HA ' ' A' ' 21' ' ' GLU . 14.3 tp -112.44 122.35 47.45 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 116.155 -0.475 . . . . 0.0 109.97 178.093 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.566 ' HB2' ' CG2' ' A' ' 52' ' ' ILE . 88.0 mtt180 -113.84 112.39 23.3 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 121.19 0.519 . . . . 0.0 111.192 177.727 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.405 ' O ' ' HA ' ' A' ' 19' ' ' VAL . 4.5 mp -94.16 105.13 16.54 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 172.449 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.606 HG23 ' HB ' ' A' ' 19' ' ' VAL . 4.0 mt -109.77 132.32 58.31 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 CA-C-N 116.385 -0.371 . . . . 0.0 110.907 -172.394 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . 0.784 ' HA2' ' HB3' ' A' ' 8' ' ' HIS . . . 152.52 -123.16 1.41 Allowed Glycine 0 N--CA 1.445 -0.747 0 C-N-CA 120.509 -0.853 . . . . 0.0 113.235 175.618 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . 0.616 ' OD2' ' HG2' ' A' ' 75' ' ' LYS . 0.5 OUTLIER -92.69 133.47 29.31 Favored Pre-proline 0 C--N 1.326 -0.447 0 C-N-CA 122.864 0.466 . . . . 0.0 110.948 -177.215 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . 0.534 ' HG3' ' OG1' ' A' ' 18' ' ' THR . 50.4 Cg_exo -49.43 -33.41 29.64 Favored 'Trans proline' 0 C--N 1.351 0.664 0 C-N-CA 124.267 3.311 . . . . 0.0 113.592 -176.236 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . 0.496 ' O ' ' HG3' ' A' ' 78' ' ' GLN . 19.1 t80 -72.71 -57.08 4.38 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.341 -178.27 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.616 ' HG2' ' OD2' ' A' ' 72' ' ' ASP . 4.6 ptpp? -72.5 -25.83 61.55 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 111.746 0.276 . . . . 0.0 111.746 -178.439 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.415 HG23 ' O ' ' A' ' 72' ' ' ASP . 26.4 t -55.94 -42.26 70.65 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 N-CA-C 109.925 -0.398 . . . . 0.0 109.925 171.424 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . 0.574 ' O ' ' HG2' ' A' ' 81' ' ' GLU . 2.3 mm100 -75.74 -44.28 42.59 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.056 178.789 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . 0.496 ' HG3' ' O ' ' A' ' 74' ' ' TYR . 53.6 mt-30 -52.87 -50.06 64.58 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.065 0.459 . . . . 0.0 110.419 177.697 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -67.43 -37.78 83.54 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.411 -0.813 . . . . 0.0 111.271 -178.315 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 42.7 t -62.55 -57.27 11.74 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.556 -178.9 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . 0.574 ' HG2' ' O ' ' A' ' 77' ' ' GLN . 10.4 pt-20 -67.68 -18.7 65.02 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.912 0.387 . . . . 0.0 110.645 -178.928 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 57.0 ttp -74.09 -50.99 17.11 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.584 174.804 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 31.8 m -76.52 -33.87 23.43 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.583 -0.281 . . . . 0.0 111.618 -176.4 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 83.5 mtp -68.37 -25.67 65.19 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 109.911 -0.403 . . . . 0.0 109.911 175.83 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -67.69 -36.25 80.32 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.655 176.364 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 56.7 mt -62.78 -35.49 71.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 121.488 0.661 . . . . 0.0 110.043 179.022 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.685 HD13 ' HD2' ' A' ' 25' ' ' PRO . 42.8 mt -88.09 -8.46 55.47 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.654 -179.381 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 21.5 tpt180 -101.76 -10.54 19.85 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.839 0.828 . . . . 0.0 109.818 -179.638 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 . . . . . 0 C--O 1.248 1.021 0 CA-C-N 114.685 -1.143 . . . . 0.0 109.779 -177.316 . . . . . . . . 0 0 . 1 stop_ save_